$RDFILE 1
$DATM 08/24/2025 11:37:00
$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL

C22H26ClN3O3
3075103-43-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 N 5.3900 6.6685 0.0 0
M  V30 5 N 8.4700 6.6685 0.0 0
M  V30 6 O 8.4700 4.0011 0.0 0
M  V30 7 C 3.8500 6.6685 0.0 0
M  V30 8 N 10.0100 6.6685 0.0 0
M  V30 9 C 7.7000 8.0021 0.0 0
M  V30 10 O 3.0800 8.0021 0.0 0
M  V30 11 O 3.0800 5.3347 0.0 0
M  V30 12 C 10.7800 8.0021 0.0 0
M  V30 13 C 1.5400 8.0021 0.0 0
M  V30 14 C 1.5400 9.5421 0.0 0
M  V30 15 C 0.0000 8.0021 0.0 0
M  V30 16 C 1.5400 6.4621 0.0 0
M  V30 17 Cl 16.9400 8.0021 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 7.7000 2.6674 0.0 0
M  V30 20 C 5.3900 1.3336 0.0 0
M  V30 21 C 8.4700 1.3336 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 23 C 7.7000 0.0000 0.0 0
M  V30 24 C 12.3200 8.0021 0.0 0
M  V30 25 C 13.0900 9.3358 0.0 0
M  V30 26 C 13.0900 6.6685 0.0 0
M  V30 27 C 14.6300 9.3358 0.0 0
M  V30 28 C 14.6300 6.6685 0.0 0
M  V30 29 C 15.4000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 29
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H37ClN4O4
3075103-94-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.0338 5.3348 0.0 0 CFG=1
M  V30 2 C 8.2638 4.0012 0.0 0
M  V30 3 N 8.2638 6.6685 0.0 0
M  V30 4 C 10.5739 5.3348 0.0 0
M  V30 5 C 6.7238 6.6685 0.0 0
M  V30 6 N 11.3439 6.6685 0.0 0
M  V30 7 O 11.3439 4.0012 0.0 0
M  V30 8 C 5.9538 8.0023 0.0 0 CFG=2
M  V30 9 O 5.9538 5.3348 0.0 0
M  V30 10 N 12.8839 6.6685 0.0 0
M  V30 11 C 10.5739 8.0023 0.0 0
M  V30 12 N 4.4137 8.0023 0.0 0
M  V30 13 C 6.7238 9.3360 0.0 0
M  V30 14 C 13.6539 8.0023 0.0 0
M  V30 15 C 3.6437 6.6685 0.0 0
M  V30 16 C 5.3901 10.1060 0.0 0
M  V30 17 C 7.4938 10.6697 0.0 0
M  V30 18 C 8.0575 8.5660 0.0 0
M  V30 19 O 2.1037 6.6685 0.0 0
M  V30 20 O 4.4137 5.3348 0.0 0
M  V30 21 C 1.3337 5.3348 0.0 0
M  V30 22 C 0.0000 6.1048 0.0 0
M  V30 23 C 0.5637 4.0012 0.0 0
M  V30 24 C 2.6673 4.5648 0.0 0
M  V30 25 Cl 19.8141 8.0023 0.0 0
M  V30 26 C 9.0338 2.6673 0.0 0
M  V30 27 C 8.2638 1.3337 0.0 0
M  V30 28 C 10.5739 2.6673 0.0 0
M  V30 29 C 9.0338 0.0000 0.0 0
M  V30 30 C 11.3439 1.3337 0.0 0
M  V30 31 C 10.5739 0.0000 0.0 0
M  V30 32 C 15.1940 8.0023 0.0 0
M  V30 33 C 15.9640 6.6685 0.0 0
M  V30 34 C 15.9640 9.3360 0.0 0
M  V30 35 C 17.5040 6.6685 0.0 0
M  V30 36 C 17.5040 9.3360 0.0 0
M  V30 37 C 18.2740 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 26
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 32
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 37
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 33 2 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 34 36
M  V30 37 2 35 37
M  V30 38 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075103-43-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075103-94-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
4-Thiomorpholineacetic acid, 1,1-dioxide
C6H11NO4S
155480-08-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 3.7570 0.0 0
M  V30 2 C 6.8513 2.9870 0.0 0
M  V30 3 O 6.8513 1.4470 0.0 0
M  V30 4 O 8.1851 3.7570 0.0 0
M  V30 5 O 0.0000 1.7145 0.0 0
M  V30 6 O 0.9899 0.0000 0.0 0
M  V30 7 N 4.1840 2.9870 0.0 0
M  V30 8 C 4.1840 1.4470 0.0 0
M  V30 9 C 2.8504 3.7570 0.0 0
M  V30 10 C 2.8504 0.6770 0.0 0
M  V30 11 C 1.5166 2.9870 0.0 0
M  V30 12 S 1.5166 1.4470 0.0 0 VAL=6
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 12
M  V30 6 2 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-hydroxy-N-(2-methylpropyl)benze...
C20H28N2O4S
157567-13-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 O 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Thiomorpholineacetamide, N-[(1S,2R)-2-hydroxy-3-[[(4-hydroxyphenyl)sulfonyl...
C26H37N3O7S2
2765293-50-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 12.1862 7.6070 0.0 0 VAL=6
M  V30 2 N 10.8524 8.3770 0.0 0
M  V30 3 O 11.4162 6.2733 0.0 0
M  V30 4 O 12.9562 8.9408 0.0 0
M  V30 5 C 9.5187 7.6070 0.0 0
M  V30 6 C 10.8524 9.9170 0.0 0
M  V30 7 C 8.1851 8.3770 0.0 0 CFG=1
M  V30 8 C 12.1862 10.6870 0.0 0
M  V30 9 C 6.8515 7.6070 0.0 0 CFG=1
M  V30 10 O 8.1851 9.9170 0.0 0
M  V30 11 C 12.1862 12.2270 0.0 0
M  V30 12 C 13.5198 9.9170 0.0 0
M  V30 13 C 5.5177 8.3770 0.0 0
M  V30 14 N 6.8515 6.0670 0.0 0
M  V30 15 C 5.5177 5.2970 0.0 0
M  V30 16 C 5.5177 3.7570 0.0 0
M  V30 17 O 4.1840 6.0670 0.0 0
M  V30 18 O 17.5209 4.5270 0.0 0
M  V30 19 O 0.9899 0.0000 0.0 0
M  V30 20 O 0.0000 1.7145 0.0 0
M  V30 21 C 13.5198 6.8370 0.0 0
M  V30 22 C 14.8535 7.6070 0.0 0
M  V30 23 C 13.5198 5.2970 0.0 0
M  V30 24 C 16.1871 6.8370 0.0 0
M  V30 25 C 14.8535 4.5270 0.0 0
M  V30 26 C 16.1871 5.2970 0.0 0
M  V30 27 C 5.5177 9.9170 0.0 0
M  V30 28 C 6.8515 10.6870 0.0 0
M  V30 29 C 4.1840 10.6870 0.0 0
M  V30 30 C 6.8515 12.2270 0.0 0
M  V30 31 C 4.1840 12.2270 0.0 0
M  V30 32 C 5.5177 12.9970 0.0 0
M  V30 33 N 4.1840 2.9870 0.0 0
M  V30 34 C 2.8504 3.7570 0.0 0
M  V30 35 C 4.1840 1.4470 0.0 0
M  V30 36 C 1.5167 2.9870 0.0 0
M  V30 37 C 2.8504 0.6770 0.0 0
M  V30 38 S 1.5167 1.4470 0.0 0 VAL=6
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 21
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=1
M  V30 14 1 9 14
M  V30 15 1 13 27
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 33
M  V30 20 1 18 26
M  V30 21 2 19 38
M  V30 22 2 20 38
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 1 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 155480-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 157567-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL

C23H40N2O7
3032888-49-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 2 C 6.6687 9.2402 0.0 0
M  V30 3 C 8.0023 6.9302 0.0 0
M  V30 4 N 5.3348 6.9302 0.0 0
M  V30 5 N 8.0023 5.3901 0.0 0
M  V30 6 O 9.3360 7.7002 0.0 0
M  V30 7 C 4.0012 7.7002 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0 CFG=1
M  V30 9 O 2.6675 6.9302 0.0 0
M  V30 10 O 4.0012 9.2402 0.0 0
M  V30 11 C 10.6697 5.3901 0.0 0
M  V30 12 C 9.3360 3.0801 0.0 0
M  V30 13 C 1.3338 7.7002 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 O 8.0023 2.3101 0.0 0
M  V30 16 O 10.6697 2.3101 0.0 0
M  V30 17 C 2.1038 9.0338 0.0 0
M  V30 18 C 0.0000 8.4702 0.0 0
M  V30 19 C 0.5638 6.3665 0.0 0
M  V30 20 C 13.3372 5.3901 0.0 0
M  V30 21 C 8.0023 0.7700 0.0 0
M  V30 22 O 14.6708 4.6201 0.0 0
M  V30 23 O 13.3372 6.9302 0.0 0
M  V30 24 C 6.6687 0.0000 0.0 0
M  V30 25 C 16.0045 5.3901 0.0 0
M  V30 26 C 17.3383 4.6201 0.0 0
M  V30 27 C 8.0023 10.0102 0.0 0
M  V30 28 C 8.0023 11.5503 0.0 0
M  V30 29 C 9.3360 9.2402 0.0 0
M  V30 30 C 9.3360 12.3203 0.0 0
M  V30 31 C 10.6697 10.0102 0.0 0
M  V30 32 C 10.6697 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 25 26
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H43N3O8
3032888-64-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 7.7002 0.0 0 CFG=2
M  V30 2 C 10.6697 9.2402 0.0 0
M  V30 3 C 9.3360 6.9302 0.0 0
M  V30 4 N 12.0033 6.9302 0.0 0
M  V30 5 N 9.3360 5.3901 0.0 0
M  V30 6 O 8.0022 7.7002 0.0 0
M  V30 7 C 13.3370 7.7002 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0 CFG=1
M  V30 9 C 14.6708 6.9302 0.0 0
M  V30 10 O 13.3370 9.2402 0.0 0
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 N 16.0045 7.7002 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 O 9.3360 2.3101 0.0 0
M  V30 16 O 6.6685 2.3101 0.0 0
M  V30 17 C 17.3382 6.9302 0.0 0
M  V30 18 C 4.0012 5.3901 0.0 0
M  V30 19 C 9.3360 0.7700 0.0 0
M  V30 20 O 18.6720 7.7002 0.0 0
M  V30 21 O 17.3382 5.3901 0.0 0
M  V30 22 O 2.6673 4.6201 0.0 0
M  V30 23 O 4.0012 6.9302 0.0 0
M  V30 24 C 10.6697 0.0000 0.0 0
M  V30 25 C 20.0057 6.9302 0.0 0
M  V30 26 C 1.3337 5.3901 0.0 0
M  V30 27 C 19.2356 5.5965 0.0 0
M  V30 28 C 21.3393 6.1601 0.0 0
M  V30 29 C 20.7757 8.2638 0.0 0
M  V30 30 C 0.0000 4.6201 0.0 0
M  V30 31 C 9.3360 10.0102 0.0 0
M  V30 32 C 8.0022 9.2402 0.0 0
M  V30 33 C 9.3360 11.5503 0.0 0
M  V30 34 C 6.6685 10.0102 0.0 0
M  V30 35 C 8.0022 12.3203 0.0 0
M  V30 36 C 6.6685 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 31
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 22 26
M  V30 27 1 25 27
M  V30 28 1 25 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 31 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032888-49-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032888-64-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40893413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar
Potency
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guzelj, Samo; Bizjak, Spela; Jakopin, Ziga
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N5-[(phenylmethoxy)carbonyl]-L-ornithine
C18H26N2O6
2480-93-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.6536 8.0021 0.0 0
M  V30 2 O 12.8836 6.6684 0.0 0
M  V30 3 C 11.3436 6.6684 0.0 0
M  V30 4 N 10.5736 5.3347 0.0 0
M  V30 5 O 10.5736 8.0021 0.0 0
M  V30 6 C 9.0336 5.3347 0.0 0
M  V30 7 C 8.2636 4.0011 0.0 0
M  V30 8 C 6.7236 4.0011 0.0 0
M  V30 9 C 5.9536 2.6674 0.0 0 CFG=1
M  V30 10 N 4.4136 2.6674 0.0 0
M  V30 11 C 6.7236 1.3336 0.0 0
M  V30 12 C 3.6436 4.0011 0.0 0
M  V30 13 O 5.9536 0.0000 0.0 0
M  V30 14 O 8.2636 1.3336 0.0 0
M  V30 15 O 2.1036 4.0011 0.0 0
M  V30 16 O 4.4136 5.3347 0.0 0
M  V30 17 C 1.3336 5.3347 0.0 0
M  V30 18 C 2.6673 6.1047 0.0 0
M  V30 19 C 0.5636 6.6684 0.0 0
M  V30 20 C 0.0000 4.5647 0.0 0
M  V30 21 C 15.1936 8.0021 0.0 0
M  V30 22 C 15.9636 9.3358 0.0 0
M  V30 23 C 15.9636 6.6684 0.0 0
M  V30 24 C 17.5036 9.3358 0.0 0
M  V30 25 C 17.5036 6.6684 0.0 0
M  V30 26 C 18.2736 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Ornithine, N5-[(phenylmethoxy)carbonyl]-, methyl ester, hydrochloride (1:1)
C14H20N2O4.ClH
5874-75-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 5.3348 3.8500 0.0 0
M  V30 3 C 6.6686 4.6200 0.0 0
M  V30 4 N 8.0022 3.8500 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 C 9.3359 4.6200 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0
M  V30 8 C 12.0034 4.6200 0.0 0
M  V30 9 C 13.3370 3.8500 0.0 0 CFG=2
M  V30 10 C 14.6707 4.6200 0.0 0
M  V30 11 N 13.3370 2.3100 0.0 0
M  V30 12 O 16.0043 3.8500 0.0 0
M  V30 13 O 14.6707 6.1601 0.0 0
M  V30 14 C 17.3381 4.6200 0.0 0
M  V30 15 C 2.6675 3.8500 0.0 0
M  V30 16 C 1.3338 4.6200 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 19 C 1.3338 1.5400 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 Cl 8.6691 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Ornithine, N2-[N2-[(1,1-dimethylethoxy)carbonyl]-N5-[(phenylmethoxy)carbony...
C32H44N4O9
19792-09-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 11.5501 0.0 0 CFG=2
M  V30 2 C 8.0021 12.3201 0.0 0
M  V30 3 N 5.3348 12.3201 0.0 0
M  V30 4 C 6.6684 10.0101 0.0 0
M  V30 5 N 8.0021 13.8602 0.0 0
M  V30 6 O 9.3359 11.5501 0.0 0
M  V30 7 C 4.0011 11.5501 0.0 0
M  V30 8 C 8.0021 9.2401 0.0 0
M  V30 9 C 9.3359 14.6302 0.0 0 CFG=2
M  V30 10 O 2.6673 12.3201 0.0 0
M  V30 11 O 4.0011 10.0101 0.0 0
M  V30 12 C 8.0021 7.7001 0.0 0
M  V30 13 C 10.6695 13.8602 0.0 0
M  V30 14 C 9.3359 16.1702 0.0 0
M  V30 15 C 1.3337 11.5501 0.0 0
M  V30 16 N 9.3359 6.9301 0.0 0
M  V30 17 C 12.0032 14.6302 0.0 0
M  V30 18 O 8.0021 16.9402 0.0 0
M  V30 19 O 10.6695 16.9402 0.0 0
M  V30 20 C 2.1037 10.2165 0.0 0
M  V30 21 C 0.0000 10.7801 0.0 0
M  V30 22 C 0.5636 12.8838 0.0 0
M  V30 23 C 9.3359 5.3901 0.0 0
M  V30 24 C 13.3369 13.8602 0.0 0
M  V30 25 C 8.0021 18.4802 0.0 0
M  V30 26 O 10.6695 4.6201 0.0 0
M  V30 27 O 8.0021 4.6201 0.0 0
M  V30 28 N 14.6707 14.6302 0.0 0
M  V30 29 C 10.6695 3.0800 0.0 0
M  V30 30 C 16.0043 13.8602 0.0 0
M  V30 31 O 17.3380 14.6302 0.0 0
M  V30 32 O 16.0043 12.3201 0.0 0
M  V30 33 C 18.6716 13.8602 0.0 0
M  V30 34 C 12.0032 2.3100 0.0 0
M  V30 35 C 13.3369 3.0800 0.0 0
M  V30 36 C 12.0032 0.7700 0.0 0
M  V30 37 C 14.6707 2.3100 0.0 0
M  V30 38 C 13.3369 0.0000 0.0 0
M  V30 39 C 14.6707 0.7700 0.0 0
M  V30 40 C 20.0054 14.6302 0.0 0
M  V30 41 C 21.3391 13.8602 0.0 0
M  V30 42 C 20.0054 16.1702 0.0 0
M  V30 43 C 22.6727 14.6302 0.0 0
M  V30 44 C 21.3391 16.9402 0.0 0
M  V30 45 C 22.6727 16.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13 CFG=3
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 14 19
M  V30 19 1 15 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 16 23
M  V30 23 1 17 24
M  V30 24 1 18 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 28
M  V30 28 1 26 29
M  V30 29 1 28 30
M  V30 30 1 29 34
M  V30 31 1 30 31
M  V30 32 2 30 32
M  V30 33 1 31 33
M  V30 34 1 33 40
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 41 2 40 41
M  V30 42 1 40 42
M  V30 43 1 41 43
M  V30 44 2 42 44
M  V30 45 2 43 45
M  V30 46 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2480-93-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5874-75-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19792-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40807666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 26198-19-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereochemical Effects on the Antimicrobial Properties of
Tetrasubstituted 2,5-Diketopiperazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grant, Thomas M.; Rennison, David; Krause, Alexandra L.; Mros, Sonya;
Ferguson, Scott A.; Cook, Gregory M.; Cameron, Alan; Arabshahi, Homayon
J.; Brimble, Margaret A.; Cahill, Patrick; Svenson, Johan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(4), 632-640

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
3-O-Acetylursolic acid
C32H50O4
7372-30-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7959 1.1333 0.0 0
M  V30 2 C 5.7887 1.1800 0.0 0
M  V30 3 C 9.1059 5.5353 0.0 0
M  V30 4 C 1.5400 1.3338 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 O 2.3101 0.0000 0.0 0
M  V30 7 C 3.0801 6.6687 0.0 0
M  V30 8 C 11.2829 1.1509 0.0 0
M  V30 9 C 12.9974 2.1408 0.0 0
M  V30 10 C 0.0000 6.6687 0.0 0
M  V30 11 O 13.8603 4.0012 0.0 0
M  V30 12 C 14.6303 5.3348 0.0 0
M  V30 13 C 13.8603 6.6687 0.0 0
M  V30 14 O 16.1704 5.3348 0.0 0
M  V30 15 C 6.9302 2.6675 0.0 0 CFG=1
M  V30 16 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 17 C 7.7002 4.0012 0.0 0 CFG=2
M  V30 18 C 7.7002 1.3338 0.0 0
M  V30 19 C 4.6201 4.0012 0.0 0
M  V30 20 C 4.6201 1.3338 0.0 0
M  V30 21 C 9.2402 4.0012 0.0 0 CFG=2
M  V30 22 C 6.9302 5.3348 0.0 0
M  V30 23 C 9.2402 1.3338 0.0 0
M  V30 24 C 3.0801 4.0012 0.0 0 CFG=2
M  V30 25 C 5.3901 5.3348 0.0 0
M  V30 26 C 3.0801 1.3338 0.0 0
M  V30 27 C 10.0102 2.6675 0.0 0 CFG=2
M  V30 28 C 10.0102 5.3348 0.0 0
M  V30 29 C 2.3101 2.6675 0.0 0 CFG=1
M  V30 30 C 2.3101 5.3348 0.0 0 CFG=1
M  V30 31 C 11.5503 2.6675 0.0 0
M  V30 32 C 11.5503 5.3348 0.0 0
M  V30 33 C 0.7700 2.6675 0.0 0
M  V30 34 C 0.7700 5.3348 0.0 0 CFG=2
M  V30 35 C 12.3203 4.0012 0.0 0 CFG=1
M  V30 36 C 0.0000 4.0012 0.0 0
M  V30 37 H 8.0987 5.4887 0.0 0
M  V30 38 H 3.8501 5.3348 0.0 0
M  V30 39 H 10.7802 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=3
M  V30 2 1 16 2 CFG=1
M  V30 3 1 21 3 CFG=3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 29 4 CFG=3
M  V30 7 1 30 7 CFG=3
M  V30 8 1 8 31
M  V30 9 1 9 31
M  V30 10 1 34 10 CFG=1
M  V30 11 1 11 12
M  V30 12 1 35 11 CFG=3
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 22
M  V30 22 1 17 37 CFG=1
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 19 25
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 21 28
M  V30 29 1 22 25
M  V30 30 1 23 27
M  V30 31 1 24 29
M  V30 32 1 24 30
M  V30 33 1 24 38 CFG=3
M  V30 34 1 26 29
M  V30 35 1 27 31
M  V30 36 1 27 39 CFG=1
M  V30 37 1 28 32
M  V30 38 1 29 33
M  V30 39 1 30 34
M  V30 40 1 31 35
M  V30 41 1 32 35
M  V30 42 1 33 36
M  V30 43 1 34 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 15 16 17 21 24 27 29 30 34 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Bromoethylamine hydrobromide
C2H6BrN.BrH
2576-47-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3100 0.0 0
M  V30 3 Br 0.0000 2.3100 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 Br 2.0005 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β)-3-(Acetyloxy)-N-(2-bromoethyl)urs-12-en-28-amide
C34H54BrNO3
2416910-54-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 5.3901 0.0 0
M  V30 2 N 16.0045 4.6201 0.0 0
M  V30 3 O 14.6708 6.9302 0.0 0
M  V30 4 C 17.3382 5.3901 0.0 0
M  V30 5 C 18.6720 4.6201 0.0 0
M  V30 6 Br 20.0057 5.3901 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 11.0682 7.6477 0.0 0
M  V30 9 C 13.3372 0.0000 0.0 0
M  V30 10 C 10.4250 8.0191 0.0 0
M  V30 11 C 6.2699 5.4426 0.0 0
M  V30 12 C 4.3449 10.4199 0.0 0
M  V30 13 C 6.3248 10.4199 0.0 0
M  V30 14 O 2.6675 9.2402 0.0 0
M  V30 15 C 1.3337 8.4702 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 O 0.0000 9.2402 0.0 0
M  V30 18 C 13.3372 4.6201 0.0 0 CFG=1
M  V30 19 C 12.0033 3.8501 0.0 0 CFG=1
M  V30 20 C 13.3372 6.1601 0.0 0
M  V30 21 C 14.6708 3.8501 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 12.0033 2.3101 0.0 0 CFG=1
M  V30 24 C 12.0033 6.9302 0.0 0
M  V30 25 C 14.6708 2.3101 0.0 0
M  V30 26 C 10.6697 6.1601 0.0 0 CFG=1
M  V30 27 C 9.3360 3.8501 0.0 0
M  V30 28 C 13.3372 1.5400 0.0 0 CFG=2
M  V30 29 C 9.3360 6.9302 0.0 0 CFG=1
M  V30 30 C 8.0023 4.6201 0.0 0
M  V30 31 C 8.0023 6.1601 0.0 0 CFG=1
M  V30 32 C 9.3360 8.4702 0.0 0
M  V30 33 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 34 C 8.0023 9.2402 0.0 0
M  V30 35 C 6.6685 8.4702 0.0 0 CFG=2
M  V30 36 C 5.3348 6.1601 0.0 0
M  V30 37 C 5.3348 9.2402 0.0 0
M  V30 38 C 4.0012 6.9302 0.0 0
M  V30 39 C 4.0012 8.4702 0.0 0 CFG=1
M  V30 40 H 10.6697 3.0801 0.0 0
M  V30 41 H 7.1190 4.8985 0.0 0
M  V30 42 H 6.6685 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 23 7 CFG=3
M  V30 8 1 26 8 CFG=1
M  V30 9 1 28 9 CFG=1
M  V30 10 1 29 10 CFG=3
M  V30 11 1 33 11 CFG=3
M  V30 12 1 12 37
M  V30 13 1 13 37
M  V30 14 1 14 15
M  V30 15 1 39 14 CFG=3
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 19 40 CFG=3
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 22 27
M  V30 28 1 23 28
M  V30 29 1 24 26
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 30 31
M  V30 36 1 31 33
M  V30 37 1 31 41 CFG=1
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 33 36
M  V30 41 1 34 35
M  V30 42 1 35 37
M  V30 43 1 35 42 CFG=1
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 18 19 23 26 28 29 31 33 35 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7372-30-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2576-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416910-54-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24554462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and radiosensitization research of ursolic acid derivatives as
SENP1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Huiqiang; Guo, Jianghong; Sun, Xiao; Gou, Wenfeng; Ning, Hongxin;
Fang, Zhennan; Liu, Qiang; Hou, Wenbin; Li, Yiliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 227113918

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL

C22H33N3O7
3032888-52-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 2 C 6.6687 9.2402 0.0 0
M  V30 3 C 8.0023 6.9302 0.0 0
M  V30 4 N 5.3348 6.9302 0.0 0
M  V30 5 N 8.0023 5.3901 0.0 0
M  V30 6 O 9.3360 7.7002 0.0 0
M  V30 7 C 4.0012 7.7002 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0 CFG=1
M  V30 9 O 2.6675 6.9302 0.0 0
M  V30 10 O 4.0012 9.2402 0.0 0
M  V30 11 C 10.6697 5.3901 0.0 0
M  V30 12 C 9.3360 3.0801 0.0 0
M  V30 13 C 1.3338 7.7002 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 O 8.0023 2.3101 0.0 0
M  V30 16 O 10.6697 2.3101 0.0 0
M  V30 17 C 0.5638 6.3665 0.0 0
M  V30 18 C 0.0000 8.4702 0.0 0
M  V30 19 C 2.1038 9.0338 0.0 0
M  V30 20 C 13.3372 5.3901 0.0 0
M  V30 21 C 8.0023 0.7700 0.0 0
M  V30 22 O 14.6708 4.6201 0.0 0
M  V30 23 O 13.3372 6.9302 0.0 0
M  V30 24 C 6.6687 0.0000 0.0 0
M  V30 25 C 16.0045 5.3901 0.0 0
M  V30 26 C 17.3383 4.6201 0.0 0
M  V30 27 C 8.0023 10.0102 0.0 0
M  V30 28 C 8.0023 11.5503 0.0 0
M  V30 29 C 9.3360 9.2402 0.0 0
M  V30 30 C 9.3360 12.3203 0.0 0
M  V30 31 C 10.6697 10.0102 0.0 0
M  V30 32 N 10.6697 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 25 26
M  V30 27 1 27 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H36N4O8
3032888-66-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 7.7002 0.0 0 CFG=2
M  V30 2 C 10.6697 9.2402 0.0 0
M  V30 3 C 9.3360 6.9302 0.0 0
M  V30 4 N 12.0033 6.9302 0.0 0
M  V30 5 N 9.3360 5.3901 0.0 0
M  V30 6 O 8.0022 7.7002 0.0 0
M  V30 7 C 13.3370 7.7002 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0 CFG=1
M  V30 9 C 14.6708 6.9302 0.0 0
M  V30 10 O 13.3370 9.2402 0.0 0
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 N 16.0045 7.7002 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 O 9.3360 2.3101 0.0 0
M  V30 16 O 6.6685 2.3101 0.0 0
M  V30 17 C 17.3382 6.9302 0.0 0
M  V30 18 C 4.0012 5.3901 0.0 0
M  V30 19 C 9.3360 0.7700 0.0 0
M  V30 20 O 18.6718 7.7002 0.0 0
M  V30 21 O 17.3382 5.3901 0.0 0
M  V30 22 O 2.6673 4.6201 0.0 0
M  V30 23 O 4.0012 6.9302 0.0 0
M  V30 24 C 10.6697 0.0000 0.0 0
M  V30 25 C 20.0057 6.9302 0.0 0
M  V30 26 C 1.3337 5.3901 0.0 0
M  V30 27 C 19.2356 5.5965 0.0 0
M  V30 28 C 21.3393 6.1601 0.0 0
M  V30 29 C 20.7757 8.2638 0.0 0
M  V30 30 C 0.0000 4.6201 0.0 0
M  V30 31 C 9.3360 10.0102 0.0 0
M  V30 32 C 9.3360 11.5503 0.0 0
M  V30 33 C 8.0022 9.2402 0.0 0
M  V30 34 C 8.0022 12.3203 0.0 0
M  V30 35 C 6.6685 10.0102 0.0 0
M  V30 36 N 6.6685 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 31
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 22 26
M  V30 27 1 25 27
M  V30 28 1 25 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 31 32
M  V30 32 2 31 33
M  V30 33 2 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 2 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032888-52-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032888-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40893417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar
Potency
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guzelj, Samo; Bizjak, Spela; Jakopin, Ziga
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Salicylic acid
C7H6O3
69-72-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]am...
C27H31N3O7S
2892016-09-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9302 0.0 0 CFG=1
M  V30 2 C 5.3348 7.7002 0.0 0 CFG=2
M  V30 3 C 2.6673 7.7002 0.0 0
M  V30 4 N 4.0010 5.3901 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 O 6.6685 6.9302 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 N 6.6685 10.0102 0.0 0
M  V30 9 O 1.3337 5.3901 0.0 0
M  V30 10 S 8.0022 9.2402 0.0 0 VAL=6
M  V30 11 C 6.6685 11.5503 0.0 0
M  V30 12 O 7.2322 7.9065 0.0 0
M  V30 13 O 8.7722 10.5739 0.0 0
M  V30 14 C 8.0022 12.3203 0.0 0
M  V30 15 C 8.0022 13.8603 0.0 0
M  V30 16 C 9.3358 11.5503 0.0 0
M  V30 17 O 0.0000 3.0801 0.0 0
M  V30 18 N 13.3370 6.1601 0.0 0 VAL=5
M  V30 19 O 14.6707 6.9302 0.0 0
M  V30 20 O 13.3370 4.6201 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 1.3337 10.0102 0.0 0
M  V30 23 C 4.0010 10.0102 0.0 0
M  V30 24 C 1.3337 11.5503 0.0 0
M  V30 25 C 4.0010 11.5503 0.0 0
M  V30 26 C 2.6673 12.3203 0.0 0
M  V30 27 C 2.6673 3.0801 0.0 0
M  V30 28 C 1.3337 2.3101 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 1.3337 0.7700 0.0 0
M  V30 31 C 4.0010 0.7700 0.0 0
M  V30 32 C 2.6673 0.0000 0.0 0
M  V30 33 C 9.3358 8.4702 0.0 0
M  V30 34 C 10.6697 9.2402 0.0 0
M  V30 35 C 9.3358 6.9302 0.0 0
M  V30 36 C 12.0033 8.4702 0.0 0
M  V30 37 C 10.6697 6.1601 0.0 0
M  V30 38 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 21
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 27
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 33
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 28
M  V30 20 2 18 19
M  V30 21 2 18 20
M  V30 22 1 18 38
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 69-72-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-4-methyl-L-phenylalanine
C15H21NO4
80102-26-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 4.0012 0.0 0
M  V30 2 C 5.9538 2.6675 0.0 0 CFG=1
M  V30 3 N 4.4137 2.6675 0.0 0
M  V30 4 C 6.7238 1.3338 0.0 0
M  V30 5 C 3.6437 4.0012 0.0 0
M  V30 6 O 8.2638 1.3338 0.0 0
M  V30 7 O 5.9538 0.0000 0.0 0
M  V30 8 O 2.1037 4.0012 0.0 0
M  V30 9 O 4.4137 5.3348 0.0 0
M  V30 10 C 1.3337 5.3348 0.0 0
M  V30 11 C 0.0000 4.5648 0.0 0
M  V30 12 C 0.5637 6.6687 0.0 0
M  V30 13 C 2.6673 6.1048 0.0 0
M  V30 14 C 12.8839 4.0012 0.0 0
M  V30 15 C 8.2638 4.0012 0.0 0
M  V30 16 C 9.0338 5.3348 0.0 0
M  V30 17 C 9.0338 2.6675 0.0 0
M  V30 18 C 10.5739 5.3348 0.0 0
M  V30 19 C 10.5739 2.6675 0.0 0
M  V30 20 C 11.3439 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pentene-1-sulfonic acid, 3-amino-1-fluoro-5-phenyl-, phenyl ester, hydrochl...
C17H18FNO3S.ClH
2761157-64-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 5.1837 0.0 0
M  V30 2 S 5.3901 3.8501 0.0 0 VAL=6
M  V30 3 C 6.7238 4.6201 0.0 0
M  V30 4 O 6.1601 2.5162 0.0 0
M  V30 5 O 4.0564 3.0800 0.0 0
M  V30 6 C 8.0575 3.8501 0.0 0
M  V30 7 F 6.7238 6.1601 0.0 0
M  V30 8 C 9.3913 4.6201 0.0 0 CFG=1
M  V30 9 C 10.7249 3.8501 0.0 0
M  V30 10 N 9.3913 6.1601 0.0 0
M  V30 11 C 12.0586 4.6201 0.0 0
M  V30 12 C 3.0801 5.1837 0.0 0
M  V30 13 C 2.3101 6.5174 0.0 0
M  V30 14 C 2.3101 3.8501 0.0 0
M  V30 15 C 0.7700 6.5174 0.0 0
M  V30 16 C 0.7700 3.8501 0.0 0
M  V30 17 C 0.0000 5.1837 0.0 0
M  V30 18 C 13.3924 3.8501 0.0 0
M  V30 19 C 13.3924 2.3100 0.0 0
M  V30 20 C 14.7261 4.6201 0.0 0
M  V30 21 C 14.7261 1.5400 0.0 0
M  V30 22 C 16.0598 3.8501 0.0 0
M  V30 23 C 16.0598 2.3100 0.0 0
M  V30 24 Cl 8.0299 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 3 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 18
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenyl (1E,3S)-3-[[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(4-methylph...
C32H37FN2O6S
2761157-84-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.1600 0.0 0 CFG=2
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 C 6.6684 7.7000 0.0 0
M  V30 4 N 8.0020 5.3900 0.0 0
M  V30 5 N 8.0020 8.4700 0.0 0
M  V30 6 O 5.3347 8.4700 0.0 0
M  V30 7 C 8.0020 3.8500 0.0 0
M  V30 8 C 8.0020 10.0100 0.0 0 CFG=1
M  V30 9 O 9.3358 3.0800 0.0 0
M  V30 10 O 6.6684 3.0800 0.0 0
M  V30 11 C 9.3358 10.7800 0.0 0
M  V30 12 C 6.6684 10.7800 0.0 0
M  V30 13 C 9.3358 1.5400 0.0 0
M  V30 14 C 10.6694 10.0100 0.0 0
M  V30 15 C 6.6684 12.3200 0.0 0
M  V30 16 C 10.8758 1.5400 0.0 0
M  V30 17 C 9.3358 0.0000 0.0 0
M  V30 18 C 7.7958 1.5400 0.0 0
M  V30 19 S 12.0031 10.7800 0.0 0 VAL=6
M  V30 20 F 10.6694 8.4700 0.0 0
M  V30 21 O 12.7731 9.4464 0.0 0
M  V30 22 O 11.2331 12.1136 0.0 0
M  V30 23 O 13.3367 11.5500 0.0 0
M  V30 24 C 0.0000 8.4700 0.0 0
M  V30 25 C 4.0011 6.1600 0.0 0
M  V30 26 C 2.6673 5.3900 0.0 0
M  V30 27 C 4.0011 7.7000 0.0 0
M  V30 28 C 1.3336 6.1600 0.0 0
M  V30 29 C 2.6673 8.4700 0.0 0
M  V30 30 C 1.3336 7.7000 0.0 0
M  V30 31 C 5.3347 13.0900 0.0 0
M  V30 32 C 4.0011 12.3200 0.0 0
M  V30 33 C 5.3347 14.6300 0.0 0
M  V30 34 C 2.6673 13.0900 0.0 0
M  V30 35 C 4.0011 15.4000 0.0 0
M  V30 36 C 2.6673 14.6300 0.0 0
M  V30 37 C 14.3131 9.4464 0.0 0
M  V30 38 C 15.0831 8.1126 0.0 0
M  V30 39 C 15.0831 10.7800 0.0 0
M  V30 40 C 16.6231 8.1126 0.0 0
M  V30 41 C 16.6231 10.7800 0.0 0
M  V30 42 C 17.3931 9.4464 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 25
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 15 31
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 2 19 23
M  V30 25 1 21 37
M  V30 26 1 24 30
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80102-26-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761157-64-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Thiazolo[5,4-c]pyridine-2-carboxylic acid, 4,5,6,7-tetrahydro-5-methyl-, hydr...
C8H10N2O2S.ClH
720720-96-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0800 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3338 1.5400 0.0 0
M  V30 4 C 8.9549 5.7017 0.0 0
M  V30 5 C 4.3348 5.7017 0.0 0
M  V30 6 C 5.1048 4.3681 0.0 0
M  V30 7 N 2.8284 5.3816 0.0 0
M  V30 8 C 5.1048 7.0354 0.0 0
M  V30 9 S 4.0743 3.2235 0.0 0
M  V30 10 C 6.6448 4.3681 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 6.6448 7.0354 0.0 0
M  V30 13 N 7.4149 5.7017 0.0 0
M  V30 14 Cl 4.4774 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxamide, 3-amino-4-hydroxy-N,N-dimethyl-, hydrobromide (1:1), ...
C9H18N2O2.BrH
2964483-51-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.2074 0.0 0
M  V30 2 N 6.9300 5.5411 0.0 0
M  V30 3 O 6.9300 2.8738 0.0 0
M  V30 4 C 6.1600 6.8749 0.0 0
M  V30 5 C 8.4700 5.5411 0.0 0
M  V30 6 N 1.5400 1.5400 0.0 0
M  V30 7 O 0.0000 4.2074 0.0 0
M  V30 8 C 4.6200 4.2074 0.0 0 CFG=1
M  V30 9 C 3.8500 2.8738 0.0 0
M  V30 10 C 3.8500 5.5411 0.0 0
M  V30 11 C 2.3100 2.8738 0.0 0 CFG=1
M  V30 12 C 2.3100 5.5411 0.0 0
M  V30 13 C 1.5400 4.2074 0.0 0 CFG=2
M  V30 14 Br 4.2350 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 11 6 CFG=1
M  V30 7 1 13 7 CFG=3
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R,5S)-5-[(Dimethylamino)carbonyl]-2-hydroxycyclohexyl]-4,5,6,7-tetrah...
C17H26N4O3S
2812463-80-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 15.6111 5.5411 0.0 0
M  V30 5 O 5.3900 0.0000 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 N 0.7700 5.3347 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 C 11.6100 4.7711 0.0 0
M  V30 12 C 11.6100 3.2311 0.0 0
M  V30 13 S 10.1453 5.2470 0.0 0
M  V30 14 C 12.9436 5.5411 0.0 0
M  V30 15 N 10.1453 2.7552 0.0 0
M  V30 16 C 12.9436 2.4611 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 N 14.2773 4.7711 0.0 0
M  V30 19 C 14.2773 3.2311 0.0 0
M  V30 20 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 21 C 4.6200 4.0011 0.0 0
M  V30 22 C 4.6200 1.3338 0.0 0 CFG=2
M  V30 23 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 24 C 3.0800 1.3338 0.0 0
M  V30 25 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 20 2 CFG=1
M  V30 5 1 4 18
M  V30 6 1 22 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 23 6 CFG=3
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 20 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 720720-96-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2964483-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2812463-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37291176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using
Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective
Synthesis of Edoxaban
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ochiai, Hidenori; Kubota, Shunichi; Sasagawa, Miwa; Mihara, Taiki;
Yamashita, Atsuhiro; Nakamata, Tomohide; Nishiyama, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(8), 1517-1532

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
4-[(2-Chloro-4-pyridinyl)oxy]benzenamine
C11H9ClN2O
630125-70-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 Cl 0.0000 1.3338 0.0 0
M  V30 3 N 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 1.3338 0.0 0
M  V30 7 C 1.5400 1.3338 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 N 2.3100 0.0000 0.0 0
M  V30 10 C 6.1600 4.0011 0.0 0
M  V30 11 C 6.9300 5.3349 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 8.4700 5.3349 0.0 0
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 7
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[(4-Fluorophenyl)amino]carbonyl]cyclopropanecarboxylic acid
C11H10FNO3
849217-48-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8402 2.2170 0.0 0
M  V30 2 N 5.1740 1.4470 0.0 0
M  V30 3 O 3.8402 3.7570 0.0 0
M  V30 4 C 1.5166 2.6268 0.0 0
M  V30 5 O 0.0000 2.3593 0.0 0
M  V30 6 O 2.0435 4.0740 0.0 0
M  V30 7 F 10.5088 4.5271 0.0 0
M  V30 8 C 2.5065 1.4470 0.0 0
M  V30 9 C 3.0332 0.0000 0.0 0
M  V30 10 C 1.5166 0.2673 0.0 0
M  V30 11 C 6.5077 2.2170 0.0 0
M  V30 12 C 6.5077 3.7570 0.0 0
M  V30 13 C 7.8413 1.4470 0.0 0
M  V30 14 C 7.8413 4.5271 0.0 0
M  V30 15 C 9.1750 2.2170 0.0 0
M  V30 16 C 9.1750 3.7570 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 8
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[(2-Chloro-4-pyridinyl)oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropaned...
C22H17ClFN3O3
2211941-75-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7999 4.8611 0.0 0
M  V30 2 N 9.1336 5.6311 0.0 0
M  V30 3 O 7.7999 3.3211 0.0 0
M  V30 4 C 5.4763 4.4514 0.0 0
M  V30 5 N 3.9597 4.7188 0.0 0
M  V30 6 O 6.0030 3.0043 0.0 0
M  V30 7 O 14.4684 2.5511 0.0 0
M  V30 8 F 0.0000 0.0000 0.0 0
M  V30 9 Cl 19.8032 2.5511 0.0 0
M  V30 10 C 6.4661 5.6311 0.0 0
M  V30 11 C 6.9929 7.0783 0.0 0
M  V30 12 C 5.4763 6.8109 0.0 0
M  V30 13 C 10.4672 4.8611 0.0 0
M  V30 14 C 10.4672 3.3211 0.0 0
M  V30 15 C 11.8009 5.6311 0.0 0
M  V30 16 C 11.8009 2.5511 0.0 0
M  V30 17 C 13.1347 4.8611 0.0 0
M  V30 18 C 13.1347 3.3211 0.0 0
M  V30 19 C 2.9698 3.5391 0.0 0
M  V30 20 C 1.4532 3.8065 0.0 0
M  V30 21 C 3.4965 2.0920 0.0 0
M  V30 22 C 0.4632 2.6268 0.0 0
M  V30 23 C 2.5065 0.9123 0.0 0
M  V30 24 C 0.9899 1.1797 0.0 0
M  V30 25 C 15.8020 3.3211 0.0 0
M  V30 26 C 17.1357 2.5511 0.0 0
M  V30 27 C 15.8020 4.8611 0.0 0
M  V30 28 C 18.4695 3.3211 0.0 0
M  V30 29 C 17.1357 5.6311 0.0 0
M  V30 30 N 18.4695 4.8611 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 1 5 19
M  V30 9 1 7 18
M  V30 10 1 7 25
M  V30 11 1 8 24
M  V30 12 1 9 28
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 630125-70-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849217-48-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211941-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31703028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-guided design and development of novel
N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Daowei; Yang, Jixia; Zhang, Qingwei; Wang, Guan; Zhang, Zixue;
Zhang, Yue; Li, Jianqi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 223113648

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cycloheptene...
C22H15F2NO3
1417404-28-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6505 1.9730 0.0 0
M  V30 2 C 1.5357 1.3874 0.0 0
M  V30 3 O 0.0000 1.5026 0.0 0
M  V30 4 O 2.2039 0.0000 0.0 0
M  V30 5 N 11.5129 6.7446 0.0 0
M  V30 6 F 14.1802 8.2846 0.0 0
M  V30 7 F 16.8476 3.6646 0.0 0
M  V30 8 C 4.8065 3.8172 0.0 0
M  V30 9 C 4.1383 5.2046 0.0 0
M  V30 10 C 6.3078 3.4745 0.0 0
M  V30 11 C 3.9389 2.5447 0.0 0
M  V30 12 C 4.8065 6.5921 0.0 0
M  V30 13 C 2.6026 5.3198 0.0 0
M  V30 14 C 7.5118 4.4346 0.0 0
M  V30 15 C 2.4032 2.6599 0.0 0
M  V30 16 C 6.3078 6.9348 0.0 0
M  V30 17 C 1.7350 4.0473 0.0 0
M  V30 18 C 7.5118 5.9746 0.0 0
M  V30 19 C 8.8455 3.6646 0.0 0
M  V30 20 C 8.8455 6.7446 0.0 0
M  V30 21 C 10.1792 4.4346 0.0 0
M  V30 22 C 10.1792 5.9746 0.0 0
M  V30 23 C 12.8465 5.9746 0.0 0
M  V30 24 C 14.1802 6.7446 0.0 0
M  V30 25 C 12.8465 4.4346 0.0 0
M  V30 26 C 15.5140 5.9746 0.0 0
M  V30 27 C 14.1802 3.6646 0.0 0
M  V30 28 C 15.5140 4.4346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 22
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, methyl ester, hydrochloride
C4H9NO2.ClH
3196-73-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0
M  V30 3 O 1.3338 3.8500 0.0 0
M  V30 4 O 2.6675 1.5400 0.0 0
M  V30 5 C 5.3348 3.0800 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 N 6.6686 3.8500 0.0 0
M  V30 8 Cl 3.3343 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cyclohep...
C26H22F2N2O4
2614242-14-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.1971 4.2878 0.0 0
M  V30 2 C 15.3119 3.7022 0.0 0
M  V30 3 N 16.8476 3.8174 0.0 0
M  V30 4 O 14.6437 2.3148 0.0 0
M  V30 5 C 17.7151 2.5448 0.0 0
M  V30 6 C 19.2508 2.6600 0.0 0
M  V30 7 C 20.1184 1.3875 0.0 0
M  V30 8 O 21.6541 1.5026 0.0 0
M  V30 9 O 19.4502 0.0000 0.0 0
M  V30 10 C 22.5216 0.2302 0.0 0
M  V30 11 N 5.3347 9.0595 0.0 0
M  V30 12 F 2.6674 10.5995 0.0 0
M  V30 13 F 0.0000 5.9795 0.0 0
M  V30 14 C 12.0413 6.1320 0.0 0
M  V30 15 C 12.7093 7.5195 0.0 0
M  V30 16 C 10.5398 5.7893 0.0 0
M  V30 17 C 12.9087 4.8595 0.0 0
M  V30 18 C 12.0413 8.9069 0.0 0
M  V30 19 C 14.2450 7.6345 0.0 0
M  V30 20 C 9.3358 6.7495 0.0 0
M  V30 21 C 14.4444 4.9747 0.0 0
M  V30 22 C 10.5398 9.2495 0.0 0
M  V30 23 C 15.1126 6.3620 0.0 0
M  V30 24 C 9.3358 8.2895 0.0 0
M  V30 25 C 8.0021 5.9795 0.0 0
M  V30 26 C 8.0021 9.0595 0.0 0
M  V30 27 C 6.6684 6.7495 0.0 0
M  V30 28 C 6.6684 8.2895 0.0 0
M  V30 29 C 4.0011 8.2895 0.0 0
M  V30 30 C 2.6674 9.0595 0.0 0
M  V30 31 C 4.0011 6.7495 0.0 0
M  V30 32 C 1.3336 8.2895 0.0 0
M  V30 33 C 2.6674 5.9795 0.0 0
M  V30 34 C 1.3336 6.7495 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 28
M  V30 12 1 11 29
M  V30 13 1 12 30
M  V30 14 1 13 34
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 20 25
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1417404-28-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3196-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614242-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31188010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Highly Selective Brain Penetrant p38α
Mitogen-Activated Protein Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tormaehlen, Niklas M.; Martorelli, Mariella; Kuhn, Annette; Maier,
Florian; Guezguez, Jamil; Burnet, Michael; Albrecht, Wolfgang; Laufer,
Stefan A.; Koch, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(2), 1225-1242

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
N-(tert-Butoxycarbonyl)-4-nitro-L-phenylalanine
C14H18N2O6
33305-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.0012 0.0 0
M  V30 2 C 7.7002 2.6675 0.0 0 CFG=1
M  V30 3 N 9.2402 2.6675 0.0 0
M  V30 4 C 6.9302 1.3338 0.0 0
M  V30 5 C 10.0102 4.0012 0.0 0
M  V30 6 O 7.7002 0.0000 0.0 0
M  V30 7 O 5.3901 1.3338 0.0 0
M  V30 8 O 11.5503 4.0012 0.0 0
M  V30 9 O 9.2402 5.3348 0.0 0
M  V30 10 C 12.3203 5.3348 0.0 0
M  V30 11 C 10.9866 6.1048 0.0 0
M  V30 12 C 13.0903 6.6687 0.0 0
M  V30 13 C 13.6539 4.5648 0.0 0
M  V30 14 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 15 O 0.0000 2.6675 0.0 0
M  V30 16 O 0.0000 5.3348 0.0 0
M  V30 17 C 5.3901 4.0012 0.0 0
M  V30 18 C 4.6201 2.6675 0.0 0
M  V30 19 C 4.6201 5.3348 0.0 0
M  V30 20 C 3.0801 2.6675 0.0 0
M  V30 21 C 3.0801 5.3348 0.0 0
M  V30 22 C 2.3101 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[4-(aminomethyl)phenyl]methyl]-, phenylmethyl ester, hydroc...
C16H18N2O2.ClH
1417694-17-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0800 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 C 6.6687 3.0800 0.0 0
M  V30 4 O 5.3348 3.8501 0.0 0
M  V30 5 O 6.6687 1.5400 0.0 0
M  V30 6 C 4.0012 3.0800 0.0 0
M  V30 7 C 14.6708 6.1601 0.0 0
M  V30 8 N 16.0046 5.3901 0.0 0
M  V30 9 C 10.6698 3.8501 0.0 0
M  V30 10 C 10.6698 5.3901 0.0 0
M  V30 11 C 12.0035 3.0800 0.0 0
M  V30 12 C 12.0035 6.1601 0.0 0
M  V30 13 C 13.3372 3.8501 0.0 0
M  V30 14 C 13.3372 5.3901 0.0 0
M  V30 15 C 2.6675 3.8501 0.0 0
M  V30 16 C 1.3338 3.0800 0.0 0
M  V30 17 C 2.6675 5.3901 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 19 C 1.3338 6.1601 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 Cl 8.0023 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C30H34N4O7
3055540-36-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.9302 0.0 0
M  V30 2 C 4.0012 7.7002 0.0 0 CFG=2
M  V30 3 C 5.3348 6.9302 0.0 0
M  V30 4 N 4.0012 9.2402 0.0 0
M  V30 5 N 6.6685 7.7002 0.0 0
M  V30 6 O 5.3348 5.3901 0.0 0
M  V30 7 C 2.6673 10.0102 0.0 0
M  V30 8 C 8.0022 6.9302 0.0 0
M  V30 9 O 2.6673 11.5503 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 C 1.3337 12.3203 0.0 0
M  V30 12 C 2.1037 13.6539 0.0 0
M  V30 13 C 0.0000 13.0903 0.0 0
M  V30 14 C 0.5637 10.9866 0.0 0
M  V30 15 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 16 O 4.0012 0.0000 0.0 0
M  V30 17 O 1.3337 0.0000 0.0 0
M  V30 18 C 13.3370 10.0102 0.0 0
M  V30 19 N 14.6708 9.2402 0.0 0
M  V30 20 C 16.0045 10.0102 0.0 0
M  V30 21 O 17.3382 9.2402 0.0 0
M  V30 22 O 16.0045 11.5503 0.0 0
M  V30 23 C 18.6718 10.0102 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 1.3337 4.6201 0.0 0
M  V30 26 C 4.0012 4.6201 0.0 0
M  V30 27 C 1.3337 3.0801 0.0 0
M  V30 28 C 4.0012 3.0801 0.0 0
M  V30 29 C 2.6673 2.3101 0.0 0
M  V30 30 C 9.3360 7.7002 0.0 0
M  V30 31 C 10.6697 6.9302 0.0 0
M  V30 32 C 9.3360 9.2402 0.0 0
M  V30 33 C 12.0033 7.7002 0.0 0
M  V30 34 C 10.6697 10.0102 0.0 0
M  V30 35 C 12.0033 9.2402 0.0 0
M  V30 36 C 20.0057 9.2402 0.0 0
M  V30 37 C 20.0057 7.7002 0.0 0
M  V30 38 C 21.3393 10.0102 0.0 0
M  V30 39 C 21.3393 6.9302 0.0 0
M  V30 40 C 22.6730 9.2402 0.0 0
M  V30 41 C 22.6730 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 30
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 29
M  V30 19 1 18 19
M  V30 20 1 18 35
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 23 36
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 33305-77-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1417694-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055540-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36512451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Structural Characterization of Macrocyclic Plasmin
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wiedemeyer, Simon J. A.; Wu, Guojie; Pham, T. L. Phuong; Lang-Henkel,
Heike; Perez Urzua, Benjamin; Whisstock, James C.; Law, Ruby H. P.;
Steinmetzer, Torsten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2023), 18(6), e202200632

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
(1S,3R)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclohexanecarboxylic acid
C12H21NO4
222530-34-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0012 3.8501 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 O 12.0033 2.3101 0.0 0
M  V30 11 O 10.6697 0.0000 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 13 C 8.0022 1.5400 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 9.3360 2.3101 0.0 0 CFG=1
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 15 9 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Bromo-5-chloro-2-pyridinamine
C5H4BrClN2
1187449-01-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 N 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R,3S)-3-[[(4-bromo-5-chloro-2-pyridinyl)amino]carbonyl...
C17H23BrClN3O3
2057506-68-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 12.0035 3.0801 0.0 0
M  V30 2 C 13.3372 2.3101 0.0 0
M  V30 3 O 14.6708 3.0801 0.0 0
M  V30 4 O 13.3372 0.7700 0.0 0
M  V30 5 C 16.0045 2.3101 0.0 0
M  V30 6 C 15.2345 0.9764 0.0 0
M  V30 7 C 17.3383 1.5400 0.0 0
M  V30 8 C 16.7745 3.6437 0.0 0
M  V30 9 C 6.6687 3.0801 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 O 6.6687 4.6201 0.0 0
M  V30 12 Br 0.0000 2.3101 0.0 0
M  V30 13 Cl 0.0000 5.3901 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 10.6697 0.7700 0.0 0
M  V30 17 C 8.0023 2.3101 0.0 0 CFG=1
M  V30 18 C 9.3360 0.0000 0.0 0
M  V30 19 C 8.0023 0.7700 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 2.6675 2.3101 0.0 0
M  V30 22 N 4.0012 4.6201 0.0 0
M  V30 23 C 1.3338 3.0801 0.0 0
M  V30 24 C 2.6675 5.3901 0.0 0
M  V30 25 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 17 9 CFG=3
M  V30 12 1 10 20
M  V30 13 1 12 23
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 222530-34-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1187449-01-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2057506-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31188286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 26189-59-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That
Enables Short Duration of Target Engagement for the Treatment of
Hematological Malignancies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barlaam, Bernard; Casella, Robert; Cidado, Justin; Cook, Calum; De Savi,
Chris; Dishington, Allan; Donald, Craig S.; Drew, Lisa; Ferguson, Andrew
D.; Ferguson, Douglas; Glossop, Steve; Grebe, Tyler; Gu, Chungang; Hande,
Sudhir; Hawkins, Janet; Hird, Alexander W.; Holmes, Jane; Horstick,
James; Jiang, Yun; Lamb, Michelle L.; McGuire, Thomas M.; Moore, Jane E.;
O'Connell, Nichole; Pike, Andy; Pike, Kurt G.; Proia, Theresa; Roberts,
Bryan; San Martin, Maryann; Sarkar, Ujjal; Shao, Wenlin; Stead, Darren;
Sumner, Neil; Thakur, Kumar; Vasbinder, Melissa M.; Varnes, Jeffrey G.;
Wang, Jianyan; Wang, Lei; Wu, Dedong; Wu, Liangwei; Yang, Bin; Yao,
Tieguang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(24), 15564-15590

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL

C18H26N2O5
3084084-40-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 4.0012 0.0 0
M  V30 2 C 5.9538 2.6675 0.0 0 CFG=1
M  V30 3 N 4.4137 2.6675 0.0 0
M  V30 4 C 6.7238 1.3337 0.0 0
M  V30 5 C 3.6437 4.0012 0.0 0
M  V30 6 O 5.9538 0.0000 0.0 0
M  V30 7 O 2.1037 4.0012 0.0 0
M  V30 8 O 4.4137 5.3348 0.0 0
M  V30 9 C 1.3337 5.3348 0.0 0
M  V30 10 C 2.6673 6.1048 0.0 0
M  V30 11 C 0.5637 6.6687 0.0 0
M  V30 12 C 0.0000 4.5648 0.0 0
M  V30 13 N 12.8839 4.0012 0.0 0
M  V30 14 C 13.6539 5.3348 0.0 0
M  V30 15 O 15.1940 5.3348 0.0 0
M  V30 16 O 12.8839 6.6687 0.0 0
M  V30 17 C 15.9640 6.6687 0.0 0
M  V30 18 C 17.5040 6.6687 0.0 0
M  V30 19 C 18.2740 8.0023 0.0 0
M  V30 20 C 8.2638 4.0012 0.0 0
M  V30 21 C 9.0338 2.6675 0.0 0
M  V30 22 C 9.0338 5.3348 0.0 0
M  V30 23 C 10.5739 2.6675 0.0 0
M  V30 24 C 10.5739 5.3348 0.0 0
M  V30 25 C 11.3439 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 2 18 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N6-[2-(Diethoxyphosphinyl)acetyl]-N2-[(1,1-dimethylethoxy)carbonyl]-L-lysine
C17H33N2O8P
1227203-83-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 15.1936 3.8500 0.0 0 VAL=5
M  V30 2 C 13.6536 3.8500 0.0 0
M  V30 3 O 16.7336 3.8500 0.0 0
M  V30 4 O 15.1936 2.3100 0.0 0
M  V30 5 O 15.1936 5.3900 0.0 0
M  V30 6 C 12.8836 5.1836 0.0 0
M  V30 7 C 17.5036 5.1836 0.0 0
M  V30 8 C 16.5273 1.5400 0.0 0
M  V30 9 N 11.3436 5.1836 0.0 0
M  V30 10 O 13.6536 6.5174 0.0 0
M  V30 11 C 19.0436 5.1836 0.0 0
M  V30 12 C 16.5273 0.0000 0.0 0
M  V30 13 C 10.5736 6.5174 0.0 0
M  V30 14 C 9.0336 6.5174 0.0 0
M  V30 15 C 8.2636 7.8511 0.0 0
M  V30 16 C 6.7236 7.8511 0.0 0
M  V30 17 C 5.9536 9.1847 0.0 0 CFG=1
M  V30 18 N 4.4136 9.1847 0.0 0
M  V30 19 C 6.7236 10.5184 0.0 0
M  V30 20 C 3.6436 7.8511 0.0 0
M  V30 21 O 8.2636 10.5185 0.0 0
M  V30 22 O 5.9536 11.8521 0.0 0
M  V30 23 O 2.1036 7.8511 0.0 0
M  V30 24 O 4.4136 6.5174 0.0 0
M  V30 25 C 1.3336 6.5174 0.0 0
M  V30 26 C 0.0000 7.2874 0.0 0
M  V30 27 C 0.5636 5.1836 0.0 0
M  V30 28 C 2.6673 5.7474 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18 CFG=3
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 23 25
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
12-Oxa-2,8-diaza-11-phosphatetradecanoic acid, 11-ethoxy-3-[[[(1S)-1-(hydroxy...
C30H49N4O10P
3084084-42-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 18.6720 8.2638 0.0 0
M  V30 2 C 17.3382 9.0338 0.0 0 CFG=1
M  V30 3 N 16.0045 8.2638 0.0 0
M  V30 4 C 17.3382 10.5739 0.0 0
M  V30 5 C 16.0045 6.7238 0.0 0
M  V30 6 O 16.0045 11.3439 0.0 0
M  V30 7 C 14.6708 5.9538 0.0 0 CFG=2
M  V30 8 O 17.3382 5.9538 0.0 0
M  V30 9 N 14.6708 4.4137 0.0 0
M  V30 10 C 13.3372 6.7238 0.0 0
M  V30 11 C 16.0045 3.6437 0.0 0
M  V30 12 C 12.0033 5.9538 0.0 0
M  V30 13 O 16.0045 2.1037 0.0 0
M  V30 14 O 17.3382 4.4137 0.0 0
M  V30 15 C 10.6697 6.7238 0.0 0
M  V30 16 C 17.3382 1.3337 0.0 0
M  V30 17 C 9.3360 5.9538 0.0 0
M  V30 18 C 16.5681 0.0000 0.0 0
M  V30 19 C 18.6720 0.5637 0.0 0
M  V30 20 C 18.1082 2.6673 0.0 0
M  V30 21 N 8.0023 6.7238 0.0 0
M  V30 22 C 6.6685 5.9538 0.0 0
M  V30 23 C 5.3348 6.7238 0.0 0
M  V30 24 O 6.6685 4.4137 0.0 0
M  V30 25 P 4.0012 5.9538 0.0 0 VAL=5
M  V30 26 O 2.6675 5.1838 0.0 0
M  V30 27 O 3.2311 7.2874 0.0 0
M  V30 28 O 4.7712 4.6201 0.0 0
M  V30 29 C 1.3337 5.9538 0.0 0
M  V30 30 C 4.0012 8.6213 0.0 0
M  V30 31 C 0.0000 5.1838 0.0 0
M  V30 32 C 3.2311 9.9549 0.0 0
M  V30 33 N 24.0068 11.3439 0.0 0
M  V30 34 C 25.3405 10.5739 0.0 0
M  V30 35 O 26.6742 11.3439 0.0 0
M  V30 36 O 25.3405 9.0338 0.0 0
M  V30 37 C 28.0078 10.5739 0.0 0
M  V30 38 C 29.3416 11.3439 0.0 0
M  V30 39 C 30.6753 10.5739 0.0 0
M  V30 40 C 20.0057 9.0338 0.0 0
M  V30 41 C 20.0057 10.5739 0.0 0
M  V30 42 C 21.3393 8.2638 0.0 0
M  V30 43 C 21.3393 11.3439 0.0 0
M  V30 44 C 22.6730 9.0338 0.0 0
M  V30 45 C 22.6730 10.5739 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 40
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 2 25 28
M  V30 29 1 26 29
M  V30 30 1 27 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 33 34
M  V30 34 1 33 45
M  V30 35 1 34 35
M  V30 36 2 34 36
M  V30 37 1 35 37
M  V30 38 1 37 38
M  V30 39 2 38 39
M  V30 40 2 40 41
M  V30 41 1 40 42
M  V30 42 1 41 43
M  V30 43 2 42 44
M  V30 44 2 43 45
M  V30 45 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3084084-40-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227203-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3084084-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41112180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of small molecule-drug conjugates based on derivatives of
natural proteasome inhibitors that exhibit selectivity for
PSMA-expressing cancer cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Obara, Takahiro; Kawano, Nanami; Tatsumi, Kengo; Katsuyama, Akira;
Nakajima, Kohei; Ogawa, Mikako; Ichikawa, Satoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2024), 108117773

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1H-indole-3-acetic acid
C10H8ClNO2
1912-44-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.1884 0.0 0
M  V30 2 C 1.1444 2.7126 0.0 0
M  V30 3 O 0.8242 1.2061 0.0 0
M  V30 4 O 0.0000 3.7430 0.0 0
M  V30 5 Cl 9.8797 2.4782 0.0 0
M  V30 6 C 5.2597 2.4782 0.0 0
M  V30 7 C 6.0297 1.1444 0.0 0
M  V30 8 C 3.7534 2.1580 0.0 0
M  V30 9 C 6.0297 3.8118 0.0 0
M  V30 10 N 4.9993 0.0000 0.0 0
M  V30 11 C 7.5697 1.1444 0.0 0
M  V30 12 C 3.5925 0.6263 0.0 0
M  V30 13 C 7.5697 3.8118 0.0 0
M  V30 14 C 8.3397 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-1H-indole-3-acetamide
C20H21ClN2O3
1990296-36-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5502 6.6685 0.0 0
M  V30 2 C 10.0102 6.6685 0.0 0
M  V30 3 N 9.2402 5.3348 0.0 0
M  V30 4 O 9.2402 8.0021 0.0 0
M  V30 5 C 7.7001 5.3348 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 Cl 18.2456 9.5908 0.0 0
M  V30 8 O 2.3100 1.3337 0.0 0
M  V30 9 C 3.0801 0.0000 0.0 0
M  V30 10 O 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 5.3348 0.0 0
M  V30 12 C 13.8518 8.1632 0.0 0
M  V30 13 C 14.1720 9.6695 0.0 0
M  V30 14 C 12.3202 8.0021 0.0 0
M  V30 15 C 14.9962 7.1326 0.0 0
M  V30 16 N 12.8383 10.4395 0.0 0
M  V30 17 C 15.6365 10.1454 0.0 0
M  V30 18 C 11.6937 9.4091 0.0 0
M  V30 19 C 16.4609 7.6087 0.0 0
M  V30 20 C 16.7811 9.1150 0.0 0
M  V30 21 C 5.3901 4.0011 0.0 0
M  V30 22 C 4.6201 2.6673 0.0 0
M  V30 23 C 4.6201 5.3348 0.0 0
M  V30 24 C 3.0801 2.6673 0.0 0
M  V30 25 C 3.0801 5.3348 0.0 0
M  V30 26 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 21
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1912-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1990296-36-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23040945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
N-α-Fluorenylmethoxycarbonyl-N-δ-tert-butoxycarbonyl-L-ornithine
C25H30N2O6
109425-55-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 5.7534 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4209 6.7709 0.0 0
M  V30 6 C 8.4209 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7546 9.0810 0.0 0
M  V30 8 C 8.4209 11.3910 0.0 0
M  V30 9 C 11.0882 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7546 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 N 13.7557 9.8510 0.0 0
M  V30 14 C 15.0894 9.0810 0.0 0
M  V30 15 O 16.4231 9.8510 0.0 0
M  V30 16 O 15.0894 7.5409 0.0 0
M  V30 17 C 17.7567 9.0810 0.0 0
M  V30 18 C 16.9867 7.7473 0.0 0
M  V30 19 C 19.0906 8.3109 0.0 0
M  V30 20 C 18.5268 10.4146 0.0 0
M  V30 21 C 4.4197 4.4609 0.0 0
M  V30 22 C 4.2588 2.9293 0.0 0
M  V30 23 C 3.0128 5.0873 0.0 0
M  V30 24 C 2.7523 2.6091 0.0 0
M  V30 25 C 5.2892 1.7849 0.0 0
M  V30 26 C 1.9823 3.9428 0.0 0
M  V30 27 C 2.5369 6.5519 0.0 0
M  V30 28 C 2.2765 1.1444 0.0 0
M  V30 29 C 4.8134 0.3202 0.0 0
M  V30 30 C 0.4760 4.2630 0.0 0
M  V30 31 C 1.0306 6.8721 0.0 0
M  V30 32 C 3.3069 0.0000 0.0 0
M  V30 33 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 22 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 26
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 29 32
M  V30 34 1 30 33
M  V30 35 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclopropaneethanamine
C5H11N
62893-54-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.1037 0.0 0
M  V30 2 C 4.2074 1.3337 0.0 0
M  V30 3 N 5.5410 2.1037 0.0 0
M  V30 4 C 1.5400 1.3337 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C30H39N3O5
2768147-21-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 12.1139 0.0 0
M  V30 2 O 5.7534 10.5739 0.0 0
M  V30 3 C 7.0871 9.8039 0.0 0
M  V30 4 N 7.0871 8.2638 0.0 0
M  V30 5 O 8.4209 10.5739 0.0 0
M  V30 6 C 8.4209 7.4938 0.0 0 CFG=1
M  V30 7 C 8.4209 5.9538 0.0 0
M  V30 8 C 9.7546 8.2638 0.0 0
M  V30 9 N 7.0871 5.1838 0.0 0
M  V30 10 O 9.7546 5.1838 0.0 0
M  V30 11 C 11.0882 7.4938 0.0 0
M  V30 12 C 7.0871 3.6437 0.0 0
M  V30 13 C 12.4219 8.2638 0.0 0
M  V30 14 C 5.7534 2.8737 0.0 0
M  V30 15 N 13.7557 7.4938 0.0 0
M  V30 16 C 15.0894 8.2638 0.0 0
M  V30 17 O 16.4231 7.4938 0.0 0
M  V30 18 O 15.0894 9.8039 0.0 0
M  V30 19 C 17.7567 8.2638 0.0 0
M  V30 20 C 16.9867 9.5975 0.0 0
M  V30 21 C 19.0906 9.0338 0.0 0
M  V30 22 C 18.5268 6.9302 0.0 0
M  V30 23 C 4.4197 12.8839 0.0 0
M  V30 24 C 4.2588 14.4155 0.0 0
M  V30 25 C 3.0128 12.2576 0.0 0
M  V30 26 C 2.7523 14.7357 0.0 0
M  V30 27 C 5.2892 15.5600 0.0 0
M  V30 28 C 1.9823 13.4020 0.0 0
M  V30 29 C 2.5369 10.7929 0.0 0
M  V30 30 C 2.2765 16.2004 0.0 0
M  V30 31 C 4.8134 17.0246 0.0 0
M  V30 32 C 0.4760 13.0818 0.0 0
M  V30 33 C 1.0306 10.4727 0.0 0
M  V30 34 C 3.3069 17.3448 0.0 0
M  V30 35 C 0.0000 11.6171 0.0 0
M  V30 36 C 5.7534 1.3337 0.0 0
M  V30 37 C 6.5234 0.0000 0.0 0
M  V30 38 C 4.9834 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 36
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 24 27
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 26 28
M  V30 31 2 26 30
M  V30 32 1 27 31
M  V30 33 2 28 32
M  V30 34 1 29 33
M  V30 35 1 30 34
M  V30 36 2 31 34
M  V30 37 1 32 35
M  V30 38 2 33 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109425-55-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62893-54-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768147-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32437851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline
Mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garsi, Jean-Baptiste; Komjati, Balazs; Cullia, Gregorio; Fejes, Imre;
Sipos, Melinda; Sipos, Zoltan; Fordos, Eszter; Markacz, Piroska; Balazs,
Barbara; Lancelot, Nathalie; Berger, Sylvie; Raimbaud, Eric; Brown,
David; Vuillard, Laurent-Michel; Haberkorn, Laure; Cukier, Cyprian;
Szlavik, Zoltan; Hanessian, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(6), 949-954

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
3-Iodobenzoic acid
C7H5IO2
618-51-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 I 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)benzenamine
C11H10F3N3
641571-11-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6201 0.0 0
M  V30 2 F 2.1038 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5638 3.2864 0.0 0
M  V30 5 N 4.0012 0.0000 0.0 0
M  V30 6 C 10.6376 4.9772 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 N 6.6687 4.6201 0.0 0
M  V30 14 C 8.0755 3.9936 0.0 0
M  V30 15 C 6.8296 6.1517 0.0 0
M  V30 16 C 9.1059 5.1382 0.0 0
M  V30 17 N 8.3359 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide
C18H13F3IN3O
1351670-02-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3036 6.1600 0.0 0
M  V30 2 C 10.6372 5.3900 0.0 0
M  V30 3 O 10.6372 3.8500 0.0 0
M  V30 4 C 6.6362 1.5400 0.0 0
M  V30 5 F 5.0962 1.5400 0.0 0
M  V30 6 F 6.6362 0.0000 0.0 0
M  V30 7 F 8.1762 1.5400 0.0 0
M  V30 8 C 0.0000 6.5171 0.0 0
M  V30 9 I 15.9720 5.3900 0.0 0
M  V30 10 C 5.3025 5.3900 0.0 0
M  V30 11 C 6.6362 6.1600 0.0 0
M  V30 12 C 5.3025 3.8500 0.0 0
M  V30 13 C 7.9700 5.3900 0.0 0
M  V30 14 C 6.6362 3.0800 0.0 0
M  V30 15 C 7.9700 3.8500 0.0 0
M  V30 16 N 3.9689 6.1600 0.0 0
M  V30 17 C 2.5619 5.5337 0.0 0
M  V30 18 C 3.8080 7.6915 0.0 0
M  V30 19 C 1.5315 6.6781 0.0 0
M  V30 20 N 2.3015 8.0117 0.0 0
M  V30 21 C 11.9709 6.1600 0.0 0
M  V30 22 C 13.3047 5.3900 0.0 0
M  V30 23 C 11.9709 7.7000 0.0 0
M  V30 24 C 14.6383 6.1600 0.0 0
M  V30 25 C 13.3047 8.4700 0.0 0
M  V30 26 C 14.6383 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 21
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 14
M  V30 9 1 8 19
M  V30 10 1 9 24
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 618-51-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 641571-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351670-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33920089
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM SOCl2 also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with
Improved Cardiac Safety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pandrala, Mallesh; Bruyneel, Arne Antoon N.; Hnatiuk, Anna P.; Mercola,
Mark; Malhotra, Sanjay V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(16), 10898-10919

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cycloheptene...
C22H15F2NO3
1417404-28-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6505 1.9730 0.0 0
M  V30 2 C 1.5357 1.3874 0.0 0
M  V30 3 O 0.0000 1.5026 0.0 0
M  V30 4 O 2.2039 0.0000 0.0 0
M  V30 5 N 11.5129 6.7446 0.0 0
M  V30 6 F 14.1802 8.2846 0.0 0
M  V30 7 F 16.8476 3.6646 0.0 0
M  V30 8 C 4.8065 3.8172 0.0 0
M  V30 9 C 4.1383 5.2046 0.0 0
M  V30 10 C 6.3078 3.4745 0.0 0
M  V30 11 C 3.9389 2.5447 0.0 0
M  V30 12 C 4.8065 6.5921 0.0 0
M  V30 13 C 2.6026 5.3198 0.0 0
M  V30 14 C 7.5118 4.4346 0.0 0
M  V30 15 C 2.4032 2.6599 0.0 0
M  V30 16 C 6.3078 6.9348 0.0 0
M  V30 17 C 1.7350 4.0473 0.0 0
M  V30 18 C 7.5118 5.9746 0.0 0
M  V30 19 C 8.8455 3.6646 0.0 0
M  V30 20 C 8.8455 6.7446 0.0 0
M  V30 21 C 10.1792 4.4346 0.0 0
M  V30 22 C 10.1792 5.9746 0.0 0
M  V30 23 C 12.8465 5.9746 0.0 0
M  V30 24 C 14.1802 6.7446 0.0 0
M  V30 25 C 12.8465 4.4346 0.0 0
M  V30 26 C 15.5140 5.9746 0.0 0
M  V30 27 C 14.1802 3.6646 0.0 0
M  V30 28 C 15.5140 4.4346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 22
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-aminobutyrate hydrochloride
C5H11NO2.ClH
13031-60-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 C 4.0012 3.8501 0.0 0
M  V30 3 O 1.3337 3.8501 0.0 0
M  V30 4 O 2.6675 1.5400 0.0 0
M  V30 5 C 5.3348 3.0800 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 6.6687 3.8501 0.0 0
M  V30 8 N 8.0023 3.0800 0.0 0
M  V30 9 Cl 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[[8-[(2,4-difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]...
C27H24F2N2O4
2614242-20-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.9214 2.9003 0.0 0
M  V30 2 C 14.7838 4.5918 0.0 0
M  V30 3 N 16.1174 5.3619 0.0 0
M  V30 4 O 14.7838 3.0518 0.0 0
M  V30 5 C 17.4511 4.5918 0.0 0
M  V30 6 C 18.7849 5.3619 0.0 0
M  V30 7 C 20.1185 4.5918 0.0 0
M  V30 8 C 21.4522 5.3619 0.0 0
M  V30 9 O 22.7858 4.5918 0.0 0
M  V30 10 O 21.4522 6.9019 0.0 0
M  V30 11 C 24.1196 5.3619 0.0 0
M  V30 12 N 3.4701 5.0896 0.0 0
M  V30 13 F 0.3987 5.3198 0.0 0
M  V30 14 F 0.0000 0.0000 0.0 0
M  V30 15 C 10.7827 5.3619 0.0 0
M  V30 16 C 10.7827 6.9019 0.0 0
M  V30 17 C 9.5787 4.4017 0.0 0
M  V30 18 C 12.1163 4.5918 0.0 0
M  V30 19 C 9.5787 7.8621 0.0 0
M  V30 20 C 12.1163 7.6719 0.0 0
M  V30 21 C 8.0772 4.7445 0.0 0
M  V30 22 C 13.4501 5.3619 0.0 0
M  V30 23 C 8.0772 7.5194 0.0 0
M  V30 24 C 13.4501 6.9019 0.0 0
M  V30 25 C 7.4091 6.1319 0.0 0
M  V30 26 C 7.2097 3.4720 0.0 0
M  V30 27 C 5.8734 6.2470 0.0 0
M  V30 28 C 5.6740 3.5870 0.0 0
M  V30 29 C 5.0058 4.9745 0.0 0
M  V30 30 C 2.6026 3.8172 0.0 0
M  V30 31 C 1.0669 3.9323 0.0 0
M  V30 32 C 3.2708 2.4297 0.0 0
M  V30 33 C 0.1994 2.6599 0.0 0
M  V30 34 C 2.4033 1.1573 0.0 0
M  V30 35 C 0.8676 1.2724 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 12 29
M  V30 13 1 12 30
M  V30 14 1 13 31
M  V30 15 1 14 35
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1417404-28-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13031-60-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614242-20-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31188011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Highly Selective Brain Penetrant p38α
Mitogen-Activated Protein Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tormaehlen, Niklas M.; Martorelli, Mariella; Kuhn, Annette; Maier,
Florian; Guezguez, Jamil; Burnet, Michael; Albrecht, Wolfgang; Laufer,
Stefan A.; Koch, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(2), 1225-1242

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
4-[(2-Nitrophenyl)amino]-4-oxo-2-butenoic acid
C10H8N2O5
36847-89-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 O 6.9300 5.3347 0.0 0
M  V30 5 C 8.4700 2.6674 0.0 0
M  V30 6 C 9.2400 1.3336 0.0 0
M  V30 7 O 8.4700 0.0000 0.0 0
M  V30 8 O 10.7800 1.3336 0.0 0
M  V30 9 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 10 O 2.3100 2.6674 0.0 0
M  V30 11 O 0.0000 4.0011 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 4.6200 6.6685 0.0 0
M  V30 15 C 1.5400 6.6685 0.0 0
M  V30 16 C 3.8500 8.0021 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 13
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-3,4-dihydro-1H-quinolin-2-one
C9H10N2O
40615-17-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 O 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(2-Nitrophenyl)-N4-(1,2,3,4-tetrahydro-2-oxo-3-quinolinyl)-2-butenediamide
C19H16N4O5
2416338-28-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0100 8.0021 0.0 0
M  V30 2 C 9.2400 6.6684 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 O 4.6200 6.6684 0.0 0
M  V30 9 O 11.5500 10.6694 0.0 0
M  V30 10 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 11 O 2.3100 0.0000 0.0 0
M  V30 12 O 4.6200 1.3336 0.0 0
M  V30 13 C 13.8600 6.6684 0.0 0
M  V30 14 C 14.6300 8.0021 0.0 0
M  V30 15 C 12.3200 6.6684 0.0 0
M  V30 16 C 14.6300 5.3347 0.0 0
M  V30 17 N 13.8600 9.3358 0.0 0
M  V30 18 C 16.1700 8.0021 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 16.1700 5.3347 0.0 0
M  V30 21 C 12.3200 9.3358 0.0 0
M  V30 22 C 16.9400 6.6684 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 2.3100 2.6673 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 0.7700 2.6673 0.0 0
M  V30 27 C 0.7700 5.3347 0.0 0
M  V30 28 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 23
M  V30 10 2 9 21
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36847-89-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40615-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416338-28-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21822010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 122-52-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase
inhibitors and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baihui; Shen, Yangli; Wu, Hu; Wu, Xiaobo; Yuan, Lvjiang; Ji, Qinggang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 195112278

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
4-[(2-Methoxyphenyl)amino]-4-oxo-2-butenoic acid
C11H11NO4
36847-94-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 O 6.9300 5.3347 0.0 0
M  V30 5 C 8.4700 2.6674 0.0 0
M  V30 6 C 9.2400 1.3336 0.0 0
M  V30 7 O 8.4700 0.0000 0.0 0
M  V30 8 O 10.7800 1.3336 0.0 0
M  V30 9 O 1.5400 4.0011 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 1.5400 6.6685 0.0 0
M  V30 15 C 3.8500 8.0021 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 12
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-3,4-dihydro-1H-quinolin-2-one
C9H10N2O
40615-17-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 O 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(2-Methoxyphenyl)-N4-(1,2,3,4-tetrahydro-2-oxo-3-quinolinyl)-2-butenediamide
C20H19N3O4
2416338-26-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0100 8.0021 0.0 0
M  V30 2 C 9.2400 6.6684 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 O 10.0100 5.3347 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 O 4.6200 6.6684 0.0 0
M  V30 9 O 11.5500 10.6694 0.0 0
M  V30 10 O 3.0800 1.3336 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 13.8600 6.6684 0.0 0
M  V30 13 C 14.6300 8.0021 0.0 0
M  V30 14 C 12.3200 6.6684 0.0 0
M  V30 15 C 14.6300 5.3347 0.0 0
M  V30 16 N 13.8600 9.3358 0.0 0
M  V30 17 C 16.1700 8.0021 0.0 0
M  V30 18 C 11.5500 8.0021 0.0 0
M  V30 19 C 16.1700 5.3347 0.0 0
M  V30 20 C 12.3200 9.3358 0.0 0
M  V30 21 C 16.9400 6.6684 0.0 0
M  V30 22 C 3.0800 4.0011 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 2.3100 5.3347 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 0.7700 5.3347 0.0 0
M  V30 27 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 22
M  V30 10 2 9 20
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36847-94-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40615-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416338-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21822008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 122-52-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase
inhibitors and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baihui; Shen, Yangli; Wu, Hu; Wu, Xiaobo; Yuan, Lvjiang; Ji, Qinggang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 195112278

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
5-Methoxyindoleacetic acid
C11H11NO3
3471-31-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2707 3.1885 0.0 0
M  V30 2 C 8.7354 2.7126 0.0 0
M  V30 3 O 9.0556 1.2061 0.0 0
M  V30 4 O 9.8798 3.7430 0.0 0
M  V30 5 O 1.5400 5.1455 0.0 0
M  V30 6 C 0.0000 5.1455 0.0 0
M  V30 7 C 4.6201 2.4782 0.0 0
M  V30 8 C 3.8500 1.1444 0.0 0
M  V30 9 C 6.1263 2.1579 0.0 0
M  V30 10 C 3.8500 3.8118 0.0 0
M  V30 11 N 4.8805 0.0000 0.0 0
M  V30 12 C 2.3100 1.1444 0.0 0
M  V30 13 C 6.2873 0.6263 0.0 0
M  V30 14 C 2.3100 3.8118 0.0 0
M  V30 15 C 1.5400 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-3-methoxybenzeneethanamine
C11H17NO2
36377-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 10.7800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Ethoxy-3-methoxyphenyl)ethyl]-5-methoxy-1H-indole-3-acetamide
C22H26N2O4
2020043-88-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5198 6.6684 0.0 0
M  V30 2 C 9.0598 6.6684 0.0 0
M  V30 3 N 9.8298 5.3347 0.0 0
M  V30 4 O 9.8298 8.0020 0.0 0
M  V30 5 C 11.3698 5.3347 0.0 0
M  V30 6 C 12.1398 4.0011 0.0 0
M  V30 7 O 1.4647 6.5780 0.0 0
M  V30 8 C 0.0000 7.0538 0.0 0
M  V30 9 O 16.7598 1.3336 0.0 0
M  V30 10 C 15.9898 0.0000 0.0 0
M  V30 11 O 18.2998 4.0011 0.0 0
M  V30 12 C 19.0698 5.3347 0.0 0
M  V30 13 C 20.6098 5.3347 0.0 0
M  V30 14 C 5.2181 8.1631 0.0 0
M  V30 15 C 6.7498 8.0020 0.0 0
M  V30 16 C 4.8980 9.6694 0.0 0
M  V30 17 C 4.0738 7.1325 0.0 0
M  V30 18 C 7.3761 9.4089 0.0 0
M  V30 19 N 6.2318 10.4394 0.0 0
M  V30 20 C 3.4334 10.1452 0.0 0
M  V30 21 C 2.6091 7.6085 0.0 0
M  V30 22 C 2.2889 9.1148 0.0 0
M  V30 23 C 13.6798 4.0011 0.0 0
M  V30 24 C 14.4498 2.6673 0.0 0
M  V30 25 C 14.4498 5.3347 0.0 0
M  V30 26 C 15.9898 2.6673 0.0 0
M  V30 27 C 15.9898 5.3347 0.0 0
M  V30 28 C 16.7598 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 28
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3471-31-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36377-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2020043-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23045625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
N-(4-Pyridinylcarbonyl)-L-phenylalanine
C15H14N2O3
98874-04-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0 CFG=2
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 7.7000 4.0011 0.0 0
M  V30 6 O 3.0800 1.3338 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 O 6.9300 5.3349 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.0100 5.3349 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 11.5500 5.3349 0.0 0
M  V30 19 C 11.5500 2.6674 0.0 0
M  V30 20 N 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 15
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenepropanamine, α-[(1E)-2-fluoro-2-[(phenylmethyl)sulfonyl]ethenyl]-, hyd...
C18H20FNO2S.ClH
2761157-71-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 S 5.3348 3.8500 0.0 0 VAL=6
M  V30 3 C 6.6686 4.6200 0.0 0
M  V30 4 O 6.1048 2.5164 0.0 0
M  V30 5 O 4.5648 5.1837 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 F 6.6686 6.1601 0.0 0
M  V30 8 C 9.3359 4.6200 0.0 0 CFG=1
M  V30 9 C 10.6697 3.8500 0.0 0
M  V30 10 N 9.3359 6.1601 0.0 0
M  V30 11 C 12.0034 4.6200 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 1.3338 3.0800 0.0 0
M  V30 14 C 2.6675 5.3900 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 1.3338 6.1601 0.0 0
M  V30 17 C 0.0000 5.3900 0.0 0
M  V30 18 C 13.3370 3.8500 0.0 0
M  V30 19 C 14.6707 4.6200 0.0 0
M  V30 20 C 13.3370 2.3100 0.0 0
M  V30 21 C 16.0045 3.8500 0.0 0
M  V30 22 C 14.6707 1.5400 0.0 0
M  V30 23 C 16.0045 2.3100 0.0 0
M  V30 24 Cl 8.0022 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 3 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 18
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2-[[(1S,2E)-3-Fluoro-1-(2-phenylethyl)-3-[(phenylmethyl)sulfonyl]-2-p...
C33H32FN3O4S
2761157-30-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 9.3358 0.0 0 CFG=2
M  V30 2 C 3.0800 9.3358 0.0 0
M  V30 3 C 5.3900 8.0021 0.0 0
M  V30 4 N 5.3900 10.6696 0.0 0
M  V30 5 N 6.9300 8.0021 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 C 4.6200 12.0032 0.0 0
M  V30 8 C 7.7000 6.6685 0.0 0 CFG=2
M  V30 9 O 3.0800 12.0032 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 9.2400 6.6685 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 10.0100 8.0021 0.0 0
M  V30 14 S 11.5500 8.0021 0.0 0 VAL=6
M  V30 15 F 9.2400 9.3358 0.0 0
M  V30 16 C 13.0900 8.0021 0.0 0
M  V30 17 O 11.5500 6.4621 0.0 0
M  V30 18 O 11.5500 9.5421 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 3.0800 6.6685 0.0 0
M  V30 22 C 0.0000 6.6685 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 0.7700 5.3347 0.0 0
M  V30 25 C 5.3900 13.3369 0.0 0
M  V30 26 C 6.9300 13.3369 0.0 0
M  V30 27 C 4.6200 14.6705 0.0 0
M  V30 28 C 7.7000 14.6705 0.0 0
M  V30 29 C 5.3900 16.0043 0.0 0
M  V30 30 N 6.9300 16.0043 0.0 0
M  V30 31 C 6.9300 2.6674 0.0 0
M  V30 32 C 7.7000 1.3338 0.0 0
M  V30 33 C 5.3900 2.6674 0.0 0
M  V30 34 C 6.9300 0.0000 0.0 0
M  V30 35 C 4.6200 1.3338 0.0 0
M  V30 36 C 5.3900 0.0000 0.0 0
M  V30 37 C 13.8600 9.3358 0.0 0
M  V30 38 C 13.0900 10.6694 0.0 0
M  V30 39 C 15.4000 9.3358 0.0 0
M  V30 40 C 13.8600 12.0032 0.0 0
M  V30 41 C 16.1700 10.6694 0.0 0
M  V30 42 C 15.4000 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 25
M  V30 11 1 8 10 CFG=3
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 1 12 31
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 2 14 18
M  V30 21 1 16 37
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98874-04-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761157-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5-Bromo-1H-indol-3-yl)acetic acid
C10H8BrNO2
40432-84-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5369 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 O 0.0000 2.6091 0.0 0
M  V30 4 O 0.5546 0.0000 0.0 0
M  V30 5 Br 8.4784 2.9553 0.0 0
M  V30 6 C 4.4773 3.7253 0.0 0
M  V30 7 C 4.4773 5.2653 0.0 0
M  V30 8 C 3.0127 3.2494 0.0 0
M  V30 9 C 5.8111 2.9553 0.0 0
M  V30 10 N 3.0127 5.7411 0.0 0
M  V30 11 C 5.8111 6.0353 0.0 0
M  V30 12 C 2.1075 4.4953 0.0 0
M  V30 13 C 7.1447 3.7253 0.0 0
M  V30 14 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-[2-(3,4-dimethoxyphenyl)ethyl]-1H-indole-3-acetamide
C20H21BrN2O3
2565618-06-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 6.6684 0.0 0
M  V30 2 C 7.5950 6.6684 0.0 0
M  V30 3 N 8.3650 5.3348 0.0 0
M  V30 4 O 8.3650 8.0021 0.0 0
M  V30 5 C 9.9050 5.3348 0.0 0
M  V30 6 C 10.6750 4.0011 0.0 0
M  V30 7 Br 0.0000 6.5780 0.0 0
M  V30 8 O 15.2951 1.3336 0.0 0
M  V30 9 C 14.5251 0.0000 0.0 0
M  V30 10 O 16.8351 4.0011 0.0 0
M  V30 11 C 17.6051 5.3348 0.0 0
M  V30 12 C 3.7535 8.1631 0.0 0
M  V30 13 C 3.4333 9.6694 0.0 0
M  V30 14 C 5.2850 8.0021 0.0 0
M  V30 15 C 2.6091 7.1326 0.0 0
M  V30 16 N 4.7670 10.4394 0.0 0
M  V30 17 C 1.9686 10.1453 0.0 0
M  V30 18 C 5.9115 9.4090 0.0 0
M  V30 19 C 1.1444 7.6086 0.0 0
M  V30 20 C 0.8242 9.1149 0.0 0
M  V30 21 C 12.2151 4.0011 0.0 0
M  V30 22 C 12.9851 2.6673 0.0 0
M  V30 23 C 12.9851 5.3348 0.0 0
M  V30 24 C 14.5251 2.6673 0.0 0
M  V30 25 C 14.5251 5.3348 0.0 0
M  V30 26 C 15.2951 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 21
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40432-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23040400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-2-methylindole-3-acetic acid
C12H13NO3
2882-15-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 1.9571 0.0 0
M  V30 2 C 1.1444 2.4329 0.0 0
M  V30 3 O 0.8242 3.9394 0.0 0
M  V30 4 O 0.0000 1.4025 0.0 0
M  V30 5 C 2.2588 5.2891 0.0 0
M  V30 6 O 8.3399 0.0000 0.0 0
M  V30 7 C 9.8799 0.0000 0.0 0
M  V30 8 C 5.2598 2.6673 0.0 0
M  V30 9 C 3.7535 2.9875 0.0 0
M  V30 10 C 6.0298 4.0010 0.0 0
M  V30 11 C 6.0298 1.3337 0.0 0
M  V30 12 C 3.5926 4.5191 0.0 0
M  V30 13 N 4.9994 5.1456 0.0 0
M  V30 14 C 7.5699 4.0010 0.0 0
M  V30 15 C 7.5699 1.3337 0.0 0
M  V30 16 C 8.3399 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(3,4-Dimethoxyphenyl)ethyl]-5-methoxy-2-methyl-1H-indole-3-acetamide
C22H26N2O4
1985862-30-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 6.6684 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 N 9.2400 5.3347 0.0 0
M  V30 4 O 9.2400 8.0020 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 10.1874 9.7291 0.0 0
M  V30 8 O 17.6051 6.5780 0.0 0
M  V30 9 C 19.0698 7.0538 0.0 0
M  V30 10 O 2.3100 1.3336 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 O 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 13.8517 8.1631 0.0 0
M  V30 15 C 12.3200 8.0020 0.0 0
M  V30 16 C 14.1719 9.6694 0.0 0
M  V30 17 C 14.9961 7.1325 0.0 0
M  V30 18 C 11.6937 9.4089 0.0 0
M  V30 19 N 12.8381 10.4394 0.0 0
M  V30 20 C 15.6364 10.1452 0.0 0
M  V30 21 C 16.4608 7.6085 0.0 0
M  V30 22 C 16.7809 9.1148 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.0800 2.6673 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 23
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 28
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2882-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1985862-30-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23045691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
4-[(3-Nitrophenyl)amino]-4-oxo-2-butenoic acid
C10H8N2O5
36847-90-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 O 13.3370 2.3101 0.0 0
M  V30 9 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 O 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0010 3.0801 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 4.0010 0.0000 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-3,4-dihydro-1H-quinolin-2-one
C9H10N2O
40615-17-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 O 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(3-Nitrophenyl)-N4-(1,2,3,4-tetrahydro-2-oxo-3-quinolinyl)-2-butenediamide
C19H16N4O5
2416338-29-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 5.3900 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 C 8.0021 5.3900 0.0 0
M  V30 4 O 6.6684 3.0800 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 C 10.6694 5.3900 0.0 0
M  V30 7 N 12.0032 4.6200 0.0 0
M  V30 8 O 10.6694 6.9300 0.0 0
M  V30 9 O 2.6674 6.9300 0.0 0
M  V30 10 N 17.3379 4.6200 0.0 0 VAL=5
M  V30 11 O 18.6716 5.3900 0.0 0
M  V30 12 O 17.3379 3.0800 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 1.3336 3.0800 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 2.6674 0.7700 0.0 0
M  V30 17 N 1.3336 4.6200 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 1.3336 0.0000 0.0 0
M  V30 21 C 2.6674 5.3900 0.0 0
M  V30 22 C 0.0000 0.7700 0.0 0
M  V30 23 C 13.3369 5.3900 0.0 0
M  V30 24 C 14.6705 4.6200 0.0 0
M  V30 25 C 13.3369 6.9300 0.0 0
M  V30 26 C 16.0041 5.3900 0.0 0
M  V30 27 C 14.6705 7.7000 0.0 0
M  V30 28 C 16.0041 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 23
M  V30 10 2 9 21
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 26
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36847-90-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40615-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416338-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21822011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 122-52-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase
inhibitors and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baihui; Shen, Yangli; Wu, Hu; Wu, Xiaobo; Yuan, Lvjiang; Ji, Qinggang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 195112278

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Benzeneacetic acid, 2-bromo-5-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-4-(phen...
C31H31BrO4Si
2983777-44-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 8.0021 0.0 0
M  V30 2 O 6.1600 8.0021 0.0 0
M  V30 3 C 4.6200 6.4621 0.0 0
M  V30 4 C 6.1600 6.4621 0.0 0
M  V30 5 C 4.6200 4.9221 0.0 0
M  V30 6 C 3.0800 6.4621 0.0 0
M  V30 7 O 9.2400 8.0021 0.0 0
M  V30 8 C 10.7800 8.0021 0.0 0
M  V30 9 C 6.1600 2.6674 0.0 0
M  V30 10 C 6.9300 1.3336 0.0 0
M  V30 11 O 6.1600 0.0000 0.0 0
M  V30 12 O 8.4700 1.3336 0.0 0
M  V30 13 Br 9.2400 2.6674 0.0 0
M  V30 14 C 3.0800 8.0021 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 9.3358 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 9.3358 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 C 4.6200 9.5421 0.0 0
M  V30 21 C 5.9536 10.3121 0.0 0
M  V30 22 C 3.2864 10.3121 0.0 0
M  V30 23 C 5.9536 11.8521 0.0 0
M  V30 24 C 3.2864 11.8521 0.0 0
M  V30 25 C 4.6200 12.6221 0.0 0
M  V30 26 C 6.9300 6.6685 0.0 0
M  V30 27 C 8.4700 6.6685 0.0 0
M  V30 28 C 6.1600 5.3347 0.0 0
M  V30 29 C 9.2400 5.3347 0.0 0
M  V30 30 C 6.9300 4.0011 0.0 0
M  V30 31 C 8.4700 4.0011 0.0 0
M  V30 32 C 11.5500 9.3358 0.0 0
M  V30 33 C 13.0900 9.3358 0.0 0
M  V30 34 C 10.7800 10.6694 0.0 0
M  V30 35 C 13.8600 10.6694 0.0 0
M  V30 36 C 11.5500 12.0032 0.0 0
M  V30 37 C 13.0900 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 26
M  V30 6 1 3 4
M  V30 7 1 3 5
M  V30 8 1 3 6
M  V30 9 1 7 8
M  V30 10 1 7 27
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 1 9 30
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 13 31
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Aminoethyl)-2-(phenylmethoxy)phenol
C15H17NO2
94026-91-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 11.5500 2.6674 0.0 0
M  V30 5 C 12.3200 4.0011 0.0 0
M  V30 6 N 13.8600 4.0011 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3338 0.0 0
M  V30 11 C 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 2-bromo-5-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-N-[2-[3-h...
C46H46BrNO5Si
2983777-45-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 9.2400 0.0 0
M  V30 2 O 4.6200 7.7000 0.0 0
M  V30 3 C 6.1600 9.2400 0.0 0
M  V30 4 C 6.1600 10.7800 0.0 0
M  V30 5 C 7.7000 9.2400 0.0 0
M  V30 6 C 6.1600 7.7000 0.0 0
M  V30 7 O 4.6200 4.6200 0.0 0
M  V30 8 C 4.6200 3.0800 0.0 0
M  V30 9 C 9.9547 7.7000 0.0 0
M  V30 10 C 11.2884 6.9300 0.0 0
M  V30 11 N 12.6221 7.7000 0.0 0
M  V30 12 O 11.2884 5.3900 0.0 0
M  V30 13 C 12.6221 9.2400 0.0 0
M  V30 14 C 13.9558 10.0100 0.0 0
M  V30 15 Br 9.9547 4.6200 0.0 0
M  V30 16 O 19.2905 10.0100 0.0 0
M  V30 17 O 19.2905 6.9300 0.0 0
M  V30 18 C 19.2905 5.3900 0.0 0
M  V30 19 C 4.6200 10.7800 0.0 0
M  V30 20 C 5.9536 11.5500 0.0 0
M  V30 21 C 3.2864 11.5500 0.0 0
M  V30 22 C 5.9536 13.0900 0.0 0
M  V30 23 C 3.2864 13.0900 0.0 0
M  V30 24 C 4.6200 13.8600 0.0 0
M  V30 25 C 3.0800 9.2400 0.0 0
M  V30 26 C 2.3100 7.9064 0.0 0
M  V30 27 C 2.3100 10.5736 0.0 0
M  V30 28 C 0.7700 7.9064 0.0 0
M  V30 29 C 0.7700 10.5736 0.0 0
M  V30 30 C 0.0000 9.2400 0.0 0
M  V30 31 C 5.9536 6.9300 0.0 0
M  V30 32 C 5.9536 5.3900 0.0 0
M  V30 33 C 7.2874 7.7000 0.0 0
M  V30 34 C 7.2874 4.6200 0.0 0
M  V30 35 C 8.6211 6.9300 0.0 0
M  V30 36 C 8.6211 5.3900 0.0 0
M  V30 37 C 3.2864 2.3100 0.0 0
M  V30 38 C 1.9527 3.0800 0.0 0
M  V30 39 C 3.2864 0.7700 0.0 0
M  V30 40 C 0.6189 2.3100 0.0 0
M  V30 41 C 1.9527 0.0000 0.0 0
M  V30 42 C 0.6189 0.7700 0.0 0
M  V30 43 C 15.2894 9.2400 0.0 0
M  V30 44 C 16.6232 10.0100 0.0 0
M  V30 45 C 15.2894 7.7000 0.0 0
M  V30 46 C 17.9569 9.2400 0.0 0
M  V30 47 C 16.6232 6.9300 0.0 0
M  V30 48 C 17.9569 7.7000 0.0 0
M  V30 49 C 20.6241 4.6200 0.0 0
M  V30 50 C 21.9579 5.3900 0.0 0
M  V30 51 C 20.6241 3.0800 0.0 0
M  V30 52 C 23.2916 4.6200 0.0 0
M  V30 53 C 21.9579 2.3100 0.0 0
M  V30 54 C 23.2916 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 2 31
M  V30 6 1 3 4
M  V30 7 1 3 5
M  V30 8 1 3 6
M  V30 9 1 7 8
M  V30 10 1 7 32
M  V30 11 1 8 37
M  V30 12 1 9 10
M  V30 13 1 9 35
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 11 13
M  V30 17 1 13 14
M  V30 18 1 14 43
M  V30 19 1 15 36
M  V30 20 1 16 46
M  V30 21 1 17 18
M  V30 22 1 17 48
M  V30 23 1 18 49
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 54 2 49 50
M  V30 55 1 49 51
M  V30 56 1 50 52
M  V30 57 2 51 53
M  V30 58 2 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2983777-44-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94026-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2983777-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38105797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Selective Dopamine Receptor Ligands Derived from
(-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Namballa, Hari K.; Dorogan, Michael; Gudipally, Ashok R.; Okafor, Sunday;
Gadhiya, Satishkumar; Harding, Wayne W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(14), 10060-10079

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
3,5-Dihydroxybenzoic acid
C7H6O4
99-10-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 O 0.0000 4.6200 0.0 0
M  V30 5 O 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-(trifluorome...
C21H27F3N2O3S
2415386-52-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8986 3.2864 0.0 0
M  V30 4 O 7.4387 5.9538 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0 CFG=1
M  V30 8 C 6.6687 1.5400 0.0 0
M  V30 9 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 C 6.6687 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 13.3372 3.8501 0.0 0
M  V30 14 N 12.0035 6.1601 0.0 0
M  V30 15 C 1.3338 7.7002 0.0 0
M  V30 16 F 2.1038 9.0338 0.0 0
M  V30 17 F 0.0000 8.4702 0.0 0
M  V30 18 F 0.5638 6.3665 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 4.0012 7.7002 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 2.6675 6.9302 0.0 0
M  V30 25 C 14.6708 4.6201 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 3.8501 0.0 0
M  V30 28 C 16.0045 6.9302 0.0 0
M  V30 29 C 17.3383 4.6201 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,5-Dihydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[[4-(trifluoromethyl)ph...
C28H31F3N2O6S
2892016-23-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 7.7000 0.0 0 VAL=6
M  V30 2 N 4.0011 9.2400 0.0 0
M  V30 3 O 5.5411 7.7000 0.0 0
M  V30 4 O 2.4611 7.7000 0.0 0
M  V30 5 C 5.3347 10.0100 0.0 0
M  V30 6 C 2.6674 10.0100 0.0 0
M  V30 7 C 6.6685 9.2400 0.0 0 CFG=1
M  V30 8 C 1.3338 9.2400 0.0 0
M  V30 9 C 8.0021 10.0100 0.0 0 CFG=1
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 C 0.0000 10.0100 0.0 0
M  V30 12 C 1.3338 7.7000 0.0 0
M  V30 13 C 8.0021 11.5500 0.0 0
M  V30 14 N 9.3358 9.2400 0.0 0
M  V30 15 C 10.6696 10.0100 0.0 0
M  V30 16 O 10.6696 11.5500 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 18 F 2.4611 1.5400 0.0 0
M  V30 19 F 4.0011 0.0000 0.0 0
M  V30 20 F 5.5411 1.5400 0.0 0
M  V30 21 O 16.0043 10.0100 0.0 0
M  V30 22 O 13.3369 5.3900 0.0 0
M  V30 23 C 4.0011 6.1600 0.0 0
M  V30 24 C 2.6674 5.3900 0.0 0
M  V30 25 C 5.3347 5.3900 0.0 0
M  V30 26 C 2.6674 3.8500 0.0 0
M  V30 27 C 5.3347 3.8500 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 6.6685 12.3200 0.0 0
M  V30 30 C 5.3347 11.5500 0.0 0
M  V30 31 C 6.6685 13.8600 0.0 0
M  V30 32 C 4.0011 12.3200 0.0 0
M  V30 33 C 5.3347 14.6300 0.0 0
M  V30 34 C 4.0011 13.8600 0.0 0
M  V30 35 C 12.0032 9.2400 0.0 0
M  V30 36 C 13.3369 10.0100 0.0 0
M  V30 37 C 12.0032 7.7000 0.0 0
M  V30 38 C 14.6705 9.2400 0.0 0
M  V30 39 C 13.3369 6.9300 0.0 0
M  V30 40 C 14.6705 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 23
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 35
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 28
M  V30 23 1 21 38
M  V30 24 1 22 39
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-10-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415386-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
4-Thiomorpholineacetic acid, 1,1-dioxide
C6H11NO4S
155480-08-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 3.7570 0.0 0
M  V30 2 C 6.8513 2.9870 0.0 0
M  V30 3 O 6.8513 1.4470 0.0 0
M  V30 4 O 8.1851 3.7570 0.0 0
M  V30 5 O 0.0000 1.7145 0.0 0
M  V30 6 O 0.9899 0.0000 0.0 0
M  V30 7 N 4.1840 2.9870 0.0 0
M  V30 8 C 4.1840 1.4470 0.0 0
M  V30 9 C 2.8504 3.7570 0.0 0
M  V30 10 C 2.8504 0.6770 0.0 0
M  V30 11 C 1.5166 2.9870 0.0 0
M  V30 12 S 1.5166 1.4470 0.0 0 VAL=6
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 12
M  V30 6 2 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Thiomorpholineacetamide, N-[(1S,2R)-2-hydroxy-3-[[(4-methoxyphenyl)sulfonyl...
C27H39N3O7S2
2765293-49-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 12.1863 7.6072 0.0 0 VAL=6
M  V30 2 N 10.8526 8.3772 0.0 0
M  V30 3 O 11.4163 6.2735 0.0 0
M  V30 4 O 12.9563 8.9410 0.0 0
M  V30 5 C 9.5189 7.6072 0.0 0
M  V30 6 C 10.8526 9.9172 0.0 0
M  V30 7 C 8.1853 8.3772 0.0 0 CFG=1
M  V30 8 C 12.1863 10.6872 0.0 0
M  V30 9 C 6.8515 7.6072 0.0 0 CFG=1
M  V30 10 O 8.1853 9.9172 0.0 0
M  V30 11 C 12.1863 12.2273 0.0 0
M  V30 12 C 13.5201 9.9172 0.0 0
M  V30 13 C 5.5178 8.3772 0.0 0
M  V30 14 N 6.8515 6.0671 0.0 0
M  V30 15 C 5.5178 5.2971 0.0 0
M  V30 16 C 5.5178 3.7571 0.0 0
M  V30 17 O 4.1841 6.0671 0.0 0
M  V30 18 O 17.5211 4.5271 0.0 0
M  V30 19 C 18.8549 5.2971 0.0 0
M  V30 20 O 0.9899 0.0000 0.0 0
M  V30 21 O 0.0000 1.7145 0.0 0
M  V30 22 C 13.5201 6.8371 0.0 0
M  V30 23 C 14.8538 7.6072 0.0 0
M  V30 24 C 13.5201 5.2971 0.0 0
M  V30 25 C 16.1874 6.8371 0.0 0
M  V30 26 C 14.8538 4.5271 0.0 0
M  V30 27 C 16.1874 5.2971 0.0 0
M  V30 28 C 5.5178 9.9172 0.0 0
M  V30 29 C 6.8515 10.6872 0.0 0
M  V30 30 C 4.1841 10.6872 0.0 0
M  V30 31 C 6.8515 12.2273 0.0 0
M  V30 32 C 4.1841 12.2273 0.0 0
M  V30 33 C 5.5178 12.9973 0.0 0
M  V30 34 N 4.1841 2.9870 0.0 0
M  V30 35 C 2.8504 3.7571 0.0 0
M  V30 36 C 4.1841 1.4470 0.0 0
M  V30 37 C 1.5166 2.9870 0.0 0
M  V30 38 C 2.8504 0.6770 0.0 0
M  V30 39 S 1.5166 1.4470 0.0 0 VAL=6
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 22
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=1
M  V30 14 1 9 14
M  V30 15 1 13 28
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 34
M  V30 20 1 18 19
M  V30 21 1 18 27
M  V30 22 2 20 39
M  V30 23 2 21 39
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 1 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 155480-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-D-phenylalanine
C14H19NO4
18942-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=2
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclohexaneacetic acid, 1-(aminomethyl)-, phenylmethyl ester, 2,2,2-trifluoro...
C16H23NO2.C2HF3O2
2413279-26-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3668 8.5807 0.0 0
M  V30 2 C 5.7006 7.8107 0.0 0
M  V30 3 O 7.0343 8.5807 0.0 0
M  V30 4 O 5.7006 6.2707 0.0 0
M  V30 5 C 8.3679 7.8107 0.0 0
M  V30 6 C 4.0231 6.6309 0.0 0
M  V30 7 N 3.4964 5.1837 0.0 0
M  V30 8 C 3.0332 7.8107 0.0 0
M  V30 9 C 2.5065 9.2578 0.0 0
M  V30 10 C 2.0433 6.6309 0.0 0
M  V30 11 C 0.9899 9.5251 0.0 0
M  V30 12 C 0.5267 6.8984 0.0 0
M  V30 13 C 0.0000 8.3455 0.0 0
M  V30 14 C 9.7015 8.5807 0.0 0
M  V30 15 C 11.0353 7.8107 0.0 0
M  V30 16 C 9.7015 10.1207 0.0 0
M  V30 17 C 12.3690 8.5807 0.0 0
M  V30 18 C 11.0353 10.8907 0.0 0
M  V30 19 C 12.3690 10.1207 0.0 0
M  V30 20 C 5.5177 2.3101 0.0 0
M  V30 21 C 6.8513 1.5400 0.0 0
M  V30 22 F 6.2877 3.6437 0.0 0
M  V30 23 F 4.1840 3.0801 0.0 0
M  V30 24 F 4.7476 0.9764 0.0 0
M  V30 25 O 8.1850 2.3101 0.0 0
M  V30 26 O 6.8513 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 1-[[[(2R)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-3-phenyl...
C30H40N2O5
2413279-27-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 5.3901 0.0 0
M  V30 2 N 9.3359 4.6201 0.0 0
M  V30 3 C 8.0021 5.3901 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 5 O 8.0021 6.9301 0.0 0
M  V30 6 C 6.6685 3.0800 0.0 0
M  V30 7 N 5.3348 5.3901 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 O 2.6673 5.3901 0.0 0
M  V30 10 O 4.0011 3.0800 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.5636 5.9537 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 2.1037 3.2864 0.0 0
M  V30 15 C 12.1862 6.6628 0.0 0
M  V30 16 C 13.1761 7.8424 0.0 0
M  V30 17 O 14.6928 7.5751 0.0 0
M  V30 18 O 12.6495 9.2896 0.0 0
M  V30 19 C 15.6827 8.7547 0.0 0
M  V30 20 C 10.6696 6.9301 0.0 0
M  V30 21 C 9.1530 6.6628 0.0 0
M  V30 22 C 11.1963 8.3773 0.0 0
M  V30 23 C 8.1631 7.8424 0.0 0
M  V30 24 C 10.2064 9.5569 0.0 0
M  V30 25 C 8.6897 9.2896 0.0 0
M  V30 26 C 17.1993 8.4874 0.0 0
M  V30 27 C 18.1892 9.6670 0.0 0
M  V30 28 C 17.7260 7.0402 0.0 0
M  V30 29 C 19.7058 9.3995 0.0 0
M  V30 30 C 19.2426 6.7727 0.0 0
M  V30 31 C 20.2325 7.9525 0.0 0
M  V30 32 C 8.0021 2.3100 0.0 0
M  V30 33 C 8.0021 0.7700 0.0 0
M  V30 34 C 9.3359 3.0800 0.0 0
M  V30 35 C 9.3359 0.0000 0.0 0
M  V30 36 C 10.6696 2.3100 0.0 0
M  V30 37 C 10.6696 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 4 7
M  V30 8 1 6 32
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 20
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 19 26
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18942-49-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2413279-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413279-27-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21978534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meena, Chhuttan L.; Singh, Dharmendra; Weinmuller, Michael; Reichart,
Florian; Dangi, Abha; Marelli, Udaya Kiran; Zahler, Stefan; Sanjayan,
Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
3-(Trifluoromethoxy)aniline
C7H6F3NO
1535-73-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 3.0800 0.0 0
M  V30 2 C 1.3337 2.3100 0.0 0
M  V30 3 F 1.3337 0.7700 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 N 8.0022 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 6.6686 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6686 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(1,1-Dimethylethoxy)carbonyl]amino]-N-[(phenylmethoxy)carbonyl]-D-alanine
C16H22N2O6
62234-36-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.3436 5.3347 0.0 0
M  V30 2 O 10.5736 4.0011 0.0 0
M  V30 3 C 9.0336 4.0011 0.0 0
M  V30 4 N 8.2636 2.6674 0.0 0
M  V30 5 O 8.2636 5.3347 0.0 0
M  V30 6 C 6.7236 2.6674 0.0 0 CFG=1
M  V30 7 C 5.9536 4.0011 0.0 0
M  V30 8 C 5.9536 1.3336 0.0 0
M  V30 9 N 4.4136 4.0011 0.0 0
M  V30 10 O 4.4136 1.3336 0.0 0
M  V30 11 O 6.7236 0.0000 0.0 0
M  V30 12 C 3.6436 5.3347 0.0 0
M  V30 13 O 2.1036 5.3347 0.0 0
M  V30 14 O 4.4136 6.6685 0.0 0
M  V30 15 C 1.3336 6.6685 0.0 0
M  V30 16 C 2.6673 7.4385 0.0 0
M  V30 17 C 0.5636 8.0021 0.0 0
M  V30 18 C 0.0000 5.8985 0.0 0
M  V30 19 C 12.8836 5.3347 0.0 0
M  V30 20 C 13.6536 4.0011 0.0 0
M  V30 21 C 13.6536 6.6685 0.0 0
M  V30 22 C 15.1936 4.0011 0.0 0
M  V30 23 C 15.1936 6.6685 0.0 0
M  V30 24 C 15.9636 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1R)-1-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-2-oxo-2-...
C23H26F3N3O6
2682842-35-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 8.0022 0.0 0 CFG=1
M  V30 2 C 9.2402 8.0022 0.0 0
M  V30 3 N 6.9302 9.3358 0.0 0
M  V30 4 C 6.9302 6.6685 0.0 0
M  V30 5 N 10.0102 9.3358 0.0 0
M  V30 6 O 10.0102 6.6685 0.0 0
M  V30 7 C 5.3901 9.3358 0.0 0
M  V30 8 N 7.7002 5.3348 0.0 0
M  V30 9 O 4.6201 10.6697 0.0 0
M  V30 10 O 4.6201 8.0022 0.0 0
M  V30 11 C 6.9302 4.0010 0.0 0
M  V30 12 C 3.0801 10.6697 0.0 0
M  V30 13 O 7.7002 2.6673 0.0 0
M  V30 14 O 5.3901 4.0010 0.0 0
M  V30 15 C 6.9302 1.3337 0.0 0
M  V30 16 C 5.5965 2.1037 0.0 0
M  V30 17 C 6.1601 0.0000 0.0 0
M  V30 18 C 8.2638 0.5637 0.0 0
M  V30 19 O 14.6303 12.0033 0.0 0
M  V30 20 C 16.1704 12.0033 0.0 0
M  V30 21 F 16.9404 13.3370 0.0 0
M  V30 22 F 17.7104 12.0033 0.0 0
M  V30 23 F 16.9404 10.6697 0.0 0
M  V30 24 C 11.5503 9.3358 0.0 0
M  V30 25 C 12.3203 10.6697 0.0 0
M  V30 26 C 12.3203 8.0022 0.0 0
M  V30 27 C 13.8603 10.6697 0.0 0
M  V30 28 C 13.8603 8.0022 0.0 0
M  V30 29 C 14.6303 9.3358 0.0 0
M  V30 30 C 2.3101 12.0033 0.0 0
M  V30 31 C 3.0801 13.3370 0.0 0
M  V30 32 C 0.7700 12.0033 0.0 0
M  V30 33 C 2.3101 14.6707 0.0 0
M  V30 34 C 0.0000 13.3370 0.0 0
M  V30 35 C 0.7700 14.6707 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 24
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 30
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 27
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1535-73-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62234-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2682842-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23939243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with
Antibacterial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamada, Yousuke; Takashima, Hajime; Walmsley, David Lee; Ushiyama,
Fumihito; Matsuda, Yohei; Kanazawa, Harumi; Yamaguchi-Sasaki, Toru;
Tanaka-Yamamoto, Nozomi; Yamagishi, Junya; Kurimoto-Tsuruta, Risa; Ogata,
Yuya; Ohtake, Norikazu; Angove, Hayley; Baker, Lisa; Harris, Richard;
Macias, Alba; Robertson, Alan; Surgenor, Allan; Watanabe, Hayato; Nakano,
Koichiro; Mima, Masashi; Iwamoto, Kunihiko; Okada, Atsushi; Takata,
Iichiro; Hitaka, Kosuke; Tanaka, Akihiro; Fujita, Kiyoko; Sugiyama,
Hiroyuki; Hubbard, Roderick E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(23), 14805-14820

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
5-Methoxytryptamine
C11H14N2O
608-07-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.1885 0.0 0
M  V30 2 C 8.7355 2.7126 0.0 0
M  V30 3 N 9.8799 3.7431 0.0 0
M  V30 4 O 1.5400 5.1456 0.0 0
M  V30 5 C 0.0000 5.1456 0.0 0
M  V30 6 C 4.6201 2.4782 0.0 0
M  V30 7 C 3.8501 1.1444 0.0 0
M  V30 8 C 6.1264 2.1579 0.0 0
M  V30 9 C 3.8501 3.8119 0.0 0
M  V30 10 N 4.8805 0.0000 0.0 0
M  V30 11 C 2.3101 1.1444 0.0 0
M  V30 12 C 6.2873 0.6263 0.0 0
M  V30 13 C 2.3101 3.8119 0.0 0
M  V30 14 C 1.5400 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-[[2-(5-methoxy-1H-indol-3-yl)ethyl]amino]-2-oxoethyl]-, 1,1...
C18H25N3O4
150184-21-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7052 3.4261 0.0 0
M  V30 2 C 8.0390 4.1961 0.0 0
M  V30 3 N 9.3726 3.4261 0.0 0
M  V30 4 C 10.7063 4.1961 0.0 0
M  V30 5 C 12.0400 3.4261 0.0 0
M  V30 6 O 10.7063 5.7362 0.0 0
M  V30 7 N 13.3738 4.1961 0.0 0
M  V30 8 C 14.7075 3.4261 0.0 0
M  V30 9 O 16.0411 4.1961 0.0 0
M  V30 10 O 14.7075 1.8861 0.0 0
M  V30 11 C 17.3748 3.4261 0.0 0
M  V30 12 C 18.1448 4.7598 0.0 0
M  V30 13 C 18.7086 2.6561 0.0 0
M  V30 14 C 16.6048 2.0924 0.0 0
M  V30 15 O 1.5065 0.3203 0.0 0
M  V30 16 C 0.0000 0.0000 0.0 0
M  V30 17 C 3.9647 3.5698 0.0 0
M  V30 18 C 2.9341 4.7142 0.0 0
M  V30 19 C 5.3715 4.1961 0.0 0
M  V30 20 C 3.4886 2.1051 0.0 0
M  V30 21 N 3.7041 6.0480 0.0 0
M  V30 22 C 1.4278 4.3940 0.0 0
M  V30 23 C 5.2106 5.7277 0.0 0
M  V30 24 C 1.9823 1.7849 0.0 0
M  V30 25 C 0.9519 2.9295 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 24
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 23
M  V30 25 1 22 25
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 608-07-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 150184-21-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31915608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit
Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects
in a Pharmacological Alzheimer's Disease Mouse Model
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Feng; Chou, C. James; Scheiner, Matthias; Poeta, Eleonora; Yuan Chen,
Natalia; Gunesch, Sandra; Hoffmann, Matthias; Sotriffer, Christoph;
Monti, Barbara; Maurice, Tangui; Decker, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(7), 3794-3812

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Lupa-12,20(29)-dien-28-oic acid, 3-(acetyloxy)-, (3β)-
C32H48O4
107277-31-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5317 6.2609 0.0 0
M  V30 2 O 2.1580 7.6677 0.0 0
M  V30 3 O 0.0000 6.0998 0.0 0
M  V30 4 C 2.4965 1.0304 0.0 0
M  V30 5 C 1.3521 0.0000 0.0 0
M  V30 6 C 3.9612 0.5546 0.0 0
M  V30 7 C 5.6510 6.5490 0.0 0
M  V30 8 C 6.9226 6.5490 0.0 0
M  V30 9 C 9.2326 2.1471 0.0 0
M  V30 10 C 13.1239 5.5417 0.0 0
M  V30 11 C 11.4094 6.5316 0.0 0
M  V30 12 O 13.9869 3.6812 0.0 0
M  V30 13 C 14.7569 2.3476 0.0 0
M  V30 14 C 13.9869 1.0139 0.0 0
M  V30 15 O 16.2969 2.3476 0.0 0
M  V30 16 C 3.2069 3.6812 0.0 0 CFG=2
M  V30 17 C 2.4369 5.0149 0.0 0 CFG=1
M  V30 18 C 4.7469 3.6812 0.0 0
M  V30 19 C 2.1763 2.5368 0.0 0 CFG=2
M  V30 20 C 3.2069 6.3487 0.0 0
M  V30 21 C 0.9305 4.6947 0.0 0
M  V30 22 C 5.5169 5.0149 0.0 0 CFG=1
M  V30 23 C 5.5169 2.3476 0.0 0
M  V30 24 C 0.7695 3.1632 0.0 0
M  V30 25 C 4.7469 6.3487 0.0 0
M  V30 26 C 7.0569 5.0149 0.0 0 CFG=1
M  V30 27 C 7.0569 2.3476 0.0 0
M  V30 28 C 7.8269 3.6812 0.0 0 CFG=1
M  V30 29 C 7.8269 6.3487 0.0 0
M  V30 30 C 9.3669 3.6812 0.0 0 CFG=2
M  V30 31 C 9.3669 6.3487 0.0 0
M  V30 32 C 10.1369 5.0149 0.0 0 CFG=2
M  V30 33 C 10.1369 2.3476 0.0 0
M  V30 34 C 11.6769 5.0149 0.0 0
M  V30 35 C 11.6769 2.3476 0.0 0
M  V30 36 C 12.4469 3.6812 0.0 0 CFG=1
M  V30 37 H 3.8332 2.2744 0.0 0
M  V30 38 H 7.9610 2.1471 0.0 0
M  V30 39 H 10.9069 6.3487 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 19 4 CFG=3
M  V30 7 1 22 7 CFG=3
M  V30 8 1 26 8 CFG=1
M  V30 9 1 30 9 CFG=1
M  V30 10 1 10 34
M  V30 11 1 11 34
M  V30 12 1 12 13
M  V30 13 1 36 12 CFG=1
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 37 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 28
M  V30 33 1 28 30
M  V30 34 1 28 38 CFG=3
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 30 33
M  V30 38 1 31 32
M  V30 39 1 32 34
M  V30 40 1 32 39 CFG=3
M  V30 41 1 33 35
M  V30 42 1 34 36
M  V30 43 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 16 17 19 22 26 28 30 32 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethylenediamine
C2H8N2
107-15-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 N 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β)-3-(Acetyloxy)-N-(2-aminoethyl)lupa-12,20(29)-dien-28-amide
C34H54N2O3
2691784-99-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.7437 5.5118 0.0 0
M  V30 2 N 15.9897 4.6066 0.0 0
M  V30 3 O 14.9048 7.0434 0.0 0
M  V30 4 C 17.3965 5.2329 0.0 0
M  V30 5 C 18.6424 4.3279 0.0 0
M  V30 6 N 20.0493 4.9542 0.0 0
M  V30 7 C 11.2930 1.4647 0.0 0
M  V30 8 C 11.7689 0.0000 0.0 0
M  V30 9 C 9.7866 1.7849 0.0 0
M  V30 10 C 11.3204 7.8212 0.0 0
M  V30 11 C 10.2192 8.4569 0.0 0
M  V30 12 C 6.0176 5.7997 0.0 0
M  V30 13 C 4.3450 10.6852 0.0 0
M  V30 14 C 6.3246 10.6852 0.0 0
M  V30 15 O 2.6674 9.5055 0.0 0
M  V30 16 C 1.3338 8.7354 0.0 0
M  V30 17 C 1.3338 7.1954 0.0 0
M  V30 18 O 0.0000 9.5054 0.0 0
M  V30 19 C 13.3369 4.8855 0.0 0 CFG=1
M  V30 20 C 12.0033 4.1155 0.0 0 CFG=2
M  V30 21 C 13.3369 6.4255 0.0 0
M  V30 22 C 14.4813 3.8549 0.0 0
M  V30 23 C 10.6695 4.8855 0.0 0
M  V30 24 C 12.3234 2.6091 0.0 0 CFG=2
M  V30 25 C 12.0033 7.1955 0.0 0
M  V30 26 C 13.8550 2.4481 0.0 0
M  V30 27 C 10.6695 6.4255 0.0 0 CFG=1
M  V30 28 C 9.3358 4.1155 0.0 0
M  V30 29 C 9.3358 7.1955 0.0 0 CFG=1
M  V30 30 C 8.0022 4.8855 0.0 0
M  V30 31 C 8.0022 6.4255 0.0 0 CFG=1
M  V30 32 C 9.3358 8.7355 0.0 0
M  V30 33 C 6.6685 7.1955 0.0 0 CFG=2
M  V30 34 C 8.0022 9.5055 0.0 0
M  V30 35 C 6.6685 8.7355 0.0 0 CFG=2
M  V30 36 C 5.3347 6.4255 0.0 0
M  V30 37 C 5.3347 9.5055 0.0 0
M  V30 38 C 4.0011 7.1955 0.0 0
M  V30 39 C 4.0011 8.7355 0.0 0 CFG=1
M  V30 40 H 10.7574 3.2103 0.0 0
M  V30 41 H 7.1188 5.1639 0.0 0
M  V30 42 H 6.6685 10.2755 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 24 7 CFG=1
M  V30 10 1 27 10 CFG=1
M  V30 11 1 29 11 CFG=3
M  V30 12 1 33 12 CFG=3
M  V30 13 1 13 37
M  V30 14 1 14 37
M  V30 15 1 15 16
M  V30 16 1 39 15 CFG=3
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 20 40 CFG=1
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 2 23 28
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 30 31
M  V30 36 1 31 33
M  V30 37 1 31 41 CFG=1
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 33 36
M  V30 41 1 34 35
M  V30 42 1 35 37
M  V30 43 1 35 42 CFG=1
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 19 20 24 27 29 31 33 35 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107277-31-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2691784-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24128601
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic
reticulum
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kraft, Oliver; Kozubek, Marie; Hoenke, Sophie; Serbian, Immo; Major,
Daniel; Csuk, Rene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 209112920

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Leucine methyl ester hydrochloride
C7H15NO2.ClH
7517-19-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 2 C 5.3347 3.0800 0.0 0
M  V30 3 C 2.6674 3.0800 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 6.6685 3.8500 0.0 0
M  V30 6 O 5.3347 1.5400 0.0 0
M  V30 7 C 1.3336 3.8500 0.0 0
M  V30 8 C 8.0021 3.0800 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 Cl 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Methoxy-1H-indole-2-carboxylic acid
C10H9NO3
103260-65-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.4944 0.0 0
M  V30 2 C 0.0000 1.4944 0.0 0
M  V30 3 C 7.6211 1.5400 0.0 0
M  V30 4 O 8.9549 2.3100 0.0 0
M  V30 5 O 7.6211 0.0000 0.0 0
M  V30 6 C 3.8501 2.8281 0.0 0
M  V30 7 C 4.6201 4.1618 0.0 0
M  V30 8 C 2.3100 2.8281 0.0 0
M  V30 9 C 4.8806 1.6836 0.0 0
M  V30 10 N 6.1265 3.8416 0.0 0
M  V30 11 C 3.8501 5.4954 0.0 0
M  V30 12 C 1.5400 4.1618 0.0 0
M  V30 13 C 6.2875 2.3100 0.0 0
M  V30 14 C 2.3100 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Leucine, N-[(4-methoxy-1H-indol-2-yl)carbonyl]-, methyl ester
C17H22N2O4
2640981-14-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.4159 3.8045 0.0 0
M  V30 2 C 12.9559 3.8045 0.0 0
M  V30 3 C 5.3348 3.8501 0.0 0
M  V30 4 N 4.0011 4.6201 0.0 0
M  V30 5 O 5.3348 2.3100 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0 CFG=1
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 O 1.3337 6.1601 0.0 0
M  V30 10 O 0.0000 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 0.0000 6.9301 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 9.1059 5.1381 0.0 0
M  V30 16 C 8.3359 6.4718 0.0 0
M  V30 17 C 10.6459 5.1381 0.0 0
M  V30 18 C 8.0754 3.9936 0.0 0
M  V30 19 N 6.8296 6.1516 0.0 0
M  V30 20 C 9.1059 7.8055 0.0 0
M  V30 21 C 11.4159 6.4718 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 C 10.6459 7.8055 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 22
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7517-19-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103260-65-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2640981-14-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35464719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 616-47-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Early Clinical Development of Lufotrelvir as a Potential Therapy for
COVID-19
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allais, Christophe; Bernhardson, David; Brown, Adam R.; Chinigo, Gary M.;
Desrosiers, Jean-Nicolas; DiRico, Kenneth J.; Hotham, Ian; Jones, Brian
P.; Kulkarni, Samir A.; Lewis, Chad A.; Lira, Ricardo; Loach, Richard P.;
Morse, Peter D.; Mousseau, James J.; Perry, Matthew A.; Peng, Zhihui;
Place, David W.; Rane, Anil M.; Samp, Lacey; Singer, Robert A.; Wang,
Zheng; Weisenburger, Gerald A.; Yayla, Hatice G.; Zanghi, Joseph M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(12), 2223-2239

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
1,4-Dihydro-6-methyl-4-oxo-1-phenyl-3-pyridazinecarboxylic acid
C12H10N2O3
68254-08-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.3901 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 O 8.0022 0.7700 0.0 0
M  V30 4 O 9.3359 3.0800 0.0 0
M  V30 5 O 8.0022 5.3901 0.0 0
M  V30 6 N 4.0011 3.0800 0.0 0
M  V30 7 N 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 6.6684 3.0800 0.0 0
M  V30 10 C 5.3348 5.3901 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 1.3337 3.0800 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, 4-bromo-2,6-difluoro-, hydrochloride (1:1)
C7H6BrF2N.ClH
1461655-72-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.2074 0.0 0
M  V30 2 N 0.0000 5.5411 0.0 0
M  V30 3 F 2.3100 6.8749 0.0 0
M  V30 4 F 2.3100 1.5400 0.0 0
M  V30 5 Br 6.9300 4.2074 0.0 0
M  V30 6 C 2.3100 4.2074 0.0 0
M  V30 7 C 3.0800 5.5411 0.0 0
M  V30 8 C 3.0800 2.8738 0.0 0
M  V30 9 C 4.6200 5.5411 0.0 0
M  V30 10 C 4.6200 2.8738 0.0 0
M  V30 11 C 5.3900 4.2074 0.0 0
M  V30 12 Cl 3.4650 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridazinecarboxamide, N-[(4-bromo-2,6-difluorophenyl)methyl]-1,4-dihydro-6...
C19H14BrF2N3O2
3033748-36-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 9.3358 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 9.2400 4.0011 0.0 0
M  V30 4 O 6.9300 2.6674 0.0 0
M  V30 5 C 10.0100 2.6674 0.0 0
M  V30 6 O 9.2400 6.6684 0.0 0
M  V30 7 F 11.5500 0.0000 0.0 0
M  V30 8 F 11.5500 5.3347 0.0 0
M  V30 9 Br 16.1700 2.6674 0.0 0
M  V30 10 N 4.6200 6.6684 0.0 0
M  V30 11 N 5.3900 5.3347 0.0 0
M  V30 12 C 5.3900 8.0021 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 6.9300 8.0021 0.0 0
M  V30 15 C 7.7000 6.6684 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 23 C 12.3200 1.3336 0.0 0
M  V30 24 C 12.3200 4.0011 0.0 0
M  V30 25 C 13.8600 1.3336 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 C 14.6300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 22
M  V30 7 2 6 15
M  V30 8 1 7 23
M  V30 9 1 8 24
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 68254-08-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1461655-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033748-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36975263
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Structure-Based Design of Inhibitors of the WD
Repeat-Containing Protein 5 (WDR5)-MYC Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Jian; Liu, Lulu; Chiang, Ying-Ling; Zhao, Mengxi; Liu, Hejun; Yang,
Fei; Shen, Lingling; Lin, Ying; Deng, Huiwen; Gao, Jingyan; Sage, David
R.; West, Laura; Llamas, Luis A.; Hao, Xin; Kawatkar, Sameer; Li, En;
Jain, Rishi K.; Tallarico, John A.; Canham, Stephen M.; Wang, He
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(12), 8310-8323

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
1,4-Dihydro-4-oxo-3-(phenylmethoxy)-2-pyridinecarboxylic acid
C13H11NO4
119736-17-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 N 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 2 6 9
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-1,1,1-Trifluoro-2-propanamine
C3H6F3N
779303-24-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0 CFG=2
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 N 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,4-Dihydro-4-oxo-3-(phenylmethoxy)-N-[(1R)-2,2,2-trifluoro-1-methylethyl]-2-...
C16H15F3N2O3
2640348-70-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 N 9.2400 4.0011 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0 CFG=2
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 9.2400 6.6685 0.0 0
M  V30 7 F 13.0900 5.3347 0.0 0
M  V30 8 F 11.5500 6.8747 0.0 0
M  V30 9 F 11.5500 3.7947 0.0 0
M  V30 10 O 4.6200 4.0011 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 O 3.0800 1.3336 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 N 7.7000 1.3336 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 C 6.9300 0.0000 0.0 0
M  V30 18 C 5.3900 0.0000 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 3.0800 6.6685 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 2.3100 8.0021 0.0 0
M  V30 23 C 0.0000 6.6685 0.0 0
M  V30 24 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 1 10 14
M  V30 12 1 11 19
M  V30 13 2 12 16
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 119736-17-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 779303-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2640348-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23753109
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the
influenza cap-dependent endonuclease inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taoda, Yoshiyuki; Miyagawa, Masayoshi; Akiyama, Toshiyuki; Tomita, Kenji;
Hasegawa, Yasushi; Yoshida, Ryu; Noshi, Takeshi; Shishido, Takao; Kawai,
Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
2,3,3-Trichloro-2-propenoic acid
C3HCl3O2
2257-35-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 Cl 2.6674 0.0000 0.0 0
M  V30 5 Cl 4.0011 3.8500 0.0 0
M  V30 6 Cl 5.3349 1.5400 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 O 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-N-ethyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxamide
C13H13F3N4O
2763378-74-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5894 1.4647 0.0 0
M  V30 2 F 8.0539 0.9888 0.0 0
M  V30 3 F 6.1135 0.0000 0.0 0
M  V30 4 F 5.1247 1.9406 0.0 0
M  V30 5 C 9.7758 2.5000 0.0 0
M  V30 6 N 11.1826 3.1264 0.0 0
M  V30 7 O 9.6147 0.9684 0.0 0
M  V30 8 C 12.4284 2.2211 0.0 0
M  V30 9 C 13.8354 2.8476 0.0 0
M  V30 10 N 0.0000 4.1752 0.0 0
M  V30 11 C 7.0652 2.9292 0.0 0
M  V30 12 N 6.1600 4.1752 0.0 0
M  V30 13 C 8.5299 3.4052 0.0 0
M  V30 14 N 7.0652 5.4211 0.0 0
M  V30 15 C 8.5299 4.9452 0.0 0
M  V30 16 C 4.6200 4.1752 0.0 0
M  V30 17 C 3.8500 5.5089 0.0 0
M  V30 18 C 3.8500 2.8415 0.0 0
M  V30 19 C 2.3100 5.5089 0.0 0
M  V30 20 C 2.3100 2.8415 0.0 0
M  V30 21 C 1.5400 4.1752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 21
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 12 16
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-1-[4-[(2,3,3-trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoro...
C16H12Cl3F3N4O2
2763378-75-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2094 6.7115 0.0 0
M  V30 2 F 12.6739 7.1875 0.0 0
M  V30 3 F 10.7335 8.1762 0.0 0
M  V30 4 F 9.7447 6.2356 0.0 0
M  V30 5 C 14.3958 5.6763 0.0 0
M  V30 6 N 15.8026 5.0498 0.0 0
M  V30 7 O 14.2347 7.2078 0.0 0
M  V30 8 C 17.0484 5.9550 0.0 0
M  V30 9 C 18.4554 5.3287 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 2.3100 2.6673 0.0 0
M  V30 13 O 4.6200 1.3336 0.0 0
M  V30 14 C 1.5400 1.3336 0.0 0
M  V30 15 Cl 1.5400 4.0011 0.0 0
M  V30 16 Cl 0.0000 1.3336 0.0 0
M  V30 17 Cl 2.3100 0.0000 0.0 0
M  V30 18 N 10.7800 4.0011 0.0 0
M  V30 19 C 11.6852 5.2469 0.0 0
M  V30 20 N 11.6852 2.7552 0.0 0
M  V30 21 C 13.1499 4.7711 0.0 0
M  V30 22 C 13.1499 3.2311 0.0 0
M  V30 23 C 9.2400 4.0011 0.0 0
M  V30 24 C 8.4700 2.6673 0.0 0
M  V30 25 C 8.4700 5.3347 0.0 0
M  V30 26 C 6.9300 2.6673 0.0 0
M  V30 27 C 6.9300 5.3347 0.0 0
M  V30 28 C 6.1600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 23
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2257-35-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2763378-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2763378-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31713170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High
Metabolic Stability and Low Toxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Sicheng; Romero, Luis O.; Deng, Shanshan; Wang, Jiaxing; Li, Yong;
Yang, Lei; Hamilton, David J.; Miller, Duane D.; Liao, Francesca-Fang;
Cordero-Morales, Julio F.; Wu, Zhongzhi; Li, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2021), 12(4), 572-578

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-2-chloroisonicotinic acid
C6H5ClN2O2
58483-95-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 N 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloropyrido[3,4-d]pyrimidin-4(3H)-one
C7H4ClN3O
171178-47-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 N 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58483-95-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171178-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37375870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated
necroptosis inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Namkyoung; Park, Chan-Jung; Kim, Younghoon; Ryu, SeongShick; Cho,
Hanna; Nam, Yunju; Han, Myeonggil; Shin, Jeon-Soo; Sim, Taebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115635

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 2-[[(phenylmethoxy)carbonyl]amino]-
C15H13NO4
63254-88-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 7.7000 6.6685 0.0 0
M  V30 6 C 3.0800 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 4.6200 1.3336 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 5.3347 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 10.0100 8.0021 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 11.5500 8.0021 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 12.3200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 10
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-(4-aminophenyl)cyclopropyl]carbamate
C14H20N2O2
1642574-87-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 2.8736 0.0 0
M  V30 2 C 3.8500 2.8736 0.0 0
M  V30 3 O 3.0800 1.5400 0.0 0
M  V30 4 O 3.0800 4.2073 0.0 0
M  V30 5 C 1.5400 1.5400 0.0 0
M  V30 6 C 1.5400 3.0800 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 N 13.6536 4.9773 0.0 0
M  V30 10 C 7.4936 4.9773 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 5.7473 0.0 0
M  V30 13 C 9.0336 4.9773 0.0 0
M  V30 14 C 9.8036 6.3109 0.0 0
M  V30 15 C 9.8036 3.6436 0.0 0
M  V30 16 C 11.3436 6.3109 0.0 0
M  V30 17 C 11.3436 3.6436 0.0 0
M  V30 18 C 12.1136 4.9773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C29H31N3O5
2414143-93-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 17.5040 4.0010 0.0 0
M  V30 2 C 18.2740 2.6673 0.0 0
M  V30 3 O 19.8141 2.6673 0.0 0
M  V30 4 O 17.5040 1.3337 0.0 0
M  V30 5 C 20.5841 1.3337 0.0 0
M  V30 6 C 21.9178 2.1037 0.0 0
M  V30 7 C 21.3541 0.0000 0.0 0
M  V30 8 C 19.2504 0.5637 0.0 0
M  V30 9 N 11.5503 10.1060 0.0 0
M  V30 10 C 10.0102 10.1060 0.0 0
M  V30 11 O 9.2402 8.7722 0.0 0
M  V30 12 N 6.9302 10.1060 0.0 0
M  V30 13 C 5.3901 10.1060 0.0 0
M  V30 14 O 4.6201 8.7722 0.0 0
M  V30 15 O 4.6201 11.4397 0.0 0
M  V30 16 C 3.0801 8.7722 0.0 0
M  V30 17 C 14.6303 4.7710 0.0 0
M  V30 18 C 15.9640 4.0010 0.0 0
M  V30 19 C 14.6303 3.2310 0.0 0
M  V30 20 C 13.8603 6.1048 0.0 0
M  V30 21 C 12.3203 6.1048 0.0 0
M  V30 22 C 14.6303 7.4385 0.0 0
M  V30 23 C 11.5503 7.4385 0.0 0
M  V30 24 C 13.8603 8.7722 0.0 0
M  V30 25 C 12.3203 8.7722 0.0 0
M  V30 26 C 9.2402 11.4397 0.0 0
M  V30 27 C 7.7002 11.4397 0.0 0
M  V30 28 C 10.0102 12.7733 0.0 0
M  V30 29 C 6.9302 12.7733 0.0 0
M  V30 30 C 9.2402 14.1070 0.0 0
M  V30 31 C 7.7002 14.1070 0.0 0
M  V30 32 C 2.3101 7.4385 0.0 0
M  V30 33 C 0.7700 7.4385 0.0 0
M  V30 34 C 3.0801 6.1048 0.0 0
M  V30 35 C 0.0000 6.1048 0.0 0
M  V30 36 C 2.3101 4.7710 0.0 0
M  V30 37 C 0.7700 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 2 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 32
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63254-88-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1642574-87-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414143-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22568847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships,
Antiproliferative Effects in Leukemia, and Gene Target Modulation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fioravanti, Rossella; Romanelli, Annalisa; Mautone, Nicola; Di Bello,
Elisabetta; Rovere, Annarita; Corinti, Davide; Zwergel, Clemens; Valente,
Sergio; Rotili, Dante; Botrugno, Oronza A.; Dessanti, Paola; Vultaggio,
Stefania; Vianello, Paola; Cappa, Anna; Binda, Claudia; Mattevi, Andrea;
Minucci, Saverio; Mercurio, Ciro; Varasi, Mario; Mai, Antonello
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(7), 643-658

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
1-Methyl octanedioate
C9H16O4
3946-32-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3101 0.0 0
M  V30 2 C 9.3360 1.5400 0.0 0
M  V30 3 O 12.0033 1.5400 0.0 0
M  V30 4 O 10.6697 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0010 1.5400 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 O 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[1-[(4-Aminophenyl)methyl]-4-piperidinyl]methyl]-2,3-dihydro-5,6-dimethoxy...
C24H30N2O3
1001848-81-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3305 7.9857 0.0 0
M  V30 2 C 8.3912 6.6229 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 O 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 13.7262 3.5428 0.0 0
M  V30 8 N 19.0610 6.6229 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 5.3901 4.0012 0.0 0
M  V30 11 C 5.6507 6.4792 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 6.8966 4.3213 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 7.0575 5.8529 0.0 0
M  V30 16 C 2.3101 4.0012 0.0 0
M  V30 17 C 3.0801 2.6675 0.0 0
M  V30 18 C 9.7250 5.8529 0.0 0
M  V30 19 C 9.7250 4.3129 0.0 0
M  V30 20 C 11.0587 6.6229 0.0 0
M  V30 21 C 11.0587 3.5428 0.0 0
M  V30 22 C 12.3923 5.8529 0.0 0
M  V30 23 N 12.3923 4.3129 0.0 0
M  V30 24 C 15.0598 4.3129 0.0 0
M  V30 25 C 16.3935 3.5428 0.0 0
M  V30 26 C 15.0598 5.8529 0.0 0
M  V30 27 C 17.7272 4.3129 0.0 0
M  V30 28 C 16.3935 6.6229 0.0 0
M  V30 29 C 17.7272 5.8529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 15
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 7 23
M  V30 9 1 7 24
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Octanoic acid, 8-[[4-[[4-[(2,3-dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)meth...
C33H44N2O6
3041972-50-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3304 7.9857 0.0 0
M  V30 2 C 8.3912 6.6231 0.0 0
M  V30 3 O 2.3101 1.3338 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 O 0.7700 4.0012 0.0 0
M  V30 6 C 0.0000 5.3348 0.0 0
M  V30 7 C 13.7260 3.5430 0.0 0
M  V30 8 N 19.0608 6.6231 0.0 0
M  V30 9 C 20.3945 5.8531 0.0 0
M  V30 10 C 21.7283 6.6231 0.0 0
M  V30 11 O 20.3945 4.3130 0.0 0
M  V30 12 C 23.0620 5.8531 0.0 0
M  V30 13 C 24.3957 6.6231 0.0 0
M  V30 14 C 25.7295 5.8531 0.0 0
M  V30 15 C 27.0632 6.6231 0.0 0
M  V30 16 C 28.3968 5.8531 0.0 0
M  V30 17 C 29.7305 6.6231 0.0 0
M  V30 18 O 31.0643 5.8531 0.0 0
M  V30 19 O 29.7305 8.1631 0.0 0
M  V30 20 C 32.3980 6.6231 0.0 0
M  V30 21 C 5.3901 4.0012 0.0 0
M  V30 22 C 4.6201 5.3348 0.0 0
M  V30 23 C 6.8966 4.3213 0.0 0
M  V30 24 C 4.6201 2.6675 0.0 0
M  V30 25 C 5.6505 6.4794 0.0 0
M  V30 26 C 3.0801 5.3348 0.0 0
M  V30 27 C 7.0575 5.8531 0.0 0
M  V30 28 C 3.0801 2.6675 0.0 0
M  V30 29 C 2.3101 4.0012 0.0 0
M  V30 30 C 9.7249 5.8531 0.0 0
M  V30 31 C 9.7249 4.3130 0.0 0
M  V30 32 C 11.0587 6.6231 0.0 0
M  V30 33 C 11.0587 3.5430 0.0 0
M  V30 34 C 12.3923 5.8531 0.0 0
M  V30 35 N 12.3923 4.3130 0.0 0
M  V30 36 C 15.0597 4.3130 0.0 0
M  V30 37 C 16.3935 3.5430 0.0 0
M  V30 38 C 15.0597 5.8531 0.0 0
M  V30 39 C 17.7272 4.3130 0.0 0
M  V30 40 C 16.3935 6.6231 0.0 0
M  V30 41 C 17.7272 5.8531 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 27
M  V30 3 1 2 30
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 1 5 6
M  V30 7 1 5 29
M  V30 8 1 7 35
M  V30 9 1 7 36
M  V30 10 1 8 9
M  V30 11 1 8 41
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 1 25 27
M  V30 31 1 26 29
M  V30 32 2 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3946-32-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1001848-81-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3041972-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40893914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC
isoforms to exert anti-glioblastoma effects
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nepali, Kunal; Wu, An-Chih; Lo, Wei-Lun; Chopra, Bhawna; Lai, Mei-Jung;
Chuang, Jian-Ying; Liou, Jing-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115054

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(Phenylmethoxy)benzenamine
C13H13NO
6373-46-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 N 11.5503 2.6673 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 7.7002 4.0010 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 9.2402 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 10.0102 2.6673 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[[4-(phenylmethoxy)phenyl]amino]carbonyl]-1-pyrroli...
C23H28N2O4
2309071-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.3520 2.6218 0.0 0
M  V30 2 N 7.6857 1.8517 0.0 0
M  V30 3 O 6.3520 4.1618 0.0 0
M  V30 4 C 3.2912 3.9845 0.0 0
M  V30 5 O 1.8265 4.4604 0.0 0
M  V30 6 O 4.4356 5.0150 0.0 0
M  V30 7 C 1.5063 5.9669 0.0 0
M  V30 8 C 0.0000 5.6467 0.0 0
M  V30 9 C 1.1861 7.4732 0.0 0
M  V30 10 C 3.0128 6.2870 0.0 0
M  V30 11 O 13.0205 4.9318 0.0 0
M  V30 12 C 14.3542 4.1618 0.0 0
M  V30 13 C 5.0184 1.8517 0.0 0 CFG=2
M  V30 14 N 3.6114 2.4782 0.0 0
M  V30 15 C 4.8573 0.3202 0.0 0
M  V30 16 C 2.5809 1.3337 0.0 0
M  V30 17 C 3.3510 0.0000 0.0 0
M  V30 18 C 9.0194 2.6218 0.0 0
M  V30 19 C 9.0194 4.1618 0.0 0
M  V30 20 C 10.3532 1.8517 0.0 0
M  V30 21 C 10.3532 4.9318 0.0 0
M  V30 22 C 11.6869 2.6218 0.0 0
M  V30 23 C 11.6869 4.1618 0.0 0
M  V30 24 C 15.6880 4.9318 0.0 0
M  V30 25 C 15.6880 6.4718 0.0 0
M  V30 26 C 17.0217 4.1618 0.0 0
M  V30 27 C 17.0217 7.2419 0.0 0
M  V30 28 C 18.3554 4.9318 0.0 0
M  V30 29 C 18.3554 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6373-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2309071-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37263130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque
Imaging
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Dominicis, Carlo; Perrotta, Paola; Dall'Angelo, Sergio; Wyffels,
Leonie; Staelens, Steven; De Meyer, G. R. Y.; Zanda, Matteo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(5), 933-939

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-carboxylic acid, 2-[[[(1S)-2-(dimethylamino)-2-oxo-1-[3-(tr...
C26H20F6N2O4
3053945-21-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.1601 0.0 0
M  V30 2 N 6.6687 6.9302 0.0 0
M  V30 3 O 9.3360 6.9302 0.0 0
M  V30 4 C 6.6687 8.4702 0.0 0 CFG=1
M  V30 5 C 8.0023 9.2402 0.0 0
M  V30 6 N 8.0023 10.7802 0.0 0
M  V30 7 O 9.3360 8.4702 0.0 0
M  V30 8 C 6.6687 11.5503 0.0 0
M  V30 9 C 9.3360 11.5503 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 O 4.0012 2.3101 0.0 0
M  V30 12 O 5.3348 0.0000 0.0 0
M  V30 13 C 14.6708 6.9302 0.0 0
M  V30 14 F 15.4408 5.5965 0.0 0
M  V30 15 F 16.0046 7.7002 0.0 0
M  V30 16 F 13.9008 8.2638 0.0 0
M  V30 17 C 1.3338 8.4702 0.0 0
M  V30 18 F 2.1038 7.1365 0.0 0
M  V30 19 F 0.0000 7.7002 0.0 0
M  V30 20 F 0.5638 9.8039 0.0 0
M  V30 21 C 9.3360 3.8501 0.0 0
M  V30 22 C 8.0023 4.6201 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 6.6687 3.8501 0.0 0
M  V30 25 C 8.0023 1.5400 0.0 0
M  V30 26 C 6.6687 2.3101 0.0 0
M  V30 27 C 10.6698 4.6201 0.0 0
M  V30 28 C 10.6698 6.1601 0.0 0
M  V30 29 C 12.0035 3.8501 0.0 0
M  V30 30 C 12.0035 6.9302 0.0 0
M  V30 31 C 13.3372 4.6201 0.0 0
M  V30 32 C 13.3372 6.1601 0.0 0
M  V30 33 C 5.3348 9.2402 0.0 0
M  V30 34 C 4.0012 8.4702 0.0 0
M  V30 35 C 5.3348 10.7802 0.0 0
M  V30 36 C 2.6675 9.2402 0.0 0
M  V30 37 C 4.0012 11.5503 0.0 0
M  V30 38 C 2.6675 10.7802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 4 2 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 33
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 26
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 32
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 17 36
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 21 27
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-2,4-dicarboxamide, N2-[(1S)-2-(dimethylamino)-2-oxo-1-[3-(tri...
C27H23F6N3O3
3053945-22-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9302 0.0 0
M  V30 2 N 6.6687 7.7002 0.0 0
M  V30 3 O 9.3360 7.7002 0.0 0
M  V30 4 C 6.6687 9.2402 0.0 0 CFG=1
M  V30 5 C 8.0023 10.0102 0.0 0
M  V30 6 N 8.0023 11.5503 0.0 0
M  V30 7 O 9.3360 9.2402 0.0 0
M  V30 8 C 6.6687 12.3203 0.0 0
M  V30 9 C 9.3360 12.3203 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 N 5.3348 0.7700 0.0 0
M  V30 12 O 4.0012 3.0801 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 14.6708 7.7002 0.0 0
M  V30 15 F 15.4408 6.3665 0.0 0
M  V30 16 F 16.0046 8.4702 0.0 0
M  V30 17 F 13.9008 9.0338 0.0 0
M  V30 18 C 1.3338 9.2402 0.0 0
M  V30 19 F 0.5638 10.5739 0.0 0
M  V30 20 F 0.0000 8.4702 0.0 0
M  V30 21 F 2.1038 7.9065 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 C 8.0023 5.3901 0.0 0
M  V30 24 C 9.3360 3.0801 0.0 0
M  V30 25 C 6.6687 4.6201 0.0 0
M  V30 26 C 8.0023 2.3101 0.0 0
M  V30 27 C 6.6687 3.0801 0.0 0
M  V30 28 C 10.6698 5.3901 0.0 0
M  V30 29 C 12.0035 4.6201 0.0 0
M  V30 30 C 10.6698 6.9302 0.0 0
M  V30 31 C 13.3372 5.3901 0.0 0
M  V30 32 C 12.0035 7.7002 0.0 0
M  V30 33 C 13.3372 6.9302 0.0 0
M  V30 34 C 5.3348 10.0102 0.0 0
M  V30 35 C 4.0012 9.2402 0.0 0
M  V30 36 C 5.3348 11.5503 0.0 0
M  V30 37 C 2.6675 10.0102 0.0 0
M  V30 38 C 4.0012 12.3203 0.0 0
M  V30 39 C 2.6675 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 4 2 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 34
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 33
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 37
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 22 28
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3053945-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053945-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38257722
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of small molecule inhibitors of natural killer group 2D
receptor (NKG2D)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Jocelyn; Nakafuku, Kohki M.; Ziff, Jeannie; Gelin, Christine F.;
Gholami, Hadi; Thompson, Aaron A.; Karpowich, Nathan K.; Limon, Luis;
Coate, Heather R.; Damm-Ganamet, Kelly L.; Shih, Amy Y.; Grant, Joanna
C.; Cote, Marjorie; Mak, Puiying A.; Pascual, Heather A.; Rives,
Marie-Laure; Edwards, James P.; Venable, Jennifer D.; Venkatesan,
Hariharan; Shi, Zhicai; Allen, Samantha J.; Sharma, Sujata; Kung,
Pei-Pei; Shireman, Brock T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2023), 96129492

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
4′-Chloro-2′-methyl[1,1′-biphenyl]-4-carboxylic acid
C14H11ClO2
1100361-06-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 0.0000 0.0 0
M  V30 2 Cl 11.5503 2.6673 0.0 0
M  V30 3 C 0.7700 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 7.7002 4.0010 0.0 0
M  V30 9 C 9.2402 1.3337 0.0 0
M  V30 10 C 9.2402 4.0010 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 13 C 4.6201 4.0010 0.0 0
M  V30 14 C 4.6201 1.3337 0.0 0
M  V30 15 C 3.0801 4.0010 0.0 0
M  V30 16 C 3.0801 1.3337 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methyl-8-(4-methyl-1-piperazinyl)-, (...
C16H25N3
3035854-55-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 5.3347 0.0 0
M  V30 2 N 4.6200 0.0000 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 3.8500 4.0011 0.0 0
M  V30 5 C 4.6200 5.3347 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 6.6685 0.0 0
M  V30 9 C 1.5400 5.3347 0.0 0
M  V30 10 C 1.5400 2.6674 0.0 0
M  V30 11 C 3.8500 1.3338 0.0 0 CFG=1
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 N 6.1600 5.3347 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 8.4700 6.6685 0.0 0
M  V30 19 N 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 11 2 CFG=1
M  V30 3 1 3 19
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-carboxamide, 4′-chloro-2′-methyl-N-[(2S)-1,2,3,4-tetrahydro...
C30H34ClN3O
3035854-56-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 9.3358 0.0 0
M  V30 2 N 6.9300 8.0020 0.0 0
M  V30 3 C 7.7000 9.3358 0.0 0
M  V30 4 O 6.9300 10.6694 0.0 0
M  V30 5 C 5.3900 0.0000 0.0 0
M  V30 6 C 13.8600 12.0031 0.0 0
M  V30 7 Cl 18.4800 9.3358 0.0 0
M  V30 8 C 3.0800 6.6684 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 2.3100 8.0020 0.0 0
M  V30 11 C 4.6200 6.6684 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 3.0800 9.3358 0.0 0
M  V30 14 C 0.7700 8.0020 0.0 0
M  V30 15 C 5.3900 8.0020 0.0 0 CFG=1
M  V30 16 C 0.0000 6.6684 0.0 0
M  V30 17 C 4.6200 9.3358 0.0 0
M  V30 18 N 3.0800 4.0011 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 5.3900 2.6673 0.0 0
M  V30 23 N 4.6200 1.3336 0.0 0
M  V30 24 C 9.2400 9.3358 0.0 0
M  V30 25 C 10.0100 10.6694 0.0 0
M  V30 26 C 10.0100 8.0020 0.0 0
M  V30 27 C 11.5500 10.6694 0.0 0
M  V30 28 C 11.5500 8.0020 0.0 0
M  V30 29 C 12.3200 9.3358 0.0 0
M  V30 30 C 13.8600 9.3358 0.0 0
M  V30 31 C 14.6300 10.6694 0.0 0
M  V30 32 C 14.6300 8.0020 0.0 0
M  V30 33 C 16.1700 10.6694 0.0 0
M  V30 34 C 16.1700 8.0020 0.0 0
M  V30 35 C 16.9400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 3 24
M  V30 6 1 5 23
M  V30 7 1 6 31
M  V30 8 1 7 35
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 18
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 29 30
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1100361-06-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035854-55-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035854-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31657448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationships for a new class of
tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sutherland, Hamish S.; Lu, Guo-Liang; Tong, Amy S. T.; Conole, Daniel;
Franzblau, Scott G.; Upton, Anna M.; Lotlikar, Manisha U.; Cooper,
Christopher B.; Palmer, Brian D.; Choi, Peter J.; Denny, William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 229114059

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroindole-3-acetic acid
C10H8ClNO2
2519-61-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 1.9571 0.0 0
M  V30 2 C 7.1955 2.4329 0.0 0
M  V30 3 O 7.5157 3.9394 0.0 0
M  V30 4 O 8.3399 1.4025 0.0 0
M  V30 5 Cl 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0012 0.0 0
M  V30 8 C 4.5864 2.9877 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 N 3.3405 5.1456 0.0 0
M  V30 11 C 0.7700 4.0012 0.0 0
M  V30 12 C 4.7473 4.5192 0.0 0
M  V30 13 C 0.7700 1.3337 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-1H-indole-3-acetamide
C20H21ClN2O3
2565618-05-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 6.6685 0.0 0
M  V30 2 C 6.7709 6.6685 0.0 0
M  V30 3 N 7.5409 5.3348 0.0 0
M  V30 4 O 7.5409 8.0021 0.0 0
M  V30 5 C 9.0809 5.3348 0.0 0
M  V30 6 C 9.8509 4.0011 0.0 0
M  V30 7 Cl 2.1051 5.6263 0.0 0
M  V30 8 O 14.4710 1.3337 0.0 0
M  V30 9 C 13.7010 0.0000 0.0 0
M  V30 10 O 16.0111 4.0011 0.0 0
M  V30 11 C 16.7811 5.3348 0.0 0
M  V30 12 C 2.9293 8.1632 0.0 0
M  V30 13 C 4.4608 8.0021 0.0 0
M  V30 14 C 2.6091 9.6695 0.0 0
M  V30 15 C 1.7849 7.1326 0.0 0
M  V30 16 C 5.0873 9.4091 0.0 0
M  V30 17 N 3.9428 10.4395 0.0 0
M  V30 18 C 1.1444 10.1454 0.0 0
M  V30 19 C 0.3202 7.6087 0.0 0
M  V30 20 C 0.0000 9.1150 0.0 0
M  V30 21 C 11.3910 4.0011 0.0 0
M  V30 22 C 12.1610 2.6673 0.0 0
M  V30 23 C 12.1610 5.3348 0.0 0
M  V30 24 C 13.7010 2.6673 0.0 0
M  V30 25 C 13.7010 5.3348 0.0 0
M  V30 26 C 14.4710 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 21
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2519-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23046042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
3,4-Dimethoxyphenethylamine
C10H15NO2
120-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 N 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1H-indole-3-acetic acid
C10H8ClNO2
1912-41-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 C 7.6825 4.1649 0.0 0
M  V30 3 O 7.2066 5.6294 0.0 0
M  V30 4 O 9.1888 3.8445 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7475 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-1H-indole-3-acetamide
C20H21ClN2O3
2309063-82-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 4.6201 0.0 0
M  V30 2 C 9.3360 3.8501 0.0 0
M  V30 3 N 8.0023 4.6201 0.0 0
M  V30 4 O 9.3360 2.3100 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 Cl 16.9776 2.5078 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 O 0.0000 1.5400 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 C 13.4103 4.4766 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 14.4407 3.3320 0.0 0
M  V30 15 C 13.8861 5.9411 0.0 0
M  V30 16 C 12.1644 2.3185 0.0 0
M  V30 17 N 13.6707 1.9983 0.0 0
M  V30 18 C 15.9471 3.6523 0.0 0
M  V30 19 C 15.3924 6.2614 0.0 0
M  V30 20 C 16.4230 5.1169 0.0 0
M  V30 21 C 4.0011 3.8501 0.0 0
M  V30 22 C 2.6675 4.6201 0.0 0
M  V30 23 C 4.0011 2.3100 0.0 0
M  V30 24 C 1.3337 3.8501 0.0 0
M  V30 25 C 2.6675 1.5400 0.0 0
M  V30 26 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 21
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-20-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1912-41-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2309063-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23041098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Fmoc-Gly-OH
C17H15NO4
29022-11-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 O 13.7554 5.2310 0.0 0
M  V30 9 O 12.4218 2.9209 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H30N4O6
2861234-17-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 9.3360 0.0 0
M  V30 2 O 6.7709 9.3360 0.0 0
M  V30 3 C 7.5409 8.0022 0.0 0
M  V30 4 N 9.0810 8.0022 0.0 0
M  V30 5 O 6.7709 6.6685 0.0 0
M  V30 6 C 9.8510 6.6685 0.0 0
M  V30 7 C 11.3910 6.6685 0.0 0
M  V30 8 N 12.1610 5.3348 0.0 0
M  V30 9 O 12.1610 8.0022 0.0 0
M  V30 10 C 13.7011 5.3348 0.0 0 CFG=1
M  V30 11 C 14.4711 4.0012 0.0 0
M  V30 12 C 14.4711 6.6685 0.0 0
M  V30 13 O 13.7011 2.6673 0.0 0
M  V30 14 O 16.0111 4.0012 0.0 0
M  V30 15 C 16.0111 6.6685 0.0 0
M  V30 16 C 14.4711 1.3337 0.0 0
M  V30 17 C 16.7811 8.0022 0.0 0
M  V30 18 C 13.1374 0.5637 0.0 0
M  V30 19 C 15.2411 0.0000 0.0 0
M  V30 20 C 15.8047 2.1037 0.0 0
M  V30 21 C 18.3212 8.0022 0.0 0
M  V30 22 O 16.0111 9.3360 0.0 0
M  V30 23 N 19.0912 9.3360 0.0 0 CHG=1 VAL=4
M  V30 24 N 19.8612 10.6697 0.0 0 CHG=-1
M  V30 25 C 4.4609 10.6697 0.0 0
M  V30 26 C 2.9293 10.8306 0.0 0
M  V30 27 C 5.0873 12.0765 0.0 0
M  V30 28 C 2.6091 12.3371 0.0 0
M  V30 29 C 1.7849 9.8002 0.0 0
M  V30 30 C 3.9428 13.1071 0.0 0
M  V30 31 C 6.5519 12.5524 0.0 0
M  V30 32 C 1.1444 12.8129 0.0 0
M  V30 33 C 0.3202 10.2760 0.0 0
M  V30 34 C 4.2630 14.6134 0.0 0
M  V30 35 C 6.8721 14.0588 0.0 0
M  V30 36 C 0.0000 11.7823 0.0 0
M  V30 37 C 5.7277 15.0893 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=1
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 2 21 23
M  V30 24 2 23 24
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 2 27 31
M  V30 31 1 28 30
M  V30 32 2 28 32
M  V30 33 1 29 33
M  V30 34 2 30 34
M  V30 35 1 31 35
M  V30 36 1 32 36
M  V30 37 2 33 36
M  V30 38 1 34 37
M  V30 39 2 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 29022-11-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861234-17-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259031
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME46 STEP1
$RXN



  1  1
$MOL
2-Amino-5-chloro-β-[[(1,1-dimethylethoxy)carbonyl]amino]benzenebutanoic acid
C15H21ClN2O4
2355306-36-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 6.6685 2.3101 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 O 9.3360 2.3101 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 O 2.6673 0.0000 0.0 0
M  V30 10 O 5.3348 0.0000 0.0 0
M  V30 11 C 10.6697 3.0801 0.0 0
M  V30 12 C 9.8996 4.4137 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 11.4397 1.7464 0.0 0
M  V30 15 N 5.3348 7.7002 0.0 0
M  V30 16 Cl 0.0000 4.6201 0.0 0
M  V30 17 C 4.0012 5.3901 0.0 0
M  V30 18 C 4.0012 6.9302 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 2.6673 7.7002 0.0 0
M  V30 21 C 1.3337 5.3901 0.0 0
M  V30 22 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 18
M  V30 16 1 16 21
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H19ClN2O3
2355306-37-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5210 4.8249 0.0 0
M  V30 2 C 8.8546 4.0549 0.0 0
M  V30 3 O 10.1883 4.8249 0.0 0
M  V30 4 O 8.8546 2.5148 0.0 0
M  V30 5 C 11.5219 4.0549 0.0 0
M  V30 6 C 12.2920 5.3885 0.0 0
M  V30 7 C 12.8558 3.2849 0.0 0
M  V30 8 C 10.7519 2.7212 0.0 0
M  V30 9 Cl 0.0000 6.6470 0.0 0
M  V30 10 O 5.6274 0.0000 0.0 0
M  V30 11 C 3.4432 4.4684 0.0 0
M  V30 12 C 2.8806 3.0349 0.0 0
M  V30 13 C 4.9148 4.9224 0.0 0
M  V30 14 C 2.4830 5.6725 0.0 0
M  V30 15 N 3.6506 1.7011 0.0 0
M  V30 16 C 1.3578 2.8053 0.0 0
M  V30 17 C 6.1872 4.0549 0.0 0
M  V30 18 C 0.9602 5.4429 0.0 0
M  V30 19 C 5.1734 1.4716 0.0 0
M  V30 20 C 0.3976 4.0094 0.0 0
M  V30 21 C 6.3024 2.5192 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 18
M  V30 10 2 10 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2355306-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2355306-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39000832
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Characterization of RGH-122, a Potent, Selective, and
Orally Bioavailable V1a Receptor Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baska, Ferenc; Bozo, Eva; Szeleczky, Zsolt; Szanto, Gabor; Vukics,
Krisztina; Szakacs, Zoltan; Domany-Kovacs, Katalin; Kurko, Dalma; Vass,
Elemer; Than, Marta; Vastag, Monika; Temesvari, Krisztina; Levai, Sandor;
Halasz, Attila Sandor; Szondine Kordas, Krisztina; Roman, Viktor;
Greiner, Istvan; Bata, Imre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(1), 643-673

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid
C9H8O4
4442-54-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitroaniline
C6H5FN2O2
364-76-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 N 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluoro-3-nitrophenyl)-2,3-dihydro-1,4-benzodioxin-6-carboxamide
C15H11FN2O5
353761-46-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 N 8.0022 3.0801 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 N 13.3370 3.0801 0.0 0 VAL=5
M  V30 5 O 13.3370 4.6201 0.0 0
M  V30 6 O 14.6707 2.3101 0.0 0
M  V30 7 F 13.3370 0.0000 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 O 1.3337 2.3101 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 O 1.3337 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 9.3358 2.3101 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3358 0.7700 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 10.6697 0.0000 0.0 0
M  V30 23 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 18
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4442-54-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-76-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 353761-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40578331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed
from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian
Cancer and Other Malignancies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pasqua, A. Elisa; Sharp, Swee Y.; Chessum, Nicola E. A.; Hayes, Angela;
Pellegrino, Loredana; Tucker, Michael J.; Miah, Asadh; Wilding, Birgit;
Evans, Lindsay E.; Rye, Carl S.; Mok, N. Yi; Liu, Manjuan; Henley, Alan
T.; Gowan, Sharon; De Billy, Emmanuel; te Poele, Robert; Powers, Marissa;
Eccles, Suzanne A.; Clarke, Paul A.; Raynaud, Florence I.; Workman, Paul;
Jones, Keith; Cheeseman, Matthew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5907-5936

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
1-Methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazole-3-carboxylic acid
C12H9F3N2O2
1781314-21-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1294 5.9173 0.0 0
M  V30 2 C 11.3158 1.5315 0.0 0
M  V30 3 O 11.1547 0.0000 0.0 0
M  V30 4 O 12.7226 2.1580 0.0 0
M  V30 5 C 1.5400 3.2068 0.0 0
M  V30 6 F 1.5400 4.7468 0.0 0
M  V30 7 F 0.0000 3.2068 0.0 0
M  V30 8 F 1.5400 1.6667 0.0 0
M  V30 9 C 7.7000 3.2068 0.0 0
M  V30 10 N 8.6052 4.4526 0.0 0
M  V30 11 C 8.6052 1.9609 0.0 0
M  V30 12 N 10.0698 3.9768 0.0 0
M  V30 13 C 10.0698 2.4367 0.0 0
M  V30 14 C 6.1600 3.2068 0.0 0
M  V30 15 C 5.3900 1.8731 0.0 0
M  V30 16 C 5.3900 4.5404 0.0 0
M  V30 17 C 3.8500 1.8731 0.0 0
M  V30 18 C 3.8500 4.5404 0.0 0
M  V30 19 C 3.0800 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-2H-pyran-3-methanamine
C6H13NO
7179-99-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 O 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 1-methyl-N-[(tetrahydro-2H-pyran-3-yl)methyl]-5-[4...
C18H20F3N3O2
3033431-98-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8017 0.0000 0.0 0
M  V30 2 C 11.4291 4.0287 0.0 0
M  V30 3 N 12.7627 3.2587 0.0 0
M  V30 4 O 11.4291 5.5688 0.0 0
M  V30 5 C 14.0964 4.0287 0.0 0
M  V30 6 C 1.5316 3.3845 0.0 0
M  V30 7 F 1.6925 4.9161 0.0 0
M  V30 8 F 0.0000 3.5455 0.0 0
M  V30 9 F 1.3706 1.8530 0.0 0
M  V30 10 C 7.6580 2.7406 0.0 0
M  V30 11 C 8.6884 3.8850 0.0 0
M  V30 12 N 8.4280 1.4070 0.0 0
M  V30 13 C 10.0954 3.2587 0.0 0
M  V30 14 N 9.9343 1.7271 0.0 0
M  V30 15 C 6.1264 2.9016 0.0 0
M  V30 16 C 5.4999 4.3086 0.0 0
M  V30 17 C 5.2212 1.6557 0.0 0
M  V30 18 C 3.9684 4.4695 0.0 0
M  V30 19 C 3.6896 1.8166 0.0 0
M  V30 20 C 3.0631 3.2236 0.0 0
M  V30 21 C 15.4302 3.2587 0.0 0
M  V30 22 C 15.4302 1.7187 0.0 0
M  V30 23 C 16.7639 4.0287 0.0 0
M  V30 24 C 16.7639 0.9487 0.0 0
M  V30 25 O 18.0976 3.2587 0.0 0
M  V30 26 C 18.0976 1.7187 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 20
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1781314-21-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7179-99-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033431-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37690207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic
Receptor Antagonist for the Modulation of Motor Dysfunction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Christie, Louisa A.; Brice, Nicola L.; Rowland, Anna; Dickson, Louise;
Anand, Rishi; Teall, Martin; Doyle, Kevin J.; Narayana, Lakshminarayana;
Mitchell, Christine; Harvey, Jenna R. M.; Mulligan, Victoria; Dawson, Lee
A.; Cragg, Stephanie J.; Carlton, Mark; Burli, Roland W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(17), 11718-11731

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 4-bromo-2-[[[(2S)-3-(dimethylamino)-2-[[(1,1-dimethylethoxy)car...
C20H26BrCl3N2O5S
3037017-04-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 5.3347 0.0 0
M  V30 2 S 8.4700 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 5 N 5.3900 5.3347 0.0 0
M  V30 6 C 5.3900 8.0021 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 N 6.1600 9.3358 0.0 0
M  V30 9 O 3.8500 8.0021 0.0 0
M  V30 10 O 3.0800 4.0011 0.0 0
M  V30 11 O 3.0800 6.6684 0.0 0
M  V30 12 C 7.7000 9.3358 0.0 0
M  V30 13 C 5.3900 10.6694 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 15 C 1.5400 5.5411 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 17 C 1.5400 2.4611 0.0 0
M  V30 18 C 13.0900 5.3347 0.0 0
M  V30 19 O 14.6300 5.3347 0.0 0
M  V30 20 O 12.3200 6.6684 0.0 0
M  V30 21 C 15.4000 6.6684 0.0 0
M  V30 22 C 16.9400 6.6684 0.0 0
M  V30 23 Cl 18.4800 6.6684 0.0 0
M  V30 24 Cl 16.9400 8.2084 0.0 0
M  V30 25 Cl 16.9400 5.1284 0.0 0
M  V30 26 Br 10.0100 0.0000 0.0 0
M  V30 27 C 10.7800 4.0011 0.0 0
M  V30 28 C 12.3200 4.0011 0.0 0
M  V30 29 C 10.0100 2.6673 0.0 0
M  V30 30 C 13.0900 2.6673 0.0 0
M  V30 31 C 10.7800 1.3336 0.0 0
M  V30 32 C 12.3200 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 28
M  V30 21 1 19 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 26 31
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 2 29 31
M  V30 31 2 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-D-serine
C8H15NO5
6368-20-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3348 3.8501 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 8.7723 0.9764 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C23H31BrCl3N3O7S
3037017-05-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.8836 5.3347 0.0 0
M  V30 2 S 11.3436 5.3347 0.0 0
M  V30 3 C 10.5736 4.0011 0.0 0
M  V30 4 C 9.0336 4.0011 0.0 0 CFG=2
M  V30 5 N 8.2636 5.3347 0.0 0
M  V30 6 C 8.2636 2.6673 0.0 0
M  V30 7 C 6.7236 5.3347 0.0 0
M  V30 8 N 9.0336 1.3336 0.0 0
M  V30 9 O 6.7236 2.6673 0.0 0
M  V30 10 C 5.9536 6.6684 0.0 0 CFG=1
M  V30 11 O 5.9536 4.0011 0.0 0
M  V30 12 C 10.5736 1.3336 0.0 0
M  V30 13 C 8.2636 0.0000 0.0 0
M  V30 14 N 4.4136 6.6684 0.0 0
M  V30 15 C 6.7236 8.0021 0.0 0
M  V30 16 C 3.6436 8.0021 0.0 0
M  V30 17 O 8.2636 8.0021 0.0 0
M  V30 18 O 2.1036 8.0021 0.0 0
M  V30 19 O 4.4136 9.3358 0.0 0
M  V30 20 C 1.3336 9.3358 0.0 0
M  V30 21 C 2.6673 10.1058 0.0 0
M  V30 22 C 0.5636 10.6694 0.0 0
M  V30 23 C 0.0000 8.5658 0.0 0
M  V30 24 C 15.9636 5.3347 0.0 0
M  V30 25 O 17.5036 5.3347 0.0 0
M  V30 26 O 15.1936 4.0011 0.0 0
M  V30 27 C 18.2736 4.0011 0.0 0
M  V30 28 C 19.8136 4.0011 0.0 0
M  V30 29 Cl 21.3536 4.0011 0.0 0
M  V30 30 Cl 19.8136 5.5411 0.0 0
M  V30 31 Cl 19.8136 2.4611 0.0 0
M  V30 32 Br 12.8836 10.6694 0.0 0
M  V30 33 C 13.6536 6.6684 0.0 0
M  V30 34 C 15.1936 6.6684 0.0 0
M  V30 35 C 12.8836 8.0021 0.0 0
M  V30 36 C 15.9636 8.0021 0.0 0
M  V30 37 C 13.6536 9.3358 0.0 0
M  V30 38 C 15.1936 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 33
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 10 15 CFG=3
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 18 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 1 24 34
M  V30 27 1 25 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 32 37
M  V30 33 2 33 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 2 35 37
M  V30 37 2 36 38
M  V30 38 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3037017-04-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6368-20-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037017-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40763496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Importance of Binding Site Hydration and Flexibility Revealed When
Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein
Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Begnini, Fabio; Geschwindner, Stefan; Johansson, Patrik; Wissler, Lisa;
Lewis, Richard J.; Danelius, Emma; Luttens, Andreas; Matricon, Pierre;
Carlsson, Jens; Lenders, Stijn; Koenig, Beate; Friedel, Anna; Sjoe,
Peter; Schiesser, Stefan; Kihlberg, Jan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 3473-3517

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
3,5-Difluorobenzoic acid
C7H4F2O2
455-40-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 F 0.0000 4.6200 0.0 0
M  V30 5 F 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-[(1S,2E)-3-fluoro-1-(2-phenylethyl)-3-(phenylsu...
C26H27FN2O3S.ClH
2761157-88-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 8.2084 0.0 0 CFG=2
M  V30 2 C 9.2400 8.2084 0.0 0
M  V30 3 N 6.9300 9.5420 0.0 0
M  V30 4 C 6.9300 6.8747 0.0 0
M  V30 5 C 10.0100 9.5420 0.0 0
M  V30 6 C 5.3900 9.5420 0.0 0
M  V30 7 C 7.7000 5.5409 0.0 0
M  V30 8 S 11.5500 9.5420 0.0 0 VAL=6
M  V30 9 F 9.2400 10.8758 0.0 0
M  V30 10 C 4.6200 10.8758 0.0 0 CFG=1
M  V30 11 O 4.6200 8.2084 0.0 0
M  V30 12 O 11.5500 11.0820 0.0 0
M  V30 13 O 11.5500 8.0020 0.0 0
M  V30 14 C 3.0800 10.8758 0.0 0
M  V30 15 N 5.3900 12.2094 0.0 0
M  V30 16 C 6.9300 4.2073 0.0 0
M  V30 17 C 7.7000 2.8736 0.0 0
M  V30 18 C 5.3900 4.2073 0.0 0
M  V30 19 C 6.9300 1.5400 0.0 0
M  V30 20 C 4.6200 2.8736 0.0 0
M  V30 21 C 5.3900 1.5400 0.0 0
M  V30 22 C 13.0900 9.5420 0.0 0
M  V30 23 C 13.8600 10.8758 0.0 0
M  V30 24 C 13.8600 8.2084 0.0 0
M  V30 25 C 15.4000 10.8758 0.0 0
M  V30 26 C 15.4000 8.2084 0.0 0
M  V30 27 C 16.1700 9.5420 0.0 0
M  V30 28 C 2.3100 12.2094 0.0 0
M  V30 29 C 0.7700 12.2094 0.0 0
M  V30 30 C 3.0800 13.5431 0.0 0
M  V30 31 C 0.0000 13.5431 0.0 0
M  V30 32 C 2.3100 14.8767 0.0 0
M  V30 33 C 0.7700 14.8767 0.0 0
M  V30 34 Cl 8.0850 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 16
M  V30 12 2 8 12
M  V30 13 2 8 13
M  V30 14 1 8 22
M  V30 15 1 10 14
M  V30 16 1 10 15 CFG=3
M  V30 17 1 14 28
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-[(3,5-Difluorobenzoyl)amino]-N-[(1S,2E)-3-fluoro-1-(2-phenylethyl)-3-(...
C33H29F3N2O4S
2761157-40-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 11.5500 0.0 0 CFG=1
M  V30 2 C 9.3358 13.0900 0.0 0
M  V30 3 N 10.6694 10.7800 0.0 0
M  V30 4 C 8.0021 10.7800 0.0 0
M  V30 5 C 12.0032 11.5500 0.0 0
M  V30 6 N 8.0021 9.2400 0.0 0
M  V30 7 O 6.6685 11.5500 0.0 0
M  V30 8 O 12.0032 13.0900 0.0 0
M  V30 9 C 6.6685 8.4700 0.0 0 CFG=1
M  V30 10 C 6.6685 6.9300 0.0 0
M  V30 11 C 5.3347 9.2400 0.0 0
M  V30 12 C 8.0021 6.1600 0.0 0
M  V30 13 C 4.0011 8.4700 0.0 0
M  V30 14 S 8.0021 4.6200 0.0 0 VAL=6
M  V30 15 F 9.3358 6.9300 0.0 0
M  V30 16 O 6.4621 4.6200 0.0 0
M  V30 17 O 9.5421 4.6200 0.0 0
M  V30 18 F 14.6705 6.9300 0.0 0
M  V30 19 F 17.3379 11.5500 0.0 0
M  V30 20 C 8.0021 13.8600 0.0 0
M  V30 21 C 8.0021 15.4000 0.0 0
M  V30 22 C 6.6685 13.0900 0.0 0
M  V30 23 C 6.6685 16.1700 0.0 0
M  V30 24 C 5.3347 13.8600 0.0 0
M  V30 25 C 5.3347 15.4000 0.0 0
M  V30 26 C 13.3369 10.7800 0.0 0
M  V30 27 C 13.3369 9.2400 0.0 0
M  V30 28 C 14.6705 11.5500 0.0 0
M  V30 29 C 14.6705 8.4700 0.0 0
M  V30 30 C 16.0041 10.7800 0.0 0
M  V30 31 C 16.0041 9.2400 0.0 0
M  V30 32 C 2.6674 9.2400 0.0 0
M  V30 33 C 2.6674 10.7800 0.0 0
M  V30 34 C 1.3338 8.4700 0.0 0
M  V30 35 C 1.3338 11.5500 0.0 0
M  V30 36 C 0.0000 9.2400 0.0 0
M  V30 37 C 0.0000 10.7800 0.0 0
M  V30 38 C 8.0021 3.0800 0.0 0
M  V30 39 C 9.3358 2.3100 0.0 0
M  V30 40 C 6.6685 2.3100 0.0 0
M  V30 41 C 9.3358 0.7700 0.0 0
M  V30 42 C 6.6685 0.7700 0.0 0
M  V30 43 C 8.0021 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 26
M  V30 10 1 6 9
M  V30 11 1 9 10
M  V30 12 1 9 11 CFG=3
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 32
M  V30 18 2 14 16
M  V30 19 2 14 17
M  V30 20 1 14 38
M  V30 21 1 18 29
M  V30 22 1 19 30
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 2 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 2 40 42
M  V30 45 2 41 43
M  V30 46 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 455-40-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761157-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-40-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
5-Bromo-1H-indazole-3-carboxylic acid
C8H5BrN2O2
1077-94-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 1.1444 0.0 0
M  V30 2 O 0.0000 0.8242 0.0 0
M  V30 3 O 2.5367 0.0000 0.0 0
M  V30 4 Br 7.4478 2.3150 0.0 0
M  V30 5 C 3.4469 3.0850 0.0 0
M  V30 6 C 3.4469 4.6250 0.0 0
M  V30 7 C 1.9822 2.6091 0.0 0
M  V30 8 C 4.7805 2.3150 0.0 0
M  V30 9 N 1.9822 5.1009 0.0 0
M  V30 10 C 4.7805 5.3950 0.0 0
M  V30 11 N 1.0769 3.8550 0.0 0
M  V30 12 C 6.1142 3.0850 0.0 0
M  V30 13 C 6.1142 4.6250 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminomethylpiperidine-1-carboxylic acid tert-butyl ester
C11H22N2O2
144222-22-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 N 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[(5-bromo-1H-indazol-3-yl)carbonyl]amino]methyl]-1-pipe...
C19H25BrN4O3
1452520-76-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 4.2074 0.0 0
M  V30 2 N 7.5950 4.2074 0.0 0
M  V30 3 O 5.2850 2.8736 0.0 0
M  V30 4 C 8.3650 2.8736 0.0 0
M  V30 5 Br 0.0000 4.1170 0.0 0
M  V30 6 C 14.5250 2.8736 0.0 0
M  V30 7 O 15.2950 1.5400 0.0 0
M  V30 8 O 15.2950 4.2074 0.0 0
M  V30 9 C 16.8350 1.5400 0.0 0
M  V30 10 C 16.8350 0.0000 0.0 0
M  V30 11 C 18.3750 1.5400 0.0 0
M  V30 12 C 16.8350 3.0800 0.0 0
M  V30 13 C 3.7534 5.7020 0.0 0
M  V30 14 C 5.2850 5.5411 0.0 0
M  V30 15 C 3.4333 7.2084 0.0 0
M  V30 16 C 2.6091 4.6716 0.0 0
M  V30 17 N 5.9114 6.9479 0.0 0
M  V30 18 N 4.7669 7.9784 0.0 0
M  V30 19 C 1.9686 7.6843 0.0 0
M  V30 20 C 1.1444 5.1474 0.0 0
M  V30 21 C 0.8242 6.6539 0.0 0
M  V30 22 C 9.9050 2.8736 0.0 0
M  V30 23 C 10.6750 1.5400 0.0 0
M  V30 24 C 10.6750 4.2074 0.0 0
M  V30 25 C 12.2150 1.5400 0.0 0
M  V30 26 C 12.2150 4.2074 0.0 0
M  V30 27 N 12.9850 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 22
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 27
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1077-94-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144222-22-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1452520-76-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31751498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide
as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's
disease: Significantly increasing the level of acetylcholine in the brain
without affecting that in intestine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Xueyang; Liu, Chang; Zou, Manxing; Xie, Huanfang; Lin, Tailiang;
Lyu, Weiping; Xu, Jian; Li, Yuan; Feng, Feng; Sun, Haopeng; Liu, Wenyuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 223113663

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
O-(1,1-Dimethylethyl)-N-[(phenylmethoxy)carbonyl]-L-threonine
C16H23NO5
16966-09-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.4137 0.0 0 CFG=2
M  V30 2 N 5.3348 3.6437 0.0 0
M  V30 3 C 2.6673 3.6437 0.0 0 CFG=1
M  V30 4 C 4.0010 5.9538 0.0 0
M  V30 5 C 6.6685 4.4137 0.0 0
M  V30 6 O 2.6673 2.1037 0.0 0
M  V30 7 C 1.3337 4.4137 0.0 0
M  V30 8 O 5.3348 6.7238 0.0 0
M  V30 9 O 2.6673 6.7238 0.0 0
M  V30 10 O 8.0022 3.6437 0.0 0
M  V30 11 O 6.6685 5.9538 0.0 0
M  V30 12 C 1.3337 1.3337 0.0 0
M  V30 13 C 9.3360 4.4137 0.0 0
M  V30 14 C 0.5637 2.6673 0.0 0
M  V30 15 C 0.0000 0.5637 0.0 0
M  V30 16 C 2.1037 0.0000 0.0 0
M  V30 17 C 10.6697 3.6437 0.0 0
M  V30 18 C 12.0033 4.4137 0.0 0
M  V30 19 C 10.6697 2.1037 0.0 0
M  V30 20 C 13.3370 3.6437 0.0 0
M  V30 21 C 12.0033 1.3337 0.0 0
M  V30 22 C 13.3370 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=3
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 10 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclohexanepropanoic acid, α-amino-, methyl ester, hydrochloride (1:1), (αS)-
C10H19NO2.ClH
17193-39-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 5.3347 5.3900 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 O 6.6684 1.5400 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 Cl 4.6679 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Alanine, O-(1,1-dimethylethyl)-N-[(phenylmethoxy)carbonyl]-L-threonyl-3-cyc...
C26H40N2O6
2481134-18-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 5.3900 0.0 0 CFG=2
M  V30 2 C 6.6685 6.1600 0.0 0
M  V30 3 N 9.3358 6.1600 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0 CFG=1
M  V30 5 N 6.6685 7.7000 0.0 0
M  V30 6 O 5.3347 5.3900 0.0 0
M  V30 7 C 10.6694 5.3900 0.0 0
M  V30 8 O 6.6685 3.0800 0.0 0
M  V30 9 C 9.3358 3.0800 0.0 0
M  V30 10 C 5.3347 8.4700 0.0 0 CFG=2
M  V30 11 O 12.0032 6.1600 0.0 0
M  V30 12 O 10.6694 3.8500 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 4.0011 7.7000 0.0 0
M  V30 15 C 5.3347 10.0100 0.0 0
M  V30 16 C 13.3369 5.3900 0.0 0
M  V30 17 C 8.2085 1.5400 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 5.1285 1.5400 0.0 0
M  V30 20 O 6.6685 10.7800 0.0 0
M  V30 21 O 4.0011 10.7800 0.0 0
M  V30 22 C 6.6685 12.3200 0.0 0
M  V30 23 C 2.6674 8.4700 0.0 0
M  V30 24 C 2.6674 10.0100 0.0 0
M  V30 25 C 1.3338 7.7000 0.0 0
M  V30 26 C 1.3338 10.7800 0.0 0
M  V30 27 C 0.0000 8.4700 0.0 0
M  V30 28 C 0.0000 10.0100 0.0 0
M  V30 29 C 14.6705 6.1600 0.0 0
M  V30 30 C 16.0041 5.3900 0.0 0
M  V30 31 C 14.6705 7.7000 0.0 0
M  V30 32 C 17.3379 6.1600 0.0 0
M  V30 33 C 16.0041 8.4700 0.0 0
M  V30 34 C 17.3379 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=1
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 10 14 CFG=1
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 14 23
M  V30 20 1 15 20
M  V30 21 2 15 21
M  V30 22 1 16 29
M  V30 23 1 20 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 16966-09-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17193-39-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2481134-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23310372
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A quick route to multiple highly potent SARS-CoV-2 main protease
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Kai S.; Ma, Xinyu R.; Ma, Yuying; Alugubelli, Yugendar R.; Scott,
Danielle A.; Vatansever, Erol C.; Drelich, Aleksandra K.; Sankaran,
Banumathi; Geng, Zhi Z.; Blankenship, Lauren R.; Ward, Hannah E.; Sheng,
Yan J.; Hsu, Jason C.; Kratch, Kaci C.; Zhao, Baoyu; Hayatshahi, Hamed
S.; Liu, Jin; Li, Pingwei; Fierke, Carol A.; Tseng, Chien-Te K.; Xu,
Shiqing; Liu, Wenshe Ray
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2021), 16(6), 942-948

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
6-Chloro-1H-indole-3-acetic acid
C10H8ClNO2
1912-44-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.1884 0.0 0
M  V30 2 C 1.1444 2.7126 0.0 0
M  V30 3 O 0.8242 1.2061 0.0 0
M  V30 4 O 0.0000 3.7430 0.0 0
M  V30 5 Cl 9.8797 2.4782 0.0 0
M  V30 6 C 5.2597 2.4782 0.0 0
M  V30 7 C 6.0297 1.1444 0.0 0
M  V30 8 C 3.7534 2.1580 0.0 0
M  V30 9 C 6.0297 3.8118 0.0 0
M  V30 10 N 4.9993 0.0000 0.0 0
M  V30 11 C 7.5697 1.1444 0.0 0
M  V30 12 C 3.5925 0.6263 0.0 0
M  V30 13 C 7.5697 3.8118 0.0 0
M  V30 14 C 8.3397 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-3-methoxybenzeneethanamine
C11H17NO2
36377-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 10.7800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-[2-(4-ethoxy-3-methoxyphenyl)ethyl]-1H-indole-3-acetamide
C21H23ClN2O3
2565618-09-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6954 6.6684 0.0 0
M  V30 2 C 8.2354 6.6684 0.0 0
M  V30 3 N 9.0054 5.3348 0.0 0
M  V30 4 O 9.0054 8.0021 0.0 0
M  V30 5 C 10.5455 5.3348 0.0 0
M  V30 6 C 11.3155 4.0011 0.0 0
M  V30 7 Cl 0.0000 9.5908 0.0 0
M  V30 8 O 15.9355 1.3337 0.0 0
M  V30 9 C 15.1655 0.0000 0.0 0
M  V30 10 O 17.4756 4.0011 0.0 0
M  V30 11 C 18.2456 5.3348 0.0 0
M  V30 12 C 19.7856 5.3348 0.0 0
M  V30 13 C 4.3938 8.1632 0.0 0
M  V30 14 C 5.9254 8.0021 0.0 0
M  V30 15 C 4.0737 9.6695 0.0 0
M  V30 16 C 3.2494 7.1326 0.0 0
M  V30 17 C 6.5519 9.4091 0.0 0
M  V30 18 N 5.4073 10.4395 0.0 0
M  V30 19 C 2.6091 10.1454 0.0 0
M  V30 20 C 1.7847 7.6086 0.0 0
M  V30 21 C 1.4646 9.1149 0.0 0
M  V30 22 C 12.8555 4.0011 0.0 0
M  V30 23 C 13.6255 2.6673 0.0 0
M  V30 24 C 13.6255 5.3348 0.0 0
M  V30 25 C 15.1655 2.6673 0.0 0
M  V30 26 C 15.1655 5.3348 0.0 0
M  V30 27 C 15.9355 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 22
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1912-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36377-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23041868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
4-Thiomorpholineacetic acid, 1,1-dioxide
C6H11NO4S
155480-08-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 3.7570 0.0 0
M  V30 2 C 6.8513 2.9870 0.0 0
M  V30 3 O 6.8513 1.4470 0.0 0
M  V30 4 O 8.1851 3.7570 0.0 0
M  V30 5 O 0.0000 1.7145 0.0 0
M  V30 6 O 0.9899 0.0000 0.0 0
M  V30 7 N 4.1840 2.9870 0.0 0
M  V30 8 C 4.1840 1.4470 0.0 0
M  V30 9 C 2.8504 3.7570 0.0 0
M  V30 10 C 2.8504 0.6770 0.0 0
M  V30 11 C 1.5166 2.9870 0.0 0
M  V30 12 S 1.5166 1.4470 0.0 0 VAL=6
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 12
M  V30 6 2 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Thiomorpholineacetamide, N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrop...
C26H36N4O8S2
2765293-73-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 12.1862 7.6071 0.0 0 VAL=6
M  V30 2 N 10.8525 8.3771 0.0 0
M  V30 3 O 12.9562 8.9409 0.0 0
M  V30 4 O 11.4161 6.2734 0.0 0
M  V30 5 C 9.5188 7.6071 0.0 0
M  V30 6 C 10.8525 9.9171 0.0 0
M  V30 7 C 8.1852 8.3771 0.0 0 CFG=1
M  V30 8 C 12.1862 10.6871 0.0 0
M  V30 9 C 6.8514 7.6071 0.0 0 CFG=1
M  V30 10 O 8.1852 9.9171 0.0 0
M  V30 11 C 12.1862 12.2271 0.0 0
M  V30 12 C 13.5200 9.9171 0.0 0
M  V30 13 C 5.5177 8.3771 0.0 0
M  V30 14 N 6.8514 6.0671 0.0 0
M  V30 15 C 5.5177 5.2970 0.0 0
M  V30 16 C 5.5177 3.7570 0.0 0
M  V30 17 O 4.1841 6.0671 0.0 0
M  V30 18 N 17.5209 4.5270 0.0 0 VAL=5
M  V30 19 O 18.8547 5.2970 0.0 0
M  V30 20 O 17.5209 2.9870 0.0 0
M  V30 21 O 0.9899 0.0000 0.0 0
M  V30 22 O 0.0000 1.7145 0.0 0
M  V30 23 C 13.5200 6.8371 0.0 0
M  V30 24 C 13.5200 5.2970 0.0 0
M  V30 25 C 14.8536 7.6071 0.0 0
M  V30 26 C 14.8536 4.5270 0.0 0
M  V30 27 C 16.1873 6.8371 0.0 0
M  V30 28 C 16.1873 5.2970 0.0 0
M  V30 29 C 5.5177 9.9171 0.0 0
M  V30 30 C 4.1841 10.6871 0.0 0
M  V30 31 C 6.8514 10.6871 0.0 0
M  V30 32 C 4.1841 12.2271 0.0 0
M  V30 33 C 6.8514 12.2271 0.0 0
M  V30 34 C 5.5177 12.9971 0.0 0
M  V30 35 N 4.1841 2.9870 0.0 0
M  V30 36 C 2.8504 3.7570 0.0 0
M  V30 37 C 4.1841 1.4470 0.0 0
M  V30 38 C 1.5166 2.9870 0.0 0
M  V30 39 C 2.8504 0.6770 0.0 0
M  V30 40 S 1.5166 1.4470 0.0 0 VAL=6
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 23
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=1
M  V30 14 1 9 14
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 35
M  V30 20 2 18 19
M  V30 21 2 18 20
M  V30 22 1 18 28
M  V30 23 2 21 40
M  V30 24 2 22 40
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 1 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 155480-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632772
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
4-Pyridinecarboxylic acid
C6H5NO2
55-22-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-[(1S,2E)-3-fluoro-1-(2-phenylethyl)-3-(phenylsu...
C27H29FN2O3S.ClH
2761158-02-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 8.2085 0.0 0 CFG=1
M  V30 2 C 5.3901 9.5422 0.0 0
M  V30 3 C 5.3901 6.8748 0.0 0
M  V30 4 N 7.7002 8.2085 0.0 0
M  V30 5 C 3.8501 9.5422 0.0 0
M  V30 6 C 6.1601 5.5410 0.0 0
M  V30 7 C 8.4702 9.5422 0.0 0
M  V30 8 S 3.0801 10.8760 0.0 0 VAL=6
M  V30 9 F 3.0801 8.2085 0.0 0
M  V30 10 C 10.0102 9.5422 0.0 0 CFG=1
M  V30 11 O 7.7002 10.8760 0.0 0
M  V30 12 O 1.7464 10.1060 0.0 0
M  V30 13 O 4.4137 11.6460 0.0 0
M  V30 14 C 10.7802 10.8760 0.0 0
M  V30 15 N 10.7802 8.2085 0.0 0
M  V30 16 C 16.9404 10.8760 0.0 0
M  V30 17 C 5.3901 4.2073 0.0 0
M  V30 18 C 6.1601 2.8737 0.0 0
M  V30 19 C 3.8501 4.2073 0.0 0
M  V30 20 C 5.3901 1.5400 0.0 0
M  V30 21 C 3.0801 2.8737 0.0 0
M  V30 22 C 3.8501 1.5400 0.0 0
M  V30 23 C 2.3101 12.2097 0.0 0
M  V30 24 C 3.0801 13.5433 0.0 0
M  V30 25 C 0.7700 12.2097 0.0 0
M  V30 26 C 2.3101 14.8770 0.0 0
M  V30 27 C 0.0000 13.5433 0.0 0
M  V30 28 C 0.7700 14.8770 0.0 0
M  V30 29 C 12.3203 10.8760 0.0 0
M  V30 30 C 13.0903 12.2097 0.0 0
M  V30 31 C 13.0903 9.5422 0.0 0
M  V30 32 C 14.6303 12.2097 0.0 0
M  V30 33 C 14.6303 9.5422 0.0 0
M  V30 34 C 15.4003 10.8760 0.0 0
M  V30 35 Cl 8.4702 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 17
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 8 13
M  V30 14 1 8 23
M  V30 15 1 10 14
M  V30 16 1 10 15 CFG=3
M  V30 17 1 14 29
M  V30 18 1 16 34
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2-[[(1S,2E)-3-Fluoro-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-...
C33H32FN3O4S
2761157-41-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0 CFG=2
M  V30 2 C 3.0800 6.6685 0.0 0
M  V30 3 C 5.3900 8.0021 0.0 0
M  V30 4 N 5.3900 5.3347 0.0 0
M  V30 5 N 6.9300 8.0021 0.0 0
M  V30 6 O 4.6200 9.3358 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 7.7000 9.3358 0.0 0 CFG=1
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 9.2400 9.3358 0.0 0
M  V30 11 C 6.9300 10.6696 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 7.7000 12.0032 0.0 0
M  V30 14 S 11.5500 8.0021 0.0 0 VAL=6
M  V30 15 F 9.2400 6.6685 0.0 0
M  V30 16 O 11.5500 6.4621 0.0 0
M  V30 17 O 11.5500 9.5421 0.0 0
M  V30 18 C 0.0000 12.0032 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 3.0800 9.3358 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 2.3100 10.6696 0.0 0
M  V30 23 C 0.0000 9.3358 0.0 0
M  V30 24 C 0.7700 10.6696 0.0 0
M  V30 25 C 5.3900 2.6674 0.0 0
M  V30 26 C 6.9300 2.6674 0.0 0
M  V30 27 C 4.6200 1.3338 0.0 0
M  V30 28 C 7.7000 1.3338 0.0 0
M  V30 29 C 5.3900 0.0000 0.0 0
M  V30 30 N 6.9300 0.0000 0.0 0
M  V30 31 C 6.9300 13.3369 0.0 0
M  V30 32 C 7.7000 14.6705 0.0 0
M  V30 33 C 5.3900 13.3369 0.0 0
M  V30 34 C 6.9300 16.0043 0.0 0
M  V30 35 C 4.6200 14.6705 0.0 0
M  V30 36 C 5.3900 16.0043 0.0 0
M  V30 37 C 13.0900 8.0021 0.0 0
M  V30 38 C 13.8600 9.3358 0.0 0
M  V30 39 C 13.8600 6.6685 0.0 0
M  V30 40 C 15.4000 9.3358 0.0 0
M  V30 41 C 15.4000 6.6685 0.0 0
M  V30 42 C 16.1700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 25
M  V30 11 1 8 10
M  V30 12 1 8 11 CFG=1
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 31
M  V30 18 2 14 16
M  V30 19 2 14 17
M  V30 20 1 14 37
M  V30 21 1 18 24
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55-22-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761158-02-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-7a,8,8-trimethyl-...
C15H28BNO2.C2HF3O2
2415205-36-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9308 5.1837 0.0 0
M  V30 2 C 1.5402 9.3367 0.0 0
M  V30 3 C 0.0000 7.4197 0.0 0
M  V30 4 C 8.0301 9.3424 0.0 0 CFG=1
M  V30 5 C 9.3638 8.5724 0.0 0
M  V30 6 N 8.0301 10.8824 0.0 0
M  V30 7 C 10.6974 9.3424 0.0 0
M  V30 8 C 10.6974 10.8824 0.0 0
M  V30 9 C 12.0312 8.5724 0.0 0
M  V30 10 C 4.2591 8.0543 0.0 0 CFG=1
M  V30 11 C 2.7187 7.4060 0.0 0 CFG=2
M  V30 12 C 5.0291 6.7207 0.0 0 CFG=2
M  V30 13 O 5.2895 9.1987 0.0 0
M  V30 14 C 1.4930 7.7974 0.0 0
M  V30 15 C 2.5438 5.2777 0.0 0
M  V30 16 C 3.8856 7.1212 0.0 0
M  V30 17 O 6.5354 7.0408 0.0 0
M  V30 18 B 6.6963 8.5724 0.0 0
M  V30 19 C 2.2413 6.5095 0.0 0 CFG=1
M  V30 20 H 3.3666 9.3094 0.0 0
M  V30 21 H 2.6499 8.9444 0.0 0
M  V30 22 H 0.8131 5.9332 0.0 0
M  V30 23 C 5.3488 2.3101 0.0 0
M  V30 24 C 6.6824 1.5400 0.0 0
M  V30 25 F 6.1188 3.6437 0.0 0
M  V30 26 F 4.0151 3.0801 0.0 0
M  V30 27 F 4.5788 0.9764 0.0 0
M  V30 28 O 8.0161 2.3101 0.0 0
M  V30 29 O 6.6824 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 2 14
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 18
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 20 CFG=3
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 21 CFG=1
M  V30 17 1 12 16 CFG=1
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 19
M  V30 22 1 16 19
M  V30 23 1 17 18
M  V30 24 1 19 22 CFG=3
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 2 24 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 10 11 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H45BN2O5
2415205-24-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3882 9.1521 0.0 0
M  V30 2 C 0.3753 7.2509 0.0 0
M  V30 3 C 0.0000 9.6812 0.0 0
M  V30 4 C 5.9928 4.0011 0.0 0 CFG=2
M  V30 5 N 7.5328 4.0011 0.0 0
M  V30 6 C 5.2228 2.6674 0.0 0
M  V30 7 C 8.3028 5.3347 0.0 0
M  V30 8 C 3.6828 2.6674 0.0 0
M  V30 9 C 9.8428 5.3347 0.0 0 CFG=1
M  V30 10 O 7.5328 6.6685 0.0 0
M  V30 11 C 2.9128 1.3338 0.0 0
M  V30 12 C 2.9128 4.0011 0.0 0
M  V30 13 C 10.6128 4.0011 0.0 0
M  V30 14 N 10.6128 6.6685 0.0 0
M  V30 15 C 12.1528 6.6685 0.0 0
M  V30 16 O 12.9228 8.0021 0.0 0
M  V30 17 O 12.9228 5.3347 0.0 0
M  V30 18 C 14.4628 8.0021 0.0 0
M  V30 19 C 14.4628 9.5421 0.0 0
M  V30 20 C 16.0028 8.0021 0.0 0
M  V30 21 C 14.4628 6.4621 0.0 0
M  V30 22 C 3.3711 7.0021 0.0 0 CFG=1
M  V30 23 C 2.3611 8.3337 0.0 0 CFG=2
M  V30 24 C 4.7047 7.7721 0.0 0 CFG=2
M  V30 25 O 3.6912 5.4958 0.0 0
M  V30 26 C 1.1040 8.6075 0.0 0
M  V30 27 C 3.2739 10.2643 0.0 0
M  V30 28 C 3.5141 7.9969 0.0 0
M  V30 29 O 5.8491 6.7417 0.0 0
M  V30 30 B 5.2228 5.3347 0.0 0
M  V30 31 C 2.3959 9.3487 0.0 0 CFG=1
M  V30 32 C 9.8428 2.6674 0.0 0
M  V30 33 C 10.6128 1.3338 0.0 0
M  V30 34 C 8.3028 2.6674 0.0 0
M  V30 35 C 9.8428 0.0000 0.0 0
M  V30 36 C 7.5328 1.3338 0.0 0
M  V30 37 C 8.3028 0.0000 0.0 0
M  V30 38 H 1.9706 6.3613 0.0 0
M  V30 39 H 1.5325 7.0356 0.0 0
M  V30 40 H 1.4473 10.5619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=1
M  V30 2 1 2 26
M  V30 3 1 3 26
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 30
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=1
M  V30 14 1 9 14
M  V30 15 1 13 32
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 22 38 CFG=1
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 23 39 CFG=3
M  V30 30 1 24 28 CFG=3
M  V30 31 1 24 29
M  V30 32 1 25 30
M  V30 33 1 26 31
M  V30 34 1 27 31
M  V30 35 1 28 31
M  V30 36 1 29 30
M  V30 37 1 31 40 CFG=1
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 4 9 22 23 24 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415205-36-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415205-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22020083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Peptide Boronate Derivatives as Histone Deacetylase and
Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of
Multiple Myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yi; Liu, Xiaoting; Xue, Junxin; Liu, Lulu; Liang, Tao; Li, Wen;
Yang, Xinying; Hou, Xuben; Fang, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(9), 4701-4715

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
2-[(3,5-Dimethyl-4-isoxazolyl)methoxy]benzoic acid
C13H13NO4
742120-03-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6798 4.0011 0.0 0
M  V30 2 C 3.9098 5.3347 0.0 0
M  V30 3 C 6.2198 1.3336 0.0 0
M  V30 4 O 4.6798 1.3336 0.0 0
M  V30 5 O 6.9898 0.0000 0.0 0
M  V30 6 C 1.9406 2.6242 0.0 0
M  V30 7 C 1.9406 8.0453 0.0 0
M  V30 8 C 6.2198 4.0011 0.0 0
M  V30 9 C 6.9898 2.6674 0.0 0
M  V30 10 C 6.9898 5.3347 0.0 0
M  V30 11 C 8.5298 2.6674 0.0 0
M  V30 12 C 8.5298 5.3347 0.0 0
M  V30 13 C 9.2998 4.0011 0.0 0
M  V30 14 C 2.3698 5.3347 0.0 0
M  V30 15 C 1.4645 4.0889 0.0 0
M  V30 16 C 1.4645 6.5806 0.0 0
M  V30 17 N 0.0000 4.5647 0.0 0
M  V30 18 O 0.0000 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 6 15
M  V30 8 1 7 16
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Aminoethyl)benzenesulfonamide
C8H12N2O2S
35303-76-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 N 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 N 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-2-[(3,5-dimethyl-4-isoxazolyl)methoxy]be...
C21H23N3O5S
1090816-80-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7118 6.2199 0.0 0
M  V30 2 N 8.0454 6.9899 0.0 0
M  V30 3 O 6.7118 4.6799 0.0 0
M  V30 4 C 9.3791 6.2199 0.0 0
M  V30 5 C 10.7128 6.9899 0.0 0
M  V30 6 O 4.0443 4.6799 0.0 0
M  V30 7 C 2.7106 3.9098 0.0 0
M  V30 8 C 0.0000 1.9406 0.0 0
M  V30 9 C 5.4212 1.9406 0.0 0
M  V30 10 S 16.0478 3.9098 0.0 0 VAL=6
M  V30 11 N 17.3814 3.1398 0.0 0
M  V30 12 O 16.8178 5.2435 0.0 0
M  V30 13 O 15.2778 2.5762 0.0 0
M  V30 14 C 5.3780 6.9899 0.0 0
M  V30 15 C 4.0443 6.2199 0.0 0
M  V30 16 C 5.3780 8.5299 0.0 0
M  V30 17 C 2.7106 6.9899 0.0 0
M  V30 18 C 4.0443 9.3000 0.0 0
M  V30 19 C 2.7106 8.5299 0.0 0
M  V30 20 C 2.7106 2.3698 0.0 0
M  V30 21 C 1.4647 1.4646 0.0 0
M  V30 22 C 3.9565 1.4646 0.0 0
M  V30 23 N 1.9406 0.0000 0.0 0
M  V30 24 O 3.4806 0.0000 0.0 0
M  V30 25 C 12.0466 6.2199 0.0 0
M  V30 26 C 12.0466 4.6799 0.0 0
M  V30 27 C 13.3803 6.9899 0.0 0
M  V30 28 C 13.3803 3.9098 0.0 0
M  V30 29 C 14.7139 6.2199 0.0 0
M  V30 30 C 14.7139 4.6799 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 20
M  V30 10 1 8 21
M  V30 11 1 9 22
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 30
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 742120-03-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35303-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1090816-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40892466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic
Potentiators for Cancer Drug Resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Siyu; Liu, Yang; Chu, Xianglin; Li, Qi; Lyu, Weiping; Liu, Yijun;
Xing, Shuaishuai; Feng, Feng; Liu, Wenyuan; Guo, Qinglong; Zhao, Li; Sun,
Haopeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H28N2O6.C2HF3O2
3031625-39-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 10.5184 0.0 0 CFG=1
M  V30 2 N 10.0100 10.5184 0.0 0
M  V30 3 C 12.3200 11.8521 0.0 0
M  V30 4 C 12.3200 9.1848 0.0 0
M  V30 5 C 9.2400 11.8521 0.0 0
M  V30 6 C 13.8600 11.8521 0.0 0
M  V30 7 O 11.5500 7.8510 0.0 0
M  V30 8 O 13.8600 9.1848 0.0 0
M  V30 9 C 7.7000 11.8521 0.0 0 CFG=1
M  V30 10 O 10.0100 13.1859 0.0 0
M  V30 11 C 14.6300 13.1857 0.0 0
M  V30 12 C 12.3200 6.5174 0.0 0
M  V30 13 C 6.9300 13.1859 0.0 0
M  V30 14 N 6.9300 10.5184 0.0 0
M  V30 15 O 16.1700 13.1859 0.0 0
M  V30 16 O 13.8600 14.5195 0.0 0
M  V30 17 C 11.5500 5.1837 0.0 0
M  V30 18 O 5.3900 13.1859 0.0 0
M  V30 19 C 16.9400 14.5195 0.0 0
M  V30 20 C 4.6200 14.5195 0.0 0
M  V30 21 C 18.4800 14.5195 0.0 0
M  V30 22 C 3.0800 14.5195 0.0 0
M  V30 23 C 2.3100 13.1859 0.0 0
M  V30 24 C 2.3100 15.8531 0.0 0
M  V30 25 C 0.7700 13.1859 0.0 0
M  V30 26 C 0.7700 15.8531 0.0 0
M  V30 27 C 0.0000 14.5195 0.0 0
M  V30 28 C 8.5732 2.3101 0.0 0
M  V30 29 C 9.9068 1.5400 0.0 0
M  V30 30 F 9.3432 3.6437 0.0 0
M  V30 31 F 7.2395 3.0801 0.0 0
M  V30 32 F 7.8031 0.9764 0.0 0
M  V30 33 O 11.2405 2.3101 0.0 0
M  V30 34 O 9.9068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=1
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 15 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 28 1 28 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 32 1 29 33
M  V30 33 2 29 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C26H39N3O9
3031089-24-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 6.9302 0.0 0 CFG=1
M  V30 2 C 9.3360 7.7002 0.0 0
M  V30 3 C 10.6697 5.3901 0.0 0
M  V30 4 N 12.0033 7.7002 0.0 0
M  V30 5 N 9.3360 9.2402 0.0 0
M  V30 6 O 8.0022 6.9302 0.0 0
M  V30 7 O 9.3360 4.6201 0.0 0
M  V30 8 C 13.3370 6.9302 0.0 0
M  V30 9 C 8.0022 10.0102 0.0 0 CFG=1
M  V30 10 C 9.3360 3.0801 0.0 0
M  V30 11 C 14.6708 7.7002 0.0 0
M  V30 12 O 13.3370 5.3901 0.0 0
M  V30 13 C 6.6685 9.2402 0.0 0
M  V30 14 C 8.0022 11.5503 0.0 0
M  V30 15 N 16.0045 6.9302 0.0 0
M  V30 16 C 5.3348 10.0102 0.0 0
M  V30 17 O 9.3360 12.3203 0.0 0
M  V30 18 O 6.6685 12.3203 0.0 0
M  V30 19 C 17.3382 7.7002 0.0 0
M  V30 20 C 4.0012 9.2402 0.0 0
M  V30 21 C 9.3360 13.8603 0.0 0
M  V30 22 O 18.6720 6.9302 0.0 0
M  V30 23 O 17.3382 9.2402 0.0 0
M  V30 24 O 2.6673 10.0102 0.0 0
M  V30 25 O 4.0012 7.7002 0.0 0
M  V30 26 C 10.6697 14.6303 0.0 0
M  V30 27 C 20.0057 7.7002 0.0 0
M  V30 28 C 1.3337 9.2402 0.0 0
M  V30 29 C 20.7757 6.3665 0.0 0
M  V30 30 C 21.3393 8.4702 0.0 0
M  V30 31 C 19.2356 9.0338 0.0 0
M  V30 32 C 0.0000 10.0102 0.0 0
M  V30 33 C 8.0022 2.3101 0.0 0
M  V30 34 C 8.0022 0.7700 0.0 0
M  V30 35 C 6.6685 3.0801 0.0 0
M  V30 36 C 6.6685 0.0000 0.0 0
M  V30 37 C 5.3348 2.3101 0.0 0
M  V30 38 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13 CFG=3
M  V30 13 1 9 14
M  V30 14 1 10 33
M  V30 15 1 11 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 20 25
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 24 28
M  V30 29 1 27 29
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 33 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 2 35 37
M  V30 37 2 36 38
M  V30 38 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3031625-39-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3031089-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34283448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their
In Vivo Adjuvant Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guzelj, Samo; Nabergoj, Sanja; Gobec, Martina; Pajk, Stane; Klancic,
Veronika; Slutter, Bram; Frkanec, Ruza; Stimac, Adela; Sket, Primoz;
Plavec, Janez; Mlinaric-Rascan, Irena; Jakopin, Ziga
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(11), 7809-7838

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
5-Methoxy-2-methylindole-3-acetic acid
C12H13NO3
2882-15-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 1.9571 0.0 0
M  V30 2 C 1.1444 2.4329 0.0 0
M  V30 3 O 0.8242 3.9394 0.0 0
M  V30 4 O 0.0000 1.4025 0.0 0
M  V30 5 C 2.2588 5.2891 0.0 0
M  V30 6 O 8.3399 0.0000 0.0 0
M  V30 7 C 9.8799 0.0000 0.0 0
M  V30 8 C 5.2598 2.6673 0.0 0
M  V30 9 C 3.7535 2.9875 0.0 0
M  V30 10 C 6.0298 4.0010 0.0 0
M  V30 11 C 6.0298 1.3337 0.0 0
M  V30 12 C 3.5926 4.5191 0.0 0
M  V30 13 N 4.9994 5.1456 0.0 0
M  V30 14 C 7.5699 4.0010 0.0 0
M  V30 15 C 7.5699 1.3337 0.0 0
M  V30 16 C 8.3399 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-3-methoxybenzeneethanamine
C11H17NO2
36377-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 10.7800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Ethoxy-3-methoxyphenyl)ethyl]-5-methoxy-2-methyl-1H-indole-3-acetamide
C23H28N2O4
2565618-13-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5198 6.6684 0.0 0
M  V30 2 C 9.0598 6.6684 0.0 0
M  V30 3 N 9.8298 5.3347 0.0 0
M  V30 4 O 9.8298 8.0020 0.0 0
M  V30 5 C 11.3698 5.3347 0.0 0
M  V30 6 C 12.1398 4.0011 0.0 0
M  V30 7 C 8.8824 9.7291 0.0 0
M  V30 8 O 1.4647 6.5780 0.0 0
M  V30 9 C 0.0000 7.0538 0.0 0
M  V30 10 O 16.7598 1.3336 0.0 0
M  V30 11 C 15.9898 0.0000 0.0 0
M  V30 12 O 18.2998 4.0011 0.0 0
M  V30 13 C 19.0698 5.3347 0.0 0
M  V30 14 C 20.6098 5.3347 0.0 0
M  V30 15 C 5.2181 8.1631 0.0 0
M  V30 16 C 4.8980 9.6694 0.0 0
M  V30 17 C 6.7498 8.0020 0.0 0
M  V30 18 C 4.0738 7.1325 0.0 0
M  V30 19 N 6.2318 10.4394 0.0 0
M  V30 20 C 3.4334 10.1452 0.0 0
M  V30 21 C 7.3761 9.4089 0.0 0
M  V30 22 C 2.6091 7.6085 0.0 0
M  V30 23 C 2.2889 9.1148 0.0 0
M  V30 24 C 13.6798 4.0011 0.0 0
M  V30 25 C 14.4498 2.6673 0.0 0
M  V30 26 C 14.4498 5.3347 0.0 0
M  V30 27 C 15.9898 2.6673 0.0 0
M  V30 28 C 15.9898 5.3347 0.0 0
M  V30 29 C 16.7598 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 24
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 8 22
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 1 20 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2882-15-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36377-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23046121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
3,5-Difluorobenzoic acid
C7H4F2O2
455-40-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 F 0.0000 4.6200 0.0 0
M  V30 5 F 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pentene-1-sulfonic acid, 3-[[(2S)-2-amino-3-(4-methylphenyl)-1-oxopropyl]am...
C27H29FN2O4S.ClH
2761158-04-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4149 8.2084 0.0 0 CFG=2
M  V30 2 C 7.6449 6.8747 0.0 0
M  V30 3 C 7.6449 9.5421 0.0 0
M  V30 4 N 9.9549 8.2084 0.0 0
M  V30 5 C 8.4149 5.5411 0.0 0
M  V30 6 C 6.1049 9.5421 0.0 0
M  V30 7 C 10.7249 9.5421 0.0 0
M  V30 8 S 5.3349 10.8758 0.0 0 VAL=6
M  V30 9 F 5.3349 8.2084 0.0 0
M  V30 10 C 12.2649 9.5421 0.0 0 CFG=1
M  V30 11 O 9.9549 10.8758 0.0 0
M  V30 12 O 4.0011 10.1058 0.0 0
M  V30 13 O 6.6685 11.6458 0.0 0
M  V30 14 O 4.5649 12.2094 0.0 0
M  V30 15 C 13.0349 10.8758 0.0 0
M  V30 16 N 13.0349 8.2084 0.0 0
M  V30 17 C 19.1949 10.8758 0.0 0
M  V30 18 C 7.6449 4.2074 0.0 0
M  V30 19 C 8.4149 2.8736 0.0 0
M  V30 20 C 6.1049 4.2074 0.0 0
M  V30 21 C 7.6449 1.5400 0.0 0
M  V30 22 C 5.3349 2.8736 0.0 0
M  V30 23 C 6.1049 1.5400 0.0 0
M  V30 24 C 2.6674 10.8758 0.0 0
M  V30 25 C 2.6674 12.4158 0.0 0
M  V30 26 C 1.3338 10.1058 0.0 0
M  V30 27 C 1.3338 13.1858 0.0 0
M  V30 28 C 0.0000 10.8758 0.0 0
M  V30 29 C 0.0000 12.4158 0.0 0
M  V30 30 C 14.5749 10.8758 0.0 0
M  V30 31 C 15.3449 9.5421 0.0 0
M  V30 32 C 15.3449 12.2094 0.0 0
M  V30 33 C 16.8849 9.5421 0.0 0
M  V30 34 C 16.8849 12.2094 0.0 0
M  V30 35 C 17.6547 10.8758 0.0 0
M  V30 36 Cl 9.5974 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 8 14
M  V30 15 1 10 15
M  V30 16 1 10 16 CFG=3
M  V30 17 1 12 24
M  V30 18 1 15 30
M  V30 19 1 17 35
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenyl (1E,3S)-3-[[(2S)-2-[(3,5-difluorobenzoyl)amino]-3-(4-methylphenyl)-1-o...
C34H31F3N2O5S
2761157-24-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 10.9310 0.0 0 CFG=1
M  V30 2 C 9.3359 12.4711 0.0 0
M  V30 3 N 10.6695 10.1610 0.0 0
M  V30 4 C 8.0022 10.1610 0.0 0
M  V30 5 C 12.0034 10.9310 0.0 0
M  V30 6 N 8.0022 8.6210 0.0 0
M  V30 7 O 6.6686 10.9310 0.0 0
M  V30 8 O 12.0034 12.4711 0.0 0
M  V30 9 C 6.6686 7.8510 0.0 0 CFG=1
M  V30 10 C 6.6686 6.3110 0.0 0
M  V30 11 C 5.3348 8.6210 0.0 0
M  V30 12 C 8.0022 5.5410 0.0 0
M  V30 13 C 4.0011 7.8510 0.0 0
M  V30 14 S 8.0022 4.0010 0.0 0 VAL=6
M  V30 15 F 9.3359 6.3110 0.0 0
M  V30 16 O 6.4622 4.0010 0.0 0
M  V30 17 O 9.5423 4.0010 0.0 0
M  V30 18 O 8.0022 2.4609 0.0 0
M  V30 19 C 4.0011 15.5511 0.0 0
M  V30 20 F 14.6707 6.3110 0.0 0
M  V30 21 F 17.3381 10.9310 0.0 0
M  V30 22 C 8.0022 13.2411 0.0 0
M  V30 23 C 8.0022 14.7811 0.0 0
M  V30 24 C 6.6686 12.4711 0.0 0
M  V30 25 C 6.6686 15.5511 0.0 0
M  V30 26 C 5.3348 13.2411 0.0 0
M  V30 27 C 5.3348 14.7811 0.0 0
M  V30 28 C 13.3370 10.1610 0.0 0
M  V30 29 C 13.3370 8.6210 0.0 0
M  V30 30 C 14.6707 10.9310 0.0 0
M  V30 31 C 14.6707 7.8510 0.0 0
M  V30 32 C 16.0043 10.1610 0.0 0
M  V30 33 C 16.0043 8.6210 0.0 0
M  V30 34 C 2.6675 8.6210 0.0 0
M  V30 35 C 2.6675 10.1610 0.0 0
M  V30 36 C 1.3338 7.8510 0.0 0
M  V30 37 C 1.3338 10.9310 0.0 0
M  V30 38 C 0.0000 8.6210 0.0 0
M  V30 39 C 0.0000 10.1610 0.0 0
M  V30 40 C 5.6922 2.6673 0.0 0
M  V30 41 C 4.1522 2.6673 0.0 0
M  V30 42 C 6.4622 1.3337 0.0 0
M  V30 43 C 3.3822 1.3337 0.0 0
M  V30 44 C 5.6922 0.0000 0.0 0
M  V30 45 C 4.1522 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 28
M  V30 10 1 6 9
M  V30 11 1 9 10
M  V30 12 1 9 11 CFG=3
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 34
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 2 14 18
M  V30 21 1 16 40
M  V30 22 1 19 27
M  V30 23 1 20 31
M  V30 24 1 21 32
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 455-40-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761158-04-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-24-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Protocatechuic acid
C7H6O4
99-50-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 5.3901 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,4-Dihydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfony...
C27H31N3O8S
2892016-11-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 9.2400 0.0 0 CFG=1
M  V30 2 C 6.6685 8.4700 0.0 0 CFG=2
M  V30 3 C 8.0021 10.7800 0.0 0
M  V30 4 N 9.3358 8.4700 0.0 0
M  V30 5 C 5.3347 9.2400 0.0 0
M  V30 6 O 6.6685 6.9300 0.0 0
M  V30 7 C 10.6696 9.2400 0.0 0
M  V30 8 N 4.0011 8.4700 0.0 0
M  V30 9 O 10.6696 10.7800 0.0 0
M  V30 10 S 4.0011 6.9300 0.0 0 VAL=6
M  V30 11 C 2.6674 9.2400 0.0 0
M  V30 12 O 5.5411 6.9300 0.0 0
M  V30 13 O 2.4611 6.9300 0.0 0
M  V30 14 C 1.3338 8.4700 0.0 0
M  V30 15 C 0.0000 9.2400 0.0 0
M  V30 16 C 1.3338 6.9300 0.0 0
M  V30 17 O 16.0043 9.2400 0.0 0
M  V30 18 O 16.0043 6.1600 0.0 0
M  V30 19 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 20 O 2.6674 0.0000 0.0 0
M  V30 21 O 5.3349 0.0000 0.0 0
M  V30 22 C 6.6685 11.5500 0.0 0
M  V30 23 C 6.6685 13.0900 0.0 0
M  V30 24 C 5.3347 10.7800 0.0 0
M  V30 25 C 5.3347 13.8600 0.0 0
M  V30 26 C 4.0011 11.5500 0.0 0
M  V30 27 C 4.0011 13.0900 0.0 0
M  V30 28 C 12.0032 8.4700 0.0 0
M  V30 29 C 13.3369 9.2400 0.0 0
M  V30 30 C 12.0032 6.9300 0.0 0
M  V30 31 C 14.6705 8.4700 0.0 0
M  V30 32 C 13.3369 6.1600 0.0 0
M  V30 33 C 14.6705 6.9300 0.0 0
M  V30 34 C 4.0011 5.3900 0.0 0
M  V30 35 C 2.6674 4.6200 0.0 0
M  V30 36 C 5.3347 4.6200 0.0 0
M  V30 37 C 2.6674 3.0800 0.0 0
M  V30 38 C 5.3349 3.0800 0.0 0
M  V30 39 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 22
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 28
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 34
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 31
M  V30 20 1 18 33
M  V30 21 2 19 20
M  V30 22 2 19 21
M  V30 23 1 19 39
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-50-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
4-Ethoxy-3-methoxybenzeneethanamine
C11H17NO2
36377-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 10.7800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5-Bromo-1H-indol-3-yl)acetic acid
C10H8BrNO2
40432-84-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5369 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 O 0.0000 2.6091 0.0 0
M  V30 4 O 0.5546 0.0000 0.0 0
M  V30 5 Br 8.4784 2.9553 0.0 0
M  V30 6 C 4.4773 3.7253 0.0 0
M  V30 7 C 4.4773 5.2653 0.0 0
M  V30 8 C 3.0127 3.2494 0.0 0
M  V30 9 C 5.8111 2.9553 0.0 0
M  V30 10 N 3.0127 5.7411 0.0 0
M  V30 11 C 5.8111 6.0353 0.0 0
M  V30 12 C 2.1075 4.4953 0.0 0
M  V30 13 C 7.1447 3.7253 0.0 0
M  V30 14 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-[2-(4-ethoxy-3-methoxyphenyl)ethyl]-1H-indole-3-acetamide
C21H23BrN2O3
2565618-11-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 6.6684 0.0 0
M  V30 2 C 7.5950 6.6684 0.0 0
M  V30 3 N 8.3650 5.3347 0.0 0
M  V30 4 O 8.3650 8.0020 0.0 0
M  V30 5 C 9.9050 5.3347 0.0 0
M  V30 6 C 10.6750 4.0011 0.0 0
M  V30 7 Br 0.0000 6.5780 0.0 0
M  V30 8 O 15.2950 1.3336 0.0 0
M  V30 9 C 14.5250 0.0000 0.0 0
M  V30 10 O 16.8350 4.0011 0.0 0
M  V30 11 C 17.6050 5.3347 0.0 0
M  V30 12 C 19.1450 5.3347 0.0 0
M  V30 13 C 3.7534 8.1631 0.0 0
M  V30 14 C 5.2850 8.0020 0.0 0
M  V30 15 C 3.4333 9.6694 0.0 0
M  V30 16 C 2.6091 7.1325 0.0 0
M  V30 17 C 5.9114 9.4089 0.0 0
M  V30 18 N 4.7669 10.4394 0.0 0
M  V30 19 C 1.9686 10.1452 0.0 0
M  V30 20 C 1.1444 7.6085 0.0 0
M  V30 21 C 0.8242 9.1148 0.0 0
M  V30 22 C 12.2150 4.0011 0.0 0
M  V30 23 C 12.9850 2.6673 0.0 0
M  V30 24 C 12.9850 5.3347 0.0 0
M  V30 25 C 14.5250 2.6673 0.0 0
M  V30 26 C 14.5250 5.3347 0.0 0
M  V30 27 C 15.2950 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 22
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36377-59-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40432-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23045819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
3,5-Difluorobenzoic acid
C7H4F2O2
455-40-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 F 0.0000 4.6200 0.0 0
M  V30 5 F 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-[(1S,2E)-3-fluoro-1-(2-phenylethyl)-3-[(phenylm...
C28H31FN2O3S.ClH
2761158-08-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4702 8.2085 0.0 0 CFG=2
M  V30 2 C 7.7002 6.8748 0.0 0
M  V30 3 C 7.7002 9.5422 0.0 0
M  V30 4 N 10.0102 8.2085 0.0 0
M  V30 5 C 8.4702 5.5412 0.0 0
M  V30 6 C 6.1601 9.5422 0.0 0
M  V30 7 C 10.7802 9.5422 0.0 0
M  V30 8 S 5.3901 10.8760 0.0 0 VAL=6
M  V30 9 F 5.3901 8.2085 0.0 0
M  V30 10 C 12.3203 9.5422 0.0 0 CFG=1
M  V30 11 O 10.0102 10.8760 0.0 0
M  V30 12 C 4.6201 12.2097 0.0 0
M  V30 13 O 4.0564 10.1060 0.0 0
M  V30 14 O 6.7238 11.6460 0.0 0
M  V30 15 C 13.0903 10.8760 0.0 0
M  V30 16 N 13.0903 8.2085 0.0 0
M  V30 17 C 19.2504 10.8760 0.0 0
M  V30 18 C 7.7002 4.2073 0.0 0
M  V30 19 C 6.1601 4.2073 0.0 0
M  V30 20 C 8.4702 2.8737 0.0 0
M  V30 21 C 5.3901 2.8737 0.0 0
M  V30 22 C 7.7002 1.5400 0.0 0
M  V30 23 C 6.1601 1.5400 0.0 0
M  V30 24 C 3.0801 12.2097 0.0 0
M  V30 25 C 2.3101 13.5433 0.0 0
M  V30 26 C 2.3101 10.8760 0.0 0
M  V30 27 C 0.7700 13.5433 0.0 0
M  V30 28 C 0.7700 10.8760 0.0 0
M  V30 29 C 0.0000 12.2097 0.0 0
M  V30 30 C 14.6303 10.8760 0.0 0
M  V30 31 C 15.4003 9.5422 0.0 0
M  V30 32 C 15.4003 12.2097 0.0 0
M  V30 33 C 16.9404 9.5422 0.0 0
M  V30 34 C 16.9404 12.2097 0.0 0
M  V30 35 C 17.7104 10.8760 0.0 0
M  V30 36 Cl 9.6252 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 8 14
M  V30 15 1 10 15
M  V30 16 1 10 16 CFG=3
M  V30 17 1 12 24
M  V30 18 1 15 30
M  V30 19 1 17 35
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-[(3,5-Difluorobenzoyl)amino]-N-[(1S,2E)-3-fluoro-1-(2-phenylethyl)-3-[...
C35H33F3N2O4S
2761157-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 11.5500 0.0 0 CFG=1
M  V30 2 C 9.3358 13.0900 0.0 0
M  V30 3 N 10.6694 10.7800 0.0 0
M  V30 4 C 8.0021 10.7800 0.0 0
M  V30 5 C 12.0032 11.5500 0.0 0
M  V30 6 N 8.0021 9.2400 0.0 0
M  V30 7 O 6.6685 11.5500 0.0 0
M  V30 8 O 12.0032 13.0900 0.0 0
M  V30 9 C 6.6685 8.4700 0.0 0 CFG=1
M  V30 10 C 6.6685 6.9300 0.0 0
M  V30 11 C 5.3347 9.2400 0.0 0
M  V30 12 C 8.0021 6.1600 0.0 0
M  V30 13 C 4.0011 8.4700 0.0 0
M  V30 14 S 8.0021 4.6200 0.0 0 VAL=6
M  V30 15 F 9.3358 6.9300 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 O 9.5421 4.6200 0.0 0
M  V30 18 O 6.4621 4.6200 0.0 0
M  V30 19 C 4.0011 16.1700 0.0 0
M  V30 20 F 14.6705 6.9300 0.0 0
M  V30 21 F 17.3379 11.5500 0.0 0
M  V30 22 C 8.0021 13.8600 0.0 0
M  V30 23 C 8.0021 15.4000 0.0 0
M  V30 24 C 6.6685 13.0900 0.0 0
M  V30 25 C 6.6685 16.1700 0.0 0
M  V30 26 C 5.3347 13.8600 0.0 0
M  V30 27 C 5.3347 15.4000 0.0 0
M  V30 28 C 13.3369 10.7800 0.0 0
M  V30 29 C 13.3369 9.2400 0.0 0
M  V30 30 C 14.6705 11.5500 0.0 0
M  V30 31 C 14.6705 8.4700 0.0 0
M  V30 32 C 16.0041 10.7800 0.0 0
M  V30 33 C 16.0041 9.2400 0.0 0
M  V30 34 C 2.6674 9.2400 0.0 0
M  V30 35 C 1.3338 8.4700 0.0 0
M  V30 36 C 2.6674 10.7800 0.0 0
M  V30 37 C 0.0000 9.2400 0.0 0
M  V30 38 C 1.3338 11.5500 0.0 0
M  V30 39 C 0.0000 10.7800 0.0 0
M  V30 40 C 6.6685 2.3100 0.0 0
M  V30 41 C 5.3347 3.0800 0.0 0
M  V30 42 C 6.6685 0.7700 0.0 0
M  V30 43 C 4.0011 2.3100 0.0 0
M  V30 44 C 5.3347 0.0000 0.0 0
M  V30 45 C 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 28
M  V30 10 1 6 9
M  V30 11 1 9 10
M  V30 12 1 9 11 CFG=3
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 34
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 2 14 18
M  V30 21 1 16 40
M  V30 22 1 19 27
M  V30 23 1 20 31
M  V30 24 1 21 32
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 455-40-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761158-08-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
trans-Cinnamic acid
C9H8O2
140-10-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Alanine, L-phenylalanyl-3-[(3S)-2-oxo-3-pyrrolidinyl]-, methyl ester, hydro...
C17H23N3O4.ClH
2640359-25-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 5.5411 0.0 0 CFG=1
M  V30 2 C 3.9098 6.8747 0.0 0
M  V30 3 N 6.2198 5.5411 0.0 0
M  V30 4 C 3.9098 4.2074 0.0 0
M  V30 5 C 6.9898 6.8747 0.0 0
M  V30 6 O 4.6798 2.8736 0.0 0
M  V30 7 O 2.3698 4.2074 0.0 0
M  V30 8 C 8.5298 6.8747 0.0 0 CFG=1
M  V30 9 O 6.2198 8.2084 0.0 0
M  V30 10 C 3.9098 1.5400 0.0 0
M  V30 11 C 9.2998 8.2084 0.0 0
M  V30 12 N 9.2998 5.5411 0.0 0
M  V30 13 O 1.9406 9.5853 0.0 0
M  V30 14 C 2.3698 6.8747 0.0 0 CFG=2
M  V30 15 C 1.4645 8.1206 0.0 0
M  V30 16 C 1.4645 5.6289 0.0 0
M  V30 17 N 0.0000 7.6447 0.0 0
M  V30 18 C 0.0000 6.1047 0.0 0
M  V30 19 C 10.8398 8.2084 0.0 0
M  V30 20 C 11.6098 6.8747 0.0 0
M  V30 21 C 11.6098 9.5422 0.0 0
M  V30 22 C 13.1498 6.8747 0.0 0
M  V30 23 C 13.1498 9.5422 0.0 0
M  V30 24 C 13.9198 8.2084 0.0 0
M  V30 25 Cl 6.9599 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 14 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 11 19
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2E)-1-Oxo-3-phenyl-2-propen-1-yl]-L-phenylalanyl-3-[(3S)-2-oxo-3-pyrrolid...
C26H29N3O5
1065478-35-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7721 4.6200 0.0 0 CFG=2
M  V30 2 C 7.7721 3.0800 0.0 0
M  V30 3 C 6.4384 5.3900 0.0 0
M  V30 4 N 9.1057 5.3900 0.0 0
M  V30 5 N 6.4384 6.9300 0.0 0
M  V30 6 O 5.1046 4.6200 0.0 0
M  V30 7 C 10.4395 4.6200 0.0 0
M  V30 8 C 5.1046 7.7000 0.0 0 CFG=2
M  V30 9 C 11.7731 5.3900 0.0 0
M  V30 10 O 10.4395 3.0800 0.0 0
M  V30 11 C 3.7710 6.9300 0.0 0
M  V30 12 C 5.1046 9.2400 0.0 0
M  V30 13 C 13.1068 4.6200 0.0 0
M  V30 14 O 6.4384 10.0100 0.0 0
M  V30 15 O 3.7710 10.0100 0.0 0
M  V30 16 C 6.4384 11.5500 0.0 0
M  V30 17 O 0.7102 5.5673 0.0 0
M  V30 18 C 6.4384 2.3100 0.0 0
M  V30 19 C 5.1046 3.0800 0.0 0
M  V30 20 C 6.4384 0.7700 0.0 0
M  V30 21 C 3.7710 2.3100 0.0 0
M  V30 22 C 5.1046 0.0000 0.0 0
M  V30 23 C 3.7710 0.7700 0.0 0
M  V30 24 C 2.4374 7.7000 0.0 0 CFG=2
M  V30 25 C 1.0306 7.0737 0.0 0
M  V30 26 C 2.2764 9.2315 0.0 0
M  V30 27 N 0.0000 8.2181 0.0 0
M  V30 28 C 0.7700 9.5517 0.0 0
M  V30 29 C 14.4404 5.3900 0.0 0
M  V30 30 C 15.7742 4.6200 0.0 0
M  V30 31 C 14.4404 6.9300 0.0 0
M  V30 32 C 17.1079 5.3900 0.0 0
M  V30 33 C 15.7742 7.7000 0.0 0
M  V30 34 C 17.1079 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 24 11 CFG=1
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 29
M  V30 18 1 14 16
M  V30 19 2 17 25
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 140-10-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2640359-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065478-35-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31497669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of peptidomimetic aldehydes
as broad-spectrum inhibitors against enterovirus and SARS-COV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Wenhao; Jochmans, Dirk; Xie, Hang; Yang, Hang; Li, Jian; Su, Haixia;
Chang, Di; Wang, Jiang; Peng, Jingjing; Zhu, Lili; Nian, Yong;
Hilgenfeld, Rolf; Jiang, Hualiang; Chen, Kaixian; Zhang, Leike; Xu,
Yechun; Neyts, Johan; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 2794-2808

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
2,4-Dihydroxybenzoic acid
C7H6O4
89-86-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-fluoro-N-(2-methylpropyl)benzen...
C20H27FN2O3S
772318-79-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 F 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-3-[[(4-Fluorophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(p...
C27H31FN2O6S
2892016-31-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.1600 0.0 0 VAL=6
M  V30 2 N 4.0011 7.7000 0.0 0
M  V30 3 O 5.5411 6.1600 0.0 0
M  V30 4 O 2.4611 6.1600 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 C 2.6674 8.4700 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 8 C 1.3338 7.7000 0.0 0
M  V30 9 C 8.0021 8.4700 0.0 0 CFG=1
M  V30 10 O 6.6685 6.1600 0.0 0
M  V30 11 C 0.0000 8.4700 0.0 0
M  V30 12 C 1.3338 6.1600 0.0 0
M  V30 13 C 8.0021 10.0100 0.0 0
M  V30 14 N 9.3358 7.7000 0.0 0
M  V30 15 C 10.6696 8.4700 0.0 0
M  V30 16 O 10.6696 10.0100 0.0 0
M  V30 17 F 4.0011 0.0000 0.0 0
M  V30 18 O 13.3369 10.0100 0.0 0
M  V30 19 O 16.0043 5.3900 0.0 0
M  V30 20 C 4.0011 4.6200 0.0 0
M  V30 21 C 2.6674 3.8500 0.0 0
M  V30 22 C 5.3347 3.8500 0.0 0
M  V30 23 C 2.6674 2.3100 0.0 0
M  V30 24 C 5.3347 2.3100 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0
M  V30 26 C 6.6685 10.7800 0.0 0
M  V30 27 C 6.6685 12.3200 0.0 0
M  V30 28 C 5.3347 10.0100 0.0 0
M  V30 29 C 5.3347 13.0900 0.0 0
M  V30 30 C 4.0011 10.7800 0.0 0
M  V30 31 C 4.0011 12.3200 0.0 0
M  V30 32 C 12.0032 7.7000 0.0 0
M  V30 33 C 13.3369 8.4700 0.0 0
M  V30 34 C 12.0032 6.1600 0.0 0
M  V30 35 C 14.6705 7.7000 0.0 0
M  V30 36 C 13.3369 5.3900 0.0 0
M  V30 37 C 14.6705 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 20
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 26
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 32
M  V30 19 1 17 25
M  V30 20 1 18 33
M  V30 21 1 19 37
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 89-86-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 772318-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Indole-2-carboxylic acid
C9H7NO2
1477-50-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 N 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[1-(4-aminobutyl)-3-piperidinyl]methyl]-, 1,1-dimethylethyl...
C15H31N3O2
3035975-21-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0
M  V30 4 O 2.6675 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 1.3338 3.0801 0.0 0
M  V30 7 C 2.1038 4.4137 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 0.5638 1.7464 0.0 0
M  V30 10 C 12.0035 3.0801 0.0 0
M  V30 11 C 13.3372 2.3101 0.0 0
M  V30 12 C 14.6708 3.0801 0.0 0
M  V30 13 C 16.0045 2.3101 0.0 0
M  V30 14 N 17.3383 3.0801 0.0 0
M  V30 15 C 8.0023 2.3101 0.0 0
M  V30 16 C 9.3360 3.0801 0.0 0
M  V30 17 C 8.0023 0.7700 0.0 0
M  V30 18 N 10.6697 2.3101 0.0 0
M  V30 19 C 9.3360 0.0000 0.0 0
M  V30 20 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[1-[4-[(1H-indol-2-ylcarbonyl)amino]butyl]-3-piperidinyl]me...
C24H36N4O3
3035975-22-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 N 7.4148 3.1854 0.0 0
M  V30 3 O 6.0811 5.4955 0.0 0
M  V30 4 C 8.7485 3.9554 0.0 0
M  V30 5 C 10.0821 3.1854 0.0 0
M  V30 6 C 11.4160 3.9554 0.0 0
M  V30 7 C 12.7496 3.1854 0.0 0
M  V30 8 C 18.0845 3.1854 0.0 0
M  V30 9 N 19.4181 3.9554 0.0 0
M  V30 10 C 20.7520 3.1854 0.0 0
M  V30 11 O 22.0856 3.9554 0.0 0
M  V30 12 O 20.7520 1.6454 0.0 0
M  V30 13 C 23.4193 3.1854 0.0 0
M  V30 14 C 24.1893 4.5192 0.0 0
M  V30 15 C 24.7530 2.4154 0.0 0
M  V30 16 C 22.6493 1.8517 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 3.3405 3.8119 0.0 0
M  V30 20 C 0.7700 2.6673 0.0 0
M  V30 21 N 4.5864 1.6538 0.0 0
M  V30 22 C 2.3101 0.0000 0.0 0
M  V30 23 C 4.7473 3.1854 0.0 0
M  V30 24 C 0.0000 1.3337 0.0 0
M  V30 25 C 0.7700 0.0000 0.0 0
M  V30 26 N 14.0833 3.9554 0.0 0
M  V30 27 C 15.4171 3.1854 0.0 0
M  V30 28 C 14.0833 5.4955 0.0 0
M  V30 29 C 16.7508 3.9554 0.0 0
M  V30 30 C 15.4171 6.2655 0.0 0
M  V30 31 C 16.7508 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 1 22 25
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1477-50-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035975-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035975-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40761033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure Activity Relationships for a Series of Eticlopride-Based
Dopamine D2/D3 Receptor Bitopic Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaik, Anver Basha; Boateng, Comfort A.; Battiti, Francisco O.; Bonifazi,
Alessandro; Cao, Jianjing; Chen, Li; Chitsazi, Rezvan; Ravi, Saiprasad;
Lee, Kuo Hao; Shi, Lei; Newman, Amy Hauck
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(20), 15313-15333

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
N-[4-(2-Propen-1-yloxy)benzoyl]glycine
C12H13NO4
171814-05-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 N 4.0010 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 O 1.3337 3.8501 0.0 0
M  V30 8 O 10.6697 4.6201 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 C 13.3370 4.6201 0.0 0
M  V30 11 C 14.6707 3.8501 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 8.0022 1.5400 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 9.3358 2.3101 0.0 0
M  V30 17 C 9.3358 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H32N4O6
2757278-37-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0 CFG=1
M  V30 2 C 6.1600 6.6684 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 N 6.1600 4.0011 0.0 0
M  V30 5 N 4.6200 6.6684 0.0 0
M  V30 6 O 6.9300 8.0020 0.0 0
M  V30 7 N 9.2400 6.6684 0.0 0
M  V30 8 C 6.9300 2.6673 0.0 0
M  V30 9 C 3.8500 8.0020 0.0 0 CFG=1
M  V30 10 C 10.7800 6.6684 0.0 0
M  V30 11 C 6.1600 1.3336 0.0 0 CFG=1
M  V30 12 O 8.4700 2.6673 0.0 0
M  V30 13 C 2.3100 8.0020 0.0 0
M  V30 14 C 4.6200 9.3358 0.0 0
M  V30 15 O 11.5500 8.0020 0.0 0
M  V30 16 O 11.5500 5.3347 0.0 0
M  V30 17 C 4.6200 1.3336 0.0 0
M  V30 18 N 6.9300 0.0000 0.0 0
M  V30 19 O 1.5400 9.3358 0.0 0
M  V30 20 O 1.5400 6.6684 0.0 0
M  V30 21 C 3.8500 10.6694 0.0 0
M  V30 22 C 13.0900 8.0020 0.0 0
M  V30 23 C 0.0000 9.3358 0.0 0
M  V30 24 C 4.6200 12.0031 0.0 0
M  V30 25 C 13.0900 9.5420 0.0 0
M  V30 26 C 14.6300 8.0020 0.0 0
M  V30 27 C 13.0900 6.4620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=3
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 11 18 CFG=1
M  V30 18 1 13 19
M  V30 19 2 13 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 19 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H43N5O9
2757278-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 7.7000 0.0 0 CFG=2
M  V30 2 C 5.3347 8.4700 0.0 0
M  V30 3 N 8.0021 8.4700 0.0 0
M  V30 4 C 6.6685 6.1600 0.0 0
M  V30 5 N 5.3347 10.0100 0.0 0
M  V30 6 O 4.0011 7.7000 0.0 0
M  V30 7 C 9.3358 7.7000 0.0 0
M  V30 8 N 5.3347 5.3900 0.0 0
M  V30 9 C 4.0011 10.7800 0.0 0 CFG=1
M  V30 10 C 10.6694 8.4700 0.0 0 CFG=2
M  V30 11 O 9.3358 6.1600 0.0 0
M  V30 12 C 5.3349 3.8500 0.0 0
M  V30 13 C 4.0011 12.3200 0.0 0
M  V30 14 C 2.6674 10.0100 0.0 0
M  V30 15 N 12.0032 7.7000 0.0 0
M  V30 16 C 10.6694 10.0100 0.0 0
M  V30 17 O 4.0011 3.0800 0.0 0
M  V30 18 O 6.6685 3.0800 0.0 0
M  V30 19 O 2.6674 13.0900 0.0 0
M  V30 20 O 5.3347 13.0900 0.0 0
M  V30 21 C 1.3338 10.7800 0.0 0
M  V30 22 C 13.3369 8.4700 0.0 0
M  V30 23 C 4.0011 1.5400 0.0 0
M  V30 24 C 2.6674 14.6300 0.0 0
M  V30 25 C 0.0000 10.0100 0.0 0
M  V30 26 C 14.6705 7.7000 0.0 0
M  V30 27 O 13.3369 10.0100 0.0 0
M  V30 28 C 5.5411 1.5400 0.0 0
M  V30 29 C 4.0011 0.0000 0.0 0
M  V30 30 C 2.4611 1.5400 0.0 0
M  V30 31 N 16.0043 8.4700 0.0 0
M  V30 32 C 17.3379 7.7000 0.0 0
M  V30 33 O 17.3379 6.1600 0.0 0
M  V30 34 O 22.6727 10.7800 0.0 0
M  V30 35 C 24.0063 10.0100 0.0 0
M  V30 36 C 25.3399 10.7800 0.0 0
M  V30 37 C 26.6737 10.0100 0.0 0
M  V30 38 C 18.6716 8.4700 0.0 0
M  V30 39 C 18.6716 10.0100 0.0 0
M  V30 40 C 20.0052 7.7000 0.0 0
M  V30 41 C 20.0052 10.7800 0.0 0
M  V30 42 C 21.3390 8.4700 0.0 0
M  V30 43 C 21.3390 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=1
M  V30 14 1 10 15
M  V30 15 1 10 16 CFG=3
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 2 13 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 17 23
M  V30 23 1 19 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 2 22 27
M  V30 27 1 23 28
M  V30 28 1 23 29
M  V30 29 1 23 30
M  V30 30 1 26 31
M  V30 31 1 31 32
M  V30 32 2 32 33
M  V30 33 1 32 38
M  V30 34 1 34 35
M  V30 35 1 34 43
M  V30 36 1 35 36
M  V30 37 2 36 37
M  V30 38 2 38 39
M  V30 39 1 38 40
M  V30 40 1 39 41
M  V30 41 2 40 42
M  V30 42 2 41 43
M  V30 43 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 171814-05-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757278-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757278-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35054320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo
biological evaluation for acute lung injury
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Yingjun; Zhang, Mengyi; Xu, Honglei; Zhang, Tingrong; Zhang,
Songming; Zhao, Xiuhe; Jiang, Peng; Li, Jing; Ye, Baijun; Sun, Yuanjun;
Wang, Mukuo; Deng, Yangping; Meng, Qing; Liu, Yang; Fu, Qiang; Lin,
Jianping; Wang, Liang; Chen, Yue
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 2971-2987

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
FMOC-L-phenylalanine
C24H21NO4
35661-40-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 5.2309 0.0 0
M  V30 2 O 8.0021 4.4608 0.0 0
M  V30 3 C 6.6685 5.2309 0.0 0
M  V30 4 N 5.3348 4.4608 0.0 0
M  V30 5 O 6.6685 6.7709 0.0 0
M  V30 6 C 4.0011 5.2309 0.0 0 CFG=2
M  V30 7 C 4.0011 6.7709 0.0 0
M  V30 8 C 2.6673 4.4608 0.0 0
M  V30 9 O 1.3337 5.2309 0.0 0
M  V30 10 O 2.6673 2.9208 0.0 0
M  V30 11 C 10.6696 4.4608 0.0 0
M  V30 12 C 10.8306 2.9293 0.0 0
M  V30 13 C 12.0764 5.0873 0.0 0
M  V30 14 C 12.3370 2.6091 0.0 0
M  V30 15 C 9.8001 1.7849 0.0 0
M  V30 16 C 13.1070 3.9428 0.0 0
M  V30 17 C 12.5523 6.5519 0.0 0
M  V30 18 C 12.8129 1.1444 0.0 0
M  V30 19 C 10.2760 0.3202 0.0 0
M  V30 20 C 14.6133 4.2630 0.0 0
M  V30 21 C 14.0588 6.8721 0.0 0
M  V30 22 C 11.7823 0.0000 0.0 0
M  V30 23 C 15.0892 5.7277 0.0 0
M  V30 24 C 2.6673 7.5409 0.0 0
M  V30 25 C 1.3337 6.7709 0.0 0
M  V30 26 C 2.6673 9.0809 0.0 0
M  V30 27 C 0.0000 7.5409 0.0 0
M  V30 28 C 1.3337 9.8509 0.0 0
M  V30 29 C 0.0000 9.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Butanamine, 1,1-diethoxy-3-methyl-, (R)-
C9H21NO2
95500-79-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0 CFG=2
M  V30 3 O 4.6200 4.0011 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 N 3.0800 6.6685 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C33H40N2O5
3037043-01-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 8.0022 0.0 0
M  V30 2 O 6.7709 8.0022 0.0 0
M  V30 3 C 7.5409 6.6685 0.0 0
M  V30 4 N 9.0810 6.6685 0.0 0
M  V30 5 O 6.7709 5.3348 0.0 0
M  V30 6 C 9.8510 5.3348 0.0 0 CFG=2
M  V30 7 C 9.0810 4.0012 0.0 0
M  V30 8 C 11.3910 5.3348 0.0 0
M  V30 9 N 12.1610 6.6685 0.0 0
M  V30 10 O 12.1610 4.0012 0.0 0
M  V30 11 C 13.7011 6.6685 0.0 0 CFG=2
M  V30 12 C 14.4711 8.0022 0.0 0
M  V30 13 C 14.4711 5.3348 0.0 0
M  V30 14 O 16.0111 8.0022 0.0 0
M  V30 15 O 13.7011 9.3360 0.0 0
M  V30 16 C 13.7011 4.0012 0.0 0
M  V30 17 C 16.0111 5.3348 0.0 0
M  V30 18 C 16.7811 9.3360 0.0 0
M  V30 19 C 14.4711 10.6697 0.0 0
M  V30 20 C 18.3212 9.3360 0.0 0
M  V30 21 C 13.7011 12.0033 0.0 0
M  V30 22 C 4.4609 9.3360 0.0 0
M  V30 23 C 2.9293 9.4969 0.0 0
M  V30 24 C 5.0873 10.7428 0.0 0
M  V30 25 C 2.6091 11.0032 0.0 0
M  V30 26 C 1.7849 8.4665 0.0 0
M  V30 27 C 3.9428 11.7732 0.0 0
M  V30 28 C 6.5519 11.2187 0.0 0
M  V30 29 C 1.1444 11.4793 0.0 0
M  V30 30 C 0.3202 8.9424 0.0 0
M  V30 31 C 4.2630 13.2797 0.0 0
M  V30 32 C 6.8721 12.7251 0.0 0
M  V30 33 C 0.0000 10.4487 0.0 0
M  V30 34 C 5.7277 13.7556 0.0 0
M  V30 35 C 9.8510 2.6673 0.0 0
M  V30 36 C 11.3910 2.6673 0.0 0
M  V30 37 C 9.0810 1.3337 0.0 0
M  V30 38 C 12.1610 1.3337 0.0 0
M  V30 39 C 9.8510 0.0000 0.0 0
M  V30 40 C 11.3910 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 35
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13 CFG=1
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 2 24 28
M  V30 29 1 25 27
M  V30 30 2 25 29
M  V30 31 1 26 30
M  V30 32 2 27 31
M  V30 33 1 28 32
M  V30 34 1 29 33
M  V30 35 2 30 33
M  V30 36 1 31 34
M  V30 37 2 32 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 35661-40-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95500-79-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037043-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40804554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with
Antiproliferative Activity in Breast Cancer Models
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Winter-Holt, Jon J.; Bardelle, Catherine; Chiarparin, Elisabetta; Dale,
Ian L.; Davey, Paul R. J.; Davies, Nichola L.; Denz, Christopher;
Fillery, Shaun M.; Guerot, Carine M.; Han, Fujin; Hughes, Samantha J.;
Kulkarni, Meghana; Liu, Zhaoqun; Milbradt, Alexander; Moss, Thomas A.;
Niu, Huijun; Patel, Joe; Rabow, Alfred A.; Schimpl, Marianne; Shi,
Junjie; Sun, Dongqing; Yang, Dejian; Guichard, Sylvie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 3306-3331

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
4-Chlorosalicylic acid
C7H5ClO3
5106-98-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-fluoro-N-(2-methylpropyl)benzen...
C20H27FN2O3S
772318-79-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 F 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[(1S,2R)-3-[[(4-fluorophenyl)sulfonyl](2-methylpropyl)amino]-2-hyd...
C27H30ClFN2O5S
2892016-33-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.1600 0.0 0 VAL=6
M  V30 2 N 4.0011 7.7000 0.0 0
M  V30 3 O 5.5411 6.1600 0.0 0
M  V30 4 O 2.4611 6.1600 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 C 2.6674 8.4700 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 8 C 1.3338 7.7000 0.0 0
M  V30 9 C 8.0021 8.4700 0.0 0 CFG=1
M  V30 10 O 6.6685 6.1600 0.0 0
M  V30 11 C 0.0000 8.4700 0.0 0
M  V30 12 C 1.3338 6.1600 0.0 0
M  V30 13 C 8.0021 10.0100 0.0 0
M  V30 14 N 9.3358 7.7000 0.0 0
M  V30 15 C 10.6696 8.4700 0.0 0
M  V30 16 O 10.6696 10.0100 0.0 0
M  V30 17 F 4.0011 0.0000 0.0 0
M  V30 18 O 13.3369 10.0100 0.0 0
M  V30 19 Cl 16.0043 5.3900 0.0 0
M  V30 20 C 4.0011 4.6200 0.0 0
M  V30 21 C 2.6674 3.8500 0.0 0
M  V30 22 C 5.3347 3.8500 0.0 0
M  V30 23 C 2.6674 2.3100 0.0 0
M  V30 24 C 5.3347 2.3100 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0
M  V30 26 C 6.6685 10.7800 0.0 0
M  V30 27 C 6.6685 12.3200 0.0 0
M  V30 28 C 5.3347 10.0100 0.0 0
M  V30 29 C 5.3347 13.0900 0.0 0
M  V30 30 C 4.0011 10.7800 0.0 0
M  V30 31 C 4.0011 12.3200 0.0 0
M  V30 32 C 12.0032 7.7000 0.0 0
M  V30 33 C 13.3369 8.4700 0.0 0
M  V30 34 C 12.0032 6.1600 0.0 0
M  V30 35 C 14.6705 7.7000 0.0 0
M  V30 36 C 13.3369 5.3900 0.0 0
M  V30 37 C 14.6705 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 20
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 26
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 32
M  V30 19 1 17 25
M  V30 20 1 18 33
M  V30 21 1 19 37
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5106-98-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 772318-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
3-Iodo-4-methylbenzoic acid
C8H7IO2
82998-57-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 I 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)benzenamine
C11H10F3N3
641571-11-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6201 0.0 0
M  V30 2 F 2.1038 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5638 3.2864 0.0 0
M  V30 5 N 4.0012 0.0000 0.0 0
M  V30 6 C 10.6376 4.9772 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 N 6.6687 4.6201 0.0 0
M  V30 14 C 8.0755 3.9936 0.0 0
M  V30 15 C 6.8296 6.1517 0.0 0
M  V30 16 C 9.1059 5.1382 0.0 0
M  V30 17 N 8.3359 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]be...
C19H15F3IN3O
926922-18-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 6.1600 0.0 0
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 O 5.3347 3.8500 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 F 10.8758 1.5400 0.0 0
M  V30 6 F 9.3358 0.0000 0.0 0
M  V30 7 F 7.7958 1.5400 0.0 0
M  V30 8 C 15.9720 6.5171 0.0 0
M  V30 9 I 0.0000 5.3900 0.0 0
M  V30 10 C 0.0000 8.4700 0.0 0
M  V30 11 C 10.6694 5.3900 0.0 0
M  V30 12 C 9.3358 6.1600 0.0 0
M  V30 13 C 10.6694 3.8500 0.0 0
M  V30 14 C 8.0020 5.3900 0.0 0
M  V30 15 C 9.3358 3.0800 0.0 0
M  V30 16 C 8.0020 3.8500 0.0 0
M  V30 17 N 12.0031 6.1600 0.0 0
M  V30 18 C 13.4100 5.5337 0.0 0
M  V30 19 C 12.1640 7.6915 0.0 0
M  V30 20 C 14.4404 6.6781 0.0 0
M  V30 21 N 13.6704 8.0117 0.0 0
M  V30 22 C 4.0011 6.1600 0.0 0
M  V30 23 C 2.6673 5.3900 0.0 0
M  V30 24 C 4.0011 7.7000 0.0 0
M  V30 25 C 1.3336 6.1600 0.0 0
M  V30 26 C 2.6673 8.4700 0.0 0
M  V30 27 C 1.3336 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 22
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 15
M  V30 9 1 8 20
M  V30 10 1 9 25
M  V30 11 1 10 27
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 82998-57-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 641571-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926922-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33920091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM SOCl2 also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with
Improved Cardiac Safety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pandrala, Mallesh; Bruyneel, Arne Antoon N.; Hnatiuk, Anna P.; Mercola,
Mark; Malhotra, Sanjay V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(16), 10898-10919

$RFMT $RIREG SCHEME71 STEP1
$RXN



  3  1
$MOL
Amantadine
C10H17N
768-94-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5321 3.0179 0.0 0
M  V30 2 C 4.1957 2.2463 0.0 0
M  V30 3 C 2.9051 3.0867 0.0 0
M  V30 4 C 4.2781 0.7086 0.0 0
M  V30 5 C 2.4986 2.2355 0.0 0
M  V30 6 C 1.6969 2.3891 0.0 0
M  V30 7 C 3.0699 0.0111 0.0 0
M  V30 8 C 1.2906 1.5379 0.0 0
M  V30 9 C 0.0000 2.3780 0.0 0
M  V30 10 C 1.7794 0.8513 0.0 0
M  V30 11 C 1.3730 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1H-pyrrole-2-carboxylic acid
C5H4BrNO2
27746-02-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 Br 6.6363 2.6672 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 4.0743 1.6836 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 2.8281 0.0 0
M  V30 9 C 4.3347 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-bromo-2-[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]-1H-...
C20H27BrN2O3
2290532-68-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.6857 3.2587 0.0 0
M  V30 2 C 6.3520 4.0287 0.0 0
M  V30 3 O 6.3520 5.5688 0.0 0
M  V30 4 C 3.2912 5.3915 0.0 0
M  V30 5 O 1.8266 5.8674 0.0 0
M  V30 6 O 4.4358 6.4219 0.0 0
M  V30 7 C 1.5065 7.3737 0.0 0
M  V30 8 C 0.0000 7.0535 0.0 0
M  V30 9 C 1.1861 8.8801 0.0 0
M  V30 10 C 3.0128 7.6940 0.0 0
M  V30 11 Br 2.7246 0.0000 0.0 0
M  V30 12 C 9.0195 4.0287 0.0 0
M  V30 13 C 10.3076 3.1902 0.0 0
M  V30 14 C 8.9373 5.5635 0.0 0
M  V30 15 C 10.7132 4.0395 0.0 0
M  V30 16 C 11.5134 3.8863 0.0 0
M  V30 17 C 10.1431 6.2598 0.0 0
M  V30 18 C 11.9191 4.7358 0.0 0
M  V30 19 C 13.2070 3.8974 0.0 0
M  V30 20 C 11.4311 5.4211 0.0 0
M  V30 21 C 11.8367 6.2707 0.0 0
M  V30 22 C 5.0184 3.2587 0.0 0
M  V30 23 N 3.6114 3.8850 0.0 0
M  V30 24 C 4.8574 1.7271 0.0 0
M  V30 25 C 2.5809 2.7406 0.0 0
M  V30 26 C 3.3510 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 18 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 768-94-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27746-02-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2290532-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39885789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide
Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for
Treating Drug-Resistant Tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Hongyi; Gao, Yongxin; Li, Wei; Sheng, Li; Cui, Keli; Wang, Bin; Fu,
Lei; Gao, Meng; Lin, Ziyun; Zou, Xiaowen; Jackson, Mary; Huang, Haihong;
Lu, Yu; Zhang, Dongfeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(15), 10534-10553

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
5-Methyl 2,5-pyridinedicarboxylate
C8H7NO4
17874-79-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 N 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H24N2O2
2630973-82-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.7700 0.0 0
M  V30 2 C 2.6673 4.6201 0.0 0
M  V30 3 N 9.3358 2.3101 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 O 12.0033 2.3101 0.0 0
M  V30 6 O 10.6697 4.6201 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 14.1070 1.7464 0.0 0
M  V30 9 C 14.6707 3.8501 0.0 0
M  V30 10 C 12.5670 4.4137 0.0 0
M  V30 11 N 0.0000 3.0801 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 6.6685 5.3901 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 4.0010 2.3101 0.0 0
M  V30 19 C 2.6673 3.0801 0.0 0
M  V30 20 C 4.0010 0.7700 0.0 0
M  V30 21 C 1.3337 2.3101 0.0 0
M  V30 22 C 2.6673 0.0000 0.0 0
M  V30 23 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 21
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 6-[[[3′-[[(1,1-dimethylethoxy)carbonyl]amino]-2,2′...
C27H29N3O5
2921717-68-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 2.3101 0.0 0
M  V30 2 C 8.0022 6.1601 0.0 0
M  V30 3 N 14.6708 3.8501 0.0 0
M  V30 4 C 16.0045 4.6201 0.0 0
M  V30 5 O 16.0045 6.1601 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 O 2.6673 4.6201 0.0 0
M  V30 9 O 4.0010 2.3101 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 2.1037 2.5164 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 0.5637 5.1838 0.0 0
M  V30 14 C 21.3393 1.5400 0.0 0
M  V30 15 O 22.6730 2.3101 0.0 0
M  V30 16 O 21.3393 0.0000 0.0 0
M  V30 17 C 24.0067 1.5400 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 12.0033 6.9302 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 9.3358 3.8501 0.0 0
M  V30 25 C 8.0022 4.6201 0.0 0
M  V30 26 C 9.3358 2.3101 0.0 0
M  V30 27 C 6.6685 3.8501 0.0 0
M  V30 28 C 8.0022 1.5400 0.0 0
M  V30 29 C 6.6685 2.3101 0.0 0
M  V30 30 C 17.3382 3.8501 0.0 0
M  V30 31 C 17.3382 2.3101 0.0 0
M  V30 32 N 18.6718 4.6201 0.0 0
M  V30 33 C 18.6718 1.5400 0.0 0
M  V30 34 C 20.0057 3.8501 0.0 0
M  V30 35 C 20.0057 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 25
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 2 4 5
M  V30 6 1 4 30
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 35
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 17874-79-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2630973-82-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2921717-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41034407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nonsymmetrically Substituted 1,1'-Biphenyl-Based Small Molecule
Inhibitors of the PD-1/PD-L1 Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hec-Galazka, Aleksandra; Tyrcha, Urszula; Barczynski, Jan; Bielski,
Przemyslaw; Mikitiuk, Michal; Gudz, Ganna P.; Kitel, Radoslaw; Musielak,
Bogdan; Plewka, Jacek; Sitar, Tomasz; Holak, Tad A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(6), 828-836

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
5-Hexyn-1-amine
C6H11N
15252-45-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6687 0.7700 0.0 0
M  V30 5 C 1.3337 0.7700 0.0 0
M  V30 6 C 8.0023 0.0000 0.0 0
M  V30 7 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 3 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C73H130N16O23
2843601-89-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  112 111 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 20.0200 12.2094 0.0 0 CFG=2
M  V30 2 C 19.2500 13.5431 0.0 0
M  V30 3 N 19.2500 10.8756 0.0 0
M  V30 4 C 21.5600 12.2094 0.0 0
M  V30 5 N 17.7100 13.5431 0.0 0
M  V30 6 O 20.0200 14.8767 0.0 0
M  V30 7 C 20.0200 9.5420 0.0 0
M  V30 8 C 22.3300 13.5431 0.0 0
M  V30 9 C 16.9400 14.8767 0.0 0 CFG=1
M  V30 10 C 19.2500 8.2084 0.0 0 CFG=1
M  V30 11 O 21.5600 9.5420 0.0 0
M  V30 12 C 23.8700 13.5431 0.0 0
M  V30 13 C 15.4000 14.8767 0.0 0
M  V30 14 C 17.7100 16.2105 0.0 0
M  V30 15 C 17.7100 8.2084 0.0 0
M  V30 16 N 20.0200 6.8747 0.0 0
M  V30 17 C 24.6400 14.8767 0.0 0
M  V30 18 N 14.6300 13.5431 0.0 0
M  V30 19 O 14.6300 16.2105 0.0 0
M  V30 20 C 16.9400 17.5441 0.0 0
M  V30 21 C 16.9400 6.8747 0.0 0
M  V30 22 C 21.5600 6.8747 0.0 0
M  V30 23 N 26.1800 14.8767 0.0 0
M  V30 24 C 13.0900 13.5431 0.0 0 CFG=2
M  V30 25 C 17.7100 18.8778 0.0 0
M  V30 26 C 15.4000 6.8747 0.0 0
M  V30 27 O 22.3300 5.5409 0.0 0
M  V30 28 O 22.3300 8.2084 0.0 0
M  V30 29 C 26.9500 16.2103 0.0 0
M  V30 30 C 12.3200 14.8767 0.0 0
M  V30 31 C 12.3200 12.2094 0.0 0
M  V30 32 C 16.9400 20.2114 0.0 0
M  V30 33 C 14.6300 5.5411 0.0 0
M  V30 34 C 23.8700 5.5409 0.0 0
M  V30 35 N 26.1800 17.5441 0.0 0
M  V30 36 N 28.4900 16.2103 0.0 0
M  V30 37 C 10.7800 14.8767 0.0 0
M  V30 38 O 13.0900 10.8756 0.0 0
M  V30 39 O 10.7800 12.2094 0.0 0
M  V30 40 N 17.7100 21.5452 0.0 0
M  V30 41 N 13.0900 5.5411 0.0 0
M  V30 42 C 23.8700 4.0009 0.0 0
M  V30 43 C 25.4100 5.5409 0.0 0
M  V30 44 C 23.8700 7.0809 0.0 0
M  V30 45 C 26.9500 18.8778 0.0 0
M  V30 46 C 29.2600 14.8767 0.0 0
M  V30 47 C 10.0100 16.2105 0.0 0
M  V30 48 C 16.9400 22.8789 0.0 0
M  V30 49 C 12.3200 4.2073 0.0 0
M  V30 50 O 26.1800 20.2114 0.0 0
M  V30 51 O 28.4900 18.8778 0.0 0
M  V30 52 O 30.8000 14.8767 0.0 0
M  V30 53 O 28.4900 13.5431 0.0 0
M  V30 54 C 8.4700 16.2105 0.0 0
M  V30 55 N 15.4000 22.8789 0.0 0
M  V30 56 N 17.7100 24.2125 0.0 0
M  V30 57 N 10.7800 4.2073 0.0 0
M  V30 58 N 13.0900 2.8736 0.0 0
M  V30 59 C 24.6400 20.2114 0.0 0
M  V30 60 C 31.5700 13.5431 0.0 0
M  V30 61 N 7.7000 14.8767 0.0 0
M  V30 62 C 14.6300 24.2125 0.0 0
M  V30 63 C 19.2500 24.2125 0.0 0
M  V30 64 C 10.0100 2.8736 0.0 0
M  V30 65 C 14.6300 2.8736 0.0 0
M  V30 66 C 24.6400 21.7514 0.0 0
M  V30 67 C 23.1000 20.2114 0.0 0
M  V30 68 C 24.6400 18.6714 0.0 0
M  V30 69 C 30.2364 12.7731 0.0 0
M  V30 70 C 32.3400 12.2094 0.0 0
M  V30 71 C 32.9036 14.3131 0.0 0
M  V30 72 C 6.1600 14.8767 0.0 0
M  V30 73 O 13.0900 24.2125 0.0 0
M  V30 74 O 15.4000 25.5461 0.0 0
M  V30 75 O 20.0200 25.5461 0.0 0
M  V30 76 O 20.0200 22.8789 0.0 0
M  V30 77 O 8.4700 2.8736 0.0 0
M  V30 78 O 10.7800 1.5400 0.0 0
M  V30 79 O 15.4000 1.5400 0.0 0
M  V30 80 O 15.4000 4.2073 0.0 0
M  V30 81 N 5.3900 16.2105 0.0 0
M  V30 82 N 5.3900 13.5431 0.0 0
M  V30 83 C 12.3200 22.8789 0.0 0
M  V30 84 C 21.5600 25.5461 0.0 0
M  V30 85 C 7.7000 1.5400 0.0 0
M  V30 86 C 16.9400 1.5400 0.0 0
M  V30 87 C 6.1600 17.5441 0.0 0
M  V30 88 C 3.8500 13.5431 0.0 0
M  V30 89 C 10.9864 23.6489 0.0 0
M  V30 90 C 11.5500 21.5451 0.0 0
M  V30 91 C 13.6536 22.1089 0.0 0
M  V30 92 C 21.5600 27.0861 0.0 0
M  V30 93 C 23.1000 25.5461 0.0 0
M  V30 94 C 21.5600 24.0061 0.0 0
M  V30 95 C 9.0336 0.7700 0.0 0
M  V30 96 C 6.9300 0.2064 0.0 0
M  V30 97 C 6.3664 2.3100 0.0 0
M  V30 98 C 16.9400 0.0000 0.0 0
M  V30 99 C 18.4800 1.5400 0.0 0
M  V30 100 C 16.9400 3.0800 0.0 0
M  V30 101 O 5.3900 18.8778 0.0 0
M  V30 102 O 7.7000 17.5441 0.0 0
M  V30 103 O 3.0800 12.2094 0.0 0
M  V30 104 O 3.0800 14.8767 0.0 0
M  V30 105 C 6.1600 20.2114 0.0 0
M  V30 106 C 1.5400 12.2094 0.0 0
M  V30 107 C 7.4936 19.4414 0.0 0
M  V30 108 C 6.9300 21.5452 0.0 0
M  V30 109 C 4.8264 20.9814 0.0 0
M  V30 110 C 1.5400 13.7494 0.0 0
M  V30 111 C 0.0000 12.2094 0.0 0
M  V30 112 C 1.5400 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=3
M  V30 14 1 10 15
M  V30 15 1 10 16 CFG=1
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 22 27
M  V30 27 2 22 28
M  V30 28 2 23 29
M  V30 29 1 24 30 CFG=3
M  V30 30 1 24 31
M  V30 31 1 25 32
M  V30 32 1 26 33
M  V30 33 1 27 34
M  V30 34 1 29 35
M  V30 35 1 29 36
M  V30 36 1 30 37
M  V30 37 1 31 38
M  V30 38 2 31 39
M  V30 39 1 32 40
M  V30 40 1 33 41
M  V30 41 1 34 42
M  V30 42 1 34 43
M  V30 43 1 34 44
M  V30 44 1 35 45
M  V30 45 1 36 46
M  V30 46 1 37 47
M  V30 47 2 40 48
M  V30 48 2 41 49
M  V30 49 1 45 50
M  V30 50 2 45 51
M  V30 51 1 46 52
M  V30 52 2 46 53
M  V30 53 1 47 54
M  V30 54 1 48 55
M  V30 55 1 48 56
M  V30 56 1 49 57
M  V30 57 1 49 58
M  V30 58 1 50 59
M  V30 59 1 52 60
M  V30 60 1 54 61
M  V30 61 1 55 62
M  V30 62 1 56 63
M  V30 63 1 57 64
M  V30 64 1 58 65
M  V30 65 1 59 66
M  V30 66 1 59 67
M  V30 67 1 59 68
M  V30 68 1 60 69
M  V30 69 1 60 70
M  V30 70 1 60 71
M  V30 71 2 61 72
M  V30 72 1 62 73
M  V30 73 2 62 74
M  V30 74 1 63 75
M  V30 75 2 63 76
M  V30 76 1 64 77
M  V30 77 2 64 78
M  V30 78 1 65 79
M  V30 79 2 65 80
M  V30 80 1 72 81
M  V30 81 1 72 82
M  V30 82 1 73 83
M  V30 83 1 75 84
M  V30 84 1 77 85
M  V30 85 1 79 86
M  V30 86 1 81 87
M  V30 87 1 82 88
M  V30 88 1 83 89
M  V30 89 1 83 90
M  V30 90 1 83 91
M  V30 91 1 84 92
M  V30 92 1 84 93
M  V30 93 1 84 94
M  V30 94 1 85 95
M  V30 95 1 85 96
M  V30 96 1 85 97
M  V30 97 1 86 98
M  V30 98 1 86 99
M  V30 99 1 86 100
M  V30 100 1 87 101
M  V30 101 2 87 102
M  V30 102 1 88 103
M  V30 103 2 88 104
M  V30 104 1 101 105
M  V30 105 1 103 106
M  V30 106 1 105 107
M  V30 107 1 105 108
M  V30 108 1 105 109
M  V30 109 1 106 110
M  V30 110 1 106 111
M  V30 111 1 106 112
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 9 10 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C79H139N17O22
2843601-86-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  118 117 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 18.8782 13.0903 0.0 0 CFG=1
M  V30 2 N 17.5445 12.3203 0.0 0
M  V30 3 C 20.2119 12.3203 0.0 0
M  V30 4 C 18.8782 14.6303 0.0 0
M  V30 5 C 16.2109 13.0903 0.0 0
M  V30 6 N 20.2119 10.7802 0.0 0
M  V30 7 O 21.5457 13.0903 0.0 0
M  V30 8 C 20.2119 15.4003 0.0 0
M  V30 9 C 14.8770 12.3203 0.0 0 CFG=2
M  V30 10 O 16.2109 14.6303 0.0 0
M  V30 11 C 21.5457 10.0102 0.0 0 CFG=2
M  V30 12 C 20.2119 16.9404 0.0 0
M  V30 13 N 13.5434 13.0903 0.0 0
M  V30 14 C 14.8770 10.7802 0.0 0
M  V30 15 C 22.8794 10.7802 0.0 0
M  V30 16 C 21.5457 8.4702 0.0 0
M  V30 17 C 21.5457 17.7104 0.0 0
M  V30 18 C 13.5434 14.6303 0.0 0
M  V30 19 C 13.5434 10.0102 0.0 0
M  V30 20 C 24.2130 10.0102 0.0 0
M  V30 21 N 22.8794 7.7002 0.0 0
M  V30 22 O 20.2119 7.7002 0.0 0
M  V30 23 N 22.8794 16.9404 0.0 0
M  V30 24 C 12.2097 15.4003 0.0 0 CFG=1
M  V30 25 O 14.8770 15.4003 0.0 0
M  V30 26 C 13.5434 8.4702 0.0 0
M  V30 27 C 25.5467 10.7802 0.0 0
M  V30 28 C 22.8794 6.1601 0.0 0
M  V30 29 C 24.2130 17.7104 0.0 0
M  V30 30 C 10.8760 14.6303 0.0 0
M  V30 31 N 12.2097 16.9404 0.0 0
M  V30 32 C 12.2097 7.7002 0.0 0
M  V30 33 C 26.8805 10.0102 0.0 0
M  V30 34 C 24.2130 5.3901 0.0 0
M  V30 35 N 24.2130 19.2504 0.0 0
M  V30 36 N 25.5467 16.9404 0.0 0
M  V30 37 C 9.5422 15.4003 0.0 0
M  V30 38 C 10.8760 17.7104 0.0 0
M  V30 39 N 12.2097 6.1601 0.0 0
M  V30 40 N 28.2142 10.7802 0.0 0
M  V30 41 C 24.2130 3.8501 0.0 0
M  V30 42 C 22.8794 20.0204 0.0 0
M  V30 43 C 26.8805 17.7104 0.0 0
M  V30 44 C 8.2085 14.6303 0.0 0
M  V30 45 O 10.8760 19.2504 0.0 0
M  V30 46 O 9.5422 16.9404 0.0 0
M  V30 47 C 10.8759 5.3901 0.0 0
M  V30 48 C 29.5479 10.0102 0.0 0
M  V30 49 C 25.5467 3.0801 0.0 0
M  V30 50 O 22.8794 21.5605 0.0 0
M  V30 51 O 21.5457 19.2504 0.0 0
M  V30 52 O 28.2142 16.9404 0.0 0
M  V30 53 O 26.8805 19.2504 0.0 0
M  V30 54 C 6.8749 15.4003 0.0 0
M  V30 55 C 12.2097 20.0204 0.0 0
M  V30 56 N 9.5422 6.1601 0.0 0
M  V30 57 N 10.8759 3.8501 0.0 0
M  V30 58 N 30.8815 10.7802 0.0 0
M  V30 59 N 29.5479 8.4702 0.0 0
M  V30 60 C 25.5467 1.5400 0.0 0
M  V30 61 C 21.5457 22.3305 0.0 0
M  V30 62 C 29.5479 17.7104 0.0 0
M  V30 63 N 5.5410 14.6303 0.0 0
M  V30 64 C 11.4397 21.3541 0.0 0
M  V30 65 C 13.5434 20.7905 0.0 0
M  V30 66 C 12.9797 18.6868 0.0 0
M  V30 67 C 8.2085 5.3901 0.0 0
M  V30 68 C 12.2097 3.0801 0.0 0
M  V30 69 C 32.2153 10.0102 0.0 0
M  V30 70 C 28.2142 7.7002 0.0 0
M  V30 71 C 25.5467 0.0000 0.0 0
M  V30 72 C 20.7757 20.9968 0.0 0
M  V30 73 C 20.2119 23.1005 0.0 0
M  V30 74 C 22.3157 23.6642 0.0 0
M  V30 75 C 30.3179 16.3767 0.0 0
M  V30 76 C 30.8815 18.4804 0.0 0
M  V30 77 C 28.7778 19.0441 0.0 0
M  V30 78 C 4.2074 15.4003 0.0 0
M  V30 79 O 6.8749 6.1601 0.0 0
M  V30 80 O 8.2085 3.8501 0.0 0
M  V30 81 O 13.5434 3.8501 0.0 0
M  V30 82 O 12.2097 1.5400 0.0 0
M  V30 83 O 33.5490 10.7802 0.0 0
M  V30 84 O 32.2153 8.4702 0.0 0
M  V30 85 O 28.2142 6.1601 0.0 0
M  V30 86 O 26.8805 8.4702 0.0 0
M  V30 87 N 4.2074 16.9404 0.0 0
M  V30 88 N 2.8737 14.6303 0.0 0
M  V30 89 C 6.8749 7.7002 0.0 0
M  V30 90 C 14.8770 3.0801 0.0 0
M  V30 91 C 34.8827 10.0102 0.0 0
M  V30 92 C 29.5479 5.3901 0.0 0
M  V30 93 C 2.8737 17.7104 0.0 0
M  V30 94 C 2.8737 13.0903 0.0 0
M  V30 95 C 5.3348 7.7002 0.0 0
M  V30 96 C 6.8749 9.2402 0.0 0
M  V30 97 C 8.4149 7.7002 0.0 0
M  V30 98 C 15.6470 4.4137 0.0 0
M  V30 99 C 16.2109 2.3101 0.0 0
M  V30 100 C 14.1070 1.7464 0.0 0
M  V30 101 C 35.6527 11.3439 0.0 0
M  V30 102 C 36.2164 9.2402 0.0 0
M  V30 103 C 34.1127 8.6765 0.0 0
M  V30 104 C 30.3179 6.7238 0.0 0
M  V30 105 C 30.8815 4.6201 0.0 0
M  V30 106 C 28.7778 4.0564 0.0 0
M  V30 107 O 2.8737 19.2504 0.0 0
M  V30 108 O 1.5400 16.9404 0.0 0
M  V30 109 O 1.5400 12.3203 0.0 0
M  V30 110 O 4.2074 12.3203 0.0 0
M  V30 111 C 4.2074 20.0204 0.0 0
M  V30 112 C 1.5400 10.7802 0.0 0
M  V30 113 C 4.9774 18.6868 0.0 0
M  V30 114 C 5.5412 20.7905 0.0 0
M  V30 115 C 3.4374 21.3541 0.0 0
M  V30 116 C 0.0000 10.7802 0.0 0
M  V30 117 C 1.5400 9.2402 0.0 0
M  V30 118 C 3.0801 10.7802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=3
M  V30 14 1 11 15 CFG=1
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 2 16 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 2 18 25
M  V30 25 1 19 26
M  V30 26 1 20 27
M  V30 27 1 21 28
M  V30 28 2 23 29
M  V30 29 1 24 30
M  V30 30 1 24 31 CFG=3
M  V30 31 1 26 32
M  V30 32 1 27 33
M  V30 33 1 28 34
M  V30 34 1 29 35
M  V30 35 1 29 36
M  V30 36 1 30 37
M  V30 37 1 31 38
M  V30 38 1 32 39
M  V30 39 1 33 40
M  V30 40 1 34 41
M  V30 41 1 35 42
M  V30 42 1 36 43
M  V30 43 1 37 44
M  V30 44 1 38 45
M  V30 45 2 38 46
M  V30 46 2 39 47
M  V30 47 2 40 48
M  V30 48 1 41 49
M  V30 49 1 42 50
M  V30 50 2 42 51
M  V30 51 1 43 52
M  V30 52 2 43 53
M  V30 53 1 44 54
M  V30 54 1 45 55
M  V30 55 1 47 56
M  V30 56 1 47 57
M  V30 57 1 48 58
M  V30 58 1 48 59
M  V30 59 1 49 60
M  V30 60 1 50 61
M  V30 61 1 52 62
M  V30 62 1 54 63
M  V30 63 1 55 64
M  V30 64 1 55 65
M  V30 65 1 55 66
M  V30 66 1 56 67
M  V30 67 1 57 68
M  V30 68 1 58 69
M  V30 69 1 59 70
M  V30 70 3 60 71
M  V30 71 1 61 72
M  V30 72 1 61 73
M  V30 73 1 61 74
M  V30 74 1 62 75
M  V30 75 1 62 76
M  V30 76 1 62 77
M  V30 77 2 63 78
M  V30 78 1 67 79
M  V30 79 2 67 80
M  V30 80 1 68 81
M  V30 81 2 68 82
M  V30 82 1 69 83
M  V30 83 2 69 84
M  V30 84 1 70 85
M  V30 85 2 70 86
M  V30 86 1 78 87
M  V30 87 1 78 88
M  V30 88 1 79 89
M  V30 89 1 81 90
M  V30 90 1 83 91
M  V30 91 1 85 92
M  V30 92 1 87 93
M  V30 93 1 88 94
M  V30 94 1 89 95
M  V30 95 1 89 96
M  V30 96 1 89 97
M  V30 97 1 90 98
M  V30 98 1 90 99
M  V30 99 1 90 100
M  V30 100 1 91 101
M  V30 101 1 91 102
M  V30 102 1 91 103
M  V30 103 1 92 104
M  V30 104 1 92 105
M  V30 105 1 92 106
M  V30 106 1 93 107
M  V30 107 2 93 108
M  V30 108 1 94 109
M  V30 109 2 94 110
M  V30 110 1 107 111
M  V30 111 1 109 112
M  V30 112 1 111 113
M  V30 113 1 111 114
M  V30 114 1 111 115
M  V30 115 1 112 116
M  V30 116 1 112 117
M  V30 117 1 112 118
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 9 11 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15252-45-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2843601-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2843601-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34708767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as
Pseudomonas aeruginosa Antibiofilm Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Jimmidi, Ravikumar; Diaconu, Andrei; Fransolet,
Maude; Michiels, Carine; De Winter, Julien; Gillon, Emilie; Imberty,
Anne; Coenye, Tom; Vincent, Stephane P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14728-14744

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  2
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-phenylalanine
C15H21NO4
114873-06-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6765 6.1048 0.0 0
M  V30 14 C 0.0000 6.6687 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2R)-2-amino-3-butyn-1-yl]oxy]methyl]-, 2-propen-1-yl este...
C15H17NO3.C2HF3O2
3026372-02-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0035 8.2638 0.0 0
M  V30 2 O 13.3372 7.4938 0.0 0
M  V30 3 O 12.0035 9.8038 0.0 0
M  V30 4 C 14.6708 8.2638 0.0 0
M  V30 5 C 16.0045 7.4938 0.0 0
M  V30 6 C 17.3383 8.2638 0.0 0
M  V30 7 C 6.6687 8.2638 0.0 0
M  V30 8 O 5.3348 7.4938 0.0 0
M  V30 9 C 4.0012 8.2638 0.0 0
M  V30 10 C 2.6675 7.4938 0.0 0 CFG=2
M  V30 11 C 1.3338 8.2638 0.0 0
M  V30 12 N 2.6675 5.9537 0.0 0
M  V30 13 C 0.0000 9.0338 0.0 0
M  V30 14 C 10.6697 7.4938 0.0 0
M  V30 15 C 9.3360 8.2638 0.0 0
M  V30 16 C 10.6697 5.9537 0.0 0
M  V30 17 C 8.0023 7.4938 0.0 0
M  V30 18 C 9.3360 5.1837 0.0 0
M  V30 19 C 8.0023 5.9537 0.0 0
M  V30 20 C 8.0023 2.3101 0.0 0
M  V30 21 C 9.3360 1.5400 0.0 0
M  V30 22 F 8.7723 3.6437 0.0 0
M  V30 23 F 6.6687 3.0801 0.0 0
M  V30 24 F 7.2323 0.9764 0.0 0
M  V30 25 O 10.6697 2.3101 0.0 0
M  V30 26 O 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 3 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 21 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H36N2O6
3026371-03-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.9538 0.0 0 CFG=2
M  V30 2 C 2.6673 6.7238 0.0 0
M  V30 3 C 5.3348 6.7238 0.0 0
M  V30 4 N 4.0012 4.4137 0.0 0
M  V30 5 N 6.6685 5.9538 0.0 0
M  V30 6 O 5.3348 8.2638 0.0 0
M  V30 7 C 2.6673 3.6437 0.0 0
M  V30 8 C 8.0022 6.7238 0.0 0 CFG=2
M  V30 9 O 2.6673 2.1037 0.0 0
M  V30 10 O 1.3337 4.4137 0.0 0
M  V30 11 C 9.3360 5.9538 0.0 0
M  V30 12 C 8.0022 8.2638 0.0 0
M  V30 13 C 1.3337 1.3337 0.0 0
M  V30 14 O 10.6697 6.7238 0.0 0
M  V30 15 C 8.0022 9.8039 0.0 0
M  V30 16 C 2.1037 0.0000 0.0 0
M  V30 17 C 0.0000 0.5637 0.0 0
M  V30 18 C 0.5637 2.6673 0.0 0
M  V30 19 C 12.0033 5.9538 0.0 0
M  V30 20 C 0.0000 11.3439 0.0 0
M  V30 21 C 17.3382 5.9538 0.0 0
M  V30 22 O 18.6718 6.7238 0.0 0
M  V30 23 O 17.3382 4.4137 0.0 0
M  V30 24 C 20.0057 5.9538 0.0 0
M  V30 25 C 21.3393 6.7238 0.0 0
M  V30 26 C 22.6730 5.9538 0.0 0
M  V30 27 C 2.6673 8.2638 0.0 0
M  V30 28 C 1.3337 9.0338 0.0 0
M  V30 29 C 4.0012 9.0338 0.0 0
M  V30 30 C 1.3337 10.5739 0.0 0
M  V30 31 C 4.0012 10.5739 0.0 0
M  V30 32 C 2.6673 11.3439 0.0 0
M  V30 33 C 13.3370 6.7238 0.0 0
M  V30 34 C 14.6708 5.9538 0.0 0
M  V30 35 C 13.3370 8.2638 0.0 0
M  V30 36 C 16.0045 6.7238 0.0 0
M  V30 37 C 14.6708 9.0338 0.0 0
M  V30 38 C 16.0045 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 3 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 19 33
M  V30 21 1 20 30
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 21 36
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 2 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 2 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 2 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H36N2O6
3026373-04-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.9538 0.0 0 CFG=2
M  V30 2 C 2.6673 6.7238 0.0 0
M  V30 3 C 5.3348 6.7238 0.0 0
M  V30 4 N 4.0012 4.4137 0.0 0
M  V30 5 N 6.6685 5.9538 0.0 0
M  V30 6 O 5.3348 8.2638 0.0 0
M  V30 7 C 2.6673 3.6437 0.0 0
M  V30 8 C 8.0022 6.7238 0.0 0 CFG=1
M  V30 9 O 2.6673 2.1037 0.0 0
M  V30 10 O 1.3337 4.4137 0.0 0
M  V30 11 C 9.3360 5.9538 0.0 0
M  V30 12 C 8.0022 8.2638 0.0 0
M  V30 13 C 1.3337 1.3337 0.0 0
M  V30 14 O 10.6697 6.7238 0.0 0
M  V30 15 C 8.0022 9.8039 0.0 0
M  V30 16 C 2.1037 0.0000 0.0 0
M  V30 17 C 0.0000 0.5637 0.0 0
M  V30 18 C 0.5637 2.6673 0.0 0
M  V30 19 C 12.0033 5.9538 0.0 0
M  V30 20 C 0.0000 11.3439 0.0 0
M  V30 21 C 17.3382 5.9538 0.0 0
M  V30 22 O 18.6718 6.7238 0.0 0
M  V30 23 O 17.3382 4.4137 0.0 0
M  V30 24 C 20.0057 5.9538 0.0 0
M  V30 25 C 21.3393 6.7238 0.0 0
M  V30 26 C 22.6730 5.9538 0.0 0
M  V30 27 C 2.6673 8.2638 0.0 0
M  V30 28 C 1.3337 9.0338 0.0 0
M  V30 29 C 4.0012 9.0338 0.0 0
M  V30 30 C 1.3337 10.5739 0.0 0
M  V30 31 C 4.0012 10.5739 0.0 0
M  V30 32 C 2.6673 11.3439 0.0 0
M  V30 33 C 13.3370 6.7238 0.0 0
M  V30 34 C 14.6708 5.9538 0.0 0
M  V30 35 C 13.3370 8.2638 0.0 0
M  V30 36 C 16.0045 6.7238 0.0 0
M  V30 37 C 14.6708 9.0338 0.0 0
M  V30 38 C 16.0045 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 3 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 19 33
M  V30 21 1 20 30
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 21 36
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 2 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 2 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 2 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 114873-06-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026372-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026371-03-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 3026373-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 8
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
2,4-Dihydroxybenzoic acid
C7H6O4
89-86-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,4-Dihydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfony...
C27H31N3O8S
2892016-13-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.9300 0.0 0 VAL=6
M  V30 2 N 4.0011 8.4700 0.0 0
M  V30 3 O 5.5411 6.9300 0.0 0
M  V30 4 O 2.4611 6.9300 0.0 0
M  V30 5 C 5.3347 9.2400 0.0 0
M  V30 6 C 2.6674 9.2400 0.0 0
M  V30 7 C 6.6685 8.4700 0.0 0 CFG=1
M  V30 8 C 1.3338 8.4700 0.0 0
M  V30 9 C 8.0021 9.2400 0.0 0 CFG=1
M  V30 10 O 6.6685 6.9300 0.0 0
M  V30 11 C 0.0000 9.2400 0.0 0
M  V30 12 C 1.3338 6.9300 0.0 0
M  V30 13 C 8.0021 10.7800 0.0 0
M  V30 14 N 9.3358 8.4700 0.0 0
M  V30 15 C 10.6696 9.2400 0.0 0
M  V30 16 O 10.6696 10.7800 0.0 0
M  V30 17 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 18 O 2.6674 0.0000 0.0 0
M  V30 19 O 5.3347 0.0000 0.0 0
M  V30 20 O 13.3369 10.7800 0.0 0
M  V30 21 O 16.0043 6.1600 0.0 0
M  V30 22 C 4.0011 5.3900 0.0 0
M  V30 23 C 5.3347 4.6200 0.0 0
M  V30 24 C 2.6674 4.6200 0.0 0
M  V30 25 C 5.3347 3.0800 0.0 0
M  V30 26 C 2.6674 3.0800 0.0 0
M  V30 27 C 4.0011 2.3100 0.0 0
M  V30 28 C 6.6685 11.5500 0.0 0
M  V30 29 C 6.6685 13.0900 0.0 0
M  V30 30 C 5.3347 10.7800 0.0 0
M  V30 31 C 5.3347 13.8600 0.0 0
M  V30 32 C 4.0011 11.5500 0.0 0
M  V30 33 C 4.0011 13.0900 0.0 0
M  V30 34 C 12.0032 8.4700 0.0 0
M  V30 35 C 13.3369 9.2400 0.0 0
M  V30 36 C 12.0032 6.9300 0.0 0
M  V30 37 C 14.6705 8.4700 0.0 0
M  V30 38 C 13.3369 6.1600 0.0 0
M  V30 39 C 14.6705 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 22
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 28
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 34
M  V30 19 2 17 18
M  V30 20 2 17 19
M  V30 21 1 17 27
M  V30 22 1 20 35
M  V30 23 1 21 39
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 89-86-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Urea
CH4N2O
57-13-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2,4(1H,3H)-quinazolinedione
C8H5ClN2O2
1640-60-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 0.0000 0.0 0
M  V30 2 O 8.4700 2.6674 0.0 0
M  V30 3 Cl 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 6.1600 4.0011 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 6.1600 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57-13-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1640-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39179504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide
Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium
tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Liu; Hu, Xueping; Lu, Yang; Xu, Ruolan; Xu, Yaping; Ma, WanLi;
Alam, Shah Md; Zhang, Tianyu; Chai, Xin; Lei, Yixuan; Ye, Qing; Dong,
Xiaowu; Kang, Yu; Che, Jinxin; Hou, Tingjun; Li, Dan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(3), 1914-1931

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Urea
CH4N2O
57-13-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1H-quinazoline-2,4-dione
C8H5BrN2O2
88145-89-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 0.0000 0.0 0
M  V30 2 O 8.4700 2.6674 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 6.1600 4.0011 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 6.1600 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57-13-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88145-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34513976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM High ligand efficiency quinazoline compounds as novel A2A adenosine
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bolteau, Raphael; Duroux, Romain; Laversin, Amelie; Vreulz, Brandon;
Shiriaeva, Anna; Stauch, Benjamin; Han, Gye Won; Cherezov, Vadim;
Renault, Nicolas; Barczyk, Amelie; Ravez, Severine; Coevoet, Mathilde;
Melnyk, Patricia; Liberelle, Maxime; Yous, Said
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 241114620

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-alanine
C18H17NO4
35661-39-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 7.0869 4.4609 0.0 0
M  V30 3 C 8.4206 5.2309 0.0 0
M  V30 4 N 9.7542 4.4609 0.0 0
M  V30 5 O 8.4206 6.7709 0.0 0
M  V30 6 C 11.0880 5.2309 0.0 0 CFG=1
M  V30 7 C 12.4216 4.4609 0.0 0
M  V30 8 C 11.0880 6.7709 0.0 0
M  V30 9 O 13.7553 5.2309 0.0 0
M  V30 10 O 12.4216 2.9209 0.0 0
M  V30 11 C 4.4195 4.4609 0.0 0
M  V30 12 C 4.2586 2.9292 0.0 0
M  V30 13 C 3.0127 5.0872 0.0 0
M  V30 14 C 2.7523 2.6091 0.0 0
M  V30 15 C 5.2890 1.7849 0.0 0
M  V30 16 C 1.9823 3.9429 0.0 0
M  V30 17 C 2.5368 6.5519 0.0 0
M  V30 18 C 2.2763 1.1445 0.0 0
M  V30 19 C 4.8131 0.3202 0.0 0
M  V30 20 C 0.4759 4.2630 0.0 0
M  V30 21 C 1.0304 6.8721 0.0 0
M  V30 22 C 3.3068 0.0000 0.0 0
M  V30 23 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H32N4O6
2861234-16-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 9.3360 0.0 0
M  V30 2 O 6.7709 9.3360 0.0 0
M  V30 3 C 7.5409 8.0022 0.0 0
M  V30 4 N 9.0810 8.0022 0.0 0
M  V30 5 O 6.7709 6.6685 0.0 0
M  V30 6 C 9.8510 6.6685 0.0 0 CFG=1
M  V30 7 C 11.3910 6.6685 0.0 0
M  V30 8 C 9.0810 5.3348 0.0 0
M  V30 9 N 12.1610 5.3348 0.0 0
M  V30 10 O 12.1610 8.0022 0.0 0
M  V30 11 C 13.7011 5.3348 0.0 0 CFG=2
M  V30 12 C 14.4711 6.6685 0.0 0
M  V30 13 C 14.4711 4.0012 0.0 0
M  V30 14 C 16.0111 6.6685 0.0 0
M  V30 15 O 13.7011 2.6673 0.0 0
M  V30 16 O 16.0111 4.0012 0.0 0
M  V30 17 C 16.7811 8.0022 0.0 0
M  V30 18 C 14.4711 1.3337 0.0 0
M  V30 19 C 18.3212 8.0022 0.0 0
M  V30 20 O 16.0111 9.3360 0.0 0
M  V30 21 C 15.8047 2.1037 0.0 0
M  V30 22 C 15.2411 0.0000 0.0 0
M  V30 23 C 13.1374 0.5637 0.0 0
M  V30 24 N 19.0912 9.3360 0.0 0 CHG=1 VAL=4
M  V30 25 N 19.8612 10.6697 0.0 0 CHG=-1
M  V30 26 C 4.4609 10.6697 0.0 0
M  V30 27 C 2.9293 10.8306 0.0 0
M  V30 28 C 5.0873 12.0765 0.0 0
M  V30 29 C 2.6091 12.3371 0.0 0
M  V30 30 C 1.7849 9.8002 0.0 0
M  V30 31 C 3.9428 13.1071 0.0 0
M  V30 32 C 6.5519 12.5524 0.0 0
M  V30 33 C 1.1444 12.8129 0.0 0
M  V30 34 C 0.3202 10.2760 0.0 0
M  V30 35 C 4.2630 14.6134 0.0 0
M  V30 36 C 6.8721 14.0588 0.0 0
M  V30 37 C 0.0000 11.7823 0.0 0
M  V30 38 C 5.7277 15.0893 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 11 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 2 19 24
M  V30 25 2 24 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 2 27 30
M  V30 30 1 28 31
M  V30 31 2 28 32
M  V30 32 1 29 31
M  V30 33 2 29 33
M  V30 34 1 30 34
M  V30 35 2 31 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 2 34 37
M  V30 39 1 35 38
M  V30 40 2 36 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 35661-39-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861234-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259030
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
1-(2-Fluorophenyl)cyclopropanecarboxylic acid
C10H9FO2
306298-00-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9909 1.9004 0.0 0
M  V30 2 O 6.5075 2.1677 0.0 0
M  V30 3 O 4.4642 0.4532 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 6 C 4.9909 4.2597 0.0 0
M  V30 7 C 3.4743 4.5272 0.0 0
M  V30 8 C 2.6673 2.3100 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Fluoro-4-pyridinyl)-1H-pyrazol-3-amine
C8H7FN4
2227482-43-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 3.0801 0.0 0
M  V30 2 N 9.3037 3.4372 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 3.0801 0.0 0
M  V30 5 C 4.0010 0.7700 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 N 1.3337 0.7700 0.0 0
M  V30 9 N 5.3348 3.0801 0.0 0
M  V30 10 C 5.4958 4.6116 0.0 0
M  V30 11 N 6.7417 2.4536 0.0 0
M  V30 12 C 7.0021 4.9318 0.0 0
M  V30 13 C 7.7721 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Fluorophenyl)-N-[1-(2-fluoro-4-pyridinyl)-1H-pyrazol-3-yl]cyclopropaneca...
C18H14F2N4O
2227482-41-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5201 4.2801 0.0 0
M  V30 2 N 5.4253 5.5260 0.0 0
M  V30 3 O 5.1465 2.8732 0.0 0
M  V30 4 F 0.0000 3.6960 0.0 0
M  V30 5 F 14.7289 5.8831 0.0 0
M  V30 6 C 2.9885 4.4411 0.0 0
M  V30 7 C 2.8810 5.9774 0.0 0
M  V30 8 C 1.6044 5.1162 0.0 0
M  V30 9 C 2.5641 2.9607 0.0 0
M  V30 10 C 1.0698 2.5881 0.0 0
M  V30 11 C 3.6338 1.8529 0.0 0
M  V30 12 C 0.6453 1.1079 0.0 0
M  V30 13 C 3.2094 0.3725 0.0 0
M  V30 14 C 1.7151 0.0000 0.0 0
M  V30 15 C 6.9568 5.3651 0.0 0
M  V30 16 N 7.9874 6.5094 0.0 0
M  V30 17 C 7.7268 4.0313 0.0 0
M  V30 18 N 9.3942 5.8831 0.0 0
M  V30 19 C 9.2332 4.3516 0.0 0
M  V30 20 C 10.7278 6.6531 0.0 0
M  V30 21 C 12.0614 5.8831 0.0 0
M  V30 22 C 10.7278 8.1931 0.0 0
M  V30 23 C 13.3952 6.6531 0.0 0
M  V30 24 C 12.0614 8.9631 0.0 0
M  V30 25 N 13.3952 8.1931 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 15
M  V30 5 1 4 10
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 306298-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227482-43-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227482-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34972319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM SOCl2 also used as solvent in stage 1,exothermic reaction in stage 2,gas
evolution was observed in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Come, Jon H.; Senter, Timothy J.; Clark, Michael P.; Court, John J.;
Gale-Day, Zachary; Gu, Wenxin; Krueger, Elaine; Liang, Jianglin; Morris,
Mark; Nanthakumar, Suganthini; O'Dowd, Hardwin; Maltais, Francois; Iyer,
Ganesh; Andreassi, John; Boucher, Christina; Considine, Tony; Moody,
Cameron S.; Taylor, William; Mohanty, Arun K.; Huang, Yulin; Zuccola,
Harmon; Coll, Joyce; Bonanno, Kenneth C.; Gagnon, Kevin J.; Gan, Lu; Lu,
Fan; Gao, Hong; Chakilam, Ananthisrinivas; Engtrakul, Juntyma; Song, Bin;
Crawford, Dan; Doyle, Elisabeth; Kramer, Tal; Vought, Bryan; Phillips,
Jonathan; Kemper, Raymond; Sanders, Martin; Swett, Rebecca; Furey,
Brinley; Winquist, Ray; Bunnage, Mark E.; Jackson, Katrina L.; Charifson,
Paul S.; Magavi, Sanjay S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(24), 17753-17776

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
2,5-Dichlorobenzoic acid
C7H4Cl2O2
50-79-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-[(1R)-1-[(3aR,4R,6R,7aS)-hexahydro-5,5,7a-trimethyl-4,6-methano-1,3...
C17H31BN2O3
2415205-29-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1912 1.9492 0.0 0
M  V30 2 C 2.3313 7.2411 0.0 0
M  V30 3 C 0.0390 6.3508 0.0 0
M  V30 4 C 7.9545 4.0011 0.0 0 CFG=2
M  V30 5 N 8.7245 5.3347 0.0 0
M  V30 6 C 8.7245 2.6675 0.0 0
M  V30 7 C 10.2645 5.3347 0.0 0
M  V30 8 C 7.9545 1.3336 0.0 0
M  V30 9 C 11.0345 6.6684 0.0 0
M  V30 10 O 11.0345 4.0011 0.0 0
M  V30 11 C 8.7245 0.0000 0.0 0
M  V30 12 C 6.4144 1.3336 0.0 0
M  V30 13 N 12.5745 6.6684 0.0 0
M  V30 14 C 4.0447 4.7711 0.0 0 CFG=1
M  V30 15 C 2.3866 4.9798 0.0 0 CFG=2
M  V30 16 C 4.0447 3.2311 0.0 0 CFG=2
M  V30 17 O 5.5094 5.2470 0.0 0
M  V30 18 C 1.5208 5.9317 0.0 0
M  V30 19 C 1.1709 3.2240 0.0 0
M  V30 20 C 3.2547 4.1497 0.0 0
M  V30 21 O 5.5092 2.7552 0.0 0
M  V30 22 B 6.4144 4.0011 0.0 0
M  V30 23 C 1.5249 4.4422 0.0 0 CFG=1
M  V30 24 H 3.8995 6.3042 0.0 0
M  V30 25 H 3.0963 6.3465 0.0 0
M  V30 26 H 0.0000 4.6571 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 2 18
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 24 CFG=3
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 25 CFG=1
M  V30 21 1 16 20 CFG=1
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 1 19 23
M  V30 26 1 20 23
M  V30 27 1 21 22
M  V30 28 1 23 26 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 14 15 16 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 2,5-dichloro-N-[2-[[(1R)-1-[(3aR,4R,6R,7aS)-hexahydro-5,5,7a-trime...
C24H33BCl2N2O4
3059678-96-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1912 1.9492 0.0 0
M  V30 2 C 2.3313 7.2411 0.0 0
M  V30 3 C 0.0390 6.3508 0.0 0
M  V30 4 C 7.9544 4.0011 0.0 0 CFG=2
M  V30 5 N 8.7245 5.3347 0.0 0
M  V30 6 C 8.7245 2.6674 0.0 0
M  V30 7 C 10.2645 5.3347 0.0 0
M  V30 8 C 7.9544 1.3336 0.0 0
M  V30 9 C 11.0345 6.6684 0.0 0
M  V30 10 O 11.0345 4.0011 0.0 0
M  V30 11 C 8.7245 0.0000 0.0 0
M  V30 12 C 6.4144 1.3336 0.0 0
M  V30 13 N 12.5745 6.6684 0.0 0
M  V30 14 C 13.3445 8.0020 0.0 0
M  V30 15 O 12.5745 9.3358 0.0 0
M  V30 16 Cl 14.8845 10.6695 0.0 0
M  V30 17 Cl 17.9645 5.3347 0.0 0
M  V30 18 C 4.0447 4.7711 0.0 0 CFG=2
M  V30 19 C 4.0447 3.2311 0.0 0 CFG=2
M  V30 20 C 2.3866 4.9798 0.0 0 CFG=2
M  V30 21 O 5.5092 5.2470 0.0 0
M  V30 22 C 3.2547 4.1497 0.0 0
M  V30 23 O 5.5092 2.7552 0.0 0
M  V30 24 C 1.5208 5.9315 0.0 0
M  V30 25 C 1.1709 3.2240 0.0 0
M  V30 26 B 6.4144 4.0011 0.0 0
M  V30 27 C 1.5249 4.4422 0.0 0 CFG=1
M  V30 28 C 14.8845 8.0020 0.0 0
M  V30 29 C 15.6545 9.3358 0.0 0
M  V30 30 C 15.6545 6.6684 0.0 0
M  V30 31 C 17.1945 9.3358 0.0 0
M  V30 32 C 17.1945 6.6684 0.0 0
M  V30 33 C 17.9645 8.0020 0.0 0
M  V30 34 H 3.8995 6.3042 0.0 0
M  V30 35 H 3.0963 6.3465 0.0 0
M  V30 36 H 0.0000 4.6571 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=3
M  V30 2 1 2 24
M  V30 3 1 3 24
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 26
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 14 28
M  V30 17 1 16 29
M  V30 18 1 17 32
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 34 CFG=3
M  V30 23 1 19 22 CFG=1
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 20 25
M  V30 27 1 20 35 CFG=1
M  V30 28 1 21 26
M  V30 29 1 22 27
M  V30 30 1 23 26
M  V30 31 1 24 27
M  V30 32 1 25 27
M  V30 33 1 27 36 CFG=3
M  V30 34 2 28 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 2 30 32
M  V30 38 2 31 33
M  V30 39 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 18 19 20 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-79-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415205-29-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3059678-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36054230
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and discovery of novel dipeptide boronic acid ester proteasome
inhibitors, an oral slowly-released prodrug for the treatment of multiple
myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xueyuan; Zhang, Wen; Wen, Tiantian; Miao, Hang; Hu, Wenjiao; Liu,
Hailong; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 250115187

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-alanine (1S,2R)-1,3-dimethyl-2-phenoxybuty...
C20H31NO5
1962942-94-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0 CFG=2
M  V30 2 O 4.0011 3.0800 0.0 0
M  V30 3 C 5.3348 5.3901 0.0 0 CFG=2
M  V30 4 C 2.6675 5.3901 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 5.3348 6.9301 0.0 0
M  V30 7 C 1.3338 4.6201 0.0 0
M  V30 8 C 2.6675 6.9301 0.0 0
M  V30 9 C 8.0022 5.3901 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0 CFG=2
M  V30 11 O 8.0022 6.9301 0.0 0
M  V30 12 N 10.6697 5.3901 0.0 0
M  V30 13 C 9.3359 3.0800 0.0 0
M  V30 14 C 12.0034 4.6201 0.0 0
M  V30 15 O 13.3370 5.3901 0.0 0
M  V30 16 O 12.0034 3.0800 0.0 0
M  V30 17 C 14.6707 4.6201 0.0 0
M  V30 18 C 13.9007 3.2864 0.0 0
M  V30 19 C 16.0045 3.8500 0.0 0
M  V30 20 C 15.4407 5.9537 0.0 0
M  V30 21 C 2.6675 2.3100 0.0 0
M  V30 22 C 2.6675 0.7700 0.0 0
M  V30 23 C 1.3338 3.0800 0.0 0
M  V30 24 C 1.3338 0.0000 0.0 0
M  V30 25 C 0.0000 2.3100 0.0 0
M  V30 26 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 3 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-4-methoxypicolinic acid
C7H7NO4
210300-09-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 O 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 N 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Hydroxy-4-methoxy-2-pyridinyl)carbonyl]-L-alanine (1S,2R)-1,3-dimethyl-...
C22H28N2O6
1962946-97-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 4.6200 0.0 0
M  V30 2 N 10.6694 5.3900 0.0 0
M  V30 3 O 12.0032 3.0800 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0 CFG=1
M  V30 5 C 8.0021 5.3900 0.0 0
M  V30 6 C 9.3358 3.0800 0.0 0
M  V30 7 O 6.6684 4.6200 0.0 0
M  V30 8 O 8.0021 6.9300 0.0 0
M  V30 9 C 5.3347 5.3900 0.0 0 CFG=1
M  V30 10 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 11 C 5.3347 6.9300 0.0 0
M  V30 12 O 4.0011 3.0800 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6674 6.9300 0.0 0
M  V30 16 O 14.6705 3.0800 0.0 0
M  V30 17 O 17.3379 4.6200 0.0 0
M  V30 18 C 18.6716 5.3900 0.0 0
M  V30 19 C 13.3369 5.3900 0.0 0
M  V30 20 C 14.6705 4.6200 0.0 0
M  V30 21 N 13.3369 6.9300 0.0 0
M  V30 22 C 16.0041 5.3900 0.0 0
M  V30 23 C 14.6705 7.7000 0.0 0
M  V30 24 C 16.0041 6.9300 0.0 0
M  V30 25 C 2.6674 2.3100 0.0 0
M  V30 26 C 1.3336 3.0800 0.0 0
M  V30 27 C 2.6674 0.7700 0.0 0
M  V30 28 C 0.0000 2.3100 0.0 0
M  V30 29 C 1.3336 0.0000 0.0 0
M  V30 30 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=3
M  V30 14 1 12 25
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 20
M  V30 18 1 17 18
M  V30 19 1 17 22
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1962942-94-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 210300-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1962946-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32657022
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of florylpicoxamid, a mimic of a macrocyclic natural product
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meyer, Kevin G.; Bravo-Altamirano, Karla; Herrick, Jessica; Loy, Brian
A.; Yao, Chenglin; Nugent, Ben; Buchan, Zachary; Daeuble, John F.;
Heemstra, Ron; Jones, David M.; Wilmot, Jeremy; Lu, Yu; DeKorver, Kyle;
DeLorbe, Johnathan; Rigoli, Jared
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 50116455

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
(1S,2R,4aR,5R,8aS)-5-[(1E)-2-(2,5-Dihydro-2-oxo-3-furanyl)ethenyl]decahydro-2...
C20H26O5
1330528-44-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0445 1.5400 0.0 0
M  V30 2 C 7.3781 2.3101 0.0 0
M  V30 3 C 8.7118 3.0801 0.0 0
M  V30 4 C 1.5166 3.7572 0.0 0
M  V30 5 O 2.5066 4.9369 0.0 0
M  V30 6 O 0.0000 4.0246 0.0 0
M  V30 7 C 0.5267 2.0427 0.0 0
M  V30 8 C 7.3781 5.3901 0.0 0
M  V30 9 O 0.7096 0.0000 0.0 0
M  V30 10 O 11.7726 4.4428 0.0 0
M  V30 11 C 4.7108 2.3101 0.0 0 CFG=2
M  V30 12 C 3.3770 3.0801 0.0 0 CFG=2
M  V30 13 C 6.0445 3.0801 0.0 0 CFG=2
M  V30 14 C 4.7108 0.7700 0.0 0
M  V30 15 C 2.0433 2.3101 0.0 0 CFG=2
M  V30 16 C 3.3770 4.6201 0.0 0
M  V30 17 C 6.0445 4.6201 0.0 0
M  V30 18 C 3.3770 0.0000 0.0 0
M  V30 19 C 2.0433 0.7700 0.0 0 CFG=2
M  V30 20 C 4.7108 5.3901 0.0 0
M  V30 21 C 10.0456 2.3101 0.0 0
M  V30 22 C 11.4525 2.9364 0.0 0
M  V30 23 C 10.2066 0.7785 0.0 0
M  V30 24 O 12.4829 1.7920 0.0 0
M  V30 25 C 11.7129 0.4583 0.0 0
M  V30 26 H 2.0433 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 2 2 3
M  V30 3 1 13 2 CFG=1
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 15 4 CFG=1
M  V30 8 1 15 7 CFG=3
M  V30 9 2 8 17
M  V30 10 1 19 9 CFG=1
M  V30 11 2 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 26 CFG=3
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 19
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R,4aR,5R,8aS)-5-[(1E)-2-(2,5-Dihydro-2-oxo-3-furanyl)ethenyl]decahydro-2...
C27H33NO4
2603150-99-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4384 5.9136 0.0 0
M  V30 2 C 5.1048 5.1436 0.0 0
M  V30 3 C 3.7712 4.3736 0.0 0
M  V30 4 C 10.9662 3.6965 0.0 0
M  V30 5 N 12.4828 3.4291 0.0 0
M  V30 6 O 9.9763 2.5168 0.0 0
M  V30 7 C 13.0095 1.9820 0.0 0
M  V30 8 C 11.9561 5.4111 0.0 0
M  V30 9 C 5.1048 2.0636 0.0 0
M  V30 10 O 11.7731 7.4536 0.0 0
M  V30 11 O 0.7104 3.0109 0.0 0
M  V30 12 C 7.7721 5.1436 0.0 0 CFG=2
M  V30 13 C 9.1059 4.3736 0.0 0 CFG=2
M  V30 14 C 6.4384 4.3736 0.0 0 CFG=2
M  V30 15 C 7.7721 6.6836 0.0 0
M  V30 16 C 10.4395 5.1436 0.0 0 CFG=2
M  V30 17 C 9.1059 2.8336 0.0 0
M  V30 18 C 6.4384 2.8336 0.0 0
M  V30 19 C 9.1059 7.4536 0.0 0
M  V30 20 C 10.4395 6.6836 0.0 0 CFG=2
M  V30 21 C 7.7721 2.0636 0.0 0
M  V30 22 C 2.4374 5.1436 0.0 0
M  V30 23 C 1.0306 4.5173 0.0 0
M  V30 24 C 2.2764 6.6751 0.0 0
M  V30 25 O 0.0000 5.6617 0.0 0
M  V30 26 C 0.7702 6.9953 0.0 0
M  V30 27 C 14.5261 1.7145 0.0 0
M  V30 28 C 15.5160 2.8943 0.0 0
M  V30 29 C 15.0529 0.2673 0.0 0
M  V30 30 C 17.0326 2.6268 0.0 0
M  V30 31 C 16.5695 0.0000 0.0 0
M  V30 32 C 17.5594 1.1796 0.0 0
M  V30 33 H 10.4395 3.6036 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 2 2 3
M  V30 3 1 14 2 CFG=1
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 27
M  V30 10 1 16 8 CFG=3
M  V30 11 2 9 18
M  V30 12 1 20 10 CFG=1
M  V30 13 2 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 33 CFG=3
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 21
M  V30 25 1 19 20
M  V30 26 1 22 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 14 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1330528-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2603150-99-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23230949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of andrographolide derivatives as potent
anti-osteoporosis agents in vitro and in vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Songxuan; Zhang, Yuting; Fang, Yuying; Chen, Hao; Hao, Mengjiao;
Tan, Qingyun; Hu, Chen; Zhou, Huihao; Xu, Jun; Gu, Qiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 213113185

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Benzyloxycarbonyl-L-leucine
C14H19NO4
2018-66-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 O 4.6200 5.3347 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0 CFG=2
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 O 0.7700 1.3338 0.0 0
M  V30 11 O 3.0800 0.0000 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 6.6685 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 11.5500 6.6685 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3S)-α-amino-2-oxo-3-pyrrolidinepropanoate
C8H14N2O3
1027601-37-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0 CFG=2
M  V30 3 C 6.4386 1.5400 0.0 0
M  V30 4 N 5.1048 3.8501 0.0 0
M  V30 5 O 7.7722 2.3101 0.0 0
M  V30 6 O 6.4386 0.0000 0.0 0
M  V30 7 C 9.1059 1.5400 0.0 0
M  V30 8 O 0.7103 0.1773 0.0 0
M  V30 9 C 2.4374 2.3101 0.0 0 CFG=2
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 N 0.0000 2.8281 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 10
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-leucyl-3-[(3S)-2-oxo-3-pyrrolidinyl]-L-alanine ...
C22H31N3O6
1429218-44-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1046 6.9300 0.0 0 CFG=1
M  V30 2 C 3.7710 6.1600 0.0 0
M  V30 3 N 6.4384 6.1600 0.0 0
M  V30 4 C 5.1046 8.4700 0.0 0
M  V30 5 C 6.4384 4.6200 0.0 0
M  V30 6 O 6.4384 9.2400 0.0 0
M  V30 7 O 3.7710 9.2400 0.0 0
M  V30 8 C 7.7721 3.8500 0.0 0 CFG=2
M  V30 9 O 5.1046 3.8500 0.0 0
M  V30 10 C 6.4384 10.7800 0.0 0
M  V30 11 N 9.1057 4.6200 0.0 0
M  V30 12 C 7.7721 2.3100 0.0 0
M  V30 13 C 10.4394 3.8500 0.0 0
M  V30 14 C 6.4384 1.5400 0.0 0
M  V30 15 O 11.7731 4.6200 0.0 0
M  V30 16 O 10.4395 2.3100 0.0 0
M  V30 17 C 6.4384 0.0000 0.0 0
M  V30 18 C 5.1046 2.3100 0.0 0
M  V30 19 C 13.1068 3.8500 0.0 0
M  V30 20 O 0.7102 4.7973 0.0 0
M  V30 21 C 2.4374 6.9300 0.0 0 CFG=2
M  V30 22 C 1.0306 6.3037 0.0 0
M  V30 23 C 2.2764 8.4615 0.0 0
M  V30 24 N 0.0000 7.4481 0.0 0
M  V30 25 C 0.7700 8.7817 0.0 0
M  V30 26 C 14.4404 4.6200 0.0 0
M  V30 27 C 14.4404 6.1600 0.0 0
M  V30 28 C 15.7742 3.8500 0.0 0
M  V30 29 C 15.7742 6.9300 0.0 0
M  V30 30 C 17.1079 4.6200 0.0 0
M  V30 31 C 17.1079 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 21 2 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 19 26
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2018-66-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1027601-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1429218-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39179130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of
3-Chymotrypsin-like Protease of SARS-CoV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grifagni, Deborah; Lenci, Elena; De Santis, Alessia; Orsetti, Andrea;
Barracchia, Carlo Giorgio; Tedesco, Filomena; Bellini Puglielli,
Raffaele; Lucarelli, Francesca; Lauriola, Angela; Assfalg, Michael;
Cantini, Francesca; Calderone, Vito; Guardavaccaro, Daniele; Trabocchi,
Andrea; DOnofrio, Mariapina; Ciofi-Baffoni, Simone
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(2), 250-257

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
S-Methyl-N-[(5-methyl-3-isoxazolyl)carbonyl]-L-cysteinyl-O-methyl-L-serine
C13H19N3O6S
2387522-94-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.8501 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 9.3360 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 N 5.3348 6.1601 0.0 0
M  V30 8 O 4.0012 3.8501 0.0 0
M  V30 9 S 5.3348 1.5400 0.0 0
M  V30 10 C 4.0012 6.9302 0.0 0 CFG=2
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 8.4702 0.0 0
M  V30 14 O 1.3337 6.9302 0.0 0
M  V30 15 O 2.6675 9.2402 0.0 0
M  V30 16 O 5.3348 9.2402 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 18 C 14.6386 4.9772 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0765 3.9938 0.0 0
M  V30 21 N 10.8306 6.1517 0.0 0
M  V30 22 C 13.1071 5.1382 0.0 0
M  V30 23 O 12.3371 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12 CFG=1
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 18 22
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pentanone, 2-amino-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-, (2S)-, 2,2,2-tri...
C9H17NO2.C2HF3O2
247068-85-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8504 6.7237 0.0 0
M  V30 2 C 4.1841 7.4937 0.0 0 CFG=1
M  V30 3 O 2.8504 5.1837 0.0 0
M  V30 4 C 5.5177 6.7237 0.0 0
M  V30 5 N 4.1841 9.0338 0.0 0
M  V30 6 C 6.8514 7.4937 0.0 0
M  V30 7 C 8.1852 6.7237 0.0 0
M  V30 8 C 6.8514 9.0338 0.0 0
M  V30 9 C 2.0434 8.9409 0.0 0
M  V30 10 C 1.5166 7.4937 0.0 0 CFG=2
M  V30 11 C 0.5268 6.3141 0.0 0
M  V30 12 O 0.0000 7.7611 0.0 0
M  V30 13 C 3.4257 2.3101 0.0 0
M  V30 14 C 4.7594 1.5400 0.0 0
M  V30 15 F 4.1958 3.6437 0.0 0
M  V30 16 F 2.0921 3.0801 0.0 0
M  V30 17 F 2.6557 0.9764 0.0 0
M  V30 18 O 6.0931 2.3101 0.0 0
M  V30 19 O 4.7594 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 10 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 14 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-Methyl-N-[(5-methyl-3-isoxazolyl)carbonyl]-L-cysteinyl-O-methyl-N-[(1S)-3-m...
C22H34N4O7S
2387523-10-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.2172 8.0021 0.0 0
M  V30 2 C 3.7572 8.0021 0.0 0 CFG=2
M  V30 3 O 1.4472 9.3359 0.0 0
M  V30 4 N 4.5272 6.6685 0.0 0
M  V30 5 C 4.5272 9.3359 0.0 0
M  V30 6 C 6.0672 6.6685 0.0 0
M  V30 7 C 3.7572 10.6696 0.0 0
M  V30 8 C 6.8372 5.3348 0.0 0 CFG=2
M  V30 9 O 6.8372 8.0021 0.0 0
M  V30 10 C 4.5272 12.0033 0.0 0
M  V30 11 C 2.2172 10.6696 0.0 0
M  V30 12 N 8.3773 5.3348 0.0 0
M  V30 13 C 6.0672 4.0011 0.0 0
M  V30 14 C 9.1473 4.0011 0.0 0
M  V30 15 O 4.5272 4.0011 0.0 0
M  V30 16 C 10.6873 4.0011 0.0 0 CFG=2
M  V30 17 O 8.3773 2.6673 0.0 0
M  V30 18 C 3.7572 2.6673 0.0 0
M  V30 19 N 11.4573 5.3348 0.0 0
M  V30 20 C 11.4573 2.6673 0.0 0
M  V30 21 C 12.9973 5.3348 0.0 0
M  V30 22 S 10.6873 1.3337 0.0 0
M  V30 23 O 13.7674 4.0011 0.0 0
M  V30 24 C 11.4573 0.0000 0.0 0
M  V30 25 C 2.6268 5.6785 0.0 0
M  V30 26 C 17.0259 8.9622 0.0 0
M  V30 27 C 1.4472 6.6685 0.0 0 CFG=2
M  V30 28 C 0.0000 7.1951 0.0 0
M  V30 29 O 0.2673 5.6785 0.0 0
M  V30 30 C 13.7674 6.6685 0.0 0
M  V30 31 N 13.1409 8.0754 0.0 0
M  V30 32 C 15.2989 6.8294 0.0 0
M  V30 33 O 14.2854 9.1059 0.0 0
M  V30 34 C 15.6191 8.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 27 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20 CFG=1
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 21 30
M  V30 25 1 22 24
M  V30 26 1 27 25 CFG=1
M  V30 27 1 26 34
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 8 16 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387522-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 247068-85-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
4-Chloroindole-3-acetic acid
C10H8ClNO2
2519-61-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 1.9571 0.0 0
M  V30 2 C 7.1955 2.4329 0.0 0
M  V30 3 O 7.5157 3.9394 0.0 0
M  V30 4 O 8.3399 1.4025 0.0 0
M  V30 5 Cl 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0012 0.0 0
M  V30 8 C 4.5864 2.9877 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 N 3.3405 5.1456 0.0 0
M  V30 11 C 0.7700 4.0012 0.0 0
M  V30 12 C 4.7473 4.5192 0.0 0
M  V30 13 C 0.7700 1.3337 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-3-methoxybenzeneethanamine
C11H17NO2
36377-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 10.7800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[2-(4-ethoxy-3-methoxyphenyl)ethyl]-1H-indole-3-acetamide
C21H23ClN2O3
2565618-08-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 6.6685 0.0 0
M  V30 2 C 6.7709 6.6685 0.0 0
M  V30 3 N 7.5409 5.3348 0.0 0
M  V30 4 O 7.5409 8.0021 0.0 0
M  V30 5 C 9.0809 5.3348 0.0 0
M  V30 6 C 9.8509 4.0011 0.0 0
M  V30 7 Cl 2.1051 5.6263 0.0 0
M  V30 8 O 14.4710 1.3337 0.0 0
M  V30 9 C 13.7010 0.0000 0.0 0
M  V30 10 O 16.0110 4.0011 0.0 0
M  V30 11 C 16.7810 5.3348 0.0 0
M  V30 12 C 18.3210 5.3348 0.0 0
M  V30 13 C 2.9293 8.1632 0.0 0
M  V30 14 C 4.4608 8.0021 0.0 0
M  V30 15 C 2.6091 9.6695 0.0 0
M  V30 16 C 1.7849 7.1326 0.0 0
M  V30 17 C 5.0873 9.4091 0.0 0
M  V30 18 N 3.9428 10.4395 0.0 0
M  V30 19 C 1.1444 10.1454 0.0 0
M  V30 20 C 0.3202 7.6086 0.0 0
M  V30 21 C 0.0000 9.1149 0.0 0
M  V30 22 C 11.3909 4.0011 0.0 0
M  V30 23 C 12.1609 2.6673 0.0 0
M  V30 24 C 12.1609 5.3348 0.0 0
M  V30 25 C 13.7010 2.6673 0.0 0
M  V30 26 C 13.7010 5.3348 0.0 0
M  V30 27 C 14.4710 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 22
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2519-61-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36377-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23040954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
7-Chloro-1H-indole-3-acetic acid
C10H8ClNO2
1912-41-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 C 7.6825 4.1649 0.0 0
M  V30 3 O 7.2066 5.6294 0.0 0
M  V30 4 O 9.1888 3.8445 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7475 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-3-methoxybenzeneethanamine
C11H17NO2
36377-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 N 10.7800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-[2-(4-ethoxy-3-methoxyphenyl)ethyl]-1H-indole-3-acetamide
C21H23ClN2O3
2565618-10-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 6.6685 0.0 0
M  V30 2 C 6.7709 6.6685 0.0 0
M  V30 3 N 7.5409 5.3348 0.0 0
M  V30 4 O 7.5409 8.0023 0.0 0
M  V30 5 C 9.0809 5.3348 0.0 0
M  V30 6 C 9.8509 4.0011 0.0 0
M  V30 7 Cl 0.8242 11.6518 0.0 0
M  V30 8 O 14.4710 1.3337 0.0 0
M  V30 9 C 13.7010 0.0000 0.0 0
M  V30 10 O 16.0110 4.0011 0.0 0
M  V30 11 C 16.7810 5.3348 0.0 0
M  V30 12 C 18.3211 5.3348 0.0 0
M  V30 13 C 2.9293 8.1632 0.0 0
M  V30 14 C 2.6091 9.6695 0.0 0
M  V30 15 C 4.4608 8.0023 0.0 0
M  V30 16 C 1.7849 7.1328 0.0 0
M  V30 17 N 3.9428 10.4395 0.0 0
M  V30 18 C 1.1444 10.1454 0.0 0
M  V30 19 C 5.0873 9.4091 0.0 0
M  V30 20 C 0.3202 7.6086 0.0 0
M  V30 21 C 0.0000 9.1149 0.0 0
M  V30 22 C 11.3909 4.0011 0.0 0
M  V30 23 C 12.1610 2.6675 0.0 0
M  V30 24 C 12.1610 5.3348 0.0 0
M  V30 25 C 13.7010 2.6675 0.0 0
M  V30 26 C 13.7010 5.3348 0.0 0
M  V30 27 C 14.4710 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 22
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1912-41-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36377-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2565618-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23044787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of tetrahydroisoquinolines
derivatives as novel, selective PDE4 inhibitors for antipsoriasis
treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Rui; Li, Heng; Zhang, Xianglei; Li, Jian; Su, Haixia; Lu, Qiukai;
Dong, Guangyu; Dou, Huixia; Fan, Chen; Gu, Zhanni; Mu, Qianwen; Tang,
Wei; Xu, Yechun; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 211113004

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
2-Phenoxy-5-pyrimidinecarboxylic acid
C11H8N2O3
927877-48-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 4.6201 0.0 0
M  V30 2 C 9.3360 1.5400 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 N 5.3348 2.3101 0.0 0
M  V30 7 N 6.6685 4.6201 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 C 8.0023 3.8501 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinecarboxylic acid, 1-(4-aminophenyl)-, 1,1-dimethylethyl ester
C16H24N2O2
2924897-08-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 N 14.6300 2.8736 0.0 0
M  V30 9 N 8.4700 2.8736 0.0 0
M  V30 10 C 7.7000 1.5400 0.0 0
M  V30 11 C 7.7000 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 6.1600 4.2073 0.0 0
M  V30 14 C 5.3900 2.8736 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 1-[4-[[(2-phenoxy-5-pyrimidinyl)carbonyl]amino]phenyl]-4-pi...
C27H30N4O4
927878-42-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.7900 5.3347 0.0 0
M  V30 2 O 21.5600 6.6685 0.0 0
M  V30 3 O 21.5600 4.0011 0.0 0
M  V30 4 C 23.1000 6.6685 0.0 0
M  V30 5 C 23.1000 5.1285 0.0 0
M  V30 6 C 24.6400 6.6685 0.0 0
M  V30 7 C 23.1000 8.2085 0.0 0
M  V30 8 N 10.0100 5.3347 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 O 10.0100 2.6674 0.0 0
M  V30 11 O 3.0800 4.0011 0.0 0
M  V30 12 N 16.1700 5.3347 0.0 0
M  V30 13 C 16.9400 6.6685 0.0 0
M  V30 14 C 16.9400 4.0011 0.0 0
M  V30 15 C 18.4800 6.6685 0.0 0
M  V30 16 C 18.4800 4.0011 0.0 0
M  V30 17 C 19.2500 5.3347 0.0 0
M  V30 18 C 14.6300 5.3347 0.0 0
M  V30 19 C 13.8600 6.6685 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0
M  V30 21 C 12.3200 6.6685 0.0 0
M  V30 22 C 12.3200 4.0011 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 7.7000 4.0011 0.0 0
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 C 6.9300 2.6674 0.0 0
M  V30 27 N 5.3900 5.3347 0.0 0
M  V30 28 N 5.3900 2.6674 0.0 0
M  V30 29 C 4.6200 4.0011 0.0 0
M  V30 30 C 2.3100 2.6674 0.0 0
M  V30 31 C 0.7700 2.6674 0.0 0
M  V30 32 C 3.0800 1.3338 0.0 0
M  V30 33 C 0.0000 1.3338 0.0 0
M  V30 34 C 2.3100 0.0000 0.0 0
M  V30 35 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 23
M  V30 10 2 9 10
M  V30 11 1 9 24
M  V30 12 1 11 29
M  V30 13 1 11 30
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 18
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 927877-48-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2924897-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 927878-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36513480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CRBN ligand expansion for hematopoietic prostaglandin D2 synthase
(H-PGDS) targeting PROTAC design and their in vitro ADME profiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Osawa, Hinata; Kurohara, Takashi; Ito, Takahito; Shibata, Norihito;
Demizu, Yosuke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 84117259

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Pentanoic acid, 5-amino-, ethyl ester, hydrochloride (1:1)
C7H15NO2.ClH
29840-57-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 4.0012 3.0800 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 2.6673 3.8501 0.0 0
M  V30 5 O 4.0012 1.5400 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 9.3360 3.0800 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 N 10.6697 3.8501 0.0 0
M  V30 11 Cl 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-D-alanyl-L-phenylalanyl-N6-[(1,1-dimethyleth...
C28H44N4O8
183444-80-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 4.6201 0.0 0 CFG=2
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 C 12.0033 5.3901 0.0 0
M  V30 4 N 9.3358 5.3901 0.0 0
M  V30 5 N 12.0033 6.9302 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 8.0022 4.6201 0.0 0
M  V30 8 C 13.3370 7.7002 0.0 0 CFG=2
M  V30 9 C 6.6685 5.3901 0.0 0 CFG=1
M  V30 10 O 8.0022 3.0801 0.0 0
M  V30 11 C 14.6707 6.9302 0.0 0
M  V30 12 C 13.3370 9.2402 0.0 0
M  V30 13 N 5.3348 4.6201 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 16.0045 7.7002 0.0 0
M  V30 16 O 14.6707 10.0102 0.0 0
M  V30 17 O 12.0033 10.0102 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 17.3382 6.9302 0.0 0
M  V30 20 O 2.6673 4.6201 0.0 0
M  V30 21 O 4.0010 6.9302 0.0 0
M  V30 22 C 18.6718 7.7002 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 N 20.0055 6.9302 0.0 0
M  V30 25 C 2.1037 6.7238 0.0 0
M  V30 26 C 0.0000 6.1601 0.0 0
M  V30 27 C 0.5637 4.0564 0.0 0
M  V30 28 C 21.3393 7.7002 0.0 0
M  V30 29 O 22.6730 6.9302 0.0 0
M  V30 30 O 21.3393 9.2402 0.0 0
M  V30 31 C 24.0067 7.7002 0.0 0
M  V30 32 C 24.7767 6.3665 0.0 0
M  V30 33 C 25.3403 8.4702 0.0 0
M  V30 34 C 23.2366 9.0338 0.0 0
M  V30 35 C 12.0033 2.3101 0.0 0
M  V30 36 C 12.0033 0.7700 0.0 0
M  V30 37 C 13.3370 3.0801 0.0 0
M  V30 38 C 13.3370 0.0000 0.0 0
M  V30 39 C 14.6707 2.3101 0.0 0
M  V30 40 C 14.6707 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 35
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=3
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 15 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 28 29
M  V30 30 2 28 30
M  V30 31 1 29 31
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 1 31 34
M  V30 35 2 35 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 2 37 39
M  V30 39 2 38 40
M  V30 40 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C35H57N5O9
3033607-24-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 14.6303 0.0 0 CFG=2
M  V30 2 C 10.6697 16.1704 0.0 0
M  V30 3 C 12.0033 13.8603 0.0 0
M  V30 4 N 9.3358 13.8603 0.0 0
M  V30 5 N 12.0033 12.3203 0.0 0
M  V30 6 O 13.3370 14.6303 0.0 0
M  V30 7 C 8.0022 14.6303 0.0 0
M  V30 8 C 13.3370 11.5503 0.0 0 CFG=1
M  V30 9 C 6.6685 13.8603 0.0 0 CFG=1
M  V30 10 O 8.0022 16.1704 0.0 0
M  V30 11 C 13.3370 10.0102 0.0 0
M  V30 12 C 14.6707 12.3203 0.0 0
M  V30 13 N 5.3348 14.6303 0.0 0
M  V30 14 C 6.6685 12.3203 0.0 0
M  V30 15 N 12.0033 9.2402 0.0 0
M  V30 16 O 14.6707 9.2402 0.0 0
M  V30 17 C 16.0045 11.5503 0.0 0
M  V30 18 C 4.0010 13.8603 0.0 0
M  V30 19 C 12.0033 7.7002 0.0 0
M  V30 20 C 17.3382 12.3203 0.0 0
M  V30 21 O 2.6673 14.6303 0.0 0
M  V30 22 O 4.0010 12.3203 0.0 0
M  V30 23 C 10.6697 6.9302 0.0 0
M  V30 24 C 18.6718 11.5503 0.0 0
M  V30 25 C 1.3337 13.8603 0.0 0
M  V30 26 C 10.6697 5.3901 0.0 0
M  V30 27 N 20.0055 12.3203 0.0 0
M  V30 28 C 2.1037 12.5266 0.0 0
M  V30 29 C 0.0000 13.0903 0.0 0
M  V30 30 C 0.5637 15.1940 0.0 0
M  V30 31 C 9.3358 4.6201 0.0 0
M  V30 32 C 21.3393 11.5503 0.0 0
M  V30 33 C 9.3358 3.0801 0.0 0
M  V30 34 O 22.6730 12.3203 0.0 0
M  V30 35 O 21.3393 10.0102 0.0 0
M  V30 36 O 8.0022 2.3101 0.0 0
M  V30 37 O 10.6697 2.3101 0.0 0
M  V30 38 C 24.0067 11.5503 0.0 0
M  V30 39 C 8.0022 0.7700 0.0 0
M  V30 40 C 24.7767 12.8839 0.0 0
M  V30 41 C 25.3403 10.7802 0.0 0
M  V30 42 C 23.2366 10.2166 0.0 0
M  V30 43 C 6.6685 0.0000 0.0 0
M  V30 44 C 12.0033 16.9404 0.0 0
M  V30 45 C 12.0033 18.4804 0.0 0
M  V30 46 C 13.3370 16.1704 0.0 0
M  V30 47 C 13.3370 19.2504 0.0 0
M  V30 48 C 14.6707 16.9404 0.0 0
M  V30 49 C 14.6707 18.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 44
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 15 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 25 28
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 1 26 31
M  V30 32 1 27 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 32 35
M  V30 36 1 33 36
M  V30 37 2 33 37
M  V30 38 1 34 38
M  V30 39 1 36 39
M  V30 40 1 38 40
M  V30 41 1 38 41
M  V30 42 1 38 42
M  V30 43 1 39 43
M  V30 44 2 44 45
M  V30 45 1 44 46
M  V30 46 1 45 47
M  V30 47 2 46 48
M  V30 48 2 47 49
M  V30 49 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 29840-57-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 183444-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033607-24-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31702269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Si113-prodrugs selectively activated by plasmin against hepatocellular
and ovarian carcinoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rango, Enrico; D'Antona, Lucia; Iovenitti, Giulia; Brai, Annalaura;
Mancini, Arianna; Zamperini, Claudio; Trivisani, Claudia Immacolata;
Marianelli, Stefano; Fallacara, Anna Lucia; Molinari, Alessio; Cianciusi,
Annarita; Schenone, Silvia; Perrotti, Nicola; Dreassi, Elena; Botta,
Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 223113653

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
2,4-Dihydroxybenzoic acid
C7H6O4
89-86-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-(trifluorome...
C21H27F3N2O3S
2415386-52-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8986 3.2864 0.0 0
M  V30 4 O 7.4387 5.9538 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0 CFG=1
M  V30 8 C 6.6687 1.5400 0.0 0
M  V30 9 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 C 6.6687 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 13.3372 3.8501 0.0 0
M  V30 14 N 12.0035 6.1601 0.0 0
M  V30 15 C 1.3338 7.7002 0.0 0
M  V30 16 F 2.1038 9.0338 0.0 0
M  V30 17 F 0.0000 8.4702 0.0 0
M  V30 18 F 0.5638 6.3665 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 4.0012 7.7002 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 2.6675 6.9302 0.0 0
M  V30 25 C 14.6708 4.6201 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 3.8501 0.0 0
M  V30 28 C 16.0045 6.9302 0.0 0
M  V30 29 C 17.3383 4.6201 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,4-Dihydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[[4-(trifluoromethyl)ph...
C28H31F3N2O6S
2892016-22-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 7.7000 0.0 0 VAL=6
M  V30 2 N 4.0011 9.2400 0.0 0
M  V30 3 O 5.5411 7.7000 0.0 0
M  V30 4 O 2.4611 7.7000 0.0 0
M  V30 5 C 5.3347 10.0100 0.0 0
M  V30 6 C 2.6674 10.0100 0.0 0
M  V30 7 C 6.6685 9.2400 0.0 0 CFG=1
M  V30 8 C 1.3338 9.2400 0.0 0
M  V30 9 C 8.0021 10.0100 0.0 0 CFG=1
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 C 0.0000 10.0100 0.0 0
M  V30 12 C 1.3338 7.7000 0.0 0
M  V30 13 C 8.0021 11.5500 0.0 0
M  V30 14 N 9.3358 9.2400 0.0 0
M  V30 15 C 10.6696 10.0100 0.0 0
M  V30 16 O 10.6696 11.5500 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 18 F 2.4611 1.5400 0.0 0
M  V30 19 F 4.0011 0.0000 0.0 0
M  V30 20 F 5.5411 1.5400 0.0 0
M  V30 21 O 13.3369 11.5500 0.0 0
M  V30 22 O 16.0043 6.9300 0.0 0
M  V30 23 C 4.0011 6.1600 0.0 0
M  V30 24 C 5.3347 5.3900 0.0 0
M  V30 25 C 2.6674 5.3900 0.0 0
M  V30 26 C 5.3347 3.8500 0.0 0
M  V30 27 C 2.6674 3.8500 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 6.6685 12.3200 0.0 0
M  V30 30 C 6.6685 13.8600 0.0 0
M  V30 31 C 5.3347 11.5500 0.0 0
M  V30 32 C 5.3347 14.6300 0.0 0
M  V30 33 C 4.0011 12.3200 0.0 0
M  V30 34 C 4.0011 13.8600 0.0 0
M  V30 35 C 12.0032 9.2400 0.0 0
M  V30 36 C 13.3369 10.0100 0.0 0
M  V30 37 C 12.0032 7.7000 0.0 0
M  V30 38 C 14.6705 9.2400 0.0 0
M  V30 39 C 13.3369 6.9300 0.0 0
M  V30 40 C 14.6705 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 23
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 35
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 28
M  V30 23 1 21 36
M  V30 24 1 22 40
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 89-86-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415386-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-L-cysteine
C37H31NO4S
103213-32-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.4610 0.0 0
M  V30 2 S 5.3348 5.2310 0.0 0
M  V30 3 C 6.6686 4.4610 0.0 0
M  V30 4 C 8.0022 5.2310 0.0 0 CFG=1
M  V30 5 N 9.3359 4.4610 0.0 0
M  V30 6 C 8.0022 6.7710 0.0 0
M  V30 7 C 10.6695 5.2310 0.0 0
M  V30 8 O 6.6686 7.5410 0.0 0
M  V30 9 O 9.3359 7.5410 0.0 0
M  V30 10 O 12.0034 4.4610 0.0 0
M  V30 11 O 10.6695 6.7710 0.0 0
M  V30 12 C 13.3370 5.2310 0.0 0
M  V30 13 C 3.2311 5.7946 0.0 0
M  V30 14 C 1.6911 5.7946 0.0 0
M  V30 15 C 4.0011 7.1283 0.0 0
M  V30 16 C 0.9211 7.1283 0.0 0
M  V30 17 C 3.2311 8.4621 0.0 0
M  V30 18 C 1.6911 8.4621 0.0 0
M  V30 19 C 2.6675 3.6910 0.0 0
M  V30 20 C 1.3338 4.4610 0.0 0
M  V30 21 C 2.6675 2.1509 0.0 0
M  V30 22 C 0.0000 3.6910 0.0 0
M  V30 23 C 1.3338 1.3809 0.0 0
M  V30 24 C 0.0000 2.1509 0.0 0
M  V30 25 C 4.7711 3.1273 0.0 0
M  V30 26 C 4.0011 1.7935 0.0 0
M  V30 27 C 6.3111 3.1273 0.0 0
M  V30 28 C 4.7711 0.4598 0.0 0
M  V30 29 C 7.0812 1.7935 0.0 0
M  V30 30 C 6.3111 0.4598 0.0 0
M  V30 31 C 14.6707 4.4610 0.0 0
M  V30 32 C 14.8316 2.9294 0.0 0
M  V30 33 C 16.0776 5.0873 0.0 0
M  V30 34 C 16.3380 2.6091 0.0 0
M  V30 35 C 13.8012 1.7849 0.0 0
M  V30 36 C 17.1080 3.9429 0.0 0
M  V30 37 C 16.5535 6.5520 0.0 0
M  V30 38 C 16.8139 1.1445 0.0 0
M  V30 39 C 14.2770 0.3203 0.0 0
M  V30 40 C 18.6143 4.2631 0.0 0
M  V30 41 C 18.0598 6.8722 0.0 0
M  V30 42 C 15.7835 0.0000 0.0 0
M  V30 43 C 19.0904 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5 CFG=1
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 2 6 9
M  V30 12 1 7 10
M  V30 13 2 7 11
M  V30 14 1 10 12
M  V30 15 1 12 31
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 32 35
M  V30 38 1 33 36
M  V30 39 2 33 37
M  V30 40 1 34 36
M  V30 41 2 34 38
M  V30 42 1 35 39
M  V30 43 2 36 40
M  V30 44 1 37 41
M  V30 45 1 38 42
M  V30 46 2 39 42
M  V30 47 1 40 43
M  V30 48 2 41 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Dodecylamine
C12H27N
124-22-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 0.7700 0.0 0
M  V30 2 C 9.3360 0.0000 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 C 10.6698 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 6 C 12.0035 0.0000 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 13.3372 0.7700 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 14.6708 0.0000 0.0 0
M  V30 11 C 1.3338 0.0000 0.0 0
M  V30 12 C 16.0046 0.7700 0.0 0
M  V30 13 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(1R)-2-(dodecylamino)-2-oxo-1-[[(triphenylmethyl)thio]methy...
C49H56N2O3S
3014485-89-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 12.7546 0.0 0
M  V30 2 S 5.3348 11.9845 0.0 0
M  V30 3 C 5.3348 10.4445 0.0 0
M  V30 4 C 6.6685 9.6745 0.0 0 CFG=1
M  V30 5 N 6.6685 8.1345 0.0 0
M  V30 6 C 8.0022 10.4445 0.0 0
M  V30 7 C 8.0022 7.3644 0.0 0
M  V30 8 N 9.3358 9.6745 0.0 0
M  V30 9 O 8.0022 11.9845 0.0 0
M  V30 10 O 8.0022 5.8244 0.0 0
M  V30 11 O 9.3358 8.1345 0.0 0
M  V30 12 C 10.6697 10.4445 0.0 0
M  V30 13 C 9.3358 5.0544 0.0 0
M  V30 14 C 12.0033 9.6745 0.0 0
M  V30 15 C 13.3370 10.4445 0.0 0
M  V30 16 C 14.6707 9.6745 0.0 0
M  V30 17 C 16.0045 10.4445 0.0 0
M  V30 18 C 17.3382 9.6745 0.0 0
M  V30 19 C 18.6718 10.4445 0.0 0
M  V30 20 C 20.0055 9.6745 0.0 0
M  V30 21 C 21.3393 10.4445 0.0 0
M  V30 22 C 22.6730 9.6745 0.0 0
M  V30 23 C 24.0067 10.4445 0.0 0
M  V30 24 C 25.3403 9.6745 0.0 0
M  V30 25 C 3.2310 11.4207 0.0 0
M  V30 26 C 1.6910 11.4207 0.0 0
M  V30 27 C 4.0010 10.0871 0.0 0
M  V30 28 C 0.9209 10.0871 0.0 0
M  V30 29 C 3.2310 8.7534 0.0 0
M  V30 30 C 1.6910 8.7534 0.0 0
M  V30 31 C 2.6673 13.5246 0.0 0
M  V30 32 C 1.3337 12.7546 0.0 0
M  V30 33 C 2.6673 15.0646 0.0 0
M  V30 34 C 0.0000 13.5246 0.0 0
M  V30 35 C 1.3337 15.8346 0.0 0
M  V30 36 C 0.0000 15.0646 0.0 0
M  V30 37 C 4.7710 14.0882 0.0 0
M  V30 38 C 4.0010 15.4219 0.0 0
M  V30 39 C 6.3111 14.0882 0.0 0
M  V30 40 C 4.7710 16.7556 0.0 0
M  V30 41 C 7.0811 15.4219 0.0 0
M  V30 42 C 6.3111 16.7556 0.0 0
M  V30 43 C 9.3358 3.5144 0.0 0
M  V30 44 C 8.0900 2.6091 0.0 0
M  V30 45 C 10.5819 2.6091 0.0 0
M  V30 46 C 8.5658 1.1444 0.0 0
M  V30 47 C 6.5836 2.9293 0.0 0
M  V30 48 C 10.1059 1.1444 0.0 0
M  V30 49 C 12.0882 2.9293 0.0 0
M  V30 50 C 7.5354 0.0000 0.0 0
M  V30 51 C 5.5531 1.7847 0.0 0
M  V30 52 C 11.1364 0.0000 0.0 0
M  V30 53 C 13.1186 1.7847 0.0 0
M  V30 54 C 6.0291 0.3202 0.0 0
M  V30 55 C 12.6428 0.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 1 31
M  V30 4 1 1 37
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5 CFG=1
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 2 6 9
M  V30 12 1 7 10
M  V30 13 2 7 11
M  V30 14 1 8 12
M  V30 15 1 10 13
M  V30 16 1 12 14
M  V30 17 1 13 43
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 18 19
M  V30 23 1 19 20
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 1 22 23
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 46 1 43 44
M  V30 47 1 43 45
M  V30 48 1 44 46
M  V30 49 2 44 47
M  V30 50 1 45 48
M  V30 51 2 45 49
M  V30 52 1 46 48
M  V30 53 2 46 50
M  V30 54 1 47 51
M  V30 55 2 48 52
M  V30 56 1 49 53
M  V30 57 1 50 54
M  V30 58 2 51 54
M  V30 59 1 52 55
M  V30 60 2 53 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103213-32-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3014485-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36116266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists:
Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a
Murine Model of Asthma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gonzalez-Cuesta, Manuel; Lai, Alan Chuan-Ying; Chi, Po-Yu; Hsu, I-Ling;
Liu, Nien-Tzu; Wu, Ko-Chien; Garcia Fernandez, Jose M.; Chang, Ya-Jen;
Ortiz Mellet, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(7), 4768-4783

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
4-Aminobenzyl alcohol
C7H9NO
623-04-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Fmoc-N′-allyloxycarbonyl-L-lysine
C25H28N2O6
146982-27-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 5.7534 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 8.4207 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7546 9.0810 0.0 0
M  V30 8 C 8.4207 11.3910 0.0 0
M  V30 9 C 11.0882 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7546 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 C 13.7556 9.8510 0.0 0
M  V30 14 N 15.0894 9.0810 0.0 0
M  V30 15 C 16.4231 9.8510 0.0 0
M  V30 16 O 17.7567 9.0810 0.0 0
M  V30 17 O 16.4231 11.3910 0.0 0
M  V30 18 C 19.0904 9.8510 0.0 0
M  V30 19 C 20.4242 9.0810 0.0 0
M  V30 20 C 21.7579 9.8510 0.0 0
M  V30 21 C 4.4197 4.4609 0.0 0
M  V30 22 C 3.0128 5.0873 0.0 0
M  V30 23 C 4.2587 2.9293 0.0 0
M  V30 24 C 1.9823 3.9428 0.0 0
M  V30 25 C 2.5369 6.5519 0.0 0
M  V30 26 C 2.7523 2.6091 0.0 0
M  V30 27 C 5.2892 1.7849 0.0 0
M  V30 28 C 0.4759 4.2630 0.0 0
M  V30 29 C 1.0304 6.8721 0.0 0
M  V30 30 C 2.2765 1.1444 0.0 0
M  V30 31 C 4.8132 0.3202 0.0 0
M  V30 32 C 0.0000 5.7277 0.0 0
M  V30 33 C 3.3069 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 2 19 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 22 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 26
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 29 32
M  V30 34 1 30 33
M  V30 35 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(5S)-5-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-6-[[4-(hydro...
C32H35N3O6
573698-75-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 13.8603 0.0 0
M  V30 2 O 5.7534 12.3203 0.0 0
M  V30 3 C 7.0871 11.5503 0.0 0
M  V30 4 N 7.0871 10.0102 0.0 0
M  V30 5 O 8.4207 12.3203 0.0 0
M  V30 6 C 8.4207 9.2402 0.0 0 CFG=1
M  V30 7 C 8.4207 7.7002 0.0 0
M  V30 8 C 9.7546 10.0102 0.0 0
M  V30 9 N 7.0871 6.9302 0.0 0
M  V30 10 O 9.7546 6.9302 0.0 0
M  V30 11 C 11.0882 9.2402 0.0 0
M  V30 12 C 12.4219 10.0102 0.0 0
M  V30 13 C 13.7556 9.2402 0.0 0
M  V30 14 N 15.0894 10.0102 0.0 0
M  V30 15 C 16.4231 9.2402 0.0 0
M  V30 16 O 17.7567 10.0102 0.0 0
M  V30 17 O 16.4231 7.7002 0.0 0
M  V30 18 C 19.0904 9.2402 0.0 0
M  V30 19 C 20.4242 10.0102 0.0 0
M  V30 20 C 21.7579 9.2402 0.0 0
M  V30 21 C 7.0871 0.7700 0.0 0
M  V30 22 O 5.7534 0.0000 0.0 0
M  V30 23 C 3.0128 14.0038 0.0 0
M  V30 24 C 1.9823 15.1484 0.0 0
M  V30 25 C 4.4197 14.6303 0.0 0
M  V30 26 C 2.5369 12.5393 0.0 0
M  V30 27 C 2.7523 16.4821 0.0 0
M  V30 28 C 0.4759 14.8282 0.0 0
M  V30 29 C 4.2587 16.1619 0.0 0
M  V30 30 C 1.0304 12.2191 0.0 0
M  V30 31 C 2.2765 17.9468 0.0 0
M  V30 32 C 0.0000 13.3635 0.0 0
M  V30 33 C 5.2892 17.3063 0.0 0
M  V30 34 C 3.3069 19.0912 0.0 0
M  V30 35 C 4.8132 18.7710 0.0 0
M  V30 36 C 7.0871 5.3901 0.0 0
M  V30 37 C 8.4207 4.6201 0.0 0
M  V30 38 C 5.7534 4.6201 0.0 0
M  V30 39 C 8.4207 3.0801 0.0 0
M  V30 40 C 5.7534 3.0801 0.0 0
M  V30 41 C 7.0871 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 36
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 41
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 29
M  V30 32 2 27 31
M  V30 33 1 28 32
M  V30 34 2 29 33
M  V30 35 2 30 32
M  V30 36 1 31 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 623-04-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 146982-27-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 573698-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34684560
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-48-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yong; Parrish, Karen E.; Tortolani, David R.; Poss, Michael A.;
Huang, Audris; Wan, Honghe; Purandare, Ashok V.; Donnell, Andrew F.;
Kempson, James; Hou, Xiaoping; Pawluczyk, Joseph; Yip, Shiuhang; Luk,
Emily; Raghavan, Nimmi; Swanson, Jesse; Smalley, James; Murtaza, Anwar;
Yang, Zheng; Augustine-Rauch, Karen; Lombardo, Louis J.; Borzilleri,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(21), 15787-15798

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Pyrrolidinepropanoic acid, α-amino-2-oxo-, methyl ester, hydrochloride (1:1...
C8H14N2O3.ClH
1429218-41-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0800 0.0 0
M  V30 2 C 5.1048 3.8501 0.0 0 CFG=2
M  V30 3 C 6.4386 3.0800 0.0 0
M  V30 4 N 5.1048 5.3901 0.0 0
M  V30 5 O 7.7722 3.8501 0.0 0
M  V30 6 O 6.4386 1.5400 0.0 0
M  V30 7 C 9.1059 3.0800 0.0 0
M  V30 8 O 0.7103 1.7173 0.0 0
M  V30 9 C 2.4374 3.8501 0.0 0 CFG=2
M  V30 10 C 1.0304 3.2236 0.0 0
M  V30 11 C 2.2763 5.3816 0.0 0
M  V30 12 N 0.0000 4.3681 0.0 0
M  V30 13 C 0.7700 5.7018 0.0 0
M  V30 14 Cl 4.5530 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 10
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-phenylalanyl-3-[(3S)-2-oxo-3-pyrrolidinyl]...
C22H31N3O6
1831065-36-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.5298 5.3347 0.0 0 CFG=2
M  V30 2 C 9.2998 4.0011 0.0 0
M  V30 3 C 6.9898 5.3347 0.0 0
M  V30 4 N 9.2998 6.6684 0.0 0
M  V30 5 N 6.2198 6.6684 0.0 0
M  V30 6 O 6.2198 4.0011 0.0 0
M  V30 7 C 10.8398 6.6684 0.0 0
M  V30 8 C 4.6798 6.6684 0.0 0 CFG=2
M  V30 9 O 11.6098 8.0022 0.0 0
M  V30 10 O 11.6098 5.3347 0.0 0
M  V30 11 C 3.9098 5.3347 0.0 0
M  V30 12 C 3.9098 8.0022 0.0 0
M  V30 13 C 13.1498 8.0022 0.0 0
M  V30 14 O 4.6798 9.3358 0.0 0
M  V30 15 O 2.3698 8.0022 0.0 0
M  V30 16 C 13.1498 9.5422 0.0 0
M  V30 17 C 14.6898 8.0022 0.0 0
M  V30 18 C 13.1498 6.4622 0.0 0
M  V30 19 C 3.9098 10.6695 0.0 0
M  V30 20 O 1.9406 2.6242 0.0 0
M  V30 21 C 8.5298 2.6673 0.0 0
M  V30 22 C 9.2998 1.3336 0.0 0
M  V30 23 C 6.9898 2.6673 0.0 0
M  V30 24 C 8.5298 0.0000 0.0 0
M  V30 25 C 6.2198 1.3336 0.0 0
M  V30 26 C 6.9898 0.0000 0.0 0
M  V30 27 C 2.3698 5.3347 0.0 0 CFG=2
M  V30 28 C 1.4645 4.0889 0.0 0
M  V30 29 C 1.4645 6.5806 0.0 0
M  V30 30 N 0.0000 4.5647 0.0 0
M  V30 31 C 0.0000 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 27 11 CFG=1
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 2 20 28
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1429218-41-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1831065-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31497680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of peptidomimetic aldehydes
as broad-spectrum inhibitors against enterovirus and SARS-COV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Wenhao; Jochmans, Dirk; Xie, Hang; Yang, Hang; Li, Jian; Su, Haixia;
Chang, Di; Wang, Jiang; Peng, Jingjing; Zhu, Lili; Nian, Yong;
Hilgenfeld, Rolf; Jiang, Hualiang; Chen, Kaixian; Zhang, Leike; Xu,
Yechun; Neyts, Johan; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 2794-2808

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
tert-Butoxycarbonyl-D-leucine
C11H21NO4
16937-99-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=1
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-(5-oxazolyl)benzenamine
C9H7BrN2O
267648-14-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.9098 0.0000 0.0 0
M  V30 2 N 8.5299 2.6673 0.0 0
M  V30 3 C 2.3698 2.6673 0.0 0
M  V30 4 C 1.4646 1.4214 0.0 0
M  V30 5 O 1.4646 3.9132 0.0 0
M  V30 6 N 0.0000 1.8973 0.0 0
M  V30 7 C 0.0000 3.4373 0.0 0
M  V30 8 C 3.9098 2.6673 0.0 0
M  V30 9 C 4.6798 1.3337 0.0 0
M  V30 10 C 4.6798 4.0010 0.0 0
M  V30 11 C 6.2198 1.3337 0.0 0
M  V30 12 C 6.2198 4.0010 0.0 0
M  V30 13 C 6.9898 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-1-[[[3-bromo-4-(5-oxazolyl)phenyl]amino]carbonyl]-3...
C20H26BrN3O4
1644249-91-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Br 13.0900 8.0021 0.0 0
M  V30 2 N 8.4700 5.3347 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 5 O 8.4700 2.6674 0.0 0
M  V30 6 N 5.3900 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 6.1600 1.3338 0.0 0
M  V30 10 O 3.0800 6.6685 0.0 0
M  V30 11 O 3.0800 4.0011 0.0 0
M  V30 12 C 7.7000 1.3338 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 C 1.5400 6.6685 0.0 0
M  V30 15 C 1.5400 8.2085 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 1.5400 5.1285 0.0 0
M  V30 18 C 13.0900 5.3347 0.0 0
M  V30 19 C 12.3200 6.6685 0.0 0
M  V30 20 C 12.3200 4.0011 0.0 0
M  V30 21 C 10.7800 6.6685 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 23 C 10.0100 5.3347 0.0 0
M  V30 24 C 14.6300 5.3347 0.0 0
M  V30 25 C 15.5352 6.5807 0.0 0
M  V30 26 O 15.5352 4.0889 0.0 0
M  V30 27 N 16.9998 6.1047 0.0 0
M  V30 28 C 16.9998 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 24
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 16937-99-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 267648-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1644249-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34006692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Structure-Activity Relationships, and In Vivo Evaluation of
Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase
1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartz, Richard A.; Ahuja, Vijay T.; Nara, Susheel J.; Kumar, C. M.
Vijaya; Brown, Jeffrey M.; Bristow, Linda J.; Rajamani, Ramkumar;
Muckelbauer, Jodi K.; Camac, Daniel; Kiefer, Susan E.; Hunihan, Lisa;
Gulianello, Michael; Lewis, Martin; Easton, Amy; Lippy, Jonathan S.;
Surti, Neha; Pattipati, Sreenivasulu N.; Dokania, Manoj; Elavazhagan,
Saravanan; Dandapani, Kumaran; Hamman, Brian D.; Allen, Jason; Kostich,
Walter; Bronson, Joanne J.; Macor, John E.; Dzierba, Carolyn D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 11090-11128

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline
C13H18F3N3
694499-26-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 4.2073 1.5400 0.0 0
M  V30 4 F 2.6673 0.0000 0.0 0
M  V30 5 F 1.1273 1.5400 0.0 0
M  V30 6 N 0.0000 6.1600 0.0 0
M  V30 7 C 10.6694 6.1600 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 3.0800 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 1.3336 5.3900 0.0 0
M  V30 14 N 6.6684 3.8500 0.0 0
M  V30 15 C 6.6684 5.3900 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 N 9.3358 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 9
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(3-chloropropoxy)-3-fluoro-
C10H10ClFO3
3035807-43-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 Cl 12.0033 4.6201 0.0 0
M  V30 6 F 4.0012 6.1601 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-(3-chloropropoxy)-3-fluoro-N-[4-[(4-methyl-1-piperazinyl)methyl]...
C23H26ClF4N3O2
3035807-31-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 8.0020 1.5400 0.0 0
M  V30 3 F 6.4620 1.5400 0.0 0
M  V30 4 F 8.0020 0.0000 0.0 0
M  V30 5 F 9.5420 1.5400 0.0 0
M  V30 6 N 10.6694 6.1600 0.0 0
M  V30 7 C 10.6694 7.7000 0.0 0
M  V30 8 O 9.3358 8.4700 0.0 0
M  V30 9 C 0.0000 6.1600 0.0 0
M  V30 10 F 13.3367 12.3200 0.0 0
M  V30 11 O 16.0041 10.7800 0.0 0
M  V30 12 C 17.3378 10.0100 0.0 0
M  V30 13 C 18.6716 10.7800 0.0 0
M  V30 14 C 20.0052 10.0100 0.0 0
M  V30 15 Cl 21.3389 10.7800 0.0 0
M  V30 16 C 6.6684 3.8500 0.0 0
M  V30 17 C 8.0020 3.0800 0.0 0
M  V30 18 C 6.6684 5.3900 0.0 0
M  V30 19 C 9.3358 3.8500 0.0 0
M  V30 20 C 8.0020 6.1600 0.0 0
M  V30 21 C 9.3358 5.3900 0.0 0
M  V30 22 N 4.0011 3.8500 0.0 0
M  V30 23 C 4.0011 5.3900 0.0 0
M  V30 24 C 2.6673 3.0800 0.0 0
M  V30 25 C 2.6673 6.1600 0.0 0
M  V30 26 C 1.3336 3.8500 0.0 0
M  V30 27 N 1.3336 5.3900 0.0 0
M  V30 28 C 12.0031 8.4700 0.0 0
M  V30 29 C 12.0031 10.0100 0.0 0
M  V30 30 C 13.3367 7.7000 0.0 0
M  V30 31 C 13.3369 10.7800 0.0 0
M  V30 32 C 14.6705 8.4700 0.0 0
M  V30 33 C 14.6705 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 17
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 2 7 8
M  V30 10 1 7 28
M  V30 11 1 9 27
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 1 11 33
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 694499-26-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035807-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035807-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40728187
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationship study of new biaryl amide
derivatives and their inhibitory effects against hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yonghua; Li, Jianrui; Gu, Yuxi; Ma, Ling; Cen, Shan; Peng, Zonggen;
Hu, Laixing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 228114033

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)acetic acid
C12H21NO4
157688-46-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 O 10.0100 5.5409 0.0 0
M  V30 11 O 12.3200 4.2073 0.0 0
M  V30 12 N 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 14 C 6.1600 4.2073 0.0 0
M  V30 15 C 7.7000 1.5400 0.0 0
M  V30 16 C 7.7000 4.2073 0.0 0
M  V30 17 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1H-indazol-3-amine
C7H6BrN3
404827-77-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 3.1885 0.0 0
M  V30 2 Br 7.2707 2.4782 0.0 0
M  V30 3 C 3.4207 1.1444 0.0 0
M  V30 4 C 2.6507 2.4782 0.0 0
M  V30 5 N 2.3903 0.0000 0.0 0
M  V30 6 C 4.9607 1.1444 0.0 0
M  V30 7 C 1.1444 2.1580 0.0 0
M  V30 8 C 3.4207 3.8118 0.0 0
M  V30 9 N 0.9835 0.6263 0.0 0
M  V30 10 C 5.7307 2.4782 0.0 0
M  V30 11 C 4.9607 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-[(6-bromo-1H-indazol-3-yl)amino]-2-oxoethyl]-1-piperid...
C19H25BrN4O3
2798054-37-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 4.6201 0.0 0
M  V30 2 C 10.6697 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 Br 19.2631 5.4371 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 O 2.6673 2.3101 0.0 0
M  V30 8 O 4.0012 0.0000 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 0.5637 2.8739 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 12 C 2.1037 0.2064 0.0 0
M  V30 13 C 14.7440 4.4766 0.0 0
M  V30 14 C 13.3370 3.8501 0.0 0
M  V30 15 C 15.7744 3.3320 0.0 0
M  V30 16 C 15.2198 5.9411 0.0 0
M  V30 17 N 13.4981 2.3185 0.0 0
M  V30 18 N 15.0044 1.9983 0.0 0
M  V30 19 C 17.2809 3.6523 0.0 0
M  V30 20 C 16.7262 6.2615 0.0 0
M  V30 21 C 17.7567 5.1169 0.0 0
M  V30 22 C 8.0022 3.8501 0.0 0
M  V30 23 C 6.6685 4.6201 0.0 0
M  V30 24 C 8.0022 2.3101 0.0 0
M  V30 25 C 5.3348 3.8501 0.0 0
M  V30 26 C 6.6685 1.5400 0.0 0
M  V30 27 N 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 22
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 27
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 157688-46-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 404827-77-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2798054-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31751503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide
as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's
disease: Significantly increasing the level of acetylcholine in the brain
without affecting that in intestine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Xueyang; Liu, Chang; Zou, Manxing; Xie, Huanfang; Lin, Tailiang;
Lyu, Weiping; Xu, Jian; Li, Yuan; Feng, Feng; Sun, Haopeng; Liu, Wenyuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 223113663

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL

C22H25ClFN3O3
3075104-34-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0 CFG=2
M  V30 2 C 10.0100 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 N 10.0100 6.6684 0.0 0
M  V30 5 N 6.9300 6.6684 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 C 11.5500 6.6684 0.0 0
M  V30 8 N 5.3900 6.6684 0.0 0
M  V30 9 C 7.7000 8.0021 0.0 0
M  V30 10 O 12.3200 8.0021 0.0 0
M  V30 11 O 12.3200 5.3347 0.0 0
M  V30 12 C 4.6200 8.0021 0.0 0
M  V30 13 C 13.8600 8.0021 0.0 0
M  V30 14 C 13.8600 9.5421 0.0 0
M  V30 15 C 15.4000 8.0021 0.0 0
M  V30 16 C 13.8600 6.4621 0.0 0
M  V30 17 F 3.0800 10.6694 0.0 0
M  V30 18 Cl 0.0000 10.6694 0.0 0
M  V30 19 C 9.2400 2.6673 0.0 0
M  V30 20 C 7.7000 2.6673 0.0 0
M  V30 21 C 10.0100 1.3336 0.0 0
M  V30 22 C 6.9300 1.3336 0.0 0
M  V30 23 C 9.2400 0.0000 0.0 0
M  V30 24 C 7.7000 0.0000 0.0 0
M  V30 25 C 3.0800 8.0021 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 2.3100 6.6684 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 0.7700 6.6684 0.0 0
M  V30 30 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 25
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 26
M  V30 19 1 18 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H36ClFN4O4
3075104-45-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 5.3900 0.0 0 CFG=1
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 N 8.0021 6.9300 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 C 6.6684 7.7000 0.0 0
M  V30 6 N 10.6694 5.3900 0.0 0
M  V30 7 O 9.3358 3.0800 0.0 0
M  V30 8 C 6.6684 9.2400 0.0 0 CFG=2
M  V30 9 O 5.3347 6.9300 0.0 0
M  V30 10 N 12.0032 4.6200 0.0 0
M  V30 11 C 10.6694 6.9300 0.0 0
M  V30 12 N 5.3347 10.0100 0.0 0
M  V30 13 C 8.0021 10.0100 0.0 0
M  V30 14 C 13.3369 5.3900 0.0 0
M  V30 15 C 4.0011 9.2400 0.0 0
M  V30 16 C 7.2321 11.3436 0.0 0
M  V30 17 C 9.3358 10.7800 0.0 0
M  V30 18 C 8.7721 8.6764 0.0 0
M  V30 19 O 2.6674 10.0100 0.0 0
M  V30 20 O 4.0011 7.7000 0.0 0
M  V30 21 C 1.3336 9.2400 0.0 0
M  V30 22 C 2.1036 7.9064 0.0 0
M  V30 23 C 0.0000 8.4700 0.0 0
M  V30 24 C 0.5636 10.5736 0.0 0
M  V30 25 F 16.0041 6.9300 0.0 0
M  V30 26 Cl 18.6716 5.3900 0.0 0
M  V30 27 C 6.6684 3.0800 0.0 0
M  V30 28 C 5.3347 2.3100 0.0 0
M  V30 29 C 8.0021 2.3100 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 8.0021 0.7700 0.0 0
M  V30 32 C 6.6684 0.0000 0.0 0
M  V30 33 C 14.6705 4.6200 0.0 0
M  V30 34 C 16.0041 5.3900 0.0 0
M  V30 35 C 14.6705 3.0800 0.0 0
M  V30 36 C 17.3379 4.6200 0.0 0
M  V30 37 C 16.0041 2.3100 0.0 0
M  V30 38 C 17.3379 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 33
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 34
M  V30 27 1 26 36
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 2 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 2 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-34-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-45-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Sodium pyruvate
C3H4O3.Na
113-24-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0800 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 C 4.0010 3.8501 0.0 0
M  V30 4 O 2.6673 1.5400 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 O 0.0000 3.0800 0.0 0
M  V30 7 Na 2.0005 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-1,2-phenylenediamine
C6H6Cl2N2
5348-42-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dichloro-3-methyl-2(1H)-quinoxalinone
C9H6Cl2N2O
73148-15-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0011 0.0 0
M  V30 2 C 6.9300 0.0000 0.0 0
M  V30 3 O 8.4700 2.6674 0.0 0
M  V30 4 Cl 1.5400 6.6685 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 N 4.6200 1.3338 0.0 0
M  V30 9 N 6.1600 4.0011 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 2 3 13
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-24-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5348-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73148-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39174762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the Dispersion and Electrostatic Components in Arene-Arene
Interactions between Ligands and G4 DNA to Develop G4-Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andreasson, Maans; Donzel, Maxime; Abrahamsson, Alva; Berner, Andreas;
Doimo, Mara; Quiroga, Anna; Eriksson, Anna; Chao, Yu-Kai; Overman,
Jeroen; Pemberton, Nils; Wanrooij, Sjoerd; Chorell, Erik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(3), 2202-2219

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
O-Methyl-N-[(5-methyl-3-isoxazolyl)carbonyl]-L-serylglycine
C11H15N3O6
2387522-99-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0287 5.3348 0.0 0
M  V30 2 N 5.5687 5.3348 0.0 0
M  V30 3 O 3.2587 4.0011 0.0 0
M  V30 4 C 6.3388 4.0011 0.0 0 CFG=1
M  V30 5 C 7.8788 4.0011 0.0 0
M  V30 6 C 5.5687 2.6673 0.0 0
M  V30 7 N 8.6488 5.3348 0.0 0
M  V30 8 O 8.6488 2.6673 0.0 0
M  V30 9 O 6.3388 1.3337 0.0 0
M  V30 10 C 10.1888 5.3348 0.0 0
M  V30 11 C 5.5687 0.0000 0.0 0
M  V30 12 C 10.9588 6.6685 0.0 0
M  V30 13 O 10.1888 8.0023 0.0 0
M  V30 14 O 12.4989 6.6685 0.0 0
M  V30 15 C 0.0000 8.9622 0.0 0
M  V30 16 C 3.2587 6.6685 0.0 0
M  V30 17 C 1.7271 6.8296 0.0 0
M  V30 18 N 3.8850 8.0754 0.0 0
M  V30 19 C 1.4070 8.3359 0.0 0
M  V30 20 O 2.7406 9.1059 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 19
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-erythro-3-Pentulose, 2-amino-4,5-anhydro-1,2-dideoxy-4-C-methyl-1-phenyl-, ...
C12H15NO2.C2HF3O2
1148157-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.7237 0.0 0
M  V30 2 C 5.3348 7.4937 0.0 0 CFG=1
M  V30 3 O 6.6684 5.1837 0.0 0
M  V30 4 C 4.0011 6.7237 0.0 0
M  V30 5 N 5.3348 9.0338 0.0 0
M  V30 6 C 7.4755 8.9409 0.0 0
M  V30 7 C 8.0022 7.4937 0.0 0 CFG=2
M  V30 8 C 8.9921 6.3141 0.0 0
M  V30 9 O 9.5188 7.7611 0.0 0
M  V30 10 C 2.6675 7.4937 0.0 0
M  V30 11 C 1.3337 6.7237 0.0 0
M  V30 12 C 2.6675 9.0338 0.0 0
M  V30 13 C 0.0000 7.4937 0.0 0
M  V30 14 C 1.3337 9.8038 0.0 0
M  V30 15 C 0.0000 9.0338 0.0 0
M  V30 16 C 4.0926 2.3101 0.0 0
M  V30 17 C 5.4262 1.5400 0.0 0
M  V30 18 F 4.8626 3.6437 0.0 0
M  V30 19 F 2.7589 3.0801 0.0 0
M  V30 20 F 3.3226 0.9764 0.0 0
M  V30 21 O 6.7599 2.3101 0.0 0
M  V30 22 O 5.4262 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 10
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C23H28N4O7
2387523-23-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.3901 0.0 0
M  V30 2 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 3 O 1.3338 4.6201 0.0 0
M  V30 4 C 4.0011 3.0801 0.0 0
M  V30 5 N 5.3350 5.3901 0.0 0
M  V30 6 C 6.6686 4.6201 0.0 0
M  V30 7 C 8.0023 5.3901 0.0 0
M  V30 8 O 6.6686 3.0801 0.0 0
M  V30 9 N 9.3360 4.6201 0.0 0
M  V30 10 C 10.6698 5.3901 0.0 0
M  V30 11 C 12.0034 4.6201 0.0 0 CFG=2
M  V30 12 O 10.6698 6.9301 0.0 0
M  V30 13 N 13.3371 5.3901 0.0 0
M  V30 14 C 12.0034 3.0801 0.0 0
M  V30 15 C 14.6708 4.6201 0.0 0
M  V30 16 O 10.6698 2.3100 0.0 0
M  V30 17 O 14.6708 3.0801 0.0 0
M  V30 18 C 10.6698 0.7700 0.0 0
M  V30 19 C 4.1841 7.1975 0.0 0
M  V30 20 C 19.9736 5.7471 0.0 0
M  V30 21 C 2.6675 6.9301 0.0 0 CFG=2
M  V30 22 C 1.1509 7.1975 0.0 0
M  V30 23 O 2.1408 8.3771 0.0 0
M  V30 24 C 2.6675 2.3100 0.0 0
M  V30 25 C 2.6675 0.7700 0.0 0
M  V30 26 C 1.3338 3.0801 0.0 0
M  V30 27 C 1.3338 0.0000 0.0 0
M  V30 28 C 0.0000 2.3100 0.0 0
M  V30 29 C 0.0002 0.7700 0.0 0
M  V30 30 C 16.0046 5.3901 0.0 0
M  V30 31 N 16.1655 6.9217 0.0 0
M  V30 32 C 17.4114 4.7636 0.0 0
M  V30 33 O 17.6718 7.2418 0.0 0
M  V30 34 C 18.4419 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=1
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 11 14 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 15 30
M  V30 20 1 16 18
M  V30 21 1 21 19 CFG=3
M  V30 22 1 20 34
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 11 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387522-99-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148157-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
4-Methoxy-1,2-phenylenediamine
C7H10N2O
102-51-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Oxalic acid
C2H2O4
144-62-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dihydro-6-methoxy-2,3-quinoxalinedione
C9H8N2O3
31910-18-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 N 2.6675 3.0801 0.0 0
M  V30 9 N 2.6675 0.0000 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 12
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 102-51-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31910-18-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39000809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and
BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ali, Imran; Cha, Hyung Jin; Lim, Byungho; Chae, Chong Hak; Youm, Jihyun;
Park, Whui Jung; Lee, Sang Ho; Kim, Jung Hwan; Jeong, Docgyun; Lim, Jae
Kyung; Hwang, Yun-Ha; Roe, Jae-Seok; Woo, Jae-Sung; Lee, Kwangho; Choi,
Gildon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 265116052

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C18H31N3O2.C2HF3O2
3056144-83-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5213 6.7238 0.0 0
M  V30 2 C 6.8550 7.4938 0.0 0
M  V30 3 C 8.1887 6.7238 0.0 0
M  V30 4 O 6.8550 9.0338 0.0 0
M  V30 5 N 9.5223 7.4938 0.0 0
M  V30 6 C 10.8562 6.7238 0.0 0
M  V30 7 C 12.1898 7.4938 0.0 0 CFG=1
M  V30 8 O 10.8562 5.1837 0.0 0
M  V30 9 C 13.5235 6.7238 0.0 0
M  V30 10 N 12.1898 9.0338 0.0 0
M  V30 11 C 14.8573 7.4938 0.0 0
M  V30 12 C 16.1910 6.7238 0.0 0
M  V30 13 C 14.8573 9.0338 0.0 0
M  V30 14 C 4.1875 7.4938 0.0 0
M  V30 15 C 2.8994 6.6551 0.0 0
M  V30 16 C 4.2697 9.0286 0.0 0
M  V30 17 C 2.4938 7.5046 0.0 0
M  V30 18 C 1.6936 7.3513 0.0 0
M  V30 19 C 3.0639 9.7248 0.0 0
M  V30 20 C 1.2881 8.2008 0.0 0
M  V30 21 C 0.0000 7.3624 0.0 0
M  V30 22 C 1.7760 8.8861 0.0 0
M  V30 23 C 1.3703 9.7358 0.0 0
M  V30 24 C 7.4287 2.3101 0.0 0
M  V30 25 C 8.7623 1.5400 0.0 0
M  V30 26 F 8.1987 3.6437 0.0 0
M  V30 27 F 6.0950 3.0801 0.0 0
M  V30 28 F 6.6586 0.9764 0.0 0
M  V30 29 O 10.0960 2.3101 0.0 0
M  V30 30 O 8.7623 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 20 21
M  V30 25 1 20 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 25 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H46N4O5
3056144-84-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 14.7866 7.0688 0.0 0
M  V30 2 C 13.4528 6.2987 0.0 0
M  V30 3 C 12.1191 7.0688 0.0 0
M  V30 4 O 13.4528 4.7587 0.0 0
M  V30 5 N 10.7855 6.2987 0.0 0
M  V30 6 C 9.4518 7.0688 0.0 0
M  V30 7 C 8.1180 6.2987 0.0 0 CFG=2
M  V30 8 O 9.4518 8.6088 0.0 0
M  V30 9 N 8.1180 4.7587 0.0 0
M  V30 10 C 6.7843 7.0688 0.0 0
M  V30 11 C 6.7843 3.9887 0.0 0
M  V30 12 C 6.7843 8.6088 0.0 0
M  V30 13 O 5.4506 4.7587 0.0 0
M  V30 14 C 5.4506 9.3788 0.0 0
M  V30 15 C 8.1180 9.3788 0.0 0
M  V30 16 C 4.0737 2.0193 0.0 0
M  V30 17 O 2.9293 0.9889 0.0 0
M  V30 18 O 3.7535 3.5256 0.0 0
M  V30 19 C 1.4646 1.4647 0.0 0
M  V30 20 C 1.9406 2.9293 0.0 0
M  V30 21 C 0.0000 1.9406 0.0 0
M  V30 22 C 0.9887 0.0000 0.0 0
M  V30 23 C 16.1203 6.2987 0.0 0
M  V30 24 C 17.4084 7.1373 0.0 0
M  V30 25 C 16.0381 4.7638 0.0 0
M  V30 26 C 17.8140 6.2878 0.0 0
M  V30 27 C 18.6142 6.4412 0.0 0
M  V30 28 C 17.2439 4.0677 0.0 0
M  V30 29 C 19.0199 5.5917 0.0 0
M  V30 30 C 20.3078 6.4299 0.0 0
M  V30 31 C 18.5318 4.9064 0.0 0
M  V30 32 C 18.9376 4.0566 0.0 0
M  V30 33 C 6.7843 2.4487 0.0 0 CFG=2
M  V30 34 N 5.5384 1.5434 0.0 0
M  V30 35 C 8.0302 1.5434 0.0 0
M  V30 36 C 6.0143 0.0787 0.0 0
M  V30 37 C 7.5543 0.0787 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 33 11 CFG=3
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 34
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 25 28
M  V30 29 1 26 29
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 28 31
M  V30 33 1 28 32
M  V30 34 1 29 30
M  V30 35 1 29 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3056144-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056144-84-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38374432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent
Positive Allosteric Modulators of the D2 Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silva-Reis, Sara C.; Correia, Xavier C.; Costa-Almeida, Hugo F.;
Pires-Lima, Beatriz L.; Maronde, Daiane; Costa, Vera M.; Garcia-Mera,
Xerardo; Cruz, Luis; Brea, Jose; Loza, Maria Isabel; Rodriguez-Borges,
Jose E.; Sampaio-Dias, Ivo E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline
C13H18F3N3
694499-26-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 4.2073 1.5400 0.0 0
M  V30 4 F 2.6673 0.0000 0.0 0
M  V30 5 F 1.1273 1.5400 0.0 0
M  V30 6 N 0.0000 6.1600 0.0 0
M  V30 7 C 10.6694 6.1600 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 3.0800 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 1.3336 5.3900 0.0 0
M  V30 14 N 6.6684 3.8500 0.0 0
M  V30 15 C 6.6684 5.3900 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 N 9.3358 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 9
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-chloro-4-(3-chloropropoxy)-
C10H10Cl2O3
3035807-44-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 Cl 12.0033 4.6201 0.0 0
M  V30 6 Cl 4.0012 6.1601 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-chloro-4-(3-chloropropoxy)-N-[4-[(4-methyl-1-piperazinyl)methyl]...
C23H26Cl2F3N3O2
3035807-32-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 8.0020 1.5400 0.0 0
M  V30 3 F 6.4620 1.5400 0.0 0
M  V30 4 F 8.0020 0.0000 0.0 0
M  V30 5 F 9.5420 1.5400 0.0 0
M  V30 6 N 10.6694 6.1600 0.0 0
M  V30 7 C 10.6694 7.7000 0.0 0
M  V30 8 O 9.3358 8.4700 0.0 0
M  V30 9 C 0.0000 6.1600 0.0 0
M  V30 10 Cl 13.3367 12.3200 0.0 0
M  V30 11 O 16.0041 10.7800 0.0 0
M  V30 12 C 17.3378 10.0100 0.0 0
M  V30 13 C 18.6716 10.7800 0.0 0
M  V30 14 C 20.0052 10.0100 0.0 0
M  V30 15 Cl 21.3389 10.7800 0.0 0
M  V30 16 C 6.6684 3.8500 0.0 0
M  V30 17 C 8.0020 3.0800 0.0 0
M  V30 18 C 6.6684 5.3900 0.0 0
M  V30 19 C 9.3358 3.8500 0.0 0
M  V30 20 C 8.0020 6.1600 0.0 0
M  V30 21 C 9.3358 5.3900 0.0 0
M  V30 22 N 4.0011 3.8500 0.0 0
M  V30 23 C 4.0011 5.3900 0.0 0
M  V30 24 C 2.6673 3.0800 0.0 0
M  V30 25 C 2.6673 6.1600 0.0 0
M  V30 26 C 1.3336 3.8500 0.0 0
M  V30 27 N 1.3336 5.3900 0.0 0
M  V30 28 C 12.0031 8.4700 0.0 0
M  V30 29 C 12.0031 10.0100 0.0 0
M  V30 30 C 13.3367 7.7000 0.0 0
M  V30 31 C 13.3369 10.7800 0.0 0
M  V30 32 C 14.6705 8.4700 0.0 0
M  V30 33 C 14.6705 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 17
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 2 7 8
M  V30 10 1 7 28
M  V30 11 1 9 27
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 1 11 33
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 694499-26-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035807-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035807-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40728204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationship study of new biaryl amide
derivatives and their inhibitory effects against hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yonghua; Li, Jianrui; Gu, Yuxi; Ma, Ling; Cen, Shan; Peng, Zonggen;
Hu, Laixing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 228114033

$RFMT $RIREG SCHEME102 STEP1
$RXN



  3  1
$MOL
2-Amino-4-fluorobenzoic acid
C7H6FNO2
446-32-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamidine acetate
C2H4O2.CH4N2
3473-63-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.8501 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 N 2.6673 4.6201 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 2 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Dimethylamino)-1-propanol
C5H13NO
3179-63-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[3-(Dimethylamino)propoxy]-4(3H)-quinazolinone
C13H17N3O2
557093-50-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 O 6.6685 4.6201 0.0 0
M  V30 3 C 8.0022 3.8501 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 N 12.0033 4.6201 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 C 13.3370 3.8501 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 N 1.3337 4.6201 0.0 0
M  V30 13 C 4.0010 1.5400 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 N 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 446-32-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3179-63-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 557093-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-170-CAS-23304717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical
Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reddy, Julakanti Satyanarayana; Chen, Chih-Ming; Coumar, Mohane Selvaraj;
Sun, Hsu-Yi; Sun, Na; Hsieh, Hsing-Pang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(4), 817-830

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL

C21H29ClFN3O3
3075104-43-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 N 8.4700 5.3347 0.0 0
M  V30 5 O 8.4700 2.6674 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 N 10.0100 5.3347 0.0 0
M  V30 8 C 7.7000 6.6684 0.0 0
M  V30 9 O 3.0800 6.6684 0.0 0
M  V30 10 O 3.0800 4.0011 0.0 0
M  V30 11 C 10.7800 6.6684 0.0 0
M  V30 12 C 1.5400 6.6684 0.0 0
M  V30 13 C 1.5400 8.2084 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 C 1.5400 5.1284 0.0 0
M  V30 16 F 12.3200 9.3358 0.0 0
M  V30 17 Cl 15.4000 9.3358 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 6.1600 1.3336 0.0 0
M  V30 20 C 3.8500 2.6674 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 C 3.0800 1.3336 0.0 0
M  V30 23 C 3.8500 0.0000 0.0 0
M  V30 24 C 12.3200 6.6684 0.0 0
M  V30 25 C 13.0900 8.0021 0.0 0
M  V30 26 C 13.0900 5.3347 0.0 0
M  V30 27 C 14.6300 8.0021 0.0 0
M  V30 28 C 14.6300 5.3347 0.0 0
M  V30 29 C 15.4000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18 CFG=3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 1 9 12
M  V30 13 1 11 24
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 25
M  V30 18 1 17 27
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H40ClFN4O4
3075104-54-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 4.0011 0.0 0 CFG=1
M  V30 2 N 6.1601 4.0011 0.0 0
M  V30 3 C 8.4701 5.3348 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 N 10.0101 5.3348 0.0 0
M  V30 6 O 7.7001 6.6684 0.0 0
M  V30 7 C 3.8500 5.3348 0.0 0 CFG=2
M  V30 8 O 6.1601 6.6684 0.0 0
M  V30 9 N 10.7801 6.6684 0.0 0
M  V30 10 C 10.7801 4.0011 0.0 0
M  V30 11 N 3.0800 6.6684 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 12.3201 6.6684 0.0 0
M  V30 14 C 3.8500 8.0022 0.0 0
M  V30 15 C 4.4137 3.2311 0.0 0
M  V30 16 C 2.3100 2.6675 0.0 0
M  V30 17 C 1.7464 4.7711 0.0 0
M  V30 18 O 3.0800 9.3359 0.0 0
M  V30 19 O 5.3901 8.0022 0.0 0
M  V30 20 C 1.5400 9.3359 0.0 0
M  V30 21 C 1.5400 10.8759 0.0 0
M  V30 22 C 0.0000 9.3359 0.0 0
M  V30 23 C 1.5400 7.7959 0.0 0
M  V30 24 F 15.4002 6.6684 0.0 0
M  V30 25 Cl 16.9402 9.3359 0.0 0
M  V30 26 C 8.4701 2.6675 0.0 0
M  V30 27 C 10.0101 2.6675 0.0 0
M  V30 28 C 7.7001 1.3337 0.0 0
M  V30 29 C 10.7801 1.3337 0.0 0
M  V30 30 C 8.4701 0.0000 0.0 0
M  V30 31 C 10.0101 0.0000 0.0 0
M  V30 32 C 13.0901 8.0022 0.0 0
M  V30 33 C 14.6302 8.0022 0.0 0
M  V30 34 C 12.3201 9.3359 0.0 0
M  V30 35 C 15.4002 9.3359 0.0 0
M  V30 36 C 13.0901 10.6695 0.0 0
M  V30 37 C 14.6302 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 26 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 7 11
M  V30 12 1 7 12 CFG=3
M  V30 13 2 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 32
M  V30 19 1 14 18
M  V30 20 2 14 19
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 24 33
M  V30 26 1 25 35
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 33 2 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 34 36
M  V30 37 2 35 37
M  V30 38 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-43-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Propargylamine
C3H5N
2450-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Difluorophenyl)amino]carbonyl]-1-methyl-α-oxo-1H-pyrrole-3-acetic acid
C14H10F2N2O4
1644485-79-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 2.7106 0.0 0
M  V30 2 N 8.5785 4.0442 0.0 0
M  V30 3 O 8.5785 1.3769 0.0 0
M  V30 4 C 5.8391 0.0000 0.0 0
M  V30 5 C 2.6528 4.3858 0.0 0
M  V30 6 C 1.2459 3.7593 0.0 0
M  V30 7 O 2.8137 5.9173 0.0 0
M  V30 8 O 0.0000 4.6645 0.0 0
M  V30 9 O 1.0849 2.2278 0.0 0
M  V30 10 F 13.1985 6.7117 0.0 0
M  V30 11 F 14.7385 4.0442 0.0 0
M  V30 12 C 6.2684 2.7106 0.0 0
M  V30 13 C 5.3632 3.9564 0.0 0
M  V30 14 N 5.3632 1.4647 0.0 0
M  V30 15 C 3.8987 3.4806 0.0 0
M  V30 16 C 3.8987 1.9406 0.0 0
M  V30 17 C 10.1185 4.0442 0.0 0
M  V30 18 C 10.8885 5.3779 0.0 0
M  V30 19 C 10.8885 2.7106 0.0 0
M  V30 20 C 12.4285 5.3779 0.0 0
M  V30 21 C 12.4285 2.7106 0.0 0
M  V30 22 C 13.1985 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 17
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 10 20
M  V30 12 1 11 22
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Difluorophenyl)amino]carbonyl]-1-methyl-α-oxo-N-2-propyn-1-yl-1H-pyr...
C17H13F2N3O3
2736516-78-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0858 4.3858 0.0 0
M  V30 2 C 13.4926 3.7593 0.0 0
M  V30 3 O 11.9247 5.9173 0.0 0
M  V30 4 N 14.7385 4.6645 0.0 0
M  V30 5 O 13.6536 2.2278 0.0 0
M  V30 6 C 16.1454 4.0382 0.0 0
M  V30 7 C 17.3913 4.9434 0.0 0
M  V30 8 C 18.6372 5.8486 0.0 0
M  V30 9 C 6.9300 2.7106 0.0 0
M  V30 10 N 6.1600 4.0442 0.0 0
M  V30 11 O 6.1600 1.3769 0.0 0
M  V30 12 C 8.8994 0.0000 0.0 0
M  V30 13 F 1.5400 6.7117 0.0 0
M  V30 14 F 0.0000 4.0442 0.0 0
M  V30 15 C 10.8398 3.4806 0.0 0
M  V30 16 C 9.3753 3.9564 0.0 0
M  V30 17 C 10.8398 1.9406 0.0 0
M  V30 18 C 8.4700 2.7106 0.0 0
M  V30 19 N 9.3753 1.4647 0.0 0
M  V30 20 C 4.6200 4.0442 0.0 0
M  V30 21 C 3.8500 5.3779 0.0 0
M  V30 22 C 3.8500 2.7106 0.0 0
M  V30 23 C 2.3100 5.3779 0.0 0
M  V30 24 C 2.3100 2.7106 0.0 0
M  V30 25 C 1.5400 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 18
M  V30 12 1 10 20
M  V30 13 1 12 19
M  V30 14 1 13 23
M  V30 15 1 14 25
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2450-71-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1644485-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2736516-78-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24782811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structure activity relationship of glyoxamide derivatives
as anti-hepatitis B virus agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amblard, Franck; Boucle, Sebastien; Bassit, Leda; Chen, Zhe; Sari, Ozkan;
Cox, Bryan; Verma, Kiran; Ozturk, Tugba; Ollinger-Russell, Olivia;
Schinazi, Raymond F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 31115952

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Allylamine
C3H7N
107-11-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 N 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Difluorophenyl)amino]carbonyl]-1-methyl-α-oxo-1H-pyrrole-3-acetic acid
C14H10F2N2O4
1644485-79-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 2.7106 0.0 0
M  V30 2 N 8.5785 4.0442 0.0 0
M  V30 3 O 8.5785 1.3769 0.0 0
M  V30 4 C 5.8391 0.0000 0.0 0
M  V30 5 C 2.6528 4.3858 0.0 0
M  V30 6 C 1.2459 3.7593 0.0 0
M  V30 7 O 2.8137 5.9173 0.0 0
M  V30 8 O 0.0000 4.6645 0.0 0
M  V30 9 O 1.0849 2.2278 0.0 0
M  V30 10 F 13.1985 6.7117 0.0 0
M  V30 11 F 14.7385 4.0442 0.0 0
M  V30 12 C 6.2684 2.7106 0.0 0
M  V30 13 C 5.3632 3.9564 0.0 0
M  V30 14 N 5.3632 1.4647 0.0 0
M  V30 15 C 3.8987 3.4806 0.0 0
M  V30 16 C 3.8987 1.9406 0.0 0
M  V30 17 C 10.1185 4.0442 0.0 0
M  V30 18 C 10.8885 5.3779 0.0 0
M  V30 19 C 10.8885 2.7106 0.0 0
M  V30 20 C 12.4285 5.3779 0.0 0
M  V30 21 C 12.4285 2.7106 0.0 0
M  V30 22 C 13.1985 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 17
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 10 20
M  V30 12 1 11 22
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-acetamide, 5-[[(3,4-difluorophenyl)amino]carbonyl]-1-methyl-α-ox...
C17H15F2N3O3
2133017-44-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0858 4.3858 0.0 0
M  V30 2 C 13.4926 3.7593 0.0 0
M  V30 3 O 11.9249 5.9173 0.0 0
M  V30 4 N 14.7386 4.6645 0.0 0
M  V30 5 O 13.6537 2.2278 0.0 0
M  V30 6 C 16.1454 4.0382 0.0 0
M  V30 7 C 17.3913 4.9434 0.0 0
M  V30 8 C 18.7983 4.3169 0.0 0
M  V30 9 C 6.9300 2.7106 0.0 0
M  V30 10 N 6.1600 4.0442 0.0 0
M  V30 11 O 6.1600 1.3769 0.0 0
M  V30 12 C 8.8994 0.0000 0.0 0
M  V30 13 F 1.5400 6.7117 0.0 0
M  V30 14 F 0.0000 4.0442 0.0 0
M  V30 15 C 10.8400 3.4806 0.0 0
M  V30 16 C 9.3753 3.9564 0.0 0
M  V30 17 C 10.8400 1.9406 0.0 0
M  V30 18 C 8.4700 2.7106 0.0 0
M  V30 19 N 9.3753 1.4647 0.0 0
M  V30 20 C 4.6200 4.0442 0.0 0
M  V30 21 C 3.8500 5.3779 0.0 0
M  V30 22 C 3.8500 2.7106 0.0 0
M  V30 23 C 2.3100 5.3779 0.0 0
M  V30 24 C 2.3100 2.7106 0.0 0
M  V30 25 C 1.5400 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 18
M  V30 12 1 10 20
M  V30 13 1 12 19
M  V30 14 1 13 23
M  V30 15 1 14 25
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-11-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1644485-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2133017-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24782812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structure activity relationship of glyoxamide derivatives
as anti-hepatitis B virus agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amblard, Franck; Boucle, Sebastien; Bassit, Leda; Chen, Zhe; Sari, Ozkan;
Cox, Bryan; Verma, Kiran; Ozturk, Tugba; Ollinger-Russell, Olivia;
Schinazi, Raymond F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 31115952

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
5-[2-Chloro-4-(trifluoromethyl)phenyl]-1-methyl-1H-pyrazole-3-carboxylic acid
C12H8ClF3N2O2
1898075-33-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1294 0.0000 0.0 0
M  V30 2 Cl 6.1600 5.3779 0.0 0
M  V30 3 C 11.3158 4.3858 0.0 0
M  V30 4 O 11.1547 5.9173 0.0 0
M  V30 5 O 12.7226 3.7593 0.0 0
M  V30 6 C 1.5400 2.7106 0.0 0
M  V30 7 F 1.5400 1.1706 0.0 0
M  V30 8 F 0.0000 2.7106 0.0 0
M  V30 9 F 1.5400 4.2506 0.0 0
M  V30 10 C 7.7000 2.7106 0.0 0
M  V30 11 C 8.6053 3.9564 0.0 0
M  V30 12 N 8.6053 1.4647 0.0 0
M  V30 13 C 10.0698 3.4806 0.0 0
M  V30 14 N 10.0698 1.9406 0.0 0
M  V30 15 C 6.1600 2.7106 0.0 0
M  V30 16 C 5.3900 4.0442 0.0 0
M  V30 17 C 5.3900 1.3769 0.0 0
M  V30 18 C 3.8500 4.0442 0.0 0
M  V30 19 C 3.8500 1.3769 0.0 0
M  V30 20 C 3.0800 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 20
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-1-methylpiperidine
C6H14N2
42389-57-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 3.0800 0.0 0
M  V30 2 C 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 N 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[2-chloro-4-(trifluoromethyl)phenyl]-1-methyl-N-...
C18H20ClF3N4O
2919850-96-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1294 0.0000 0.0 0
M  V30 2 Cl 6.1600 5.3778 0.0 0
M  V30 3 C 11.3158 4.3858 0.0 0
M  V30 4 N 12.7226 3.7593 0.0 0
M  V30 5 O 11.1548 5.9173 0.0 0
M  V30 6 C 1.5400 2.7106 0.0 0
M  V30 7 F 1.5400 4.2506 0.0 0
M  V30 8 F 0.0000 2.7106 0.0 0
M  V30 9 F 1.5400 1.1706 0.0 0
M  V30 10 C 18.0282 4.3169 0.0 0
M  V30 11 C 7.7000 2.7106 0.0 0
M  V30 12 C 8.6052 3.9564 0.0 0
M  V30 13 N 8.6052 1.4645 0.0 0
M  V30 14 C 10.0699 3.4806 0.0 0
M  V30 15 N 10.0699 1.9406 0.0 0
M  V30 16 C 6.1600 2.7106 0.0 0
M  V30 17 C 5.3900 4.0442 0.0 0
M  V30 18 C 5.3900 1.3768 0.0 0
M  V30 19 C 3.8500 4.0442 0.0 0
M  V30 20 C 3.8500 1.3768 0.0 0
M  V30 21 C 3.0800 2.7106 0.0 0
M  V30 22 C 13.9686 4.6645 0.0 0
M  V30 23 C 15.3754 4.0382 0.0 0
M  V30 24 C 13.8075 6.1960 0.0 0
M  V30 25 N 16.6212 4.9432 0.0 0
M  V30 26 C 15.0533 7.1012 0.0 0
M  V30 27 C 16.4603 6.4749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 21
M  V30 11 1 10 25
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1898075-33-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42389-57-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919850-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37690229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic
Receptor Antagonist for the Modulation of Motor Dysfunction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Christie, Louisa A.; Brice, Nicola L.; Rowland, Anna; Dickson, Louise;
Anand, Rishi; Teall, Martin; Doyle, Kevin J.; Narayana, Lakshminarayana;
Mitchell, Christine; Harvey, Jenna R. M.; Mulligan, Victoria; Dawson, Lee
A.; Cragg, Stephanie J.; Carlton, Mark; Burli, Roland W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(17), 11718-11731

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
2H-Thiopyran-3-carboxylic acid, tetrahydro-, 1,1-dioxide
C6H10O4S
167011-35-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 1.5400 0.0 0
M  V30 2 O 5.5177 0.0000 0.0 0
M  V30 3 O 6.8515 2.3100 0.0 0
M  V30 4 O 0.0000 2.5773 0.0 0
M  V30 5 O 0.9899 0.8629 0.0 0
M  V30 6 C 4.1840 2.3100 0.0 0
M  V30 7 C 2.8504 1.5400 0.0 0
M  V30 8 C 4.1840 3.8500 0.0 0
M  V30 9 S 1.5167 2.3100 0.0 0 VAL=6
M  V30 10 C 2.8504 4.6200 0.0 0
M  V30 11 C 1.5167 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 9
M  V30 5 2 5 9
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-amino-2-methoxy-5-(methylamino)phenyl]carbamate
C13H21N3O3
2217628-26-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 5.3901 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 O 8.0023 5.3901 0.0 0
M  V30 4 O 6.6685 3.0801 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.5660 3.2864 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 10.1060 5.9538 0.0 0
M  V30 9 O 2.6673 6.9302 0.0 0
M  V30 10 C 1.3337 7.7002 0.0 0
M  V30 11 N 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 N 0.0000 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 1.3337 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H29N3O6S
3032481-79-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.8516 5.3901 0.0 0
M  V30 2 C 5.5178 4.6201 0.0 0
M  V30 3 O 5.5178 3.0801 0.0 0
M  V30 4 N 9.5189 6.9302 0.0 0
M  V30 5 C 10.8526 7.7002 0.0 0
M  V30 6 O 9.5189 0.7700 0.0 0
M  V30 7 C 8.1853 0.0000 0.0 0
M  V30 8 N 12.1864 2.3101 0.0 0
M  V30 9 C 13.5201 3.0801 0.0 0
M  V30 10 O 14.8538 2.3101 0.0 0
M  V30 11 O 13.5201 4.6201 0.0 0
M  V30 12 C 16.1874 3.0801 0.0 0
M  V30 13 C 16.9575 1.7464 0.0 0
M  V30 14 C 17.5213 3.8501 0.0 0
M  V30 15 C 15.4174 4.4137 0.0 0
M  V30 16 O 0.0000 5.6575 0.0 0
M  V30 17 O 0.9899 3.9429 0.0 0
M  V30 18 C 8.1853 4.6201 0.0 0
M  V30 19 C 9.5189 5.3901 0.0 0
M  V30 20 C 8.1853 3.0801 0.0 0
M  V30 21 C 10.8526 4.6201 0.0 0
M  V30 22 C 9.5189 2.3101 0.0 0
M  V30 23 C 10.8526 3.0801 0.0 0
M  V30 24 C 4.1841 5.3901 0.0 0
M  V30 25 C 2.8504 4.6201 0.0 0
M  V30 26 C 4.1841 6.9302 0.0 0
M  V30 27 S 1.5168 5.3901 0.0 0 VAL=6
M  V30 28 C 2.8504 7.7002 0.0 0
M  V30 29 C 1.5168 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 8 9
M  V30 10 1 8 23
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 27
M  V30 18 2 17 27
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 167011-35-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2217628-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032481-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bothe, Ulrich; Guenther, Judith; Nubbemeyer, Reinhard; Siebeneicher,
Holger; Ring, Sven; Boemer, Ulf; Peters, Michaele; Rausch, Alexandra;
Denner, Karsten; Himmel, Herbert; Sutter, Andreas; Terebesi, Ildiko;
Lange, Martin; Wengner, Antje M.; Guimond, Nicolas; Thaler, Tobias;
Platzek, Johannes; Eberspaecher, Uwe; Schaefer, Martina; Steuber, Holger;
Zollner, Thomas M.; Steinmeyer, Andreas; Schmidt, Nicole
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1225-1242

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
1-(3-Cyanophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
C12H6F3N3O2
209917-93-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9735 6.7983 0.0 0
M  V30 2 O 0.5088 7.2743 0.0 0
M  V30 3 O 3.1179 7.8289 0.0 0
M  V30 4 C 1.4068 1.4070 0.0 0
M  V30 5 F 2.8136 0.7805 0.0 0
M  V30 6 F 0.7805 0.0000 0.0 0
M  V30 7 F 0.0000 2.0333 0.0 0
M  V30 8 C 9.0353 4.6657 0.0 0
M  V30 9 N 10.3690 3.8956 0.0 0
M  V30 10 N 3.7005 4.6657 0.0 0
M  V30 11 C 2.2937 5.2920 0.0 0
M  V30 12 N 3.5396 3.1339 0.0 0
M  V30 13 C 1.2631 4.1474 0.0 0
M  V30 14 C 2.0331 2.8138 0.0 0
M  V30 15 C 5.0342 5.4357 0.0 0
M  V30 16 C 6.3680 4.6657 0.0 0
M  V30 17 C 5.0342 6.9757 0.0 0
M  V30 18 C 7.7017 5.4357 0.0 0
M  V30 19 C 6.3680 7.7457 0.0 0
M  V30 20 C 7.7017 6.9757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14
M  V30 8 3 8 9
M  V30 9 1 8 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-fluorobenzenemethanol
C7H8FNO
1565613-80-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 6.6686 3.8500 0.0 0
M  V30 3 F 2.6675 0.0000 0.0 0
M  V30 4 N 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Cyanophenyl)-N-[3-fluoro-5-(hydroxymethyl)phenyl]-3-(trifluoromethyl)-1H...
C19H12F4N4O2
1809016-27-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 6.8342 0.0 0
M  V30 2 N 5.3901 6.8342 0.0 0
M  V30 3 O 7.7002 8.1679 0.0 0
M  V30 4 C 8.0573 1.5316 0.0 0
M  V30 5 F 9.5889 1.3706 0.0 0
M  V30 6 F 7.8962 0.0000 0.0 0
M  V30 7 F 6.5256 1.6925 0.0 0
M  V30 8 C 14.3055 6.9881 0.0 0
M  V30 9 N 15.8118 6.6679 0.0 0
M  V30 10 C 0.7700 9.5017 0.0 0
M  V30 11 O 0.0000 10.8354 0.0 0
M  V30 12 F 5.3901 12.1690 0.0 0
M  V30 13 N 9.2317 5.3396 0.0 0
M  V30 14 C 7.7002 5.5005 0.0 0
M  V30 15 N 9.5519 3.8331 0.0 0
M  V30 16 C 7.0738 4.0937 0.0 0
M  V30 17 C 8.2182 3.0631 0.0 0
M  V30 18 C 10.2622 6.4840 0.0 0
M  V30 19 C 11.7686 6.1638 0.0 0
M  V30 20 C 9.7863 7.9487 0.0 0
M  V30 21 C 12.7991 7.3082 0.0 0
M  V30 22 C 10.8169 9.0931 0.0 0
M  V30 23 C 12.3232 8.7730 0.0 0
M  V30 24 C 4.6201 8.1679 0.0 0
M  V30 25 C 3.0801 8.1679 0.0 0
M  V30 26 C 5.3901 9.5017 0.0 0
M  V30 27 C 2.3101 9.5017 0.0 0
M  V30 28 C 4.6201 10.8354 0.0 0
M  V30 29 C 3.0801 10.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 17
M  V30 9 3 8 9
M  V30 10 1 8 21
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 209917-93-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1565613-80-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809016-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34105912
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 132705-51-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective,
and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary
Angioedema (HAE)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kotian, Pravin L.; Wu, Minwan; Vadlakonda, Satish; Chintareddy, Venkat;
Lu, Pengcheng; Juarez, Luis; Kellogg-Yelder, Debra; Chen, Xilin; Muppa,
Saritha; Chambers-Wilson, Ramanda; Davis Parker, Cynthia; Williams,
Jason; Polach, Kevin J.; Zhang, Weihe; Raman, Krishnan; Babu, Yarlagadda
S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(17), 12453-12468

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cycloheptene...
C22H15F2NO3
1417404-28-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6505 1.9730 0.0 0
M  V30 2 C 1.5357 1.3874 0.0 0
M  V30 3 O 0.0000 1.5026 0.0 0
M  V30 4 O 2.2039 0.0000 0.0 0
M  V30 5 N 11.5129 6.7446 0.0 0
M  V30 6 F 14.1802 8.2846 0.0 0
M  V30 7 F 16.8476 3.6646 0.0 0
M  V30 8 C 4.8065 3.8172 0.0 0
M  V30 9 C 4.1383 5.2046 0.0 0
M  V30 10 C 6.3078 3.4745 0.0 0
M  V30 11 C 3.9389 2.5447 0.0 0
M  V30 12 C 4.8065 6.5921 0.0 0
M  V30 13 C 2.6026 5.3198 0.0 0
M  V30 14 C 7.5118 4.4346 0.0 0
M  V30 15 C 2.4032 2.6599 0.0 0
M  V30 16 C 6.3078 6.9348 0.0 0
M  V30 17 C 1.7350 4.0473 0.0 0
M  V30 18 C 7.5118 5.9746 0.0 0
M  V30 19 C 8.8455 3.6646 0.0 0
M  V30 20 C 8.8455 6.7446 0.0 0
M  V30 21 C 10.1792 4.4346 0.0 0
M  V30 22 C 10.1792 5.9746 0.0 0
M  V30 23 C 12.8465 5.9746 0.0 0
M  V30 24 C 14.1802 6.7446 0.0 0
M  V30 25 C 12.8465 4.4346 0.0 0
M  V30 26 C 15.5140 5.9746 0.0 0
M  V30 27 C 14.1802 3.6646 0.0 0
M  V30 28 C 15.5140 4.4346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 22
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylalanine, methyl ester, hydrochloride (1:1)
C10H13NO2.ClH
5619-07-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 5.3347 5.3900 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 O 6.6684 1.5400 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 Cl 4.6679 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cyclohep...
C32H26F2N2O4
2614242-25-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.5308 2.9283 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 N 5.3347 5.3900 0.0 0
M  V30 4 O 6.6684 3.0800 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 6 C 4.0009 3.0800 0.0 0
M  V30 7 C 2.6673 5.3900 0.0 0
M  V30 8 O 2.6673 6.9300 0.0 0
M  V30 9 O 1.3336 4.6200 0.0 0
M  V30 10 C 1.3336 7.7000 0.0 0
M  V30 11 N 17.9819 5.1177 0.0 0
M  V30 12 F 21.0534 5.3478 0.0 0
M  V30 13 F 21.4520 0.0280 0.0 0
M  V30 14 C 10.6695 5.3900 0.0 0
M  V30 15 C 10.6695 6.9300 0.0 0
M  V30 16 C 11.8734 4.4298 0.0 0
M  V30 17 C 9.3358 4.6200 0.0 0
M  V30 18 C 11.8734 7.8901 0.0 0
M  V30 19 C 9.3358 7.7000 0.0 0
M  V30 20 C 13.3748 4.7725 0.0 0
M  V30 21 C 8.0020 5.3900 0.0 0
M  V30 22 C 13.3748 7.5474 0.0 0
M  V30 23 C 8.0020 6.9300 0.0 0
M  V30 24 C 14.0430 6.1600 0.0 0
M  V30 25 C 14.2424 3.5000 0.0 0
M  V30 26 C 15.5787 6.2751 0.0 0
M  V30 27 C 15.7781 3.6152 0.0 0
M  V30 28 C 16.4462 5.0026 0.0 0
M  V30 29 C 18.8495 3.8452 0.0 0
M  V30 30 C 20.3852 3.9604 0.0 0
M  V30 31 C 18.1813 2.4578 0.0 0
M  V30 32 C 21.2527 2.6879 0.0 0
M  V30 33 C 19.0488 1.1853 0.0 0
M  V30 34 C 20.5845 1.3005 0.0 0
M  V30 35 C 2.6673 2.3100 0.0 0
M  V30 36 C 1.3336 3.0800 0.0 0
M  V30 37 C 2.6673 0.7700 0.0 0
M  V30 38 C 0.0000 2.3100 0.0 0
M  V30 39 C 1.3336 0.0000 0.0 0
M  V30 40 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 35
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 28
M  V30 13 1 11 29
M  V30 14 1 12 30
M  V30 15 1 13 34
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 2 20 25
M  V30 27 2 21 23
M  V30 28 1 22 24
M  V30 29 2 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1417404-28-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5619-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614242-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31188014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Highly Selective Brain Penetrant p38α
Mitogen-Activated Protein Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tormaehlen, Niklas M.; Martorelli, Mariella; Kuhn, Annette; Maier,
Florian; Guezguez, Jamil; Burnet, Michael; Albrecht, Wolfgang; Laufer,
Stefan A.; Koch, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(2), 1225-1242

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-(4-aminophenyl)cyclopropyl]carbamate
C14H20N2O2
1642574-87-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 2.8736 0.0 0
M  V30 2 C 3.8500 2.8736 0.0 0
M  V30 3 O 3.0800 1.5400 0.0 0
M  V30 4 O 3.0800 4.2073 0.0 0
M  V30 5 C 1.5400 1.5400 0.0 0
M  V30 6 C 1.5400 3.0800 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 N 13.6536 4.9773 0.0 0
M  V30 10 C 7.4936 4.9773 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 5.7473 0.0 0
M  V30 13 C 9.0336 4.9773 0.0 0
M  V30 14 C 9.8036 6.3109 0.0 0
M  V30 15 C 9.8036 3.6436 0.0 0
M  V30 16 C 11.3436 6.3109 0.0 0
M  V30 17 C 11.3436 3.6436 0.0 0
M  V30 18 C 12.1136 4.9773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(Phenylmethoxy)carbonyl]amino][1,1′-biphenyl]-4-carboxylic acid
C21H17NO4
2414144-46-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 O 9.2400 5.3347 0.0 0
M  V30 4 O 6.9300 6.6684 0.0 0
M  V30 5 C 10.0100 6.6684 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 O 6.9300 1.3336 0.0 0
M  V30 8 O 4.6200 0.0000 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 3.0800 2.6674 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 6.6684 0.0 0
M  V30 16 C 3.0800 8.0021 0.0 0
M  V30 17 C 0.7700 6.6684 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 C 0.7700 9.3358 0.0 0
M  V30 21 C 11.5500 6.6684 0.0 0
M  V30 22 C 12.3200 5.3347 0.0 0
M  V30 23 C 12.3200 8.0021 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 25 C 13.8600 8.0021 0.0 0
M  V30 26 C 14.6300 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 10
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C35H35N3O5
2414142-57-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 18.2736 14.1067 0.0 0
M  V30 2 C 19.8136 14.1067 0.0 0
M  V30 3 O 20.5836 15.4403 0.0 0
M  V30 4 O 20.5836 12.7731 0.0 0
M  V30 5 C 22.1236 15.4403 0.0 0
M  V30 6 C 22.1236 13.9003 0.0 0
M  V30 7 C 23.6636 15.4403 0.0 0
M  V30 8 C 22.1236 16.9803 0.0 0
M  V30 9 N 10.0100 12.0031 0.0 0
M  V30 10 C 9.2400 10.6694 0.0 0
M  V30 11 O 10.0100 9.3356 0.0 0
M  V30 12 N 7.7000 8.0020 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 O 7.7000 5.3347 0.0 0
M  V30 15 O 5.3900 6.6684 0.0 0
M  V30 16 C 6.9300 4.0009 0.0 0
M  V30 17 C 16.1700 12.0031 0.0 0
M  V30 18 C 17.5036 12.7731 0.0 0
M  V30 19 C 17.5036 11.2331 0.0 0
M  V30 20 C 14.6300 12.0031 0.0 0
M  V30 21 C 13.8600 10.6694 0.0 0
M  V30 22 C 13.8600 13.3367 0.0 0
M  V30 23 C 12.3200 10.6694 0.0 0
M  V30 24 C 12.3200 13.3367 0.0 0
M  V30 25 C 11.5500 12.0031 0.0 0
M  V30 26 C 7.7000 10.6694 0.0 0
M  V30 27 C 6.9300 9.3356 0.0 0
M  V30 28 C 6.9300 12.0031 0.0 0
M  V30 29 C 5.3900 9.3356 0.0 0
M  V30 30 C 5.3900 12.0031 0.0 0
M  V30 31 C 4.6200 10.6694 0.0 0
M  V30 32 C 3.0800 10.6694 0.0 0
M  V30 33 C 2.3100 9.3356 0.0 0
M  V30 34 C 2.3100 12.0031 0.0 0
M  V30 35 C 0.7700 9.3356 0.0 0
M  V30 36 C 0.7700 12.0031 0.0 0
M  V30 37 C 0.0000 10.6694 0.0 0
M  V30 38 C 7.7000 2.6673 0.0 0
M  V30 39 C 9.2400 2.6673 0.0 0
M  V30 40 C 6.9300 1.3336 0.0 0
M  V30 41 C 10.0100 1.3336 0.0 0
M  V30 42 C 7.7000 0.0000 0.0 0
M  V30 43 C 9.2400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 2 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 38
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 31 32
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1642574-87-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2414144-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414142-57-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22568850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships,
Antiproliferative Effects in Leukemia, and Gene Target Modulation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fioravanti, Rossella; Romanelli, Annalisa; Mautone, Nicola; Di Bello,
Elisabetta; Rovere, Annarita; Corinti, Davide; Zwergel, Clemens; Valente,
Sergio; Rotili, Dante; Botrugno, Oronza A.; Dessanti, Paola; Vultaggio,
Stefania; Vianello, Paola; Cappa, Anna; Binda, Claudia; Mattevi, Andrea;
Minucci, Saverio; Mercurio, Ciro; Varasi, Mario; Mai, Antonello
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(7), 643-658

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 2-amino-4,5-dimethoxy-, methyl ester
C10H13NO4
26759-46-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 N 4.0012 6.9302 0.0 0
M  V30 6 O 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[3,4′-Bipyridazine]-6-carboxylic acid
C9H6N4O2
2913152-05-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 C 4.6201 0.0000 0.0 0
M  V30 6 N 4.6201 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 N 3.0801 2.6673 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 6.9302 1.3337 0.0 0
M  V30 11 C 7.7002 2.6673 0.0 0
M  V30 12 C 7.7002 0.0000 0.0 0
M  V30 13 C 9.2402 2.6673 0.0 0
M  V30 14 N 9.2402 0.0000 0.0 0
M  V30 15 N 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-[([3,4′-bipyridazin]-6-ylcarbonyl)amino]-4,5-dimethoxy-, meth...
C19H17N5O5
2913152-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.3347 0.0 0
M  V30 2 C 7.7000 6.6684 0.0 0
M  V30 3 O 6.9300 8.0021 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 O 4.6200 1.3336 0.0 0
M  V30 6 O 6.9300 2.6674 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 2.3100 8.0021 0.0 0
M  V30 9 C 3.0800 9.3358 0.0 0
M  V30 10 O 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 4.6200 6.6684 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 9.2400 6.6684 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 N 10.0100 8.0021 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 N 11.5500 8.0021 0.0 0
M  V30 23 C 12.3200 6.6684 0.0 0
M  V30 24 C 13.8600 6.6684 0.0 0
M  V30 25 C 14.6300 8.0021 0.0 0
M  V30 26 C 14.6300 5.3347 0.0 0
M  V30 27 C 16.1700 8.0021 0.0 0
M  V30 28 N 16.1700 5.3347 0.0 0
M  V30 29 N 16.9400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 16
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 26759-46-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2913152-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2913152-10-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35647838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives
as Stimulator of Interferon Genes (STING) Receptor Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shan, Bin; Hou, Hui; Zhang, Keke; Li, Rui; Shen, Chang; Chen, Zhengyang;
Xu, Peijia; Cui, Rongrong; Su, Zhaoming; Zhang, Changfa; Yang, Ruirui;
Zhou, Guizhen; Liu, Yadan; Guo, Hao; Chen, Kaixian; Fu, Wei; Jiang,
Hualiang; Zhang, Sulin; Zheng, Mingyue
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(5), 3327-3347

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL

C22H26ClN3O3
3075103-43-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 N 5.3900 6.6685 0.0 0
M  V30 5 N 8.4700 6.6685 0.0 0
M  V30 6 O 8.4700 4.0011 0.0 0
M  V30 7 C 3.8500 6.6685 0.0 0
M  V30 8 N 10.0100 6.6685 0.0 0
M  V30 9 C 7.7000 8.0021 0.0 0
M  V30 10 O 3.0800 8.0021 0.0 0
M  V30 11 O 3.0800 5.3347 0.0 0
M  V30 12 C 10.7800 8.0021 0.0 0
M  V30 13 C 1.5400 8.0021 0.0 0
M  V30 14 C 1.5400 9.5421 0.0 0
M  V30 15 C 0.0000 8.0021 0.0 0
M  V30 16 C 1.5400 6.4621 0.0 0
M  V30 17 Cl 16.9400 8.0021 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 7.7000 2.6674 0.0 0
M  V30 20 C 5.3900 1.3336 0.0 0
M  V30 21 C 8.4700 1.3336 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 23 C 7.7000 0.0000 0.0 0
M  V30 24 C 12.3200 8.0021 0.0 0
M  V30 25 C 13.0900 9.3358 0.0 0
M  V30 26 C 13.0900 6.6685 0.0 0
M  V30 27 C 14.6300 9.3358 0.0 0
M  V30 28 C 14.6300 6.6685 0.0 0
M  V30 29 C 15.4000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 29
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2,4-Dichlorophenoxy)acetic acid
C8H6Cl2O3
94-75-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 8.0021 0.0000 0.0 0
M  V30 5 O 9.3358 2.3100 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 Cl 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[2-(2,4-dichlorophenoxy)acetyl]-, (2E)-2-[(4-chlorophenyl)...
C25H22Cl3N3O3
3075103-52-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 7.7000 0.0 0 CFG=2
M  V30 2 C 8.0021 9.2400 0.0 0
M  V30 3 C 6.6684 6.9300 0.0 0
M  V30 4 N 9.3358 6.9300 0.0 0
M  V30 5 N 6.6684 5.3900 0.0 0
M  V30 6 O 5.3347 7.7000 0.0 0
M  V30 7 C 10.6694 7.7000 0.0 0
M  V30 8 N 5.3347 4.6200 0.0 0
M  V30 9 C 8.0021 4.6200 0.0 0
M  V30 10 C 12.0032 6.9300 0.0 0
M  V30 11 O 10.6694 9.2400 0.0 0
M  V30 12 C 5.3347 3.0800 0.0 0
M  V30 13 O 13.3369 7.7000 0.0 0
M  V30 14 Cl 16.0041 9.2400 0.0 0
M  V30 15 Cl 0.0000 0.0000 0.0 0
M  V30 16 Cl 18.6716 4.6200 0.0 0
M  V30 17 C 6.6684 10.0100 0.0 0
M  V30 18 C 6.6684 11.5500 0.0 0
M  V30 19 C 5.3347 9.2400 0.0 0
M  V30 20 C 5.3347 12.3200 0.0 0
M  V30 21 C 4.0011 10.0100 0.0 0
M  V30 22 C 4.0011 11.5500 0.0 0
M  V30 23 C 4.0011 2.3100 0.0 0
M  V30 24 C 2.6674 3.0800 0.0 0
M  V30 25 C 4.0011 0.7700 0.0 0
M  V30 26 C 1.3336 2.3100 0.0 0
M  V30 27 C 2.6674 0.0000 0.0 0
M  V30 28 C 1.3336 0.7700 0.0 0
M  V30 29 C 14.6705 6.9300 0.0 0
M  V30 30 C 16.0041 7.7000 0.0 0
M  V30 31 C 14.6705 5.3900 0.0 0
M  V30 32 C 17.3379 6.9300 0.0 0
M  V30 33 C 16.0041 4.6200 0.0 0
M  V30 34 C 17.3379 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 23
M  V30 15 1 13 29
M  V30 16 1 14 30
M  V30 17 1 15 28
M  V30 18 1 16 34
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075103-43-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94-75-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075103-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
L-Alanine, 3-(methylsulfonyl)-N-[(1S)-2,2,2-trifluoro-1-(4-nitrophenyl)ethyl]-
C12H13F3N2O6S
3085792-03-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0 CFG=1
M  V30 2 N 5.3901 2.6675 0.0 0
M  V30 3 C 5.3901 5.3348 0.0 0
M  V30 4 C 3.8500 2.6675 0.0 0 CFG=2
M  V30 5 F 4.6201 6.6686 0.0 0
M  V30 6 F 6.7237 6.1048 0.0 0
M  V30 7 F 4.0564 4.5648 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 S 1.5400 4.0011 0.0 0 VAL=6
M  V30 11 O 3.8500 0.0000 0.0 0
M  V30 12 O 1.5400 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 O 1.5400 2.4611 0.0 0
M  V30 15 O 1.5400 5.5411 0.0 0
M  V30 16 N 12.3201 4.0011 0.0 0 VAL=5
M  V30 17 O 13.0901 5.3348 0.0 0
M  V30 18 O 13.0901 2.6675 0.0 0
M  V30 19 C 7.7001 4.0011 0.0 0
M  V30 20 C 8.4701 2.6675 0.0 0
M  V30 21 C 8.4701 5.3348 0.0 0
M  V30 22 C 10.0101 2.6675 0.0 0
M  V30 23 C 10.0101 5.3348 0.0 0
M  V30 24 C 10.7801 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8 CFG=3
M  V30 9 1 4 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 10 15
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-2-Amino-3-(phenylmethoxy)propanenitrile
C10H12N2O
645394-47-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 2.6674 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 7.7000 1.3338 0.0 0 CFG=2
M  V30 5 C 9.2400 1.3338 0.0 0
M  V30 6 N 6.9300 0.0000 0.0 0
M  V30 7 N 10.7800 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 3 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Propanamide, N-[(1R)-1-cyano-2-(phenylmethoxy)ethyl]-3-(methylsulfonyl)-2-[[(...
C22H23F3N4O6S
3085792-16-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.6685 0.0 0 CFG=1
M  V30 2 N 6.1601 6.6685 0.0 0
M  V30 3 C 3.8501 8.0022 0.0 0
M  V30 4 C 6.9302 8.0022 0.0 0 CFG=1
M  V30 5 F 3.0801 9.3360 0.0 0
M  V30 6 F 2.5164 7.2322 0.0 0
M  V30 7 F 5.1838 8.7722 0.0 0
M  V30 8 C 8.4702 8.0022 0.0 0
M  V30 9 C 6.1601 9.3360 0.0 0
M  V30 10 N 9.2402 6.6685 0.0 0
M  V30 11 O 9.2402 9.3360 0.0 0
M  V30 12 S 6.9302 10.6697 0.0 0 VAL=6
M  V30 13 C 10.7802 6.6685 0.0 0 CFG=2
M  V30 14 C 7.7002 12.0033 0.0 0
M  V30 15 O 5.5965 11.4397 0.0 0
M  V30 16 O 8.2638 9.8996 0.0 0
M  V30 17 C 11.5503 5.3348 0.0 0
M  V30 18 C 11.5503 8.0022 0.0 0
M  V30 19 O 13.0903 5.3348 0.0 0
M  V30 20 N 12.3203 9.3360 0.0 0
M  V30 21 C 13.8603 4.0012 0.0 0
M  V30 22 N 1.5400 1.3337 0.0 0 VAL=5
M  V30 23 O 2.3101 0.0000 0.0 0
M  V30 24 O 0.0000 1.3337 0.0 0
M  V30 25 C 3.8501 5.3348 0.0 0
M  V30 26 C 4.6201 4.0012 0.0 0
M  V30 27 C 2.3101 5.3348 0.0 0
M  V30 28 C 3.8501 2.6673 0.0 0
M  V30 29 C 1.5400 4.0012 0.0 0
M  V30 30 C 2.3101 2.6673 0.0 0
M  V30 31 C 15.4003 4.0012 0.0 0
M  V30 32 C 16.1704 2.6673 0.0 0
M  V30 33 C 16.1704 5.3348 0.0 0
M  V30 34 C 17.7104 2.6673 0.0 0
M  V30 35 C 17.7104 5.3348 0.0 0
M  V30 36 C 18.4804 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 4 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17 CFG=3
M  V30 18 1 13 18
M  V30 19 1 17 19
M  V30 20 3 18 20
M  V30 21 1 19 21
M  V30 22 1 21 31
M  V30 23 2 22 23
M  V30 24 2 22 24
M  V30 25 1 22 30
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 4 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3085792-03-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 645394-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085792-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41033879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-75-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on
Affinity, Selectivity, and Permeability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meta, Mergim; Zimmer, Collin; Fuchs, Natalie; Zecher, Maximilian
Johannes; Lahu, Albin; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(6), 837-844

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
4-Methoxysalicylic acid
C8H8O4
2237-36-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-fluoro-N-(2-methylpropyl)benzen...
C20H27FN2O3S
772318-79-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 F 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-3-[[(4-Fluorophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(p...
C28H33FN2O6S
2892016-34-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 8.4700 0.0 0 CFG=1
M  V30 2 C 6.6685 7.7000 0.0 0 CFG=2
M  V30 3 C 8.0021 10.0100 0.0 0
M  V30 4 N 9.3358 7.7000 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 O 6.6685 6.1600 0.0 0
M  V30 7 C 10.6694 8.4700 0.0 0
M  V30 8 N 4.0011 7.7000 0.0 0
M  V30 9 O 10.6694 10.0100 0.0 0
M  V30 10 S 4.0011 6.1600 0.0 0 VAL=6
M  V30 11 C 2.6674 8.4700 0.0 0
M  V30 12 O 5.5411 6.1600 0.0 0
M  V30 13 O 2.4611 6.1600 0.0 0
M  V30 14 C 1.3338 7.7000 0.0 0
M  V30 15 C 0.0000 8.4700 0.0 0
M  V30 16 C 1.3338 6.1600 0.0 0
M  V30 17 O 13.3369 10.0100 0.0 0
M  V30 18 O 16.0041 5.3900 0.0 0
M  V30 19 C 17.3379 6.1600 0.0 0
M  V30 20 F 4.0011 0.0000 0.0 0
M  V30 21 C 6.6685 10.7800 0.0 0
M  V30 22 C 6.6685 12.3200 0.0 0
M  V30 23 C 5.3347 10.0100 0.0 0
M  V30 24 C 5.3347 13.0900 0.0 0
M  V30 25 C 4.0011 10.7800 0.0 0
M  V30 26 C 4.0011 12.3200 0.0 0
M  V30 27 C 12.0032 7.7000 0.0 0
M  V30 28 C 13.3369 8.4700 0.0 0
M  V30 29 C 12.0032 6.1600 0.0 0
M  V30 30 C 14.6705 7.7000 0.0 0
M  V30 31 C 13.3369 5.3900 0.0 0
M  V30 32 C 14.6705 6.1600 0.0 0
M  V30 33 C 4.0011 4.6200 0.0 0
M  V30 34 C 2.6674 3.8500 0.0 0
M  V30 35 C 5.3347 3.8500 0.0 0
M  V30 36 C 2.6674 2.3100 0.0 0
M  V30 37 C 5.3347 2.3100 0.0 0
M  V30 38 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 21
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 27
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 33
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 28
M  V30 20 1 18 19
M  V30 21 1 18 32
M  V30 22 1 20 38
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2237-36-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 772318-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-34-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382516
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
trans-4-Amino-α,α-dimethylcyclohexanemethanol
C9H19NO
899806-45-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 1.5400 3.0800 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0 CFG=2
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 6 1 CFG=3
M  V30 5 1 11 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Chloro-7-cyclopropyl-1,8-naphthyridine-3-carboxylic acid
C12H9ClN2O2
2255313-91-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5424 1.5400 0.0 0
M  V30 2 O 10.8760 2.3101 0.0 0
M  V30 3 O 9.5424 0.0000 0.0 0
M  V30 4 Cl 1.5400 1.5400 0.0 0
M  V30 5 C 5.5412 2.3101 0.0 0
M  V30 6 C 5.5412 3.8501 0.0 0
M  V30 7 C 6.8749 1.5400 0.0 0
M  V30 8 C 4.2075 1.5400 0.0 0
M  V30 9 N 4.2075 4.6201 0.0 0
M  V30 10 N 6.8749 4.6201 0.0 0
M  V30 11 C 8.2085 2.3101 0.0 0
M  V30 12 C 2.8737 2.3101 0.0 0
M  V30 13 C 2.8737 3.8501 0.0 0
M  V30 14 C 8.2085 3.8501 0.0 0
M  V30 15 C 1.5400 4.6201 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 0.7700 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-7-cyclopropyl-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-1,8-na...
C21H26ClN3O2
2255311-99-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8036 4.0011 0.0 0
M  V30 2 N 10.5736 5.3349 0.0 0
M  V30 3 O 10.5736 2.6674 0.0 0
M  V30 4 Cl 2.8736 0.0000 0.0 0
M  V30 5 C 16.7336 5.3349 0.0 0
M  V30 6 C 16.7336 6.8749 0.0 0
M  V30 7 C 18.2736 5.3349 0.0 0
M  V30 8 O 16.7336 3.7949 0.0 0
M  V30 9 C 5.9536 2.6674 0.0 0
M  V30 10 C 5.1836 4.0011 0.0 0
M  V30 11 C 7.4936 2.6674 0.0 0
M  V30 12 C 5.1836 1.3338 0.0 0
M  V30 13 N 3.6436 4.0011 0.0 0
M  V30 14 N 5.9536 5.3349 0.0 0
M  V30 15 C 8.2636 4.0011 0.0 0
M  V30 16 C 3.6436 1.3338 0.0 0
M  V30 17 C 2.8736 2.6674 0.0 0
M  V30 18 C 7.4936 5.3349 0.0 0
M  V30 19 C 1.3336 2.6674 0.0 0
M  V30 20 C 0.0000 1.8974 0.0 0
M  V30 21 C 0.0000 3.4374 0.0 0
M  V30 22 C 12.1136 5.3349 0.0 0 CFG=1
M  V30 23 C 12.8836 4.0011 0.0 0
M  V30 24 C 12.8836 6.6685 0.0 0
M  V30 25 C 14.4236 4.0011 0.0 0
M  V30 26 C 14.4236 6.6685 0.0 0
M  V30 27 C 15.1936 5.3349 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 22 2 CFG=1
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 27 5 CFG=3
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 899806-45-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2255313-91-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2255311-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38094931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The exploration of aza-quinolines as hematopoietic prostaglandin D
synthase (H-PGDS) inhibitors with low brain exposure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cadilla, Rodolfo; Deaton, David N.; Do, Young; Elkins, Patricia A.;
Ennulat, Daniela; Guss, Jeffrey H.; Holt, Jason; Jeune, Michael R.; King,
Andrew G.; Klapwijk, Jan C.; Kramer, H. Fritz; Kramer, Nicholas J.;
Laffan, Susan B.; Masuria, Paresh I.; McDougal, Alan V.; Mortenson, Paul
N.; Musetti, Caterina; Peckham, Gregory E.; Pietrak, Beth L.; Poole,
Chuck; Price, Daniel J.; Rendina, Alan R.; Sati, Girish; Saxty, Gordon;
Shearer, Barry G.; Shewchuk, Lisa M.; Sneddon, Helen F.; Stewart, Eugene
L.; Stuart, J. Darren; Thomas, Dean N.; Thomson, Stephen A.; Ward, Paris;
Wilson, Joseph W.; Xu, Tiahshun; Youngman, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(23), 115791

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
6-Quinolinecarboxylic acid
C10H7NO2
10349-57-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 N 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(5-Methoxy-2-quinolinyl)-1,3-benzenediamine
C16H15N3O
2499499-66-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 4.0011 0.0 0
M  V30 2 C 0.0000 4.0011 0.0 0
M  V30 3 N 8.4700 2.6674 0.0 0
M  V30 4 N 13.0900 5.3347 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 N 6.1600 1.3338 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 C 1.5400 1.3338 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 9.2400 6.6685 0.0 0
M  V30 20 C 10.7800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 3 15
M  V30 5 1 4 18
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[(5-Methoxy-2-quinolinyl)amino]phenyl]-6-quinolinecarboxamide
C26H20N4O2
2499499-58-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 19.2500 4.0011 0.0 0
M  V30 2 C 20.7900 4.0011 0.0 0
M  V30 3 N 12.3200 2.6674 0.0 0
M  V30 4 N 7.7000 5.3347 0.0 0
M  V30 5 C 6.9300 6.6684 0.0 0
M  V30 6 O 7.7000 8.0021 0.0 0
M  V30 7 C 16.1700 1.3336 0.0 0
M  V30 8 C 16.9400 2.6674 0.0 0
M  V30 9 N 14.6300 1.3336 0.0 0
M  V30 10 C 16.9400 0.0000 0.0 0
M  V30 11 C 18.4800 2.6674 0.0 0
M  V30 12 C 16.1700 4.0011 0.0 0
M  V30 13 C 13.8600 2.6674 0.0 0
M  V30 14 C 18.4800 0.0000 0.0 0
M  V30 15 C 19.2500 1.3336 0.0 0
M  V30 16 C 14.6300 4.0011 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 11.5500 6.6684 0.0 0
M  V30 22 C 10.0100 6.6684 0.0 0
M  V30 23 C 5.3900 6.6684 0.0 0
M  V30 24 C 4.6200 8.0021 0.0 0
M  V30 25 C 4.6200 5.3347 0.0 0
M  V30 26 C 3.0800 8.0021 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 N 0.7700 6.6684 0.0 0
M  V30 31 C 0.7700 9.3358 0.0 0
M  V30 32 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 2 5 6
M  V30 8 1 5 23
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 26 29
M  V30 32 1 27 28
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10349-57-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2499499-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2499499-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22759240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents
with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis,
in-vitro cell-based and oncogenic kinase assessments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Damasy, Ashraf K.; Haque, Mamunul Md.; Park, Jung Woo; Shin, Sang
Chul; Lee, Jun-Seok; Kim, Eunice Eun-Kyeong; Keum, Gyochang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 208112756

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
3-(Trifluoromethoxy)aniline
C7H6F3NO
1535-73-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 3.0800 0.0 0
M  V30 2 C 1.3337 2.3100 0.0 0
M  V30 3 F 1.3337 0.7700 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 N 8.0022 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 6.6686 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6686 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Phenylmethyl) hydrogen N-[(1,1-dimethylethoxy)carbonyl]-D-aspartate
C16H21NO6
51186-58-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 5.3349 0.0 0
M  V30 2 O 10.0100 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 O 7.7000 5.3349 0.0 0
M  V30 6 C 6.1600 2.6674 0.0 0 CFG=2
M  V30 7 N 5.3900 4.0011 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 3.8500 1.3338 0.0 0
M  V30 11 O 6.1600 0.0000 0.0 0
M  V30 12 O 3.0800 5.3349 0.0 0
M  V30 13 O 3.0800 2.6674 0.0 0
M  V30 14 C 1.5400 5.3349 0.0 0
M  V30 15 C 1.5400 3.7949 0.0 0
M  V30 16 C 0.0000 5.3349 0.0 0
M  V30 17 C 1.5400 6.8749 0.0 0
M  V30 18 C 12.3200 5.3349 0.0 0
M  V30 19 C 13.0900 4.0011 0.0 0
M  V30 20 C 13.0900 6.6685 0.0 0
M  V30 21 C 14.6300 4.0011 0.0 0
M  V30 22 C 14.6300 6.6685 0.0 0
M  V30 23 C 15.4000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (3R)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-oxo-4-[[3-(triflu...
C23H25F3N2O6
2682842-44-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.0102 8.0022 0.0 0
M  V30 2 C 9.2402 6.6685 0.0 0
M  V30 3 C 7.7002 6.6685 0.0 0 CFG=2
M  V30 4 O 10.0102 5.3348 0.0 0
M  V30 5 C 6.9302 8.0022 0.0 0
M  V30 6 N 6.9302 5.3348 0.0 0
M  V30 7 C 5.3901 8.0022 0.0 0
M  V30 8 C 7.7002 4.0010 0.0 0
M  V30 9 O 4.6201 9.3360 0.0 0
M  V30 10 O 4.6201 6.6685 0.0 0
M  V30 11 O 6.9302 2.6673 0.0 0
M  V30 12 O 9.2402 4.0010 0.0 0
M  V30 13 C 3.0801 9.3360 0.0 0
M  V30 14 C 7.7002 1.3337 0.0 0
M  V30 15 C 6.3665 0.5637 0.0 0
M  V30 16 C 8.4702 0.0000 0.0 0
M  V30 17 C 9.0338 2.1037 0.0 0
M  V30 18 O 14.6303 10.6697 0.0 0
M  V30 19 C 16.1704 10.6697 0.0 0
M  V30 20 F 16.9404 9.3358 0.0 0
M  V30 21 F 17.7104 10.6697 0.0 0
M  V30 22 F 16.9404 12.0033 0.0 0
M  V30 23 C 11.5503 8.0022 0.0 0
M  V30 24 C 12.3203 9.3360 0.0 0
M  V30 25 C 12.3203 6.6685 0.0 0
M  V30 26 C 13.8603 9.3360 0.0 0
M  V30 27 C 13.8603 6.6685 0.0 0
M  V30 28 C 14.6303 8.0022 0.0 0
M  V30 29 C 2.3101 10.6697 0.0 0
M  V30 30 C 3.0801 12.0033 0.0 0
M  V30 31 C 0.7700 10.6697 0.0 0
M  V30 32 C 2.3101 13.3370 0.0 0
M  V30 33 C 0.0000 12.0033 0.0 0
M  V30 34 C 0.7700 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 26
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1535-73-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51186-58-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2682842-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23939255
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with
Antibacterial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamada, Yousuke; Takashima, Hajime; Walmsley, David Lee; Ushiyama,
Fumihito; Matsuda, Yohei; Kanazawa, Harumi; Yamaguchi-Sasaki, Toru;
Tanaka-Yamamoto, Nozomi; Yamagishi, Junya; Kurimoto-Tsuruta, Risa; Ogata,
Yuya; Ohtake, Norikazu; Angove, Hayley; Baker, Lisa; Harris, Richard;
Macias, Alba; Robertson, Alan; Surgenor, Allan; Watanabe, Hayato; Nakano,
Koichiro; Mima, Masashi; Iwamoto, Kunihiko; Okada, Atsushi; Takata,
Iichiro; Hitaka, Kosuke; Tanaka, Akihiro; Fujita, Kiyoko; Sugiyama,
Hiroyuki; Hubbard, Roderick E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(23), 14805-14820

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Hexanedioic acid, 3-[4-cyclopropyl-5-[cis-3-(2,2-dimethylpropyl)cyclobutyl]-3...
C22H33NO5.C8H11N
3008246-52-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 8.2084 0.0 0 CFG=2
M  V30 2 C 4.6200 9.5421 0.0 0
M  V30 3 C 4.6200 6.8748 0.0 0
M  V30 4 C 3.0800 9.5421 0.0 0
M  V30 5 C 5.3900 5.5411 0.0 0
M  V30 6 C 2.3100 10.8758 0.0 0
M  V30 7 O 4.6200 4.2073 0.0 0
M  V30 8 O 6.9300 5.5411 0.0 0
M  V30 9 O 0.7700 10.8758 0.0 0
M  V30 10 O 3.0800 12.2095 0.0 0
M  V30 11 C 0.0000 12.2095 0.0 0
M  V30 12 C 13.5535 12.0689 0.0 0
M  V30 13 C 14.9603 11.4426 0.0 0
M  V30 14 C 14.3340 10.0358 0.0 0
M  V30 15 C 16.3671 10.8162 0.0 0
M  V30 16 C 15.5866 12.8495 0.0 0
M  V30 17 C 7.8351 9.4543 0.0 0
M  V30 18 C 9.2998 8.9784 0.0 0
M  V30 19 C 6.9300 8.2084 0.0 0
M  V30 20 O 9.2998 7.4384 0.0 0
M  V30 21 N 7.8351 6.9626 0.0 0
M  V30 22 C 7.3592 10.9190 0.0 0
M  V30 23 C 7.6794 12.4252 0.0 0
M  V30 24 C 6.2148 11.9494 0.0 0
M  V30 25 C 10.5456 9.8836 0.0 0 CFG=1
M  V30 26 C 12.0667 9.6428 0.0 0
M  V30 27 C 10.7865 11.4047 0.0 0
M  V30 28 C 12.3075 11.1638 0.0 0 CFG=2
M  V30 29 C 6.2585 1.3337 0.0 0 CFG=1
M  V30 30 C 5.4885 2.6673 0.0 0
M  V30 31 N 5.4885 0.0000 0.0 0
M  V30 32 C 7.7986 1.3337 0.0 0
M  V30 33 C 8.5686 0.0000 0.0 0
M  V30 34 C 8.5686 2.6673 0.0 0
M  V30 35 C 10.1086 0.0000 0.0 0
M  V30 36 C 10.1086 2.6673 0.0 0
M  V30 37 C 10.8786 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 28 12 CFG=1
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22
M  V30 20 1 18 20
M  V30 21 1 25 18 CFG=1
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31 CFG=1
M  V30 33 1 29 32
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 25 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-methylaniline
C7H8ClN
615-65-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 C 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(γS)-γ-[2-[(2-Chloro-4-methylphenyl)amino]-2-oxoethyl]-4-cyclopropyl-5-[cis-3...
C28H37ClN2O4
1404380-58-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0 CFG=1
M  V30 2 C 8.4700 6.6684 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 C 6.9300 6.6684 0.0 0
M  V30 5 C 9.2400 2.6673 0.0 0
M  V30 6 N 6.1600 8.0021 0.0 0
M  V30 7 O 6.1600 5.3347 0.0 0
M  V30 8 C 8.4700 1.3336 0.0 0
M  V30 9 O 6.9300 1.3336 0.0 0
M  V30 10 O 9.2400 0.0000 0.0 0
M  V30 11 C 17.4035 9.1952 0.0 0
M  V30 12 C 18.8103 8.5689 0.0 0
M  V30 13 C 19.4367 9.9757 0.0 0
M  V30 14 C 20.2171 7.9424 0.0 0
M  V30 15 C 18.1840 7.1619 0.0 0
M  V30 16 Cl 4.6200 10.6694 0.0 0
M  V30 17 C 0.0000 8.0021 0.0 0
M  V30 18 C 11.6851 6.5806 0.0 0
M  V30 19 C 13.1498 6.1047 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 O 13.1498 4.5647 0.0 0
M  V30 22 N 11.6851 4.0889 0.0 0
M  V30 23 C 11.2092 8.0453 0.0 0
M  V30 24 C 11.5294 9.5515 0.0 0
M  V30 25 C 10.0648 9.0757 0.0 0
M  V30 26 C 14.3956 7.0099 0.0 0 CFG=2
M  V30 27 C 14.6365 8.5310 0.0 0
M  V30 28 C 15.9167 6.7691 0.0 0
M  V30 29 C 16.1575 8.2900 0.0 0 CFG=1
M  V30 30 C 4.6200 8.0021 0.0 0
M  V30 31 C 3.8500 9.3358 0.0 0
M  V30 32 C 3.8500 6.6684 0.0 0
M  V30 33 C 2.3100 9.3358 0.0 0
M  V30 34 C 2.3100 6.6684 0.0 0
M  V30 35 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 30
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 29 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 31
M  V30 18 1 17 35
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23
M  V30 22 1 19 21
M  V30 23 1 26 19 CFG=1
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3008246-52-1
$DTYPE RXN:RCT(1):AMD
$DATUM spn rct
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1404380-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38940080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 3)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key
Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced
Dynamic Resolution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takiguchi, Hiromu; Watanabe, Takashi; Ogo, Takashi; Ishibashi, Hideaki;
Yokota, Katsuyuki; Obika, Shingo; Inaba, Takashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(12), 2355-2364

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-phenylalanine
C15H21NO4
114873-06-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6765 6.1048 0.0 0
M  V30 14 C 0.0000 6.6687 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4-carboxylic acid, 1-[(4S)-4,5-diamino-5-oxopentyl]-, methy...
C9H15N5O3.C2HF3O2
3026371-64-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.7238 0.0 0
M  V30 2 C 5.3348 7.4938 0.0 0
M  V30 3 C 4.0010 6.7238 0.0 0
M  V30 4 C 2.6673 7.4938 0.0 0 CFG=2
M  V30 5 C 1.3337 6.7238 0.0 0
M  V30 6 N 2.6673 9.0338 0.0 0
M  V30 7 N 1.3337 5.1837 0.0 0
M  V30 8 O 0.0000 7.4938 0.0 0
M  V30 9 C 11.9711 7.8509 0.0 0
M  V30 10 O 12.8764 9.0968 0.0 0
M  V30 11 O 12.5976 6.4439 0.0 0
M  V30 12 C 14.4079 8.9359 0.0 0
M  V30 13 N 8.0022 7.4938 0.0 0
M  V30 14 C 9.4091 6.8673 0.0 0
M  V30 15 N 8.1633 9.0253 0.0 0
M  V30 16 C 10.4396 8.0118 0.0 0
M  V30 17 N 9.6696 9.3455 0.0 0
M  V30 18 C 6.5371 2.3101 0.0 0
M  V30 19 C 7.8708 1.5400 0.0 0
M  V30 20 F 7.3072 3.6437 0.0 0
M  V30 21 F 5.2035 3.0801 0.0 0
M  V30 22 F 5.7671 0.9764 0.0 0
M  V30 23 O 9.2045 2.3101 0.0 0
M  V30 24 O 7.8708 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 19 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C24H34N6O6
3026370-76-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.1601 0.0 0 CFG=2
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 8.0023 6.9302 0.0 0
M  V30 4 N 5.3348 6.9302 0.0 0
M  V30 5 N 8.0023 8.4702 0.0 0
M  V30 6 O 9.3360 6.1601 0.0 0
M  V30 7 C 4.0012 6.1601 0.0 0
M  V30 8 C 9.3360 9.2402 0.0 0 CFG=2
M  V30 9 O 2.6675 6.9302 0.0 0
M  V30 10 O 4.0012 4.6201 0.0 0
M  V30 11 C 10.6697 8.4702 0.0 0
M  V30 12 C 9.3360 10.7802 0.0 0
M  V30 13 C 1.3337 6.1601 0.0 0
M  V30 14 C 12.0033 9.2402 0.0 0
M  V30 15 N 10.6697 11.5503 0.0 0
M  V30 16 O 8.0023 11.5503 0.0 0
M  V30 17 C 0.5637 7.4938 0.0 0
M  V30 18 C 0.0000 5.3901 0.0 0
M  V30 19 C 2.1037 4.8265 0.0 0
M  V30 20 C 13.3372 8.4702 0.0 0
M  V30 21 C 9.3360 0.0000 0.0 0
M  V30 22 C 18.6398 9.5973 0.0 0
M  V30 23 O 19.5450 10.8432 0.0 0
M  V30 24 O 19.2661 8.1904 0.0 0
M  V30 25 C 21.0766 10.6823 0.0 0
M  V30 26 C 8.0023 3.8501 0.0 0
M  V30 27 C 8.0023 2.3101 0.0 0
M  V30 28 C 9.3360 4.6201 0.0 0
M  V30 29 C 9.3360 1.5400 0.0 0
M  V30 30 C 10.6697 3.8501 0.0 0
M  V30 31 C 10.6697 2.3101 0.0 0
M  V30 32 N 14.6708 9.2402 0.0 0
M  V30 33 C 16.0776 8.6139 0.0 0
M  V30 34 N 14.8318 10.7718 0.0 0
M  V30 35 C 17.1082 9.7583 0.0 0
M  V30 36 N 16.3382 11.0919 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 26
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 20 32
M  V30 22 1 21 29
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 22 35
M  V30 26 1 23 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 114873-06-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026371-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026370-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
5-(2-Chloro-4-methoxyphenyl)-1-methyl-1H-pyrazole-3-carboxylic acid
C12H11ClN2O3
1368644-06-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5933 0.0000 0.0 0
M  V30 2 Cl 6.5626 5.3779 0.0 0
M  V30 3 C 1.4068 4.3858 0.0 0
M  V30 4 O 1.5679 5.9174 0.0 0
M  V30 5 O 0.0000 3.7593 0.0 0
M  V30 6 O 11.1827 2.7106 0.0 0
M  V30 7 C 11.9527 1.3769 0.0 0
M  V30 8 C 5.0226 2.7106 0.0 0
M  V30 9 N 4.1174 1.4647 0.0 0
M  V30 10 C 4.1174 3.9565 0.0 0
M  V30 11 N 2.6528 1.9406 0.0 0
M  V30 12 C 2.6528 3.4806 0.0 0
M  V30 13 C 6.5626 2.7106 0.0 0
M  V30 14 C 7.3327 4.0443 0.0 0
M  V30 15 C 7.3327 1.3769 0.0 0
M  V30 16 C 8.8727 4.0443 0.0 0
M  V30 17 C 8.8727 1.3769 0.0 0
M  V30 18 C 9.6427 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-1-Methyl-3-piperidinamine
C6H14N2
902152-76-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 3.0800 0.0 0
M  V30 2 C 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0 CFG=1
M  V30 5 N 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=3
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-(2-chloro-4-methoxyphenyl)-1-methyl-N-[(3S)-1-me...
C18H23ClN4O2
2919851-73-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.2959 0.0000 0.0 0
M  V30 2 Cl 11.6924 5.5544 0.0 0
M  V30 3 C 6.6685 4.0287 0.0 0
M  V30 4 N 5.3348 3.2587 0.0 0
M  V30 5 O 6.6685 5.5688 0.0 0
M  V30 6 O 16.5660 3.3845 0.0 0
M  V30 7 C 17.4711 2.1386 0.0 0
M  V30 8 C 0.0000 3.2587 0.0 0
M  V30 9 C 10.4396 2.7406 0.0 0
M  V30 10 C 9.4090 3.8850 0.0 0
M  V30 11 N 9.6696 1.4070 0.0 0
M  V30 12 C 8.0022 3.2587 0.0 0
M  V30 13 N 8.1631 1.7271 0.0 0
M  V30 14 C 11.9711 2.9016 0.0 0
M  V30 15 C 12.5975 4.3086 0.0 0
M  V30 16 C 12.8764 1.6557 0.0 0
M  V30 17 C 14.1292 4.4695 0.0 0
M  V30 18 C 14.4079 1.8166 0.0 0
M  V30 19 C 15.0343 3.2236 0.0 0
M  V30 20 C 4.0010 4.0287 0.0 0 CFG=1
M  V30 21 C 2.6673 3.2587 0.0 0
M  V30 22 C 4.0010 5.5688 0.0 0
M  V30 23 N 1.3337 4.0287 0.0 0
M  V30 24 C 2.6673 6.3388 0.0 0
M  V30 25 C 1.3337 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 20 4 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 23
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1368644-06-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 902152-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919851-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37690250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic
Receptor Antagonist for the Modulation of Motor Dysfunction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Christie, Louisa A.; Brice, Nicola L.; Rowland, Anna; Dickson, Louise;
Anand, Rishi; Teall, Martin; Doyle, Kevin J.; Narayana, Lakshminarayana;
Mitchell, Christine; Harvey, Jenna R. M.; Mulligan, Victoria; Dawson, Lee
A.; Cragg, Stephanie J.; Carlton, Mark; Burli, Roland W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(17), 11718-11731

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Difluoroacetic acid
C2H2F2O2
381-73-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 F 4.0010 2.3101 0.0 0
M  V30 4 F 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[[2-amino-4-[(ethylamino)carbonyl]phenyl]amino...
C20H32N4O3
3034365-71-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.3359 1.5400 0.0 0
M  V30 2 C 6.6684 0.0000 0.0 0
M  V30 3 N 12.0034 0.0000 0.0 0
M  V30 4 C 4.0011 4.6201 0.0 0
M  V30 5 O 2.6675 3.8500 0.0 0
M  V30 6 O 4.0011 6.1601 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 C 0.5636 3.2864 0.0 0
M  V30 9 C 0.0000 5.3901 0.0 0
M  V30 10 C 2.1037 5.9537 0.0 0
M  V30 11 C 14.6707 4.6201 0.0 0
M  V30 12 N 16.0043 3.8500 0.0 0
M  V30 13 O 14.6707 6.1601 0.0 0
M  V30 14 C 17.3381 4.6201 0.0 0
M  V30 15 C 18.6718 3.8500 0.0 0
M  V30 16 C 8.0022 2.3100 0.0 0 CFG=1
M  V30 17 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 18 C 8.0022 3.8500 0.0 0
M  V30 19 C 5.3348 2.3100 0.0 0
M  V30 20 C 6.6684 4.6201 0.0 0
M  V30 21 N 5.3348 3.8500 0.0 0
M  V30 22 C 10.6695 2.3100 0.0 0
M  V30 23 C 12.0034 1.5400 0.0 0
M  V30 24 C 10.6695 3.8500 0.0 0
M  V30 25 C 13.3370 2.3100 0.0 0
M  V30 26 C 12.0034 4.6201 0.0 0
M  V30 27 C 13.3370 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 1 22
M  V30 3 1 17 2 CFG=1
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 27
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[[2-[(2,2-difluoroacetyl)amino]-4-[(ethylamino...
C22H32F2N4O4
3034365-99-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 9.3360 0.0 0
M  V30 2 N 3.8501 9.3360 0.0 0
M  V30 3 C 2.3101 9.3360 0.0 0
M  V30 4 C 1.5400 10.6697 0.0 0
M  V30 5 O 1.5400 8.0023 0.0 0
M  V30 6 F 0.0000 10.6697 0.0 0
M  V30 7 F 2.3101 12.0033 0.0 0
M  V30 8 C 3.8501 4.0012 0.0 0
M  V30 9 N 4.6201 2.6673 0.0 0
M  V30 10 O 2.3101 4.0012 0.0 0
M  V30 11 C 3.8501 1.3337 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 8.4702 12.0033 0.0 0
M  V30 14 C 13.0903 9.3360 0.0 0
M  V30 15 O 13.8603 10.6697 0.0 0
M  V30 16 O 13.8603 8.0023 0.0 0
M  V30 17 C 15.4003 10.6697 0.0 0
M  V30 18 C 15.4003 9.1296 0.0 0
M  V30 19 C 16.9404 10.6697 0.0 0
M  V30 20 C 15.4003 12.2097 0.0 0
M  V30 21 C 6.1601 8.0023 0.0 0
M  V30 22 C 4.6201 8.0023 0.0 0
M  V30 23 C 6.9302 6.6685 0.0 0
M  V30 24 C 3.8501 6.6685 0.0 0
M  V30 25 C 6.1601 5.3348 0.0 0
M  V30 26 C 4.6201 5.3348 0.0 0
M  V30 27 C 8.4702 9.3360 0.0 0 CFG=1
M  V30 28 C 9.2402 10.6697 0.0 0 CFG=1
M  V30 29 C 9.2402 8.0023 0.0 0
M  V30 30 C 10.7802 10.6697 0.0 0
M  V30 31 C 10.7802 8.0023 0.0 0
M  V30 32 N 11.5503 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 27 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 28 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 32
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 381-73-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3034365-71-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3034365-99-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35314251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of High-Affinity Small-Molecule Binders of the Epigenetic
Reader YEATS4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Londregan, Allyn T.; Aitmakhanova, Karlygash; Bennett, James; Byrnes,
Laura J.; Canterbury, Daniel P.; Cheng, Xiayun; Christott, Thomas;
Clemens, Jennifer; Coffey, Steven B.; Dias, Joao M.; Dowling, Matthew S.;
Farnie, Gillian; Fedorov, Oleg; Fennell, Kimberly F.; Gamble, Vicki;
Gileadi, Carina; Giroud, Charline; Harris, Michael R.; Hollingshead,
Brett D.; Huber, Kilian; Korczynska, Magdalena; Lapham, Kimberly; Loria,
Paula M.; Narayanan, Arjun; Owen, Dafydd R.; Raux, Brigitt; Sahasrabudhe,
Parag V.; Ruggeri, Roger B.; Saez, Laura Diaz; Stock, Ingrid A.; Thuma,
Benjamin A.; Tsai, Andy; Varghese, Alison E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(1), 460-472

$RFMT $RIREG SCHEME122 STEP1
$RXN



  3  2
$MOL
Diphenylacetic acid
C14H12O2
117-34-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 4.0011 0.7700 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 14 C 6.6685 5.3900 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2R)-2-[[(2S)-2-amino-3-(3-methylphenyl)-1-oxopropyl]amino...
C25H28N2O4.C2HF3O2
3026372-08-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0055 9.0338 0.0 0
M  V30 2 O 21.3393 8.2638 0.0 0
M  V30 3 O 20.0055 10.5738 0.0 0
M  V30 4 C 22.6730 9.0338 0.0 0
M  V30 5 C 24.0067 8.2638 0.0 0
M  V30 6 C 25.3403 9.0338 0.0 0
M  V30 7 C 14.6707 9.0338 0.0 0
M  V30 8 O 13.3370 8.2638 0.0 0
M  V30 9 C 12.0033 9.0338 0.0 0
M  V30 10 C 10.6697 8.2638 0.0 0 CFG=1
M  V30 11 N 9.3358 9.0338 0.0 0
M  V30 12 C 10.6697 6.7238 0.0 0
M  V30 13 C 8.0022 8.2638 0.0 0
M  V30 14 C 10.6697 5.1837 0.0 0
M  V30 15 C 6.6685 9.0338 0.0 0 CFG=1
M  V30 16 O 8.0022 6.7238 0.0 0
M  V30 17 C 5.3348 8.2638 0.0 0
M  V30 18 N 6.6685 10.5738 0.0 0
M  V30 19 C 0.0000 8.2638 0.0 0
M  V30 20 C 18.6718 8.2638 0.0 0
M  V30 21 C 17.3382 9.0338 0.0 0
M  V30 22 C 18.6718 6.7238 0.0 0
M  V30 23 C 16.0045 8.2638 0.0 0
M  V30 24 C 17.3382 5.9537 0.0 0
M  V30 25 C 16.0045 6.7238 0.0 0
M  V30 26 C 4.0010 9.0338 0.0 0
M  V30 27 C 2.6673 8.2638 0.0 0
M  V30 28 C 4.0010 10.5738 0.0 0
M  V30 29 C 1.3337 9.0338 0.0 0
M  V30 30 C 2.6673 11.3439 0.0 0
M  V30 31 C 1.3337 10.5738 0.0 0
M  V30 32 C 12.0033 2.3101 0.0 0
M  V30 33 C 13.3370 1.5400 0.0 0
M  V30 34 F 12.7733 3.6437 0.0 0
M  V30 35 F 10.6697 3.0801 0.0 0
M  V30 36 F 11.2333 0.9764 0.0 0
M  V30 37 O 14.6707 2.3101 0.0 0
M  V30 38 O 13.3370 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 3 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 15 18 CFG=3
M  V30 19 1 17 26
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 32 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 2 33 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2S)-2-[[(2S)-2-amino-3-(3-methylphenyl)-1-oxopropyl]amino...
C25H28N2O4.C2HF3O2
3026373-07-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0055 9.0338 0.0 0
M  V30 2 O 21.3393 8.2638 0.0 0
M  V30 3 O 20.0055 10.5738 0.0 0
M  V30 4 C 22.6730 9.0338 0.0 0
M  V30 5 C 24.0067 8.2638 0.0 0
M  V30 6 C 25.3403 9.0338 0.0 0
M  V30 7 C 14.6707 9.0338 0.0 0
M  V30 8 O 13.3370 8.2638 0.0 0
M  V30 9 C 12.0033 9.0338 0.0 0
M  V30 10 C 10.6697 8.2638 0.0 0 CFG=2
M  V30 11 N 9.3358 9.0338 0.0 0
M  V30 12 C 10.6697 6.7238 0.0 0
M  V30 13 C 8.0022 8.2638 0.0 0
M  V30 14 C 10.6697 5.1837 0.0 0
M  V30 15 C 6.6685 9.0338 0.0 0 CFG=1
M  V30 16 O 8.0022 6.7238 0.0 0
M  V30 17 C 5.3348 8.2638 0.0 0
M  V30 18 N 6.6685 10.5738 0.0 0
M  V30 19 C 0.0000 8.2638 0.0 0
M  V30 20 C 18.6718 8.2638 0.0 0
M  V30 21 C 17.3382 9.0338 0.0 0
M  V30 22 C 18.6718 6.7238 0.0 0
M  V30 23 C 16.0045 8.2638 0.0 0
M  V30 24 C 17.3382 5.9537 0.0 0
M  V30 25 C 16.0045 6.7238 0.0 0
M  V30 26 C 4.0010 9.0338 0.0 0
M  V30 27 C 2.6673 8.2638 0.0 0
M  V30 28 C 4.0010 10.5738 0.0 0
M  V30 29 C 1.3337 9.0338 0.0 0
M  V30 30 C 2.6673 11.3439 0.0 0
M  V30 31 C 1.3337 10.5738 0.0 0
M  V30 32 C 12.0033 2.3101 0.0 0
M  V30 33 C 13.3370 1.5400 0.0 0
M  V30 34 F 12.7733 3.6437 0.0 0
M  V30 35 F 10.6697 3.0801 0.0 0
M  V30 36 F 11.2333 0.9764 0.0 0
M  V30 37 O 14.6707 2.3101 0.0 0
M  V30 38 O 13.3370 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 3 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 15 18 CFG=3
M  V30 19 1 17 26
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 32 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 2 33 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2R)-2-[[(2S)-2-[(2,2-diphenylacetyl)amino]-3-(3-methylphe...
C39H38N2O5
3026372-19-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 C 4.0010 4.6201 0.0 0
M  V30 3 N 5.3348 5.3901 0.0 0
M  V30 4 O 2.6673 5.3901 0.0 0
M  V30 5 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 6 C 4.0010 7.7002 0.0 0
M  V30 7 C 6.6685 7.7002 0.0 0
M  V30 8 N 8.0022 6.9302 0.0 0
M  V30 9 O 6.6685 9.2402 0.0 0
M  V30 10 C 9.3358 7.7002 0.0 0 CFG=2
M  V30 11 C 10.6697 6.9302 0.0 0
M  V30 12 C 9.3358 9.2402 0.0 0
M  V30 13 O 12.0033 7.7002 0.0 0
M  V30 14 C 9.3358 10.7802 0.0 0
M  V30 15 C 13.3370 6.9302 0.0 0
M  V30 16 C 1.3337 12.3203 0.0 0
M  V30 17 C 18.6718 6.9302 0.0 0
M  V30 18 O 20.0057 7.7002 0.0 0
M  V30 19 O 18.6718 5.3901 0.0 0
M  V30 20 C 21.3393 6.9302 0.0 0
M  V30 21 C 22.6730 7.7002 0.0 0
M  V30 22 C 24.0067 6.9302 0.0 0
M  V30 23 C 2.6673 2.3101 0.0 0
M  V30 24 C 2.6673 0.7700 0.0 0
M  V30 25 C 1.3337 3.0801 0.0 0
M  V30 26 C 1.3337 0.0000 0.0 0
M  V30 27 C 0.0000 2.3101 0.0 0
M  V30 28 C 0.0000 0.7700 0.0 0
M  V30 29 C 5.3348 2.3101 0.0 0
M  V30 30 C 6.6685 3.0801 0.0 0
M  V30 31 C 5.3348 0.7700 0.0 0
M  V30 32 C 8.0022 2.3101 0.0 0
M  V30 33 C 6.6685 0.0000 0.0 0
M  V30 34 C 8.0022 0.7700 0.0 0
M  V30 35 C 4.0010 9.2402 0.0 0
M  V30 36 C 2.6673 10.0102 0.0 0
M  V30 37 C 5.3348 10.0102 0.0 0
M  V30 38 C 2.6673 11.5503 0.0 0
M  V30 39 C 5.3348 11.5503 0.0 0
M  V30 40 C 4.0010 12.3203 0.0 0
M  V30 41 C 14.6708 7.7002 0.0 0
M  V30 42 C 16.0045 6.9302 0.0 0
M  V30 43 C 14.6707 9.2402 0.0 0
M  V30 44 C 17.3382 7.7002 0.0 0
M  V30 45 C 16.0045 10.0102 0.0 0
M  V30 46 C 17.3382 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6 CFG=1
M  V30 8 1 5 7
M  V30 9 1 6 35
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 10 11 CFG=3
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 3 12 14
M  V30 17 1 13 15
M  V30 18 1 15 41
M  V30 19 1 16 38
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 1 17 44
M  V30 23 1 18 20
M  V30 24 1 20 21
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 44 2 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 2 43 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2S)-2-[[(2S)-2-[(2,2-diphenylacetyl)amino]-3-(3-methylphe...
C39H38N2O5
3026372-21-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 C 4.0010 4.6201 0.0 0
M  V30 3 N 5.3348 5.3901 0.0 0
M  V30 4 O 2.6673 5.3901 0.0 0
M  V30 5 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 6 C 4.0010 7.7002 0.0 0
M  V30 7 C 6.6685 7.7002 0.0 0
M  V30 8 N 8.0022 6.9302 0.0 0
M  V30 9 O 6.6685 9.2402 0.0 0
M  V30 10 C 9.3358 7.7002 0.0 0 CFG=1
M  V30 11 C 10.6697 6.9302 0.0 0
M  V30 12 C 9.3358 9.2402 0.0 0
M  V30 13 O 12.0033 7.7002 0.0 0
M  V30 14 C 9.3358 10.7802 0.0 0
M  V30 15 C 13.3370 6.9302 0.0 0
M  V30 16 C 1.3337 12.3203 0.0 0
M  V30 17 C 18.6718 6.9302 0.0 0
M  V30 18 O 20.0057 7.7002 0.0 0
M  V30 19 O 18.6718 5.3901 0.0 0
M  V30 20 C 21.3393 6.9302 0.0 0
M  V30 21 C 22.6730 7.7002 0.0 0
M  V30 22 C 24.0067 6.9302 0.0 0
M  V30 23 C 2.6673 2.3101 0.0 0
M  V30 24 C 2.6673 0.7700 0.0 0
M  V30 25 C 1.3337 3.0801 0.0 0
M  V30 26 C 1.3337 0.0000 0.0 0
M  V30 27 C 0.0000 2.3101 0.0 0
M  V30 28 C 0.0000 0.7700 0.0 0
M  V30 29 C 5.3348 2.3101 0.0 0
M  V30 30 C 6.6685 3.0801 0.0 0
M  V30 31 C 5.3348 0.7700 0.0 0
M  V30 32 C 8.0022 2.3101 0.0 0
M  V30 33 C 6.6685 0.0000 0.0 0
M  V30 34 C 8.0022 0.7700 0.0 0
M  V30 35 C 4.0010 9.2402 0.0 0
M  V30 36 C 2.6673 10.0102 0.0 0
M  V30 37 C 5.3348 10.0102 0.0 0
M  V30 38 C 2.6673 11.5503 0.0 0
M  V30 39 C 5.3348 11.5503 0.0 0
M  V30 40 C 4.0010 12.3203 0.0 0
M  V30 41 C 14.6708 7.7002 0.0 0
M  V30 42 C 16.0045 6.9302 0.0 0
M  V30 43 C 14.6707 9.2402 0.0 0
M  V30 44 C 17.3382 7.7002 0.0 0
M  V30 45 C 16.0045 10.0102 0.0 0
M  V30 46 C 17.3382 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6 CFG=1
M  V30 8 1 5 7
M  V30 9 1 6 35
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 10 11 CFG=1
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 3 12 14
M  V30 17 1 13 15
M  V30 18 1 15 41
M  V30 19 1 16 38
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 1 17 44
M  V30 23 1 18 20
M  V30 24 1 20 21
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 44 2 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 2 43 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 117-34-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026372-08-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3026373-07-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026372-19-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 3026372-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 10
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
o-Phenylenediamine
C6H8N2
95-54-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-(2-Methoxy-2-oxoethoxy)phenyl]-1H-benzimidazole-6-carboxylic acid
C17H14N2O5
2766688-22-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 O 13.8646 3.0800 0.0 0
M  V30 5 C 14.6346 4.4136 0.0 0
M  V30 6 C 16.1746 4.4136 0.0 0
M  V30 7 O 16.9446 5.7473 0.0 0
M  V30 8 O 16.9446 3.0800 0.0 0
M  V30 9 C 18.4846 5.7473 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 N 6.7994 1.8341 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 N 6.7994 4.3259 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 7.7046 3.0800 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 2.6674 3.8500 0.0 0
M  V30 19 C 9.2446 3.0800 0.0 0
M  V30 20 C 10.0146 4.4136 0.0 0
M  V30 21 C 10.0146 1.7462 0.0 0
M  V30 22 C 11.5546 4.4136 0.0 0
M  V30 23 C 11.5546 1.7462 0.0 0
M  V30 24 C 12.3246 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[4-[6-[[(2-aminophenyl)amino]carbonyl]-1H-benzimidazol-2-yl]phenoxy]...
C23H20N4O4
2766688-34-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 N 4.0011 3.0800 0.0 0
M  V30 3 O 5.3347 0.7700 0.0 0
M  V30 4 O 17.8656 3.8500 0.0 0
M  V30 5 C 18.6356 5.1837 0.0 0
M  V30 6 C 20.1756 5.1837 0.0 0
M  V30 7 O 20.9456 6.5173 0.0 0
M  V30 8 O 20.9456 3.8500 0.0 0
M  V30 9 C 22.4856 6.5173 0.0 0
M  V30 10 N 1.3336 4.6200 0.0 0
M  V30 11 C 9.3358 3.0800 0.0 0
M  V30 12 C 9.3358 4.6200 0.0 0
M  V30 13 N 10.8004 2.6041 0.0 0
M  V30 14 C 8.0020 2.3100 0.0 0
M  V30 15 N 10.8004 5.0959 0.0 0
M  V30 16 C 8.0020 5.3900 0.0 0
M  V30 17 C 11.7056 3.8500 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0
M  V30 19 C 6.6684 4.6200 0.0 0
M  V30 20 C 13.2456 3.8500 0.0 0
M  V30 21 C 14.0156 2.5162 0.0 0
M  V30 22 C 14.0156 5.1837 0.0 0
M  V30 23 C 15.5556 2.5162 0.0 0
M  V30 24 C 15.5556 5.1837 0.0 0
M  V30 25 C 16.3256 3.8500 0.0 0
M  V30 26 C 2.6673 2.3100 0.0 0
M  V30 27 C 1.3336 3.0800 0.0 0
M  V30 28 C 2.6673 0.7700 0.0 0
M  V30 29 C 0.0000 2.3100 0.0 0
M  V30 30 C 1.3336 0.0000 0.0 0
M  V30 31 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 27
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 95-54-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2766688-22-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766688-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32019465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy
In Vivo That Trigger Antitumor Immunity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Chen; Li, Xue; Zhao, Huajun; Liu, Meng; Du, Jintong; Zhang, Jian;
Yang, Xinying; Hou, Xuben; Fang, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 3667-3683

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-D-phenylalanine
C14H19NO4
18942-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=2
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxylic acid, 1-amino-, phenylmethyl ester, 2,2,2-trifluoroacet...
C14H19NO2.C2HF3O2
2413279-66-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3670 6.7237 0.0 0
M  V30 2 O 5.7007 7.4938 0.0 0
M  V30 3 O 4.3670 5.1837 0.0 0
M  V30 4 C 7.0344 6.7237 0.0 0
M  V30 5 N 4.0232 8.6734 0.0 0
M  V30 6 C 3.0332 7.4938 0.0 0
M  V30 7 C 2.5065 6.0466 0.0 0
M  V30 8 C 2.0433 8.6734 0.0 0
M  V30 9 C 0.9899 5.7792 0.0 0
M  V30 10 C 0.5267 8.4061 0.0 0
M  V30 11 C 0.0000 6.9589 0.0 0
M  V30 12 C 8.3680 7.4938 0.0 0
M  V30 13 C 8.3680 9.0338 0.0 0
M  V30 14 C 9.7018 6.7237 0.0 0
M  V30 15 C 9.7018 9.8038 0.0 0
M  V30 16 C 11.0355 7.4938 0.0 0
M  V30 17 C 11.0355 9.0338 0.0 0
M  V30 18 C 4.8509 2.3101 0.0 0
M  V30 19 C 6.1846 1.5400 0.0 0
M  V30 20 F 5.6209 3.6437 0.0 0
M  V30 21 F 3.5173 3.0801 0.0 0
M  V30 22 F 4.0809 0.9764 0.0 0
M  V30 23 O 7.5183 2.3101 0.0 0
M  V30 24 O 6.1846 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 19 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C28H36N2O5
2413279-31-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 8.0023 0.0 0
M  V30 2 C 5.3901 8.0023 0.0 0
M  V30 3 C 4.6201 6.6684 0.0 0 CFG=2
M  V30 4 O 4.6201 9.3359 0.0 0
M  V30 5 C 3.0800 6.6684 0.0 0
M  V30 6 N 5.3901 5.3348 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 O 5.3901 2.6675 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 5.9537 0.5636 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 13 C 3.2863 2.1037 0.0 0
M  V30 14 C 8.8798 8.3460 0.0 0
M  V30 15 O 10.3269 8.8727 0.0 0
M  V30 16 O 8.6124 6.8294 0.0 0
M  V30 17 C 11.5067 7.8828 0.0 0
M  V30 18 C 7.7001 9.3359 0.0 0
M  V30 19 C 6.2529 9.8626 0.0 0
M  V30 20 C 8.8798 10.3258 0.0 0
M  V30 21 C 5.9854 11.3792 0.0 0
M  V30 22 C 8.6124 11.8425 0.0 0
M  V30 23 C 7.1653 12.3691 0.0 0
M  V30 24 C 12.9537 8.4094 0.0 0
M  V30 25 C 13.2212 9.9262 0.0 0
M  V30 26 C 14.1335 7.4197 0.0 0
M  V30 27 C 14.6684 10.4529 0.0 0
M  V30 28 C 15.5807 7.9464 0.0 0
M  V30 29 C 15.8480 9.4630 0.0 0
M  V30 30 C 2.3100 8.0023 0.0 0
M  V30 31 C 0.7700 8.0023 0.0 0
M  V30 32 C 3.0800 9.3359 0.0 0
M  V30 33 C 0.0000 9.3359 0.0 0
M  V30 34 C 2.3100 10.6696 0.0 0
M  V30 35 C 0.7700 10.6696 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 3 6
M  V30 7 1 5 30
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 17 24
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18942-49-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2413279-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413279-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21978536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meena, Chhuttan L.; Singh, Dharmendra; Weinmuller, Michael; Reichart,
Florian; Dangi, Abha; Marelli, Udaya Kiran; Zahler, Stefan; Sanjayan,
Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
4-Methoxysalicylic acid
C8H8O4
2237-36-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]am...
C28H33N3O8S
2892016-17-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 8.4700 0.0 0
M  V30 2 S 4.0011 6.9300 0.0 0 VAL=6
M  V30 3 C 5.3347 9.2400 0.0 0
M  V30 4 C 2.6674 9.2400 0.0 0
M  V30 5 O 5.5411 6.9300 0.0 0
M  V30 6 O 2.4611 6.9300 0.0 0
M  V30 7 C 6.6685 8.4700 0.0 0 CFG=1
M  V30 8 C 1.3338 8.4700 0.0 0
M  V30 9 C 8.0021 9.2400 0.0 0 CFG=2
M  V30 10 O 6.6685 6.9300 0.0 0
M  V30 11 C 0.0000 9.2400 0.0 0
M  V30 12 C 1.3338 6.9300 0.0 0
M  V30 13 N 9.3358 8.4700 0.0 0
M  V30 14 C 8.0021 10.7800 0.0 0
M  V30 15 C 10.6694 9.2400 0.0 0
M  V30 16 O 10.6694 10.7800 0.0 0
M  V30 17 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 18 O 2.6674 0.0000 0.0 0
M  V30 19 O 5.3347 0.0000 0.0 0
M  V30 20 O 13.3369 10.7800 0.0 0
M  V30 21 O 16.0041 6.1600 0.0 0
M  V30 22 C 17.3379 6.9300 0.0 0
M  V30 23 C 4.0011 5.3900 0.0 0
M  V30 24 C 5.3347 4.6200 0.0 0
M  V30 25 C 2.6674 4.6200 0.0 0
M  V30 26 C 5.3347 3.0800 0.0 0
M  V30 27 C 2.6674 3.0800 0.0 0
M  V30 28 C 4.0011 2.3100 0.0 0
M  V30 29 C 6.6685 11.5500 0.0 0
M  V30 30 C 6.6685 13.0900 0.0 0
M  V30 31 C 5.3347 10.7800 0.0 0
M  V30 32 C 5.3347 13.8600 0.0 0
M  V30 33 C 4.0011 11.5500 0.0 0
M  V30 34 C 4.0011 13.0900 0.0 0
M  V30 35 C 12.0032 8.4700 0.0 0
M  V30 36 C 13.3369 9.2400 0.0 0
M  V30 37 C 12.0032 6.9300 0.0 0
M  V30 38 C 14.6705 8.4700 0.0 0
M  V30 39 C 13.3369 6.1600 0.0 0
M  V30 40 C 14.6705 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 23
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=3
M  V30 15 1 13 15
M  V30 16 1 14 29
M  V30 17 2 15 16
M  V30 18 1 15 35
M  V30 19 2 17 18
M  V30 20 2 17 19
M  V30 21 1 17 28
M  V30 22 1 20 36
M  V30 23 1 21 22
M  V30 24 1 21 40
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2237-36-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Formamidine acetate
C2H4O2.CH4N2
3473-63-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.8501 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 N 2.6673 4.6201 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 2 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5-difluorobenzoic acid
C7H5F2NO2
83506-93-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 F 5.3901 5.3349 0.0 0
M  V30 6 F 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Difluoro-4(3H)-quinazolinone
C8H4F2N2O
205259-37-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 F 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83506-93-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205259-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38180209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Small Molecule Inhibitors and Ligand Directed Degraders
of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Young; Whitefield, Brandon; Nevius, Erin; Hill, Mark; DelRosario,
Joselyn; Sinitsyna, Nadia; Shanmugasundaram, Veerabahu; Mukherjee,
Debarati; Shi, Lihong; Mayne, Christopher Glenn; Rousseau, Anne-Marie;
Bernard, Steffen M.; Buenviaje, Jennifer; Khambatta, Gody; El Samin,
Miriam; Wallace, Michael; Nie, Zhe; Sivakumar, Pallavur; Hamann, Lawrence
G.; McDonnell, Donald P.; D'Agostino, Laura Akullian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(23), 15750-15760

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
N-[(5-Methyl-3-isoxazolyl)carbonyl]glycyl-O-methyl-L-serine
C11H15N3O6
2387523-00-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 9.3359 6.1601 0.0 0
M  V30 4 C 6.6684 4.6201 0.0 0
M  V30 5 C 5.3348 3.8500 0.0 0
M  V30 6 N 4.0011 4.6201 0.0 0
M  V30 7 O 5.3348 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0 CFG=2
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 O 1.3337 1.5400 0.0 0
M  V30 12 O 0.0000 3.8500 0.0 0
M  V30 13 O 1.3337 6.1601 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 14.6385 3.4929 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0
M  V30 17 C 12.0763 4.4764 0.0 0
M  V30 18 N 10.8305 2.3185 0.0 0
M  V30 19 C 13.1069 3.3320 0.0 0
M  V30 20 O 12.3369 1.9983 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 15 19
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-erythro-3-Pentulose, 2-amino-4,5-anhydro-1,2-dideoxy-4-C-methyl-1-phenyl-, ...
C12H15NO2.C2HF3O2
1148157-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.7237 0.0 0
M  V30 2 C 5.3348 7.4937 0.0 0 CFG=1
M  V30 3 O 6.6684 5.1837 0.0 0
M  V30 4 C 4.0011 6.7237 0.0 0
M  V30 5 N 5.3348 9.0338 0.0 0
M  V30 6 C 7.4755 8.9409 0.0 0
M  V30 7 C 8.0022 7.4937 0.0 0 CFG=2
M  V30 8 C 8.9921 6.3141 0.0 0
M  V30 9 O 9.5188 7.7611 0.0 0
M  V30 10 C 2.6675 7.4937 0.0 0
M  V30 11 C 1.3337 6.7237 0.0 0
M  V30 12 C 2.6675 9.0338 0.0 0
M  V30 13 C 0.0000 7.4937 0.0 0
M  V30 14 C 1.3337 9.8038 0.0 0
M  V30 15 C 0.0000 9.0338 0.0 0
M  V30 16 C 4.0926 2.3101 0.0 0
M  V30 17 C 5.4262 1.5400 0.0 0
M  V30 18 F 4.8626 3.6437 0.0 0
M  V30 19 F 2.7589 3.0801 0.0 0
M  V30 20 F 3.3226 0.9764 0.0 0
M  V30 21 O 6.7599 2.3101 0.0 0
M  V30 22 O 5.4262 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 10
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C23H28N4O7
2387523-25-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 8.4701 0.0 0
M  V30 2 C 5.3349 6.9301 0.0 0 CFG=1
M  V30 3 O 4.0011 9.2401 0.0 0
M  V30 4 C 4.0011 6.1600 0.0 0
M  V30 5 N 6.6686 6.1600 0.0 0
M  V30 6 C 6.6686 4.6200 0.0 0
M  V30 7 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 8 O 5.3349 3.8500 0.0 0
M  V30 9 N 9.3359 4.6200 0.0 0
M  V30 10 C 8.0022 2.3100 0.0 0
M  V30 11 C 10.6697 3.8500 0.0 0
M  V30 12 O 6.6686 1.5400 0.0 0
M  V30 13 C 12.0033 4.6200 0.0 0
M  V30 14 O 10.6697 2.3100 0.0 0
M  V30 15 C 6.6686 0.0000 0.0 0
M  V30 16 N 13.3370 3.8500 0.0 0
M  V30 17 C 14.6706 4.6200 0.0 0
M  V30 18 O 14.6706 6.1600 0.0 0
M  V30 19 C 7.6585 8.0603 0.0 0
M  V30 20 C 19.9733 3.4929 0.0 0
M  V30 21 C 6.6686 9.2401 0.0 0 CFG=2
M  V30 22 C 6.1419 10.6871 0.0 0
M  V30 23 O 7.6585 10.4197 0.0 0
M  V30 24 C 2.6675 6.9301 0.0 0
M  V30 25 C 1.3338 6.1600 0.0 0
M  V30 26 C 2.6675 8.4701 0.0 0
M  V30 27 C 0.0000 6.9301 0.0 0
M  V30 28 C 1.3338 9.2401 0.0 0
M  V30 29 C 0.0000 8.4701 0.0 0
M  V30 30 C 16.0044 3.8500 0.0 0
M  V30 31 N 16.1654 2.3183 0.0 0
M  V30 32 C 17.4112 4.4764 0.0 0
M  V30 33 O 17.6716 1.9982 0.0 0
M  V30 34 C 18.4416 3.3318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=1
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 16 17
M  V30 19 2 17 18
M  V30 20 1 17 30
M  V30 21 1 21 19 CFG=3
M  V30 22 1 20 34
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 7 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387523-00-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148157-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3-Aminophenyl)-N-(1-methyl-1H-pyrazol-4-yl)-4-pyrimidinamine
C14H14N6
2412733-73-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 2.3101 0.0 0
M  V30 2 N 0.0000 3.0801 0.0 0
M  V30 3 C 14.6386 3.4372 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 8.0023 3.0801 0.0 0
M  V30 8 C 6.6685 5.3901 0.0 0
M  V30 9 N 8.0023 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.8306 4.6116 0.0 0
M  V30 18 C 12.0765 2.4537 0.0 0
M  V30 19 N 12.3371 4.9318 0.0 0
M  V30 20 N 13.1071 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 16
M  V30 3 1 2 13
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[[3-[6-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl...
C21H25N7O3
2412734-26-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 18.6720 2.3101 0.0 0
M  V30 2 N 9.3360 3.0801 0.0 0
M  V30 3 C 8.0023 2.3101 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0023 0.7700 0.0 0
M  V30 6 N 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 O 2.6675 2.3101 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.1037 4.4137 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 0.5637 1.7464 0.0 0
M  V30 14 C 23.9746 3.4372 0.0 0
M  V30 15 C 14.6708 3.0801 0.0 0
M  V30 16 C 16.0045 2.3101 0.0 0
M  V30 17 N 14.6708 4.6201 0.0 0
M  V30 18 C 17.3382 3.0801 0.0 0
M  V30 19 C 16.0045 5.3901 0.0 0
M  V30 20 N 17.3382 4.6201 0.0 0
M  V30 21 C 13.3372 2.3101 0.0 0
M  V30 22 C 12.0033 3.0801 0.0 0
M  V30 23 C 13.3372 0.7700 0.0 0
M  V30 24 C 10.6697 2.3101 0.0 0
M  V30 25 C 12.0033 0.0000 0.0 0
M  V30 26 C 10.6697 0.7700 0.0 0
M  V30 27 C 20.0057 3.0801 0.0 0
M  V30 28 C 20.1666 4.6116 0.0 0
M  V30 29 C 21.4125 2.4537 0.0 0
M  V30 30 N 21.6730 4.9318 0.0 0
M  V30 31 N 22.4431 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 31
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 21
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2412733-73-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412734-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21607012
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and pharmacological evaluation of 4- or
6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shu, Lei; Chen, Chengjuan; Huan, Xueting; Huang, Hao; Wang, Manman;
Zhang, Jianqiu; Yan, Yile; Liu, Jianming; Zhang, Tiantai; Zhang, Dayong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 191112148pp.

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Tetrazole-5-acetic acid
C3H4N4O2
21743-75-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 C 5.1049 1.8517 0.0 0
M  V30 3 O 5.1049 0.3117 0.0 0
M  V30 4 O 6.4385 2.6217 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 N 2.2765 0.3202 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 9 N 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-3-Amino-4,4,4-trifluoro-1-p-tolyl-3-[4-(4,4,4-trifluorobutoxy)phenyl]buta...
C21H21F6NO2
1441057-79-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 3.0800 0.0 0 CFG=1
M  V30 2 C 6.9300 3.0800 0.0 0
M  V30 3 C 8.4700 1.5400 0.0 0
M  V30 4 N 8.4700 4.6200 0.0 0
M  V30 5 C 6.1600 4.4136 0.0 0
M  V30 6 F 10.0100 1.5400 0.0 0
M  V30 7 F 8.4700 0.0000 0.0 0
M  V30 8 F 6.9300 1.5400 0.0 0
M  V30 9 O 6.9300 5.7473 0.0 0
M  V30 10 O 14.6300 3.0800 0.0 0
M  V30 11 C 15.4000 4.4136 0.0 0
M  V30 12 C 16.9400 4.4136 0.0 0
M  V30 13 C 17.7100 5.7473 0.0 0
M  V30 14 C 19.2500 5.7473 0.0 0
M  V30 15 F 20.7900 5.7473 0.0 0
M  V30 16 F 19.2500 4.2073 0.0 0
M  V30 17 F 19.2500 7.2873 0.0 0
M  V30 18 C 0.0000 4.4136 0.0 0
M  V30 19 C 10.0100 3.0800 0.0 0
M  V30 20 C 10.7800 4.4136 0.0 0
M  V30 21 C 10.7800 1.7462 0.0 0
M  V30 22 C 12.3200 4.4136 0.0 0
M  V30 23 C 12.3200 1.7462 0.0 0
M  V30 24 C 13.0900 3.0800 0.0 0
M  V30 25 C 4.6200 4.4136 0.0 0
M  V30 26 C 3.8500 3.0800 0.0 0
M  V30 27 C 3.8500 5.7473 0.0 0
M  V30 28 C 2.3100 3.0800 0.0 0
M  V30 29 C 2.3100 5.7473 0.0 0
M  V30 30 C 1.5400 4.4136 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 2 5 9
M  V30 10 1 5 25
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 30
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-3-(4-Methylphenyl)-3-oxo-1-[4-(4,4,4-trifluorobutoxy)phenyl]-1-(trifl...
C24H23F6N5O3
2765826-08-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4717 8.4700 0.0 0 CFG=2
M  V30 2 C 6.4717 6.9300 0.0 0
M  V30 3 N 4.9317 8.4700 0.0 0
M  V30 4 C 6.4717 10.0100 0.0 0
M  V30 5 C 5.1381 6.1600 0.0 0
M  V30 6 C 4.1617 9.8038 0.0 0
M  V30 7 F 8.0117 10.0100 0.0 0
M  V30 8 F 6.4717 11.5500 0.0 0
M  V30 9 F 4.9317 10.0100 0.0 0
M  V30 10 O 3.8044 6.9300 0.0 0
M  V30 11 C 2.6217 9.8038 0.0 0
M  V30 12 O 4.9317 11.1374 0.0 0
M  V30 13 O 12.6317 8.4700 0.0 0
M  V30 14 C 13.4017 9.8038 0.0 0
M  V30 15 C 14.9417 9.8038 0.0 0
M  V30 16 C 15.7117 11.1374 0.0 0
M  V30 17 C 17.2517 11.1374 0.0 0
M  V30 18 F 18.7917 11.1374 0.0 0
M  V30 19 F 17.2517 12.6774 0.0 0
M  V30 20 F 17.2517 9.5974 0.0 0
M  V30 21 C 5.1381 0.0000 0.0 0
M  V30 22 C 8.0117 8.4700 0.0 0
M  V30 23 C 8.7817 7.1364 0.0 0
M  V30 24 C 8.7817 9.8038 0.0 0
M  V30 25 C 10.3217 7.1364 0.0 0
M  V30 26 C 10.3217 9.8038 0.0 0
M  V30 27 C 11.0917 8.4700 0.0 0
M  V30 28 C 5.1381 4.6200 0.0 0
M  V30 29 C 6.4717 3.8500 0.0 0
M  V30 30 C 3.8044 3.8500 0.0 0
M  V30 31 C 6.4717 2.3100 0.0 0
M  V30 32 C 3.8044 2.3100 0.0 0
M  V30 33 C 5.1381 1.5400 0.0 0
M  V30 34 C 1.8517 11.1374 0.0 0
M  V30 35 N 2.4782 12.5442 0.0 0
M  V30 36 N 0.3202 11.2984 0.0 0
M  V30 37 N 1.3336 13.5748 0.0 0
M  V30 38 N 0.0000 12.8048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 22
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 2 5 10
M  V30 11 1 5 28
M  V30 12 1 6 11
M  V30 13 2 6 12
M  V30 14 1 11 34
M  V30 15 1 13 14
M  V30 16 1 13 27
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 21 33
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 1 34 35
M  V30 37 2 34 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 21743-75-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1441057-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765826-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31683636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable, optimization study, optimized on base, solvent and temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward
the MGAT2 Clinical Candidate, BMS-963272
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kempson, James; Hou, Xiaoping; Sun, Jung-Hui; Wong, Michael; Pawluczyk,
Joseph; Li, Jianqing; Krishnananthan, Subramaniam; Simmons, Eric M.;
Hsiao, Yi; Li, Yi-Xin; Sun, Dawn; Wu, Dauh-Rurng; Meng, Wei; Ahmad,
Saleem; Negash, Lidet; Brigance, Robert; Turdi, Huji; Hangeland, Jon J.;
Lawrence, R. Michael; Devasthale, Pratik; Robl, Jeffrey A.; Mathur,
Arvind
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(4), 1327-1335

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Oleanolic acid
C30H48O3
508-02-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4730 5.7183 0.0 0
M  V30 2 C 6.4658 5.6716 0.0 0
M  V30 3 C 9.7830 1.3163 0.0 0
M  V30 4 C 2.2170 5.5178 0.0 0
M  V30 5 O 2.9870 6.8516 0.0 0
M  V30 6 O 0.6770 5.5178 0.0 0
M  V30 7 C 11.9599 5.7007 0.0 0
M  V30 8 C 13.6744 4.7108 0.0 0
M  V30 9 C 1.7145 0.0000 0.0 0
M  V30 10 C 0.0000 0.9899 0.0 0
M  V30 11 O 14.5373 2.8504 0.0 0
M  V30 12 C 7.6071 4.1841 0.0 0 CFG=1
M  V30 13 C 6.0671 4.1841 0.0 0 CFG=1
M  V30 14 C 8.3771 2.8504 0.0 0 CFG=2
M  V30 15 C 8.3771 5.5178 0.0 0
M  V30 16 C 5.2971 2.8504 0.0 0
M  V30 17 C 5.2971 5.5178 0.0 0
M  V30 18 C 9.9172 2.8504 0.0 0 CFG=2
M  V30 19 C 7.6071 1.5168 0.0 0
M  V30 20 C 9.9172 5.5178 0.0 0
M  V30 21 C 3.7571 2.8504 0.0 0 CFG=2
M  V30 22 C 6.0671 1.5168 0.0 0
M  V30 23 C 3.7571 5.5178 0.0 0
M  V30 24 C 10.6872 4.1841 0.0 0 CFG=2
M  V30 25 C 10.6872 1.5168 0.0 0
M  V30 26 C 2.9870 4.1841 0.0 0 CFG=1
M  V30 27 C 2.9870 1.5168 0.0 0
M  V30 28 C 12.2272 4.1841 0.0 0
M  V30 29 C 12.2272 1.5168 0.0 0
M  V30 30 C 1.4470 4.1841 0.0 0
M  V30 31 C 1.4470 1.5168 0.0 0
M  V30 32 C 12.9972 2.8504 0.0 0 CFG=1
M  V30 33 C 0.6770 2.8504 0.0 0
M  V30 34 H 8.7759 1.3629 0.0 0
M  V30 35 H 4.5271 1.5168 0.0 0
M  V30 36 H 11.4572 5.5178 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 13 2 CFG=3
M  V30 3 1 18 3 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 26 4 CFG=1
M  V30 7 1 7 28
M  V30 8 1 8 28
M  V30 9 1 9 31
M  V30 10 1 10 31
M  V30 11 1 32 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 34 CFG=3
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 23
M  V30 24 1 18 24
M  V30 25 1 18 25
M  V30 26 1 19 22
M  V30 27 1 20 24
M  V30 28 1 21 26
M  V30 29 1 21 27
M  V30 30 1 21 35 CFG=1
M  V30 31 1 23 26
M  V30 32 1 24 28
M  V30 33 1 24 36 CFG=3
M  V30 34 1 25 29
M  V30 35 1 26 30
M  V30 36 1 27 31
M  V30 37 1 28 32
M  V30 38 1 29 32
M  V30 39 1 30 33
M  V30 40 1 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 12 13 14 18 21 24 26 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Arginine, methyl ester, hydrochloride (1:?)
C7H16N4O2.xClH
22888-59-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0800 0.0 0 CFG=2
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 C 2.6673 3.8501 0.0 0
M  V30 4 N 4.0012 1.5400 0.0 0
M  V30 5 C 6.6685 3.0800 0.0 0
M  V30 6 O 1.3337 3.0800 0.0 0
M  V30 7 O 2.6673 5.3901 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 N 9.3360 3.0800 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 N 12.0033 3.0800 0.0 0
M  V30 13 N 10.6697 5.3901 0.0 0
M  V30 14 Cl 6.0017 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N2-[(3β)-3-Hydroxy-28-oxoolean-12-en-28-yl]-L-arginine methyl ester
C37H62N4O4
2387339-93-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.0296 0.0 0
M  V30 2 N 5.3347 4.2596 0.0 0
M  V30 3 O 6.6684 6.5696 0.0 0
M  V30 4 C 4.0011 5.0296 0.0 0 CFG=2
M  V30 5 C 4.0011 6.5696 0.0 0
M  V30 6 C 2.6674 4.2596 0.0 0
M  V30 7 C 2.6674 7.3396 0.0 0
M  V30 8 O 1.3336 5.0296 0.0 0
M  V30 9 O 2.6674 2.7196 0.0 0
M  V30 10 C 2.6674 8.8796 0.0 0
M  V30 11 C 0.0000 4.2596 0.0 0
M  V30 12 N 1.3336 9.6496 0.0 0
M  V30 13 C 1.3336 11.1896 0.0 0
M  V30 14 N 0.0000 11.9596 0.0 0
M  V30 15 N 2.6674 11.9596 0.0 0
M  V30 16 C 10.0186 7.1953 0.0 0
M  V30 17 C 7.0122 0.0000 0.0 0
M  V30 18 C 8.9921 0.0000 0.0 0
M  V30 19 C 11.1199 7.8312 0.0 0
M  V30 20 C 15.3213 5.1739 0.0 0
M  V30 21 C 16.9941 10.0594 0.0 0
M  V30 22 C 15.0142 10.0594 0.0 0
M  V30 23 O 18.6716 8.8796 0.0 0
M  V30 24 C 8.0021 4.2596 0.0 0 CFG=1
M  V30 25 C 9.3358 3.4896 0.0 0 CFG=1
M  V30 26 C 8.0021 5.7996 0.0 0
M  V30 27 C 6.6684 3.4896 0.0 0
M  V30 28 C 10.6694 4.2596 0.0 0
M  V30 29 C 9.3358 1.9496 0.0 0
M  V30 30 C 9.3358 6.5696 0.0 0
M  V30 31 C 6.6684 1.9496 0.0 0
M  V30 32 C 10.6694 5.7996 0.0 0 CFG=1
M  V30 33 C 12.0032 3.4896 0.0 0
M  V30 34 C 8.0021 1.1796 0.0 0
M  V30 35 C 12.0032 6.5696 0.0 0 CFG=1
M  V30 36 C 13.3369 4.2596 0.0 0
M  V30 37 C 13.3369 5.7996 0.0 0 CFG=1
M  V30 38 C 12.0032 8.1096 0.0 0
M  V30 39 C 14.6705 6.5696 0.0 0 CFG=2
M  V30 40 C 13.3369 8.8796 0.0 0
M  V30 41 C 14.6705 8.1096 0.0 0 CFG=2
M  V30 42 C 16.0041 5.7996 0.0 0
M  V30 43 C 16.0041 8.8796 0.0 0
M  V30 44 C 17.3379 6.5696 0.0 0
M  V30 45 C 17.3379 8.1096 0.0 0 CFG=1
M  V30 46 H 10.6694 2.7196 0.0 0
M  V30 47 H 14.2202 4.5382 0.0 0
M  V30 48 H 14.6705 9.6496 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 32 16 CFG=3
M  V30 17 1 17 34
M  V30 18 1 18 34
M  V30 19 1 35 19 CFG=1
M  V30 20 1 39 20 CFG=1
M  V30 21 1 21 43
M  V30 22 1 22 43
M  V30 23 1 45 23 CFG=1
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 29 1 25 46 CFG=1
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 28 33
M  V30 34 1 29 34
M  V30 35 1 30 32
M  V30 36 1 31 34
M  V30 37 1 32 35
M  V30 38 1 33 36
M  V30 39 1 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 1 37 39
M  V30 43 1 37 47 CFG=3
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 39 42
M  V30 47 1 40 41
M  V30 48 1 41 43
M  V30 49 1 41 48 CFG=3
M  V30 50 1 42 44
M  V30 51 1 43 45
M  V30 52 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 4 24 25 32 35 37 39 41 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 508-02-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22888-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387339-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37984123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pentacyclic triterpene-amino acid derivatives induced apoptosis and
autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Li-qiong; Sun, Li; Zhou, Yu-qing; Liu, Jing-jing; Wang, Quan-de;
Mo, Wei-bin; Cheng, Ke-guang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 94117478

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cycloheptene...
C22H15F2NO3
1417404-28-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6505 1.9730 0.0 0
M  V30 2 C 1.5357 1.3874 0.0 0
M  V30 3 O 0.0000 1.5026 0.0 0
M  V30 4 O 2.2039 0.0000 0.0 0
M  V30 5 N 11.5129 6.7446 0.0 0
M  V30 6 F 14.1802 8.2846 0.0 0
M  V30 7 F 16.8476 3.6646 0.0 0
M  V30 8 C 4.8065 3.8172 0.0 0
M  V30 9 C 4.1383 5.2046 0.0 0
M  V30 10 C 6.3078 3.4745 0.0 0
M  V30 11 C 3.9389 2.5447 0.0 0
M  V30 12 C 4.8065 6.5921 0.0 0
M  V30 13 C 2.6026 5.3198 0.0 0
M  V30 14 C 7.5118 4.4346 0.0 0
M  V30 15 C 2.4032 2.6599 0.0 0
M  V30 16 C 6.3078 6.9348 0.0 0
M  V30 17 C 1.7350 4.0473 0.0 0
M  V30 18 C 7.5118 5.9746 0.0 0
M  V30 19 C 8.8455 3.6646 0.0 0
M  V30 20 C 8.8455 6.7446 0.0 0
M  V30 21 C 10.1792 4.4346 0.0 0
M  V30 22 C 10.1792 5.9746 0.0 0
M  V30 23 C 12.8465 5.9746 0.0 0
M  V30 24 C 14.1802 6.7446 0.0 0
M  V30 25 C 12.8465 4.4346 0.0 0
M  V30 26 C 15.5140 5.9746 0.0 0
M  V30 27 C 14.1802 3.6646 0.0 0
M  V30 28 C 15.5140 4.4346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 22
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Glutamic acid, 1,5-dimethyl ester, hydrochloride (1:1)
C7H13NO4.ClH
23150-65-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0800 0.0 0 CFG=2
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 C 2.6673 3.8501 0.0 0
M  V30 4 N 4.0012 1.5400 0.0 0
M  V30 5 C 6.6685 3.0800 0.0 0
M  V30 6 O 1.3337 3.0800 0.0 0
M  V30 7 O 2.6673 5.3901 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 O 9.3360 3.0800 0.0 0
M  V30 11 O 8.0023 5.3901 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 Cl 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,5-Dimethyl N-[[8-[(2,4-difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo...
C29H26F2N2O6
1417404-44-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.2167 8.9683 0.0 0
M  V30 2 C 6.1600 8.0021 0.0 0
M  V30 3 N 4.6200 8.0021 0.0 0
M  V30 4 O 6.9300 6.6685 0.0 0
M  V30 5 C 3.8500 6.6685 0.0 0 CFG=2
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 O 1.5400 8.0021 0.0 0
M  V30 10 O 1.5400 5.3347 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 0.0000 8.0021 0.0 0
M  V30 13 O 3.8500 1.3338 0.0 0
M  V30 14 O 6.1600 2.6674 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 N 15.7089 14.0899 0.0 0
M  V30 17 F 18.2536 15.8250 0.0 0
M  V30 18 F 21.2588 11.4173 0.0 0
M  V30 19 C 9.2400 10.6694 0.0 0
M  V30 20 C 8.4700 12.0032 0.0 0
M  V30 21 C 10.7628 10.4400 0.0 0
M  V30 22 C 8.4700 9.3358 0.0 0
M  V30 23 C 9.0326 13.4367 0.0 0
M  V30 24 C 6.9300 12.0032 0.0 0
M  V30 25 C 11.8916 11.4875 0.0 0
M  V30 26 C 6.9300 9.3358 0.0 0
M  V30 27 C 10.5042 13.8906 0.0 0
M  V30 28 C 6.1600 10.6694 0.0 0
M  V30 29 C 11.7765 13.0232 0.0 0
M  V30 30 C 13.2791 10.8193 0.0 0
M  V30 31 C 13.0490 13.8906 0.0 0
M  V30 32 C 14.5516 11.6868 0.0 0
M  V30 33 C 14.4364 13.2224 0.0 0
M  V30 34 C 17.0963 13.4217 0.0 0
M  V30 35 C 18.3688 14.2894 0.0 0
M  V30 36 C 17.2115 11.8860 0.0 0
M  V30 37 C 19.7562 13.6211 0.0 0
M  V30 38 C 18.5989 11.2180 0.0 0
M  V30 39 C 19.8714 12.0855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 26
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 16 33
M  V30 17 1 16 34
M  V30 18 1 17 35
M  V30 19 1 18 39
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 25 30
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1417404-28-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23150-65-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1417404-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31188013
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Highly Selective Brain Penetrant p38α
Mitogen-Activated Protein Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tormaehlen, Niklas M.; Martorelli, Mariella; Kuhn, Annette; Maier,
Florian; Guezguez, Jamil; Burnet, Michael; Albrecht, Wolfgang; Laufer,
Stefan A.; Koch, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(2), 1225-1242

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
(2R)-2-Methyl-3-butenoic acid
C5H8O2
20626-49-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl N-[3-amino-4-[2-[(1S)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-3-buten-...
C22H28N4O4
1329171-26-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 8.2638 0.0 0
M  V30 2 C 4.0012 5.9538 0.0 0 CFG=2
M  V30 3 N 4.0012 4.4137 0.0 0
M  V30 4 C 2.6675 6.7238 0.0 0
M  V30 5 C 2.6675 3.6437 0.0 0
M  V30 6 C 2.6675 8.2638 0.0 0
M  V30 7 O 2.6675 2.1037 0.0 0
M  V30 8 O 1.3338 4.4137 0.0 0
M  V30 9 C 1.3338 9.0338 0.0 0
M  V30 10 C 1.3338 1.3337 0.0 0
M  V30 11 C 2.1038 0.0000 0.0 0
M  V30 12 C 0.0000 0.5637 0.0 0
M  V30 13 C 0.5638 2.6673 0.0 0
M  V30 14 N 13.3372 3.6437 0.0 0
M  V30 15 C 14.6708 4.4137 0.0 0
M  V30 16 O 16.0045 3.6437 0.0 0
M  V30 17 O 14.6708 5.9538 0.0 0
M  V30 18 C 17.3383 4.4137 0.0 0
M  V30 19 C 8.0023 6.7238 0.0 0
M  V30 20 C 6.6687 5.9538 0.0 0
M  V30 21 C 8.0023 8.2638 0.0 0
M  V30 22 C 5.3348 6.7238 0.0 0
M  V30 23 C 6.6687 9.0338 0.0 0
M  V30 24 N 5.3348 8.2638 0.0 0
M  V30 25 C 9.3360 5.9538 0.0 0
M  V30 26 C 10.6697 6.7238 0.0 0
M  V30 27 C 9.3360 4.4137 0.0 0
M  V30 28 C 12.0035 5.9538 0.0 0
M  V30 29 C 10.6697 3.6437 0.0 0
M  V30 30 C 12.0035 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 26
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 30
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 25
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl N-[4-[2-[(1S)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-3-buten-1-yl]-4-...
C27H34N4O5
1422387-17-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 9.3356 0.0 0
M  V30 2 C 3.0800 9.3356 0.0 0
M  V30 3 C 2.3100 10.6694 0.0 0 CFG=2
M  V30 4 O 2.3100 8.0020 0.0 0
M  V30 5 C 0.7700 10.6694 0.0 0
M  V30 6 C 3.0800 12.0031 0.0 0
M  V30 7 C 0.0000 12.0031 0.0 0
M  V30 8 N 4.6200 4.0009 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 O 4.6200 1.3336 0.0 0
M  V30 11 O 6.9300 2.6673 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 11.5500 10.6694 0.0 0 CFG=2
M  V30 14 N 12.3200 9.3356 0.0 0
M  V30 15 C 12.3200 12.0031 0.0 0
M  V30 16 C 13.8600 9.3356 0.0 0
M  V30 17 C 11.5500 13.3367 0.0 0
M  V30 18 O 14.6300 8.0020 0.0 0
M  V30 19 O 14.6300 10.6694 0.0 0
M  V30 20 C 12.3200 14.6703 0.0 0
M  V30 21 C 16.1700 8.0020 0.0 0
M  V30 22 C 16.1700 6.4620 0.0 0
M  V30 23 C 17.7100 8.0020 0.0 0
M  V30 24 C 16.1700 9.5420 0.0 0
M  V30 25 C 5.3900 8.0020 0.0 0
M  V30 26 C 6.9300 8.0020 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 7.7000 6.6684 0.0 0
M  V30 29 C 5.3900 5.3347 0.0 0
M  V30 30 C 6.9300 5.3347 0.0 0
M  V30 31 C 7.7000 9.3356 0.0 0
M  V30 32 C 9.2400 9.3356 0.0 0
M  V30 33 C 6.9300 10.6694 0.0 0
M  V30 34 C 10.0100 10.6694 0.0 0
M  V30 35 C 7.7000 12.0031 0.0 0
M  V30 36 N 9.2400 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=1
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15 CFG=3
M  V30 15 1 13 34
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 26 31
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 32 1 31 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20626-49-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1329171-26-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1422387-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21782635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of
Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing
Phenylazole Carboxamide P1 Groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Corte, James R.; Pinto, Donald J. P.; Fang, Tianan; Osuna, Honey; Yang,
Wu; Wang, Yufeng; Lai, Amy; Clark, Charles G.; Sun, Jung-Hui; Rampulla,
Richard; Mathur, Arvind; Kaspady, Mahammed; Neithnadka, Premsai Rai; Li,
Yi-Xin Cindy; Rossi, Karen A.; Myers, Joseph E.; Sheriff, Steven; Lou,
Zhen; Harper, Timothy W.; Huang, Christine; Zheng, Joanna J.; Bozarth,
Jeffrey M.; Wu, Yiming; Wong, Pancras C.; Crain, Earl J.; Seiffert,
Dietmar A.; Luettgen, Joseph M.; Lam, Patrick Y. S.; Wexler, Ruth R.;
Ewing, William R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(2), 784-803

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (2S,4S)-4-hydroxy-1,2-pyrrolidinedicarboxylate
C10H17NO5
87691-27-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 3.8549 0.0 0
M  V30 2 O 5.9256 5.1886 0.0 0
M  V30 3 O 5.9256 2.5213 0.0 0
M  V30 4 C 7.4656 5.1886 0.0 0
M  V30 5 C 7.4656 6.7286 0.0 0
M  V30 6 C 9.0056 5.1886 0.0 0
M  V30 7 C 7.4656 3.6486 0.0 0
M  V30 8 C 3.1864 1.1444 0.0 0
M  V30 9 O 4.6927 0.8242 0.0 0
M  V30 10 O 2.1559 0.0000 0.0 0
M  V30 11 O 0.0000 5.5302 0.0 0
M  V30 12 N 3.6156 3.8549 0.0 0
M  V30 13 C 2.7104 2.6091 0.0 0 CFG=2
M  V30 14 C 2.7104 5.1008 0.0 0
M  V30 15 C 1.2459 3.0849 0.0 0
M  V30 16 C 1.2459 4.6249 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 13 8 CFG=3
M  V30 11 1 16 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(4-Methyl-5-thiazolyl)benzenemethanamine
C11H12N2S
1448189-30-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9406 0.0000 0.0 0
M  V30 2 C 8.5299 2.7105 0.0 0
M  V30 3 N 9.3000 4.0441 0.0 0
M  V30 4 C 3.9098 2.7105 0.0 0
M  V30 5 C 4.6799 4.0441 0.0 0
M  V30 6 C 4.6799 1.3768 0.0 0
M  V30 7 C 6.2199 4.0441 0.0 0
M  V30 8 C 6.2199 1.3768 0.0 0
M  V30 9 C 6.9899 2.7105 0.0 0
M  V30 10 C 2.3698 2.7105 0.0 0
M  V30 11 C 1.4646 1.4646 0.0 0
M  V30 12 S 1.4646 3.9563 0.0 0
M  V30 13 N 0.0000 1.9404 0.0 0
M  V30 14 C 0.0000 3.4805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4S)-4-hydroxy-2-[[[[4-(4-methyl-5-thiazolyl)phenyl]meth...
C21H27N3O4S
1797406-73-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0133 5.3027 0.0 0
M  V30 2 N 8.5533 5.3027 0.0 0
M  V30 3 O 6.2433 6.6363 0.0 0
M  V30 4 C 9.3233 6.6363 0.0 0
M  V30 5 C 3.6814 4.9525 0.0 0
M  V30 6 O 2.1749 4.6322 0.0 0
M  V30 7 O 4.1572 6.4170 0.0 0
M  V30 8 C 1.1445 5.7767 0.0 0
M  V30 9 C 0.0000 4.7463 0.0 0
M  V30 10 C 0.1141 6.9211 0.0 0
M  V30 11 C 2.2889 6.8071 0.0 0
M  V30 12 O 5.8862 0.0000 0.0 0
M  V30 13 C 15.9127 9.3469 0.0 0
M  V30 14 C 6.2433 3.9689 0.0 0 CFG=2
M  V30 15 N 4.7118 3.8080 0.0 0
M  V30 16 C 6.8698 2.5621 0.0 0
M  V30 17 C 4.3916 2.3017 0.0 0
M  V30 18 C 5.7253 1.5317 0.0 0 CFG=2
M  V30 19 C 10.8633 6.6363 0.0 0
M  V30 20 C 11.6333 7.9700 0.0 0
M  V30 21 C 11.6333 5.3027 0.0 0
M  V30 22 C 13.1733 7.9700 0.0 0
M  V30 23 C 13.1733 5.3027 0.0 0
M  V30 24 C 13.9433 6.6363 0.0 0
M  V30 25 C 15.4833 6.6363 0.0 0
M  V30 26 C 16.3885 7.8822 0.0 0
M  V30 27 S 16.3885 5.3905 0.0 0
M  V30 28 N 17.8532 7.4063 0.0 0
M  V30 29 C 17.8532 5.8663 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 18 12 CFG=3
M  V30 14 1 13 26
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87691-27-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448189-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1797406-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41446153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-guided design and optimization of covalent VHL-targeted
sulfonyl fluoride PROTACs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shah, Rishi R.; De Vita, Elena; Sathyamurthi, Preethi S.; Conole, Daniel;
Zhang, Xinyue; Fellows, Elliot; Dickinson, Eleanor R.; Fleites, Carlos
M.; Queisser, Markus A.; Harling, John D.; Tate, Edward W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4641-4654

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
4-Methoxysalicylic acid
C8H8O4
2237-36-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-(trifluorome...
C21H27F3N2O3S
2415386-52-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8986 3.2864 0.0 0
M  V30 4 O 7.4387 5.9538 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0 CFG=1
M  V30 8 C 6.6687 1.5400 0.0 0
M  V30 9 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 C 6.6687 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 13.3372 3.8501 0.0 0
M  V30 14 N 12.0035 6.1601 0.0 0
M  V30 15 C 1.3338 7.7002 0.0 0
M  V30 16 F 2.1038 9.0338 0.0 0
M  V30 17 F 0.0000 8.4702 0.0 0
M  V30 18 F 0.5638 6.3665 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 4.0012 7.7002 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 2.6675 6.9302 0.0 0
M  V30 25 C 14.6708 4.6201 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 3.8501 0.0 0
M  V30 28 C 16.0045 6.9302 0.0 0
M  V30 29 C 17.3383 4.6201 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[[4-(trifluoromethyl)phenyl...
C29H33F3N2O6S
2892016-25-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 7.7000 0.0 0 VAL=6
M  V30 2 N 4.0011 9.2400 0.0 0
M  V30 3 O 2.4611 7.7000 0.0 0
M  V30 4 O 5.5411 7.7000 0.0 0
M  V30 5 C 5.3347 10.0100 0.0 0
M  V30 6 C 2.6674 10.0100 0.0 0
M  V30 7 C 6.6685 9.2400 0.0 0 CFG=1
M  V30 8 C 1.3338 9.2400 0.0 0
M  V30 9 C 8.0021 10.0100 0.0 0 CFG=1
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 C 0.0000 10.0100 0.0 0
M  V30 12 C 1.3338 7.7000 0.0 0
M  V30 13 C 8.0021 11.5500 0.0 0
M  V30 14 N 9.3358 9.2400 0.0 0
M  V30 15 C 10.6694 10.0100 0.0 0
M  V30 16 O 10.6694 11.5500 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 18 F 5.5411 1.5400 0.0 0
M  V30 19 F 4.0011 0.0000 0.0 0
M  V30 20 F 2.4611 1.5400 0.0 0
M  V30 21 O 13.3369 11.5500 0.0 0
M  V30 22 O 16.0041 6.9300 0.0 0
M  V30 23 C 17.3379 7.7000 0.0 0
M  V30 24 C 4.0011 6.1600 0.0 0
M  V30 25 C 2.6674 5.3900 0.0 0
M  V30 26 C 5.3347 5.3900 0.0 0
M  V30 27 C 2.6674 3.8500 0.0 0
M  V30 28 C 5.3347 3.8500 0.0 0
M  V30 29 C 4.0011 3.0800 0.0 0
M  V30 30 C 6.6685 12.3200 0.0 0
M  V30 31 C 5.3347 11.5500 0.0 0
M  V30 32 C 6.6685 13.8600 0.0 0
M  V30 33 C 4.0011 12.3200 0.0 0
M  V30 34 C 5.3347 14.6300 0.0 0
M  V30 35 C 4.0011 13.8600 0.0 0
M  V30 36 C 12.0032 9.2400 0.0 0
M  V30 37 C 13.3369 10.0100 0.0 0
M  V30 38 C 12.0032 7.7000 0.0 0
M  V30 39 C 14.6705 9.2400 0.0 0
M  V30 40 C 13.3369 6.9300 0.0 0
M  V30 41 C 14.6705 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 24
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 36
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 29
M  V30 23 1 21 37
M  V30 24 1 22 23
M  V30 25 1 22 41
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2237-36-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415386-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
5-Cyano-3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-2-methylbenzoic acid
C16H20N2O3
2691175-30-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6673 8.4700 0.0 0
M  V30 4 C 6.6684 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 O 9.3358 7.7000 0.0 0
M  V30 7 O 10.6694 5.3900 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 5.3900 0.0 0
M  V30 14 C 6.6684 3.0800 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 2.6673 3.8500 0.0 0
M  V30 19 C 0.0000 5.3900 0.0 0
M  V30 20 C 1.3336 3.0800 0.0 0
M  V30 21 O 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 3 8 9
M  V30 10 1 8 14
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Aminomethyl)-4,6-dimethyl-2(1H)-pyridinone
C8H12N2O
771579-27-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 N 0.0000 4.0011 0.0 0
M  V30 3 C 2.3100 5.3349 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyano-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl(tetra...
C24H30N4O3
1403593-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6674 8.4700 0.0 0
M  V30 4 C 6.6685 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 N 10.6694 5.3900 0.0 0
M  V30 7 O 9.3358 7.7000 0.0 0
M  V30 8 C 12.0032 6.1600 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 6.6685 0.0000 0.0 0
M  V30 11 C 12.0032 3.0800 0.0 0
M  V30 12 O 14.6705 7.7000 0.0 0
M  V30 13 C 17.3379 3.0800 0.0 0
M  V30 14 C 5.3347 5.3900 0.0 0
M  V30 15 C 6.6685 6.1600 0.0 0
M  V30 16 C 5.3347 3.8500 0.0 0
M  V30 17 C 8.0021 5.3900 0.0 0
M  V30 18 C 6.6685 3.0800 0.0 0
M  V30 19 C 8.0021 3.8500 0.0 0
M  V30 20 C 2.6674 5.3900 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 2.6674 3.8500 0.0 0
M  V30 23 C 0.0000 5.3900 0.0 0
M  V30 24 C 1.3338 3.0800 0.0 0
M  V30 25 O 0.0000 3.8500 0.0 0
M  V30 26 C 13.3369 5.3900 0.0 0
M  V30 27 C 13.3369 3.8500 0.0 0
M  V30 28 C 14.6705 6.1600 0.0 0
M  V30 29 C 14.6705 3.0800 0.0 0
M  V30 30 N 16.0041 5.3900 0.0 0
M  V30 31 C 16.0041 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 8
M  V30 10 1 8 26
M  V30 11 3 9 10
M  V30 12 1 9 18
M  V30 13 1 11 27
M  V30 14 2 12 28
M  V30 15 1 13 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2691175-30-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 771579-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403593-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36826818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive
Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of
Zeste Homologue 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Yang, Hong; Li, Bingbing; Li, Jiayi; Li, Huaxuan; Shi,
Qiongyu; Li, Bang; Wang, Zekun; Zheng, Jiahong; Zhang, Ying; Dong, Hui;
Huang, Xun; Wang, Yuanxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7629-7644

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
C10H17NO5
13726-69-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 3.8549 0.0 0
M  V30 2 O 5.9256 5.1886 0.0 0
M  V30 3 O 5.9256 2.5213 0.0 0
M  V30 4 C 7.4656 5.1886 0.0 0
M  V30 5 C 7.4656 6.7286 0.0 0
M  V30 6 C 9.0056 5.1886 0.0 0
M  V30 7 C 7.4656 3.6486 0.0 0
M  V30 8 C 3.1864 1.1444 0.0 0
M  V30 9 O 4.6927 0.8242 0.0 0
M  V30 10 O 2.1559 0.0000 0.0 0
M  V30 11 O 0.0000 5.5302 0.0 0
M  V30 12 N 3.6156 3.8549 0.0 0
M  V30 13 C 2.7104 2.6091 0.0 0 CFG=2
M  V30 14 C 2.7104 5.1008 0.0 0
M  V30 15 C 1.2459 3.0849 0.0 0
M  V30 16 C 1.2459 4.6249 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 13 8 CFG=3
M  V30 11 1 16 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(4-Methyl-5-thiazolyl)benzenemethanamine
C11H12N2S
1448189-30-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9406 0.0000 0.0 0
M  V30 2 C 8.5299 2.7105 0.0 0
M  V30 3 N 9.3000 4.0441 0.0 0
M  V30 4 C 3.9098 2.7105 0.0 0
M  V30 5 C 4.6799 4.0441 0.0 0
M  V30 6 C 4.6799 1.3768 0.0 0
M  V30 7 C 6.2199 4.0441 0.0 0
M  V30 8 C 6.2199 1.3768 0.0 0
M  V30 9 C 6.9899 2.7105 0.0 0
M  V30 10 C 2.3698 2.7105 0.0 0
M  V30 11 C 1.4646 1.4646 0.0 0
M  V30 12 S 1.4646 3.9563 0.0 0
M  V30 13 N 0.0000 1.9404 0.0 0
M  V30 14 C 0.0000 3.4805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-hydroxy-2-[[[[4-(4-methyl-5-thiazolyl)phenyl]meth...
C21H27N3O4S
1448191-54-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0133 5.3027 0.0 0
M  V30 2 N 8.5533 5.3027 0.0 0
M  V30 3 O 6.2433 6.6363 0.0 0
M  V30 4 C 9.3233 6.6363 0.0 0
M  V30 5 C 3.6814 4.9525 0.0 0
M  V30 6 O 2.1749 4.6322 0.0 0
M  V30 7 O 4.1572 6.4170 0.0 0
M  V30 8 C 1.1445 5.7767 0.0 0
M  V30 9 C 0.0000 4.7463 0.0 0
M  V30 10 C 0.1141 6.9211 0.0 0
M  V30 11 C 2.2889 6.8071 0.0 0
M  V30 12 O 5.8862 0.0000 0.0 0
M  V30 13 C 15.9127 9.3469 0.0 0
M  V30 14 C 6.2433 3.9689 0.0 0 CFG=2
M  V30 15 N 4.7118 3.8080 0.0 0
M  V30 16 C 6.8698 2.5621 0.0 0
M  V30 17 C 4.3916 2.3017 0.0 0
M  V30 18 C 5.7253 1.5317 0.0 0 CFG=1
M  V30 19 C 10.8633 6.6363 0.0 0
M  V30 20 C 11.6333 7.9700 0.0 0
M  V30 21 C 11.6333 5.3027 0.0 0
M  V30 22 C 13.1733 7.9700 0.0 0
M  V30 23 C 13.1733 5.3027 0.0 0
M  V30 24 C 13.9433 6.6363 0.0 0
M  V30 25 C 15.4833 6.6363 0.0 0
M  V30 26 C 16.3885 7.8822 0.0 0
M  V30 27 S 16.3885 5.3905 0.0 0
M  V30 28 N 17.8532 7.4063 0.0 0
M  V30 29 C 17.8532 5.8663 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 18 12 CFG=1
M  V30 14 1 13 26
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13726-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448189-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448191-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23413494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of SK-575 as a Highly Potent and Efficacious
Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Chaoguo; Yang, Jie; Chen, Yong; Zhou, Peiting; Wang, Yingwei; Du,
Wu; Zhao, Lifeng; Chen, Yuanwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(19), 11012-11033

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
C10H17NO5
13726-69-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 3.8549 0.0 0
M  V30 2 O 5.9256 5.1886 0.0 0
M  V30 3 O 5.9256 2.5213 0.0 0
M  V30 4 C 7.4656 5.1886 0.0 0
M  V30 5 C 7.4656 6.7286 0.0 0
M  V30 6 C 9.0056 5.1886 0.0 0
M  V30 7 C 7.4656 3.6486 0.0 0
M  V30 8 C 3.1864 1.1444 0.0 0
M  V30 9 O 4.6927 0.8242 0.0 0
M  V30 10 O 2.1559 0.0000 0.0 0
M  V30 11 O 0.0000 5.5302 0.0 0
M  V30 12 N 3.6156 3.8549 0.0 0
M  V30 13 C 2.7104 2.6091 0.0 0 CFG=2
M  V30 14 C 2.7104 5.1008 0.0 0
M  V30 15 C 1.2459 3.0849 0.0 0
M  V30 16 C 1.2459 4.6249 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 13 8 CFG=3
M  V30 11 1 16 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(4-Methyl-5-thiazolyl)benzenemethanamine
C11H12N2S
1448189-30-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9406 0.0000 0.0 0
M  V30 2 C 8.5299 2.7105 0.0 0
M  V30 3 N 9.3000 4.0441 0.0 0
M  V30 4 C 3.9098 2.7105 0.0 0
M  V30 5 C 4.6799 4.0441 0.0 0
M  V30 6 C 4.6799 1.3768 0.0 0
M  V30 7 C 6.2199 4.0441 0.0 0
M  V30 8 C 6.2199 1.3768 0.0 0
M  V30 9 C 6.9899 2.7105 0.0 0
M  V30 10 C 2.3698 2.7105 0.0 0
M  V30 11 C 1.4646 1.4646 0.0 0
M  V30 12 S 1.4646 3.9563 0.0 0
M  V30 13 N 0.0000 1.9404 0.0 0
M  V30 14 C 0.0000 3.4805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-hydroxy-2-[[[[4-(4-methyl-5-thiazolyl)phenyl]meth...
C21H27N3O4S
1448191-54-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0133 5.3027 0.0 0
M  V30 2 N 8.5533 5.3027 0.0 0
M  V30 3 O 6.2433 6.6363 0.0 0
M  V30 4 C 9.3233 6.6363 0.0 0
M  V30 5 C 3.6814 4.9525 0.0 0
M  V30 6 O 2.1749 4.6322 0.0 0
M  V30 7 O 4.1572 6.4170 0.0 0
M  V30 8 C 1.1445 5.7767 0.0 0
M  V30 9 C 0.0000 4.7463 0.0 0
M  V30 10 C 0.1141 6.9211 0.0 0
M  V30 11 C 2.2889 6.8071 0.0 0
M  V30 12 O 5.8862 0.0000 0.0 0
M  V30 13 C 15.9127 9.3469 0.0 0
M  V30 14 C 6.2433 3.9689 0.0 0 CFG=2
M  V30 15 N 4.7118 3.8080 0.0 0
M  V30 16 C 6.8698 2.5621 0.0 0
M  V30 17 C 4.3916 2.3017 0.0 0
M  V30 18 C 5.7253 1.5317 0.0 0 CFG=1
M  V30 19 C 10.8633 6.6363 0.0 0
M  V30 20 C 11.6333 7.9700 0.0 0
M  V30 21 C 11.6333 5.3027 0.0 0
M  V30 22 C 13.1733 7.9700 0.0 0
M  V30 23 C 13.1733 5.3027 0.0 0
M  V30 24 C 13.9433 6.6363 0.0 0
M  V30 25 C 15.4833 6.6363 0.0 0
M  V30 26 C 16.3885 7.8822 0.0 0
M  V30 27 S 16.3885 5.3905 0.0 0
M  V30 28 N 17.8532 7.4063 0.0 0
M  V30 29 C 17.8532 5.8663 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 18 12 CFG=1
M  V30 14 1 13 26
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13726-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448189-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448191-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27641723
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance
Therapeutic Activity against Lymphoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tu, Yalin; Sun, Yameng; Qiao, Shuang; Luo, Yao; Liu, Panpan; Jiang,
Zhong-Xing; Hu, Yumin; Wang, Zifeng; Huang, Peng; Wen, Shijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(14), 10167-10184

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL

C22H24Cl2FN3O3
3075104-38-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.6685 0.0 0 CFG=2
M  V30 2 C 4.6201 6.6685 0.0 0
M  V30 3 C 6.9302 8.0022 0.0 0
M  V30 4 N 6.9302 5.3348 0.0 0
M  V30 5 N 8.4702 8.0022 0.0 0
M  V30 6 O 6.1601 9.3360 0.0 0
M  V30 7 C 6.1601 4.0010 0.0 0
M  V30 8 N 9.2402 9.3360 0.0 0
M  V30 9 C 9.2402 6.6685 0.0 0
M  V30 10 O 6.9302 2.6673 0.0 0
M  V30 11 O 4.6201 4.0010 0.0 0
M  V30 12 C 10.7802 9.3360 0.0 0
M  V30 13 C 6.1601 1.3337 0.0 0
M  V30 14 C 4.8265 2.1037 0.0 0
M  V30 15 C 5.3901 0.0000 0.0 0
M  V30 16 C 7.4938 0.5637 0.0 0
M  V30 17 Cl 0.0000 9.3360 0.0 0
M  V30 18 F 13.8603 9.3360 0.0 0
M  V30 19 Cl 15.4003 12.0033 0.0 0
M  V30 20 C 3.8501 8.0022 0.0 0
M  V30 21 C 2.3101 8.0022 0.0 0
M  V30 22 C 4.6201 9.3360 0.0 0
M  V30 23 C 1.5400 9.3360 0.0 0
M  V30 24 C 3.8501 10.6697 0.0 0
M  V30 25 C 2.3101 10.6697 0.0 0
M  V30 26 C 11.5503 10.6697 0.0 0
M  V30 27 C 13.0903 10.6697 0.0 0
M  V30 28 C 10.7802 12.0033 0.0 0
M  V30 29 C 13.8603 12.0033 0.0 0
M  V30 30 C 11.5503 13.3370 0.0 0
M  V30 31 C 13.0903 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 23
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H35Cl2FN4O4
3075104-49-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0 CFG=1
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 N 8.0022 6.9301 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 C 6.6684 7.7001 0.0 0
M  V30 6 N 10.6695 5.3901 0.0 0
M  V30 7 O 9.3359 3.0800 0.0 0
M  V30 8 C 6.6684 9.2401 0.0 0 CFG=2
M  V30 9 O 5.3348 6.9301 0.0 0
M  V30 10 N 12.0034 4.6201 0.0 0
M  V30 11 C 10.6695 6.9301 0.0 0
M  V30 12 N 5.3348 10.0101 0.0 0
M  V30 13 C 8.0022 10.0101 0.0 0
M  V30 14 C 13.3370 5.3901 0.0 0
M  V30 15 C 4.0011 9.2401 0.0 0
M  V30 16 C 7.2322 11.3438 0.0 0
M  V30 17 C 9.3359 10.7801 0.0 0
M  V30 18 C 8.7722 8.6765 0.0 0
M  V30 19 O 2.6675 10.0101 0.0 0
M  V30 20 O 4.0011 7.7001 0.0 0
M  V30 21 C 1.3337 9.2401 0.0 0
M  V30 22 C 2.1037 7.9064 0.0 0
M  V30 23 C 0.0000 8.4701 0.0 0
M  V30 24 C 0.5636 10.5738 0.0 0
M  V30 25 Cl 4.0011 0.0000 0.0 0
M  V30 26 F 16.0043 6.9301 0.0 0
M  V30 27 Cl 18.6718 5.3901 0.0 0
M  V30 28 C 6.6684 3.0800 0.0 0
M  V30 29 C 5.3348 2.3100 0.0 0
M  V30 30 C 8.0022 2.3100 0.0 0
M  V30 31 C 5.3348 0.7700 0.0 0
M  V30 32 C 8.0022 0.7700 0.0 0
M  V30 33 C 6.6684 0.0000 0.0 0
M  V30 34 C 14.6707 4.6201 0.0 0
M  V30 35 C 16.0043 5.3901 0.0 0
M  V30 36 C 14.6707 3.0800 0.0 0
M  V30 37 C 17.3381 4.6201 0.0 0
M  V30 38 C 16.0043 2.3100 0.0 0
M  V30 39 C 17.3381 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 34
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 31
M  V30 27 1 26 35
M  V30 28 1 27 37
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-phenylalanine
C15H21NO4
114873-06-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6765 6.1048 0.0 0
M  V30 14 C 0.0000 6.6687 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-1-acetic acid, 4-[[(2S)-2,3-diamino-3-oxopropoxy]methyl]-, ...
C9H15N5O4.C2HF3O2
3026371-88-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.7237 0.0 0
M  V30 2 O 5.3348 7.4938 0.0 0
M  V30 3 C 4.0011 6.7237 0.0 0
M  V30 4 C 2.6673 7.4938 0.0 0 CFG=2
M  V30 5 C 1.3337 6.7237 0.0 0
M  V30 6 N 2.6673 9.0338 0.0 0
M  V30 7 N 1.3337 5.1837 0.0 0
M  V30 8 O 0.0000 7.4938 0.0 0
M  V30 9 C 11.9711 7.8509 0.0 0
M  V30 10 C 12.8763 9.0968 0.0 0
M  V30 11 O 14.4079 8.9357 0.0 0
M  V30 12 O 12.2500 10.5036 0.0 0
M  V30 13 C 15.3131 10.1817 0.0 0
M  V30 14 C 8.0021 7.4938 0.0 0
M  V30 15 C 9.4091 6.8673 0.0 0
M  V30 16 N 8.1632 9.0253 0.0 0
M  V30 17 N 10.4395 8.0118 0.0 0
M  V30 18 N 9.6695 9.3455 0.0 0
M  V30 19 C 6.9897 2.3101 0.0 0
M  V30 20 C 8.3234 1.5400 0.0 0
M  V30 21 F 7.7597 3.6437 0.0 0
M  V30 22 F 5.6561 3.0801 0.0 0
M  V30 23 F 6.2197 0.9764 0.0 0
M  V30 24 O 9.6571 2.3101 0.0 0
M  V30 25 O 8.3234 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 20 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C24H34N6O7
3026370-92-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 5.3900 8.0021 0.0 0
M  V30 5 N 8.4700 8.0021 0.0 0
M  V30 6 O 8.4700 5.3347 0.0 0
M  V30 7 C 3.8500 8.0021 0.0 0
M  V30 8 C 10.0100 8.0021 0.0 0 CFG=2
M  V30 9 O 3.0800 9.3358 0.0 0
M  V30 10 O 3.0800 6.6684 0.0 0
M  V30 11 C 10.7800 6.6684 0.0 0
M  V30 12 C 10.7800 9.3358 0.0 0
M  V30 13 C 1.5400 9.3358 0.0 0
M  V30 14 O 12.3200 6.6684 0.0 0
M  V30 15 N 12.3200 9.3358 0.0 0
M  V30 16 O 10.0100 10.6694 0.0 0
M  V30 17 C 1.5400 7.7958 0.0 0
M  V30 18 C 0.0000 9.3358 0.0 0
M  V30 19 C 1.5400 10.8758 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 C 18.2458 3.6595 0.0 0
M  V30 23 C 19.6526 4.2860 0.0 0
M  V30 24 O 20.8984 3.3808 0.0 0
M  V30 25 O 19.8136 5.8175 0.0 0
M  V30 26 C 22.3054 4.0071 0.0 0
M  V30 27 C 6.1600 4.0011 0.0 0
M  V30 28 C 5.3900 2.6674 0.0 0
M  V30 29 C 7.7000 4.0011 0.0 0
M  V30 30 C 6.1600 1.3336 0.0 0
M  V30 31 C 8.4700 2.6674 0.0 0
M  V30 32 C 7.7000 1.3336 0.0 0
M  V30 33 C 14.6300 5.3347 0.0 0
M  V30 34 C 15.5352 4.0889 0.0 0
M  V30 35 N 15.5352 6.5806 0.0 0
M  V30 36 N 16.9999 4.5647 0.0 0
M  V30 37 N 16.9999 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 20 33
M  V30 22 1 21 30
M  V30 23 1 22 23
M  V30 24 1 22 36
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 2 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 114873-06-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026371-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026370-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676316
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Diphenylacetic acid
C14H12O2
117-34-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 4.0011 0.7700 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 14 C 6.6685 5.3900 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H29N3O5.C2HF3O2
3026371-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.9404 7.8511 0.0 0
M  V30 2 O 18.4804 7.8511 0.0 0
M  V30 3 O 16.1704 6.5174 0.0 0
M  V30 4 C 19.2504 6.5174 0.0 0
M  V30 5 C 20.7905 6.5174 0.0 0
M  V30 6 C 21.5605 5.1837 0.0 0
M  V30 7 C 12.3203 10.5186 0.0 0
M  V30 8 O 11.5503 11.8522 0.0 0
M  V30 9 C 10.0102 11.8522 0.0 0
M  V30 10 C 9.2402 13.1860 0.0 0 CFG=1
M  V30 11 N 7.7002 13.1860 0.0 0
M  V30 12 C 10.0102 14.5197 0.0 0
M  V30 13 C 6.9302 11.8522 0.0 0
M  V30 14 N 9.2402 15.8534 0.0 0
M  V30 15 O 11.5503 14.5197 0.0 0
M  V30 16 C 5.3901 11.8522 0.0 0 CFG=1
M  V30 17 O 7.7002 10.5186 0.0 0
M  V30 18 C 4.6201 10.5186 0.0 0
M  V30 19 N 4.6201 13.1860 0.0 0
M  V30 20 C 0.0000 7.8512 0.0 0
M  V30 21 C 16.1704 9.1849 0.0 0
M  V30 22 C 14.6303 9.1849 0.0 0
M  V30 23 C 16.9404 10.5186 0.0 0
M  V30 24 C 13.8603 10.5186 0.0 0
M  V30 25 C 16.1704 11.8522 0.0 0
M  V30 26 C 14.6303 11.8522 0.0 0
M  V30 27 C 3.0801 10.5186 0.0 0
M  V30 28 C 2.3101 9.1849 0.0 0
M  V30 29 C 2.3101 11.8522 0.0 0
M  V30 30 C 0.7700 9.1849 0.0 0
M  V30 31 C 0.7700 11.8522 0.0 0
M  V30 32 C 0.0000 10.5186 0.0 0
M  V30 33 C 10.1134 2.3101 0.0 0
M  V30 34 C 11.4471 1.5400 0.0 0
M  V30 35 F 10.8834 3.6437 0.0 0
M  V30 36 F 8.7797 3.0801 0.0 0
M  V30 37 F 9.3434 0.9764 0.0 0
M  V30 38 O 12.7807 2.3101 0.0 0
M  V30 39 O 11.4471 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 18 27
M  V30 21 1 20 30
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 33 36
M  V30 37 1 33 37
M  V30 38 1 34 38
M  V30 39 2 34 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C38H39N3O6
3026370-34-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9301 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 N 6.6684 6.9301 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 8.0021 6.1601 0.0 0 CFG=2
M  V30 6 C 8.0021 4.6201 0.0 0
M  V30 7 C 9.3357 6.9301 0.0 0
M  V30 8 N 9.3357 8.4701 0.0 0
M  V30 9 O 10.6695 6.1601 0.0 0
M  V30 10 C 10.6695 9.2401 0.0 0 CFG=2
M  V30 11 C 12.0032 8.4701 0.0 0
M  V30 12 C 10.6695 10.7801 0.0 0
M  V30 13 O 13.3369 9.2401 0.0 0
M  V30 14 N 12.0032 11.5501 0.0 0
M  V30 15 O 9.3357 11.5501 0.0 0
M  V30 16 C 14.6705 8.4701 0.0 0
M  V30 17 C 10.6695 0.0000 0.0 0
M  V30 18 C 20.0053 8.4701 0.0 0
M  V30 19 O 21.3391 9.2401 0.0 0
M  V30 20 O 20.0053 6.9301 0.0 0
M  V30 21 C 22.6727 8.4701 0.0 0
M  V30 22 C 24.0064 9.2401 0.0 0
M  V30 23 C 25.3401 8.4701 0.0 0
M  V30 24 C 2.6673 6.1601 0.0 0
M  V30 25 C 1.3337 6.9301 0.0 0
M  V30 26 C 2.6673 4.6201 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 1.3337 3.8500 0.0 0
M  V30 29 C 0.0000 4.6201 0.0 0
M  V30 30 C 4.0010 8.4701 0.0 0
M  V30 31 C 5.3348 9.2401 0.0 0
M  V30 32 C 2.6673 9.2401 0.0 0
M  V30 33 C 5.3348 10.7801 0.0 0
M  V30 34 C 2.6673 10.7801 0.0 0
M  V30 35 C 4.0010 11.5501 0.0 0
M  V30 36 C 9.3357 3.8500 0.0 0
M  V30 37 C 9.3357 2.3100 0.0 0
M  V30 38 C 10.6695 4.6201 0.0 0
M  V30 39 C 10.6695 1.5400 0.0 0
M  V30 40 C 12.0032 3.8500 0.0 0
M  V30 41 C 12.0032 2.3100 0.0 0
M  V30 42 C 16.0043 9.2401 0.0 0
M  V30 43 C 17.3380 8.4701 0.0 0
M  V30 44 C 16.0043 10.7801 0.0 0
M  V30 45 C 18.6716 9.2401 0.0 0
M  V30 46 C 17.3380 11.5501 0.0 0
M  V30 47 C 18.6716 10.7801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 1 30
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6 CFG=3
M  V30 8 1 5 7
M  V30 9 1 6 36
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 10 11 CFG=3
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 16 42
M  V30 20 1 17 39
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 45
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 45 2 42 43
M  V30 46 1 42 44
M  V30 47 1 43 45
M  V30 48 2 44 46
M  V30 49 2 45 47
M  V30 50 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 117-34-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026371-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026370-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
6-Trifluoromethyl-2-pyridinecarboxylic acid
C7H4F3NO2
131747-42-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 N 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-amino-1H-indazole-6-carboxylate
C9H9N3O2
1000373-79-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 2.6673 0.0 0
M  V30 2 O 7.0574 4.0012 0.0 0
M  V30 3 O 7.0574 1.3337 0.0 0
M  V30 4 C 8.5974 4.0012 0.0 0
M  V30 5 N 4.7473 0.0000 0.0 0
M  V30 6 C 2.4373 4.0012 0.0 0
M  V30 7 C 1.6672 2.6673 0.0 0
M  V30 8 C 3.9773 4.0012 0.0 0
M  V30 9 N 1.4068 5.1456 0.0 0
M  V30 10 C 2.4373 1.3337 0.0 0
M  V30 11 C 0.1609 2.9877 0.0 0
M  V30 12 C 4.7473 2.6673 0.0 0
M  V30 13 N 0.0000 4.5192 0.0 0
M  V30 14 C 3.9773 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[[6-(trifluoromethyl)-2-pyridinyl]carbonyl]amino]-1H-indazole-6-car...
C16H11F3N4O3
1799836-52-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.8501 0.0 0
M  V30 2 C 6.4794 4.6201 0.0 0
M  V30 3 O 6.4794 6.1601 0.0 0
M  V30 4 C 2.4782 2.3101 0.0 0
M  V30 5 O 1.1446 1.5400 0.0 0
M  V30 6 O 3.8119 1.5400 0.0 0
M  V30 7 C 1.1446 0.0000 0.0 0
M  V30 8 C 11.8142 4.6201 0.0 0
M  V30 9 F 12.5842 3.2863 0.0 0
M  V30 10 F 13.1479 5.3901 0.0 0
M  V30 11 F 11.0442 5.9538 0.0 0
M  V30 12 C 3.8119 4.6201 0.0 0
M  V30 13 C 2.4782 3.8501 0.0 0
M  V30 14 C 3.8119 6.1601 0.0 0
M  V30 15 C 1.1446 4.6201 0.0 0
M  V30 16 C 2.4782 6.9302 0.0 0
M  V30 17 C 1.1446 6.1601 0.0 0
M  V30 18 C 2.1580 8.4365 0.0 0
M  V30 19 N 0.0000 7.1906 0.0 0
M  V30 20 N 0.6265 8.5974 0.0 0
M  V30 21 C 7.8131 3.8501 0.0 0
M  V30 22 N 9.1467 4.6201 0.0 0
M  V30 23 C 7.8131 2.3101 0.0 0
M  V30 24 C 10.4804 3.8501 0.0 0
M  V30 25 C 9.1467 1.5400 0.0 0
M  V30 26 C 10.4804 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 24
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 131747-42-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000373-79-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799836-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39101046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD
Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang; Ji, Nan; Browne, Chris M.; Campbell,
Veronica; Chen, Dapeng; Enerson, Brad; Fei, Xue; Huang, Xin; Klaus,
Christine R.; Li, Haoran; Mayo, Michele; McDonald, Alice A.; Paul, Atanu;
Rong, Haojing; Sharma, Kirti; Shi, Yatao; Slavin, Anthony; Walther, Dirk
M.; Yuan, Karen; Zhang, Yi; Zhu, Xiao; Kelleher, Joe; Walker, Duncan;
Mainolfi, Nello
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(13), 10548-10566

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cycloheptene...
C22H15F2NO3
1417404-28-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6505 1.9730 0.0 0
M  V30 2 C 1.5357 1.3874 0.0 0
M  V30 3 O 0.0000 1.5026 0.0 0
M  V30 4 O 2.2039 0.0000 0.0 0
M  V30 5 N 11.5129 6.7446 0.0 0
M  V30 6 F 14.1802 8.2846 0.0 0
M  V30 7 F 16.8476 3.6646 0.0 0
M  V30 8 C 4.8065 3.8172 0.0 0
M  V30 9 C 4.1383 5.2046 0.0 0
M  V30 10 C 6.3078 3.4745 0.0 0
M  V30 11 C 3.9389 2.5447 0.0 0
M  V30 12 C 4.8065 6.5921 0.0 0
M  V30 13 C 2.6026 5.3198 0.0 0
M  V30 14 C 7.5118 4.4346 0.0 0
M  V30 15 C 2.4032 2.6599 0.0 0
M  V30 16 C 6.3078 6.9348 0.0 0
M  V30 17 C 1.7350 4.0473 0.0 0
M  V30 18 C 7.5118 5.9746 0.0 0
M  V30 19 C 8.8455 3.6646 0.0 0
M  V30 20 C 8.8455 6.7446 0.0 0
M  V30 21 C 10.1792 4.4346 0.0 0
M  V30 22 C 10.1792 5.9746 0.0 0
M  V30 23 C 12.8465 5.9746 0.0 0
M  V30 24 C 14.1802 6.7446 0.0 0
M  V30 25 C 12.8465 4.4346 0.0 0
M  V30 26 C 15.5140 5.9746 0.0 0
M  V30 27 C 14.1802 3.6646 0.0 0
M  V30 28 C 15.5140 4.4346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 22
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tryptamine hydrochloride
C10H12N2.ClH
343-94-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.7285 0.0 0
M  V30 2 C 7.1955 4.2526 0.0 0
M  V30 3 N 8.3399 5.2831 0.0 0
M  V30 4 C 3.0801 4.0182 0.0 0
M  V30 5 C 2.3101 2.6844 0.0 0
M  V30 6 C 4.5864 3.6980 0.0 0
M  V30 7 C 2.3101 5.3519 0.0 0
M  V30 8 N 3.3405 1.5400 0.0 0
M  V30 9 C 0.7700 2.6844 0.0 0
M  V30 10 C 4.7473 2.1663 0.0 0
M  V30 11 C 0.7700 5.3519 0.0 0
M  V30 12 C 0.0000 4.0182 0.0 0
M  V30 13 Cl 4.1699 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[(2,4-Difluorophenyl)amino]-10,11-dihydro-N-[2-(1H-indol-3-yl)ethyl]-5-oxo-...
C32H25F2N3O2
2614241-47-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.1971 5.2921 0.0 0
M  V30 2 C 15.3119 4.7064 0.0 0
M  V30 3 N 16.8476 4.8214 0.0 0
M  V30 4 O 14.6437 3.3189 0.0 0
M  V30 5 C 17.7151 3.5491 0.0 0
M  V30 6 C 19.2508 3.6641 0.0 0
M  V30 7 N 5.3347 10.0636 0.0 0
M  V30 8 F 2.6674 11.6036 0.0 0
M  V30 9 F 0.0000 6.9836 0.0 0
M  V30 10 C 12.0413 7.1362 0.0 0
M  V30 11 C 12.7093 8.5236 0.0 0
M  V30 12 C 10.5398 6.7934 0.0 0
M  V30 13 C 12.9087 5.8637 0.0 0
M  V30 14 C 12.0413 9.9111 0.0 0
M  V30 15 C 14.2450 8.6388 0.0 0
M  V30 16 C 9.3358 7.7536 0.0 0
M  V30 17 C 14.4444 5.9787 0.0 0
M  V30 18 C 10.5398 10.2538 0.0 0
M  V30 19 C 15.1126 7.3663 0.0 0
M  V30 20 C 9.3358 9.2936 0.0 0
M  V30 21 C 8.0021 6.9836 0.0 0
M  V30 22 C 8.0021 10.0636 0.0 0
M  V30 23 C 6.6684 7.7536 0.0 0
M  V30 24 C 6.6684 9.2936 0.0 0
M  V30 25 C 4.0011 9.2936 0.0 0
M  V30 26 C 2.6674 10.0636 0.0 0
M  V30 27 C 4.0011 7.7536 0.0 0
M  V30 28 C 1.3336 9.2936 0.0 0
M  V30 29 C 2.6674 6.9836 0.0 0
M  V30 30 C 1.3336 7.7536 0.0 0
M  V30 31 C 20.1183 2.3918 0.0 0
M  V30 32 C 21.6576 2.3457 0.0 0
M  V30 33 C 19.5988 0.9420 0.0 0
M  V30 34 C 22.0895 0.8675 0.0 0
M  V30 35 C 22.7219 3.4588 0.0 0
M  V30 36 N 20.8171 0.0000 0.0 0
M  V30 37 C 23.5856 0.5023 0.0 0
M  V30 38 C 24.2180 3.0937 0.0 0
M  V30 39 C 24.6499 1.6155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 31
M  V30 8 1 7 24
M  V30 9 1 7 25
M  V30 10 1 8 26
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 16 21
M  V30 23 2 17 19
M  V30 24 1 18 20
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 2 32 35
M  V30 39 1 33 36
M  V30 40 1 34 36
M  V30 41 2 34 37
M  V30 42 1 35 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1417404-28-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 343-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614241-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31187992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Highly Selective Brain Penetrant p38α
Mitogen-Activated Protein Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tormaehlen, Niklas M.; Martorelli, Mariella; Kuhn, Annette; Maier,
Florian; Guezguez, Jamil; Burnet, Michael; Albrecht, Wolfgang; Laufer,
Stefan A.; Koch, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(2), 1225-1242

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Tetrazole-5-acetic acid
C3H4N4O2
21743-75-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 C 5.1049 1.8517 0.0 0
M  V30 3 O 5.1049 0.3117 0.0 0
M  V30 4 O 6.4385 2.6217 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 N 2.2765 0.3202 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 9 N 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-3-Amino-4,4,4-trifluoro-1-(4-methylphenyl)-3-[4-[(6,6,6-trifluorohexyl)o...
C23H25F6NO2
1441058-04-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 5.5409 0.0 0 CFG=1
M  V30 2 C 6.9300 5.5409 0.0 0
M  V30 3 C 8.4700 7.0809 0.0 0
M  V30 4 N 8.4700 4.0009 0.0 0
M  V30 5 C 6.1600 4.2073 0.0 0
M  V30 6 F 10.0100 7.0809 0.0 0
M  V30 7 F 8.4700 8.6209 0.0 0
M  V30 8 F 6.9300 7.0809 0.0 0
M  V30 9 O 6.9300 2.8736 0.0 0
M  V30 10 O 14.6300 5.5409 0.0 0
M  V30 11 C 15.4000 4.2073 0.0 0
M  V30 12 C 16.9400 4.2073 0.0 0
M  V30 13 C 17.7100 2.8736 0.0 0
M  V30 14 C 19.2500 2.8736 0.0 0
M  V30 15 C 20.0200 1.5400 0.0 0
M  V30 16 C 21.5600 1.5400 0.0 0
M  V30 17 F 23.1000 1.5400 0.0 0
M  V30 18 F 21.5600 3.0800 0.0 0
M  V30 19 F 21.5600 0.0000 0.0 0
M  V30 20 C 0.0000 4.2073 0.0 0
M  V30 21 C 10.0100 5.5409 0.0 0
M  V30 22 C 10.7800 4.2073 0.0 0
M  V30 23 C 10.7800 6.8747 0.0 0
M  V30 24 C 12.3200 4.2073 0.0 0
M  V30 25 C 12.3200 6.8747 0.0 0
M  V30 26 C 13.0900 5.5409 0.0 0
M  V30 27 C 4.6200 4.2073 0.0 0
M  V30 28 C 3.8500 5.5409 0.0 0
M  V30 29 C 3.8500 2.8736 0.0 0
M  V30 30 C 2.3100 5.5409 0.0 0
M  V30 31 C 2.3100 2.8736 0.0 0
M  V30 32 C 1.5400 4.2073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 21
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 2 5 9
M  V30 10 1 5 27
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 32
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-Tetrazole-5-acetamide, N-[(1S)-3-(4-methylphenyl)-3-oxo-1-[4-[(6,6,6-trifl...
C26H27F6N5O3
3035755-54-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4717 8.4700 0.0 0 CFG=2
M  V30 2 C 6.4717 6.9300 0.0 0
M  V30 3 N 4.9317 8.4700 0.0 0
M  V30 4 C 6.4717 10.0100 0.0 0
M  V30 5 C 5.1381 6.1600 0.0 0
M  V30 6 C 4.1617 9.8036 0.0 0
M  V30 7 F 8.0117 10.0100 0.0 0
M  V30 8 F 6.4717 11.5500 0.0 0
M  V30 9 F 4.9317 10.0100 0.0 0
M  V30 10 O 3.8044 6.9300 0.0 0
M  V30 11 C 2.6217 9.8036 0.0 0
M  V30 12 O 4.9317 11.1373 0.0 0
M  V30 13 O 12.6317 8.4700 0.0 0
M  V30 14 C 13.4017 9.8036 0.0 0
M  V30 15 C 14.9417 9.8036 0.0 0
M  V30 16 C 15.7117 11.1373 0.0 0
M  V30 17 C 17.2517 11.1373 0.0 0
M  V30 18 C 18.0217 12.4709 0.0 0
M  V30 19 C 19.5617 12.4709 0.0 0
M  V30 20 F 21.1017 12.4709 0.0 0
M  V30 21 F 19.5617 14.0109 0.0 0
M  V30 22 F 19.5617 10.9309 0.0 0
M  V30 23 C 5.1381 0.0000 0.0 0
M  V30 24 C 8.0117 8.4700 0.0 0
M  V30 25 C 8.7817 7.1362 0.0 0
M  V30 26 C 8.7817 9.8036 0.0 0
M  V30 27 C 10.3217 7.1362 0.0 0
M  V30 28 C 10.3217 9.8036 0.0 0
M  V30 29 C 11.0917 8.4700 0.0 0
M  V30 30 C 5.1381 4.6200 0.0 0
M  V30 31 C 6.4717 3.8500 0.0 0
M  V30 32 C 3.8044 3.8500 0.0 0
M  V30 33 C 6.4717 2.3100 0.0 0
M  V30 34 C 3.8044 2.3100 0.0 0
M  V30 35 C 5.1381 1.5400 0.0 0
M  V30 36 C 1.8517 11.1373 0.0 0
M  V30 37 N 0.3202 11.2982 0.0 0
M  V30 38 N 2.4782 12.5442 0.0 0
M  V30 39 N 0.0000 12.8046 0.0 0
M  V30 40 N 1.3336 13.5746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 24 CFG=3
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 2 5 10
M  V30 11 1 5 30
M  V30 12 1 6 11
M  V30 13 2 6 12
M  V30 14 1 11 36
M  V30 15 1 13 14
M  V30 16 1 13 29
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 23 35
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 38 1 36 37
M  V30 39 2 36 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 21743-75-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1441058-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035755-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40674244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent,
Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Turdi, Huji; Chao, Hannguang; Hangeland, Jon J.; Ahmad, Saleem; Meng,
Wei; Brigance, Robert; Zhao, Guohua; Wang, Wei; Moore, Fang; Ye,
Xiang-Yang; Mathur, Arvind; Hou, Xiaoping; Kempson, James; Wu,
Dauh-Rurng; Li, Yi-Xin; Azzara, Anthony V.; Ma, Zhengping; Chu,
Ching-Hsuen; Chen, Luping; Cullen, Mary Jane; Rooney, Suzanne; Harvey,
Susan; Kopcho, Lisa; Panemangelor, Reshma; Abell, Lynn; O'Malley, Kevin;
Keim, William J.; Dierks, Elizabeth; Chang, Shu; Foster, Kimberly; Apedo,
Atsu; Harden, David; Dabros, Marta; Gao, Qi; Pelleymounter, Mary Ann;
Whaley, Jean M.; Robl, Jeffrey A.; Cheng, Dong; Lawrence, R. Michael;
Devasthale, Pratik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14773-14792

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL

C22H24ClF2N3O3
3075104-37-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.6685 0.0 0 CFG=2
M  V30 2 C 4.6201 6.6685 0.0 0
M  V30 3 C 6.9302 8.0022 0.0 0
M  V30 4 N 6.9302 5.3348 0.0 0
M  V30 5 N 8.4702 8.0022 0.0 0
M  V30 6 O 6.1601 9.3360 0.0 0
M  V30 7 C 6.1601 4.0010 0.0 0
M  V30 8 N 9.2402 9.3360 0.0 0
M  V30 9 C 9.2402 6.6685 0.0 0
M  V30 10 O 6.9302 2.6673 0.0 0
M  V30 11 O 4.6201 4.0010 0.0 0
M  V30 12 C 10.7802 9.3360 0.0 0
M  V30 13 C 6.1601 1.3337 0.0 0
M  V30 14 C 4.8265 2.1037 0.0 0
M  V30 15 C 5.3901 0.0000 0.0 0
M  V30 16 C 7.4938 0.5637 0.0 0
M  V30 17 F 0.0000 9.3360 0.0 0
M  V30 18 F 13.8603 9.3360 0.0 0
M  V30 19 Cl 15.4003 12.0033 0.0 0
M  V30 20 C 3.8501 8.0022 0.0 0
M  V30 21 C 2.3101 8.0022 0.0 0
M  V30 22 C 4.6201 9.3360 0.0 0
M  V30 23 C 1.5400 9.3360 0.0 0
M  V30 24 C 3.8501 10.6697 0.0 0
M  V30 25 C 2.3101 10.6697 0.0 0
M  V30 26 C 11.5503 10.6697 0.0 0
M  V30 27 C 13.0903 10.6697 0.0 0
M  V30 28 C 10.7802 12.0033 0.0 0
M  V30 29 C 13.8603 12.0033 0.0 0
M  V30 30 C 11.5503 13.3370 0.0 0
M  V30 31 C 13.0903 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 23
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H35ClF2N4O4
3075104-48-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0 CFG=1
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 N 8.0022 6.9301 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 C 6.6684 7.7001 0.0 0
M  V30 6 N 10.6695 5.3901 0.0 0
M  V30 7 O 9.3359 3.0800 0.0 0
M  V30 8 C 6.6684 9.2401 0.0 0 CFG=2
M  V30 9 O 5.3348 6.9301 0.0 0
M  V30 10 N 12.0034 4.6201 0.0 0
M  V30 11 C 10.6695 6.9301 0.0 0
M  V30 12 N 5.3348 10.0101 0.0 0
M  V30 13 C 8.0022 10.0101 0.0 0
M  V30 14 C 13.3370 5.3901 0.0 0
M  V30 15 C 4.0011 9.2401 0.0 0
M  V30 16 C 7.2322 11.3438 0.0 0
M  V30 17 C 9.3359 10.7801 0.0 0
M  V30 18 C 8.7722 8.6765 0.0 0
M  V30 19 O 2.6675 10.0101 0.0 0
M  V30 20 O 4.0011 7.7001 0.0 0
M  V30 21 C 1.3337 9.2401 0.0 0
M  V30 22 C 2.1037 7.9064 0.0 0
M  V30 23 C 0.0000 8.4701 0.0 0
M  V30 24 C 0.5636 10.5738 0.0 0
M  V30 25 F 4.0011 0.0000 0.0 0
M  V30 26 F 16.0043 6.9301 0.0 0
M  V30 27 Cl 18.6718 5.3901 0.0 0
M  V30 28 C 6.6684 3.0800 0.0 0
M  V30 29 C 5.3348 2.3100 0.0 0
M  V30 30 C 8.0022 2.3100 0.0 0
M  V30 31 C 5.3348 0.7700 0.0 0
M  V30 32 C 8.0022 0.7700 0.0 0
M  V30 33 C 6.6684 0.0000 0.0 0
M  V30 34 C 14.6707 4.6201 0.0 0
M  V30 35 C 16.0043 5.3901 0.0 0
M  V30 36 C 14.6707 3.0800 0.0 0
M  V30 37 C 17.3381 4.6201 0.0 0
M  V30 38 C 16.0043 2.3100 0.0 0
M  V30 39 C 17.3381 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 34
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 31
M  V30 27 1 26 35
M  V30 28 1 27 37
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-37-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL

C22H24ClF2N3O3
3075104-39-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 6.6684 0.0 0 CFG=2
M  V30 2 C 10.0100 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 10.0100 8.0020 0.0 0
M  V30 5 N 6.9300 8.0020 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 C 11.5500 8.0020 0.0 0
M  V30 8 N 5.3900 8.0020 0.0 0
M  V30 9 C 7.7000 9.3358 0.0 0
M  V30 10 O 12.3200 9.3358 0.0 0
M  V30 11 O 12.3200 6.6684 0.0 0
M  V30 12 C 4.6200 9.3358 0.0 0
M  V30 13 C 13.8600 9.3358 0.0 0
M  V30 14 C 13.8600 10.8758 0.0 0
M  V30 15 C 15.4000 9.3358 0.0 0
M  V30 16 C 13.8600 7.7958 0.0 0
M  V30 17 F 6.9300 0.0000 0.0 0
M  V30 18 F 3.0800 12.0031 0.0 0
M  V30 19 Cl 0.0000 12.0031 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 10.0100 2.6673 0.0 0
M  V30 23 C 6.9300 2.6673 0.0 0
M  V30 24 C 9.2400 1.3336 0.0 0
M  V30 25 C 7.7000 1.3336 0.0 0
M  V30 26 C 3.0800 9.3358 0.0 0
M  V30 27 C 2.3100 10.6694 0.0 0
M  V30 28 C 2.3100 8.0020 0.0 0
M  V30 29 C 0.7700 10.6694 0.0 0
M  V30 30 C 0.7700 8.0020 0.0 0
M  V30 31 C 0.0000 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 25
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H35ClF2N4O4
3075104-50-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 6.9300 0.0 0 CFG=1
M  V30 2 C 6.6684 6.1600 0.0 0
M  V30 3 N 8.0021 8.4700 0.0 0
M  V30 4 C 9.3358 6.1600 0.0 0
M  V30 5 C 6.6684 9.2400 0.0 0
M  V30 6 N 10.6694 6.9300 0.0 0
M  V30 7 O 9.3358 4.6200 0.0 0
M  V30 8 C 6.6684 10.7800 0.0 0 CFG=2
M  V30 9 O 5.3347 8.4700 0.0 0
M  V30 10 N 12.0032 6.1600 0.0 0
M  V30 11 C 10.6694 8.4700 0.0 0
M  V30 12 N 5.3347 11.5500 0.0 0
M  V30 13 C 8.0021 11.5500 0.0 0
M  V30 14 C 13.3369 6.9300 0.0 0
M  V30 15 C 4.0011 10.7800 0.0 0
M  V30 16 C 7.2321 12.8836 0.0 0
M  V30 17 C 9.3358 12.3200 0.0 0
M  V30 18 C 8.7721 10.2164 0.0 0
M  V30 19 O 2.6674 11.5500 0.0 0
M  V30 20 O 4.0011 9.2400 0.0 0
M  V30 21 C 1.3336 10.7800 0.0 0
M  V30 22 C 2.1036 9.4464 0.0 0
M  V30 23 C 0.0000 10.0100 0.0 0
M  V30 24 C 0.5636 12.1136 0.0 0
M  V30 25 F 6.6684 0.0000 0.0 0
M  V30 26 F 16.0041 8.4700 0.0 0
M  V30 27 Cl 18.6716 6.9300 0.0 0
M  V30 28 C 6.6684 4.6200 0.0 0
M  V30 29 C 8.0021 3.8500 0.0 0
M  V30 30 C 5.3347 3.8500 0.0 0
M  V30 31 C 8.0021 2.3100 0.0 0
M  V30 32 C 5.3347 2.3100 0.0 0
M  V30 33 C 6.6684 1.5400 0.0 0
M  V30 34 C 14.6705 6.1600 0.0 0
M  V30 35 C 16.0041 6.9300 0.0 0
M  V30 36 C 14.6705 4.6200 0.0 0
M  V30 37 C 17.3379 6.1600 0.0 0
M  V30 38 C 16.0041 3.8500 0.0 0
M  V30 39 C 17.3379 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 34
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 33
M  V30 27 1 26 35
M  V30 28 1 27 37
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-39-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-50-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL

C22H24Cl2FN3O3
3075104-40-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 6.6684 0.0 0 CFG=2
M  V30 2 C 10.0100 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 10.0100 8.0020 0.0 0
M  V30 5 N 6.9300 8.0020 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 C 11.5500 8.0020 0.0 0
M  V30 8 N 5.3900 8.0020 0.0 0
M  V30 9 C 7.7000 9.3358 0.0 0
M  V30 10 O 12.3200 9.3358 0.0 0
M  V30 11 O 12.3200 6.6684 0.0 0
M  V30 12 C 4.6200 9.3358 0.0 0
M  V30 13 C 13.8600 9.3358 0.0 0
M  V30 14 C 13.8600 7.7958 0.0 0
M  V30 15 C 15.4000 9.3358 0.0 0
M  V30 16 C 13.8600 10.8758 0.0 0
M  V30 17 Cl 6.9300 0.0000 0.0 0
M  V30 18 F 3.0800 12.0031 0.0 0
M  V30 19 Cl 0.0000 12.0031 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 10.0100 2.6673 0.0 0
M  V30 23 C 6.9300 2.6673 0.0 0
M  V30 24 C 9.2400 1.3336 0.0 0
M  V30 25 C 7.7000 1.3336 0.0 0
M  V30 26 C 3.0800 9.3358 0.0 0
M  V30 27 C 2.3100 10.6694 0.0 0
M  V30 28 C 2.3100 8.0020 0.0 0
M  V30 29 C 0.7700 10.6694 0.0 0
M  V30 30 C 0.7700 8.0020 0.0 0
M  V30 31 C 0.0000 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 25
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H35Cl2FN4O4
3075104-51-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 6.9300 0.0 0 CFG=1
M  V30 2 C 6.6684 6.1600 0.0 0
M  V30 3 N 8.0021 8.4700 0.0 0
M  V30 4 C 9.3358 6.1600 0.0 0
M  V30 5 C 6.6684 9.2400 0.0 0
M  V30 6 N 10.6694 6.9300 0.0 0
M  V30 7 O 9.3358 4.6200 0.0 0
M  V30 8 C 6.6684 10.7800 0.0 0 CFG=2
M  V30 9 O 5.3347 8.4700 0.0 0
M  V30 10 N 12.0032 6.1600 0.0 0
M  V30 11 C 10.6694 8.4700 0.0 0
M  V30 12 N 5.3347 11.5500 0.0 0
M  V30 13 C 8.0021 11.5500 0.0 0
M  V30 14 C 13.3369 6.9300 0.0 0
M  V30 15 C 4.0011 10.7800 0.0 0
M  V30 16 C 7.2321 12.8836 0.0 0
M  V30 17 C 9.3358 12.3200 0.0 0
M  V30 18 C 8.7721 10.2164 0.0 0
M  V30 19 O 2.6674 11.5500 0.0 0
M  V30 20 O 4.0011 9.2400 0.0 0
M  V30 21 C 1.3336 10.7800 0.0 0
M  V30 22 C 2.1036 9.4464 0.0 0
M  V30 23 C 0.0000 10.0100 0.0 0
M  V30 24 C 0.5636 12.1136 0.0 0
M  V30 25 Cl 6.6684 0.0000 0.0 0
M  V30 26 F 16.0041 8.4700 0.0 0
M  V30 27 Cl 18.6716 6.9300 0.0 0
M  V30 28 C 6.6684 4.6200 0.0 0
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 8.0021 3.8500 0.0 0
M  V30 31 C 5.3347 2.3100 0.0 0
M  V30 32 C 8.0021 2.3100 0.0 0
M  V30 33 C 6.6684 1.5400 0.0 0
M  V30 34 C 14.6705 6.1600 0.0 0
M  V30 35 C 16.0041 6.9300 0.0 0
M  V30 36 C 14.6705 4.6200 0.0 0
M  V30 37 C 17.3379 6.1600 0.0 0
M  V30 38 C 16.0041 3.8500 0.0 0
M  V30 39 C 17.3379 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 34
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 33
M  V30 27 1 26 35
M  V30 28 1 27 37
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-40-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
N1-Cyclopropyl-1,2-benzenediamine
C9H12N2
118482-03-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 N 1.3338 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3338 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3338 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3349 2.3100 0.0 0
M  V30 10 C 6.8749 2.3100 0.0 0
M  V30 11 C 6.1049 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-1-[(phenylmethoxy)carbonyl]-4-pi...
C21H30N2O6
368866-15-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 4.0012 0.0 0
M  V30 2 C 12.3203 2.6675 0.0 0 CFG=1
M  V30 3 N 13.8603 2.6675 0.0 0
M  V30 4 C 11.5503 1.3337 0.0 0
M  V30 5 C 14.6303 4.0012 0.0 0
M  V30 6 O 12.3203 0.0000 0.0 0
M  V30 7 O 10.0102 1.3337 0.0 0
M  V30 8 O 16.1704 4.0012 0.0 0
M  V30 9 O 13.8603 5.3348 0.0 0
M  V30 10 C 16.9404 5.3348 0.0 0
M  V30 11 C 15.6067 6.1048 0.0 0
M  V30 12 C 17.7104 6.6685 0.0 0
M  V30 13 C 18.2740 4.5648 0.0 0
M  V30 14 C 5.3901 4.0012 0.0 0
M  V30 15 O 4.6201 5.3348 0.0 0
M  V30 16 O 4.6201 2.6675 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 10.0102 4.0012 0.0 0
M  V30 19 C 9.2402 2.6675 0.0 0
M  V30 20 C 9.2402 5.3348 0.0 0
M  V30 21 C 7.7002 2.6675 0.0 0
M  V30 22 C 7.7002 5.3348 0.0 0
M  V30 23 N 6.9302 4.0012 0.0 0
M  V30 24 C 2.3101 6.6685 0.0 0
M  V30 25 C 0.7700 6.6685 0.0 0
M  V30 26 C 3.0801 8.0023 0.0 0
M  V30 27 C 0.0000 8.0023 0.0 0
M  V30 28 C 2.3101 9.3360 0.0 0
M  V30 29 C 0.7700 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 17 24
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[(2S)-3-[[2-(cyclopropylamino)phenyl]amino]-2-[[(1,1-dimethyle...
C30H40N4O5
2762438-73-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.7238 2.8737 0.0 0
M  V30 2 N 8.2638 5.5412 0.0 0
M  V30 3 C 6.7238 5.5412 0.0 0
M  V30 4 C 5.9538 6.8749 0.0 0 CFG=1
M  V30 5 O 5.9538 4.2074 0.0 0
M  V30 6 C 6.7238 8.2085 0.0 0
M  V30 7 N 4.4137 6.8749 0.0 0
M  V30 8 C 3.6437 8.2085 0.0 0
M  V30 9 O 2.1037 8.2085 0.0 0
M  V30 10 O 4.4137 9.5422 0.0 0
M  V30 11 C 1.3337 9.5422 0.0 0
M  V30 12 C 0.0000 8.7722 0.0 0
M  V30 13 C 0.5637 10.8760 0.0 0
M  V30 14 C 2.6673 10.3122 0.0 0
M  V30 15 C 12.8839 8.2085 0.0 0
M  V30 16 O 13.6539 9.5422 0.0 0
M  V30 17 O 13.6539 6.8749 0.0 0
M  V30 18 C 15.1940 9.5422 0.0 0
M  V30 19 C 8.2638 2.8737 0.0 0
M  V30 20 C 9.0338 4.2074 0.0 0
M  V30 21 C 9.0338 1.5400 0.0 0
M  V30 22 C 10.5739 4.2074 0.0 0
M  V30 23 C 10.5739 1.5400 0.0 0
M  V30 24 C 11.3439 2.8737 0.0 0
M  V30 25 C 5.9538 1.5400 0.0 0
M  V30 26 C 5.9538 0.0000 0.0 0
M  V30 27 C 4.6201 0.7700 0.0 0
M  V30 28 C 8.2638 8.2085 0.0 0
M  V30 29 C 9.0338 9.5422 0.0 0
M  V30 30 C 9.0338 6.8749 0.0 0
M  V30 31 C 10.5739 9.5422 0.0 0
M  V30 32 C 10.5739 6.8749 0.0 0
M  V30 33 N 11.3439 8.2085 0.0 0
M  V30 34 C 15.9640 10.8760 0.0 0
M  V30 35 C 17.5040 10.8760 0.0 0
M  V30 36 C 15.1940 12.2097 0.0 0
M  V30 37 C 18.2740 12.2097 0.0 0
M  V30 38 C 15.9640 13.5434 0.0 0
M  V30 39 C 17.5040 13.5434 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=1
M  V30 9 1 6 28
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 33
M  V30 20 1 16 18
M  V30 21 1 18 34
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 118482-03-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 368866-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2762438-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31670168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR)
Antagonist with Propensity for Accumulation and Responsiveness in Ileum
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Teno, Naoki; Iguchi, Yusuke; Oda, Keisuke; Yamashita, Yukiko; Masuda,
Arisa; Fujimori, Ko; Une, Mizuho; Gohda, Keigo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2021), 12(3), 420-425

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline
C13H18F3N3
694499-26-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 4.2073 1.5400 0.0 0
M  V30 4 F 2.6673 0.0000 0.0 0
M  V30 5 F 1.1273 1.5400 0.0 0
M  V30 6 N 0.0000 6.1600 0.0 0
M  V30 7 C 10.6694 6.1600 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 3.0800 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 1.3336 5.3900 0.0 0
M  V30 14 N 6.6684 3.8500 0.0 0
M  V30 15 C 6.6684 5.3900 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 N 9.3358 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 9
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C9H8ClNO5
3035807-47-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6673 6.9301 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 O 6.6684 4.6201 0.0 0
M  V30 5 C 8.0022 3.8500 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 Cl 10.6695 3.8500 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Chloroethoxy)-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)p...
C22H24ClF3N4O4
2374752-21-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 8.0021 1.5400 0.0 0
M  V30 3 F 6.4621 1.5400 0.0 0
M  V30 4 F 8.0021 0.0000 0.0 0
M  V30 5 F 9.5421 1.5400 0.0 0
M  V30 6 N 10.6694 6.1600 0.0 0
M  V30 7 C 10.6694 7.7000 0.0 0
M  V30 8 O 9.3358 8.4700 0.0 0
M  V30 9 C 0.0000 6.1600 0.0 0
M  V30 10 N 13.3369 12.3200 0.0 0 VAL=5
M  V30 11 O 14.6705 13.0900 0.0 0
M  V30 12 O 12.0031 13.0900 0.0 0
M  V30 13 O 16.0041 10.7800 0.0 0
M  V30 14 C 17.3378 10.0100 0.0 0
M  V30 15 C 18.6716 10.7800 0.0 0
M  V30 16 Cl 20.0052 10.0100 0.0 0
M  V30 17 C 6.6684 3.8500 0.0 0
M  V30 18 C 8.0021 3.0800 0.0 0
M  V30 19 C 6.6684 5.3900 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 8.0021 6.1600 0.0 0
M  V30 22 C 9.3358 5.3900 0.0 0
M  V30 23 N 4.0011 3.8500 0.0 0
M  V30 24 C 2.6674 3.0800 0.0 0
M  V30 25 C 4.0011 5.3900 0.0 0
M  V30 26 C 1.3336 3.8500 0.0 0
M  V30 27 C 2.6674 6.1600 0.0 0
M  V30 28 N 1.3336 5.3900 0.0 0
M  V30 29 C 12.0031 8.4700 0.0 0
M  V30 30 C 12.0031 10.0100 0.0 0
M  V30 31 C 13.3369 7.7000 0.0 0
M  V30 32 C 13.3369 10.7800 0.0 0
M  V30 33 C 14.6705 8.4700 0.0 0
M  V30 34 C 14.6705 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 18
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 2 7 8
M  V30 10 1 7 29
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 2 10 12
M  V30 14 1 10 32
M  V30 15 1 13 14
M  V30 16 1 13 34
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 694499-26-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035807-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2374752-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40728206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationship study of new biaryl amide
derivatives and their inhibitory effects against hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yonghua; Li, Jianrui; Gu, Yuxi; Ma, Ling; Cen, Shan; Peng, Zonggen;
Hu, Laixing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 228114033

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL

C22H24Cl2FN3O3
3075104-36-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0 CFG=2
M  V30 2 C 10.0100 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 N 10.0100 6.6684 0.0 0
M  V30 5 N 6.9300 6.6684 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 C 11.5500 6.6684 0.0 0
M  V30 8 N 5.3900 6.6684 0.0 0
M  V30 9 C 7.7000 8.0021 0.0 0
M  V30 10 O 12.3200 8.0021 0.0 0
M  V30 11 O 12.3200 5.3347 0.0 0
M  V30 12 C 4.6200 8.0021 0.0 0
M  V30 13 C 13.8600 8.0021 0.0 0
M  V30 14 C 13.8600 6.4621 0.0 0
M  V30 15 C 15.4000 8.0021 0.0 0
M  V30 16 C 13.8600 9.5421 0.0 0
M  V30 17 Cl 11.5500 1.3336 0.0 0
M  V30 18 F 3.0800 10.6694 0.0 0
M  V30 19 Cl 0.0000 10.6694 0.0 0
M  V30 20 C 9.2400 2.6673 0.0 0
M  V30 21 C 10.0100 1.3336 0.0 0
M  V30 22 C 7.7000 2.6673 0.0 0
M  V30 23 C 9.2400 0.0000 0.0 0
M  V30 24 C 6.9300 1.3336 0.0 0
M  V30 25 C 7.7000 0.0000 0.0 0
M  V30 26 C 3.0800 8.0021 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 0.7700 6.6684 0.0 0
M  V30 31 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 21
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H35Cl2FN4O4
3075104-47-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 9.3358 0.0 0 CFG=1
M  V30 2 C 5.3901 10.6697 0.0 0
M  V30 3 N 5.3901 8.0022 0.0 0
M  V30 4 C 7.7002 9.3358 0.0 0
M  V30 5 C 3.8501 8.0022 0.0 0
M  V30 6 N 8.4702 8.0022 0.0 0
M  V30 7 O 8.4702 10.6697 0.0 0
M  V30 8 C 3.0801 6.6685 0.0 0 CFG=2
M  V30 9 O 3.0801 9.3358 0.0 0
M  V30 10 N 10.0102 8.0022 0.0 0
M  V30 11 C 7.7002 6.6685 0.0 0
M  V30 12 N 3.8501 5.3348 0.0 0
M  V30 13 C 1.5400 6.6685 0.0 0
M  V30 14 C 10.7802 6.6685 0.0 0
M  V30 15 C 3.0801 4.0010 0.0 0
M  V30 16 C 1.5400 5.1285 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 1.5400 8.2085 0.0 0
M  V30 19 O 3.8501 2.6673 0.0 0
M  V30 20 O 1.5400 4.0010 0.0 0
M  V30 21 C 3.0801 1.3337 0.0 0
M  V30 22 C 1.7464 2.1037 0.0 0
M  V30 23 C 2.3101 0.0000 0.0 0
M  V30 24 C 4.4137 0.5637 0.0 0
M  V30 25 Cl 3.8501 13.3370 0.0 0
M  V30 26 F 12.3203 4.0010 0.0 0
M  V30 27 Cl 15.4003 4.0010 0.0 0
M  V30 28 C 6.1601 12.0033 0.0 0
M  V30 29 C 5.3901 13.3370 0.0 0
M  V30 30 C 7.7002 12.0033 0.0 0
M  V30 31 C 6.1601 14.6707 0.0 0
M  V30 32 C 8.4702 13.3370 0.0 0
M  V30 33 C 7.7002 14.6707 0.0 0
M  V30 34 C 12.3203 6.6685 0.0 0
M  V30 35 C 13.0903 5.3348 0.0 0
M  V30 36 C 13.0903 8.0022 0.0 0
M  V30 37 C 14.6303 5.3348 0.0 0
M  V30 38 C 14.6303 8.0022 0.0 0
M  V30 39 C 15.4003 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 34
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 29
M  V30 27 1 26 35
M  V30 28 1 27 37
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
5-Hexynoic acid
C6H8O2
53293-00-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 3 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-[5-Oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]-L-tyrosine methyl ester
C18H17N3O7S
1446557-76-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.8993 3.7711 0.0 0
M  V30 2 S 3.5673 3.4209 0.0 0 VAL=6
M  V30 3 O 4.7117 4.4513 0.0 0
M  V30 4 O 2.4228 2.3903 0.0 0
M  V30 5 O 2.8708 0.1435 0.0 0
M  V30 6 C 13.0594 3.7711 0.0 0
M  V30 7 C 13.8294 5.1047 0.0 0 CFG=2
M  V30 8 C 15.3694 5.1047 0.0 0
M  V30 9 N 13.0594 6.4384 0.0 0
M  V30 10 O 16.1395 6.4384 0.0 0
M  V30 11 O 16.1395 3.7711 0.0 0
M  V30 12 C 17.6795 6.4384 0.0 0
M  V30 13 C 6.1293 2.4374 0.0 0
M  V30 14 C 4.5977 2.2763 0.0 0
M  V30 15 N 6.7558 1.0304 0.0 0
M  V30 16 N 4.2776 0.7700 0.0 0 VAL=5
M  V30 17 O 5.6112 0.0000 0.0 0
M  V30 18 C 8.4393 3.7711 0.0 0
M  V30 19 C 9.2093 2.4374 0.0 0
M  V30 20 C 9.2093 5.1047 0.0 0
M  V30 21 C 10.7494 2.4374 0.0 0
M  V30 22 C 10.7494 5.1047 0.0 0
M  V30 23 C 11.5194 3.7711 0.0 0
M  V30 24 C 2.5367 4.5652 0.0 0
M  V30 25 C 3.0127 6.0300 0.0 0
M  V30 26 C 1.0304 4.2451 0.0 0
M  V30 27 C 1.9822 7.1744 0.0 0
M  V30 28 C 0.0000 5.3896 0.0 0
M  V30 29 C 0.4759 6.8542 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 2 24
M  V30 7 2 5 16
M  V30 8 1 6 7
M  V30 9 1 6 23
M  V30 10 1 7 8
M  V30 11 1 7 9 CFG=3
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Tyrosine, O-[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]-N-(1-oxo-5-he...
C24H23N3O8S
2982239-51-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.8993 5.3348 0.0 0
M  V30 2 S 3.5673 5.6850 0.0 0 VAL=6
M  V30 3 O 2.4228 6.7156 0.0 0
M  V30 4 O 4.7117 4.6546 0.0 0
M  V30 5 O 2.8708 8.9622 0.0 0
M  V30 6 C 13.0594 5.3348 0.0 0
M  V30 7 C 13.8295 4.0011 0.0 0 CFG=1
M  V30 8 N 15.3695 4.0011 0.0 0
M  V30 9 C 13.0594 2.6675 0.0 0
M  V30 10 C 16.1395 5.3348 0.0 0
M  V30 11 O 13.8295 1.3337 0.0 0
M  V30 12 O 11.5194 2.6675 0.0 0
M  V30 13 C 17.6795 5.3348 0.0 0
M  V30 14 O 15.3695 6.6685 0.0 0
M  V30 15 C 13.0594 0.0000 0.0 0
M  V30 16 C 18.4495 6.6685 0.0 0
M  V30 17 C 19.9896 6.6685 0.0 0
M  V30 18 C 20.7596 8.0023 0.0 0
M  V30 19 C 21.5296 9.3360 0.0 0
M  V30 20 C 6.1293 6.6685 0.0 0
M  V30 21 C 4.5978 6.8296 0.0 0
M  V30 22 N 6.7558 8.0754 0.0 0
M  V30 23 N 4.2776 8.3359 0.0 0 VAL=5
M  V30 24 O 5.6112 9.1059 0.0 0
M  V30 25 C 8.4394 5.3348 0.0 0
M  V30 26 C 9.2094 6.6685 0.0 0
M  V30 27 C 9.2094 4.0011 0.0 0
M  V30 28 C 10.7494 6.6685 0.0 0
M  V30 29 C 10.7494 4.0011 0.0 0
M  V30 30 C 11.5194 5.3348 0.0 0
M  V30 31 C 2.5367 4.5406 0.0 0
M  V30 32 C 1.0304 4.8608 0.0 0
M  V30 33 C 3.0128 3.0759 0.0 0
M  V30 34 C 0.0000 3.7162 0.0 0
M  V30 35 C 1.9822 1.9315 0.0 0
M  V30 36 C 0.4759 2.2517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 25
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 2 31
M  V30 7 2 5 23
M  V30 8 1 6 7
M  V30 9 1 6 30
M  V30 10 1 7 8 CFG=3
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 9 12
M  V30 15 1 10 13
M  V30 16 2 10 14
M  V30 17 1 11 15
M  V30 18 1 13 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 3 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53293-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1446557-76-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2982239-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40674680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm
Eradication and Antibacterial Activities for Intervention of
Device-Related Infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fei, Yue; Wu, Jianbing; An, Hong-Wei; Zhu, Kai; Peng, Bo; Cai, Junquan;
Zhang, Yihua; Li, Li-Li; Wang, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9127-9135

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL

C20H23ClFN3O3S
3075104-41-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.1046 0.0 0 CFG=2
M  V30 2 C 10.0100 3.7710 0.0 0
M  V30 3 C 7.7000 5.1046 0.0 0
M  V30 4 N 10.0100 6.4383 0.0 0
M  V30 5 N 6.9300 6.4383 0.0 0
M  V30 6 O 6.9300 3.7710 0.0 0
M  V30 7 C 11.5500 6.4383 0.0 0
M  V30 8 N 5.3900 6.4383 0.0 0
M  V30 9 C 7.7000 7.7721 0.0 0
M  V30 10 O 12.3200 7.7721 0.0 0
M  V30 11 O 12.3200 5.1046 0.0 0
M  V30 12 C 4.6200 7.7721 0.0 0
M  V30 13 C 13.8600 7.7721 0.0 0
M  V30 14 C 13.8600 6.2321 0.0 0
M  V30 15 C 15.4000 7.7721 0.0 0
M  V30 16 C 13.8600 9.3121 0.0 0
M  V30 17 F 3.0800 10.4394 0.0 0
M  V30 18 Cl 0.0000 10.4394 0.0 0
M  V30 19 C 9.2400 2.4374 0.0 0
M  V30 20 C 9.8663 1.0304 0.0 0
M  V30 21 S 7.7085 2.2763 0.0 0
M  V30 22 C 8.7219 0.0000 0.0 0
M  V30 23 C 7.3883 0.7700 0.0 0
M  V30 24 C 3.0800 7.7721 0.0 0
M  V30 25 C 2.3100 9.1057 0.0 0
M  V30 26 C 2.3100 6.4383 0.0 0
M  V30 27 C 0.7700 9.1057 0.0 0
M  V30 28 C 0.7700 6.4383 0.0 0
M  V30 29 C 0.0000 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 25
M  V30 19 1 18 27
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C26H34ClFN4O4S
3075104-52-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6798 0.0 0 CFG=1
M  V30 2 C 6.6684 3.9098 0.0 0
M  V30 3 N 8.0023 6.2198 0.0 0
M  V30 4 C 9.3359 3.9098 0.0 0
M  V30 5 C 6.6684 6.9898 0.0 0
M  V30 6 N 10.6696 4.6798 0.0 0
M  V30 7 O 9.3359 2.3698 0.0 0
M  V30 8 C 6.6684 8.5299 0.0 0 CFG=2
M  V30 9 O 5.3348 6.2198 0.0 0
M  V30 10 N 12.0034 3.9098 0.0 0
M  V30 11 C 10.6696 6.2198 0.0 0
M  V30 12 N 5.3348 9.2999 0.0 0
M  V30 13 C 8.0023 9.2999 0.0 0
M  V30 14 C 13.3370 4.6798 0.0 0
M  V30 15 C 4.0011 8.5299 0.0 0
M  V30 16 C 7.2322 10.6335 0.0 0
M  V30 17 C 9.3359 10.0699 0.0 0
M  V30 18 C 8.7723 7.9662 0.0 0
M  V30 19 O 2.6675 9.2999 0.0 0
M  V30 20 O 4.0011 6.9898 0.0 0
M  V30 21 C 1.3337 8.5299 0.0 0
M  V30 22 C 2.1037 7.1962 0.0 0
M  V30 23 C 0.0000 7.7599 0.0 0
M  V30 24 C 0.5636 9.8635 0.0 0
M  V30 25 F 16.0044 6.2198 0.0 0
M  V30 26 Cl 18.6718 4.6798 0.0 0
M  V30 27 C 6.6684 2.3698 0.0 0
M  V30 28 C 7.9145 1.4646 0.0 0
M  V30 29 S 5.4226 1.4646 0.0 0
M  V30 30 C 7.4385 0.0000 0.0 0
M  V30 31 C 5.8984 0.0000 0.0 0
M  V30 32 C 14.6707 3.9098 0.0 0
M  V30 33 C 16.0044 4.6798 0.0 0
M  V30 34 C 14.6707 2.3698 0.0 0
M  V30 35 C 17.3382 3.9098 0.0 0
M  V30 36 C 16.0044 1.5998 0.0 0
M  V30 37 C 17.3382 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 32
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 33
M  V30 27 1 26 35
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 31
M  V30 33 2 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 34 36
M  V30 37 2 35 37
M  V30 38 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-41-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941810
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL

C22H24ClF2N3O3
3075104-35-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0 CFG=2
M  V30 2 C 10.0100 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 N 10.0100 6.6684 0.0 0
M  V30 5 N 6.9300 6.6684 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 C 11.5500 6.6684 0.0 0
M  V30 8 N 5.3900 6.6684 0.0 0
M  V30 9 C 7.7000 8.0021 0.0 0
M  V30 10 O 12.3200 8.0021 0.0 0
M  V30 11 O 12.3200 5.3347 0.0 0
M  V30 12 C 4.6200 8.0021 0.0 0
M  V30 13 C 13.8600 8.0021 0.0 0
M  V30 14 C 13.8600 6.4621 0.0 0
M  V30 15 C 15.4000 8.0021 0.0 0
M  V30 16 C 13.8600 9.5421 0.0 0
M  V30 17 F 11.5500 1.3336 0.0 0
M  V30 18 F 3.0800 10.6694 0.0 0
M  V30 19 Cl 0.0000 10.6694 0.0 0
M  V30 20 C 9.2400 2.6673 0.0 0
M  V30 21 C 10.0100 1.3336 0.0 0
M  V30 22 C 7.7000 2.6673 0.0 0
M  V30 23 C 9.2400 0.0000 0.0 0
M  V30 24 C 6.9300 1.3336 0.0 0
M  V30 25 C 7.7000 0.0000 0.0 0
M  V30 26 C 3.0800 8.0021 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 0.7700 6.6684 0.0 0
M  V30 31 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 10 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 21
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-L-tert-leucine
C11H21NO4
62965-35-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0 CFG=2
M  V30 2 N 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 2.6675 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 0.5637 2.6673 0.0 0
M  V30 9 O 1.3337 4.4137 0.0 0
M  V30 10 O 4.0012 4.4137 0.0 0
M  V30 11 O 6.6685 1.3337 0.0 0
M  V30 12 O 5.3348 3.6437 0.0 0
M  V30 13 C 8.0023 2.1037 0.0 0
M  V30 14 C 7.2323 3.4374 0.0 0
M  V30 15 C 9.3360 2.8737 0.0 0
M  V30 16 C 8.7723 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H35ClF2N4O4
3075104-46-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 9.3358 0.0 0 CFG=1
M  V30 2 C 5.3901 10.6697 0.0 0
M  V30 3 N 5.3901 8.0022 0.0 0
M  V30 4 C 7.7002 9.3358 0.0 0
M  V30 5 C 3.8501 8.0022 0.0 0
M  V30 6 N 8.4702 8.0022 0.0 0
M  V30 7 O 8.4702 10.6697 0.0 0
M  V30 8 C 3.0801 6.6685 0.0 0 CFG=2
M  V30 9 O 3.0801 9.3358 0.0 0
M  V30 10 N 10.0102 8.0022 0.0 0
M  V30 11 C 7.7002 6.6685 0.0 0
M  V30 12 N 3.8501 5.3348 0.0 0
M  V30 13 C 1.5400 6.6685 0.0 0
M  V30 14 C 10.7802 6.6685 0.0 0
M  V30 15 C 3.0801 4.0010 0.0 0
M  V30 16 C 1.5400 5.1285 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 1.5400 8.2085 0.0 0
M  V30 19 O 3.8501 2.6673 0.0 0
M  V30 20 O 1.5400 4.0010 0.0 0
M  V30 21 C 3.0801 1.3337 0.0 0
M  V30 22 C 1.7464 2.1037 0.0 0
M  V30 23 C 2.3101 0.0000 0.0 0
M  V30 24 C 4.4137 0.5637 0.0 0
M  V30 25 F 3.8501 13.3370 0.0 0
M  V30 26 F 12.3203 4.0010 0.0 0
M  V30 27 Cl 15.4003 4.0010 0.0 0
M  V30 28 C 6.1601 12.0033 0.0 0
M  V30 29 C 5.3901 13.3370 0.0 0
M  V30 30 C 7.7002 12.0033 0.0 0
M  V30 31 C 6.1601 14.6707 0.0 0
M  V30 32 C 8.4702 13.3370 0.0 0
M  V30 33 C 7.7002 14.6707 0.0 0
M  V30 34 C 12.3203 6.6685 0.0 0
M  V30 35 C 13.0903 5.3348 0.0 0
M  V30 36 C 13.0903 8.0022 0.0 0
M  V30 37 C 14.6303 5.3348 0.0 0
M  V30 38 C 14.6303 8.0022 0.0 0
M  V30 39 C 15.4003 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13 CFG=1
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 34
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 29
M  V30 27 1 26 35
M  V30 28 1 27 37
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3075104-35-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62965-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3075104-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-45941791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3,see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent
SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breidenbach, Julian; Voget, Rabea; Si, Yaoyao; Hingst, Alexandra; Claff,
Tobias; Sylvester, Katharina; Wolf, Valentina; Krasniqi, Vesa; Useini,
Abibe; Straeter, Norbert; Ogura, Yukino; Kawaguchi, Atsushi; Mueller,
Christa E.; Guetschow, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8757-8790

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-hydroxy-N-(2-methylpropyl)benze...
C20H28N2O4S
157567-13-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 O 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Morpholinecarboxylic acid, 4-methyl-, (3S)-
C6H11NO3
1315051-74-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0 CFG=2
M  V30 6 N 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 O 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=3
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-N-[(1S,2R)-2-Hydroxy-3-[[(4-hydroxyphenyl)sulfonyl](2-methylpropyl)amino...
C26H37N3O6S
2765293-27-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 8.4700 0.0 0 CFG=1
M  V30 2 C 6.6684 7.7000 0.0 0 CFG=2
M  V30 3 C 8.0020 10.0100 0.0 0
M  V30 4 N 9.3356 7.7000 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 O 6.6684 6.1600 0.0 0
M  V30 7 C 10.6694 8.4700 0.0 0
M  V30 8 N 4.0009 7.7000 0.0 0
M  V30 9 O 10.6694 10.0100 0.0 0
M  V30 10 S 4.0009 6.1600 0.0 0 VAL=6
M  V30 11 C 2.6673 8.4700 0.0 0
M  V30 12 O 2.4609 6.1600 0.0 0
M  V30 13 O 5.5409 6.1600 0.0 0
M  V30 14 C 1.3336 7.7000 0.0 0
M  V30 15 C 0.0000 8.4700 0.0 0
M  V30 16 C 1.3336 6.1600 0.0 0
M  V30 17 C 13.3367 10.0100 0.0 0
M  V30 18 O 4.0009 0.0000 0.0 0
M  V30 19 C 6.6684 10.7800 0.0 0
M  V30 20 C 6.6684 12.3200 0.0 0
M  V30 21 C 5.3347 10.0100 0.0 0
M  V30 22 C 5.3347 13.0900 0.0 0
M  V30 23 C 4.0009 10.7800 0.0 0
M  V30 24 C 4.0009 12.3200 0.0 0
M  V30 25 C 12.0031 7.7000 0.0 0 CFG=2
M  V30 26 N 13.3367 8.4700 0.0 0
M  V30 27 C 12.0031 6.1600 0.0 0
M  V30 28 C 14.6703 7.7000 0.0 0
M  V30 29 O 13.3367 5.3900 0.0 0
M  V30 30 C 14.6703 6.1600 0.0 0
M  V30 31 C 4.0009 4.6200 0.0 0
M  V30 32 C 2.6673 3.8500 0.0 0
M  V30 33 C 5.3347 3.8500 0.0 0
M  V30 34 C 2.6673 2.3100 0.0 0
M  V30 35 C 5.3347 2.3100 0.0 0
M  V30 36 C 4.0009 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 19
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 25 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 31
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 26
M  V30 20 1 18 36
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 157567-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315051-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-27-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
2-Benzofurancarboxylic acid
C9H6O3
496-41-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 O 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[1-(4-aminobutyl)-3-piperidinyl]methyl]-, 1,1-dimethylethyl...
C15H31N3O2
3035975-21-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0
M  V30 4 O 2.6675 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 1.3338 3.0801 0.0 0
M  V30 7 C 2.1038 4.4137 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 0.5638 1.7464 0.0 0
M  V30 10 C 12.0035 3.0801 0.0 0
M  V30 11 C 13.3372 2.3101 0.0 0
M  V30 12 C 14.6708 3.0801 0.0 0
M  V30 13 C 16.0045 2.3101 0.0 0
M  V30 14 N 17.3383 3.0801 0.0 0
M  V30 15 C 8.0023 2.3101 0.0 0
M  V30 16 C 9.3360 3.0801 0.0 0
M  V30 17 C 8.0023 0.7700 0.0 0
M  V30 18 N 10.6697 2.3101 0.0 0
M  V30 19 C 9.3360 0.0000 0.0 0
M  V30 20 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[1-[4-[(2-benzofuranylcarbonyl)amino]butyl]-3-piperidinyl]m...
C24H35N3O4
3035975-23-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 N 7.4148 3.1854 0.0 0
M  V30 3 O 6.0811 5.4955 0.0 0
M  V30 4 C 8.7485 3.9554 0.0 0
M  V30 5 C 10.0821 3.1854 0.0 0
M  V30 6 C 11.4160 3.9554 0.0 0
M  V30 7 C 12.7496 3.1854 0.0 0
M  V30 8 C 18.0845 3.1854 0.0 0
M  V30 9 N 19.4181 3.9554 0.0 0
M  V30 10 C 20.7520 3.1854 0.0 0
M  V30 11 O 22.0856 3.9554 0.0 0
M  V30 12 O 20.7520 1.6454 0.0 0
M  V30 13 C 23.4193 3.1854 0.0 0
M  V30 14 C 24.1893 4.5192 0.0 0
M  V30 15 C 24.7530 2.4154 0.0 0
M  V30 16 C 22.6493 1.8517 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 3.3405 3.8119 0.0 0
M  V30 20 C 0.7700 2.6673 0.0 0
M  V30 21 O 4.5864 1.6538 0.0 0
M  V30 22 C 2.3101 0.0000 0.0 0
M  V30 23 C 4.7473 3.1854 0.0 0
M  V30 24 C 0.0000 1.3337 0.0 0
M  V30 25 C 0.7700 0.0000 0.0 0
M  V30 26 N 14.0833 3.9554 0.0 0
M  V30 27 C 15.4171 3.1854 0.0 0
M  V30 28 C 14.0833 5.4955 0.0 0
M  V30 29 C 16.7508 3.9554 0.0 0
M  V30 30 C 15.4171 6.2655 0.0 0
M  V30 31 C 16.7508 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 1 22 25
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 496-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035975-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035975-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40761032
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure Activity Relationships for a Series of Eticlopride-Based
Dopamine D2/D3 Receptor Bitopic Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaik, Anver Basha; Boateng, Comfort A.; Battiti, Francisco O.; Bonifazi,
Alessandro; Cao, Jianjing; Chen, Li; Chitsazi, Rezvan; Ravi, Saiprasad;
Lee, Kuo Hao; Shi, Lei; Newman, Amy Hauck
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(20), 15313-15333

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-leucine
C22H25NO4
139551-74-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.2309 0.0 0
M  V30 2 O 6.6685 4.4609 0.0 0
M  V30 3 C 5.3348 5.2309 0.0 0
M  V30 4 N 4.0012 4.4609 0.0 0
M  V30 5 O 5.3348 6.7709 0.0 0
M  V30 6 C 2.6673 5.2309 0.0 0 CFG=2
M  V30 7 C 2.6673 6.7709 0.0 0
M  V30 8 C 1.3337 4.4609 0.0 0
M  V30 9 C 1.3337 7.5409 0.0 0
M  V30 10 O 0.0000 5.2309 0.0 0
M  V30 11 O 1.3337 2.9208 0.0 0
M  V30 12 C 2.6673 8.3109 0.0 0
M  V30 13 C 1.3337 9.0810 0.0 0
M  V30 14 C 0.0000 6.7709 0.0 0
M  V30 15 C 9.3360 4.4609 0.0 0
M  V30 16 C 10.7428 5.0873 0.0 0
M  V30 17 C 9.4969 2.9293 0.0 0
M  V30 18 C 11.7732 3.9428 0.0 0
M  V30 19 C 11.2187 6.5519 0.0 0
M  V30 20 C 11.0032 2.6091 0.0 0
M  V30 21 C 8.4665 1.7849 0.0 0
M  V30 22 C 13.2797 4.2630 0.0 0
M  V30 23 C 12.7251 6.8721 0.0 0
M  V30 24 C 11.4793 1.1444 0.0 0
M  V30 25 C 8.9424 0.3202 0.0 0
M  V30 26 C 13.7556 5.7277 0.0 0
M  V30 27 C 10.4487 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 20
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C32H40N4O6
2861234-25-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 8.4702 0.0 0
M  V30 2 O 7.0871 7.7001 0.0 0
M  V30 3 C 8.4207 8.4702 0.0 0
M  V30 4 N 9.7545 7.7001 0.0 0
M  V30 5 O 8.4207 10.0102 0.0 0
M  V30 6 C 11.0882 8.4702 0.0 0 CFG=1
M  V30 7 C 12.4219 7.7001 0.0 0
M  V30 8 C 11.0882 10.0102 0.0 0
M  V30 9 N 12.4219 6.1601 0.0 0
M  V30 10 O 13.7555 8.4702 0.0 0
M  V30 11 C 12.4219 10.7802 0.0 0
M  V30 12 C 13.7555 5.3901 0.0 0 CFG=2
M  V30 13 C 11.0882 11.5502 0.0 0
M  V30 14 C 12.4219 12.3202 0.0 0
M  V30 15 C 13.7555 10.0102 0.0 0
M  V30 16 C 15.0893 6.1601 0.0 0
M  V30 17 C 13.7555 3.8501 0.0 0
M  V30 18 C 16.4230 5.3901 0.0 0
M  V30 19 O 15.0893 3.0801 0.0 0
M  V30 20 O 12.4219 3.0801 0.0 0
M  V30 21 C 17.7567 6.1601 0.0 0
M  V30 22 C 15.0893 1.5400 0.0 0
M  V30 23 C 19.0903 5.3901 0.0 0
M  V30 24 O 17.7567 7.7001 0.0 0
M  V30 25 C 16.6294 1.5400 0.0 0
M  V30 26 C 15.0893 0.0000 0.0 0
M  V30 27 C 13.5493 1.5400 0.0 0
M  V30 28 N 20.4242 6.1601 0.0 0 CHG=1 VAL=4
M  V30 29 N 21.7578 6.9301 0.0 0 CHG=-1
M  V30 30 C 4.4197 7.7001 0.0 0
M  V30 31 C 4.2586 6.1686 0.0 0
M  V30 32 C 3.0128 8.3265 0.0 0
M  V30 33 C 2.7523 5.8484 0.0 0
M  V30 34 C 5.2892 5.0240 0.0 0
M  V30 35 C 1.9823 7.1821 0.0 0
M  V30 36 C 2.5369 9.7912 0.0 0
M  V30 37 C 2.2765 4.3837 0.0 0
M  V30 38 C 4.8132 3.5595 0.0 0
M  V30 39 C 0.4759 7.5022 0.0 0
M  V30 40 C 1.0304 10.1114 0.0 0
M  V30 41 C 3.3069 3.2393 0.0 0
M  V30 42 C 0.0000 8.9670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16 CFG=1
M  V30 17 1 12 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 22 26
M  V30 27 1 22 27
M  V30 28 2 23 28
M  V30 29 2 28 29
M  V30 30 1 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 2 31 34
M  V30 34 1 32 35
M  V30 35 2 32 36
M  V30 36 1 33 35
M  V30 37 2 33 37
M  V30 38 1 34 38
M  V30 39 2 35 39
M  V30 40 1 36 40
M  V30 41 1 37 41
M  V30 42 2 38 41
M  V30 43 1 39 42
M  V30 44 2 40 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 139551-74-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861234-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
cis-4-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclohexaneacetic acid
C13H23NO4
327156-95-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.5637 0.0 0
M  V30 2 C 4.0010 1.3337 0.0 0
M  V30 3 O 2.6673 0.5637 0.0 0
M  V30 4 O 4.0010 2.8737 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 0.0000 2.1037 0.0 0
M  V30 8 C 0.5637 0.0000 0.0 0
M  V30 9 C 10.6697 3.6437 0.0 0
M  V30 10 C 12.0033 2.8737 0.0 0
M  V30 11 O 12.0033 1.3337 0.0 0
M  V30 12 O 13.3370 3.6437 0.0 0
M  V30 13 C 6.6685 1.3337 0.0 0 CFG=2
M  V30 14 C 6.6685 2.8737 0.0 0
M  V30 15 C 8.0022 0.5637 0.0 0
M  V30 16 C 8.0022 3.6437 0.0 0
M  V30 17 C 9.3360 1.3337 0.0 0
M  V30 18 C 9.3360 2.8737 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 18 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C32H33N3O3.ClH
3076055-76-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.8747 0.0 0 CFG=2
M  V30 2 C 6.9300 5.5411 0.0 0
M  V30 3 N 6.9300 8.2084 0.0 0
M  V30 4 C 9.2400 6.8747 0.0 0
M  V30 5 C 5.3900 8.2084 0.0 0
M  V30 6 N 10.0100 8.2084 0.0 0
M  V30 7 O 10.0100 5.5411 0.0 0
M  V30 8 C 4.6200 9.5421 0.0 0 CFG=2
M  V30 9 O 4.6200 6.8747 0.0 0
M  V30 10 C 11.5500 8.2084 0.0 0
M  V30 11 N 5.3900 10.8758 0.0 0
M  V30 12 C 12.3200 9.5421 0.0 0
M  V30 13 O 18.4800 9.5421 0.0 0
M  V30 14 C 19.2500 10.8758 0.0 0
M  V30 15 C 7.7000 4.2073 0.0 0
M  V30 16 C 6.9300 2.8736 0.0 0
M  V30 17 C 9.2400 4.2073 0.0 0
M  V30 18 C 7.7000 1.5400 0.0 0
M  V30 19 C 10.0100 2.8736 0.0 0
M  V30 20 C 9.2400 1.5400 0.0 0
M  V30 21 C 3.0800 9.5421 0.0 0
M  V30 22 C 2.3100 8.2084 0.0 0
M  V30 23 C 2.3100 10.8758 0.0 0
M  V30 24 C 0.7700 8.2084 0.0 0
M  V30 25 C 0.7700 10.8758 0.0 0
M  V30 26 C 0.0000 9.5421 0.0 0
M  V30 27 C 13.8600 9.5421 0.0 0
M  V30 28 C 14.6300 8.2084 0.0 0
M  V30 29 C 14.6300 10.8758 0.0 0
M  V30 30 C 16.1700 8.2084 0.0 0
M  V30 31 C 16.1700 10.8758 0.0 0
M  V30 32 C 16.9400 9.5421 0.0 0
M  V30 33 C 20.7900 10.8758 0.0 0
M  V30 34 C 21.5600 9.5421 0.0 0
M  V30 35 C 21.5600 12.2094 0.0 0
M  V30 36 C 23.1000 9.5421 0.0 0
M  V30 37 C 23.1000 12.2094 0.0 0
M  V30 38 C 23.8700 10.8758 0.0 0
M  V30 39 Cl 11.9350 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 8 21
M  V30 13 1 10 12
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 32
M  V30 17 1 14 33
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C45H54N4O6
3076055-77-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 7.7002 0.0 0 CFG=2
M  V30 2 C 16.0045 6.9302 0.0 0
M  V30 3 N 13.3370 6.9302 0.0 0
M  V30 4 N 16.0045 5.3901 0.0 0
M  V30 5 O 17.3382 7.7002 0.0 0
M  V30 6 C 12.0033 7.7002 0.0 0
M  V30 7 C 17.3382 4.6201 0.0 0 CFG=1
M  V30 8 C 10.6697 6.9302 0.0 0
M  V30 9 O 12.0033 9.2402 0.0 0
M  V30 10 C 17.3382 3.0801 0.0 0
M  V30 11 C 18.6720 5.3901 0.0 0
M  V30 12 N 20.0057 4.6201 0.0 0
M  V30 13 O 18.6718 6.9302 0.0 0
M  V30 14 C 20.0057 3.0801 0.0 0
M  V30 15 C 21.3393 2.3101 0.0 0
M  V30 16 N 5.3348 10.0102 0.0 0
M  V30 17 C 4.0012 9.2402 0.0 0
M  V30 18 O 2.6673 10.0102 0.0 0
M  V30 19 O 4.0012 7.7002 0.0 0
M  V30 20 C 1.3337 9.2402 0.0 0
M  V30 21 C 2.1037 7.9065 0.0 0
M  V30 22 C 0.0000 8.4702 0.0 0
M  V30 23 C 0.5637 10.5739 0.0 0
M  V30 24 O 26.6742 5.3901 0.0 0
M  V30 25 C 28.0078 4.6201 0.0 0
M  V30 26 C 14.6708 9.2402 0.0 0
M  V30 27 C 13.3370 10.0102 0.0 0
M  V30 28 C 16.0045 10.0102 0.0 0
M  V30 29 C 13.3370 11.5503 0.0 0
M  V30 30 C 16.0045 11.5503 0.0 0
M  V30 31 C 14.6708 12.3203 0.0 0
M  V30 32 C 9.3360 7.7002 0.0 0 CFG=2
M  V30 33 C 9.3360 9.2402 0.0 0
M  V30 34 C 8.0022 6.9302 0.0 0
M  V30 35 C 8.0022 10.0102 0.0 0
M  V30 36 C 6.6685 7.7002 0.0 0
M  V30 37 C 6.6685 9.2402 0.0 0 CFG=1
M  V30 38 C 16.0045 2.3101 0.0 0
M  V30 39 C 14.6708 3.0801 0.0 0
M  V30 40 C 16.0045 0.7700 0.0 0
M  V30 41 C 13.3370 2.3101 0.0 0
M  V30 42 C 14.6708 0.0000 0.0 0
M  V30 43 C 13.3372 0.7700 0.0 0
M  V30 44 C 22.6730 3.0801 0.0 0
M  V30 45 C 24.0068 2.3101 0.0 0
M  V30 46 C 22.6730 4.6201 0.0 0
M  V30 47 C 25.3405 3.0801 0.0 0
M  V30 48 C 24.0068 5.3901 0.0 0
M  V30 49 C 25.3405 4.6201 0.0 0
M  V30 50 C 29.3416 5.3901 0.0 0
M  V30 51 C 29.3416 6.9302 0.0 0
M  V30 52 C 30.6753 4.6201 0.0 0
M  V30 53 C 30.6753 7.7002 0.0 0
M  V30 54 C 32.0090 5.3901 0.0 0
M  V30 55 C 32.0090 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 7 11
M  V30 12 1 32 8 CFG=3
M  V30 13 1 10 38
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 15 44
M  V30 19 1 16 17
M  V30 20 1 37 16 CFG=3
M  V30 21 1 17 18
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 20 23
M  V30 27 1 24 25
M  V30 28 1 24 49
M  V30 29 1 25 50
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 48 2 44 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 2 46 48
M  V30 52 2 47 49
M  V30 53 1 48 49
M  V30 54 2 50 51
M  V30 55 1 50 52
M  V30 56 1 51 53
M  V30 57 2 52 54
M  V30 58 2 53 55
M  V30 59 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 32 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 327156-95-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3076055-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3076055-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-44725302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Potent Mcl-1 Inhibitors: Structural Investigations on
Macrocycles Originating from a DNA-Encoded Chemical Library Screen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hekking, Koen F. W.; Maroto, Sergio; van Kekem, Kees; Haasjes, Frank S.;
Slootweg, Jack C.; Oude Alink, Patrick G. B.; Dirks, Ron; Sardana,
Malvika; Bolster, Marjon G.; Kuijpers, Brian; Smith, Dennis; Doodeman,
Robin; Scheepstra, Marcel; Zech, Birgit; Mulvihill, Mark; Renzetti, Louis
M.; Babiss, Lee; Centrella, Paolo A.; Clark, Matthew A.; Cuozzo, John W.;
Guie, Marie-Aude; Sigel, Eric; Habeshian, Sevan; Hupp, Christopher D.;
Liu, Julie; Thomson, Heather A.; Zhang, Ying; Keefe, Anthony D.; Mueller,
Gerhard; Gremmen, Stijn
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(4), 3039-3065

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  2
$MOL
4-Iodobenzoic acid
C7H5IO2
619-58-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2R)-2-[[(2S)-2-amino-3-(3-methylphenyl)-1-oxopropyl]amino...
C25H28N2O4.C2HF3O2
3026372-08-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0055 9.0338 0.0 0
M  V30 2 O 21.3393 8.2638 0.0 0
M  V30 3 O 20.0055 10.5738 0.0 0
M  V30 4 C 22.6730 9.0338 0.0 0
M  V30 5 C 24.0067 8.2638 0.0 0
M  V30 6 C 25.3403 9.0338 0.0 0
M  V30 7 C 14.6707 9.0338 0.0 0
M  V30 8 O 13.3370 8.2638 0.0 0
M  V30 9 C 12.0033 9.0338 0.0 0
M  V30 10 C 10.6697 8.2638 0.0 0 CFG=1
M  V30 11 N 9.3358 9.0338 0.0 0
M  V30 12 C 10.6697 6.7238 0.0 0
M  V30 13 C 8.0022 8.2638 0.0 0
M  V30 14 C 10.6697 5.1837 0.0 0
M  V30 15 C 6.6685 9.0338 0.0 0 CFG=1
M  V30 16 O 8.0022 6.7238 0.0 0
M  V30 17 C 5.3348 8.2638 0.0 0
M  V30 18 N 6.6685 10.5738 0.0 0
M  V30 19 C 0.0000 8.2638 0.0 0
M  V30 20 C 18.6718 8.2638 0.0 0
M  V30 21 C 17.3382 9.0338 0.0 0
M  V30 22 C 18.6718 6.7238 0.0 0
M  V30 23 C 16.0045 8.2638 0.0 0
M  V30 24 C 17.3382 5.9537 0.0 0
M  V30 25 C 16.0045 6.7238 0.0 0
M  V30 26 C 4.0010 9.0338 0.0 0
M  V30 27 C 2.6673 8.2638 0.0 0
M  V30 28 C 4.0010 10.5738 0.0 0
M  V30 29 C 1.3337 9.0338 0.0 0
M  V30 30 C 2.6673 11.3439 0.0 0
M  V30 31 C 1.3337 10.5738 0.0 0
M  V30 32 C 12.0033 2.3101 0.0 0
M  V30 33 C 13.3370 1.5400 0.0 0
M  V30 34 F 12.7733 3.6437 0.0 0
M  V30 35 F 10.6697 3.0801 0.0 0
M  V30 36 F 11.2333 0.9764 0.0 0
M  V30 37 O 14.6707 2.3101 0.0 0
M  V30 38 O 13.3370 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 3 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 15 18 CFG=3
M  V30 19 1 17 26
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 32 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 2 33 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2S)-2-[[(2S)-2-amino-3-(3-methylphenyl)-1-oxopropyl]amino...
C25H28N2O4.C2HF3O2
3026373-07-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0055 9.0338 0.0 0
M  V30 2 O 21.3393 8.2638 0.0 0
M  V30 3 O 20.0055 10.5738 0.0 0
M  V30 4 C 22.6730 9.0338 0.0 0
M  V30 5 C 24.0067 8.2638 0.0 0
M  V30 6 C 25.3403 9.0338 0.0 0
M  V30 7 C 14.6707 9.0338 0.0 0
M  V30 8 O 13.3370 8.2638 0.0 0
M  V30 9 C 12.0033 9.0338 0.0 0
M  V30 10 C 10.6697 8.2638 0.0 0 CFG=2
M  V30 11 N 9.3358 9.0338 0.0 0
M  V30 12 C 10.6697 6.7238 0.0 0
M  V30 13 C 8.0022 8.2638 0.0 0
M  V30 14 C 10.6697 5.1837 0.0 0
M  V30 15 C 6.6685 9.0338 0.0 0 CFG=1
M  V30 16 O 8.0022 6.7238 0.0 0
M  V30 17 C 5.3348 8.2638 0.0 0
M  V30 18 N 6.6685 10.5738 0.0 0
M  V30 19 C 0.0000 8.2638 0.0 0
M  V30 20 C 18.6718 8.2638 0.0 0
M  V30 21 C 17.3382 9.0338 0.0 0
M  V30 22 C 18.6718 6.7238 0.0 0
M  V30 23 C 16.0045 8.2638 0.0 0
M  V30 24 C 17.3382 5.9537 0.0 0
M  V30 25 C 16.0045 6.7238 0.0 0
M  V30 26 C 4.0010 9.0338 0.0 0
M  V30 27 C 2.6673 8.2638 0.0 0
M  V30 28 C 4.0010 10.5738 0.0 0
M  V30 29 C 1.3337 9.0338 0.0 0
M  V30 30 C 2.6673 11.3439 0.0 0
M  V30 31 C 1.3337 10.5738 0.0 0
M  V30 32 C 12.0033 2.3101 0.0 0
M  V30 33 C 13.3370 1.5400 0.0 0
M  V30 34 F 12.7733 3.6437 0.0 0
M  V30 35 F 10.6697 3.0801 0.0 0
M  V30 36 F 11.2333 0.9764 0.0 0
M  V30 37 O 14.6707 2.3101 0.0 0
M  V30 38 O 13.3370 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 3 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 15 18 CFG=3
M  V30 19 1 17 26
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 32 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 2 33 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2R)-2-[[(2S)-2-[(4-iodobenzoyl)amino]-3-(3-methylphenyl)-...
C32H31IN2O5
3026372-27-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 8.0020 0.0 0 CFG=1
M  V30 2 C 4.6200 8.0020 0.0 0
M  V30 3 N 6.9300 6.6684 0.0 0
M  V30 4 C 6.9300 9.3356 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 N 8.4700 9.3356 0.0 0
M  V30 7 O 6.1600 10.6694 0.0 0
M  V30 8 O 4.6200 5.3347 0.0 0
M  V30 9 C 9.2400 10.6694 0.0 0 CFG=2
M  V30 10 C 10.7800 10.6694 0.0 0
M  V30 11 C 8.4700 12.0031 0.0 0
M  V30 12 O 11.5500 9.3356 0.0 0
M  V30 13 C 7.7000 13.3367 0.0 0
M  V30 14 C 13.0900 9.3356 0.0 0
M  V30 15 C 0.0000 10.6694 0.0 0
M  V30 16 I 9.2400 0.0000 0.0 0
M  V30 17 C 17.7100 12.0031 0.0 0
M  V30 18 O 18.4800 13.3367 0.0 0
M  V30 19 O 18.4800 10.6694 0.0 0
M  V30 20 C 20.0200 13.3367 0.0 0
M  V30 21 C 20.7900 14.6703 0.0 0
M  V30 22 C 22.3300 14.6703 0.0 0
M  V30 23 C 3.8500 9.3356 0.0 0
M  V30 24 C 2.3100 9.3356 0.0 0
M  V30 25 C 4.6200 10.6694 0.0 0
M  V30 26 C 1.5400 10.6694 0.0 0
M  V30 27 C 3.8500 12.0031 0.0 0
M  V30 28 C 2.3100 12.0031 0.0 0
M  V30 29 C 6.9300 4.0009 0.0 0
M  V30 30 C 6.1600 2.6673 0.0 0
M  V30 31 C 8.4700 4.0009 0.0 0
M  V30 32 C 6.9300 1.3336 0.0 0
M  V30 33 C 9.2400 2.6673 0.0 0
M  V30 34 C 8.4700 1.3336 0.0 0
M  V30 35 C 13.8600 10.6694 0.0 0
M  V30 36 C 15.4000 10.6694 0.0 0
M  V30 37 C 13.0900 12.0031 0.0 0
M  V30 38 C 16.1700 12.0031 0.0 0
M  V30 39 C 13.8600 13.3367 0.0 0
M  V30 40 C 15.4000 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 23
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 29
M  V30 10 1 6 9
M  V30 11 1 9 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 3 11 13
M  V30 15 1 12 14
M  V30 16 1 14 35
M  V30 17 1 15 26
M  V30 18 1 16 34
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 38
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[[[(2S)-2-[[(2S)-2-[(4-iodobenzoyl)amino]-3-(3-methylphenyl)-...
C32H31IN2O5
3026372-29-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 8.0020 0.0 0 CFG=1
M  V30 2 C 4.6200 8.0020 0.0 0
M  V30 3 N 6.9300 6.6684 0.0 0
M  V30 4 C 6.9300 9.3356 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 N 8.4700 9.3356 0.0 0
M  V30 7 O 6.1600 10.6694 0.0 0
M  V30 8 O 4.6200 5.3347 0.0 0
M  V30 9 C 9.2400 10.6694 0.0 0 CFG=1
M  V30 10 C 10.7800 10.6694 0.0 0
M  V30 11 C 8.4700 12.0031 0.0 0
M  V30 12 O 11.5500 9.3356 0.0 0
M  V30 13 C 7.7000 13.3367 0.0 0
M  V30 14 C 13.0900 9.3356 0.0 0
M  V30 15 C 0.0000 10.6694 0.0 0
M  V30 16 I 9.2400 0.0000 0.0 0
M  V30 17 C 17.7100 12.0031 0.0 0
M  V30 18 O 18.4800 13.3367 0.0 0
M  V30 19 O 18.4800 10.6694 0.0 0
M  V30 20 C 20.0200 13.3367 0.0 0
M  V30 21 C 20.7900 14.6703 0.0 0
M  V30 22 C 22.3300 14.6703 0.0 0
M  V30 23 C 3.8500 9.3356 0.0 0
M  V30 24 C 2.3100 9.3356 0.0 0
M  V30 25 C 4.6200 10.6694 0.0 0
M  V30 26 C 1.5400 10.6694 0.0 0
M  V30 27 C 3.8500 12.0031 0.0 0
M  V30 28 C 2.3100 12.0031 0.0 0
M  V30 29 C 6.9300 4.0009 0.0 0
M  V30 30 C 6.1600 2.6673 0.0 0
M  V30 31 C 8.4700 4.0009 0.0 0
M  V30 32 C 6.9300 1.3336 0.0 0
M  V30 33 C 9.2400 2.6673 0.0 0
M  V30 34 C 8.4700 1.3336 0.0 0
M  V30 35 C 13.8600 10.6694 0.0 0
M  V30 36 C 15.4000 10.6694 0.0 0
M  V30 37 C 13.0900 12.0031 0.0 0
M  V30 38 C 16.1700 12.0031 0.0 0
M  V30 39 C 13.8600 13.3367 0.0 0
M  V30 40 C 15.4000 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 23
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 29
M  V30 10 1 6 9
M  V30 11 1 9 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 3 11 13
M  V30 15 1 12 14
M  V30 16 1 14 35
M  V30 17 1 15 26
M  V30 18 1 16 34
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 38
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026372-08-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3026373-07-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026372-27-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 3026372-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 8
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL

C26H42N2O7
3032888-56-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 2 C 8.0023 6.9302 0.0 0
M  V30 3 N 5.3348 6.9302 0.0 0
M  V30 4 N 8.0023 5.3901 0.0 0
M  V30 5 O 9.3360 7.7002 0.0 0
M  V30 6 C 4.0012 7.7002 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0 CFG=1
M  V30 8 O 2.6675 6.9302 0.0 0
M  V30 9 O 4.0012 9.2402 0.0 0
M  V30 10 C 10.6697 5.3901 0.0 0
M  V30 11 C 9.3360 3.0801 0.0 0
M  V30 12 C 1.3338 7.7002 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 O 8.0023 2.3101 0.0 0
M  V30 15 O 10.6697 2.3101 0.0 0
M  V30 16 C 2.1038 9.0338 0.0 0
M  V30 17 C 0.0000 8.4702 0.0 0
M  V30 18 C 0.5638 6.3665 0.0 0
M  V30 19 C 13.3372 5.3901 0.0 0
M  V30 20 C 8.0023 0.7700 0.0 0
M  V30 21 O 14.6708 4.6201 0.0 0
M  V30 22 O 13.3372 6.9302 0.0 0
M  V30 23 C 6.6687 0.0000 0.0 0
M  V30 24 C 16.0045 5.3901 0.0 0
M  V30 25 C 17.3383 4.6201 0.0 0
M  V30 26 C 6.6687 9.2402 0.0 0
M  V30 27 C 8.0390 9.9365 0.0 0
M  V30 28 C 5.2983 9.9365 0.0 0
M  V30 29 C 7.5061 10.7125 0.0 0
M  V30 30 C 8.0390 11.3288 0.0 0
M  V30 31 C 5.2983 11.3288 0.0 0
M  V30 32 C 7.5061 12.1048 0.0 0
M  V30 33 C 8.8761 12.8011 0.0 0
M  V30 34 C 6.6687 12.0249 0.0 0
M  V30 35 C 6.1356 12.8011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 24 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 30 33
M  V30 33 1 30 34
M  V30 34 1 31 34
M  V30 35 1 31 35
M  V30 36 1 32 33
M  V30 37 1 32 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C28H45N3O8
3032888-68-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 7.7002 0.0 0 CFG=2
M  V30 2 C 12.0033 6.9302 0.0 0
M  V30 3 N 9.3360 6.9302 0.0 0
M  V30 4 N 12.0033 5.3901 0.0 0
M  V30 5 O 13.3372 7.7002 0.0 0
M  V30 6 C 8.0023 7.7002 0.0 0
M  V30 7 C 13.3372 4.6201 0.0 0 CFG=1
M  V30 8 C 6.6685 6.9302 0.0 0
M  V30 9 O 8.0023 9.2402 0.0 0
M  V30 10 C 14.6708 5.3901 0.0 0
M  V30 11 C 13.3372 3.0801 0.0 0
M  V30 12 N 5.3348 7.7002 0.0 0
M  V30 13 C 16.0045 4.6201 0.0 0
M  V30 14 O 12.0033 2.3101 0.0 0
M  V30 15 O 14.6708 2.3101 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 17 C 17.3382 5.3901 0.0 0
M  V30 18 C 12.0033 0.7700 0.0 0
M  V30 19 O 2.6673 7.7002 0.0 0
M  V30 20 O 4.0012 5.3901 0.0 0
M  V30 21 O 18.6720 4.6201 0.0 0
M  V30 22 O 17.3382 6.9302 0.0 0
M  V30 23 C 10.6697 0.0000 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 25 C 20.0057 5.3901 0.0 0
M  V30 26 C 0.5637 8.2638 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 2.1037 5.5965 0.0 0
M  V30 29 C 21.3393 4.6201 0.0 0
M  V30 30 C 10.6697 9.2402 0.0 0
M  V30 31 C 12.0400 9.9365 0.0 0
M  V30 32 C 9.2993 9.9365 0.0 0
M  V30 33 C 11.5071 10.7125 0.0 0
M  V30 34 C 12.0400 11.3288 0.0 0
M  V30 35 C 9.2993 11.3288 0.0 0
M  V30 36 C 11.5071 12.1048 0.0 0
M  V30 37 C 12.8771 12.8011 0.0 0
M  V30 38 C 10.6697 12.0249 0.0 0
M  V30 39 C 10.1367 12.8011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 30 CFG=1
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 21 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 30 31
M  V30 31 1 30 32
M  V30 32 1 30 33
M  V30 33 1 31 34
M  V30 34 1 32 35
M  V30 35 1 33 36
M  V30 36 1 34 37
M  V30 37 1 34 38
M  V30 38 1 35 38
M  V30 39 1 35 39
M  V30 40 1 36 37
M  V30 41 1 36 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032888-56-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032888-68-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40893416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar
Potency
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guzelj, Samo; Bizjak, Spela; Jakopin, Ziga
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
S-Methyl-N-[(5-methyl-3-isoxazolyl)carbonyl]-L-cysteinyl-S-methyl-L-cysteine
C13H19N3O5S2
2387522-98-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.8501 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 9.3360 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 N 5.3348 6.1601 0.0 0
M  V30 8 O 4.0012 3.8501 0.0 0
M  V30 9 S 5.3348 1.5400 0.0 0
M  V30 10 C 4.0012 6.9302 0.0 0 CFG=2
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 8.4702 0.0 0
M  V30 14 S 1.3337 6.9302 0.0 0
M  V30 15 O 2.6675 9.2402 0.0 0
M  V30 16 O 5.3348 9.2402 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 18 C 14.6386 4.9772 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0765 3.9938 0.0 0
M  V30 21 N 10.8306 6.1517 0.0 0
M  V30 22 C 13.1071 5.1382 0.0 0
M  V30 23 O 12.3371 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12 CFG=1
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 18 22
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-erythro-3-Pentulose, 2-amino-4,5-anhydro-1,2-dideoxy-4-C-methyl-1-phenyl-, ...
C12H15NO2.C2HF3O2
1148157-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.7237 0.0 0
M  V30 2 C 5.3348 7.4937 0.0 0 CFG=1
M  V30 3 O 6.6684 5.1837 0.0 0
M  V30 4 C 4.0011 6.7237 0.0 0
M  V30 5 N 5.3348 9.0338 0.0 0
M  V30 6 C 7.4755 8.9409 0.0 0
M  V30 7 C 8.0022 7.4937 0.0 0 CFG=2
M  V30 8 C 8.9921 6.3141 0.0 0
M  V30 9 O 9.5188 7.7611 0.0 0
M  V30 10 C 2.6675 7.4937 0.0 0
M  V30 11 C 1.3337 6.7237 0.0 0
M  V30 12 C 2.6675 9.0338 0.0 0
M  V30 13 C 0.0000 7.4937 0.0 0
M  V30 14 C 1.3337 9.8038 0.0 0
M  V30 15 C 0.0000 9.0338 0.0 0
M  V30 16 C 4.0926 2.3101 0.0 0
M  V30 17 C 5.4262 1.5400 0.0 0
M  V30 18 F 4.8626 3.6437 0.0 0
M  V30 19 F 2.7589 3.0801 0.0 0
M  V30 20 F 3.3226 0.9764 0.0 0
M  V30 21 O 6.7599 2.3101 0.0 0
M  V30 22 O 5.4262 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 10
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C25H32N4O6S2
2387523-20-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.3901 0.0 0
M  V30 2 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 3 O 1.3338 4.6201 0.0 0
M  V30 4 C 4.0011 3.0800 0.0 0
M  V30 5 N 5.3350 5.3901 0.0 0
M  V30 6 C 6.6686 4.6201 0.0 0
M  V30 7 C 8.0023 5.3901 0.0 0 CFG=2
M  V30 8 O 6.6686 3.0800 0.0 0
M  V30 9 N 9.3359 4.6201 0.0 0
M  V30 10 C 8.0023 6.9301 0.0 0
M  V30 11 C 10.6697 5.3901 0.0 0
M  V30 12 S 6.6686 7.7001 0.0 0
M  V30 13 C 12.0034 4.6201 0.0 0 CFG=2
M  V30 14 O 10.6697 6.9301 0.0 0
M  V30 15 C 6.6686 9.2401 0.0 0
M  V30 16 N 13.3371 5.3901 0.0 0
M  V30 17 C 12.0034 3.0800 0.0 0
M  V30 18 C 14.6707 4.6201 0.0 0
M  V30 19 S 10.6697 2.3100 0.0 0
M  V30 20 O 14.6707 3.0800 0.0 0
M  V30 21 C 10.6697 0.7700 0.0 0
M  V30 22 C 4.1841 7.1975 0.0 0
M  V30 23 C 19.9735 5.7472 0.0 0
M  V30 24 C 2.6675 6.9301 0.0 0 CFG=2
M  V30 25 C 1.1509 7.1975 0.0 0
M  V30 26 O 2.1408 8.3773 0.0 0
M  V30 27 C 2.6675 2.3100 0.0 0
M  V30 28 C 1.3338 3.0800 0.0 0
M  V30 29 C 2.6675 0.7700 0.0 0
M  V30 30 C 0.0000 2.3100 0.0 0
M  V30 31 C 1.3338 0.0000 0.0 0
M  V30 32 C 0.0000 0.7700 0.0 0
M  V30 33 C 16.0045 5.3901 0.0 0
M  V30 34 N 16.1655 6.9216 0.0 0
M  V30 35 C 17.4114 4.7638 0.0 0
M  V30 36 O 17.6718 7.2418 0.0 0
M  V30 37 C 18.4418 5.9081 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=1
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 18 33
M  V30 23 1 19 21
M  V30 24 1 24 22 CFG=3
M  V30 25 1 23 37
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 7 13 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387522-98-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148157-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
trans-3-Amino-1-methylcyclobutanol
C5H11NO
1363381-26-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.1037 0.0 0
M  V30 2 O 0.5637 0.0000 0.0 0
M  V30 3 N 4.9250 2.2959 0.0 0
M  V30 4 C 2.1037 2.6673 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0 CFG=1
M  V30 6 C 3.4375 1.8973 0.0 0 CFG=2
M  V30 7 C 2.6675 0.5637 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 5 2 CFG=1
M  V30 3 1 6 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,8-Naphthyridine-3-carboxylic acid, 6-chloro-7-[(2S)-2-methyl-1-azetidinyl]-...
C13H12ClN3O2.Li
2255314-45-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7179 1.5400 0.0 0
M  V30 2 C 1.0889 6.8364 0.0 0
M  V30 3 C 10.6479 5.5411 0.0 0
M  V30 4 O 11.4179 4.2074 0.0 0
M  V30 5 O 11.4179 6.8749 0.0 0
M  V30 6 C 3.7179 4.2074 0.0 0
M  V30 7 N 4.4879 5.5411 0.0 0
M  V30 8 C 4.4879 2.8738 0.0 0
M  V30 9 C 6.0279 5.5411 0.0 0
M  V30 10 C 6.0279 2.8738 0.0 0
M  V30 11 C 6.7979 4.2074 0.0 0
M  V30 12 N 6.7979 6.8749 0.0 0
M  V30 13 C 8.3379 4.2074 0.0 0
M  V30 14 C 8.3379 6.8749 0.0 0
M  V30 15 C 9.1079 5.5411 0.0 0
M  V30 16 N 2.1779 4.2074 0.0 0
M  V30 17 C 1.0889 5.2964 0.0 0 CFG=1
M  V30 18 C 1.0889 3.1185 0.0 0
M  V30 19 C 0.0000 4.2074 0.0 0
M  V30 20 Li 5.7089 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 17 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-(trans-3-hydroxy-3-methylcyclobutyl)-7-[(2S)-2-methyl-1-azetidinyl...
C18H21ClN4O2
2255312-50-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7179 0.0000 0.0 0
M  V30 2 C 1.0889 5.2964 0.0 0
M  V30 3 C 10.6479 4.0011 0.0 0
M  V30 4 N 11.4179 5.3347 0.0 0
M  V30 5 O 11.4179 2.6673 0.0 0
M  V30 6 C 16.2248 4.2458 0.0 0
M  V30 7 O 16.2248 6.4236 0.0 0
M  V30 8 C 3.7179 2.6673 0.0 0
M  V30 9 N 4.4879 4.0011 0.0 0
M  V30 10 C 4.4879 1.3336 0.0 0
M  V30 11 C 6.0279 4.0011 0.0 0
M  V30 12 C 6.0279 1.3336 0.0 0
M  V30 13 C 6.7979 2.6673 0.0 0
M  V30 14 N 6.7979 5.3347 0.0 0
M  V30 15 C 8.3379 2.6673 0.0 0
M  V30 16 C 8.3379 5.3347 0.0 0
M  V30 17 C 9.1079 4.0011 0.0 0
M  V30 18 N 2.1779 2.6673 0.0 0
M  V30 19 C 1.0889 3.7564 0.0 0 CFG=1
M  V30 20 C 1.0889 1.5783 0.0 0
M  V30 21 C 0.0000 2.6673 0.0 0
M  V30 22 C 12.9579 5.3347 0.0 0 CFG=2
M  V30 23 C 14.0470 6.4236 0.0 0
M  V30 24 C 14.0470 4.2458 0.0 0
M  V30 25 C 15.1359 5.3347 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 19 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 22 4 CFG=1
M  V30 7 1 25 6 CFG=1
M  V30 8 1 25 7 CFG=3
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 18
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 19 22 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1363381-26-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2255314-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2255312-50-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38094948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The exploration of aza-quinolines as hematopoietic prostaglandin D
synthase (H-PGDS) inhibitors with low brain exposure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cadilla, Rodolfo; Deaton, David N.; Do, Young; Elkins, Patricia A.;
Ennulat, Daniela; Guss, Jeffrey H.; Holt, Jason; Jeune, Michael R.; King,
Andrew G.; Klapwijk, Jan C.; Kramer, H. Fritz; Kramer, Nicholas J.;
Laffan, Susan B.; Masuria, Paresh I.; McDougal, Alan V.; Mortenson, Paul
N.; Musetti, Caterina; Peckham, Gregory E.; Pietrak, Beth L.; Poole,
Chuck; Price, Daniel J.; Rendina, Alan R.; Sati, Girish; Saxty, Gordon;
Shearer, Barry G.; Shewchuk, Lisa M.; Sneddon, Helen F.; Stewart, Eugene
L.; Stuart, J. Darren; Thomas, Dean N.; Thomson, Stephen A.; Ward, Paris;
Wilson, Joseph W.; Xu, Tiahshun; Youngman, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(23), 115791

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Indole-2-carboxylic acid
C9H7NO2
1477-50-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 N 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-2-Hydroxy-3-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(...
C30H35N3O5S
2883496-21-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 9.2400 0.0 0
M  V30 2 N 9.3358 8.4700 0.0 0
M  V30 3 O 10.6696 10.7800 0.0 0
M  V30 4 C 8.0021 9.2400 0.0 0 CFG=1
M  V30 5 C 6.6685 8.4700 0.0 0 CFG=2
M  V30 6 C 8.0021 10.7800 0.0 0
M  V30 7 C 5.3347 9.2400 0.0 0
M  V30 8 O 6.6685 6.9300 0.0 0
M  V30 9 N 4.0011 8.4700 0.0 0
M  V30 10 S 4.0011 6.9300 0.0 0 VAL=6
M  V30 11 C 2.6674 9.2400 0.0 0
M  V30 12 O 5.5411 6.9300 0.0 0
M  V30 13 O 2.4611 6.9300 0.0 0
M  V30 14 C 1.3338 8.4700 0.0 0
M  V30 15 C 0.0000 9.2400 0.0 0
M  V30 16 C 1.3338 6.9300 0.0 0
M  V30 17 O 4.0011 0.7700 0.0 0
M  V30 18 C 2.6674 0.0000 0.0 0
M  V30 19 C 13.6706 6.6183 0.0 0
M  V30 20 C 14.4406 7.9519 0.0 0
M  V30 21 C 12.1642 6.9385 0.0 0
M  V30 22 C 14.4406 5.2845 0.0 0
M  V30 23 N 13.4100 9.0963 0.0 0
M  V30 24 C 15.9806 7.9519 0.0 0
M  V30 25 C 12.0032 8.4700 0.0 0
M  V30 26 C 15.9806 5.2845 0.0 0
M  V30 27 C 16.7506 6.6183 0.0 0
M  V30 28 C 6.6685 11.5500 0.0 0
M  V30 29 C 6.6685 13.0900 0.0 0
M  V30 30 C 5.3347 10.7800 0.0 0
M  V30 31 C 5.3347 13.8600 0.0 0
M  V30 32 C 4.0011 11.5500 0.0 0
M  V30 33 C 4.0011 13.0900 0.0 0
M  V30 34 C 4.0011 5.3900 0.0 0
M  V30 35 C 5.3347 4.6200 0.0 0
M  V30 36 C 2.6674 4.6200 0.0 0
M  V30 37 C 5.3347 3.0800 0.0 0
M  V30 38 C 2.6674 3.0800 0.0 0
M  V30 39 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 28
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 34
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 39
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 25
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1477-50-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2883496-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35111055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure based design and evaluation of benzoheterocycle derivatives as
potential dual HIV-1 protease and reverse transcriptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Shan, Qi; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning;
Wang, Minghua; Zhou, Jinming; Cen, Shan; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 246114981

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
trans-4-Amino-α,α-dimethylcyclohexanemethanol
C9H19NO
899806-45-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 1.5400 3.0800 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0 CFG=2
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 6 1 CFG=3
M  V30 5 1 11 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Chloro-7-methoxy-1,8-naphthyridine-3-carboxylic acid
C10H7ClN2O3
2255314-49-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 2.6674 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 Cl 7.7000 0.0000 0.0 0
M  V30 5 O 9.2400 2.6674 0.0 0
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 N 6.9300 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 3.0800 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-7-methoxy-1,8-naphth...
C19H24ClN3O3
2255312-46-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 4.0011 0.0 0
M  V30 2 N 10.0100 5.3349 0.0 0
M  V30 3 O 10.0100 2.6674 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 O 0.7700 2.6674 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 16.1700 5.3349 0.0 0
M  V30 8 C 16.1700 6.8749 0.0 0
M  V30 9 C 17.7100 5.3349 0.0 0
M  V30 10 O 16.1700 3.7949 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 N 3.0800 4.0011 0.0 0
M  V30 16 N 5.3900 5.3349 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 3.0800 1.3338 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 6.9300 5.3349 0.0 0
M  V30 21 C 11.5500 5.3349 0.0 0 CFG=1
M  V30 22 C 12.3200 4.0011 0.0 0
M  V30 23 C 12.3200 6.6685 0.0 0
M  V30 24 C 13.8600 4.0011 0.0 0
M  V30 25 C 13.8600 6.6685 0.0 0
M  V30 26 C 14.6300 5.3349 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 21 2 CFG=1
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 26 7 CFG=3
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 899806-45-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2255314-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2255312-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38094932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The exploration of aza-quinolines as hematopoietic prostaglandin D
synthase (H-PGDS) inhibitors with low brain exposure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cadilla, Rodolfo; Deaton, David N.; Do, Young; Elkins, Patricia A.;
Ennulat, Daniela; Guss, Jeffrey H.; Holt, Jason; Jeune, Michael R.; King,
Andrew G.; Klapwijk, Jan C.; Kramer, H. Fritz; Kramer, Nicholas J.;
Laffan, Susan B.; Masuria, Paresh I.; McDougal, Alan V.; Mortenson, Paul
N.; Musetti, Caterina; Peckham, Gregory E.; Pietrak, Beth L.; Poole,
Chuck; Price, Daniel J.; Rendina, Alan R.; Sati, Girish; Saxty, Gordon;
Shearer, Barry G.; Shewchuk, Lisa M.; Sneddon, Helen F.; Stewart, Eugene
L.; Stuart, J. Darren; Thomas, Dean N.; Thomson, Stephen A.; Ward, Paris;
Wilson, Joseph W.; Xu, Tiahshun; Youngman, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(23), 115791

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
5-Cyano-3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-2-methylbenzoic acid
C16H20N2O3
2691175-30-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6673 8.4700 0.0 0
M  V30 4 C 6.6684 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 O 9.3358 7.7000 0.0 0
M  V30 7 O 10.6694 5.3900 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 5.3900 0.0 0
M  V30 14 C 6.6684 3.0800 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 2.6673 3.8500 0.0 0
M  V30 19 C 0.0000 5.3900 0.0 0
M  V30 20 C 1.3336 3.0800 0.0 0
M  V30 21 O 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 3 8 9
M  V30 10 1 8 14
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Aminomethyl)-6-methyl-4-propyl-2(1H)-pyridinone
C10H16N2O
1346575-64-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 C 8.0021 4.6200 0.0 0
M  V30 4 C 2.6674 6.1600 0.0 0
M  V30 5 N 1.3336 6.9300 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyano-N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-3-[ethyl(...
C26H34N4O3
2691175-32-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6674 8.4700 0.0 0
M  V30 4 C 6.6685 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 N 10.6694 5.3900 0.0 0
M  V30 7 O 9.3358 7.7000 0.0 0
M  V30 8 C 12.0032 6.1600 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 6.6685 0.0000 0.0 0
M  V30 11 C 14.6705 7.7000 0.0 0
M  V30 12 C 16.0041 8.4700 0.0 0
M  V30 13 C 16.0041 10.0100 0.0 0
M  V30 14 O 12.0032 3.0800 0.0 0
M  V30 15 C 17.3379 3.0800 0.0 0
M  V30 16 C 5.3347 5.3900 0.0 0
M  V30 17 C 6.6685 6.1600 0.0 0
M  V30 18 C 5.3347 3.8500 0.0 0
M  V30 19 C 8.0021 5.3900 0.0 0
M  V30 20 C 6.6685 3.0800 0.0 0
M  V30 21 C 8.0021 3.8500 0.0 0
M  V30 22 C 2.6674 5.3900 0.0 0
M  V30 23 C 1.3338 6.1600 0.0 0
M  V30 24 C 2.6674 3.8500 0.0 0
M  V30 25 C 0.0000 5.3900 0.0 0
M  V30 26 C 1.3338 3.0800 0.0 0
M  V30 27 O 0.0000 3.8500 0.0 0
M  V30 28 C 13.3369 5.3900 0.0 0
M  V30 29 C 14.6705 6.1600 0.0 0
M  V30 30 C 13.3369 3.8500 0.0 0
M  V30 31 C 16.0041 5.3900 0.0 0
M  V30 32 N 14.6705 3.0800 0.0 0
M  V30 33 C 16.0041 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 22
M  V30 4 1 2 3
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 1 8 28
M  V30 11 3 9 10
M  V30 12 1 9 20
M  V30 13 1 11 12
M  V30 14 1 11 29
M  V30 15 1 12 13
M  V30 16 2 14 30
M  V30 17 1 15 33
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2691175-30-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346575-64-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2691175-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36826816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive
Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of
Zeste Homologue 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Yang, Hong; Li, Bingbing; Li, Jiayi; Li, Huaxuan; Shi,
Qiongyu; Li, Bang; Wang, Zekun; Zheng, Jiahong; Zhang, Ying; Dong, Hui;
Huang, Xun; Wang, Yuanxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7629-7644

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL

C21H31ClN2O3
3061155-02-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 5.3900 8.0020 0.0 0
M  V30 4 C 7.7000 6.6684 0.0 0
M  V30 5 C 3.8500 8.0020 0.0 0
M  V30 6 N 8.4700 8.0020 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 O 3.0800 9.3358 0.0 0
M  V30 9 O 3.0800 6.6684 0.0 0
M  V30 10 C 10.0100 8.0020 0.0 0
M  V30 11 C 1.5400 9.3358 0.0 0
M  V30 12 C 10.7800 9.3358 0.0 0
M  V30 13 C 1.5400 10.8758 0.0 0
M  V30 14 C 0.0000 9.3358 0.0 0
M  V30 15 C 1.5400 7.7958 0.0 0
M  V30 16 C 12.3200 9.3358 0.0 0
M  V30 17 C 13.0900 10.6694 0.0 0
M  V30 18 C 14.6300 10.6694 0.0 0
M  V30 19 C 15.4000 12.0031 0.0 0
M  V30 20 C 16.9400 12.0031 0.0 0
M  V30 21 Cl 8.4700 0.0000 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 5.3900 2.6673 0.0 0
M  V30 24 C 7.7000 4.0011 0.0 0
M  V30 25 C 6.1600 1.3336 0.0 0
M  V30 26 C 8.4700 2.6673 0.0 0
M  V30 27 C 7.7000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 2 19 20
M  V30 21 1 21 27
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(R)-1-tert-Butoxycarbonylpyrrolidine-2-carboxylic acid
C11H19NO4
101555-60-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 3.3450 0.0 0
M  V30 2 O 7.0036 4.1150 0.0 0
M  V30 3 O 5.6699 1.8049 0.0 0
M  V30 4 C 8.3374 3.3450 0.0 0
M  V30 5 C 7.5674 2.0113 0.0 0
M  V30 6 C 9.6711 2.5749 0.0 0
M  V30 7 C 9.1075 4.6786 0.0 0
M  V30 8 C 2.6091 1.9822 0.0 0
M  V30 9 C 1.1446 1.5063 0.0 0
M  V30 10 O 0.0000 2.5367 0.0 0
M  V30 11 O 0.8244 0.0000 0.0 0
M  V30 12 N 4.3363 4.1150 0.0 0
M  V30 13 C 2.9293 3.4886 0.0 0 CFG=1
M  V30 14 C 4.1752 5.6465 0.0 0
M  V30 15 C 1.8989 4.6330 0.0 0
M  V30 16 C 2.6689 5.9667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 13 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H40ClN3O4
3061155-05-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.0192 12.0463 0.0 0
M  V30 2 O 0.9888 13.1907 0.0 0
M  V30 3 O 3.5255 12.3665 0.0 0
M  V30 4 C 1.4647 14.6554 0.0 0
M  V30 5 C 0.0000 15.1313 0.0 0
M  V30 6 C 1.9406 16.1201 0.0 0
M  V30 7 C 2.9292 14.1796 0.0 0
M  V30 8 C 3.9886 9.3358 0.0 0
M  V30 9 C 4.7586 8.0021 0.0 0
M  V30 10 N 6.2986 8.0021 0.0 0
M  V30 11 O 3.9886 6.6685 0.0 0
M  V30 12 C 7.0686 6.6685 0.0 0 CFG=1
M  V30 13 C 6.2986 5.3347 0.0 0
M  V30 14 C 8.6086 6.6685 0.0 0
M  V30 15 N 9.3786 8.0021 0.0 0
M  V30 16 O 9.3786 5.3347 0.0 0
M  V30 17 C 10.9186 8.0021 0.0 0
M  V30 18 C 11.6886 9.3358 0.0 0
M  V30 19 C 13.2286 9.3358 0.0 0
M  V30 20 C 13.9986 10.6694 0.0 0
M  V30 21 C 15.5386 10.6694 0.0 0
M  V30 22 C 16.3086 12.0032 0.0 0
M  V30 23 C 17.8486 12.0032 0.0 0
M  V30 24 Cl 9.3786 0.0000 0.0 0
M  V30 25 N 1.5434 10.5816 0.0 0
M  V30 26 C 2.4486 9.3358 0.0 0 CFG=1
M  V30 27 C 0.0787 10.1058 0.0 0
M  V30 28 C 1.5434 8.0899 0.0 0
M  V30 29 C 0.0787 8.5658 0.0 0
M  V30 30 C 7.0686 4.0011 0.0 0
M  V30 31 C 6.2986 2.6674 0.0 0
M  V30 32 C 8.6086 4.0011 0.0 0
M  V30 33 C 7.0686 1.3338 0.0 0
M  V30 34 C 9.3786 2.6674 0.0 0
M  V30 35 C 8.6086 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 26 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 22 23
M  V30 25 1 24 35
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3061155-02-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101555-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061155-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42895457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro
from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent
Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant
Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xu; Gotchev, Dimitar; Fan, Kristi Yi; Vega, Marvin M.; Mani,
Nagraj; McGovern-Gooch, Kayleigh; Cuconati, Andrea; Tercero, Breanna;
Wang, Xiaohe; Carpino, Philip; Maskos, Klaus; Centrella, Paolo A.;
Schmitt, Andreas; Preuss, Franziska; Prasad, Archna; Chen, Chia-yi;
Clark, Matthew A.; Guilinger, John P.; Johnstone, Shawn; von Konig,
Konstanze; Keefe, Anthony D.; Liu, Jenny; Turcotte, Stephane; Zhang,
Ying; Konz Makino, Debora L.; Lam, Angela M.; Cole, Andrew G.; Sofia,
Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(21), 19623-19667

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Difluorophenyl)amino]carbonyl]-1-methyl-α-oxo-1H-pyrrole-3-acetic acid
C14H10F2N2O4
1644485-79-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 2.7106 0.0 0
M  V30 2 N 8.5785 4.0442 0.0 0
M  V30 3 O 8.5785 1.3769 0.0 0
M  V30 4 C 5.8391 0.0000 0.0 0
M  V30 5 C 2.6528 4.3858 0.0 0
M  V30 6 C 1.2459 3.7593 0.0 0
M  V30 7 O 2.8137 5.9173 0.0 0
M  V30 8 O 0.0000 4.6645 0.0 0
M  V30 9 O 1.0849 2.2278 0.0 0
M  V30 10 F 13.1985 6.7117 0.0 0
M  V30 11 F 14.7385 4.0442 0.0 0
M  V30 12 C 6.2684 2.7106 0.0 0
M  V30 13 C 5.3632 3.9564 0.0 0
M  V30 14 N 5.3632 1.4647 0.0 0
M  V30 15 C 3.8987 3.4806 0.0 0
M  V30 16 C 3.8987 1.9406 0.0 0
M  V30 17 C 10.1185 4.0442 0.0 0
M  V30 18 C 10.8885 5.3779 0.0 0
M  V30 19 C 10.8885 2.7106 0.0 0
M  V30 20 C 12.4285 5.3779 0.0 0
M  V30 21 C 12.4285 2.7106 0.0 0
M  V30 22 C 13.1985 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 17
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 10 20
M  V30 12 1 11 22
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Difluorophenyl)amino]carbonyl]-1-methyl-α-oxo-N-(phenylmethyl)-1H-py...
C21H17F2N3O3
2133017-48-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0553 4.0287 0.0 0
M  V30 2 C 13.3891 3.2587 0.0 0
M  V30 3 O 12.0553 5.5687 0.0 0
M  V30 4 N 14.7228 4.0287 0.0 0
M  V30 5 O 13.3891 1.7187 0.0 0
M  V30 6 C 16.0564 3.2587 0.0 0
M  V30 7 C 6.7527 2.9016 0.0 0
M  V30 8 N 6.1264 4.3084 0.0 0
M  V30 9 O 5.8475 1.6557 0.0 0
M  V30 10 C 8.4279 0.0000 0.0 0
M  V30 11 F 1.8105 7.4442 0.0 0
M  V30 12 F 0.0000 4.9524 0.0 0
M  V30 13 C 10.7216 3.2587 0.0 0
M  V30 14 C 9.3148 3.8850 0.0 0
M  V30 15 C 10.5607 1.7271 0.0 0
M  V30 16 C 8.2842 2.7406 0.0 0
M  V30 17 N 9.0543 1.4068 0.0 0
M  V30 18 C 4.5948 4.4695 0.0 0
M  V30 19 C 3.9683 5.8763 0.0 0
M  V30 20 C 3.6896 3.2236 0.0 0
M  V30 21 C 2.4368 6.0373 0.0 0
M  V30 22 C 2.1580 3.3845 0.0 0
M  V30 23 C 1.5316 4.7913 0.0 0
M  V30 24 C 17.3901 4.0287 0.0 0
M  V30 25 C 17.3901 5.5687 0.0 0
M  V30 26 C 18.7239 3.2587 0.0 0
M  V30 27 C 18.7239 6.3387 0.0 0
M  V30 28 C 20.0576 4.0287 0.0 0
M  V30 29 C 20.0576 5.5687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 8 18
M  V30 12 1 10 17
M  V30 13 1 11 21
M  V30 14 1 12 23
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1644485-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2133017-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24782813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structure activity relationship of glyoxamide derivatives
as anti-hepatitis B virus agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amblard, Franck; Boucle, Sebastien; Bassit, Leda; Chen, Zhe; Sari, Ozkan;
Cox, Bryan; Verma, Kiran; Ozturk, Tugba; Ollinger-Russell, Olivia;
Schinazi, Raymond F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 31115952

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Morpholinecarboxylic acid, 4-methyl-, (3S)-
C6H11NO3
1315051-74-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0 CFG=2
M  V30 6 N 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 O 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=3
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-N-[(1S,2R)-2-Hydroxy-3-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino...
C27H39N3O6S
2765293-26-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9302 0.0 0 CFG=1
M  V30 2 C 5.3348 7.7002 0.0 0 CFG=2
M  V30 3 C 2.6673 7.7002 0.0 0
M  V30 4 N 4.0010 5.3901 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 O 6.6685 6.9302 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 N 6.6685 10.0102 0.0 0
M  V30 9 O 1.3337 5.3901 0.0 0
M  V30 10 S 8.0022 9.2402 0.0 0 VAL=6
M  V30 11 C 6.6685 11.5503 0.0 0
M  V30 12 O 8.7722 10.5739 0.0 0
M  V30 13 O 7.2322 7.9065 0.0 0
M  V30 14 C 8.0022 12.3203 0.0 0
M  V30 15 C 8.0022 13.8603 0.0 0
M  V30 16 C 9.3358 11.5503 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 O 13.3370 6.1601 0.0 0
M  V30 19 C 14.6707 6.9302 0.0 0
M  V30 20 C 2.6673 9.2402 0.0 0
M  V30 21 C 1.3337 10.0102 0.0 0
M  V30 22 C 4.0010 10.0102 0.0 0
M  V30 23 C 1.3337 11.5503 0.0 0
M  V30 24 C 4.0010 11.5503 0.0 0
M  V30 25 C 2.6673 12.3203 0.0 0
M  V30 26 C 2.6673 3.0801 0.0 0 CFG=2
M  V30 27 N 1.3337 2.3101 0.0 0
M  V30 28 C 4.0010 2.3101 0.0 0
M  V30 29 C 1.3337 0.7700 0.0 0
M  V30 30 O 4.0010 0.7700 0.0 0
M  V30 31 C 2.6673 0.0000 0.0 0
M  V30 32 C 9.3358 8.4702 0.0 0
M  V30 33 C 10.6697 9.2402 0.0 0
M  V30 34 C 9.3358 6.9302 0.0 0
M  V30 35 C 12.0033 8.4702 0.0 0
M  V30 36 C 10.6697 6.1601 0.0 0
M  V30 37 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 20
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 26 7 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 32
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 27
M  V30 20 1 18 19
M  V30 21 1 18 37
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315051-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-26-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Syringic acid
C9H10O5
530-57-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 5.3901 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 O 6.6687 5.3901 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 O 5.3348 0.0000 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-fluoro-N-(2-methylpropyl)benzen...
C20H27FN2O3S
772318-79-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 F 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-3-[[(4-Fluorophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(p...
C29H35FN2O7S
2892016-35-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 8.4700 0.0 0
M  V30 2 N 9.3358 7.7000 0.0 0
M  V30 3 O 10.6696 10.0100 0.0 0
M  V30 4 C 8.0021 8.4700 0.0 0 CFG=2
M  V30 5 C 8.0021 10.0100 0.0 0
M  V30 6 C 6.6685 7.7000 0.0 0 CFG=2
M  V30 7 C 5.3347 8.4700 0.0 0
M  V30 8 O 6.6685 6.1600 0.0 0
M  V30 9 N 4.0011 7.7000 0.0 0
M  V30 10 S 4.0011 6.1600 0.0 0 VAL=6
M  V30 11 C 2.6674 8.4700 0.0 0
M  V30 12 O 2.4611 6.1600 0.0 0
M  V30 13 O 5.5411 6.1600 0.0 0
M  V30 14 C 1.3338 7.7000 0.0 0
M  V30 15 C 0.0000 8.4700 0.0 0
M  V30 16 C 1.3338 6.1600 0.0 0
M  V30 17 O 16.0043 8.4700 0.0 0
M  V30 18 C 16.0043 10.0100 0.0 0
M  V30 19 O 13.3369 3.8500 0.0 0
M  V30 20 C 14.6705 3.0800 0.0 0
M  V30 21 O 16.0043 5.3900 0.0 0
M  V30 22 F 4.0011 0.0000 0.0 0
M  V30 23 C 12.0032 7.7000 0.0 0
M  V30 24 C 13.3369 8.4700 0.0 0
M  V30 25 C 12.0032 6.1600 0.0 0
M  V30 26 C 14.6705 7.7000 0.0 0
M  V30 27 C 13.3369 5.3900 0.0 0
M  V30 28 C 14.6705 6.1600 0.0 0
M  V30 29 C 6.6685 10.7800 0.0 0
M  V30 30 C 6.6685 12.3200 0.0 0
M  V30 31 C 5.3347 10.0100 0.0 0
M  V30 32 C 5.3347 13.0900 0.0 0
M  V30 33 C 4.0011 10.7800 0.0 0
M  V30 34 C 4.0011 12.3200 0.0 0
M  V30 35 C 4.0011 4.6200 0.0 0
M  V30 36 C 5.3349 3.8500 0.0 0
M  V30 37 C 2.6674 3.8500 0.0 0
M  V30 38 C 5.3349 2.3100 0.0 0
M  V30 39 C 2.6674 2.3100 0.0 0
M  V30 40 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 29
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 35
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 26
M  V30 21 1 19 20
M  V30 22 1 19 27
M  V30 23 1 21 28
M  V30 24 1 22 40
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-57-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 772318-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) 4-[1-(4-carboxyphenyl)-4-piperidinyl]-1-piperazinecarbo...
C21H31N3O4
223535-95-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1704 2.8737 0.0 0
M  V30 2 O 16.9404 1.5400 0.0 0
M  V30 3 O 16.9404 4.2074 0.0 0
M  V30 4 C 18.4804 1.5400 0.0 0
M  V30 5 C 18.4804 3.0801 0.0 0
M  V30 6 C 20.0204 1.5400 0.0 0
M  V30 7 C 18.4804 0.0000 0.0 0
M  V30 8 C 0.7700 2.8737 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 O 0.0000 4.2074 0.0 0
M  V30 11 C 10.0102 2.8737 0.0 0
M  V30 12 C 9.2402 1.5400 0.0 0
M  V30 13 C 9.2402 4.2074 0.0 0
M  V30 14 C 7.7002 1.5400 0.0 0
M  V30 15 C 7.7002 4.2074 0.0 0
M  V30 16 N 6.9302 2.8737 0.0 0
M  V30 17 N 11.5503 2.8737 0.0 0
M  V30 18 C 12.3203 4.2074 0.0 0
M  V30 19 C 12.3203 1.5400 0.0 0
M  V30 20 C 13.8603 4.2074 0.0 0
M  V30 21 C 13.8603 1.5400 0.0 0
M  V30 22 N 14.6303 2.8737 0.0 0
M  V30 23 C 5.3901 2.8737 0.0 0
M  V30 24 C 4.6201 1.5400 0.0 0
M  V30 25 C 4.6201 4.2074 0.0 0
M  V30 26 C 3.0801 1.5400 0.0 0
M  V30 27 C 3.0801 4.2074 0.0 0
M  V30 28 C 2.3101 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 28
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 16 23
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(trans-4-Aminocyclohexyl)methylamino]-2-chlorobenzonitrile
C14H18ClN3
2616553-29-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 Cl 1.3337 1.5400 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 N 0.0000 5.3901 0.0 0
M  V30 6 N 12.0033 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0 CFG=2
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 1.5400 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 13 1 CFG=1
M  V30 4 1 3 10
M  V30 5 3 4 5
M  V30 6 1 4 12
M  V30 7 1 18 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[1-[4-[[[trans-4-[(3-chloro-4-cyanophenyl)methylamino]cyc...
C35H47ClN6O3
2830636-79-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.5637 2.8737 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 2.1037 0.2064 0.0 0
M  V30 8 C 17.3382 9.2402 0.0 0
M  V30 9 N 18.6720 8.4702 0.0 0
M  V30 10 O 17.3382 10.7802 0.0 0
M  V30 11 N 24.0068 11.5503 0.0 0
M  V30 12 C 24.0068 13.0903 0.0 0
M  V30 13 Cl 29.3416 11.5503 0.0 0
M  V30 14 C 29.3416 8.4702 0.0 0
M  V30 15 N 30.6753 7.7002 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 10.6697 6.9302 0.0 0
M  V30 21 N 12.0033 6.1601 0.0 0
M  V30 22 N 8.0023 3.8501 0.0 0
M  V30 23 C 8.0023 2.3101 0.0 0
M  V30 24 C 6.6685 4.6201 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0
M  V30 26 C 5.3348 3.8501 0.0 0
M  V30 27 N 5.3348 2.3101 0.0 0
M  V30 28 C 13.3372 6.9302 0.0 0
M  V30 29 C 13.3372 8.4702 0.0 0
M  V30 30 C 14.6708 6.1601 0.0 0
M  V30 31 C 14.6708 9.2402 0.0 0
M  V30 32 C 16.0045 6.9302 0.0 0
M  V30 33 C 16.0045 8.4702 0.0 0
M  V30 34 C 20.0057 9.2402 0.0 0 CFG=2
M  V30 35 C 20.0057 10.7802 0.0 0
M  V30 36 C 21.3393 8.4702 0.0 0
M  V30 37 C 21.3393 11.5503 0.0 0
M  V30 38 C 22.6730 9.2402 0.0 0
M  V30 39 C 22.6730 10.7802 0.0 0 CFG=2
M  V30 40 C 25.3405 10.7802 0.0 0
M  V30 41 C 26.6742 11.5503 0.0 0
M  V30 42 C 25.3405 9.2402 0.0 0
M  V30 43 C 28.0078 10.7802 0.0 0
M  V30 44 C 26.6742 8.4702 0.0 0
M  V30 45 C 28.0078 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 33
M  V30 11 1 34 9 CFG=1
M  V30 12 1 11 12
M  V30 13 1 39 11 CFG=3
M  V30 14 1 11 40
M  V30 15 1 13 43
M  V30 16 3 14 15
M  V30 17 1 14 45
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 22
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 21 28
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 34 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 223535-95-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2616553-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2830636-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34568109
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC
Degrader of Androgen Receptor for the Treatment of Advanced Prostate
Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Weiguo; Zhao, Lijie; Han, Xin; Qin, Chong; Miao, Bukeyan;
McEachern, Donna; Wang, Yu; Metwally, Hoda; Kirchhoff, Paul D.; Wang, Lu;
Matvekas, Aleksas; He, Miao; Wen, Bo; Sun, Duxin; Wang, Shaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(18), 13487-13509

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
4-[3,5-Dimethyl-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-4-yl]benzenamine
C17H27N3OSi
2488667-98-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8367 5.3914 0.0 0
M  V30 2 C 6.2701 0.0000 0.0 0
M  V30 3 C 9.8975 4.0286 0.0 0
M  V30 4 O 11.2313 3.2586 0.0 0
M  V30 5 C 12.5650 4.0286 0.0 0
M  V30 6 C 13.8987 3.2586 0.0 0
M  V30 7 Si 15.2323 4.0286 0.0 0
M  V30 8 C 16.5661 4.7986 0.0 0
M  V30 9 C 14.4623 5.3624 0.0 0
M  V30 10 C 16.0023 2.6949 0.0 0
M  V30 11 N 0.0000 3.3845 0.0 0
M  V30 12 C 6.1264 2.7405 0.0 0
M  V30 13 C 7.1570 3.8850 0.0 0
M  V30 14 C 6.8964 1.4068 0.0 0
M  V30 15 N 8.5638 3.2586 0.0 0
M  V30 16 N 8.4029 1.7270 0.0 0
M  V30 17 C 4.5948 2.9016 0.0 0
M  V30 18 C 3.6896 1.6557 0.0 0
M  V30 19 C 3.9685 4.3084 0.0 0
M  V30 20 C 2.1580 1.8166 0.0 0
M  V30 21 C 2.4368 4.4693 0.0 0
M  V30 22 C 1.5317 3.2234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 22
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-β-Cyclopropyl-α-[[(1,1-dimethylethoxy)carbonyl]amino]cyclopropanepropano...
C14H23NO4
2548967-22-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.8737 0.0 0
M  V30 2 C 4.2075 3.6437 0.0 0 CFG=1
M  V30 3 N 5.5412 2.8737 0.0 0
M  V30 4 C 4.2075 5.1838 0.0 0
M  V30 5 C 6.8749 3.6437 0.0 0
M  V30 6 O 5.5412 5.9538 0.0 0
M  V30 7 O 2.8737 5.9538 0.0 0
M  V30 8 O 8.2085 2.8737 0.0 0
M  V30 9 O 6.8749 5.1838 0.0 0
M  V30 10 C 9.5424 3.6437 0.0 0
M  V30 11 C 8.7723 4.9774 0.0 0
M  V30 12 C 10.8760 4.4137 0.0 0
M  V30 13 C 10.3124 2.3101 0.0 0
M  V30 14 C 1.5400 3.6437 0.0 0
M  V30 15 C 0.0000 3.6437 0.0 0
M  V30 16 C 0.7700 4.9774 0.0 0
M  V30 17 C 2.8737 1.3337 0.0 0
M  V30 18 C 3.6437 0.0000 0.0 0
M  V30 19 C 2.1037 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 14
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 2 5 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C31H48N4O4Si
2548974-55-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 8.0020 0.0 0
M  V30 2 C 3.6437 6.6684 0.0 0 CFG=2
M  V30 3 C 5.1837 6.6684 0.0 0
M  V30 4 N 2.8737 5.3347 0.0 0
M  V30 5 N 5.9537 8.0020 0.0 0
M  V30 6 O 5.9537 5.3347 0.0 0
M  V30 7 C 3.6437 4.0009 0.0 0
M  V30 8 O 2.8737 2.6673 0.0 0
M  V30 9 O 5.1837 4.0009 0.0 0
M  V30 10 C 3.6437 1.3336 0.0 0
M  V30 11 C 2.3100 0.5636 0.0 0
M  V30 12 C 4.4137 0.0000 0.0 0
M  V30 13 C 4.9773 2.1037 0.0 0
M  V30 14 C 12.5431 10.7126 0.0 0
M  V30 15 C 12.5431 5.2916 0.0 0
M  V30 16 C 15.7295 9.6773 0.0 0
M  V30 17 O 17.1363 9.0509 0.0 0
M  V30 18 C 18.3821 9.9562 0.0 0
M  V30 19 C 19.7891 9.3297 0.0 0
M  V30 20 Si 21.0350 10.2349 0.0 0
M  V30 21 C 22.2808 11.1401 0.0 0
M  V30 22 C 20.1298 11.4808 0.0 0
M  V30 23 C 21.9402 8.9890 0.0 0
M  V30 24 C 3.6437 9.3357 0.0 0
M  V30 25 C 3.6437 10.8758 0.0 0
M  V30 26 C 4.9773 10.1058 0.0 0
M  V30 27 C 1.3336 8.0020 0.0 0
M  V30 28 C 0.0000 8.7720 0.0 0
M  V30 29 C 0.0000 7.2320 0.0 0
M  V30 30 C 7.4937 8.0020 0.0 0
M  V30 31 C 8.2637 6.6684 0.0 0
M  V30 32 C 8.2637 9.3358 0.0 0
M  V30 33 C 9.8037 6.6684 0.0 0
M  V30 34 C 9.8037 9.3358 0.0 0
M  V30 35 C 10.5737 8.0020 0.0 0
M  V30 36 C 12.1137 8.0020 0.0 0
M  V30 37 C 13.0189 9.2479 0.0 0
M  V30 38 C 13.0189 6.7562 0.0 0
M  V30 39 N 14.4836 8.7720 0.0 0
M  V30 40 N 14.4836 7.2320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 24
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 4 7
M  V30 9 1 5 30
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 37
M  V30 17 1 15 38
M  V30 18 1 16 17
M  V30 19 1 16 39
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 38 1 35 36
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2488667-98-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2548967-22-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2548974-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33408939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A
Protein-Protein Interaction Modulator for the Potential Treatment of
Psoriasis and Other Inflammatory Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Mark D.; Dack, Kevin N.; de Groot, Marcel J.; Lambert, Maja;
Sennbro, Carl J.; Larsen, Mogens; Stahlhut, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(13), 8828-8842

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Boc-L-valine
C10H19NO4
13734-41-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2S,3R,4R)-4-amino-3-(2-propen-1-yl)-1,2-pyrro...
C14H24N2O4
2376707-33-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0620 5.3914 0.0 0
M  V30 2 O 8.5266 5.8674 0.0 0
M  V30 3 O 5.9174 6.4219 0.0 0
M  V30 4 C 8.8467 7.3737 0.0 0
M  V30 5 C 4.0012 4.0287 0.0 0
M  V30 6 O 2.6673 3.2587 0.0 0
M  V30 7 O 4.0012 5.5688 0.0 0
M  V30 8 C 1.3337 4.0287 0.0 0
M  V30 9 C 0.5637 2.6949 0.0 0
M  V30 10 C 0.0000 4.7987 0.0 0
M  V30 11 C 2.1037 5.3624 0.0 0
M  V30 12 C 9.3038 2.9016 0.0 0
M  V30 13 C 10.2090 1.6557 0.0 0
M  V30 14 C 11.7406 1.8166 0.0 0
M  V30 15 N 7.6286 0.0000 0.0 0
M  V30 16 C 6.7417 3.8850 0.0 0 CFG=2
M  V30 17 N 5.3348 3.2587 0.0 0
M  V30 18 C 7.7722 2.7406 0.0 0 CFG=2
M  V30 19 C 5.4958 1.7270 0.0 0
M  V30 20 C 7.0022 1.4068 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 18 12 CFG=3
M  V30 14 2 13 14
M  V30 15 1 20 15 CFG=1
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 18 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2S,3R,4R)-4-[[(2S)-2-[[(1,1-dimethylethoxy)ca...
C24H41N3O7
2376705-18-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3648 2.6528 0.0 0
M  V30 2 O 6.2700 1.4070 0.0 0
M  V30 3 O 3.8333 2.4919 0.0 0
M  V30 4 C 5.6435 0.0000 0.0 0
M  V30 5 C 8.6419 3.3494 0.0 0
M  V30 6 C 10.1067 3.8252 0.0 0
M  V30 7 C 11.2510 2.7948 0.0 0
M  V30 8 C 3.6896 5.5544 0.0 0
M  V30 9 O 3.0632 6.9612 0.0 0
M  V30 10 O 2.7843 4.3085 0.0 0
M  V30 11 C 1.5315 7.1223 0.0 0
M  V30 12 C 1.3706 5.5906 0.0 0
M  V30 13 C 0.0000 7.2832 0.0 0
M  V30 14 C 1.6926 8.6538 0.0 0
M  V30 15 N 8.9921 6.6815 0.0 0
M  V30 16 C 8.9921 8.2215 0.0 0
M  V30 17 C 10.3260 8.9915 0.0 0 CFG=2
M  V30 18 O 7.6585 8.9915 0.0 0
M  V30 19 N 11.6596 8.2215 0.0 0
M  V30 20 C 10.3260 10.5315 0.0 0
M  V30 21 C 12.9933 8.9915 0.0 0
M  V30 22 C 8.9921 11.3016 0.0 0
M  V30 23 C 11.6596 11.3016 0.0 0
M  V30 24 O 14.3269 8.2215 0.0 0
M  V30 25 O 12.9933 10.5315 0.0 0
M  V30 26 C 15.6607 8.9915 0.0 0
M  V30 27 C 14.8907 10.3252 0.0 0
M  V30 28 C 16.9944 9.7615 0.0 0
M  V30 29 C 16.4307 7.6577 0.0 0
M  V30 30 C 5.9911 4.0596 0.0 0 CFG=1
M  V30 31 C 7.4976 4.3798 0.0 0 CFG=2
M  V30 32 N 5.2211 5.3934 0.0 0
M  V30 33 C 7.6585 5.9115 0.0 0 CFG=1
M  V30 34 C 6.2517 6.5378 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 30 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 31 5 CFG=1
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 32
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 33 15 CFG=3
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20 CFG=3
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 2 21 25
M  V30 26 1 24 26
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 30 31 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376707-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376705-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35396616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Discovery of Proline-Derived Arginase Inhibitors with
Improved Oral Bioavailability for Immuno-Oncology
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Min; Zhang, Hongjun; Li, Derun; Childers, Matthew; Pu, Qinglin;
Palte, Rachel L.; Gathiaka, Symon; Lyons, Thomas W.; Palani, Anandan;
Fan, Peter W.; Spacciapoli, Peter; Miller, J. Richard; Cho, Hyelim;
Cheng, Mangeng; Chakravarthy, Kalyan; O'Neil, Jennifer; Eangoor,
Padmanabhan; Beard, Adam; Kim, Hai-Young; Sauri, Josep; Gunaydin, Hakan;
Sloman, David L.; Siliphaivanh, Phieng; Cumming, Jared; Fischer,
Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
S-Methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-cysteinyl-S-methyl-L-cysteine
C13H19N3O4S3
2387522-95-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.8501 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 9.3360 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 N 5.3348 6.1601 0.0 0
M  V30 8 O 4.0012 3.8501 0.0 0
M  V30 9 S 5.3348 1.5400 0.0 0
M  V30 10 C 4.0012 6.9302 0.0 0 CFG=2
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 8.4702 0.0 0
M  V30 14 S 1.3337 6.9302 0.0 0
M  V30 15 O 2.6675 9.2402 0.0 0
M  V30 16 O 5.3348 9.2402 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 18 C 14.6386 4.9772 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 S 12.0765 3.9938 0.0 0
M  V30 21 C 10.8306 6.1517 0.0 0
M  V30 22 C 13.1071 5.1382 0.0 0
M  V30 23 N 12.3371 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12 CFG=1
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 18 22
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-erythro-3-Pentulose, 2-amino-4,5-anhydro-1,2-dideoxy-4-C-methyl-1-phenyl-, ...
C12H15NO2.C2HF3O2
1148157-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.7237 0.0 0
M  V30 2 C 5.3348 7.4937 0.0 0 CFG=1
M  V30 3 O 6.6684 5.1837 0.0 0
M  V30 4 C 4.0011 6.7237 0.0 0
M  V30 5 N 5.3348 9.0338 0.0 0
M  V30 6 C 7.4755 8.9409 0.0 0
M  V30 7 C 8.0022 7.4937 0.0 0 CFG=2
M  V30 8 C 8.9921 6.3141 0.0 0
M  V30 9 O 9.5188 7.7611 0.0 0
M  V30 10 C 2.6675 7.4937 0.0 0
M  V30 11 C 1.3337 6.7237 0.0 0
M  V30 12 C 2.6675 9.0338 0.0 0
M  V30 13 C 0.0000 7.4937 0.0 0
M  V30 14 C 1.3337 9.8038 0.0 0
M  V30 15 C 0.0000 9.0338 0.0 0
M  V30 16 C 4.0926 2.3101 0.0 0
M  V30 17 C 5.4262 1.5400 0.0 0
M  V30 18 F 4.8626 3.6437 0.0 0
M  V30 19 F 2.7589 3.0801 0.0 0
M  V30 20 F 3.3226 0.9764 0.0 0
M  V30 21 O 6.7599 2.3101 0.0 0
M  V30 22 O 5.4262 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 10
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-Methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-cysteinyl-S-methyl-N-[(1S)-2-[(...
C25H32N4O5S3
2387523-22-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.3901 0.0 0
M  V30 2 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 3 O 1.3338 4.6201 0.0 0
M  V30 4 C 4.0011 3.0800 0.0 0
M  V30 5 N 5.3350 5.3901 0.0 0
M  V30 6 C 6.6686 4.6201 0.0 0
M  V30 7 C 8.0023 5.3901 0.0 0 CFG=2
M  V30 8 O 6.6686 3.0800 0.0 0
M  V30 9 N 9.3359 4.6201 0.0 0
M  V30 10 C 8.0023 6.9301 0.0 0
M  V30 11 C 10.6697 5.3901 0.0 0
M  V30 12 S 6.6686 7.7001 0.0 0
M  V30 13 C 12.0034 4.6201 0.0 0 CFG=2
M  V30 14 O 10.6697 6.9301 0.0 0
M  V30 15 C 6.6686 9.2401 0.0 0
M  V30 16 N 13.3371 5.3901 0.0 0
M  V30 17 C 12.0034 3.0800 0.0 0
M  V30 18 C 14.6707 4.6201 0.0 0
M  V30 19 S 10.6697 2.3100 0.0 0
M  V30 20 O 14.6707 3.0800 0.0 0
M  V30 21 C 10.6697 0.7700 0.0 0
M  V30 22 C 4.1841 7.1975 0.0 0
M  V30 23 C 19.9735 5.7472 0.0 0
M  V30 24 C 2.6675 6.9301 0.0 0 CFG=2
M  V30 25 C 1.1509 7.1975 0.0 0
M  V30 26 O 2.1408 8.3773 0.0 0
M  V30 27 C 2.6675 2.3100 0.0 0
M  V30 28 C 1.3338 3.0800 0.0 0
M  V30 29 C 2.6675 0.7700 0.0 0
M  V30 30 C 0.0000 2.3100 0.0 0
M  V30 31 C 1.3338 0.0000 0.0 0
M  V30 32 C 0.0000 0.7700 0.0 0
M  V30 33 C 16.0045 5.3901 0.0 0
M  V30 34 C 16.1655 6.9216 0.0 0
M  V30 35 S 17.4114 4.7638 0.0 0
M  V30 36 N 17.6718 7.2418 0.0 0
M  V30 37 C 18.4418 5.9081 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=1
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 18 33
M  V30 23 1 19 21
M  V30 24 1 24 22 CFG=3
M  V30 25 1 23 37
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 7 13 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387522-95-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148157-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545377
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
4-Thiazolemethanamine, 2-phenyl-, hydrochloride (1:1)
C10H10N2S.ClH
857997-89-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2359 4.5489 0.0 0
M  V30 2 N 9.6427 3.9226 0.0 0
M  V30 3 C 4.6201 2.8737 0.0 0
M  V30 4 N 5.5253 4.1195 0.0 0
M  V30 5 S 5.5253 1.6278 0.0 0
M  V30 6 C 6.9898 3.6437 0.0 0
M  V30 7 C 6.9898 2.1036 0.0 0
M  V30 8 C 3.0800 2.8737 0.0 0
M  V30 9 C 2.3100 1.5400 0.0 0
M  V30 10 C 2.3100 4.2073 0.0 0
M  V30 11 C 0.7700 1.5400 0.0 0
M  V30 12 C 0.7700 4.2073 0.0 0
M  V30 13 C 0.0000 2.8737 0.0 0
M  V30 14 Cl 4.8213 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl] hydrogen butanedioate
C14H22O4
1092569-57-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5029 5.5476 0.0 0
M  V30 2 O 6.3920 4.0011 0.0 0
M  V30 3 C 7.1620 2.6675 0.0 0
M  V30 4 C 8.7020 2.6675 0.0 0
M  V30 5 O 6.3920 1.3337 0.0 0
M  V30 6 C 9.4720 1.3337 0.0 0
M  V30 7 C 11.0120 1.3337 0.0 0
M  V30 8 O 11.7821 2.6675 0.0 0
M  V30 9 O 11.7821 0.0000 0.0 0
M  V30 10 C 2.0053 1.1658 0.0 0
M  V30 11 C 0.0000 2.8269 0.0 0
M  V30 12 C 3.4338 4.4393 0.0 0 CFG=2
M  V30 13 C 4.8520 4.0011 0.0 0 CFG=2
M  V30 14 C 1.5274 2.6299 0.0 0
M  V30 15 C 2.9724 5.7612 0.0 0
M  V30 16 C 3.6190 3.6203 0.0 0
M  V30 17 C 2.2965 3.8242 0.0 0 CFG=1
M  V30 18 C 1.8676 5.3403 0.0 0
M  V30 19 H 0.7734 4.0516 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 14
M  V30 11 1 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl 4-oxo-4-[[(2-phenyl-4-thiaz...
C24H30N2O3S
2656367-51-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5392 5.0435 0.0 0
M  V30 2 O 4.9485 4.6487 0.0 0
M  V30 3 C 6.2823 3.8787 0.0 0
M  V30 4 C 7.6160 4.6487 0.0 0
M  V30 5 O 6.2823 2.3387 0.0 0
M  V30 6 C 8.9496 3.8787 0.0 0
M  V30 7 C 10.2833 4.6487 0.0 0
M  V30 8 N 11.6171 3.8787 0.0 0
M  V30 9 O 10.2833 6.1887 0.0 0
M  V30 10 C 12.9508 4.6487 0.0 0
M  V30 11 C 2.5672 0.0000 0.0 0
M  V30 12 C 0.0000 0.4358 0.0 0
M  V30 13 C 2.1676 3.5490 0.0 0 CFG=2
M  V30 14 C 3.6149 3.8787 0.0 0 CFG=2
M  V30 15 C 1.4213 1.0289 0.0 0
M  V30 16 C 1.1071 4.4633 0.0 0
M  V30 17 C 2.7375 2.9325 0.0 0
M  V30 18 C 1.4903 2.4479 0.0 0 CFG=1
M  V30 19 C 0.3607 3.5463 0.0 0
M  V30 20 C 14.2844 3.8787 0.0 0
M  V30 21 N 15.6914 4.5052 0.0 0
M  V30 22 C 14.4453 2.3471 0.0 0
M  V30 23 C 16.7218 3.3606 0.0 0
M  V30 24 S 15.9518 2.0270 0.0 0
M  V30 25 C 18.2533 3.5216 0.0 0
M  V30 26 C 19.1586 2.2757 0.0 0
M  V30 27 C 18.8797 4.9285 0.0 0
M  V30 28 C 20.6901 2.4368 0.0 0
M  V30 29 C 20.4114 5.0894 0.0 0
M  V30 30 C 21.3166 3.8436 0.0 0
M  V30 31 H 0.0574 1.8831 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 14 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 20
M  V30 12 1 11 15
M  V30 13 1 12 15
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 18 31 CFG=3
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 857997-89-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1092569-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2656367-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23701514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, fungicidal activities and structure-activity
relationship studies of (-)-borneol derivatives containing
2-aryl-thiazole scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Danling; Zheng, Shumin; Zhang, Tianyuan; Cheng, Yong-Xian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 45128006

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
3-[Ethyl(tetrahydro-2H-pyran-4-yl)amino]-2-methyl-5-nitrobenzoic acid
C15H20N2O5
2691174-96-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 5.3900 0.0 0
M  V30 2 C 4.0011 6.9300 0.0 0
M  V30 3 C 2.6673 7.7000 0.0 0
M  V30 4 C 6.6684 6.9300 0.0 0
M  V30 5 C 9.3358 5.3900 0.0 0
M  V30 6 O 9.3358 6.9300 0.0 0
M  V30 7 O 10.6694 4.6200 0.0 0
M  V30 8 N 6.6684 0.7700 0.0 0 VAL=5
M  V30 9 O 5.3347 0.0000 0.0 0
M  V30 10 O 8.0021 0.0000 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 6.6684 5.3900 0.0 0
M  V30 13 C 5.3347 3.0800 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 1.3336 5.3900 0.0 0
M  V30 19 C 2.6673 3.0800 0.0 0
M  V30 20 C 0.0000 4.6200 0.0 0
M  V30 21 C 1.3336 2.3100 0.0 0
M  V30 22 O 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 15
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Aminomethyl)-4,6-dimethyl-2(1H)-pyridinone
C8H12N2O
771579-27-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 N 0.0000 4.0011 0.0 0
M  V30 3 C 2.3100 5.3349 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl(tetrahydro-2H...
C23H30N4O5
2691174-97-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 5.3900 0.0 0
M  V30 2 C 4.0011 6.9300 0.0 0
M  V30 3 C 2.6674 7.7000 0.0 0
M  V30 4 C 6.6685 6.9300 0.0 0
M  V30 5 C 9.3358 5.3900 0.0 0
M  V30 6 N 10.6694 4.6200 0.0 0
M  V30 7 O 9.3358 6.9300 0.0 0
M  V30 8 C 12.0032 5.3900 0.0 0
M  V30 9 N 6.6685 0.7700 0.0 0 VAL=5
M  V30 10 O 5.3347 0.0000 0.0 0
M  V30 11 O 8.0021 0.0000 0.0 0
M  V30 12 C 12.0032 2.3100 0.0 0
M  V30 13 O 14.6705 6.9300 0.0 0
M  V30 14 C 17.3379 2.3100 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 6.6685 5.3900 0.0 0
M  V30 17 C 5.3347 3.0800 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 20 C 8.0021 3.0800 0.0 0
M  V30 21 C 2.6674 4.6200 0.0 0
M  V30 22 C 2.6674 3.0800 0.0 0
M  V30 23 C 1.3338 5.3900 0.0 0
M  V30 24 C 1.3338 2.3100 0.0 0
M  V30 25 C 0.0000 4.6200 0.0 0
M  V30 26 O 0.0000 3.0800 0.0 0
M  V30 27 C 13.3369 4.6200 0.0 0
M  V30 28 C 13.3369 3.0800 0.0 0
M  V30 29 C 14.6705 5.3900 0.0 0
M  V30 30 C 14.6705 2.3100 0.0 0
M  V30 31 N 16.0041 4.6200 0.0 0
M  V30 32 C 16.0041 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 1 6 8
M  V30 10 1 8 27
M  V30 11 2 9 10
M  V30 12 2 9 11
M  V30 13 1 9 19
M  V30 14 1 12 28
M  V30 15 2 13 29
M  V30 16 1 14 32
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2691174-96-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 771579-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2691174-97-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36826801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive
Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of
Zeste Homologue 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Yang, Hong; Li, Bingbing; Li, Jiayi; Li, Huaxuan; Shi,
Qiongyu; Li, Bang; Wang, Zekun; Zheng, Jiahong; Zhang, Ying; Dong, Hui;
Huang, Xun; Wang, Yuanxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7629-7644

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid
C9H8O4
4442-54-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Amino-2-methylphenyl)-2-methyl-6-quinolinecarboxamide
C18H17N3O
1693733-61-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0011 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 O 4.6201 5.3348 0.0 0
M  V30 4 C 13.8602 5.3348 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 N 0.0000 5.3348 0.0 0
M  V30 7 C 9.2401 5.3348 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 7.7001 5.3348 0.0 0
M  V30 10 C 10.0101 6.6686 0.0 0
M  V30 11 C 9.2401 2.6675 0.0 0
M  V30 12 N 11.5501 4.0011 0.0 0
M  V30 13 C 6.9301 4.0011 0.0 0
M  V30 14 C 11.5501 6.6686 0.0 0
M  V30 15 C 7.7001 2.6675 0.0 0
M  V30 16 C 12.3201 5.3348 0.0 0
M  V30 17 C 3.0800 2.6675 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 0.7700 1.3338 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 17
M  V30 5 1 4 16
M  V30 6 1 5 18
M  V30 7 1 6 21
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[[(2,3-Dihydro-1,4-benzodioxin-6-yl)carbonyl]amino]-2-methylphenyl]-2-me...
C27H23N3O4
1693731-14-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 6.6684 0.0 0
M  V30 2 N 11.5500 8.0021 0.0 0
M  V30 3 O 11.5500 5.3347 0.0 0
M  V30 4 C 20.7900 5.3347 0.0 0
M  V30 5 C 10.0100 10.6694 0.0 0
M  V30 6 N 6.9300 5.3347 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 O 4.6200 6.6684 0.0 0
M  V30 9 C 16.1700 5.3347 0.0 0
M  V30 10 C 16.9400 6.6684 0.0 0
M  V30 11 C 14.6300 5.3347 0.0 0
M  V30 12 C 16.9400 4.0011 0.0 0
M  V30 13 C 16.1700 8.0021 0.0 0
M  V30 14 N 18.4800 6.6684 0.0 0
M  V30 15 C 13.8600 6.6684 0.0 0
M  V30 16 C 18.4800 4.0011 0.0 0
M  V30 17 C 14.6300 8.0021 0.0 0
M  V30 18 C 19.2500 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 9.2400 6.6684 0.0 0
M  V30 21 C 9.2400 9.3358 0.0 0
M  V30 22 C 7.7000 6.6684 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 4.6200 4.0011 0.0 0
M  V30 26 C 3.0800 4.0011 0.0 0
M  V30 27 C 5.3900 2.6673 0.0 0
M  V30 28 C 2.3100 2.6673 0.0 0
M  V30 29 C 4.6200 1.3336 0.0 0
M  V30 30 C 3.0800 1.3336 0.0 0
M  V30 31 O 0.7700 2.6673 0.0 0
M  V30 32 O 2.3100 0.0000 0.0 0
M  V30 33 C 0.0000 1.3336 0.0 0
M  V30 34 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 19
M  V30 5 1 4 18
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 2 7 8
M  V30 10 1 7 25
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 2 29 30
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4442-54-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1693733-61-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693731-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40578371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed
from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian
Cancer and Other Malignancies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pasqua, A. Elisa; Sharp, Swee Y.; Chessum, Nicola E. A.; Hayes, Angela;
Pellegrino, Loredana; Tucker, Michael J.; Miah, Asadh; Wilding, Birgit;
Evans, Lindsay E.; Rye, Carl S.; Mok, N. Yi; Liu, Manjuan; Henley, Alan
T.; Gowan, Sharon; De Billy, Emmanuel; te Poele, Robert; Powers, Marissa;
Eccles, Suzanne A.; Clarke, Paul A.; Raynaud, Florence I.; Workman, Paul;
Jones, Keith; Cheeseman, Matthew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5907-5936

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[(1S)-1-(aminocarbonyl)-3-methylbutyl]carbamate
C11H22N2O3
70533-96-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-5-hydroxy-L-tryptophan
C16H20N2O5
119768-45-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 5.2891 0.0 0
M  V30 2 C 5.8243 6.6228 0.0 0 CFG=1
M  V30 3 N 7.3643 6.6228 0.0 0
M  V30 4 C 5.0543 7.9564 0.0 0
M  V30 5 C 8.1343 5.2891 0.0 0
M  V30 6 O 3.5143 7.9564 0.0 0
M  V30 7 O 5.8243 9.2902 0.0 0
M  V30 8 O 9.6743 5.2891 0.0 0
M  V30 9 O 7.3643 3.9555 0.0 0
M  V30 10 C 10.4443 3.9555 0.0 0
M  V30 11 C 11.7779 4.7255 0.0 0
M  V30 12 C 11.2143 2.6217 0.0 0
M  V30 13 C 9.1106 3.1855 0.0 0
M  V30 14 O 2.1050 0.0000 0.0 0
M  V30 15 C 2.6091 4.0433 0.0 0
M  V30 16 C 3.5143 5.2891 0.0 0
M  V30 17 C 1.1444 4.5191 0.0 0
M  V30 18 C 2.9292 2.5368 0.0 0
M  V30 19 C 2.6091 6.5350 0.0 0
M  V30 20 N 1.1444 6.0591 0.0 0
M  V30 21 C 0.0000 3.4887 0.0 0
M  V30 22 C 1.7849 1.5064 0.0 0
M  V30 23 C 0.3202 1.9823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 22
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C22H32N4O5
3058604-53-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.0550 0.0 0
M  V30 2 C 6.6684 7.5950 0.0 0 CFG=2
M  V30 3 C 5.3348 8.3650 0.0 0
M  V30 4 N 8.0021 8.3650 0.0 0
M  V30 5 N 5.3348 9.9050 0.0 0
M  V30 6 O 4.0009 7.5950 0.0 0
M  V30 7 C 9.3359 7.5950 0.0 0
M  V30 8 C 4.0009 10.6750 0.0 0 CFG=2
M  V30 9 O 10.6695 8.3650 0.0 0
M  V30 10 O 9.3359 6.0550 0.0 0
M  V30 11 C 2.6673 9.9050 0.0 0
M  V30 12 C 4.0009 12.2151 0.0 0
M  V30 13 C 12.0032 7.5950 0.0 0
M  V30 14 C 1.3336 10.6750 0.0 0
M  V30 15 N 2.6673 12.9851 0.0 0
M  V30 16 O 5.3348 12.9851 0.0 0
M  V30 17 C 12.7732 8.9288 0.0 0
M  V30 18 C 13.3368 6.8250 0.0 0
M  V30 19 C 11.2331 6.2614 0.0 0
M  V30 20 C 1.3336 12.2151 0.0 0
M  V30 21 C 0.0000 9.9050 0.0 0
M  V30 22 O 6.7588 0.0000 0.0 0
M  V30 23 C 5.1737 3.7535 0.0 0
M  V30 24 C 5.3348 5.2850 0.0 0
M  V30 25 C 3.6674 3.4333 0.0 0
M  V30 26 C 6.2042 2.6091 0.0 0
M  V30 27 C 3.9278 5.9115 0.0 0
M  V30 28 N 2.8974 4.7670 0.0 0
M  V30 29 C 3.1915 1.9686 0.0 0
M  V30 30 C 5.7284 1.1444 0.0 0
M  V30 31 C 4.2219 0.8242 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 14 21
M  V30 22 1 22 30
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 2 24 27
M  V30 27 1 25 28
M  V30 28 2 25 29
M  V30 29 1 26 30
M  V30 30 1 27 28
M  V30 31 1 29 31
M  V30 32 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 70533-96-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119768-45-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3058604-53-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39925573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of
Macrocyclic Inhibitors of the 20S Proteasome
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gotz, Marion G.; Godwin, Kacey; Price, Rachel; Dorn, Robert;
Merrill-Steskal, Gabriel; Klemmer, William; Hansen, Hunter; Produturi,
Gautam; Rocha, Megan; Palmer, Mathias; Molacek, Lea; Strater, Zack;
Groll, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(4), 533-539

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-hydroxy-N-(2-methylpropyl)benze...
C20H28N2O4S
157567-13-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 O 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-1-[(1,1-Dimethylethoxy)carbonyl]-3-pyrrolidineacetic acid
C11H19NO4
204688-60-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.7798 0.0 0
M  V30 2 O 2.6673 3.0098 0.0 0
M  V30 3 O 4.0011 5.3199 0.0 0
M  V30 4 C 1.3337 3.7798 0.0 0
M  V30 5 C 2.1037 5.1135 0.0 0
M  V30 6 C 0.0000 4.5499 0.0 0
M  V30 7 C 0.5637 2.4462 0.0 0
M  V30 8 C 9.3038 2.6527 0.0 0
M  V30 9 C 10.2090 1.4068 0.0 0
M  V30 10 O 11.7406 1.5679 0.0 0
M  V30 11 O 9.5825 0.0000 0.0 0
M  V30 12 N 5.3348 3.0098 0.0 0
M  V30 13 C 6.7416 3.6363 0.0 0
M  V30 14 C 5.4957 1.4783 0.0 0
M  V30 15 C 7.7722 2.4918 0.0 0 CFG=1
M  V30 16 C 7.0022 1.1581 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 15 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[2-[[(1S,2R)-2-hydroxy-3-[[(4-hydroxyphenyl)s...
C31H45N3O7S
2925287-31-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 8.4700 0.0 0 CFG=1
M  V30 2 C 6.6684 7.7000 0.0 0 CFG=2
M  V30 3 C 8.0020 10.0100 0.0 0
M  V30 4 N 9.3356 7.7000 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 O 6.6684 6.1600 0.0 0
M  V30 7 C 10.6694 8.4700 0.0 0
M  V30 8 N 4.0009 7.7000 0.0 0
M  V30 9 C 12.0031 7.7000 0.0 0
M  V30 10 O 10.6694 10.0100 0.0 0
M  V30 11 S 4.0009 6.1600 0.0 0 VAL=6
M  V30 12 C 2.6673 8.4700 0.0 0
M  V30 13 O 5.5409 6.1600 0.0 0
M  V30 14 O 2.4609 6.1600 0.0 0
M  V30 15 C 1.3336 7.7000 0.0 0
M  V30 16 C 1.3336 6.1600 0.0 0
M  V30 17 C 0.0000 8.4700 0.0 0
M  V30 18 C 17.3056 8.8271 0.0 0
M  V30 19 O 18.2108 10.0730 0.0 0
M  V30 20 O 17.9319 7.4202 0.0 0
M  V30 21 C 19.7423 9.9121 0.0 0
M  V30 22 C 19.9033 11.4436 0.0 0
M  V30 23 C 21.2739 9.7510 0.0 0
M  V30 24 C 19.5814 8.3804 0.0 0
M  V30 25 O 4.0009 0.0000 0.0 0
M  V30 26 C 6.6684 10.7800 0.0 0
M  V30 27 C 5.3347 10.0100 0.0 0
M  V30 28 C 6.6684 12.3200 0.0 0
M  V30 29 C 4.0009 10.7800 0.0 0
M  V30 30 C 5.3347 13.0900 0.0 0
M  V30 31 C 4.0009 12.3200 0.0 0
M  V30 32 C 13.3367 8.4700 0.0 0 CFG=1
M  V30 33 C 14.7437 7.8437 0.0 0
M  V30 34 C 13.4976 10.0015 0.0 0
M  V30 35 N 15.7741 8.9881 0.0 0
M  V30 36 C 15.0041 10.3217 0.0 0
M  V30 37 C 4.0009 4.6200 0.0 0
M  V30 38 C 2.6673 3.8500 0.0 0
M  V30 39 C 5.3347 3.8500 0.0 0
M  V30 40 C 2.6673 2.3100 0.0 0
M  V30 41 C 5.3347 2.3100 0.0 0
M  V30 42 C 4.0009 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 26
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 32 9 CFG=1
M  V30 14 2 11 13
M  V30 15 2 11 14
M  V30 16 1 11 37
M  V30 17 1 12 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 18 35
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 1 25 42
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 157567-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 204688-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925287-31-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36491257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel HIV-1 protease
inhibitors containing pyrrolidine-derived P2 ligands to combat
drug-resistant variant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Huiyu; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning; Wang,
Minghua; Cen, Shan; Zhu, Mei; Shan, Qi; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 255115389

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3R)-1,3-pyrrolidinedicarboxylate
C10H17NO4
72925-16-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 3.2067 0.0 0
M  V30 2 O 3.0800 4.5405 0.0 0
M  V30 3 O 3.0800 1.8731 0.0 0
M  V30 4 C 1.5400 4.5405 0.0 0
M  V30 5 C 1.5400 3.0005 0.0 0
M  V30 6 C 0.0000 4.5405 0.0 0
M  V30 7 C 1.5400 6.0805 0.0 0
M  V30 8 C 9.0058 1.5317 0.0 0
M  V30 9 O 8.8447 0.0000 0.0 0
M  V30 10 O 10.4126 2.1580 0.0 0
M  V30 11 N 5.3900 3.2067 0.0 0
M  V30 12 C 6.2952 1.9609 0.0 0
M  V30 13 C 6.2952 4.4528 0.0 0
M  V30 14 C 7.7598 2.4367 0.0 0 CFG=2
M  V30 15 C 7.7598 3.9767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide
C20H29N3O3S
169280-56-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 N 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[[[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-met...
C30H44N4O6S
2925287-38-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 8.4700 0.0 0 CFG=1
M  V30 2 C 6.6684 7.7000 0.0 0 CFG=2
M  V30 3 C 8.0020 10.0100 0.0 0
M  V30 4 N 9.3358 7.7000 0.0 0
M  V30 5 C 5.3347 8.4700 0.0 0
M  V30 6 O 6.6684 6.1600 0.0 0
M  V30 7 C 10.6694 8.4700 0.0 0
M  V30 8 N 4.0009 7.7000 0.0 0
M  V30 9 O 10.6694 10.0100 0.0 0
M  V30 10 S 4.0009 6.1600 0.0 0 VAL=6
M  V30 11 C 2.6673 8.4700 0.0 0
M  V30 12 O 2.4609 6.1600 0.0 0
M  V30 13 O 5.5409 6.1600 0.0 0
M  V30 14 C 1.3336 7.7000 0.0 0
M  V30 15 C 0.0000 8.4700 0.0 0
M  V30 16 C 1.3336 6.1600 0.0 0
M  V30 17 C 15.9720 7.3429 0.0 0
M  V30 18 O 16.8772 6.0970 0.0 0
M  V30 19 O 16.5983 8.7498 0.0 0
M  V30 20 C 18.4087 6.2579 0.0 0
M  V30 21 C 18.5696 4.7264 0.0 0
M  V30 22 C 19.9402 6.4190 0.0 0
M  V30 23 C 18.2478 7.7896 0.0 0
M  V30 24 N 4.0009 0.0000 0.0 0
M  V30 25 C 6.6684 10.7800 0.0 0
M  V30 26 C 5.3347 10.0100 0.0 0
M  V30 27 C 6.6684 12.3200 0.0 0
M  V30 28 C 4.0009 10.7800 0.0 0
M  V30 29 C 5.3347 13.0900 0.0 0
M  V30 30 C 4.0009 12.3200 0.0 0
M  V30 31 C 12.0031 7.7000 0.0 0 CFG=2
M  V30 32 C 13.4099 8.3263 0.0 0
M  V30 33 C 12.1640 6.1685 0.0 0
M  V30 34 N 14.4404 7.1819 0.0 0
M  V30 35 C 13.6704 5.8483 0.0 0
M  V30 36 C 4.0009 4.6200 0.0 0
M  V30 37 C 2.6673 3.8500 0.0 0
M  V30 38 C 5.3347 3.8500 0.0 0
M  V30 39 C 2.6673 2.3100 0.0 0
M  V30 40 C 5.3347 2.3100 0.0 0
M  V30 41 C 4.0009 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 25
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 31 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 36
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 34
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 41
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 1 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 72925-16-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 169280-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925287-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36491264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel HIV-1 protease
inhibitors containing pyrrolidine-derived P2 ligands to combat
drug-resistant variant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Huiyu; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning; Wang,
Minghua; Cen, Shan; Zhu, Mei; Shan, Qi; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 255115389

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Syringic acid
C9H10O5
530-57-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 5.3901 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 O 6.6687 5.3901 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 O 5.3348 0.0000 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-(trifluorome...
C21H27F3N2O3S
2415386-52-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8986 3.2864 0.0 0
M  V30 4 O 7.4387 5.9538 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0 CFG=1
M  V30 8 C 6.6687 1.5400 0.0 0
M  V30 9 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 C 6.6687 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 13.3372 3.8501 0.0 0
M  V30 14 N 12.0035 6.1601 0.0 0
M  V30 15 C 1.3338 7.7002 0.0 0
M  V30 16 F 2.1038 9.0338 0.0 0
M  V30 17 F 0.0000 8.4702 0.0 0
M  V30 18 F 0.5638 6.3665 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 4.0012 7.7002 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 2.6675 6.9302 0.0 0
M  V30 25 C 14.6708 4.6201 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 3.8501 0.0 0
M  V30 28 C 16.0045 6.9302 0.0 0
M  V30 29 C 17.3383 4.6201 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[[4-(trifluoromethyl)phenyl...
C30H35F3N2O7S
2892016-27-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.3439 6.6685 0.0 0
M  V30 2 N 9.8039 6.6685 0.0 0
M  V30 3 O 12.1139 8.0022 0.0 0
M  V30 4 C 9.0338 8.0022 0.0 0 CFG=1
M  V30 5 C 7.4938 8.0022 0.0 0 CFG=2
M  V30 6 C 9.8039 9.3360 0.0 0
M  V30 7 C 6.7238 9.3360 0.0 0
M  V30 8 O 6.7238 6.6685 0.0 0
M  V30 9 N 5.1838 9.3360 0.0 0
M  V30 10 S 4.4137 8.0022 0.0 0 VAL=6
M  V30 11 C 4.4137 10.6697 0.0 0
M  V30 12 O 5.7474 7.2322 0.0 0
M  V30 13 O 3.0801 8.7722 0.0 0
M  V30 14 C 2.8737 10.6697 0.0 0
M  V30 15 C 2.1037 12.0033 0.0 0
M  V30 16 C 2.1037 9.3360 0.0 0
M  V30 17 O 11.3439 1.3337 0.0 0
M  V30 18 C 12.1139 0.0000 0.0 0
M  V30 19 O 15.9640 4.0010 0.0 0
M  V30 20 C 16.7340 5.3348 0.0 0
M  V30 21 O 14.4240 1.3337 0.0 0
M  V30 22 C 1.3337 2.6673 0.0 0
M  V30 23 F 0.0000 3.4374 0.0 0
M  V30 24 F 0.5637 1.3337 0.0 0
M  V30 25 F 2.6673 1.8973 0.0 0
M  V30 26 C 12.1139 5.3348 0.0 0
M  V30 27 C 11.3439 4.0010 0.0 0
M  V30 28 C 13.6539 5.3348 0.0 0
M  V30 29 C 12.1139 2.6673 0.0 0
M  V30 30 C 14.4240 4.0010 0.0 0
M  V30 31 C 13.6539 2.6673 0.0 0
M  V30 32 C 9.0338 10.6697 0.0 0
M  V30 33 C 9.8039 12.0033 0.0 0
M  V30 34 C 7.4938 10.6697 0.0 0
M  V30 35 C 9.0338 13.3370 0.0 0
M  V30 36 C 6.7238 12.0033 0.0 0
M  V30 37 C 7.4938 13.3370 0.0 0
M  V30 38 C 3.6437 6.6685 0.0 0
M  V30 39 C 2.1037 6.6685 0.0 0
M  V30 40 C 4.4137 5.3348 0.0 0
M  V30 41 C 1.3337 5.3348 0.0 0
M  V30 42 C 3.6437 4.0010 0.0 0
M  V30 43 C 2.1037 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 32
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 38
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 29
M  V30 21 1 19 20
M  V30 22 1 19 30
M  V30 23 1 21 31
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 1 22 43
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-57-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415386-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892016-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A kind of HIV-1 protease inhibitors containing phenols with antiviral
activity against DRV-resistant variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Shangjiu; Ma, Ling; Dong, Biao; Shan, Qi; Zhou, Jinming; Zhang,
Guoning; Wang, Minghua; Cen, Shan; Zhu, Mei; Wang, Juxian; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 64116760

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Morpholinecarboxylic acid, 4-methyl-, (3S)-
C6H11NO3
1315051-74-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0 CFG=2
M  V30 6 N 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 O 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=3
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-N-[(1S,2R)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-...
C26H36N4O7S
2765293-25-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9302 0.0 0 CFG=1
M  V30 2 C 5.3348 7.7002 0.0 0 CFG=2
M  V30 3 C 2.6673 7.7002 0.0 0
M  V30 4 N 4.0010 5.3901 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 O 6.6685 6.9302 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 N 6.6685 10.0102 0.0 0
M  V30 9 O 1.3337 5.3901 0.0 0
M  V30 10 S 8.0022 9.2402 0.0 0 VAL=6
M  V30 11 C 6.6685 11.5503 0.0 0
M  V30 12 O 7.2322 7.9065 0.0 0
M  V30 13 O 8.7722 10.5739 0.0 0
M  V30 14 C 8.0022 12.3203 0.0 0
M  V30 15 C 8.0022 13.8603 0.0 0
M  V30 16 C 9.3358 11.5503 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 N 13.3370 6.1601 0.0 0 VAL=5
M  V30 19 O 14.6707 6.9302 0.0 0
M  V30 20 O 13.3370 4.6201 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 1.3337 10.0102 0.0 0
M  V30 23 C 4.0010 10.0102 0.0 0
M  V30 24 C 1.3337 11.5503 0.0 0
M  V30 25 C 4.0010 11.5503 0.0 0
M  V30 26 C 2.6673 12.3203 0.0 0
M  V30 27 C 2.6673 3.0801 0.0 0 CFG=2
M  V30 28 N 1.3337 2.3101 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 1.3337 0.7700 0.0 0
M  V30 31 O 4.0010 0.7700 0.0 0
M  V30 32 C 2.6673 0.0000 0.0 0
M  V30 33 C 9.3358 8.4702 0.0 0
M  V30 34 C 10.6697 9.2402 0.0 0
M  V30 35 C 9.3358 6.9302 0.0 0
M  V30 36 C 12.0033 8.4702 0.0 0
M  V30 37 C 10.6697 6.1601 0.0 0
M  V30 38 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 21
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 27 7 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 33
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 28
M  V30 20 2 18 19
M  V30 21 2 18 20
M  V30 22 1 18 38
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315051-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-25-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632729
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
5-Methyl-1H-indole-2-carboxylic acid
C10H9NO2
10241-97-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Piperidinecarboxylic acid, 4-amino-1-(phenylsulfonyl)-, methyl ester, hydro...
C13H18N2O4S.ClH
2711028-00-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.6201 0.0 0 VAL=6
M  V30 2 O 3.2311 5.9537 0.0 0
M  V30 3 O 4.7712 3.2864 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 O 10.6697 5.3901 0.0 0
M  V30 6 O 9.3360 3.0800 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 N 9.3360 7.7001 0.0 0
M  V30 9 N 5.3348 5.3901 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 5.3348 6.9301 0.0 0
M  V30 12 C 8.0022 5.3901 0.0 0 CFG=2
M  V30 13 C 6.6685 7.7001 0.0 0
M  V30 14 C 8.0022 6.9301 0.0 0 CFG=1
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 Cl 6.0017 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 12 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 14 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Methyl (3R,4R)-4-[[(5-methyl-1H-indol-2-yl)carbonyl]amino]-1-(phenylsulfo...
C23H25N3O5S
2602442-12-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 6.6685 0.0 0
M  V30 2 N 10.7800 5.3347 0.0 0
M  V30 3 O 10.7800 8.0021 0.0 0
M  V30 4 C 19.4610 8.2085 0.0 0
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 O 8.4700 1.3338 0.0 0
M  V30 7 O 10.7800 2.6674 0.0 0
M  V30 8 C 9.2400 0.0000 0.0 0
M  V30 9 S 4.6200 5.3347 0.0 0 VAL=6
M  V30 10 O 4.6200 3.7947 0.0 0
M  V30 11 O 4.6200 6.8747 0.0 0
M  V30 12 C 15.4599 7.4385 0.0 0
M  V30 13 C 15.4599 5.8985 0.0 0
M  V30 14 C 13.9952 7.9144 0.0 0
M  V30 15 C 16.7935 8.2085 0.0 0
M  V30 16 N 13.9952 5.4225 0.0 0
M  V30 17 C 16.7935 5.1285 0.0 0
M  V30 18 C 13.0900 6.6685 0.0 0
M  V30 19 C 18.1272 7.4385 0.0 0
M  V30 20 C 18.1272 5.8985 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0 CFG=1
M  V30 22 C 8.4700 4.0011 0.0 0 CFG=1
M  V30 23 C 8.4700 6.6685 0.0 0
M  V30 24 C 6.9300 4.0011 0.0 0
M  V30 25 C 6.9300 6.6685 0.0 0
M  V30 26 N 6.1600 5.3347 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 29 C 2.3100 6.6685 0.0 0
M  V30 30 C 0.7700 4.0011 0.0 0
M  V30 31 C 0.7700 6.6685 0.0 0
M  V30 32 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 21 2 CFG=3
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 22 5 CFG=1
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 26
M  V30 13 1 9 27
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10241-97-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2711028-00-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602442-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24414274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Optimization of Pyrrolidine Derivatives as Highly
Potent Ghrelin Receptor Full Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cooper, Martin; Llinas, Antonio; Hansen, Peter; Caffrey, Moya; Ray, Asim;
Sjoedin, Stina; Shamovsky, Igor; Wada, Hiroki; Jellesmark Jensen, Tina;
Sivars, Ulf; Hultin, Leif; Andersson, Ulf; Lundqvist, Sara; Gedda, Karin;
Jinton, Lisa; Krutroek, Nina; Lewis, Richard; Jansson, Paul; Gardelli,
Cristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9705-9730

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentanoic acid
C10H19NO4
27219-07-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 4.0010 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0010 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 14 O 13.3370 2.3101 0.0 0
M  V30 15 O 12.0033 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthalenecarboxylic acid, 6-amino-4-[[(1,1-dimethylethoxy)carbonyl]oxy]-,...
C17H19NO5
3031795-19-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 5.3348 0.0 0
M  V30 2 C 7.7002 6.6685 0.0 0
M  V30 3 O 9.2402 6.6685 0.0 0
M  V30 4 O 6.9302 8.0023 0.0 0
M  V30 5 C 10.0102 8.0023 0.0 0
M  V30 6 C 8.6765 8.7723 0.0 0
M  V30 7 C 10.7802 9.3360 0.0 0
M  V30 8 C 11.3439 7.2323 0.0 0
M  V30 9 N 5.3901 0.0000 0.0 0
M  V30 10 C 2.3101 8.0023 0.0 0
M  V30 11 O 0.7700 8.0023 0.0 0
M  V30 12 O 3.0801 9.3360 0.0 0
M  V30 13 C 0.0000 9.3360 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 5.3901 5.3348 0.0 0
M  V30 17 C 5.3901 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 2.3101 2.6675 0.0 0
M  V30 20 C 4.6201 6.6685 0.0 0
M  V30 21 C 4.6201 1.3337 0.0 0
M  V30 22 C 3.0801 6.6685 0.0 0
M  V30 23 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthalenecarboxylic acid, 6-[[5-[[(1,1-dimethylethoxy)carbonyl]amino]-1-o...
C27H36N2O8
3031795-20-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 8.0020 0.0 0
M  V30 2 C 3.8500 8.0020 0.0 0
M  V30 3 O 3.0800 9.3356 0.0 0
M  V30 4 O 3.0800 6.6684 0.0 0
M  V30 5 C 1.5400 9.3356 0.0 0
M  V30 6 C 1.5400 10.8756 0.0 0
M  V30 7 C 0.0000 9.3356 0.0 0
M  V30 8 C 1.5400 7.7956 0.0 0
M  V30 9 N 10.7800 9.3356 0.0 0
M  V30 10 C 12.3200 9.3356 0.0 0
M  V30 11 C 13.0900 10.6694 0.0 0
M  V30 12 O 13.0900 8.0020 0.0 0
M  V30 13 C 14.6300 10.6694 0.0 0
M  V30 14 C 15.4000 12.0031 0.0 0
M  V30 15 C 16.9400 12.0031 0.0 0
M  V30 16 N 17.7100 13.3367 0.0 0
M  V30 17 C 19.2500 13.3367 0.0 0
M  V30 18 O 20.0200 14.6703 0.0 0
M  V30 19 O 20.0200 12.0031 0.0 0
M  V30 20 C 21.5600 14.6703 0.0 0
M  V30 21 C 21.5600 13.1303 0.0 0
M  V30 22 C 23.1000 14.6703 0.0 0
M  V30 23 C 21.5600 16.2103 0.0 0
M  V30 24 C 5.3900 2.6673 0.0 0
M  V30 25 O 6.1600 1.3336 0.0 0
M  V30 26 O 3.8500 2.6673 0.0 0
M  V30 27 C 5.3900 0.0000 0.0 0
M  V30 28 C 7.7000 6.6684 0.0 0
M  V30 29 C 6.1600 6.6684 0.0 0
M  V30 30 C 8.4700 5.3347 0.0 0
M  V30 31 C 8.4700 8.0020 0.0 0
M  V30 32 C 5.3900 5.3347 0.0 0
M  V30 33 C 7.7000 4.0009 0.0 0
M  V30 34 C 10.0100 5.3347 0.0 0
M  V30 35 C 10.0100 8.0020 0.0 0
M  V30 36 C 6.1600 4.0009 0.0 0
M  V30 37 C 10.7800 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 35
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 1 24 36
M  V30 27 1 25 27
M  V30 28 1 28 29
M  V30 29 2 28 30
M  V30 30 1 28 31
M  V30 31 2 29 32
M  V30 32 1 30 33
M  V30 33 1 30 34
M  V30 34 2 31 35
M  V30 35 1 32 36
M  V30 36 2 33 36
M  V30 37 2 34 37
M  V30 38 1 35 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27219-07-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3031795-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3031795-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40763299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Steglich esterification
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Turning Nonselective Inhibitors of Type I Protein Arginine
Methyltransferases into Potent and Selective Inhibitors of Protein
Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and
Fragment-Growing Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iannelli, Giulia; Milite, Ciro; Marechal, Nils; Cura, Vincent; Bonnefond,
Luc; Troffer-Charlier, Nathalie; Feoli, Alessandra; Rescigno, Donatella;
Wang, Yalong; Cipriano, Alessandra; Viviano, Monica; Bedford, Mark T.;
Cavarelli, Jean; Castellano, Sabrina; Sbardella, Gianluca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(17), 11574-11606

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
1-[(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl] hydrogen butanedioate
C14H22O4
1092569-57-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5029 5.5476 0.0 0
M  V30 2 O 6.3920 4.0011 0.0 0
M  V30 3 C 7.1620 2.6675 0.0 0
M  V30 4 C 8.7020 2.6675 0.0 0
M  V30 5 O 6.3920 1.3337 0.0 0
M  V30 6 C 9.4720 1.3337 0.0 0
M  V30 7 C 11.0120 1.3337 0.0 0
M  V30 8 O 11.7821 2.6675 0.0 0
M  V30 9 O 11.7821 0.0000 0.0 0
M  V30 10 C 2.0053 1.1658 0.0 0
M  V30 11 C 0.0000 2.8269 0.0 0
M  V30 12 C 3.4338 4.4393 0.0 0 CFG=2
M  V30 13 C 4.8520 4.0011 0.0 0 CFG=2
M  V30 14 C 1.5274 2.6299 0.0 0
M  V30 15 C 2.9724 5.7612 0.0 0
M  V30 16 C 3.6190 3.6203 0.0 0
M  V30 17 C 2.2965 3.8242 0.0 0 CFG=1
M  V30 18 C 1.8676 5.3403 0.0 0
M  V30 19 H 0.7734 4.0516 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 14
M  V30 11 1 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Thiazolemethanamine, 2-(4-methylphenyl)-, hydrochloride (1:1)
C11H12N2S.ClH
2566496-79-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 4.5489 0.0 0
M  V30 2 N 11.1826 3.9225 0.0 0
M  V30 3 C 0.0000 2.8736 0.0 0
M  V30 4 C 6.1600 2.8736 0.0 0
M  V30 5 N 7.0652 4.1195 0.0 0
M  V30 6 S 7.0652 1.6278 0.0 0
M  V30 7 C 8.5298 3.6437 0.0 0
M  V30 8 C 8.5298 2.1036 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 3.8500 1.5400 0.0 0
M  V30 11 C 3.8500 4.2073 0.0 0
M  V30 12 C 2.3100 1.5400 0.0 0
M  V30 13 C 2.3100 4.2073 0.0 0
M  V30 14 C 1.5400 2.8736 0.0 0
M  V30 15 Cl 5.5913 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl 4-[[[2-(4-methylphenyl)-4-t...
C25H32N2O3S
2656367-52-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5392 5.0436 0.0 0
M  V30 2 O 4.9486 4.6487 0.0 0
M  V30 3 C 6.2823 3.8787 0.0 0
M  V30 4 C 7.6159 4.6487 0.0 0
M  V30 5 O 6.2823 2.3387 0.0 0
M  V30 6 C 8.9496 3.8787 0.0 0
M  V30 7 C 10.2834 4.6487 0.0 0
M  V30 8 N 11.6171 3.8787 0.0 0
M  V30 9 O 10.2834 6.1888 0.0 0
M  V30 10 C 12.9508 4.6487 0.0 0
M  V30 11 C 2.5671 0.0000 0.0 0
M  V30 12 C 0.0000 0.4358 0.0 0
M  V30 13 C 22.8482 4.0045 0.0 0
M  V30 14 C 2.1674 3.5490 0.0 0 CFG=2
M  V30 15 C 3.6148 3.8787 0.0 0 CFG=2
M  V30 16 C 1.4213 1.0289 0.0 0
M  V30 17 C 1.1070 4.4633 0.0 0
M  V30 18 C 2.7376 2.9325 0.0 0
M  V30 19 C 1.4901 2.4479 0.0 0 CFG=1
M  V30 20 C 0.3605 3.5464 0.0 0
M  V30 21 C 14.2844 3.8787 0.0 0
M  V30 22 N 15.6914 4.5052 0.0 0
M  V30 23 C 14.4455 2.3472 0.0 0
M  V30 24 C 16.7218 3.3607 0.0 0
M  V30 25 S 15.9518 2.0270 0.0 0
M  V30 26 C 18.2534 3.5216 0.0 0
M  V30 27 C 18.8799 4.9286 0.0 0
M  V30 28 C 19.1586 2.2757 0.0 0
M  V30 29 C 20.4115 5.0895 0.0 0
M  V30 30 C 20.6904 2.4368 0.0 0
M  V30 31 C 21.3167 3.8436 0.0 0
M  V30 32 H 0.0574 1.8832 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 21
M  V30 12 1 11 16
M  V30 13 1 12 16
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 19 32 CFG=3
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1092569-57-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2566496-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2656367-52-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23698808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, fungicidal activities and structure-activity
relationship studies of (-)-borneol derivatives containing
2-aryl-thiazole scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Danling; Zheng, Shumin; Zhang, Tianyuan; Cheng, Yong-Xian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 45128006

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Benzonitrile, 4-[(trans-4-aminocyclohexyl)oxy]-2-chloro-, hydrochloride (1:1)
C13H15ClN2O.ClH
1335049-54-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 5.3901 0.0 0
M  V30 2 Cl 1.3337 5.3901 0.0 0
M  V30 3 C 1.3337 2.3100 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 12.0033 2.3100 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 4.0012 5.3901 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0012 2.3100 0.0 0
M  V30 11 C 2.6673 3.0800 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0 CFG=2
M  V30 13 C 9.3360 5.3901 0.0 0
M  V30 14 C 8.0022 3.0800 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 C 9.3360 2.3100 0.0 0
M  V30 17 C 10.6697 3.0800 0.0 0 CFG=2
M  V30 18 Cl 6.0017 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 9
M  V30 4 3 3 4
M  V30 5 1 3 11
M  V30 6 1 17 5 CFG=3
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Pyridazinecarboxylic acid, 6-[4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]met...
C17H29N3O3Si
2964558-71-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1700 2.8736 0.0 0
M  V30 2 O 16.9400 1.5400 0.0 0
M  V30 3 O 16.9400 4.2073 0.0 0
M  V30 4 C 5.3900 2.8736 0.0 0
M  V30 5 O 4.6200 1.5400 0.0 0
M  V30 6 Si 3.0800 1.5400 0.0 0
M  V30 7 C 1.5400 1.5400 0.0 0
M  V30 8 C 3.0800 3.0800 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 1.5400 3.0800 0.0 0
M  V30 13 C 11.5500 2.8736 0.0 0
M  V30 14 C 12.3200 4.2073 0.0 0
M  V30 15 N 12.3200 1.5400 0.0 0
M  V30 16 C 13.8600 4.2073 0.0 0
M  V30 17 N 13.8600 1.5400 0.0 0
M  V30 18 C 14.6300 2.8736 0.0 0
M  V30 19 N 10.0100 2.8736 0.0 0
M  V30 20 C 9.2400 1.5400 0.0 0
M  V30 21 C 9.2400 4.2073 0.0 0
M  V30 22 C 7.7000 1.5400 0.0 0
M  V30 23 C 7.7000 4.2073 0.0 0
M  V30 24 C 6.9300 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridazinecarboxamide, N-[trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4...
C30H42ClN5O3Si
2964558-72-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 7.4938 0.0 0
M  V30 2 N 16.0045 6.7238 0.0 0
M  V30 3 O 14.6708 9.0338 0.0 0
M  V30 4 C 5.3348 2.1037 0.0 0
M  V30 5 O 4.0012 2.8737 0.0 0
M  V30 6 Si 2.6675 2.1037 0.0 0
M  V30 7 C 1.3338 1.3337 0.0 0
M  V30 8 C 3.4375 0.7700 0.0 0
M  V30 9 C 1.8975 3.4374 0.0 0
M  V30 10 C 0.5638 2.6673 0.0 0
M  V30 11 C 0.0000 0.5637 0.0 0
M  V30 12 C 2.1038 0.0000 0.0 0
M  V30 13 O 21.3393 9.8039 0.0 0
M  V30 14 Cl 26.6742 9.8039 0.0 0
M  V30 15 C 26.6742 6.7238 0.0 0
M  V30 16 N 28.0080 5.9538 0.0 0
M  V30 17 C 10.6697 5.1838 0.0 0
M  V30 18 C 12.0035 4.4137 0.0 0
M  V30 19 N 10.6697 6.7238 0.0 0
M  V30 20 C 13.3372 5.1838 0.0 0
M  V30 21 N 12.0035 7.4938 0.0 0
M  V30 22 C 13.3372 6.7238 0.0 0
M  V30 23 N 9.3360 4.4137 0.0 0
M  V30 24 C 9.3360 2.8737 0.0 0
M  V30 25 C 8.0023 5.1838 0.0 0
M  V30 26 C 8.0023 2.1037 0.0 0
M  V30 27 C 6.6687 4.4137 0.0 0
M  V30 28 C 6.6687 2.8737 0.0 0
M  V30 29 C 17.3383 7.4938 0.0 0 CFG=1
M  V30 30 C 17.3383 9.0338 0.0 0
M  V30 31 C 18.6720 6.7238 0.0 0
M  V30 32 C 18.6720 9.8039 0.0 0
M  V30 33 C 20.0057 7.4938 0.0 0
M  V30 34 C 20.0057 9.0338 0.0 0 CFG=1
M  V30 35 C 22.6731 9.0338 0.0 0
M  V30 36 C 24.0068 9.8039 0.0 0
M  V30 37 C 22.6731 7.4938 0.0 0
M  V30 38 C 25.3405 9.0338 0.0 0
M  V30 39 C 24.0068 6.7238 0.0 0
M  V30 40 C 25.3405 7.4938 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 29 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 34 13 CFG=1
M  V30 15 1 13 35
M  V30 16 1 14 38
M  V30 17 3 15 16
M  V30 18 1 15 40
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 17 23
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1335049-54-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2964558-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2964558-72-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40310343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel selective agents for the degradation of AR/AR-V7 to treat advanced
prostate cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Yifei; Lv, Guangyao; Xiu, Ruijuan; Yang, Huijie; Wang, Wenyan; Yu,
Pengfei; Zhang, Jianzhao; Ye, Liang; Wang, Hongbo; Tian, Jingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 271116400

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
5-Cyano-3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-2-methylbenzoic acid
C16H20N2O3
2691175-30-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6673 8.4700 0.0 0
M  V30 4 C 6.6684 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 O 9.3358 7.7000 0.0 0
M  V30 7 O 10.6694 5.3900 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 5.3900 0.0 0
M  V30 14 C 6.6684 3.0800 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 2.6673 3.8500 0.0 0
M  V30 19 C 0.0000 5.3900 0.0 0
M  V30 20 C 1.3336 3.0800 0.0 0
M  V30 21 O 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 3 8 9
M  V30 10 1 8 14
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Aminomethyl)-6-methyl-4-(methylthio)-2(1H)-pyridinone
C8H12N2OS
2326563-29-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 N 0.0000 5.3348 0.0 0
M  V30 5 O 2.3100 6.6686 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyano-N-[[1,2-dihydro-6-methyl-4-(methylthio)-2-oxo-3-pyridinyl]methyl]-3-[...
C24H30N4O3S
2691175-36-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6674 8.4700 0.0 0
M  V30 4 C 6.6685 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 N 10.6694 5.3900 0.0 0
M  V30 7 O 9.3358 7.7000 0.0 0
M  V30 8 C 12.0032 6.1600 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 6.6685 0.0000 0.0 0
M  V30 11 S 14.6705 7.7000 0.0 0
M  V30 12 C 16.0041 8.4700 0.0 0
M  V30 13 O 12.0032 3.0800 0.0 0
M  V30 14 C 17.3379 3.0800 0.0 0
M  V30 15 C 5.3347 5.3900 0.0 0
M  V30 16 C 6.6685 6.1600 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 18 C 8.0021 5.3900 0.0 0
M  V30 19 C 6.6685 3.0800 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0
M  V30 21 C 2.6674 5.3900 0.0 0
M  V30 22 C 2.6674 3.8500 0.0 0
M  V30 23 C 1.3338 6.1600 0.0 0
M  V30 24 C 1.3338 3.0800 0.0 0
M  V30 25 C 0.0000 5.3900 0.0 0
M  V30 26 O 0.0000 3.8500 0.0 0
M  V30 27 C 13.3369 5.3900 0.0 0
M  V30 28 C 14.6705 6.1600 0.0 0
M  V30 29 C 13.3369 3.8500 0.0 0
M  V30 30 C 16.0041 5.3900 0.0 0
M  V30 31 N 14.6705 3.0800 0.0 0
M  V30 32 C 16.0041 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 1 6 8
M  V30 10 1 8 27
M  V30 11 3 9 10
M  V30 12 1 9 19
M  V30 13 1 11 12
M  V30 14 1 11 28
M  V30 15 2 13 29
M  V30 16 1 14 32
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2691175-30-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2326563-29-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2691175-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36826820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive
Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of
Zeste Homologue 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Yang, Hong; Li, Bingbing; Li, Jiayi; Li, Huaxuan; Shi,
Qiongyu; Li, Bang; Wang, Zekun; Zheng, Jiahong; Zhang, Ying; Dong, Hui;
Huang, Xun; Wang, Yuanxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7629-7644

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Boc-L-valine
C10H19NO4
13734-41-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Alanine, L-phenylalanyl-3-[(3S)-2-oxo-3-pyrrolidinyl]-, methyl ester, hydro...
C17H23N3O4.ClH
2640359-25-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 5.5411 0.0 0 CFG=1
M  V30 2 C 3.9098 6.8747 0.0 0
M  V30 3 N 6.2198 5.5411 0.0 0
M  V30 4 C 3.9098 4.2074 0.0 0
M  V30 5 C 6.9898 6.8747 0.0 0
M  V30 6 O 4.6798 2.8736 0.0 0
M  V30 7 O 2.3698 4.2074 0.0 0
M  V30 8 C 8.5298 6.8747 0.0 0 CFG=1
M  V30 9 O 6.2198 8.2084 0.0 0
M  V30 10 C 3.9098 1.5400 0.0 0
M  V30 11 C 9.2998 8.2084 0.0 0
M  V30 12 N 9.2998 5.5411 0.0 0
M  V30 13 O 1.9406 9.5853 0.0 0
M  V30 14 C 2.3698 6.8747 0.0 0 CFG=2
M  V30 15 C 1.4645 8.1206 0.0 0
M  V30 16 C 1.4645 5.6289 0.0 0
M  V30 17 N 0.0000 7.6447 0.0 0
M  V30 18 C 0.0000 6.1047 0.0 0
M  V30 19 C 10.8398 8.2084 0.0 0
M  V30 20 C 11.6098 6.8747 0.0 0
M  V30 21 C 11.6098 9.5422 0.0 0
M  V30 22 C 13.1498 6.8747 0.0 0
M  V30 23 C 13.1498 9.5422 0.0 0
M  V30 24 C 13.9198 8.2084 0.0 0
M  V30 25 Cl 6.9599 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 14 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 11 19
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 8 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-L-phenylalanyl-3-[(3S)-2-...
C27H40N4O7
2640359-27-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7721 4.6200 0.0 0 CFG=1
M  V30 2 C 6.4384 5.3900 0.0 0
M  V30 3 C 7.7721 3.0800 0.0 0
M  V30 4 N 9.1057 5.3900 0.0 0
M  V30 5 N 6.4384 6.9300 0.0 0
M  V30 6 O 5.1046 4.6200 0.0 0
M  V30 7 C 10.4394 4.6200 0.0 0
M  V30 8 C 5.1046 7.7000 0.0 0 CFG=2
M  V30 9 C 11.7731 5.3900 0.0 0 CFG=2
M  V30 10 O 10.4394 3.0800 0.0 0
M  V30 11 C 3.7710 6.9300 0.0 0
M  V30 12 C 5.1046 9.2400 0.0 0
M  V30 13 N 13.1068 4.6200 0.0 0
M  V30 14 C 11.7731 6.9300 0.0 0
M  V30 15 O 6.4384 10.0100 0.0 0
M  V30 16 O 3.7710 10.0100 0.0 0
M  V30 17 C 14.4404 5.3900 0.0 0
M  V30 18 C 10.4394 7.7000 0.0 0
M  V30 19 C 13.1068 7.7000 0.0 0
M  V30 20 C 6.4384 11.5500 0.0 0
M  V30 21 O 15.7741 4.6200 0.0 0
M  V30 22 O 14.4404 6.9300 0.0 0
M  V30 23 C 17.1079 5.3900 0.0 0
M  V30 24 C 17.8779 4.0564 0.0 0
M  V30 25 C 18.4415 6.1600 0.0 0
M  V30 26 C 16.3379 6.7236 0.0 0
M  V30 27 O 0.7102 5.5673 0.0 0
M  V30 28 C 6.4384 2.3100 0.0 0
M  V30 29 C 6.4384 0.7700 0.0 0
M  V30 30 C 5.1046 3.0800 0.0 0
M  V30 31 C 5.1046 0.0000 0.0 0
M  V30 32 C 3.7710 2.3100 0.0 0
M  V30 33 C 3.7710 0.7700 0.0 0
M  V30 34 C 2.4374 7.7000 0.0 0 CFG=2
M  V30 35 C 1.0304 7.0737 0.0 0
M  V30 36 C 2.2764 9.2315 0.0 0
M  V30 37 N 0.0000 8.2181 0.0 0
M  V30 38 C 0.7700 9.5517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 28
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=3
M  V30 15 1 34 11 CFG=1
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 17 21
M  V30 23 2 17 22
M  V30 24 1 21 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 27 35
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 35 1 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 8 9 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2640359-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2640359-27-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31497747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of peptidomimetic aldehydes
as broad-spectrum inhibitors against enterovirus and SARS-COV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Wenhao; Jochmans, Dirk; Xie, Hang; Yang, Hang; Li, Jian; Su, Haixia;
Chang, Di; Wang, Jiang; Peng, Jingjing; Zhu, Lili; Nian, Yong;
Hilgenfeld, Rolf; Jiang, Hualiang; Chen, Kaixian; Zhang, Leike; Xu,
Yechun; Neyts, Johan; Liu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 2794-2808

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
4-Aminobenzyl alcohol
C7H9NO
623-04-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-L-ornithine
C26H32N4O6
159858-21-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 5.7533 0.0 0
M  V30 2 O 6.7708 5.7533 0.0 0
M  V30 3 C 7.5408 7.0870 0.0 0
M  V30 4 N 9.0808 7.0870 0.0 0
M  V30 5 O 6.7708 8.4206 0.0 0
M  V30 6 C 9.8508 8.4206 0.0 0 CFG=1
M  V30 7 C 11.3909 8.4206 0.0 0
M  V30 8 C 9.0808 9.7543 0.0 0
M  V30 9 N 12.1609 9.7543 0.0 0
M  V30 10 O 12.1609 7.0870 0.0 0
M  V30 11 C 9.8508 11.0881 0.0 0
M  V30 12 C 7.5408 9.7543 0.0 0
M  V30 13 C 13.7009 9.7543 0.0 0 CFG=2
M  V30 14 C 14.4709 8.4206 0.0 0
M  V30 15 C 14.4709 11.0881 0.0 0
M  V30 16 C 16.0109 8.4206 0.0 0
M  V30 17 O 16.0109 11.0881 0.0 0
M  V30 18 O 13.7009 12.4217 0.0 0
M  V30 19 C 16.7809 7.0870 0.0 0
M  V30 20 N 18.3209 7.0870 0.0 0
M  V30 21 C 19.0909 5.7533 0.0 0
M  V30 22 N 18.3209 4.4195 0.0 0
M  V30 23 O 20.6309 5.7533 0.0 0
M  V30 24 C 4.4608 4.4195 0.0 0
M  V30 25 C 5.0873 3.0127 0.0 0
M  V30 26 C 2.9293 4.2586 0.0 0
M  V30 27 C 3.9427 1.9823 0.0 0
M  V30 28 C 6.5518 2.5369 0.0 0
M  V30 29 C 2.6091 2.7523 0.0 0
M  V30 30 C 1.7849 5.2890 0.0 0
M  V30 31 C 4.2629 0.4759 0.0 0
M  V30 32 C 6.8720 1.0304 0.0 0
M  V30 33 C 1.1444 2.2764 0.0 0
M  V30 34 C 0.3202 4.8132 0.0 0
M  V30 35 C 5.7276 0.0000 0.0 0
M  V30 36 C 0.0000 3.3069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14 CFG=3
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 25 28
M  V30 28 1 26 29
M  V30 29 2 26 30
M  V30 30 1 27 29
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 2 29 33
M  V30 34 1 30 34
M  V30 35 1 31 35
M  V30 36 2 32 35
M  V30 37 1 33 36
M  V30 38 2 34 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxy...
C33H39N5O6
159858-22-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 7.7002 0.0 0
M  V30 2 O 14.6708 6.9302 0.0 0
M  V30 3 C 13.3372 7.7002 0.0 0
M  V30 4 N 12.0033 6.9302 0.0 0
M  V30 5 O 13.3372 9.2402 0.0 0
M  V30 6 C 10.6697 7.7002 0.0 0 CFG=1
M  V30 7 C 9.3360 6.9302 0.0 0
M  V30 8 C 10.6697 9.2402 0.0 0
M  V30 9 N 8.0023 7.7002 0.0 0
M  V30 10 O 9.3360 5.3901 0.0 0
M  V30 11 C 9.3360 10.0102 0.0 0
M  V30 12 C 12.0033 10.0102 0.0 0
M  V30 13 C 6.6685 6.9302 0.0 0 CFG=1
M  V30 14 C 5.3348 7.7002 0.0 0
M  V30 15 C 6.6685 5.3901 0.0 0
M  V30 16 N 5.3348 9.2402 0.0 0
M  V30 17 O 4.0012 6.9302 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 N 4.0012 2.3101 0.0 0
M  V30 21 C 4.0012 0.7700 0.0 0
M  V30 22 N 5.3348 0.0000 0.0 0
M  V30 23 O 2.6675 0.0000 0.0 0
M  V30 24 C 0.0000 12.3203 0.0 0
M  V30 25 O 0.0000 13.8603 0.0 0
M  V30 26 C 17.3382 6.9302 0.0 0
M  V30 27 C 17.4992 5.3986 0.0 0
M  V30 28 C 18.7451 7.5565 0.0 0
M  V30 29 C 19.0056 5.0784 0.0 0
M  V30 30 C 16.4687 4.2540 0.0 0
M  V30 31 C 19.7756 6.4121 0.0 0
M  V30 32 C 19.2210 9.0212 0.0 0
M  V30 33 C 19.4814 3.6137 0.0 0
M  V30 34 C 16.9447 2.7895 0.0 0
M  V30 35 C 21.2820 6.7323 0.0 0
M  V30 36 C 20.7275 9.3414 0.0 0
M  V30 37 C 18.4510 2.4693 0.0 0
M  V30 38 C 21.7579 8.1970 0.0 0
M  V30 39 C 4.0012 10.0102 0.0 0
M  V30 40 C 4.0012 11.5503 0.0 0
M  V30 41 C 2.6675 9.2402 0.0 0
M  V30 42 C 2.6675 12.3203 0.0 0
M  V30 43 C 1.3337 10.0102 0.0 0
M  V30 44 C 1.3337 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 13 15 CFG=1
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 39
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 24 25
M  V30 26 1 24 44
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 27 30
M  V30 31 1 28 31
M  V30 32 2 28 32
M  V30 33 1 29 31
M  V30 34 2 29 33
M  V30 35 1 30 34
M  V30 36 2 31 35
M  V30 37 1 32 36
M  V30 38 1 33 37
M  V30 39 2 34 37
M  V30 40 1 35 38
M  V30 41 2 36 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 623-04-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159858-21-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 159858-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38179439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16357-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM in the dark
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting
Potent Antitumor Efficacy in Pancreatic Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Li-ping; Bai, Wei-qi; Zhou, Dan-dan; Wu, Xiao-fan; Zhang, Lan-wen;
Cui, A-long; Xie, Zi-hui; Gao, Rui-juan; Zhen, Yong-su; Li, Zhuo-Rong;
Miao, Qing-fang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(21), 14700-14715

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
(2β,3α)-2,3-Bis(acetyloxy)-20-oxo-30-norlupan-28-oic acid
C33H50O7
2511353-36-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5317 7.9142 0.0 0
M  V30 2 O 2.1580 9.3210 0.0 0
M  V30 3 O 0.0000 7.7533 0.0 0
M  V30 4 C 2.4965 2.6839 0.0 0
M  V30 5 C 3.9612 2.2079 0.0 0
M  V30 6 O 1.3521 1.6533 0.0 0
M  V30 7 C 5.6510 8.2025 0.0 0
M  V30 8 C 6.6582 8.1558 0.0 0
M  V30 9 C 9.2326 3.8006 0.0 0
M  V30 10 C 13.1239 7.1950 0.0 0
M  V30 11 C 11.4094 8.1849 0.0 0
M  V30 12 O 12.4469 2.6673 0.0 0
M  V30 13 C 11.6769 1.3336 0.0 0
M  V30 14 C 12.4469 0.0000 0.0 0
M  V30 15 O 10.1369 1.3336 0.0 0
M  V30 16 O 13.9869 5.3347 0.0 0
M  V30 17 C 14.7569 4.0009 0.0 0
M  V30 18 C 13.9869 2.6673 0.0 0
M  V30 19 O 16.2969 4.0009 0.0 0
M  V30 20 C 2.4369 6.6684 0.0 0 CFG=1
M  V30 21 C 3.2069 5.3347 0.0 0 CFG=2
M  V30 22 C 3.2069 8.0020 0.0 0
M  V30 23 C 0.9305 6.3482 0.0 0
M  V30 24 C 4.7469 5.3347 0.0 0 CFG=1
M  V30 25 C 2.1763 4.1902 0.0 0 CFG=2
M  V30 26 C 4.7469 8.0020 0.0 0
M  V30 27 C 0.7695 4.8165 0.0 0
M  V30 28 C 5.5169 6.6684 0.0 0 CFG=1
M  V30 29 C 5.5169 4.0009 0.0 0
M  V30 30 C 7.0569 6.6684 0.0 0 CFG=1
M  V30 31 C 7.0569 4.0009 0.0 0
M  V30 32 C 7.8269 5.3347 0.0 0 CFG=1
M  V30 33 C 7.8269 8.0020 0.0 0
M  V30 34 C 9.3669 5.3347 0.0 0 CFG=2
M  V30 35 C 9.3669 8.0020 0.0 0
M  V30 36 C 10.1369 6.6684 0.0 0 CFG=2
M  V30 37 C 10.1369 4.0009 0.0 0
M  V30 38 C 11.6769 6.6684 0.0 0
M  V30 39 C 11.6769 4.0009 0.0 0 CFG=2
M  V30 40 C 12.4469 5.3347 0.0 0 CFG=1
M  V30 41 H 3.4478 3.8137 0.0 0
M  V30 42 H 4.3482 3.8471 0.0 0
M  V30 43 H 7.9610 3.8006 0.0 0
M  V30 44 H 10.9069 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 20 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 25 4 CFG=3
M  V30 7 1 28 7 CFG=3
M  V30 8 1 30 8 CFG=1
M  V30 9 1 34 9 CFG=1
M  V30 10 1 10 38
M  V30 11 1 11 38
M  V30 12 1 12 13
M  V30 13 1 39 12 CFG=1
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 40 16 CFG=1
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 1 21 25
M  V30 25 1 21 41 CFG=3
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 24 29
M  V30 30 1 24 42 CFG=1
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 30 33
M  V30 37 1 31 32
M  V30 38 1 32 34
M  V30 39 1 32 43 CFG=3
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 34 37
M  V30 43 1 35 36
M  V30 44 1 36 38
M  V30 45 1 36 44 CFG=3
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 20 21 24 25 28 30 32 34 36 39 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2β,3β)-2,3-Bis(acetyloxy)-20-oxo-N-(phenylmethyl)-30-norlupan-28-amide
C40H57NO6
2511353-37-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.7653 7.9144 0.0 0
M  V30 2 N 16.2968 7.7535 0.0 0
M  V30 3 O 14.1388 9.3212 0.0 0
M  V30 4 C 17.2020 8.9993 0.0 0
M  V30 5 C 13.8003 2.6839 0.0 0
M  V30 6 C 12.3356 2.2081 0.0 0
M  V30 7 O 14.9447 1.6535 0.0 0
M  V30 8 C 10.6458 8.2027 0.0 0
M  V30 9 C 9.3742 8.2027 0.0 0
M  V30 10 C 7.0642 3.8006 0.0 0
M  V30 11 C 3.1729 7.1952 0.0 0
M  V30 12 C 4.8874 8.1851 0.0 0
M  V30 13 O 3.8500 2.6674 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 6.1600 1.3338 0.0 0
M  V30 16 O 3.8500 0.0000 0.0 0
M  V30 17 O 2.3100 5.3347 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 20 O 2.3100 2.6674 0.0 0
M  V30 21 C 13.8601 6.6685 0.0 0 CFG=1
M  V30 22 C 13.0901 5.3347 0.0 0 CFG=2
M  V30 23 C 13.0901 8.0022 0.0 0
M  V30 24 C 15.3664 6.3484 0.0 0
M  V30 25 C 11.5501 5.3347 0.0 0 CFG=1
M  V30 26 C 14.1205 4.1904 0.0 0 CFG=2
M  V30 27 C 11.5501 8.0022 0.0 0
M  V30 28 C 15.5273 4.8167 0.0 0
M  V30 29 C 10.7801 6.6685 0.0 0 CFG=1
M  V30 30 C 10.7801 4.0011 0.0 0
M  V30 31 C 9.2400 6.6685 0.0 0 CFG=1
M  V30 32 C 9.2400 4.0011 0.0 0
M  V30 33 C 8.4700 5.3347 0.0 0 CFG=1
M  V30 34 C 8.4700 8.0022 0.0 0
M  V30 35 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 36 C 6.9300 8.0022 0.0 0
M  V30 37 C 6.1600 6.6685 0.0 0 CFG=2
M  V30 38 C 6.1600 4.0011 0.0 0
M  V30 39 C 4.6200 6.6685 0.0 0
M  V30 40 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 41 C 3.8500 5.3347 0.0 0 CFG=1
M  V30 42 C 18.7336 8.8383 0.0 0
M  V30 43 C 19.3599 7.4315 0.0 0
M  V30 44 C 19.6388 10.0843 0.0 0
M  V30 45 C 20.8914 7.2705 0.0 0
M  V30 46 C 21.1703 9.9232 0.0 0
M  V30 47 C 21.7967 8.5164 0.0 0
M  V30 48 H 13.1169 3.7950 0.0 0
M  V30 49 H 11.6842 3.8006 0.0 0
M  V30 50 H 8.3358 3.8006 0.0 0
M  V30 51 H 5.3900 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 42
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 26 5 CFG=1
M  V30 9 1 29 8 CFG=1
M  V30 10 1 31 9 CFG=3
M  V30 11 1 35 10 CFG=3
M  V30 12 1 11 39
M  V30 13 1 12 39
M  V30 14 1 13 14
M  V30 15 1 40 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 17 18
M  V30 19 1 41 17 CFG=3
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 22 26
M  V30 27 1 22 48 CFG=1
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 1 25 49 CFG=3
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 31 34
M  V30 39 1 32 33
M  V30 40 1 33 35
M  V30 41 1 33 50 CFG=1
M  V30 42 1 34 36
M  V30 43 1 35 37
M  V30 44 1 35 38
M  V30 45 1 36 37
M  V30 46 1 37 39
M  V30 47 1 37 51 CFG=1
M  V30 48 1 38 40
M  V30 49 1 39 41
M  V30 50 1 40 41
M  V30 51 2 42 43
M  V30 52 1 42 44
M  V30 53 1 43 45
M  V30 54 2 44 46
M  V30 55 2 45 47
M  V30 56 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 21 22 25 26 29 31 33 35 37 40 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2511353-36-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2511353-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22856831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Betulinic acid derived amides are highly cytotoxic, apoptotic and
selective
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoenke, Sophie; Heise, Niels V.; Kahnt, Michael; Deigner, Hans-Peter;
Csuk, Rene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 207112815

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Boc-L-pipecolic acid
C11H19NO4
26250-84-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 6.8749 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 3.7949 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, 4-fluoro-, 2-propen-1-yl ester, hydrochloride (1:1)
C12H14FNO2.ClH
2411459-88-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0 CFG=2
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 N 6.6685 5.3901 0.0 0
M  V30 5 O 9.3360 3.8501 0.0 0
M  V30 6 O 8.0022 1.5400 0.0 0
M  V30 7 C 10.6697 3.0800 0.0 0
M  V30 8 C 12.0033 3.8501 0.0 0
M  V30 9 C 13.3370 3.0800 0.0 0
M  V30 10 F 0.0000 6.1601 0.0 0
M  V30 11 C 4.0010 3.8501 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 2.6673 3.0800 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 Cl 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, N-[[(2S)-1-[(1,1-dimethylethoxy)carbonyl]-2-piperidinyl]carb...
C23H31FN2O5
2984600-23-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 8.0022 0.0 0
M  V30 2 N 8.2638 8.0022 0.0 0
M  V30 3 O 5.9538 6.6685 0.0 0
M  V30 4 C 9.0338 6.6685 0.0 0 CFG=2
M  V30 5 C 8.2638 5.3348 0.0 0
M  V30 6 C 10.5739 6.6685 0.0 0
M  V30 7 O 11.3439 8.0022 0.0 0
M  V30 8 O 11.3439 5.3348 0.0 0
M  V30 9 C 12.8839 8.0022 0.0 0
M  V30 10 C 13.6539 9.3360 0.0 0
M  V30 11 C 15.1940 9.3360 0.0 0
M  V30 12 C 3.6437 8.0022 0.0 0
M  V30 13 O 2.1037 8.0022 0.0 0
M  V30 14 O 4.4137 6.6685 0.0 0
M  V30 15 C 1.3337 6.6685 0.0 0
M  V30 16 C 2.6673 5.8985 0.0 0
M  V30 17 C 0.5637 5.3348 0.0 0
M  V30 18 C 0.0000 7.4385 0.0 0
M  V30 19 F 11.3439 0.0000 0.0 0
M  V30 20 C 5.9538 9.3360 0.0 0 CFG=2
M  V30 21 N 4.4137 9.3360 0.0 0
M  V30 22 C 6.7238 10.6697 0.0 0
M  V30 23 C 3.6437 10.6697 0.0 0
M  V30 24 C 5.9538 12.0033 0.0 0
M  V30 25 C 4.4137 12.0033 0.0 0
M  V30 26 C 9.0338 4.0012 0.0 0
M  V30 27 C 10.5739 4.0012 0.0 0
M  V30 28 C 8.2638 2.6673 0.0 0
M  V30 29 C 11.3439 2.6673 0.0 0
M  V30 30 C 9.0338 1.3337 0.0 0
M  V30 31 C 10.5739 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 20 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 31
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 26250-84-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2411459-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2984600-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37713576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Analysis of Structure-Activity Relationships of Novel Inhibitors of the
Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria
meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scheuplein, Nicolas J.; Bzdyl, Nicole M.; Lohr, Theresa; Kibble, Emily
A.; Hasenkopf, Anja; Herbst, Carina; Sarkar-Tyson, Mitali; Holzgrabe,
Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(13), 8876-8895

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
N-(Benzyloxycarbonyl)-6-aminohexanoic acid
C14H19NO4
1947-00-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 O 6.6687 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 12.0035 3.0801 0.0 0
M  V30 9 C 13.3372 2.3101 0.0 0
M  V30 10 C 14.6708 3.0801 0.0 0
M  V30 11 C 16.0045 2.3101 0.0 0
M  V30 12 O 17.3383 3.0801 0.0 0
M  V30 13 O 16.0045 0.7700 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 15 C 1.3338 3.0801 0.0 0
M  V30 16 C 2.6675 0.7700 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3338 0.0000 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-methanamine, 1-[1-[cis-4-(1-methylethyl)cyclohexyl]-4-piperidinyl...
C23H35N3.2ClH
2685734-99-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.6265 5.6437 0.0 0
M  V30 2 N 0.0000 7.0507 0.0 0
M  V30 3 C 13.9313 11.3910 0.0 0
M  V30 4 C 15.2651 10.6210 0.0 0
M  V30 5 C 13.9313 12.9310 0.0 0
M  V30 6 N 4.5955 6.0009 0.0 0
M  V30 7 C 4.4344 4.4693 0.0 0
M  V30 8 C 3.1885 6.6273 0.0 0
M  V30 9 C 2.9281 4.1491 0.0 0
M  V30 10 C 5.4650 3.3249 0.0 0
M  V30 11 C 2.1580 5.4828 0.0 0
M  V30 12 C 2.4522 2.6844 0.0 0
M  V30 13 C 4.9889 1.8602 0.0 0
M  V30 14 C 3.4826 1.5400 0.0 0
M  V30 15 C 5.9291 6.7709 0.0 0
M  V30 16 C 7.2628 6.0009 0.0 0
M  V30 17 C 5.9291 8.3109 0.0 0
M  V30 18 C 8.5965 6.7709 0.0 0
M  V30 19 C 7.2628 9.0809 0.0 0
M  V30 20 N 8.5965 8.3109 0.0 0
M  V30 21 C 9.9303 9.0809 0.0 0 CFG=1
M  V30 22 C 9.9303 10.6210 0.0 0
M  V30 23 C 11.2640 8.3109 0.0 0
M  V30 24 C 11.2640 11.3910 0.0 0
M  V30 25 C 12.5976 9.0809 0.0 0
M  V30 26 C 12.5976 10.6210 0.0 0 CFG=2
M  V30 27 Cl 7.6326 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 26 3 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 20 CFG=3
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[6-[[[1-[1-[cis-4-(1-methylethyl)cyclohexyl]-4-piperidinyl]-1H...
C37H52N4O3
2411399-03-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.0381 3.7827 0.0 0
M  V30 2 N 14.8081 5.1164 0.0 0
M  V30 3 C 16.3481 5.1164 0.0 0
M  V30 4 C 17.1181 6.4500 0.0 0
M  V30 5 O 17.1181 3.7827 0.0 0
M  V30 6 C 18.6581 6.4500 0.0 0
M  V30 7 C 19.4281 7.7837 0.0 0
M  V30 8 C 20.9681 7.7837 0.0 0
M  V30 9 C 21.7381 9.1175 0.0 0
M  V30 10 N 23.2781 9.1175 0.0 0
M  V30 11 C 24.0481 10.4511 0.0 0
M  V30 12 O 25.5882 10.4511 0.0 0
M  V30 13 O 23.2781 11.7848 0.0 0
M  V30 14 C 26.3582 11.7848 0.0 0
M  V30 15 C 1.4070 10.8891 0.0 0
M  V30 16 C 0.0000 10.2626 0.0 0
M  V30 17 C 1.5679 12.4206 0.0 0
M  V30 18 N 10.1282 4.5527 0.0 0
M  V30 19 C 10.1282 3.0127 0.0 0
M  V30 20 C 11.5929 5.0286 0.0 0
M  V30 21 C 11.5929 2.5367 0.0 0
M  V30 22 C 8.9838 1.9821 0.0 0
M  V30 23 C 12.4981 3.7827 0.0 0
M  V30 24 C 11.9130 1.0304 0.0 0
M  V30 25 C 9.3040 0.4759 0.0 0
M  V30 26 C 10.7685 0.0000 0.0 0
M  V30 27 C 8.8823 5.4578 0.0 0
M  V30 28 C 9.0432 6.9895 0.0 0
M  V30 29 C 7.4754 4.8315 0.0 0
M  V30 30 C 7.7974 7.8945 0.0 0
M  V30 31 C 6.2295 5.7367 0.0 0
M  V30 32 N 6.3906 7.2682 0.0 0
M  V30 33 C 5.1446 8.1734 0.0 0 CFG=1
M  V30 34 C 3.7378 7.5471 0.0 0
M  V30 35 C 5.3056 9.7050 0.0 0
M  V30 36 C 2.4919 8.4522 0.0 0
M  V30 37 C 4.0598 10.6102 0.0 0
M  V30 38 C 2.6528 9.9839 0.0 0 CFG=2
M  V30 39 C 27.8982 11.7848 0.0 0
M  V30 40 C 28.6682 13.1184 0.0 0
M  V30 41 C 28.6682 10.4511 0.0 0
M  V30 42 C 30.2080 13.1184 0.0 0
M  V30 43 C 30.2082 10.4511 0.0 0
M  V30 44 C 30.9782 11.7848 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 39
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 38 15 CFG=3
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 27
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 2 20 23
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 32 CFG=3
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 33 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1947-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2685734-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411399-03-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23938496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Structure-Activity Relationships of Nociceptin Receptor
Partial Agonists That Afford Symptom Ablation in Parkinson's Disease
Models
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kamakolanu, Uma Gayathri; Meyer, Michael E.; Yasuda, Dennis; Polgar,
Willma E.; Marti, Matteo; Mercatelli, Daniela; Pisano, Clarissa Anna;
Brugnoli, Alberto; Morari, Michele; Zaveri, Nurulain T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(5), 2688-2704

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) 4-(4-carboxyphenyl)-1-piperazinecarboxylate
C16H22N2O4
162046-66-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 2.8737 0.0 0
M  V30 2 O 12.3203 1.5400 0.0 0
M  V30 3 O 12.3203 4.2074 0.0 0
M  V30 4 C 13.8603 1.5400 0.0 0
M  V30 5 C 13.8603 3.0801 0.0 0
M  V30 6 C 15.4003 1.5400 0.0 0
M  V30 7 C 13.8603 0.0000 0.0 0
M  V30 8 C 0.7700 2.8737 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 O 0.0000 4.2074 0.0 0
M  V30 11 N 6.9302 2.8737 0.0 0
M  V30 12 C 7.7002 4.2074 0.0 0
M  V30 13 C 7.7002 1.5400 0.0 0
M  V30 14 C 9.2402 4.2074 0.0 0
M  V30 15 C 9.2402 1.5400 0.0 0
M  V30 16 N 10.0102 2.8737 0.0 0
M  V30 17 C 5.3901 2.8737 0.0 0
M  V30 18 C 4.6201 1.5400 0.0 0
M  V30 19 C 4.6201 4.2074 0.0 0
M  V30 20 C 3.0801 1.5400 0.0 0
M  V30 21 C 3.0801 4.2074 0.0 0
M  V30 22 C 2.3101 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(trans-4-Aminocyclohexyl)oxy]-2-chlorobenzonitrile
C13H15ClN2O
1335195-90-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.8501 0.0 0
M  V30 2 Cl 1.3337 3.8501 0.0 0
M  V30 3 C 1.3337 0.7700 0.0 0
M  V30 4 N 0.0000 0.0000 0.0 0
M  V30 5 N 12.0033 0.7700 0.0 0
M  V30 6 C 5.3348 3.0801 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0 CFG=2
M  V30 13 C 8.0022 1.5400 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 0.7700 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 1.5400 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 9
M  V30 4 3 3 4
M  V30 5 1 3 11
M  V30 6 1 17 5 CFG=1
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[4-[[[trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl]amino]c...
C29H35ClN4O4
2222119-02-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3338 1.5400 0.0 0
M  V30 5 C 0.5638 2.8737 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 2.1038 0.2064 0.0 0
M  V30 8 C 13.3372 6.9302 0.0 0
M  V30 9 N 14.6708 6.1601 0.0 0
M  V30 10 O 13.3372 8.4702 0.0 0
M  V30 11 O 20.0057 9.2402 0.0 0
M  V30 12 Cl 25.3405 9.2402 0.0 0
M  V30 13 C 25.3405 6.1601 0.0 0
M  V30 14 N 26.6743 5.3901 0.0 0
M  V30 15 N 8.0023 3.8501 0.0 0
M  V30 16 C 6.6687 4.6201 0.0 0
M  V30 17 C 8.0023 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 6.6687 1.5400 0.0 0
M  V30 20 N 5.3348 2.3101 0.0 0
M  V30 21 C 9.3360 4.6201 0.0 0
M  V30 22 C 9.3360 6.1601 0.0 0
M  V30 23 C 10.6698 3.8501 0.0 0
M  V30 24 C 10.6698 6.9302 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 C 12.0035 6.1601 0.0 0
M  V30 27 C 16.0046 6.9302 0.0 0 CFG=1
M  V30 28 C 16.0046 8.4702 0.0 0
M  V30 29 C 17.3383 6.1601 0.0 0
M  V30 30 C 17.3383 9.2402 0.0 0
M  V30 31 C 18.6720 6.9302 0.0 0
M  V30 32 C 18.6720 8.4702 0.0 0 CFG=1
M  V30 33 C 21.3395 8.4702 0.0 0
M  V30 34 C 22.6731 9.2402 0.0 0
M  V30 35 C 21.3395 6.9302 0.0 0
M  V30 36 C 24.0068 8.4702 0.0 0
M  V30 37 C 22.6731 6.1601 0.0 0
M  V30 38 C 24.0068 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 26
M  V30 11 1 27 9 CFG=3
M  V30 12 1 32 11 CFG=1
M  V30 13 1 11 33
M  V30 14 1 12 36
M  V30 15 3 13 14
M  V30 16 1 13 38
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 21
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 27 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 162046-66-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1335195-90-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222119-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34568026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC
Degrader of Androgen Receptor for the Treatment of Advanced Prostate
Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Weiguo; Zhao, Lijie; Han, Xin; Qin, Chong; Miao, Bukeyan;
McEachern, Donna; Wang, Yu; Metwally, Hoda; Kirchhoff, Paul D.; Wang, Lu;
Matvekas, Aleksas; He, Miao; Wen, Bo; Sun, Duxin; Wang, Shaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(18), 13487-13509

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
o-Phenylenediamine
C6H8N2
95-54-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (2R)-4-[4-carboxy-2-(trifluoromethyl)-5-thiazolyl]-2-me...
C15H20F3N3O4S
1646267-98-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4323 1.1444 0.0 0
M  V30 2 O 3.4017 0.0000 0.0 0
M  V30 3 O 5.9385 0.8242 0.0 0
M  V30 4 C 1.2459 5.5301 0.0 0
M  V30 5 F 0.3406 4.2843 0.0 0
M  V30 6 F 0.0000 6.4354 0.0 0
M  V30 7 F 2.1511 6.7760 0.0 0
M  V30 8 C 9.4815 6.5224 0.0 0
M  V30 9 C 11.0215 3.8549 0.0 0
M  V30 10 O 11.7915 2.5213 0.0 0
M  V30 11 O 11.7915 5.1886 0.0 0
M  V30 12 C 13.3315 2.5213 0.0 0
M  V30 13 C 13.3315 4.0613 0.0 0
M  V30 14 C 14.8715 2.5213 0.0 0
M  V30 15 C 13.3315 0.9813 0.0 0
M  V30 16 C 4.8615 3.8549 0.0 0
M  V30 17 C 3.9564 2.6091 0.0 0
M  V30 18 S 3.9564 5.1008 0.0 0
M  V30 19 N 2.4917 3.0849 0.0 0
M  V30 20 C 2.4917 4.6249 0.0 0
M  V30 21 N 6.4015 3.8549 0.0 0
M  V30 22 C 7.1715 5.1886 0.0 0
M  V30 23 C 7.1715 2.5213 0.0 0
M  V30 24 C 8.7115 5.1886 0.0 0 CFG=1
M  V30 25 C 8.7115 2.5213 0.0 0
M  V30 26 N 9.4815 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 20
M  V30 8 1 24 8 CFG=1
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 26
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[4-[[(2-aminophenyl)amino]carbonyl]-2-(trifluo...
C21H26F3N5O3S
2835443-86-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4323 5.5383 0.0 0
M  V30 2 N 3.4017 4.3939 0.0 0
M  V30 3 O 5.9385 5.2181 0.0 0
M  V30 4 C 1.2459 9.9241 0.0 0
M  V30 5 F 2.1511 11.1699 0.0 0
M  V30 6 F 0.0000 10.8293 0.0 0
M  V30 7 F 0.3406 8.6782 0.0 0
M  V30 8 C 9.4815 10.9161 0.0 0
M  V30 9 C 11.0215 8.2489 0.0 0
M  V30 10 O 11.7915 6.9152 0.0 0
M  V30 11 O 11.7915 9.5825 0.0 0
M  V30 12 C 13.3315 6.9152 0.0 0
M  V30 13 C 13.3315 5.3752 0.0 0
M  V30 14 C 14.8715 6.9152 0.0 0
M  V30 15 C 13.3315 8.4552 0.0 0
M  V30 16 N 1.3409 2.1050 0.0 0
M  V30 17 C 4.8615 8.2489 0.0 0
M  V30 18 C 3.9564 7.0030 0.0 0
M  V30 19 S 3.9564 9.4947 0.0 0
M  V30 20 N 2.4917 7.4789 0.0 0
M  V30 21 C 2.4917 9.0189 0.0 0
M  V30 22 N 6.4015 8.2489 0.0 0
M  V30 23 C 7.1715 9.5825 0.0 0
M  V30 24 C 7.1715 6.9152 0.0 0
M  V30 25 C 8.7115 9.5825 0.0 0 CFG=1
M  V30 26 C 8.7115 6.9152 0.0 0
M  V30 27 N 9.4815 8.2489 0.0 0
M  V30 28 C 3.8777 2.9292 0.0 0
M  V30 29 C 2.8472 1.7849 0.0 0
M  V30 30 C 5.3840 2.6091 0.0 0
M  V30 31 C 3.3230 0.3202 0.0 0
M  V30 32 C 5.8599 1.1444 0.0 0
M  V30 33 C 4.8294 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 21
M  V30 9 1 25 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 29
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 95-54-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1646267-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2835443-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34105538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Pharmacological Evaluation of
Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic
Potential in Autoimmune Diseases: Discovery of ACT-672125
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caroff, Eva; Meyer, Emmanuel A.; Aanismaa, Paivi; Froidevaux, Sylvie;
Keller, Marcel; Piali, Luca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(16), 10918-10933

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
3-(2H-1,2,3-Triazol-2-yl)picolinic acid
C8H6N4O2
1252907-86-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 0.7700 2.6674 0.0 0
M  V30 8 C 0.7700 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 N 5.5252 2.7552 0.0 0
M  V30 12 N 5.5252 5.2469 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 14 C 6.9898 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, compd. wit...
C12H17F3N4.C10H16O4S
3058618-68-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.3319 10.9003 0.0 0
M  V30 2 C 4.8719 8.2328 0.0 0
M  V30 3 C 5.6419 6.8992 0.0 0
M  V30 4 C 9.4919 10.9003 0.0 0
M  V30 5 F 9.4919 9.3603 0.0 0
M  V30 6 F 11.0319 10.9003 0.0 0
M  V30 7 F 9.4919 12.4403 0.0 0
M  V30 8 N 0.0000 11.2505 0.0 0
M  V30 9 C 4.8719 10.9003 0.0 0
M  V30 10 C 5.6419 9.5666 0.0 0
M  V30 11 N 5.6419 12.2339 0.0 0
M  V30 12 N 7.1819 9.5666 0.0 0
M  V30 13 C 7.1819 12.2339 0.0 0
M  V30 14 C 7.9519 10.9003 0.0 0
M  V30 15 C 2.5619 12.2339 0.0 0 CFG=2
M  V30 16 C 1.0304 12.3948 0.0 0 CFG=2
M  V30 17 C 3.1884 13.6409 0.0 0
M  V30 18 C 0.7102 13.9013 0.0 0
M  V30 19 C 2.0439 14.6713 0.0 0
M  V30 20 C 6.7742 2.6593 0.0 0
M  V30 21 S 7.5442 3.9929 0.0 0 VAL=6
M  V30 22 O 8.8778 3.2229 0.0 0
M  V30 23 O 6.2105 4.7629 0.0 0
M  V30 24 O 8.3142 5.3265 0.0 0
M  V30 25 C 3.0917 5.3592 0.0 0
M  V30 26 C 3.6972 0.8188 0.0 0
M  V30 27 O 5.2365 0.0000 0.0 0
M  V30 28 C 5.2342 2.6593 0.0 0
M  V30 29 C 3.6934 3.1288 0.0 0
M  V30 30 C 4.4663 1.3336 0.0 0
M  V30 31 C 4.4618 3.9926 0.0 0
M  V30 32 C 2.1542 2.6542 0.0 0
M  V30 33 C 2.9263 1.3310 0.0 0
M  V30 34 C 2.9220 3.9900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 14
M  V30 9 1 16 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 28
M  V30 23 2 21 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 25 29
M  V30 27 1 26 29
M  V30 28 2 27 30
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 29 32
M  V30 33 1 30 33
M  V30 34 1 31 34
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C20H21F3N8O
3058618-70-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4774 4.6714 0.0 0
M  V30 2 N 5.9837 4.3513 0.0 0
M  V30 3 O 4.0015 6.1360 0.0 0
M  V30 4 N 9.3158 4.0009 0.0 0
M  V30 5 C 10.8558 1.3336 0.0 0
M  V30 6 C 11.6258 0.0000 0.0 0
M  V30 7 C 15.4758 4.0009 0.0 0
M  V30 8 F 15.4758 5.5409 0.0 0
M  V30 9 F 17.0158 4.0009 0.0 0
M  V30 10 F 15.4758 2.4609 0.0 0
M  V30 11 C 1.9406 3.8471 0.0 0
M  V30 12 C 3.4468 3.5269 0.0 0
M  V30 13 C 0.9101 2.7027 0.0 0
M  V30 14 N 3.9228 2.0624 0.0 0
M  V30 15 C 1.3860 1.2380 0.0 0
M  V30 16 C 2.8923 0.9178 0.0 0
M  V30 17 N 1.4647 5.3118 0.0 0
M  V30 18 N 2.3699 6.5576 0.0 0
M  V30 19 N 0.0000 5.7876 0.0 0
M  V30 20 C 1.4647 7.8035 0.0 0
M  V30 21 C 0.0000 7.3276 0.0 0
M  V30 22 C 7.0142 5.4956 0.0 0 CFG=2
M  V30 23 C 8.5458 5.3347 0.0 0 CFG=2
M  V30 24 C 6.6939 7.0021 0.0 0
M  V30 25 C 9.1721 6.7415 0.0 0
M  V30 26 C 8.0277 7.7721 0.0 0
M  V30 27 C 10.8558 4.0009 0.0 0
M  V30 28 C 11.6258 2.6673 0.0 0
M  V30 29 N 11.6258 5.3347 0.0 0
M  V30 30 N 13.1658 2.6673 0.0 0
M  V30 31 C 13.1658 5.3347 0.0 0
M  V30 32 C 13.9358 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 22 2 CFG=3
M  V30 5 1 23 4 CFG=1
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 5 28
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 32
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 11 17
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1252907-86-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3058618-68-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3058618-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39486271
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and first-time disclosure of CVN766, an exquisitely selective
orexin 1 receptor antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glen, Angela; Burli, Roland W.; Livermore, David; Buffham, William;
Merison, Stephanie; Rowland, Anna E.; Newman, Robert; Fieldhouse,
Charlotte; Miller, David J.; Dawson, Lee A.; Matthews, Kim; Carlton, Mark
B.; Brice, Nicola L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2024), 100129629

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3R)-1,3-pyrrolidinedicarboxylate
C10H17NO4
72925-16-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 3.2067 0.0 0
M  V30 2 O 3.0800 4.5405 0.0 0
M  V30 3 O 3.0800 1.8731 0.0 0
M  V30 4 C 1.5400 4.5405 0.0 0
M  V30 5 C 1.5400 3.0005 0.0 0
M  V30 6 C 0.0000 4.5405 0.0 0
M  V30 7 C 1.5400 6.0805 0.0 0
M  V30 8 C 9.0058 1.5317 0.0 0
M  V30 9 O 8.8447 0.0000 0.0 0
M  V30 10 O 10.4126 2.1580 0.0 0
M  V30 11 N 5.3900 3.2067 0.0 0
M  V30 12 C 6.2952 1.9609 0.0 0
M  V30 13 C 6.2952 4.4528 0.0 0
M  V30 14 C 7.7598 2.4367 0.0 0 CFG=2
M  V30 15 C 7.7598 3.9767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[[[(1S,2R)-2-hydroxy-3-[[(4-methoxyphenyl)sul...
C31H45N3O7S
2925287-34-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 9.2400 0.0 0 CFG=1
M  V30 2 C 6.6684 8.4700 0.0 0 CFG=2
M  V30 3 C 8.0020 10.7800 0.0 0
M  V30 4 N 9.3358 8.4700 0.0 0
M  V30 5 C 5.3347 9.2400 0.0 0
M  V30 6 O 6.6684 6.9300 0.0 0
M  V30 7 C 10.6694 9.2400 0.0 0
M  V30 8 N 4.0009 8.4700 0.0 0
M  V30 9 O 10.6694 10.7800 0.0 0
M  V30 10 S 4.0011 6.9300 0.0 0 VAL=6
M  V30 11 C 2.6673 9.2400 0.0 0
M  V30 12 O 2.4611 6.9300 0.0 0
M  V30 13 O 5.5411 6.9300 0.0 0
M  V30 14 C 1.3336 8.4700 0.0 0
M  V30 15 C 0.0000 9.2400 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 15.9720 8.1129 0.0 0
M  V30 18 O 16.8772 6.8670 0.0 0
M  V30 19 O 16.5983 9.5198 0.0 0
M  V30 20 C 18.4087 7.0279 0.0 0
M  V30 21 C 18.2478 8.5596 0.0 0
M  V30 22 C 19.9402 7.1890 0.0 0
M  V30 23 C 18.5696 5.4964 0.0 0
M  V30 24 O 4.0011 0.7700 0.0 0
M  V30 25 C 2.6673 0.0000 0.0 0
M  V30 26 C 6.6684 11.5500 0.0 0
M  V30 27 C 5.3347 10.7800 0.0 0
M  V30 28 C 6.6684 13.0900 0.0 0
M  V30 29 C 4.0009 11.5500 0.0 0
M  V30 30 C 5.3347 13.8600 0.0 0
M  V30 31 C 4.0009 13.0900 0.0 0
M  V30 32 C 12.0031 8.4700 0.0 0 CFG=2
M  V30 33 C 13.4099 9.0963 0.0 0
M  V30 34 C 12.1640 6.9385 0.0 0
M  V30 35 N 14.4404 7.9519 0.0 0
M  V30 36 C 13.6704 6.6183 0.0 0
M  V30 37 C 4.0011 5.3900 0.0 0
M  V30 38 C 2.6673 4.6200 0.0 0
M  V30 39 C 5.3347 4.6200 0.0 0
M  V30 40 C 2.6673 3.0800 0.0 0
M  V30 41 C 5.3347 3.0800 0.0 0
M  V30 42 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 26
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 32 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 37
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 35
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 25
M  V30 27 1 24 42
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 72925-16-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925287-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36491266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel HIV-1 protease
inhibitors containing pyrrolidine-derived P2 ligands to combat
drug-resistant variant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Huiyu; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning; Wang,
Minghua; Cen, Shan; Zhu, Mei; Shan, Qi; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 255115389

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
5-Cyano-3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-2-methylbenzoic acid
C16H20N2O3
2691175-30-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6673 8.4700 0.0 0
M  V30 4 C 6.6684 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 O 9.3358 7.7000 0.0 0
M  V30 7 O 10.6694 5.3900 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 C 6.6684 6.1600 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 5.3900 0.0 0
M  V30 14 C 6.6684 3.0800 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 2.6673 3.8500 0.0 0
M  V30 19 C 0.0000 5.3900 0.0 0
M  V30 20 C 1.3336 3.0800 0.0 0
M  V30 21 O 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 3 8 9
M  V30 10 1 8 14
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Aminomethyl)-4-methoxy-6-methyl-2(1H)-pyridinone
C8H12N2O2
1438382-15-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 N 0.0000 5.3348 0.0 0
M  V30 5 O 2.3100 6.6686 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyano-N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl...
C24H30N4O4
2691175-34-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 2.6674 8.4700 0.0 0
M  V30 4 C 6.6685 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0
M  V30 6 N 10.6694 5.3900 0.0 0
M  V30 7 O 9.3358 7.7000 0.0 0
M  V30 8 C 12.0032 6.1600 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 6.6685 0.0000 0.0 0
M  V30 11 O 14.6705 7.7000 0.0 0
M  V30 12 C 16.0041 8.4700 0.0 0
M  V30 13 O 12.0032 3.0800 0.0 0
M  V30 14 C 17.3379 3.0800 0.0 0
M  V30 15 C 5.3347 5.3900 0.0 0
M  V30 16 C 6.6685 6.1600 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 18 C 8.0021 5.3900 0.0 0
M  V30 19 C 6.6685 3.0800 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0
M  V30 21 C 2.6674 5.3900 0.0 0
M  V30 22 C 2.6674 3.8500 0.0 0
M  V30 23 C 1.3338 6.1600 0.0 0
M  V30 24 C 1.3338 3.0800 0.0 0
M  V30 25 C 0.0000 5.3900 0.0 0
M  V30 26 O 0.0000 3.8500 0.0 0
M  V30 27 C 13.3369 5.3900 0.0 0
M  V30 28 C 14.6705 6.1600 0.0 0
M  V30 29 C 13.3369 3.8500 0.0 0
M  V30 30 C 16.0041 5.3900 0.0 0
M  V30 31 N 14.6705 3.0800 0.0 0
M  V30 32 C 16.0041 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 1 6 8
M  V30 10 1 8 27
M  V30 11 3 9 10
M  V30 12 1 9 19
M  V30 13 1 11 12
M  V30 14 1 11 28
M  V30 15 2 13 29
M  V30 16 1 14 32
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2691175-30-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1438382-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2691175-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36826830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive
Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of
Zeste Homologue 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Yang, Hong; Li, Bingbing; Li, Jiayi; Li, Huaxuan; Shi,
Qiongyu; Li, Bang; Wang, Zekun; Zheng, Jiahong; Zhang, Ying; Dong, Hui;
Huang, Xun; Wang, Yuanxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7629-7644

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3S)-4-(3,4-dichlorophenyl)-1,3-piperazinedicarboxylate
C16H20Cl2N2O4
2768834-59-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3338 0.0 0
M  V30 2 O 4.6200 1.3338 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Cl 1.5400 6.6685 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 O 11.5500 5.3349 0.0 0
M  V30 7 O 11.5500 2.6674 0.0 0
M  V30 8 C 13.0900 5.3349 0.0 0
M  V30 9 C 13.0900 6.8749 0.0 0
M  V30 10 C 14.6300 5.3349 0.0 0
M  V30 11 C 13.0900 3.7949 0.0 0
M  V30 12 Cl 0.0000 4.0011 0.0 0
M  V30 13 N 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0 CFG=2
M  V30 15 C 6.9300 5.3349 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3349 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 3.8500 5.3349 0.0 0
M  V30 21 C 3.8500 2.6674 0.0 0
M  V30 22 C 2.3100 5.3349 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Thiophenemethanamine
C5H7NS
27757-85-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-4-(3,4-dichlorophenyl)-3-[[(2-thienylmethyl)amino]carb...
C21H25Cl2N3O3S
2768834-60-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.4384 0.0 0
M  V30 2 N 6.9302 5.1048 0.0 0
M  V30 3 O 4.6201 6.4384 0.0 0
M  V30 4 C 6.1601 3.7711 0.0 0
M  V30 5 C 10.7802 9.1059 0.0 0
M  V30 6 O 11.5503 10.4396 0.0 0
M  V30 7 O 11.5503 7.7722 0.0 0
M  V30 8 C 13.0903 10.4396 0.0 0
M  V30 9 C 13.0903 8.8995 0.0 0
M  V30 10 C 14.6303 10.4396 0.0 0
M  V30 11 C 13.0903 11.9796 0.0 0
M  V30 12 Cl 1.5400 11.7733 0.0 0
M  V30 13 Cl 0.0000 9.1059 0.0 0
M  V30 14 N 6.1601 9.1059 0.0 0
M  V30 15 C 6.9302 7.7722 0.0 0 CFG=2
M  V30 16 C 6.9302 10.4396 0.0 0
M  V30 17 C 8.4702 7.7722 0.0 0
M  V30 18 C 8.4702 10.4396 0.0 0
M  V30 19 N 9.2402 9.1059 0.0 0
M  V30 20 C 4.6201 9.1059 0.0 0
M  V30 21 C 3.8501 10.4396 0.0 0
M  V30 22 C 3.8501 7.7722 0.0 0
M  V30 23 C 2.3101 10.4396 0.0 0
M  V30 24 C 2.3101 7.7722 0.0 0
M  V30 25 C 1.5400 9.1059 0.0 0
M  V30 26 C 6.9302 2.4374 0.0 0
M  V30 27 C 8.4617 2.2763 0.0 0
M  V30 28 S 6.3038 1.0304 0.0 0
M  V30 29 C 8.7819 0.7700 0.0 0
M  V30 30 C 7.4482 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 23
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2768834-59-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27757-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768834-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38559346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine
Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus
2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable
Druggability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Shenghua; Song, Letian; Sylvester, Katharina; Mercorelli, Beatrice;
Loregian, Arianna; Toth, Karoly; Weisse, Renato H.; Useini, Abibe;
Strater, Norbert; Yang, Mianling; Ye, Bing; Tollefson, Ann E.; Muller,
Christa E.; Liu, Xinyong; Zhan, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(23), 16426-16440

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3S)-4-(3,4-dichlorophenyl)-1,3-piperazinedicarboxylate
C16H20Cl2N2O4
2768834-59-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3338 0.0 0
M  V30 2 O 4.6200 1.3338 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Cl 1.5400 6.6685 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 O 11.5500 5.3349 0.0 0
M  V30 7 O 11.5500 2.6674 0.0 0
M  V30 8 C 13.0900 5.3349 0.0 0
M  V30 9 C 13.0900 6.8749 0.0 0
M  V30 10 C 14.6300 5.3349 0.0 0
M  V30 11 C 13.0900 3.7949 0.0 0
M  V30 12 Cl 0.0000 4.0011 0.0 0
M  V30 13 N 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0 CFG=2
M  V30 15 C 6.9300 5.3349 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3349 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 3.8500 5.3349 0.0 0
M  V30 21 C 3.8500 2.6674 0.0 0
M  V30 22 C 2.3100 5.3349 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Thiophenemethanamine
C5H7NS
27757-85-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-4-(3,4-dichlorophenyl)-3-[[(2-thienylmethyl)amino]carb...
C21H25Cl2N3O3S
2768834-60-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.4384 0.0 0
M  V30 2 N 6.9302 5.1048 0.0 0
M  V30 3 O 4.6201 6.4384 0.0 0
M  V30 4 C 6.1601 3.7711 0.0 0
M  V30 5 C 10.7802 9.1059 0.0 0
M  V30 6 O 11.5503 10.4396 0.0 0
M  V30 7 O 11.5503 7.7722 0.0 0
M  V30 8 C 13.0903 10.4396 0.0 0
M  V30 9 C 13.0903 8.8995 0.0 0
M  V30 10 C 14.6303 10.4396 0.0 0
M  V30 11 C 13.0903 11.9796 0.0 0
M  V30 12 Cl 1.5400 11.7733 0.0 0
M  V30 13 Cl 0.0000 9.1059 0.0 0
M  V30 14 N 6.1601 9.1059 0.0 0
M  V30 15 C 6.9302 7.7722 0.0 0 CFG=2
M  V30 16 C 6.9302 10.4396 0.0 0
M  V30 17 C 8.4702 7.7722 0.0 0
M  V30 18 C 8.4702 10.4396 0.0 0
M  V30 19 N 9.2402 9.1059 0.0 0
M  V30 20 C 4.6201 9.1059 0.0 0
M  V30 21 C 3.8501 10.4396 0.0 0
M  V30 22 C 3.8501 7.7722 0.0 0
M  V30 23 C 2.3101 10.4396 0.0 0
M  V30 24 C 2.3101 7.7722 0.0 0
M  V30 25 C 1.5400 9.1059 0.0 0
M  V30 26 C 6.9302 2.4374 0.0 0
M  V30 27 C 8.4617 2.2763 0.0 0
M  V30 28 S 6.3038 1.0304 0.0 0
M  V30 29 C 8.7819 0.7700 0.0 0
M  V30 30 C 7.4482 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 23
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2768834-59-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27757-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768834-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40410330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Crystallographic Studies of Nonpeptidic Piperazine
Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Shenghua; Song, Letian; Claff, Tobias; Woodson, Molly; Sylvester,
Katharina; Jing, Lanlan; Weisse, Renato H.; Cheng, Yusen; Strater,
Norbert; Schakel, Laura; Gutschow, Michael; Ye, Bing; Yang, Mianling;
Zhang, Tao; Kang, Dongwei; Toth, Karoly; Tavis, John; Tollefson, Ann E.;
Muller, Christa E.; Zhan, Peng; Liu, Xinyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(24), 16902-16917

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3S)-4-(3,4-dichlorophenyl)-1,3-piperazinedicarboxylate
C16H20Cl2N2O4
2768834-59-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3338 0.0 0
M  V30 2 O 4.6200 1.3338 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 Cl 1.5400 6.6685 0.0 0
M  V30 5 C 10.7800 4.0011 0.0 0
M  V30 6 O 11.5500 5.3349 0.0 0
M  V30 7 O 11.5500 2.6674 0.0 0
M  V30 8 C 13.0900 5.3349 0.0 0
M  V30 9 C 13.0900 6.8749 0.0 0
M  V30 10 C 14.6300 5.3349 0.0 0
M  V30 11 C 13.0900 3.7949 0.0 0
M  V30 12 Cl 0.0000 4.0011 0.0 0
M  V30 13 N 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0 CFG=2
M  V30 15 C 6.9300 5.3349 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3349 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 3.8500 5.3349 0.0 0
M  V30 21 C 3.8500 2.6674 0.0 0
M  V30 22 C 2.3100 5.3349 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Thiophenemethanamine
C5H7NS
27757-85-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-4-(3,4-dichlorophenyl)-3-[[(2-thienylmethyl)amino]carb...
C21H25Cl2N3O3S
2768834-60-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.4384 0.0 0
M  V30 2 N 6.9302 5.1048 0.0 0
M  V30 3 O 4.6201 6.4384 0.0 0
M  V30 4 C 6.1601 3.7711 0.0 0
M  V30 5 C 10.7802 9.1059 0.0 0
M  V30 6 O 11.5503 10.4396 0.0 0
M  V30 7 O 11.5503 7.7722 0.0 0
M  V30 8 C 13.0903 10.4396 0.0 0
M  V30 9 C 13.0903 8.8995 0.0 0
M  V30 10 C 14.6303 10.4396 0.0 0
M  V30 11 C 13.0903 11.9796 0.0 0
M  V30 12 Cl 1.5400 11.7733 0.0 0
M  V30 13 Cl 0.0000 9.1059 0.0 0
M  V30 14 N 6.1601 9.1059 0.0 0
M  V30 15 C 6.9302 7.7722 0.0 0 CFG=2
M  V30 16 C 6.9302 10.4396 0.0 0
M  V30 17 C 8.4702 7.7722 0.0 0
M  V30 18 C 8.4702 10.4396 0.0 0
M  V30 19 N 9.2402 9.1059 0.0 0
M  V30 20 C 4.6201 9.1059 0.0 0
M  V30 21 C 3.8501 10.4396 0.0 0
M  V30 22 C 3.8501 7.7722 0.0 0
M  V30 23 C 2.3101 10.4396 0.0 0
M  V30 24 C 2.3101 7.7722 0.0 0
M  V30 25 C 1.5400 9.1059 0.0 0
M  V30 26 C 6.9302 2.4374 0.0 0
M  V30 27 C 8.4617 2.2763 0.0 0
M  V30 28 S 6.3038 1.0304 0.0 0
M  V30 29 C 8.7819 0.7700 0.0 0
M  V30 30 C 7.4482 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 23
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2768834-59-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27757-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768834-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39884154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Crystallographic Studies of Trisubstituted Piperazine
Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High
Target Specificity and Low Toxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Shenghua; Sylvester, Katharina; Song, Letian; Claff, Tobias; Jing,
Lanlan; Woodson, Molly; Weisse, Renato H.; Cheng, Yusen; Schakel, Laura;
Petry, Marvin; Gutschow, Michael; Schiedel, Anke C.; Strater, Norbert;
Kang, Dongwei; Xu, Shujing; Toth, Karoly; Tavis, John; Tollefson, Ann E.;
Muller, Christa E.; Liu, Xinyong; Zhan, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(19), 13343-13364

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-1-[(1,1-Dimethylethoxy)carbonyl]-3-pyrrolidineacetic acid
C11H19NO4
204688-61-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.7798 0.0 0
M  V30 2 O 2.6673 3.0098 0.0 0
M  V30 3 O 4.0011 5.3199 0.0 0
M  V30 4 C 1.3337 3.7798 0.0 0
M  V30 5 C 2.1037 5.1135 0.0 0
M  V30 6 C 0.0000 4.5499 0.0 0
M  V30 7 C 0.5637 2.4462 0.0 0
M  V30 8 C 9.3038 2.6527 0.0 0
M  V30 9 C 10.2090 1.4068 0.0 0
M  V30 10 O 11.7406 1.5679 0.0 0
M  V30 11 O 9.5825 0.0000 0.0 0
M  V30 12 N 5.3348 3.0098 0.0 0
M  V30 13 C 6.7416 3.6363 0.0 0
M  V30 14 C 5.4957 1.4783 0.0 0
M  V30 15 C 7.7722 2.4918 0.0 0 CFG=2
M  V30 16 C 7.0022 1.1581 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 15 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[2-[[(1S,2R)-2-hydroxy-3-[[(4-methoxyphenyl)s...
C32H47N3O7S
2925287-32-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.6201 8.0022 0.0 0 VAL=6
M  V30 2 N 5.3901 6.6685 0.0 0
M  V30 3 O 5.9538 8.7722 0.0 0
M  V30 4 O 3.2864 7.2322 0.0 0
M  V30 5 C 6.9302 6.6685 0.0 0
M  V30 6 C 4.6201 5.3348 0.0 0
M  V30 7 C 7.7002 5.3348 0.0 0 CFG=1
M  V30 8 C 3.0801 5.3348 0.0 0
M  V30 9 C 9.2402 5.3348 0.0 0 CFG=1
M  V30 10 O 6.9302 4.0010 0.0 0
M  V30 11 C 2.3101 6.6685 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 13 C 10.0102 4.0010 0.0 0
M  V30 14 N 10.0102 6.6685 0.0 0
M  V30 15 C 11.5503 6.6685 0.0 0
M  V30 16 C 12.3203 8.0022 0.0 0
M  V30 17 O 12.3203 5.3348 0.0 0
M  V30 18 O 1.5400 13.3370 0.0 0
M  V30 19 C 0.0000 13.3370 0.0 0
M  V30 20 C 17.4760 9.6774 0.0 0
M  V30 21 O 18.8830 9.0511 0.0 0
M  V30 22 O 17.3151 11.2090 0.0 0
M  V30 23 C 20.1289 9.9563 0.0 0
M  V30 24 C 21.0341 8.7103 0.0 0
M  V30 25 C 21.3747 10.8614 0.0 0
M  V30 26 C 19.2236 11.2022 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 2.3101 9.3360 0.0 0
M  V30 29 C 4.6201 10.6697 0.0 0
M  V30 30 C 1.5400 10.6697 0.0 0
M  V30 31 C 3.8501 12.0033 0.0 0
M  V30 32 C 2.3101 12.0033 0.0 0
M  V30 33 C 9.2402 2.6673 0.0 0
M  V30 34 C 7.7002 2.6673 0.0 0
M  V30 35 C 10.0102 1.3337 0.0 0
M  V30 36 C 6.9302 1.3337 0.0 0
M  V30 37 C 9.2402 0.0000 0.0 0
M  V30 38 C 7.7002 0.0000 0.0 0
M  V30 39 C 13.8603 8.0022 0.0 0 CFG=2
M  V30 40 C 14.7655 9.2481 0.0 0
M  V30 41 C 14.7655 6.7563 0.0 0
M  V30 42 N 16.2301 8.7722 0.0 0
M  V30 43 C 16.2301 7.2322 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 27
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=1
M  V30 14 1 9 14
M  V30 15 1 13 33
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 39 16 CFG=1
M  V30 20 1 18 19
M  V30 21 1 18 32
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 20 42
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 41 1 39 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 9 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 204688-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925287-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36491262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel HIV-1 protease
inhibitors containing pyrrolidine-derived P2 ligands to combat
drug-resistant variant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Huiyu; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning; Wang,
Minghua; Cen, Shan; Zhu, Mei; Shan, Qi; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 255115389

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
N-[2-Amino-4-(1,1-dimethylethyl)phenyl]acetamide
C12H18N2O
342045-14-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6674 0.0 0
M  V30 2 C 1.5400 1.1274 0.0 0
M  V30 3 C 0.0000 2.6674 0.0 0
M  V30 4 C 1.5400 4.2074 0.0 0
M  V30 5 N 6.1600 0.0000 0.0 0
M  V30 6 N 7.7000 2.6674 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 O 7.7000 5.3349 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 5.3900 1.3338 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4-carboxylic acid, 1-(2,5-dimethoxyphenyl)-5-methyl-
C12H13N3O4
1267548-16-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3337 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 C 6.5894 6.7117 0.0 0
M  V30 4 O 1.5400 6.6684 0.0 0
M  V30 5 C 0.0000 6.6684 0.0 0
M  V30 6 C 9.7759 5.6763 0.0 0
M  V30 7 O 11.1827 5.0499 0.0 0
M  V30 8 O 9.6148 7.2079 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6675 0.0 0
M  V30 11 C 3.8500 5.3348 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0
M  V30 13 C 2.3100 5.3348 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 15 N 6.1601 4.0011 0.0 0
M  V30 16 C 7.0653 5.2470 0.0 0
M  V30 17 N 7.0653 2.7552 0.0 0
M  V30 18 C 8.5298 4.7711 0.0 0
M  V30 19 N 8.5298 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(Acetylamino)-5-(1,1-dimethylethyl)phenyl]-1-(2,5-dimethoxyphenyl)-5-met...
C24H29N5O4
2883814-35-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.2500 9.1699 0.0 0
M  V30 2 C 13.1550 10.4158 0.0 0
M  V30 3 C 9.7292 4.0273 0.0 0
M  V30 4 O 14.7554 3.5424 0.0 0
M  V30 5 C 16.2870 3.3814 0.0 0
M  V30 6 C 6.6684 5.3901 0.0 0
M  V30 7 N 5.3348 6.1601 0.0 0
M  V30 8 O 6.6684 3.8501 0.0 0
M  V30 9 N 2.6673 7.7001 0.0 0
M  V30 10 C 1.3337 8.4701 0.0 0
M  V30 11 C 0.0000 7.7001 0.0 0
M  V30 12 O 1.3337 10.0101 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 1.1273 1.5400 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 4.2073 1.5400 0.0 0
M  V30 17 C 11.9711 6.5172 0.0 0
M  V30 18 C 12.8763 7.7631 0.0 0
M  V30 19 C 12.5975 5.1103 0.0 0
M  V30 20 C 14.4078 7.6020 0.0 0
M  V30 21 C 14.1291 4.9493 0.0 0
M  V30 22 C 15.0343 6.1952 0.0 0
M  V30 23 N 10.4395 6.6782 0.0 0
M  V30 24 C 9.4091 5.5336 0.0 0
M  V30 25 N 9.6695 8.0118 0.0 0
M  V30 26 C 8.0021 6.1601 0.0 0
M  V30 27 N 8.1630 7.6916 0.0 0
M  V30 28 C 4.0010 5.3901 0.0 0
M  V30 29 C 2.6673 6.1601 0.0 0
M  V30 30 C 4.0010 3.8501 0.0 0
M  V30 31 C 1.3337 5.3901 0.0 0
M  V30 32 C 2.6673 3.0800 0.0 0
M  V30 33 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 24
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 7 28
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 32
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 342045-14-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1267548-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2883814-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39011906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel,
Potent, and Selective Inverse Agonists and Antagonists of PXR
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yongtao; Lin, Wenwei; Chai, Sergio C.; Wu, Jing; Annu, Kavya; Chen,
Taosheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(24), 16829-16859

$RFMT $RIREG SCHEME197 STEP1
$RXN



  1  1
$MOL
2-[(1S)-1-[[(2R)-6-Amino-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxohexyl]a...
C19H32N4O5S
2452190-20-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 9.3358 0.0 0 CFG=2
M  V30 2 N 8.4702 8.0022 0.0 0
M  V30 3 C 8.4702 10.6697 0.0 0
M  V30 4 C 6.9302 8.0022 0.0 0
M  V30 5 C 9.2402 12.0033 0.0 0
M  V30 6 C 6.9302 10.6697 0.0 0
M  V30 7 C 6.1601 6.6685 0.0 0 CFG=1
M  V30 8 O 6.1601 9.3358 0.0 0
M  V30 9 N 6.9302 5.3348 0.0 0
M  V30 10 C 4.6201 6.6685 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 3.8501 8.0022 0.0 0
M  V30 13 O 6.9302 2.6673 0.0 0
M  V30 14 O 4.6201 4.0010 0.0 0
M  V30 15 C 2.3101 8.0022 0.0 0
M  V30 16 C 6.1601 1.3337 0.0 0
M  V30 17 C 1.5400 9.3358 0.0 0
M  V30 18 C 7.4938 0.5637 0.0 0
M  V30 19 C 5.3901 0.0000 0.0 0
M  V30 20 C 4.8265 2.1037 0.0 0
M  V30 21 N 0.0000 9.3358 0.0 0
M  V30 22 C 14.3961 11.0111 0.0 0
M  V30 23 O 14.2350 12.5427 0.0 0
M  V30 24 O 15.8029 10.3848 0.0 0
M  V30 25 C 10.7802 9.3358 0.0 0
M  V30 26 N 11.6855 10.5819 0.0 0
M  V30 27 S 11.6855 8.0900 0.0 0
M  V30 28 C 13.1500 10.1059 0.0 0
M  V30 29 C 13.1500 8.5658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 1 22 28
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C19H30N4O4S
2452190-21-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0165 7.8671 0.0 0
M  V30 2 C 4.2794 8.7483 0.0 0
M  V30 3 C 1.6218 8.5202 0.0 0
M  V30 4 O 5.9140 7.7431 0.0 0
M  V30 5 O 1.2443 0.0000 0.0 0
M  V30 6 N 8.4666 6.1737 0.0 0
M  V30 7 C 9.8003 5.4037 0.0 0
M  V30 8 O 11.1340 6.1737 0.0 0
M  V30 9 O 9.8003 3.8636 0.0 0
M  V30 10 C 12.4677 5.4037 0.0 0
M  V30 11 C 13.2377 6.7373 0.0 0
M  V30 12 C 13.8015 4.6337 0.0 0
M  V30 13 C 11.6976 4.0700 0.0 0
M  V30 14 C 1.9043 5.2914 0.0 0
M  V30 15 C 3.1481 6.3326 0.0 0 CFG=2
M  V30 16 N 2.4580 3.8573 0.0 0
M  V30 17 S 0.3728 5.1633 0.0 0
M  V30 18 N 4.4889 5.5547 0.0 0
M  V30 19 C 1.2824 2.8411 0.0 0
M  V30 20 C 0.0000 3.6842 0.0 0
M  V30 21 C 5.8347 6.2051 0.0 0
M  V30 22 C 1.9890 1.3481 0.0 0
M  V30 23 C 7.1328 5.4037 0.0 0 CFG=2
M  V30 24 N 3.4735 1.5266 0.0 0
M  V30 25 C 7.1775 3.8921 0.0 0
M  V30 26 C 4.6714 0.7080 0.0 0
M  V30 27 C 5.9533 3.0095 0.0 0
M  V30 28 C 6.0714 1.4653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 2 4 21
M  V30 5 2 5 22
M  V30 6 1 6 7
M  V30 7 1 23 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 19 20
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2452190-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2452190-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23663728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Automated design of macrocycles for therapeutic applications: From small
molecules to peptides and proteins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sindhikara, Dan; Wagner, Michael; Gkeka, Paraskevi; Gussregen, Stefan;
Tiwari, Garima; Hessler, Gerhard; Yapici, Engin; Li, Ziyu; Evers, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(20), 12100-12115

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Glycine, N-[(3-amino-6-chloro-2-pyrazinyl)carbonyl]-
C7H7ClN4O3
3042822-32-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 5.3347 3.8500 0.0 0
M  V30 3 O 4.0011 6.1600 0.0 0
M  V30 4 C 6.6684 4.6200 0.0 0
M  V30 5 C 8.0021 3.8500 0.0 0
M  V30 6 O 9.3358 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 N 1.3336 6.1600 0.0 0
M  V30 9 Cl 1.3336 0.0000 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 N 2.6674 2.3100 0.0 0
M  V30 13 N 0.0000 3.8500 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 11
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2-[4-amino-3-(ethylamino)phenoxy]-, 1-methylethyl ester, hydroch...
C13H20N2O3.ClH
3042822-36-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.8501 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 C 9.3360 3.8501 0.0 0
M  V30 4 O 10.6697 4.6201 0.0 0
M  V30 5 O 9.3360 2.3100 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 12.0033 2.3100 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 1.3337 3.8501 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 N 1.3337 6.9301 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 4.0010 6.9301 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 Cl 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2-[4-[[2-[[(3-amino-6-chloro-2-pyrazinyl)carbonyl]amino]acetyl]a...
C20H25ClN6O5
3042822-38-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 2.6673 0.0 0
M  V30 2 C 10.0102 1.3337 0.0 0
M  V30 3 C 9.2402 0.0000 0.0 0
M  V30 4 N 7.7002 5.3348 0.0 0
M  V30 5 C 6.9302 6.6685 0.0 0
M  V30 6 C 5.3901 6.6685 0.0 0
M  V30 7 O 7.7002 8.0022 0.0 0
M  V30 8 N 4.6201 8.0022 0.0 0
M  V30 9 C 3.0801 8.0022 0.0 0
M  V30 10 O 2.3101 6.6685 0.0 0
M  V30 11 O 13.8603 5.3348 0.0 0
M  V30 12 C 14.6303 6.6685 0.0 0
M  V30 13 C 16.1704 6.6685 0.0 0
M  V30 14 O 16.9404 8.0022 0.0 0
M  V30 15 O 16.9404 5.3348 0.0 0
M  V30 16 C 18.4804 8.0022 0.0 0
M  V30 17 C 19.2504 6.6685 0.0 0
M  V30 18 C 19.2504 9.3360 0.0 0
M  V30 19 N 0.0000 8.0022 0.0 0
M  V30 20 Cl 3.0801 13.3370 0.0 0
M  V30 21 C 10.0102 4.0010 0.0 0
M  V30 22 C 9.2402 5.3348 0.0 0
M  V30 23 C 11.5503 4.0010 0.0 0
M  V30 24 C 10.0102 6.6685 0.0 0
M  V30 25 C 12.3203 5.3348 0.0 0
M  V30 26 C 11.5503 6.6685 0.0 0
M  V30 27 C 2.3101 9.3360 0.0 0
M  V30 28 C 0.7700 9.3360 0.0 0
M  V30 29 N 3.0801 10.6697 0.0 0
M  V30 30 N 0.0000 10.6697 0.0 0
M  V30 31 C 2.3101 12.0033 0.0 0
M  V30 32 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 27
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 19 28
M  V30 21 1 20 31
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3042822-32-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3042822-36-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3042822-38-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39099375
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and development of BI 1265162, an ENaC inhibitor for the
treatment of cystic fibrosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Betzemeier, Bodo; Braun, Clemens; Sieger, Peter; Heckel, Armin; Linz,
Guenter; Linehan, Brian; Veser, Thomas; Wiedenmayer, Dieter; Kley, Joerg
T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 265116038

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
L-Phenylalanine, methyl ester, hydrochloride
C10H13NO2.ClH
7524-50-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 5.3347 5.3900 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 O 6.6684 1.5400 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 Cl 4.6679 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2-Nitrophenyl)sulfonyl]-L-tryptophan
C17H15N3O6S
866187-04-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 4.0011 0.0 0
M  V30 2 C 5.8243 2.6674 0.0 0 CFG=1
M  V30 3 N 7.3643 2.6674 0.0 0
M  V30 4 C 5.0543 1.3336 0.0 0
M  V30 5 S 8.1343 4.0011 0.0 0 VAL=6
M  V30 6 O 3.5143 1.3336 0.0 0
M  V30 7 O 5.8243 0.0000 0.0 0
M  V30 8 O 6.8007 4.7711 0.0 0
M  V30 9 O 9.4680 3.2311 0.0 0
M  V30 10 N 11.2143 4.0011 0.0 0 VAL=5
M  V30 11 O 10.4443 2.6674 0.0 0
M  V30 12 O 12.7543 4.0011 0.0 0
M  V30 13 C 3.5143 4.0011 0.0 0
M  V30 14 C 2.6091 5.2470 0.0 0
M  V30 15 C 2.6091 2.7552 0.0 0
M  V30 16 C 1.1445 4.7711 0.0 0
M  V30 17 C 2.9292 6.7534 0.0 0
M  V30 18 N 1.1445 3.2311 0.0 0
M  V30 19 C 0.0000 5.8015 0.0 0
M  V30 20 C 1.7849 7.7838 0.0 0
M  V30 21 C 0.3202 7.3080 0.0 0
M  V30 22 C 8.9043 5.3347 0.0 0
M  V30 23 C 10.4443 5.3347 0.0 0
M  V30 24 C 8.1343 6.6685 0.0 0
M  V30 25 C 11.2143 6.6685 0.0 0
M  V30 26 C 8.9043 8.0022 0.0 0
M  V30 27 C 10.4443 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 2 5 9
M  V30 10 1 5 22
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 23
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H26N4O7S
3052255-81-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 7.7002 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0 CFG=1
M  V30 3 N 8.0022 5.3901 0.0 0
M  V30 4 C 6.6685 7.7002 0.0 0
M  V30 5 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 6 N 6.6685 9.2402 0.0 0
M  V30 7 O 5.3348 6.9302 0.0 0
M  V30 8 O 5.8985 5.9538 0.0 0
M  V30 9 O 7.4385 3.2864 0.0 0
M  V30 10 C 5.3348 10.0102 0.0 0 CFG=2
M  V30 11 C 4.0012 9.2402 0.0 0
M  V30 12 C 5.3348 11.5503 0.0 0
M  V30 13 O 6.6685 12.3203 0.0 0
M  V30 14 O 4.0012 12.3203 0.0 0
M  V30 15 C 6.6685 13.8603 0.0 0
M  V30 16 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 17 O 6.6685 0.0000 0.0 0
M  V30 18 O 8.0022 2.3101 0.0 0
M  V30 19 C 12.0765 7.5565 0.0 0
M  V30 20 C 10.6697 6.9302 0.0 0
M  V30 21 C 13.1071 6.4121 0.0 0
M  V30 22 C 12.5524 9.0212 0.0 0
M  V30 23 C 10.8306 5.3986 0.0 0
M  V30 24 N 12.3371 5.0784 0.0 0
M  V30 25 C 14.6134 6.7323 0.0 0
M  V30 26 C 14.0588 9.3414 0.0 0
M  V30 27 C 15.0893 8.1970 0.0 0
M  V30 28 C 5.3348 3.8501 0.0 0
M  V30 29 C 5.3348 2.3101 0.0 0
M  V30 30 C 4.0012 4.6201 0.0 0
M  V30 31 C 4.0012 1.5400 0.0 0
M  V30 32 C 2.6673 3.8501 0.0 0
M  V30 33 C 2.6673 2.3101 0.0 0
M  V30 34 C 2.6673 10.0102 0.0 0
M  V30 35 C 1.3337 9.2402 0.0 0
M  V30 36 C 2.6673 11.5503 0.0 0
M  V30 37 C 0.0000 10.0102 0.0 0
M  V30 38 C 1.3337 12.3203 0.0 0
M  V30 39 C 0.0000 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 2 5 9
M  V30 10 1 5 28
M  V30 11 1 6 10
M  V30 12 1 10 11 CFG=1
M  V30 13 1 10 12
M  V30 14 1 11 34
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 2 16 18
M  V30 20 1 16 29
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 24
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7524-50-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866187-04-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052255-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37215001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel PEX5-PEX14 protein-protein interaction (PPI)
inhibitors based on an oxopiperazine template
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marciniak, Monika; Mroz, Piotr; Napolitano, Valeria; Kalel, Vishal C.;
Fino, Roberto; Pykacz, Emilia; Schliebs, Wolfgang; Plettenburg, Oliver;
Erdmann, Ralf; Sattler, Michael; Popowicz, Grzegorz M.; Dawidowski,
Maciej
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 258115587

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
2-Amino-2-methyl-1-propanol
C4H11NO
124-68-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 C 2.1037 0.0000 0.0 0
M  V30 4 C 0.0000 0.5637 0.0 0
M  V30 5 N 0.5637 2.6673 0.0 0
M  V30 6 O 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 2-[(3R)-3-[(3-ethoxy-2-pyridinyl)oxy]-1-piperidi...
C17H20N4O4
3034673-70-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.8501 0.0 0
M  V30 2 C 13.3370 1.5400 0.0 0
M  V30 3 O 14.6707 2.3101 0.0 0
M  V30 4 O 13.3370 0.0000 0.0 0
M  V30 5 O 1.3337 2.3101 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 9.3358 3.8501 0.0 0
M  V30 9 N 9.3358 2.3101 0.0 0
M  V30 10 N 10.6697 4.6201 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 12.0033 3.8501 0.0 0
M  V30 13 C 12.0033 2.3101 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 8.0022 6.1601 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0 CFG=2
M  V30 18 C 6.6685 6.9302 0.0 0
M  V30 19 C 5.3348 6.1601 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 1.3337 3.8501 0.0 0
M  V30 22 N 2.6673 6.1601 0.0 0
M  V30 23 C 0.0000 4.6201 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 25 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 14
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxamide, 2-[(3R)-3-[(3-ethoxy-2-pyridinyl)oxy]-1-piperidinyl]...
C21H29N5O4
3034673-71-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.0800 0.0 0
M  V30 2 C 13.3369 5.3900 0.0 0
M  V30 3 N 14.6705 4.6200 0.0 0
M  V30 4 O 13.3369 6.9300 0.0 0
M  V30 5 C 16.0043 5.3900 0.0 0
M  V30 6 C 16.7743 4.0564 0.0 0
M  V30 7 C 17.3379 6.1600 0.0 0
M  V30 8 C 15.2343 6.7236 0.0 0
M  V30 9 O 18.3143 4.0564 0.0 0
M  V30 10 O 1.3338 4.6200 0.0 0
M  V30 11 C 0.0000 5.3900 0.0 0
M  V30 12 C 0.0000 6.9300 0.0 0
M  V30 13 N 8.0021 2.3100 0.0 0
M  V30 14 C 6.6685 3.0800 0.0 0
M  V30 15 C 8.0021 0.7700 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 9.3358 3.0800 0.0 0
M  V30 20 N 9.3358 4.6200 0.0 0
M  V30 21 N 10.6696 2.3100 0.0 0
M  V30 22 C 10.6696 5.3900 0.0 0
M  V30 23 C 12.0032 3.0800 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0
M  V30 25 C 2.6674 2.3100 0.0 0
M  V30 26 C 1.3338 3.0800 0.0 0
M  V30 27 N 2.6674 0.7700 0.0 0
M  V30 28 C 0.0000 2.3100 0.0 0
M  V30 29 C 1.3338 0.0000 0.0 0
M  V30 30 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 24
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 124-68-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3034673-70-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3034673-71-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34698514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor
of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic
Steatohepatitis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Futatsugi, Kentaro; Cabral, Shawn; Kung, Daniel W.; Huard, Kim; Lee,
Esther; Boehm, Markus; Bauman, Jonathan; Clark, Ronald W.; Coffey, Steven
B.; Crowley, Collin; Dechert-Schmitt, Anne-Marie; Dowling, Matthew S.;
Dullea, Robert; Gosset, James R.; Kalgutkar, Amit S.; Kou, Kou; Li,
Qifang; Lian, Yajing; Loria, Paula M.; Londregan, Allyn T.; Niosi, Mark;
Orozco, Christine; Pettersen, John C.; Pfefferkorn, Jeffrey A.;
Polivkova, Jana; Ross, Trenton T.; Sharma, Raman; Stock, Ingrid A.; Tesz,
Gregory; Wisniewska, Hanna; Goodwin, Bryan; Price, David A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(22), 15000-15013

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Diphenylacetic acid
C14H12O2
117-34-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 4.0011 0.7700 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 14 C 6.6685 5.3900 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H26IN3O5.C2HF3O2
3026371-24-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.9404 7.8511 0.0 0
M  V30 2 O 18.4804 7.8511 0.0 0
M  V30 3 O 16.1704 6.5174 0.0 0
M  V30 4 C 19.2504 6.5174 0.0 0
M  V30 5 C 20.7905 6.5174 0.0 0
M  V30 6 C 21.5605 5.1837 0.0 0
M  V30 7 C 12.3203 10.5186 0.0 0
M  V30 8 O 11.5503 11.8522 0.0 0
M  V30 9 C 10.0102 11.8522 0.0 0
M  V30 10 C 9.2402 13.1860 0.0 0 CFG=1
M  V30 11 N 7.7002 13.1860 0.0 0
M  V30 12 C 10.0102 14.5197 0.0 0
M  V30 13 C 6.9302 11.8522 0.0 0
M  V30 14 N 9.2402 15.8534 0.0 0
M  V30 15 O 11.5503 14.5197 0.0 0
M  V30 16 C 5.3901 11.8522 0.0 0 CFG=1
M  V30 17 O 7.7002 10.5186 0.0 0
M  V30 18 C 4.6201 10.5186 0.0 0
M  V30 19 N 4.6201 13.1860 0.0 0
M  V30 20 I 0.0000 7.8512 0.0 0
M  V30 21 C 16.1704 9.1849 0.0 0
M  V30 22 C 14.6303 9.1849 0.0 0
M  V30 23 C 16.9404 10.5186 0.0 0
M  V30 24 C 13.8603 10.5186 0.0 0
M  V30 25 C 16.1704 11.8522 0.0 0
M  V30 26 C 14.6303 11.8522 0.0 0
M  V30 27 C 3.0801 10.5186 0.0 0
M  V30 28 C 2.3101 9.1849 0.0 0
M  V30 29 C 2.3101 11.8522 0.0 0
M  V30 30 C 0.7700 9.1849 0.0 0
M  V30 31 C 0.7700 11.8522 0.0 0
M  V30 32 C 0.0000 10.5186 0.0 0
M  V30 33 C 10.1134 2.3101 0.0 0
M  V30 34 C 11.4471 1.5400 0.0 0
M  V30 35 F 10.8834 3.6437 0.0 0
M  V30 36 F 8.7797 3.0801 0.0 0
M  V30 37 F 9.3434 0.9764 0.0 0
M  V30 38 O 12.7807 2.3101 0.0 0
M  V30 39 O 11.4471 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 18 27
M  V30 21 1 20 30
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 33 36
M  V30 37 1 33 37
M  V30 38 1 34 38
M  V30 39 2 34 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C37H36IN3O6
3026370-37-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9301 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 N 6.6684 6.9301 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 8.0021 6.1601 0.0 0 CFG=2
M  V30 6 C 8.0021 4.6201 0.0 0
M  V30 7 C 9.3357 6.9301 0.0 0
M  V30 8 N 9.3357 8.4701 0.0 0
M  V30 9 O 10.6695 6.1601 0.0 0
M  V30 10 C 10.6695 9.2401 0.0 0 CFG=2
M  V30 11 C 12.0032 8.4701 0.0 0
M  V30 12 C 10.6695 10.7801 0.0 0
M  V30 13 O 13.3369 9.2401 0.0 0
M  V30 14 N 12.0032 11.5501 0.0 0
M  V30 15 O 9.3357 11.5501 0.0 0
M  V30 16 C 14.6705 8.4701 0.0 0
M  V30 17 I 10.6695 0.0000 0.0 0
M  V30 18 C 20.0053 8.4701 0.0 0
M  V30 19 O 21.3391 9.2401 0.0 0
M  V30 20 O 20.0053 6.9301 0.0 0
M  V30 21 C 22.6727 8.4701 0.0 0
M  V30 22 C 24.0064 9.2401 0.0 0
M  V30 23 C 25.3401 8.4701 0.0 0
M  V30 24 C 2.6673 6.1601 0.0 0
M  V30 25 C 1.3337 6.9301 0.0 0
M  V30 26 C 2.6673 4.6201 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 1.3337 3.8500 0.0 0
M  V30 29 C 0.0000 4.6201 0.0 0
M  V30 30 C 4.0010 8.4701 0.0 0
M  V30 31 C 5.3348 9.2401 0.0 0
M  V30 32 C 2.6673 9.2401 0.0 0
M  V30 33 C 5.3348 10.7801 0.0 0
M  V30 34 C 2.6673 10.7801 0.0 0
M  V30 35 C 4.0010 11.5501 0.0 0
M  V30 36 C 9.3357 3.8500 0.0 0
M  V30 37 C 9.3357 2.3100 0.0 0
M  V30 38 C 10.6695 4.6201 0.0 0
M  V30 39 C 10.6695 1.5400 0.0 0
M  V30 40 C 12.0032 3.8500 0.0 0
M  V30 41 C 12.0032 2.3100 0.0 0
M  V30 42 C 16.0043 9.2401 0.0 0
M  V30 43 C 17.3380 8.4701 0.0 0
M  V30 44 C 16.0043 10.7801 0.0 0
M  V30 45 C 18.6716 9.2401 0.0 0
M  V30 46 C 17.3380 11.5501 0.0 0
M  V30 47 C 18.6716 10.7801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 1 30
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6 CFG=3
M  V30 8 1 5 7
M  V30 9 1 6 36
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 10 11 CFG=3
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 16 42
M  V30 20 1 17 39
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 45
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 45 2 42 43
M  V30 46 1 42 44
M  V30 47 1 43 45
M  V30 48 2 44 46
M  V30 49 2 45 47
M  V30 50 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 117-34-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026371-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026370-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40676296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dipeptide-derived alkynes as potent and selective irreversible inhibitors
of cysteine cathepsins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Behring, Lydia; Ruiz-Gomez, Gloria; Trapp, Christian; Morales, Maryann;
Wodtke, Robert; Koeckerling, Martin; Kopka, Klaus; Pisabarro, M. Teresa;
Pietzsch, Jens; Loeser, Reik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 3818-3851

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 4-(4-aminophenoxy)-1-piperidinecarboxylate
C16H24N2O3
138227-63-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 4.6201 0.0 0
M  V30 2 C 4.0010 1.5400 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 0.5637 2.8737 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 N 14.6707 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 12.0033 4.6201 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 19 C 13.3370 3.8501 0.0 0
M  V30 20 C 12.0033 1.5400 0.0 0
M  V30 21 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
cis-(αR)-4-(6-Fluoro-4-quinolinyl)-α-methylcyclohexaneacetic acid
C18H20FNO2
1923836-34-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 1.3336 6.9300 0.0 0
M  V30 2 C 9.5187 4.3525 0.0 0 CFG=1
M  V30 3 C 10.5087 5.5323 0.0 0
M  V30 4 C 10.0454 2.9054 0.0 0
M  V30 5 O 12.0252 5.2648 0.0 0
M  V30 6 O 9.9820 6.9793 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 N 1.3336 0.7700 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 1.3336 5.3900 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 17 C 5.3347 3.0800 0.0 0 CFG=2
M  V30 18 C 5.3347 4.6200 0.0 0
M  V30 19 C 6.6684 2.3100 0.0 0
M  V30 20 C 6.6684 5.3900 0.0 0
M  V30 21 C 8.0021 3.0800 0.0 0
M  V30 22 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 23 H 8.5288 6.0670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 17 7 CFG=1
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 22 23 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[4-[[(2R)-2-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]-1-o...
C34H42FN3O4
2872618-08-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.5701 0.0000 0.0 0
M  V30 2 C 9.3798 5.2214 0.0 0 CFG=1
M  V30 3 C 10.7136 4.4514 0.0 0
M  V30 4 C 9.3798 6.7614 0.0 0
M  V30 5 N 12.0473 5.2214 0.0 0
M  V30 6 O 10.7136 2.9114 0.0 0
M  V30 7 O 17.3820 2.1414 0.0 0
M  V30 8 C 22.7167 5.2214 0.0 0
M  V30 9 O 24.0503 4.4514 0.0 0
M  V30 10 O 22.7167 6.7614 0.0 0
M  V30 11 C 25.3841 5.2214 0.0 0
M  V30 12 C 26.1541 3.8877 0.0 0
M  V30 13 C 26.7178 5.9914 0.0 0
M  V30 14 C 24.6141 6.5550 0.0 0
M  V30 15 C 2.5065 4.0739 0.0 0
M  V30 16 C 3.4964 5.2537 0.0 0
M  V30 17 C 0.9899 4.3414 0.0 0
M  V30 18 C 3.0332 2.6268 0.0 0
M  V30 19 C 2.9697 6.7008 0.0 0
M  V30 20 N 0.4632 5.7886 0.0 0
M  V30 21 C 0.0000 3.1616 0.0 0
M  V30 22 C 2.0433 1.4471 0.0 0
M  V30 23 C 1.4531 6.9682 0.0 0
M  V30 24 C 0.5267 1.7145 0.0 0
M  V30 25 C 5.0130 4.9862 0.0 0 CFG=2
M  V30 26 C 5.5397 3.5391 0.0 0
M  V30 27 C 6.0029 6.1660 0.0 0
M  V30 28 C 7.0563 3.2717 0.0 0
M  V30 29 C 7.5195 5.8985 0.0 0
M  V30 30 C 8.0462 4.4514 0.0 0 CFG=1
M  V30 31 C 13.3809 4.4514 0.0 0
M  V30 32 C 14.7147 5.2214 0.0 0
M  V30 33 C 13.3809 2.9114 0.0 0
M  V30 34 C 16.0483 4.4514 0.0 0
M  V30 35 C 14.7147 2.1414 0.0 0
M  V30 36 C 16.0483 2.9114 0.0 0
M  V30 37 C 18.7156 2.9114 0.0 0
M  V30 38 C 18.7156 4.4514 0.0 0
M  V30 39 C 20.0494 2.1414 0.0 0
M  V30 40 C 20.0494 5.2214 0.0 0
M  V30 41 C 21.3831 2.9114 0.0 0
M  V30 42 N 21.3831 4.4514 0.0 0
M  V30 43 H 9.0361 3.2717 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 30
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 31
M  V30 8 1 7 36
M  V30 9 1 7 37
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 42
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 25 16 CFG=3
M  V30 22 1 17 20
M  V30 23 1 17 21
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 2 20 23
M  V30 27 2 21 24
M  V30 28 1 22 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 30 43 CFG=1
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 1 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 25 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 138227-63-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1923836-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2872618-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35008196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Characterization of a Novel Indoleamine
2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bollu, Lakshmi R.; Bommi, Prashant V.; Monsen, Paige J.; Zhai, Lijie;
Lauing, Kristen L.; Bell, April; Kim, Miri; Ladomersky, Erik; Yang,
Xinyu; Platanias, Leonidas C.; Matei, Daniela E.; Bonini, Marcelo G.;
Munshi, Hidayatullah G.; Hashizume, Rintaro; Wu, Jennifer D.; Zhang, Bin;
James, Charles David; Chen, Peiwen; Kocherginsky, Masha; Horbinski,
Craig; Cameron, Michael D.; Grigorescu, Arabela A.; Yamini, Bakhtiar;
Lukas, Rimas V.; Schiltz, Gary E.; Wainwright, Derek A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(23), 15642-15662

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
(2R)-2-Methyl-3-butenoic acid
C5H8O2
20626-49-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[4-[4-amino-1-(difluoromethyl)-1H-pyrazol-5-yl]-2...
C18H23F2N5O2
1802431-20-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.6850 0.0 0
M  V30 2 F 0.0000 6.0051 0.0 0
M  V30 3 F 1.9823 4.2204 0.0 0
M  V30 4 N 6.2012 8.3955 0.0 0
M  V30 5 C 8.6884 4.0011 0.0 0 CFG=2
M  V30 6 N 9.4584 5.3348 0.0 0
M  V30 7 C 9.4584 2.6673 0.0 0
M  V30 8 C 10.9985 5.3348 0.0 0
M  V30 9 C 8.6884 1.3336 0.0 0
M  V30 10 O 11.7685 6.6684 0.0 0
M  V30 11 O 11.7685 4.0011 0.0 0
M  V30 12 C 9.4584 0.0000 0.0 0
M  V30 13 C 13.3085 6.6684 0.0 0
M  V30 14 C 13.3085 5.1284 0.0 0
M  V30 15 C 14.8485 6.6684 0.0 0
M  V30 16 C 13.3085 8.2084 0.0 0
M  V30 17 C 4.0684 6.6684 0.0 0
M  V30 18 N 2.5369 6.8295 0.0 0
M  V30 19 C 4.6947 8.0754 0.0 0
M  V30 20 N 2.2167 8.3358 0.0 0
M  V30 21 C 3.5503 9.1058 0.0 0
M  V30 22 C 4.8384 5.3348 0.0 0
M  V30 23 C 6.3784 5.3348 0.0 0
M  V30 24 C 4.0684 4.0011 0.0 0
M  V30 25 C 7.1484 4.0011 0.0 0
M  V30 26 C 4.8384 2.6673 0.0 0
M  V30 27 N 6.3784 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 25
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 22
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[4-[1-(difluoromethyl)-4-[[(2R)-2-methyl-1-oxo-3-...
C23H29F2N5O3
1802431-21-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 13.3419 5.8913 0.0 0
M  V30 2 C 14.8484 6.2114 0.0 0
M  V30 3 C 15.8788 5.0669 0.0 0 CFG=2
M  V30 4 O 15.3242 7.6760 0.0 0
M  V30 5 C 17.3852 5.3872 0.0 0
M  V30 6 C 15.4029 3.6024 0.0 0
M  V30 7 C 18.4156 4.2427 0.0 0
M  V30 8 C 8.6473 8.6018 0.0 0
M  V30 9 F 8.1714 10.0664 0.0 0
M  V30 10 F 7.6168 7.4573 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0 CFG=2
M  V30 12 N 5.3900 2.8736 0.0 0
M  V30 13 C 5.3900 5.5411 0.0 0
M  V30 14 C 3.8500 2.8736 0.0 0
M  V30 15 C 3.8500 5.5411 0.0 0
M  V30 16 O 3.0800 1.5400 0.0 0
M  V30 17 O 3.0800 4.2073 0.0 0
M  V30 18 C 3.0800 6.8747 0.0 0
M  V30 19 C 1.5400 1.5400 0.0 0
M  V30 20 C 1.5400 3.0800 0.0 0
M  V30 21 C 0.0000 1.5400 0.0 0
M  V30 22 C 1.5400 0.0000 0.0 0
M  V30 23 C 10.7800 6.8747 0.0 0
M  V30 24 C 12.3115 7.0356 0.0 0
M  V30 25 N 10.1537 8.2815 0.0 0
M  V30 26 C 12.6317 8.5421 0.0 0
M  V30 27 N 11.2981 9.3121 0.0 0
M  V30 28 C 10.0100 5.5411 0.0 0
M  V30 29 C 8.4700 5.5411 0.0 0
M  V30 30 C 10.7800 4.2073 0.0 0
M  V30 31 C 7.7000 4.2073 0.0 0
M  V30 32 C 10.0100 2.8736 0.0 0
M  V30 33 N 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=1
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 25
M  V30 11 1 11 12
M  V30 12 1 11 13 CFG=1
M  V30 13 1 11 31
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 23 28
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 29 1 28 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20626-49-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1802431-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802431-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34334401
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of
Factor XIa in Clinical Studies for Antithrombotic Therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dilger, Andrew K.; Pabbisetty, Kumar B.; Corte, James R.; De Lucca,
Indawati; Fang, Tianan; Yang, Wu; Pinto, Donald J. P.; Wang, Yufeng; Zhu,
Yeheng; Mathur, Arvind; Li, Jianqing; Hou, Xiaoping; Smith, Daniel; Sun,
Dawn; Zhang, Huiping; Krishnananthan, Subramaniam; Wu, Dauh-Rurng; Myers,
Joseph E. Jr.; Sheriff, Steven; Rossi, Karen A.; Chacko, Silvi; Zheng,
Joanna J.; Galella, Michael A.; Ziemba, Theresa; Dierks, Elizabeth A.;
Bozarth, Jeffrey M.; Wu, Yiming; Crain, Earl; Wong, Pancras C.; Luettgen,
Joseph M.; Wexler, Ruth R.; Ewing, William R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(3), 1770-1785

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Isobutylamine
C4H11N
78-81-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C35H41N3O7
2364482-32-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 9.2401 0.0 0
M  V30 2 O 12.0034 10.0101 0.0 0
M  V30 3 C 10.6695 9.2401 0.0 0
M  V30 4 N 9.3359 10.0101 0.0 0
M  V30 5 O 10.6695 7.7001 0.0 0
M  V30 6 C 8.0022 9.2401 0.0 0 CFG=1
M  V30 7 C 8.0022 7.7001 0.0 0
M  V30 8 C 6.6686 10.0101 0.0 0
M  V30 9 N 6.6686 6.9301 0.0 0
M  V30 10 O 9.3359 6.9301 0.0 0
M  V30 11 C 6.6686 11.5501 0.0 0
M  V30 12 C 6.6686 5.3901 0.0 0 CFG=1
M  V30 13 N 5.3348 7.7001 0.0 0
M  V30 14 C 8.0022 12.3201 0.0 0
M  V30 15 C 5.3348 12.3201 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 4.0011 6.9301 0.0 0
M  V30 19 O 8.0022 3.0800 0.0 0
M  V30 20 O 9.3359 5.3901 0.0 0
M  V30 21 O 2.6675 7.7001 0.0 0
M  V30 22 O 4.0011 5.3901 0.0 0
M  V30 23 C 1.3338 6.9301 0.0 0
M  V30 24 C 2.1038 5.5964 0.0 0
M  V30 25 C 0.0000 6.1601 0.0 0
M  V30 26 C 0.5638 8.2637 0.0 0
M  V30 27 C 14.6707 10.0101 0.0 0
M  V30 28 C 14.8316 11.5417 0.0 0
M  V30 29 C 16.0776 9.3836 0.0 0
M  V30 30 C 16.3380 11.8618 0.0 0
M  V30 31 C 13.8012 12.6860 0.0 0
M  V30 32 C 17.1080 10.5282 0.0 0
M  V30 33 C 16.5535 7.9191 0.0 0
M  V30 34 C 16.8139 13.3265 0.0 0
M  V30 35 C 14.2770 14.1508 0.0 0
M  V30 36 C 18.6143 10.2080 0.0 0
M  V30 37 C 18.0598 7.5989 0.0 0
M  V30 38 C 15.7835 14.4709 0.0 0
M  V30 39 C 19.0904 8.7433 0.0 0
M  V30 40 C 5.3348 3.0800 0.0 0
M  V30 41 C 6.6686 2.3100 0.0 0
M  V30 42 C 4.0011 2.3100 0.0 0
M  V30 43 C 6.6686 0.7700 0.0 0
M  V30 44 C 4.0011 0.7700 0.0 0
M  V30 45 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16 CFG=1
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 16 40
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 21 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 32 1 29 32
M  V30 33 2 29 33
M  V30 34 1 30 32
M  V30 35 2 30 34
M  V30 36 1 31 35
M  V30 37 2 32 36
M  V30 38 1 33 37
M  V30 39 1 34 38
M  V30 40 2 35 38
M  V30 41 1 36 39
M  V30 42 2 37 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C39H50N4O6
2429959-78-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 9.2402 0.0 0
M  V30 2 O 12.0035 10.0102 0.0 0
M  V30 3 C 10.6697 9.2402 0.0 0
M  V30 4 N 9.3360 10.0102 0.0 0
M  V30 5 O 10.6697 7.7002 0.0 0
M  V30 6 C 8.0023 9.2402 0.0 0 CFG=1
M  V30 7 C 8.0023 7.7002 0.0 0
M  V30 8 C 6.6687 10.0102 0.0 0
M  V30 9 N 6.6687 6.9302 0.0 0
M  V30 10 O 9.3360 6.9302 0.0 0
M  V30 11 C 6.6687 11.5503 0.0 0
M  V30 12 C 6.6687 5.3901 0.0 0 CFG=1
M  V30 13 N 5.3348 7.7002 0.0 0
M  V30 14 C 5.3348 12.3203 0.0 0
M  V30 15 C 8.0023 12.3203 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 4.0012 6.9302 0.0 0
M  V30 19 N 8.0023 3.0801 0.0 0
M  V30 20 O 9.3360 5.3901 0.0 0
M  V30 21 O 2.6675 7.7002 0.0 0
M  V30 22 O 4.0012 5.3901 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 1.3338 6.9302 0.0 0
M  V30 25 C 9.3360 0.7700 0.0 0
M  V30 26 C 0.5638 8.2638 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 2.1038 5.5965 0.0 0
M  V30 29 C 10.6697 0.0000 0.0 0
M  V30 30 C 8.0023 0.0000 0.0 0
M  V30 31 C 14.6708 10.0102 0.0 0
M  V30 32 C 16.0778 9.3837 0.0 0
M  V30 33 C 14.8318 11.5418 0.0 0
M  V30 34 C 17.1082 10.5283 0.0 0
M  V30 35 C 16.5537 7.9192 0.0 0
M  V30 36 C 16.3382 11.8620 0.0 0
M  V30 37 C 13.8013 12.6863 0.0 0
M  V30 38 C 18.6145 10.2081 0.0 0
M  V30 39 C 18.0600 7.5990 0.0 0
M  V30 40 C 16.8141 13.3267 0.0 0
M  V30 41 C 14.2772 14.1509 0.0 0
M  V30 42 C 19.0906 8.7434 0.0 0
M  V30 43 C 15.7837 14.4711 0.0 0
M  V30 44 C 5.3348 3.0801 0.0 0
M  V30 45 C 4.0012 2.3101 0.0 0
M  V30 46 C 6.6687 2.3101 0.0 0
M  V30 47 C 4.0012 0.7700 0.0 0
M  V30 48 C 6.6687 0.7700 0.0 0
M  V30 49 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 31
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16 CFG=1
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 16 44
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 21 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 32 35
M  V30 36 1 33 36
M  V30 37 2 33 37
M  V30 38 1 34 36
M  V30 39 2 34 38
M  V30 40 1 35 39
M  V30 41 2 36 40
M  V30 42 1 37 41
M  V30 43 1 38 42
M  V30 44 2 39 42
M  V30 45 1 40 43
M  V30 46 2 41 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 2 46 48
M  V30 51 2 47 49
M  V30 52 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-81-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2364482-32-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2429959-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22631808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 330645-87-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of backbone-aminated analogs of
gramicidin S
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rathman, Benjamin M.; Allen, Jessie L.; Shaw, Lindsey N.; Del Valle, Juan
R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
2-Benzofurancarboxylic acid
C9H6O3
496-41-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 O 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-2-Hydroxy-3-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(...
C30H34N2O6S
2883496-03-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 9.2400 0.0 0
M  V30 2 N 9.3358 8.4700 0.0 0
M  V30 3 O 10.6696 10.7800 0.0 0
M  V30 4 C 8.0021 9.2400 0.0 0 CFG=1
M  V30 5 C 6.6685 8.4700 0.0 0 CFG=2
M  V30 6 C 8.0021 10.7800 0.0 0
M  V30 7 C 5.3347 9.2400 0.0 0
M  V30 8 O 6.6685 6.9300 0.0 0
M  V30 9 N 4.0011 8.4700 0.0 0
M  V30 10 S 4.0011 6.9300 0.0 0 VAL=6
M  V30 11 C 2.6674 9.2400 0.0 0
M  V30 12 O 5.5411 6.9300 0.0 0
M  V30 13 O 2.4611 6.9300 0.0 0
M  V30 14 C 1.3338 8.4700 0.0 0
M  V30 15 C 0.0000 9.2400 0.0 0
M  V30 16 C 1.3338 6.9300 0.0 0
M  V30 17 O 4.0011 0.7700 0.0 0
M  V30 18 C 2.6674 0.0000 0.0 0
M  V30 19 C 13.6706 6.6183 0.0 0
M  V30 20 C 14.4406 7.9519 0.0 0
M  V30 21 C 12.1642 6.9385 0.0 0
M  V30 22 C 14.4406 5.2845 0.0 0
M  V30 23 O 13.4100 9.0963 0.0 0
M  V30 24 C 15.9806 7.9519 0.0 0
M  V30 25 C 12.0032 8.4700 0.0 0
M  V30 26 C 15.9806 5.2845 0.0 0
M  V30 27 C 16.7506 6.6183 0.0 0
M  V30 28 C 6.6685 11.5500 0.0 0
M  V30 29 C 5.3347 10.7800 0.0 0
M  V30 30 C 6.6685 13.0900 0.0 0
M  V30 31 C 4.0011 11.5500 0.0 0
M  V30 32 C 5.3347 13.8600 0.0 0
M  V30 33 C 4.0011 13.0900 0.0 0
M  V30 34 C 4.0011 5.3900 0.0 0
M  V30 35 C 5.3347 4.6200 0.0 0
M  V30 36 C 2.6674 4.6200 0.0 0
M  V30 37 C 5.3347 3.0800 0.0 0
M  V30 38 C 2.6674 3.0800 0.0 0
M  V30 39 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 28
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 34
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 39
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 25
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 496-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2883496-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35110941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure based design and evaluation of benzoheterocycle derivatives as
potential dual HIV-1 protease and reverse transcriptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Shan, Qi; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning;
Wang, Minghua; Zhou, Jinming; Cen, Shan; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 246114981

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
2-Benzofurancarboxylic acid
C9H6O3
496-41-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 O 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide
C20H29N3O3S
169280-56-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 N 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(ph...
C29H33N3O5S
2883496-14-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 8.4700 0.0 0
M  V30 2 N 9.3358 7.7000 0.0 0
M  V30 3 O 10.6696 10.0100 0.0 0
M  V30 4 C 8.0021 8.4700 0.0 0 CFG=1
M  V30 5 C 6.6685 7.7000 0.0 0 CFG=2
M  V30 6 C 8.0021 10.0100 0.0 0
M  V30 7 C 5.3347 8.4700 0.0 0
M  V30 8 O 6.6685 6.1600 0.0 0
M  V30 9 N 4.0011 7.7000 0.0 0
M  V30 10 S 4.0011 6.1600 0.0 0 VAL=6
M  V30 11 C 2.6674 8.4700 0.0 0
M  V30 12 O 5.5411 6.1600 0.0 0
M  V30 13 O 2.4611 6.1600 0.0 0
M  V30 14 C 1.3338 7.7000 0.0 0
M  V30 15 C 0.0000 8.4700 0.0 0
M  V30 16 C 1.3338 6.1600 0.0 0
M  V30 17 N 4.0011 0.0000 0.0 0
M  V30 18 C 13.6706 5.8483 0.0 0
M  V30 19 C 14.4406 7.1819 0.0 0
M  V30 20 C 12.1642 6.1685 0.0 0
M  V30 21 C 14.4406 4.5145 0.0 0
M  V30 22 O 13.4100 8.3263 0.0 0
M  V30 23 C 15.9806 7.1819 0.0 0
M  V30 24 C 12.0032 7.7000 0.0 0
M  V30 25 C 15.9806 4.5145 0.0 0
M  V30 26 C 16.7506 5.8483 0.0 0
M  V30 27 C 6.6685 10.7800 0.0 0
M  V30 28 C 6.6685 12.3200 0.0 0
M  V30 29 C 5.3347 10.0100 0.0 0
M  V30 30 C 5.3347 13.0900 0.0 0
M  V30 31 C 4.0011 10.7800 0.0 0
M  V30 32 C 4.0011 12.3200 0.0 0
M  V30 33 C 4.0011 4.6200 0.0 0
M  V30 34 C 2.6674 3.8500 0.0 0
M  V30 35 C 5.3347 3.8500 0.0 0
M  V30 36 C 2.6674 2.3100 0.0 0
M  V30 37 C 5.3347 2.3100 0.0 0
M  V30 38 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 27
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 33
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 38
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 1 22 24
M  V30 28 1 23 26
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 496-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 169280-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2883496-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35111050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure based design and evaluation of benzoheterocycle derivatives as
potential dual HIV-1 protease and reverse transcriptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Shan, Qi; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning;
Wang, Minghua; Zhou, Jinming; Cen, Shan; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 246114981

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Benzenemethanamine, 4-amino-, hydrochloride (1:1)
C7H10N2.ClH
140401-57-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.8737 0.0 0
M  V30 2 N 0.0000 4.2073 0.0 0
M  V30 3 N 6.9302 2.8737 0.0 0
M  V30 4 C 2.3101 2.8737 0.0 0
M  V30 5 C 3.0801 4.2073 0.0 0
M  V30 6 C 3.0801 1.5400 0.0 0
M  V30 7 C 4.6201 4.2073 0.0 0
M  V30 8 C 4.6201 1.5400 0.0 0
M  V30 9 C 5.3901 2.8737 0.0 0
M  V30 10 Cl 3.4651 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thien...
C26H28FN5O3S
3064695-54-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=3
M  V30 2 C 11.9711 5.7472 0.0 0
M  V30 3 C 12.8763 6.9931 0.0 0
M  V30 4 C 14.4079 6.8322 0.0 0
M  V30 5 C 15.3131 8.0781 0.0 0
M  V30 6 C 16.8447 7.9171 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 C 1.3337 7.7001 0.0 0
M  V30 9 O 0.0000 6.9301 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 O 23.2464 8.6871 0.0 0
M  V30 12 N 8.0021 5.3901 0.0 0
M  V30 13 C 9.4091 4.7638 0.0 0
M  V30 14 N 8.1632 6.9217 0.0 0
M  V30 15 C 10.4395 5.9082 0.0 0
M  V30 16 N 9.6695 7.2418 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6673 6.9301 0.0 0
M  V30 23 C 6.6685 3.0801 0.0 0
M  V30 24 C 5.3348 2.3100 0.0 0
M  V30 25 C 8.0021 2.3100 0.0 0
M  V30 26 C 5.3348 0.7700 0.0 0
M  V30 27 C 8.0021 0.7700 0.0 0
M  V30 28 C 6.6685 0.0000 0.0 0
M  V30 29 C 17.7499 9.1630 0.0 0 CFG=2
M  V30 30 C 19.2899 9.1630 0.0 0 CFG=1
M  V30 31 S 17.2740 10.6276 0.0 0
M  V30 32 C 19.7658 10.6276 0.0 0 CFG=1
M  V30 33 N 20.5358 8.2578 0.0 0
M  V30 34 C 18.5199 11.5328 0.0 0
M  V30 35 N 21.3058 10.6276 0.0 0
M  V30 36 C 21.7818 9.1630 0.0 0
M  V30 37 H 18.8141 7.6983 0.0 0
M  V30 38 H 20.2418 12.0923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 2 3
M  V30 5 1 2 15
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 29 6 CFG=3
M  V30 10 1 7 26
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 22
M  V30 14 2 11 36
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 37 CFG=1
M  V30 37 1 31 34
M  V30 38 1 32 34
M  V30 39 1 32 35
M  V30 40 1 32 38 CFG=1
M  V30 41 1 33 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[(4-aminophenyl)methyl]-4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-h...
C33H36FN7O2S
3064695-46-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.5777 4.6200 0.0 0 CFG=3
M  V30 2 C 11.2752 5.7472 0.0 0
M  V30 3 C 10.3699 6.9930 0.0 0
M  V30 4 C 8.8384 6.8321 0.0 0
M  V30 5 C 7.9332 8.0780 0.0 0
M  V30 6 C 6.4017 7.9170 0.0 0
M  V30 7 F 13.9104 0.0000 0.0 0
M  V30 8 C 21.9125 7.7000 0.0 0
M  V30 9 N 23.2463 6.9300 0.0 0
M  V30 10 O 21.9125 9.2400 0.0 0
M  V30 11 C 24.5799 7.7000 0.0 0
M  V30 12 N 29.9146 4.6200 0.0 0
M  V30 13 O 0.0000 8.6870 0.0 0
M  V30 14 N 15.2441 5.3900 0.0 0
M  V30 15 C 13.8373 4.7637 0.0 0
M  V30 16 N 15.0831 6.9216 0.0 0
M  V30 17 C 12.8067 5.9081 0.0 0
M  V30 18 N 13.5767 7.2417 0.0 0
M  V30 19 C 17.9115 5.3900 0.0 0
M  V30 20 C 19.2452 4.6200 0.0 0
M  V30 21 C 17.9115 6.9300 0.0 0
M  V30 22 C 20.5788 5.3900 0.0 0
M  V30 23 C 19.2452 7.7000 0.0 0
M  V30 24 C 20.5788 6.9300 0.0 0
M  V30 25 C 16.5777 3.0800 0.0 0
M  V30 26 C 15.2441 2.3100 0.0 0
M  V30 27 C 17.9115 2.3100 0.0 0
M  V30 28 C 15.2441 0.7700 0.0 0
M  V30 29 C 17.9115 0.7700 0.0 0
M  V30 30 C 16.5777 0.0000 0.0 0
M  V30 31 C 25.9136 6.9300 0.0 0
M  V30 32 C 27.2472 7.7000 0.0 0
M  V30 33 C 25.9136 5.3900 0.0 0
M  V30 34 C 28.5810 6.9300 0.0 0
M  V30 35 C 27.2472 4.6200 0.0 0
M  V30 36 C 28.5810 5.3900 0.0 0
M  V30 37 C 5.4964 9.1629 0.0 0 CFG=2
M  V30 38 C 3.9564 9.1629 0.0 0 CFG=1
M  V30 39 S 5.9723 10.6274 0.0 0
M  V30 40 C 3.4806 10.6274 0.0 0 CFG=1
M  V30 41 N 2.7106 8.2577 0.0 0
M  V30 42 C 4.7264 11.5327 0.0 0
M  V30 43 N 1.9406 10.6274 0.0 0
M  V30 44 C 1.4647 9.1629 0.0 0
M  V30 45 H 4.4323 7.6982 0.0 0
M  V30 46 H 3.0047 12.0921 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 1 2 17
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 37 6 CFG=1
M  V30 10 1 7 28
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 24
M  V30 14 1 9 11
M  V30 15 1 11 31
M  V30 16 1 12 36
M  V30 17 2 13 44
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 38 41
M  V30 45 1 38 45 CFG=3
M  V30 46 1 39 42
M  V30 47 1 40 42
M  V30 48 1 40 43
M  V30 49 1 40 46 CFG=3
M  V30 50 1 41 44
M  V30 51 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 37 38 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 140401-57-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3064695-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3064695-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43968813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown,product obtained as mixture of
diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural study of potent triazole-based inhibitors of Staphylococcus
aureus biotin protein ligase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stachura, Damian L.; Nguyen, Stephanie; Polyak, Steven W.; Jovcevski,
Blagojce; Bruning, John B.; Abell, Andrew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(3), 285-290

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
S-Methyl-N-[(5-methyl-3-isoxazolyl)carbonyl]-L-cysteinyl-O-methyl-L-serine
C13H19N3O6S
2387522-94-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.8501 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 9.3360 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 N 5.3348 6.1601 0.0 0
M  V30 8 O 4.0012 3.8501 0.0 0
M  V30 9 S 5.3348 1.5400 0.0 0
M  V30 10 C 4.0012 6.9302 0.0 0 CFG=2
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 8.4702 0.0 0
M  V30 14 O 1.3337 6.9302 0.0 0
M  V30 15 O 2.6675 9.2402 0.0 0
M  V30 16 O 5.3348 9.2402 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 18 C 14.6386 4.9772 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0765 3.9938 0.0 0
M  V30 21 N 10.8306 6.1517 0.0 0
M  V30 22 C 13.1071 5.1382 0.0 0
M  V30 23 O 12.3371 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12 CFG=1
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 18 22
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-erythro-3-Pentulose, 2-amino-4,5-anhydro-1,2-dideoxy-4-C-methyl-1-phenyl-, ...
C12H15NO2.C2HF3O2
1148157-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.7237 0.0 0
M  V30 2 C 5.3348 7.4937 0.0 0 CFG=1
M  V30 3 O 6.6684 5.1837 0.0 0
M  V30 4 C 4.0011 6.7237 0.0 0
M  V30 5 N 5.3348 9.0338 0.0 0
M  V30 6 C 7.4755 8.9409 0.0 0
M  V30 7 C 8.0022 7.4937 0.0 0 CFG=2
M  V30 8 C 8.9921 6.3141 0.0 0
M  V30 9 O 9.5188 7.7611 0.0 0
M  V30 10 C 2.6675 7.4937 0.0 0
M  V30 11 C 1.3337 6.7237 0.0 0
M  V30 12 C 2.6675 9.0338 0.0 0
M  V30 13 C 0.0000 7.4937 0.0 0
M  V30 14 C 1.3337 9.8038 0.0 0
M  V30 15 C 0.0000 9.0338 0.0 0
M  V30 16 C 4.0926 2.3101 0.0 0
M  V30 17 C 5.4262 1.5400 0.0 0
M  V30 18 F 4.8626 3.6437 0.0 0
M  V30 19 F 2.7589 3.0801 0.0 0
M  V30 20 F 3.3226 0.9764 0.0 0
M  V30 21 O 6.7599 2.3101 0.0 0
M  V30 22 O 5.4262 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 10
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C25H32N4O7S
2387523-13-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.3901 0.0 0
M  V30 2 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 3 O 1.3338 4.6201 0.0 0
M  V30 4 C 4.0011 3.0800 0.0 0
M  V30 5 N 5.3350 5.3901 0.0 0
M  V30 6 C 6.6686 4.6201 0.0 0
M  V30 7 C 8.0023 5.3901 0.0 0 CFG=2
M  V30 8 O 6.6686 3.0800 0.0 0
M  V30 9 N 9.3359 4.6201 0.0 0
M  V30 10 C 8.0023 6.9301 0.0 0
M  V30 11 C 10.6697 5.3901 0.0 0
M  V30 12 O 6.6686 7.7001 0.0 0
M  V30 13 C 12.0034 4.6201 0.0 0 CFG=2
M  V30 14 O 10.6697 6.9301 0.0 0
M  V30 15 C 6.6686 9.2401 0.0 0
M  V30 16 N 13.3371 5.3901 0.0 0
M  V30 17 C 12.0034 3.0800 0.0 0
M  V30 18 C 14.6707 4.6201 0.0 0
M  V30 19 S 10.6697 2.3100 0.0 0
M  V30 20 O 14.6707 3.0800 0.0 0
M  V30 21 C 10.6697 0.7700 0.0 0
M  V30 22 C 4.1841 7.1975 0.0 0
M  V30 23 C 19.9735 5.7472 0.0 0
M  V30 24 C 2.6675 6.9301 0.0 0 CFG=2
M  V30 25 C 1.1509 7.1975 0.0 0
M  V30 26 O 2.1408 8.3773 0.0 0
M  V30 27 C 2.6675 2.3100 0.0 0
M  V30 28 C 1.3338 3.0800 0.0 0
M  V30 29 C 2.6675 0.7700 0.0 0
M  V30 30 C 0.0000 2.3100 0.0 0
M  V30 31 C 1.3338 0.0000 0.0 0
M  V30 32 C 0.0000 0.7700 0.0 0
M  V30 33 C 16.0045 5.3901 0.0 0
M  V30 34 N 16.1655 6.9216 0.0 0
M  V30 35 C 17.4114 4.7638 0.0 0
M  V30 36 O 17.6718 7.2418 0.0 0
M  V30 37 C 18.4418 5.9081 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=1
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 18 33
M  V30 23 1 19 21
M  V30 24 1 24 22 CFG=3
M  V30 25 1 23 37
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 7 13 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387522-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148157-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Isobutylamine
C4H11N
78-81-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C35H41N3O7
2364482-32-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 9.2401 0.0 0
M  V30 2 O 12.0034 10.0101 0.0 0
M  V30 3 C 10.6695 9.2401 0.0 0
M  V30 4 N 9.3359 10.0101 0.0 0
M  V30 5 O 10.6695 7.7001 0.0 0
M  V30 6 C 8.0022 9.2401 0.0 0 CFG=1
M  V30 7 C 8.0022 7.7001 0.0 0
M  V30 8 C 6.6686 10.0101 0.0 0
M  V30 9 N 6.6686 6.9301 0.0 0
M  V30 10 O 9.3359 6.9301 0.0 0
M  V30 11 C 6.6686 11.5501 0.0 0
M  V30 12 C 6.6686 5.3901 0.0 0 CFG=1
M  V30 13 N 5.3348 7.7001 0.0 0
M  V30 14 C 8.0022 12.3201 0.0 0
M  V30 15 C 5.3348 12.3201 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 4.0011 6.9301 0.0 0
M  V30 19 O 8.0022 3.0800 0.0 0
M  V30 20 O 9.3359 5.3901 0.0 0
M  V30 21 O 2.6675 7.7001 0.0 0
M  V30 22 O 4.0011 5.3901 0.0 0
M  V30 23 C 1.3338 6.9301 0.0 0
M  V30 24 C 2.1038 5.5964 0.0 0
M  V30 25 C 0.0000 6.1601 0.0 0
M  V30 26 C 0.5638 8.2637 0.0 0
M  V30 27 C 14.6707 10.0101 0.0 0
M  V30 28 C 14.8316 11.5417 0.0 0
M  V30 29 C 16.0776 9.3836 0.0 0
M  V30 30 C 16.3380 11.8618 0.0 0
M  V30 31 C 13.8012 12.6860 0.0 0
M  V30 32 C 17.1080 10.5282 0.0 0
M  V30 33 C 16.5535 7.9191 0.0 0
M  V30 34 C 16.8139 13.3265 0.0 0
M  V30 35 C 14.2770 14.1508 0.0 0
M  V30 36 C 18.6143 10.2080 0.0 0
M  V30 37 C 18.0598 7.5989 0.0 0
M  V30 38 C 15.7835 14.4709 0.0 0
M  V30 39 C 19.0904 8.7433 0.0 0
M  V30 40 C 5.3348 3.0800 0.0 0
M  V30 41 C 6.6686 2.3100 0.0 0
M  V30 42 C 4.0011 2.3100 0.0 0
M  V30 43 C 6.6686 0.7700 0.0 0
M  V30 44 C 4.0011 0.7700 0.0 0
M  V30 45 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16 CFG=1
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 16 40
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 21 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 32 1 29 32
M  V30 33 2 29 33
M  V30 34 1 30 32
M  V30 35 2 30 34
M  V30 36 1 31 35
M  V30 37 2 32 36
M  V30 38 1 33 37
M  V30 39 1 34 38
M  V30 40 2 35 38
M  V30 41 1 36 39
M  V30 42 2 37 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C39H50N4O6
2429959-77-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 9.2402 0.0 0
M  V30 2 O 12.0035 10.0102 0.0 0
M  V30 3 C 10.6697 9.2402 0.0 0
M  V30 4 N 9.3360 10.0102 0.0 0
M  V30 5 O 10.6697 7.7002 0.0 0
M  V30 6 C 8.0023 9.2402 0.0 0 CFG=1
M  V30 7 C 8.0023 7.7002 0.0 0
M  V30 8 C 6.6687 10.0102 0.0 0
M  V30 9 N 6.6687 6.9302 0.0 0
M  V30 10 O 9.3360 6.9302 0.0 0
M  V30 11 C 6.6687 11.5503 0.0 0
M  V30 12 C 6.6687 5.3901 0.0 0 CFG=2
M  V30 13 N 5.3348 7.7002 0.0 0
M  V30 14 C 5.3348 12.3203 0.0 0
M  V30 15 C 8.0023 12.3203 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 4.0012 6.9302 0.0 0
M  V30 19 N 8.0023 3.0801 0.0 0
M  V30 20 O 9.3360 5.3901 0.0 0
M  V30 21 O 2.6675 7.7002 0.0 0
M  V30 22 O 4.0012 5.3901 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 1.3338 6.9302 0.0 0
M  V30 25 C 9.3360 0.7700 0.0 0
M  V30 26 C 0.5638 8.2638 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 28 C 2.1038 5.5965 0.0 0
M  V30 29 C 10.6697 0.0000 0.0 0
M  V30 30 C 8.0023 0.0000 0.0 0
M  V30 31 C 14.6708 10.0102 0.0 0
M  V30 32 C 16.0778 9.3837 0.0 0
M  V30 33 C 14.8318 11.5418 0.0 0
M  V30 34 C 17.1082 10.5283 0.0 0
M  V30 35 C 16.5537 7.9192 0.0 0
M  V30 36 C 16.3382 11.8620 0.0 0
M  V30 37 C 13.8013 12.6863 0.0 0
M  V30 38 C 18.6145 10.2081 0.0 0
M  V30 39 C 18.0600 7.5990 0.0 0
M  V30 40 C 16.8141 13.3267 0.0 0
M  V30 41 C 14.2772 14.1509 0.0 0
M  V30 42 C 19.0906 8.7434 0.0 0
M  V30 43 C 15.7837 14.4711 0.0 0
M  V30 44 C 5.3348 3.0801 0.0 0
M  V30 45 C 4.0012 2.3101 0.0 0
M  V30 46 C 6.6687 2.3101 0.0 0
M  V30 47 C 4.0012 0.7700 0.0 0
M  V30 48 C 6.6687 0.7700 0.0 0
M  V30 49 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 31
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16 CFG=3
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 16 44
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 21 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 32 35
M  V30 36 1 33 36
M  V30 37 2 33 37
M  V30 38 1 34 36
M  V30 39 2 34 38
M  V30 40 1 35 39
M  V30 41 2 36 40
M  V30 42 1 37 41
M  V30 43 1 38 42
M  V30 44 2 39 42
M  V30 45 1 40 43
M  V30 46 2 41 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 2 46 48
M  V30 51 2 47 49
M  V30 52 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-81-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2364482-32-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2429959-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22631809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 330645-87-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of backbone-aminated analogs of
gramicidin S
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rathman, Benjamin M.; Allen, Jessie L.; Shaw, Lindsey N.; Del Valle, Juan
R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
2-(1,1-Dimethylethyl) 3,4-dihydro-2,8(1H)-isoquinolinedicarboxylate
C15H19NO4
878798-87-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 O 4.6200 1.3338 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 O 7.7000 6.6685 0.0 0
M  V30 6 O 7.7000 4.0011 0.0 0
M  V30 7 C 9.2400 6.6685 0.0 0
M  V30 8 C 9.2400 5.1285 0.0 0
M  V30 9 C 10.7800 6.6685 0.0 0
M  V30 10 C 9.2400 8.2085 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 N 5.3900 5.3347 0.0 0
M  V30 19 C 4.6200 6.6685 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminobenzothiazole
C7H6N2S
136-95-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.5772 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 2.6673 0.7700 0.0 0
M  V30 4 N 4.1321 2.7859 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 S 4.1321 0.2941 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 5.0371 1.5400 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 8
M  V30 10 1 7 10
M  V30 11 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoqu...
C22H23N3O3S
1235034-71-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4955 4.0012 0.0 0
M  V30 2 N 3.9554 4.0012 0.0 0
M  V30 3 O 6.2655 5.3348 0.0 0
M  V30 4 C 10.8856 5.3348 0.0 0
M  V30 5 O 12.4256 5.3348 0.0 0
M  V30 6 O 10.1156 6.6685 0.0 0
M  V30 7 C 13.1956 6.6685 0.0 0
M  V30 8 C 14.5293 5.8985 0.0 0
M  V30 9 C 13.9656 8.0023 0.0 0
M  V30 10 C 11.8620 7.4385 0.0 0
M  V30 11 C 7.8055 2.6675 0.0 0
M  V30 12 C 6.2655 2.6675 0.0 0
M  V30 13 C 8.5755 1.3337 0.0 0
M  V30 14 C 8.5755 4.0012 0.0 0
M  V30 15 C 5.4955 1.3337 0.0 0
M  V30 16 C 10.1156 1.3337 0.0 0
M  V30 17 C 7.8055 0.0000 0.0 0
M  V30 18 N 10.1156 4.0012 0.0 0
M  V30 19 C 6.2655 0.0000 0.0 0
M  V30 20 C 10.8856 2.6675 0.0 0
M  V30 21 C 3.1854 5.3348 0.0 0
M  V30 22 N 3.8119 6.7418 0.0 0
M  V30 23 S 1.6538 5.4958 0.0 0
M  V30 24 C 2.6673 7.7722 0.0 0
M  V30 25 C 1.3337 7.0022 0.0 0
M  V30 26 C 2.6673 9.3123 0.0 0
M  V30 27 C 0.0000 7.7722 0.0 0
M  V30 28 C 1.3337 10.0823 0.0 0
M  V30 29 C 0.0000 9.3123 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 878798-87-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 136-95-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235034-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24304120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable
BCL-XL Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Le; Doherty, George A.; Judd, Andrew S.; Tao, Zhi-Fu; Hansen, T.
Matthew; Frey, Robin R.; Song, Xiaohong; Bruncko, Milan; Kunzer, Aaron
R.; Wang, Xilu; Wendt, Michael D.; Flygare, John A.; Catron, Nathaniel
D.; Judge, Russell A.; Park, Chang H.; Shekhar, Shashank; Phillips,
Darren C.; Nimmer, Paul; Smith, Morey L.; Tahir, Stephen K.; Xiao, Yu;
Xue, John; Zhang, Haichao; Le, Phuong N.; Mitten, Michael J.; Boghaert,
Erwin R.; Gao, Wenqing; Kovar, Peter; Choo, Edna F.; Diaz, Dolores;
Fairbrother, Wayne J.; Elmore, Steven W.; Sampath, Deepak; Leverson, Joel
D.; Souers, Andrew James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Benzyloxycarbonyl-L-leucine
C14H19NO4
2018-66-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 O 4.6200 5.3347 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0 CFG=2
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 O 0.7700 1.3338 0.0 0
M  V30 11 O 3.0800 0.0000 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 6.6685 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 11.5500 6.6685 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Tryptophan, methyl ester, hydrochloride (1:1)
C12H14N2O2.ClH
7524-52-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 4.1618 0.0 0
M  V30 2 C 7.0869 3.3918 0.0 0 CFG=2
M  V30 3 C 8.4206 4.1618 0.0 0
M  V30 4 N 7.0869 1.8518 0.0 0
M  V30 5 O 9.7544 3.3918 0.0 0
M  V30 6 O 8.4206 5.7018 0.0 0
M  V30 7 C 11.0880 4.1618 0.0 0
M  V30 8 C 3.0127 4.0182 0.0 0
M  V30 9 C 4.4196 3.3918 0.0 0
M  V30 10 C 1.9823 2.8738 0.0 0
M  V30 11 C 2.5368 5.4829 0.0 0
M  V30 12 C 4.2586 1.8602 0.0 0
M  V30 13 N 2.7523 1.5400 0.0 0
M  V30 14 C 0.4759 3.1940 0.0 0
M  V30 15 C 1.0304 5.8030 0.0 0
M  V30 16 C 0.0000 4.6585 0.0 0
M  V30 17 Cl 5.5440 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-leucyl-L-tryptophan methyl ester
C26H31N3O5
14437-50-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 6.1600 0.0 0
M  V30 2 C 7.0869 6.9300 0.0 0 CFG=1
M  V30 3 N 8.4207 6.1600 0.0 0
M  V30 4 C 7.0869 8.4700 0.0 0
M  V30 5 C 8.4207 4.6200 0.0 0
M  V30 6 O 8.4207 9.2400 0.0 0
M  V30 7 O 5.7533 9.2400 0.0 0
M  V30 8 C 9.7544 3.8500 0.0 0 CFG=2
M  V30 9 O 7.0869 3.8500 0.0 0
M  V30 10 C 8.4207 10.7800 0.0 0
M  V30 11 N 11.0880 4.6200 0.0 0
M  V30 12 C 9.7544 2.3100 0.0 0
M  V30 13 C 12.4216 3.8500 0.0 0
M  V30 14 C 8.4207 1.5400 0.0 0
M  V30 15 O 13.7554 4.6200 0.0 0
M  V30 16 O 12.4216 2.3100 0.0 0
M  V30 17 C 8.4207 0.0000 0.0 0
M  V30 18 C 7.0869 2.3100 0.0 0
M  V30 19 C 15.0891 3.8500 0.0 0
M  V30 20 C 3.0127 6.3037 0.0 0
M  V30 21 C 4.4196 6.9300 0.0 0
M  V30 22 C 1.9823 7.4481 0.0 0
M  V30 23 C 2.5368 4.8390 0.0 0
M  V30 24 C 4.2587 8.4615 0.0 0
M  V30 25 N 2.7523 8.7817 0.0 0
M  V30 26 C 0.4760 7.1279 0.0 0
M  V30 27 C 1.0306 4.5188 0.0 0
M  V30 28 C 0.0000 5.6632 0.0 0
M  V30 29 C 16.4227 4.6200 0.0 0
M  V30 30 C 17.7564 3.8500 0.0 0
M  V30 31 C 16.4227 6.1600 0.0 0
M  V30 32 C 19.0901 4.6200 0.0 0
M  V30 33 C 17.7564 6.9300 0.0 0
M  V30 34 C 19.0901 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 19 29
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 25
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2018-66-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7524-52-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14437-50-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41063830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new class of α-ketoamide derivatives with potent anticancer and
anti-SARS-CoV-2 activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Juan; Liang, Boqiang; Chen, Yiling; Fuk-Woo Chan, Jasper; Yuan,
Shuofeng; Ye, Hui; Nie, Linlin; Zhou, Jiao; Wu, Yi; Wu, Meixian; Huang,
Lina S.; An, Jing; Warshel, Arieh; Yuen, Kwok-Yung; Ciechanover, Aaron;
Huang, Ziwei; Xu, Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 215113267

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Imidazo[1,2-a]pyridin-6-amine, 8-fluoro-2-methyl-
C8H8FN3
1643412-36-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6674 0.0000 0.0 0
M  V30 2 C 7.9110 3.0800 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 5.4658 4.3259 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 N 5.4658 1.8341 0.0 0
M  V30 10 C 6.3710 3.0800 0.0 0
M  V30 11 C 1.3338 3.8500 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(3R)-3-[[(1,1-Dimethylethoxy)carbonyl]methylamino]-1-pyrrolidinyl]-2-pyrim...
C15H22N4O4
2743340-80-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.5458 1.5317 0.0 0
M  V30 2 C 11.9526 2.1580 0.0 0
M  V30 3 C 10.3848 0.0000 0.0 0
M  V30 4 O 13.1986 1.2528 0.0 0
M  V30 5 O 12.1136 3.6895 0.0 0
M  V30 6 C 14.6054 1.8791 0.0 0
M  V30 7 C 15.2317 0.4723 0.0 0
M  V30 8 C 16.0123 2.5056 0.0 0
M  V30 9 C 13.9790 3.2861 0.0 0
M  V30 10 C 0.7700 3.2067 0.0 0
M  V30 11 O 0.0000 4.5405 0.0 0
M  V30 12 O 0.0000 1.8731 0.0 0
M  V30 13 N 6.9300 3.2067 0.0 0
M  V30 14 C 7.8352 1.9609 0.0 0
M  V30 15 C 7.8352 4.4528 0.0 0
M  V30 16 C 9.2999 2.4367 0.0 0 CFG=2
M  V30 17 C 9.2999 3.9767 0.0 0
M  V30 18 C 5.3900 3.2067 0.0 0
M  V30 19 C 4.6200 1.8731 0.0 0
M  V30 20 C 4.6200 4.5405 0.0 0
M  V30 21 N 3.0800 1.8731 0.0 0
M  V30 22 N 3.0800 4.5405 0.0 0
M  V30 23 C 2.3100 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 23
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(3R)-1-[2-[[(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)am...
C23H28FN7O3
3033861-51-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 3.0010 5.2892 0.0 0
M  V30 2 N 7.6210 2.6217 0.0 0
M  V30 3 C 8.3910 3.9555 0.0 0
M  V30 4 O 7.6210 5.2892 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 N 18.1669 5.6307 0.0 0
M  V30 7 C 19.5737 5.0043 0.0 0
M  V30 8 C 18.0058 7.1623 0.0 0
M  V30 9 O 20.8195 5.9095 0.0 0
M  V30 10 O 19.7346 3.4727 0.0 0
M  V30 11 C 22.2265 5.2832 0.0 0
M  V30 12 C 22.8528 6.6899 0.0 0
M  V30 13 C 23.6333 4.6567 0.0 0
M  V30 14 C 21.6000 3.8762 0.0 0
M  V30 15 N 3.7710 1.2881 0.0 0
M  V30 16 C 3.0010 2.6217 0.0 0
M  V30 17 C 5.3110 1.2881 0.0 0
M  V30 18 C 2.7406 0.1437 0.0 0
M  V30 19 C 3.7710 3.9555 0.0 0
M  V30 20 N 1.4946 2.3015 0.0 0
M  V30 21 C 6.0810 2.6217 0.0 0
M  V30 22 C 1.3336 0.7700 0.0 0
M  V30 23 C 5.3110 3.9555 0.0 0
M  V30 24 C 9.9310 3.9555 0.0 0
M  V30 25 N 10.7011 2.6219 0.0 0
M  V30 26 N 10.7011 5.2892 0.0 0
M  V30 27 C 12.2411 2.6219 0.0 0
M  V30 28 C 12.2411 5.2892 0.0 0
M  V30 29 C 13.0111 3.9555 0.0 0
M  V30 30 N 14.5511 3.9555 0.0 0
M  V30 31 C 15.4563 5.2014 0.0 0
M  V30 32 C 15.4563 2.7096 0.0 0
M  V30 33 C 16.9208 4.7255 0.0 0 CFG=2
M  V30 34 C 16.9208 3.1855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 2 3 4
M  V30 5 1 3 24
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 33 6 CFG=3
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 2 19 23
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 1 29 30
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1643412-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2743340-80-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033861-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38064680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Optimization of RNA-Splicing Modulators as Huntingtin
Protein-Lowering Agents for the Treatment of Huntington's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Longbin; Malagu, Karine; Haughan, Alan F.; Khetarpal, Vinod; Stott,
Andrew J.; Esmieu, William; Vater, Huw D.; Webster, Stephen J.; Van de
Poel, Amanda J.; Clissold, Cole; Cosgrove, Brett; Sutton, Benjamin;
Spencer, Jonathan A.; Breccia, Perla; Gancia, Emanuela; Bonomo, Silvia;
Ladduwahetty, Tammy; Lazari, Ovadia; Patel, Hiral; Atton, Helen C.;
Clifton, Steve; Mota, Daniel M.; Magnani, Dario; ONeill, Amy; Stebbeds,
Marta; Macabuag, Natsuko; Todd, Daniel; Herva, Maria E.; Mitchell,
Philip; Visser, Mijke; Compte Sancerni, Sara; Grand Moursel, Laure; da
Silva, Marta; Kritikou, Eva; Heikkinen, Taneli T.; Bolkvadze, Tamuna;
Fodale, Valentina; Spadafora, Debora; Daldin, Manuel; Bresciani, Alberto;
Mangette, John E.; Doherty, Elizabeth M.; Lee, Matthew R.; Herbst, Todd;
Monteagudo, Edith; Macdonald, Douglas; Plotnikov, Nikolay V.; Chambers,
Mark; McAllister, George; Munoz-Sanjuan, Ignacio; Dominguez, Celia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(18), 13205-13246

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valine
C21H23NO4
84000-11-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 7.0870 4.4608 0.0 0
M  V30 3 C 8.4206 5.2308 0.0 0
M  V30 4 N 9.7543 4.4608 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 11.0881 5.2308 0.0 0 CFG=2
M  V30 7 C 9.7543 2.9208 0.0 0
M  V30 8 C 11.0881 6.7708 0.0 0
M  V30 9 C 12.4217 4.4608 0.0 0
M  V30 10 C 9.7543 7.5408 0.0 0
M  V30 11 C 12.4217 7.5408 0.0 0
M  V30 12 O 13.7554 5.2308 0.0 0
M  V30 13 O 12.4217 2.9208 0.0 0
M  V30 14 C 4.4195 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0127 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2890 1.7849 0.0 0
M  V30 19 C 1.9823 3.9427 0.0 0
M  V30 20 C 2.5369 6.5518 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2629 0.0 0
M  V30 24 C 1.0304 6.8720 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R,4S,5S)-4-[[(2S)-2-amino-3-methyl-1-oxobutyl]methylamino...
C19H38N2O4
177423-00-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.8501 0.0 0 CFG=2
M  V30 2 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 3 N 9.3358 4.6201 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0 CFG=1
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 O 6.6685 6.1601 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 9.3358 6.1601 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 9.3358 1.5400 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 5.3348 6.9302 0.0 0
M  V30 13 C 12.0033 4.6201 0.0 0 CFG=1
M  V30 14 O 10.6697 2.3101 0.0 0
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 O 2.6673 3.8501 0.0 0
M  V30 17 O 4.0010 6.1601 0.0 0
M  V30 18 C 13.3370 3.8501 0.0 0
M  V30 19 N 12.0033 6.1601 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 13.3370 2.3101 0.0 0
M  V30 22 C 14.6707 4.6201 0.0 0
M  V30 23 C 0.5637 3.2864 0.0 0
M  V30 24 C 0.0000 5.3901 0.0 0
M  V30 25 C 2.1037 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10 CFG=1
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 9 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 13 18
M  V30 18 1 13 19 CFG=1
M  V30 19 1 16 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 4 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-(1,1-dimet...
C40H59N3O7
474645-25-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 3.8501 0.0 0
M  V30 2 O 7.0871 4.6201 0.0 0
M  V30 3 C 8.4207 3.8501 0.0 0
M  V30 4 N 9.7544 4.6201 0.0 0
M  V30 5 O 8.4207 2.3101 0.0 0
M  V30 6 C 11.0881 3.8501 0.0 0 CFG=1
M  V30 7 C 9.7544 6.1601 0.0 0
M  V30 8 C 12.4219 4.6201 0.0 0
M  V30 9 C 11.0881 2.3101 0.0 0
M  V30 10 N 13.7556 3.8501 0.0 0
M  V30 11 O 12.4219 6.1601 0.0 0
M  V30 12 C 12.4219 1.5400 0.0 0
M  V30 13 C 9.7544 1.5400 0.0 0
M  V30 14 C 15.0892 4.6201 0.0 0 CFG=1
M  V30 15 C 16.4229 3.8501 0.0 0
M  V30 16 C 15.0892 6.1601 0.0 0
M  V30 17 N 17.7567 4.6201 0.0 0
M  V30 18 O 16.4229 2.3101 0.0 0
M  V30 19 C 13.7556 6.9302 0.0 0
M  V30 20 C 16.4229 6.9302 0.0 0
M  V30 21 C 19.0904 3.8501 0.0 0 CFG=1
M  V30 22 C 17.7567 6.1601 0.0 0
M  V30 23 C 20.4241 4.6201 0.0 0 CFG=2
M  V30 24 C 19.0904 2.3101 0.0 0 CFG=1
M  V30 25 C 21.7577 3.8501 0.0 0
M  V30 26 O 20.4241 6.1601 0.0 0
M  V30 27 C 20.4241 1.5400 0.0 0
M  V30 28 C 17.7567 1.5400 0.0 0
M  V30 29 C 23.0916 4.6201 0.0 0
M  V30 30 C 21.7577 6.9302 0.0 0
M  V30 31 C 20.4241 0.0000 0.0 0
M  V30 32 O 24.4252 3.8501 0.0 0
M  V30 33 O 23.0916 6.1601 0.0 0
M  V30 34 C 25.7589 4.6201 0.0 0
M  V30 35 C 26.5289 3.2864 0.0 0
M  V30 36 C 27.0926 5.3901 0.0 0
M  V30 37 C 24.9889 5.9538 0.0 0
M  V30 38 C 4.4196 4.6201 0.0 0
M  V30 39 C 4.2587 6.1517 0.0 0
M  V30 40 C 3.0128 3.9936 0.0 0
M  V30 41 C 2.7522 6.4718 0.0 0
M  V30 42 C 5.2891 7.2961 0.0 0
M  V30 43 C 1.9822 5.1382 0.0 0
M  V30 44 C 2.5367 2.5290 0.0 0
M  V30 45 C 2.2763 7.9366 0.0 0
M  V30 46 C 4.8132 8.7608 0.0 0
M  V30 47 C 0.4759 4.8180 0.0 0
M  V30 48 C 1.0304 2.2089 0.0 0
M  V30 49 C 3.3068 9.0810 0.0 0
M  V30 50 C 0.0000 3.3533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 38
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=1
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 21 17 CFG=3
M  V30 22 1 17 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 23 25
M  V30 26 1 23 26 CFG=3
M  V30 27 1 24 27
M  V30 28 1 24 28 CFG=3
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 29 32
M  V30 33 2 29 33
M  V30 34 1 32 34
M  V30 35 1 34 35
M  V30 36 1 34 36
M  V30 37 1 34 37
M  V30 38 1 38 39
M  V30 39 1 38 40
M  V30 40 1 39 41
M  V30 41 2 39 42
M  V30 42 1 40 43
M  V30 43 2 40 44
M  V30 44 1 41 43
M  V30 45 2 41 45
M  V30 46 1 42 46
M  V30 47 2 43 47
M  V30 48 1 44 48
M  V30 49 1 45 49
M  V30 50 2 46 49
M  V30 51 1 47 50
M  V30 52 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 14 21 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 84000-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177423-00-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 474645-25-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38179436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1609-47-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting
Potent Antitumor Efficacy in Pancreatic Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Li-ping; Bai, Wei-qi; Zhou, Dan-dan; Wu, Xiao-fan; Zhang, Lan-wen;
Cui, A-long; Xie, Zi-hui; Gao, Rui-juan; Zhen, Yong-su; Li, Zhuo-Rong;
Miao, Qing-fang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(21), 14700-14715

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
D-Phenylalanine, 4-chloro-N-[(1,1-dimethylethoxy)carbonyl]-, 5-hexen-1-yl ester
C20H28ClNO4
3061154-94-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 5.3900 8.0020 0.0 0
M  V30 4 C 7.7000 6.6684 0.0 0
M  V30 5 C 3.8500 8.0020 0.0 0
M  V30 6 O 8.4700 8.0020 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 O 3.0800 9.3358 0.0 0
M  V30 9 O 3.0800 6.6684 0.0 0
M  V30 10 C 10.0100 8.0020 0.0 0
M  V30 11 C 1.5400 9.3358 0.0 0
M  V30 12 C 10.7800 9.3358 0.0 0
M  V30 13 C 1.5400 7.7958 0.0 0
M  V30 14 C 0.0000 9.3358 0.0 0
M  V30 15 C 1.5400 10.8758 0.0 0
M  V30 16 C 12.3200 9.3358 0.0 0
M  V30 17 C 13.0900 10.6694 0.0 0
M  V30 18 C 14.6300 10.6694 0.0 0
M  V30 19 C 15.4000 12.0031 0.0 0
M  V30 20 Cl 8.4700 0.0000 0.0 0
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 7.7000 4.0011 0.0 0
M  V30 23 C 5.3900 2.6673 0.0 0
M  V30 24 C 8.4700 2.6673 0.0 0
M  V30 25 C 6.1600 1.3336 0.0 0
M  V30 26 C 7.7000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 2 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(R)-1-tert-Butoxycarbonylpyrrolidine-2-carboxylic acid
C11H19NO4
101555-60-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 3.3450 0.0 0
M  V30 2 O 7.0036 4.1150 0.0 0
M  V30 3 O 5.6699 1.8049 0.0 0
M  V30 4 C 8.3374 3.3450 0.0 0
M  V30 5 C 7.5674 2.0113 0.0 0
M  V30 6 C 9.6711 2.5749 0.0 0
M  V30 7 C 9.1075 4.6786 0.0 0
M  V30 8 C 2.6091 1.9822 0.0 0
M  V30 9 C 1.1446 1.5063 0.0 0
M  V30 10 O 0.0000 2.5367 0.0 0
M  V30 11 O 0.8244 0.0000 0.0 0
M  V30 12 N 4.3363 4.1150 0.0 0
M  V30 13 C 2.9293 3.4886 0.0 0 CFG=1
M  V30 14 C 4.1752 5.6465 0.0 0
M  V30 15 C 1.8989 4.6330 0.0 0
M  V30 16 C 2.6689 5.9667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 13 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 2-[2-[[(1R)-1-[(4-chlorophenyl)methyl]-2-(5-hex...
C26H37ClN2O5
3061154-97-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.1119 12.3534 0.0 0
M  V30 2 O 15.6184 12.6736 0.0 0
M  V30 3 O 13.6361 10.8887 0.0 0
M  V30 4 C 16.6488 11.5291 0.0 0
M  V30 5 C 17.7932 12.5596 0.0 0
M  V30 6 C 17.6792 10.3847 0.0 0
M  V30 7 C 15.5043 10.4986 0.0 0
M  V30 8 C 10.7800 12.0032 0.0 0
M  V30 9 C 9.2400 12.0032 0.0 0
M  V30 10 N 8.4700 10.6694 0.0 0
M  V30 11 O 8.4700 13.3369 0.0 0
M  V30 12 C 6.9300 10.6694 0.0 0 CFG=1
M  V30 13 C 6.1600 12.0032 0.0 0
M  V30 14 C 6.1600 9.3358 0.0 0
M  V30 15 O 6.9300 8.0021 0.0 0
M  V30 16 O 4.6200 9.3358 0.0 0
M  V30 17 C 6.1600 6.6685 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 C 6.9300 2.6674 0.0 0
M  V30 21 C 6.1600 1.3338 0.0 0
M  V30 22 C 6.9300 0.0000 0.0 0
M  V30 23 Cl 0.0000 12.0032 0.0 0
M  V30 24 N 13.0815 13.4978 0.0 0
M  V30 25 C 11.5500 13.3369 0.0 0 CFG=1
M  V30 26 C 13.4017 15.0042 0.0 0
M  V30 27 C 10.9235 14.7437 0.0 0
M  V30 28 C 12.0681 15.7742 0.0 0
M  V30 29 C 4.6200 12.0032 0.0 0
M  V30 30 C 3.8500 10.6694 0.0 0
M  V30 31 C 3.8500 13.3369 0.0 0
M  V30 32 C 2.3100 10.6694 0.0 0
M  V30 33 C 2.3100 13.3369 0.0 0
M  V30 34 C 1.5400 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 25 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 2 21 22
M  V30 24 1 23 34
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3061154-94-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101555-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061154-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42895448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro
from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent
Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant
Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xu; Gotchev, Dimitar; Fan, Kristi Yi; Vega, Marvin M.; Mani,
Nagraj; McGovern-Gooch, Kayleigh; Cuconati, Andrea; Tercero, Breanna;
Wang, Xiaohe; Carpino, Philip; Maskos, Klaus; Centrella, Paolo A.;
Schmitt, Andreas; Preuss, Franziska; Prasad, Archna; Chen, Chia-yi;
Clark, Matthew A.; Guilinger, John P.; Johnstone, Shawn; von Konig,
Konstanze; Keefe, Anthony D.; Liu, Jenny; Turcotte, Stephane; Zhang,
Ying; Konz Makino, Debora L.; Lam, Angela M.; Cole, Andrew G.; Sofia,
Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(21), 19623-19667

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-L-tryptophan
C16H20N2O4
13139-14-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 4.0011 0.0 0
M  V30 2 C 5.8243 2.6674 0.0 0 CFG=1
M  V30 3 N 7.3643 2.6674 0.0 0
M  V30 4 C 5.0543 1.3336 0.0 0
M  V30 5 C 8.1343 4.0011 0.0 0
M  V30 6 O 3.5143 1.3336 0.0 0
M  V30 7 O 5.8243 0.0000 0.0 0
M  V30 8 O 9.6743 4.0011 0.0 0
M  V30 9 O 7.3643 5.3347 0.0 0
M  V30 10 C 10.4443 5.3347 0.0 0
M  V30 11 C 11.7780 4.5647 0.0 0
M  V30 12 C 11.2143 6.6684 0.0 0
M  V30 13 C 9.1107 6.1047 0.0 0
M  V30 14 C 2.6091 5.2470 0.0 0
M  V30 15 C 3.5143 4.0011 0.0 0
M  V30 16 C 1.1444 4.7711 0.0 0
M  V30 17 C 2.9292 6.7534 0.0 0
M  V30 18 C 2.6091 2.7552 0.0 0
M  V30 19 N 1.1444 3.2311 0.0 0
M  V30 20 C 0.0000 5.8015 0.0 0
M  V30 21 C 1.7849 7.7838 0.0 0
M  V30 22 C 0.3202 7.3080 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(1E)-2-(3,5-Dimethoxyphenyl)ethenyl]benzenamine
C16H17NO2
586410-15-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 1.3337 5.3901 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 O 4.0010 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 N 13.3370 7.7002 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 9.3360 5.3901 0.0 0
M  V30 15 C 9.3360 6.9302 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 10.6697 7.7002 0.0 0
M  V30 18 C 12.0033 5.3901 0.0 0
M  V30 19 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H35N3O5
3081937-77-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.7533 0.0 0
M  V30 2 C 6.1600 7.0869 0.0 0 CFG=2
M  V30 3 C 7.7000 7.0869 0.0 0
M  V30 4 N 5.3900 8.4206 0.0 0
M  V30 5 N 8.4700 8.4206 0.0 0
M  V30 6 O 8.4700 5.7533 0.0 0
M  V30 7 C 3.8500 8.4206 0.0 0
M  V30 8 O 3.0800 9.7542 0.0 0
M  V30 9 O 3.0800 7.0869 0.0 0
M  V30 10 C 1.5400 9.7542 0.0 0
M  V30 11 C 1.5400 11.2942 0.0 0
M  V30 12 C 0.0000 9.7542 0.0 0
M  V30 13 C 1.5400 8.2142 0.0 0
M  V30 14 C 14.6300 8.4206 0.0 0
M  V30 15 C 15.4000 9.7542 0.0 0
M  V30 16 O 20.0200 12.4216 0.0 0
M  V30 17 C 21.5600 12.4216 0.0 0
M  V30 18 O 20.0200 7.0869 0.0 0
M  V30 19 C 21.5600 7.0869 0.0 0
M  V30 20 C 6.1600 4.4195 0.0 0
M  V30 21 C 5.5337 3.0127 0.0 0
M  V30 22 C 7.6915 4.2586 0.0 0
M  V30 23 C 6.6781 1.9823 0.0 0
M  V30 24 C 4.0690 2.5368 0.0 0
M  V30 25 N 8.0117 2.7523 0.0 0
M  V30 26 C 6.3579 0.4759 0.0 0
M  V30 27 C 3.7488 1.0304 0.0 0
M  V30 28 C 4.8932 0.0000 0.0 0
M  V30 29 C 10.0100 8.4206 0.0 0
M  V30 30 C 10.7800 9.7542 0.0 0
M  V30 31 C 10.7800 7.0869 0.0 0
M  V30 32 C 12.3200 9.7542 0.0 0
M  V30 33 C 12.3200 7.0869 0.0 0
M  V30 34 C 13.0900 8.4206 0.0 0
M  V30 35 C 16.9400 9.7542 0.0 0
M  V30 36 C 17.7100 11.0880 0.0 0
M  V30 37 C 17.7100 8.4206 0.0 0
M  V30 38 C 19.2500 11.0880 0.0 0
M  V30 39 C 19.2500 8.4206 0.0 0
M  V30 40 C 20.0200 9.7542 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 29
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 14 15
M  V30 16 1 14 34
M  V30 17 1 15 35
M  V30 18 1 16 17
M  V30 19 1 16 38
M  V30 20 1 18 19
M  V30 21 1 18 39
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13139-14-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586410-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3081937-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41302566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Structure-Activity Relationship Study of Amino Acid Derivatives of
Pterostilbene Analogues Toward Human Breast Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cordella, Fabiana; Dragone, Nicola; D'Orsi, Rosarita; Saponaro, Concetta;
Vergara, Daniele; Lessi, Marco; Angelici, Gaetano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2024), 19(14), e202300727

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
L-Tryptophan methyl ester
C12H14N2O2
4299-70-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 2.6218 0.0 0
M  V30 2 C 7.0869 1.8518 0.0 0 CFG=2
M  V30 3 C 8.4206 2.6218 0.0 0
M  V30 4 N 7.0869 0.3118 0.0 0
M  V30 5 O 9.7544 1.8518 0.0 0
M  V30 6 O 8.4206 4.1618 0.0 0
M  V30 7 C 11.0880 2.6218 0.0 0
M  V30 8 C 3.0127 2.4782 0.0 0
M  V30 9 C 4.4196 1.8518 0.0 0
M  V30 10 C 1.9823 1.3338 0.0 0
M  V30 11 C 2.5368 3.9429 0.0 0
M  V30 12 C 4.2586 0.3202 0.0 0
M  V30 13 N 2.7523 0.0000 0.0 0
M  V30 14 C 0.4759 1.6540 0.0 0
M  V30 15 C 1.0304 4.2630 0.0 0
M  V30 16 C 0.0000 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(2-Carboxyethyl)-4-nitroheptanedioic acid
C10H15NO8
59085-15-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3348 0.0 0
M  V30 2 C 6.6685 4.5648 0.0 0
M  V30 3 C 4.5648 4.0012 0.0 0
M  V30 4 C 4.0012 6.1048 0.0 0
M  V30 5 N 6.1048 6.6687 0.0 0 VAL=5
M  V30 6 C 8.0023 5.3348 0.0 0
M  V30 7 C 5.3348 2.6675 0.0 0
M  V30 8 C 2.6673 5.3348 0.0 0
M  V30 9 O 7.6449 6.6687 0.0 0
M  V30 10 O 5.3348 8.0023 0.0 0
M  V30 11 C 9.3360 4.5648 0.0 0
M  V30 12 C 4.5648 1.3337 0.0 0
M  V30 13 C 1.3337 6.1048 0.0 0
M  V30 14 O 9.3360 3.0248 0.0 0
M  V30 15 O 10.6697 5.3348 0.0 0
M  V30 16 O 3.0248 1.3337 0.0 0
M  V30 17 O 5.3348 0.0000 0.0 0
M  V30 18 O 0.0000 5.3348 0.0 0
M  V30 19 O 1.3337 7.6449 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tryptophan, N,N′-[4-[3-[[(1S)-1-(1H-indol-3-ylmethyl)-2-methoxy-2-oxoethyl]...
C46H51N7O11
2644023-48-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  64 69 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.0880 10.4394 0.0 0
M  V30 2 C 10.3180 9.1057 0.0 0
M  V30 3 C 9.7542 11.2094 0.0 0
M  V30 4 C 11.8580 11.7730 0.0 0
M  V30 5 N 12.4216 9.6694 0.0 0 VAL=5
M  V30 6 C 11.0880 7.7721 0.0 0
M  V30 7 C 9.7542 12.7494 0.0 0
M  V30 8 C 13.3980 11.7730 0.0 0
M  V30 9 O 13.7553 10.4394 0.0 0
M  V30 10 O 12.4216 8.1294 0.0 0
M  V30 11 C 10.3180 6.4383 0.0 0
M  V30 12 C 8.4206 13.5194 0.0 0
M  V30 13 C 14.1680 13.1068 0.0 0
M  V30 14 N 11.0880 5.1046 0.0 0
M  V30 15 O 8.7780 6.4383 0.0 0
M  V30 16 N 8.4206 15.0594 0.0 0
M  V30 17 O 7.0869 12.7494 0.0 0
M  V30 18 N 15.7080 13.1068 0.0 0
M  V30 19 O 13.3980 14.4404 0.0 0
M  V30 20 C 10.3180 3.7710 0.0 0 CFG=2
M  V30 21 C 7.0869 15.8294 0.0 0 CFG=2
M  V30 22 C 16.4780 14.4404 0.0 0 CFG=2
M  V30 23 C 8.7780 3.7710 0.0 0
M  V30 24 C 11.0880 2.4374 0.0 0
M  V30 25 C 5.7533 15.0594 0.0 0
M  V30 26 C 7.0869 17.3694 0.0 0
M  V30 27 C 18.0180 14.4404 0.0 0
M  V30 28 C 15.7080 15.7741 0.0 0
M  V30 29 O 12.6280 2.4374 0.0 0
M  V30 30 O 10.3180 1.1036 0.0 0
M  V30 31 O 8.4206 18.1394 0.0 0
M  V30 32 O 5.7533 18.1394 0.0 0
M  V30 33 O 16.4780 17.1077 0.0 0
M  V30 34 O 14.1680 15.7741 0.0 0
M  V30 35 C 13.3980 1.1036 0.0 0
M  V30 36 C 8.4206 19.6794 0.0 0
M  V30 37 C 15.7080 18.4415 0.0 0
M  V30 38 C 8.0080 2.4374 0.0 0
M  V30 39 C 6.4763 2.2763 0.0 0
M  V30 40 C 8.6343 1.0304 0.0 0
M  V30 41 C 6.1561 0.7700 0.0 0
M  V30 42 C 5.3319 3.3068 0.0 0
M  V30 43 N 7.4899 0.0000 0.0 0
M  V30 44 C 4.6916 0.2941 0.0 0
M  V30 45 C 3.8672 2.8308 0.0 0
M  V30 46 C 3.5471 1.3246 0.0 0
M  V30 47 C 4.4195 15.8294 0.0 0
M  V30 48 C 3.0127 15.2030 0.0 0
M  V30 49 C 4.2586 17.3609 0.0 0
M  V30 50 C 1.9823 16.3474 0.0 0
M  V30 51 C 2.5368 13.7383 0.0 0
M  V30 52 N 2.7523 17.6810 0.0 0
M  V30 53 C 0.4759 16.0272 0.0 0
M  V30 54 C 1.0304 13.4182 0.0 0
M  V30 55 C 0.0000 14.5627 0.0 0
M  V30 56 C 18.7880 13.1068 0.0 0
M  V30 57 C 20.3195 12.9457 0.0 0
M  V30 58 C 18.1615 11.6998 0.0 0
M  V30 59 C 20.6397 11.4394 0.0 0
M  V30 60 C 21.4639 13.9763 0.0 0
M  V30 61 N 19.3061 10.6694 0.0 0
M  V30 62 C 22.1044 10.9636 0.0 0
M  V30 63 C 22.9286 13.5004 0.0 0
M  V30 64 C 23.2488 11.9940 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 16 21
M  V30 21 1 18 22
M  V30 22 1 20 23 CFG=3
M  V30 23 1 20 24
M  V30 24 1 21 25 CFG=1
M  V30 25 1 21 26
M  V30 26 1 22 27 CFG=3
M  V30 27 1 22 28
M  V30 28 1 23 38
M  V30 29 1 24 29
M  V30 30 2 24 30
M  V30 31 1 25 47
M  V30 32 1 26 31
M  V30 33 2 26 32
M  V30 34 1 27 56
M  V30 35 1 28 33
M  V30 36 2 28 34
M  V30 37 1 29 35
M  V30 38 1 31 36
M  V30 39 1 33 37
M  V30 40 1 38 39
M  V30 41 2 38 40
M  V30 42 1 39 41
M  V30 43 2 39 42
M  V30 44 1 40 43
M  V30 45 1 41 43
M  V30 46 2 41 44
M  V30 47 1 42 45
M  V30 48 1 44 46
M  V30 49 2 45 46
M  V30 50 1 47 48
M  V30 51 2 47 49
M  V30 52 1 48 50
M  V30 53 2 48 51
M  V30 54 1 49 52
M  V30 55 1 50 52
M  V30 56 2 50 53
M  V30 57 1 51 54
M  V30 58 1 53 55
M  V30 59 2 54 55
M  V30 60 1 56 57
M  V30 61 2 56 58
M  V30 62 1 57 59
M  V30 63 2 57 60
M  V30 64 1 58 61
M  V30 65 1 59 61
M  V30 66 2 59 62
M  V30 67 1 60 63
M  V30 68 1 62 64
M  V30 69 2 63 64
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4299-70-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 59085-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2644023-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23922679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scaffold Simplification Strategy Leads to a Novel Generation of Dual
Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez-Gualda, Belen; Sun, Liang; Marti-Mari, Olaia; Noppen, Sam;
Abdelnabi, Rana; Bator, Carol M.; Quesada, Ernesto; Delang, Leen;
Mirabelli, Carmen; Lee, Hyunwook; Schols, Dominique; Neyts, Johan;
Hafenstein, Susan; Camarasa, Maria-Jose; Gago, Federico; San-Felix, Ana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(1), 349-368

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-hydroxy-N-(2-methylpropyl)benze...
C20H28N2O4S
157567-13-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 O 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) (2R)-2,4-morpholinedicarboxylate
C10H17NO5
884512-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 O 9.3360 4.6201 0.0 0
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0 CFG=2
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 O 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[[(1S,2R)-2-hydroxy-3-[[(4-hydroxyphenyl)sulfonyl](...
C30H43N3O8S
2765293-59-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 8.4701 0.0 0 CFG=1
M  V30 2 C 6.6684 7.7001 0.0 0 CFG=2
M  V30 3 C 8.0022 10.0101 0.0 0
M  V30 4 N 9.3359 7.7001 0.0 0
M  V30 5 C 5.3348 8.4701 0.0 0
M  V30 6 O 6.6684 6.1601 0.0 0
M  V30 7 C 10.6695 8.4701 0.0 0
M  V30 8 N 4.0011 7.7001 0.0 0
M  V30 9 O 10.6695 10.0101 0.0 0
M  V30 10 S 4.0011 6.1601 0.0 0 VAL=6
M  V30 11 C 2.6675 8.4701 0.0 0
M  V30 12 O 2.4611 6.1601 0.0 0
M  V30 13 O 5.5411 6.1601 0.0 0
M  V30 14 C 1.3337 7.7001 0.0 0
M  V30 15 C 0.0000 8.4701 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 16.0043 8.4701 0.0 0
M  V30 18 O 17.3380 7.7001 0.0 0
M  V30 19 O 16.0043 10.0101 0.0 0
M  V30 20 C 18.6718 8.4701 0.0 0
M  V30 21 C 19.4418 7.1364 0.0 0
M  V30 22 C 20.0054 9.2401 0.0 0
M  V30 23 C 17.9018 9.8037 0.0 0
M  V30 24 O 4.0011 0.0000 0.0 0
M  V30 25 C 6.6684 10.7801 0.0 0
M  V30 26 C 6.6684 12.3201 0.0 0
M  V30 27 C 5.3348 10.0101 0.0 0
M  V30 28 C 5.3348 13.0901 0.0 0
M  V30 29 C 4.0011 10.7801 0.0 0
M  V30 30 C 4.0011 12.3201 0.0 0
M  V30 31 C 12.0032 7.7001 0.0 0 CFG=2
M  V30 32 C 13.3370 8.4701 0.0 0
M  V30 33 O 12.0032 6.1601 0.0 0
M  V30 34 N 14.6707 7.7001 0.0 0
M  V30 35 C 13.3370 5.3901 0.0 0
M  V30 36 C 14.6707 6.1601 0.0 0
M  V30 37 C 4.0011 4.6201 0.0 0
M  V30 38 C 5.3348 3.8500 0.0 0
M  V30 39 C 2.6675 3.8500 0.0 0
M  V30 40 C 5.3348 2.3100 0.0 0
M  V30 41 C 2.6675 2.3100 0.0 0
M  V30 42 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 25
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 31 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 37
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 34
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 42
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 1 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 157567-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 884512-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3R)-1,3-pyrrolidinedicarboxylate
C10H17NO4
72925-16-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 3.2067 0.0 0
M  V30 2 O 3.0800 4.5405 0.0 0
M  V30 3 O 3.0800 1.8731 0.0 0
M  V30 4 C 1.5400 4.5405 0.0 0
M  V30 5 C 1.5400 3.0005 0.0 0
M  V30 6 C 0.0000 4.5405 0.0 0
M  V30 7 C 1.5400 6.0805 0.0 0
M  V30 8 C 9.0058 1.5317 0.0 0
M  V30 9 O 8.8447 0.0000 0.0 0
M  V30 10 O 10.4126 2.1580 0.0 0
M  V30 11 N 5.3900 3.2067 0.0 0
M  V30 12 C 6.2952 1.9609 0.0 0
M  V30 13 C 6.2952 4.4528 0.0 0
M  V30 14 C 7.7598 2.4367 0.0 0 CFG=2
M  V30 15 C 7.7598 3.9767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[[[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-n...
C30H42N4O8S
2925287-37-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 9.2400 0.0 0 CFG=1
M  V30 2 C 6.6684 8.4700 0.0 0 CFG=2
M  V30 3 C 8.0020 10.7800 0.0 0
M  V30 4 N 9.3358 8.4700 0.0 0
M  V30 5 C 5.3347 9.2400 0.0 0
M  V30 6 O 6.6684 6.9300 0.0 0
M  V30 7 C 10.6694 9.2400 0.0 0
M  V30 8 N 4.0009 8.4700 0.0 0
M  V30 9 O 10.6694 10.7800 0.0 0
M  V30 10 S 4.0009 6.9300 0.0 0 VAL=6
M  V30 11 C 2.6673 9.2400 0.0 0
M  V30 12 O 2.4611 6.9300 0.0 0
M  V30 13 O 5.5409 6.9300 0.0 0
M  V30 14 C 1.3336 8.4700 0.0 0
M  V30 15 C 0.0000 9.2400 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 15.9720 8.1129 0.0 0
M  V30 18 O 16.8772 6.8670 0.0 0
M  V30 19 O 16.5983 9.5198 0.0 0
M  V30 20 C 18.4087 7.0279 0.0 0
M  V30 21 C 18.5696 5.4964 0.0 0
M  V30 22 C 19.9402 7.1890 0.0 0
M  V30 23 C 18.2478 8.5596 0.0 0
M  V30 24 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 25 O 5.3347 0.0000 0.0 0
M  V30 26 O 2.6673 0.0000 0.0 0
M  V30 27 C 6.6684 11.5500 0.0 0
M  V30 28 C 6.6684 13.0900 0.0 0
M  V30 29 C 5.3347 10.7800 0.0 0
M  V30 30 C 5.3347 13.8600 0.0 0
M  V30 31 C 4.0009 11.5500 0.0 0
M  V30 32 C 4.0009 13.0900 0.0 0
M  V30 33 C 12.0031 8.4700 0.0 0 CFG=2
M  V30 34 C 13.4099 9.0963 0.0 0
M  V30 35 C 12.1640 6.9385 0.0 0
M  V30 36 N 14.4404 7.9519 0.0 0
M  V30 37 C 13.6704 6.6183 0.0 0
M  V30 38 C 4.0009 5.3900 0.0 0
M  V30 39 C 5.3347 4.6200 0.0 0
M  V30 40 C 2.6673 4.6200 0.0 0
M  V30 41 C 5.3347 3.0800 0.0 0
M  V30 42 C 2.6673 3.0800 0.0 0
M  V30 43 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 27
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 33 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 38
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 36
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 24 25
M  V30 27 2 24 26
M  V30 28 1 24 43
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 1 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 72925-16-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925287-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36491274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel HIV-1 protease
inhibitors containing pyrrolidine-derived P2 ligands to combat
drug-resistant variant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Huiyu; Ma, Ling; Dong, Biao; Wang, Juxian; Zhang, Guoning; Wang,
Minghua; Cen, Shan; Zhu, Mei; Shan, Qi; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 255115389

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
N-BOC-ethylenediamine
C7H16N2O2
57260-73-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 N 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxylic acid
C17H14ClNO4S
473257-46-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7534 4.8385 0.0 0 VAL=6
M  V30 2 O 4.9834 6.1721 0.0 0
M  V30 3 O 6.5234 3.5048 0.0 0
M  V30 4 C 5.4032 1.5063 0.0 0
M  V30 5 O 5.0830 0.0000 0.0 0
M  V30 6 O 6.8678 1.9823 0.0 0
M  V30 7 Cl 0.5546 7.9444 0.0 0
M  V30 8 C 8.4207 9.4585 0.0 0
M  V30 9 C 11.0882 4.8385 0.0 0
M  V30 10 C 4.4197 4.0684 0.0 0
M  V30 11 C 3.0128 4.6948 0.0 0
M  V30 12 C 4.2586 2.5369 0.0 0
M  V30 13 C 1.9823 3.5504 0.0 0
M  V30 14 C 2.5369 6.1595 0.0 0
M  V30 15 N 2.7523 2.2167 0.0 0
M  V30 16 C 0.4759 3.8706 0.0 0
M  V30 17 C 1.0304 6.4797 0.0 0
M  V30 18 C 0.0000 5.3353 0.0 0
M  V30 19 C 7.0871 5.6085 0.0 0
M  V30 20 C 7.0871 7.1485 0.0 0
M  V30 21 C 8.4207 4.8385 0.0 0
M  V30 22 C 8.4207 7.9185 0.0 0
M  V30 23 C 9.7545 5.6085 0.0 0
M  V30 24 C 9.7545 7.1485 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 7 17
M  V30 9 1 8 22
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-...
C24H28ClN3O5S
2649272-96-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.0737 5.7308 0.0 0 VAL=6
M  V30 2 O 3.9292 4.7004 0.0 0
M  V30 3 O 6.2181 6.7612 0.0 0
M  V30 4 C 8.4056 6.0810 0.0 0
M  V30 5 N 9.9456 6.0810 0.0 0
M  V30 6 O 7.6356 7.4146 0.0 0
M  V30 7 C 10.7156 7.4146 0.0 0
M  V30 8 C 12.2556 7.4146 0.0 0
M  V30 9 N 13.0256 8.7484 0.0 0
M  V30 10 C 14.5656 8.7484 0.0 0
M  V30 11 O 15.3356 10.0821 0.0 0
M  V30 12 O 15.3356 7.4146 0.0 0
M  V30 13 C 16.8756 10.0821 0.0 0
M  V30 14 C 16.8756 11.6221 0.0 0
M  V30 15 C 18.4156 10.0821 0.0 0
M  V30 16 C 16.8756 8.5421 0.0 0
M  V30 17 Cl 3.1165 0.0000 0.0 0
M  V30 18 C 0.0000 7.3794 0.0 0
M  V30 19 C 3.9644 10.9489 0.0 0
M  V30 20 C 6.1041 4.5864 0.0 0
M  V30 21 C 5.7839 3.0800 0.0 0
M  V30 22 C 7.6356 4.7474 0.0 0
M  V30 23 C 7.1176 2.3100 0.0 0
M  V30 24 C 4.4501 2.3100 0.0 0
M  V30 25 N 8.2619 3.3404 0.0 0
M  V30 26 C 7.1176 0.7700 0.0 0
M  V30 27 C 4.4501 0.7700 0.0 0
M  V30 28 C 5.7839 0.0000 0.0 0
M  V30 29 C 4.0431 6.8752 0.0 0
M  V30 30 C 2.5368 6.5550 0.0 0
M  V30 31 C 4.5190 8.3399 0.0 0
M  V30 32 C 1.5063 7.6995 0.0 0
M  V30 33 C 3.4886 9.4842 0.0 0
M  V30 34 C 1.9823 9.1641 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 27
M  V30 19 1 18 32
M  V30 20 1 19 33
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57260-73-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 473257-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2649272-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33066357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester
functionalities as potent HIV-1 non-nucleoside reverse transcriptase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Shujing; Song, Shu; Sun, Lin; Gao, Ping; Gao, Shenghua; Ma, Yue;
Kang, Dongwei; Cheng, Yusen; Zhang, Xujie; Cherukupalli, Srinivasulu; De
Clercq, Erik; Pannecouque, Christophe; Liu, Xinyong; Zhan, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 53116531

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
D-Phenylalanine, 4-chloro-N-[(1,1-dimethylethoxy)carbonyl]-, 6-hepten-1-yl ester
C21H30ClNO4
3061154-72-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 5.3900 8.0020 0.0 0
M  V30 4 C 7.7000 6.6684 0.0 0
M  V30 5 C 3.8500 8.0020 0.0 0
M  V30 6 O 8.4700 8.0020 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 O 3.0800 9.3358 0.0 0
M  V30 9 O 3.0800 6.6684 0.0 0
M  V30 10 C 10.0100 8.0020 0.0 0
M  V30 11 C 1.5400 9.3358 0.0 0
M  V30 12 C 10.7800 9.3358 0.0 0
M  V30 13 C 1.5400 10.8758 0.0 0
M  V30 14 C 0.0000 9.3358 0.0 0
M  V30 15 C 1.5400 7.7958 0.0 0
M  V30 16 C 12.3200 9.3358 0.0 0
M  V30 17 C 13.0900 10.6694 0.0 0
M  V30 18 C 14.6300 10.6694 0.0 0
M  V30 19 C 15.4000 12.0031 0.0 0
M  V30 20 C 16.9400 12.0031 0.0 0
M  V30 21 Cl 8.4700 0.0000 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 5.3900 2.6673 0.0 0
M  V30 24 C 7.7000 4.0011 0.0 0
M  V30 25 C 6.1600 1.3336 0.0 0
M  V30 26 C 8.4700 2.6673 0.0 0
M  V30 27 C 7.7000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 2 19 20
M  V30 21 1 21 27
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(R)-1-tert-Butoxycarbonylpyrrolidine-2-carboxylic acid
C11H19NO4
101555-60-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 3.3450 0.0 0
M  V30 2 O 7.0036 4.1150 0.0 0
M  V30 3 O 5.6699 1.8049 0.0 0
M  V30 4 C 8.3374 3.3450 0.0 0
M  V30 5 C 7.5674 2.0113 0.0 0
M  V30 6 C 9.6711 2.5749 0.0 0
M  V30 7 C 9.1075 4.6786 0.0 0
M  V30 8 C 2.6091 1.9822 0.0 0
M  V30 9 C 1.1446 1.5063 0.0 0
M  V30 10 O 0.0000 2.5367 0.0 0
M  V30 11 O 0.8244 0.0000 0.0 0
M  V30 12 N 4.3363 4.1150 0.0 0
M  V30 13 C 2.9293 3.4886 0.0 0 CFG=1
M  V30 14 C 4.1752 5.6465 0.0 0
M  V30 15 C 1.8989 4.6330 0.0 0
M  V30 16 C 2.6689 5.9667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 13 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H39ClN2O5
3061154-96-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.0192 12.0463 0.0 0
M  V30 2 O 0.9888 13.1907 0.0 0
M  V30 3 O 3.5255 12.3665 0.0 0
M  V30 4 C 1.4647 14.6554 0.0 0
M  V30 5 C 0.0000 15.1313 0.0 0
M  V30 6 C 1.9406 16.1201 0.0 0
M  V30 7 C 2.9292 14.1796 0.0 0
M  V30 8 C 3.9886 9.3358 0.0 0
M  V30 9 C 4.7586 8.0021 0.0 0
M  V30 10 N 6.2986 8.0021 0.0 0
M  V30 11 O 3.9886 6.6685 0.0 0
M  V30 12 C 7.0686 6.6685 0.0 0 CFG=1
M  V30 13 C 6.2986 5.3347 0.0 0
M  V30 14 C 8.6086 6.6685 0.0 0
M  V30 15 O 9.3786 8.0021 0.0 0
M  V30 16 O 9.3786 5.3347 0.0 0
M  V30 17 C 10.9186 8.0021 0.0 0
M  V30 18 C 11.6886 9.3358 0.0 0
M  V30 19 C 13.2286 9.3358 0.0 0
M  V30 20 C 13.9986 10.6694 0.0 0
M  V30 21 C 15.5386 10.6694 0.0 0
M  V30 22 C 16.3086 12.0032 0.0 0
M  V30 23 C 17.8486 12.0032 0.0 0
M  V30 24 Cl 9.3786 0.0000 0.0 0
M  V30 25 N 1.5434 10.5816 0.0 0
M  V30 26 C 2.4486 9.3358 0.0 0 CFG=1
M  V30 27 C 0.0787 10.1058 0.0 0
M  V30 28 C 1.5434 8.0899 0.0 0
M  V30 29 C 0.0787 8.5658 0.0 0
M  V30 30 C 7.0686 4.0011 0.0 0
M  V30 31 C 8.6086 4.0011 0.0 0
M  V30 32 C 6.2986 2.6674 0.0 0
M  V30 33 C 9.3786 2.6674 0.0 0
M  V30 34 C 7.0686 1.3338 0.0 0
M  V30 35 C 8.6086 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 26 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 22 23
M  V30 25 1 24 35
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3061154-72-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101555-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061154-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42895446
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro
from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent
Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant
Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xu; Gotchev, Dimitar; Fan, Kristi Yi; Vega, Marvin M.; Mani,
Nagraj; McGovern-Gooch, Kayleigh; Cuconati, Andrea; Tercero, Breanna;
Wang, Xiaohe; Carpino, Philip; Maskos, Klaus; Centrella, Paolo A.;
Schmitt, Andreas; Preuss, Franziska; Prasad, Archna; Chen, Chia-yi;
Clark, Matthew A.; Guilinger, John P.; Johnstone, Shawn; von Konig,
Konstanze; Keefe, Anthony D.; Liu, Jenny; Turcotte, Stephane; Zhang,
Ying; Konz Makino, Debora L.; Lam, Angela M.; Cole, Andrew G.; Sofia,
Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(21), 19623-19667

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Benzoic acid
C7H6O2
65-85-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C33H29N3O4
2919713-64-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 C 11.7732 2.8281 0.0 0
M  V30 11 C 11.0032 4.1618 0.0 0
M  V30 12 C 10.7428 1.6836 0.0 0
M  V30 13 C 13.3133 2.8281 0.0 0
M  V30 14 N 9.4969 3.8416 0.0 0
M  V30 15 C 11.7732 5.4955 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 14.0833 4.1618 0.0 0
M  V30 18 C 13.3133 5.4955 0.0 0
M  V30 19 C 15.6233 4.1618 0.0 0
M  V30 20 C 16.3934 2.8281 0.0 0
M  V30 21 C 16.3934 5.4955 0.0 0
M  V30 22 C 17.9334 2.8281 0.0 0
M  V30 23 C 17.9334 5.4955 0.0 0
M  V30 24 C 18.7034 4.1618 0.0 0
M  V30 25 N 6.6685 2.3101 0.0 0
M  V30 26 C 5.3348 1.5400 0.0 0
M  V30 27 C 6.6685 3.8501 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 5.3348 4.6201 0.0 0
M  V30 30 C 4.0012 3.8501 0.0 0
M  V30 31 C 2.6673 1.5400 0.0 0
M  V30 32 C 2.6673 4.6201 0.0 0
M  V30 33 C 1.3337 2.3101 0.0 0
M  V30 34 C 1.3337 3.8501 0.0 0
M  V30 35 C 22.5535 5.4955 0.0 0
M  V30 36 C 23.3235 6.8291 0.0 0
M  V30 37 C 23.3235 4.1618 0.0 0
M  V30 38 C 24.8635 6.8291 0.0 0
M  V30 39 C 24.8635 4.1618 0.0 0
M  V30 40 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 24
M  V30 6 2 4 5
M  V30 7 1 4 35
M  V30 8 1 6 7
M  V30 9 1 6 33
M  V30 10 1 8 9
M  V30 11 1 8 34
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 16
M  V30 20 1 15 18
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 28 31
M  V30 35 1 29 30
M  V30 36 2 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide
C20H29N3O3S
169280-56-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 N 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) (2R)-2,4-morpholinedicarboxylate
C10H17NO5
884512-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 O 9.3360 4.6201 0.0 0
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0 CFG=2
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 O 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylprop...
C30H44N4O7S
2765293-61-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 8.4701 0.0 0 CFG=1
M  V30 2 C 6.6684 7.7001 0.0 0 CFG=2
M  V30 3 C 8.0022 10.0101 0.0 0
M  V30 4 N 9.3359 7.7001 0.0 0
M  V30 5 C 5.3348 8.4701 0.0 0
M  V30 6 O 6.6684 6.1601 0.0 0
M  V30 7 C 10.6695 8.4701 0.0 0
M  V30 8 N 4.0011 7.7001 0.0 0
M  V30 9 O 10.6695 10.0101 0.0 0
M  V30 10 S 4.0011 6.1601 0.0 0 VAL=6
M  V30 11 C 2.6675 8.4701 0.0 0
M  V30 12 O 2.4611 6.1601 0.0 0
M  V30 13 O 5.5411 6.1601 0.0 0
M  V30 14 C 1.3337 7.7001 0.0 0
M  V30 15 C 0.0000 8.4701 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 16.0043 8.4701 0.0 0
M  V30 18 O 17.3380 7.7001 0.0 0
M  V30 19 O 16.0043 10.0101 0.0 0
M  V30 20 C 18.6718 8.4701 0.0 0
M  V30 21 C 19.4418 7.1364 0.0 0
M  V30 22 C 20.0054 9.2401 0.0 0
M  V30 23 C 17.9018 9.8037 0.0 0
M  V30 24 N 4.0011 0.0000 0.0 0
M  V30 25 C 6.6684 10.7801 0.0 0
M  V30 26 C 6.6684 12.3201 0.0 0
M  V30 27 C 5.3348 10.0101 0.0 0
M  V30 28 C 5.3348 13.0901 0.0 0
M  V30 29 C 4.0011 10.7801 0.0 0
M  V30 30 C 4.0011 12.3201 0.0 0
M  V30 31 C 12.0032 7.7001 0.0 0 CFG=2
M  V30 32 C 13.3370 8.4701 0.0 0
M  V30 33 O 12.0032 6.1601 0.0 0
M  V30 34 N 14.6707 7.7001 0.0 0
M  V30 35 C 13.3370 5.3901 0.0 0
M  V30 36 C 14.6707 6.1601 0.0 0
M  V30 37 C 4.0011 4.6201 0.0 0
M  V30 38 C 5.3348 3.8500 0.0 0
M  V30 39 C 2.6675 3.8500 0.0 0
M  V30 40 C 5.3348 2.3100 0.0 0
M  V30 41 C 2.6675 2.3100 0.0 0
M  V30 42 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 25
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 31 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 37
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 34
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 42
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 1 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 169280-56-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 884512-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632751
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
2-Aminophenol
C6H7NO
95-55-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (2R)-4-[4-carboxy-2-(trifluoromethyl)-5-thiazolyl]-2-me...
C15H20F3N3O4S
1646267-98-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4323 1.1444 0.0 0
M  V30 2 O 3.4017 0.0000 0.0 0
M  V30 3 O 5.9385 0.8242 0.0 0
M  V30 4 C 1.2459 5.5301 0.0 0
M  V30 5 F 0.3406 4.2843 0.0 0
M  V30 6 F 0.0000 6.4354 0.0 0
M  V30 7 F 2.1511 6.7760 0.0 0
M  V30 8 C 9.4815 6.5224 0.0 0
M  V30 9 C 11.0215 3.8549 0.0 0
M  V30 10 O 11.7915 2.5213 0.0 0
M  V30 11 O 11.7915 5.1886 0.0 0
M  V30 12 C 13.3315 2.5213 0.0 0
M  V30 13 C 13.3315 4.0613 0.0 0
M  V30 14 C 14.8715 2.5213 0.0 0
M  V30 15 C 13.3315 0.9813 0.0 0
M  V30 16 C 4.8615 3.8549 0.0 0
M  V30 17 C 3.9564 2.6091 0.0 0
M  V30 18 S 3.9564 5.1008 0.0 0
M  V30 19 N 2.4917 3.0849 0.0 0
M  V30 20 C 2.4917 4.6249 0.0 0
M  V30 21 N 6.4015 3.8549 0.0 0
M  V30 22 C 7.1715 5.1886 0.0 0
M  V30 23 C 7.1715 2.5213 0.0 0
M  V30 24 C 8.7115 5.1886 0.0 0 CFG=1
M  V30 25 C 8.7115 2.5213 0.0 0
M  V30 26 N 9.4815 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 20
M  V30 8 1 24 8 CFG=1
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 26
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-4-[4-[[(2-hydroxyphenyl)amino]carbonyl]-2-(trifluorome...
C21H25F3N4O4S
2816047-06-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4323 5.5383 0.0 0
M  V30 2 N 3.4017 4.3939 0.0 0
M  V30 3 O 5.9385 5.2181 0.0 0
M  V30 4 C 1.2459 9.9241 0.0 0
M  V30 5 F 2.1511 11.1699 0.0 0
M  V30 6 F 0.0000 10.8293 0.0 0
M  V30 7 F 0.3406 8.6782 0.0 0
M  V30 8 C 9.4815 10.9161 0.0 0
M  V30 9 C 11.0215 8.2489 0.0 0
M  V30 10 O 11.7915 6.9152 0.0 0
M  V30 11 O 11.7915 9.5825 0.0 0
M  V30 12 C 13.3315 6.9152 0.0 0
M  V30 13 C 13.3315 5.3752 0.0 0
M  V30 14 C 14.8715 6.9152 0.0 0
M  V30 15 C 13.3315 8.4552 0.0 0
M  V30 16 O 1.3409 2.1050 0.0 0
M  V30 17 C 4.8615 8.2489 0.0 0
M  V30 18 C 3.9564 7.0030 0.0 0
M  V30 19 S 3.9564 9.4947 0.0 0
M  V30 20 N 2.4917 7.4789 0.0 0
M  V30 21 C 2.4917 9.0189 0.0 0
M  V30 22 N 6.4015 8.2489 0.0 0
M  V30 23 C 7.1715 9.5825 0.0 0
M  V30 24 C 7.1715 6.9152 0.0 0
M  V30 25 C 8.7115 9.5825 0.0 0 CFG=1
M  V30 26 C 8.7115 6.9152 0.0 0
M  V30 27 N 9.4815 8.2489 0.0 0
M  V30 28 C 3.8777 2.9292 0.0 0
M  V30 29 C 2.8472 1.7849 0.0 0
M  V30 30 C 5.3840 2.6091 0.0 0
M  V30 31 C 3.3230 0.3202 0.0 0
M  V30 32 C 5.8599 1.1444 0.0 0
M  V30 33 C 4.8294 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 21
M  V30 9 1 25 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 29
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 95-55-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1646267-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2816047-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34105610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Pharmacological Evaluation of
Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic
Potential in Autoimmune Diseases: Discovery of ACT-672125
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caroff, Eva; Meyer, Emmanuel A.; Aanismaa, Paivi; Froidevaux, Sylvie;
Keller, Marcel; Piali, Luca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(16), 10918-10933

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
D-Phenylalanine, 4-chloro-N-[(1,1-dimethylethoxy)carbonyl]-, 7-octen-1-yl ester
C22H32ClNO4
3061154-95-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 5.3900 8.0020 0.0 0
M  V30 4 C 7.7000 6.6684 0.0 0
M  V30 5 C 3.8500 8.0020 0.0 0
M  V30 6 O 8.4700 8.0020 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 O 3.0800 9.3358 0.0 0
M  V30 9 O 3.0800 6.6684 0.0 0
M  V30 10 C 10.0100 8.0020 0.0 0
M  V30 11 C 1.5400 9.3358 0.0 0
M  V30 12 C 10.7800 9.3358 0.0 0
M  V30 13 C 1.5400 7.7958 0.0 0
M  V30 14 C 0.0000 9.3358 0.0 0
M  V30 15 C 1.5400 10.8758 0.0 0
M  V30 16 C 12.3200 9.3358 0.0 0
M  V30 17 C 13.0900 10.6694 0.0 0
M  V30 18 C 14.6300 10.6694 0.0 0
M  V30 19 C 15.4000 12.0031 0.0 0
M  V30 20 C 16.9400 12.0031 0.0 0
M  V30 21 C 17.7100 13.3367 0.0 0
M  V30 22 Cl 8.4700 0.0000 0.0 0
M  V30 23 C 6.1600 4.0011 0.0 0
M  V30 24 C 7.7000 4.0011 0.0 0
M  V30 25 C 5.3900 2.6673 0.0 0
M  V30 26 C 8.4700 2.6673 0.0 0
M  V30 27 C 6.1600 1.3336 0.0 0
M  V30 28 C 7.7000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 23
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 2 20 21
M  V30 22 1 22 28
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(R)-1-tert-Butoxycarbonylpyrrolidine-2-carboxylic acid
C11H19NO4
101555-60-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 3.3450 0.0 0
M  V30 2 O 7.0036 4.1150 0.0 0
M  V30 3 O 5.6699 1.8049 0.0 0
M  V30 4 C 8.3374 3.3450 0.0 0
M  V30 5 C 7.5674 2.0113 0.0 0
M  V30 6 C 9.6711 2.5749 0.0 0
M  V30 7 C 9.1075 4.6786 0.0 0
M  V30 8 C 2.6091 1.9822 0.0 0
M  V30 9 C 1.1446 1.5063 0.0 0
M  V30 10 O 0.0000 2.5367 0.0 0
M  V30 11 O 0.8244 0.0000 0.0 0
M  V30 12 N 4.3363 4.1150 0.0 0
M  V30 13 C 2.9293 3.4886 0.0 0 CFG=1
M  V30 14 C 4.1752 5.6465 0.0 0
M  V30 15 C 1.8989 4.6330 0.0 0
M  V30 16 C 2.6689 5.9667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 13 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 2-[2-[[(1R)-1-[(4-chlorophenyl)methyl]-2-(7-oct...
C28H41ClN2O5
3061154-98-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.0192 12.0463 0.0 0
M  V30 2 O 0.9888 13.1907 0.0 0
M  V30 3 O 3.5255 12.3665 0.0 0
M  V30 4 C 1.4647 14.6554 0.0 0
M  V30 5 C 0.0000 15.1313 0.0 0
M  V30 6 C 1.9406 16.1201 0.0 0
M  V30 7 C 2.9292 14.1796 0.0 0
M  V30 8 C 3.9886 9.3358 0.0 0
M  V30 9 C 4.7586 8.0021 0.0 0
M  V30 10 N 6.2986 8.0021 0.0 0
M  V30 11 O 3.9886 6.6685 0.0 0
M  V30 12 C 7.0686 6.6685 0.0 0 CFG=1
M  V30 13 C 6.2986 5.3347 0.0 0
M  V30 14 C 8.6086 6.6685 0.0 0
M  V30 15 O 9.3786 8.0021 0.0 0
M  V30 16 O 9.3786 5.3347 0.0 0
M  V30 17 C 10.9186 8.0021 0.0 0
M  V30 18 C 11.6886 9.3358 0.0 0
M  V30 19 C 13.2286 9.3358 0.0 0
M  V30 20 C 13.9986 10.6694 0.0 0
M  V30 21 C 15.5386 10.6694 0.0 0
M  V30 22 C 16.3086 12.0032 0.0 0
M  V30 23 C 17.8486 12.0032 0.0 0
M  V30 24 C 18.6186 13.3369 0.0 0
M  V30 25 Cl 9.3786 0.0000 0.0 0
M  V30 26 N 1.5434 10.5816 0.0 0
M  V30 27 C 2.4486 9.3358 0.0 0 CFG=1
M  V30 28 C 0.0787 10.1058 0.0 0
M  V30 29 C 1.5434 8.0899 0.0 0
M  V30 30 C 0.0787 8.5658 0.0 0
M  V30 31 C 7.0686 4.0011 0.0 0
M  V30 32 C 8.6086 4.0011 0.0 0
M  V30 33 C 6.2986 2.6674 0.0 0
M  V30 34 C 9.3786 2.6674 0.0 0
M  V30 35 C 7.0686 1.3338 0.0 0
M  V30 36 C 8.6086 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 27 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 31
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 2 23 24
M  V30 26 1 25 36
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3061154-95-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101555-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061154-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42895443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro
from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent
Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant
Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xu; Gotchev, Dimitar; Fan, Kristi Yi; Vega, Marvin M.; Mani,
Nagraj; McGovern-Gooch, Kayleigh; Cuconati, Andrea; Tercero, Breanna;
Wang, Xiaohe; Carpino, Philip; Maskos, Klaus; Centrella, Paolo A.;
Schmitt, Andreas; Preuss, Franziska; Prasad, Archna; Chen, Chia-yi;
Clark, Matthew A.; Guilinger, John P.; Johnstone, Shawn; von Konig,
Konstanze; Keefe, Anthony D.; Liu, Jenny; Turcotte, Stephane; Zhang,
Ying; Konz Makino, Debora L.; Lam, Angela M.; Cole, Andrew G.; Sofia,
Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(21), 19623-19667

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
1-[(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl] hydrogen butanedioate
C14H22O4
1092569-57-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5029 5.5476 0.0 0
M  V30 2 O 6.3920 4.0011 0.0 0
M  V30 3 C 7.1620 2.6675 0.0 0
M  V30 4 C 8.7020 2.6675 0.0 0
M  V30 5 O 6.3920 1.3337 0.0 0
M  V30 6 C 9.4720 1.3337 0.0 0
M  V30 7 C 11.0120 1.3337 0.0 0
M  V30 8 O 11.7821 2.6675 0.0 0
M  V30 9 O 11.7821 0.0000 0.0 0
M  V30 10 C 2.0053 1.1658 0.0 0
M  V30 11 C 0.0000 2.8269 0.0 0
M  V30 12 C 3.4338 4.4393 0.0 0 CFG=2
M  V30 13 C 4.8520 4.0011 0.0 0 CFG=2
M  V30 14 C 1.5274 2.6299 0.0 0
M  V30 15 C 2.9724 5.7612 0.0 0
M  V30 16 C 3.6190 3.6203 0.0 0
M  V30 17 C 2.2965 3.8242 0.0 0 CFG=1
M  V30 18 C 1.8676 5.3403 0.0 0
M  V30 19 H 0.7734 4.0516 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 14
M  V30 11 1 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Thiazolemethanamine, 2-(4-fluorophenyl)-, hydrochloride (1:1)
C10H9FN2S.ClH
1187932-83-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 4.5489 0.0 0
M  V30 2 N 11.1826 3.9225 0.0 0
M  V30 3 F 0.0000 2.8736 0.0 0
M  V30 4 C 6.1600 2.8736 0.0 0
M  V30 5 N 7.0652 4.1195 0.0 0
M  V30 6 S 7.0652 1.6278 0.0 0
M  V30 7 C 8.5298 3.6437 0.0 0
M  V30 8 C 8.5298 2.1036 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 3.8500 1.5400 0.0 0
M  V30 11 C 3.8500 4.2073 0.0 0
M  V30 12 C 2.3100 1.5400 0.0 0
M  V30 13 C 2.3100 4.2073 0.0 0
M  V30 14 C 1.5400 2.8736 0.0 0
M  V30 15 Cl 5.5913 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl 4-[[[2-(4-fluorophenyl)-4-t...
C24H29FN2O3S
2656367-54-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5392 5.0436 0.0 0
M  V30 2 O 4.9486 4.6487 0.0 0
M  V30 3 C 6.2823 3.8787 0.0 0
M  V30 4 C 7.6159 4.6487 0.0 0
M  V30 5 O 6.2823 2.3387 0.0 0
M  V30 6 C 8.9496 3.8787 0.0 0
M  V30 7 C 10.2834 4.6487 0.0 0
M  V30 8 N 11.6171 3.8787 0.0 0
M  V30 9 O 10.2834 6.1888 0.0 0
M  V30 10 C 12.9508 4.6487 0.0 0
M  V30 11 C 2.5671 0.0000 0.0 0
M  V30 12 C 0.0000 0.4358 0.0 0
M  V30 13 F 22.8482 4.0045 0.0 0
M  V30 14 C 2.1674 3.5490 0.0 0 CFG=2
M  V30 15 C 3.6148 3.8787 0.0 0 CFG=2
M  V30 16 C 1.4213 1.0289 0.0 0
M  V30 17 C 1.1070 4.4633 0.0 0
M  V30 18 C 2.7376 2.9325 0.0 0
M  V30 19 C 1.4901 2.4479 0.0 0 CFG=1
M  V30 20 C 0.3605 3.5464 0.0 0
M  V30 21 C 14.2844 3.8787 0.0 0
M  V30 22 N 15.6914 4.5052 0.0 0
M  V30 23 C 14.4455 2.3472 0.0 0
M  V30 24 C 16.7218 3.3607 0.0 0
M  V30 25 S 15.9518 2.0270 0.0 0
M  V30 26 C 18.2534 3.5216 0.0 0
M  V30 27 C 18.8799 4.9286 0.0 0
M  V30 28 C 19.1586 2.2757 0.0 0
M  V30 29 C 20.4115 5.0895 0.0 0
M  V30 30 C 20.6904 2.4368 0.0 0
M  V30 31 C 21.3167 3.8436 0.0 0
M  V30 32 H 0.0574 1.8832 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 21
M  V30 12 1 11 16
M  V30 13 1 12 16
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 19 32 CFG=3
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1092569-57-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1187932-83-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2656367-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23701150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, fungicidal activities and structure-activity
relationship studies of (-)-borneol derivatives containing
2-aryl-thiazole scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Danling; Zheng, Shumin; Zhang, Tianyuan; Cheng, Yong-Xian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 45128006

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
4-Thiazolemethanamine, 2-(4-chlorophenyl)-, hydrochloride (1:1)
C10H9ClN2S.ClH
690632-35-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 4.5489 0.0 0
M  V30 2 N 11.1826 3.9225 0.0 0
M  V30 3 Cl 0.0000 2.8736 0.0 0
M  V30 4 C 6.1600 2.8736 0.0 0
M  V30 5 N 7.0652 4.1195 0.0 0
M  V30 6 S 7.0652 1.6278 0.0 0
M  V30 7 C 8.5298 3.6437 0.0 0
M  V30 8 C 8.5298 2.1036 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 3.8500 1.5400 0.0 0
M  V30 11 C 3.8500 4.2073 0.0 0
M  V30 12 C 2.3100 1.5400 0.0 0
M  V30 13 C 2.3100 4.2073 0.0 0
M  V30 14 C 1.5400 2.8736 0.0 0
M  V30 15 Cl 5.5913 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl] hydrogen butanedioate
C14H22O4
1092569-57-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5029 5.5476 0.0 0
M  V30 2 O 6.3920 4.0011 0.0 0
M  V30 3 C 7.1620 2.6675 0.0 0
M  V30 4 C 8.7020 2.6675 0.0 0
M  V30 5 O 6.3920 1.3337 0.0 0
M  V30 6 C 9.4720 1.3337 0.0 0
M  V30 7 C 11.0120 1.3337 0.0 0
M  V30 8 O 11.7821 2.6675 0.0 0
M  V30 9 O 11.7821 0.0000 0.0 0
M  V30 10 C 2.0053 1.1658 0.0 0
M  V30 11 C 0.0000 2.8269 0.0 0
M  V30 12 C 3.4338 4.4393 0.0 0 CFG=2
M  V30 13 C 4.8520 4.0011 0.0 0 CFG=2
M  V30 14 C 1.5274 2.6299 0.0 0
M  V30 15 C 2.9724 5.7612 0.0 0
M  V30 16 C 3.6190 3.6203 0.0 0
M  V30 17 C 2.2965 3.8242 0.0 0 CFG=1
M  V30 18 C 1.8676 5.3403 0.0 0
M  V30 19 H 0.7734 4.0516 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 14
M  V30 11 1 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl 4-[[[2-(4-chlorophenyl)-4-t...
C24H29ClN2O3S
2656367-53-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.5392 5.0436 0.0 0
M  V30 2 O 4.9486 4.6487 0.0 0
M  V30 3 C 6.2823 3.8787 0.0 0
M  V30 4 C 7.6159 4.6487 0.0 0
M  V30 5 O 6.2823 2.3387 0.0 0
M  V30 6 C 8.9496 3.8787 0.0 0
M  V30 7 C 10.2834 4.6487 0.0 0
M  V30 8 N 11.6171 3.8787 0.0 0
M  V30 9 O 10.2834 6.1888 0.0 0
M  V30 10 C 12.9508 4.6487 0.0 0
M  V30 11 C 2.5671 0.0000 0.0 0
M  V30 12 C 0.0000 0.4358 0.0 0
M  V30 13 Cl 22.8482 4.0045 0.0 0
M  V30 14 C 2.1674 3.5490 0.0 0 CFG=2
M  V30 15 C 3.6148 3.8787 0.0 0 CFG=2
M  V30 16 C 1.4213 1.0289 0.0 0
M  V30 17 C 1.1070 4.4633 0.0 0
M  V30 18 C 2.7376 2.9325 0.0 0
M  V30 19 C 1.4901 2.4479 0.0 0 CFG=1
M  V30 20 C 0.3605 3.5464 0.0 0
M  V30 21 C 14.2844 3.8787 0.0 0
M  V30 22 N 15.6914 4.5052 0.0 0
M  V30 23 C 14.4455 2.3472 0.0 0
M  V30 24 C 16.7218 3.3607 0.0 0
M  V30 25 S 15.9518 2.0270 0.0 0
M  V30 26 C 18.2534 3.5216 0.0 0
M  V30 27 C 18.8799 4.9286 0.0 0
M  V30 28 C 19.1586 2.2757 0.0 0
M  V30 29 C 20.4115 5.0895 0.0 0
M  V30 30 C 20.6904 2.4368 0.0 0
M  V30 31 C 21.3167 3.8436 0.0 0
M  V30 32 H 0.0574 1.8832 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 21
M  V30 12 1 11 16
M  V30 13 1 12 16
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 19 32 CFG=3
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 690632-35-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1092569-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2656367-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23696722
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, fungicidal activities and structure-activity
relationship studies of (-)-borneol derivatives containing
2-aryl-thiazole scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Danling; Zheng, Shumin; Zhang, Tianyuan; Cheng, Yong-Xian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 45128006

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[4-[5-[(dimethylamino)carbonyl]-1-methyl-1H-pyrrol-3-yl]p...
C19H25N3O3
2101433-29-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1579 2.9016 0.0 0
M  V30 2 N 1.5316 4.3084 0.0 0
M  V30 3 O 1.2527 1.6557 0.0 0
M  V30 4 C 0.0000 4.4695 0.0 0
M  V30 5 C 2.4368 5.5544 0.0 0
M  V30 6 C 3.8331 0.0000 0.0 0
M  V30 7 N 11.4617 6.3388 0.0 0
M  V30 8 C 12.7955 5.5688 0.0 0
M  V30 9 O 14.1292 6.3388 0.0 0
M  V30 10 O 12.7955 4.0287 0.0 0
M  V30 11 C 15.4629 5.5688 0.0 0
M  V30 12 C 14.6928 4.2351 0.0 0
M  V30 13 C 16.7965 4.7987 0.0 0
M  V30 14 C 16.2329 6.9024 0.0 0
M  V30 15 C 6.1269 3.2587 0.0 0
M  V30 16 C 4.7200 3.8850 0.0 0
M  V30 17 C 5.9659 1.7271 0.0 0
M  V30 18 C 3.6896 2.7406 0.0 0
M  V30 19 N 4.4596 1.4068 0.0 0
M  V30 20 C 7.4607 4.0287 0.0 0
M  V30 21 C 8.7944 3.2587 0.0 0
M  V30 22 C 7.4607 5.5688 0.0 0
M  V30 23 C 10.1280 4.0287 0.0 0
M  V30 24 C 8.7944 6.3388 0.0 0
M  V30 25 C 10.1280 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 19
M  V30 7 1 7 8
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-tert-Butoxycarbonylamino-1-methyl-1H-pyrrole-2-carboxylic acid
C11H16N2O4
77716-11-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.9052 2.9016 0.0 0
M  V30 2 O 0.0000 1.6557 0.0 0
M  V30 3 O 0.2789 4.3084 0.0 0
M  V30 4 C 2.5805 0.0000 0.0 0
M  V30 5 N 6.2080 4.0287 0.0 0
M  V30 6 C 7.5417 3.2587 0.0 0
M  V30 7 O 8.8754 4.0287 0.0 0
M  V30 8 O 7.5417 1.7187 0.0 0
M  V30 9 C 10.2090 3.2587 0.0 0
M  V30 10 C 10.9791 4.5924 0.0 0
M  V30 11 C 11.5429 2.4887 0.0 0
M  V30 12 C 9.4390 1.9250 0.0 0
M  V30 13 C 2.4369 2.7406 0.0 0
M  V30 14 C 3.4674 3.8850 0.0 0
M  V30 15 N 3.2070 1.4068 0.0 0
M  V30 16 C 4.8742 3.2587 0.0 0
M  V30 17 C 4.7133 1.7271 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[5-[[[4-[5-[(dimethylamino)carbonyl]-1-methyl-1H-pyrrol-3...
C25H31N5O4
2101433-31-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4070 2.4368 0.0 0
M  V30 2 N 1.5679 0.9052 0.0 0
M  V30 3 O 0.0000 3.0631 0.0 0
M  V30 4 C 2.9748 0.2789 0.0 0
M  V30 5 C 0.3220 0.0000 0.0 0
M  V30 6 C 1.4070 5.7872 0.0 0
M  V30 7 N 11.1826 4.1120 0.0 0
M  V30 8 C 11.9526 5.4456 0.0 0
M  V30 9 O 11.1826 6.7793 0.0 0
M  V30 10 C 13.9220 8.1562 0.0 0
M  V30 11 N 17.1084 3.7704 0.0 0
M  V30 12 C 18.5154 4.3969 0.0 0
M  V30 13 O 19.7612 3.4917 0.0 0
M  V30 14 O 18.6763 5.9284 0.0 0
M  V30 15 C 21.1680 4.1180 0.0 0
M  V30 16 C 21.7945 2.7112 0.0 0
M  V30 17 C 22.5750 4.7445 0.0 0
M  V30 18 C 20.5417 5.5249 0.0 0
M  V30 19 C 5.0226 4.1120 0.0 0
M  V30 20 C 4.1175 2.8661 0.0 0
M  V30 21 C 4.1175 5.3578 0.0 0
M  V30 22 C 2.6528 3.3420 0.0 0
M  V30 23 N 2.6528 4.8820 0.0 0
M  V30 24 C 6.5626 4.1120 0.0 0
M  V30 25 C 7.3326 5.4456 0.0 0
M  V30 26 C 7.3326 2.7783 0.0 0
M  V30 27 C 8.8726 5.4456 0.0 0
M  V30 28 C 8.8726 2.7783 0.0 0
M  V30 29 C 9.6426 4.1120 0.0 0
M  V30 30 C 13.4926 5.4456 0.0 0
M  V30 31 C 14.3978 4.1998 0.0 0
M  V30 32 N 14.3978 6.6915 0.0 0
M  V30 33 C 15.8625 4.6756 0.0 0
M  V30 34 C 15.8625 6.2156 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 1 7 29
M  V30 9 2 8 9
M  V30 10 1 8 30
M  V30 11 1 10 32
M  V30 12 1 11 12
M  V30 13 1 11 33
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 24
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2101433-29-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77716-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101433-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24942483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring
with Activity against Multidrug-Resistant Gram-Negative Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Picconi, Pietro; Hind, Charlotte K.; Nahar, Kazi S.; Jamshidi, Shirin; Di
Maggio, Lucia; Saeed, Naima; Evans, Bonnie; Solomons, Jessica; Wand,
Matthew E.; Sutton, J. Mark; Rahman, Khondaker Miraz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(13), 6941-6958

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
2-Furanmethanamine
C5H7NO
617-89-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Fluorophenyl)methyl]-2,3-dihydro-3,3-dimethyl-2-oxo-1H-indole-6-carboxy...
C18H16FNO3
2259626-67-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5190 2.9292 0.0 0
M  V30 2 O 2.5498 5.6398 0.0 0
M  V30 3 C 5.6213 8.2926 0.0 0
M  V30 4 C 3.6612 7.6556 0.0 0
M  V30 5 C 10.4606 4.0998 0.0 0
M  V30 6 O 10.4606 2.5598 0.0 0
M  V30 7 O 11.7942 4.8698 0.0 0
M  V30 8 F 3.5673 0.0000 0.0 0
M  V30 9 C 6.4595 4.8698 0.0 0
M  V30 10 N 4.9950 4.3939 0.0 0
M  V30 11 C 6.4595 6.4098 0.0 0
M  V30 12 C 7.7932 4.0998 0.0 0
M  V30 13 C 4.0898 5.6398 0.0 0
M  V30 14 C 4.9950 6.8856 0.0 0
M  V30 15 C 7.7932 7.1798 0.0 0
M  V30 16 C 9.1270 4.8698 0.0 0
M  V30 17 C 9.1270 6.4098 0.0 0
M  V30 18 C 3.0127 2.6091 0.0 0
M  V30 19 C 2.5368 1.1445 0.0 0
M  V30 20 C 1.9823 3.7536 0.0 0
M  V30 21 C 1.0304 0.8244 0.0 0
M  V30 22 C 0.4759 3.4334 0.0 0
M  V30 23 C 0.0000 1.9687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 18
M  V30 3 2 2 13
M  V30 4 1 3 14
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Fluorophenyl)methyl]-N-(2-furanylmethyl)-2,3-dihydro-3,3-dimethyl-2-oxo...
C23H21FN2O3
2259624-70-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5191 2.9292 0.0 0
M  V30 2 O 2.5498 5.6398 0.0 0
M  V30 3 C 5.6213 8.2926 0.0 0
M  V30 4 C 3.6614 7.6556 0.0 0
M  V30 5 C 10.4606 4.0998 0.0 0
M  V30 6 N 11.7942 4.8698 0.0 0
M  V30 7 O 10.4606 2.5598 0.0 0
M  V30 8 C 13.1280 4.0998 0.0 0
M  V30 9 F 3.5673 0.0000 0.0 0
M  V30 10 C 6.4595 4.8698 0.0 0
M  V30 11 N 4.9950 4.3939 0.0 0
M  V30 12 C 6.4595 6.4098 0.0 0
M  V30 13 C 7.7933 4.0998 0.0 0
M  V30 14 C 4.0898 5.6398 0.0 0
M  V30 15 C 4.9950 6.8856 0.0 0
M  V30 16 C 7.7933 7.1798 0.0 0
M  V30 17 C 9.1270 4.8698 0.0 0
M  V30 18 C 9.1270 6.4098 0.0 0
M  V30 19 C 3.0127 2.6091 0.0 0
M  V30 20 C 2.5368 1.1445 0.0 0
M  V30 21 C 1.9823 3.7536 0.0 0
M  V30 22 C 1.0306 0.8244 0.0 0
M  V30 23 C 0.4759 3.4334 0.0 0
M  V30 24 C 0.0000 1.9687 0.0 0
M  V30 25 C 14.4617 4.8698 0.0 0
M  V30 26 C 14.6226 6.4013 0.0 0
M  V30 27 O 15.8685 4.2435 0.0 0
M  V30 28 C 16.1290 6.7215 0.0 0
M  V30 29 C 16.8990 5.3878 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 19
M  V30 3 2 2 14
M  V30 4 1 3 15
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 8
M  V30 10 1 8 25
M  V30 11 1 9 20
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 617-89-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2259626-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2259624-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23881400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of potent small molecule activators of human STING
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pryde, David C.; Middya, Sandip; Banerjee, Monali; Shrivastava, Ritesh;
Basu, Sourav; Ghosh, Rajib; Yadav, Dharmendra B.; Surya, Arjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 209112869

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
6-Carboxycoumarin
C10H6O4
7734-80-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 1.5400 0.0 0
M  V30 2 O 8.0023 0.0000 0.0 0
M  V30 3 O 9.3360 2.3101 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.0012 3.8501 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 O 2.6675 4.6201 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)b...
C21H30N2O4S
2396534-97-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-N-[(1R,2S)-2-Hydroxy-3-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]...
C31H34N2O7S
2396534-39-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 9.2401 0.0 0
M  V30 2 N 9.3359 8.4701 0.0 0
M  V30 3 O 10.6695 10.7801 0.0 0
M  V30 4 C 8.0022 9.2401 0.0 0 CFG=1
M  V30 5 C 6.6684 8.4701 0.0 0 CFG=2
M  V30 6 C 8.0022 10.7801 0.0 0
M  V30 7 C 5.3348 9.2401 0.0 0
M  V30 8 O 6.6684 6.9301 0.0 0
M  V30 9 N 4.0011 8.4701 0.0 0
M  V30 10 S 4.0011 6.9301 0.0 0 VAL=6
M  V30 11 C 2.6675 9.2401 0.0 0
M  V30 12 O 5.5411 6.9301 0.0 0
M  V30 13 O 2.4611 6.9301 0.0 0
M  V30 14 C 1.3337 8.4701 0.0 0
M  V30 15 C 0.0000 9.2401 0.0 0
M  V30 16 C 1.3337 6.9301 0.0 0
M  V30 17 O 18.6718 6.1601 0.0 0
M  V30 18 O 4.0011 0.7700 0.0 0
M  V30 19 C 2.6675 0.0000 0.0 0
M  V30 20 C 14.6707 8.4701 0.0 0
M  V30 21 C 14.6707 6.9301 0.0 0
M  V30 22 C 13.3370 9.2401 0.0 0
M  V30 23 C 16.0043 9.2401 0.0 0
M  V30 24 C 13.3370 6.1601 0.0 0
M  V30 25 O 16.0043 6.1601 0.0 0
M  V30 26 C 12.0034 8.4701 0.0 0
M  V30 27 C 17.3381 8.4701 0.0 0
M  V30 28 C 12.0034 6.9301 0.0 0
M  V30 29 C 17.3381 6.9301 0.0 0
M  V30 30 C 6.6684 11.5501 0.0 0
M  V30 31 C 6.6684 13.0901 0.0 0
M  V30 32 C 5.3348 10.7801 0.0 0
M  V30 33 C 5.3348 13.8602 0.0 0
M  V30 34 C 4.0011 11.5501 0.0 0
M  V30 35 C 4.0011 13.0901 0.0 0
M  V30 36 C 4.0011 5.3901 0.0 0
M  V30 37 C 5.3348 4.6201 0.0 0
M  V30 38 C 2.6675 4.6201 0.0 0
M  V30 39 C 5.3348 3.0800 0.0 0
M  V30 40 C 2.6675 3.0800 0.0 0
M  V30 41 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 30
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 36
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 2 17 29
M  V30 20 1 18 19
M  V30 21 1 18 41
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7734-80-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2396534-97-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2396534-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21717118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design and Structure-Activity relationship of coumarin
derivatives effective on HIV-1 protease and partially on HIV-1 reverse
transcriptase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Ma, Ling; Wen, Jiajia; Dong, Biao; Wang, Yujia; Wang, Zhen;
Zhou, Jinming; Zhang, Guoning; Wang, Juxian; Guo, Ying; Liang, Chen; Cen,
Shan; Wang, Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 186111900

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Cyclohexanecarboxylic acid, 4-amino-, methyl ester, trans-
C8H15NO2
62456-15-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0 CFG=2
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 11 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
13-Oxa-2,6,8,19-tetraazatricyclo[12.3.1.13,7]nonadeca-1(18),3,5,7(19),10,14,1...
C16H16N4O3
3036049-14-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6156 5.3079 0.0 0
M  V30 2 O 10.1535 5.3079 0.0 0
M  V30 3 O 7.8467 6.6396 0.0 0
M  V30 4 C 0.0000 7.5543 0.0 0
M  V30 5 C 6.2996 3.9750 0.0 0
M  V30 6 C 7.8467 3.9761 0.0 0
M  V30 7 N 5.7016 5.3477 0.0 0
M  V30 8 N 5.5309 2.6563 0.0 0
M  V30 9 C 8.6173 2.6394 0.0 0
M  V30 10 C 4.2641 5.7669 0.0 0
M  V30 11 C 6.3038 1.2998 0.0 0
M  V30 12 N 7.8438 1.3033 0.0 0
M  V30 13 C 3.0535 4.8371 0.0 0
M  V30 14 C 4.0690 7.3017 0.0 0
M  V30 15 N 5.3961 0.0000 0.0 0
M  V30 16 C 1.6100 5.4318 0.0 0
M  V30 17 C 2.6454 7.8965 0.0 0
M  V30 18 C 3.8372 0.3709 0.0 0
M  V30 19 C 1.4182 6.9598 0.0 0
M  V30 20 O 0.4357 4.3667 0.0 0
M  V30 21 C 3.5441 1.8534 0.0 0
M  V30 22 C 1.0013 2.8673 0.0 0
M  V30 23 C 2.5090 2.7646 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 19
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 12
M  V30 15 2 11 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 19
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxylic acid, 4-[[(15-methyl-13-oxa-2,6,8,19-tetraazatricyclo[1...
C24H29N5O4
3036049-15-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8254 6.2621 0.0 0
M  V30 2 N 9.1592 7.0321 0.0 0
M  V30 3 O 7.8254 4.7221 0.0 0
M  V30 4 C 1.4784 0.0000 0.0 0
M  V30 5 C 14.4939 3.9521 0.0 0
M  V30 6 O 15.8275 4.7221 0.0 0
M  V30 7 O 14.4939 2.4121 0.0 0
M  V30 8 C 17.1611 3.9521 0.0 0
M  V30 9 C 5.1496 6.2583 0.0 0
M  V30 10 C 6.4917 7.0321 0.0 0
M  V30 11 N 5.3181 4.7685 0.0 0
M  V30 12 N 3.8226 7.0170 0.0 0
M  V30 13 C 6.4908 8.5772 0.0 0
M  V30 14 C 4.2815 3.6852 0.0 0
M  V30 15 C 3.8137 8.5806 0.0 0
M  V30 16 N 5.1508 9.3484 0.0 0
M  V30 17 C 2.7660 3.8854 0.0 0
M  V30 18 C 4.8807 2.2564 0.0 0
M  V30 19 N 2.3758 9.2532 0.0 0
M  V30 20 C 1.8118 2.6468 0.0 0
M  V30 21 C 3.9439 1.0278 0.0 0
M  V30 22 C 1.2094 8.1511 0.0 0
M  V30 23 C 2.4106 1.2257 0.0 0
M  V30 24 O 0.2603 2.9825 0.0 0
M  V30 25 C 1.6975 6.7187 0.0 0
M  V30 26 C 0.0000 4.5661 0.0 0
M  V30 27 C 1.2560 5.4100 0.0 0
M  V30 28 C 10.4928 6.2621 0.0 0 CFG=1
M  V30 29 C 11.8264 7.0321 0.0 0
M  V30 30 C 10.4928 4.7221 0.0 0
M  V30 31 C 13.1601 6.2621 0.0 0
M  V30 32 C 11.8264 3.9521 0.0 0
M  V30 33 C 13.1601 4.7221 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 28 2 CFG=3
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 33 5 CFG=1
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 16
M  V30 20 2 15 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 20 24
M  V30 26 2 21 23
M  V30 27 1 22 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 28 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62456-15-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036049-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036049-15-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39875252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kong, Deyu; Tian, Qiang; Chen, Zhilong; Zheng, Hongchao; Stashko, Michael
A.; Yan, Dan; Earp, H. Shelton; Frye, Stephen V.; DeRyckere, Deborah;
Kireev, Dmitri; Graham, Douglas K.; Wang, Xiaodong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(7), 5866-5882

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Fmoc-D-phenylalanine
C24H21NO4
86123-10-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 5.2309 0.0 0
M  V30 2 O 8.0021 4.4608 0.0 0
M  V30 3 C 6.6685 5.2309 0.0 0
M  V30 4 N 5.3348 4.4608 0.0 0
M  V30 5 O 6.6685 6.7709 0.0 0
M  V30 6 C 4.0011 5.2309 0.0 0 CFG=1
M  V30 7 C 4.0011 6.7709 0.0 0
M  V30 8 C 2.6673 4.4608 0.0 0
M  V30 9 O 1.3337 5.2309 0.0 0
M  V30 10 O 2.6673 2.9208 0.0 0
M  V30 11 C 10.6696 4.4608 0.0 0
M  V30 12 C 10.8306 2.9293 0.0 0
M  V30 13 C 12.0764 5.0873 0.0 0
M  V30 14 C 12.3370 2.6091 0.0 0
M  V30 15 C 9.8001 1.7849 0.0 0
M  V30 16 C 13.1070 3.9428 0.0 0
M  V30 17 C 12.5523 6.5519 0.0 0
M  V30 18 C 12.8129 1.1444 0.0 0
M  V30 19 C 10.2760 0.3202 0.0 0
M  V30 20 C 14.6133 4.2630 0.0 0
M  V30 21 C 14.0588 6.8721 0.0 0
M  V30 22 C 11.7823 0.0000 0.0 0
M  V30 23 C 15.0892 5.7277 0.0 0
M  V30 24 C 2.6673 7.5409 0.0 0
M  V30 25 C 1.3337 6.7709 0.0 0
M  V30 26 C 2.6673 9.0809 0.0 0
M  V30 27 C 0.0000 7.5409 0.0 0
M  V30 28 C 1.3337 9.8509 0.0 0
M  V30 29 C 0.0000 9.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H36N4O6
3032404-37-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 8.4700 0.0 0
M  V30 2 O 7.0869 7.7000 0.0 0
M  V30 3 C 8.4206 8.4700 0.0 0
M  V30 4 N 9.7544 7.7000 0.0 0
M  V30 5 O 8.4206 10.0100 0.0 0
M  V30 6 C 11.0880 8.4700 0.0 0 CFG=1
M  V30 7 C 11.0880 10.0100 0.0 0
M  V30 8 C 12.4216 7.7000 0.0 0
M  V30 9 N 12.4216 6.1600 0.0 0
M  V30 10 O 13.7553 8.4700 0.0 0
M  V30 11 C 13.7553 5.3900 0.0 0 CFG=2
M  V30 12 C 15.0891 6.1600 0.0 0
M  V30 13 C 13.7553 3.8500 0.0 0
M  V30 14 C 16.4227 5.3900 0.0 0
M  V30 15 O 15.0891 3.0800 0.0 0
M  V30 16 O 12.4216 3.0800 0.0 0
M  V30 17 C 17.7564 6.1600 0.0 0
M  V30 18 C 15.0891 1.5400 0.0 0
M  V30 19 C 19.0900 5.3900 0.0 0
M  V30 20 O 17.7564 7.7000 0.0 0
M  V30 21 C 13.5491 1.5400 0.0 0
M  V30 22 C 15.0891 0.0000 0.0 0
M  V30 23 C 16.6291 1.5400 0.0 0
M  V30 24 N 20.4238 6.1600 0.0 0 CHG=1 VAL=4
M  V30 25 N 21.7574 6.9300 0.0 0 CHG=-1
M  V30 26 C 4.4196 7.7000 0.0 0
M  V30 27 C 4.2586 6.1685 0.0 0
M  V30 28 C 3.0127 8.3263 0.0 0
M  V30 29 C 2.7523 5.8483 0.0 0
M  V30 30 C 5.2891 5.0239 0.0 0
M  V30 31 C 1.9823 7.1819 0.0 0
M  V30 32 C 2.5368 9.7910 0.0 0
M  V30 33 C 2.2764 4.3836 0.0 0
M  V30 34 C 4.8131 3.5594 0.0 0
M  V30 35 C 0.4759 7.5021 0.0 0
M  V30 36 C 1.0304 10.1112 0.0 0
M  V30 37 C 3.3068 3.2392 0.0 0
M  V30 38 C 0.0000 8.9668 0.0 0
M  V30 39 C 12.4216 10.7800 0.0 0
M  V30 40 C 12.4216 12.3200 0.0 0
M  V30 41 C 13.7553 10.0100 0.0 0
M  V30 42 C 13.7553 13.0900 0.0 0
M  V30 43 C 15.0891 10.7800 0.0 0
M  V30 44 C 15.0891 12.3200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 39
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12 CFG=1
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 2 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 27 30
M  V30 31 1 28 31
M  V30 32 2 28 32
M  V30 33 1 29 31
M  V30 34 2 29 33
M  V30 35 1 30 34
M  V30 36 2 31 35
M  V30 37 1 32 36
M  V30 38 1 33 37
M  V30 39 2 34 37
M  V30 40 1 35 38
M  V30 41 2 36 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86123-10-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032404-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259020
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-D-phenylalanine
C14H19NO4
18942-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=2
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-2-methoxy-, phenylmethyl ester, 2,2,2-trifluoroacetate ...
C15H15NO3.C2HF3O2
2413279-63-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 7.4938 0.0 0
M  V30 2 O 6.6685 8.2638 0.0 0
M  V30 3 O 5.3348 5.9537 0.0 0
M  V30 4 C 8.0022 7.4938 0.0 0
M  V30 5 O 2.6673 5.9537 0.0 0
M  V30 6 C 1.3337 5.1837 0.0 0
M  V30 7 N 0.0000 7.4938 0.0 0
M  V30 8 C 4.0012 8.2638 0.0 0
M  V30 9 C 2.6673 7.4938 0.0 0
M  V30 10 C 4.0012 9.8038 0.0 0
M  V30 11 C 1.3337 8.2638 0.0 0
M  V30 12 C 2.6673 10.5738 0.0 0
M  V30 13 C 1.3337 9.8038 0.0 0
M  V30 14 C 9.3360 8.2638 0.0 0
M  V30 15 C 9.3360 9.8038 0.0 0
M  V30 16 C 10.6697 7.4938 0.0 0
M  V30 17 C 10.6697 10.5738 0.0 0
M  V30 18 C 12.0033 8.2638 0.0 0
M  V30 19 C 12.0033 9.8038 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 6.6685 1.5400 0.0 0
M  V30 22 F 6.1048 3.6437 0.0 0
M  V30 23 F 4.0012 3.0801 0.0 0
M  V30 24 F 4.5648 0.9764 0.0 0
M  V30 25 O 8.0022 2.3101 0.0 0
M  V30 26 O 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 9
M  V30 8 1 7 11
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C29H32N2O6
2413279-29-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 4 O 8.4700 6.6685 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 N 5.3900 6.6685 0.0 0
M  V30 7 C 3.8500 6.6685 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 O 3.0800 5.3347 0.0 0
M  V30 10 C 1.5400 8.0021 0.0 0
M  V30 11 C 1.5400 6.4621 0.0 0
M  V30 12 C 0.0000 8.0021 0.0 0
M  V30 13 C 1.5400 9.5421 0.0 0
M  V30 14 O 10.0100 6.6685 0.0 0
M  V30 15 C 10.7800 8.0021 0.0 0
M  V30 16 C 13.0900 6.6685 0.0 0
M  V30 17 O 14.6300 6.6685 0.0 0
M  V30 18 O 12.3200 8.0021 0.0 0
M  V30 19 C 15.4000 8.0021 0.0 0
M  V30 20 C 10.0100 4.0011 0.0 0
M  V30 21 C 10.7800 5.3347 0.0 0
M  V30 22 C 10.7800 2.6674 0.0 0
M  V30 23 C 12.3200 5.3347 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 25 C 13.0900 4.0011 0.0 0
M  V30 26 C 6.1600 2.6674 0.0 0
M  V30 27 C 5.3900 1.3336 0.0 0
M  V30 28 C 7.7000 2.6674 0.0 0
M  V30 29 C 6.1600 0.0000 0.0 0
M  V30 30 C 8.4700 1.3336 0.0 0
M  V30 31 C 7.7000 0.0000 0.0 0
M  V30 32 C 16.9400 8.0021 0.0 0
M  V30 33 C 17.7100 6.6685 0.0 0
M  V30 34 C 17.7100 9.3358 0.0 0
M  V30 35 C 19.2500 6.6685 0.0 0
M  V30 36 C 19.2500 9.3358 0.0 0
M  V30 37 C 20.0200 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 3 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 1 14 21
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 23
M  V30 20 1 17 19
M  V30 21 1 19 32
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18942-49-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2413279-63-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413279-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21978537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meena, Chhuttan L.; Singh, Dharmendra; Weinmuller, Michael; Reichart,
Florian; Dangi, Abha; Marelli, Udaya Kiran; Zahler, Stefan; Sanjayan,
Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
4-(1,1-Dimethylethyl) (2R)-2,4-morpholinedicarboxylate
C10H17NO5
884512-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 O 9.3360 4.6201 0.0 0
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0 CFG=2
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 O 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-(methylamino)-N-(2-methylpropyl...
C21H31N3O3S
2765293-23-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 N 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 0.7700 2.6673 0.0 0
M  V30 25 C 3.0800 1.3336 0.0 0
M  V30 26 C 0.0000 1.3336 0.0 0
M  V30 27 C 2.3100 0.0000 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[[(1S,2R)-2-hydroxy-3-[[[4-(methylamino)phenyl]sulf...
C31H46N4O7S
2765293-62-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 6.9302 0.0 0 VAL=6
M  V30 2 N 4.0012 8.4702 0.0 0
M  V30 3 O 2.4611 6.9302 0.0 0
M  V30 4 O 5.5412 6.9302 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 C 2.6675 9.2402 0.0 0
M  V30 7 C 6.6685 8.4702 0.0 0 CFG=1
M  V30 8 C 1.3337 8.4702 0.0 0
M  V30 9 C 8.0023 9.2402 0.0 0 CFG=1
M  V30 10 O 6.6685 6.9302 0.0 0
M  V30 11 C 0.0000 9.2402 0.0 0
M  V30 12 C 1.3337 6.9302 0.0 0
M  V30 13 C 8.0023 10.7802 0.0 0
M  V30 14 N 9.3360 8.4702 0.0 0
M  V30 15 C 10.6697 9.2402 0.0 0
M  V30 16 O 10.6697 10.7802 0.0 0
M  V30 17 N 4.0012 0.7700 0.0 0
M  V30 18 C 2.6675 0.0000 0.0 0
M  V30 19 C 16.0045 9.2402 0.0 0
M  V30 20 O 17.3382 8.4702 0.0 0
M  V30 21 O 16.0045 10.7802 0.0 0
M  V30 22 C 18.6720 9.2402 0.0 0
M  V30 23 C 17.9020 10.5739 0.0 0
M  V30 24 C 20.0057 10.0102 0.0 0
M  V30 25 C 19.4420 7.9065 0.0 0
M  V30 26 C 4.0012 5.3901 0.0 0
M  V30 27 C 5.3348 4.6201 0.0 0
M  V30 28 C 2.6675 4.6201 0.0 0
M  V30 29 C 5.3348 3.0801 0.0 0
M  V30 30 C 2.6675 3.0801 0.0 0
M  V30 31 C 4.0012 2.3101 0.0 0
M  V30 32 C 6.6685 11.5503 0.0 0
M  V30 33 C 6.6685 13.0903 0.0 0
M  V30 34 C 5.3348 10.7802 0.0 0
M  V30 35 C 5.3348 13.8603 0.0 0
M  V30 36 C 4.0012 11.5503 0.0 0
M  V30 37 C 4.0012 13.0903 0.0 0
M  V30 38 C 12.0033 8.4702 0.0 0 CFG=2
M  V30 39 C 13.3372 9.2402 0.0 0
M  V30 40 O 12.0033 6.9302 0.0 0
M  V30 41 N 14.6708 8.4702 0.0 0
M  V30 42 C 13.3372 6.1601 0.0 0
M  V30 43 C 14.6708 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 26
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13 CFG=3
M  V30 14 1 9 14
M  V30 15 1 13 32
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 38 15 CFG=1
M  V30 19 1 17 18
M  V30 20 1 17 31
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 41
M  V30 24 1 20 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 1 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 9 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 884512-77-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2765293-23-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
(2E)-3-(3-Chlorophenyl)-2-propenoic acid
C9H7ClO2
14473-90-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole-9-ethanamine
C15H17N3O
2521791-65-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8661 2.6091 0.0 0
M  V30 2 C 3.8965 1.4647 0.0 0
M  V30 3 N 3.4207 0.0000 0.0 0
M  V30 4 O 8.8076 3.7796 0.0 0
M  V30 5 C 10.1413 4.5496 0.0 0
M  V30 6 C 0.0000 4.2347 0.0 0
M  V30 7 C 4.8065 4.5496 0.0 0
M  V30 8 C 4.8065 6.0897 0.0 0
M  V30 9 N 3.3420 4.0738 0.0 0
M  V30 10 C 6.1402 3.7796 0.0 0
M  V30 11 C 3.3420 6.5655 0.0 0
M  V30 12 C 6.1402 6.8597 0.0 0
M  V30 13 C 2.4368 5.3196 0.0 0
M  V30 14 C 7.4740 4.5496 0.0 0
M  V30 15 C 2.7155 7.9725 0.0 0
M  V30 16 C 7.4740 6.0897 0.0 0
M  V30 17 C 0.9052 5.4806 0.0 0
M  V30 18 C 1.1840 8.1334 0.0 0
M  V30 19 N 0.2787 6.8875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, 3-(3-chlorophenyl)-N-[2-(7-methoxy-1-methyl-9H-pyrido[3,4-b]in...
C24H22ClN3O2
3056621-74-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 7.5198 0.0 0
M  V30 2 C 7.0869 6.7498 0.0 0
M  V30 3 N 8.4208 7.5198 0.0 0
M  V30 4 C 9.7544 6.7498 0.0 0
M  V30 5 C 11.0881 7.5198 0.0 0
M  V30 6 O 9.7544 5.2098 0.0 0
M  V30 7 C 12.4218 6.7498 0.0 0
M  V30 8 O 5.8437 1.4646 0.0 0
M  V30 9 C 5.3678 0.0000 0.0 0
M  V30 10 C 3.5673 9.9853 0.0 0
M  V30 11 Cl 17.7566 6.7498 0.0 0
M  V30 12 C 4.2587 5.2183 0.0 0
M  V30 13 N 4.4196 6.7498 0.0 0
M  V30 14 C 2.7522 4.8981 0.0 0
M  V30 15 C 5.2891 4.0737 0.0 0
M  V30 16 C 3.0126 7.3761 0.0 0
M  V30 17 C 1.9822 6.2317 0.0 0
M  V30 18 C 2.2763 3.4334 0.0 0
M  V30 19 C 4.8132 2.6091 0.0 0
M  V30 20 C 2.5367 8.8409 0.0 0
M  V30 21 C 0.4759 6.5519 0.0 0
M  V30 22 C 3.3068 2.2890 0.0 0
M  V30 23 N 1.0304 9.1610 0.0 0
M  V30 24 C 0.0000 8.0166 0.0 0
M  V30 25 C 13.7556 7.5198 0.0 0
M  V30 26 C 15.0893 6.7498 0.0 0
M  V30 27 C 13.7556 9.0599 0.0 0
M  V30 28 C 16.4229 7.5198 0.0 0
M  V30 29 C 15.0893 9.8299 0.0 0
M  V30 30 C 16.4229 9.0599 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 1 8 19
M  V30 11 1 10 20
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14473-90-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2521791-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056621-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37912636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antiplasmodial evaluation of new amide-,
carbamate-, and ureido-type harmicines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marinovic, Marina; Rimac, Hrvoje; de Carvalho, Lais Pessanha; Rola, C.;
Santana, S.; Pavic, Kristina; Held, Jana; Prudencio, Miguel; Rajic,
Zrinka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 94117468

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methyl anthranilate
C8H9NO2
134-20-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 N 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fmoc-Lys(Boc)-OH
C26H32N2O6
71989-26-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0870 7.5408 0.0 0
M  V30 4 N 7.0870 9.0808 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 8.4206 9.8508 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0808 0.0 0
M  V30 8 C 8.4206 11.3908 0.0 0
M  V30 9 C 11.0881 9.8508 0.0 0
M  V30 10 O 7.0870 12.1609 0.0 0
M  V30 11 O 9.7544 12.1609 0.0 0
M  V30 12 C 12.4217 9.0808 0.0 0
M  V30 13 C 13.7554 9.8508 0.0 0
M  V30 14 N 15.0892 9.0808 0.0 0
M  V30 15 C 16.4228 9.8508 0.0 0
M  V30 16 O 17.7565 9.0808 0.0 0
M  V30 17 O 16.4228 11.3908 0.0 0
M  V30 18 C 19.0901 9.8508 0.0 0
M  V30 19 C 18.3201 11.1846 0.0 0
M  V30 20 C 20.4239 10.6208 0.0 0
M  V30 21 C 19.8603 8.5172 0.0 0
M  V30 22 C 4.4197 4.4608 0.0 0
M  V30 23 C 4.2586 2.9293 0.0 0
M  V30 24 C 3.0127 5.0873 0.0 0
M  V30 25 C 2.7523 2.6091 0.0 0
M  V30 26 C 5.2892 1.7847 0.0 0
M  V30 27 C 1.9823 3.9427 0.0 0
M  V30 28 C 2.5369 6.5518 0.0 0
M  V30 29 C 2.2764 1.1444 0.0 0
M  V30 30 C 4.8133 0.3202 0.0 0
M  V30 31 C 0.4759 4.2629 0.0 0
M  V30 32 C 1.0306 6.8720 0.0 0
M  V30 33 C 3.3069 0.0000 0.0 0
M  V30 34 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 1 24 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 33
M  V30 35 1 31 34
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-[[(2S)-6-[[(1,1-dimethylethoxy)carbonyl]amino]-2-[[(9H-fluore...
C34H39N3O7
3033295-76-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 5.7534 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=1
M  V30 7 C 8.4208 11.3910 0.0 0
M  V30 8 C 9.7546 9.0810 0.0 0
M  V30 9 N 7.0871 12.1610 0.0 0
M  V30 10 O 9.7546 12.1610 0.0 0
M  V30 11 C 11.0882 9.8510 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 C 13.7556 9.8510 0.0 0
M  V30 14 N 15.0894 9.0810 0.0 0
M  V30 15 C 16.4231 9.8510 0.0 0
M  V30 16 O 17.7567 9.0810 0.0 0
M  V30 17 O 16.4231 11.3910 0.0 0
M  V30 18 C 19.0904 9.8510 0.0 0
M  V30 19 C 19.8604 8.5173 0.0 0
M  V30 20 C 20.4242 10.6210 0.0 0
M  V30 21 C 18.3204 11.1846 0.0 0
M  V30 22 C 4.4197 13.7011 0.0 0
M  V30 23 O 3.0859 14.4711 0.0 0
M  V30 24 O 4.4197 12.1610 0.0 0
M  V30 25 C 1.7523 13.7011 0.0 0
M  V30 26 C 4.2587 2.9293 0.0 0
M  V30 27 C 4.4197 4.4609 0.0 0
M  V30 28 C 2.7523 2.6091 0.0 0
M  V30 29 C 5.2892 1.7849 0.0 0
M  V30 30 C 3.0128 5.0873 0.0 0
M  V30 31 C 1.9823 3.9428 0.0 0
M  V30 32 C 2.2765 1.1444 0.0 0
M  V30 33 C 4.8134 0.3202 0.0 0
M  V30 34 C 2.5369 6.5519 0.0 0
M  V30 35 C 0.4759 4.2630 0.0 0
M  V30 36 C 3.3069 0.0000 0.0 0
M  V30 37 C 1.0306 6.8721 0.0 0
M  V30 38 C 0.0000 5.7277 0.0 0
M  V30 39 C 7.0871 13.7011 0.0 0
M  V30 40 C 5.7534 14.4711 0.0 0
M  V30 41 C 8.4208 14.4711 0.0 0
M  V30 42 C 5.7534 16.0111 0.0 0
M  V30 43 C 8.4208 16.0111 0.0 0
M  V30 44 C 7.0871 16.7811 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 39
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 22 40
M  V30 26 1 23 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 2 26 29
M  V30 30 1 27 30
M  V30 31 1 28 31
M  V30 32 2 28 32
M  V30 33 1 29 33
M  V30 34 1 30 31
M  V30 35 2 30 34
M  V30 36 2 31 35
M  V30 37 1 32 36
M  V30 38 2 33 36
M  V30 39 1 34 37
M  V30 40 1 35 38
M  V30 41 2 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 134-20-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71989-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033295-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34611186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and characterization of PROTAC degraders specific to protein
N-terminal methyltransferase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Qilong; Wu, Wei; Jia, Kaimin; Qi, Guangyan; Sun, Xiuzhi Susan; Li,
Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 244114830

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
(αS)-α-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]benzenebutanoic acid
C25H23NO4
132684-59-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 9.7544 12.1610 0.0 0
M  V30 11 O 7.0871 12.1610 0.0 0
M  V30 12 C 4.4196 4.4609 0.0 0
M  V30 13 C 3.0128 5.0873 0.0 0
M  V30 14 C 4.2587 2.9293 0.0 0
M  V30 15 C 1.9822 3.9428 0.0 0
M  V30 16 C 2.5369 6.5519 0.0 0
M  V30 17 C 2.7522 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 0.4759 4.2630 0.0 0
M  V30 20 C 1.0304 6.8721 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.0000 5.7277 0.0 0
M  V30 24 C 3.3069 0.0000 0.0 0
M  V30 25 C 12.4219 9.0810 0.0 0
M  V30 26 C 13.7556 9.8510 0.0 0
M  V30 27 C 12.4219 7.5409 0.0 0
M  V30 28 C 15.0893 9.0810 0.0 0
M  V30 29 C 13.7556 6.7709 0.0 0
M  V30 30 C 15.0893 7.5409 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 25
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C35H38N4O6
2861234-22-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 6.9301 0.0 0
M  V30 2 O 7.0871 7.7001 0.0 0
M  V30 3 C 8.4207 6.9301 0.0 0
M  V30 4 N 9.7545 7.7001 0.0 0
M  V30 5 O 8.4207 5.3901 0.0 0
M  V30 6 C 11.0882 6.9301 0.0 0 CFG=1
M  V30 7 C 12.4219 7.7001 0.0 0
M  V30 8 C 11.0882 5.3901 0.0 0
M  V30 9 N 12.4219 9.2402 0.0 0
M  V30 10 O 13.7555 6.9301 0.0 0
M  V30 11 C 12.4219 4.6201 0.0 0
M  V30 12 C 13.7555 10.0102 0.0 0 CFG=2
M  V30 13 C 15.0893 9.2402 0.0 0
M  V30 14 C 13.7555 11.5502 0.0 0
M  V30 15 C 16.4230 10.0102 0.0 0
M  V30 16 O 15.0893 12.3202 0.0 0
M  V30 17 O 12.4219 12.3202 0.0 0
M  V30 18 C 17.7567 9.2402 0.0 0
M  V30 19 C 15.0893 13.8603 0.0 0
M  V30 20 C 19.0903 10.0102 0.0 0
M  V30 21 O 17.7567 7.7001 0.0 0
M  V30 22 C 16.6294 13.8603 0.0 0
M  V30 23 C 15.0893 15.4003 0.0 0
M  V30 24 C 13.5493 13.8603 0.0 0
M  V30 25 N 20.4242 9.2402 0.0 0 CHG=1 VAL=4
M  V30 26 N 21.7578 8.4702 0.0 0 CHG=-1
M  V30 27 C 4.4197 7.7001 0.0 0
M  V30 28 C 4.2586 9.2317 0.0 0
M  V30 29 C 3.0128 7.0738 0.0 0
M  V30 30 C 2.7523 9.5519 0.0 0
M  V30 31 C 5.2892 10.3762 0.0 0
M  V30 32 C 1.9823 8.2182 0.0 0
M  V30 33 C 2.5369 5.6091 0.0 0
M  V30 34 C 2.2765 11.0166 0.0 0
M  V30 35 C 4.8132 11.8408 0.0 0
M  V30 36 C 0.4759 7.8980 0.0 0
M  V30 37 C 1.0304 5.2889 0.0 0
M  V30 38 C 3.3069 12.1610 0.0 0
M  V30 39 C 0.0000 6.4333 0.0 0
M  V30 40 C 12.4219 3.0801 0.0 0
M  V30 41 C 11.0882 2.3100 0.0 0
M  V30 42 C 13.7555 2.3100 0.0 0
M  V30 43 C 11.0882 0.7700 0.0 0
M  V30 44 C 13.7555 0.7700 0.0 0
M  V30 45 C 12.4219 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 40
M  V30 14 1 12 13 CFG=3
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 1 19 24
M  V30 26 2 20 25
M  V30 27 2 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 32 1 29 32
M  V30 33 2 29 33
M  V30 34 1 30 32
M  V30 35 2 30 34
M  V30 36 1 31 35
M  V30 37 2 32 36
M  V30 38 1 33 37
M  V30 39 1 34 38
M  V30 40 2 35 38
M  V30 41 1 36 39
M  V30 42 2 37 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 132684-59-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861234-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
4-Methoxybenzoic acid
C8H8O3
100-09-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C34H31N3O5
2919713-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 O 27.1736 5.4955 0.0 0
M  V30 11 C 27.9436 6.8291 0.0 0
M  V30 12 C 11.7732 2.8281 0.0 0
M  V30 13 C 11.0032 4.1618 0.0 0
M  V30 14 C 10.7428 1.6836 0.0 0
M  V30 15 C 13.3133 2.8281 0.0 0
M  V30 16 N 9.4969 3.8416 0.0 0
M  V30 17 C 11.7732 5.4955 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 14.0833 4.1618 0.0 0
M  V30 20 C 13.3133 5.4955 0.0 0
M  V30 21 C 15.6233 4.1618 0.0 0
M  V30 22 C 16.3933 2.8281 0.0 0
M  V30 23 C 16.3933 5.4955 0.0 0
M  V30 24 C 17.9334 2.8281 0.0 0
M  V30 25 C 17.9334 5.4955 0.0 0
M  V30 26 C 18.7034 4.1618 0.0 0
M  V30 27 N 6.6685 2.3101 0.0 0
M  V30 28 C 5.3348 1.5400 0.0 0
M  V30 29 C 6.6685 3.8501 0.0 0
M  V30 30 C 4.0010 2.3101 0.0 0
M  V30 31 C 5.3348 4.6201 0.0 0
M  V30 32 C 4.0010 3.8501 0.0 0
M  V30 33 C 2.6673 1.5400 0.0 0
M  V30 34 C 2.6673 4.6201 0.0 0
M  V30 35 C 1.3337 2.3101 0.0 0
M  V30 36 C 1.3337 3.8501 0.0 0
M  V30 37 C 22.5535 5.4955 0.0 0
M  V30 38 C 23.3235 4.1618 0.0 0
M  V30 39 C 23.3235 6.8291 0.0 0
M  V30 40 C 24.8635 4.1618 0.0 0
M  V30 41 C 24.8635 6.8291 0.0 0
M  V30 42 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 27
M  V30 4 1 3 4
M  V30 5 1 3 26
M  V30 6 2 4 5
M  V30 7 1 4 37
M  V30 8 1 6 7
M  V30 9 1 6 35
M  V30 10 1 8 9
M  V30 11 1 8 36
M  V30 12 1 10 11
M  V30 13 1 10 42
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 32
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-77-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tyrosine benzyl ester
C16H17NO3
42406-77-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0 CFG=2
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0022 3.8501 0.0 0
M  V30 5 O 5.3348 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 C 4.0010 1.5400 0.0 0
M  V30 8 O 14.6707 4.6201 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 12.0033 4.6201 0.0 0
M  V30 13 C 13.3370 2.3101 0.0 0
M  V30 14 C 13.3370 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 15
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C26H32N2O6
2410547-63-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 8.0022 0.0 0
M  V30 2 N 7.7002 8.0022 0.0 0
M  V30 3 O 10.0102 6.6685 0.0 0
M  V30 4 C 6.9302 6.6685 0.0 0 CFG=2
M  V30 5 C 7.7002 5.3348 0.0 0
M  V30 6 C 5.3901 6.6685 0.0 0
M  V30 7 O 4.6201 8.0022 0.0 0
M  V30 8 O 4.6201 5.3348 0.0 0
M  V30 9 C 3.0801 8.0022 0.0 0
M  V30 10 C 12.5722 8.3524 0.0 0
M  V30 11 O 14.0787 8.6727 0.0 0
M  V30 12 O 12.0963 6.8878 0.0 0
M  V30 13 C 15.1091 7.5281 0.0 0
M  V30 14 C 13.9646 6.4977 0.0 0
M  V30 15 C 16.1396 6.3837 0.0 0
M  V30 16 C 16.2535 8.5586 0.0 0
M  V30 17 O 4.6201 0.0000 0.0 0
M  V30 18 C 10.0102 9.3360 0.0 0 CFG=2
M  V30 19 N 11.5418 9.4969 0.0 0
M  V30 20 C 9.3837 10.7428 0.0 0
M  V30 21 C 11.8620 11.0032 0.0 0
M  V30 22 C 10.5283 11.7733 0.0 0
M  V30 23 C 6.9302 4.0012 0.0 0
M  V30 24 C 7.7002 2.6673 0.0 0
M  V30 25 C 5.3901 4.0012 0.0 0
M  V30 26 C 6.9302 1.3337 0.0 0
M  V30 27 C 4.6201 2.6673 0.0 0
M  V30 28 C 5.3901 1.3337 0.0 0
M  V30 29 C 2.3101 9.3360 0.0 0
M  V30 30 C 0.7700 9.3360 0.0 0
M  V30 31 C 3.0801 10.6697 0.0 0
M  V30 32 C 0.0000 10.6697 0.0 0
M  V30 33 C 2.3101 12.0033 0.0 0
M  V30 34 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 23
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 10 19
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 17 28
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42406-77-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2410547-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31446392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for
Alzheimer's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Min Jae; Bhattarai, Deepak; Jang, Hyeryung; Baek, Ahreum; Yeo, In
Jun; Lee, Seongsoo; Miller, Zachary; Lee, Sukyeong; Hong, Jin Tae; Kim,
Dong-Eun; Lee, Wooin; Kim, Kyung Bo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 10934-10950

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
5-Bromopentanoic acid
C5H9BrO2
2067-33-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 Br 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, 3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]...
C22H30N4O3S
1448297-52-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0133 5.3027 0.0 0
M  V30 2 N 8.5533 5.3027 0.0 0
M  V30 3 O 6.2433 6.6363 0.0 0
M  V30 4 C 9.3233 6.6363 0.0 0
M  V30 5 C 3.6814 4.9525 0.0 0
M  V30 6 C 2.1749 4.6322 0.0 0 CFG=1
M  V30 7 O 4.1572 6.4170 0.0 0
M  V30 8 C 1.1445 5.7767 0.0 0
M  V30 9 N 1.6991 3.1676 0.0 0
M  V30 10 C 0.0000 4.7463 0.0 0
M  V30 11 C 0.1141 6.9211 0.0 0
M  V30 12 C 2.2889 6.8071 0.0 0
M  V30 13 O 5.8862 0.0000 0.0 0
M  V30 14 C 15.9127 9.3469 0.0 0
M  V30 15 C 6.2433 3.9689 0.0 0 CFG=2
M  V30 16 N 4.7118 3.8080 0.0 0
M  V30 17 C 6.8698 2.5621 0.0 0
M  V30 18 C 4.3916 2.3017 0.0 0
M  V30 19 C 5.7253 1.5317 0.0 0 CFG=1
M  V30 20 C 10.8633 6.6363 0.0 0
M  V30 21 C 11.6333 7.9700 0.0 0
M  V30 22 C 11.6333 5.3027 0.0 0
M  V30 23 C 13.1733 7.9700 0.0 0
M  V30 24 C 13.1733 5.3027 0.0 0
M  V30 25 C 13.9434 6.6363 0.0 0
M  V30 26 C 15.4834 6.6363 0.0 0
M  V30 27 S 16.3886 5.3905 0.0 0
M  V30 28 C 16.3886 7.8822 0.0 0
M  V30 29 C 17.8533 5.8663 0.0 0
M  V30 30 N 17.8533 7.4063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 6 9 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 19 13 CFG=1
M  V30 15 1 14 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, N-(5-bromo-1-oxopentyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-me...
C27H37BrN4O4S
2162120-79-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3725 5.3348 0.0 0
M  V30 2 C 15.9126 5.3348 0.0 0 CFG=2
M  V30 3 O 13.6025 6.6687 0.0 0
M  V30 4 N 16.6826 4.0012 0.0 0
M  V30 5 C 16.6826 6.6687 0.0 0
M  V30 6 C 18.2226 4.0012 0.0 0
M  V30 7 C 15.3489 7.4387 0.0 0
M  V30 8 C 17.4526 8.0023 0.0 0
M  V30 9 C 18.0164 5.8986 0.0 0
M  V30 10 C 18.9926 2.6675 0.0 0
M  V30 11 O 18.9926 5.3348 0.0 0
M  V30 12 C 20.5327 2.6675 0.0 0
M  V30 13 C 21.3027 1.3337 0.0 0
M  V30 14 C 22.8427 1.3337 0.0 0
M  V30 15 Br 23.6127 0.0000 0.0 0
M  V30 16 C 11.0405 4.9846 0.0 0
M  V30 17 N 9.5340 4.6645 0.0 0
M  V30 18 O 11.5164 6.4494 0.0 0
M  V30 19 C 8.5036 5.8089 0.0 0
M  V30 20 O 13.2455 0.0322 0.0 0
M  V30 21 C 1.4946 7.0903 0.0 0
M  V30 22 N 13.6025 4.0012 0.0 0
M  V30 23 C 12.0709 3.8402 0.0 0 CFG=2
M  V30 24 C 14.2290 2.5943 0.0 0
M  V30 25 C 11.7508 2.3338 0.0 0
M  V30 26 C 13.0844 1.5638 0.0 0 CFG=2
M  V30 27 C 6.9973 5.4887 0.0 0
M  V30 28 C 6.5214 4.0241 0.0 0
M  V30 29 C 5.9667 6.6332 0.0 0
M  V30 30 C 5.0150 3.7039 0.0 0
M  V30 31 C 4.4604 6.3131 0.0 0
M  V30 32 C 3.9845 4.8483 0.0 0
M  V30 33 C 2.4781 4.5282 0.0 0
M  V30 34 C 1.3337 5.5586 0.0 0
M  V30 35 S 1.8517 3.1213 0.0 0
M  V30 36 N 0.0000 4.7886 0.0 0
M  V30 37 C 0.3202 3.2823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 23 16 CFG=1
M  V30 19 1 17 19
M  V30 20 1 19 27
M  V30 21 1 26 20 CFG=3
M  V30 22 1 21 34
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 1 32 33
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 23 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2067-33-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448297-52-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2162120-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36967878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of intracellular self-assembly protein degraders driven by
tumor-specific activatable bioorthogonal reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Si, Ru; Hai, Ping; Zheng, Yongbiao; Wang, Jin; Zhang, Qingqing; Li,
Yanchen; Pan, Xiaoyan; Zhang, Jie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 257115497

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
1-Adamantanecarboxylic acid
C11H16O2
828-51-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5319 1.5430 0.0 0
M  V30 2 O 5.5319 0.0000 0.0 0
M  V30 3 O 6.8681 2.3145 0.0 0
M  V30 4 C 4.1955 2.3145 0.0 0
M  V30 5 C 2.9049 1.4742 0.0 0
M  V30 6 C 4.2779 3.8522 0.0 0
M  V30 7 C 2.4985 2.3253 0.0 0
M  V30 8 C 1.6968 2.1717 0.0 0
M  V30 9 C 3.0697 4.5498 0.0 0
M  V30 10 C 1.2904 3.0228 0.0 0
M  V30 11 C 0.0000 2.1828 0.0 0
M  V30 12 C 1.7794 3.7095 0.0 0
M  V30 13 C 1.3729 4.5607 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Diamino-1-(phenylmethyl)-3-propyl-2,4(1H,3H)-pyrimidinedione
C14H18N4O2
200557-55-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 N 4.0012 1.5400 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 N 6.6685 0.0000 0.0 0
M  V30 8 O 9.3360 1.5400 0.0 0
M  V30 9 N 5.3348 3.8501 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 N 8.0022 3.8501 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 2 2 10
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 5 6
M  V30 8 1 7 13
M  V30 9 2 8 14
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tricyclo[3.3.1.13,7]decane-1-carboxamide, N-[6-amino-1,2,3,4-tetrahydro-2,4-d...
C25H32N4O3
2969809-75-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1009 6.6685 0.0 0
M  V30 2 N 5.8709 5.3348 0.0 0
M  V30 3 O 5.8709 8.0023 0.0 0
M  V30 4 N 7.4110 8.0023 0.0 0
M  V30 5 O 7.4110 2.6675 0.0 0
M  V30 6 C 10.4910 8.0023 0.0 0
M  V30 7 C 10.4910 2.6675 0.0 0
M  V30 8 C 9.7210 1.3337 0.0 0
M  V30 9 C 10.4910 0.0000 0.0 0
M  V30 10 O 12.0311 5.3348 0.0 0
M  V30 11 C 3.5609 6.6685 0.0 0
M  V30 12 C 2.8646 8.0388 0.0 0
M  V30 13 C 2.8646 5.2982 0.0 0
M  V30 14 C 2.0886 7.5060 0.0 0
M  V30 15 C 1.4723 8.0388 0.0 0
M  V30 16 C 1.4723 5.2982 0.0 0
M  V30 17 C 0.6962 7.5060 0.0 0
M  V30 18 C 0.0000 8.8760 0.0 0
M  V30 19 C 0.7762 6.6685 0.0 0
M  V30 20 C 0.0000 6.1355 0.0 0
M  V30 21 C 7.4110 5.3348 0.0 0
M  V30 22 C 8.1810 6.6685 0.0 0
M  V30 23 C 8.1810 4.0012 0.0 0
M  V30 24 N 9.7210 6.6685 0.0 0
M  V30 25 N 9.7210 4.0012 0.0 0
M  V30 26 C 10.4910 5.3348 0.0 0
M  V30 27 C 12.0311 8.0023 0.0 0
M  V30 28 C 12.8011 6.6685 0.0 0
M  V30 29 C 12.8011 9.3360 0.0 0
M  V30 30 C 14.3411 6.6685 0.0 0
M  V30 31 C 14.3411 9.3360 0.0 0
M  V30 32 C 15.1111 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 21
M  V30 5 1 4 22
M  V30 6 2 5 23
M  V30 7 1 6 24
M  V30 8 1 6 27
M  V30 9 1 7 8
M  V30 10 1 7 25
M  V30 11 1 8 9
M  V30 12 2 10 26
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 1 16 20
M  V30 23 1 17 18
M  V30 24 1 17 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 828-51-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 200557-55-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2969809-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39736960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1075198-30-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development and Application of Subtype-Selective Fluorescent Antagonists
for the Study of the Human Adenosine A1 Receptor in Living Cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Comeo, Eleonora; Trinh, Phuc; Nguyen, Anh T.; Nowell, Cameron J.; Kindon,
Nicholas D.; Soave, Mark; Stoddart, Leigh A.; White, Jonathan M.; Hill,
Stephen J.; Kellam, Barrie; Halls, Michelle L.; May, Lauren T.;
Scammells, Peter J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(10), 6670-6695

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
(2E)-3-(4-Chlorophenyl)-2-propenoic acid
C9H7ClO2
940-62-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1-Methyl-9H-pyrido[3,4-b]indol-6-yl)oxy]ethanamine
C14H15N3O
2685741-31-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8078 1.2736 0.0 0
M  V30 2 C 10.1415 2.0436 0.0 0
M  V30 3 C 11.4752 1.2736 0.0 0
M  V30 4 N 12.8090 2.0436 0.0 0
M  V30 5 C 0.0000 3.8986 0.0 0
M  V30 6 C 4.8067 2.0436 0.0 0
M  V30 7 C 3.3420 1.5677 0.0 0
M  V30 8 C 4.8067 3.5836 0.0 0
M  V30 9 C 6.1404 1.2736 0.0 0
M  V30 10 C 2.4369 2.8136 0.0 0
M  V30 11 C 2.7157 0.1609 0.0 0
M  V30 12 N 3.3420 4.0596 0.0 0
M  V30 13 C 6.1404 4.3536 0.0 0
M  V30 14 C 7.4740 2.0436 0.0 0
M  V30 15 C 0.9052 2.6527 0.0 0
M  V30 16 C 1.1841 0.0000 0.0 0
M  V30 17 C 7.4740 3.5836 0.0 0
M  V30 18 N 0.2789 1.2459 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(4-Chlorophenyl)-N-[2-[(1-methyl-9H-pyrido[3,4-b]indol-6-yl)oxy]ethyl]...
C23H20ClN3O2
2685741-69-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8078 1.5400 0.0 0
M  V30 2 C 10.1414 2.3101 0.0 0
M  V30 3 C 11.4751 1.5400 0.0 0
M  V30 4 N 12.8089 2.3101 0.0 0
M  V30 5 C 14.1426 1.5400 0.0 0
M  V30 6 C 15.4763 2.3101 0.0 0
M  V30 7 O 14.1426 0.0000 0.0 0
M  V30 8 C 16.8099 1.5400 0.0 0
M  V30 9 C 0.0000 4.1650 0.0 0
M  V30 10 Cl 22.1448 4.6201 0.0 0
M  V30 11 C 4.8066 2.3101 0.0 0
M  V30 12 C 3.3420 1.8342 0.0 0
M  V30 13 C 4.8066 3.8501 0.0 0
M  V30 14 C 6.1403 1.5400 0.0 0
M  V30 15 C 2.4368 3.0801 0.0 0
M  V30 16 C 2.7155 0.4272 0.0 0
M  V30 17 N 3.3420 4.3260 0.0 0
M  V30 18 C 6.1403 4.6201 0.0 0
M  V30 19 C 7.4741 2.3101 0.0 0
M  V30 20 C 0.9051 2.9191 0.0 0
M  V30 21 C 1.1840 0.2663 0.0 0
M  V30 22 C 7.4741 3.8501 0.0 0
M  V30 23 N 0.2787 1.5122 0.0 0
M  V30 24 C 18.1438 2.3101 0.0 0
M  V30 25 C 19.4774 1.5400 0.0 0
M  V30 26 C 18.1438 3.8501 0.0 0
M  V30 27 C 20.8111 2.3101 0.0 0
M  V30 28 C 19.4774 4.6201 0.0 0
M  V30 29 C 20.8111 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 8 24
M  V30 10 1 9 20
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 2 15 20
M  V30 22 1 16 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 940-62-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2685741-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2685741-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23896427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Further investigation of harmicines as novel antiplasmodial agents:
Synthesis, structure-activity relationship and insight into the mechanism
of action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marinovic, Marina; Poje, Goran; Perkovic, Ivana; Fontinha, Diana;
Prudencio, Miguel; Held, Jana; Pessanha de Carvalho, Lais; Tandaric,
Tana; Vianello, Robert; Rajic, Zrinka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 224113687

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
trans-4-Fluorocinnamic acid
C9H7FO2
14290-86-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 F 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1-Methyl-9H-pyrido[3,4-b]indol-6-yl)oxy]ethanamine
C14H15N3O
2685741-31-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8078 1.2736 0.0 0
M  V30 2 C 10.1415 2.0436 0.0 0
M  V30 3 C 11.4752 1.2736 0.0 0
M  V30 4 N 12.8090 2.0436 0.0 0
M  V30 5 C 0.0000 3.8986 0.0 0
M  V30 6 C 4.8067 2.0436 0.0 0
M  V30 7 C 3.3420 1.5677 0.0 0
M  V30 8 C 4.8067 3.5836 0.0 0
M  V30 9 C 6.1404 1.2736 0.0 0
M  V30 10 C 2.4369 2.8136 0.0 0
M  V30 11 C 2.7157 0.1609 0.0 0
M  V30 12 N 3.3420 4.0596 0.0 0
M  V30 13 C 6.1404 4.3536 0.0 0
M  V30 14 C 7.4740 2.0436 0.0 0
M  V30 15 C 0.9052 2.6527 0.0 0
M  V30 16 C 1.1841 0.0000 0.0 0
M  V30 17 C 7.4740 3.5836 0.0 0
M  V30 18 N 0.2789 1.2459 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(4-Fluorophenyl)-N-[2-[(1-methyl-9H-pyrido[3,4-b]indol-6-yl)oxy]ethyl]...
C23H20FN3O2
2685741-68-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8078 1.5400 0.0 0
M  V30 2 C 10.1414 2.3101 0.0 0
M  V30 3 C 11.4751 1.5400 0.0 0
M  V30 4 N 12.8089 2.3101 0.0 0
M  V30 5 C 14.1426 1.5400 0.0 0
M  V30 6 C 15.4763 2.3101 0.0 0
M  V30 7 O 14.1426 0.0000 0.0 0
M  V30 8 C 16.8099 1.5400 0.0 0
M  V30 9 C 0.0000 4.1650 0.0 0
M  V30 10 F 22.1448 4.6201 0.0 0
M  V30 11 C 4.8066 2.3101 0.0 0
M  V30 12 C 3.3420 1.8342 0.0 0
M  V30 13 C 4.8066 3.8501 0.0 0
M  V30 14 C 6.1403 1.5400 0.0 0
M  V30 15 C 2.4368 3.0801 0.0 0
M  V30 16 C 2.7155 0.4272 0.0 0
M  V30 17 N 3.3420 4.3260 0.0 0
M  V30 18 C 6.1403 4.6201 0.0 0
M  V30 19 C 7.4741 2.3101 0.0 0
M  V30 20 C 0.9051 2.9191 0.0 0
M  V30 21 C 1.1840 0.2663 0.0 0
M  V30 22 C 7.4741 3.8501 0.0 0
M  V30 23 N 0.2787 1.5122 0.0 0
M  V30 24 C 18.1438 2.3101 0.0 0
M  V30 25 C 19.4774 1.5400 0.0 0
M  V30 26 C 18.1438 3.8501 0.0 0
M  V30 27 C 20.8111 2.3101 0.0 0
M  V30 28 C 19.4774 4.6201 0.0 0
M  V30 29 C 20.8111 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 8 24
M  V30 10 1 9 20
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 2 15 20
M  V30 22 1 16 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14290-86-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2685741-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2685741-68-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23896755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Further investigation of harmicines as novel antiplasmodial agents:
Synthesis, structure-activity relationship and insight into the mechanism
of action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marinovic, Marina; Poje, Goran; Perkovic, Ivana; Fontinha, Diana;
Prudencio, Miguel; Held, Jana; Pessanha de Carvalho, Lais; Tandaric,
Tana; Vianello, Robert; Rajic, Zrinka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 224113687

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Cyanoacetic acid
C3H3NO2
372-09-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3336 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3336 0.0 0
M  V30 6 N 5.3900 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 3 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[5-[(2,6-Dichloro-3,5-dimethoxyphenyl)methoxy]-2-pyrimidinyl]-3-methyl-1,2...
C20H20Cl2N4O3
2093305-95-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6694 5.3900 0.0 0
M  V30 2 O 9.3358 4.6200 0.0 0
M  V30 3 Cl 13.3369 6.9300 0.0 0
M  V30 4 Cl 10.6694 2.3100 0.0 0
M  V30 5 O 16.0041 5.3900 0.0 0
M  V30 6 C 17.3379 4.6200 0.0 0
M  V30 7 O 13.3369 0.7700 0.0 0
M  V30 8 C 14.6705 0.0000 0.0 0
M  V30 9 N 4.0011 7.7000 0.0 0
M  V30 10 C 1.3338 9.2400 0.0 0
M  V30 11 N 4.0011 4.6200 0.0 0
M  V30 12 C 12.0032 4.6200 0.0 0
M  V30 13 C 13.3369 5.3900 0.0 0
M  V30 14 C 12.0032 3.0800 0.0 0
M  V30 15 C 14.6705 4.6200 0.0 0
M  V30 16 C 13.3369 2.3100 0.0 0
M  V30 17 C 14.6705 3.0800 0.0 0
M  V30 18 C 8.0021 5.3900 0.0 0
M  V30 19 C 6.6685 4.6200 0.0 0
M  V30 20 C 8.0021 6.9300 0.0 0
M  V30 21 N 5.3347 5.3900 0.0 0
M  V30 22 N 6.6685 7.7000 0.0 0
M  V30 23 C 5.3347 6.9300 0.0 0
M  V30 24 C 2.6674 6.9300 0.0 0
M  V30 25 C 1.3338 7.7000 0.0 0
M  V30 26 C 2.6674 5.3900 0.0 0
M  V30 27 C 0.0000 6.9300 0.0 0
M  V30 28 C 1.3338 4.6200 0.0 0
M  V30 29 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 1 3 13
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 23
M  V30 11 1 9 24
M  V30 12 1 10 25
M  V30 13 1 11 26
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Cyano-N-[2-[[5-[(2,6-dichloro-3,5-dimethoxyphenyl)methoxy]-2-pyrimidinyl]am...
C23H21Cl2N5O4
2745203-62-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.0900 4.0011 0.0 0
M  V30 2 N 16.1700 4.0011 0.0 0
M  V30 3 C 17.7100 4.0011 0.0 0
M  V30 4 C 18.4800 5.3347 0.0 0
M  V30 5 O 18.4800 2.6674 0.0 0
M  V30 6 C 20.0200 5.3347 0.0 0
M  V30 7 N 21.5600 5.3347 0.0 0
M  V30 8 C 11.5500 1.3336 0.0 0
M  V30 9 O 6.9300 4.0011 0.0 0
M  V30 10 C 6.1600 5.3347 0.0 0
M  V30 11 Cl 4.6200 8.0021 0.0 0
M  V30 12 Cl 4.6200 2.6674 0.0 0
M  V30 13 O 1.5400 8.0021 0.0 0
M  V30 14 C 0.0000 8.0021 0.0 0
M  V30 15 O 1.5400 2.6674 0.0 0
M  V30 16 C 0.0000 2.6674 0.0 0
M  V30 17 C 13.8600 2.6674 0.0 0
M  V30 18 C 15.4000 2.6674 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 20 C 16.1700 1.3336 0.0 0
M  V30 21 C 13.8600 0.0000 0.0 0
M  V30 22 C 15.4000 0.0000 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 N 10.7800 2.6674 0.0 0
M  V30 25 N 10.7800 5.3347 0.0 0
M  V30 26 C 9.2400 2.6674 0.0 0
M  V30 27 C 9.2400 5.3347 0.0 0
M  V30 28 C 8.4700 4.0011 0.0 0
M  V30 29 C 4.6200 5.3347 0.0 0
M  V30 30 C 3.8500 6.6685 0.0 0
M  V30 31 C 3.8500 4.0011 0.0 0
M  V30 32 C 2.3100 6.6685 0.0 0
M  V30 33 C 2.3100 4.0011 0.0 0
M  V30 34 C 1.5400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 3 6 7
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 28
M  V30 12 1 10 29
M  V30 13 1 11 30
M  V30 14 1 12 31
M  V30 15 1 13 14
M  V30 16 1 13 32
M  V30 17 1 15 16
M  V30 18 1 15 33
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 372-09-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2093305-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2745203-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25082100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigation of Covalent Warheads in the Design of
2-Aminopyrimidine-based FGFR4 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deng, Wuqing; Chen, Xiaojuan; Jiang, Kaili; Song, Xiaojuan; Huang,
Minhao; Tu, Zheng-Chao; Zhang, Zhang; Lin, Xiaojing; Ortega, Raquel;
Patterson, Adam V.; Smaill, Jeff B.; Ding, Ke; Chen, Suming; Chen,
Yongheng; Lu, Xiaoyun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2021), 12(4), 647-652

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
3-(3-Methylbutyl)benzoic acid
C12H16O2
105337-81-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 9.3359 3.0800 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 C 10.6695 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1-Benzopyran-2-one, 3-amino-4-hydroxy-7-nitro-, hydrochloride (1:1)
C9H6N2O5.ClH
2083629-05-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 N 0.0000 3.0800 0.0 0
M  V30 3 N 8.0023 6.1601 0.0 0 VAL=5
M  V30 4 O 9.3360 5.3901 0.0 0
M  V30 5 O 8.0023 7.7001 0.0 0
M  V30 6 O 0.0000 6.1601 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 4.0012 5.3901 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 O 2.6675 6.1601 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 6.6685 5.3901 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 Cl 4.6680 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 13
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxy-7-nitro-2-oxo-2H-1-benzopyran-3-yl)-3-(3-methylbutyl)benzamide
C21H20N2O6
2756363-68-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.1601 0.0 0
M  V30 2 N 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 3.8501 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 9.3360 1.5400 0.0 0
M  V30 9 C 16.0045 3.8501 0.0 0
M  V30 10 C 17.3382 4.6201 0.0 0
M  V30 11 C 18.6720 3.8501 0.0 0
M  V30 12 C 18.6720 2.3101 0.0 0
M  V30 13 C 20.0057 4.6201 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 4.0012 4.6201 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 O 6.6685 1.5400 0.0 0
M  V30 20 C 8.0023 3.8501 0.0 0
M  V30 21 C 2.6675 3.8501 0.0 0
M  V30 22 C 2.6675 2.3101 0.0 0
M  V30 23 C 8.0023 2.3101 0.0 0
M  V30 24 C 12.0033 4.6201 0.0 0
M  V30 25 C 13.3372 3.8501 0.0 0
M  V30 26 C 12.0033 6.1601 0.0 0
M  V30 27 C 14.6708 4.6201 0.0 0
M  V30 28 C 13.3372 6.9302 0.0 0
M  V30 29 C 14.6708 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 2 3 4
M  V30 5 1 3 24
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 2 8 23
M  V30 10 1 9 10
M  V30 11 1 9 27
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 2 21 22
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105337-81-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2083629-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2756363-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25136532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Demonstrating Ligandability of the LC3A and LC3B Adapter Interface
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartmann, Markus; Huber, Jessica; Kramer, Jan S.; Heering, Jan; Pietsch,
Larissa; Stark, Holger; Odadzic, Dalibor; Bischoff, Iris; Fuerst, Robert;
Schroeder, Martin; Akutsu, Masato; Chaikuad, Apirat; Doetsch, Volker;
Knapp, Stefan; Biondi, Ricardo M.; Rogov, Vladimir V.; Proschak, Ewgenij
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(7), 3720-3746

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C24H24N2O5
2632874-41-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6201 0.0 0
M  V30 2 O 8.0022 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8049 2.7300 0.0 0
M  V30 9 C 20.3365 2.8910 0.0 0
M  V30 10 O 18.1786 1.3230 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 N 6.6685 3.8501 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 9.3360 3.8501 0.0 0
M  V30 22 O 10.7428 4.4764 0.0 0
M  V30 23 C 9.4969 2.3185 0.0 0
M  V30 24 C 11.7732 3.3320 0.0 0
M  V30 25 C 11.0032 1.9983 0.0 0
M  V30 26 C 13.3050 3.4930 0.0 0
M  V30 27 C 14.2100 2.2471 0.0 0
M  V30 28 C 13.9313 4.8999 0.0 0
M  V30 29 C 15.7418 2.4080 0.0 0
M  V30 30 C 15.4629 5.0609 0.0 0
M  V30 31 C 16.3681 3.8150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2632874-41-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
2-Pyridinemethanamine
C6H8N2
3731-51-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thien...
C26H28FN5O3S
3064695-54-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=3
M  V30 2 C 11.9711 5.7472 0.0 0
M  V30 3 C 12.8763 6.9931 0.0 0
M  V30 4 C 14.4079 6.8322 0.0 0
M  V30 5 C 15.3131 8.0781 0.0 0
M  V30 6 C 16.8447 7.9171 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 C 1.3337 7.7001 0.0 0
M  V30 9 O 0.0000 6.9301 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 O 23.2464 8.6871 0.0 0
M  V30 12 N 8.0021 5.3901 0.0 0
M  V30 13 C 9.4091 4.7638 0.0 0
M  V30 14 N 8.1632 6.9217 0.0 0
M  V30 15 C 10.4395 5.9082 0.0 0
M  V30 16 N 9.6695 7.2418 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6673 6.9301 0.0 0
M  V30 23 C 6.6685 3.0801 0.0 0
M  V30 24 C 5.3348 2.3100 0.0 0
M  V30 25 C 8.0021 2.3100 0.0 0
M  V30 26 C 5.3348 0.7700 0.0 0
M  V30 27 C 8.0021 0.7700 0.0 0
M  V30 28 C 6.6685 0.0000 0.0 0
M  V30 29 C 17.7499 9.1630 0.0 0 CFG=2
M  V30 30 C 19.2899 9.1630 0.0 0 CFG=1
M  V30 31 S 17.2740 10.6276 0.0 0
M  V30 32 C 19.7658 10.6276 0.0 0 CFG=1
M  V30 33 N 20.5358 8.2578 0.0 0
M  V30 34 C 18.5199 11.5328 0.0 0
M  V30 35 N 21.3058 10.6276 0.0 0
M  V30 36 C 21.7818 9.1630 0.0 0
M  V30 37 H 18.8141 7.6983 0.0 0
M  V30 38 H 20.2418 12.0923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 2 3
M  V30 5 1 2 15
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 29 6 CFG=3
M  V30 10 1 7 26
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 22
M  V30 14 2 11 36
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 37 CFG=1
M  V30 37 1 31 34
M  V30 38 1 32 34
M  V30 39 1 32 35
M  V30 40 1 32 38 CFG=1
M  V30 41 1 33 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3...
C32H34FN7O2S
3064695-45-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 4.6200 0.0 0 CFG=3
M  V30 2 C 17.3058 5.7472 0.0 0
M  V30 3 C 18.2111 6.9930 0.0 0
M  V30 4 C 19.7426 6.8321 0.0 0
M  V30 5 C 20.6478 8.0780 0.0 0
M  V30 6 C 22.1793 7.9170 0.0 0
M  V30 7 F 14.6706 0.0000 0.0 0
M  V30 8 C 6.6685 7.7000 0.0 0
M  V30 9 N 5.3347 6.9300 0.0 0
M  V30 10 O 6.6685 9.2400 0.0 0
M  V30 11 C 4.0011 7.7000 0.0 0
M  V30 12 O 28.5810 8.6870 0.0 0
M  V30 13 N 13.3369 5.3900 0.0 0
M  V30 14 C 14.7437 4.7637 0.0 0
M  V30 15 N 13.4979 6.9216 0.0 0
M  V30 16 C 15.7743 5.9081 0.0 0
M  V30 17 N 15.0043 7.2417 0.0 0
M  V30 18 C 10.6695 5.3900 0.0 0
M  V30 19 C 10.6695 6.9300 0.0 0
M  V30 20 C 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 7.7000 0.0 0
M  V30 22 C 8.0022 5.3900 0.0 0
M  V30 23 C 8.0022 6.9300 0.0 0
M  V30 24 C 12.0033 3.0800 0.0 0
M  V30 25 C 13.3369 2.3100 0.0 0
M  V30 26 C 10.6695 2.3100 0.0 0
M  V30 27 C 13.3369 0.7700 0.0 0
M  V30 28 C 10.6695 0.7700 0.0 0
M  V30 29 C 12.0033 0.0000 0.0 0
M  V30 30 C 2.6674 6.9300 0.0 0
M  V30 31 C 2.6674 5.3900 0.0 0
M  V30 32 N 1.3338 7.7000 0.0 0
M  V30 33 C 1.3338 4.6200 0.0 0
M  V30 34 C 0.0000 6.9300 0.0 0
M  V30 35 C 0.0000 5.3900 0.0 0
M  V30 36 C 23.0846 9.1629 0.0 0 CFG=2
M  V30 37 C 24.6246 9.1629 0.0 0 CFG=1
M  V30 38 S 22.6087 10.6274 0.0 0
M  V30 39 C 25.1004 10.6274 0.0 0 CFG=1
M  V30 40 N 25.8704 8.2577 0.0 0
M  V30 41 C 23.8546 11.5327 0.0 0
M  V30 42 N 26.6404 10.6274 0.0 0
M  V30 43 C 27.1163 9.1629 0.0 0
M  V30 44 H 24.1487 7.6982 0.0 0
M  V30 45 H 25.5763 12.0921 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 2 3
M  V30 5 1 2 16
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 36 6 CFG=3
M  V30 10 1 7 27
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 23
M  V30 14 1 9 11
M  V30 15 1 11 30
M  V30 16 2 12 43
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 37 40
M  V30 44 1 37 44 CFG=1
M  V30 45 1 38 41
M  V30 46 1 39 41
M  V30 47 1 39 42
M  V30 48 1 39 45 CFG=1
M  V30 49 1 40 43
M  V30 50 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 36 37 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3731-51-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3064695-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3064695-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43968812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown,product obtained as mixture of
diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural study of potent triazole-based inhibitors of Staphylococcus
aureus biotin protein ligase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stachura, Damian L.; Nguyen, Stephanie; Polyak, Steven W.; Jovcevski,
Blagojce; Bruning, John B.; Abell, Andrew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(3), 285-290

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
5-Methyl-1H-indole-2-carboxylic acid
C10H9NO2
10241-97-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Pyrrolidinedicarboxylic acid, 4-amino-, 1-(1,1-dimethylethyl) 3-methyl es...
C11H20N2O4.ClH
2602442-39-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.5687 0.0 0
M  V30 2 O 2.6675 4.7987 0.0 0
M  V30 3 O 4.0012 7.1088 0.0 0
M  V30 4 C 1.3337 5.5687 0.0 0
M  V30 5 C 0.5637 4.2351 0.0 0
M  V30 6 C 0.0000 6.3387 0.0 0
M  V30 7 C 2.1037 6.9024 0.0 0
M  V30 8 C 9.3038 4.4416 0.0 0
M  V30 9 O 9.9303 5.8486 0.0 0
M  V30 10 O 10.2090 3.1957 0.0 0
M  V30 11 C 11.4619 6.0095 0.0 0
M  V30 12 N 7.6286 1.5400 0.0 0
M  V30 13 N 5.3348 4.7987 0.0 0
M  V30 14 C 6.7418 5.4250 0.0 0
M  V30 15 C 5.4959 3.2671 0.0 0
M  V30 16 C 7.7722 4.2806 0.0 0 CFG=2
M  V30 17 C 7.0022 2.9470 0.0 0 CFG=2
M  V30 18 Cl 5.7309 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 16 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 17 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 3-methyl (3S,4R)-4-[[(5-methyl-1H-indol-2-yl)carbonyl]a...
C21H27N3O5
2602442-40-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.0545 5.3196 0.0 0
M  V30 2 C 9.8245 6.6533 0.0 0
M  V30 3 O 9.0545 7.9869 0.0 0
M  V30 4 C 7.0851 2.6091 0.0 0
M  V30 5 O 6.0547 1.4647 0.0 0
M  V30 6 O 8.5914 2.2889 0.0 0
M  V30 7 C 6.5306 0.0000 0.0 0
M  V30 8 C 3.8987 6.9949 0.0 0
M  V30 9 O 2.4919 6.3684 0.0 0
M  V30 10 O 4.0596 8.5264 0.0 0
M  V30 11 C 1.2459 7.2736 0.0 0
M  V30 12 C 0.3408 6.0277 0.0 0
M  V30 13 C 0.0000 8.1788 0.0 0
M  V30 14 C 2.1511 8.5195 0.0 0
M  V30 15 C 17.7353 8.1933 0.0 0
M  V30 16 C 7.5145 5.3196 0.0 0 CFG=1
M  V30 17 C 6.6093 4.0738 0.0 0 CFG=1
M  V30 18 C 6.6093 6.5655 0.0 0
M  V30 19 C 5.1446 4.5496 0.0 0
M  V30 20 N 5.1446 6.0897 0.0 0
M  V30 21 C 11.3645 6.6533 0.0 0
M  V30 22 C 12.2696 7.8992 0.0 0
M  V30 23 N 12.2696 5.4074 0.0 0
M  V30 24 C 13.7343 7.4233 0.0 0
M  V30 25 C 13.7343 5.8833 0.0 0
M  V30 26 C 15.0679 8.1933 0.0 0
M  V30 27 C 15.0679 5.1133 0.0 0
M  V30 28 C 16.4017 7.4233 0.0 0
M  V30 29 C 16.4017 5.8833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 20
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10241-97-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2602442-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602442-40-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24414310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Optimization of Pyrrolidine Derivatives as Highly
Potent Ghrelin Receptor Full Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cooper, Martin; Llinas, Antonio; Hansen, Peter; Caffrey, Moya; Ray, Asim;
Sjoedin, Stina; Shamovsky, Igor; Wada, Hiroki; Jellesmark Jensen, Tina;
Sivars, Ulf; Hultin, Leif; Andersson, Ulf; Lundqvist, Sara; Gedda, Karin;
Jinton, Lisa; Krutroek, Nina; Lewis, Richard; Jansson, Paul; Gardelli,
Cristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9705-9730

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
N-(tert-Butoxycarbonyl)glycine
C7H13NO4
4530-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 0.5637 0.9764 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.1037 3.6437 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 O 8.0023 0.0000 0.0 0
M  V30 12 O 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-1,3-dihydrospiro[2H-indene-2,3′-[3H]pyrrolo[2,3-b]pyridin]-2′(1′H)-one
C15H13N3O
938460-60-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9554 0.0000 0.0 0
M  V30 2 N 10.3637 2.5589 0.0 0
M  V30 3 C 3.8119 2.7406 0.0 0
M  V30 4 C 2.6673 3.7712 0.0 0
M  V30 5 C 4.9563 1.7102 0.0 0
M  V30 6 C 4.4382 4.1476 0.0 0
M  V30 7 C 3.1854 1.3338 0.0 0
M  V30 8 C 1.3337 3.0012 0.0 0
M  V30 9 C 2.6673 5.3112 0.0 0
M  V30 10 C 6.2901 2.4802 0.0 0
M  V30 11 C 5.9697 3.9865 0.0 0
M  V30 12 N 1.6538 1.4947 0.0 0
M  V30 13 N 0.0000 3.7712 0.0 0
M  V30 14 C 1.3337 6.0812 0.0 0
M  V30 15 C 7.7546 2.0043 0.0 0
M  V30 16 C 7.1143 5.0171 0.0 0
M  V30 17 C 0.0000 5.3112 0.0 0
M  V30 18 C 8.8992 3.0348 0.0 0
M  V30 19 C 8.5789 4.5412 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 11
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H24N4O4
2252343-64-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4031 9.9549 0.0 0
M  V30 2 N 10.7070 5.5411 0.0 0
M  V30 3 C 11.4770 4.2074 0.0 0
M  V30 4 C 13.0170 4.2074 0.0 0
M  V30 5 O 10.7070 2.8736 0.0 0
M  V30 6 N 13.7870 2.8736 0.0 0
M  V30 7 C 15.3270 2.8736 0.0 0
M  V30 8 O 16.0970 1.5400 0.0 0
M  V30 9 O 16.0970 4.2074 0.0 0
M  V30 10 C 17.6370 1.5400 0.0 0
M  V30 11 C 17.6370 3.0800 0.0 0
M  V30 12 C 19.1770 1.5400 0.0 0
M  V30 13 C 17.6370 0.0000 0.0 0
M  V30 14 C 4.4196 7.3928 0.0 0
M  V30 15 C 3.0127 6.7665 0.0 0
M  V30 16 C 5.8264 8.0192 0.0 0
M  V30 17 C 4.5806 5.8612 0.0 0
M  V30 18 C 4.2587 8.9243 0.0 0
M  V30 19 C 1.9823 7.9108 0.0 0
M  V30 20 C 2.5368 5.3018 0.0 0
M  V30 21 C 6.8570 6.8747 0.0 0
M  V30 22 C 6.0870 5.5411 0.0 0
M  V30 23 N 2.7523 9.2446 0.0 0
M  V30 24 N 0.4760 7.5907 0.0 0
M  V30 25 C 1.0306 4.9816 0.0 0
M  V30 26 C 8.3970 6.8747 0.0 0
M  V30 27 C 6.8570 4.2074 0.0 0
M  V30 28 C 0.0000 6.1261 0.0 0
M  V30 29 C 9.1670 5.5411 0.0 0
M  V30 30 C 8.3970 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 29
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 19 23
M  V30 24 2 19 24
M  V30 25 1 20 25
M  V30 26 1 21 22
M  V30 27 2 21 26
M  V30 28 2 22 27
M  V30 29 1 24 28
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4530-20-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 938460-60-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2252343-64-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25849341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a First-In-Class Small Molecule Antagonist against the
Adrenomedullin-2 Receptor: Structure-Activity Relationships and
Optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zirimwabagabo, Jean-Olivier; Jailani, Ameera B. A.; Avgoustou, Paris;
Tozer, Matthew J.; Gibson, Karl R.; Glossop, Paul A.; Mills, James E. J.;
Porter, Roderick A.; Blaney, Paul; Wang, Ning; Skerry, Timothy M.;
Richards, Gareth O.; Harrity, Joseph P. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(6), 3299-3319

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
1-(1-Methylethyl)-1H-pyrazole-5-carboxylic acid
C7H10N2O2
920006-32-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 3.7710 0.0 0
M  V30 2 O 0.0000 3.7710 0.0 0
M  V30 3 O 2.3100 5.1048 0.0 0
M  V30 4 C 4.8721 3.4208 0.0 0
M  V30 5 C 4.3961 4.8855 0.0 0
M  V30 6 C 6.3784 3.1006 0.0 0
M  V30 7 C 2.3100 2.4374 0.0 0
M  V30 8 N 3.8415 2.2764 0.0 0
M  V30 9 C 1.6837 1.0306 0.0 0
M  V30 10 N 4.1617 0.7700 0.0 0
M  V30 11 C 2.8281 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 8
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-β-cyclopropyl-N-[4-[3,5-dimethyl-1-[[2-(trimethylsilyl)ethoxy]me...
C26H40N4O2Si
2446808-54-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8738 6.3686 0.0 0
M  V30 2 C 4.2075 7.1386 0.0 0 CFG=2
M  V30 3 C 5.5412 6.3686 0.0 0
M  V30 4 N 4.2075 8.6787 0.0 0
M  V30 5 N 6.8748 7.1386 0.0 0
M  V30 6 O 5.5412 4.8286 0.0 0
M  V30 7 C 13.9368 6.1914 0.0 0
M  V30 8 C 11.2262 1.4964 0.0 0
M  V30 9 C 16.1786 3.7015 0.0 0
M  V30 10 O 17.0838 2.4556 0.0 0
M  V30 11 C 18.6154 2.6165 0.0 0
M  V30 12 C 19.5206 1.3706 0.0 0
M  V30 13 Si 21.0522 1.5316 0.0 0
M  V30 14 C 22.5839 1.6926 0.0 0
M  V30 15 C 21.2133 0.0000 0.0 0
M  V30 16 C 20.8912 3.0633 0.0 0
M  V30 17 C 1.5400 7.1386 0.0 0
M  V30 18 C 0.7700 8.4723 0.0 0
M  V30 19 C 0.0000 7.1386 0.0 0
M  V30 20 C 2.8738 4.8286 0.0 0
M  V30 21 C 3.6439 3.4949 0.0 0
M  V30 22 C 2.1038 3.4949 0.0 0
M  V30 23 C 8.2087 6.3686 0.0 0
M  V30 24 C 9.5423 7.1386 0.0 0
M  V30 25 C 8.2087 4.8286 0.0 0
M  V30 26 C 10.8760 6.3686 0.0 0
M  V30 27 C 9.5423 4.0586 0.0 0
M  V30 28 C 10.8760 4.8286 0.0 0
M  V30 29 C 12.2096 4.0586 0.0 0
M  V30 30 C 13.6166 4.6849 0.0 0
M  V30 31 C 12.3707 2.5270 0.0 0
M  V30 32 N 14.6471 3.5405 0.0 0
M  V30 33 N 13.8770 2.2069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 1 2 4 CFG=3
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 5 23
M  V30 9 1 7 30
M  V30 10 1 8 31
M  V30 11 1 9 10
M  V30 12 1 9 32
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 28 29
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2,2-Dicyclopropyl-1-[[[4-[3,5-dimethyl-1-[[2-(trimethylsilyl)ethoxy]m...
C33H48N6O3Si
2446806-89-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1048 2.1037 0.0 0
M  V30 2 C 5.1048 3.6437 0.0 0 CFG=1
M  V30 3 N 3.7711 4.4137 0.0 0
M  V30 4 C 6.4384 4.4137 0.0 0
M  V30 5 C 3.7711 5.9538 0.0 0
M  V30 6 N 7.7722 3.6437 0.0 0
M  V30 7 O 6.4384 5.9538 0.0 0
M  V30 8 O 5.1048 6.7238 0.0 0
M  V30 9 C 3.4209 9.2859 0.0 0
M  V30 10 C 4.8854 8.8099 0.0 0
M  V30 11 C 3.1007 10.7922 0.0 0
M  V30 12 C 14.8341 4.5910 0.0 0
M  V30 13 C 12.1236 9.2859 0.0 0
M  V30 14 C 17.0760 7.0809 0.0 0
M  V30 15 O 17.9813 8.3268 0.0 0
M  V30 16 C 19.5128 8.1659 0.0 0
M  V30 17 C 20.4181 9.4118 0.0 0
M  V30 18 Si 21.9496 9.2508 0.0 0
M  V30 19 C 23.4812 9.0897 0.0 0
M  V30 20 C 22.1106 10.7824 0.0 0
M  V30 21 C 21.7887 7.7191 0.0 0
M  V30 22 C 3.7711 1.3337 0.0 0
M  V30 23 C 2.2310 1.3337 0.0 0
M  V30 24 C 3.0011 0.0000 0.0 0
M  V30 25 C 6.4384 1.3337 0.0 0
M  V30 26 C 7.2084 0.0000 0.0 0
M  V30 27 C 7.9785 1.3337 0.0 0
M  V30 28 C 2.4374 6.7238 0.0 0
M  V30 29 N 2.2763 8.2554 0.0 0
M  V30 30 C 1.0304 6.0975 0.0 0
M  V30 31 N 0.7700 8.5755 0.0 0
M  V30 32 C 0.0000 7.2419 0.0 0
M  V30 33 C 9.1059 4.4137 0.0 0
M  V30 34 C 10.4396 3.6437 0.0 0
M  V30 35 C 9.1059 5.9538 0.0 0
M  V30 36 C 11.7733 4.4137 0.0 0
M  V30 37 C 10.4396 6.7238 0.0 0
M  V30 38 C 11.7733 5.9538 0.0 0
M  V30 39 C 13.1071 6.7238 0.0 0
M  V30 40 C 14.5139 6.0975 0.0 0
M  V30 41 C 13.2680 8.2554 0.0 0
M  V30 42 N 15.5443 7.2419 0.0 0
M  V30 43 N 14.7743 8.5755 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 22
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 1 5 28
M  V30 11 1 6 33
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 9 29
M  V30 15 1 12 40
M  V30 16 1 13 41
M  V30 17 1 14 15
M  V30 18 1 14 42
M  V30 19 1 15 16
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 18 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 1 38 39
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 920006-32-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2446808-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2446806-89-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33408941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A
Protein-Protein Interaction Modulator for the Potential Treatment of
Psoriasis and Other Inflammatory Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Mark D.; Dack, Kevin N.; de Groot, Marcel J.; Lambert, Maja;
Sennbro, Carl J.; Larsen, Mogens; Stahlhut, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(13), 8828-8842

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
4-Cyanobenzoic acid
C8H5NO2
619-65-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-cyano-N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ca...
C34H28N4O4
2919713-72-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 C 27.1736 5.4955 0.0 0
M  V30 11 N 28.7136 5.4955 0.0 0
M  V30 12 C 11.7732 2.8281 0.0 0
M  V30 13 C 11.0032 4.1618 0.0 0
M  V30 14 C 10.7428 1.6836 0.0 0
M  V30 15 C 13.3133 2.8281 0.0 0
M  V30 16 N 9.4969 3.8416 0.0 0
M  V30 17 C 11.7732 5.4955 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 14.0833 4.1618 0.0 0
M  V30 20 C 13.3133 5.4955 0.0 0
M  V30 21 C 15.6233 4.1618 0.0 0
M  V30 22 C 16.3933 2.8281 0.0 0
M  V30 23 C 16.3933 5.4955 0.0 0
M  V30 24 C 17.9334 2.8281 0.0 0
M  V30 25 C 17.9334 5.4955 0.0 0
M  V30 26 C 18.7034 4.1618 0.0 0
M  V30 27 N 6.6685 2.3101 0.0 0
M  V30 28 C 5.3348 1.5400 0.0 0
M  V30 29 C 6.6685 3.8501 0.0 0
M  V30 30 C 4.0012 2.3101 0.0 0
M  V30 31 C 5.3348 4.6201 0.0 0
M  V30 32 C 4.0010 3.8501 0.0 0
M  V30 33 C 2.6673 1.5400 0.0 0
M  V30 34 C 2.6673 4.6201 0.0 0
M  V30 35 C 1.3337 2.3101 0.0 0
M  V30 36 C 1.3337 3.8501 0.0 0
M  V30 37 C 22.5535 5.4955 0.0 0
M  V30 38 C 23.3235 4.1618 0.0 0
M  V30 39 C 23.3235 6.8291 0.0 0
M  V30 40 C 24.8635 4.1618 0.0 0
M  V30 41 C 24.8635 6.8291 0.0 0
M  V30 42 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 27
M  V30 4 1 3 4
M  V30 5 1 3 26
M  V30 6 2 4 5
M  V30 7 1 4 37
M  V30 8 1 6 7
M  V30 9 1 6 35
M  V30 10 1 8 9
M  V30 11 1 8 36
M  V30 12 3 10 11
M  V30 13 1 10 42
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 32
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-65-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
3-Methoxybenzoic acid
C8H8O3
586-38-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C34H31N3O5
2919713-76-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 8.0023 0.0 0
M  V30 2 O 6.9302 9.3360 0.0 0
M  V30 3 N 19.6123 11.8524 0.0 0
M  V30 4 C 20.9460 11.0824 0.0 0
M  V30 5 O 20.9460 9.5424 0.0 0
M  V30 6 O 0.7700 4.0012 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 O 2.3101 1.3337 0.0 0
M  V30 9 C 3.0801 0.0000 0.0 0
M  V30 10 O 26.2808 11.0824 0.0 0
M  V30 11 C 27.6147 11.8524 0.0 0
M  V30 12 C 11.6102 8.7723 0.0 0
M  V30 13 C 11.6102 7.2323 0.0 0
M  V30 14 C 10.1454 9.2482 0.0 0
M  V30 15 C 12.9438 9.5424 0.0 0
M  V30 16 N 10.1454 6.7564 0.0 0
M  V30 17 C 12.9438 6.4623 0.0 0
M  V30 18 C 9.2402 8.0023 0.0 0
M  V30 19 C 14.2775 8.7723 0.0 0
M  V30 20 C 14.2775 7.2323 0.0 0
M  V30 21 C 15.6112 9.5424 0.0 0
M  V30 22 C 15.6112 11.0824 0.0 0
M  V30 23 C 16.9450 8.7723 0.0 0
M  V30 24 C 16.9450 11.8524 0.0 0
M  V30 25 C 18.2787 9.5424 0.0 0
M  V30 26 C 18.2787 11.0824 0.0 0
M  V30 27 N 6.9302 6.6685 0.0 0
M  V30 28 C 5.3901 6.6685 0.0 0
M  V30 29 C 7.7002 5.3348 0.0 0
M  V30 30 C 4.6201 5.3348 0.0 0
M  V30 31 C 6.9302 4.0012 0.0 0
M  V30 32 C 5.3901 4.0012 0.0 0
M  V30 33 C 3.0801 5.3348 0.0 0
M  V30 34 C 4.6201 2.6675 0.0 0
M  V30 35 C 2.3101 4.0012 0.0 0
M  V30 36 C 3.0801 2.6675 0.0 0
M  V30 37 C 22.2798 11.8524 0.0 0
M  V30 38 C 23.6135 11.0824 0.0 0
M  V30 39 C 22.2798 13.3924 0.0 0
M  V30 40 C 24.9472 11.8524 0.0 0
M  V30 41 C 23.6135 14.1625 0.0 0
M  V30 42 C 24.9472 13.3924 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 27
M  V30 4 1 3 4
M  V30 5 1 3 26
M  V30 6 2 4 5
M  V30 7 1 4 37
M  V30 8 1 6 7
M  V30 9 1 6 35
M  V30 10 1 8 9
M  V30 11 1 8 36
M  V30 12 1 10 11
M  V30 13 1 10 40
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 32
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586-38-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
L-Tryptophan methyl ester
C12H14N2O2
4299-70-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 2.6218 0.0 0
M  V30 2 C 7.0869 1.8518 0.0 0 CFG=2
M  V30 3 C 8.4206 2.6218 0.0 0
M  V30 4 N 7.0869 0.3118 0.0 0
M  V30 5 O 9.7544 1.8518 0.0 0
M  V30 6 O 8.4206 4.1618 0.0 0
M  V30 7 C 11.0880 2.6218 0.0 0
M  V30 8 C 3.0127 2.4782 0.0 0
M  V30 9 C 4.4196 1.8518 0.0 0
M  V30 10 C 1.9823 1.3338 0.0 0
M  V30 11 C 2.5368 3.9429 0.0 0
M  V30 12 C 4.2586 0.3202 0.0 0
M  V30 13 N 2.7523 0.0000 0.0 0
M  V30 14 C 0.4759 1.6540 0.0 0
M  V30 15 C 1.0304 4.2630 0.0 0
M  V30 16 C 0.0000 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,3′-[[2,2-Bis[(2-carboxyethoxy)methyl]-1,3-propanediyl]bis(oxy)]bis[propanoi...
C17H28O12
35638-19-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 8.0023 0.0 0
M  V30 2 C 6.6687 8.7723 0.0 0
M  V30 3 C 8.7723 9.3360 0.0 0
M  V30 4 C 9.3360 7.2323 0.0 0
M  V30 5 C 7.2323 6.6687 0.0 0
M  V30 6 O 5.3348 8.0023 0.0 0
M  V30 7 O 8.0023 10.6698 0.0 0
M  V30 8 O 10.6698 8.0023 0.0 0
M  V30 9 O 8.0023 5.3348 0.0 0
M  V30 10 C 4.0012 8.7723 0.0 0
M  V30 11 C 8.7723 12.0035 0.0 0
M  V30 12 C 12.0035 7.2323 0.0 0
M  V30 13 C 7.2323 4.0012 0.0 0
M  V30 14 C 2.6675 8.0023 0.0 0
M  V30 15 C 8.0023 13.3372 0.0 0
M  V30 16 C 13.3372 8.0023 0.0 0
M  V30 17 C 8.0023 2.6675 0.0 0
M  V30 18 C 1.3338 8.7723 0.0 0
M  V30 19 C 8.7723 14.6708 0.0 0
M  V30 20 C 14.6708 7.2323 0.0 0
M  V30 21 C 7.2323 1.3338 0.0 0
M  V30 22 O 1.3338 10.3124 0.0 0
M  V30 23 O 0.0000 8.0023 0.0 0
M  V30 24 O 10.3124 14.6708 0.0 0
M  V30 25 O 8.0023 16.0046 0.0 0
M  V30 26 O 14.6708 5.6923 0.0 0
M  V30 27 O 16.0046 8.0023 0.0 0
M  V30 28 O 5.6923 1.3338 0.0 0
M  V30 29 O 8.0023 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 18 23
M  V30 23 1 19 24
M  V30 24 2 19 25
M  V30 25 1 20 26
M  V30 26 2 20 27
M  V30 27 1 21 28
M  V30 28 2 21 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,17-Dimethyl (2S,16S)-2,16-bis(1H-indol-3-ylmethyl)-9,9-bis[[3-[[(1S)-1-(1H-...
C65H76N8O16
138424-03-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  89 96 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.7555 14.4710 0.0 0
M  V30 2 C 15.0891 15.2410 0.0 0
M  V30 3 C 13.7555 16.0110 0.0 0
M  V30 4 C 15.0891 13.7010 0.0 0
M  V30 5 C 12.4218 13.7010 0.0 0
M  V30 6 O 16.4228 14.4710 0.0 0
M  V30 7 O 12.4218 16.7810 0.0 0
M  V30 8 O 15.0891 12.1609 0.0 0
M  V30 9 O 11.0880 14.4710 0.0 0
M  V30 10 C 17.7566 15.2410 0.0 0
M  V30 11 C 12.4218 18.3210 0.0 0
M  V30 12 C 16.4228 11.3909 0.0 0
M  V30 13 C 9.7543 13.7010 0.0 0
M  V30 14 C 19.0903 14.4710 0.0 0
M  V30 15 C 11.0880 19.0910 0.0 0
M  V30 16 C 16.4228 9.8509 0.0 0
M  V30 17 C 9.7543 12.1609 0.0 0
M  V30 18 C 20.4239 15.2410 0.0 0
M  V30 19 C 11.0880 20.6311 0.0 0
M  V30 20 C 17.7566 9.0809 0.0 0
M  V30 21 C 8.4207 11.3909 0.0 0
M  V30 22 N 20.4239 16.7810 0.0 0
M  V30 23 O 21.7576 14.4710 0.0 0
M  V30 24 N 9.7543 21.4011 0.0 0
M  V30 25 O 12.4218 21.4011 0.0 0
M  V30 26 N 17.7566 7.5409 0.0 0
M  V30 27 O 19.0903 9.8509 0.0 0
M  V30 28 N 8.4207 9.8509 0.0 0
M  V30 29 O 7.0870 12.1609 0.0 0
M  V30 30 C 21.7576 17.5510 0.0 0 CFG=2
M  V30 31 C 9.7543 22.9411 0.0 0 CFG=2
M  V30 32 C 19.0903 6.7709 0.0 0 CFG=2
M  V30 33 C 7.0870 9.0809 0.0 0 CFG=2
M  V30 34 C 23.0914 16.7810 0.0 0
M  V30 35 C 21.7576 19.0910 0.0 0
M  V30 36 C 8.4207 23.7111 0.0 0
M  V30 37 C 11.0880 23.7111 0.0 0
M  V30 38 C 19.0903 5.2308 0.0 0
M  V30 39 C 20.4239 7.5409 0.0 0
M  V30 40 C 5.7532 9.8509 0.0 0
M  V30 41 C 7.0870 7.5409 0.0 0
M  V30 42 O 20.4239 19.8611 0.0 0
M  V30 43 O 23.0914 19.8611 0.0 0
M  V30 44 O 11.0880 25.2511 0.0 0
M  V30 45 O 12.4218 22.9411 0.0 0
M  V30 46 O 21.7576 6.7709 0.0 0
M  V30 47 O 20.4239 9.0809 0.0 0
M  V30 48 O 8.4207 6.7709 0.0 0
M  V30 49 O 5.7532 6.7709 0.0 0
M  V30 50 C 20.4239 21.4011 0.0 0
M  V30 51 C 12.4218 26.0211 0.0 0
M  V30 52 C 23.0914 7.5409 0.0 0
M  V30 53 C 8.4207 5.2308 0.0 0
M  V30 54 C 24.4251 17.5510 0.0 0
M  V30 55 C 25.8319 16.9247 0.0 0
M  V30 56 C 24.5860 19.0826 0.0 0
M  V30 57 C 26.8625 18.0691 0.0 0
M  V30 58 C 26.3079 15.4600 0.0 0
M  V30 59 N 26.0924 19.4027 0.0 0
M  V30 60 C 28.3688 17.7489 0.0 0
M  V30 61 C 27.8142 15.1398 0.0 0
M  V30 62 C 28.8446 16.2844 0.0 0
M  V30 63 C 7.0870 22.9411 0.0 0
M  V30 64 C 5.6801 23.5676 0.0 0
M  V30 65 C 6.9259 21.4095 0.0 0
M  V30 66 C 4.6496 22.4230 0.0 0
M  V30 67 C 5.2042 25.0321 0.0 0
M  V30 68 N 5.4196 21.0894 0.0 0
M  V30 69 C 3.1432 22.7432 0.0 0
M  V30 70 C 3.6977 25.3523 0.0 0
M  V30 71 C 2.6673 24.2079 0.0 0
M  V30 72 C 17.7566 4.4608 0.0 0
M  V30 73 C 17.5955 2.9293 0.0 0
M  V30 74 C 16.3496 5.0873 0.0 0
M  V30 75 C 16.0892 2.6091 0.0 0
M  V30 76 C 18.6261 1.7849 0.0 0
M  V30 77 N 15.3192 3.9428 0.0 0
M  V30 78 C 15.6134 1.1444 0.0 0
M  V30 79 C 18.1502 0.3202 0.0 0
M  V30 80 C 16.6438 0.0000 0.0 0
M  V30 81 C 4.4196 9.0809 0.0 0
M  V30 82 C 3.0127 9.7074 0.0 0
M  V30 83 C 4.2586 7.5493 0.0 0
M  V30 84 C 1.9822 8.5628 0.0 0
M  V30 85 C 2.5367 11.1719 0.0 0
M  V30 86 N 2.7522 7.2292 0.0 0
M  V30 87 C 0.4759 8.8830 0.0 0
M  V30 88 C 1.0304 11.4921 0.0 0
M  V30 89 C 0.0000 10.3477 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 18 23
M  V30 23 1 19 24
M  V30 24 2 19 25
M  V30 25 1 20 26
M  V30 26 2 20 27
M  V30 27 1 21 28
M  V30 28 2 21 29
M  V30 29 1 22 30
M  V30 30 1 24 31
M  V30 31 1 26 32
M  V30 32 1 28 33
M  V30 33 1 30 34 CFG=3
M  V30 34 1 30 35
M  V30 35 1 31 36 CFG=1
M  V30 36 1 31 37
M  V30 37 1 32 38 CFG=3
M  V30 38 1 32 39
M  V30 39 1 33 40 CFG=3
M  V30 40 1 33 41
M  V30 41 1 34 54
M  V30 42 1 35 42
M  V30 43 2 35 43
M  V30 44 1 36 63
M  V30 45 1 37 44
M  V30 46 2 37 45
M  V30 47 1 38 72
M  V30 48 1 39 46
M  V30 49 2 39 47
M  V30 50 1 40 81
M  V30 51 1 41 48
M  V30 52 2 41 49
M  V30 53 1 42 50
M  V30 54 1 44 51
M  V30 55 1 46 52
M  V30 56 1 48 53
M  V30 57 1 54 55
M  V30 58 2 54 56
M  V30 59 1 55 57
M  V30 60 2 55 58
M  V30 61 1 56 59
M  V30 62 1 57 59
M  V30 63 2 57 60
M  V30 64 1 58 61
M  V30 65 1 60 62
M  V30 66 2 61 62
M  V30 67 1 63 64
M  V30 68 2 63 65
M  V30 69 1 64 66
M  V30 70 2 64 67
M  V30 71 1 65 68
M  V30 72 1 66 68
M  V30 73 2 66 69
M  V30 74 1 67 70
M  V30 75 1 69 71
M  V30 76 2 70 71
M  V30 77 1 72 73
M  V30 78 2 72 74
M  V30 79 1 73 75
M  V30 80 2 73 76
M  V30 81 1 74 77
M  V30 82 1 75 77
M  V30 83 2 75 78
M  V30 84 1 76 79
M  V30 85 1 78 80
M  V30 86 2 79 80
M  V30 87 1 81 82
M  V30 88 2 81 83
M  V30 89 1 82 84
M  V30 90 2 82 85
M  V30 91 1 83 86
M  V30 92 1 84 86
M  V30 93 2 84 87
M  V30 94 1 85 88
M  V30 95 1 87 89
M  V30 96 2 88 89
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 30 31 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4299-70-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35638-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 138424-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23923283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scaffold Simplification Strategy Leads to a Novel Generation of Dual
Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez-Gualda, Belen; Sun, Liang; Marti-Mari, Olaia; Noppen, Sam;
Abdelnabi, Rana; Bator, Carol M.; Quesada, Ernesto; Delang, Leen;
Mirabelli, Carmen; Lee, Hyunwook; Schols, Dominique; Neyts, Johan;
Hafenstein, Susan; Camarasa, Maria-Jose; Gago, Federico; San-Felix, Ana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(1), 349-368

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
1H-Pyrazole-1-propanoic acid, 5-cyclopropyl-4-[cis-3-(2,2-dimethylpropyl)cycl...
C28H40N2O3
3032485-30-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.9771 4.0011 0.0 0 CFG=3
M  V30 2 C 11.7471 5.3347 0.0 0
M  V30 3 C 11.7471 2.6674 0.0 0
M  V30 4 C 13.2871 5.3347 0.0 0
M  V30 5 C 10.9771 1.3336 0.0 0
M  V30 6 C 14.0571 6.6684 0.0 0
M  V30 7 O 11.7471 0.0000 0.0 0
M  V30 8 O 9.4371 1.3336 0.0 0
M  V30 9 O 15.5971 6.6684 0.0 0
M  V30 10 C 16.3671 8.0021 0.0 0
M  V30 11 C 2.8136 7.8615 0.0 0
M  V30 12 C 1.4068 7.2352 0.0 0
M  V30 13 C 0.7805 8.6420 0.0 0
M  V30 14 C 0.0000 6.6088 0.0 0
M  V30 15 C 2.0331 5.8283 0.0 0
M  V30 16 C 8.5321 5.2469 0.0 0
M  V30 17 C 7.0674 4.7711 0.0 0
M  V30 18 N 9.4371 4.0011 0.0 0
M  V30 19 C 7.0674 3.2311 0.0 0
M  V30 20 N 8.5321 2.7552 0.0 0
M  V30 21 C 9.0079 6.7116 0.0 0
M  V30 22 C 10.1523 7.7420 0.0 0
M  V30 23 C 8.6878 8.2179 0.0 0
M  V30 24 C 5.8215 5.6763 0.0 0 CFG=1
M  V30 25 C 4.3005 5.4353 0.0 0
M  V30 26 C 5.5807 7.1973 0.0 0
M  V30 27 C 4.0596 6.9563 0.0 0 CFG=2
M  V30 28 C 17.9071 8.0021 0.0 0
M  V30 29 C 18.6771 6.6684 0.0 0
M  V30 30 C 18.6771 9.3358 0.0 0
M  V30 31 C 20.2171 6.6684 0.0 0
M  V30 32 C 20.2171 9.3358 0.0 0
M  V30 33 C 20.9871 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 27 11 CFG=3
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21
M  V30 20 1 17 19
M  V30 21 1 24 17 CFG=3
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-methylaniline
C7H8ClN
615-65-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 C 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-1-propanamide, N-(2-chloro-4-methylphenyl)-5-cyclopropyl-4-[cis-3...
C35H46ClN3O2
3032485-31-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 10.6696 0.0 0 CFG=3
M  V30 2 C 8.4700 12.0032 0.0 0
M  V30 3 C 8.4700 9.3358 0.0 0
M  V30 4 C 6.9300 12.0032 0.0 0
M  V30 5 C 9.2400 8.0021 0.0 0
M  V30 6 N 6.1600 13.3369 0.0 0
M  V30 7 O 6.1600 10.6696 0.0 0
M  V30 8 C 8.4700 6.6685 0.0 0
M  V30 9 O 9.2400 5.3347 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 17.4035 14.5301 0.0 0
M  V30 12 C 18.8103 13.9036 0.0 0
M  V30 13 C 19.4366 15.3105 0.0 0
M  V30 14 C 20.2171 13.2773 0.0 0
M  V30 15 C 18.1840 12.4968 0.0 0
M  V30 16 Cl 4.6200 16.0043 0.0 0
M  V30 17 C 0.0000 13.3369 0.0 0
M  V30 18 C 11.6851 11.9154 0.0 0
M  V30 19 C 13.1498 11.4396 0.0 0
M  V30 20 N 10.7800 10.6696 0.0 0
M  V30 21 C 13.1498 9.8996 0.0 0
M  V30 22 N 11.6851 9.4236 0.0 0
M  V30 23 C 11.2092 13.3800 0.0 0
M  V30 24 C 11.5294 14.8864 0.0 0
M  V30 25 C 10.0648 14.4106 0.0 0
M  V30 26 C 14.3956 12.3446 0.0 0 CFG=1
M  V30 27 C 15.9167 12.1038 0.0 0
M  V30 28 C 14.6365 13.8657 0.0 0
M  V30 29 C 16.1575 13.6248 0.0 0 CFG=2
M  V30 30 C 4.6200 13.3369 0.0 0
M  V30 31 C 3.8500 14.6705 0.0 0
M  V30 32 C 3.8500 12.0032 0.0 0
M  V30 33 C 2.3100 14.6705 0.0 0
M  V30 34 C 2.3100 12.0032 0.0 0
M  V30 35 C 1.5400 13.3369 0.0 0
M  V30 36 C 9.2400 2.6674 0.0 0
M  V30 37 C 10.7800 2.6674 0.0 0
M  V30 38 C 8.4700 1.3338 0.0 0
M  V30 39 C 11.5500 1.3338 0.0 0
M  V30 40 C 9.2400 0.0000 0.0 0
M  V30 41 C 10.7800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 30
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 36
M  V30 13 1 11 12
M  V30 14 1 29 11 CFG=1
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 16 31
M  V30 19 1 17 35
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 23
M  V30 23 1 19 21
M  V30 24 1 26 19 CFG=1
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032485-30-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032485-31-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39000609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical
Development
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maeba, Takaki; Hirata, Kazuyuki; Kotoku, Masayuki; Seki, Noriyoshi;
Maeda, Katsuya; Hirashima, Shintaro; Yamanaka, Hiroshi; Sakai, Takayuki;
Obika, Shingo; Hori, Akimi; Hara, Yoshinori; Noji, Satoru; Suwa,
Yoshihiro; Yokota, Masahiro; Fujioka, Shingo; Yamaguchi, Takayuki;
Katsuda, Yoshiaki; Hata, Takahiro; Miyagawa, Naoki; Arita, Kojo; Nomura,
Yukihiro; Taniguchi, Toshio; Asahina, Kota; Aratsu, Yusuke; Naka, Yuichi;
Adachi, Tsuyoshi; Nomura, Akihiro; Akai, Shota; Oshida, Shin-ichi; Pai,
Sudhakar; Crowe, Paul; Bradley, Erin; Steensma, Ruo; Tao, Haiyan; Fenn,
Morgan; Babine, Robert; Li, Xiaolin; Thacher, Scott; Soeta, Takahiro;
Ukaji, Yutaka; Shiozaki, Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 952-970

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL

C22H32N4O5
3058604-53-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.0550 0.0 0
M  V30 2 C 6.6684 7.5950 0.0 0 CFG=2
M  V30 3 C 5.3348 8.3650 0.0 0
M  V30 4 N 8.0021 8.3650 0.0 0
M  V30 5 N 5.3348 9.9050 0.0 0
M  V30 6 O 4.0009 7.5950 0.0 0
M  V30 7 C 9.3359 7.5950 0.0 0
M  V30 8 C 4.0009 10.6750 0.0 0 CFG=2
M  V30 9 O 10.6695 8.3650 0.0 0
M  V30 10 O 9.3359 6.0550 0.0 0
M  V30 11 C 2.6673 9.9050 0.0 0
M  V30 12 C 4.0009 12.2151 0.0 0
M  V30 13 C 12.0032 7.5950 0.0 0
M  V30 14 C 1.3336 10.6750 0.0 0
M  V30 15 N 2.6673 12.9851 0.0 0
M  V30 16 O 5.3348 12.9851 0.0 0
M  V30 17 C 12.7732 8.9288 0.0 0
M  V30 18 C 13.3368 6.8250 0.0 0
M  V30 19 C 11.2331 6.2614 0.0 0
M  V30 20 C 1.3336 12.2151 0.0 0
M  V30 21 C 0.0000 9.9050 0.0 0
M  V30 22 O 6.7588 0.0000 0.0 0
M  V30 23 C 5.1737 3.7535 0.0 0
M  V30 24 C 5.3348 5.2850 0.0 0
M  V30 25 C 3.6674 3.4333 0.0 0
M  V30 26 C 6.2042 2.6091 0.0 0
M  V30 27 C 3.9278 5.9115 0.0 0
M  V30 28 N 2.8974 4.7670 0.0 0
M  V30 29 C 3.1915 1.9686 0.0 0
M  V30 30 C 5.7284 1.1444 0.0 0
M  V30 31 C 4.2219 0.8242 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 14 21
M  V30 22 1 22 30
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 2 24 27
M  V30 27 1 25 28
M  V30 28 2 25 29
M  V30 29 1 26 30
M  V30 30 1 27 28
M  V30 31 1 29 31
M  V30 32 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
BOC-L-leucine
C11H21NO4
13139-15-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H43N5O6
3058604-54-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 7.7002 0.0 0
M  V30 2 C 7.0871 6.9302 0.0 0 CFG=1
M  V30 3 N 8.4208 7.7002 0.0 0
M  V30 4 C 7.0871 5.3901 0.0 0
M  V30 5 C 8.4208 9.2402 0.0 0
M  V30 6 N 8.4208 4.6201 0.0 0
M  V30 7 O 5.7533 4.6201 0.0 0
M  V30 8 C 9.7544 10.0102 0.0 0 CFG=2
M  V30 9 O 7.0871 10.0102 0.0 0
M  V30 10 C 8.4208 3.0801 0.0 0 CFG=2
M  V30 11 N 11.0881 9.2402 0.0 0
M  V30 12 C 9.7544 11.5503 0.0 0
M  V30 13 C 7.0871 2.3101 0.0 0
M  V30 14 C 9.7544 2.3101 0.0 0
M  V30 15 C 12.4219 10.0102 0.0 0
M  V30 16 C 8.4208 12.3203 0.0 0
M  V30 17 C 7.0871 0.7700 0.0 0
M  V30 18 N 11.0881 3.0801 0.0 0
M  V30 19 O 9.7544 0.7700 0.0 0
M  V30 20 O 13.7556 9.2402 0.0 0
M  V30 21 O 12.4219 11.5503 0.0 0
M  V30 22 C 7.0871 11.5503 0.0 0
M  V30 23 C 8.4208 13.8603 0.0 0
M  V30 24 C 5.7533 0.0000 0.0 0
M  V30 25 C 8.4208 0.0000 0.0 0
M  V30 26 C 15.0893 10.0102 0.0 0
M  V30 27 C 14.3192 11.3439 0.0 0
M  V30 28 C 16.4229 10.7802 0.0 0
M  V30 29 C 15.8593 8.6766 0.0 0
M  V30 30 O 0.5546 10.8061 0.0 0
M  V30 31 C 3.0128 7.5565 0.0 0
M  V30 32 C 4.4196 6.9302 0.0 0
M  V30 33 C 1.9822 6.4121 0.0 0
M  V30 34 C 2.5367 9.0212 0.0 0
M  V30 35 C 4.2587 5.3986 0.0 0
M  V30 36 N 2.7522 5.0784 0.0 0
M  V30 37 C 0.4759 6.7323 0.0 0
M  V30 38 C 1.0304 9.3414 0.0 0
M  V30 39 C 0.0000 8.1970 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 32
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 10 13 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 2 15 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 17 24
M  V30 25 1 17 25
M  V30 26 1 20 26
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 30 38
M  V30 31 1 31 32
M  V30 32 1 31 33
M  V30 33 2 31 34
M  V30 34 2 32 35
M  V30 35 1 33 36
M  V30 36 2 33 37
M  V30 37 1 34 38
M  V30 38 1 35 36
M  V30 39 1 37 39
M  V30 40 2 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3058604-53-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13139-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3058604-54-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39925568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of
Macrocyclic Inhibitors of the 20S Proteasome
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gotz, Marion G.; Godwin, Kacey; Price, Rachel; Dorn, Robert;
Merrill-Steskal, Gabriel; Klemmer, William; Hansen, Hunter; Produturi,
Gautam; Rocha, Megan; Palmer, Mathias; Molacek, Lea; Strater, Zack;
Groll, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(4), 533-539

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
8-Bromooctanoic acid
C8H15BrO2
17696-11-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 Br 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, 3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]...
C22H30N4O3S
1448297-52-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0133 5.3027 0.0 0
M  V30 2 N 8.5533 5.3027 0.0 0
M  V30 3 O 6.2433 6.6363 0.0 0
M  V30 4 C 9.3233 6.6363 0.0 0
M  V30 5 C 3.6814 4.9525 0.0 0
M  V30 6 C 2.1749 4.6322 0.0 0 CFG=1
M  V30 7 O 4.1572 6.4170 0.0 0
M  V30 8 C 1.1445 5.7767 0.0 0
M  V30 9 N 1.6991 3.1676 0.0 0
M  V30 10 C 0.0000 4.7463 0.0 0
M  V30 11 C 0.1141 6.9211 0.0 0
M  V30 12 C 2.2889 6.8071 0.0 0
M  V30 13 O 5.8862 0.0000 0.0 0
M  V30 14 C 15.9127 9.3469 0.0 0
M  V30 15 C 6.2433 3.9689 0.0 0 CFG=2
M  V30 16 N 4.7118 3.8080 0.0 0
M  V30 17 C 6.8698 2.5621 0.0 0
M  V30 18 C 4.3916 2.3017 0.0 0
M  V30 19 C 5.7253 1.5317 0.0 0 CFG=1
M  V30 20 C 10.8633 6.6363 0.0 0
M  V30 21 C 11.6333 7.9700 0.0 0
M  V30 22 C 11.6333 5.3027 0.0 0
M  V30 23 C 13.1733 7.9700 0.0 0
M  V30 24 C 13.1733 5.3027 0.0 0
M  V30 25 C 13.9434 6.6363 0.0 0
M  V30 26 C 15.4834 6.6363 0.0 0
M  V30 27 S 16.3886 5.3905 0.0 0
M  V30 28 C 16.3886 7.8822 0.0 0
M  V30 29 C 17.8533 5.8663 0.0 0
M  V30 30 N 17.8533 7.4063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 6 9 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 19 13 CFG=1
M  V30 15 1 14 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, N-(8-bromo-1-oxooctyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-met...
C30H43BrN4O4S
2408342-03-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3723 6.6684 0.0 0
M  V30 2 C 15.9123 6.6684 0.0 0 CFG=2
M  V30 3 O 13.6023 8.0022 0.0 0
M  V30 4 N 16.6823 5.3348 0.0 0
M  V30 5 C 16.6823 8.0022 0.0 0
M  V30 6 C 18.2223 5.3348 0.0 0
M  V30 7 C 15.3487 8.7722 0.0 0
M  V30 8 C 17.4523 9.3359 0.0 0
M  V30 9 C 18.0161 7.2322 0.0 0
M  V30 10 C 18.9923 4.0011 0.0 0
M  V30 11 O 18.9923 6.6684 0.0 0
M  V30 12 C 20.5324 4.0011 0.0 0
M  V30 13 C 21.3024 2.6675 0.0 0
M  V30 14 C 22.8424 2.6675 0.0 0
M  V30 15 C 23.6124 1.3336 0.0 0
M  V30 16 C 25.1524 1.3336 0.0 0
M  V30 17 C 25.9224 0.0000 0.0 0
M  V30 18 Br 27.4624 0.0000 0.0 0
M  V30 19 C 11.0403 6.3182 0.0 0
M  V30 20 N 9.5339 5.9980 0.0 0
M  V30 21 O 11.5162 7.7829 0.0 0
M  V30 22 C 8.5035 7.1426 0.0 0
M  V30 23 O 13.2453 1.3658 0.0 0
M  V30 24 C 1.4946 8.4239 0.0 0
M  V30 25 N 13.6023 5.3348 0.0 0
M  V30 26 C 12.0708 5.1738 0.0 0 CFG=2
M  V30 27 C 14.2288 3.9280 0.0 0
M  V30 28 C 11.7506 3.6674 0.0 0
M  V30 29 C 13.0842 2.8974 0.0 0 CFG=2
M  V30 30 C 6.9972 6.8224 0.0 0
M  V30 31 C 6.5213 5.3577 0.0 0
M  V30 32 C 5.9666 7.9668 0.0 0
M  V30 33 C 5.0149 5.0375 0.0 0
M  V30 34 C 4.4603 7.6466 0.0 0
M  V30 35 C 3.9845 6.1819 0.0 0
M  V30 36 C 2.4780 5.8617 0.0 0
M  V30 37 C 1.3336 6.8922 0.0 0
M  V30 38 S 1.8517 4.4549 0.0 0
M  V30 39 N 0.0000 6.1222 0.0 0
M  V30 40 C 0.3202 4.6159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 26 19 CFG=1
M  V30 22 1 20 22
M  V30 23 1 22 30
M  V30 24 1 29 23 CFG=3
M  V30 25 1 24 37
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 37 1 35 36
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 17696-11-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448297-52-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2408342-03-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35336755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of potent small molecule PROTACs targeting mutant EGFR
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Hong-Yi; Yang, Xue-Yan; Lei, Hao; Xi, Xiao-Xiao; Lu, She-Min;
Zhang, Jun-Jie; Xin, Minhang; Zhang, San-Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 208112781

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Benzenamine, 3-chloro-4-[3-(methyl-2-propyn-1-ylamino)propoxy]-
C13H17ClN2O
2927489-53-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3358 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 C 13.3370 3.0801 0.0 0
M  V30 9 C 14.6707 3.8501 0.0 0
M  V30 10 Cl 2.6673 4.6201 0.0 0
M  V30 11 N 0.0000 0.0000 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 3 8 9
M  V30 10 1 10 13
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Methylethyl)-2,4-bis(phenylmethoxy)benzoic acid
C24H24O4
909871-48-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 4.6201 0.0 0
M  V30 2 C 4.0010 6.1601 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 9.3360 6.1601 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 O 9.3360 0.0000 0.0 0
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 2.6673 6.9302 0.0 0
M  V30 18 C 2.6673 8.4702 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 1.3337 9.2402 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 0.0000 8.4702 0.0 0
M  V30 23 C 10.6697 6.9302 0.0 0
M  V30 24 C 10.6697 8.4702 0.0 0
M  V30 25 C 12.0033 6.1601 0.0 0
M  V30 26 C 12.0033 9.2402 0.0 0
M  V30 27 C 13.3370 6.9302 0.0 0
M  V30 28 C 13.3370 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 12
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 23
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 16
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[3-chloro-4-[3-(methyl-2-propyn-1-ylamino)propoxy]phenyl]-5-(1-m...
C37H39ClN2O4
2927489-57-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0100 5.3347 0.0 0
M  V30 2 C 9.2400 4.0009 0.0 0
M  V30 3 C 11.5500 8.0020 0.0 0
M  V30 4 N 12.3200 9.3358 0.0 0
M  V30 5 O 12.3200 6.6684 0.0 0
M  V30 6 O 5.3900 8.0020 0.0 0
M  V30 7 C 4.6200 6.6684 0.0 0
M  V30 8 C 6.9300 10.6694 0.0 0
M  V30 9 C 5.3900 10.6694 0.0 0
M  V30 10 C 7.7000 12.0031 0.0 0
M  V30 11 Cl 16.9400 6.6684 0.0 0
M  V30 12 O 18.4800 9.3358 0.0 0
M  V30 13 C 19.2500 10.6694 0.0 0
M  V30 14 C 20.7900 10.6694 0.0 0
M  V30 15 C 21.5600 12.0031 0.0 0
M  V30 16 N 23.1000 12.0031 0.0 0
M  V30 17 C 23.8700 13.3367 0.0 0
M  V30 18 C 23.8700 10.6694 0.0 0
M  V30 19 C 25.4100 13.3367 0.0 0
M  V30 20 C 26.9500 13.3367 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 10.0100 8.0020 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 9.2400 9.3358 0.0 0
M  V30 25 C 6.9300 8.0020 0.0 0
M  V30 26 C 7.7000 9.3358 0.0 0
M  V30 27 C 10.0100 2.6673 0.0 0
M  V30 28 C 9.2400 1.3336 0.0 0
M  V30 29 C 11.5500 2.6673 0.0 0
M  V30 30 C 10.0100 0.0000 0.0 0
M  V30 31 C 12.3200 1.3336 0.0 0
M  V30 32 C 11.5500 0.0000 0.0 0
M  V30 33 C 13.8600 9.3358 0.0 0
M  V30 34 C 14.6300 8.0020 0.0 0
M  V30 35 C 14.6300 10.6694 0.0 0
M  V30 36 C 16.1700 8.0020 0.0 0
M  V30 37 C 16.1700 10.6694 0.0 0
M  V30 38 C 16.9400 9.3358 0.0 0
M  V30 39 C 3.0800 6.6684 0.0 0
M  V30 40 C 2.3100 5.3347 0.0 0
M  V30 41 C 2.3100 8.0020 0.0 0
M  V30 42 C 0.7700 5.3347 0.0 0
M  V30 43 C 0.7700 8.0020 0.0 0
M  V30 44 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 27
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 33
M  V30 8 1 6 7
M  V30 9 1 6 25
M  V30 10 1 7 39
M  V30 11 1 8 9
M  V30 12 1 8 10
M  V30 13 1 8 26
M  V30 14 1 11 36
M  V30 15 1 12 13
M  V30 16 1 12 38
M  V30 17 1 13 14
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 3 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2927489-53-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 909871-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2927489-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36550984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological activity of dual monoamine oxidase A
and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated
4-isopropylresorcinol for glioblastoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tseng, Hui-Ju; Banerjee, Suddhasatwa; Qian, Bin; Lai, Mei-Jung; Wu,
Tung-Yun; Hsu, Tsung-I.; Lin, Tony Eight; Hsu, Kai-Cheng; Chuang,
Kuo-Hsiang; Liou, Jing-Ping; Shih, Jean C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 256115459

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
tert-Butyl (3-aminopropyl)carbamate
C8H18N2O2
75178-96-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 N 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxylic acid
C17H14ClNO4S
473257-46-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7534 4.8385 0.0 0 VAL=6
M  V30 2 O 4.9834 6.1721 0.0 0
M  V30 3 O 6.5234 3.5048 0.0 0
M  V30 4 C 5.4032 1.5063 0.0 0
M  V30 5 O 5.0830 0.0000 0.0 0
M  V30 6 O 6.8678 1.9823 0.0 0
M  V30 7 Cl 0.5546 7.9444 0.0 0
M  V30 8 C 8.4207 9.4585 0.0 0
M  V30 9 C 11.0882 4.8385 0.0 0
M  V30 10 C 4.4197 4.0684 0.0 0
M  V30 11 C 3.0128 4.6948 0.0 0
M  V30 12 C 4.2586 2.5369 0.0 0
M  V30 13 C 1.9823 3.5504 0.0 0
M  V30 14 C 2.5369 6.1595 0.0 0
M  V30 15 N 2.7523 2.2167 0.0 0
M  V30 16 C 0.4759 3.8706 0.0 0
M  V30 17 C 1.0304 6.4797 0.0 0
M  V30 18 C 0.0000 5.3353 0.0 0
M  V30 19 C 7.0871 5.6085 0.0 0
M  V30 20 C 7.0871 7.1485 0.0 0
M  V30 21 C 8.4207 4.8385 0.0 0
M  V30 22 C 8.4207 7.9185 0.0 0
M  V30 23 C 9.7545 5.6085 0.0 0
M  V30 24 C 9.7545 7.1485 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 7 17
M  V30 9 1 8 22
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-...
C25H30ClN3O5S
2649272-98-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.5605 5.0736 0.0 0 VAL=6
M  V30 2 O 3.0540 5.3938 0.0 0
M  V30 3 O 6.0668 4.7535 0.0 0
M  V30 4 C 7.6212 6.4364 0.0 0
M  V30 5 N 8.9550 7.2064 0.0 0
M  V30 6 O 7.6212 4.8964 0.0 0
M  V30 7 C 10.2887 6.4364 0.0 0
M  V30 8 C 11.6223 7.2064 0.0 0
M  V30 9 C 12.9560 6.4364 0.0 0
M  V30 10 N 14.2898 7.2064 0.0 0
M  V30 11 C 15.6235 6.4364 0.0 0
M  V30 12 O 16.9572 7.2064 0.0 0
M  V30 13 O 15.6235 4.8964 0.0 0
M  V30 14 C 18.2908 6.4364 0.0 0
M  V30 15 C 17.5208 5.1027 0.0 0
M  V30 16 C 19.6247 5.6664 0.0 0
M  V30 17 C 19.0608 7.7701 0.0 0
M  V30 18 Cl 0.0000 9.0582 0.0 0
M  V30 19 C 0.9907 1.1091 0.0 0
M  V30 20 C 6.2090 0.0000 0.0 0
M  V30 21 C 4.8807 6.5801 0.0 0
M  V30 22 C 3.8501 7.7245 0.0 0
M  V30 23 C 6.2875 7.2064 0.0 0
M  V30 24 C 4.6201 9.0582 0.0 0
M  V30 25 C 2.3101 7.7245 0.0 0
M  V30 26 N 6.1266 8.7380 0.0 0
M  V30 27 C 3.8501 10.3918 0.0 0
M  V30 28 C 1.5400 9.0582 0.0 0
M  V30 29 C 2.3101 10.3918 0.0 0
M  V30 30 C 4.2402 3.5673 0.0 0
M  V30 31 C 2.7756 3.0913 0.0 0
M  V30 32 C 5.3847 2.5367 0.0 0
M  V30 33 C 2.4554 1.5850 0.0 0
M  V30 34 C 5.0646 1.0304 0.0 0
M  V30 35 C 3.5998 0.5546 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 28
M  V30 20 1 19 33
M  V30 21 1 20 34
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75178-96-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 473257-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2649272-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33066360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester
functionalities as potent HIV-1 non-nucleoside reverse transcriptase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Shujing; Song, Shu; Sun, Lin; Gao, Ping; Gao, Shenghua; Ma, Yue;
Kang, Dongwei; Cheng, Yusen; Zhang, Xujie; Cherukupalli, Srinivasulu; De
Clercq, Erik; Pannecouque, Christophe; Liu, Xinyong; Zhan, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 53116531

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
5-Methyl 2,5-pyridinedicarboxylate
C8H7NO4
17874-79-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 N 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxamide, N-(3′-amino-2,2′-dimethyl[1,1′-biphenyl]-3-yl)-5-[[4-[...
C32H44N4O2Si
3080149-47-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 9.3358 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 10.6697 0.7700 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 C 16.0045 5.3901 0.0 0
M  V30 8 O 21.3393 2.3101 0.0 0
M  V30 9 Si 22.6730 3.0801 0.0 0
M  V30 10 C 24.0067 3.8501 0.0 0
M  V30 11 C 23.4430 1.7464 0.0 0
M  V30 12 C 21.9030 4.4137 0.0 0
M  V30 13 C 24.7767 2.5164 0.0 0
M  V30 14 C 25.3403 4.6201 0.0 0
M  V30 15 C 23.2366 5.1838 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 8.0022 2.3101 0.0 0
M  V30 20 C 6.6685 0.0000 0.0 0
M  V30 21 C 8.0022 0.7700 0.0 0
M  V30 22 C 4.0010 3.0801 0.0 0
M  V30 23 C 2.6673 2.3101 0.0 0
M  V30 24 C 4.0010 4.6201 0.0 0
M  V30 25 C 1.3337 3.0801 0.0 0
M  V30 26 C 2.6673 5.3901 0.0 0
M  V30 27 C 1.3337 4.6201 0.0 0
M  V30 28 C 12.0033 3.0801 0.0 0
M  V30 29 C 12.0033 4.6201 0.0 0
M  V30 30 N 13.3370 2.3101 0.0 0
M  V30 31 C 13.3370 5.3901 0.0 0
M  V30 32 C 14.6707 3.0801 0.0 0
M  V30 33 C 14.6707 4.6201 0.0 0
M  V30 34 N 17.3382 4.6201 0.0 0
M  V30 35 C 17.3382 3.0801 0.0 0
M  V30 36 C 18.6718 5.3901 0.0 0
M  V30 37 C 18.6718 2.3101 0.0 0
M  V30 38 C 20.0055 4.6201 0.0 0
M  V30 39 C 20.0055 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 2 4 5
M  V30 6 1 4 28
M  V30 7 1 6 25
M  V30 8 1 7 33
M  V30 9 1 7 34
M  V30 10 1 8 9
M  V30 11 1 8 39
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 1 10 14
M  V30 17 1 10 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 22
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C40H49N5O5Si
3080149-48-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 22.6730 2.3101 0.0 0
M  V30 2 C 18.6718 6.1601 0.0 0
M  V30 3 N 25.3405 3.8501 0.0 0
M  V30 4 C 26.6742 4.6201 0.0 0
M  V30 5 O 26.6742 6.1601 0.0 0
M  V30 6 N 16.0045 4.6201 0.0 0
M  V30 7 C 14.6707 3.8501 0.0 0
M  V30 8 O 14.6707 2.3101 0.0 0
M  V30 9 C 32.0090 1.5400 0.0 0
M  V30 10 O 33.3427 2.3101 0.0 0
M  V30 11 O 32.0090 0.0000 0.0 0
M  V30 12 C 34.6763 1.5400 0.0 0
M  V30 13 C 9.3358 6.9302 0.0 0
M  V30 14 O 4.0010 3.8501 0.0 0
M  V30 15 Si 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.8973 3.2864 0.0 0
M  V30 18 C 3.4374 5.9538 0.0 0
M  V30 19 C 2.1037 6.7238 0.0 0
M  V30 20 C 0.0000 6.1601 0.0 0
M  V30 21 C 0.5637 4.0564 0.0 0
M  V30 22 C 21.3393 4.6201 0.0 0
M  V30 23 C 22.6730 3.8501 0.0 0
M  V30 24 C 21.3393 6.1601 0.0 0
M  V30 25 C 24.0067 4.6201 0.0 0
M  V30 26 C 22.6730 6.9302 0.0 0
M  V30 27 C 24.0067 6.1601 0.0 0
M  V30 28 C 20.0057 3.8501 0.0 0
M  V30 29 C 18.6718 4.6201 0.0 0
M  V30 30 C 20.0057 2.3101 0.0 0
M  V30 31 C 17.3382 3.8501 0.0 0
M  V30 32 C 18.6718 1.5400 0.0 0
M  V30 33 C 17.3382 2.3101 0.0 0
M  V30 34 C 28.0078 3.8501 0.0 0
M  V30 35 C 28.0078 2.3101 0.0 0
M  V30 36 N 29.3415 4.6201 0.0 0
M  V30 37 C 29.3415 1.5400 0.0 0
M  V30 38 C 30.6753 3.8501 0.0 0
M  V30 39 C 30.6753 2.3101 0.0 0
M  V30 40 C 13.3370 4.6201 0.0 0
M  V30 41 C 12.0033 3.8501 0.0 0
M  V30 42 N 13.3370 6.1601 0.0 0
M  V30 43 C 10.6697 4.6201 0.0 0
M  V30 44 C 12.0033 6.9302 0.0 0
M  V30 45 C 10.6697 6.1601 0.0 0
M  V30 46 N 8.0022 6.1601 0.0 0
M  V30 47 C 6.6685 6.9302 0.0 0
M  V30 48 C 8.0022 4.6201 0.0 0
M  V30 49 C 5.3348 6.1601 0.0 0
M  V30 50 C 6.6685 3.8501 0.0 0
M  V30 51 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 2 29
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 2 4 5
M  V30 6 1 4 34
M  V30 7 1 6 7
M  V30 8 1 6 31
M  V30 9 2 7 8
M  V30 10 1 7 40
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 39
M  V30 14 1 10 12
M  V30 15 1 13 45
M  V30 16 1 13 46
M  V30 17 1 14 15
M  V30 18 1 14 51
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 15 18
M  V30 22 1 16 19
M  V30 23 1 16 20
M  V30 24 1 16 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 22 28
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 50 1 46 47
M  V30 51 1 46 48
M  V30 52 1 47 49
M  V30 53 1 48 50
M  V30 54 1 49 51
M  V30 55 1 50 51
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 17874-79-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3080149-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3080149-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41034446
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nonsymmetrically Substituted 1,1'-Biphenyl-Based Small Molecule
Inhibitors of the PD-1/PD-L1 Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hec-Galazka, Aleksandra; Tyrcha, Urszula; Barczynski, Jan; Bielski,
Przemyslaw; Mikitiuk, Michal; Gudz, Ganna P.; Kitel, Radoslaw; Musielak,
Bogdan; Plewka, Jacek; Sitar, Tomasz; Holak, Tad A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(6), 828-836

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
3-Azabicyclo[3.1.0]hexane-2-carboxamide, 3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2...
C27H39F3N4O5
3094306-01-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0558 5.7097 0.0 0
M  V30 2 N 5.5495 6.0299 0.0 0
M  V30 3 O 7.5317 4.2450 0.0 0
M  V30 4 C 4.5190 4.8855 0.0 0 CFG=2
M  V30 5 C 4.9950 3.4208 0.0 0
M  V30 6 C 3.0127 5.2057 0.0 0
M  V30 7 C 2.5368 6.6702 0.0 0
M  V30 8 C 1.0304 6.9904 0.0 0
M  V30 9 C 3.5673 7.8147 0.0 0
M  V30 10 C 0.0000 5.8460 0.0 0
M  V30 11 O 0.5546 8.4551 0.0 0
M  V30 12 C 8.2929 11.3476 0.0 0
M  V30 13 C 6.2495 10.1678 0.0 0
M  V30 14 C 10.3879 5.3595 0.0 0
M  V30 15 C 11.9279 5.3595 0.0 0 CFG=2
M  V30 16 O 9.6179 4.0259 0.0 0
M  V30 17 N 12.6979 6.6931 0.0 0
M  V30 18 C 12.6979 4.0259 0.0 0
M  V30 19 C 14.2379 6.6931 0.0 0
M  V30 20 C 14.0316 4.7959 0.0 0
M  V30 21 C 13.4679 2.6921 0.0 0
M  V30 22 C 11.3641 3.2559 0.0 0
M  V30 23 C 15.0079 8.0268 0.0 0
M  V30 24 O 15.0079 5.3595 0.0 0
M  V30 25 F 15.7779 9.3606 0.0 0
M  V30 26 F 13.6741 8.7968 0.0 0
M  V30 27 F 16.3416 7.2568 0.0 0
M  V30 28 O 5.6915 0.1437 0.0 0
M  V30 29 C 7.7661 8.3605 0.0 0 CFG=2
M  V30 30 C 9.0999 9.1305 0.0 0 CFG=2
M  V30 31 C 8.0864 6.8541 0.0 0 CFG=1
M  V30 32 C 7.7661 9.9005 0.0 0
M  V30 33 C 10.2442 8.1001 0.0 0
M  V30 34 N 9.6179 6.6931 0.0 0
M  V30 35 C 3.9644 2.2764 0.0 0 CFG=2
M  V30 36 C 4.2846 0.7700 0.0 0
M  V30 37 C 2.4329 2.4374 0.0 0
M  V30 38 N 2.9509 0.0000 0.0 0
M  V30 39 C 1.8066 1.0304 0.0 0
M  V30 40 H 6.2345 8.1996 0.0 0
M  V30 41 H 10.0051 10.3764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 31 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 35 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 12 32
M  V30 14 1 13 32
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 34
M  V30 18 1 15 17
M  V30 19 1 15 18 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 19 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 2 28 36
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 29 40 CFG=3
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 41 CFG=3
M  V30 37 1 31 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 4 15 29 30 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl) (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,3-d...
C13H21NO4
219754-02-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.2642 1.1444 0.0 0
M  V30 2 O 3.2336 0.0000 0.0 0
M  V30 3 O 5.7705 0.8242 0.0 0
M  V30 4 C 0.0000 5.0346 0.0 0
M  V30 5 C 0.0000 2.6753 0.0 0
M  V30 6 C 6.2334 3.8550 0.0 0
M  V30 7 O 7.0034 5.1887 0.0 0
M  V30 8 O 7.0034 2.5213 0.0 0
M  V30 9 C 8.5434 5.1887 0.0 0
M  V30 10 C 8.5434 6.7287 0.0 0
M  V30 11 C 10.0835 5.1887 0.0 0
M  V30 12 C 8.5434 3.6486 0.0 0
M  V30 13 C 2.3236 3.0850 0.0 0 CFG=2
M  V30 14 C 2.3236 4.6250 0.0 0 CFG=2
M  V30 15 C 3.7882 2.6091 0.0 0 CFG=1
M  V30 16 C 0.9899 3.8550 0.0 0
M  V30 17 C 3.7882 5.1009 0.0 0
M  V30 18 N 4.6934 3.8550 0.0 0
M  V30 19 H 1.6971 1.6782 0.0 0
M  V30 20 H 1.6971 6.0318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 4 16
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 19 CFG=3
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 14 20 CFG=3
M  V30 20 1 15 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (1R,2S,5S)-2-[[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxo-3-pyrroli...
C20H32N4O5
2755813-10-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.3519 4.9798 0.0 0
M  V30 2 N 7.6856 4.2098 0.0 0
M  V30 3 O 6.3519 6.5198 0.0 0
M  V30 4 C 9.0194 4.9798 0.0 0 CFG=2
M  V30 5 C 9.0194 6.5198 0.0 0
M  V30 6 C 10.3530 4.2098 0.0 0
M  V30 7 N 11.6867 4.9798 0.0 0
M  V30 8 O 10.3530 2.6698 0.0 0
M  V30 9 C 3.4333 0.0000 0.0 0
M  V30 10 C 5.7411 0.4905 0.0 0
M  V30 11 C 3.2912 6.3425 0.0 0
M  V30 12 O 1.8266 6.8184 0.0 0
M  V30 13 O 4.4357 7.3729 0.0 0
M  V30 14 C 1.5064 8.3247 0.0 0
M  V30 15 C 0.0000 8.0045 0.0 0
M  V30 16 C 1.1863 9.8311 0.0 0
M  V30 17 C 3.0127 8.6448 0.0 0
M  V30 18 O 9.3696 9.8517 0.0 0
M  V30 19 C 4.8573 2.6781 0.0 0 CFG=2
M  V30 20 C 3.3509 2.3579 0.0 0 CFG=2
M  V30 21 C 5.0183 4.2098 0.0 0 CFG=1
M  V30 22 C 4.3815 1.2135 0.0 0
M  V30 23 C 2.5809 3.6917 0.0 0
M  V30 24 N 3.6115 4.8361 0.0 0
M  V30 25 C 10.3530 7.2898 0.0 0 CFG=2
M  V30 26 C 10.5139 8.8213 0.0 0
M  V30 27 C 11.7598 6.6633 0.0 0
M  V30 28 N 12.0204 9.1415 0.0 0
M  V30 29 C 12.7904 7.8078 0.0 0
M  V30 30 H 6.3636 2.3579 0.0 0
M  V30 31 H 2.1050 1.4527 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 25 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 22
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 24
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 18 26
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 19 30 CFG=3
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 20 31 CFG=3
M  V30 27 1 21 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 19 20 21 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3094306-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 219754-02-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2755813-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41746955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 3 (stage 3)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the potent covalent inhibitor with an acrylate warhead for
SARS-CoV-2 3CL protease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shen, Wen; Chen, Xinyao; Zhou, Liping; Cheng, Yan; Zhang, Yan; Jiang,
Xiangrui; Sun, Haiguo; Shen, Jingshan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2024), 112129942

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
5-Methyl-1H-indole-2-carboxylic acid
C10H9NO2
10241-97-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 3-ethyl (3S,4S)-4-amino-1,3-piperidinedicarboxylate
C13H24N2O4
2602442-14-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2636 2.6674 0.0 0
M  V30 2 O 9.0336 4.0011 0.0 0
M  V30 3 O 9.0336 1.3336 0.0 0
M  V30 4 C 10.5736 4.0011 0.0 0
M  V30 5 C 11.3436 5.3347 0.0 0
M  V30 6 N 6.7236 0.0000 0.0 0
M  V30 7 C 3.6436 5.3347 0.0 0
M  V30 8 O 2.1036 5.3347 0.0 0
M  V30 9 O 4.4136 6.6685 0.0 0
M  V30 10 C 1.3336 6.6685 0.0 0
M  V30 11 C 0.0000 5.8985 0.0 0
M  V30 12 C 0.5636 8.0021 0.0 0
M  V30 13 C 2.6673 7.4385 0.0 0
M  V30 14 C 6.7236 2.6674 0.0 0 CFG=2
M  V30 15 C 5.9536 4.0011 0.0 0
M  V30 16 C 5.9536 1.3336 0.0 0 CFG=1
M  V30 17 N 4.4136 4.0011 0.0 0
M  V30 18 C 4.4136 1.3336 0.0 0
M  V30 19 C 3.6436 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 16 6 CFG=1
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 3-ethyl (3S,4S)-4-[[(5-methyl-1H-indol-2-yl)carbonyl]am...
C23H31N3O5
2602442-15-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 4.0011 0.0 0
M  V30 2 O 7.7000 2.6674 0.0 0
M  V30 3 O 10.0100 4.0011 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 C 7.7000 0.0000 0.0 0
M  V30 6 N 10.0100 6.6684 0.0 0
M  V30 7 C 10.7800 8.0021 0.0 0
M  V30 8 O 10.0100 9.3358 0.0 0
M  V30 9 C 3.8500 6.6685 0.0 0
M  V30 10 O 3.0800 8.0021 0.0 0
M  V30 11 O 3.0800 5.3347 0.0 0
M  V30 12 C 1.5400 8.0021 0.0 0
M  V30 13 C 1.5400 6.4621 0.0 0
M  V30 14 C 0.0000 8.0021 0.0 0
M  V30 15 C 1.5400 9.5421 0.0 0
M  V30 16 C 18.6910 9.5421 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 18 C 8.4700 6.6685 0.0 0 CFG=1
M  V30 19 C 6.1600 5.3347 0.0 0
M  V30 20 C 7.7000 8.0021 0.0 0
M  V30 21 N 5.3900 6.6684 0.0 0
M  V30 22 C 6.1600 8.0021 0.0 0
M  V30 23 C 12.3200 8.0021 0.0 0
M  V30 24 C 13.2252 9.2480 0.0 0
M  V30 25 N 13.2252 6.7563 0.0 0
M  V30 26 C 14.6899 8.7721 0.0 0
M  V30 27 C 14.6899 7.2321 0.0 0
M  V30 28 C 16.0235 9.5421 0.0 0
M  V30 29 C 16.0235 6.4621 0.0 0
M  V30 30 C 17.3572 8.7721 0.0 0
M  V30 31 C 17.3572 7.2321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 18 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 7 23
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 30
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10241-97-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2602442-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602442-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24414281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Optimization of Pyrrolidine Derivatives as Highly
Potent Ghrelin Receptor Full Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cooper, Martin; Llinas, Antonio; Hansen, Peter; Caffrey, Moya; Ray, Asim;
Sjoedin, Stina; Shamovsky, Igor; Wada, Hiroki; Jellesmark Jensen, Tina;
Sivars, Ulf; Hultin, Leif; Andersson, Ulf; Lundqvist, Sara; Gedda, Karin;
Jinton, Lisa; Krutroek, Nina; Lewis, Richard; Jansson, Paul; Gardelli,
Cristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9705-9730

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Propionic acid
C3H6O2
79-09-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C25H26N2O5
2892485-49-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6201 0.0 0
M  V30 2 O 8.0022 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8049 2.7300 0.0 0
M  V30 9 C 20.3365 2.8910 0.0 0
M  V30 10 O 18.1786 1.3230 0.0 0
M  V30 11 C 21.2417 1.6451 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 N 6.6685 3.8501 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 2.3101 0.0 0
M  V30 21 C 6.6685 2.3101 0.0 0
M  V30 22 C 9.3360 3.8501 0.0 0
M  V30 23 O 10.7428 4.4764 0.0 0
M  V30 24 C 9.4969 2.3185 0.0 0
M  V30 25 C 11.7732 3.3320 0.0 0
M  V30 26 C 11.0032 1.9983 0.0 0
M  V30 27 C 13.3050 3.4930 0.0 0
M  V30 28 C 14.2100 2.2471 0.0 0
M  V30 29 C 13.9313 4.8999 0.0 0
M  V30 30 C 15.7418 2.4080 0.0 0
M  V30 31 C 15.4629 5.0609 0.0 0
M  V30 32 C 16.3681 3.8150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 2 19 20
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid
C9H8O4
4442-54-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Quinolinecarboxamide, N-(5-amino-2-bromophenyl)-2-methyl-
C17H14BrN3O
1693735-21-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0011 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 O 4.6201 5.3348 0.0 0
M  V30 4 C 13.8602 5.3348 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 N 0.0000 5.3348 0.0 0
M  V30 7 C 9.2401 5.3348 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 7.7001 5.3348 0.0 0
M  V30 10 C 10.0101 6.6686 0.0 0
M  V30 11 C 9.2401 2.6675 0.0 0
M  V30 12 N 11.5501 4.0011 0.0 0
M  V30 13 C 6.9301 4.0011 0.0 0
M  V30 14 C 11.5501 6.6686 0.0 0
M  V30 15 C 7.7001 2.6675 0.0 0
M  V30 16 C 12.3201 5.3348 0.0 0
M  V30 17 C 3.0800 2.6675 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 0.7700 1.3338 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 17
M  V30 5 1 4 16
M  V30 6 1 5 18
M  V30 7 1 6 21
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Bromo-5-[[(2,3-dihydro-1,4-benzodioxin-6-yl)carbonyl]amino]phenyl]-2-met...
C26H20BrN3O4
1693735-22-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 6.6684 0.0 0
M  V30 2 N 11.5500 8.0021 0.0 0
M  V30 3 O 11.5500 5.3347 0.0 0
M  V30 4 C 20.7900 5.3347 0.0 0
M  V30 5 Br 10.0100 10.6694 0.0 0
M  V30 6 N 6.9300 5.3347 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 O 4.6200 6.6684 0.0 0
M  V30 9 C 16.1700 5.3347 0.0 0
M  V30 10 C 16.9400 6.6684 0.0 0
M  V30 11 C 14.6300 5.3347 0.0 0
M  V30 12 C 16.9400 4.0011 0.0 0
M  V30 13 C 16.1700 8.0021 0.0 0
M  V30 14 N 18.4800 6.6684 0.0 0
M  V30 15 C 13.8600 6.6684 0.0 0
M  V30 16 C 18.4800 4.0011 0.0 0
M  V30 17 C 14.6300 8.0021 0.0 0
M  V30 18 C 19.2500 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 9.2400 6.6684 0.0 0
M  V30 21 C 9.2400 9.3358 0.0 0
M  V30 22 C 7.7000 6.6684 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 4.6200 4.0011 0.0 0
M  V30 26 C 3.0800 4.0011 0.0 0
M  V30 27 C 5.3900 2.6673 0.0 0
M  V30 28 C 2.3100 2.6673 0.0 0
M  V30 29 C 4.6200 1.3336 0.0 0
M  V30 30 C 3.0800 1.3336 0.0 0
M  V30 31 O 0.7700 2.6673 0.0 0
M  V30 32 O 2.3100 0.0000 0.0 0
M  V30 33 C 0.0000 1.3336 0.0 0
M  V30 34 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 19
M  V30 5 1 4 18
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 2 7 8
M  V30 10 1 7 25
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 2 29 30
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4442-54-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1693735-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693735-22-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40578485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM pyridine also used as a solvent in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed
from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian
Cancer and Other Malignancies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pasqua, A. Elisa; Sharp, Swee Y.; Chessum, Nicola E. A.; Hayes, Angela;
Pellegrino, Loredana; Tucker, Michael J.; Miah, Asadh; Wilding, Birgit;
Evans, Lindsay E.; Rye, Carl S.; Mok, N. Yi; Liu, Manjuan; Henley, Alan
T.; Gowan, Sharon; De Billy, Emmanuel; te Poele, Robert; Powers, Marissa;
Eccles, Suzanne A.; Clarke, Paul A.; Raynaud, Florence I.; Workman, Paul;
Jones, Keith; Cheeseman, Matthew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5907-5936

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzene...
C20H27N3O5S
251105-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.8500 0.0 0
M  V30 2 S 6.6686 4.6201 0.0 0 VAL=6
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 O 5.8986 3.2864 0.0 0
M  V30 6 O 7.4386 5.9537 0.0 0
M  V30 7 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 12.0034 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6695 2.3100 0.0 0
M  V30 11 C 6.6686 0.0000 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 13.3370 3.8500 0.0 0
M  V30 14 N 12.0034 6.1601 0.0 0
M  V30 15 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 16 O 1.3338 9.2401 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 4.0011 4.6201 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 2.6675 6.9301 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 26 C 16.0043 3.8500 0.0 0
M  V30 27 C 16.0043 6.9301 0.0 0
M  V30 28 C 17.3381 4.6201 0.0 0
M  V30 29 C 17.3381 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 18
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) (2R)-2,4-morpholinedicarboxylate
C10H17NO5
884512-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 O 9.3360 4.6201 0.0 0
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0 CFG=2
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 O 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophe...
C30H42N4O9S
2765293-60-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 9.2402 0.0 0 CFG=1
M  V30 2 C 6.6685 8.4702 0.0 0 CFG=2
M  V30 3 C 8.0023 10.7802 0.0 0
M  V30 4 N 9.3360 8.4702 0.0 0
M  V30 5 C 5.3348 9.2402 0.0 0
M  V30 6 O 6.6685 6.9302 0.0 0
M  V30 7 C 10.6697 9.2402 0.0 0
M  V30 8 N 4.0012 8.4702 0.0 0
M  V30 9 O 10.6697 10.7802 0.0 0
M  V30 10 S 4.0012 6.9302 0.0 0 VAL=6
M  V30 11 C 2.6675 9.2402 0.0 0
M  V30 12 O 2.4611 6.9302 0.0 0
M  V30 13 O 5.5412 6.9302 0.0 0
M  V30 14 C 1.3337 8.4702 0.0 0
M  V30 15 C 0.0000 9.2402 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 16.0045 9.2402 0.0 0
M  V30 18 O 17.3382 8.4702 0.0 0
M  V30 19 O 16.0045 10.7802 0.0 0
M  V30 20 C 18.6720 9.2402 0.0 0
M  V30 21 C 19.4420 7.9065 0.0 0
M  V30 22 C 20.0057 10.0102 0.0 0
M  V30 23 C 17.9020 10.5739 0.0 0
M  V30 24 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 25 O 2.6675 0.0000 0.0 0
M  V30 26 O 5.3348 0.0000 0.0 0
M  V30 27 C 6.6685 11.5503 0.0 0
M  V30 28 C 5.3348 10.7802 0.0 0
M  V30 29 C 6.6685 13.0903 0.0 0
M  V30 30 C 4.0012 11.5503 0.0 0
M  V30 31 C 5.3348 13.8603 0.0 0
M  V30 32 C 4.0012 13.0903 0.0 0
M  V30 33 C 12.0033 8.4702 0.0 0 CFG=2
M  V30 34 C 13.3372 9.2402 0.0 0
M  V30 35 O 12.0033 6.9302 0.0 0
M  V30 36 N 14.6708 8.4702 0.0 0
M  V30 37 C 13.3372 6.1601 0.0 0
M  V30 38 C 14.6708 6.9302 0.0 0
M  V30 39 C 4.0012 5.3901 0.0 0
M  V30 40 C 2.6675 4.6201 0.0 0
M  V30 41 C 5.3348 4.6201 0.0 0
M  V30 42 C 2.6675 3.0801 0.0 0
M  V30 43 C 5.3348 3.0801 0.0 0
M  V30 44 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 27
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 33 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 39
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 36
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 24 25
M  V30 27 2 24 26
M  V30 28 1 24 44
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 1 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 38
M  V30 41 2 39 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 2 41 43
M  V30 45 2 42 44
M  V30 46 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 251105-80-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 884512-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-60-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
3-Pyridinemethanamine
C6H8N2
3731-52-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thien...
C26H28FN5O3S
3064695-54-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=3
M  V30 2 C 11.9711 5.7472 0.0 0
M  V30 3 C 12.8763 6.9931 0.0 0
M  V30 4 C 14.4079 6.8322 0.0 0
M  V30 5 C 15.3131 8.0781 0.0 0
M  V30 6 C 16.8447 7.9171 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 C 1.3337 7.7001 0.0 0
M  V30 9 O 0.0000 6.9301 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 O 23.2464 8.6871 0.0 0
M  V30 12 N 8.0021 5.3901 0.0 0
M  V30 13 C 9.4091 4.7638 0.0 0
M  V30 14 N 8.1632 6.9217 0.0 0
M  V30 15 C 10.4395 5.9082 0.0 0
M  V30 16 N 9.6695 7.2418 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6673 6.9301 0.0 0
M  V30 23 C 6.6685 3.0801 0.0 0
M  V30 24 C 5.3348 2.3100 0.0 0
M  V30 25 C 8.0021 2.3100 0.0 0
M  V30 26 C 5.3348 0.7700 0.0 0
M  V30 27 C 8.0021 0.7700 0.0 0
M  V30 28 C 6.6685 0.0000 0.0 0
M  V30 29 C 17.7499 9.1630 0.0 0 CFG=2
M  V30 30 C 19.2899 9.1630 0.0 0 CFG=1
M  V30 31 S 17.2740 10.6276 0.0 0
M  V30 32 C 19.7658 10.6276 0.0 0 CFG=1
M  V30 33 N 20.5358 8.2578 0.0 0
M  V30 34 C 18.5199 11.5328 0.0 0
M  V30 35 N 21.3058 10.6276 0.0 0
M  V30 36 C 21.7818 9.1630 0.0 0
M  V30 37 H 18.8141 7.6983 0.0 0
M  V30 38 H 20.2418 12.0923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 2 3
M  V30 5 1 2 15
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 29 6 CFG=3
M  V30 10 1 7 26
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 22
M  V30 14 2 11 36
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 37 CFG=1
M  V30 37 1 31 34
M  V30 38 1 32 34
M  V30 39 1 32 35
M  V30 40 1 32 38 CFG=1
M  V30 41 1 33 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3...
C32H34FN7O2S
3064695-44-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 4.6200 0.0 0 CFG=3
M  V30 2 C 17.3058 5.7472 0.0 0
M  V30 3 C 18.2111 6.9930 0.0 0
M  V30 4 C 19.7426 6.8321 0.0 0
M  V30 5 C 20.6478 8.0780 0.0 0
M  V30 6 C 22.1793 7.9170 0.0 0
M  V30 7 F 14.6706 0.0000 0.0 0
M  V30 8 C 6.6685 7.7000 0.0 0
M  V30 9 N 5.3347 6.9300 0.0 0
M  V30 10 O 6.6685 9.2400 0.0 0
M  V30 11 C 4.0011 7.7000 0.0 0
M  V30 12 O 28.5810 8.6870 0.0 0
M  V30 13 N 13.3369 5.3900 0.0 0
M  V30 14 C 14.7437 4.7637 0.0 0
M  V30 15 N 13.4979 6.9216 0.0 0
M  V30 16 C 15.7743 5.9081 0.0 0
M  V30 17 N 15.0043 7.2417 0.0 0
M  V30 18 C 10.6695 5.3900 0.0 0
M  V30 19 C 9.3358 4.6200 0.0 0
M  V30 20 C 10.6695 6.9300 0.0 0
M  V30 21 C 8.0022 5.3900 0.0 0
M  V30 22 C 9.3358 7.7000 0.0 0
M  V30 23 C 8.0022 6.9300 0.0 0
M  V30 24 C 12.0033 3.0800 0.0 0
M  V30 25 C 13.3369 2.3100 0.0 0
M  V30 26 C 10.6695 2.3100 0.0 0
M  V30 27 C 13.3369 0.7700 0.0 0
M  V30 28 C 10.6695 0.7700 0.0 0
M  V30 29 C 12.0033 0.0000 0.0 0
M  V30 30 C 2.6674 6.9300 0.0 0
M  V30 31 C 1.3338 7.7000 0.0 0
M  V30 32 C 2.6674 5.3900 0.0 0
M  V30 33 C 0.0000 6.9300 0.0 0
M  V30 34 N 1.3338 4.6200 0.0 0
M  V30 35 C 0.0000 5.3900 0.0 0
M  V30 36 C 23.0846 9.1629 0.0 0 CFG=2
M  V30 37 C 24.6246 9.1629 0.0 0 CFG=1
M  V30 38 S 22.6087 10.6274 0.0 0
M  V30 39 C 25.1004 10.6274 0.0 0 CFG=1
M  V30 40 N 25.8704 8.2577 0.0 0
M  V30 41 C 23.8546 11.5327 0.0 0
M  V30 42 N 26.6404 10.6274 0.0 0
M  V30 43 C 27.1163 9.1629 0.0 0
M  V30 44 H 24.1487 7.6982 0.0 0
M  V30 45 H 25.5763 12.0921 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 2 3
M  V30 5 1 2 16
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 36 6 CFG=3
M  V30 10 1 7 27
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 23
M  V30 14 1 9 11
M  V30 15 1 11 30
M  V30 16 2 12 43
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 37 40
M  V30 44 1 37 44 CFG=1
M  V30 45 1 38 41
M  V30 46 1 39 41
M  V30 47 1 39 42
M  V30 48 1 39 45 CFG=1
M  V30 49 1 40 43
M  V30 50 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 36 37 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3731-52-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3064695-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3064695-44-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43968811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown,product obtained as mixture of
diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural study of potent triazole-based inhibitors of Staphylococcus
aureus biotin protein ligase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stachura, Damian L.; Nguyen, Stephanie; Polyak, Steven W.; Jovcevski,
Blagojce; Bruning, John B.; Abell, Andrew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(3), 285-290

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
2-Hexanamine, 5,5-difluoro-1,1-dimethoxy-, (2S)-
C8H17F2NO2
2952553-12-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0 CFG=1
M  V30 3 O 8.0023 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 8.0023 0.0000 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 F 0.5637 3.6437 0.0 0
M  V30 13 F 2.1037 0.9764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Azaspiro[4.5]decane-2,3-dicarboxylic acid, 2-(phenylmethyl) ester, (3S)-
C18H23NO4
3056237-98-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 O 7.3326 5.1887 0.0 0
M  V30 3 O 7.3326 2.5213 0.0 0
M  V30 4 C 8.8726 5.1887 0.0 0
M  V30 5 C 4.5932 1.1445 0.0 0
M  V30 6 O 6.0996 0.8244 0.0 0
M  V30 7 O 3.5628 0.0000 0.0 0
M  V30 8 C 2.6528 4.6251 0.0 0
M  V30 9 C 4.1173 5.1009 0.0 0
M  V30 10 C 2.6528 3.0851 0.0 0
M  V30 11 C 1.2459 3.9986 0.0 0
M  V30 12 C 2.8137 6.1566 0.0 0
M  V30 13 N 5.0226 3.8551 0.0 0
M  V30 14 C 4.1173 2.6091 0.0 0 CFG=1
M  V30 15 C 0.0000 4.9038 0.0 0
M  V30 16 C 1.5679 7.0618 0.0 0
M  V30 17 C 0.1609 6.4354 0.0 0
M  V30 18 C 9.6426 6.5224 0.0 0
M  V30 19 C 8.8726 7.8560 0.0 0
M  V30 20 C 11.1826 6.5224 0.0 0
M  V30 21 C 9.6426 9.1898 0.0 0
M  V30 22 C 11.9526 7.8560 0.0 0
M  V30 23 C 11.1826 9.1898 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 14 5 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Azaspiro[4.5]decane-2-carboxylic acid, 3-[[[(1S)-1-(dimethoxymethyl)-4,4-di...
C26H38F2N2O5
3056237-99-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.8342 0.0 0
M  V30 2 N 4.6201 6.8342 0.0 0
M  V30 3 O 6.9302 8.1679 0.0 0
M  V30 4 C 3.8501 8.1679 0.0 0 CFG=1
M  V30 5 C 2.3101 8.1679 0.0 0
M  V30 6 C 4.6201 9.5017 0.0 0
M  V30 7 O 1.5400 9.5017 0.0 0
M  V30 8 O 1.5400 6.8342 0.0 0
M  V30 9 C 3.8501 10.8354 0.0 0
M  V30 10 C 0.0000 9.5017 0.0 0
M  V30 11 C 0.0000 6.8342 0.0 0
M  V30 12 C 4.6201 12.1690 0.0 0
M  V30 13 C 5.3901 13.5027 0.0 0
M  V30 14 F 3.2864 12.9391 0.0 0
M  V30 15 F 5.9538 11.3990 0.0 0
M  V30 16 C 9.4923 6.4840 0.0 0
M  V30 17 O 10.9986 6.1638 0.0 0
M  V30 18 O 9.0163 7.9487 0.0 0
M  V30 19 C 12.0290 7.3082 0.0 0
M  V30 20 C 7.4482 3.0631 0.0 0
M  V30 21 C 6.3038 4.0936 0.0 0
M  V30 22 C 8.7819 3.8331 0.0 0
M  V30 23 C 6.0414 2.4368 0.0 0
M  V30 24 C 8.6941 2.1579 0.0 0
M  V30 25 C 6.9302 5.5005 0.0 0 CFG=1
M  V30 26 N 8.4617 5.3396 0.0 0
M  V30 27 C 5.8803 0.9051 0.0 0
M  V30 28 C 8.5332 0.6263 0.0 0
M  V30 29 C 7.1264 0.0000 0.0 0
M  V30 30 C 13.5355 6.9881 0.0 0
M  V30 31 C 14.0114 5.5235 0.0 0
M  V30 32 C 14.5659 8.1326 0.0 0
M  V30 33 C 15.5178 5.2033 0.0 0
M  V30 34 C 16.0724 7.8124 0.0 0
M  V30 35 C 16.5483 6.3477 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 25 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 26
M  V30 19 1 17 19
M  V30 20 1 19 30
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 26
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2952553-12-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3056237-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056237-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42085218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 156311-85-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a
novel difluorinated glutamine mimic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shurtleff, Valerie W.; Layton, Mark E.; Parish, Craig A.; Perkins, James
J.; Schreier, John D.; Wang, Yunyi; Adam, Gregory C.; Alvarez, Nadine;
Bahmanjah, Soheila; Bahnck-Teets, Carolyn M.; Boyce, Christopher W.;
Burlein, Christine; Cabalu, Tamara D.; Campbell, Brian T.; Carroll,
Steven S.; Chang, Wonsuk; de Lera Ruiz, Manuel; Dolgov, Enriko; Fay, John
F.; Fox, Nicholas G.; Goh, Shih Lin; Hartingh, Timothy J.; Hurzy,
Danielle M.; Kelly, Michael J. III; Klein, Daniel J.; Klingler,
Franca-Maria; Krishnamurthy, Harini; Kudalkar, Shalley; Mayhood, Todd W.;
McKenna, Philip M.; Murray, Edward M.; Nahas, Debbie; Nawrat, Christopher
C.; Park, Steven; Qian, Dongming; Roecker, Anthony J.; Sharma, Vijeta;
Shipe, William D.; Su, Jing; Taggart, Robert V.; Truong, Quang; Wu, Yin;
Zhou, Xiaoyan; Zhuang, Ningning; Perlin, David S.; Olsen, David B.; Howe,
John A.; McCauley, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(5), 3935-3958

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
4-Ethoxybenzoic acid
C9H10O3
619-86-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C35H33N3O5
2919713-78-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 O 27.1736 5.4955 0.0 0
M  V30 11 C 27.9436 6.8291 0.0 0
M  V30 12 C 29.4836 6.8291 0.0 0
M  V30 13 C 11.7732 2.8281 0.0 0
M  V30 14 C 11.0032 4.1618 0.0 0
M  V30 15 C 10.7428 1.6836 0.0 0
M  V30 16 C 13.3133 2.8281 0.0 0
M  V30 17 N 9.4969 3.8416 0.0 0
M  V30 18 C 11.7732 5.4955 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 20 C 14.0833 4.1618 0.0 0
M  V30 21 C 13.3133 5.4955 0.0 0
M  V30 22 C 15.6233 4.1618 0.0 0
M  V30 23 C 16.3933 5.4955 0.0 0
M  V30 24 C 16.3933 2.8281 0.0 0
M  V30 25 C 17.9334 5.4955 0.0 0
M  V30 26 C 17.9334 2.8281 0.0 0
M  V30 27 C 18.7034 4.1618 0.0 0
M  V30 28 N 6.6685 2.3101 0.0 0
M  V30 29 C 5.3348 1.5400 0.0 0
M  V30 30 C 6.6685 3.8501 0.0 0
M  V30 31 C 4.0012 2.3101 0.0 0
M  V30 32 C 5.3348 4.6201 0.0 0
M  V30 33 C 4.0012 3.8501 0.0 0
M  V30 34 C 2.6673 1.5400 0.0 0
M  V30 35 C 2.6673 4.6201 0.0 0
M  V30 36 C 1.3337 2.3101 0.0 0
M  V30 37 C 1.3337 3.8501 0.0 0
M  V30 38 C 22.5535 5.4955 0.0 0
M  V30 39 C 23.3235 4.1618 0.0 0
M  V30 40 C 23.3235 6.8291 0.0 0
M  V30 41 C 24.8635 4.1618 0.0 0
M  V30 42 C 24.8635 6.8291 0.0 0
M  V30 43 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 28
M  V30 4 1 3 4
M  V30 5 1 3 27
M  V30 6 2 4 5
M  V30 7 1 4 38
M  V30 8 1 6 7
M  V30 9 1 6 36
M  V30 10 1 8 9
M  V30 11 1 8 37
M  V30 12 1 10 11
M  V30 13 1 10 43
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 31 34
M  V30 38 1 32 33
M  V30 39 2 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 37
M  V30 43 2 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-86-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-78-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
6-Trifluoromethyl-2-pyridinecarboxylic acid
C7H4F3NO2
131747-42-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 N 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5-amino-6-chloro-1H-indazole-1-carboxylate
C12H14ClN3O2
1799836-41-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2597 3.1059 0.0 0
M  V30 2 O 8.5934 3.8760 0.0 0
M  V30 3 O 7.2597 1.5659 0.0 0
M  V30 4 C 9.9271 3.1059 0.0 0
M  V30 5 C 9.1570 1.7721 0.0 0
M  V30 6 C 11.2607 2.3359 0.0 0
M  V30 7 C 10.6971 4.4396 0.0 0
M  V30 8 Cl 2.0609 0.0000 0.0 0
M  V30 9 N 0.0000 2.2890 0.0 0
M  V30 10 C 4.5191 3.2495 0.0 0
M  V30 11 N 5.9259 3.8760 0.0 0
M  V30 12 C 3.4886 4.3940 0.0 0
M  V30 13 C 4.0432 1.7849 0.0 0
M  V30 14 N 5.7650 5.4075 0.0 0
M  V30 15 C 4.2587 5.7277 0.0 0
M  V30 16 C 1.9822 4.0739 0.0 0
M  V30 17 C 2.5367 1.4647 0.0 0
M  V30 18 C 1.5063 2.6091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 17
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 15
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-chloro-5-[[[6-(trifluoromethyl)-2-pyridinyl]carbonyl]amin...
C19H16ClF3N4O3
1799836-43-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6542 5.3304 0.0 0
M  V30 2 O 15.6848 6.4749 0.0 0
M  V30 3 O 15.1302 3.8658 0.0 0
M  V30 4 C 17.1911 6.1547 0.0 0
M  V30 5 C 17.5113 7.6611 0.0 0
M  V30 6 C 18.6975 5.8344 0.0 0
M  V30 7 C 16.8709 4.6483 0.0 0
M  V30 8 Cl 10.6697 0.7700 0.0 0
M  V30 9 N 8.0023 2.3101 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 11 O 6.6687 4.6201 0.0 0
M  V30 12 C 1.3338 3.0801 0.0 0
M  V30 13 F 0.5638 1.7464 0.0 0
M  V30 14 F 0.0000 3.8501 0.0 0
M  V30 15 F 2.1038 4.4137 0.0 0
M  V30 16 C 12.0035 4.6201 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 N 13.1479 5.6505 0.0 0
M  V30 19 C 12.0035 3.0801 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 C 10.9898 6.8964 0.0 0
M  V30 22 N 12.5216 7.0575 0.0 0
M  V30 23 C 10.6697 2.3101 0.0 0
M  V30 24 C 9.3360 3.0801 0.0 0
M  V30 25 C 5.3348 2.3101 0.0 0
M  V30 26 N 4.0012 3.0801 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 2.6675 2.3101 0.0 0
M  V30 29 C 4.0012 0.0000 0.0 0
M  V30 30 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 1 9 24
M  V30 11 2 10 11
M  V30 12 1 10 25
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 131747-42-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1799836-41-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799836-43-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of 6-(trifluoromethyl)pyridine-2-carboxylic acid and
HOBt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bothe, Ulrich; Guenther, Judith; Nubbemeyer, Reinhard; Siebeneicher,
Holger; Ring, Sven; Boemer, Ulf; Peters, Michaele; Rausch, Alexandra;
Denner, Karsten; Himmel, Herbert; Sutter, Andreas; Terebesi, Ildiko;
Lange, Martin; Wengner, Antje M.; Guimond, Nicolas; Thaler, Tobias;
Platzek, Johannes; Eberspaecher, Uwe; Schaefer, Martina; Steuber, Holger;
Zollner, Thomas M.; Steinmeyer, Andreas; Schmidt, Nicole
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1225-1242

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Veratric acid
C9H10O4
93-07-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 6.6687 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 O 1.3337 6.9302 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C35H33N3O6
2919713-81-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 7.9566 0.0 0
M  V30 2 O 8.0020 9.4966 0.0 0
M  V30 3 N 20.2430 5.3347 0.0 0
M  V30 4 C 21.0130 4.0011 0.0 0
M  V30 5 O 20.2430 2.6674 0.0 0
M  V30 6 O 0.0000 7.9566 0.0 0
M  V30 7 C 0.0000 9.4966 0.0 0
M  V30 8 O 0.0000 4.8766 0.0 0
M  V30 9 C 0.0000 3.3366 0.0 0
M  V30 10 O 25.6330 1.3338 0.0 0
M  V30 11 C 24.8630 0.0000 0.0 0
M  V30 12 O 27.1730 4.0011 0.0 0
M  V30 13 C 27.9430 5.3347 0.0 0
M  V30 14 C 11.7730 6.6685 0.0 0
M  V30 15 C 11.0030 5.3347 0.0 0
M  V30 16 C 10.7426 7.8129 0.0 0
M  V30 17 C 13.3130 6.6685 0.0 0
M  V30 18 N 9.4967 5.6549 0.0 0
M  V30 19 C 11.7730 4.0011 0.0 0
M  V30 20 C 9.3358 7.1866 0.0 0
M  V30 21 C 14.0830 5.3347 0.0 0
M  V30 22 C 13.3130 4.0011 0.0 0
M  V30 23 C 15.6230 5.3347 0.0 0
M  V30 24 C 16.3930 4.0011 0.0 0
M  V30 25 C 16.3930 6.6685 0.0 0
M  V30 26 C 17.9330 4.0011 0.0 0
M  V30 27 C 17.9330 6.6685 0.0 0
M  V30 28 C 18.7030 5.3347 0.0 0
M  V30 29 N 6.6684 7.1866 0.0 0
M  V30 30 C 5.3347 7.9566 0.0 0
M  V30 31 C 6.6684 5.6466 0.0 0
M  V30 32 C 4.0011 7.1866 0.0 0
M  V30 33 C 5.3347 4.8766 0.0 0
M  V30 34 C 4.0011 5.6466 0.0 0
M  V30 35 C 2.6673 7.9566 0.0 0
M  V30 36 C 2.6673 4.8766 0.0 0
M  V30 37 C 1.3336 7.1866 0.0 0
M  V30 38 C 1.3336 5.6466 0.0 0
M  V30 39 C 22.5530 4.0011 0.0 0
M  V30 40 C 23.3230 2.6674 0.0 0
M  V30 41 C 23.3230 5.3347 0.0 0
M  V30 42 C 24.8630 2.6674 0.0 0
M  V30 43 C 24.8630 5.3347 0.0 0
M  V30 44 C 25.6330 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 29
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 2 4 5
M  V30 7 1 4 39
M  V30 8 1 6 7
M  V30 9 1 6 37
M  V30 10 1 8 9
M  V30 11 1 8 38
M  V30 12 1 10 11
M  V30 13 1 10 42
M  V30 14 1 12 13
M  V30 15 1 12 44
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 32 35
M  V30 39 1 33 34
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 38
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93-07-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Bromoacetic acid
C2H3BrO2
79-08-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pomalidomide
C13H11N3O4
19171-19-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 5.7904 0.0 0
M  V30 2 O 4.6078 0.3694 0.0 0
M  V30 3 O 6.5770 5.7473 0.0 0
M  V30 4 N 1.3336 0.0000 0.0 0
M  V30 5 O 11.1970 3.0800 0.0 0
M  V30 6 N 5.0370 3.0800 0.0 0
M  V30 7 C 4.1320 4.3259 0.0 0
M  V30 8 C 4.1320 1.8340 0.0 0
M  V30 9 C 2.6673 3.8500 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 6.5770 3.0800 0.0 0
M  V30 16 C 7.3470 4.4136 0.0 0
M  V30 17 C 7.3470 1.7462 0.0 0
M  V30 18 N 8.8870 4.4136 0.0 0
M  V30 19 C 8.8870 1.7462 0.0 0
M  V30 20 C 9.6570 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 8
M  V30 3 2 3 16
M  V30 4 1 4 12
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl...
C15H12BrN3O5
2351106-38-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.0619 5.3181 0.0 0
M  V30 2 N 10.0822 4.0010 0.0 0
M  V30 3 C 11.6222 4.0010 0.0 0
M  V30 4 C 12.3922 5.3348 0.0 0
M  V30 5 O 12.3922 2.6673 0.0 0
M  V30 6 Br 13.9322 5.3348 0.0 0
M  V30 7 O 4.3513 0.6234 0.0 0
M  V30 8 O 2.6675 1.6454 0.0 0
M  V30 9 O 0.0000 6.2654 0.0 0
M  V30 10 C 7.7722 2.6673 0.0 0
M  V30 11 C 7.0021 1.3337 0.0 0
M  V30 12 C 6.7417 3.8119 0.0 0
M  V30 13 C 9.3122 2.6673 0.0 0
M  V30 14 C 5.4957 1.6538 0.0 0
M  V30 15 C 7.7722 0.0000 0.0 0
M  V30 16 N 5.3348 3.1854 0.0 0
M  V30 17 C 10.0822 1.3337 0.0 0
M  V30 18 C 9.3122 0.0000 0.0 0
M  V30 19 C 4.0011 3.9554 0.0 0
M  V30 20 C 2.6675 3.1854 0.0 0
M  V30 21 C 4.0011 5.4954 0.0 0
M  V30 22 N 1.3337 3.9554 0.0 0
M  V30 23 C 2.6675 6.2654 0.0 0
M  V30 24 C 1.3337 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 14
M  V30 8 2 8 20
M  V30 9 2 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19171-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2351106-38-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40188463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12
and CDK13
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Jianzhang; Chang, Yu; Tien, Jean Ching-Yi; Wang, Zhen; Zhou, Yang;
Zhang, Pujuan; Huang, Weixue; Vo, Josh; Apel, Ingrid J.; Wang, Cynthia;
Zeng, Victoria Zhixuan; Cheng, Yunhui; Li, Shuqin; Wang, George Xiaoju;
Chinnaiyan, Arul M.; Ding, Ke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(16), 11066-11083

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Isobutyric acid
C4H8O2
79-31-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C26H28N2O5
2892485-50-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6201 0.0 0
M  V30 2 O 8.0021 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8995 3.9759 0.0 0
M  V30 8 C 18.8047 2.7300 0.0 0
M  V30 9 C 20.3363 2.8909 0.0 0
M  V30 10 O 18.1784 1.3230 0.0 0
M  V30 11 C 21.2415 1.6451 0.0 0
M  V30 12 C 20.9628 4.2979 0.0 0
M  V30 13 C 4.0011 3.8501 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 5.3348 1.5400 0.0 0
M  V30 19 N 6.6684 3.8501 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 1.3337 2.3100 0.0 0
M  V30 22 C 6.6684 2.3100 0.0 0
M  V30 23 C 9.3359 3.8501 0.0 0
M  V30 24 O 10.7427 4.4764 0.0 0
M  V30 25 C 9.4968 2.3185 0.0 0
M  V30 26 C 11.7732 3.3320 0.0 0
M  V30 27 C 11.0031 1.9983 0.0 0
M  V30 28 C 13.3049 3.4929 0.0 0
M  V30 29 C 14.2099 2.2470 0.0 0
M  V30 30 C 13.9312 4.8999 0.0 0
M  V30 31 C 15.7416 2.4080 0.0 0
M  V30 32 C 15.4627 5.0608 0.0 0
M  V30 33 C 16.3680 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 23
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 1 7 33
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 2 20 21
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-31-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-50-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
N-(2,5-Dichlorobenzoyl)-S-methyl-L-cysteinyl-O-methyl-L-serine
C15H18Cl2N2O5S
2387522-92-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0009 3.8500 0.0 0
M  V30 2 N 5.3347 4.6200 0.0 0
M  V30 3 O 4.0009 2.3100 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0 CFG=1
M  V30 5 C 8.0020 4.6200 0.0 0
M  V30 6 C 6.6684 2.3100 0.0 0
M  V30 7 N 8.0020 6.1600 0.0 0
M  V30 8 O 9.3358 3.8500 0.0 0
M  V30 9 S 8.0020 1.5400 0.0 0
M  V30 10 C 9.3358 6.9300 0.0 0 CFG=2
M  V30 11 C 8.0020 0.0000 0.0 0
M  V30 12 C 10.6694 6.1600 0.0 0
M  V30 13 C 9.3358 8.4700 0.0 0
M  V30 14 O 12.0031 6.9300 0.0 0
M  V30 15 O 8.0020 9.2400 0.0 0
M  V30 16 O 10.6694 9.2400 0.0 0
M  V30 17 C 13.3367 6.1600 0.0 0
M  V30 18 Cl 1.3336 2.3100 0.0 0
M  V30 19 Cl 1.3336 8.4700 0.0 0
M  V30 20 C 2.6673 4.6200 0.0 0
M  V30 21 C 1.3336 3.8500 0.0 0
M  V30 22 C 2.6673 6.1600 0.0 0
M  V30 23 C 0.0000 4.6200 0.0 0
M  V30 24 C 1.3336 6.9300 0.0 0
M  V30 25 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 18 21
M  V30 19 1 19 24
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-erythro-3-Pentulose, 2-amino-4,5-anhydro-1,2-dideoxy-4-C-methyl-1-phenyl-, ...
C12H15NO2.C2HF3O2
1148157-29-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.7237 0.0 0
M  V30 2 C 5.3348 7.4937 0.0 0 CFG=1
M  V30 3 O 6.6684 5.1837 0.0 0
M  V30 4 C 4.0011 6.7237 0.0 0
M  V30 5 N 5.3348 9.0338 0.0 0
M  V30 6 C 7.4755 8.9409 0.0 0
M  V30 7 C 8.0022 7.4937 0.0 0 CFG=2
M  V30 8 C 8.9921 6.3141 0.0 0
M  V30 9 O 9.5188 7.7611 0.0 0
M  V30 10 C 2.6675 7.4937 0.0 0
M  V30 11 C 1.3337 6.7237 0.0 0
M  V30 12 C 2.6675 9.0338 0.0 0
M  V30 13 C 0.0000 7.4937 0.0 0
M  V30 14 C 1.3337 9.8038 0.0 0
M  V30 15 C 0.0000 9.0338 0.0 0
M  V30 16 C 4.0926 2.3101 0.0 0
M  V30 17 C 5.4262 1.5400 0.0 0
M  V30 18 F 4.8626 3.6437 0.0 0
M  V30 19 F 2.7589 3.0801 0.0 0
M  V30 20 F 3.3226 0.9764 0.0 0
M  V30 21 O 6.7599 2.3101 0.0 0
M  V30 22 O 5.4262 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 10
M  V30 7 1 7 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(2,5-Dichlorobenzoyl)-S-methyl-L-cysteinyl-O-methyl-N-[(1S)-2-[(2R)-2-methy...
C27H31Cl2N3O6S
2387523-12-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.8503 0.0 0
M  V30 2 C 5.3901 4.1841 0.0 0 CFG=1
M  V30 3 O 3.0801 2.8503 0.0 0
M  V30 4 C 4.6201 5.5178 0.0 0
M  V30 5 N 6.9302 4.1841 0.0 0
M  V30 6 C 7.7002 5.5178 0.0 0
M  V30 7 C 9.2402 5.5178 0.0 0 CFG=2
M  V30 8 O 6.9302 6.8515 0.0 0
M  V30 9 N 10.0102 6.8515 0.0 0
M  V30 10 C 10.0102 4.1841 0.0 0
M  V30 11 C 11.5503 6.8515 0.0 0
M  V30 12 O 9.2402 2.8503 0.0 0
M  V30 13 C 12.3203 8.1851 0.0 0 CFG=2
M  V30 14 O 12.3203 5.5178 0.0 0
M  V30 15 C 10.0102 1.5166 0.0 0
M  V30 16 N 13.8603 8.1851 0.0 0
M  V30 17 C 11.5503 9.5189 0.0 0
M  V30 18 C 14.6303 9.5189 0.0 0
M  V30 19 S 10.0102 9.5189 0.0 0
M  V30 20 O 13.8603 10.8526 0.0 0
M  V30 21 C 9.2402 10.8526 0.0 0
M  V30 22 C 6.8373 2.0433 0.0 0
M  V30 23 Cl 16.1704 12.1863 0.0 0
M  V30 24 Cl 19.2504 6.8515 0.0 0
M  V30 25 C 5.3901 1.5166 0.0 0 CFG=2
M  V30 26 C 4.2105 0.5267 0.0 0
M  V30 27 O 5.6575 0.0000 0.0 0
M  V30 28 C 3.0801 5.5178 0.0 0
M  V30 29 C 2.3101 4.1841 0.0 0
M  V30 30 C 2.3101 6.8515 0.0 0
M  V30 31 C 0.7700 4.1841 0.0 0
M  V30 32 C 0.7700 6.8515 0.0 0
M  V30 33 C 0.0000 5.5178 0.0 0
M  V30 34 C 16.1704 9.5189 0.0 0
M  V30 35 C 16.9404 10.8526 0.0 0
M  V30 36 C 16.9404 8.1851 0.0 0
M  V30 37 C 18.4804 10.8526 0.0 0
M  V30 38 C 18.4804 8.1851 0.0 0
M  V30 39 C 19.2504 9.5189 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 25 1 CFG=3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17 CFG=3
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 18 34
M  V30 23 1 19 21
M  V30 24 1 25 22 CFG=1
M  V30 25 1 23 35
M  V30 26 1 24 38
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 7 13 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2387522-92-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148157-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387523-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31545365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel tripeptide propylene oxide proteasome inhibitors for
the treatment of multiple myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen; Wang, Xueyuan; Zhang, Haoyang; Wen, Tiantian; Yang, Lin;
Miao, Hang; Wang, Jia; Liu, Hailong; Yang, Xu; Lei, Meng; Zhu, Yongqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 40116182

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
4-Iodobenzoic acid
C7H5IO2
619-58-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C33H28IN3O4
2919713-71-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 I 27.1736 5.4955 0.0 0
M  V30 11 C 11.7732 2.8281 0.0 0
M  V30 12 C 11.0032 4.1618 0.0 0
M  V30 13 C 10.7428 1.6836 0.0 0
M  V30 14 C 13.3133 2.8281 0.0 0
M  V30 15 N 9.4969 3.8416 0.0 0
M  V30 16 C 11.7732 5.4955 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 14.0833 4.1618 0.0 0
M  V30 19 C 13.3133 5.4955 0.0 0
M  V30 20 C 15.6233 4.1618 0.0 0
M  V30 21 C 16.3933 2.8281 0.0 0
M  V30 22 C 16.3933 5.4955 0.0 0
M  V30 23 C 17.9334 2.8281 0.0 0
M  V30 24 C 17.9334 5.4955 0.0 0
M  V30 25 C 18.7034 4.1618 0.0 0
M  V30 26 N 6.6685 2.3101 0.0 0
M  V30 27 C 5.3348 1.5400 0.0 0
M  V30 28 C 6.6685 3.8501 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 5.3348 4.6201 0.0 0
M  V30 31 C 4.0010 3.8501 0.0 0
M  V30 32 C 2.6673 1.5400 0.0 0
M  V30 33 C 2.6673 4.6201 0.0 0
M  V30 34 C 1.3337 2.3101 0.0 0
M  V30 35 C 1.3337 3.8501 0.0 0
M  V30 36 C 22.5535 5.4955 0.0 0
M  V30 37 C 23.3235 6.8291 0.0 0
M  V30 38 C 23.3235 4.1618 0.0 0
M  V30 39 C 24.8635 6.8291 0.0 0
M  V30 40 C 24.8635 4.1618 0.0 0
M  V30 41 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 41
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-71-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
3-Amino-N-[(phenylmethoxy)carbonyl]-L-alanine 1,1-dimethylethyl ester
C15H22N2O4
77215-55-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.4137 0.0 0 CFG=1
M  V30 2 N 5.3348 3.6437 0.0 0
M  V30 3 C 2.6673 3.6437 0.0 0
M  V30 4 C 4.0010 5.9538 0.0 0
M  V30 5 C 6.6685 4.4137 0.0 0
M  V30 6 O 2.6673 2.1037 0.0 0
M  V30 7 O 1.3337 4.4137 0.0 0
M  V30 8 N 2.6673 6.7238 0.0 0
M  V30 9 O 8.0022 3.6437 0.0 0
M  V30 10 O 6.6685 5.9538 0.0 0
M  V30 11 C 1.3337 1.3337 0.0 0
M  V30 12 C 9.3360 4.4137 0.0 0
M  V30 13 C 0.5637 2.6673 0.0 0
M  V30 14 C 0.0000 0.5637 0.0 0
M  V30 15 C 2.1037 0.0000 0.0 0
M  V30 16 C 10.6697 3.6437 0.0 0
M  V30 17 C 12.0033 4.4137 0.0 0
M  V30 18 C 10.6697 2.1037 0.0 0
M  V30 19 C 13.3370 3.6437 0.0 0
M  V30 20 C 12.0033 1.3337 0.0 0
M  V30 21 C 13.3370 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-oxo-1H-imidazo[4,5-b]pyridine-1-acetic acid
C8H7N3O3
1557886-05-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3320 0.0 0
M  V30 2 C 7.1955 2.8561 0.0 0
M  V30 3 O 7.5157 1.3498 0.0 0
M  V30 4 O 8.3399 3.8866 0.0 0
M  V30 5 O 6.0811 0.0000 0.0 0
M  V30 6 C 3.0801 2.6218 0.0 0
M  V30 7 N 4.5864 2.3016 0.0 0
M  V30 8 C 2.3101 1.2881 0.0 0
M  V30 9 C 2.3101 3.9554 0.0 0
M  V30 10 C 4.7473 0.7700 0.0 0
M  V30 11 N 3.3405 0.1435 0.0 0
M  V30 12 N 0.7700 1.2881 0.0 0
M  V30 13 C 0.7700 3.9554 0.0 0
M  V30 14 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H27N5O6
3085623-12-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0544 8.0022 0.0 0
M  V30 2 C 5.8244 6.6685 0.0 0
M  V30 3 N 7.3644 6.6685 0.0 0
M  V30 4 O 5.0544 5.3348 0.0 0
M  V30 5 C 8.1345 5.3348 0.0 0
M  V30 6 C 9.6745 5.3348 0.0 0 CFG=1
M  V30 7 N 10.4445 6.6685 0.0 0
M  V30 8 C 10.4445 4.0012 0.0 0
M  V30 9 C 11.9845 6.6685 0.0 0
M  V30 10 O 9.6745 2.6673 0.0 0
M  V30 11 O 11.9845 4.0012 0.0 0
M  V30 12 O 12.7546 8.0022 0.0 0
M  V30 13 O 12.7546 5.3348 0.0 0
M  V30 14 C 10.4445 1.3337 0.0 0
M  V30 15 C 14.2946 8.0022 0.0 0
M  V30 16 C 11.7782 2.1037 0.0 0
M  V30 17 C 11.2145 0.0000 0.0 0
M  V30 18 C 9.1108 0.5637 0.0 0
M  V30 19 O 3.0850 5.2917 0.0 0
M  V30 20 C 2.6091 9.2482 0.0 0
M  V30 21 N 3.5144 8.0022 0.0 0
M  V30 22 C 1.1446 8.7722 0.0 0
M  V30 23 C 2.9293 10.7545 0.0 0
M  V30 24 C 2.6091 6.7563 0.0 0
M  V30 25 N 1.1446 7.2322 0.0 0
M  V30 26 N 0.0000 9.8028 0.0 0
M  V30 27 C 1.7849 11.7850 0.0 0
M  V30 28 C 0.3202 11.3091 0.0 0
M  V30 29 C 15.0646 9.3360 0.0 0
M  V30 30 C 16.6046 9.3360 0.0 0
M  V30 31 C 14.2946 10.6697 0.0 0
M  V30 32 C 17.3747 10.6697 0.0 0
M  V30 33 C 15.0646 12.0033 0.0 0
M  V30 34 C 16.6046 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 29
M  V30 20 2 19 24
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 25
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 77215-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1557886-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3085623-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41034619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sabat, Mark; Carney, Daniel W.; Hernandez-Torres, Gloria; Gibson, Tony
S.; Balakrishna, Deepika; Zou, Hua; Xu, Rui; Chen, Chien-Hung; de Jong,
Ron; Dougan, Douglas R.; Qin, Ling; Bigi-Botterill, Simone V.; Chambers,
Alison; Miura, Joanne; Johnson, Lucas K.; Ermolieff, Jacques; Johns,
Deidre; Selimkhanov, Jangir; Kwok, Lily; DeMent, Kevin; Proffitt, Chris;
Vu, Phong; Lindsey, Erick A.; Ivetac, Tony; Jennings, Andy; Wang, Haixia;
Manam, Padma; Santos, Cipriano; Fullenwider, Cody; Manohar, Rohan; Flick,
Andrew C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(12), 10306-10320

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
4-Bromobenzoic acid
C7H5BrO2
586-76-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-bromo-N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ca...
C33H28BrN3O4
2919713-70-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 Br 27.1736 5.4955 0.0 0
M  V30 11 C 11.7732 2.8281 0.0 0
M  V30 12 C 11.0032 4.1618 0.0 0
M  V30 13 C 10.7428 1.6836 0.0 0
M  V30 14 C 13.3133 2.8281 0.0 0
M  V30 15 N 9.4969 3.8416 0.0 0
M  V30 16 C 11.7732 5.4955 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 14.0833 4.1618 0.0 0
M  V30 19 C 13.3133 5.4955 0.0 0
M  V30 20 C 15.6233 4.1618 0.0 0
M  V30 21 C 16.3933 2.8281 0.0 0
M  V30 22 C 16.3933 5.4955 0.0 0
M  V30 23 C 17.9334 2.8281 0.0 0
M  V30 24 C 17.9334 5.4955 0.0 0
M  V30 25 C 18.7034 4.1618 0.0 0
M  V30 26 N 6.6685 2.3101 0.0 0
M  V30 27 C 5.3348 1.5400 0.0 0
M  V30 28 C 6.6685 3.8501 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 5.3348 4.6201 0.0 0
M  V30 31 C 4.0010 3.8501 0.0 0
M  V30 32 C 2.6673 1.5400 0.0 0
M  V30 33 C 2.6673 4.6201 0.0 0
M  V30 34 C 1.3337 2.3101 0.0 0
M  V30 35 C 1.3337 3.8501 0.0 0
M  V30 36 C 22.5535 5.4955 0.0 0
M  V30 37 C 23.3235 6.8291 0.0 0
M  V30 38 C 23.3235 4.1618 0.0 0
M  V30 39 C 24.8635 6.8291 0.0 0
M  V30 40 C 24.8635 4.1618 0.0 0
M  V30 41 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 41
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586-76-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzoic acid
C7H5ClO2
74-11-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-chloro-N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)c...
C33H28ClN3O4
2919713-62-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 Cl 27.1736 5.4955 0.0 0
M  V30 11 C 11.7732 2.8281 0.0 0
M  V30 12 C 11.0032 4.1618 0.0 0
M  V30 13 C 10.7428 1.6836 0.0 0
M  V30 14 C 13.3133 2.8281 0.0 0
M  V30 15 N 9.4969 3.8416 0.0 0
M  V30 16 C 11.7732 5.4955 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 14.0833 4.1618 0.0 0
M  V30 19 C 13.3133 5.4955 0.0 0
M  V30 20 C 15.6233 4.1618 0.0 0
M  V30 21 C 16.3933 5.4955 0.0 0
M  V30 22 C 16.3933 2.8281 0.0 0
M  V30 23 C 17.9334 5.4955 0.0 0
M  V30 24 C 17.9334 2.8281 0.0 0
M  V30 25 C 18.7034 4.1618 0.0 0
M  V30 26 N 6.6685 2.3101 0.0 0
M  V30 27 C 5.3348 1.5400 0.0 0
M  V30 28 C 6.6685 3.8501 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 5.3348 4.6201 0.0 0
M  V30 31 C 4.0010 3.8501 0.0 0
M  V30 32 C 2.6673 1.5400 0.0 0
M  V30 33 C 2.6673 4.6201 0.0 0
M  V30 34 C 1.3337 2.3101 0.0 0
M  V30 35 C 1.3337 3.8501 0.0 0
M  V30 36 C 22.5535 5.4955 0.0 0
M  V30 37 C 23.3235 6.8291 0.0 0
M  V30 38 C 23.3235 4.1618 0.0 0
M  V30 39 C 24.8635 6.8291 0.0 0
M  V30 40 C 24.8635 4.1618 0.0 0
M  V30 41 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 41
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
4-Fluorobenzoic acid
C7H5FO2
456-22-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C33H28FN3O4
2919713-67-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1618 0.0 0
M  V30 4 C 21.0135 5.4955 0.0 0
M  V30 5 O 20.2434 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 F 27.1736 5.4955 0.0 0
M  V30 11 C 11.7732 2.8281 0.0 0
M  V30 12 C 11.0032 4.1618 0.0 0
M  V30 13 C 10.7428 1.6836 0.0 0
M  V30 14 C 13.3133 2.8281 0.0 0
M  V30 15 N 9.4969 3.8416 0.0 0
M  V30 16 C 11.7732 5.4955 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 14.0833 4.1618 0.0 0
M  V30 19 C 13.3133 5.4955 0.0 0
M  V30 20 C 15.6233 4.1618 0.0 0
M  V30 21 C 16.3933 2.8281 0.0 0
M  V30 22 C 16.3933 5.4955 0.0 0
M  V30 23 C 17.9334 2.8281 0.0 0
M  V30 24 C 17.9334 5.4955 0.0 0
M  V30 25 C 18.7034 4.1618 0.0 0
M  V30 26 N 6.6685 2.3101 0.0 0
M  V30 27 C 5.3348 1.5400 0.0 0
M  V30 28 C 6.6685 3.8501 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 5.3348 4.6201 0.0 0
M  V30 31 C 4.0010 3.8501 0.0 0
M  V30 32 C 2.6673 1.5400 0.0 0
M  V30 33 C 2.6673 4.6201 0.0 0
M  V30 34 C 1.3337 2.3101 0.0 0
M  V30 35 C 1.3337 3.8501 0.0 0
M  V30 36 C 22.5535 5.4955 0.0 0
M  V30 37 C 23.3235 6.8291 0.0 0
M  V30 38 C 23.3235 4.1618 0.0 0
M  V30 39 C 24.8635 6.8291 0.0 0
M  V30 40 C 24.8635 4.1618 0.0 0
M  V30 41 C 25.6336 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 41
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 456-22-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
3-Piperidinepropanamide, α-amino-2-oxo-, hydrochloride (1:1), (αS,3S)-
C8H15N3O2.ClH
2755951-93-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 N 5.3347 5.3900 0.0 0
M  V30 5 N 8.0021 3.8500 0.0 0
M  V30 6 O 6.6685 1.5400 0.0 0
M  V30 7 O 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0 CFG=2
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 N 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 Cl 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 9
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C13H19F3N2O5
3047146-06-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8385 6.8342 0.0 0
M  V30 2 C 6.3785 6.8342 0.0 0 CFG=2
M  V30 3 O 4.0685 8.1680 0.0 0
M  V30 4 N 7.1485 5.5005 0.0 0
M  V30 5 C 7.1485 8.1680 0.0 0
M  V30 6 C 8.6886 5.5005 0.0 0
M  V30 7 C 6.3785 9.5017 0.0 0
M  V30 8 C 8.6886 8.1680 0.0 0
M  V30 9 O 9.4586 4.1669 0.0 0
M  V30 10 O 9.4586 6.8342 0.0 0
M  V30 11 C 10.9986 4.1669 0.0 0
M  V30 12 C 1.5063 6.4840 0.0 0
M  V30 13 O 0.0000 6.1638 0.0 0
M  V30 14 O 1.9823 7.9487 0.0 0
M  V30 15 C 3.7113 1.5316 0.0 0
M  V30 16 F 5.2429 1.6927 0.0 0
M  V30 17 F 3.8723 0.0000 0.0 0
M  V30 18 F 2.1798 1.3706 0.0 0
M  V30 19 N 4.0685 5.5005 0.0 0
M  V30 20 C 2.5369 5.3396 0.0 0 CFG=2
M  V30 21 C 4.6948 4.0937 0.0 0
M  V30 22 C 2.2167 3.8331 0.0 0
M  V30 23 C 3.5504 3.0631 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 20 12 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 23 15 CFG=3
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C21H32F3N5O6
3047146-09-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.7293 6.7983 0.0 0
M  V30 2 C 11.1939 7.2743 0.0 0 CFG=2
M  V30 3 O 8.5847 7.8289 0.0 0
M  V30 4 N 12.3384 6.2437 0.0 0
M  V30 5 C 11.5140 8.7806 0.0 0
M  V30 6 C 13.8030 6.7196 0.0 0
M  V30 7 C 10.3696 9.8111 0.0 0
M  V30 8 C 12.9787 9.2565 0.0 0
M  V30 9 O 14.9475 5.6892 0.0 0
M  V30 10 O 14.1231 8.2261 0.0 0
M  V30 11 C 16.4121 6.1650 0.0 0
M  V30 12 C 6.6685 5.4357 0.0 0
M  V30 13 N 5.3348 4.6657 0.0 0
M  V30 14 O 6.6685 6.9757 0.0 0
M  V30 15 C 4.0010 5.4357 0.0 0 CFG=2
M  V30 16 C 4.0010 6.9757 0.0 0
M  V30 17 C 2.6673 4.6657 0.0 0
M  V30 18 N 1.3337 5.4357 0.0 0
M  V30 19 O 2.6673 3.1256 0.0 0
M  V30 20 C 10.2959 1.4070 0.0 0
M  V30 21 F 11.7028 2.0333 0.0 0
M  V30 22 F 10.9223 0.0000 0.0 0
M  V30 23 F 8.8890 0.7805 0.0 0
M  V30 24 O 4.0010 10.0558 0.0 0
M  V30 25 N 9.4091 5.2920 0.0 0
M  V30 26 C 8.0021 4.6657 0.0 0 CFG=2
M  V30 27 C 10.4395 4.1476 0.0 0
M  V30 28 C 8.1631 3.1340 0.0 0
M  V30 29 C 9.6695 2.8138 0.0 0 CFG=2
M  V30 30 C 2.6673 7.7457 0.0 0 CFG=2
M  V30 31 C 2.6673 9.2858 0.0 0
M  V30 32 C 1.3337 6.9757 0.0 0
M  V30 33 N 1.3337 10.0558 0.0 0
M  V30 34 C 0.0000 7.7457 0.0 0
M  V30 35 C 0.0000 9.2858 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 26 12 CFG=1
M  V30 15 1 13 15
M  V30 16 1 15 16 CFG=3
M  V30 17 1 15 17
M  V30 18 1 30 16 CFG=3
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 29 20 CFG=3
M  V30 25 2 24 31
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 15 26 29 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2755951-93-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3047146-06-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047146-09-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40533936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical
Candidate for the Treatment of COVID-19
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allerton, Charlotte M. N.; Arcari, Joel T.; Aschenbrenner, Lisa M.;
Avery, Melissa; Bechle, Bruce M.; Behzadi, Mohammad Amin; Boras, Britton;
Buzon, Leanne M.; Cardin, Rhonda D.; Catlin, Natasha R.; Carlo, Anthony
A.; Coffman, Karen J.; Dantonio, Alyssa; Di, Li; Eng, Heather; Farley,
Kathleen A.; Ferre, Rose Ann; Gernhardt, Steven S.; Gibson, Scott A.;
Greasley, Samantha E.; Greenfield, Siennah R.; Hurst, Brett L.;
Kalgutkar, Amit S.; Kimito, Emi; Lanyon, Lorraine F.; Lovett, Gabrielle
H.; Lian, Yajing; Liu, Wei; Martinez Alsina, Luis A.; Noell, Stephen;
Obach, R. Scott; Owen, Dafydd R.; Patel, Nandini C.; Rai, Devendra K.;
Reese, Matthew R.; Rothan, Hussin A.; Sakata, Sylvie; Sammons, Matthew
F.; Sathish, Jean G.; Sharma, Raman; Steppan, Claire M.; Tuttle, Jamison
B.; Verhoest, Patrick R.; Wei, Liuqing; Yang, Qingyi; Yurgelonis, Irina;
Zhu, Yuao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(16), 13550-13571

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
(2E)-3-[3-(Trifluoromethoxy)phenyl]-2-propenoic acid
C10H7F3O3
175675-63-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 F 1.3337 3.8501 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 O 12.0033 2.3101 0.0 0
M  V30 10 O 10.6697 0.0000 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole-9-ethanamine
C15H17N3O
2521791-65-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8661 2.6091 0.0 0
M  V30 2 C 3.8965 1.4647 0.0 0
M  V30 3 N 3.4207 0.0000 0.0 0
M  V30 4 O 8.8076 3.7796 0.0 0
M  V30 5 C 10.1413 4.5496 0.0 0
M  V30 6 C 0.0000 4.2347 0.0 0
M  V30 7 C 4.8065 4.5496 0.0 0
M  V30 8 C 4.8065 6.0897 0.0 0
M  V30 9 N 3.3420 4.0738 0.0 0
M  V30 10 C 6.1402 3.7796 0.0 0
M  V30 11 C 3.3420 6.5655 0.0 0
M  V30 12 C 6.1402 6.8597 0.0 0
M  V30 13 C 2.4368 5.3196 0.0 0
M  V30 14 C 7.4740 4.5496 0.0 0
M  V30 15 C 2.7155 7.9725 0.0 0
M  V30 16 C 7.4740 6.0897 0.0 0
M  V30 17 C 0.9052 5.4806 0.0 0
M  V30 18 C 1.1840 8.1334 0.0 0
M  V30 19 N 0.2787 6.8875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N-[2-(7-methoxy-1-methyl-9H-pyrido[3,4-b]indol-9-yl)ethyl]-3-[...
C25H22F3N3O3
3056621-75-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 7.5198 0.0 0
M  V30 2 C 7.0870 6.7498 0.0 0
M  V30 3 N 8.4207 7.5198 0.0 0
M  V30 4 C 9.7545 6.7498 0.0 0
M  V30 5 C 11.0882 7.5198 0.0 0
M  V30 6 O 9.7545 5.2097 0.0 0
M  V30 7 C 12.4218 6.7498 0.0 0
M  V30 8 O 5.8438 1.4646 0.0 0
M  V30 9 C 5.3679 0.0000 0.0 0
M  V30 10 C 3.5673 9.9852 0.0 0
M  V30 11 O 17.7566 6.7498 0.0 0
M  V30 12 C 19.0903 7.5198 0.0 0
M  V30 13 F 20.4241 6.7498 0.0 0
M  V30 14 F 20.4241 8.2898 0.0 0
M  V30 15 F 19.0903 9.0598 0.0 0
M  V30 16 C 4.2586 5.2182 0.0 0
M  V30 17 N 4.4197 6.7498 0.0 0
M  V30 18 C 2.7523 4.8980 0.0 0
M  V30 19 C 5.2892 4.0737 0.0 0
M  V30 20 C 3.0127 7.3761 0.0 0
M  V30 21 C 1.9823 6.2317 0.0 0
M  V30 22 C 2.2765 3.4333 0.0 0
M  V30 23 C 4.8133 2.6091 0.0 0
M  V30 24 C 2.5369 8.8408 0.0 0
M  V30 25 C 0.4759 6.5519 0.0 0
M  V30 26 C 3.3069 2.2889 0.0 0
M  V30 27 N 1.0306 9.1610 0.0 0
M  V30 28 C 0.0000 8.0166 0.0 0
M  V30 29 C 13.7555 7.5198 0.0 0
M  V30 30 C 15.0893 6.7498 0.0 0
M  V30 31 C 13.7555 9.0598 0.0 0
M  V30 32 C 16.4229 7.5198 0.0 0
M  V30 33 C 15.0893 9.8298 0.0 0
M  V30 34 C 16.4229 9.0598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 7 29
M  V30 9 1 8 9
M  V30 10 1 8 23
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 32
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 21
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 175675-63-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2521791-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056621-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37912635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antiplasmodial evaluation of new amide-,
carbamate-, and ureido-type harmicines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marinovic, Marina; Rimac, Hrvoje; de Carvalho, Lais Pessanha; Rola, C.;
Santana, S.; Pavic, Kristina; Held, Jana; Prudencio, Miguel; Rajic,
Zrinka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 94117468

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Cyclopropanecarboxylic acid
C4H6O2
1759-53-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 1.5400 0.0 0
M  V30 2 O 4.2074 2.3101 0.0 0
M  V30 3 O 2.8737 0.0000 0.0 0
M  V30 4 C 1.5400 2.3101 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 0.7700 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C26H26N2O5
2892485-54-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6200 0.0 0
M  V30 2 O 8.0022 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 18.8046 2.7300 0.0 0
M  V30 9 O 18.1783 1.3230 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 5.3347 1.5400 0.0 0
M  V30 16 N 6.6684 3.8500 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 2.3100 0.0 0
M  V30 19 C 6.6684 2.3100 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 O 10.7426 4.4763 0.0 0
M  V30 22 C 9.4968 2.3185 0.0 0
M  V30 23 C 11.7732 3.3320 0.0 0
M  V30 24 C 11.0032 1.9983 0.0 0
M  V30 25 C 13.3047 3.4929 0.0 0
M  V30 26 C 13.9311 4.8998 0.0 0
M  V30 27 C 14.2100 2.2470 0.0 0
M  V30 28 C 15.4626 5.0608 0.0 0
M  V30 29 C 15.7415 2.4080 0.0 0
M  V30 30 C 16.3678 3.8149 0.0 0
M  V30 31 C 20.3363 2.8909 0.0 0
M  V30 32 C 21.7431 2.2646 0.0 0
M  V30 33 C 21.5821 3.7961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1759-53-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
4-[5-(Ethylsulfonyl)-2-fluorophenyl]-6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,...
C17H15FN2O5S
1643671-68-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.3349 0.0 0
M  V30 2 C 5.2892 1.3338 0.0 0
M  V30 3 O 6.8293 1.3338 0.0 0
M  V30 4 O 4.5192 0.0000 0.0 0
M  V30 5 F 4.0012 9.7250 0.0 0
M  V30 6 C 0.0000 7.4150 0.0 0
M  V30 7 S 9.3360 6.6449 0.0 0 VAL=6
M  V30 8 C 10.6697 5.8749 0.0 0
M  V30 9 O 10.1060 7.9786 0.0 0
M  V30 10 O 8.5660 5.3111 0.0 0
M  V30 11 C 12.0033 6.6449 0.0 0
M  V30 12 C 4.0012 5.1049 0.0 0
M  V30 13 C 4.0012 6.6449 0.0 0
M  V30 14 C 2.6673 4.3349 0.0 0
M  V30 15 C 5.1456 4.0743 0.0 0
M  V30 16 C 2.6673 7.4150 0.0 0
M  V30 17 N 2.9875 2.8284 0.0 0
M  V30 18 C 1.3337 5.1049 0.0 0
M  V30 19 C 4.5192 2.6675 0.0 0
M  V30 20 N 1.3337 6.6449 0.0 0
M  V30 21 C 5.3348 7.4150 0.0 0
M  V30 22 C 6.6685 6.6449 0.0 0
M  V30 23 C 5.3348 8.9550 0.0 0
M  V30 24 C 8.0022 7.4150 0.0 0
M  V30 25 C 6.6685 9.7250 0.0 0
M  V30 26 C 8.0022 8.9550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 5 23
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 24
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 21
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethylamine
C2H7N
75-04-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 N 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-4-[5-(ethylsulfonyl)-2-fluorophenyl]-6,7-dihydro-6-methyl-7-oxo-1H-py...
C19H20FN3O4S
1643671-69-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 12.0033 0.0 0
M  V30 2 C 8.3912 6.7141 0.0 0
M  V30 3 N 9.7249 7.4841 0.0 0
M  V30 4 O 8.3912 5.1741 0.0 0
M  V30 5 C 11.0587 6.7141 0.0 0
M  V30 6 C 12.3923 7.4841 0.0 0
M  V30 7 F 0.0000 8.0022 0.0 0
M  V30 8 C 2.3101 12.0033 0.0 0
M  V30 9 S 3.0801 2.6673 0.0 0 VAL=6
M  V30 10 C 3.8501 1.3337 0.0 0
M  V30 11 O 4.4137 3.4374 0.0 0
M  V30 12 O 1.7464 1.8973 0.0 0
M  V30 13 C 3.0801 0.0000 0.0 0
M  V30 14 C 4.6201 8.0022 0.0 0
M  V30 15 C 3.0801 8.0022 0.0 0
M  V30 16 C 5.3901 9.3360 0.0 0
M  V30 17 C 5.6505 6.8578 0.0 0
M  V30 18 C 2.3101 9.3360 0.0 0
M  V30 19 N 6.8966 9.0158 0.0 0
M  V30 20 C 4.6201 10.6697 0.0 0
M  V30 21 C 7.0575 7.4841 0.0 0
M  V30 22 N 3.0801 10.6697 0.0 0
M  V30 23 C 2.3101 6.6685 0.0 0
M  V30 24 C 3.0801 5.3348 0.0 0
M  V30 25 C 0.7700 6.6685 0.0 0
M  V30 26 C 2.3101 4.0012 0.0 0
M  V30 27 C 0.0000 5.3348 0.0 0
M  V30 28 C 0.7700 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 25
M  V30 8 1 8 22
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 9 12
M  V30 12 1 9 26
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 23
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1643671-68-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643671-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24358105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide
(ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second
Bromodomain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheppard, George S.; Wang, Le; Fidanze, Steven D.; Hasvold, Lisa A.; Liu,
Dachun; Pratt, John K.; Park, Chang H.; Longenecker, Kenton; Qiu, Wei;
Torrent, Maricel; Kovar, Peter J.; Bui, Mai; Faivre, Emily; Huang,
Xiaoli; Lin, Xiaoyu; Wilcox, Denise; Zhang, Lu; Shen, Yu; Albert, Daniel
H.; Magoc, Terrance J.; Rajaraman, Ganesh; Kati, Warren M.; McDaniel,
Keith F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5585-5623

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
1-(4-Methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylic acid
C19H14N2O3
942217-34-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 0.7700 0.0 0
M  V30 2 O 3.5812 0.0000 0.0 0
M  V30 3 O 6.2487 0.0000 0.0 0
M  V30 4 O 11.5835 7.7002 0.0 0
M  V30 5 C 12.9172 6.9302 0.0 0
M  V30 6 C 4.9150 5.3901 0.0 0
M  V30 7 C 3.5812 4.6201 0.0 0
M  V30 8 C 6.2487 4.6201 0.0 0
M  V30 9 N 4.5948 6.8964 0.0 0
M  V30 10 C 2.4368 5.6505 0.0 0
M  V30 11 C 3.5812 3.0801 0.0 0
M  V30 12 N 6.2487 3.0801 0.0 0
M  V30 13 C 3.0631 7.0574 0.0 0
M  V30 14 C 0.9052 5.4896 0.0 0
M  V30 15 C 4.9150 2.3101 0.0 0
M  V30 16 C 2.1579 8.3032 0.0 0
M  V30 17 C 0.0000 6.7355 0.0 0
M  V30 18 C 0.6263 8.1423 0.0 0
M  V30 19 C 7.5824 5.3901 0.0 0
M  V30 20 C 8.9160 4.6201 0.0 0
M  V30 21 C 7.5824 6.9302 0.0 0
M  V30 22 C 10.2498 5.3901 0.0 0
M  V30 23 C 8.9160 7.7002 0.0 0
M  V30 24 C 10.2498 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-([1,4′-Bipiperidin]-1′-ylmethyl)benzenamine
C17H27N3
1307702-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 N 6.6685 4.6201 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, N-[4-([1,4′-bipiperidin]-1′-ylmethyl)ph...
C36H39N5O2
3002420-78-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3358 8.9401 0.0 0
M  V30 4 O 0.0000 9.7102 0.0 0
M  V30 5 C 0.0000 11.2502 0.0 0
M  V30 6 C 16.0044 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0
M  V30 10 N 4.1903 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0
M  V30 17 C 4.1903 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0010 7.4001 0.0 0
M  V30 21 C 2.6673 6.6301 0.0 0
M  V30 22 C 4.0010 8.9401 0.0 0
M  V30 23 C 1.3337 7.4001 0.0 0
M  V30 24 C 2.6673 9.7102 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 26 C 12.0033 7.4001 0.0 0
M  V30 27 C 12.0033 8.9401 0.0 0
M  V30 28 C 13.3369 6.6301 0.0 0
M  V30 29 C 13.3369 9.7102 0.0 0
M  V30 30 C 14.6707 7.4001 0.0 0
M  V30 31 C 14.6707 8.9401 0.0 0
M  V30 32 N 17.3381 8.9401 0.0 0
M  V30 33 C 17.3381 7.4001 0.0 0
M  V30 34 C 18.6717 9.7102 0.0 0
M  V30 35 C 18.6717 6.6301 0.0 0
M  V30 36 C 20.0055 8.9401 0.0 0
M  V30 37 C 20.0055 7.4001 0.0 0
M  V30 38 N 21.3392 6.6301 0.0 0
M  V30 39 C 22.6729 7.4001 0.0 0
M  V30 40 C 21.3392 5.0901 0.0 0
M  V30 41 C 24.0065 6.6301 0.0 0
M  V30 42 C 22.6729 4.3201 0.0 0
M  V30 43 C 24.0065 5.0901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 6 31
M  V30 8 1 6 32
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 9 20
M  V30 16 1 10 14
M  V30 17 1 11 14
M  V30 18 2 11 15
M  V30 19 1 12 16
M  V30 20 2 13 16
M  V30 21 2 14 17
M  V30 22 1 15 18
M  V30 23 1 17 19
M  V30 24 2 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 43 1 37 38
M  V30 44 1 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 942217-34-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1307702-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3002420-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38589174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the
Treatment of Cystic Echinococcosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu,
Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan,
Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16680-16693

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
trans-Crotonic acid
C4H6O2
107-93-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenamide, N-[4-[5-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbony...
C26H26N2O5
2897680-78-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6200 0.0 0
M  V30 2 O 8.0022 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8995 3.9758 0.0 0
M  V30 8 C 18.8046 2.7300 0.0 0
M  V30 9 C 20.3363 2.8909 0.0 0
M  V30 10 O 18.1783 1.3230 0.0 0
M  V30 11 C 21.2415 1.6450 0.0 0
M  V30 12 C 22.7730 1.8060 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 2.6674 4.6200 0.0 0
M  V30 17 C 2.6674 1.5400 0.0 0
M  V30 18 C 5.3347 1.5400 0.0 0
M  V30 19 N 6.6684 3.8500 0.0 0
M  V30 20 C 1.3336 3.8500 0.0 0
M  V30 21 C 1.3336 2.3100 0.0 0
M  V30 22 C 6.6684 2.3100 0.0 0
M  V30 23 C 9.3358 3.8500 0.0 0
M  V30 24 O 10.7426 4.4763 0.0 0
M  V30 25 C 9.4968 2.3185 0.0 0
M  V30 26 C 11.7732 3.3320 0.0 0
M  V30 27 C 11.0032 1.9983 0.0 0
M  V30 28 C 13.3047 3.4929 0.0 0
M  V30 29 C 13.9311 4.8998 0.0 0
M  V30 30 C 14.2100 2.2470 0.0 0
M  V30 31 C 15.4628 5.0608 0.0 0
M  V30 32 C 15.7415 2.4080 0.0 0
M  V30 33 C 16.3678 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 23
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 1 7 33
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 2 20 21
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-93-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2897680-78-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Pentanoic acid
C5H10O2
109-52-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C27H30N2O5
2892485-51-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6200 0.0 0
M  V30 2 O 8.0022 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8995 3.9758 0.0 0
M  V30 8 C 18.8047 2.7300 0.0 0
M  V30 9 C 20.3363 2.8909 0.0 0
M  V30 10 O 18.1783 1.3230 0.0 0
M  V30 11 C 21.2415 1.6450 0.0 0
M  V30 12 C 22.7730 1.8060 0.0 0
M  V30 13 C 23.6782 0.5601 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 5.3347 4.6200 0.0 0
M  V30 17 C 2.6674 4.6200 0.0 0
M  V30 18 C 2.6674 1.5400 0.0 0
M  V30 19 C 5.3347 1.5400 0.0 0
M  V30 20 N 6.6685 3.8500 0.0 0
M  V30 21 C 1.3338 3.8500 0.0 0
M  V30 22 C 1.3338 2.3100 0.0 0
M  V30 23 C 6.6685 2.3100 0.0 0
M  V30 24 C 9.3358 3.8500 0.0 0
M  V30 25 O 10.7428 4.4763 0.0 0
M  V30 26 C 9.4968 2.3185 0.0 0
M  V30 27 C 11.7732 3.3320 0.0 0
M  V30 28 C 11.0032 1.9983 0.0 0
M  V30 29 C 13.3047 3.4929 0.0 0
M  V30 30 C 14.2100 2.2470 0.0 0
M  V30 31 C 13.9311 4.8998 0.0 0
M  V30 32 C 15.7415 2.4080 0.0 0
M  V30 33 C 15.4628 5.0608 0.0 0
M  V30 34 C 16.3680 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 24
M  V30 4 1 3 4
M  V30 5 1 3 21
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 7 8
M  V30 9 1 7 34
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 2 21 22
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-52-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromo-3-methoxybenzoic acid
C8H8BrNO3
864293-44-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 4.0011 6.1600 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 C 8.0021 3.8500 0.0 0
M  V30 7 Br 4.0011 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-8-methoxy-4(3H)-quinazolinone
C9H7BrN2O2
1616828-53-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6200 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 Br 4.0011 0.0000 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 N 1.3336 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 10
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 864293-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616828-53-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38625390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-Based Screening Identifies New Quinazolinone-Based Inositol
Hexakisphosphate Kinase (IP6K) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heitmann, Tyler; Liao, Gangling; de Leon, Pablo; Ernst, Glen; Buchler,
Ingrid; Wei, Huijun; Shlevkov, Evgeny; Brown, Dean; Fitzek, Martina;
Collier, Matthew; Smith, David M.; Barrow, James C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Cyclopentanecarboxylic acid
C6H10O2
3400-45-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 O 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 C 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C28H30N2O5
2892485-56-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6200 0.0 0
M  V30 2 O 8.0022 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8995 3.9758 0.0 0
M  V30 8 C 18.8047 2.7300 0.0 0
M  V30 9 O 18.1783 1.3230 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 5.3347 1.5400 0.0 0
M  V30 16 N 6.6685 3.8500 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 1.3338 2.3100 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 O 10.7428 4.4763 0.0 0
M  V30 22 C 9.4968 2.3185 0.0 0
M  V30 23 C 11.7732 3.3320 0.0 0
M  V30 24 C 11.0032 1.9983 0.0 0
M  V30 25 C 13.3047 3.4929 0.0 0
M  V30 26 C 13.9311 4.8998 0.0 0
M  V30 27 C 14.2100 2.2470 0.0 0
M  V30 28 C 15.4628 5.0608 0.0 0
M  V30 29 C 15.7415 2.4080 0.0 0
M  V30 30 C 16.3680 3.8149 0.0 0
M  V30 31 C 20.3363 2.8909 0.0 0
M  V30 32 C 21.1063 4.2245 0.0 0
M  V30 33 C 21.3667 1.7465 0.0 0
M  V30 34 C 22.6126 3.9044 0.0 0
M  V30 35 C 22.7736 2.3728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3400-45-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443513
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Cyclobutanecarboxylic acid
C5H8O2
3721-95-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.0890 1.4875 0.0 0
M  V30 2 O 0.0000 2.5765 0.0 0
M  V30 3 O 0.6904 0.0000 0.0 0
M  V30 4 C 2.5765 1.8862 0.0 0
M  V30 5 C 3.3465 3.2199 0.0 0
M  V30 6 C 3.9101 1.1162 0.0 0
M  V30 7 C 4.6802 2.4499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C27H28N2O5
2892485-55-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6200 0.0 0
M  V30 2 O 8.0022 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8995 3.9758 0.0 0
M  V30 8 C 18.8047 2.7300 0.0 0
M  V30 9 O 18.1783 1.3230 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 5.3347 1.5400 0.0 0
M  V30 16 N 6.6685 3.8500 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 1.3338 2.3100 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 O 10.7428 4.4763 0.0 0
M  V30 22 C 9.4968 2.3185 0.0 0
M  V30 23 C 11.7732 3.3320 0.0 0
M  V30 24 C 11.0032 1.9983 0.0 0
M  V30 25 C 13.3047 3.4929 0.0 0
M  V30 26 C 13.9312 4.8998 0.0 0
M  V30 27 C 14.2100 2.2470 0.0 0
M  V30 28 C 15.4628 5.0608 0.0 0
M  V30 29 C 15.7415 2.4080 0.0 0
M  V30 30 C 16.3680 3.8149 0.0 0
M  V30 31 C 20.3363 2.8909 0.0 0
M  V30 32 C 21.3054 4.0878 0.0 0
M  V30 33 C 21.5330 1.9218 0.0 0
M  V30 34 C 22.5023 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3721-95-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-55-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Pivalic acid
C5H10O2
75-98-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 C 0.5637 0.9764 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 2.1037 3.6437 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C27H30N2O5
2892485-52-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 O 8.0023 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8047 2.7300 0.0 0
M  V30 9 C 20.3365 2.8909 0.0 0
M  V30 10 O 18.1784 1.3230 0.0 0
M  V30 11 C 20.1754 4.4225 0.0 0
M  V30 12 C 21.8680 3.0519 0.0 0
M  V30 13 C 20.4974 1.3594 0.0 0
M  V30 14 C 4.0011 3.8501 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 2.6675 4.6201 0.0 0
M  V30 18 C 2.6675 1.5400 0.0 0
M  V30 19 C 5.3348 1.5400 0.0 0
M  V30 20 N 6.6684 3.8501 0.0 0
M  V30 21 C 1.3337 3.8501 0.0 0
M  V30 22 C 1.3337 2.3100 0.0 0
M  V30 23 C 6.6684 2.3100 0.0 0
M  V30 24 C 9.3359 3.8501 0.0 0
M  V30 25 O 10.7427 4.4764 0.0 0
M  V30 26 C 9.4969 2.3185 0.0 0
M  V30 27 C 11.7733 3.3320 0.0 0
M  V30 28 C 11.0033 1.9983 0.0 0
M  V30 29 C 13.3049 3.4929 0.0 0
M  V30 30 C 13.9312 4.8999 0.0 0
M  V30 31 C 14.2101 2.2470 0.0 0
M  V30 32 C 15.4627 5.0608 0.0 0
M  V30 33 C 15.7416 2.4080 0.0 0
M  V30 34 C 16.3680 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 24
M  V30 4 1 3 4
M  V30 5 1 3 21
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 7 8
M  V30 9 1 7 34
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 2 21 22
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-98-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-52-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL

C21H37N3O7
2761691-58-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3573 4.5478 0.0 0
M  V30 2 C 10.8973 4.5478 0.0 0 CFG=2
M  V30 3 O 8.5873 3.2141 0.0 0
M  V30 4 N 11.6673 5.8814 0.0 0
M  V30 5 C 11.6673 3.2141 0.0 0 CFG=2
M  V30 6 C 13.2073 5.8814 0.0 0
M  V30 7 C 10.8973 1.8805 0.0 0
M  V30 8 O 13.2073 3.2141 0.0 0
M  V30 9 O 13.9773 7.2152 0.0 0
M  V30 10 O 13.9773 4.5478 0.0 0
M  V30 11 C 15.5173 7.2152 0.0 0
M  V30 12 C 15.5173 5.6752 0.0 0
M  V30 13 C 17.0573 7.2152 0.0 0
M  V30 14 C 15.5173 8.7552 0.0 0
M  V30 15 C 6.0254 4.8980 0.0 0
M  V30 16 N 4.5190 5.2181 0.0 0
M  V30 17 O 6.5013 3.4334 0.0 0
M  V30 18 C 3.4886 4.0738 0.0 0 CFG=1
M  V30 19 C 1.9821 4.3939 0.0 0
M  V30 20 C 3.9644 2.6091 0.0 0
M  V30 21 O 1.5063 5.8586 0.0 0
M  V30 22 O 0.9517 3.2496 0.0 0
M  V30 23 C 2.9340 1.4647 0.0 0
M  V30 24 C 0.0000 6.1788 0.0 0
M  V30 25 C 1.4276 1.7849 0.0 0
M  V30 26 C 3.4099 0.0000 0.0 0
M  V30 27 N 8.5873 5.8814 0.0 0
M  V30 28 C 7.0558 6.0425 0.0 0 CFG=2
M  V30 29 C 9.2138 7.2884 0.0 0
M  V30 30 C 6.7357 7.5488 0.0 0
M  V30 31 C 8.0693 8.3188 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 28 15 CFG=3
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20 CFG=1
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 5 18 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-O-benzylserine
C15H21NO5
23680-31-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.0336 5.3347 0.0 0
M  V30 2 O 8.2636 4.0011 0.0 0
M  V30 3 C 6.7236 4.0011 0.0 0
M  V30 4 C 5.9536 2.6674 0.0 0 CFG=1
M  V30 5 N 4.4136 2.6674 0.0 0
M  V30 6 C 6.7236 1.3338 0.0 0
M  V30 7 C 3.6436 4.0011 0.0 0
M  V30 8 O 5.9536 0.0000 0.0 0
M  V30 9 O 8.2636 1.3338 0.0 0
M  V30 10 O 2.1036 4.0011 0.0 0
M  V30 11 O 4.4136 5.3347 0.0 0
M  V30 12 C 1.3336 5.3347 0.0 0
M  V30 13 C 0.0000 4.5647 0.0 0
M  V30 14 C 0.5636 6.6685 0.0 0
M  V30 15 C 2.6673 6.1047 0.0 0
M  V30 16 C 10.5736 5.3347 0.0 0
M  V30 17 C 11.3436 4.0011 0.0 0
M  V30 18 C 11.3436 6.6685 0.0 0
M  V30 19 C 12.8836 4.0011 0.0 0
M  V30 20 C 12.8836 6.6685 0.0 0
M  V30 21 C 13.6536 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C31H48N4O9
2761691-53-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5502 9.3358 0.0 0
M  V30 2 C 10.0102 9.3358 0.0 0 CFG=2
M  V30 3 O 12.3202 10.6696 0.0 0
M  V30 4 N 9.2401 8.0021 0.0 0
M  V30 5 C 9.2401 10.6696 0.0 0 CFG=2
M  V30 6 C 7.7001 8.0021 0.0 0
M  V30 7 C 10.0102 12.0033 0.0 0
M  V30 8 O 7.7001 10.6696 0.0 0
M  V30 9 C 6.9301 6.6685 0.0 0 CFG=1
M  V30 10 O 6.9301 9.3358 0.0 0
M  V30 11 C 5.3901 6.6685 0.0 0
M  V30 12 N 7.7001 5.3348 0.0 0
M  V30 13 O 4.6201 8.0021 0.0 0
M  V30 14 C 6.9301 4.0010 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 O 7.7001 2.6673 0.0 0
M  V30 17 O 5.3901 4.0010 0.0 0
M  V30 18 C 6.9301 1.3337 0.0 0
M  V30 19 C 5.5964 2.1037 0.0 0
M  V30 20 C 6.1601 0.0000 0.0 0
M  V30 21 C 8.2638 0.5636 0.0 0
M  V30 22 C 14.8822 8.9856 0.0 0
M  V30 23 N 16.3886 8.6654 0.0 0
M  V30 24 O 14.4063 10.4503 0.0 0
M  V30 25 C 17.4191 9.8100 0.0 0 CFG=1
M  V30 26 C 18.9255 9.4898 0.0 0
M  V30 27 C 16.9432 11.2745 0.0 0
M  V30 28 O 19.4014 8.0251 0.0 0
M  V30 29 O 19.9559 10.6342 0.0 0
M  V30 30 C 17.9736 12.4191 0.0 0
M  V30 31 C 20.9077 7.7049 0.0 0
M  V30 32 C 19.4801 12.0989 0.0 0
M  V30 33 C 17.4978 13.8836 0.0 0
M  V30 34 N 12.3202 8.0021 0.0 0
M  V30 35 C 13.8517 7.8412 0.0 0 CFG=2
M  V30 36 C 11.6937 6.5953 0.0 0
M  V30 37 C 14.1719 6.3347 0.0 0
M  V30 38 C 12.8383 5.5647 0.0 0
M  V30 39 C 2.3100 9.3358 0.0 0
M  V30 40 C 0.7700 9.3358 0.0 0
M  V30 41 C 3.0800 10.6696 0.0 0
M  V30 42 C 0.0000 10.6696 0.0 0
M  V30 43 C 2.3100 12.0033 0.0 0
M  V30 44 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 34
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 39
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 35 22 CFG=3
M  V30 26 1 23 25
M  V30 27 1 25 26
M  V30 28 1 25 27 CFG=1
M  V30 29 1 26 28
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 1 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 1 37 38
M  V30 40 2 39 40
M  V30 41 1 39 41
M  V30 42 1 40 42
M  V30 43 2 41 43
M  V30 44 2 42 44
M  V30 45 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 5 9 25 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2761691-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23680-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761691-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31592226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel macrocyclic peptidomimetics targeting the Polo-box domain of
Polo-like kinase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ryu, SeongShick; Park, Jung-Eun; Ham, Young Jin; Lim, Daniel C.;
Kwiatkowski, Nicholas P.; Kim, Do-Hee; Bhunia, Debabrata; Kim, Nam Doo;
Yaffe, Michael B.; Son, Woolim; Kim, Namkyoung; Choi, Tae-Ik; Swain,
Puspanjali; Kim, Cheol-Hee; Lee, Jin-Young; Gray, Nathanael S.; Lee,
Kyung S.; Sim, Taebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(3), 1915-1932

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
(1S,5S,6S)-5-(2,3-Difluorophenyl)-3-[[(1,1-dimethylethoxy)carbonyl][[2-(trime...
C24H34F2N2O5SSi
1874241-01-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 8.8975 0.0 0
M  V30 2 O 0.0000 8.8975 0.0 0
M  V30 3 O 2.3100 10.2312 0.0 0
M  V30 4 C 2.6538 4.0740 0.0 0
M  V30 5 N 6.3112 8.3337 0.0 0
M  V30 6 C 6.3112 9.8737 0.0 0
M  V30 7 C 7.6449 7.5637 0.0 0
M  V30 8 O 7.6449 10.6438 0.0 0
M  V30 9 O 4.9774 10.6438 0.0 0
M  V30 10 O 8.9785 8.3337 0.0 0
M  V30 11 C 7.6449 12.1838 0.0 0
M  V30 12 C 10.3122 7.5637 0.0 0
M  V30 13 C 9.1849 12.1838 0.0 0
M  V30 14 C 7.6449 13.7238 0.0 0
M  V30 15 C 6.1048 12.1838 0.0 0
M  V30 16 C 11.6460 8.3337 0.0 0
M  V30 17 Si 12.9797 7.5637 0.0 0
M  V30 18 C 14.3133 6.7937 0.0 0
M  V30 19 C 12.2097 6.2300 0.0 0
M  V30 20 C 13.7497 8.8975 0.0 0
M  V30 21 F 2.5903 2.3595 0.0 0
M  V30 22 F 4.5700 0.0000 0.0 0
M  V30 23 C 2.3100 7.5637 0.0 0 CFG=2
M  V30 24 C 2.3100 6.0237 0.0 0 CFG=2
M  V30 25 C 0.9764 6.7937 0.0 0
M  V30 26 S 3.6437 8.3337 0.0 0
M  V30 27 C 3.6437 5.2537 0.0 0 CFG=2
M  V30 28 C 4.9774 7.5637 0.0 0
M  V30 29 N 4.9774 6.0237 0.0 0
M  V30 30 C 4.6336 4.0740 0.0 0
M  V30 31 C 4.1069 2.6268 0.0 0
M  V30 32 C 6.1503 4.3413 0.0 0
M  V30 33 C 5.0969 1.4472 0.0 0
M  V30 34 C 7.1402 3.1617 0.0 0
M  V30 35 C 6.6135 1.7145 0.0 0
M  V30 36 H 1.5400 4.6900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=1
M  V30 4 1 27 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 28
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 31
M  V30 22 1 22 33
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 24 25
M  V30 27 1 24 27
M  V30 28 1 24 36 CFG=1
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30 CFG=3
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 23 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,5S,6S)-5-(2,3-difluorophenyl)-5-methyl-1-[(methylami...
C25H37F2N3O4SSi
1874240-91-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 8.8975 0.0 0
M  V30 2 N 0.7700 8.8975 0.0 0
M  V30 3 O 3.0801 10.2312 0.0 0
M  V30 4 C 0.0000 10.2312 0.0 0
M  V30 5 C 3.4238 4.0740 0.0 0
M  V30 6 N 7.0812 8.3337 0.0 0
M  V30 7 C 7.0812 9.8738 0.0 0
M  V30 8 C 8.4149 7.5637 0.0 0
M  V30 9 O 8.4149 10.6438 0.0 0
M  V30 10 O 5.7474 10.6438 0.0 0
M  V30 11 O 9.7486 8.3337 0.0 0
M  V30 12 C 8.4149 12.1838 0.0 0
M  V30 13 C 11.0822 7.5637 0.0 0
M  V30 14 C 9.9549 12.1838 0.0 0
M  V30 15 C 8.4149 13.7239 0.0 0
M  V30 16 C 6.8749 12.1838 0.0 0
M  V30 17 C 12.4161 8.3337 0.0 0
M  V30 18 Si 13.7497 7.5637 0.0 0
M  V30 19 C 15.0834 6.7937 0.0 0
M  V30 20 C 12.9797 6.2301 0.0 0
M  V30 21 C 14.5197 8.8975 0.0 0
M  V30 22 F 3.3604 2.3595 0.0 0
M  V30 23 F 5.3401 0.0000 0.0 0
M  V30 24 C 3.0801 7.5637 0.0 0 CFG=2
M  V30 25 C 3.0801 6.0237 0.0 0 CFG=2
M  V30 26 C 1.7464 6.7937 0.0 0
M  V30 27 S 4.4137 8.3337 0.0 0
M  V30 28 C 4.4137 5.2537 0.0 0 CFG=2
M  V30 29 C 5.7474 7.5637 0.0 0
M  V30 30 N 5.7474 6.0237 0.0 0
M  V30 31 C 5.4037 4.0740 0.0 0
M  V30 32 C 4.8770 2.6268 0.0 0
M  V30 33 C 6.9203 4.3414 0.0 0
M  V30 34 C 5.8669 1.4472 0.0 0
M  V30 35 C 7.9102 3.1617 0.0 0
M  V30 36 C 7.3835 1.7145 0.0 0
M  V30 37 H 2.3101 4.6900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 28 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 29
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 32
M  V30 23 1 23 34
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 26
M  V30 28 1 25 28
M  V30 29 1 25 37 CFG=1
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 28 31 CFG=3
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 25 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1874241-01-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1874240-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23901334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid
Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo
Selectivity over BACE2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pettus, Liping H.; Bourbeau, Matthew P.; Bradley, Jodi; Bartberger,
Michael D.; Chen, Kui; Hickman, Dean; Johnson, Michael; Liu, Qingyian;
Manning, James R.; Nanez, Adrian; Siegmund, Aaron C.; Wen, Paul H.;
Whittington, Douglas A.; Allen, Jennifer R.; Wood, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(5), 2263-2281

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Dithiodiglycolic acid
C4H6O4S2
505-73-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 1.5400 0.0 0
M  V30 2 S 5.3348 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 9.3360 1.5400 0.0 0
M  V30 10 O 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanaminium, N-[9-[2-[[(4-aminobutyl)amino]carbonyl]phenyl]-6-(diethylamino)...
C32H43N4O2
2899263-61-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.8032 9.3615 0.0 0
M  V30 2 N 12.9830 10.3514 0.0 0
M  V30 3 O 12.0707 7.8449 0.0 0
M  V30 4 C 14.4301 9.8247 0.0 0
M  V30 5 C 15.6097 10.8147 0.0 0
M  V30 6 C 17.0569 10.2878 0.0 0
M  V30 7 C 18.2365 11.2777 0.0 0
M  V30 8 N 19.6837 10.7510 0.0 0
M  V30 9 N 2.3100 8.0021 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 C 1.5400 9.3358 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.0000 9.3358 0.0 0
M  V30 14 N 11.5500 2.6674 0.0 0 CHG=1 VAL=4
M  V30 15 C 10.7800 1.3338 0.0 0
M  V30 16 C 13.0900 2.6674 0.0 0
M  V30 17 C 11.5500 0.0000 0.0 0
M  V30 18 C 13.8600 1.3338 0.0 0
M  V30 19 C 8.4700 8.0021 0.0 0
M  V30 20 C 6.9300 8.0021 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 6.1600 6.6685 0.0 0
M  V30 23 C 6.1600 9.3358 0.0 0
M  V30 24 C 8.4700 5.3347 0.0 0
M  V30 25 C 10.7800 6.6685 0.0 0
M  V30 26 O 6.9300 5.3347 0.0 0
M  V30 27 C 4.6200 6.6685 0.0 0
M  V30 28 C 4.6200 9.3358 0.0 0
M  V30 29 C 9.2400 4.0011 0.0 0
M  V30 30 C 11.5500 5.3347 0.0 0
M  V30 31 C 3.8500 8.0021 0.0 0
M  V30 32 C 10.7800 4.0011 0.0 0
M  V30 33 C 8.8686 9.4896 0.0 0
M  V30 34 C 10.3560 9.8882 0.0 0
M  V30 35 C 7.7796 10.5786 0.0 0
M  V30 36 C 10.7546 11.3758 0.0 0
M  V30 37 C 8.1782 12.0661 0.0 0
M  V30 38 C 9.6657 12.4648 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 34
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 31
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 32
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 33
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 22 27
M  V30 28 2 23 28
M  V30 29 1 24 26
M  V30 30 2 24 29
M  V30 31 2 25 30
M  V30 32 2 27 31
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 1 30 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanaminium, N-[9-[2-[[[4-[[2-[(carboxymethyl)dithio]acetyl]amino]butyl]amin...
C36H47N4O5S2
2899263-57-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.8033 9.3616 0.0 0
M  V30 2 N 12.9829 10.3515 0.0 0
M  V30 3 O 12.0706 7.8450 0.0 0
M  V30 4 C 14.4301 9.8248 0.0 0
M  V30 5 C 15.6099 10.8146 0.0 0
M  V30 6 C 17.0570 10.2879 0.0 0
M  V30 7 C 18.2366 11.2778 0.0 0
M  V30 8 N 19.6838 10.7511 0.0 0
M  V30 9 C 20.8634 11.7410 0.0 0
M  V30 10 C 22.3106 11.2144 0.0 0
M  V30 11 O 20.5961 13.2576 0.0 0
M  V30 12 S 23.4904 12.2041 0.0 0
M  V30 13 S 24.9375 11.6774 0.0 0
M  V30 14 C 26.1172 12.6674 0.0 0
M  V30 15 C 27.5643 12.1407 0.0 0
M  V30 16 O 27.8318 10.6241 0.0 0
M  V30 17 O 28.7440 13.1306 0.0 0
M  V30 18 N 2.3099 8.0022 0.0 0
M  V30 19 C 1.5400 6.6684 0.0 0
M  V30 20 C 1.5400 9.3359 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 22 C 0.0000 9.3359 0.0 0
M  V30 23 N 11.5499 2.6675 0.0 0 CHG=1 VAL=4
M  V30 24 C 10.7799 1.3336 0.0 0
M  V30 25 C 13.0899 2.6675 0.0 0
M  V30 26 C 11.5499 0.0000 0.0 0
M  V30 27 C 13.8599 1.3336 0.0 0
M  V30 28 C 8.4699 8.0022 0.0 0
M  V30 29 C 6.9299 8.0022 0.0 0
M  V30 30 C 9.2399 6.6684 0.0 0
M  V30 31 C 6.1599 6.6684 0.0 0
M  V30 32 C 6.1599 9.3359 0.0 0
M  V30 33 C 8.4699 5.3347 0.0 0
M  V30 34 C 10.7799 6.6684 0.0 0
M  V30 35 O 6.9299 5.3347 0.0 0
M  V30 36 C 4.6199 6.6684 0.0 0
M  V30 37 C 4.6199 9.3359 0.0 0
M  V30 38 C 9.2399 4.0011 0.0 0
M  V30 39 C 11.5499 5.3347 0.0 0
M  V30 40 C 3.8499 8.0022 0.0 0
M  V30 41 C 10.7799 4.0011 0.0 0
M  V30 42 C 8.8686 9.4897 0.0 0
M  V30 43 C 10.3561 9.8883 0.0 0
M  V30 44 C 7.7797 10.5786 0.0 0
M  V30 45 C 10.7547 11.3757 0.0 0
M  V30 46 C 8.1782 12.0661 0.0 0
M  V30 47 C 9.6657 12.4647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 43
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 40
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 2 23 41
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 28 29
M  V30 29 2 28 30
M  V30 30 1 28 42
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 30 33
M  V30 34 1 30 34
M  V30 35 1 31 35
M  V30 36 1 31 36
M  V30 37 2 32 37
M  V30 38 1 33 35
M  V30 39 2 33 38
M  V30 40 2 34 39
M  V30 41 2 36 40
M  V30 42 1 37 40
M  V30 43 1 38 41
M  V30 44 1 39 41
M  V30 45 2 42 43
M  V30 46 1 42 44
M  V30 47 1 43 45
M  V30 48 2 44 46
M  V30 49 2 45 47
M  V30 50 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 505-73-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2899263-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2899263-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34560348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tumor-microenvironmental-response Bi-functional molecules for efficient
imaging and anti-tumor activity therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Jin; Si, Ru; Zhang, Qingqing; Pan, Xiaoyan; Zhang, Jie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 230114120

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL

C21H30Cl2N2O3
3061155-03-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=1
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 5.3900 8.0020 0.0 0
M  V30 5 N 8.4700 8.0020 0.0 0
M  V30 6 O 8.4700 5.3347 0.0 0
M  V30 7 C 3.8500 8.0020 0.0 0
M  V30 8 C 10.0100 8.0020 0.0 0
M  V30 9 O 3.0800 9.3358 0.0 0
M  V30 10 O 3.0800 6.6684 0.0 0
M  V30 11 C 10.7800 9.3358 0.0 0
M  V30 12 C 1.5400 9.3358 0.0 0
M  V30 13 C 12.3200 9.3358 0.0 0
M  V30 14 C 1.5400 10.8758 0.0 0
M  V30 15 C 0.0000 9.3358 0.0 0
M  V30 16 C 1.5400 7.7958 0.0 0
M  V30 17 C 13.0900 10.6694 0.0 0
M  V30 18 C 14.6300 10.6694 0.0 0
M  V30 19 C 15.4000 12.0031 0.0 0
M  V30 20 C 16.9400 12.0031 0.0 0
M  V30 21 Cl 3.8500 2.6673 0.0 0
M  V30 22 Cl 8.4700 0.0000 0.0 0
M  V30 23 C 6.1600 4.0011 0.0 0
M  V30 24 C 5.3900 2.6673 0.0 0
M  V30 25 C 7.7000 4.0011 0.0 0
M  V30 26 C 6.1600 1.3336 0.0 0
M  V30 27 C 8.4700 2.6673 0.0 0
M  V30 28 C 7.7000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 23
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 2 19 20
M  V30 21 1 21 24
M  V30 22 1 22 28
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C13H21NO4
3061155-30-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 4.1535 0.0 0
M  V30 2 O 7.0036 3.3835 0.0 0
M  V30 3 O 5.6699 5.6935 0.0 0
M  V30 4 C 8.3374 4.1535 0.0 0
M  V30 5 C 9.1075 2.8196 0.0 0
M  V30 6 C 9.6711 4.9235 0.0 0
M  V30 7 C 7.5674 5.4871 0.0 0
M  V30 8 C 2.6091 5.5161 0.0 0
M  V30 9 C 1.1446 5.9921 0.0 0
M  V30 10 O 0.0000 4.9615 0.0 0
M  V30 11 O 0.8244 7.4984 0.0 0
M  V30 12 C 2.6689 1.5316 0.0 0
M  V30 13 C 4.1752 1.8517 0.0 0
M  V30 14 C 1.8989 2.8652 0.0 0
M  V30 15 C 1.4230 0.6263 0.0 0
M  V30 16 C 2.8298 0.0000 0.0 0
M  V30 17 N 4.3363 3.3835 0.0 0
M  V30 18 C 2.9293 4.0098 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 18 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H41Cl2N3O4
3061155-36-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4721 12.0463 0.0 0
M  V30 2 O 2.4417 13.1907 0.0 0
M  V30 3 O 4.9785 12.3665 0.0 0
M  V30 4 C 2.9175 14.6554 0.0 0
M  V30 5 C 1.4528 15.1313 0.0 0
M  V30 6 C 3.3934 16.1201 0.0 0
M  V30 7 C 4.3822 14.1796 0.0 0
M  V30 8 C 5.4414 9.3358 0.0 0
M  V30 9 C 6.2114 8.0021 0.0 0
M  V30 10 N 7.7514 8.0021 0.0 0
M  V30 11 O 5.4414 6.6685 0.0 0
M  V30 12 C 8.5214 6.6685 0.0 0 CFG=1
M  V30 13 C 7.7514 5.3347 0.0 0
M  V30 14 C 10.0614 6.6685 0.0 0
M  V30 15 N 10.8314 8.0021 0.0 0
M  V30 16 O 10.8314 5.3347 0.0 0
M  V30 17 C 12.3714 8.0021 0.0 0
M  V30 18 C 13.1414 9.3358 0.0 0
M  V30 19 C 14.6814 9.3358 0.0 0
M  V30 20 C 15.4514 10.6694 0.0 0
M  V30 21 C 16.9914 10.6694 0.0 0
M  V30 22 C 17.7614 12.0032 0.0 0
M  V30 23 C 19.3014 12.0032 0.0 0
M  V30 24 Cl 6.2114 2.6674 0.0 0
M  V30 25 Cl 10.8314 0.0000 0.0 0
M  V30 26 C 1.5315 8.5658 0.0 0
M  V30 27 C 1.5315 10.1058 0.0 0
M  V30 28 C 2.9962 8.0899 0.0 0
M  V30 29 C 0.0000 8.4049 0.0 0
M  V30 30 C 0.9052 7.1590 0.0 0
M  V30 31 N 2.9962 10.5816 0.0 0
M  V30 32 C 3.9014 9.3358 0.0 0 CFG=2
M  V30 33 C 8.5214 4.0011 0.0 0
M  V30 34 C 7.7514 2.6674 0.0 0
M  V30 35 C 10.0614 4.0011 0.0 0
M  V30 36 C 8.5214 1.3338 0.0 0
M  V30 37 C 10.8314 2.6674 0.0 0
M  V30 38 C 10.0614 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 31
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 32 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 33
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 22 23
M  V30 25 1 24 34
M  V30 26 1 25 38
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3061155-03-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3061155-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061155-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42895499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro
from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent
Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant
Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xu; Gotchev, Dimitar; Fan, Kristi Yi; Vega, Marvin M.; Mani,
Nagraj; McGovern-Gooch, Kayleigh; Cuconati, Andrea; Tercero, Breanna;
Wang, Xiaohe; Carpino, Philip; Maskos, Klaus; Centrella, Paolo A.;
Schmitt, Andreas; Preuss, Franziska; Prasad, Archna; Chen, Chia-yi;
Clark, Matthew A.; Guilinger, John P.; Johnstone, Shawn; von Konig,
Konstanze; Keefe, Anthony D.; Liu, Jenny; Turcotte, Stephane; Zhang,
Ying; Konz Makino, Debora L.; Lam, Angela M.; Cole, Andrew G.; Sofia,
Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(21), 19623-19667

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
3,3-Dimethylbutanoic acid
C6H12O2
1070-83-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 C 3.8500 2.8736 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 3.0800 0.0 0
M  V30 7 O 3.0800 4.2073 0.0 0
M  V30 8 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-[4-[5-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]...
C28H32N2O5
2897680-76-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 4.6200 0.0 0
M  V30 2 O 8.0020 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 18.8046 2.7300 0.0 0
M  V30 9 C 20.3361 2.8909 0.0 0
M  V30 10 O 18.1783 1.3230 0.0 0
M  V30 11 C 21.2413 1.6450 0.0 0
M  V30 12 C 22.4872 2.5503 0.0 0
M  V30 13 C 22.1465 0.3992 0.0 0
M  V30 14 C 19.9955 0.7398 0.0 0
M  V30 15 C 4.0011 3.8500 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 18 C 2.6673 4.6200 0.0 0
M  V30 19 C 2.6673 1.5400 0.0 0
M  V30 20 C 5.3347 1.5400 0.0 0
M  V30 21 N 6.6684 3.8500 0.0 0
M  V30 22 C 1.3336 3.8500 0.0 0
M  V30 23 C 1.3336 2.3100 0.0 0
M  V30 24 C 6.6684 2.3100 0.0 0
M  V30 25 C 9.3358 3.8500 0.0 0
M  V30 26 O 10.7426 4.4763 0.0 0
M  V30 27 C 9.4968 2.3185 0.0 0
M  V30 28 C 11.7731 3.3320 0.0 0
M  V30 29 C 11.0030 1.9983 0.0 0
M  V30 30 C 13.3047 3.4929 0.0 0
M  V30 31 C 14.2098 2.2470 0.0 0
M  V30 32 C 13.9311 4.8998 0.0 0
M  V30 33 C 15.7415 2.4080 0.0 0
M  V30 34 C 15.4626 5.0608 0.0 0
M  V30 35 C 16.3678 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 21
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 22
M  V30 6 1 5 6
M  V30 7 1 5 23
M  V30 8 1 7 8
M  V30 9 1 7 35
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1070-83-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2897680-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
4-(1,1-Dimethylethoxy)benzoic acid
C11H14O3
13205-47-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 C 0.5637 5.1838 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 2.1037 2.5164 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 O 8.0023 0.0000 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C37H37N3O5
2919713-79-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1619 0.0 0
M  V30 4 C 21.0135 5.4956 0.0 0
M  V30 5 O 20.2434 6.8293 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 O 27.1736 5.4956 0.0 0
M  V30 11 C 27.9436 6.8293 0.0 0
M  V30 12 C 29.2773 6.0593 0.0 0
M  V30 13 C 28.7136 8.1631 0.0 0
M  V30 14 C 26.6099 7.5993 0.0 0
M  V30 15 C 11.7732 2.8283 0.0 0
M  V30 16 C 11.0032 4.1619 0.0 0
M  V30 17 C 10.7428 1.6837 0.0 0
M  V30 18 C 13.3133 2.8283 0.0 0
M  V30 19 N 9.4969 3.8418 0.0 0
M  V30 20 C 11.7732 5.4956 0.0 0
M  V30 21 C 9.3358 2.3101 0.0 0
M  V30 22 C 14.0833 4.1619 0.0 0
M  V30 23 C 13.3133 5.4956 0.0 0
M  V30 24 C 15.6233 4.1619 0.0 0
M  V30 25 C 16.3933 5.4956 0.0 0
M  V30 26 C 16.3933 2.8283 0.0 0
M  V30 27 C 17.9334 5.4956 0.0 0
M  V30 28 C 17.9334 2.8283 0.0 0
M  V30 29 C 18.7034 4.1619 0.0 0
M  V30 30 N 6.6685 2.3101 0.0 0
M  V30 31 C 5.3348 1.5400 0.0 0
M  V30 32 C 6.6685 3.8501 0.0 0
M  V30 33 C 4.0010 2.3101 0.0 0
M  V30 34 C 5.3348 4.6201 0.0 0
M  V30 35 C 4.0010 3.8501 0.0 0
M  V30 36 C 2.6673 1.5400 0.0 0
M  V30 37 C 2.6673 4.6201 0.0 0
M  V30 38 C 1.3337 2.3101 0.0 0
M  V30 39 C 1.3337 3.8501 0.0 0
M  V30 40 C 22.5535 5.4956 0.0 0
M  V30 41 C 23.3235 4.1619 0.0 0
M  V30 42 C 23.3235 6.8293 0.0 0
M  V30 43 C 24.8635 4.1619 0.0 0
M  V30 44 C 24.8635 6.8293 0.0 0
M  V30 45 C 25.6336 5.4956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 21
M  V30 3 1 1 30
M  V30 4 1 3 4
M  V30 5 1 3 29
M  V30 6 2 4 5
M  V30 7 1 4 40
M  V30 8 1 6 7
M  V30 9 1 6 38
M  V30 10 1 8 9
M  V30 11 1 8 39
M  V30 12 1 10 11
M  V30 13 1 10 45
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 21
M  V30 25 1 20 23
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 35
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13205-47-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
BOC-L-leucine
C11H21NO4
13139-15-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Pyrrolidinone, 3-[(2S)-2-amino-3-oxo-4-(2,3,5,6-tetrafluorophenoxy)butyl]-,...
C14H14F4N2O3.ClH
2882939-05-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 C 6.6686 5.3900 0.0 0
M  V30 3 C 8.0022 6.1601 0.0 0
M  V30 4 C 9.3359 5.3900 0.0 0 CFG=1
M  V30 5 O 8.0022 7.7001 0.0 0
M  V30 6 C 10.6697 6.1601 0.0 0
M  V30 7 N 9.3359 3.8500 0.0 0
M  V30 8 F 5.3348 3.0800 0.0 0
M  V30 9 F 2.6675 7.7001 0.0 0
M  V30 10 F 2.6675 1.5400 0.0 0
M  V30 11 F 0.0000 6.1601 0.0 0
M  V30 12 O 13.7303 7.5228 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 C 2.6675 6.1601 0.0 0
M  V30 16 C 2.6675 3.0800 0.0 0
M  V30 17 C 1.3338 5.3900 0.0 0
M  V30 18 C 1.3338 3.8500 0.0 0
M  V30 19 C 12.0034 5.3900 0.0 0 CFG=2
M  V30 20 C 13.4102 6.0164 0.0 0
M  V30 21 C 12.1643 3.8585 0.0 0
M  V30 22 N 14.4407 4.8720 0.0 0
M  V30 23 C 13.6707 3.5383 0.0 0
M  V30 24 Cl 7.2204 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 19 6 CFG=1
M  V30 9 1 8 14
M  V30 10 1 9 15
M  V30 11 1 10 16
M  V30 12 1 11 17
M  V30 13 2 12 20
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pentanamide, 2-amino-4-methyl-N-[(1S)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]met...
C20H25F4N3O4.ClH
2882939-04-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 7.9784 0.0 0
M  V30 2 C 6.1601 7.9784 0.0 0
M  V30 3 C 6.9302 6.6448 0.0 0
M  V30 4 C 8.4702 6.6448 0.0 0 CFG=1
M  V30 5 O 6.1601 5.3111 0.0 0
M  V30 6 C 9.2402 5.3111 0.0 0
M  V30 7 N 9.2402 7.9784 0.0 0
M  V30 8 C 10.7802 7.9784 0.0 0
M  V30 9 C 11.5503 9.3122 0.0 0 CFG=1
M  V30 10 O 11.5503 6.6448 0.0 0
M  V30 11 C 13.0903 9.3122 0.0 0
M  V30 12 N 10.7802 10.6459 0.0 0
M  V30 13 C 13.8603 10.6459 0.0 0
M  V30 14 C 13.0903 11.9796 0.0 0
M  V30 15 C 15.4003 10.6459 0.0 0
M  V30 16 F 6.1601 10.6459 0.0 0
M  V30 17 F 1.5400 7.9784 0.0 0
M  V30 18 F 4.6201 13.3133 0.0 0
M  V30 19 F 0.0000 10.6459 0.0 0
M  V30 20 O 10.6030 2.2503 0.0 0
M  V30 21 C 3.8501 9.3122 0.0 0
M  V30 22 C 4.6201 10.6459 0.0 0
M  V30 23 C 2.3101 9.3122 0.0 0
M  V30 24 C 3.8501 11.9796 0.0 0
M  V30 25 C 1.5400 10.6459 0.0 0
M  V30 26 C 2.3101 11.9796 0.0 0
M  V30 27 C 8.4702 3.9773 0.0 0 CFG=2
M  V30 28 C 9.0965 2.5704 0.0 0
M  V30 29 C 6.9386 3.8163 0.0 0
M  V30 30 N 7.9521 1.5400 0.0 0
M  V30 31 C 6.6184 2.3100 0.0 0
M  V30 32 Cl 7.7002 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 4 7
M  V30 8 1 27 6 CFG=1
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12 CFG=1
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 22
M  V30 18 1 17 23
M  V30 19 1 18 24
M  V30 20 1 19 25
M  V30 21 2 20 28
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 9 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13139-15-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2882939-05-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2882939-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39325848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a
Novel Warhead
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dayan Elshan, N. G. R.; Wolff, Karen C.; Riva, Laura; Woods, Ashley K.;
Grabovyi, Gennadii; Wilson, Katy; Pedroarena, James; Ghorai, Sourav;
Nazarian, Armen; Weiss, Frank; Liu, Yuyin; Mazumdar, Wrickban; Song,
Lirui; Okwor, Neechi; Malvin, Jacqueline; Bakowski, Malina A.; Beutler,
Nathan; Kirkpatrick, Melanie G.; Gebara-Lamb, Amal; Huang, Edward;
Nguyen-Tran, Van T. B.; Chi, Victor; Li, Shuangwei; Rogers, Thomas F.;
McNamara, Case W.; Gupta, Anil Kumar; Rahimi, Alireza; Chen, Jian
Jeffrey; Joseph, Sean B.; Schultz, Peter G.; Chatterjee, Arnab K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(4), 2369-2378

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
α-(4-Methylphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)-...
C23H26N4O2S
2892557-01-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1466 5.3901 0.0 0
M  V30 2 C 9.1466 6.9301 0.0 0
M  V30 3 O 7.8130 7.7001 0.0 0
M  V30 4 O 10.4803 7.7001 0.0 0
M  V30 5 C 14.4814 2.3100 0.0 0
M  V30 6 C 2.4782 3.0800 0.0 0
M  V30 7 C 2.1580 4.5863 0.0 0
M  V30 8 C 3.8119 2.3100 0.0 0
M  V30 9 C 1.1444 2.3100 0.0 0
M  V30 10 C 0.6263 4.7474 0.0 0
M  V30 11 C 3.0631 5.8324 0.0 0
M  V30 12 N 3.8119 0.7700 0.0 0
M  V30 13 S 0.0000 3.3405 0.0 0
M  V30 14 N 1.1444 0.7700 0.0 0
M  V30 15 C 0.0000 6.1542 0.0 0
M  V30 16 C 2.4368 7.2392 0.0 0
M  V30 17 C 2.4782 0.0000 0.0 0
M  V30 18 C 0.9052 7.4001 0.0 0
M  V30 19 N 5.1455 3.0800 0.0 0
M  V30 20 C 6.4792 2.3100 0.0 0
M  V30 21 C 5.1455 4.6201 0.0 0
M  V30 22 C 7.8130 3.0800 0.0 0
M  V30 23 C 6.4792 5.3901 0.0 0
M  V30 24 N 7.8130 4.6201 0.0 0
M  V30 25 C 10.4803 4.6201 0.0 0
M  V30 26 C 11.8141 5.3901 0.0 0
M  V30 27 C 10.4803 3.0800 0.0 0
M  V30 28 C 13.1478 4.6201 0.0 0
M  V30 29 C 11.8140 2.3100 0.0 0
M  V30 30 C 13.1478 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 30
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 19
M  V30 14 1 9 13
M  V30 15 2 9 14
M  V30 16 1 10 13
M  V30 17 1 10 15
M  V30 18 1 11 16
M  V30 19 2 12 17
M  V30 20 1 14 17
M  V30 21 1 15 18
M  V30 22 1 16 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-α-(4-methylphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,...
C30H33N5O2S
2892557-09-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 6.1601 0.0 0
M  V30 2 C 10.4803 6.9301 0.0 0
M  V30 3 N 11.8140 6.1601 0.0 0
M  V30 4 O 10.4803 8.4701 0.0 0
M  V30 5 C 9.1467 0.0000 0.0 0
M  V30 6 O 17.1488 9.2401 0.0 0
M  V30 7 C 18.4824 8.4701 0.0 0
M  V30 8 C 2.4780 8.4701 0.0 0
M  V30 9 C 3.8119 9.2401 0.0 0
M  V30 10 C 2.1579 6.9638 0.0 0
M  V30 11 C 1.1444 9.2401 0.0 0
M  V30 12 N 3.8119 10.7802 0.0 0
M  V30 13 C 0.6263 6.8027 0.0 0
M  V30 14 C 3.0631 5.7178 0.0 0
M  V30 15 S 0.0000 8.2097 0.0 0
M  V30 16 N 1.1444 10.7802 0.0 0
M  V30 17 C 2.4780 11.5502 0.0 0
M  V30 18 C 0.0000 5.3959 0.0 0
M  V30 19 C 2.4368 4.3110 0.0 0
M  V30 20 C 0.9051 4.1501 0.0 0
M  V30 21 N 5.1455 8.4701 0.0 0
M  V30 22 C 6.4792 9.2401 0.0 0
M  V30 23 C 5.1455 6.9301 0.0 0
M  V30 24 C 7.8128 8.4701 0.0 0
M  V30 25 C 6.4792 6.1601 0.0 0
M  V30 26 N 7.8128 6.9301 0.0 0
M  V30 27 C 9.1467 4.6201 0.0 0
M  V30 28 C 10.4803 3.8501 0.0 0
M  V30 29 C 7.8128 3.8501 0.0 0
M  V30 30 C 10.4803 2.3100 0.0 0
M  V30 31 C 7.8128 2.3100 0.0 0
M  V30 32 C 9.1467 1.5400 0.0 0
M  V30 33 C 13.1476 6.9301 0.0 0
M  V30 34 C 14.4814 6.1601 0.0 0
M  V30 35 C 13.1476 8.4701 0.0 0
M  V30 36 C 15.8151 6.9301 0.0 0
M  V30 37 C 14.4814 9.2401 0.0 0
M  V30 38 C 15.8151 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 33
M  V30 7 1 5 32
M  V30 8 1 6 7
M  V30 9 1 6 38
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 9 21
M  V30 15 2 10 13
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 2 11 16
M  V30 19 2 12 17
M  V30 20 1 13 15
M  V30 21 1 13 18
M  V30 22 1 14 19
M  V30 23 1 16 17
M  V30 24 1 18 20
M  V30 25 1 19 20
M  V30 26 1 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-01-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-09-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
4-Chloro-α,α-difluorobenzeneacetic acid
C8H5ClF2O2
475301-73-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3336 0.0 0
M  V30 3 F 2.3100 4.2073 0.0 0
M  V30 4 F 0.9764 3.4373 0.0 0
M  V30 5 O 0.0000 1.3336 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 Cl 8.4700 2.6673 0.0 0
M  V30 8 C 3.8500 2.6673 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.1600 1.3336 0.0 0
M  V30 13 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Piperidinedione, 3-[5-(aminomethyl)-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-,...
C14H15N3O3.CH4O3S
1158265-65-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5894 4.6200 0.0 0
M  V30 2 O 4.6200 9.9980 0.0 0
M  V30 3 O 0.0000 7.3306 0.0 0
M  V30 4 C 12.5309 8.8706 0.0 0
M  V30 5 N 13.8647 8.1006 0.0 0
M  V30 6 N 6.1600 7.3306 0.0 0
M  V30 7 C 7.0652 6.0847 0.0 0
M  V30 8 C 7.0652 8.5764 0.0 0
M  V30 9 C 8.5299 6.5606 0.0 0
M  V30 10 C 8.5299 8.1006 0.0 0
M  V30 11 C 9.8636 5.7906 0.0 0
M  V30 12 C 9.8636 8.8706 0.0 0
M  V30 13 C 11.1972 6.5606 0.0 0
M  V30 14 C 11.1972 8.1006 0.0 0
M  V30 15 C 4.6200 7.3306 0.0 0
M  V30 16 C 3.8500 8.6642 0.0 0
M  V30 17 C 3.8500 5.9969 0.0 0
M  V30 18 N 2.3100 8.6642 0.0 0
M  V30 19 C 2.3100 5.9969 0.0 0
M  V30 20 C 1.5400 7.3306 0.0 0
M  V30 21 S 6.9323 1.5400 0.0 0 VAL=6
M  V30 22 C 5.3923 1.5400 0.0 0
M  V30 23 O 6.9323 3.0800 0.0 0
M  V30 24 O 6.9323 0.0000 0.0 0
M  V30 25 O 8.4723 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 16
M  V30 3 2 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]m...
C22H18ClF2N3O4
1860875-51-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 15.2776 5.7905 0.0 0
M  V30 2 O 17.2468 0.4126 0.0 0
M  V30 3 O 21.8669 3.0801 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 N 8.0022 2.3101 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 O 6.6685 0.0000 0.0 0
M  V30 9 F 6.1048 3.6437 0.0 0
M  V30 10 F 4.5648 0.9762 0.0 0
M  V30 11 Cl 0.0000 5.3901 0.0 0
M  V30 12 N 15.7068 3.0801 0.0 0
M  V30 13 C 14.8017 1.8340 0.0 0
M  V30 14 C 14.8017 4.3260 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 13.3370 3.8501 0.0 0
M  V30 17 C 12.0033 1.5400 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 17.2468 3.0801 0.0 0
M  V30 22 C 18.0169 1.7462 0.0 0
M  V30 23 C 18.0169 4.4137 0.0 0
M  V30 24 N 19.5569 1.7462 0.0 0
M  V30 25 C 19.5569 4.4137 0.0 0
M  V30 26 C 20.3269 3.0801 0.0 0
M  V30 27 C 4.0010 3.0801 0.0 0
M  V30 28 C 2.6673 2.3101 0.0 0
M  V30 29 C 4.0010 4.6201 0.0 0
M  V30 30 C 1.3337 3.0801 0.0 0
M  V30 31 C 2.6673 5.3901 0.0 0
M  V30 32 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 22
M  V30 3 2 3 26
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 27
M  V30 12 1 11 32
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 475301-73-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1158265-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1860875-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33986158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on reagent, base and temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Advancing Scalable Chemistry toward Novel CELMoDs: Process Development
for the Synthesis of CC-90009
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zacuto, Michael J.; Williams, Michael J.; Zhang, Weihong; Han, Jianxin;
Beauchamps, Marie G.; Kothare, Mohit; Konnecke, William; Smith, Randi;
Feigelson, Gregg
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(9), 2739-2748

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
3-Chlorobenzoic acid
C7H5ClO2
535-80-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-chloro-N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)c...
C33H28ClN3O4
2919713-69-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 8.0023 0.0 0
M  V30 2 O 6.9301 9.3359 0.0 0
M  V30 3 N 19.6122 11.8523 0.0 0
M  V30 4 C 20.9460 11.0823 0.0 0
M  V30 5 O 20.9460 9.5423 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 O 2.3100 1.3337 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 Cl 26.2808 11.0823 0.0 0
M  V30 11 C 11.6101 8.7723 0.0 0
M  V30 12 C 11.6101 7.2322 0.0 0
M  V30 13 C 10.1453 9.2481 0.0 0
M  V30 14 C 12.9437 9.5423 0.0 0
M  V30 15 N 10.1453 6.7564 0.0 0
M  V30 16 C 12.9437 6.4622 0.0 0
M  V30 17 C 9.2401 8.0023 0.0 0
M  V30 18 C 14.2774 8.7723 0.0 0
M  V30 19 C 14.2774 7.2322 0.0 0
M  V30 20 C 15.6112 9.5423 0.0 0
M  V30 21 C 15.6112 11.0823 0.0 0
M  V30 22 C 16.9448 8.7723 0.0 0
M  V30 23 C 16.9448 11.8523 0.0 0
M  V30 24 C 18.2785 9.5423 0.0 0
M  V30 25 C 18.2785 11.0823 0.0 0
M  V30 26 N 6.9301 6.6686 0.0 0
M  V30 27 C 5.3901 6.6686 0.0 0
M  V30 28 C 7.7001 5.3348 0.0 0
M  V30 29 C 4.6201 5.3348 0.0 0
M  V30 30 C 6.9301 4.0011 0.0 0
M  V30 31 C 5.3901 4.0011 0.0 0
M  V30 32 C 3.0800 5.3348 0.0 0
M  V30 33 C 4.6201 2.6675 0.0 0
M  V30 34 C 2.3100 4.0011 0.0 0
M  V30 35 C 3.0800 2.6675 0.0 0
M  V30 36 C 22.2796 11.8523 0.0 0
M  V30 37 C 23.6133 11.0823 0.0 0
M  V30 38 C 22.2796 13.3923 0.0 0
M  V30 39 C 24.9470 11.8523 0.0 0
M  V30 40 C 23.6133 14.1623 0.0 0
M  V30 41 C 24.9470 13.3923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 39
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 535-80-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830489
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
3-Fluorobenzoic acid
C7H5FO2
455-38-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C33H28FN3O4
2919713-66-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 8.0023 0.0 0
M  V30 2 O 6.9301 9.3359 0.0 0
M  V30 3 N 19.6122 11.8523 0.0 0
M  V30 4 C 20.9460 11.0823 0.0 0
M  V30 5 O 20.9460 9.5423 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 O 2.3100 1.3337 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 F 26.2808 11.0823 0.0 0
M  V30 11 C 11.6101 8.7723 0.0 0
M  V30 12 C 11.6101 7.2322 0.0 0
M  V30 13 C 10.1453 9.2481 0.0 0
M  V30 14 C 12.9437 9.5423 0.0 0
M  V30 15 N 10.1453 6.7564 0.0 0
M  V30 16 C 12.9437 6.4622 0.0 0
M  V30 17 C 9.2401 8.0023 0.0 0
M  V30 18 C 14.2774 8.7723 0.0 0
M  V30 19 C 14.2774 7.2322 0.0 0
M  V30 20 C 15.6112 9.5423 0.0 0
M  V30 21 C 15.6112 11.0823 0.0 0
M  V30 22 C 16.9448 8.7723 0.0 0
M  V30 23 C 16.9448 11.8523 0.0 0
M  V30 24 C 18.2785 9.5423 0.0 0
M  V30 25 C 18.2785 11.0823 0.0 0
M  V30 26 N 6.9301 6.6686 0.0 0
M  V30 27 C 5.3901 6.6686 0.0 0
M  V30 28 C 7.7001 5.3348 0.0 0
M  V30 29 C 4.6201 5.3348 0.0 0
M  V30 30 C 6.9301 4.0011 0.0 0
M  V30 31 C 5.3901 4.0011 0.0 0
M  V30 32 C 3.0800 5.3348 0.0 0
M  V30 33 C 4.6201 2.6675 0.0 0
M  V30 34 C 2.3100 4.0011 0.0 0
M  V30 35 C 3.0800 2.6675 0.0 0
M  V30 36 C 22.2796 11.8523 0.0 0
M  V30 37 C 23.6133 11.0823 0.0 0
M  V30 38 C 22.2796 13.3923 0.0 0
M  V30 39 C 24.9470 11.8523 0.0 0
M  V30 40 C 23.6133 14.1623 0.0 0
M  V30 41 C 24.9470 13.3923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 39
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 455-38-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
4-(Trifluoromethoxy)benzoic acid
C8H5F3O3
330-12-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 F 0.0000 4.6201 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 1.3337 2.3101 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 O 9.3360 2.3101 0.0 0
M  V30 8 O 8.0023 0.0000 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C34H28F3N3O5
2919713-80-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 8.0022 0.0000 0.0 0
M  V30 3 N 20.2434 4.1619 0.0 0
M  V30 4 C 21.0135 5.4956 0.0 0
M  V30 5 O 20.2434 6.8293 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 O 27.1736 5.4956 0.0 0
M  V30 11 C 27.9436 6.8293 0.0 0
M  V30 12 F 27.1736 8.1631 0.0 0
M  V30 13 F 28.7136 8.1631 0.0 0
M  V30 14 F 29.4836 6.8293 0.0 0
M  V30 15 C 11.7732 2.8283 0.0 0
M  V30 16 C 11.0032 4.1619 0.0 0
M  V30 17 C 10.7428 1.6837 0.0 0
M  V30 18 C 13.3133 2.8283 0.0 0
M  V30 19 N 9.4969 3.8418 0.0 0
M  V30 20 C 11.7732 5.4956 0.0 0
M  V30 21 C 9.3360 2.3101 0.0 0
M  V30 22 C 14.0833 4.1619 0.0 0
M  V30 23 C 13.3133 5.4956 0.0 0
M  V30 24 C 15.6233 4.1619 0.0 0
M  V30 25 C 16.3934 2.8283 0.0 0
M  V30 26 C 16.3934 5.4956 0.0 0
M  V30 27 C 17.9334 2.8283 0.0 0
M  V30 28 C 17.9334 5.4956 0.0 0
M  V30 29 C 18.7034 4.1619 0.0 0
M  V30 30 N 6.6685 2.3101 0.0 0
M  V30 31 C 5.3348 1.5400 0.0 0
M  V30 32 C 6.6685 3.8501 0.0 0
M  V30 33 C 4.0010 2.3101 0.0 0
M  V30 34 C 5.3348 4.6201 0.0 0
M  V30 35 C 4.0010 3.8501 0.0 0
M  V30 36 C 2.6673 1.5400 0.0 0
M  V30 37 C 2.6673 4.6201 0.0 0
M  V30 38 C 1.3337 2.3101 0.0 0
M  V30 39 C 1.3337 3.8501 0.0 0
M  V30 40 C 22.5535 5.4956 0.0 0
M  V30 41 C 23.3235 6.8293 0.0 0
M  V30 42 C 23.3235 4.1619 0.0 0
M  V30 43 C 24.8635 6.8293 0.0 0
M  V30 44 C 24.8635 4.1619 0.0 0
M  V30 45 C 25.6336 5.4956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 21
M  V30 3 1 1 30
M  V30 4 1 3 4
M  V30 5 1 3 29
M  V30 6 2 4 5
M  V30 7 1 4 40
M  V30 8 1 6 7
M  V30 9 1 6 38
M  V30 10 1 8 9
M  V30 11 1 8 39
M  V30 12 1 10 11
M  V30 13 1 10 45
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 21
M  V30 25 1 20 23
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 35
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 330-12-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
4-Chloro-α,α-difluorobenzeneacetic acid
C8H5ClF2O2
475301-73-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3336 0.0 0
M  V30 3 F 2.3100 4.2073 0.0 0
M  V30 4 F 0.9764 3.4373 0.0 0
M  V30 5 O 0.0000 1.3336 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 Cl 8.4700 2.6673 0.0 0
M  V30 8 C 3.8500 2.6673 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.1600 1.3336 0.0 0
M  V30 13 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[5-(Aminomethyl)-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-2,6-piperidinedione
C14H15N3O3
1010100-28-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5894 0.0000 0.0 0
M  V30 2 O 4.6200 5.3780 0.0 0
M  V30 3 O 0.0000 2.7106 0.0 0
M  V30 4 C 12.5309 4.2506 0.0 0
M  V30 5 N 13.8647 3.4806 0.0 0
M  V30 6 N 6.1600 2.7106 0.0 0
M  V30 7 C 7.0652 1.4647 0.0 0
M  V30 8 C 7.0652 3.9564 0.0 0
M  V30 9 C 8.5299 1.9406 0.0 0
M  V30 10 C 8.5299 3.4806 0.0 0
M  V30 11 C 9.8636 1.1706 0.0 0
M  V30 12 C 9.8636 4.2506 0.0 0
M  V30 13 C 11.1972 1.9406 0.0 0
M  V30 14 C 11.1972 3.4806 0.0 0
M  V30 15 C 4.6200 2.7106 0.0 0
M  V30 16 C 3.8500 4.0442 0.0 0
M  V30 17 C 3.8500 1.3769 0.0 0
M  V30 18 N 2.3100 4.0442 0.0 0
M  V30 19 C 2.3100 1.3769 0.0 0
M  V30 20 C 1.5400 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 16
M  V30 3 2 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]m...
C22H18ClF2N3O4
1860875-51-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 15.2776 5.7905 0.0 0
M  V30 2 O 17.2468 0.4126 0.0 0
M  V30 3 O 21.8669 3.0801 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 N 8.0022 2.3101 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 O 6.6685 0.0000 0.0 0
M  V30 9 F 6.1048 3.6437 0.0 0
M  V30 10 F 4.5648 0.9762 0.0 0
M  V30 11 Cl 0.0000 5.3901 0.0 0
M  V30 12 N 15.7068 3.0801 0.0 0
M  V30 13 C 14.8017 1.8340 0.0 0
M  V30 14 C 14.8017 4.3260 0.0 0
M  V30 15 C 13.3370 2.3101 0.0 0
M  V30 16 C 13.3370 3.8501 0.0 0
M  V30 17 C 12.0033 1.5400 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 17.2468 3.0801 0.0 0
M  V30 22 C 18.0169 1.7462 0.0 0
M  V30 23 C 18.0169 4.4137 0.0 0
M  V30 24 N 19.5569 1.7462 0.0 0
M  V30 25 C 19.5569 4.4137 0.0 0
M  V30 26 C 20.3269 3.0801 0.0 0
M  V30 27 C 4.0010 3.0801 0.0 0
M  V30 28 C 2.6673 2.3101 0.0 0
M  V30 29 C 4.0010 4.6201 0.0 0
M  V30 30 C 1.3337 3.0801 0.0 0
M  V30 31 C 2.6673 5.3901 0.0 0
M  V30 32 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 22
M  V30 3 2 3 26
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 27
M  V30 12 1 11 32
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 475301-73-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1010100-28-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1860875-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24495739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective
Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hansen, Joshua D.; Correa, Matthew; Alexander, Matt; Nagy, Mark; Huang,
Dehua; Sapienza, John; Lu, Gang; LeBrun, Laurie A.; Cathers, Brian E.;
Zhang, Weihong; Tang, Yang; Ammirante, Massimo; Narla, Rama K.; Piccotti,
Joseph R.; Pourdehnad, Michael; Lopez-Girona, Antonia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(4), 1835-1843

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
2-Chlorobenzoic acid
C7H5ClO2
118-91-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-chloro-N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)c...
C33H28ClN3O4
2919713-68-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 6.6231 0.0 0
M  V30 2 O 8.0022 8.1631 0.0 0
M  V30 3 N 20.2434 4.0012 0.0 0
M  V30 4 C 21.0135 2.6675 0.0 0
M  V30 5 O 20.2434 1.3338 0.0 0
M  V30 6 O 0.0000 6.6231 0.0 0
M  V30 7 C 0.0000 8.1631 0.0 0
M  V30 8 O 0.0000 3.5430 0.0 0
M  V30 9 C 0.0000 2.0030 0.0 0
M  V30 10 Cl 22.5535 0.0000 0.0 0
M  V30 11 C 11.7732 5.3348 0.0 0
M  V30 12 C 11.0032 4.0012 0.0 0
M  V30 13 C 10.7428 6.4794 0.0 0
M  V30 14 C 13.3133 5.3348 0.0 0
M  V30 15 N 9.4969 4.3213 0.0 0
M  V30 16 C 11.7732 2.6675 0.0 0
M  V30 17 C 9.3360 5.8531 0.0 0
M  V30 18 C 14.0833 4.0012 0.0 0
M  V30 19 C 13.3133 2.6675 0.0 0
M  V30 20 C 15.6233 4.0012 0.0 0
M  V30 21 C 16.3934 5.3348 0.0 0
M  V30 22 C 16.3934 2.6675 0.0 0
M  V30 23 C 17.9334 5.3348 0.0 0
M  V30 24 C 17.9334 2.6675 0.0 0
M  V30 25 C 18.7034 4.0012 0.0 0
M  V30 26 N 6.6685 5.8531 0.0 0
M  V30 27 C 5.3348 6.6231 0.0 0
M  V30 28 C 6.6685 4.3130 0.0 0
M  V30 29 C 4.0012 5.8531 0.0 0
M  V30 30 C 5.3348 3.5430 0.0 0
M  V30 31 C 4.0012 4.3130 0.0 0
M  V30 32 C 2.6673 6.6231 0.0 0
M  V30 33 C 2.6673 3.5430 0.0 0
M  V30 34 C 1.3337 5.8531 0.0 0
M  V30 35 C 1.3337 4.3130 0.0 0
M  V30 36 C 22.5535 2.6675 0.0 0
M  V30 37 C 23.3235 1.3338 0.0 0
M  V30 38 C 23.3235 4.0012 0.0 0
M  V30 39 C 24.8635 1.3338 0.0 0
M  V30 40 C 24.8635 4.0012 0.0 0
M  V30 41 C 25.6336 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 37
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 118-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-68-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
2-Fluorobenzoic acid
C7H5FO2
445-29-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C33H28FN3O4
2919713-65-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 6.6231 0.0 0
M  V30 2 O 8.0022 8.1631 0.0 0
M  V30 3 N 20.2434 4.0012 0.0 0
M  V30 4 C 21.0135 2.6675 0.0 0
M  V30 5 O 20.2434 1.3338 0.0 0
M  V30 6 O 0.0000 6.6231 0.0 0
M  V30 7 C 0.0000 8.1631 0.0 0
M  V30 8 O 0.0000 3.5430 0.0 0
M  V30 9 C 0.0000 2.0030 0.0 0
M  V30 10 F 22.5535 0.0000 0.0 0
M  V30 11 C 11.7732 5.3348 0.0 0
M  V30 12 C 11.0032 4.0012 0.0 0
M  V30 13 C 10.7428 6.4794 0.0 0
M  V30 14 C 13.3133 5.3348 0.0 0
M  V30 15 N 9.4969 4.3213 0.0 0
M  V30 16 C 11.7732 2.6675 0.0 0
M  V30 17 C 9.3360 5.8531 0.0 0
M  V30 18 C 14.0833 4.0012 0.0 0
M  V30 19 C 13.3133 2.6675 0.0 0
M  V30 20 C 15.6233 4.0012 0.0 0
M  V30 21 C 16.3934 5.3348 0.0 0
M  V30 22 C 16.3934 2.6675 0.0 0
M  V30 23 C 17.9334 5.3348 0.0 0
M  V30 24 C 17.9334 2.6675 0.0 0
M  V30 25 C 18.7034 4.0012 0.0 0
M  V30 26 N 6.6685 5.8531 0.0 0
M  V30 27 C 5.3348 6.6231 0.0 0
M  V30 28 C 6.6685 4.3130 0.0 0
M  V30 29 C 4.0012 5.8531 0.0 0
M  V30 30 C 5.3348 3.5430 0.0 0
M  V30 31 C 4.0012 4.3130 0.0 0
M  V30 32 C 2.6673 6.6231 0.0 0
M  V30 33 C 2.6673 3.5430 0.0 0
M  V30 34 C 1.3337 5.8531 0.0 0
M  V30 35 C 1.3337 4.3130 0.0 0
M  V30 36 C 22.5535 2.6675 0.0 0
M  V30 37 C 23.3235 1.3338 0.0 0
M  V30 38 C 23.3235 4.0012 0.0 0
M  V30 39 C 24.8635 1.3338 0.0 0
M  V30 40 C 24.8635 4.0012 0.0 0
M  V30 41 C 25.6336 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 37
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 445-29-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
2-Methyl-2H-indazole-5-carboxylic acid
C9H8N2O2
1197943-94-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 9.2446 3.0800 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 6.7994 1.8341 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 6.7994 4.3259 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 N 7.7046 3.0800 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Pyrimidinediamine, N4-[4-(difluoromethoxy)phenyl]-2-ethoxy-
C13H14F2N4O2
2924825-25-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 2.6675 0.0 0
M  V30 2 N 6.9301 0.0000 0.0 0
M  V30 3 O 10.0101 5.3348 0.0 0
M  V30 4 C 11.5501 5.3348 0.0 0
M  V30 5 C 12.3201 6.6684 0.0 0
M  V30 6 O 2.3100 8.0022 0.0 0
M  V30 7 C 0.7700 8.0022 0.0 0
M  V30 8 F 0.0000 6.6684 0.0 0
M  V30 9 F 0.0000 9.3359 0.0 0
M  V30 10 C 6.9301 2.6675 0.0 0
M  V30 11 N 7.7001 4.0011 0.0 0
M  V30 12 C 7.7001 1.3337 0.0 0
M  V30 13 C 9.2401 4.0011 0.0 0
M  V30 14 C 9.2401 1.3337 0.0 0
M  V30 15 N 10.0101 2.6675 0.0 0
M  V30 16 C 4.6201 4.0011 0.0 0
M  V30 17 C 5.3901 5.3348 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 4.6201 6.6684 0.0 0
M  V30 20 C 2.3100 5.3348 0.0 0
M  V30 21 C 3.0800 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indazole-5-carboxamide, N-[4-[[4-(difluoromethoxy)phenyl]amino]-2-ethoxy-5...
C22H20F2N6O3
2924825-28-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7012 8.0021 0.0 0
M  V30 2 N 7.6212 8.0021 0.0 0
M  V30 3 C 6.0812 8.0021 0.0 0
M  V30 4 O 5.3112 6.6684 0.0 0
M  V30 5 O 10.7012 2.6673 0.0 0
M  V30 6 C 9.9312 1.3337 0.0 0
M  V30 7 C 10.7012 0.0000 0.0 0
M  V30 8 O 16.8611 8.0021 0.0 0
M  V30 9 C 17.6311 9.3359 0.0 0
M  V30 10 F 16.8611 10.6695 0.0 0
M  V30 11 F 19.1713 9.3359 0.0 0
M  V30 12 C 0.0000 13.2912 0.0 0
M  V30 13 C 9.9312 6.6684 0.0 0
M  V30 14 C 8.3912 6.6684 0.0 0
M  V30 15 N 10.7012 5.3348 0.0 0
M  V30 16 C 7.6212 5.3348 0.0 0
M  V30 17 C 9.9312 4.0011 0.0 0
M  V30 18 N 8.3912 4.0011 0.0 0
M  V30 19 C 12.2412 8.0021 0.0 0
M  V30 20 C 13.0113 6.6684 0.0 0
M  V30 21 C 13.0113 9.3359 0.0 0
M  V30 22 C 14.5513 6.6684 0.0 0
M  V30 23 C 14.5513 9.3359 0.0 0
M  V30 24 C 15.3211 8.0021 0.0 0
M  V30 25 C 5.3112 9.3359 0.0 0
M  V30 26 C 3.7710 9.3359 0.0 0
M  V30 27 C 6.0812 10.6695 0.0 0
M  V30 28 C 3.0010 10.6695 0.0 0
M  V30 29 C 5.3112 12.0032 0.0 0
M  V30 30 C 3.7712 12.0032 0.0 0
M  V30 31 C 1.4947 10.9897 0.0 0
M  V30 32 N 2.7406 13.1477 0.0 0
M  V30 33 N 1.3338 12.5212 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 2 3 4
M  V30 6 1 3 25
M  V30 7 1 5 6
M  V30 8 1 5 17
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 8 24
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 12 33
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 1 29 30
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1197943-94-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2924825-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2924825-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40329369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Structural Optimization of Methionine Adenosyltransferase 2A
(MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Silong; Qing, Luolong; Wang, Ziwei; Zhang, Yu; Li, Yuanyuan; Fang,
Huaxiang; Liu, Yi; He, Huan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(7), 4849-4867

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
2-Methoxybenzoic acid
C8H8O3
579-75-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C34H31N3O5
2919713-75-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 7.9566 0.0 0
M  V30 2 O 8.0020 9.4966 0.0 0
M  V30 3 N 20.2430 5.3347 0.0 0
M  V30 4 C 21.0130 4.0011 0.0 0
M  V30 5 O 20.2430 2.6674 0.0 0
M  V30 6 O 0.0000 7.9566 0.0 0
M  V30 7 C 0.0000 9.4966 0.0 0
M  V30 8 O 0.0000 4.8766 0.0 0
M  V30 9 C 0.0000 3.3366 0.0 0
M  V30 10 O 22.5530 1.3338 0.0 0
M  V30 11 C 23.3230 0.0000 0.0 0
M  V30 12 C 11.7730 6.6685 0.0 0
M  V30 13 C 11.0030 5.3347 0.0 0
M  V30 14 C 10.7426 7.8129 0.0 0
M  V30 15 C 13.3130 6.6685 0.0 0
M  V30 16 N 9.4967 5.6549 0.0 0
M  V30 17 C 11.7730 4.0011 0.0 0
M  V30 18 C 9.3358 7.1866 0.0 0
M  V30 19 C 14.0830 5.3347 0.0 0
M  V30 20 C 13.3130 4.0011 0.0 0
M  V30 21 C 15.6230 5.3347 0.0 0
M  V30 22 C 16.3930 6.6685 0.0 0
M  V30 23 C 16.3930 4.0011 0.0 0
M  V30 24 C 17.9330 6.6685 0.0 0
M  V30 25 C 17.9330 4.0011 0.0 0
M  V30 26 C 18.7030 5.3347 0.0 0
M  V30 27 N 6.6684 7.1866 0.0 0
M  V30 28 C 5.3347 7.9566 0.0 0
M  V30 29 C 6.6684 5.6466 0.0 0
M  V30 30 C 4.0009 7.1866 0.0 0
M  V30 31 C 5.3347 4.8766 0.0 0
M  V30 32 C 4.0009 5.6466 0.0 0
M  V30 33 C 2.6673 7.9566 0.0 0
M  V30 34 C 2.6673 4.8766 0.0 0
M  V30 35 C 1.3336 7.1866 0.0 0
M  V30 36 C 1.3336 5.6466 0.0 0
M  V30 37 C 22.5530 4.0011 0.0 0
M  V30 38 C 23.3230 2.6674 0.0 0
M  V30 39 C 23.3230 5.3347 0.0 0
M  V30 40 C 24.8630 2.6674 0.0 0
M  V30 41 C 24.8630 5.3347 0.0 0
M  V30 42 C 25.6330 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 27
M  V30 4 1 3 4
M  V30 5 1 3 26
M  V30 6 2 4 5
M  V30 7 1 4 37
M  V30 8 1 6 7
M  V30 9 1 6 35
M  V30 10 1 8 9
M  V30 11 1 8 36
M  V30 12 1 10 11
M  V30 13 1 10 38
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 32
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 579-75-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-L-tryptophan
C16H20N2O4
13139-14-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 4.0011 0.0 0
M  V30 2 C 5.8243 2.6674 0.0 0 CFG=1
M  V30 3 N 7.3643 2.6674 0.0 0
M  V30 4 C 5.0543 1.3336 0.0 0
M  V30 5 C 8.1343 4.0011 0.0 0
M  V30 6 O 3.5143 1.3336 0.0 0
M  V30 7 O 5.8243 0.0000 0.0 0
M  V30 8 O 9.6743 4.0011 0.0 0
M  V30 9 O 7.3643 5.3347 0.0 0
M  V30 10 C 10.4443 5.3347 0.0 0
M  V30 11 C 11.7780 4.5647 0.0 0
M  V30 12 C 11.2143 6.6684 0.0 0
M  V30 13 C 9.1107 6.1047 0.0 0
M  V30 14 C 2.6091 5.2470 0.0 0
M  V30 15 C 3.5143 4.0011 0.0 0
M  V30 16 C 1.1444 4.7711 0.0 0
M  V30 17 C 2.9292 6.7534 0.0 0
M  V30 18 C 2.6091 2.7552 0.0 0
M  V30 19 N 1.1444 3.2311 0.0 0
M  V30 20 C 0.0000 5.8015 0.0 0
M  V30 21 C 1.7849 7.7838 0.0 0
M  V30 22 C 0.3202 7.3080 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-7a,8,8-trimethyl-...
C15H28BNO2.C2HF3O2
2415205-36-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9308 5.1837 0.0 0
M  V30 2 C 1.5402 9.3367 0.0 0
M  V30 3 C 0.0000 7.4197 0.0 0
M  V30 4 C 8.0301 9.3424 0.0 0 CFG=1
M  V30 5 C 9.3638 8.5724 0.0 0
M  V30 6 N 8.0301 10.8824 0.0 0
M  V30 7 C 10.6974 9.3424 0.0 0
M  V30 8 C 10.6974 10.8824 0.0 0
M  V30 9 C 12.0312 8.5724 0.0 0
M  V30 10 C 4.2591 8.0543 0.0 0 CFG=1
M  V30 11 C 2.7187 7.4060 0.0 0 CFG=2
M  V30 12 C 5.0291 6.7207 0.0 0 CFG=2
M  V30 13 O 5.2895 9.1987 0.0 0
M  V30 14 C 1.4930 7.7974 0.0 0
M  V30 15 C 2.5438 5.2777 0.0 0
M  V30 16 C 3.8856 7.1212 0.0 0
M  V30 17 O 6.5354 7.0408 0.0 0
M  V30 18 B 6.6963 8.5724 0.0 0
M  V30 19 C 2.2413 6.5095 0.0 0 CFG=1
M  V30 20 H 3.3666 9.3094 0.0 0
M  V30 21 H 2.6499 8.9444 0.0 0
M  V30 22 H 0.8131 5.9332 0.0 0
M  V30 23 C 5.3488 2.3101 0.0 0
M  V30 24 C 6.6824 1.5400 0.0 0
M  V30 25 F 6.1188 3.6437 0.0 0
M  V30 26 F 4.0151 3.0801 0.0 0
M  V30 27 F 4.5788 0.9764 0.0 0
M  V30 28 O 8.0161 2.3101 0.0 0
M  V30 29 O 6.6824 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 2 14
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 18
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 20 CFG=3
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 21 CFG=1
M  V30 17 1 12 16 CFG=1
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 19
M  V30 22 1 16 19
M  V30 23 1 17 18
M  V30 24 1 19 22 CFG=3
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 2 24 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 10 11 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C31H46BN3O5
2415205-26-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3882 10.9044 0.0 0
M  V30 2 C 0.3753 9.0033 0.0 0
M  V30 3 C 0.0000 11.4336 0.0 0
M  V30 4 C 5.9928 5.7534 0.0 0 CFG=2
M  V30 5 N 7.5329 5.7534 0.0 0
M  V30 6 C 5.2228 4.4197 0.0 0
M  V30 7 C 8.3029 7.0870 0.0 0
M  V30 8 C 3.6828 4.4197 0.0 0
M  V30 9 C 9.8429 7.0870 0.0 0 CFG=1
M  V30 10 O 7.5329 8.4208 0.0 0
M  V30 11 C 2.9128 3.0859 0.0 0
M  V30 12 C 2.9128 5.7534 0.0 0
M  V30 13 C 10.6129 5.7534 0.0 0
M  V30 14 N 10.6129 8.4208 0.0 0
M  V30 15 C 12.1529 8.4208 0.0 0
M  V30 16 O 12.9229 9.7545 0.0 0
M  V30 17 O 12.9229 7.0870 0.0 0
M  V30 18 C 14.4630 9.7545 0.0 0
M  V30 19 C 14.4630 11.2945 0.0 0
M  V30 20 C 16.0030 9.7545 0.0 0
M  V30 21 C 14.4630 8.2145 0.0 0
M  V30 22 C 3.3711 8.7544 0.0 0 CFG=1
M  V30 23 C 2.3612 10.0861 0.0 0 CFG=2
M  V30 24 C 4.7048 9.5244 0.0 0 CFG=2
M  V30 25 O 3.6913 7.2481 0.0 0
M  V30 26 C 1.1040 10.3599 0.0 0
M  V30 27 C 3.2739 12.0166 0.0 0
M  V30 28 C 3.5142 9.7493 0.0 0
M  V30 29 O 5.8492 8.4940 0.0 0
M  V30 30 B 5.2228 7.0870 0.0 0
M  V30 31 C 2.3960 11.1011 0.0 0 CFG=1
M  V30 32 C 9.8429 4.4197 0.0 0
M  V30 33 C 10.4692 3.0127 0.0 0
M  V30 34 C 8.3113 4.2586 0.0 0
M  V30 35 C 9.3248 1.9823 0.0 0
M  V30 36 C 11.9339 2.5369 0.0 0
M  V30 37 N 7.9912 2.7523 0.0 0
M  V30 38 C 9.6450 0.4760 0.0 0
M  V30 39 C 12.2541 1.0306 0.0 0
M  V30 40 C 11.1096 0.0000 0.0 0
M  V30 41 H 1.9706 8.1136 0.0 0
M  V30 42 H 1.5325 8.7880 0.0 0
M  V30 43 H 1.4473 12.3143 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=1
M  V30 2 1 2 26
M  V30 3 1 3 26
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 30
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 32
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 22 41 CFG=1
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 23 42 CFG=3
M  V30 30 1 24 28 CFG=3
M  V30 31 1 24 29
M  V30 32 1 25 30
M  V30 33 1 26 31
M  V30 34 1 27 31
M  V30 35 1 28 31
M  V30 36 1 29 30
M  V30 37 1 31 43 CFG=1
M  V30 38 1 32 33
M  V30 39 2 32 34
M  V30 40 1 33 35
M  V30 41 2 33 36
M  V30 42 1 34 37
M  V30 43 1 35 37
M  V30 44 2 35 38
M  V30 45 1 36 39
M  V30 46 1 38 40
M  V30 47 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 4 9 22 23 24 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13139-14-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415205-36-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415205-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22020084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Peptide Boronate Derivatives as Histone Deacetylase and
Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of
Multiple Myeloma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yi; Liu, Xiaoting; Xue, Junxin; Liu, Lulu; Liang, Tao; Li, Wen;
Yang, Xinying; Hou, Xuben; Fang, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(9), 4701-4715

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
3,4,5-Trimethoxybenzoic acid
C10H12O5
118-41-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3336 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3347 0.0000 0.0 0
M  V30 5 O 1.3336 5.3900 0.0 0
M  V30 6 C 1.3336 6.9300 0.0 0
M  V30 7 C 6.6685 5.3900 0.0 0
M  V30 8 O 8.0021 4.6200 0.0 0
M  V30 9 O 6.6685 6.9300 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 5.3347 3.0800 0.0 0
M  V30 14 C 4.0011 5.3900 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C36H35N3O7
2919713-82-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 7.9566 0.0 0
M  V30 2 O 8.0020 9.4966 0.0 0
M  V30 3 N 20.2430 5.3347 0.0 0
M  V30 4 C 21.0130 4.0011 0.0 0
M  V30 5 O 20.2430 2.6674 0.0 0
M  V30 6 O 0.0000 7.9566 0.0 0
M  V30 7 C 0.0000 9.4966 0.0 0
M  V30 8 O 0.0000 4.8766 0.0 0
M  V30 9 C 0.0000 3.3366 0.0 0
M  V30 10 O 25.6330 6.6685 0.0 0
M  V30 11 C 24.8630 8.0021 0.0 0
M  V30 12 O 25.6330 1.3338 0.0 0
M  V30 13 C 24.8630 0.0000 0.0 0
M  V30 14 O 27.1730 4.0011 0.0 0
M  V30 15 C 27.9430 2.6674 0.0 0
M  V30 16 C 11.7730 6.6685 0.0 0
M  V30 17 C 11.0030 5.3347 0.0 0
M  V30 18 C 10.7426 7.8129 0.0 0
M  V30 19 C 13.3130 6.6685 0.0 0
M  V30 20 N 9.4967 5.6549 0.0 0
M  V30 21 C 11.7730 4.0011 0.0 0
M  V30 22 C 9.3358 7.1866 0.0 0
M  V30 23 C 14.0830 5.3347 0.0 0
M  V30 24 C 13.3130 4.0011 0.0 0
M  V30 25 C 15.6230 5.3347 0.0 0
M  V30 26 C 16.3930 4.0011 0.0 0
M  V30 27 C 16.3930 6.6685 0.0 0
M  V30 28 C 17.9330 4.0011 0.0 0
M  V30 29 C 17.9330 6.6685 0.0 0
M  V30 30 C 18.7030 5.3347 0.0 0
M  V30 31 N 6.6684 7.1866 0.0 0
M  V30 32 C 5.3347 7.9566 0.0 0
M  V30 33 C 6.6684 5.6466 0.0 0
M  V30 34 C 4.0011 7.1866 0.0 0
M  V30 35 C 5.3347 4.8766 0.0 0
M  V30 36 C 4.0011 5.6466 0.0 0
M  V30 37 C 2.6673 7.9566 0.0 0
M  V30 38 C 2.6673 4.8766 0.0 0
M  V30 39 C 1.3336 7.1866 0.0 0
M  V30 40 C 1.3336 5.6466 0.0 0
M  V30 41 C 22.5530 4.0011 0.0 0
M  V30 42 C 23.3230 5.3347 0.0 0
M  V30 43 C 23.3230 2.6674 0.0 0
M  V30 44 C 24.8630 5.3347 0.0 0
M  V30 45 C 24.8630 2.6674 0.0 0
M  V30 46 C 25.6330 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 22
M  V30 3 1 1 31
M  V30 4 1 3 4
M  V30 5 1 3 30
M  V30 6 2 4 5
M  V30 7 1 4 41
M  V30 8 1 6 7
M  V30 9 1 6 39
M  V30 10 1 8 9
M  V30 11 1 8 40
M  V30 12 1 10 11
M  V30 13 1 10 44
M  V30 14 1 12 13
M  V30 15 1 12 45
M  V30 16 1 14 15
M  V30 17 1 14 46
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 22
M  V30 26 1 21 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 34 37
M  V30 41 1 35 36
M  V30 42 2 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 118-41-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
4-(Trifluoromethyl)benzoic acid
C8H5F3O2
455-24-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C34H28F3N3O4
2919713-73-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 C 21.0130 5.4953 0.0 0
M  V30 5 O 20.2430 6.8291 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6200 0.0 0
M  V30 9 C 0.0000 6.1600 0.0 0
M  V30 10 C 27.1730 5.4953 0.0 0
M  V30 11 F 27.1730 7.0353 0.0 0
M  V30 12 F 28.7130 5.4953 0.0 0
M  V30 13 F 27.1730 3.9553 0.0 0
M  V30 14 C 11.7730 2.8281 0.0 0
M  V30 15 C 11.0030 4.1617 0.0 0
M  V30 16 C 10.7426 1.6835 0.0 0
M  V30 17 C 13.3130 2.8281 0.0 0
M  V30 18 N 9.4967 3.8415 0.0 0
M  V30 19 C 11.7730 5.4953 0.0 0
M  V30 20 C 9.3358 2.3100 0.0 0
M  V30 21 C 14.0830 4.1617 0.0 0
M  V30 22 C 13.3130 5.4953 0.0 0
M  V30 23 C 15.6230 4.1617 0.0 0
M  V30 24 C 16.3930 2.8281 0.0 0
M  V30 25 C 16.3930 5.4953 0.0 0
M  V30 26 C 17.9330 2.8281 0.0 0
M  V30 27 C 17.9330 5.4953 0.0 0
M  V30 28 C 18.7030 4.1617 0.0 0
M  V30 29 N 6.6684 2.3100 0.0 0
M  V30 30 C 5.3347 1.5400 0.0 0
M  V30 31 C 6.6684 3.8500 0.0 0
M  V30 32 C 4.0011 2.3100 0.0 0
M  V30 33 C 5.3347 4.6200 0.0 0
M  V30 34 C 4.0009 3.8500 0.0 0
M  V30 35 C 2.6673 1.5400 0.0 0
M  V30 36 C 2.6673 4.6200 0.0 0
M  V30 37 C 1.3336 2.3100 0.0 0
M  V30 38 C 1.3336 3.8500 0.0 0
M  V30 39 C 22.5530 5.4953 0.0 0
M  V30 40 C 23.3230 4.1617 0.0 0
M  V30 41 C 23.3230 6.8291 0.0 0
M  V30 42 C 24.8630 4.1617 0.0 0
M  V30 43 C 24.8630 6.8291 0.0 0
M  V30 44 C 25.6330 5.4953 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 29
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 2 4 5
M  V30 7 1 4 39
M  V30 8 1 6 7
M  V30 9 1 6 37
M  V30 10 1 8 9
M  V30 11 1 8 38
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 44
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 32 35
M  V30 39 1 33 34
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 38
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 455-24-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919713-73-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
1-(3-Cyanophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
C12H6F3N3O2
209917-93-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9735 6.7983 0.0 0
M  V30 2 O 0.5088 7.2743 0.0 0
M  V30 3 O 3.1179 7.8289 0.0 0
M  V30 4 C 1.4068 1.4070 0.0 0
M  V30 5 F 2.8136 0.7805 0.0 0
M  V30 6 F 0.7805 0.0000 0.0 0
M  V30 7 F 0.0000 2.0333 0.0 0
M  V30 8 C 9.0353 4.6657 0.0 0
M  V30 9 N 10.3690 3.8956 0.0 0
M  V30 10 N 3.7005 4.6657 0.0 0
M  V30 11 C 2.2937 5.2920 0.0 0
M  V30 12 N 3.5396 3.1339 0.0 0
M  V30 13 C 1.2631 4.1474 0.0 0
M  V30 14 C 2.0331 2.8138 0.0 0
M  V30 15 C 5.0342 5.4357 0.0 0
M  V30 16 C 6.3680 4.6657 0.0 0
M  V30 17 C 5.0342 6.9757 0.0 0
M  V30 18 C 7.7017 5.4357 0.0 0
M  V30 19 C 6.3680 7.7457 0.0 0
M  V30 20 C 7.7017 6.9757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14
M  V30 8 3 8 9
M  V30 9 1 8 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3-Aminophenyl)-α-(2-cyclopropylethyl)-3-pyridinemethanol
C17H20N2O
1809015-50-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 C 6.1600 4.6200 0.0 0
M  V30 3 O 4.6200 6.1600 0.0 0
M  V30 4 C 6.9300 5.9536 0.0 0
M  V30 5 N 0.0000 7.2873 0.0 0
M  V30 6 C 3.0800 4.6200 0.0 0
M  V30 7 C 2.3100 5.9536 0.0 0
M  V30 8 C 2.3100 3.2862 0.0 0
M  V30 9 C 0.7700 5.9536 0.0 0
M  V30 10 C 0.7700 3.2862 0.0 0
M  V30 11 C 0.0000 4.6200 0.0 0
M  V30 12 C 4.6200 3.0800 0.0 0
M  V30 13 C 3.2864 2.3100 0.0 0
M  V30 14 C 5.9536 2.3100 0.0 0
M  V30 15 C 3.2864 0.7700 0.0 0
M  V30 16 N 5.9536 0.7700 0.0 0
M  V30 17 C 4.6200 0.0000 0.0 0
M  V30 18 C 8.4700 5.9536 0.0 0
M  V30 19 C 9.8036 6.7236 0.0 0
M  V30 20 C 9.8036 5.1836 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 1 12
M  V30 5 1 2 4
M  V30 6 1 4 18
M  V30 7 1 5 9
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Cyanophenyl)-N-[3-[3-cyclopropyl-1-hydroxy-1-(3-pyridinyl)propyl]phenyl]...
C29H24F3N5O2
1809015-51-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.3439 6.8342 0.0 0
M  V30 2 N 9.8039 6.8342 0.0 0
M  V30 3 O 12.1139 8.1680 0.0 0
M  V30 4 C 12.4710 1.5316 0.0 0
M  V30 5 F 14.0026 1.3706 0.0 0
M  V30 6 F 12.3101 0.0000 0.0 0
M  V30 7 F 10.9395 1.6927 0.0 0
M  V30 8 C 18.7193 6.9882 0.0 0
M  V30 9 N 20.2256 6.6679 0.0 0
M  V30 10 C 5.1838 9.5017 0.0 0
M  V30 11 C 3.6437 9.5017 0.0 0
M  V30 12 O 5.1838 7.9617 0.0 0
M  V30 13 C 2.8737 8.1680 0.0 0
M  V30 14 N 13.6455 5.3396 0.0 0
M  V30 15 C 12.1139 5.5005 0.0 0
M  V30 16 N 13.9656 3.8331 0.0 0
M  V30 17 C 11.4876 4.0937 0.0 0
M  V30 18 C 12.6320 3.0631 0.0 0
M  V30 19 C 14.6761 6.4840 0.0 0
M  V30 20 C 16.1824 6.1638 0.0 0
M  V30 21 C 14.2000 7.9487 0.0 0
M  V30 22 C 17.2128 7.3084 0.0 0
M  V30 23 C 15.2306 9.0931 0.0 0
M  V30 24 C 16.7369 8.7730 0.0 0
M  V30 25 C 9.0338 8.1680 0.0 0
M  V30 26 C 7.4938 8.1680 0.0 0
M  V30 27 C 9.8039 9.5017 0.0 0
M  V30 28 C 6.7238 9.5017 0.0 0
M  V30 29 C 9.0338 10.8354 0.0 0
M  V30 30 C 7.4938 10.8354 0.0 0
M  V30 31 C 5.1838 11.0417 0.0 0
M  V30 32 C 3.8501 11.8118 0.0 0
M  V30 33 C 6.5174 11.8118 0.0 0
M  V30 34 C 3.8501 13.3518 0.0 0
M  V30 35 N 6.5174 13.3518 0.0 0
M  V30 36 C 5.1838 14.1218 0.0 0
M  V30 37 C 1.3337 8.1680 0.0 0
M  V30 38 C 0.0000 8.9380 0.0 0
M  V30 39 C 0.0000 7.3980 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 25
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 18
M  V30 9 3 8 9
M  V30 10 1 8 22
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 28
M  V30 14 1 10 31
M  V30 15 1 11 13
M  V30 16 1 13 37
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 19
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 209917-93-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1809015-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809015-51-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34609720
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 132705-51-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and optimization of orally bioavailable and potent plasma
Kallikrein inhibitors bearing a quaternary carbon
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Weihe; Vadlakonda, Satish; Wu, Minwan; Chintareddy, Venkat;
Vogeti, Ln; Juarez, Luis; Muppa, Saritha; Parker, Cynthia;
Kellogg-Yelder, Debra; Williams, Jason; Polach, Kevin; Chen, Xilin;
Raman, Krishnan; Babu, Y. S.; Kotian, Pravin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 73117035

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 4-aminobenzoate
C11H15NO2
18144-47-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Chloro-2-cyanophenyl)-5-methoxy-α-methyl-2-oxo-1(2H)-pyridineacetic acid
C16H13ClN2O4
1630193-84-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6686 0.0 0
M  V30 2 C 5.3901 8.0022 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 N 3.8500 0.0000 0.0 0
M  V30 5 O 7.7001 1.3337 0.0 0
M  V30 6 Cl 0.0000 6.6686 0.0 0
M  V30 7 C 9.2401 4.0011 0.0 0
M  V30 8 C 10.0101 5.3348 0.0 0
M  V30 9 C 10.0101 2.6675 0.0 0
M  V30 10 O 9.2401 6.6686 0.0 0
M  V30 11 O 11.5501 5.3348 0.0 0
M  V30 12 C 4.6201 4.0011 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 5.3901 2.6675 0.0 0
M  V30 15 C 6.9301 5.3348 0.0 0
M  V30 16 C 6.9301 2.6675 0.0 0
M  V30 17 N 7.7001 4.0011 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 2.3100 2.6675 0.0 0
M  V30 20 C 2.3100 5.3348 0.0 0
M  V30 21 C 0.7700 2.6675 0.0 0
M  V30 22 C 0.7700 5.3348 0.0 0
M  V30 23 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 3 3 4
M  V30 4 1 3 19
M  V30 5 2 5 16
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1(2H)-pyr...
C27H26ClN3O5
1630193-87-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 2.3100 0.0 0
M  V30 2 C 6.6684 1.5400 0.0 0
M  V30 3 C 1.3336 6.1600 0.0 0
M  V30 4 N 1.3336 7.7000 0.0 0
M  V30 5 O 5.3347 8.4700 0.0 0
M  V30 6 Cl 1.3336 0.0000 0.0 0
M  V30 7 C 8.0021 6.9300 0.0 0
M  V30 8 C 9.3358 6.1600 0.0 0
M  V30 9 C 8.0021 8.4700 0.0 0
M  V30 10 N 10.6694 6.9300 0.0 0
M  V30 11 O 9.3358 4.6200 0.0 0
M  V30 12 C 16.0041 3.8500 0.0 0
M  V30 13 O 17.3378 4.6200 0.0 0
M  V30 14 O 16.0041 2.3100 0.0 0
M  V30 15 C 18.6716 3.8500 0.0 0
M  V30 16 C 17.9016 2.5164 0.0 0
M  V30 17 C 20.0052 3.0800 0.0 0
M  V30 18 C 19.4416 5.1836 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 5.3347 3.8500 0.0 0
M  V30 21 C 4.0011 6.1600 0.0 0
M  V30 22 C 6.6684 4.6200 0.0 0
M  V30 23 C 5.3347 6.9300 0.0 0
M  V30 24 N 6.6684 6.1600 0.0 0
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 1.3336 4.6200 0.0 0
M  V30 27 C 2.6674 2.3100 0.0 0
M  V30 28 C 0.0000 3.8500 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0
M  V30 30 C 0.0000 2.3100 0.0 0
M  V30 31 C 12.0031 6.1600 0.0 0
M  V30 32 C 13.3369 6.9300 0.0 0
M  V30 33 C 12.0031 4.6200 0.0 0
M  V30 34 C 14.6705 6.1600 0.0 0
M  V30 35 C 13.3369 3.8500 0.0 0
M  V30 36 C 14.6705 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 3 3 4
M  V30 4 1 3 26
M  V30 5 2 5 23
M  V30 6 1 6 29
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 24
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 31
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 36
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 25
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18144-47-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630193-84-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630193-87-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37692131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Preclinical Characterization Program toward Asundexian (BAY
2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment
of Thromboembolic Disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roehrig, Susanne; Ackerstaff, Jens; Jimenez Nunez, Eloisa; Teller,
Henrik; Ellerbrock, Pascal; Meier, Katharina; Heitmeier, Stefan;
Tersteegen, Adrian; Stampfuss, Jan; Lang, Dieter; Schlemmer, Karl-Heinz;
Schaefer, Martina; Gericke, Kersten M.; Kinzel, Tom; Meibom, Daniel;
Schmidt, Martina; Gerdes, Christoph; Follmann, Markus; Hillisch,
Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(17), 12203-12224

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL

C12H5ClD6N2O3
2919852-24-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5932 1.4645 0.0 0
M  V30 2 Cl 6.5626 6.8426 0.0 0
M  V30 3 C 1.4068 5.8503 0.0 0
M  V30 4 O 0.0000 5.2240 0.0 0
M  V30 5 O 1.5679 7.3819 0.0 0
M  V30 6 O 11.1826 4.1751 0.0 0
M  V30 7 C 11.9526 5.5088 0.0 0
M  V30 8 C 5.0226 4.1751 0.0 0
M  V30 9 N 4.1174 2.9292 0.0 0
M  V30 10 C 4.1174 5.4210 0.0 0
M  V30 11 N 2.6528 3.4051 0.0 0
M  V30 12 C 2.6528 4.9451 0.0 0
M  V30 13 C 6.5626 4.1751 0.0 0
M  V30 14 C 7.3326 5.5088 0.0 0
M  V30 15 C 7.3326 2.8415 0.0 0
M  V30 16 C 8.8726 5.5088 0.0 0
M  V30 17 C 8.8726 2.8415 0.0 0
M  V30 18 C 9.6426 4.1751 0.0 0
M  V30 19 H 6.0997 1.1444 0.0 0 MASS=2
M  V30 20 H 5.0692 0.0000 0.0 0 MASS=2
M  V30 21 H 3.5628 0.3202 0.0 0 MASS=2
M  V30 22 H 13.4926 5.5088 0.0 0 MASS=2
M  V30 23 H 12.7226 6.8426 0.0 0 MASS=2
M  V30 24 H 11.1826 6.8426 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 20
M  V30 4 1 1 21
M  V30 5 1 2 14
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 3 12
M  V30 9 1 6 7
M  V30 10 1 6 18
M  V30 11 1 7 22
M  V30 12 1 7 23
M  V30 13 1 7 24
M  V30 14 1 8 9
M  V30 15 2 8 10
M  V30 16 1 8 13
M  V30 17 1 9 11
M  V30 18 1 10 12
M  V30 19 2 11 12
M  V30 20 2 13 14
M  V30 21 1 13 15
M  V30 22 1 14 16
M  V30 23 2 15 17
M  V30 24 2 16 18
M  V30 25 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-tert-Butyl 3-aminopiperidine-1-carboxylate
C10H20N2O2
625471-18-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 N 9.3360 3.0801 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0 CFG=1
M  V30 13 C 6.6685 0.0000 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 12 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C22H23ClD6N4O4
3033432-04-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4280 1.4070 0.0 0
M  V30 2 Cl 7.0315 6.9613 0.0 0
M  V30 3 C 12.0554 5.4357 0.0 0
M  V30 4 N 13.3891 4.6657 0.0 0
M  V30 5 O 12.0554 6.9757 0.0 0
M  V30 6 O 2.1579 4.7915 0.0 0
M  V30 7 C 1.5316 6.1983 0.0 0
M  V30 8 C 18.7239 4.6657 0.0 0
M  V30 9 O 20.0577 5.4357 0.0 0
M  V30 10 O 18.7240 3.1257 0.0 0
M  V30 11 C 21.3914 4.6657 0.0 0
M  V30 12 C 20.6214 3.3319 0.0 0
M  V30 13 C 22.7250 3.8957 0.0 0
M  V30 14 C 22.1614 5.9994 0.0 0
M  V30 15 C 8.2843 4.1476 0.0 0
M  V30 16 C 9.3147 5.2920 0.0 0
M  V30 17 N 9.0543 2.8138 0.0 0
M  V30 18 C 10.7217 4.6657 0.0 0
M  V30 19 N 10.5608 3.1340 0.0 0
M  V30 20 C 6.7527 4.3086 0.0 0
M  V30 21 C 6.1264 5.7154 0.0 0
M  V30 22 C 5.8475 3.0627 0.0 0
M  V30 23 C 4.5947 5.8765 0.0 0
M  V30 24 C 4.3159 3.2236 0.0 0
M  V30 25 C 3.6896 4.6304 0.0 0
M  V30 26 C 14.7229 5.4357 0.0 0 CFG=1
M  V30 27 C 16.0565 4.6657 0.0 0
M  V30 28 C 14.7229 6.9757 0.0 0
M  V30 29 N 17.3902 5.4357 0.0 0
M  V30 30 C 16.0565 7.7458 0.0 0
M  V30 31 C 17.3902 6.9757 0.0 0
M  V30 32 H 6.8964 1.2460 0.0 0 MASS=2
M  V30 33 H 7.8015 0.0000 0.0 0 MASS=2
M  V30 34 H 9.3332 0.1611 0.0 0 MASS=2
M  V30 35 H 0.0000 6.3593 0.0 0 MASS=2
M  V30 36 H 0.9052 7.6053 0.0 0 MASS=2
M  V30 37 H 2.4368 7.4442 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 32
M  V30 3 1 1 33
M  V30 4 1 1 34
M  V30 5 1 2 21
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 3 18
M  V30 9 1 26 4 CFG=1
M  V30 10 1 6 7
M  V30 11 1 6 25
M  V30 12 1 7 35
M  V30 13 1 7 36
M  V30 14 1 7 37
M  V30 15 1 8 9
M  V30 16 2 8 10
M  V30 17 1 8 29
M  V30 18 1 9 11
M  V30 19 1 11 12
M  V30 20 1 11 13
M  V30 21 1 11 14
M  V30 22 2 15 16
M  V30 23 1 15 17
M  V30 24 1 15 20
M  V30 25 1 16 18
M  V30 26 1 17 19
M  V30 27 2 18 19
M  V30 28 2 20 21
M  V30 29 1 20 22
M  V30 30 1 21 23
M  V30 31 2 22 24
M  V30 32 2 23 25
M  V30 33 1 24 25
M  V30 34 1 26 27
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 30
M  V30 38 1 29 31
M  V30 39 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2919852-24-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 625471-18-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033432-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37690313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic
Receptor Antagonist for the Modulation of Motor Dysfunction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Christie, Louisa A.; Brice, Nicola L.; Rowland, Anna; Dickson, Louise;
Anand, Rishi; Teall, Martin; Doyle, Kevin J.; Narayana, Lakshminarayana;
Mitchell, Christine; Harvey, Jenna R. M.; Mulligan, Victoria; Dawson, Lee
A.; Cragg, Stephanie J.; Carlton, Mark; Burli, Roland W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(17), 11718-11731

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
4-Phenoxybenzoic acid
C13H10O3
2215-77-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 4.6201 0.0 0
M  V30 2 C 9.3360 1.5400 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 O 9.3360 0.0000 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, [5-(4-aminophenyl)-1H-indol-2-yl](3,4-dihydro-6,7-dimethoxy-2(1H)-...
C26H25N3O3
2919713-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 1.5400 0.0 0
M  V30 2 O 8.0020 0.0000 0.0 0
M  V30 3 N 20.2430 4.1617 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 4.6200 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 11.7730 2.8281 0.0 0
M  V30 9 C 11.0030 4.1617 0.0 0
M  V30 10 C 10.7426 1.6837 0.0 0
M  V30 11 C 13.3130 2.8281 0.0 0
M  V30 12 N 9.4967 3.8415 0.0 0
M  V30 13 C 11.7730 5.4955 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 14.0830 4.1617 0.0 0
M  V30 16 C 13.3130 5.4955 0.0 0
M  V30 17 C 15.6230 4.1617 0.0 0
M  V30 18 C 16.3930 2.8281 0.0 0
M  V30 19 C 16.3930 5.4955 0.0 0
M  V30 20 C 17.9330 2.8281 0.0 0
M  V30 21 C 17.9330 5.4955 0.0 0
M  V30 22 C 18.7030 4.1617 0.0 0
M  V30 23 N 6.6684 2.3100 0.0 0
M  V30 24 C 5.3347 1.5400 0.0 0
M  V30 25 C 6.6684 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 5.3347 4.6200 0.0 0
M  V30 28 C 4.0009 3.8500 0.0 0
M  V30 29 C 2.6673 1.5400 0.0 0
M  V30 30 C 2.6673 4.6200 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0
M  V30 32 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 23
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 31
M  V30 7 1 6 7
M  V30 8 1 6 32
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[4-[2-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-...
C39H33N3O5
2925367-79-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 8.0022 0.0 0
M  V30 2 O 6.9300 9.3358 0.0 0
M  V30 3 N 19.6120 11.8522 0.0 0
M  V30 4 C 20.9456 11.0822 0.0 0
M  V30 5 O 20.9456 9.5422 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3347 0.0 0
M  V30 8 O 2.3100 1.3336 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 O 26.2804 14.1622 0.0 0
M  V30 11 C 11.6098 8.7722 0.0 0
M  V30 12 C 11.6098 7.2322 0.0 0
M  V30 13 C 10.1453 9.2481 0.0 0
M  V30 14 C 12.9436 9.5422 0.0 0
M  V30 15 N 10.1453 6.7563 0.0 0
M  V30 16 C 12.9436 6.4622 0.0 0
M  V30 17 C 9.2400 8.0022 0.0 0
M  V30 18 C 14.2773 8.7722 0.0 0
M  V30 19 C 14.2773 7.2322 0.0 0
M  V30 20 C 15.6109 9.5422 0.0 0
M  V30 21 C 16.9446 8.7722 0.0 0
M  V30 22 C 15.6109 11.0822 0.0 0
M  V30 23 C 18.2784 9.5422 0.0 0
M  V30 24 C 16.9446 11.8522 0.0 0
M  V30 25 C 18.2784 11.0822 0.0 0
M  V30 26 N 6.9300 6.6684 0.0 0
M  V30 27 C 5.3900 6.6684 0.0 0
M  V30 28 C 7.7000 5.3347 0.0 0
M  V30 29 C 4.6200 5.3347 0.0 0
M  V30 30 C 6.9300 4.0011 0.0 0
M  V30 31 C 5.3900 4.0011 0.0 0
M  V30 32 C 3.0800 5.3347 0.0 0
M  V30 33 C 4.6200 2.6674 0.0 0
M  V30 34 C 2.3100 4.0011 0.0 0
M  V30 35 C 3.0800 2.6674 0.0 0
M  V30 36 C 22.2793 11.8522 0.0 0
M  V30 37 C 23.6131 11.0822 0.0 0
M  V30 38 C 22.2793 13.3922 0.0 0
M  V30 39 C 24.9467 11.8522 0.0 0
M  V30 40 C 23.6131 14.1622 0.0 0
M  V30 41 C 24.9467 13.3922 0.0 0
M  V30 42 C 27.6140 13.3922 0.0 0
M  V30 43 C 27.6140 11.8522 0.0 0
M  V30 44 C 28.9478 14.1622 0.0 0
M  V30 45 C 28.9478 11.0822 0.0 0
M  V30 46 C 30.2815 13.3922 0.0 0
M  V30 47 C 30.2815 11.8522 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 2 4 5
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 8 35
M  V30 12 1 10 41
M  V30 13 1 10 42
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 2 12 16
M  V30 19 2 13 17
M  V30 20 1 14 18
M  V30 21 1 15 17
M  V30 22 1 16 19
M  V30 23 2 18 19
M  V30 24 1 18 20
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 31 1 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 29 32
M  V30 37 1 30 31
M  V30 38 2 31 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 35
M  V30 42 2 36 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 40
M  V30 46 2 39 41
M  V30 47 1 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2215-77-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2919713-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925367-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36830495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein
Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug
Resistance Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Cai, Yue; Yang, Xue; Li, Yasheng; Wu, Qihao; Yu, Yanlei;
Chen, Zhen; Wei, Bin; Tian, Jin-Miao; Bao, Xiaoze; Ye, Xinyi; Chen,
Jianwei; Zhang, Huawei; Mou, Xiaozhou; Sun, Xuanrong; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(8), 5550-5566

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide
C20H29N3O3S
169280-56-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.8500 0.0 0
M  V30 2 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 6.1048 5.9537 0.0 0
M  V30 6 O 4.5648 3.2864 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0 CFG=1
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0 CFG=1
M  V30 10 O 9.3359 2.3100 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 12.0034 3.8500 0.0 0
M  V30 14 N 10.6697 6.1601 0.0 0
M  V30 15 N 0.0000 7.7001 0.0 0
M  V30 16 C 4.0011 5.3901 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 C 2.6675 4.6201 0.0 0
M  V30 19 C 2.6675 7.7001 0.0 0
M  V30 20 C 1.3338 5.3901 0.0 0
M  V30 21 C 1.3338 6.9301 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 14.6707 6.9301 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 16.0045 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 22
M  V30 16 1 15 21
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(S)-4-(tert-Butoxycarbonyl)morpholine-3-carboxylic acid
C10H17NO5
783350-37-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 6.8749 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 3.7949 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylprop...
C30H44N4O7S
2765293-55-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 9.2401 0.0 0
M  V30 2 N 8.0022 8.4701 0.0 0
M  V30 3 O 5.3348 8.4701 0.0 0
M  V30 4 C 8.0022 6.9301 0.0 0 CFG=2
M  V30 5 C 6.6686 6.1601 0.0 0
M  V30 6 C 9.3359 6.1601 0.0 0 CFG=2
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 O 10.6695 6.9301 0.0 0
M  V30 9 N 10.6695 3.8500 0.0 0
M  V30 10 S 12.0034 4.6201 0.0 0 VAL=6
M  V30 11 C 10.6695 2.3100 0.0 0
M  V30 12 O 11.2333 5.9537 0.0 0
M  V30 13 O 12.7734 3.2864 0.0 0
M  V30 14 C 12.0034 1.5400 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 C 13.3370 2.3100 0.0 0
M  V30 17 C 4.0011 10.7801 0.0 0
M  V30 18 O 2.6675 11.5501 0.0 0
M  V30 19 O 4.0011 9.2401 0.0 0
M  V30 20 C 1.3338 10.7801 0.0 0
M  V30 21 C 0.5638 12.1138 0.0 0
M  V30 22 C 0.0000 10.0101 0.0 0
M  V30 23 C 2.1038 9.4465 0.0 0
M  V30 24 N 17.3381 7.7001 0.0 0
M  V30 25 C 6.6686 10.7801 0.0 0 CFG=2
M  V30 26 N 5.3348 11.5501 0.0 0
M  V30 27 C 8.0022 11.5501 0.0 0
M  V30 28 C 5.3348 13.0901 0.0 0
M  V30 29 O 8.0022 13.0901 0.0 0
M  V30 30 C 6.6686 13.8602 0.0 0
M  V30 31 C 6.6686 4.6201 0.0 0
M  V30 32 C 8.0022 3.8500 0.0 0
M  V30 33 C 5.3348 3.8500 0.0 0
M  V30 34 C 8.0022 2.3100 0.0 0
M  V30 35 C 5.3348 2.3100 0.0 0
M  V30 36 C 6.6686 1.5400 0.0 0
M  V30 37 C 13.3370 5.3901 0.0 0
M  V30 38 C 13.3370 6.9301 0.0 0
M  V30 39 C 14.6707 4.6201 0.0 0
M  V30 40 C 14.6707 7.7001 0.0 0
M  V30 41 C 16.0043 5.3901 0.0 0
M  V30 42 C 16.0043 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 25 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 31
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 37
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 26
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 42
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 6 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 169280-56-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 783350-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Acetic acid, 2-[[5-cyano-4-phenyl-6-(phenylamino)-2-pyrimidinyl]thio]-
C19H14N4O2S
2953073-26-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 9.3359 0.0 0
M  V30 2 N 8.4701 10.6695 0.0 0
M  V30 3 N 4.6201 9.3359 0.0 0
M  V30 4 S 4.6201 4.0011 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 3.0800 1.3337 0.0 0
M  V30 9 C 7.7001 6.6684 0.0 0
M  V30 10 C 6.9301 8.0022 0.0 0
M  V30 11 N 6.9301 5.3348 0.0 0
M  V30 12 C 5.3901 8.0022 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 N 4.6201 6.6684 0.0 0
M  V30 15 C 9.2401 6.6684 0.0 0
M  V30 16 C 10.0101 8.0022 0.0 0
M  V30 17 C 10.0101 5.3348 0.0 0
M  V30 18 C 11.5501 8.0022 0.0 0
M  V30 19 C 11.5501 5.3348 0.0 0
M  V30 20 C 12.3201 6.6684 0.0 0
M  V30 21 C 3.0800 9.3359 0.0 0
M  V30 22 C 2.3100 10.6695 0.0 0
M  V30 23 C 2.3100 8.0022 0.0 0
M  V30 24 C 0.7700 10.6695 0.0 0
M  V30 25 C 0.7700 8.0022 0.0 0
M  V30 26 C 0.0000 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 15
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Aminoethoxy)-3-(phenylsulfonyl)furoxan
C10H11N3O5S
186408-95-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 4.0012 0.0 0 VAL=6
M  V30 2 O 1.7462 4.7712 0.0 0
M  V30 3 O 4.4137 3.2311 0.0 0
M  V30 4 O 6.4121 4.3514 0.0 0
M  V30 5 C 7.9185 4.6715 0.0 0
M  V30 6 C 8.9490 3.5271 0.0 0
M  V30 7 N 10.4553 3.8473 0.0 0
M  V30 8 O 1.7173 7.0620 0.0 0
M  V30 9 C 3.8501 5.3348 0.0 0
M  V30 10 C 5.3816 5.4958 0.0 0
M  V30 11 N 3.2236 6.7418 0.0 0 VAL=5
M  V30 12 N 5.7018 7.0022 0.0 0
M  V30 13 O 4.3682 7.7722 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 0.7700 2.6675 0.0 0
M  V30 16 C 3.0801 1.3337 0.0 0
M  V30 17 C 0.0000 1.3337 0.0 0
M  V30 18 C 2.3101 0.0000 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 14
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 8 11
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, 2-[[5-cyano-4-phenyl-6-(phenylamino)-2-pyrimidinyl]thio]-N-[2-[[5-...
C29H23N7O6S2
2953073-12-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 6.6685 0.0 0
M  V30 2 N 0.0000 6.6685 0.0 0
M  V30 3 N 3.0800 4.0011 0.0 0
M  V30 4 S 7.7000 6.6685 0.0 0
M  V30 5 C 8.4700 8.0021 0.0 0
M  V30 6 C 10.0100 8.0021 0.0 0
M  V30 7 N 10.7800 9.3358 0.0 0
M  V30 8 O 10.7800 6.6685 0.0 0
M  V30 9 C 12.3200 9.3358 0.0 0
M  V30 10 C 13.0900 10.6696 0.0 0
M  V30 11 O 14.6300 10.6696 0.0 0
M  V30 12 S 17.9619 11.0198 0.0 0 VAL=6
M  V30 13 O 16.8176 9.9892 0.0 0
M  V30 14 O 19.1065 12.0502 0.0 0
M  V30 15 O 18.6585 14.2969 0.0 0
M  V30 16 C 3.8500 8.0021 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 N 5.3900 8.0021 0.0 0
M  V30 19 C 3.8500 5.3347 0.0 0
M  V30 20 C 6.1600 6.6685 0.0 0
M  V30 21 N 5.3900 5.3347 0.0 0
M  V30 22 C 3.0800 9.3358 0.0 0
M  V30 23 C 3.8500 10.6696 0.0 0
M  V30 24 C 1.5400 9.3358 0.0 0
M  V30 25 C 3.0800 12.0032 0.0 0
M  V30 26 C 0.7700 10.6696 0.0 0
M  V30 27 C 1.5400 12.0032 0.0 0
M  V30 28 C 3.8500 2.6674 0.0 0
M  V30 29 C 3.0800 1.3338 0.0 0
M  V30 30 C 5.3900 2.6674 0.0 0
M  V30 31 C 3.8500 0.0000 0.0 0
M  V30 32 C 6.1600 1.3338 0.0 0
M  V30 33 C 5.3900 0.0000 0.0 0
M  V30 34 C 15.4000 12.0032 0.0 0
M  V30 35 C 16.9315 12.1642 0.0 0
M  V30 36 N 14.7735 13.4100 0.0 0
M  V30 37 N 17.2517 13.6706 0.0 0 VAL=5
M  V30 38 O 15.9181 14.4406 0.0 0
M  V30 39 C 18.9925 9.8753 0.0 0
M  V30 40 C 18.5165 8.4107 0.0 0
M  V30 41 C 20.4988 10.1954 0.0 0
M  V30 42 C 19.5471 7.2662 0.0 0
M  V30 43 C 21.5292 9.0510 0.0 0
M  V30 44 C 21.0533 7.5863 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 17
M  V30 3 1 3 19
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 34
M  V30 14 2 12 13
M  V30 15 2 12 14
M  V30 16 1 12 35
M  V30 17 1 12 39
M  V30 18 2 15 37
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 16 22
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2953073-26-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 186408-95-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2953073-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37137463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of nitric oxide-releasing
5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chi, Lingling; Wang, Hao; Yu, Fuqiang; Gao, Chao; Dai, Honglin; Si,
Xiaojie; Dong, Yuze; Liu, Hongmin; Zhang, Qiurong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2023), 92129389

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
1-Naphthoic acid
C11H8O2
86-55-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3338 0.0 0
M  V30 2 O 6.9300 1.3338 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C33H28N2O5
2892485-65-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.9722 7.4754 0.0 0
M  V30 2 O 16.5985 8.8824 0.0 0
M  V30 3 O 23.2825 4.2206 0.0 0
M  V30 4 C 23.9088 5.6275 0.0 0
M  V30 5 O 22.0297 1.4070 0.0 0
M  V30 6 C 21.4034 0.0000 0.0 0
M  V30 7 N 6.6684 10.9126 0.0 0
M  V30 8 C 5.3348 10.1426 0.0 0
M  V30 9 O 5.3348 8.6026 0.0 0
M  V30 10 C 19.3142 5.1446 0.0 0
M  V30 11 C 18.6877 3.7378 0.0 0
M  V30 12 C 18.4090 6.3905 0.0 0
M  V30 13 C 20.8457 5.3055 0.0 0
M  V30 14 C 19.5929 2.4918 0.0 0
M  V30 15 C 17.1562 3.5767 0.0 0
M  V30 16 N 16.8774 6.2295 0.0 0
M  V30 17 C 21.7510 4.0597 0.0 0
M  V30 18 C 21.1245 2.6528 0.0 0
M  V30 19 C 16.2509 4.8226 0.0 0
M  V30 20 C 14.4406 7.3145 0.0 0
M  V30 21 O 13.4100 8.4589 0.0 0
M  V30 22 C 13.6706 5.9808 0.0 0
M  V30 23 C 12.0032 7.8326 0.0 0
M  V30 24 C 12.1642 6.3010 0.0 0
M  V30 25 C 10.6696 8.6026 0.0 0
M  V30 26 C 10.6696 10.1426 0.0 0
M  V30 27 C 9.3358 7.8326 0.0 0
M  V30 28 C 9.3358 10.9126 0.0 0
M  V30 29 C 8.0021 8.6026 0.0 0
M  V30 30 C 8.0021 10.1426 0.0 0
M  V30 31 C 4.0010 10.9126 0.0 0
M  V30 32 C 2.6673 10.1426 0.0 0
M  V30 33 C 4.0010 12.4526 0.0 0
M  V30 34 C 1.3337 10.9126 0.0 0
M  V30 35 C 2.6673 8.6026 0.0 0
M  V30 36 C 2.6673 13.2226 0.0 0
M  V30 37 C 1.3337 12.4526 0.0 0
M  V30 38 C 0.0000 10.1426 0.0 0
M  V30 39 C 1.3337 7.8326 0.0 0
M  V30 40 C 0.0000 8.6026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 32 35
M  V30 39 1 33 36
M  V30 40 1 34 37
M  V30 41 1 34 38
M  V30 42 2 35 39
M  V30 43 2 36 37
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Cinnamic acid
C9H8O2
621-82-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N-[4-[5-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbon...
C31H28N2O5
2897680-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4412 2.3681 0.0 0
M  V30 2 O 8.6022 0.8365 0.0 0
M  V30 3 O 0.4829 1.5317 0.0 0
M  V30 4 C 0.6439 0.0000 0.0 0
M  V30 5 O 0.1611 4.5948 0.0 0
M  V30 6 C 0.0000 6.1263 0.0 0
M  V30 7 N 18.2171 4.0433 0.0 0
M  V30 8 C 18.9871 5.3769 0.0 0
M  V30 9 C 20.5271 5.3769 0.0 0
M  V30 10 O 18.2171 6.7106 0.0 0
M  V30 11 C 21.2971 6.7106 0.0 0
M  V30 12 C 4.3816 2.7156 0.0 0
M  V30 13 C 4.2207 4.2472 0.0 0
M  V30 14 C 5.7884 2.0893 0.0 0
M  V30 15 C 3.1358 1.8104 0.0 0
M  V30 16 C 2.8137 4.8735 0.0 0
M  V30 17 C 5.4666 5.1524 0.0 0
M  V30 18 N 7.0344 2.9944 0.0 0
M  V30 19 C 1.7288 2.4368 0.0 0
M  V30 20 C 1.5679 3.9684 0.0 0
M  V30 21 C 6.8734 4.5261 0.0 0
M  V30 22 C 9.6871 3.2733 0.0 0
M  V30 23 O 11.1518 2.7974 0.0 0
M  V30 24 C 9.6871 4.8133 0.0 0
M  V30 25 C 12.0570 4.0433 0.0 0
M  V30 26 C 11.1518 5.2892 0.0 0
M  V30 27 C 13.5970 4.0433 0.0 0
M  V30 28 C 14.3670 2.7096 0.0 0
M  V30 29 C 14.3670 5.3769 0.0 0
M  V30 30 C 15.9070 2.7096 0.0 0
M  V30 31 C 15.9070 5.3769 0.0 0
M  V30 32 C 16.6771 4.0433 0.0 0
M  V30 33 C 22.8371 6.7106 0.0 0
M  V30 34 C 23.6071 5.3769 0.0 0
M  V30 35 C 23.6071 8.0444 0.0 0
M  V30 36 C 25.1471 5.3769 0.0 0
M  V30 37 C 25.1471 8.0444 0.0 0
M  V30 38 C 25.9171 6.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11 CFG=2
M  V30 13 1 11 33
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 2 19 20
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 621-82-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2897680-77-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
3-Oxabicyclo[3.1.0]hexan-6-amine, hydrochloride (1:1), (1α,5α,6α)-
C5H9NO.ClH
1048962-49-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.2435 3.7168 0.0 0
M  V30 2 C 2.3698 4.4869 0.0 0 CFG=1
M  V30 3 C 2.3698 2.9468 0.0 0 CFG=2
M  V30 4 C 3.7035 3.7168 0.0 0 CFG=2
M  V30 5 C 0.9052 4.9627 0.0 0
M  V30 6 C 0.9052 2.4710 0.0 0
M  V30 7 O 0.0000 3.7168 0.0 0
M  V30 8 H 2.9961 5.8937 0.0 0
M  V30 9 H 2.9961 1.5400 0.0 0
M  V30 10 Cl 2.6218 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 8 CFG=3
M  V30 6 1 3 4
M  V30 7 1 3 6
M  V30 8 1 3 9 CFG=3
M  V30 9 1 5 7
M  V30 10 1 6 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R)-2-(Fluoromethyl)-2,3-dihydro-7-[(methylamino)carbonyl]-3-phenyl-5...
C18H16FNO4
2138475-74-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3754 1.3338 0.0 0
M  V30 2 F 5.1454 0.0000 0.0 0
M  V30 3 C 9.6646 4.3348 0.0 0
M  V30 4 N 10.9982 5.1048 0.0 0
M  V30 5 O 9.6646 2.7948 0.0 0
M  V30 6 C 12.3320 4.3348 0.0 0
M  V30 7 C 6.9973 8.9548 0.0 0
M  V30 8 O 5.6635 9.7248 0.0 0
M  V30 9 O 8.3309 9.7248 0.0 0
M  V30 10 C 4.5191 4.0742 0.0 0 CFG=2
M  V30 11 C 5.6635 5.1048 0.0 0
M  V30 12 C 5.1454 2.6674 0.0 0 CFG=1
M  V30 13 C 6.9973 4.3348 0.0 0
M  V30 14 C 5.6635 6.6448 0.0 0
M  V30 15 O 6.6770 2.8284 0.0 0
M  V30 16 C 8.3309 5.1048 0.0 0
M  V30 17 C 6.9973 7.4148 0.0 0
M  V30 18 C 8.3309 6.6448 0.0 0
M  V30 19 C 3.0127 4.3944 0.0 0
M  V30 20 C 2.5368 5.8591 0.0 0
M  V30 21 C 1.9823 3.2500 0.0 0
M  V30 22 C 1.0306 6.1792 0.0 0
M  V30 23 C 0.4760 3.5702 0.0 0
M  V30 24 C 0.0000 5.0349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 19 CFG=1
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5,7-Benzofurandicarboxamide, 2-(fluoromethyl)-2,3-dihydro-N7-methyl-N5-(1α,5β...
C23H23FN2O4
2139228-58-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3347 9.6646 0.0 0
M  V30 2 N 5.1047 10.9983 0.0 0
M  V30 3 O 2.7947 9.6646 0.0 0
M  V30 4 C 4.3347 12.3321 0.0 0
M  V30 5 C 1.3336 4.3755 0.0 0
M  V30 6 F 0.0000 5.1455 0.0 0
M  V30 7 C 8.9547 6.9973 0.0 0
M  V30 8 N 9.7247 8.3310 0.0 0
M  V30 9 O 9.7247 5.6635 0.0 0
M  V30 10 C 5.1047 5.6635 0.0 0
M  V30 11 C 4.3347 6.9973 0.0 0
M  V30 12 C 4.0742 4.5192 0.0 0 CFG=2
M  V30 13 C 6.6447 5.6635 0.0 0
M  V30 14 C 5.1047 8.3310 0.0 0
M  V30 15 O 2.8284 6.6770 0.0 0
M  V30 16 C 2.6674 5.1455 0.0 0 CFG=1
M  V30 17 C 7.4147 6.9973 0.0 0
M  V30 18 C 6.6447 8.3310 0.0 0
M  V30 19 C 4.3944 3.0127 0.0 0
M  V30 20 C 3.2500 1.9823 0.0 0
M  V30 21 C 5.8591 2.5369 0.0 0
M  V30 22 C 3.5702 0.4760 0.0 0
M  V30 23 C 6.1793 1.0306 0.0 0
M  V30 24 C 5.0347 0.0000 0.0 0
M  V30 25 C 11.2647 8.3310 0.0 0 CFG=1
M  V30 26 C 12.5985 9.1010 0.0 0 CFG=1
M  V30 27 C 12.5985 7.5610 0.0 0 CFG=2
M  V30 28 C 14.0630 9.5768 0.0 0
M  V30 29 C 14.0630 7.0851 0.0 0
M  V30 30 O 14.9683 8.3310 0.0 0
M  V30 31 H 11.9720 10.5078 0.0 0
M  V30 32 H 11.9720 6.1540 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 16 5 CFG=1
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 25 8 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 19 CFG=3
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 26 31 CFG=3
M  V30 33 1 27 29
M  V30 34 1 27 32 CFG=3
M  V30 35 1 28 30
M  V30 36 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 12 16 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1048962-49-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2138475-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139228-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31168985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled
by High-Throughput Experimentation and a Claisen Rearrangement in Flow
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alder, Catherine M.; Gray, Matthew; Huff, Chelsea A.; Manning, Calvin O.;
Preston, Alex; Rushworth, Philip; Shuster, Leanna E.; Watson, Robert J.;
Wheelhouse, Katherine M. P.; Williams, Glynn D.; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(2), 365-379

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
3-Oxabicyclo[3.1.0]hexan-6-amine, hydrochloride (1:1), (1α,5α,6α)-
C5H9NO.ClH
1048962-49-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.2435 3.7168 0.0 0
M  V30 2 C 2.3698 4.4869 0.0 0 CFG=1
M  V30 3 C 2.3698 2.9468 0.0 0 CFG=2
M  V30 4 C 3.7035 3.7168 0.0 0 CFG=2
M  V30 5 C 0.9052 4.9627 0.0 0
M  V30 6 C 0.9052 2.4710 0.0 0
M  V30 7 O 0.0000 3.7168 0.0 0
M  V30 8 H 2.9961 5.8937 0.0 0
M  V30 9 H 2.9961 1.5400 0.0 0
M  V30 10 Cl 2.6218 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 8 CFG=3
M  V30 6 1 3 4
M  V30 7 1 3 6
M  V30 8 1 3 9 CFG=3
M  V30 9 1 5 7
M  V30 10 1 6 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,3S)-2-(Fluoromethyl)-2,3-dihydro-7-[(methylamino)carbonyl]-3-phenyl-5-ben...
C18H16FNO4
2138475-04-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.3754 1.3338 0.0 0
M  V30 2 F 5.1454 0.0000 0.0 0
M  V30 3 C 9.6646 4.3348 0.0 0
M  V30 4 N 10.9982 5.1048 0.0 0
M  V30 5 O 9.6646 2.7948 0.0 0
M  V30 6 C 12.3320 4.3348 0.0 0
M  V30 7 C 6.9973 8.9548 0.0 0
M  V30 8 O 5.6635 9.7248 0.0 0
M  V30 9 O 8.3309 9.7248 0.0 0
M  V30 10 C 4.5191 4.0742 0.0 0 CFG=2
M  V30 11 C 5.6635 5.1048 0.0 0
M  V30 12 C 5.1454 2.6674 0.0 0 CFG=1
M  V30 13 C 6.9973 4.3348 0.0 0
M  V30 14 C 5.6635 6.6448 0.0 0
M  V30 15 O 6.6770 2.8284 0.0 0
M  V30 16 C 8.3309 5.1048 0.0 0
M  V30 17 C 6.9973 7.4148 0.0 0
M  V30 18 C 8.3309 6.6448 0.0 0
M  V30 19 C 3.0127 4.3944 0.0 0
M  V30 20 C 2.5368 5.8591 0.0 0
M  V30 21 C 1.9823 3.2500 0.0 0
M  V30 22 C 1.0306 6.1792 0.0 0
M  V30 23 C 0.4760 3.5702 0.0 0
M  V30 24 C 0.0000 5.0349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 19 CFG=1
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,3S)-2-(Fluoromethyl)-2,3-dihydro-N7-methyl-N5-(1α,5β,6β)-3-oxabicyclo[3.1...
C23H23FN2O4
2138473-38-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.3347 9.6646 0.0 0
M  V30 2 N 5.1047 10.9983 0.0 0
M  V30 3 O 2.7947 9.6646 0.0 0
M  V30 4 C 4.3347 12.3321 0.0 0
M  V30 5 C 1.3336 4.3755 0.0 0
M  V30 6 F 0.0000 5.1455 0.0 0
M  V30 7 C 8.9547 6.9973 0.0 0
M  V30 8 N 9.7247 8.3310 0.0 0
M  V30 9 O 9.7247 5.6635 0.0 0
M  V30 10 C 5.1047 5.6635 0.0 0
M  V30 11 C 4.3347 6.9973 0.0 0
M  V30 12 C 4.0742 4.5192 0.0 0 CFG=2
M  V30 13 C 6.6447 5.6635 0.0 0
M  V30 14 C 5.1047 8.3310 0.0 0
M  V30 15 O 2.8284 6.6770 0.0 0
M  V30 16 C 2.6674 5.1455 0.0 0 CFG=1
M  V30 17 C 7.4147 6.9973 0.0 0
M  V30 18 C 6.6447 8.3310 0.0 0
M  V30 19 C 4.3944 3.0127 0.0 0
M  V30 20 C 3.2500 1.9823 0.0 0
M  V30 21 C 5.8591 2.5369 0.0 0
M  V30 22 C 3.5702 0.4760 0.0 0
M  V30 23 C 6.1793 1.0306 0.0 0
M  V30 24 C 5.0347 0.0000 0.0 0
M  V30 25 C 11.2647 8.3310 0.0 0 CFG=2
M  V30 26 C 12.5985 9.1010 0.0 0 CFG=2
M  V30 27 C 12.5985 7.5610 0.0 0 CFG=1
M  V30 28 C 14.0630 9.5768 0.0 0
M  V30 29 C 14.0630 7.0851 0.0 0
M  V30 30 O 14.9683 8.3310 0.0 0
M  V30 31 H 11.9720 10.5078 0.0 0
M  V30 32 H 11.9720 6.1540 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 16 5 CFG=1
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 25 8 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 19 CFG=3
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 26 31 CFG=1
M  V30 33 1 27 29
M  V30 34 1 27 32 CFG=1
M  V30 35 1 28 30
M  V30 36 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 16 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1048962-49-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2138475-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138473-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24250402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the
Bromodomain and Extra-Terminal (BET) Family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Preston, Alex; Atkinson, Stephen J.; Bamborough, Paul; Chung, Chun-wa;
Gordon, Laurie J.; Grandi, Paola; Gray, James R. J.; Harrison, Lee A.;
Lewis, Antonia J.; Lugo, David; Messenger, Cassie; Michon, Anne-Marie;
Mitchell, Darren J.; Prinjha, Rab K.; Rioja, Inmaculada; Seal, Jon;
Taylor, Simon; Thesmar, Pierre; Wall, Ian D.; Watson, Robert J.; Woolven,
James M.; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N6-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-lysine
C26H32N2O6
115186-31-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 5.9538 0.0 0
M  V30 2 O 13.3372 6.7238 0.0 0
M  V30 3 C 12.0035 5.9538 0.0 0
M  V30 4 N 10.6697 6.7238 0.0 0
M  V30 5 O 12.0035 4.4137 0.0 0
M  V30 6 C 9.3360 5.9538 0.0 0
M  V30 7 C 8.0023 6.7238 0.0 0
M  V30 8 C 6.6687 5.9538 0.0 0
M  V30 9 C 5.3348 6.7238 0.0 0
M  V30 10 C 4.0012 5.9538 0.0 0 CFG=2
M  V30 11 N 4.0012 4.4137 0.0 0
M  V30 12 C 2.6675 6.7238 0.0 0
M  V30 13 C 2.6675 3.6437 0.0 0
M  V30 14 O 1.3338 5.9538 0.0 0
M  V30 15 O 2.6675 8.2638 0.0 0
M  V30 16 O 2.6675 2.1037 0.0 0
M  V30 17 O 1.3338 4.4137 0.0 0
M  V30 18 C 1.3338 1.3337 0.0 0
M  V30 19 C 0.5638 2.6673 0.0 0
M  V30 20 C 0.0000 0.5637 0.0 0
M  V30 21 C 2.1038 0.0000 0.0 0
M  V30 22 C 16.0045 6.7238 0.0 0
M  V30 23 C 17.4115 6.0975 0.0 0
M  V30 24 C 16.1656 8.2554 0.0 0
M  V30 25 C 18.4419 7.2419 0.0 0
M  V30 26 C 17.8873 4.6327 0.0 0
M  V30 27 C 17.6719 8.5755 0.0 0
M  V30 28 C 15.1350 9.3999 0.0 0
M  V30 29 C 19.9484 6.9217 0.0 0
M  V30 30 C 19.3936 4.3126 0.0 0
M  V30 31 C 18.1478 10.0402 0.0 0
M  V30 32 C 15.6109 10.8645 0.0 0
M  V30 33 C 20.4242 5.4570 0.0 0
M  V30 34 C 17.1173 11.1846 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 1 24 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 33
M  V30 35 1 31 34
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Thiazolecarboxylic acid, 2-[(1S)-1-amino-2-methylpropyl]-, ethyl ester, 2,2...
C10H16N2O2S.C2HF3O2
1017321-07-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 7.8512 0.0 0 CFG=1
M  V30 2 C 1.5400 6.5174 0.0 0
M  V30 3 N 1.5400 9.1848 0.0 0
M  V30 4 C 0.0000 6.5174 0.0 0
M  V30 5 C 2.3100 5.1837 0.0 0
M  V30 6 C 7.4658 9.5264 0.0 0
M  V30 7 O 8.8726 8.8999 0.0 0
M  V30 8 O 7.3047 11.0579 0.0 0
M  V30 9 C 10.1185 9.8051 0.0 0
M  V30 10 C 11.5254 9.1788 0.0 0
M  V30 11 C 3.8500 7.8512 0.0 0
M  V30 12 N 4.7552 9.0970 0.0 0
M  V30 13 S 4.7552 6.6053 0.0 0
M  V30 14 C 6.2199 8.6212 0.0 0
M  V30 15 C 6.2199 7.0812 0.0 0
M  V30 16 C 5.0959 2.3101 0.0 0
M  V30 17 C 6.4295 1.5400 0.0 0
M  V30 18 F 5.8659 3.6437 0.0 0
M  V30 19 F 3.7622 3.0801 0.0 0
M  V30 20 F 4.3259 0.9764 0.0 0
M  V30 21 O 7.7632 2.3101 0.0 0
M  V30 22 O 6.4295 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 17 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-1-[[(2R)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-6-[[(9H-fluore...
C36H46N4O7S
2452190-19-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 12.0033 0.0 0
M  V30 2 O 5.8243 10.6695 0.0 0
M  V30 3 C 7.3643 10.6695 0.0 0
M  V30 4 N 8.1343 9.3358 0.0 0
M  V30 5 O 8.1343 12.0033 0.0 0
M  V30 6 C 9.6743 9.3358 0.0 0
M  V30 7 C 10.4443 8.0022 0.0 0
M  V30 8 C 11.9843 8.0022 0.0 0
M  V30 9 C 12.7543 6.6685 0.0 0
M  V30 10 C 14.2944 6.6685 0.0 0 CFG=1
M  V30 11 C 15.0644 8.0022 0.0 0
M  V30 12 N 15.0644 5.3347 0.0 0
M  V30 13 N 16.6044 8.0022 0.0 0
M  V30 14 O 14.2944 9.3358 0.0 0
M  V30 15 C 14.2944 4.0011 0.0 0
M  V30 16 C 17.3744 9.3358 0.0 0 CFG=2
M  V30 17 O 15.0644 2.6674 0.0 0
M  V30 18 O 12.7543 4.0011 0.0 0
M  V30 19 C 16.6044 10.6695 0.0 0
M  V30 20 C 14.2944 1.3338 0.0 0
M  V30 21 C 15.0644 10.6695 0.0 0
M  V30 22 C 17.3744 12.0033 0.0 0
M  V30 23 C 12.9607 2.1038 0.0 0
M  V30 24 C 13.5243 0.0000 0.0 0
M  V30 25 C 15.6280 0.5638 0.0 0
M  V30 26 C 22.5302 11.0111 0.0 0
M  V30 27 O 23.9370 10.3847 0.0 0
M  V30 28 O 22.3691 12.5426 0.0 0
M  V30 29 C 25.1828 11.2899 0.0 0
M  V30 30 C 26.5898 10.6635 0.0 0
M  V30 31 C 3.5143 12.0033 0.0 0
M  V30 32 C 2.6091 13.2491 0.0 0
M  V30 33 C 2.6091 10.7574 0.0 0
M  V30 34 C 1.1445 12.7733 0.0 0
M  V30 35 C 2.9292 14.7554 0.0 0
M  V30 36 C 1.1445 11.2333 0.0 0
M  V30 37 C 2.9292 9.2510 0.0 0
M  V30 38 C 0.0000 13.8037 0.0 0
M  V30 39 C 1.7849 15.7860 0.0 0
M  V30 40 C 0.0000 10.2027 0.0 0
M  V30 41 C 1.7849 8.2206 0.0 0
M  V30 42 C 0.3202 15.3100 0.0 0
M  V30 43 C 0.3202 8.6964 0.0 0
M  V30 44 C 18.9144 9.3358 0.0 0
M  V30 45 N 19.8196 10.5817 0.0 0
M  V30 46 S 19.8196 8.0900 0.0 0
M  V30 47 C 21.2841 10.1058 0.0 0
M  V30 48 C 21.2843 8.5658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 31
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 16 44
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 20 24
M  V30 26 1 20 25
M  V30 27 1 26 27
M  V30 28 2 26 28
M  V30 29 1 26 47
M  V30 30 1 27 29
M  V30 31 1 29 30
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 32 35
M  V30 36 1 33 36
M  V30 37 2 33 37
M  V30 38 1 34 36
M  V30 39 2 34 38
M  V30 40 1 35 39
M  V30 41 2 36 40
M  V30 42 1 37 41
M  V30 43 1 38 42
M  V30 44 2 39 42
M  V30 45 1 40 43
M  V30 46 2 41 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 1 46 48
M  V30 51 2 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 115186-31-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1017321-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2452190-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23663323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Automated design of macrocycles for therapeutic applications: From small
molecules to peptides and proteins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sindhikara, Dan; Wagner, Michael; Gkeka, Paraskevi; Gussregen, Stefan;
Tiwari, Garima; Hessler, Gerhard; Yapici, Engin; Li, Ziyu; Evers, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(20), 12100-12115

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
2′-[2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]ethyl][2,4′-bithiazole]-4-carb...
C24H19N3O4S2
308849-82-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7545 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0882 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 21.4955 6.8762 0.0 0
M  V30 9 O 22.8293 6.1062 0.0 0
M  V30 10 O 21.4955 8.4162 0.0 0
M  V30 11 C 4.4197 4.4610 0.0 0
M  V30 12 C 4.2586 2.9294 0.0 0
M  V30 13 C 3.0127 5.0873 0.0 0
M  V30 14 C 2.7523 2.6091 0.0 0
M  V30 15 C 5.2892 1.7849 0.0 0
M  V30 16 C 1.9823 3.9429 0.0 0
M  V30 17 C 2.5369 6.5520 0.0 0
M  V30 18 C 2.2765 1.1445 0.0 0
M  V30 19 C 4.8133 0.3203 0.0 0
M  V30 20 C 0.4759 4.2631 0.0 0
M  V30 21 C 1.0306 6.8722 0.0 0
M  V30 22 C 3.3069 0.0000 0.0 0
M  V30 23 C 0.0000 5.7277 0.0 0
M  V30 24 C 13.7555 5.2310 0.0 0
M  V30 25 N 15.1624 4.6045 0.0 0
M  V30 26 S 13.9166 6.7625 0.0 0
M  V30 27 C 16.1929 5.7491 0.0 0
M  V30 28 C 15.4229 7.0827 0.0 0
M  V30 29 C 17.7244 5.5881 0.0 0
M  V30 30 N 18.7550 6.7325 0.0 0
M  V30 31 S 18.4944 4.2543 0.0 0
M  V30 32 C 20.1618 6.1062 0.0 0
M  V30 33 C 20.0009 4.5745 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 32
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-aminopropyl)-N-[4-[[(1,1-dimethylethoxy)carbonyl]amino...
C17H35N3O4
68076-39-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 3.8500 5.3347 0.0 0
M  V30 3 C 6.1600 6.6684 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 O 3.0800 6.6684 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 7.7000 6.6684 0.0 0
M  V30 8 C 5.3900 2.6673 0.0 0
M  V30 9 C 1.5400 6.6684 0.0 0
M  V30 10 C 8.4700 8.0021 0.0 0
M  V30 11 C 6.1600 1.3336 0.0 0
M  V30 12 C 1.5400 5.1284 0.0 0
M  V30 13 C 0.0000 6.6684 0.0 0
M  V30 14 C 1.5400 8.2084 0.0 0
M  V30 15 C 10.0100 8.0021 0.0 0
M  V30 16 N 5.3900 0.0000 0.0 0
M  V30 17 N 10.7800 9.3358 0.0 0
M  V30 18 C 12.3200 9.3358 0.0 0
M  V30 19 O 13.0900 10.6694 0.0 0
M  V30 20 O 13.0900 8.0021 0.0 0
M  V30 21 C 14.6300 10.6694 0.0 0
M  V30 22 C 14.6300 12.2094 0.0 0
M  V30 23 C 16.1700 10.6694 0.0 0
M  V30 24 C 14.6300 9.1294 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[4-[[(1,1-dimethylethoxy)carbonyl]amino]butyl]-N-[3-[[[2′-[2...
C41H52N6O7S2
2636656-78-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 17.2980 0.0 0
M  V30 2 O 6.7709 17.2980 0.0 0
M  V30 3 C 7.5409 15.9643 0.0 0
M  V30 4 N 9.0809 15.9643 0.0 0
M  V30 5 O 6.7709 14.6307 0.0 0
M  V30 6 C 9.8509 14.6307 0.0 0
M  V30 7 C 11.3909 14.6307 0.0 0
M  V30 8 C 18.0414 8.0021 0.0 0
M  V30 9 N 19.5814 8.0021 0.0 0
M  V30 10 O 17.2714 6.6685 0.0 0
M  V30 11 C 20.3514 6.6685 0.0 0
M  V30 12 C 21.8914 6.6685 0.0 0
M  V30 13 C 22.6614 5.3348 0.0 0
M  V30 14 N 24.2015 5.3348 0.0 0
M  V30 15 C 24.9715 6.6685 0.0 0
M  V30 16 C 24.9715 4.0011 0.0 0
M  V30 17 C 26.5115 6.6685 0.0 0
M  V30 18 O 24.2015 2.6673 0.0 0
M  V30 19 O 26.5115 4.0011 0.0 0
M  V30 20 C 27.2815 8.0023 0.0 0
M  V30 21 C 24.9715 1.3337 0.0 0
M  V30 22 C 28.8215 8.0023 0.0 0
M  V30 23 C 23.6378 0.5636 0.0 0
M  V30 24 C 25.7415 0.0000 0.0 0
M  V30 25 C 26.3053 2.1037 0.0 0
M  V30 26 N 29.5915 9.3359 0.0 0
M  V30 27 C 31.1316 9.3359 0.0 0
M  V30 28 O 31.9016 10.6696 0.0 0
M  V30 29 O 31.9016 8.0023 0.0 0
M  V30 30 C 33.4416 10.6696 0.0 0
M  V30 31 C 33.4416 9.1296 0.0 0
M  V30 32 C 34.9816 10.6696 0.0 0
M  V30 33 C 33.4416 12.2096 0.0 0
M  V30 34 C 4.4608 18.6318 0.0 0
M  V30 35 C 5.0872 20.0386 0.0 0
M  V30 36 C 2.9293 18.7927 0.0 0
M  V30 37 C 3.9428 21.0691 0.0 0
M  V30 38 C 6.5519 20.5145 0.0 0
M  V30 39 C 2.6091 20.2990 0.0 0
M  V30 40 C 1.7847 17.7623 0.0 0
M  V30 41 C 4.2629 22.5755 0.0 0
M  V30 42 C 6.8720 22.0209 0.0 0
M  V30 43 C 1.1444 20.7751 0.0 0
M  V30 44 C 0.3202 18.2382 0.0 0
M  V30 45 C 5.7277 23.0514 0.0 0
M  V30 46 C 0.0000 19.7445 0.0 0
M  V30 47 C 12.1609 13.2970 0.0 0
M  V30 48 N 13.6925 13.1359 0.0 0
M  V30 49 S 11.5346 11.8901 0.0 0
M  V30 50 C 14.0127 11.6296 0.0 0
M  V30 51 C 12.6790 10.8596 0.0 0
M  V30 52 C 15.4196 11.0032 0.0 0
M  V30 53 N 15.7398 9.4969 0.0 0
M  V30 54 S 16.7533 11.7732 0.0 0
M  V30 55 C 17.2714 9.3359 0.0 0
M  V30 56 C 17.8978 10.7427 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 34
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 47
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 55
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 26 27
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 1 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 35 38
M  V30 39 1 36 39
M  V30 40 2 36 40
M  V30 41 1 37 39
M  V30 42 2 37 41
M  V30 43 1 38 42
M  V30 44 2 39 43
M  V30 45 1 40 44
M  V30 46 1 41 45
M  V30 47 2 42 45
M  V30 48 1 43 46
M  V30 49 2 44 46
M  V30 50 2 47 48
M  V30 51 1 47 49
M  V30 52 1 48 50
M  V30 53 1 49 51
M  V30 54 2 50 51
M  V30 55 1 50 52
M  V30 56 2 52 53
M  V30 57 1 52 54
M  V30 58 1 53 55
M  V30 59 1 54 56
M  V30 60 2 55 56
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 308849-82-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68076-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2636656-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40411251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of
Oncogenic miRNAs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maucort, Chloe; Bonnet, Maurinne; Ortuno, Jean-Claude; Tucker, Gordon;
Quissac, Emie; Verreault, Maite; Azoulay, Stephane; Di Giorgio,
Christophe; Di Giorgio, Audrey; Duca, Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(15), 10639-10657

$RFMT $RIREG SCHEME320 STEP1
$RXN



  6  1
$MOL
1-(9H-Fluoren-9-ylmethyl) (2S)-1,2-piperidinedicarboxylate
C21H21NO4
86069-86-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.2308 0.0 0
M  V30 2 O 5.3348 4.4608 0.0 0
M  V30 3 C 4.0011 5.2308 0.0 0
M  V30 4 O 4.0011 6.7709 0.0 0
M  V30 5 C 1.3337 6.7709 0.0 0
M  V30 6 O 2.6675 7.5409 0.0 0
M  V30 7 O 0.0000 7.5409 0.0 0
M  V30 8 C 8.0023 4.4608 0.0 0
M  V30 9 C 8.1632 2.9293 0.0 0
M  V30 10 C 9.4091 5.0873 0.0 0
M  V30 11 C 9.6695 2.6091 0.0 0
M  V30 12 C 7.1328 1.7849 0.0 0
M  V30 13 C 10.4395 3.9428 0.0 0
M  V30 14 C 9.8850 6.5519 0.0 0
M  V30 15 C 10.1454 1.1444 0.0 0
M  V30 16 C 7.6086 0.3202 0.0 0
M  V30 17 C 11.9460 4.2629 0.0 0
M  V30 18 C 11.3914 6.8721 0.0 0
M  V30 19 C 9.1149 0.0000 0.0 0
M  V30 20 C 12.4218 5.7277 0.0 0
M  V30 21 N 2.6675 4.4608 0.0 0
M  V30 22 C 1.3337 5.2308 0.0 0 CFG=2
M  V30 23 C 2.6675 2.9208 0.0 0
M  V30 24 C 0.0000 4.4608 0.0 0
M  V30 25 C 1.3337 2.1508 0.0 0
M  V30 26 C 0.0000 2.9208 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 21
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 22 5 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 2 18 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-N-[(phenylmethoxy)carbonyl]-D-ala...
C26H24N2O6
185968-90-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0
M  V30 7 C 10.4443 7.7838 0.0 0 CFG=2
M  V30 8 N 11.9843 7.7838 0.0 0
M  V30 9 C 9.6743 9.1174 0.0 0
M  V30 10 C 12.7543 6.4500 0.0 0
M  V30 11 O 8.1343 9.1174 0.0 0
M  V30 12 O 10.4443 10.4511 0.0 0
M  V30 13 O 14.2943 6.4500 0.0 0
M  V30 14 O 11.9843 5.1163 0.0 0
M  V30 15 C 15.0643 5.1163 0.0 0
M  V30 16 C 3.5143 3.7827 0.0 0
M  V30 17 C 2.6091 5.0286 0.0 0
M  V30 18 C 2.6091 2.5368 0.0 0
M  V30 19 C 1.1445 4.5527 0.0 0
M  V30 20 C 2.9292 6.5348 0.0 0
M  V30 21 C 1.1445 3.0127 0.0 0
M  V30 22 C 2.9292 1.0304 0.0 0
M  V30 23 C 0.0000 5.5831 0.0 0
M  V30 24 C 1.7849 7.5654 0.0 0
M  V30 25 C 0.0000 1.9823 0.0 0
M  V30 26 C 1.7849 0.0000 0.0 0
M  V30 27 C 0.3202 7.0895 0.0 0
M  V30 28 C 0.3202 0.4759 0.0 0
M  V30 29 C 16.6043 5.1163 0.0 0
M  V30 30 C 17.3743 3.7827 0.0 0
M  V30 31 C 17.3743 6.4500 0.0 0
M  V30 32 C 18.9143 3.7827 0.0 0
M  V30 33 C 18.9143 6.4500 0.0 0
M  V30 34 C 19.6843 5.1163 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 13 15
M  V30 16 1 15 29
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 2 24 27
M  V30 30 1 25 28
M  V30 31 2 26 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valine
C21H23NO4
84000-11-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 7.0870 4.4608 0.0 0
M  V30 3 C 8.4206 5.2308 0.0 0
M  V30 4 N 9.7543 4.4608 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 11.0881 5.2308 0.0 0 CFG=2
M  V30 7 C 9.7543 2.9208 0.0 0
M  V30 8 C 11.0881 6.7708 0.0 0
M  V30 9 C 12.4217 4.4608 0.0 0
M  V30 10 C 9.7543 7.5408 0.0 0
M  V30 11 C 12.4217 7.5408 0.0 0
M  V30 12 O 13.7554 5.2308 0.0 0
M  V30 13 O 12.4217 2.9208 0.0 0
M  V30 14 C 4.4195 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0127 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2890 1.7849 0.0 0
M  V30 19 C 1.9823 3.9427 0.0 0
M  V30 20 C 2.5369 6.5518 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2629 0.0 0
M  V30 24 C 1.0304 6.8720 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(9-Fluorenylmethoxycarbonyl)-N-methylglycine
C18H17NO4
77128-70-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 7.0869 4.4609 0.0 0
M  V30 3 C 8.4206 5.2309 0.0 0
M  V30 4 N 9.7542 4.4609 0.0 0
M  V30 5 O 8.4206 6.7709 0.0 0
M  V30 6 C 11.0880 5.2309 0.0 0
M  V30 7 C 9.7542 2.9209 0.0 0
M  V30 8 C 12.4216 4.4609 0.0 0
M  V30 9 O 13.7553 5.2309 0.0 0
M  V30 10 O 12.4216 2.9209 0.0 0
M  V30 11 C 4.4195 4.4609 0.0 0
M  V30 12 C 4.2586 2.9292 0.0 0
M  V30 13 C 3.0127 5.0872 0.0 0
M  V30 14 C 2.7523 2.6091 0.0 0
M  V30 15 C 5.2890 1.7849 0.0 0
M  V30 16 C 1.9823 3.9429 0.0 0
M  V30 17 C 2.5368 6.5519 0.0 0
M  V30 18 C 2.2763 1.1445 0.0 0
M  V30 19 C 4.8131 0.3202 0.0 0
M  V30 20 C 0.4759 4.2630 0.0 0
M  V30 21 C 1.0304 6.8721 0.0 0
M  V30 22 C 3.3068 0.0000 0.0 0
M  V30 23 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fmoc-Gly-OH
C17H15NO4
29022-11-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 O 13.7554 5.2310 0.0 0
M  V30 9 O 12.4218 2.9209 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-...
C23H26N2O6
131570-56-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7531 5.3900 0.0 0
M  V30 2 O 7.0869 6.1600 0.0 0
M  V30 3 C 8.4206 5.3900 0.0 0
M  V30 4 N 9.7542 6.1600 0.0 0
M  V30 5 O 8.4206 3.8500 0.0 0
M  V30 6 C 11.0878 5.3900 0.0 0
M  V30 7 C 12.4216 6.1600 0.0 0 CFG=2
M  V30 8 N 13.7553 5.3900 0.0 0
M  V30 9 C 12.4216 7.7000 0.0 0
M  V30 10 C 13.7553 3.8500 0.0 0
M  V30 11 O 11.0878 8.4700 0.0 0
M  V30 12 O 13.7553 8.4700 0.0 0
M  V30 13 O 15.0889 3.0800 0.0 0
M  V30 14 O 12.4216 3.0800 0.0 0
M  V30 15 C 15.0889 1.5400 0.0 0
M  V30 16 C 13.5489 1.5400 0.0 0
M  V30 17 C 15.0889 0.0000 0.0 0
M  V30 18 C 16.6289 1.5400 0.0 0
M  V30 19 C 4.4195 6.1600 0.0 0
M  V30 20 C 4.2586 7.6915 0.0 0
M  V30 21 C 3.0127 5.5335 0.0 0
M  V30 22 C 2.7521 8.0117 0.0 0
M  V30 23 C 5.2890 8.8359 0.0 0
M  V30 24 C 1.9821 6.6781 0.0 0
M  V30 25 C 2.5368 4.0690 0.0 0
M  V30 26 C 2.2763 9.4764 0.0 0
M  V30 27 C 4.8131 10.3006 0.0 0
M  V30 28 C 0.4759 6.3579 0.0 0
M  V30 29 C 1.0304 3.7488 0.0 0
M  V30 30 C 3.3068 10.6208 0.0 0
M  V30 31 C 0.0000 4.8932 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C53H84N12O15
3068605-50-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  80 82 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 21.3390 6.7236 0.0 0
M  V30 2 C 22.6727 5.9536 0.0 0 CFG=2
M  V30 3 O 20.0052 5.9536 0.0 0
M  V30 4 C 24.0063 6.7236 0.0 0
M  V30 5 N 22.6727 4.4136 0.0 0
M  V30 6 N 25.3399 5.9536 0.0 0
M  V30 7 C 21.3390 3.6436 0.0 0
M  V30 8 C 26.6737 6.7236 0.0 0
M  V30 9 O 21.3390 2.1036 0.0 0
M  V30 10 O 20.0052 4.4136 0.0 0
M  V30 11 C 28.0074 5.9536 0.0 0 CFG=2
M  V30 12 O 26.6737 8.2636 0.0 0
M  V30 13 C 20.0052 1.3336 0.0 0
M  V30 14 N 29.3410 6.7236 0.0 0
M  V30 15 C 28.0074 4.4136 0.0 0
M  V30 16 C 20.7752 0.0000 0.0 0
M  V30 17 C 18.6716 0.5636 0.0 0
M  V30 18 C 19.2352 2.6673 0.0 0
M  V30 19 C 30.6746 5.9536 0.0 0
M  V30 20 C 29.3410 8.2636 0.0 0
M  V30 21 C 29.3410 3.6436 0.0 0
M  V30 22 C 26.6737 3.6436 0.0 0
M  V30 23 C 32.0084 6.7236 0.0 0
M  V30 24 O 30.6746 4.4136 0.0 0
M  V30 25 N 33.3421 5.9536 0.0 0
M  V30 26 C 34.6757 6.7236 0.0 0
M  V30 27 C 33.3421 4.4136 0.0 0
M  V30 28 C 36.0094 5.9536 0.0 0
M  V30 29 O 34.6757 8.2636 0.0 0
M  V30 30 N 37.3432 6.7236 0.0 0
M  V30 31 C 18.6716 8.2636 0.0 0
M  V30 32 N 17.3379 9.0336 0.0 0
M  V30 33 O 18.6716 6.7236 0.0 0
M  V30 34 C 16.0043 8.2636 0.0 0
M  V30 35 C 14.6705 9.0336 0.0 0
M  V30 36 N 13.3369 8.2636 0.0 0
M  V30 37 O 14.6705 10.5736 0.0 0
M  V30 38 C 12.0032 9.0336 0.0 0
M  V30 39 C 13.3369 6.7236 0.0 0
M  V30 40 C 10.6694 8.2636 0.0 0
M  V30 41 N 9.3358 9.0336 0.0 0
M  V30 42 O 10.6694 6.7236 0.0 0
M  V30 43 C 9.3358 10.5736 0.0 0 CFG=1
M  V30 44 C 8.0021 8.2636 0.0 0
M  V30 45 C 8.0021 11.3436 0.0 0
M  V30 46 C 10.6694 11.3436 0.0 0
M  V30 47 N 6.6685 10.5736 0.0 0
M  V30 48 O 8.0021 12.8836 0.0 0
M  V30 49 C 10.6694 12.8836 0.0 0
M  V30 50 C 12.0032 10.5736 0.0 0
M  V30 51 C 6.6685 9.0336 0.0 0
M  V30 52 C 5.3347 8.2636 0.0 0 CFG=1
M  V30 53 C 4.0011 9.0336 0.0 0
M  V30 54 N 5.3347 6.7236 0.0 0
M  V30 55 O 2.6674 8.2636 0.0 0
M  V30 56 C 4.0011 5.9536 0.0 0
M  V30 57 O 2.6674 6.7236 0.0 0
M  V30 58 O 4.0011 4.4136 0.0 0
M  V30 59 C 1.3338 5.9536 0.0 0
M  V30 60 C 1.3338 10.5736 0.0 0
M  V30 61 O 0.0000 11.3436 0.0 0
M  V30 62 O 1.3338 9.0336 0.0 0
M  V30 63 N 21.3390 8.2636 0.0 0
M  V30 64 C 20.0052 9.0336 0.0 0 CFG=2
M  V30 65 C 22.6727 9.0336 0.0 0
M  V30 66 C 20.0052 10.5736 0.0 0
M  V30 67 C 22.6727 10.5736 0.0 0
M  V30 68 C 21.3390 11.3436 0.0 0
M  V30 69 N 4.0011 10.5736 0.0 0
M  V30 70 C 2.6674 11.3436 0.0 0 CFG=2
M  V30 71 C 5.3347 11.3436 0.0 0
M  V30 72 C 2.6674 12.8836 0.0 0
M  V30 73 C 5.3347 12.8836 0.0 0
M  V30 74 C 4.0011 13.6536 0.0 0
M  V30 75 C 1.3338 4.4136 0.0 0
M  V30 76 C 2.6674 3.6436 0.0 0
M  V30 77 C 0.0000 3.6436 0.0 0
M  V30 78 C 2.6674 2.1036 0.0 0
M  V30 79 C 0.0002 2.1036 0.0 0
M  V30 80 C 1.3338 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 63
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 1 15 22
M  V30 23 1 19 23
M  V30 24 2 19 24
M  V30 25 1 23 25
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 26 29
M  V30 30 1 28 30
M  V30 31 1 31 32
M  V30 32 2 31 33
M  V30 33 1 64 31 CFG=3
M  V30 34 1 32 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 2 35 37
M  V30 38 1 36 38
M  V30 39 1 36 39
M  V30 40 1 38 40
M  V30 41 1 40 41
M  V30 42 2 40 42
M  V30 43 1 41 43
M  V30 44 1 41 44
M  V30 45 1 43 45
M  V30 46 1 43 46 CFG=3
M  V30 47 1 45 47
M  V30 48 2 45 48
M  V30 49 1 46 49
M  V30 50 1 46 50
M  V30 51 1 47 51
M  V30 52 1 51 52
M  V30 53 1 52 53
M  V30 54 1 52 54 CFG=1
M  V30 55 2 53 55
M  V30 56 1 53 69
M  V30 57 1 54 56
M  V30 58 1 56 57
M  V30 59 2 56 58
M  V30 60 1 57 59
M  V30 61 1 59 75
M  V30 62 1 60 61
M  V30 63 2 60 62
M  V30 64 1 70 60 CFG=3
M  V30 65 1 63 64
M  V30 66 1 63 65
M  V30 67 1 64 66
M  V30 68 1 65 67
M  V30 69 1 66 68
M  V30 70 1 67 68
M  V30 71 1 69 70
M  V30 72 1 69 71
M  V30 73 1 70 72
M  V30 74 1 71 73
M  V30 75 1 72 74
M  V30 76 1 73 74
M  V30 77 2 75 76
M  V30 78 1 75 77
M  V30 79 1 76 78
M  V30 80 2 77 79
M  V30 81 2 78 80
M  V30 82 1 79 80
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 11 43 52 64 70)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86069-86-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185968-90-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 84000-11-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 77128-70-2
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 29022-11-5
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 131570-56-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3068605-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43967946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 13
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, attachment to 2-chlorotrityl resin in stage
1,solid phase peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of bis-intercalating peptides and their
application as antibody-drug conjugate payloads
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Petersen, Mark E.; Brant, Michael G.; Lasalle, Manuel; Fung, Vincent K.
C.; Rojas, Andrea Hernandez; Wong, Jodi; Das, Samir; Barnscher, Stuart
D.; Rich, Jamie R.; Winters, Geoffrey C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(12), 8288-8309

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
(S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-(3-fluorophenyl)propionic acid
C24H20FNO4
198560-68-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 O 9.7544 12.1610 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 F 15.0893 9.0810 0.0 0
M  V30 12 C 4.4196 4.4609 0.0 0
M  V30 13 C 3.0128 5.0873 0.0 0
M  V30 14 C 4.2587 2.9293 0.0 0
M  V30 15 C 1.9822 3.9428 0.0 0
M  V30 16 C 2.5369 6.5519 0.0 0
M  V30 17 C 2.7522 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 0.4759 4.2630 0.0 0
M  V30 20 C 1.0304 6.8721 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.0000 5.7277 0.0 0
M  V30 24 C 3.3069 0.0000 0.0 0
M  V30 25 C 11.0881 9.8510 0.0 0
M  V30 26 C 12.4219 9.0810 0.0 0
M  V30 27 C 11.0881 11.3910 0.0 0
M  V30 28 C 13.7556 9.8510 0.0 0
M  V30 29 C 12.4219 12.1610 0.0 0
M  V30 30 C 13.7556 11.3910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H35FN4O6
2861234-23-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 6.1600 0.0 0
M  V30 2 O 7.0869 6.9300 0.0 0
M  V30 3 C 8.4206 6.1600 0.0 0
M  V30 4 N 9.7544 6.9300 0.0 0
M  V30 5 O 8.4206 4.6200 0.0 0
M  V30 6 C 11.0880 6.1600 0.0 0 CFG=2
M  V30 7 C 11.0880 4.6200 0.0 0
M  V30 8 C 12.4216 6.9300 0.0 0
M  V30 9 N 12.4216 8.4700 0.0 0
M  V30 10 O 13.7553 6.1600 0.0 0
M  V30 11 C 13.7553 9.2400 0.0 0 CFG=2
M  V30 12 C 15.0891 8.4700 0.0 0
M  V30 13 C 13.7553 10.7800 0.0 0
M  V30 14 C 16.4227 9.2400 0.0 0
M  V30 15 O 15.0891 11.5500 0.0 0
M  V30 16 O 12.4216 11.5500 0.0 0
M  V30 17 C 17.7564 8.4700 0.0 0
M  V30 18 C 15.0891 13.0900 0.0 0
M  V30 19 C 19.0900 9.2400 0.0 0
M  V30 20 O 17.7564 6.9300 0.0 0
M  V30 21 C 13.5491 13.0900 0.0 0
M  V30 22 C 15.0891 14.6300 0.0 0
M  V30 23 C 16.6291 13.0900 0.0 0
M  V30 24 N 20.4238 8.4700 0.0 0 CHG=1 VAL=4
M  V30 25 N 21.7574 7.7000 0.0 0 CHG=-1
M  V30 26 F 13.7553 0.0000 0.0 0
M  V30 27 C 4.4196 6.9300 0.0 0
M  V30 28 C 4.2586 8.4615 0.0 0
M  V30 29 C 3.0127 6.3037 0.0 0
M  V30 30 C 2.7523 8.7817 0.0 0
M  V30 31 C 5.2891 9.6061 0.0 0
M  V30 32 C 1.9823 7.4481 0.0 0
M  V30 33 C 2.5368 4.8390 0.0 0
M  V30 34 C 2.2764 10.2464 0.0 0
M  V30 35 C 4.8131 11.0706 0.0 0
M  V30 36 C 0.4759 7.1279 0.0 0
M  V30 37 C 1.0304 4.5188 0.0 0
M  V30 38 C 3.3068 11.3908 0.0 0
M  V30 39 C 0.0000 5.6632 0.0 0
M  V30 40 C 12.4216 3.8500 0.0 0
M  V30 41 C 12.4216 2.3100 0.0 0
M  V30 42 C 13.7553 4.6200 0.0 0
M  V30 43 C 13.7553 1.5400 0.0 0
M  V30 44 C 15.0891 3.8500 0.0 0
M  V30 45 C 15.0891 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 40
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12 CFG=3
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 2 24 25
M  V30 27 1 26 43
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 32 1 29 32
M  V30 33 2 29 33
M  V30 34 1 30 32
M  V30 35 2 30 34
M  V30 36 1 31 35
M  V30 37 2 32 36
M  V30 38 1 33 37
M  V30 39 1 34 38
M  V30 40 2 35 38
M  V30 41 1 36 39
M  V30 42 2 37 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 198560-68-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861234-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259024
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
(S)-4-(tert-Butoxycarbonyl)morpholine-3-carboxylic acid
C10H17NO5
783350-37-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 6.8749 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 3.7949 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-(methylamino)-N-(2-methylpropyl...
C21H31N3O3S
2765293-23-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 N 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 0.7700 2.6673 0.0 0
M  V30 25 C 3.0800 1.3336 0.0 0
M  V30 26 C 0.0000 1.3336 0.0 0
M  V30 27 C 2.3100 0.0000 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[[(1S,2R)-2-hydroxy-3-[[[4-(methylamino)phenyl]sulf...
C31H46N4O7S
2765293-56-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 9.2400 0.0 0
M  V30 2 N 8.0021 8.4700 0.0 0
M  V30 3 O 5.3347 8.4700 0.0 0
M  V30 4 C 8.0021 6.9300 0.0 0 CFG=2
M  V30 5 C 6.6684 6.1600 0.0 0
M  V30 6 C 9.3358 6.1600 0.0 0 CFG=2
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 O 10.6694 6.9300 0.0 0
M  V30 9 N 10.6694 3.8500 0.0 0
M  V30 10 S 12.0031 4.6200 0.0 0 VAL=6
M  V30 11 C 10.6694 2.3100 0.0 0
M  V30 12 O 12.7732 3.2864 0.0 0
M  V30 13 O 11.2332 5.9536 0.0 0
M  V30 14 C 12.0032 1.5400 0.0 0
M  V30 15 C 12.0032 0.0000 0.0 0
M  V30 16 C 13.3369 2.3100 0.0 0
M  V30 17 C 4.0011 10.7800 0.0 0
M  V30 18 O 2.6674 11.5500 0.0 0
M  V30 19 O 4.0011 9.2400 0.0 0
M  V30 20 C 1.3336 10.7800 0.0 0
M  V30 21 C 2.1036 9.4464 0.0 0
M  V30 22 C 0.0000 10.0100 0.0 0
M  V30 23 C 0.5636 12.1136 0.0 0
M  V30 24 N 17.3379 7.7000 0.0 0
M  V30 25 C 18.6716 6.9300 0.0 0
M  V30 26 C 6.6684 10.7800 0.0 0 CFG=2
M  V30 27 N 5.3347 11.5500 0.0 0
M  V30 28 C 8.0021 11.5500 0.0 0
M  V30 29 C 5.3347 13.0900 0.0 0
M  V30 30 O 8.0021 13.0900 0.0 0
M  V30 31 C 6.6684 13.8600 0.0 0
M  V30 32 C 6.6684 4.6200 0.0 0
M  V30 33 C 5.3347 3.8500 0.0 0
M  V30 34 C 8.0021 3.8500 0.0 0
M  V30 35 C 5.3347 2.3100 0.0 0
M  V30 36 C 8.0021 2.3100 0.0 0
M  V30 37 C 6.6684 1.5400 0.0 0
M  V30 38 C 13.3369 5.3900 0.0 0
M  V30 39 C 14.6705 4.6200 0.0 0
M  V30 40 C 13.3369 6.9300 0.0 0
M  V30 41 C 16.0041 5.3900 0.0 0
M  V30 42 C 14.6705 7.7000 0.0 0
M  V30 43 C 16.0041 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 26 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 32
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 38
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 27
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 25
M  V30 27 1 24 43
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 6 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 783350-37-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2765293-23-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-56-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-N-(2-methylpropyl)benze...
C21H30N2O4S
159005-71-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 O 9.2400 5.1284 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 8.0021 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 8 C 7.7000 9.3358 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 C 6.9300 10.6694 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 5.3900 2.6673 0.0 0
M  V30 15 O 15.4000 6.6684 0.0 0
M  V30 16 C 16.1700 5.3347 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.0900 8.0021 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6673 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 23
M  V30 16 1 15 16
M  V30 17 1 15 22
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(S)-4-(tert-Butoxycarbonyl)morpholine-3-carboxylic acid
C10H17NO5
783350-37-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 6.8749 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 3.7949 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[[(1S,2R)-2-hydroxy-3-[[(4-methoxyphenyl)sulfonyl](...
C31H45N3O8S
2765293-52-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 9.2400 0.0 0
M  V30 2 N 8.0021 8.4700 0.0 0
M  V30 3 O 5.3347 8.4700 0.0 0
M  V30 4 C 8.0021 6.9300 0.0 0 CFG=2
M  V30 5 C 6.6684 6.1600 0.0 0
M  V30 6 C 9.3358 6.1600 0.0 0 CFG=2
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 O 10.6694 6.9300 0.0 0
M  V30 9 N 10.6694 3.8500 0.0 0
M  V30 10 S 12.0032 4.6200 0.0 0 VAL=6
M  V30 11 C 10.6694 2.3100 0.0 0
M  V30 12 O 12.7732 3.2864 0.0 0
M  V30 13 O 11.2332 5.9536 0.0 0
M  V30 14 C 12.0032 1.5400 0.0 0
M  V30 15 C 12.0032 0.0000 0.0 0
M  V30 16 C 13.3369 2.3100 0.0 0
M  V30 17 C 4.0011 10.7800 0.0 0
M  V30 18 O 2.6674 11.5500 0.0 0
M  V30 19 O 4.0011 9.2400 0.0 0
M  V30 20 C 1.3336 10.7800 0.0 0
M  V30 21 C 0.5636 12.1136 0.0 0
M  V30 22 C 0.0000 10.0100 0.0 0
M  V30 23 C 2.1036 9.4464 0.0 0
M  V30 24 O 17.3379 7.7000 0.0 0
M  V30 25 C 18.6716 6.9300 0.0 0
M  V30 26 C 6.6684 10.7800 0.0 0 CFG=2
M  V30 27 N 5.3347 11.5500 0.0 0
M  V30 28 C 8.0021 11.5500 0.0 0
M  V30 29 C 5.3347 13.0900 0.0 0
M  V30 30 O 8.0021 13.0900 0.0 0
M  V30 31 C 6.6684 13.8600 0.0 0
M  V30 32 C 6.6685 4.6200 0.0 0
M  V30 33 C 5.3347 3.8500 0.0 0
M  V30 34 C 8.0021 3.8500 0.0 0
M  V30 35 C 5.3347 2.3100 0.0 0
M  V30 36 C 8.0021 2.3100 0.0 0
M  V30 37 C 6.6685 1.5400 0.0 0
M  V30 38 C 13.3369 5.3900 0.0 0
M  V30 39 C 13.3369 6.9300 0.0 0
M  V30 40 C 14.6705 4.6200 0.0 0
M  V30 41 C 14.6705 7.7000 0.0 0
M  V30 42 C 16.0041 5.3900 0.0 0
M  V30 43 C 16.0041 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 26 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 32
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 38
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 27
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 25
M  V30 27 1 24 43
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 6 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159005-71-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 783350-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632736
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
(4R)-4-Hydroxy-1-[(2R)-3-methyl-2-(3-methyl-5-isoxazolyl)-1-oxobutyl]-L-proline
C14H20N2O5
2313230-59-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5253 4.0287 0.0 0
M  V30 2 C 5.8591 3.2587 0.0 0 CFG=1
M  V30 3 O 4.5253 5.5687 0.0 0
M  V30 4 C 5.8591 1.7187 0.0 0
M  V30 5 C 7.1928 0.9486 0.0 0
M  V30 6 C 4.5253 0.9486 0.0 0
M  V30 7 C 1.4647 5.3914 0.0 0
M  V30 8 O 2.6091 6.4219 0.0 0
M  V30 9 O 0.0000 5.8673 0.0 0
M  V30 10 O 0.8980 0.0000 0.0 0
M  V30 11 C 11.1617 4.3858 0.0 0
M  V30 12 N 3.1917 3.2587 0.0 0
M  V30 13 C 1.7849 3.8850 0.0 0 CFG=2
M  V30 14 C 3.0307 1.7271 0.0 0
M  V30 15 C 0.7543 2.7406 0.0 0
M  V30 16 C 1.5243 1.4068 0.0 0 CFG=2
M  V30 17 C 7.1928 4.0287 0.0 0
M  V30 18 C 8.5996 3.4022 0.0 0
M  V30 19 O 7.3537 5.5602 0.0 0
M  V30 20 C 9.6302 4.5467 0.0 0
M  V30 21 N 8.8602 5.8804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 17
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 13 7 CFG=1
M  V30 11 1 16 10 CFG=3
M  V30 12 1 11 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, 4-(4-chloro-5-thiazolyl)-, hydrochloride (1:1)
C10H9ClN2S.ClH
3055533-14-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.9406 1.5400 0.0 0
M  V30 2 C 8.5299 4.2505 0.0 0
M  V30 3 N 9.3000 5.5841 0.0 0
M  V30 4 C 3.9098 4.2505 0.0 0
M  V30 5 C 4.6799 5.5841 0.0 0
M  V30 6 C 4.6799 2.9168 0.0 0
M  V30 7 C 6.2199 5.5841 0.0 0
M  V30 8 C 6.2199 2.9168 0.0 0
M  V30 9 C 6.9899 4.2505 0.0 0
M  V30 10 C 2.3698 4.2505 0.0 0
M  V30 11 C 1.4646 3.0046 0.0 0
M  V30 12 S 1.4646 5.4963 0.0 0
M  V30 13 N 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 5.0205 0.0 0
M  V30 15 Cl 4.6500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyrrolidinecarboxamide, N-[[4-(4-chloro-5-thiazolyl)phenyl]methyl]-4-hydrox...
C24H27ClN4O4S
3055532-94-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2011 4.9525 0.0 0
M  V30 2 C 4.6947 4.6322 0.0 0 CFG=1
M  V30 3 O 6.6770 6.4171 0.0 0
M  V30 4 C 4.2189 3.1676 0.0 0
M  V30 5 C 2.7126 2.8475 0.0 0
M  V30 6 C 5.2494 2.0231 0.0 0
M  V30 7 C 9.5331 5.3027 0.0 0
M  V30 8 N 11.0731 5.3027 0.0 0
M  V30 9 O 8.7631 6.6364 0.0 0
M  V30 10 C 11.8431 6.6364 0.0 0
M  V30 11 O 8.4061 0.0000 0.0 0
M  V30 12 C 0.0000 7.3428 0.0 0
M  V30 13 Cl 18.4325 9.3469 0.0 0
M  V30 14 N 7.2316 3.8080 0.0 0
M  V30 15 C 8.7631 3.9689 0.0 0 CFG=2
M  V30 16 C 6.9114 2.3017 0.0 0
M  V30 17 C 9.3896 2.5621 0.0 0
M  V30 18 C 8.2450 1.5317 0.0 0 CFG=2
M  V30 19 C 3.6643 5.7767 0.0 0
M  V30 20 O 3.9845 7.2830 0.0 0
M  V30 21 C 2.1328 5.6158 0.0 0
M  V30 22 N 2.6508 8.0530 0.0 0
M  V30 23 C 1.5064 7.0226 0.0 0
M  V30 24 C 13.3831 6.6364 0.0 0
M  V30 25 C 14.1531 7.9700 0.0 0
M  V30 26 C 14.1531 5.3027 0.0 0
M  V30 27 C 15.6931 7.9700 0.0 0
M  V30 28 C 15.6931 5.3027 0.0 0
M  V30 29 C 16.4631 6.6364 0.0 0
M  V30 30 C 18.0032 6.6364 0.0 0
M  V30 31 C 18.9084 7.8822 0.0 0
M  V30 32 S 18.9084 5.3905 0.0 0
M  V30 33 N 20.3731 7.4064 0.0 0
M  V30 34 C 20.3731 5.8664 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 19
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 15 7 CFG=3
M  V30 11 1 8 10
M  V30 12 1 10 24
M  V30 13 1 18 11 CFG=1
M  V30 14 1 12 23
M  V30 15 1 13 31
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 29 30
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2313230-59-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3055533-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055532-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36342034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic Potency and Property Assessment of VHL Ligands and
Implications on PROTAC Design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krieger, Johannes; Sorrell, Fiona J.; Wegener, Ansgar A.; Leuthner,
Birgitta; Machrouhi-Porcher, Fouzia; Hecht, Martin; Leibrock, Eva M.;
Mueller, Juliane E.; Eisert, Jonathan; Hartung, Ingo V.; Schlesiger,
Sarah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2023), 18(8), e202200615

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
tert-Butyl (3-aminopropyl)carbamate
C8H18N2O2
75178-96-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 N 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(3-fluorophenyl)[4-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thien...
C26H28FN5O3S
3064695-54-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=3
M  V30 2 C 11.9711 5.7472 0.0 0
M  V30 3 C 12.8763 6.9931 0.0 0
M  V30 4 C 14.4079 6.8322 0.0 0
M  V30 5 C 15.3131 8.0781 0.0 0
M  V30 6 C 16.8447 7.9171 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 C 1.3337 7.7001 0.0 0
M  V30 9 O 0.0000 6.9301 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 O 23.2464 8.6871 0.0 0
M  V30 12 N 8.0021 5.3901 0.0 0
M  V30 13 C 9.4091 4.7638 0.0 0
M  V30 14 N 8.1632 6.9217 0.0 0
M  V30 15 C 10.4395 5.9082 0.0 0
M  V30 16 N 9.6695 7.2418 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 5.3348 6.9301 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 4.0011 7.7001 0.0 0
M  V30 22 C 2.6673 6.9301 0.0 0
M  V30 23 C 6.6685 3.0801 0.0 0
M  V30 24 C 5.3348 2.3100 0.0 0
M  V30 25 C 8.0021 2.3100 0.0 0
M  V30 26 C 5.3348 0.7700 0.0 0
M  V30 27 C 8.0021 0.7700 0.0 0
M  V30 28 C 6.6685 0.0000 0.0 0
M  V30 29 C 17.7499 9.1630 0.0 0 CFG=2
M  V30 30 C 19.2899 9.1630 0.0 0 CFG=1
M  V30 31 S 17.2740 10.6276 0.0 0
M  V30 32 C 19.7658 10.6276 0.0 0 CFG=1
M  V30 33 N 20.5358 8.2578 0.0 0
M  V30 34 C 18.5199 11.5328 0.0 0
M  V30 35 N 21.3058 10.6276 0.0 0
M  V30 36 C 21.7818 9.1630 0.0 0
M  V30 37 H 18.8141 7.6983 0.0 0
M  V30 38 H 20.2418 12.0923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 2 3
M  V30 5 1 2 15
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 29 6 CFG=3
M  V30 10 1 7 26
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 22
M  V30 14 2 11 36
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 37 CFG=1
M  V30 37 1 31 34
M  V30 38 1 32 34
M  V30 39 1 32 35
M  V30 40 1 32 38 CFG=1
M  V30 41 1 33 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H44FN7O4S
3064695-55-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.5780 4.6201 0.0 0 CFG=3
M  V30 2 C 11.2754 5.7473 0.0 0
M  V30 3 C 10.3701 6.9931 0.0 0
M  V30 4 C 8.8386 6.8322 0.0 0
M  V30 5 C 7.9333 8.0781 0.0 0
M  V30 6 C 6.4018 7.9172 0.0 0
M  V30 7 F 13.9105 0.0000 0.0 0
M  V30 8 C 21.9128 7.7002 0.0 0
M  V30 9 N 23.2465 6.9302 0.0 0
M  V30 10 O 21.9128 9.2402 0.0 0
M  V30 11 C 24.5802 7.7002 0.0 0
M  V30 12 C 25.9140 6.9302 0.0 0
M  V30 13 C 27.2477 7.7002 0.0 0
M  V30 14 N 28.5813 6.9302 0.0 0
M  V30 15 C 29.9150 7.7002 0.0 0
M  V30 16 O 31.2488 6.9302 0.0 0
M  V30 17 O 29.9150 9.2402 0.0 0
M  V30 18 C 32.5825 7.7002 0.0 0
M  V30 19 C 31.8125 9.0338 0.0 0
M  V30 20 C 33.9162 8.4702 0.0 0
M  V30 21 C 33.3525 6.3665 0.0 0
M  V30 22 O 0.0000 8.6872 0.0 0
M  V30 23 N 15.2443 5.3901 0.0 0
M  V30 24 C 13.8374 4.7638 0.0 0
M  V30 25 N 15.0832 6.9217 0.0 0
M  V30 26 C 12.8069 5.9082 0.0 0
M  V30 27 N 13.5769 7.2419 0.0 0
M  V30 28 C 17.9117 5.3901 0.0 0
M  V30 29 C 19.2453 4.6201 0.0 0
M  V30 30 C 17.9117 6.9302 0.0 0
M  V30 31 C 20.5792 5.3901 0.0 0
M  V30 32 C 19.2453 7.7002 0.0 0
M  V30 33 C 20.5792 6.9302 0.0 0
M  V30 34 C 16.5780 3.0801 0.0 0
M  V30 35 C 15.2443 2.3101 0.0 0
M  V30 36 C 17.9117 2.3101 0.0 0
M  V30 37 C 15.2443 0.7700 0.0 0
M  V30 38 C 17.9117 0.7700 0.0 0
M  V30 39 C 16.5780 0.0000 0.0 0
M  V30 40 C 5.4965 9.1630 0.0 0 CFG=2
M  V30 41 C 3.9565 9.1630 0.0 0 CFG=1
M  V30 42 S 5.9724 10.6276 0.0 0
M  V30 43 C 3.4806 10.6276 0.0 0 CFG=1
M  V30 44 N 2.7106 8.2578 0.0 0
M  V30 45 C 4.7265 11.5329 0.0 0
M  V30 46 N 1.9406 10.6276 0.0 0
M  V30 47 C 1.4646 9.1630 0.0 0
M  V30 48 H 4.4324 7.6983 0.0 0
M  V30 49 H 3.0046 12.0923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 28
M  V30 3 1 1 34
M  V30 4 1 2 3
M  V30 5 1 2 26
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 40 6 CFG=1
M  V30 10 1 7 37
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 8 33
M  V30 14 1 9 11
M  V30 15 1 11 12
M  V30 16 1 12 13
M  V30 17 1 13 14
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 18 21
M  V30 25 2 22 47
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 1 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 1 41 44
M  V30 47 1 41 48 CFG=3
M  V30 48 1 42 45
M  V30 49 1 43 45
M  V30 50 1 43 46
M  V30 51 1 43 49 CFG=3
M  V30 52 1 44 47
M  V30 53 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 40 41 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75178-96-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3064695-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3064695-55-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43968824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural study of potent triazole-based inhibitors of Staphylococcus
aureus biotin protein ligase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stachura, Damian L.; Nguyen, Stephanie; Polyak, Steven W.; Jovcevski,
Blagojce; Bruning, John B.; Abell, Andrew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(3), 285-290

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) 4-(4-carboxyphenyl)-1-piperazinecarboxylate
C16H22N2O4
162046-66-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 2.8737 0.0 0
M  V30 2 O 12.3203 1.5400 0.0 0
M  V30 3 O 12.3203 4.2074 0.0 0
M  V30 4 C 13.8603 1.5400 0.0 0
M  V30 5 C 13.8603 3.0801 0.0 0
M  V30 6 C 15.4003 1.5400 0.0 0
M  V30 7 C 13.8603 0.0000 0.0 0
M  V30 8 C 0.7700 2.8737 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 O 0.0000 4.2074 0.0 0
M  V30 11 N 6.9302 2.8737 0.0 0
M  V30 12 C 7.7002 4.2074 0.0 0
M  V30 13 C 7.7002 1.5400 0.0 0
M  V30 14 C 9.2402 4.2074 0.0 0
M  V30 15 C 9.2402 1.5400 0.0 0
M  V30 16 N 10.0102 2.8737 0.0 0
M  V30 17 C 5.3901 2.8737 0.0 0
M  V30 18 C 4.6201 1.5400 0.0 0
M  V30 19 C 4.6201 4.2074 0.0 0
M  V30 20 C 3.0801 1.5400 0.0 0
M  V30 21 C 3.0801 4.2074 0.0 0
M  V30 22 C 2.3101 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-[(trans-3-amino-2,2,4,4-tetramethylcyclobutyl)oxy]-2-chloro-,...
C15H19ClN2O.ClH
1818885-55-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7450 4.2073 0.0 0
M  V30 2 C 0.0000 6.3382 0.0 0
M  V30 3 C 1.0889 4.4520 0.0 0
M  V30 4 C 4.8612 6.6300 0.0 0
M  V30 5 C 3.7722 8.5161 0.0 0
M  V30 6 N 1.1160 8.7608 0.0 0
M  V30 7 Cl 8.3650 1.5400 0.0 0
M  V30 8 C 9.9050 4.2073 0.0 0
M  V30 9 N 11.4450 4.2073 0.0 0
M  V30 10 C 2.9750 5.5411 0.0 0 CFG=1
M  V30 11 C 1.4875 5.9396 0.0 0
M  V30 12 C 3.3735 7.0286 0.0 0
M  V30 13 C 1.8860 7.4271 0.0 0 CFG=1
M  V30 14 C 5.2850 4.2073 0.0 0
M  V30 15 C 6.0550 2.8736 0.0 0
M  V30 16 C 6.0550 5.5411 0.0 0
M  V30 17 C 7.5950 2.8736 0.0 0
M  V30 18 C 7.5950 5.5411 0.0 0
M  V30 19 C 8.3650 4.2073 0.0 0
M  V30 20 Cl 5.7225 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 1 14
M  V30 3 1 2 11
M  V30 4 1 3 11
M  V30 5 1 4 12
M  V30 6 1 5 12
M  V30 7 1 13 6 CFG=1
M  V30 8 1 7 17
M  V30 9 3 8 9
M  V30 10 1 8 19
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[4-[[[trans-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetrameth...
C31H39ClN4O4
2760704-84-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 8.7891 0.0 0
M  V30 2 C 10.9774 8.8162 0.0 0
M  V30 3 C 9.0913 9.9052 0.0 0
M  V30 4 C 6.9132 6.1329 0.0 0
M  V30 5 C 8.7994 5.0439 0.0 0
M  V30 6 N 11.2221 6.1601 0.0 0
M  V30 7 C 12.5557 6.9302 0.0 0
M  V30 8 O 12.5557 8.4702 0.0 0
M  V30 9 Cl 1.3337 8.7891 0.0 0
M  V30 10 C 1.3337 5.7091 0.0 0
M  V30 11 N 0.0000 4.9390 0.0 0
M  V30 12 C 21.8917 1.5400 0.0 0
M  V30 13 O 23.2254 2.3101 0.0 0
M  V30 14 O 21.8917 0.0000 0.0 0
M  V30 15 C 24.5592 1.5400 0.0 0
M  V30 16 C 25.3292 2.8737 0.0 0
M  V30 17 C 25.8929 0.7700 0.0 0
M  V30 18 C 23.7892 0.2062 0.0 0
M  V30 19 C 8.0023 8.0191 0.0 0 CFG=2
M  V30 20 C 9.4898 8.4177 0.0 0
M  V30 21 C 8.4009 6.5316 0.0 0
M  V30 22 C 9.8884 6.9302 0.0 0 CFG=2
M  V30 23 C 5.3348 8.0191 0.0 0
M  V30 24 C 4.0012 8.7891 0.0 0
M  V30 25 C 5.3348 6.4791 0.0 0
M  V30 26 C 2.6673 8.0191 0.0 0
M  V30 27 C 4.0012 5.7091 0.0 0
M  V30 28 C 2.6675 6.4791 0.0 0
M  V30 29 C 13.8896 6.1601 0.0 0
M  V30 30 C 13.8896 4.6201 0.0 0
M  V30 31 C 15.2232 6.9302 0.0 0
M  V30 32 C 15.2232 3.8501 0.0 0
M  V30 33 C 16.5569 6.1601 0.0 0
M  V30 34 C 16.5569 4.6201 0.0 0
M  V30 35 N 17.8906 3.8501 0.0 0
M  V30 36 C 17.8906 2.3101 0.0 0
M  V30 37 C 19.2244 4.6201 0.0 0
M  V30 38 C 19.2244 1.5400 0.0 0
M  V30 39 C 20.5581 3.8501 0.0 0
M  V30 40 N 20.5581 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 1 23
M  V30 3 1 2 20
M  V30 4 1 3 20
M  V30 5 1 4 21
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 22 6 CFG=3
M  V30 9 2 7 8
M  V30 10 1 7 29
M  V30 11 1 9 26
M  V30 12 3 10 11
M  V30 13 1 10 28
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 40
M  V30 17 1 13 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 1 34 35
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 162046-66-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1818885-55-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2760704-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40486251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and characterization of cereblon-mediated androgen receptor
proteolysis-targeting chimeras
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takwale, Akshay D.; Jo, Seung-Hyun; Jeon, Yeong Uk; Kim, Hyung Soo; Shin,
Choong Hoon; Lee, Heung Kyoung; Ahn, Sunjoo; Lee, Chong Ock; Du Ha, Jae;
Kim, Jeong-Hoon; Hwang, Jong Yeon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 208112769

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
1-Naphthaleneacetic acid
C12H10O2
86-87-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 C 6.6685 3.0800 0.0 0
M  V30 3 O 6.6685 4.6200 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 1.3336 3.0800 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C34H30N2O5
2892485-67-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4412 7.0100 0.0 0
M  V30 2 O 8.6022 8.5415 0.0 0
M  V30 3 O 0.4829 7.8465 0.0 0
M  V30 4 C 0.6439 9.3780 0.0 0
M  V30 5 O 0.1611 4.7833 0.0 0
M  V30 6 C 0.0000 3.2517 0.0 0
M  V30 7 N 18.2171 5.3347 0.0 0
M  V30 8 C 18.9871 4.0011 0.0 0
M  V30 9 C 20.5271 4.0011 0.0 0
M  V30 10 O 18.2171 2.6674 0.0 0
M  V30 11 C 4.3816 6.6624 0.0 0
M  V30 12 C 4.2207 5.1308 0.0 0
M  V30 13 C 5.7884 7.2889 0.0 0
M  V30 14 C 3.1358 7.5676 0.0 0
M  V30 15 C 2.8137 4.5045 0.0 0
M  V30 16 C 5.4666 4.2256 0.0 0
M  V30 17 N 7.0344 6.3836 0.0 0
M  V30 18 C 1.7288 6.9413 0.0 0
M  V30 19 C 1.5679 5.4096 0.0 0
M  V30 20 C 6.8734 4.8521 0.0 0
M  V30 21 C 9.6871 6.1047 0.0 0
M  V30 22 O 11.1518 6.5806 0.0 0
M  V30 23 C 9.6871 4.5647 0.0 0
M  V30 24 C 12.0570 5.3347 0.0 0
M  V30 25 C 11.1518 4.0889 0.0 0
M  V30 26 C 13.5970 5.3347 0.0 0
M  V30 27 C 14.3670 4.0011 0.0 0
M  V30 28 C 14.3670 6.6684 0.0 0
M  V30 29 C 15.9070 4.0011 0.0 0
M  V30 30 C 15.9070 6.6684 0.0 0
M  V30 31 C 16.6771 5.3347 0.0 0
M  V30 32 C 21.2971 2.6674 0.0 0
M  V30 33 C 22.8371 2.6674 0.0 0
M  V30 34 C 20.5271 1.3336 0.0 0
M  V30 35 C 23.6071 1.3336 0.0 0
M  V30 36 C 23.6071 4.0011 0.0 0
M  V30 37 C 21.2971 0.0000 0.0 0
M  V30 38 C 22.8371 0.0000 0.0 0
M  V30 39 C 25.1471 1.3336 0.0 0
M  V30 40 C 25.1471 4.0011 0.0 0
M  V30 41 C 25.9171 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 32
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 2 18 19
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 33 36
M  V30 40 1 34 37
M  V30 41 1 35 38
M  V30 42 1 35 39
M  V30 43 2 36 40
M  V30 44 2 37 38
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86-87-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-(trifluoromethyl)-L-phenylalanine
C25H20F3NO4
247113-86-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 O 11.9843 7.7838 0.0 0
M  V30 10 O 9.6743 9.1174 0.0 0
M  V30 11 C 16.6043 5.1163 0.0 0
M  V30 12 F 16.6043 3.5763 0.0 0
M  V30 13 F 18.1443 5.1163 0.0 0
M  V30 14 F 16.6043 6.6563 0.0 0
M  V30 15 C 3.5143 3.7827 0.0 0
M  V30 16 C 2.6091 2.5368 0.0 0
M  V30 17 C 2.6091 5.0286 0.0 0
M  V30 18 C 1.1445 3.0127 0.0 0
M  V30 19 C 2.9292 1.0304 0.0 0
M  V30 20 C 1.1445 4.5527 0.0 0
M  V30 21 C 2.9292 6.5350 0.0 0
M  V30 22 C 0.0000 1.9823 0.0 0
M  V30 23 C 1.7849 0.0000 0.0 0
M  V30 24 C 0.0000 5.5831 0.0 0
M  V30 25 C 1.7849 7.5654 0.0 0
M  V30 26 C 0.3202 0.4759 0.0 0
M  V30 27 C 0.3202 7.0895 0.0 0
M  V30 28 C 11.9843 5.1163 0.0 0
M  V30 29 C 12.7543 3.7827 0.0 0
M  V30 30 C 12.7543 6.4500 0.0 0
M  V30 31 C 14.2943 3.7827 0.0 0
M  V30 32 C 14.2943 6.4500 0.0 0
M  V30 33 C 15.0643 5.1163 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 28
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 33
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 20
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 2 25 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Diazenylidene-5-oxo-L-norleucine 1,1-dimethylethyl ester
C10H17N3O3
2851863-10-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=1
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 9.3360 3.8501 0.0 0
M  V30 15 N 12.0033 2.3101 0.0 0 CHG=1 VAL=4
M  V30 16 N 13.3370 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C35H35F3N4O6
2861234-24-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 8.4702 0.0 0
M  V30 2 O 14.6708 7.7002 0.0 0
M  V30 3 C 13.3372 8.4702 0.0 0
M  V30 4 N 12.0033 7.7002 0.0 0
M  V30 5 O 13.3372 10.0102 0.0 0
M  V30 6 C 10.6697 8.4702 0.0 0 CFG=2
M  V30 7 C 10.6697 10.0102 0.0 0
M  V30 8 C 9.3360 7.7002 0.0 0
M  V30 9 N 9.3360 6.1601 0.0 0
M  V30 10 O 8.0023 8.4702 0.0 0
M  V30 11 C 8.0023 5.3901 0.0 0 CFG=2
M  V30 12 C 6.6685 6.1601 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 O 6.6685 3.0801 0.0 0
M  V30 16 O 9.3360 3.0801 0.0 0
M  V30 17 C 4.0012 6.1601 0.0 0
M  V30 18 C 6.6685 1.5400 0.0 0
M  V30 19 C 2.6675 5.3901 0.0 0
M  V30 20 O 4.0012 7.7002 0.0 0
M  V30 21 C 8.2085 1.5400 0.0 0
M  V30 22 C 6.6685 0.0000 0.0 0
M  V30 23 C 5.1285 1.5400 0.0 0
M  V30 24 N 1.3337 6.1601 0.0 0 CHG=1 VAL=4
M  V30 25 N 0.0000 6.9302 0.0 0 CHG=-1
M  V30 26 C 5.3348 13.0903 0.0 0
M  V30 27 F 4.5648 11.7566 0.0 0
M  V30 28 F 4.0012 13.8603 0.0 0
M  V30 29 F 6.1048 14.4240 0.0 0
M  V30 30 C 17.3382 7.7002 0.0 0
M  V30 31 C 18.7451 8.3265 0.0 0
M  V30 32 C 17.4992 6.1686 0.0 0
M  V30 33 C 19.7756 7.1821 0.0 0
M  V30 34 C 19.2210 9.7912 0.0 0
M  V30 35 C 19.0056 5.8484 0.0 0
M  V30 36 C 16.4687 5.0241 0.0 0
M  V30 37 C 21.2820 7.5023 0.0 0
M  V30 38 C 20.7275 10.1114 0.0 0
M  V30 39 C 19.4814 4.3837 0.0 0
M  V30 40 C 16.9447 3.5595 0.0 0
M  V30 41 C 21.7579 8.9668 0.0 0
M  V30 42 C 18.4510 3.2393 0.0 0
M  V30 43 C 9.3360 10.7802 0.0 0
M  V30 44 C 9.3360 12.3203 0.0 0
M  V30 45 C 8.0023 10.0102 0.0 0
M  V30 46 C 8.0023 13.0903 0.0 0
M  V30 47 C 6.6685 10.7802 0.0 0
M  V30 48 C 6.6685 12.3203 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 43
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12 CFG=3
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 2 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 26 48
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 31 34
M  V30 35 1 32 35
M  V30 36 2 32 36
M  V30 37 1 33 35
M  V30 38 2 33 37
M  V30 39 1 34 38
M  V30 40 2 35 39
M  V30 41 1 36 40
M  V30 42 1 37 41
M  V30 43 2 38 41
M  V30 44 1 39 42
M  V30 45 2 40 42
M  V30 46 2 43 44
M  V30 47 1 43 45
M  V30 48 1 44 46
M  V30 49 2 45 47
M  V30 50 2 46 48
M  V30 51 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 247113-86-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851863-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861234-24-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic
stability and tumor delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novotna, Katerina; Tenora, Lukas; Prchalova, Eva; Paule, James; Alt,
Jesse; Veeravalli, Vijay; Lam, Jenny; Wu, Ying; Snajdr, Ivan; Gori,
Sadakatali; Mettu, Vijaya Saradhi; Tsukamoto, Takashi; Majer, Pavel;
Slusher, Barbara S.; Rais, Rana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(22), 15493-15510

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
3,5-Difluoro-L-phenylalanine methyl ester
C10H11F2NO2
473567-59-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0 CFG=2
M  V30 3 C 8.0021 4.6200 0.0 0
M  V30 4 N 6.6684 2.3100 0.0 0
M  V30 5 O 9.3358 3.8500 0.0 0
M  V30 6 O 8.0021 6.1600 0.0 0
M  V30 7 C 10.6694 4.6200 0.0 0
M  V30 8 F 0.0000 4.6200 0.0 0
M  V30 9 F 2.6673 0.0000 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 2.6673 4.6200 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C20H17F6N3O3
2249977-10-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 2.9014 0.0 0
M  V30 2 F 3.7016 1.6555 0.0 0
M  V30 3 F 1.2648 2.7404 0.0 0
M  V30 4 C 6.4237 6.9300 0.0 0
M  V30 5 C 7.7575 6.1600 0.0 0
M  V30 6 N 9.0911 6.9300 0.0 0
M  V30 7 O 7.7575 4.6200 0.0 0
M  V30 8 C 10.4248 6.1600 0.0 0 CFG=2
M  V30 9 C 10.4248 4.6200 0.0 0
M  V30 10 C 11.7584 6.9300 0.0 0
M  V30 11 O 11.7584 8.4700 0.0 0
M  V30 12 O 13.0922 6.1600 0.0 0
M  V30 13 C 13.0922 9.2400 0.0 0
M  V30 14 F 4.3200 8.7465 0.0 0
M  V30 15 F 2.4374 9.5847 0.0 0
M  V30 16 F 13.0922 0.0000 0.0 0
M  V30 17 F 15.7595 4.6200 0.0 0
M  V30 18 C 2.6527 5.6420 0.0 0
M  V30 19 C 1.2459 6.2683 0.0 0 CFG=1
M  V30 20 C 3.6832 6.7864 0.0 0
M  V30 21 C 3.4227 4.3083 0.0 0
M  V30 22 C 1.4068 7.7998 0.0 0 CFG=2
M  V30 23 C 0.0000 7.1735 0.0 0
M  V30 24 N 5.0900 6.1600 0.0 0
M  V30 25 C 2.9132 8.1202 0.0 0
M  V30 26 N 4.9291 4.6285 0.0 0
M  V30 27 C 11.7584 3.8500 0.0 0
M  V30 28 C 11.7584 2.3100 0.0 0
M  V30 29 C 13.0922 4.6200 0.0 0
M  V30 30 C 13.0922 1.5400 0.0 0
M  V30 31 C 14.4259 3.8500 0.0 0
M  V30 32 C 14.4259 2.3100 0.0 0
M  V30 33 H 0.4759 4.9346 0.0 0
M  V30 34 H 0.9309 9.2645 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 27
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 14 25
M  V30 16 1 15 25
M  V30 17 1 16 30
M  V30 18 1 17 31
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 19 33 CFG=3
M  V30 25 1 20 24
M  V30 26 1 20 25
M  V30 27 2 21 26
M  V30 28 1 22 23
M  V30 29 1 22 25
M  V30 30 1 22 34 CFG=3
M  V30 31 1 24 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 19 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 473567-59-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2249977-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of EDC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Formamidine acetate
C2H4O2.CH4N2
3473-63-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.8501 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 N 2.6673 4.6201 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 2 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4-bromo-3,6-difluoro-
C7H4BrF2NO2
1698535-33-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 N 2.3100 5.3349 0.0 0
M  V30 5 F 2.3100 0.0000 0.0 0
M  V30 6 F 5.3900 5.3349 0.0 0
M  V30 7 Br 6.9300 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-5,8-difluoro-4(3H)-quinazolinone
C8H3BrF2N2O
2250340-29-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3900 5.3349 0.0 0
M  V30 2 F 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 Br 6.9300 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 N 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 2 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1698535-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2250340-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40188152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant
GTPase KRASG12C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason G.; Bagal, Sharan K.; Bickerton, Sue; Bodnarchuk, Michael
S.; Boyd, Scott; Breed, Jason; Carbajo, Rodrigo J.; Cassar, Doyle J.;
Chakraborty, Atanu; Cosulich, Sabina; Cumming, Iain; Davies, Michael;
Davies, Nichola L.; Eatherton, Andrew; Evans, Laura; Feron, Lyman;
Fillery, Shaun; Gleave, Emma S.; Goldberg, Frederick W.; Hanson, Lyndsey;
Harlfinger, Stephanie; Howard, Martin; Howells, Rachel; Jackson, Anne;
Kemmitt, Paul; Lamont, Gillian; Lamont, Scott; Lewis, Hilary J.; Liu,
Libin; Niedbala, Michael J.; Phillips, Christopher; Polanski, Radek;
Raubo, Piotr; Robb, Graeme; Robinson, David M.; Ross, Sarah; Sanders,
Matthew G.; Tonge, Michael; Whiteley, Rebecca; Wilkinson, Stephen; Yang,
Junsheng; Zhang, Wenman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(9), 6940-6952

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL

C16H20N2O4
2713439-23-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.4159 3.8045 0.0 0
M  V30 2 C 12.9559 3.8045 0.0 0
M  V30 3 C 5.3348 3.8501 0.0 0
M  V30 4 N 4.0011 4.6201 0.0 0
M  V30 5 O 5.3348 2.3100 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0 CFG=2
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 O 1.3337 6.1601 0.0 0
M  V30 11 O 0.0000 3.8501 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 9.1058 5.1381 0.0 0
M  V30 15 C 8.3358 6.4718 0.0 0
M  V30 16 C 10.6459 5.1381 0.0 0
M  V30 17 C 8.0754 3.9936 0.0 0
M  V30 18 N 6.8295 6.1516 0.0 0
M  V30 19 C 9.1058 7.8054 0.0 0
M  V30 20 C 11.4159 6.4718 0.0 0
M  V30 21 C 6.6684 4.6201 0.0 0
M  V30 22 C 10.6459 7.8054 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Pyrrolidinepropanoic acid, α-amino-2-oxo-, methyl ester, (αS,3S)-, 4-methyl...
C8H14N2O3.C7H8O3S
2720867-05-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 6.1600 0.0 0
M  V30 2 C 5.1048 6.9301 0.0 0 CFG=2
M  V30 3 C 6.4386 6.1600 0.0 0
M  V30 4 N 5.1048 8.4701 0.0 0
M  V30 5 O 7.7722 6.9301 0.0 0
M  V30 6 O 6.4386 4.6200 0.0 0
M  V30 7 C 9.1059 6.1600 0.0 0
M  V30 8 O 0.7103 4.7973 0.0 0
M  V30 9 C 2.4374 6.9301 0.0 0 CFG=2
M  V30 10 C 1.0304 6.3036 0.0 0
M  V30 11 C 2.2763 8.4616 0.0 0
M  V30 12 N 0.0000 7.4481 0.0 0
M  V30 13 C 0.7700 8.7818 0.0 0
M  V30 14 S 2.2430 1.5400 0.0 0 VAL=6
M  V30 15 O 2.2430 3.0800 0.0 0
M  V30 16 O 2.2430 0.0000 0.0 0
M  V30 17 O 0.7030 1.5400 0.0 0
M  V30 18 C 8.4030 1.5400 0.0 0
M  V30 19 C 3.7830 1.5400 0.0 0
M  V30 20 C 4.5530 0.2064 0.0 0
M  V30 21 C 4.5530 2.8736 0.0 0
M  V30 22 C 6.0930 0.2064 0.0 0
M  V30 23 C 6.0930 2.8736 0.0 0
M  V30 24 C 6.8630 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 10
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 14 19
M  V30 18 1 18 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C24H32N4O6
2648754-93-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 16.5205 3.8044 0.0 0
M  V30 2 C 18.0605 3.8044 0.0 0
M  V30 3 C 10.4395 3.8500 0.0 0
M  V30 4 N 9.1057 4.6200 0.0 0
M  V30 5 O 10.4395 2.3100 0.0 0
M  V30 6 C 7.7721 3.8500 0.0 0 CFG=1
M  V30 7 C 6.4384 4.6200 0.0 0
M  V30 8 C 7.7721 2.3100 0.0 0
M  V30 9 N 6.4384 6.1600 0.0 0
M  V30 10 O 5.1048 3.8500 0.0 0
M  V30 11 C 6.4384 1.5400 0.0 0
M  V30 12 C 5.1048 6.9300 0.0 0 CFG=2
M  V30 13 C 5.1048 2.3100 0.0 0
M  V30 14 C 6.4384 0.0000 0.0 0
M  V30 15 C 3.7710 6.1600 0.0 0
M  V30 16 C 5.1048 8.4700 0.0 0
M  V30 17 O 6.4384 9.2400 0.0 0
M  V30 18 O 3.7710 9.2400 0.0 0
M  V30 19 C 6.4384 10.7800 0.0 0
M  V30 20 O 0.7104 4.7973 0.0 0
M  V30 21 C 14.2105 5.1381 0.0 0
M  V30 22 C 13.4405 6.4717 0.0 0
M  V30 23 C 13.1799 3.9937 0.0 0
M  V30 24 C 15.7505 5.1381 0.0 0
M  V30 25 N 11.9341 6.1515 0.0 0
M  V30 26 C 14.2105 7.8055 0.0 0
M  V30 27 C 11.7731 4.6200 0.0 0
M  V30 28 C 16.5205 6.4717 0.0 0
M  V30 29 C 15.7505 7.8055 0.0 0
M  V30 30 C 2.4374 6.9300 0.0 0 CFG=2
M  V30 31 C 1.0306 6.3037 0.0 0
M  V30 32 C 2.2764 8.4615 0.0 0
M  V30 33 N 0.0000 7.4481 0.0 0
M  V30 34 C 0.7700 8.7817 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 27
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15 CFG=1
M  V30 16 1 12 16
M  V30 17 1 30 15 CFG=1
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 2 20 31
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 27
M  V30 30 1 26 29
M  V30 31 2 28 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 12 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2713439-23-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2720867-05-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648754-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35464726
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 13161-30-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 78-93-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Early Clinical Development of Lufotrelvir as a Potential Therapy for
COVID-19
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allais, Christophe; Bernhardson, David; Brown, Adam R.; Chinigo, Gary M.;
Desrosiers, Jean-Nicolas; DiRico, Kenneth J.; Hotham, Ian; Jones, Brian
P.; Kulkarni, Samir A.; Lewis, Chad A.; Lira, Ricardo; Loach, Richard P.;
Morse, Peter D.; Mousseau, James J.; Perry, Matthew A.; Peng, Zhihui;
Place, David W.; Rane, Anil M.; Samp, Lacey; Singer, Robert A.; Wang,
Zheng; Weisenburger, Gerald A.; Yayla, Hatice G.; Zanghi, Joseph M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(12), 2223-2239

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Valproic acid
C8H16O2
99-66-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 O 0.7700 1.3338 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Gemcitabine hydrochloride
C9H11F2N3O4.ClH
122111-03-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.9743 3.2671 0.0 0
M  V30 2 F 4.5952 1.7354 0.0 0
M  V30 3 O 4.5952 7.8786 0.0 0
M  V30 4 O 2.3015 1.5400 0.0 0
M  V30 5 C 0.6263 4.4415 0.0 0
M  V30 6 O 0.0000 5.8485 0.0 0
M  V30 7 N 9.9299 7.8786 0.0 0
M  V30 8 C 4.5952 4.7986 0.0 0 CFG=2
M  V30 9 C 4.4343 3.2671 0.0 0
M  V30 10 O 3.1884 5.4250 0.0 0
M  V30 11 C 2.9278 2.9469 0.0 0 CFG=2
M  V30 12 C 2.1578 4.2806 0.0 0 CFG=2
M  V30 13 N 5.9288 5.5686 0.0 0
M  V30 14 C 5.9288 7.1086 0.0 0
M  V30 15 C 7.2626 4.7986 0.0 0
M  V30 16 N 7.2626 7.8786 0.0 0
M  V30 17 C 8.5963 5.5686 0.0 0
M  V30 18 C 8.5963 7.1086 0.0 0
M  V30 19 Cl 4.9650 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 9
M  V30 3 2 3 14
M  V30 4 1 11 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 12 5 CFG=1
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13 CFG=1
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2′-Deoxy-2′,2′-difluoro-N-(1-oxo-2-propylpentyl)cytidine
C17H25F2N3O5
892128-60-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 5.9744 8.4617 0.0 0
M  V30 2 F 4.5955 9.9934 0.0 0
M  V30 3 O 4.5955 3.8501 0.0 0
M  V30 4 O 2.3016 10.1889 0.0 0
M  V30 5 C 0.6265 7.2873 0.0 0
M  V30 6 O 0.0000 5.8803 0.0 0
M  V30 7 N 9.9303 3.8501 0.0 0
M  V30 8 C 11.2640 4.6201 0.0 0
M  V30 9 C 12.5976 3.8501 0.0 0
M  V30 10 O 11.2640 6.1601 0.0 0
M  V30 11 C 13.9313 4.6201 0.0 0
M  V30 12 C 12.5976 2.3101 0.0 0
M  V30 13 C 15.2651 3.8501 0.0 0
M  V30 14 C 13.9313 1.5400 0.0 0
M  V30 15 C 16.5988 4.6201 0.0 0
M  V30 16 C 13.9313 0.0000 0.0 0
M  V30 17 C 4.5955 6.9302 0.0 0 CFG=2
M  V30 18 C 4.4344 8.4617 0.0 0
M  V30 19 O 3.1885 6.3038 0.0 0
M  V30 20 C 2.9281 8.7819 0.0 0 CFG=2
M  V30 21 C 2.1580 7.4482 0.0 0 CFG=2
M  V30 22 N 5.9291 6.1601 0.0 0
M  V30 23 C 5.9291 4.6201 0.0 0
M  V30 24 C 7.2628 6.9302 0.0 0
M  V30 25 N 7.2628 3.8501 0.0 0
M  V30 26 C 8.5965 6.1601 0.0 0
M  V30 27 C 8.5965 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 18
M  V30 3 2 3 23
M  V30 4 1 20 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22 CFG=3
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122111-03-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892128-60-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40642694
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate
Prodrug of Gemcitabine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Liang; Qi, Kangjing; Xu, Jie; Xing, Yan; Wang, Xuejian; Tong,
Ling; He, Zengguo; Xu, Wenfang; Li, Xiaoyang; Jiang, Yuqi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(6), 4150-4166

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) 3-methyl (3S,4S)-4-amino-1,3-piperidinedicarboxylate
C12H22N2O4
859855-38-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 O 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 N 1.3337 5.3901 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 O 8.0023 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 10.1060 3.6437 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 8.5660 0.9764 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0 CFG=2
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0 CFG=1
M  V30 16 N 5.3348 3.0801 0.0 0
M  V30 17 C 4.0012 5.3901 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 15 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-(2,4-Difluorophenyl)-3-isoxazolecarboxylic acid
C10H5F2NO3
1083224-23-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.5626 5.8742 0.0 0
M  V30 2 C 1.4068 1.5315 0.0 0
M  V30 3 O 1.5679 0.0000 0.0 0
M  V30 4 O 0.0000 2.1580 0.0 0
M  V30 5 F 11.1826 3.2068 0.0 0
M  V30 6 C 5.0226 3.2068 0.0 0
M  V30 7 C 4.1174 1.9609 0.0 0
M  V30 8 O 4.1174 4.4526 0.0 0
M  V30 9 C 2.6528 2.4368 0.0 0
M  V30 10 N 2.6528 3.9768 0.0 0
M  V30 11 C 6.5626 3.2068 0.0 0
M  V30 12 C 7.3326 4.5406 0.0 0
M  V30 13 C 7.3326 1.8731 0.0 0
M  V30 14 C 8.8726 4.5406 0.0 0
M  V30 15 C 8.8726 1.8731 0.0 0
M  V30 16 C 9.6426 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 3-methyl (3S,4S)-4-[[[5-(2,4-difluorophenyl)-3-isoxazol...
C22H25F2N3O6
2178053-38-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.2035 2.6673 0.0 0
M  V30 2 O 11.9735 1.3336 0.0 0
M  V30 3 O 9.6635 2.6673 0.0 0
M  V30 4 C 11.2035 0.0000 0.0 0
M  V30 5 N 9.6635 5.3347 0.0 0
M  V30 6 C 8.8935 6.6684 0.0 0
M  V30 7 O 9.6635 8.0020 0.0 0
M  V30 8 C 15.8235 5.3347 0.0 0
M  V30 9 O 16.5935 6.6684 0.0 0
M  V30 10 O 16.5935 4.0009 0.0 0
M  V30 11 C 18.1335 6.6684 0.0 0
M  V30 12 C 18.1335 5.1284 0.0 0
M  V30 13 C 19.6735 6.6684 0.0 0
M  V30 14 C 18.1335 8.2084 0.0 0
M  V30 15 F 2.1699 6.1856 0.0 0
M  V30 16 F 0.0000 11.0590 0.0 0
M  V30 17 C 11.9735 4.0009 0.0 0 CFG=1
M  V30 18 C 11.2035 5.3347 0.0 0 CFG=1
M  V30 19 C 13.5135 4.0009 0.0 0
M  V30 20 C 11.9735 6.6684 0.0 0
M  V30 21 N 14.2835 5.3347 0.0 0
M  V30 22 C 13.5135 6.6684 0.0 0
M  V30 23 C 7.3535 6.6684 0.0 0
M  V30 24 C 6.4483 7.9142 0.0 0
M  V30 25 N 6.4483 5.4225 0.0 0
M  V30 26 C 4.9836 7.4384 0.0 0
M  V30 27 O 4.9836 5.8984 0.0 0
M  V30 28 C 3.7377 8.3436 0.0 0
M  V30 29 C 2.3309 7.7171 0.0 0
M  V30 30 C 3.8987 9.8751 0.0 0
M  V30 31 C 1.0849 8.6223 0.0 0
M  V30 32 C 2.6528 10.7803 0.0 0
M  V30 33 C 1.2460 10.1538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=1
M  V30 7 2 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 29
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 859855-38-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1083224-23-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178053-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24100902
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist
ACT-1004-1239
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richard-Bildstein, Sylvia; Aissaoui, Hamed; Pothier, Julien; Schafer,
Gabriel; Gnerre, Carmela; Lindenberg, Eleanor; Lehembre, Francois;
Pouzol, Laetitia; Guerry, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(24), 15864-15882

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
2-Benzofurancarboxylic acid
C9H6O3
496-41-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 O 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C31H26N2O6
2892485-62-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6201 0.0 0
M  V30 2 O 8.0022 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8049 2.7300 0.0 0
M  V30 9 O 18.1784 1.3230 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 N 6.6685 3.8501 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 9.3358 3.8501 0.0 0
M  V30 21 O 10.7428 4.4764 0.0 0
M  V30 22 C 9.4969 2.3185 0.0 0
M  V30 23 C 11.7732 3.3320 0.0 0
M  V30 24 C 11.0032 1.9983 0.0 0
M  V30 25 C 13.3048 3.4930 0.0 0
M  V30 26 C 14.2100 2.2471 0.0 0
M  V30 27 C 13.9313 4.8999 0.0 0
M  V30 28 C 15.7416 2.4080 0.0 0
M  V30 29 C 15.4629 5.0609 0.0 0
M  V30 30 C 16.3681 3.8150 0.0 0
M  V30 31 C 20.3365 2.8910 0.0 0
M  V30 32 C 21.1065 4.2246 0.0 0
M  V30 33 O 21.3669 1.7466 0.0 0
M  V30 34 C 22.6129 3.9044 0.0 0
M  V30 35 C 22.7739 2.3729 0.0 0
M  V30 36 C 23.8588 4.8097 0.0 0
M  V30 37 C 24.1807 1.7466 0.0 0
M  V30 38 C 25.2656 4.1833 0.0 0
M  V30 39 C 25.4266 2.6518 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 496-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-62-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
5-(2,4-Difluorophenyl)-3-isoxazolecarboxylic acid
C10H5F2NO3
1083224-23-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.5626 5.8742 0.0 0
M  V30 2 C 1.4068 1.5315 0.0 0
M  V30 3 O 1.5679 0.0000 0.0 0
M  V30 4 O 0.0000 2.1580 0.0 0
M  V30 5 F 11.1826 3.2068 0.0 0
M  V30 6 C 5.0226 3.2068 0.0 0
M  V30 7 C 4.1174 1.9609 0.0 0
M  V30 8 O 4.1174 4.4526 0.0 0
M  V30 9 C 2.6528 2.4368 0.0 0
M  V30 10 N 2.6528 3.9768 0.0 0
M  V30 11 C 6.5626 3.2068 0.0 0
M  V30 12 C 7.3326 4.5406 0.0 0
M  V30 13 C 7.3326 1.8731 0.0 0
M  V30 14 C 8.8726 4.5406 0.0 0
M  V30 15 C 8.8726 1.8731 0.0 0
M  V30 16 C 9.6426 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Piperidinedicarboxylic acid, 4-amino-, (3R,4S)-, 1-(1,1-dimethylethyl) 3-...
C12H22N2O4.C2HF3O2
3026294-17-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 7.4938 0.0 0
M  V30 2 O 1.3337 5.9537 0.0 0
M  V30 3 O 0.0000 8.2638 0.0 0
M  V30 4 C 0.0000 5.1837 0.0 0
M  V30 5 N 1.3337 10.5738 0.0 0
M  V30 6 C 6.6685 7.4938 0.0 0
M  V30 7 O 8.0023 8.2638 0.0 0
M  V30 8 O 6.6685 5.9537 0.0 0
M  V30 9 C 9.3360 7.4938 0.0 0
M  V30 10 C 10.1060 8.8274 0.0 0
M  V30 11 C 10.6697 6.7238 0.0 0
M  V30 12 C 8.5660 6.1601 0.0 0
M  V30 13 C 2.6673 8.2638 0.0 0 CFG=1
M  V30 14 C 4.0012 7.4938 0.0 0
M  V30 15 C 2.6673 9.8038 0.0 0 CFG=1
M  V30 16 N 5.3348 8.2638 0.0 0
M  V30 17 C 4.0012 10.5738 0.0 0
M  V30 18 C 5.3348 9.8038 0.0 0
M  V30 19 C 4.6680 2.3101 0.0 0
M  V30 20 C 6.0017 1.5400 0.0 0
M  V30 21 F 5.4380 3.6437 0.0 0
M  V30 22 F 3.3343 3.0801 0.0 0
M  V30 23 F 3.8980 0.9764 0.0 0
M  V30 24 O 7.3353 2.3101 0.0 0
M  V30 25 O 6.0017 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 15 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 20 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,3-Piperidinedicarboxylic acid, 4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]car...
C22H25F2N3O6
3026294-18-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.2035 2.6673 0.0 0
M  V30 2 O 11.9735 1.3336 0.0 0
M  V30 3 O 9.6635 2.6673 0.0 0
M  V30 4 C 11.2035 0.0000 0.0 0
M  V30 5 N 9.6635 5.3347 0.0 0
M  V30 6 C 8.8935 6.6684 0.0 0
M  V30 7 O 9.6635 8.0020 0.0 0
M  V30 8 C 15.8235 5.3347 0.0 0
M  V30 9 O 16.5935 6.6684 0.0 0
M  V30 10 O 16.5935 4.0009 0.0 0
M  V30 11 C 18.1335 6.6684 0.0 0
M  V30 12 C 18.1335 5.1284 0.0 0
M  V30 13 C 19.6735 6.6684 0.0 0
M  V30 14 C 18.1335 8.2084 0.0 0
M  V30 15 F 2.1699 6.1856 0.0 0
M  V30 16 F 0.0000 11.0590 0.0 0
M  V30 17 C 11.9735 4.0009 0.0 0 CFG=2
M  V30 18 C 11.2035 5.3347 0.0 0 CFG=1
M  V30 19 C 13.5135 4.0009 0.0 0
M  V30 20 C 11.9735 6.6684 0.0 0
M  V30 21 N 14.2835 5.3347 0.0 0
M  V30 22 C 13.5135 6.6684 0.0 0
M  V30 23 C 7.3535 6.6684 0.0 0
M  V30 24 C 6.4483 7.9142 0.0 0
M  V30 25 N 6.4483 5.4225 0.0 0
M  V30 26 C 4.9836 7.4384 0.0 0
M  V30 27 O 4.9836 5.8984 0.0 0
M  V30 28 C 3.7377 8.3436 0.0 0
M  V30 29 C 2.3309 7.7171 0.0 0
M  V30 30 C 3.8987 9.8751 0.0 0
M  V30 31 C 1.0849 8.6223 0.0 0
M  V30 32 C 2.6528 10.7803 0.0 0
M  V30 33 C 1.2460 10.1538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=1
M  V30 7 2 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 29
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1083224-23-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026294-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026294-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38927965
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM e.r. 99.7:0.3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Scalable, Stereoselective second Generation Route for
CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel
Telescoped Sequence of Transesterification, cis-to-trans-Epimerization
and Saponification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schafer, Gabriel; Fleischer, Tony; Merot, Aurelien; Erhardt, Michael;
Mathys, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(6), 2103-2116

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
5-(2,4-Difluorophenyl)-3-isoxazolecarboxylic acid
C10H5F2NO3
1083224-23-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.5626 5.8742 0.0 0
M  V30 2 C 1.4068 1.5315 0.0 0
M  V30 3 O 1.5679 0.0000 0.0 0
M  V30 4 O 0.0000 2.1580 0.0 0
M  V30 5 F 11.1826 3.2068 0.0 0
M  V30 6 C 5.0226 3.2068 0.0 0
M  V30 7 C 4.1174 1.9609 0.0 0
M  V30 8 O 4.1174 4.4526 0.0 0
M  V30 9 C 2.6528 2.4368 0.0 0
M  V30 10 N 2.6528 3.9768 0.0 0
M  V30 11 C 6.5626 3.2068 0.0 0
M  V30 12 C 7.3326 4.5406 0.0 0
M  V30 13 C 7.3326 1.8731 0.0 0
M  V30 14 C 8.8726 4.5406 0.0 0
M  V30 15 C 8.8726 1.8731 0.0 0
M  V30 16 C 9.6426 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Piperidinedicarboxylic acid, 4-amino-, 1-(1,1-dimethylethyl) 3-methyl est...
C12H22N2O4.C2HF3O2
3026554-59-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 7.4938 0.0 0
M  V30 2 O 1.3337 5.9537 0.0 0
M  V30 3 O 0.0000 8.2638 0.0 0
M  V30 4 C 0.0000 5.1837 0.0 0
M  V30 5 N 1.3337 10.5738 0.0 0
M  V30 6 C 6.6685 7.4938 0.0 0
M  V30 7 O 8.0023 8.2638 0.0 0
M  V30 8 O 6.6685 5.9537 0.0 0
M  V30 9 C 9.3360 7.4938 0.0 0
M  V30 10 C 10.1060 8.8274 0.0 0
M  V30 11 C 10.6697 6.7238 0.0 0
M  V30 12 C 8.5660 6.1601 0.0 0
M  V30 13 C 2.6673 8.2638 0.0 0
M  V30 14 C 4.0012 7.4938 0.0 0
M  V30 15 C 2.6673 9.8038 0.0 0
M  V30 16 N 5.3348 8.2638 0.0 0
M  V30 17 C 4.0012 10.5738 0.0 0
M  V30 18 C 5.3348 9.8038 0.0 0
M  V30 19 C 4.6680 2.3101 0.0 0
M  V30 20 C 6.0017 1.5400 0.0 0
M  V30 21 F 5.4380 3.6437 0.0 0
M  V30 22 F 3.3343 3.0801 0.0 0
M  V30 23 F 3.8980 0.9764 0.0 0
M  V30 24 O 7.3353 2.3101 0.0 0
M  V30 25 O 6.0017 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 20 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Piperidinedicarboxylic acid, 4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]car...
C22H25F2N3O6
3026294-19-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2035 2.6673 0.0 0
M  V30 2 O 11.9735 1.3336 0.0 0
M  V30 3 O 9.6635 2.6673 0.0 0
M  V30 4 C 11.2035 0.0000 0.0 0
M  V30 5 N 9.6635 5.3347 0.0 0
M  V30 6 C 8.8935 6.6684 0.0 0
M  V30 7 O 9.6635 8.0020 0.0 0
M  V30 8 C 15.8235 5.3347 0.0 0
M  V30 9 O 16.5935 6.6684 0.0 0
M  V30 10 O 16.5935 4.0009 0.0 0
M  V30 11 C 18.1335 6.6684 0.0 0
M  V30 12 C 18.1335 5.1284 0.0 0
M  V30 13 C 19.6735 6.6684 0.0 0
M  V30 14 C 18.1335 8.2084 0.0 0
M  V30 15 F 2.1699 6.1856 0.0 0
M  V30 16 F 0.0000 11.0590 0.0 0
M  V30 17 C 11.9735 4.0009 0.0 0
M  V30 18 C 11.2035 5.3347 0.0 0
M  V30 19 C 13.5135 4.0009 0.0 0
M  V30 20 C 11.9735 6.6684 0.0 0
M  V30 21 N 14.2835 5.3347 0.0 0
M  V30 22 C 13.5135 6.6684 0.0 0
M  V30 23 C 7.3535 6.6684 0.0 0
M  V30 24 C 6.4483 7.9142 0.0 0
M  V30 25 N 6.4483 5.4225 0.0 0
M  V30 26 C 4.9836 7.4384 0.0 0
M  V30 27 O 4.9836 5.8984 0.0 0
M  V30 28 C 3.7377 8.3436 0.0 0
M  V30 29 C 2.3309 7.7171 0.0 0
M  V30 30 C 3.8987 9.8751 0.0 0
M  V30 31 C 1.0849 8.6223 0.0 0
M  V30 32 C 2.6528 10.7803 0.0 0
M  V30 33 C 1.2460 10.1540 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 29
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1083224-23-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3026554-59-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026294-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38928206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (cis:trans = 2:1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Scalable, Racemic first Generation Route for CXCR7
Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent
Separation of Enantiomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schafer, Gabriel; Fleischer, Tony; Ahmetovic, Muhamed; Guerry, Philippe;
Abele, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(6), 2090-2102

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Indomethacin
C19H16ClNO4
53-86-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8398 7.7394 0.0 0
M  V30 2 O 7.0698 9.0731 0.0 0
M  V30 3 C 6.7127 2.4367 0.0 0
M  V30 4 C 5.4668 1.5315 0.0 0
M  V30 5 O 4.0601 2.1580 0.0 0
M  V30 6 O 5.6278 0.0000 0.0 0
M  V30 7 C 9.2026 4.6787 0.0 0
M  V30 8 O 1.1444 4.8170 0.0 0
M  V30 9 C 0.0000 5.8475 0.0 0
M  V30 10 Cl 13.9998 7.7394 0.0 0
M  V30 11 C 5.5383 6.2447 0.0 0
M  V30 12 C 5.2181 4.7384 0.0 0
M  V30 13 N 7.0698 6.4056 0.0 0
M  V30 14 C 4.3939 7.2751 0.0 0
M  V30 15 C 6.5518 3.9684 0.0 0
M  V30 16 C 3.7534 4.2624 0.0 0
M  V30 17 C 7.6963 4.9988 0.0 0
M  V30 18 C 2.9292 6.7993 0.0 0
M  V30 19 C 2.6091 5.2930 0.0 0
M  V30 20 C 9.3798 7.7394 0.0 0
M  V30 21 C 10.1498 6.4056 0.0 0
M  V30 22 C 10.1498 9.0731 0.0 0
M  V30 23 C 11.6898 6.4056 0.0 0
M  V30 24 C 11.6898 9.0731 0.0 0
M  V30 25 C 12.4598 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 19
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N1-Didodecyl-N2-methyl-1,2-ethanediamine
C27H59N2.I
2128731-38-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8600 5.3900 0.0 0 CHG=1 VAL=4
M  V30 2 C 12.3200 5.3900 0.0 0
M  V30 3 C 15.4000 5.3900 0.0 0
M  V30 4 C 13.8600 3.8500 0.0 0
M  V30 5 C 13.8600 6.9300 0.0 0
M  V30 6 C 11.5500 6.7236 0.0 0
M  V30 7 C 16.1700 6.7236 0.0 0
M  V30 8 C 12.5264 3.0800 0.0 0
M  V30 9 C 10.0100 6.7236 0.0 0
M  V30 10 C 17.7100 6.7236 0.0 0
M  V30 11 N 12.5264 1.5400 0.0 0
M  V30 12 C 9.2400 8.0574 0.0 0
M  V30 13 C 18.4800 8.0574 0.0 0
M  V30 14 C 7.7000 8.0574 0.0 0
M  V30 15 C 20.0200 8.0574 0.0 0
M  V30 16 C 6.9300 9.3911 0.0 0
M  V30 17 C 20.7900 9.3911 0.0 0
M  V30 18 C 5.3900 9.3911 0.0 0
M  V30 19 C 22.3300 9.3911 0.0 0
M  V30 20 C 4.6200 10.7247 0.0 0
M  V30 21 C 23.1000 10.7247 0.0 0
M  V30 22 C 3.0800 10.7247 0.0 0
M  V30 23 C 24.6400 10.7247 0.0 0
M  V30 24 C 2.3100 12.0585 0.0 0
M  V30 25 C 25.4100 12.0585 0.0 0
M  V30 26 C 0.7700 12.0585 0.0 0
M  V30 27 C 26.9500 12.0585 0.0 0
M  V30 28 C 0.0000 13.3921 0.0 0
M  V30 29 C 27.7200 13.3921 0.0 0
M  V30 30 I 13.8600 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Dodecanaminium, N-[2-[[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3...
C46H73ClN3O3.I
3055833-34-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6276 19.8704 0.0 0
M  V30 2 O 5.7885 18.3388 0.0 0
M  V30 3 C 10.7835 21.5457 0.0 0
M  V30 4 C 11.5535 20.2120 0.0 0
M  V30 5 N 13.0935 20.2120 0.0 0
M  V30 6 O 10.7835 18.8783 0.0 0
M  V30 7 C 13.8635 18.8783 0.0 0
M  V30 8 C 15.4036 18.8783 0.0 0
M  V30 9 N 16.1736 17.5445 0.0 0 CHG=1 VAL=4
M  V30 10 C 16.9436 16.2108 0.0 0
M  V30 11 C 17.5073 18.3145 0.0 0
M  V30 12 C 14.8398 16.7745 0.0 0
M  V30 13 C 16.1736 14.8772 0.0 0
M  V30 14 C 18.8409 17.5445 0.0 0
M  V30 15 C 16.9436 13.5433 0.0 0
M  V30 16 C 20.1746 18.3145 0.0 0
M  V30 17 C 16.1736 12.2097 0.0 0
M  V30 18 C 21.5084 17.5445 0.0 0
M  V30 19 C 16.9436 10.8760 0.0 0
M  V30 20 C 22.8421 18.3145 0.0 0
M  V30 21 C 16.1736 9.5423 0.0 0
M  V30 22 C 24.1758 17.5445 0.0 0
M  V30 23 C 16.9436 8.2085 0.0 0
M  V30 24 C 25.5094 18.3145 0.0 0
M  V30 25 C 16.1736 6.8748 0.0 0
M  V30 26 C 26.8432 17.5445 0.0 0
M  V30 27 C 16.9436 5.5412 0.0 0
M  V30 28 C 28.1769 18.3145 0.0 0
M  V30 29 C 16.1736 4.2075 0.0 0
M  V30 30 C 29.5106 17.5445 0.0 0
M  V30 31 C 16.9436 2.8737 0.0 0
M  V30 32 C 30.8443 18.3145 0.0 0
M  V30 33 C 16.1736 1.5400 0.0 0
M  V30 34 C 32.1781 17.5445 0.0 0
M  V30 35 C 8.8141 18.8350 0.0 0
M  V30 36 O 7.8342 26.8347 0.0 0
M  V30 37 C 6.6896 27.8653 0.0 0
M  V30 38 Cl 0.0000 22.3760 0.0 0
M  V30 39 C 6.8735 22.3157 0.0 0
M  V30 40 C 8.3382 22.7915 0.0 0
M  V30 41 N 6.8735 20.7756 0.0 0
M  V30 42 C 5.7291 23.3461 0.0 0
M  V30 43 C 9.2434 21.5457 0.0 0
M  V30 44 C 8.6584 24.2980 0.0 0
M  V30 45 C 8.3382 20.2998 0.0 0
M  V30 46 C 6.0493 24.8526 0.0 0
M  V30 47 C 7.5138 25.3284 0.0 0
M  V30 48 C 4.2208 20.4969 0.0 0
M  V30 49 C 2.9747 19.5917 0.0 0
M  V30 50 C 4.0597 22.0285 0.0 0
M  V30 51 C 1.5679 20.2180 0.0 0
M  V30 52 C 2.6529 22.6548 0.0 0
M  V30 53 C 1.4070 21.7496 0.0 0
M  V30 54 I 16.0890 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 41
M  V30 3 1 1 48
M  V30 4 1 3 4
M  V30 5 1 3 43
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 35 45
M  V30 37 1 36 37
M  V30 38 1 36 47
M  V30 39 1 38 53
M  V30 40 1 39 40
M  V30 41 1 39 41
M  V30 42 2 39 42
M  V30 43 1 40 43
M  V30 44 2 40 44
M  V30 45 1 41 45
M  V30 46 1 42 46
M  V30 47 2 43 45
M  V30 48 1 44 47
M  V30 49 2 46 47
M  V30 50 2 48 49
M  V30 51 1 48 50
M  V30 52 1 49 51
M  V30 53 2 50 52
M  V30 54 2 51 53
M  V30 55 1 52 53
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53-86-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2128731-38-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055833-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37275703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM inert in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA
Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the
Treatment of Lung and Breast Cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vaidya, Sandeep; Mohod, Annie; Eedara, Abhisheik Chowdary; Andugulapati,
Sai Balaji; Pabbaraja, Srihari
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2023), 18(16), e202300097

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
N,3-Bis[(1,1-dimethylethoxy)carbonyl]-L-histidine
C16H25N3O6
77205-61-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 3 N 5.3347 3.0800 0.0 0
M  V30 4 C 6.6684 0.7700 0.0 0
M  V30 5 C 4.0009 2.3100 0.0 0
M  V30 6 O 8.0020 0.0000 0.0 0
M  V30 7 O 5.3347 0.0000 0.0 0
M  V30 8 O 2.6673 3.0800 0.0 0
M  V30 9 O 4.0009 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 0.5636 3.6438 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 2.1037 0.9764 0.0 0
M  V30 14 C 10.7126 5.0494 0.0 0
M  V30 15 O 11.8570 6.0798 0.0 0
M  V30 16 O 11.0328 3.5431 0.0 0
M  V30 17 C 13.3217 5.6039 0.0 0
M  V30 18 C 12.8458 4.1394 0.0 0
M  V30 19 C 14.7862 5.1281 0.0 0
M  V30 20 C 13.7975 7.0686 0.0 0
M  V30 21 C 8.0020 4.6200 0.0 0
M  V30 22 N 9.2479 5.5252 0.0 0
M  V30 23 C 6.7562 5.5252 0.0 0
M  V30 24 C 8.7720 6.9899 0.0 0
M  V30 25 N 7.2320 6.9899 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 22
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(1E)-2-(3,5-Dimethoxyphenyl)ethenyl]benzenamine
C16H17NO2
586410-15-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 1.3337 5.3901 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 O 4.0010 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 N 13.3370 7.7002 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 9.3360 5.3901 0.0 0
M  V30 15 C 9.3360 6.9302 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 10.6697 7.7002 0.0 0
M  V30 18 C 12.0033 5.3901 0.0 0
M  V30 19 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazole-1-carboxylic acid, 5-[(2S)-3-[[4-[(1E)-2-(3,5-dimethoxyphenyl)et...
C32H40N4O7
3081937-81-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7842 6.7236 0.0 0
M  V30 2 C 8.1178 5.9536 0.0 0 CFG=2
M  V30 3 C 9.4516 6.7236 0.0 0
M  V30 4 N 8.1178 4.4136 0.0 0
M  V30 5 N 10.7852 5.9536 0.0 0
M  V30 6 O 9.4516 8.2636 0.0 0
M  V30 7 C 6.7842 3.6436 0.0 0
M  V30 8 O 6.7842 2.1036 0.0 0
M  V30 9 O 5.4505 4.4136 0.0 0
M  V30 10 C 5.4505 1.3336 0.0 0
M  V30 11 C 4.6805 2.6673 0.0 0
M  V30 12 C 4.1167 0.5636 0.0 0
M  V30 13 C 6.2205 0.0000 0.0 0
M  V30 14 C 4.0736 8.6930 0.0 0
M  V30 15 O 2.9292 9.7234 0.0 0
M  V30 16 O 3.7534 7.1866 0.0 0
M  V30 17 C 1.4645 9.2475 0.0 0
M  V30 18 C 0.9887 10.7122 0.0 0
M  V30 19 C 0.0000 8.7717 0.0 0
M  V30 20 C 1.9404 7.7829 0.0 0
M  V30 21 C 16.1199 9.0336 0.0 0
M  V30 22 C 17.4536 8.2636 0.0 0
M  V30 23 O 20.1210 12.8836 0.0 0
M  V30 24 C 21.4547 13.6536 0.0 0
M  V30 25 O 22.7883 8.2636 0.0 0
M  V30 26 C 24.1219 9.0336 0.0 0
M  V30 27 C 6.7842 8.2636 0.0 0
M  V30 28 N 5.5383 9.1689 0.0 0
M  V30 29 C 8.0300 9.1689 0.0 0
M  V30 30 C 6.0142 10.6335 0.0 0
M  V30 31 N 7.5542 10.6335 0.0 0
M  V30 32 C 12.1189 6.7236 0.0 0
M  V30 33 C 12.1189 8.2636 0.0 0
M  V30 34 C 13.4525 5.9536 0.0 0
M  V30 35 C 13.4525 9.0336 0.0 0
M  V30 36 C 14.7863 6.7236 0.0 0
M  V30 37 C 14.7863 8.2636 0.0 0
M  V30 38 C 18.7872 9.0336 0.0 0
M  V30 39 C 18.7872 10.5736 0.0 0
M  V30 40 C 20.1210 8.2636 0.0 0
M  V30 41 C 20.1210 11.3436 0.0 0
M  V30 42 C 21.4547 9.0336 0.0 0
M  V30 43 C 21.4547 10.5736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 32
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 28
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 21 22
M  V30 23 1 21 37
M  V30 24 1 22 38
M  V30 25 1 23 24
M  V30 26 1 23 41
M  V30 27 1 25 26
M  V30 28 1 25 42
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 77205-61-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586410-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3081937-81-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41302576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Structure-Activity Relationship Study of Amino Acid Derivatives of
Pterostilbene Analogues Toward Human Breast Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cordella, Fabiana; Dragone, Nicola; D'Orsi, Rosarita; Saponaro, Concetta;
Vergara, Daniele; Lessi, Marco; Angelici, Gaetano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2024), 19(14), e202300727

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
4-[(tert-Butoxycarbonyl)amino]butanoic acid
C9H17NO4
57294-38-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 2.1037 3.6437 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 0.5637 0.9764 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0022 1.5400 0.0 0
M  V30 11 C 9.3360 2.3101 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 13 O 10.6697 0.0000 0.0 0
M  V30 14 O 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lenalidomide
C13H13N3O3
191732-72-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 5.7904 0.0 0
M  V30 2 O 6.5770 0.4126 0.0 0
M  V30 3 N 1.3336 0.0000 0.0 0
M  V30 4 O 11.1970 3.0800 0.0 0
M  V30 5 N 5.0370 3.0800 0.0 0
M  V30 6 C 4.1320 4.3259 0.0 0
M  V30 7 C 4.1320 1.8340 0.0 0
M  V30 8 C 2.6673 3.8500 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.5770 3.0800 0.0 0
M  V30 15 C 7.3470 1.7462 0.0 0
M  V30 16 C 7.3470 4.4136 0.0 0
M  V30 17 N 8.8870 1.7462 0.0 0
M  V30 18 C 8.8870 4.4136 0.0 0
M  V30 19 C 9.6570 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 15
M  V30 3 1 3 11
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoind...
C22H28N4O6
2353563-39-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0823 6.6685 0.0 0
M  V30 2 C 11.6223 6.6685 0.0 0
M  V30 3 C 12.3923 5.3348 0.0 0
M  V30 4 O 12.3923 8.0022 0.0 0
M  V30 5 C 13.9324 5.3348 0.0 0
M  V30 6 C 14.7024 4.0012 0.0 0
M  V30 7 N 16.2424 4.0012 0.0 0
M  V30 8 C 17.0124 2.6673 0.0 0
M  V30 9 O 18.5525 2.6673 0.0 0
M  V30 10 O 16.2424 1.3337 0.0 0
M  V30 11 C 19.3225 1.3337 0.0 0
M  V30 12 C 17.9888 0.5637 0.0 0
M  V30 13 C 20.0925 0.0000 0.0 0
M  V30 14 C 20.6562 2.1037 0.0 0
M  V30 15 O 4.3514 10.0463 0.0 0
M  V30 16 O 5.3348 4.4040 0.0 0
M  V30 17 O 0.0000 4.4040 0.0 0
M  V30 18 C 7.7722 8.0022 0.0 0
M  V30 19 C 7.0022 9.3360 0.0 0
M  V30 20 C 9.3123 8.0023 0.0 0
M  V30 21 C 6.7417 6.8578 0.0 0
M  V30 22 C 5.4958 9.0158 0.0 0
M  V30 23 C 7.7722 10.6697 0.0 0
M  V30 24 C 10.0823 9.3360 0.0 0
M  V30 25 N 5.3348 7.4841 0.0 0
M  V30 26 C 9.3123 10.6697 0.0 0
M  V30 27 C 4.0012 6.7141 0.0 0
M  V30 28 C 4.0012 5.1741 0.0 0
M  V30 29 C 2.6675 7.4841 0.0 0
M  V30 30 N 2.6675 4.4040 0.0 0
M  V30 31 C 1.3337 6.7141 0.0 0
M  V30 32 C 1.3337 5.1741 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 22
M  V30 16 2 16 28
M  V30 17 2 17 32
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57294-38-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 191732-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2353563-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43597120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of selective platelet-derived growth factor receptor-beta
(PDGFR-β) bifunctional small-molecule degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Si, Ru; Liu, Nanxin; Wang, Jin; Zhang, Qingqing; Li, Yanchen; Pan,
Xiaoyan; Zhang, Jie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 77117115

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
(S)-4-(tert-Butoxycarbonyl)morpholine-3-carboxylic acid
C10H17NO5
783350-37-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 6.8749 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 3.7949 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-(methylsulfo...
C21H30N2O5S2
2765293-24-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 7.4387 5.9538 0.0 0
M  V30 4 O 5.8986 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0 CFG=1
M  V30 8 C 6.6687 1.5400 0.0 0
M  V30 9 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 C 6.6687 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 13.3372 3.8501 0.0 0
M  V30 14 N 12.0035 6.1601 0.0 0
M  V30 15 S 1.3338 7.7002 0.0 0 VAL=6
M  V30 16 C 0.0000 8.4702 0.0 0
M  V30 17 O 0.5638 6.3665 0.0 0
M  V30 18 O 2.1038 9.0338 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 4.0012 7.7002 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 2.6675 6.9302 0.0 0
M  V30 25 C 14.6708 4.6201 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 3.8501 0.0 0
M  V30 28 C 16.0045 6.9302 0.0 0
M  V30 29 C 17.3383 4.6201 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 13 25
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 15 18
M  V30 19 1 15 24
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[[4-(methyls...
C31H45N3O9S2
2765293-57-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 9.2402 0.0 0
M  V30 2 N 8.0023 8.4702 0.0 0
M  V30 3 O 5.3348 8.4702 0.0 0
M  V30 4 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 5 C 6.6685 6.1601 0.0 0
M  V30 6 C 9.3360 6.1601 0.0 0 CFG=2
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 10.6697 6.9302 0.0 0
M  V30 9 N 10.6697 3.8501 0.0 0
M  V30 10 S 12.0035 4.6201 0.0 0 VAL=6
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 O 12.7735 3.2864 0.0 0
M  V30 13 O 11.2335 5.9538 0.0 0
M  V30 14 C 12.0035 1.5400 0.0 0
M  V30 15 C 12.0035 0.0000 0.0 0
M  V30 16 C 13.3372 2.3101 0.0 0
M  V30 17 C 4.0012 10.7802 0.0 0
M  V30 18 O 2.6675 11.5503 0.0 0
M  V30 19 O 4.0012 9.2402 0.0 0
M  V30 20 C 1.3337 10.7802 0.0 0
M  V30 21 C 0.5637 12.1139 0.0 0
M  V30 22 C 0.0000 10.0102 0.0 0
M  V30 23 C 2.1037 9.4466 0.0 0
M  V30 24 S 17.3383 7.7002 0.0 0 VAL=6
M  V30 25 C 18.6720 8.4702 0.0 0
M  V30 26 O 16.5683 9.0338 0.0 0
M  V30 27 O 18.1083 6.3665 0.0 0
M  V30 28 C 6.6685 10.7802 0.0 0 CFG=2
M  V30 29 N 5.3348 11.5503 0.0 0
M  V30 30 C 8.0023 11.5503 0.0 0
M  V30 31 C 5.3348 13.0903 0.0 0
M  V30 32 O 8.0023 13.0903 0.0 0
M  V30 33 C 6.6685 13.8603 0.0 0
M  V30 34 C 6.6685 4.6201 0.0 0
M  V30 35 C 5.3348 3.8501 0.0 0
M  V30 36 C 8.0023 3.8501 0.0 0
M  V30 37 C 5.3348 2.3101 0.0 0
M  V30 38 C 8.0023 2.3101 0.0 0
M  V30 39 C 6.6685 1.5400 0.0 0
M  V30 40 C 13.3372 5.3901 0.0 0
M  V30 41 C 13.3372 6.9302 0.0 0
M  V30 42 C 14.6708 4.6201 0.0 0
M  V30 43 C 14.6708 7.7002 0.0 0
M  V30 44 C 16.0045 5.3901 0.0 0
M  V30 45 C 16.0045 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 28 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 34
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 10 40
M  V30 16 1 11 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 29
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 24 27
M  V30 29 1 24 45
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 42 2 40 41
M  V30 43 1 40 42
M  V30 44 1 41 43
M  V30 45 2 42 44
M  V30 46 2 43 45
M  V30 47 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 6 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 783350-37-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2765293-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765293-57-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31632737
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of protease inhibitors
containing morpholine cores with remarkable potency against both HIV-1
subtypes B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Mei; Zhou, Huiyu; Ma, Ling; Dong, Biao; Ding, Jiwei; Zhou, Jinming;
Wang, Juxian; Zhang, Guoning; Wang, Minghua; Shan, Qi; Cen, Shan; Wang,
Yucheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 233114251

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-L-valyl-4-hydroxy-N-...
C27H38N4O5S
1448189-98-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 5.3026 0.0 0
M  V30 2 C 6.1601 5.3026 0.0 0 CFG=2
M  V30 3 O 8.4701 6.6363 0.0 0
M  V30 4 N 5.3901 3.9689 0.0 0
M  V30 5 C 5.3901 6.6363 0.0 0
M  V30 6 C 3.8501 3.9689 0.0 0
M  V30 7 C 4.0563 5.8663 0.0 0
M  V30 8 C 4.6201 7.9699 0.0 0
M  V30 9 C 6.7237 7.4063 0.0 0
M  V30 10 O 3.0800 2.6351 0.0 0
M  V30 11 O 3.0800 5.3026 0.0 0
M  V30 12 C 1.5400 2.6351 0.0 0
M  V30 13 C 1.5400 1.0951 0.0 0
M  V30 14 C 0.0000 2.6351 0.0 0
M  V30 15 C 1.5400 4.1752 0.0 0
M  V30 16 C 11.0321 4.9524 0.0 0
M  V30 17 N 12.5386 4.6322 0.0 0
M  V30 18 O 10.5562 6.4170 0.0 0
M  V30 19 C 13.5690 5.7766 0.0 0
M  V30 20 O 8.8271 0.0000 0.0 0
M  V30 21 C 20.5779 7.0579 0.0 0
M  V30 22 N 8.4701 3.9689 0.0 0
M  V30 23 C 10.0017 3.8079 0.0 0 CFG=2
M  V30 24 C 7.8436 2.5620 0.0 0
M  V30 25 C 10.3218 2.3016 0.0 0
M  V30 26 C 8.9882 1.5316 0.0 0 CFG=2
M  V30 27 C 15.0753 5.4565 0.0 0
M  V30 28 C 15.5511 3.9917 0.0 0
M  V30 29 C 16.1059 6.6008 0.0 0
M  V30 30 C 17.0576 3.6716 0.0 0
M  V30 31 C 17.6122 6.2807 0.0 0
M  V30 32 C 18.0880 4.8161 0.0 0
M  V30 33 C 19.5945 4.4959 0.0 0
M  V30 34 C 20.7389 5.5264 0.0 0
M  V30 35 S 20.2208 3.0890 0.0 0
M  V30 36 N 22.0725 4.7564 0.0 0
M  V30 37 C 21.7523 3.2499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 23 16 CFG=3
M  V30 19 1 17 19
M  V30 20 1 19 27
M  V30 21 1 26 20 CFG=1
M  V30 22 1 21 34
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 1 32 33
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 23 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-[(tert-Butoxycarbonyl)amino]hexanoic acid
C11H21NO4
6404-29-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 1.5400 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 O 4.0010 3.8501 0.0 0
M  V30 6 C 2.1037 3.6437 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 0.5637 0.9764 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 8.0022 1.5400 0.0 0
M  V30 11 C 9.3358 2.3101 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 13 C 12.0033 2.3101 0.0 0
M  V30 14 C 13.3370 1.5400 0.0 0
M  V30 15 O 13.3370 0.0000 0.0 0
M  V30 16 O 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, N-[6-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxohexyl]-3-methy...
C33H49N5O6S
2412055-00-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3724 9.3358 0.0 0
M  V30 2 C 15.9124 9.3358 0.0 0 CFG=2
M  V30 3 O 13.6024 10.6694 0.0 0
M  V30 4 N 16.6824 8.0020 0.0 0
M  V30 5 C 16.6824 10.6694 0.0 0
M  V30 6 C 18.2224 8.0020 0.0 0
M  V30 7 C 18.0162 9.8994 0.0 0
M  V30 8 C 17.4524 12.0031 0.0 0
M  V30 9 C 15.3487 11.4394 0.0 0
M  V30 10 C 18.9924 6.6684 0.0 0
M  V30 11 O 18.9924 9.3358 0.0 0
M  V30 12 C 20.5324 6.6684 0.0 0
M  V30 13 C 21.3024 5.3347 0.0 0
M  V30 14 C 22.8424 5.3347 0.0 0
M  V30 15 C 23.6124 4.0011 0.0 0
M  V30 16 N 25.1524 4.0011 0.0 0
M  V30 17 C 25.9224 2.6673 0.0 0
M  V30 18 O 27.4624 2.6673 0.0 0
M  V30 19 O 25.1524 1.3336 0.0 0
M  V30 20 C 28.2324 1.3336 0.0 0
M  V30 21 C 26.8987 0.5636 0.0 0
M  V30 22 C 29.0024 0.0000 0.0 0
M  V30 23 C 29.5662 2.1036 0.0 0
M  V30 24 C 11.0404 8.9854 0.0 0
M  V30 25 N 9.5340 8.6653 0.0 0
M  V30 26 O 11.5163 10.4501 0.0 0
M  V30 27 C 8.5036 9.8098 0.0 0
M  V30 28 O 13.2454 4.0331 0.0 0
M  V30 29 C 1.4947 11.0911 0.0 0
M  V30 30 N 13.6024 8.0020 0.0 0
M  V30 31 C 12.0708 7.8411 0.0 0 CFG=2
M  V30 32 C 14.2288 6.5952 0.0 0
M  V30 33 C 11.7507 6.3348 0.0 0
M  V30 34 C 13.0843 5.5648 0.0 0 CFG=2
M  V30 35 C 6.9973 9.4896 0.0 0
M  V30 36 C 6.5213 8.0249 0.0 0
M  V30 37 C 5.9667 10.6340 0.0 0
M  V30 38 C 5.0150 7.7048 0.0 0
M  V30 39 C 4.4605 10.3138 0.0 0
M  V30 40 C 3.9846 8.8491 0.0 0
M  V30 41 C 2.4782 8.5290 0.0 0
M  V30 42 C 1.3338 9.5596 0.0 0
M  V30 43 S 1.8518 7.1222 0.0 0
M  V30 44 N 0.0000 8.7896 0.0 0
M  V30 45 C 0.3203 7.2831 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 30
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 1 31 24 CFG=1
M  V30 27 1 25 27
M  V30 28 1 27 35
M  V30 29 1 34 28 CFG=3
M  V30 30 1 29 42
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 34
M  V30 36 2 35 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 2 37 39
M  V30 40 2 38 40
M  V30 41 1 39 40
M  V30 42 1 40 41
M  V30 43 2 41 42
M  V30 44 1 41 43
M  V30 45 1 42 44
M  V30 46 1 43 45
M  V30 47 2 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 31 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1448189-98-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6404-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412055-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-23416807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of SK-575 as a Highly Potent and Efficacious
Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Chaoguo; Yang, Jie; Chen, Yong; Zhou, Peiting; Wang, Yingwei; Du,
Wu; Zhao, Lifeng; Chen, Yuanwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(19), 11012-11033

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Imidazo[1,2-a]pyridin-6-amine, 8-fluoro-2-methyl-
C8H8FN3
1643412-36-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6674 0.0000 0.0 0
M  V30 2 C 7.9110 3.0800 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 5.4658 4.3259 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 N 5.4658 1.8341 0.0 0
M  V30 10 C 6.3710 3.0800 0.0 0
M  V30 11 C 1.3338 3.8500 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(3R)-3-[[(1,1-Dimethylethoxy)carbonyl]methylamino]-1-pyrrolidinyl]-3-pyrid...
C15H22N4O4
2743342-83-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.5458 1.5317 0.0 0
M  V30 2 C 11.9526 2.1580 0.0 0
M  V30 3 C 10.3848 0.0000 0.0 0
M  V30 4 O 13.1986 1.2528 0.0 0
M  V30 5 O 12.1136 3.6895 0.0 0
M  V30 6 C 14.6054 1.8791 0.0 0
M  V30 7 C 15.2317 0.4723 0.0 0
M  V30 8 C 16.0123 2.5056 0.0 0
M  V30 9 C 13.9790 3.2861 0.0 0
M  V30 10 C 0.7700 3.2067 0.0 0
M  V30 11 O 0.0000 4.5405 0.0 0
M  V30 12 O 0.0000 1.8731 0.0 0
M  V30 13 N 6.9300 3.2067 0.0 0
M  V30 14 C 7.8352 1.9609 0.0 0
M  V30 15 C 7.8352 4.4528 0.0 0
M  V30 16 C 9.2999 2.4367 0.0 0 CFG=2
M  V30 17 C 9.2999 3.9767 0.0 0
M  V30 18 C 5.3900 3.2067 0.0 0
M  V30 19 C 4.6200 1.8731 0.0 0
M  V30 20 N 4.6200 4.5405 0.0 0
M  V30 21 C 3.0800 1.8731 0.0 0
M  V30 22 N 3.0800 4.5405 0.0 0
M  V30 23 C 2.3100 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 23
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3R)-1-[6-[[(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl...
C23H28FN7O3
2743340-78-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 3.0010 5.2892 0.0 0
M  V30 2 N 7.6211 2.6219 0.0 0
M  V30 3 C 8.3911 3.9555 0.0 0
M  V30 4 O 7.6211 5.2892 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 N 18.1670 5.6308 0.0 0
M  V30 7 C 19.5738 5.0043 0.0 0
M  V30 8 C 18.0059 7.1623 0.0 0
M  V30 9 O 20.8197 5.9095 0.0 0
M  V30 10 O 19.7348 3.4727 0.0 0
M  V30 11 C 22.2267 5.2832 0.0 0
M  V30 12 C 22.8530 6.6900 0.0 0
M  V30 13 C 23.6335 4.6567 0.0 0
M  V30 14 C 21.6002 3.8762 0.0 0
M  V30 15 N 3.7711 1.2881 0.0 0
M  V30 16 C 3.0010 2.6217 0.0 0
M  V30 17 C 5.3111 1.2881 0.0 0
M  V30 18 C 2.7406 0.1437 0.0 0
M  V30 19 C 3.7711 3.9555 0.0 0
M  V30 20 N 1.4946 2.3016 0.0 0
M  V30 21 C 6.0811 2.6217 0.0 0
M  V30 22 C 1.3337 0.7700 0.0 0
M  V30 23 C 5.3111 3.9555 0.0 0
M  V30 24 C 9.9311 3.9555 0.0 0
M  V30 25 C 10.7011 5.2892 0.0 0
M  V30 26 N 10.7011 2.6219 0.0 0
M  V30 27 C 12.2412 5.2892 0.0 0
M  V30 28 N 12.2412 2.6219 0.0 0
M  V30 29 C 13.0112 3.9555 0.0 0
M  V30 30 N 14.5512 3.9555 0.0 0
M  V30 31 C 15.4564 5.2014 0.0 0
M  V30 32 C 15.4564 2.7097 0.0 0
M  V30 33 C 16.9210 4.7256 0.0 0 CFG=2
M  V30 34 C 16.9210 3.1855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 2 3 4
M  V30 5 1 3 24
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 33 6 CFG=3
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 2 19 23
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 29 30
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1643412-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2743342-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2743340-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38064665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Optimization of RNA-Splicing Modulators as Huntingtin
Protein-Lowering Agents for the Treatment of Huntington's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Longbin; Malagu, Karine; Haughan, Alan F.; Khetarpal, Vinod; Stott,
Andrew J.; Esmieu, William; Vater, Huw D.; Webster, Stephen J.; Van de
Poel, Amanda J.; Clissold, Cole; Cosgrove, Brett; Sutton, Benjamin;
Spencer, Jonathan A.; Breccia, Perla; Gancia, Emanuela; Bonomo, Silvia;
Ladduwahetty, Tammy; Lazari, Ovadia; Patel, Hiral; Atton, Helen C.;
Clifton, Steve; Mota, Daniel M.; Magnani, Dario; ONeill, Amy; Stebbeds,
Marta; Macabuag, Natsuko; Todd, Daniel; Herva, Maria E.; Mitchell,
Philip; Visser, Mijke; Compte Sancerni, Sara; Grand Moursel, Laure; da
Silva, Marta; Kritikou, Eva; Heikkinen, Taneli T.; Bolkvadze, Tamuna;
Fodale, Valentina; Spadafora, Debora; Daldin, Manuel; Bresciani, Alberto;
Mangette, John E.; Doherty, Elizabeth M.; Lee, Matthew R.; Herbst, Todd;
Monteagudo, Edith; Macdonald, Douglas; Plotnikov, Nikolay V.; Chambers,
Mark; McAllister, George; Munoz-Sanjuan, Ignacio; Dominguez, Celia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(18), 13205-13246

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Cyclobutylamine
C4H9N
2516-34-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7179 1.0889 0.0 0
M  V30 2 C 2.1779 1.0889 0.0 0
M  V30 3 C 1.0889 2.1779 0.0 0
M  V30 4 C 1.0889 0.0000 0.0 0
M  V30 5 C 0.0000 1.0889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinepentanoic acid, β-[[[1-cyclopentyl-5-(2,6-dimethoxyphenyl)-1H-pyr...
C27H38N4O5.ClH
2763783-96-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.3420 3.8644 0.0 0
M  V30 2 C 2.7155 2.4575 0.0 0
M  V30 3 O 2.7844 9.1700 0.0 0
M  V30 4 C 1.8791 10.4159 0.0 0
M  V30 5 C 8.3659 5.3901 0.0 0
M  V30 6 N 9.6995 6.1601 0.0 0
M  V30 7 O 8.3659 3.8500 0.0 0
M  V30 8 C 11.0332 5.3901 0.0 0 CFG=2
M  V30 9 C 12.3668 6.1601 0.0 0
M  V30 10 C 11.0332 3.8500 0.0 0
M  V30 11 C 12.3668 7.7001 0.0 0
M  V30 12 C 12.3668 3.0800 0.0 0
M  V30 13 O 13.7007 3.8500 0.0 0
M  V30 14 O 12.3668 1.5400 0.0 0
M  V30 15 C 4.5948 6.6781 0.0 0
M  V30 16 N 5.3648 8.0119 0.0 0
M  V30 17 C 5.6252 5.5337 0.0 0
M  V30 18 N 6.8711 7.6916 0.0 0
M  V30 19 C 7.0320 6.1601 0.0 0
M  V30 20 C 3.0631 6.5172 0.0 0
M  V30 21 C 2.4368 5.1104 0.0 0
M  V30 22 C 2.1579 7.7631 0.0 0
M  V30 23 C 0.9052 4.9493 0.0 0
M  V30 24 C 0.6263 7.6021 0.0 0
M  V30 25 C 0.0000 6.1952 0.0 0
M  V30 26 C 4.7383 9.4188 0.0 0
M  V30 27 C 3.2320 9.7389 0.0 0
M  V30 28 C 5.5084 10.7524 0.0 0
M  V30 29 C 3.0710 11.2705 0.0 0
M  V30 30 C 4.4779 11.8970 0.0 0
M  V30 31 N 13.7007 8.4701 0.0 0
M  V30 32 C 15.0343 7.7001 0.0 0
M  V30 33 C 13.7007 10.0101 0.0 0
M  V30 34 C 16.3680 8.4701 0.0 0
M  V30 35 C 15.0343 10.7801 0.0 0
M  V30 36 C 16.3680 10.0101 0.0 0
M  V30 37 Cl 8.1840 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10 CFG=1
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 20
M  V30 19 1 16 18
M  V30 20 1 16 26
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperidinepentanamide, N-cyclobutyl-β-[[[1-cyclopentyl-5-(2,6-dimethoxyphen...
C31H45N5O4.ClH
1839557-08-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.5424 13.3753 0.0 0
M  V30 2 C 4.7035 14.9070 0.0 0
M  V30 3 O 1.4068 9.0594 0.0 0
M  V30 4 C 0.0000 8.4331 0.0 0
M  V30 5 C 8.1303 9.5422 0.0 0
M  V30 6 N 8.9003 8.2085 0.0 0
M  V30 7 O 8.9003 10.8758 0.0 0
M  V30 8 C 10.4403 8.2085 0.0 0 CFG=2
M  V30 9 C 11.2103 6.8747 0.0 0
M  V30 10 C 11.2103 9.5422 0.0 0
M  V30 11 C 10.4403 5.5411 0.0 0
M  V30 12 C 12.7503 9.5422 0.0 0
M  V30 13 N 13.5203 10.8758 0.0 0
M  V30 14 O 13.5203 8.2085 0.0 0
M  V30 15 C 4.2205 10.3122 0.0 0
M  V30 16 N 4.2205 8.7722 0.0 0
M  V30 17 C 5.6851 10.7881 0.0 0
M  V30 18 N 5.6851 8.2963 0.0 0
M  V30 19 C 6.5903 9.5422 0.0 0
M  V30 20 C 2.9747 11.2174 0.0 0
M  V30 21 C 3.1356 12.7489 0.0 0
M  V30 22 C 1.5677 10.5909 0.0 0
M  V30 23 C 1.8897 13.6542 0.0 0
M  V30 24 C 0.3219 11.4962 0.0 0
M  V30 25 C 0.4828 13.0277 0.0 0
M  V30 26 C 2.9747 7.8670 0.0 0
M  V30 27 C 1.5100 8.3428 0.0 0
M  V30 28 C 2.9747 6.3270 0.0 0
M  V30 29 C 0.6048 7.0970 0.0 0
M  V30 30 C 1.5100 5.8511 0.0 0
M  V30 31 N 11.2103 4.2074 0.0 0
M  V30 32 C 12.7503 4.2074 0.0 0
M  V30 33 C 10.4403 2.8738 0.0 0
M  V30 34 C 13.5203 2.8738 0.0 0
M  V30 35 C 11.2103 1.5400 0.0 0
M  V30 36 C 12.7503 1.5400 0.0 0
M  V30 37 C 15.0604 10.8758 0.0 0
M  V30 38 C 16.1493 9.7869 0.0 0
M  V30 39 C 16.1493 11.9648 0.0 0
M  V30 40 C 17.2382 10.8758 0.0 0
M  V30 41 Cl 8.6191 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 37
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 20
M  V30 20 1 16 18
M  V30 21 1 16 26
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2516-34-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2763783-96-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1839557-08-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31809349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product is further converted to HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic
Syndrome in Mice
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Narayanan, Sanju; Wang, Shaobin; Vasukuttan, Vineetha; Vyas Devambatla,
Ravi Kumar; Dai, Donghua; Jin, Chunyang; Snyder, Rodney; Laudermilk,
Lucas; Runyon, Scott P.; Maitra, Rangan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(6), 3006-3025

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Lenalidomide
C13H13N3O3
191732-72-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 5.7904 0.0 0
M  V30 2 O 6.5770 0.4126 0.0 0
M  V30 3 N 1.3336 0.0000 0.0 0
M  V30 4 O 11.1970 3.0800 0.0 0
M  V30 5 N 5.0370 3.0800 0.0 0
M  V30 6 C 4.1320 4.3259 0.0 0
M  V30 7 C 4.1320 1.8340 0.0 0
M  V30 8 C 2.6673 3.8500 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 6.5770 3.0800 0.0 0
M  V30 15 C 7.3470 1.7462 0.0 0
M  V30 16 C 7.3470 4.4136 0.0 0
M  V30 17 N 8.8870 1.7462 0.0 0
M  V30 18 C 8.8870 4.4136 0.0 0
M  V30 19 C 9.6570 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 15
M  V30 3 1 3 11
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 5,8,11-trioxa-2-azatridecanedioate
C13H25NO7
462100-06-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 O 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 14 O 13.3372 2.3101 0.0 0
M  V30 15 C 14.6708 1.5400 0.0 0
M  V30 16 C 16.0045 2.3101 0.0 0
M  V30 17 O 17.3382 1.5400 0.0 0
M  V30 18 C 18.6720 2.3101 0.0 0
M  V30 19 C 20.0057 1.5400 0.0 0
M  V30 20 O 21.3393 2.3101 0.0 0
M  V30 21 O 20.0057 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[2-(2-Aminoethoxy)ethoxy]ethoxy]-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihy...
C21H28N4O7
2138440-80-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0821 8.0020 0.0 0
M  V30 2 C 11.6221 8.0020 0.0 0
M  V30 3 C 12.3921 6.6684 0.0 0
M  V30 4 O 12.3921 9.3358 0.0 0
M  V30 5 O 13.9321 6.6684 0.0 0
M  V30 6 C 14.7021 5.3347 0.0 0
M  V30 7 C 16.2421 5.3347 0.0 0
M  V30 8 O 17.0121 4.0011 0.0 0
M  V30 9 C 18.5521 4.0011 0.0 0
M  V30 10 C 19.3221 2.6673 0.0 0
M  V30 11 O 20.8621 2.6673 0.0 0
M  V30 12 C 21.6321 1.3336 0.0 0
M  V30 13 C 23.1721 1.3336 0.0 0
M  V30 14 N 23.9421 0.0000 0.0 0
M  V30 15 O 4.3513 11.3797 0.0 0
M  V30 16 O 5.3347 5.7377 0.0 0
M  V30 17 O 0.0000 5.7377 0.0 0
M  V30 18 C 7.7721 9.3358 0.0 0
M  V30 19 C 7.0021 10.6694 0.0 0
M  V30 20 C 9.3121 9.3358 0.0 0
M  V30 21 C 6.7417 8.1913 0.0 0
M  V30 22 C 5.4956 10.3493 0.0 0
M  V30 23 C 7.7721 12.0031 0.0 0
M  V30 24 C 10.0821 10.6694 0.0 0
M  V30 25 N 5.3347 8.8177 0.0 0
M  V30 26 C 9.3121 12.0031 0.0 0
M  V30 27 C 4.0011 8.0477 0.0 0
M  V30 28 C 4.0011 6.5077 0.0 0
M  V30 29 C 2.6674 8.8177 0.0 0
M  V30 30 N 2.6674 5.7377 0.0 0
M  V30 31 C 1.3336 8.0477 0.0 0
M  V30 32 C 1.3336 6.5077 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 15 22
M  V30 16 2 16 28
M  V30 17 2 17 32
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 191732-72-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 462100-06-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138440-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37428756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PROTACs Targeting MLKL Protect Cells from Necroptosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rathje, Oliver H.; Perryman, Lara; Payne, Richard J.; Hamprecht, Dieter
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(16), 11216-11236

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
α-(4-Fluorophenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)-...
C22H23FN4O2S
2892557-06-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1466 5.3901 0.0 0
M  V30 2 C 9.1466 6.9301 0.0 0
M  V30 3 O 7.8130 7.7001 0.0 0
M  V30 4 O 10.4803 7.7001 0.0 0
M  V30 5 F 14.4814 2.3100 0.0 0
M  V30 6 C 2.4782 3.0800 0.0 0
M  V30 7 C 2.1580 4.5863 0.0 0
M  V30 8 C 3.8119 2.3100 0.0 0
M  V30 9 C 1.1444 2.3100 0.0 0
M  V30 10 C 0.6263 4.7474 0.0 0
M  V30 11 C 3.0631 5.8324 0.0 0
M  V30 12 N 3.8119 0.7700 0.0 0
M  V30 13 S 0.0000 3.3405 0.0 0
M  V30 14 N 1.1444 0.7700 0.0 0
M  V30 15 C 0.0000 6.1542 0.0 0
M  V30 16 C 2.4368 7.2392 0.0 0
M  V30 17 C 2.4782 0.0000 0.0 0
M  V30 18 C 0.9052 7.4001 0.0 0
M  V30 19 N 5.1455 3.0800 0.0 0
M  V30 20 C 6.4792 2.3100 0.0 0
M  V30 21 C 5.1455 4.6201 0.0 0
M  V30 22 C 7.8130 3.0800 0.0 0
M  V30 23 C 6.4792 5.3901 0.0 0
M  V30 24 N 7.8130 4.6201 0.0 0
M  V30 25 C 10.4803 4.6201 0.0 0
M  V30 26 C 11.8141 5.3901 0.0 0
M  V30 27 C 10.4803 3.0800 0.0 0
M  V30 28 C 13.1478 4.6201 0.0 0
M  V30 29 C 11.8140 2.3100 0.0 0
M  V30 30 C 13.1478 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 30
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 19
M  V30 14 1 9 13
M  V30 15 2 9 14
M  V30 16 1 10 13
M  V30 17 1 10 15
M  V30 18 1 11 16
M  V30 19 2 12 17
M  V30 20 1 14 17
M  V30 21 1 15 18
M  V30 22 1 16 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(4-Fluorophenyl)-N-(4-methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,...
C29H30FN5O2S
2892557-14-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 6.1601 0.0 0
M  V30 2 C 10.4803 6.9301 0.0 0
M  V30 3 N 11.8140 6.1601 0.0 0
M  V30 4 O 10.4803 8.4701 0.0 0
M  V30 5 F 9.1467 0.0000 0.0 0
M  V30 6 O 17.1488 9.2401 0.0 0
M  V30 7 C 18.4824 8.4701 0.0 0
M  V30 8 C 2.4780 8.4701 0.0 0
M  V30 9 C 3.8119 9.2401 0.0 0
M  V30 10 C 2.1579 6.9638 0.0 0
M  V30 11 C 1.1444 9.2401 0.0 0
M  V30 12 N 3.8119 10.7802 0.0 0
M  V30 13 C 0.6263 6.8027 0.0 0
M  V30 14 C 3.0631 5.7178 0.0 0
M  V30 15 S 0.0000 8.2097 0.0 0
M  V30 16 N 1.1444 10.7802 0.0 0
M  V30 17 C 2.4780 11.5502 0.0 0
M  V30 18 C 0.0000 5.3959 0.0 0
M  V30 19 C 2.4368 4.3110 0.0 0
M  V30 20 C 0.9051 4.1501 0.0 0
M  V30 21 N 5.1455 8.4701 0.0 0
M  V30 22 C 6.4792 9.2401 0.0 0
M  V30 23 C 5.1455 6.9301 0.0 0
M  V30 24 C 7.8128 8.4701 0.0 0
M  V30 25 C 6.4792 6.1601 0.0 0
M  V30 26 N 7.8128 6.9301 0.0 0
M  V30 27 C 9.1467 4.6201 0.0 0
M  V30 28 C 7.8128 3.8501 0.0 0
M  V30 29 C 10.4803 3.8501 0.0 0
M  V30 30 C 7.8128 2.3100 0.0 0
M  V30 31 C 10.4803 2.3100 0.0 0
M  V30 32 C 9.1467 1.5400 0.0 0
M  V30 33 C 13.1476 6.9301 0.0 0
M  V30 34 C 13.1476 8.4701 0.0 0
M  V30 35 C 14.4814 6.1601 0.0 0
M  V30 36 C 14.4814 9.2401 0.0 0
M  V30 37 C 15.8151 6.9301 0.0 0
M  V30 38 C 15.8151 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 33
M  V30 7 1 5 32
M  V30 8 1 6 7
M  V30 9 1 6 38
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 9 21
M  V30 15 2 10 13
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 2 11 16
M  V30 19 2 12 17
M  V30 20 1 13 15
M  V30 21 1 13 18
M  V30 22 1 14 19
M  V30 23 1 16 17
M  V30 24 1 18 20
M  V30 25 1 19 20
M  V30 26 1 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-06-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297639
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
α-(4-Methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)...
C23H26N4O3S
2892557-00-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 5.3901 0.0 0
M  V30 2 C 9.1467 6.9302 0.0 0
M  V30 3 O 7.8131 7.7002 0.0 0
M  V30 4 O 10.4804 7.7002 0.0 0
M  V30 5 O 14.4816 2.3101 0.0 0
M  V30 6 C 15.8152 3.0801 0.0 0
M  V30 7 C 2.4782 3.0801 0.0 0
M  V30 8 C 2.1579 4.5864 0.0 0
M  V30 9 C 3.8119 2.3101 0.0 0
M  V30 10 C 1.1444 2.3101 0.0 0
M  V30 11 C 0.6263 4.7475 0.0 0
M  V30 12 C 3.0631 5.8324 0.0 0
M  V30 13 N 3.8119 0.7700 0.0 0
M  V30 14 S 0.0000 3.3405 0.0 0
M  V30 15 N 1.1444 0.7700 0.0 0
M  V30 16 C 0.0000 6.1543 0.0 0
M  V30 17 C 2.4368 7.2392 0.0 0
M  V30 18 C 2.4782 0.0000 0.0 0
M  V30 19 C 0.9052 7.4002 0.0 0
M  V30 20 N 5.1456 3.0801 0.0 0
M  V30 21 C 6.4792 2.3101 0.0 0
M  V30 22 C 5.1456 4.6201 0.0 0
M  V30 23 C 7.8131 3.0801 0.0 0
M  V30 24 C 6.4792 5.3901 0.0 0
M  V30 25 N 7.8131 4.6201 0.0 0
M  V30 26 C 10.4804 4.6201 0.0 0
M  V30 27 C 10.4804 3.0801 0.0 0
M  V30 28 C 11.8141 5.3901 0.0 0
M  V30 29 C 11.8141 2.3101 0.0 0
M  V30 30 C 13.1479 4.6201 0.0 0
M  V30 31 C 13.1479 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 6
M  V30 7 1 5 31
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 20
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 1 11 14
M  V30 18 1 11 16
M  V30 19 1 12 17
M  V30 20 2 13 18
M  V30 21 1 15 18
M  V30 22 1 16 19
M  V30 23 1 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,α-Bis(4-methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-...
C30H33N5O3S
2892557-08-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9302 0.0 0
M  V30 2 C 9.3360 7.7002 0.0 0
M  V30 3 N 10.6697 6.9302 0.0 0
M  V30 4 O 9.3360 9.2402 0.0 0
M  V30 5 O 8.0023 0.7700 0.0 0
M  V30 6 C 6.6687 0.0000 0.0 0
M  V30 7 O 16.0045 10.0102 0.0 0
M  V30 8 C 17.3383 9.2402 0.0 0
M  V30 9 C 2.6675 11.5503 0.0 0
M  V30 10 C 3.8119 12.5807 0.0 0
M  V30 11 C 2.6675 10.0102 0.0 0
M  V30 12 C 1.3338 12.3203 0.0 0
M  V30 13 C 3.1856 13.9875 0.0 0
M  V30 14 C 5.3436 12.4198 0.0 0
M  V30 15 N 1.3338 9.2402 0.0 0
M  V30 16 S 1.6540 13.8266 0.0 0
M  V30 17 N 0.0000 11.5503 0.0 0
M  V30 18 C 4.0908 15.2334 0.0 0
M  V30 19 C 6.2487 13.6656 0.0 0
M  V30 20 C 0.0000 10.0102 0.0 0
M  V30 21 C 5.6224 15.0725 0.0 0
M  V30 22 N 4.0012 9.2402 0.0 0
M  V30 23 C 5.3348 10.0102 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 6.6687 9.2402 0.0 0
M  V30 26 C 5.3348 6.9302 0.0 0
M  V30 27 N 6.6687 7.7002 0.0 0
M  V30 28 C 8.0023 5.3901 0.0 0
M  V30 29 C 9.3360 4.6201 0.0 0
M  V30 30 C 6.6687 4.6201 0.0 0
M  V30 31 C 9.3360 3.0801 0.0 0
M  V30 32 C 6.6687 3.0801 0.0 0
M  V30 33 C 8.0023 2.3101 0.0 0
M  V30 34 C 12.0035 7.7002 0.0 0
M  V30 35 C 12.0035 9.2402 0.0 0
M  V30 36 C 13.3372 6.9302 0.0 0
M  V30 37 C 13.3372 10.0102 0.0 0
M  V30 38 C 14.6708 7.7002 0.0 0
M  V30 39 C 14.6708 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 1 28
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 34
M  V30 7 1 5 6
M  V30 8 1 5 33
M  V30 9 1 7 8
M  V30 10 1 7 39
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 2 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 11 22
M  V30 18 1 12 16
M  V30 19 2 12 17
M  V30 20 1 13 16
M  V30 21 1 13 18
M  V30 22 1 14 19
M  V30 23 2 15 20
M  V30 24 1 17 20
M  V30 25 1 18 21
M  V30 26 1 19 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-00-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
1H-1,2,3-Triazole-4-carboxylic acid, 1-[2-methoxy-5-methyl-4-(phenylmethoxy)p...
C19H19N3O4
3059971-30-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5626 1.3336 0.0 0
M  V30 2 C 7.3326 0.0000 0.0 0
M  V30 3 C 4.5932 6.7117 0.0 0
M  V30 4 C 9.6426 6.6684 0.0 0
M  V30 5 C 1.4068 5.6763 0.0 0
M  V30 6 O 0.0000 5.0498 0.0 0
M  V30 7 O 1.5679 7.2079 0.0 0
M  V30 8 O 11.1826 4.0011 0.0 0
M  V30 9 C 11.9526 2.6674 0.0 0
M  V30 10 C 6.5626 4.0011 0.0 0
M  V30 11 C 7.3326 2.6674 0.0 0
M  V30 12 C 7.3326 5.3347 0.0 0
M  V30 13 C 8.8726 2.6674 0.0 0
M  V30 14 C 8.8726 5.3347 0.0 0
M  V30 15 C 9.6426 4.0011 0.0 0
M  V30 16 N 5.0226 4.0011 0.0 0
M  V30 17 C 4.1174 5.2470 0.0 0
M  V30 18 N 4.1174 2.7552 0.0 0
M  V30 19 C 2.6528 4.7711 0.0 0
M  V30 20 N 2.6528 3.2311 0.0 0
M  V30 21 C 13.4926 2.6674 0.0 0
M  V30 22 C 14.2626 1.3336 0.0 0
M  V30 23 C 14.2626 4.0011 0.0 0
M  V30 24 C 15.8026 1.3336 0.0 0
M  V30 25 C 15.8026 4.0011 0.0 0
M  V30 26 C 16.5726 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 17
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butoxy-5-(1,1-dimethylethyl)benzenamine
C14H23NO
33353-65-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6674 0.0 0
M  V30 2 C 1.5400 4.2074 0.0 0
M  V30 3 C 0.0000 2.6674 0.0 0
M  V30 4 C 1.5400 1.1274 0.0 0
M  V30 5 N 6.1600 0.0000 0.0 0
M  V30 6 O 7.7000 2.6674 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 10.7800 5.3349 0.0 0
M  V30 10 C 12.3200 5.3349 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.8500 1.3338 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 5.3900 1.3338 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4-carboxamide, N-[2-butoxy-5-(1,1-dimethylethyl)phenyl]-1-[...
C33H40N4O4
3059971-31-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.5119 10.1214 0.0 0
M  V30 2 C 13.2820 11.4550 0.0 0
M  V30 3 C 10.5427 4.7434 0.0 0
M  V30 4 C 15.5920 4.7867 0.0 0
M  V30 5 C 7.3563 5.7787 0.0 0
M  V30 6 N 5.9494 6.4052 0.0 0
M  V30 7 O 7.5172 4.2472 0.0 0
M  V30 8 O 17.1320 7.4539 0.0 0
M  V30 9 C 17.9020 8.7876 0.0 0
M  V30 10 O 3.1356 7.6578 0.0 0
M  V30 11 C 1.7288 8.2843 0.0 0
M  V30 12 C 1.5679 9.8159 0.0 0
M  V30 13 C 0.1609 10.4422 0.0 0
M  V30 14 C 0.0000 11.9739 0.0 0
M  V30 15 C 3.7795 1.5317 0.0 0
M  V30 16 C 5.3112 1.6926 0.0 0
M  V30 17 C 3.9406 0.0000 0.0 0
M  V30 18 C 2.2479 1.3706 0.0 0
M  V30 19 C 12.5119 7.4539 0.0 0
M  V30 20 C 13.2820 8.7876 0.0 0
M  V30 21 C 13.2820 6.1203 0.0 0
M  V30 22 C 14.8220 8.7876 0.0 0
M  V30 23 C 14.8220 6.1203 0.0 0
M  V30 24 C 15.5920 7.4539 0.0 0
M  V30 25 N 10.9719 7.4539 0.0 0
M  V30 26 C 10.0667 6.2081 0.0 0
M  V30 27 N 10.0667 8.6998 0.0 0
M  V30 28 C 8.6022 6.6839 0.0 0
M  V30 29 N 8.6022 8.2239 0.0 0
M  V30 30 C 4.7035 5.5000 0.0 0
M  V30 31 C 3.2967 6.1263 0.0 0
M  V30 32 C 4.8644 3.9684 0.0 0
M  V30 33 C 2.0507 5.2211 0.0 0
M  V30 34 C 3.6186 3.0632 0.0 0
M  V30 35 C 2.2118 3.6896 0.0 0
M  V30 36 C 19.4420 8.7876 0.0 0
M  V30 37 C 20.2120 10.1214 0.0 0
M  V30 38 C 20.2120 7.4539 0.0 0
M  V30 39 C 21.7520 10.1214 0.0 0
M  V30 40 C 21.7520 7.4539 0.0 0
M  V30 41 C 22.5220 8.7876 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 3 26
M  V30 4 1 4 23
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 28
M  V30 8 1 6 30
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 9 36
M  V30 12 1 10 11
M  V30 13 1 10 31
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 34
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 25
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3059971-30-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33353-65-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3059971-31-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42806422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances
Chemotherapy Efficacy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huber, Andrew D.; Jung, Young-Hwan; Li, Yongtao; Lin, Wenwei; Wu, Jing;
Poudel, Shyaron; Carrigan, Annalise G.; Mishra, Ashutosh; High, Anthony
A.; Chen, Taosheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(20), 18549-18575

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
9H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(3-methoxyphenyl)-
C19H14N2O3
1007695-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 0.7700 0.0 0
M  V30 2 O 3.5812 0.0000 0.0 0
M  V30 3 O 6.2487 0.0000 0.0 0
M  V30 4 O 11.5835 4.6201 0.0 0
M  V30 5 C 12.9172 5.3901 0.0 0
M  V30 6 C 4.9150 5.3901 0.0 0
M  V30 7 C 3.5812 4.6201 0.0 0
M  V30 8 C 6.2487 4.6201 0.0 0
M  V30 9 N 4.5948 6.8964 0.0 0
M  V30 10 C 2.4368 5.6505 0.0 0
M  V30 11 C 3.5812 3.0801 0.0 0
M  V30 12 N 6.2487 3.0801 0.0 0
M  V30 13 C 3.0631 7.0574 0.0 0
M  V30 14 C 0.9052 5.4896 0.0 0
M  V30 15 C 4.9150 2.3101 0.0 0
M  V30 16 C 2.1579 8.3032 0.0 0
M  V30 17 C 0.0000 6.7355 0.0 0
M  V30 18 C 0.6263 8.1423 0.0 0
M  V30 19 C 7.5824 5.3901 0.0 0
M  V30 20 C 8.9160 4.6201 0.0 0
M  V30 21 C 7.5824 6.9302 0.0 0
M  V30 22 C 10.2498 5.3901 0.0 0
M  V30 23 C 8.9160 7.7002 0.0 0
M  V30 24 C 10.2498 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-([1,4′-Bipiperidin]-1′-ylmethyl)benzenamine
C17H27N3
1307702-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 N 6.6685 4.6201 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, N-[4-([1,4′-bipiperidin]-1′-ylmethyl)ph...
C36H39N5O2
3002420-79-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 8.5288 0.0 0
M  V30 2 N 10.7800 8.5288 0.0 0
M  V30 3 O 8.4700 9.8626 0.0 0
M  V30 4 O 1.5400 8.5288 0.0 0
M  V30 5 C 0.0000 8.5288 0.0 0
M  V30 6 C 13.8600 13.8635 0.0 0
M  V30 7 C 6.9300 4.5278 0.0 0
M  V30 8 C 8.4700 4.5278 0.0 0
M  V30 9 C 6.1600 5.8615 0.0 0
M  V30 10 N 6.4541 3.0632 0.0 0
M  V30 11 C 8.9459 3.0632 0.0 0
M  V30 12 C 9.2400 5.8615 0.0 0
M  V30 13 N 6.9300 7.1952 0.0 0
M  V30 14 C 7.7000 2.1580 0.0 0
M  V30 15 C 10.3528 2.4369 0.0 0
M  V30 16 C 8.4700 7.1952 0.0 0
M  V30 17 C 7.8609 0.6265 0.0 0
M  V30 18 C 10.5137 0.9052 0.0 0
M  V30 19 C 9.2679 0.0000 0.0 0
M  V30 20 C 4.6200 5.8615 0.0 0
M  V30 21 C 3.8500 7.1952 0.0 0
M  V30 22 C 3.8500 4.5278 0.0 0
M  V30 23 C 2.3100 7.1952 0.0 0
M  V30 24 C 2.3100 4.5278 0.0 0
M  V30 25 C 1.5400 5.8615 0.0 0
M  V30 26 C 11.5500 9.8626 0.0 0
M  V30 27 C 13.0900 9.8626 0.0 0
M  V30 28 C 10.7800 11.1963 0.0 0
M  V30 29 C 13.8600 11.1963 0.0 0
M  V30 30 C 11.5500 12.5299 0.0 0
M  V30 31 C 13.0900 12.5299 0.0 0
M  V30 32 N 15.4000 13.8635 0.0 0
M  V30 33 C 16.1700 12.5299 0.0 0
M  V30 34 C 16.1700 15.1973 0.0 0
M  V30 35 C 17.7100 12.5299 0.0 0
M  V30 36 C 17.7100 15.1973 0.0 0
M  V30 37 C 18.4800 13.8635 0.0 0
M  V30 38 N 20.0200 13.8635 0.0 0
M  V30 39 C 20.7900 12.5299 0.0 0
M  V30 40 C 20.7900 15.1973 0.0 0
M  V30 41 C 22.3300 12.5299 0.0 0
M  V30 42 C 22.3300 15.1973 0.0 0
M  V30 43 C 23.1000 13.8635 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 6 31
M  V30 8 1 6 32
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 9 20
M  V30 16 1 10 14
M  V30 17 1 11 14
M  V30 18 2 11 15
M  V30 19 1 12 16
M  V30 20 2 13 16
M  V30 21 2 14 17
M  V30 22 1 15 18
M  V30 23 1 17 19
M  V30 24 2 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 43 1 37 38
M  V30 44 1 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1007695-49-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1307702-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3002420-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38589175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the
Treatment of Cystic Echinococcosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu,
Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan,
Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16680-16693

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
2-([1,1′-Biphenyl]-4-ylmethyl)-1,6-dihydro-6-oxo-5-(phenylmethoxy)-4-pyrimidi...
C25H20N2O4
1192587-51-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 4.6200 0.0 0
M  V30 2 C 4.0011 3.0800 0.0 0
M  V30 3 C 4.0011 7.7000 0.0 0
M  V30 4 O 4.0011 9.2400 0.0 0
M  V30 5 O 2.6674 6.9300 0.0 0
M  V30 6 O 6.6685 3.0800 0.0 0
M  V30 7 C 9.3358 7.7000 0.0 0
M  V30 8 C 5.3347 5.3900 0.0 0
M  V30 9 C 5.3347 6.9300 0.0 0
M  V30 10 C 6.6685 4.6200 0.0 0
M  V30 11 N 6.6685 7.7000 0.0 0
M  V30 12 N 8.0021 5.3900 0.0 0
M  V30 13 C 8.0021 6.9300 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 2.6674 0.7700 0.0 0
M  V30 16 C 1.3338 3.0800 0.0 0
M  V30 17 C 1.3338 0.0000 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 20 C 10.6694 6.9300 0.0 0
M  V30 21 C 10.6694 5.3900 0.0 0
M  V30 22 C 12.0032 7.7000 0.0 0
M  V30 23 C 12.0032 4.6200 0.0 0
M  V30 24 C 13.3369 6.9300 0.0 0
M  V30 25 C 13.3369 5.3900 0.0 0
M  V30 26 C 14.6705 4.6200 0.0 0
M  V30 27 C 16.0041 5.3900 0.0 0
M  V30 28 C 14.6705 3.0800 0.0 0
M  V30 29 C 17.3379 4.6200 0.0 0
M  V30 30 C 16.0041 2.3100 0.0 0
M  V30 31 C 17.3379 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 2 6 10
M  V30 8 1 7 13
M  V30 9 1 7 20
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine ethyl ester hydrochloride
C4H9NO2.ClH
623-33-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 O 4.0011 3.8500 0.0 0
M  V30 3 C 1.3338 3.8500 0.0 0
M  V30 4 O 2.6675 1.5400 0.0 0
M  V30 5 C 5.3348 3.0800 0.0 0
M  V30 6 N 0.0000 3.0800 0.0 0
M  V30 7 C 6.6686 3.8500 0.0 0
M  V30 8 Cl 3.3343 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-([1,1′-Biphenyl]-4-ylmethyl)-1,6-dihydro-6-oxo-5-(phenylmethoxy)-4-pyri...
C29H27N3O5
1192587-52-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8603 8.0022 0.0 0
M  V30 2 N 14.6303 9.3360 0.0 0
M  V30 3 O 14.6303 6.6685 0.0 0
M  V30 4 C 16.1704 9.3360 0.0 0
M  V30 5 C 16.9404 10.6697 0.0 0
M  V30 6 O 18.4804 10.6697 0.0 0
M  V30 7 O 16.1704 12.0033 0.0 0
M  V30 8 C 19.2504 12.0033 0.0 0
M  V30 9 C 20.7905 12.0033 0.0 0
M  V30 10 O 12.3203 5.3348 0.0 0
M  V30 11 C 11.5503 4.0012 0.0 0
M  V30 12 O 9.2402 5.3348 0.0 0
M  V30 13 C 9.2402 10.6697 0.0 0
M  V30 14 C 12.3203 8.0022 0.0 0
M  V30 15 C 11.5503 6.6685 0.0 0
M  V30 16 N 11.5503 9.3360 0.0 0
M  V30 17 C 10.0102 6.6685 0.0 0
M  V30 18 C 10.0102 9.3360 0.0 0
M  V30 19 N 9.2402 8.0022 0.0 0
M  V30 20 C 12.3203 2.6673 0.0 0
M  V30 21 C 11.5503 1.3337 0.0 0
M  V30 22 C 13.8603 2.6673 0.0 0
M  V30 23 C 12.3203 0.0000 0.0 0
M  V30 24 C 14.6303 1.3337 0.0 0
M  V30 25 C 13.8603 0.0000 0.0 0
M  V30 26 C 7.7002 10.6697 0.0 0
M  V30 27 C 6.9302 12.0033 0.0 0
M  V30 28 C 6.9302 9.3360 0.0 0
M  V30 29 C 5.3901 12.0033 0.0 0
M  V30 30 C 5.3901 9.3360 0.0 0
M  V30 31 C 4.6201 10.6697 0.0 0
M  V30 32 C 3.0801 10.6697 0.0 0
M  V30 33 C 2.3101 9.3360 0.0 0
M  V30 34 C 2.3101 12.0033 0.0 0
M  V30 35 C 0.7700 9.3360 0.0 0
M  V30 36 C 0.7700 12.0033 0.0 0
M  V30 37 C 0.0000 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 1 11 20
M  V30 13 2 12 17
M  V30 14 1 13 18
M  V30 15 1 13 26
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 31 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1192587-51-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-33-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192587-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40871414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of DS44470011: An oral hypoxia-inducible factor prolyl
hydroxylase inhibitor for the treatment of renal anemia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fukuda, Takeshi; Kuribayashi, Takeshi; Takano, Rieko; Sasaki, Koji;
Tsuji, Takashi; Niitsu, Yoichi; Ishii, Ken; Hashimoto, Masami; Baba,
Daichi; Ito, Shuichiro; Tanaka, Naoki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2024), 108129799

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
tert-Butyl 4-aminopiperidine-1-carboxylate
C10H20N2O2
87120-72-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indole-2-carboxylic acid
C17H14ClNO4S
473257-46-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7534 4.8385 0.0 0 VAL=6
M  V30 2 O 4.9834 6.1721 0.0 0
M  V30 3 O 6.5234 3.5048 0.0 0
M  V30 4 C 5.4032 1.5063 0.0 0
M  V30 5 O 5.0830 0.0000 0.0 0
M  V30 6 O 6.8678 1.9823 0.0 0
M  V30 7 Cl 0.5546 7.9444 0.0 0
M  V30 8 C 8.4207 9.4585 0.0 0
M  V30 9 C 11.0882 4.8385 0.0 0
M  V30 10 C 4.4197 4.0684 0.0 0
M  V30 11 C 3.0128 4.6948 0.0 0
M  V30 12 C 4.2586 2.5369 0.0 0
M  V30 13 C 1.9823 3.5504 0.0 0
M  V30 14 C 2.5369 6.1595 0.0 0
M  V30 15 N 2.7523 2.2167 0.0 0
M  V30 16 C 0.4759 3.8706 0.0 0
M  V30 17 C 1.0304 6.4797 0.0 0
M  V30 18 C 0.0000 5.3353 0.0 0
M  V30 19 C 7.0871 5.6085 0.0 0
M  V30 20 C 7.0871 7.1485 0.0 0
M  V30 21 C 8.4207 4.8385 0.0 0
M  V30 22 C 8.4207 7.9185 0.0 0
M  V30 23 C 9.7545 5.6085 0.0 0
M  V30 24 C 9.7545 7.1485 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 7 17
M  V30 9 1 8 22
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-2-y...
C27H32ClN3O5S
2055145-99-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.9416 5.2181 0.0 0 VAL=6
M  V30 2 O 4.4769 4.7423 0.0 0
M  V30 3 O 7.4062 5.6941 0.0 0
M  V30 4 C 7.9110 7.9287 0.0 0
M  V30 5 N 8.6810 9.2623 0.0 0
M  V30 6 O 8.6810 6.5950 0.0 0
M  V30 7 Cl 0.0000 6.3887 0.0 0
M  V30 8 C 4.8325 0.0000 0.0 0
M  V30 9 C 9.9061 1.6486 0.0 0
M  V30 10 C 14.8410 9.2623 0.0 0
M  V30 11 O 15.6110 10.5961 0.0 0
M  V30 12 O 15.6110 7.9287 0.0 0
M  V30 13 C 17.1510 10.5961 0.0 0
M  V30 14 C 17.1510 9.0561 0.0 0
M  V30 15 C 18.6910 10.5961 0.0 0
M  V30 16 C 17.1510 12.1361 0.0 0
M  V30 17 C 5.4658 6.6828 0.0 0
M  V30 18 C 4.0011 7.1587 0.0 0
M  V30 19 C 6.3710 7.9287 0.0 0
M  V30 20 C 4.0011 8.6987 0.0 0
M  V30 21 C 2.6674 6.3887 0.0 0
M  V30 22 N 5.4658 9.1745 0.0 0
M  V30 23 C 2.6674 9.4687 0.0 0
M  V30 24 C 1.3338 7.1587 0.0 0
M  V30 25 C 1.3338 8.6987 0.0 0
M  V30 26 C 6.4175 3.7536 0.0 0
M  V30 27 C 5.3871 2.6091 0.0 0
M  V30 28 C 7.9239 3.4334 0.0 0
M  V30 29 C 5.8629 1.1445 0.0 0
M  V30 30 C 8.3998 1.9687 0.0 0
M  V30 31 C 7.3692 0.8244 0.0 0
M  V30 32 C 10.2210 9.2623 0.0 0
M  V30 33 C 10.9910 7.9287 0.0 0
M  V30 34 C 10.9910 10.5961 0.0 0
M  V30 35 C 12.5310 7.9287 0.0 0
M  V30 36 C 12.5310 10.5961 0.0 0
M  V30 37 N 13.3010 9.2623 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 19
M  V30 8 1 5 32
M  V30 9 1 7 24
M  V30 10 1 8 29
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 10 37
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87120-72-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 473257-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055145-99-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33066374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester
functionalities as potent HIV-1 non-nucleoside reverse transcriptase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Shujing; Song, Shu; Sun, Lin; Gao, Ping; Gao, Shenghua; Ma, Yue;
Kang, Dongwei; Cheng, Yusen; Zhang, Xujie; Cherukupalli, Srinivasulu; De
Clercq, Erik; Pannecouque, Christophe; Liu, Xinyong; Zhan, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 53116531

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
1-(5-Bromo-3-pyridinyl)-3-methoxy-1H-pyrazole-4-carboxylic acid
C10H8BrN3O3
2411382-98-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.9051 4.1475 0.0 0
M  V30 2 O 0.2787 5.5544 0.0 0
M  V30 3 O 0.0000 2.9016 0.0 0
M  V30 4 O 2.5803 1.2459 0.0 0
M  V30 5 C 3.4856 0.0000 0.0 0
M  V30 6 Br 10.2089 4.5046 0.0 0
M  V30 7 N 4.8741 4.5046 0.0 0
M  V30 8 C 3.4672 5.1309 0.0 0
M  V30 9 N 4.7131 2.9730 0.0 0
M  V30 10 C 2.4368 3.9865 0.0 0
M  V30 11 C 3.2068 2.6529 0.0 0
M  V30 12 C 6.2079 5.2746 0.0 0
M  V30 13 C 7.5415 4.5046 0.0 0
M  V30 14 C 6.2079 6.8146 0.0 0
M  V30 15 C 8.8752 5.2746 0.0 0
M  V30 16 N 7.5415 7.5847 0.0 0
M  V30 17 C 8.8752 6.8146 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[4-(1-Methylethyl)-4H-1,2,4-triazol-3-yl]-2-pyridinamine
C10H13N5
1448427-99-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 3.4208 0.0 0
M  V30 2 C 0.0000 3.1006 0.0 0
M  V30 3 C 1.9823 4.8855 0.0 0
M  V30 4 N 8.6884 5.1048 0.0 0
M  V30 5 C 4.0684 2.4374 0.0 0
M  V30 6 N 2.5368 2.2764 0.0 0
M  V30 7 N 4.6947 1.0306 0.0 0
M  V30 8 C 2.2167 0.7700 0.0 0
M  V30 9 N 3.5503 0.0000 0.0 0
M  V30 10 C 4.8384 3.7710 0.0 0
M  V30 11 N 6.3784 3.7710 0.0 0
M  V30 12 C 4.0684 5.1048 0.0 0
M  V30 13 C 7.1484 5.1048 0.0 0
M  V30 14 C 4.8384 6.4384 0.0 0
M  V30 15 C 6.3784 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromo-3-pyridinyl)-3-methoxy-N-[6-[4-(1-methylethyl)-4H-1,2,4-triazol-3-...
C20H19BrN8O2
2411383-00-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.4584 3.8549 0.0 0
M  V30 2 N 8.6884 5.1887 0.0 0
M  V30 3 O 8.6884 2.5213 0.0 0
M  V30 4 O 11.4277 1.1445 0.0 0
M  V30 5 C 12.4581 0.0000 0.0 0
M  V30 6 Br 18.6737 5.1826 0.0 0
M  V30 7 C 1.5064 6.8726 0.0 0
M  V30 8 C 1.9823 5.4079 0.0 0
M  V30 9 C 0.0000 7.1927 0.0 0
M  V30 10 N 13.3683 4.6249 0.0 0
M  V30 11 C 11.9036 5.1009 0.0 0
M  V30 12 N 13.3683 3.0849 0.0 0
M  V30 13 C 10.9984 3.8549 0.0 0
M  V30 14 C 11.9036 2.6091 0.0 0
M  V30 15 C 14.6141 5.5301 0.0 0
M  V30 16 C 16.0209 4.9038 0.0 0
M  V30 17 C 14.4531 7.0617 0.0 0
M  V30 18 C 17.2668 5.8090 0.0 0
M  V30 19 N 15.6991 7.9669 0.0 0
M  V30 20 C 17.1059 7.3406 0.0 0
M  V30 21 C 7.1484 5.1887 0.0 0
M  V30 22 N 6.3784 6.5224 0.0 0
M  V30 23 C 6.3784 3.8549 0.0 0
M  V30 24 C 4.8384 6.5224 0.0 0
M  V30 25 C 4.8384 3.8549 0.0 0
M  V30 26 C 4.0684 5.1887 0.0 0
M  V30 27 C 4.0684 7.8560 0.0 0
M  V30 28 N 2.5368 8.0169 0.0 0
M  V30 29 N 4.6948 9.2629 0.0 0
M  V30 30 C 2.2167 9.5234 0.0 0
M  V30 31 N 3.5503 10.2934 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 21
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 2 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2411382-98-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448427-99-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411383-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37387770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1)
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xin, Zhili; Himmelbauer, Martin K.; Jones, J. Howard; Enyedy, Istvan;
Gilfillan, Rab; Hesson, Thomas; King, Kristopher; Marcotte, Douglas J.;
Murugan, Paramasivam; Santoro, Joseph C.; Gonzalez-Lopez de Turiso, Felix
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(4), 485-490

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
5-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-2-carboxylic acid
C17H11BrO5
1353747-19-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3358 2.3101 0.0 0
M  V30 3 O 6.6685 5.3901 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 Br 14.6707 5.3901 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 O 2.6673 3.0801 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 12.0033 5.3901 0.0 0
M  V30 22 C 13.3370 3.0801 0.0 0
M  V30 23 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 18
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, methyl ester, hydrochloride
C10H13NO2.ClH
7524-50-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 5.3347 5.3900 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 O 6.6684 1.5400 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 Cl 4.6679 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[[5-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-2-yl]carbonyl]-L-phenyla...
C27H22BrNO6
2454588-22-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.3370 6.9301 0.0 0
M  V30 2 C 14.6707 7.7001 0.0 0
M  V30 3 O 12.0032 4.6201 0.0 0
M  V30 4 C 6.6684 4.6201 0.0 0
M  V30 5 N 5.3348 5.3901 0.0 0
M  V30 6 O 6.6684 3.0800 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0 CFG=2
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 5.3901 0.0 0
M  V30 10 O 2.6675 6.9301 0.0 0
M  V30 11 O 1.3337 4.6201 0.0 0
M  V30 12 C 1.3337 7.7001 0.0 0
M  V30 13 Br 20.0054 4.6201 0.0 0
M  V30 14 C 9.3359 7.7001 0.0 0
M  V30 15 C 10.6695 6.9301 0.0 0
M  V30 16 O 8.0022 6.9301 0.0 0
M  V30 17 C 9.3359 9.2401 0.0 0
M  V30 18 C 12.0032 7.7001 0.0 0
M  V30 19 C 10.6695 5.3901 0.0 0
M  V30 20 C 8.0022 5.3901 0.0 0
M  V30 21 C 10.6695 10.0101 0.0 0
M  V30 22 C 12.0032 9.2401 0.0 0
M  V30 23 C 9.3359 4.6201 0.0 0
M  V30 24 C 16.0043 6.9301 0.0 0
M  V30 25 C 17.3380 7.7001 0.0 0
M  V30 26 C 16.0043 5.3901 0.0 0
M  V30 27 C 18.6718 6.9301 0.0 0
M  V30 28 C 17.3380 4.6201 0.0 0
M  V30 29 C 18.6718 5.3901 0.0 0
M  V30 30 C 2.6675 2.3100 0.0 0
M  V30 31 C 1.3337 3.0800 0.0 0
M  V30 32 C 2.6675 0.7700 0.0 0
M  V30 33 C 0.0000 2.3100 0.0 0
M  V30 34 C 1.3337 0.0000 0.0 0
M  V30 35 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 24
M  V30 4 2 3 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 30
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 2 21 22
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1353747-19-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7524-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454588-22-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22401841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromones bearing amino acid residues: Easily accessible and potent
inhibitors of the breast cancer resistance protein ABCG2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roussel, Emile; Moreno, Alexis; Altounian, Nicolas; Philouze, Christian;
Peres, Basile; Thomas, Aline; Renaudet, Olivier; Falson, Pierre;
Boumendjel, Ahcene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 202112503

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
5-Amino-1,3-dihydrospiro[2H-indene-2,3′-[3H]pyrrolo[2,3-b]pyridin]-2′(1′H)-one
C15H13N3O
938460-60-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9554 0.0000 0.0 0
M  V30 2 N 10.3637 2.5589 0.0 0
M  V30 3 C 3.8119 2.7406 0.0 0
M  V30 4 C 2.6673 3.7712 0.0 0
M  V30 5 C 4.9563 1.7102 0.0 0
M  V30 6 C 4.4382 4.1476 0.0 0
M  V30 7 C 3.1854 1.3338 0.0 0
M  V30 8 C 1.3337 3.0012 0.0 0
M  V30 9 C 2.6673 5.3112 0.0 0
M  V30 10 C 6.2901 2.4802 0.0 0
M  V30 11 C 5.9697 3.9865 0.0 0
M  V30 12 N 1.6538 1.4947 0.0 0
M  V30 13 N 0.0000 3.7712 0.0 0
M  V30 14 C 1.3337 6.0812 0.0 0
M  V30 15 C 7.7546 2.0043 0.0 0
M  V30 16 C 7.1143 5.0171 0.0 0
M  V30 17 C 0.0000 5.3112 0.0 0
M  V30 18 C 8.8992 3.0348 0.0 0
M  V30 19 C 8.5789 4.5412 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 11
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Bromophenyl)methyl]-N-(2,2-dimethyl-1-oxopropyl)glycine
C14H18BrNO3
2252342-91-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.6437 4.0012 0.0 0
M  V30 2 C 4.4137 5.3348 0.0 0
M  V30 3 C 2.1037 4.0012 0.0 0
M  V30 4 C 4.4137 2.6675 0.0 0
M  V30 5 C 1.3337 5.3348 0.0 0
M  V30 6 O 1.3337 2.6675 0.0 0
M  V30 7 C 3.6437 1.3337 0.0 0
M  V30 8 C 2.6673 6.1048 0.0 0
M  V30 9 C 0.5637 6.6687 0.0 0
M  V30 10 C 0.0000 4.5648 0.0 0
M  V30 11 O 4.4137 0.0000 0.0 0
M  V30 12 O 2.1037 1.3337 0.0 0
M  V30 13 Br 5.9538 8.0023 0.0 0
M  V30 14 C 5.9538 5.3348 0.0 0
M  V30 15 C 6.7238 6.6687 0.0 0
M  V30 16 C 6.7238 4.0012 0.0 0
M  V30 17 C 8.2638 6.6687 0.0 0
M  V30 18 C 8.2638 4.0012 0.0 0
M  V30 19 C 9.0338 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 13 15
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C29H29BrN4O3
2252343-35-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.8022 1.9094 0.0 0
M  V30 2 N 8.0020 3.0800 0.0 0
M  V30 3 C 6.6684 3.8500 0.0 0
M  V30 4 C 5.3347 3.0800 0.0 0
M  V30 5 O 6.6684 5.3900 0.0 0
M  V30 6 N 4.0009 3.8500 0.0 0
M  V30 7 C 4.0009 5.3900 0.0 0
M  V30 8 C 2.6673 3.0800 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 O 1.3336 3.8500 0.0 0
M  V30 11 C 1.1273 1.5400 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 4.2073 1.5400 0.0 0
M  V30 14 Br 4.0009 8.4700 0.0 0
M  V30 15 C 14.3728 4.6200 0.0 0
M  V30 16 C 15.2780 5.8659 0.0 0
M  V30 17 C 13.4678 5.8659 0.0 0
M  V30 18 C 13.4678 3.3741 0.0 0
M  V30 19 C 15.2780 3.3741 0.0 0
M  V30 20 C 16.7427 5.3900 0.0 0
M  V30 21 C 14.9579 7.3723 0.0 0
M  V30 22 C 12.0031 5.3900 0.0 0
M  V30 23 C 12.0031 3.8500 0.0 0
M  V30 24 N 16.7427 3.8500 0.0 0
M  V30 25 N 17.8871 6.4204 0.0 0
M  V30 26 C 16.1024 8.4027 0.0 0
M  V30 27 C 10.6694 6.1600 0.0 0
M  V30 28 C 10.6694 3.0800 0.0 0
M  V30 29 C 17.5669 7.9268 0.0 0
M  V30 30 C 9.3356 5.3900 0.0 0
M  V30 31 C 9.3358 3.8500 0.0 0
M  V30 32 C 2.6673 6.1600 0.0 0
M  V30 33 C 2.6673 7.7000 0.0 0
M  V30 34 C 1.3336 5.3900 0.0 0
M  V30 35 C 1.3336 8.4700 0.0 0
M  V30 36 C 0.0000 6.1600 0.0 0
M  V30 37 C 0.0000 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 1 2 31
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 14 33
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 24
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 1 22 23
M  V30 29 2 22 27
M  V30 30 2 23 28
M  V30 31 1 25 29
M  V30 32 2 26 29
M  V30 33 1 27 30
M  V30 34 1 28 31
M  V30 35 2 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 938460-60-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2252342-91-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2252343-35-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25849249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a First-In-Class Small Molecule Antagonist against the
Adrenomedullin-2 Receptor: Structure-Activity Relationships and
Optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zirimwabagabo, Jean-Olivier; Jailani, Ameera B. A.; Avgoustou, Paris;
Tozer, Matthew J.; Gibson, Karl R.; Glossop, Paul A.; Mills, James E. J.;
Porter, Roderick A.; Blaney, Paul; Wang, Ning; Skerry, Timothy M.;
Richards, Gareth O.; Harrity, Joseph P. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(6), 3299-3319

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL

C31H48N4O9
2761691-53-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5502 9.3358 0.0 0
M  V30 2 C 10.0102 9.3358 0.0 0 CFG=2
M  V30 3 O 12.3202 10.6696 0.0 0
M  V30 4 N 9.2401 8.0021 0.0 0
M  V30 5 C 9.2401 10.6696 0.0 0 CFG=2
M  V30 6 C 7.7001 8.0021 0.0 0
M  V30 7 C 10.0102 12.0033 0.0 0
M  V30 8 O 7.7001 10.6696 0.0 0
M  V30 9 C 6.9301 6.6685 0.0 0 CFG=1
M  V30 10 O 6.9301 9.3358 0.0 0
M  V30 11 C 5.3901 6.6685 0.0 0
M  V30 12 N 7.7001 5.3348 0.0 0
M  V30 13 O 4.6201 8.0021 0.0 0
M  V30 14 C 6.9301 4.0010 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 O 7.7001 2.6673 0.0 0
M  V30 17 O 5.3901 4.0010 0.0 0
M  V30 18 C 6.9301 1.3337 0.0 0
M  V30 19 C 5.5964 2.1037 0.0 0
M  V30 20 C 6.1601 0.0000 0.0 0
M  V30 21 C 8.2638 0.5636 0.0 0
M  V30 22 C 14.8822 8.9856 0.0 0
M  V30 23 N 16.3886 8.6654 0.0 0
M  V30 24 O 14.4063 10.4503 0.0 0
M  V30 25 C 17.4191 9.8100 0.0 0 CFG=1
M  V30 26 C 18.9255 9.4898 0.0 0
M  V30 27 C 16.9432 11.2745 0.0 0
M  V30 28 O 19.4014 8.0251 0.0 0
M  V30 29 O 19.9559 10.6342 0.0 0
M  V30 30 C 17.9736 12.4191 0.0 0
M  V30 31 C 20.9077 7.7049 0.0 0
M  V30 32 C 19.4801 12.0989 0.0 0
M  V30 33 C 17.4978 13.8836 0.0 0
M  V30 34 N 12.3202 8.0021 0.0 0
M  V30 35 C 13.8517 7.8412 0.0 0 CFG=2
M  V30 36 C 11.6937 6.5953 0.0 0
M  V30 37 C 14.1719 6.3347 0.0 0
M  V30 38 C 12.8383 5.5647 0.0 0
M  V30 39 C 2.3100 9.3358 0.0 0
M  V30 40 C 0.7700 9.3358 0.0 0
M  V30 41 C 3.0800 10.6696 0.0 0
M  V30 42 C 0.0000 10.6696 0.0 0
M  V30 43 C 2.3100 12.0033 0.0 0
M  V30 44 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 34
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 39
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 35 22 CFG=3
M  V30 26 1 23 25
M  V30 27 1 25 26
M  V30 28 1 25 27 CFG=1
M  V30 29 1 26 28
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 1 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 1 37 38
M  V30 40 2 39 40
M  V30 41 1 39 41
M  V30 42 1 40 42
M  V30 43 2 41 43
M  V30 44 2 42 44
M  V30 45 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 5 9 25 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
BOC-L-glutamine
C10H18N2O5
13726-85-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 2.6675 0.0 0 CFG=2
M  V30 2 N 4.4137 2.6675 0.0 0
M  V30 3 C 6.7237 4.0011 0.0 0
M  V30 4 C 6.7237 1.3338 0.0 0
M  V30 5 C 3.6437 4.0011 0.0 0
M  V30 6 C 8.2637 4.0011 0.0 0
M  V30 7 O 5.9537 0.0000 0.0 0
M  V30 8 O 8.2637 1.3338 0.0 0
M  V30 9 O 2.1037 4.0011 0.0 0
M  V30 10 O 4.4137 5.3348 0.0 0
M  V30 11 C 9.0337 5.3348 0.0 0
M  V30 12 C 1.3337 5.3348 0.0 0
M  V30 13 N 8.2637 6.6686 0.0 0
M  V30 14 O 10.5738 5.3348 0.0 0
M  V30 15 C 0.0000 4.5648 0.0 0
M  V30 16 C 0.5636 6.6686 0.0 0
M  V30 17 C 2.6673 6.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C36H56N6O11
2761691-54-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6301 10.6695 0.0 0
M  V30 2 C 13.0901 10.6695 0.0 0 CFG=2
M  V30 3 O 15.4001 12.0032 0.0 0
M  V30 4 N 12.3201 9.3357 0.0 0
M  V30 5 C 12.3201 12.0032 0.0 0 CFG=2
M  V30 6 C 10.7801 9.3357 0.0 0
M  V30 7 C 13.0901 13.3368 0.0 0
M  V30 8 O 10.7801 12.0032 0.0 0
M  V30 9 C 10.0101 8.0021 0.0 0 CFG=2
M  V30 10 O 10.0101 10.6695 0.0 0
M  V30 11 N 8.4701 8.0021 0.0 0
M  V30 12 C 10.7801 6.6684 0.0 0
M  V30 13 C 7.7001 9.3357 0.0 0
M  V30 14 O 10.0101 5.3348 0.0 0
M  V30 15 C 6.1600 9.3357 0.0 0 CFG=2
M  V30 16 O 8.4701 10.6695 0.0 0
M  V30 17 C 10.7801 4.0010 0.0 0
M  V30 18 N 5.3900 8.0021 0.0 0
M  V30 19 C 5.3900 10.6695 0.0 0
M  V30 20 C 3.8500 8.0021 0.0 0
M  V30 21 C 6.1600 12.0032 0.0 0
M  V30 22 O 3.0800 6.6684 0.0 0
M  V30 23 O 3.0800 9.3357 0.0 0
M  V30 24 C 5.3900 13.3368 0.0 0
M  V30 25 C 1.5400 6.6684 0.0 0
M  V30 26 N 3.8500 13.3368 0.0 0
M  V30 27 O 6.1600 14.6705 0.0 0
M  V30 28 C 1.5400 5.1284 0.0 0
M  V30 29 C 0.0000 6.6684 0.0 0
M  V30 30 C 1.5400 8.2084 0.0 0
M  V30 31 C 17.9621 10.3193 0.0 0
M  V30 32 N 19.4685 9.9990 0.0 0
M  V30 33 O 17.4862 11.7839 0.0 0
M  V30 34 C 20.4989 11.1435 0.0 0 CFG=1
M  V30 35 C 22.0054 10.8234 0.0 0
M  V30 36 C 20.0231 12.6081 0.0 0
M  V30 37 O 22.4813 9.3587 0.0 0
M  V30 38 O 23.0358 11.9677 0.0 0
M  V30 39 C 21.0535 13.7526 0.0 0
M  V30 40 C 23.9875 9.0385 0.0 0
M  V30 41 C 22.5599 13.4324 0.0 0
M  V30 42 C 20.5776 15.2172 0.0 0
M  V30 43 N 15.4001 9.3357 0.0 0
M  V30 44 C 16.9317 9.1748 0.0 0 CFG=2
M  V30 45 C 14.7736 7.9289 0.0 0
M  V30 46 C 17.2518 7.6685 0.0 0
M  V30 47 C 15.9182 6.8985 0.0 0
M  V30 48 C 10.0101 2.6673 0.0 0
M  V30 49 C 8.4701 2.6673 0.0 0
M  V30 50 C 10.7801 1.3337 0.0 0
M  V30 51 C 7.7001 1.3337 0.0 0
M  V30 52 C 10.0101 0.0000 0.0 0
M  V30 53 C 8.4701 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 43
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19 CFG=1
M  V30 20 1 17 48
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 1 31 32
M  V30 33 2 31 33
M  V30 34 1 44 31 CFG=3
M  V30 35 1 32 34
M  V30 36 1 34 35
M  V30 37 1 34 36 CFG=1
M  V30 38 1 35 37
M  V30 39 2 35 38
M  V30 40 1 36 39
M  V30 41 1 37 40
M  V30 42 1 39 41
M  V30 43 1 39 42
M  V30 44 1 43 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 47
M  V30 49 2 48 49
M  V30 50 1 48 50
M  V30 51 1 49 51
M  V30 52 2 50 52
M  V30 53 2 51 53
M  V30 54 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 5 9 15 34 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2761691-53-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13726-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761691-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31592277
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel macrocyclic peptidomimetics targeting the Polo-box domain of
Polo-like kinase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ryu, SeongShick; Park, Jung-Eun; Ham, Young Jin; Lim, Daniel C.;
Kwiatkowski, Nicholas P.; Kim, Do-Hee; Bhunia, Debabrata; Kim, Nam Doo;
Yaffe, Michael B.; Son, Woolim; Kim, Namkyoung; Choi, Tae-Ik; Swain,
Puspanjali; Kim, Cheol-Hee; Lee, Jin-Young; Gray, Nathanael S.; Lee,
Kyung S.; Sim, Taebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(3), 1915-1932

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid
C9H8O4
4442-54-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-[(1S,2E)-3-fluoro-1-(2-phenylethyl)-3-(phenylsu...
C27H29FN2O3S.ClH
2761157-96-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 13.0900 9.5420 0.0 0 VAL=6
M  V30 2 C 11.5500 9.5420 0.0 0
M  V30 3 O 13.0900 11.0820 0.0 0
M  V30 4 O 13.0900 8.0020 0.0 0
M  V30 5 C 10.7800 8.2084 0.0 0
M  V30 6 F 10.7800 10.8758 0.0 0
M  V30 7 C 9.2400 8.2084 0.0 0 CFG=2
M  V30 8 N 8.4700 9.5420 0.0 0
M  V30 9 C 8.4700 6.8747 0.0 0
M  V30 10 C 6.9300 9.5420 0.0 0
M  V30 11 C 9.2400 5.5409 0.0 0
M  V30 12 C 6.1600 10.8758 0.0 0 CFG=1
M  V30 13 O 6.1600 8.2084 0.0 0
M  V30 14 C 4.6200 10.8758 0.0 0
M  V30 15 N 6.9300 12.2094 0.0 0
M  V30 16 C 0.0000 13.5431 0.0 0
M  V30 17 C 14.6300 9.5420 0.0 0
M  V30 18 C 15.4000 10.8758 0.0 0
M  V30 19 C 15.4000 8.2084 0.0 0
M  V30 20 C 16.9400 10.8758 0.0 0
M  V30 21 C 16.9400 8.2084 0.0 0
M  V30 22 C 17.7100 9.5420 0.0 0
M  V30 23 C 8.4700 4.2073 0.0 0
M  V30 24 C 6.9300 4.2073 0.0 0
M  V30 25 C 9.2400 2.8736 0.0 0
M  V30 26 C 6.1600 2.8736 0.0 0
M  V30 27 C 8.4700 1.5400 0.0 0
M  V30 28 C 6.9300 1.5400 0.0 0
M  V30 29 C 3.8500 12.2094 0.0 0
M  V30 30 C 2.3100 12.2094 0.0 0
M  V30 31 C 4.6200 13.5431 0.0 0
M  V30 32 C 1.5400 13.5431 0.0 0
M  V30 33 C 3.8500 14.8767 0.0 0
M  V30 34 C 2.3100 14.8767 0.0 0
M  V30 35 Cl 8.8550 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 2 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 23
M  V30 15 1 12 14
M  V30 16 1 12 15 CFG=3
M  V30 17 1 14 29
M  V30 18 1 16 32
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2-[[(1S,2E)-3-Fluoro-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-...
C36H35FN2O6S
2761157-45-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 11.5500 0.0 0
M  V30 2 N 10.6694 10.7800 0.0 0
M  V30 3 O 12.0032 13.0900 0.0 0
M  V30 4 C 9.3358 11.5500 0.0 0 CFG=2
M  V30 5 C 9.3358 13.0900 0.0 0
M  V30 6 C 8.0021 10.7800 0.0 0
M  V30 7 N 8.0021 9.2400 0.0 0
M  V30 8 O 6.6684 11.5500 0.0 0
M  V30 9 C 6.6684 8.4700 0.0 0 CFG=1
M  V30 10 C 6.6685 6.9300 0.0 0
M  V30 11 C 5.3347 9.2400 0.0 0
M  V30 12 C 8.0021 6.1600 0.0 0
M  V30 13 C 4.0011 8.4700 0.0 0
M  V30 14 S 8.0021 4.6200 0.0 0 VAL=6
M  V30 15 F 9.3358 6.9300 0.0 0
M  V30 16 O 9.5421 4.6200 0.0 0
M  V30 17 O 6.4621 4.6200 0.0 0
M  V30 18 C 6.6684 17.7100 0.0 0
M  V30 19 C 16.0041 10.7800 0.0 0
M  V30 20 C 16.0041 9.2400 0.0 0
M  V30 21 C 14.6705 11.5500 0.0 0
M  V30 22 O 17.3379 11.5500 0.0 0
M  V30 23 C 14.6705 8.4700 0.0 0
M  V30 24 O 17.3379 8.4700 0.0 0
M  V30 25 C 13.3369 10.7800 0.0 0
M  V30 26 C 18.6716 10.7800 0.0 0
M  V30 27 C 13.3369 9.2400 0.0 0
M  V30 28 C 18.6716 9.2400 0.0 0
M  V30 29 C 8.0021 13.8600 0.0 0
M  V30 30 C 8.0021 15.4000 0.0 0
M  V30 31 C 6.6684 13.0900 0.0 0
M  V30 32 C 6.6684 16.1700 0.0 0
M  V30 33 C 5.3347 13.8600 0.0 0
M  V30 34 C 5.3347 15.4000 0.0 0
M  V30 35 C 2.6674 9.2400 0.0 0
M  V30 36 C 1.3336 8.4700 0.0 0
M  V30 37 C 2.6674 10.7800 0.0 0
M  V30 38 C 0.0000 9.2400 0.0 0
M  V30 39 C 1.3336 11.5500 0.0 0
M  V30 40 C 0.0000 10.7800 0.0 0
M  V30 41 C 8.0021 3.0800 0.0 0
M  V30 42 C 6.6685 2.3100 0.0 0
M  V30 43 C 9.3358 2.3100 0.0 0
M  V30 44 C 6.6685 0.7700 0.0 0
M  V30 45 C 9.3358 0.7700 0.0 0
M  V30 46 C 8.0021 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 29
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11 CFG=3
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 35
M  V30 18 2 14 16
M  V30 19 2 14 17
M  V30 20 1 14 41
M  V30 21 1 18 32
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 2 25 27
M  V30 32 1 26 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4442-54-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761157-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761157-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31593501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible
Inhibitors of the Trypanosomal Cysteine Protease Rhodesain:
Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In
Vivo Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sascha; Fuchs, Natalie; Johe, Patrick; Wagner, Annika; Diehl,
Erika; Yuliani, Tri; Zimmer, Collin; Barthels, Fabian; Zimmermann, Robert
A.; Klein, Philipp; Waigel, Waldemar; Meyr, Jessica; Opatz, Till; Tenzer,
Stefan; Distler, Ute; Raeder, Hans-Joachim; Kersten, Christian; Engels,
Bernd; Hellmich, Ute A.; Klein, Jochen; Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12322-12358

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
4-(5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)-α-[4-(trifluorometh...
C23H23F3N4O2S
2892557-07-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3031 8.0021 0.0 0
M  V30 2 C 7.5331 9.3358 0.0 0
M  V30 3 O 5.9931 9.3358 0.0 0
M  V30 4 O 8.3031 10.6694 0.0 0
M  V30 5 C 14.4631 8.0020 0.0 0
M  V30 6 F 14.4631 9.5422 0.0 0
M  V30 7 F 16.0031 8.0020 0.0 0
M  V30 8 F 14.4631 6.4620 0.0 0
M  V30 9 C 3.6831 2.6673 0.0 0
M  V30 10 C 2.6527 3.8118 0.0 0
M  V30 11 C 5.2231 2.6674 0.0 0
M  V30 12 C 2.9131 1.3336 0.0 0
M  V30 13 C 1.2459 3.1855 0.0 0
M  V30 14 C 2.8136 5.3433 0.0 0
M  V30 15 N 5.9931 1.3336 0.0 0
M  V30 16 S 1.4068 1.6538 0.0 0
M  V30 17 N 3.6831 0.0000 0.0 0
M  V30 18 C 0.0000 4.0905 0.0 0
M  V30 19 C 1.5677 6.2486 0.0 0
M  V30 20 C 5.2231 0.0000 0.0 0
M  V30 21 C 0.1609 5.6222 0.0 0
M  V30 22 N 5.9931 4.0011 0.0 0
M  V30 23 C 7.5331 4.0011 0.0 0
M  V30 24 C 5.2231 5.3347 0.0 0
M  V30 25 C 8.3031 5.3347 0.0 0
M  V30 26 C 5.9931 6.6684 0.0 0
M  V30 27 N 7.5331 6.6684 0.0 0
M  V30 28 C 9.8431 8.0021 0.0 0
M  V30 29 C 10.6131 9.3358 0.0 0
M  V30 30 C 10.6131 6.6684 0.0 0
M  V30 31 C 12.1531 9.3358 0.0 0
M  V30 32 C 12.1531 6.6684 0.0 0
M  V30 33 C 12.9231 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 1 28
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 33
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 22
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 13 16
M  V30 20 1 13 18
M  V30 21 1 14 19
M  V30 22 2 15 20
M  V30 23 1 17 20
M  V30 24 1 18 21
M  V30 25 1 19 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)...
C30H30F3N5O2S
2892557-15-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 7.7002 0.0 0
M  V30 2 C 9.3360 8.4702 0.0 0
M  V30 3 N 10.6697 7.7002 0.0 0
M  V30 4 O 9.3360 10.0102 0.0 0
M  V30 5 C 8.0023 1.5400 0.0 0
M  V30 6 F 9.5424 1.5400 0.0 0
M  V30 7 F 8.0023 0.0000 0.0 0
M  V30 8 F 6.4623 1.5400 0.0 0
M  V30 9 O 16.0045 10.7802 0.0 0
M  V30 10 C 17.3383 10.0102 0.0 0
M  V30 11 C 2.6675 12.3203 0.0 0
M  V30 12 C 2.6675 10.7802 0.0 0
M  V30 13 C 3.8119 13.3507 0.0 0
M  V30 14 C 1.3338 13.0903 0.0 0
M  V30 15 N 1.3338 10.0102 0.0 0
M  V30 16 C 3.1856 14.7575 0.0 0
M  V30 17 C 5.3436 13.1898 0.0 0
M  V30 18 S 1.6540 14.5966 0.0 0
M  V30 19 N 0.0000 12.3203 0.0 0
M  V30 20 C 0.0000 10.7802 0.0 0
M  V30 21 C 4.0908 16.0034 0.0 0
M  V30 22 C 6.2487 14.4357 0.0 0
M  V30 23 C 5.6224 15.8425 0.0 0
M  V30 24 N 4.0012 10.0102 0.0 0
M  V30 25 C 4.0012 8.4702 0.0 0
M  V30 26 C 5.3348 10.7802 0.0 0
M  V30 27 C 5.3348 7.7002 0.0 0
M  V30 28 C 6.6687 10.0102 0.0 0
M  V30 29 N 6.6687 8.4702 0.0 0
M  V30 30 C 8.0023 6.1601 0.0 0
M  V30 31 C 9.3360 5.3901 0.0 0
M  V30 32 C 6.6687 5.3901 0.0 0
M  V30 33 C 9.3360 3.8501 0.0 0
M  V30 34 C 6.6687 3.8501 0.0 0
M  V30 35 C 8.0023 3.0801 0.0 0
M  V30 36 C 12.0035 8.4702 0.0 0
M  V30 37 C 13.3372 7.7002 0.0 0
M  V30 38 C 12.0035 10.0102 0.0 0
M  V30 39 C 14.6708 8.4702 0.0 0
M  V30 40 C 13.3372 10.7802 0.0 0
M  V30 41 C 14.6708 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 29
M  V30 3 1 1 30
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 36
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 35
M  V30 11 1 9 10
M  V30 12 1 9 41
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 12 24
M  V30 18 2 13 16
M  V30 19 1 13 17
M  V30 20 1 14 18
M  V30 21 2 14 19
M  V30 22 2 15 20
M  V30 23 1 16 18
M  V30 24 1 16 21
M  V30 25 1 17 22
M  V30 26 1 19 20
M  V30 27 1 21 23
M  V30 28 1 22 23
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-07-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Monomethyl succinate
C5H8O4
3878-55-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 O 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5-Amino-1,3-dihydro-2H-isoindol-2-yl)[5-(1-methylethyl)-2,4-bis(phenylmethox...
C32H32N2O3
913000-10-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 6.9300 0.0 0
M  V30 2 O 10.6696 5.3900 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 C 6.6685 4.6200 0.0 0
M  V30 5 C 8.0021 11.5500 0.0 0
M  V30 6 C 9.3358 12.3200 0.0 0
M  V30 7 C 6.6685 12.3200 0.0 0
M  V30 8 O 5.3347 10.0100 0.0 0
M  V30 9 C 4.0011 9.2400 0.0 0
M  V30 10 N 18.2906 9.5517 0.0 0
M  V30 11 C 9.3358 7.7000 0.0 0
M  V30 12 C 8.0021 6.9300 0.0 0
M  V30 13 C 9.3358 9.2400 0.0 0
M  V30 14 C 6.6685 7.7000 0.0 0
M  V30 15 C 8.0021 10.0100 0.0 0
M  V30 16 C 6.6685 9.2400 0.0 0
M  V30 17 N 12.0032 7.7000 0.0 0
M  V30 18 C 13.4100 7.0737 0.0 0
M  V30 19 C 12.1642 9.2315 0.0 0
M  V30 20 C 14.4406 8.2181 0.0 0
M  V30 21 C 13.6706 9.5517 0.0 0
M  V30 22 C 15.9806 8.2181 0.0 0
M  V30 23 C 14.4406 10.8855 0.0 0
M  V30 24 C 16.7506 9.5517 0.0 0
M  V30 25 C 15.9806 10.8855 0.0 0
M  V30 26 C 6.6685 3.0800 0.0 0
M  V30 27 C 8.0021 2.3100 0.0 0
M  V30 28 C 5.3347 2.3100 0.0 0
M  V30 29 C 8.0021 0.7700 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 6.6685 0.0000 0.0 0
M  V30 32 C 2.6674 10.0100 0.0 0
M  V30 33 C 1.3338 9.2400 0.0 0
M  V30 34 C 2.6674 11.5500 0.0 0
M  V30 35 C 0.0000 10.0100 0.0 0
M  V30 36 C 1.3338 12.3200 0.0 0
M  V30 37 C 0.0000 11.5500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 26
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 15
M  V30 10 1 8 9
M  V30 11 1 8 16
M  V30 12 1 9 32
M  V30 13 1 10 24
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[2,3-dihydro-2-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)benzoyl]-1H...
C37H38N2O6
2411955-16-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6694 6.9300 0.0 0
M  V30 2 O 10.6694 5.3900 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 C 6.6685 4.6200 0.0 0
M  V30 5 C 8.0021 11.5500 0.0 0
M  V30 6 C 9.3358 12.3200 0.0 0
M  V30 7 C 6.6685 12.3200 0.0 0
M  V30 8 O 5.3347 10.0100 0.0 0
M  V30 9 C 4.0011 9.2400 0.0 0
M  V30 10 N 18.2906 9.5518 0.0 0
M  V30 11 C 19.0606 10.8855 0.0 0
M  V30 12 C 20.6006 10.8855 0.0 0
M  V30 13 O 18.2906 12.2191 0.0 0
M  V30 14 C 21.3706 12.2191 0.0 0
M  V30 15 C 22.9106 12.2191 0.0 0
M  V30 16 O 23.6806 13.5529 0.0 0
M  V30 17 O 23.6806 10.8855 0.0 0
M  V30 18 C 25.2206 13.5529 0.0 0
M  V30 19 C 9.3358 7.7000 0.0 0
M  V30 20 C 8.0021 6.9300 0.0 0
M  V30 21 C 9.3358 9.2400 0.0 0
M  V30 22 C 6.6685 7.7000 0.0 0
M  V30 23 C 8.0021 10.0100 0.0 0
M  V30 24 C 6.6685 9.2400 0.0 0
M  V30 25 N 12.0032 7.7000 0.0 0
M  V30 26 C 13.4100 7.0737 0.0 0
M  V30 27 C 12.1642 9.2317 0.0 0
M  V30 28 C 14.4406 8.2182 0.0 0
M  V30 29 C 13.6706 9.5518 0.0 0
M  V30 30 C 15.9804 8.2182 0.0 0
M  V30 31 C 14.4406 10.8855 0.0 0
M  V30 32 C 16.7506 9.5518 0.0 0
M  V30 33 C 15.9806 10.8855 0.0 0
M  V30 34 C 6.6685 3.0800 0.0 0
M  V30 35 C 8.0021 2.3100 0.0 0
M  V30 36 C 5.3347 2.3100 0.0 0
M  V30 37 C 8.0021 0.7700 0.0 0
M  V30 38 C 5.3347 0.7700 0.0 0
M  V30 39 C 6.6685 0.0000 0.0 0
M  V30 40 C 2.6674 10.0100 0.0 0
M  V30 41 C 1.3338 9.2400 0.0 0
M  V30 42 C 2.6674 11.5500 0.0 0
M  V30 43 C 0.0000 10.0100 0.0 0
M  V30 44 C 1.3338 12.3200 0.0 0
M  V30 45 C 0.0000 11.5500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 4 34
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 23
M  V30 10 1 8 9
M  V30 11 1 8 24
M  V30 12 1 9 40
M  V30 13 1 10 11
M  V30 14 1 10 32
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 1 12 14
M  V30 18 1 14 15
M  V30 19 1 15 16
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3878-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 913000-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411955-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21533229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing
the growth of lung cancer in vitro and in vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ojha, Ritu; Nepali, Kunal; Chen, Chun-Han; Chuang, Kuo-Hsiang; Wu,
Tung-Yun; Lin, Tony Eight; Hsu, Kai-Cheng; Chao, Min-Wu; Lai, Mei-Jung;
Lin, Mei-Hsiang; Huang, Han-Li; Chang, Chao-Di; Pan, Shiow-Lin; Chen,
Mei-Chuan; Liou, Jing-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 190112086pp.

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
L-Proline, 1-[(1-naphthalenyl)acetyl]-
C17H17NO3
32667-98-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 3.7710 0.0 0
M  V30 2 C 6.9300 3.7710 0.0 0
M  V30 3 O 7.7000 5.1046 0.0 0
M  V30 4 C 10.2621 3.4208 0.0 0
M  V30 5 O 11.7684 3.1006 0.0 0
M  V30 6 O 9.7861 4.8855 0.0 0
M  V30 7 C 3.0800 5.1046 0.0 0
M  V30 8 C 4.6200 5.1046 0.0 0
M  V30 9 C 2.3100 6.4384 0.0 0
M  V30 10 C 2.3100 3.7710 0.0 0
M  V30 11 C 5.3900 6.4384 0.0 0
M  V30 12 C 3.0800 7.7721 0.0 0
M  V30 13 C 0.7700 6.4384 0.0 0
M  V30 14 C 0.7700 3.7710 0.0 0
M  V30 15 C 4.6200 7.7721 0.0 0
M  V30 16 C 0.0000 5.1046 0.0 0
M  V30 17 N 7.7000 2.4374 0.0 0
M  V30 18 C 9.2315 2.2764 0.0 0 CFG=2
M  V30 19 C 7.0737 1.0304 0.0 0
M  V30 20 C 9.5517 0.7700 0.0 0
M  V30 21 C 8.2181 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 2 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-[[(2S)-2-amino-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxoh...
C19H29N3O5
3033295-77-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.8501 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 N 6.6685 2.3101 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 C 10.6697 4.6201 0.0 0
M  V30 9 C 12.0035 3.8501 0.0 0
M  V30 10 N 13.3372 4.6201 0.0 0
M  V30 11 C 14.6708 3.8501 0.0 0
M  V30 12 O 16.0045 4.6201 0.0 0
M  V30 13 O 14.6708 2.3101 0.0 0
M  V30 14 C 17.3383 3.8501 0.0 0
M  V30 15 C 18.1083 5.1838 0.0 0
M  V30 16 C 18.6720 3.0801 0.0 0
M  V30 17 C 16.5683 2.5164 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 O 0.0000 1.5400 0.0 0
M  V30 20 O 2.6675 1.5400 0.0 0
M  V30 21 C 0.0000 0.0000 0.0 0
M  V30 22 C 2.6675 4.6201 0.0 0
M  V30 23 C 1.3337 3.8501 0.0 0
M  V30 24 C 2.6675 6.1601 0.0 0
M  V30 25 C 0.0000 4.6201 0.0 0
M  V30 26 C 1.3337 6.9302 0.0 0
M  V30 27 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 23
M  V30 21 1 19 21
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C36H44N4O7
3033295-78-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.0787 14.0075 0.0 0
M  V30 2 C 12.5724 13.6874 0.0 0
M  V30 3 O 12.0963 12.2226 0.0 0
M  V30 4 C 9.2402 13.3372 0.0 0
M  V30 5 N 7.7002 13.3372 0.0 0
M  V30 6 O 10.0102 12.0035 0.0 0
M  V30 7 C 6.9302 12.0035 0.0 0 CFG=1
M  V30 8 C 5.3901 12.0035 0.0 0
M  V30 9 C 7.7002 10.6697 0.0 0
M  V30 10 N 4.6201 13.3372 0.0 0
M  V30 11 O 4.6201 10.6697 0.0 0
M  V30 12 C 6.9302 9.3360 0.0 0
M  V30 13 C 7.7002 8.0023 0.0 0
M  V30 14 C 6.9302 6.6685 0.0 0
M  V30 15 N 7.7002 5.3348 0.0 0
M  V30 16 C 6.9302 4.0012 0.0 0
M  V30 17 O 7.7002 2.6675 0.0 0
M  V30 18 O 5.3901 4.0012 0.0 0
M  V30 19 C 6.9302 1.3337 0.0 0
M  V30 20 C 5.5965 2.1037 0.0 0
M  V30 21 C 6.1601 0.0000 0.0 0
M  V30 22 C 8.2638 0.5637 0.0 0
M  V30 23 C 3.0801 16.0045 0.0 0
M  V30 24 O 2.3101 17.3383 0.0 0
M  V30 25 O 4.6201 16.0045 0.0 0
M  V30 26 C 3.0801 18.6720 0.0 0
M  V30 27 C 16.6156 13.1833 0.0 0
M  V30 28 C 15.1091 12.8631 0.0 0
M  V30 29 C 17.6460 12.0388 0.0 0
M  V30 30 C 17.0914 14.6479 0.0 0
M  V30 31 C 14.6332 11.3984 0.0 0
M  V30 32 C 17.1701 10.5742 0.0 0
M  V30 33 C 19.1525 12.3589 0.0 0
M  V30 34 C 18.5979 14.9680 0.0 0
M  V30 35 C 15.6638 10.2540 0.0 0
M  V30 36 C 19.6283 13.8237 0.0 0
M  V30 37 N 11.5418 14.8318 0.0 0
M  V30 38 C 10.0102 14.6708 0.0 0 CFG=2
M  V30 39 C 11.8620 16.3382 0.0 0
M  V30 40 C 9.3839 16.0776 0.0 0
M  V30 41 C 10.5283 17.1082 0.0 0
M  V30 42 C 3.0801 13.3372 0.0 0
M  V30 43 C 2.3101 14.6708 0.0 0
M  V30 44 C 2.3101 12.0035 0.0 0
M  V30 45 C 0.7700 14.6708 0.0 0
M  V30 46 C 0.7700 12.0035 0.0 0
M  V30 47 C 0.0000 13.3372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 2 2 3
M  V30 4 1 2 37
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 38 4 CFG=3
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=1
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 42
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 23 43
M  V30 28 1 24 26
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 1 27 30
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 1 29 33
M  V30 35 2 30 34
M  V30 36 1 31 35
M  V30 37 2 32 35
M  V30 38 2 33 36
M  V30 39 1 34 36
M  V30 40 1 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 45 2 42 43
M  V30 46 1 42 44
M  V30 47 1 43 45
M  V30 48 2 44 46
M  V30 49 2 45 47
M  V30 50 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32667-98-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033295-77-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033295-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34611184
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and characterization of PROTAC degraders specific to protein
N-terminal methyltransferase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Qilong; Wu, Wei; Jia, Kaimin; Qi, Guangyan; Sun, Xiuzhi Susan; Li,
Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 244114830

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
2-(3-Fluorophenyl)imidazo[1,2-a]pyridine-6-carboxylic acid
C14H9FN2O2
1282673-31-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.9318 0.0 0
M  V30 2 O 0.0000 3.5981 0.0 0
M  V30 3 O 0.0000 6.2655 0.0 0
M  V30 4 F 12.3923 3.0801 0.0 0
M  V30 5 N 4.6201 3.5981 0.0 0
M  V30 6 C 5.3901 4.9318 0.0 0
M  V30 7 C 5.6505 2.4536 0.0 0
M  V30 8 C 3.0801 3.5981 0.0 0
M  V30 9 N 6.8966 4.6116 0.0 0
M  V30 10 C 4.6201 6.2655 0.0 0
M  V30 11 C 7.0575 3.0801 0.0 0
M  V30 12 C 2.3101 4.9318 0.0 0
M  V30 13 C 3.0801 6.2655 0.0 0
M  V30 14 C 8.3912 2.3101 0.0 0
M  V30 15 C 9.7249 3.0801 0.0 0
M  V30 16 C 8.3912 0.7700 0.0 0
M  V30 17 C 11.0587 2.3101 0.0 0
M  V30 18 C 9.7249 0.0000 0.0 0
M  V30 19 C 11.0587 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,5S)-5-Aminotetrahydro-α,α-dimethyl-2H-pyran-2-methanol
C8H17NO2
2101630-08-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 1.5400 3.0800 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0 CFG=1
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 O 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 6 1 CFG=1
M  V30 5 1 11 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2-(3-Fluorophenyl)-N-[(3R,6S)-tetrahydro-6-(1-hydroxy-1-methylethyl)-2H-p...
C22H24FN3O3
2662603-15-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.6221 4.9317 0.0 0
M  V30 2 N 12.3921 6.2653 0.0 0
M  V30 3 O 12.3921 3.5981 0.0 0
M  V30 4 F 0.0000 3.0800 0.0 0
M  V30 5 C 18.5521 6.2653 0.0 0
M  V30 6 C 18.5521 4.7253 0.0 0
M  V30 7 C 20.0921 6.2653 0.0 0
M  V30 8 O 18.5521 7.8053 0.0 0
M  V30 9 N 7.7721 3.5981 0.0 0
M  V30 10 C 7.0021 4.9317 0.0 0
M  V30 11 C 6.7417 2.4535 0.0 0
M  V30 12 C 9.3121 3.5981 0.0 0
M  V30 13 N 5.4956 4.6115 0.0 0
M  V30 14 C 7.7721 6.2653 0.0 0
M  V30 15 C 5.3347 3.0800 0.0 0
M  V30 16 C 10.0821 4.9317 0.0 0
M  V30 17 C 9.3121 6.2653 0.0 0
M  V30 18 C 4.0011 2.3100 0.0 0
M  V30 19 C 2.6674 3.0800 0.0 0
M  V30 20 C 4.0011 0.7700 0.0 0
M  V30 21 C 1.3336 2.3100 0.0 0
M  V30 22 C 2.6674 0.0000 0.0 0
M  V30 23 C 1.3336 0.7700 0.0 0
M  V30 24 C 13.9321 6.2653 0.0 0 CFG=2
M  V30 25 C 14.7021 4.9317 0.0 0
M  V30 26 C 14.7021 7.5991 0.0 0
M  V30 27 C 16.2421 4.9317 0.0 0
M  V30 28 O 16.2421 7.5991 0.0 0
M  V30 29 C 17.0121 6.2653 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 24 2 CFG=3
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 29 5 CFG=1
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1282673-31-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101630-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2662603-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23963694
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A knowledge-based, structural-aided discovery of a novel class of
2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulte, Christie A.; Deaton, David N.; Diaz, Elsie; Do, Young; Gampe,
Robert T.; Guss, Jeffrey H.; Hancock, Ashley P.; Hobbs, Heather; Hodgson,
Simon T.; Holt, Jason; Jeune, Michael R.; Kahler, Kirsten M.; Kramer, H.
Fritz; Le, Joelle; Mortenson, Paul N.; Musetti, Caterina; Nolte, Robert
T.; Orband-Miller, Lisa A.; Peckham, Gregory E.; Petrov, Kim G.; Pietrak,
Beth L.; Poole, Chuck; Price, Daniel J.; Saxty, Gordon; Shillings,
Anthony; Smalley, Terrence L. Jr.; Somers, Don O.; Stewart, Eugene L.;
Stuart, J. Darren; Thomson, Stephen A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 47128113

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Benzo[b]thiophene-2-carboxylic acid
C9H6O2S
6314-28-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 S 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C31H26N2O5S
2892485-63-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6201 0.0 0
M  V30 2 O 8.0022 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8049 2.7300 0.0 0
M  V30 9 O 18.1784 1.3230 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 N 6.6685 3.8501 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 9.3358 3.8501 0.0 0
M  V30 21 O 10.7428 4.4764 0.0 0
M  V30 22 C 9.4969 2.3185 0.0 0
M  V30 23 C 11.7732 3.3320 0.0 0
M  V30 24 C 11.0032 1.9983 0.0 0
M  V30 25 C 13.3048 3.4930 0.0 0
M  V30 26 C 13.9313 4.8999 0.0 0
M  V30 27 C 14.2100 2.2471 0.0 0
M  V30 28 C 15.4629 5.0609 0.0 0
M  V30 29 C 15.7416 2.4080 0.0 0
M  V30 30 C 16.3681 3.8150 0.0 0
M  V30 31 C 20.3365 2.8910 0.0 0
M  V30 32 C 21.3669 1.7466 0.0 0
M  V30 33 S 21.1065 4.2246 0.0 0
M  V30 34 C 22.7739 2.3729 0.0 0
M  V30 35 C 22.6129 3.9044 0.0 0
M  V30 36 C 24.1807 1.7466 0.0 0
M  V30 37 C 23.8588 4.8097 0.0 0
M  V30 38 C 25.4266 2.6518 0.0 0
M  V30 39 C 25.2656 4.1833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6314-28-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-63-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
L-Phenylalanine, N-acetyl-3-fluoro-4-nitro-
C11H11FN2O5
3058604-41-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 4.6201 0.0 0 VAL=5
M  V30 2 O 10.6697 3.8501 0.0 0
M  V30 3 O 9.3360 6.1601 0.0 0
M  V30 4 F 9.3360 1.5400 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0 CFG=1
M  V30 7 N 2.6673 3.8501 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 O 0.0000 3.8501 0.0 0
M  V30 14 C 8.0023 3.8501 0.0 0
M  V30 15 C 8.0023 2.3101 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 6.6685 1.5400 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C23H35N5O4.C2HF3O2
3058604-56-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 11.2387 0.0 0
M  V30 2 C 6.6684 12.7787 0.0 0 CFG=2
M  V30 3 C 5.3347 13.5487 0.0 0
M  V30 4 N 8.0020 13.5487 0.0 0
M  V30 5 N 5.3347 15.0887 0.0 0
M  V30 6 O 4.0009 12.7787 0.0 0
M  V30 7 C 9.3356 12.7787 0.0 0
M  V30 8 C 4.0009 15.8587 0.0 0 CFG=2
M  V30 9 C 10.6694 13.5487 0.0 0 CFG=1
M  V30 10 O 9.3356 11.2387 0.0 0
M  V30 11 C 2.6673 15.0887 0.0 0
M  V30 12 C 4.0009 17.3987 0.0 0
M  V30 13 C 12.0031 12.7787 0.0 0
M  V30 14 N 10.6694 15.0887 0.0 0
M  V30 15 C 1.3336 15.8587 0.0 0
M  V30 16 N 5.3347 18.1687 0.0 0
M  V30 17 O 2.6673 18.1687 0.0 0
M  V30 18 C 13.3367 13.5487 0.0 0
M  V30 19 C 0.0000 15.0887 0.0 0
M  V30 20 C 1.3336 17.3987 0.0 0
M  V30 21 C 13.3367 15.0887 0.0 0
M  V30 22 C 14.6703 12.7787 0.0 0
M  V30 23 O 6.7588 5.1837 0.0 0
M  V30 24 C 5.1736 8.9372 0.0 0
M  V30 25 C 5.3347 10.4687 0.0 0
M  V30 26 C 3.6674 8.6170 0.0 0
M  V30 27 C 6.2042 7.7928 0.0 0
M  V30 28 C 3.9278 11.0952 0.0 0
M  V30 29 N 2.8974 9.9506 0.0 0
M  V30 30 C 3.1915 7.1523 0.0 0
M  V30 31 C 5.7282 6.3281 0.0 0
M  V30 32 C 4.2219 6.0079 0.0 0
M  V30 33 C 6.6683 2.3101 0.0 0
M  V30 34 C 8.0020 1.5400 0.0 0
M  V30 35 F 7.4384 3.6437 0.0 0
M  V30 36 F 5.3347 3.0801 0.0 0
M  V30 37 F 5.8983 0.9764 0.0 0
M  V30 38 O 9.3357 2.3101 0.0 0
M  V30 39 O 8.0020 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 23 31
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 2 24 27
M  V30 27 2 25 28
M  V30 28 1 26 29
M  V30 29 2 26 30
M  V30 30 1 27 31
M  V30 31 1 28 29
M  V30 32 1 30 32
M  V30 33 2 31 32
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 33 36
M  V30 37 1 33 37
M  V30 38 1 34 38
M  V30 39 2 34 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H44FN7O8
3058604-57-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 6.0551 0.0 0
M  V30 2 C 10.6696 7.5951 0.0 0 CFG=1
M  V30 3 N 9.3360 8.3651 0.0 0
M  V30 4 C 12.0034 8.3651 0.0 0
M  V30 5 C 8.0023 7.5951 0.0 0
M  V30 6 N 12.0034 9.9052 0.0 0
M  V30 7 O 13.3371 7.5951 0.0 0
M  V30 8 C 6.6686 8.3651 0.0 0 CFG=2
M  V30 9 O 8.0023 6.0551 0.0 0
M  V30 10 C 13.3371 10.6752 0.0 0 CFG=2
M  V30 11 N 5.3348 7.5951 0.0 0
M  V30 12 C 6.6686 9.9052 0.0 0
M  V30 13 C 14.6708 9.9052 0.0 0
M  V30 14 C 13.3371 12.2152 0.0 0
M  V30 15 C 5.3348 6.0551 0.0 0
M  V30 16 C 8.0023 10.6752 0.0 0
M  V30 17 C 16.0044 10.6752 0.0 0
M  V30 18 N 12.0034 12.9852 0.0 0
M  V30 19 O 14.6708 12.9852 0.0 0
M  V30 20 C 4.0011 5.2851 0.0 0 CFG=1
M  V30 21 O 6.6686 5.2851 0.0 0
M  V30 22 C 9.3360 9.9052 0.0 0
M  V30 23 C 8.0023 12.2152 0.0 0
M  V30 24 C 17.3383 9.9052 0.0 0
M  V30 25 C 16.0044 12.2152 0.0 0
M  V30 26 C 2.6675 6.0551 0.0 0
M  V30 27 N 4.0011 3.7450 0.0 0
M  V30 28 C 2.6675 2.9750 0.0 0
M  V30 29 C 2.6675 1.4350 0.0 0
M  V30 30 O 1.3338 3.7450 0.0 0
M  V30 31 O 10.5792 0.0000 0.0 0
M  V30 32 F 0.0000 10.6752 0.0 0
M  V30 33 N 2.6675 12.2152 0.0 0 VAL=5
M  V30 34 O 1.3338 12.9852 0.0 0
M  V30 35 O 4.0011 12.9852 0.0 0
M  V30 36 C 12.1644 3.7535 0.0 0
M  V30 37 C 12.0034 5.2851 0.0 0
M  V30 38 C 13.6707 3.4333 0.0 0
M  V30 39 C 11.1339 2.6091 0.0 0
M  V30 40 C 13.4103 5.9116 0.0 0
M  V30 41 N 14.4407 4.7670 0.0 0
M  V30 42 C 14.1467 1.9686 0.0 0
M  V30 43 C 11.6098 1.1444 0.0 0
M  V30 44 C 13.1161 0.8242 0.0 0
M  V30 45 C 2.6675 7.5951 0.0 0
M  V30 46 C 1.3338 8.3651 0.0 0
M  V30 47 C 4.0011 8.3651 0.0 0
M  V30 48 C 1.3338 9.9052 0.0 0
M  V30 49 C 4.0011 9.9052 0.0 0
M  V30 50 C 2.6675 10.6752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 37
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 10 13 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 2 15 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 17 24
M  V30 25 1 17 25
M  V30 26 1 20 26
M  V30 27 1 20 27 CFG=1
M  V30 28 1 26 45
M  V30 29 1 27 28
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 32 1 31 43
M  V30 33 1 32 48
M  V30 34 2 33 34
M  V30 35 2 33 35
M  V30 36 1 33 50
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 2 36 39
M  V30 40 2 37 40
M  V30 41 1 38 41
M  V30 42 2 38 42
M  V30 43 1 39 43
M  V30 44 1 40 41
M  V30 45 1 42 44
M  V30 46 2 43 44
M  V30 47 2 45 46
M  V30 48 1 45 47
M  V30 49 1 46 48
M  V30 50 2 47 49
M  V30 51 2 48 50
M  V30 52 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 8 10 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3058604-41-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3058604-56-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3058604-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39925583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of
Macrocyclic Inhibitors of the 20S Proteasome
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gotz, Marion G.; Godwin, Kacey; Price, Rachel; Dorn, Robert;
Merrill-Steskal, Gabriel; Klemmer, William; Hansen, Hunter; Produturi,
Gautam; Rocha, Megan; Palmer, Mathias; Molacek, Lea; Strater, Zack;
Groll, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2024), 15(4), 533-539

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
4-([1,4′-Bipiperidin]-1′-ylmethyl)benzenamine
C17H27N3
1307702-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 N 6.6685 4.6201 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,5-Dimethoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylic acid
C20H16N2O4
2088194-00-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9149 0.7700 0.0 0
M  V30 2 O 6.2485 0.0000 0.0 0
M  V30 3 O 3.5811 0.0000 0.0 0
M  V30 4 O 8.9158 9.2400 0.0 0
M  V30 5 C 10.2496 10.0100 0.0 0
M  V30 6 O 11.5833 4.6200 0.0 0
M  V30 7 C 12.9169 5.3900 0.0 0
M  V30 8 C 4.9149 5.3900 0.0 0
M  V30 9 C 6.2485 4.6200 0.0 0
M  V30 10 C 3.5811 4.6200 0.0 0
M  V30 11 N 4.5947 6.8963 0.0 0
M  V30 12 N 6.2485 3.0800 0.0 0
M  V30 13 C 2.4367 5.6504 0.0 0
M  V30 14 C 3.5811 3.0800 0.0 0
M  V30 15 C 3.0631 7.0574 0.0 0
M  V30 16 C 4.9149 2.3100 0.0 0
M  V30 17 C 0.9052 5.4895 0.0 0
M  V30 18 C 2.1578 8.3032 0.0 0
M  V30 19 C 0.0000 6.7353 0.0 0
M  V30 20 C 0.6263 8.1423 0.0 0
M  V30 21 C 7.5822 5.3900 0.0 0
M  V30 22 C 7.5822 6.9300 0.0 0
M  V30 23 C 8.9158 4.6200 0.0 0
M  V30 24 C 8.9158 7.7000 0.0 0
M  V30 25 C 10.2496 5.3900 0.0 0
M  V30 26 C 10.2496 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 21
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 2 13 17
M  V30 19 1 14 16
M  V30 20 2 15 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, N-[4-([1,4′-bipiperidin]-1′-ylmethyl)ph...
C37H41N5O3
3002420-84-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 7.4001 0.0 0
M  V30 2 N 12.0033 6.6301 0.0 0
M  V30 3 O 10.6696 8.9401 0.0 0
M  V30 4 O 1.3337 6.6301 0.0 0
M  V30 5 C 0.0000 7.4001 0.0 0
M  V30 6 O 4.0010 11.2502 0.0 0
M  V30 7 C 2.6673 12.0202 0.0 0
M  V30 8 C 17.3381 9.7102 0.0 0
M  V30 9 C 6.6685 5.0901 0.0 0
M  V30 10 C 8.0021 4.3201 0.0 0
M  V30 11 C 6.6685 6.6301 0.0 0
M  V30 12 N 5.5239 4.0597 0.0 0
M  V30 13 C 7.6819 2.8138 0.0 0
M  V30 14 C 9.3358 5.0901 0.0 0
M  V30 15 N 8.0021 7.4001 0.0 0
M  V30 16 C 6.1504 2.6527 0.0 0
M  V30 17 C 8.5872 1.5679 0.0 0
M  V30 18 C 9.3358 6.6301 0.0 0
M  V30 19 C 5.5239 1.2459 0.0 0
M  V30 20 C 7.9607 0.1609 0.0 0
M  V30 21 C 6.4291 0.0000 0.0 0
M  V30 22 C 5.3348 7.4001 0.0 0
M  V30 23 C 4.0010 6.6301 0.0 0
M  V30 24 C 5.3348 8.9401 0.0 0
M  V30 25 C 2.6673 7.4001 0.0 0
M  V30 26 C 4.0010 9.7102 0.0 0
M  V30 27 C 2.6673 8.9401 0.0 0
M  V30 28 C 13.3369 7.4001 0.0 0
M  V30 29 C 14.6706 6.6301 0.0 0
M  V30 30 C 13.3369 8.9401 0.0 0
M  V30 31 C 16.0044 7.4001 0.0 0
M  V30 32 C 14.6706 9.7102 0.0 0
M  V30 33 C 16.0044 8.9401 0.0 0
M  V30 34 N 18.6717 8.9401 0.0 0
M  V30 35 C 18.6717 7.4001 0.0 0
M  V30 36 C 20.0054 9.7102 0.0 0
M  V30 37 C 20.0054 6.6301 0.0 0
M  V30 38 C 21.3392 8.9401 0.0 0
M  V30 39 C 21.3392 7.4001 0.0 0
M  V30 40 N 22.6729 6.6301 0.0 0
M  V30 41 C 24.0065 7.4001 0.0 0
M  V30 42 C 22.6729 5.0901 0.0 0
M  V30 43 C 25.3402 6.6301 0.0 0
M  V30 44 C 24.0065 4.3201 0.0 0
M  V30 45 C 25.3402 5.0901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 6 7
M  V30 8 1 6 26
M  V30 9 1 8 33
M  V30 10 1 8 34
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 11 22
M  V30 18 1 12 16
M  V30 19 1 13 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 2 15 18
M  V30 23 2 16 19
M  V30 24 1 17 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1307702-36-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2088194-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3002420-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38589180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the
Treatment of Cystic Echinococcosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu,
Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan,
Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16680-16693

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
C9H7F6NO
722-92-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.0467 3.0800 0.0 0
M  V30 2 C 2.0467 1.5400 0.0 0
M  V30 3 C 1.3957 4.4757 0.0 0
M  V30 4 O 0.5590 2.6814 0.0 0
M  V30 5 F 0.5067 1.5400 0.0 0
M  V30 6 F 2.0467 0.0000 0.0 0
M  V30 7 F 3.5867 1.5400 0.0 0
M  V30 8 F 2.7916 5.1265 0.0 0
M  V30 9 F 0.7449 5.8714 0.0 0
M  V30 10 F 0.0000 3.8249 0.0 0
M  V30 11 N 8.2067 3.0800 0.0 0
M  V30 12 C 3.5867 3.0800 0.0 0
M  V30 13 C 4.3567 4.4136 0.0 0
M  V30 14 C 4.3567 1.7464 0.0 0
M  V30 15 C 5.8967 4.4136 0.0 0
M  V30 16 C 5.8967 1.7464 0.0 0
M  V30 17 C 6.6667 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 3 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,1-Dimethylethyl) 1,3-dihydro-5-[(2-methoxyethyl)sulfonyl]-2H-isoindole-1...
C17H23NO7S
2101238-13-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8194 1.1444 0.0 0
M  V30 2 O 4.3129 0.8242 0.0 0
M  V30 3 O 6.8498 0.0000 0.0 0
M  V30 4 C 3.8500 3.8549 0.0 0
M  V30 5 O 3.0800 5.1886 0.0 0
M  V30 6 O 3.0800 2.5213 0.0 0
M  V30 7 C 1.5400 5.1886 0.0 0
M  V30 8 C 1.5400 6.7286 0.0 0
M  V30 9 C 0.0000 5.1886 0.0 0
M  V30 10 C 1.5400 3.6486 0.0 0
M  V30 11 S 11.7609 5.3950 0.0 0 VAL=6
M  V30 12 C 13.0945 6.1650 0.0 0
M  V30 13 O 12.5309 4.0613 0.0 0
M  V30 14 O 10.9909 6.7286 0.0 0
M  V30 15 C 14.4283 5.3950 0.0 0
M  V30 16 O 15.7620 6.1650 0.0 0
M  V30 17 C 17.0956 5.3950 0.0 0
M  V30 18 C 7.7598 3.0849 0.0 0
M  V30 19 C 6.2952 2.6091 0.0 0
M  V30 20 C 7.7598 4.6250 0.0 0
M  V30 21 C 9.0936 2.3149 0.0 0
M  V30 22 N 5.3900 3.8549 0.0 0
M  V30 23 C 6.2952 5.1008 0.0 0
M  V30 24 C 9.0936 5.3950 0.0 0
M  V30 25 C 10.4272 3.0849 0.0 0
M  V30 26 C 10.4272 4.6250 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 26
M  V30 15 1 12 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 1,3-dihydro-5-[(2-methoxyethyl)sulfonyl]-1-[[[4-[2,2,2-trif...
C26H28F6N2O7S
2101238-05-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6582 7.0620 0.0 0
M  V30 2 N 8.1824 8.5266 0.0 0
M  V30 3 O 7.6278 5.9174 0.0 0
M  V30 4 C 10.0210 4.0012 0.0 0
M  V30 5 O 10.7910 2.6675 0.0 0
M  V30 6 O 8.4810 4.0012 0.0 0
M  V30 7 C 10.0210 1.3337 0.0 0
M  V30 8 C 8.6873 2.1037 0.0 0
M  V30 9 C 9.2510 0.0000 0.0 0
M  V30 10 C 11.3547 0.5637 0.0 0
M  V30 11 S 15.3102 10.0823 0.0 0 VAL=6
M  V30 12 C 16.6439 10.8523 0.0 0
M  V30 13 O 14.5402 11.4160 0.0 0
M  V30 14 O 16.0803 8.7486 0.0 0
M  V30 15 C 17.9776 10.0823 0.0 0
M  V30 16 O 19.3113 10.8523 0.0 0
M  V30 17 C 20.6451 10.0823 0.0 0
M  V30 18 C 2.1568 9.8074 0.0 0
M  V30 19 C 2.4770 11.3137 0.0 0
M  V30 20 C 1.2300 8.5774 0.0 0
M  V30 21 O 0.7846 10.5066 0.0 0
M  V30 22 F 3.9833 10.9935 0.0 0
M  V30 23 F 2.7972 12.8202 0.0 0
M  V30 24 F 0.9707 11.6339 0.0 0
M  V30 25 F 0.0000 9.5043 0.0 0
M  V30 26 F 0.3032 7.3475 0.0 0
M  V30 27 F 2.4599 7.6506 0.0 0
M  V30 28 C 11.3091 7.7722 0.0 0
M  V30 29 C 10.1645 6.7418 0.0 0
M  V30 30 C 12.6428 7.0022 0.0 0
M  V30 31 C 11.3091 9.3123 0.0 0
M  V30 32 N 10.7910 5.3348 0.0 0
M  V30 33 C 12.3226 5.4959 0.0 0
M  V30 34 C 13.9764 7.7722 0.0 0
M  V30 35 C 12.6428 10.0823 0.0 0
M  V30 36 C 13.9764 9.3123 0.0 0
M  V30 37 C 6.6759 8.8467 0.0 0
M  V30 38 C 5.6455 7.7023 0.0 0
M  V30 39 C 6.2000 10.3115 0.0 0
M  V30 40 C 4.1391 8.0225 0.0 0
M  V30 41 C 4.6937 10.6316 0.0 0
M  V30 42 C 3.6631 9.4872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 29
M  V30 4 1 2 37
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 32
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 36
M  V30 16 1 12 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 42
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 20 26
M  V30 28 1 20 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 2 28 31
M  V30 32 1 29 32
M  V30 33 1 30 33
M  V30 34 2 30 34
M  V30 35 1 31 35
M  V30 36 1 32 33
M  V30 37 1 34 36
M  V30 38 2 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 722-92-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101238-13-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101238-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31159913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of
Retinoic Acid Receptor-Related Orphan Receptor C2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Narjes, Frank; Llinas, Antonio; von Berg, Stefan; Jirholt, Johan; Lever,
Sarah; Pehrson, Rikard; Collins, Mia; Malmberg, Anna; Svanberg, Petter;
Xue, Yafeng; Olsson, Roine I.; Malmberg, Jesper; Hughes, Glyn; Hossain,
Nafizal; Grindebacke, Hanna; Leffler, Agnes; Krutroek, Nina; Baeck,
Elisabeth; Ramnegaard, Marie; Lepistoe, Matti; Thunberg, Linda; Aagaard,
Anna; McPheat, Jane; Hansson, Eva L.; Chen, Rongfeng; Xiong, Yao;
Hansson, Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(18), 13807-13829

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Benzo[b]thiophene-3-carboxylic acid
C9H6O2S
5381-25-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.1885 0.0 0
M  V30 2 O 7.1956 2.7126 0.0 0
M  V30 3 O 5.4107 4.6949 0.0 0
M  V30 4 C 3.0800 2.4782 0.0 0
M  V30 5 C 2.3100 1.1445 0.0 0
M  V30 6 C 4.5865 2.1580 0.0 0
M  V30 7 C 2.3100 3.8119 0.0 0
M  V30 8 S 3.3406 0.0000 0.0 0
M  V30 9 C 0.7700 1.1445 0.0 0
M  V30 10 C 4.7474 0.6265 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C31H26N2O5S
2892485-64-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.8047 3.4202 0.0 0
M  V30 2 N 17.8995 4.6661 0.0 0
M  V30 3 O 18.1783 2.0134 0.0 0
M  V30 4 C 8.0022 5.3103 0.0 0
M  V30 5 O 8.0022 6.8503 0.0 0
M  V30 6 O 0.0000 5.3103 0.0 0
M  V30 7 C 0.0000 6.8503 0.0 0
M  V30 8 O 0.0000 2.2302 0.0 0
M  V30 9 C 0.0000 0.6902 0.0 0
M  V30 10 C 21.3667 2.4368 0.0 0
M  V30 11 C 20.3363 3.5811 0.0 0
M  V30 12 C 22.7736 3.0631 0.0 0
M  V30 13 C 21.2058 0.9052 0.0 0
M  V30 14 C 21.1063 4.9149 0.0 0
M  V30 15 S 22.6126 4.5948 0.0 0
M  V30 16 C 24.0195 2.1579 0.0 0
M  V30 17 C 22.4516 0.0000 0.0 0
M  V30 18 C 23.8584 0.6263 0.0 0
M  V30 19 C 16.3678 4.5051 0.0 0
M  V30 20 C 15.7415 3.0982 0.0 0
M  V30 21 C 15.4628 5.7510 0.0 0
M  V30 22 C 14.2100 2.9373 0.0 0
M  V30 23 C 13.9311 5.5901 0.0 0
M  V30 24 C 13.3047 4.1831 0.0 0
M  V30 25 C 11.7732 4.0222 0.0 0
M  V30 26 O 10.7428 5.1667 0.0 0
M  V30 27 C 11.0032 2.6885 0.0 0
M  V30 28 C 9.3358 4.5403 0.0 0
M  V30 29 C 9.4968 3.0087 0.0 0
M  V30 30 N 6.6685 4.5403 0.0 0
M  V30 31 C 5.3347 5.3103 0.0 0
M  V30 32 C 6.6685 3.0002 0.0 0
M  V30 33 C 4.0011 4.5403 0.0 0
M  V30 34 C 5.3347 2.2302 0.0 0
M  V30 35 C 4.0011 3.0002 0.0 0
M  V30 36 C 2.6674 5.3103 0.0 0
M  V30 37 C 2.6674 2.2302 0.0 0
M  V30 38 C 1.3338 4.5403 0.0 0
M  V30 39 C 1.3338 3.0002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 19
M  V30 5 2 4 5
M  V30 6 1 4 28
M  V30 7 1 4 30
M  V30 8 1 6 7
M  V30 9 1 6 38
M  V30 10 1 8 9
M  V30 11 1 8 39
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 25
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 35
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5381-25-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME365 STEP1
$RXN



  7  1
$MOL
Fmoc-cysteine
C18H17NO4S
135248-89-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=1
M  V30 7 C 12.4219 4.4608 0.0 0
M  V30 8 C 11.0882 6.7709 0.0 0
M  V30 9 O 12.4219 2.9208 0.0 0
M  V30 10 O 13.7555 5.2309 0.0 0
M  V30 11 S 12.4219 7.5409 0.0 0
M  V30 12 C 4.4196 4.4608 0.0 0
M  V30 13 C 4.2586 2.9293 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 2.7523 2.6091 0.0 0
M  V30 16 C 5.2891 1.7849 0.0 0
M  V30 17 C 1.9823 3.9428 0.0 0
M  V30 18 C 2.5369 6.5519 0.0 0
M  V30 19 C 2.2763 1.1444 0.0 0
M  V30 20 C 4.8132 0.3202 0.0 0
M  V30 21 C 0.4759 4.2630 0.0 0
M  V30 22 C 1.0304 6.8721 0.0 0
M  V30 23 C 3.3069 0.0000 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-Pro-OH
C20H19NO4
71989-31-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3182 3.0203 0.0 0
M  V30 2 O 6.3486 4.1647 0.0 0
M  V30 3 C 7.8550 3.8445 0.0 0
M  V30 4 O 8.3309 2.3800 0.0 0
M  V30 5 C 11.1870 3.4943 0.0 0
M  V30 6 O 10.4170 2.1607 0.0 0
M  V30 7 O 12.7271 3.4943 0.0 0
M  V30 8 C 3.8119 3.3405 0.0 0
M  V30 9 C 3.1854 4.7474 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 1.6538 4.5863 0.0 0
M  V30 12 C 3.8119 6.1542 0.0 0
M  V30 13 C 1.3337 3.0800 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 0.7486 5.8322 0.0 0
M  V30 16 C 2.9066 7.4001 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 1.3337 0.0000 0.0 0
M  V30 19 C 1.3751 7.2392 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 21 N 8.8855 4.9891 0.0 0
M  V30 22 C 10.4170 4.8280 0.0 0 CFG=2
M  V30 23 C 8.5653 6.4954 0.0 0
M  V30 24 C 11.0435 6.2349 0.0 0
M  V30 25 C 9.8990 7.2654 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 21
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 22 5 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 2 18 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-L-Trp(Boc)-OH
C31H30N2O6
143824-78-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4609 0.0 0
M  V30 3 C 8.4208 5.2309 0.0 0
M  V30 4 N 9.7544 4.4609 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4219 4.4609 0.0 0
M  V30 9 O 13.7556 5.2309 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 C 16.3909 7.8981 0.0 0
M  V30 12 O 17.2961 9.1440 0.0 0
M  V30 13 O 17.0172 6.4911 0.0 0
M  V30 14 C 18.8277 8.9830 0.0 0
M  V30 15 C 18.6668 7.4513 0.0 0
M  V30 16 C 20.3592 8.8219 0.0 0
M  V30 17 C 18.9886 10.5146 0.0 0
M  V30 18 C 4.4196 4.4609 0.0 0
M  V30 19 C 4.2587 2.9293 0.0 0
M  V30 20 C 3.0128 5.0872 0.0 0
M  V30 21 C 2.7523 2.6091 0.0 0
M  V30 22 C 5.2891 1.7847 0.0 0
M  V30 23 C 1.9823 3.9428 0.0 0
M  V30 24 C 2.5369 6.5519 0.0 0
M  V30 25 C 2.2763 1.1444 0.0 0
M  V30 26 C 4.8132 0.3202 0.0 0
M  V30 27 C 0.4759 4.2630 0.0 0
M  V30 28 C 1.0304 6.8721 0.0 0
M  V30 29 C 3.3069 0.0000 0.0 0
M  V30 30 C 0.0000 5.7277 0.0 0
M  V30 31 C 12.4219 7.5409 0.0 0
M  V30 32 C 12.5828 9.0725 0.0 0
M  V30 33 C 13.8287 6.9146 0.0 0
M  V30 34 C 14.0893 9.3927 0.0 0
M  V30 35 C 11.5524 10.2170 0.0 0
M  V30 36 N 14.8593 8.0590 0.0 0
M  V30 37 C 14.5652 10.8574 0.0 0
M  V30 38 C 12.0283 11.6816 0.0 0
M  V30 39 C 13.5346 12.0018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 36
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 23
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 2 28 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 2 32 35
M  V30 38 1 33 36
M  V30 39 1 34 36
M  V30 40 2 34 37
M  V30 41 1 35 38
M  V30 42 1 37 39
M  V30 43 2 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-L-Asp(OtBu)-OH
C23H25NO6
71989-14-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 C 11.9843 5.1163 0.0 0
M  V30 10 O 11.9843 7.7838 0.0 0
M  V30 11 O 9.6743 9.1174 0.0 0
M  V30 12 O 12.7543 3.7827 0.0 0
M  V30 13 O 12.7543 6.4500 0.0 0
M  V30 14 C 14.2943 3.7827 0.0 0
M  V30 15 C 14.2943 5.3227 0.0 0
M  V30 16 C 15.8343 3.7827 0.0 0
M  V30 17 C 14.2943 2.2427 0.0 0
M  V30 18 C 3.5143 3.7827 0.0 0
M  V30 19 C 2.6091 5.0286 0.0 0
M  V30 20 C 2.6091 2.5368 0.0 0
M  V30 21 C 1.1445 4.5527 0.0 0
M  V30 22 C 2.9292 6.5350 0.0 0
M  V30 23 C 1.1445 3.0127 0.0 0
M  V30 24 C 2.9292 1.0304 0.0 0
M  V30 25 C 0.0000 5.5831 0.0 0
M  V30 26 C 1.7849 7.5654 0.0 0
M  V30 27 C 0.0000 1.9823 0.0 0
M  V30 28 C 1.7849 0.0000 0.0 0
M  V30 29 C 0.3202 7.0895 0.0 0
M  V30 30 C 0.3202 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-Gly-OH
C17H15NO4
29022-11-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 O 13.7554 5.2310 0.0 0
M  V30 9 O 12.4218 2.9209 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N6-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminom...
C35H42N4O7S
1159680-21-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 5.7534 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 8.4207 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4207 11.3910 0.0 0
M  V30 9 C 11.0882 9.8510 0.0 0
M  V30 10 O 9.7544 12.1610 0.0 0
M  V30 11 O 7.0871 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 C 13.7556 9.8510 0.0 0
M  V30 14 N 15.0894 9.0810 0.0 0
M  V30 15 C 16.4231 9.8510 0.0 0
M  V30 16 N 17.7567 9.0810 0.0 0
M  V30 17 N 16.4231 11.3910 0.0 0
M  V30 18 S 19.0904 9.8510 0.0 0 VAL=6
M  V30 19 O 18.3204 11.1846 0.0 0
M  V30 20 O 19.8604 8.5173 0.0 0
M  V30 21 C 21.7579 8.3109 0.0 0
M  V30 22 C 19.0904 12.9310 0.0 0
M  V30 23 C 21.7579 14.4711 0.0 0
M  V30 24 C 26.6059 12.4214 0.0 0
M  V30 25 C 26.6059 10.3606 0.0 0
M  V30 26 C 4.4196 4.4609 0.0 0
M  V30 27 C 4.2587 2.9293 0.0 0
M  V30 28 C 3.0128 5.0873 0.0 0
M  V30 29 C 2.7523 2.6091 0.0 0
M  V30 30 C 5.2892 1.7849 0.0 0
M  V30 31 C 1.9823 3.9428 0.0 0
M  V30 32 C 2.5369 6.5519 0.0 0
M  V30 33 C 2.2765 1.1444 0.0 0
M  V30 34 C 4.8132 0.3202 0.0 0
M  V30 35 C 0.4759 4.2630 0.0 0
M  V30 36 C 1.0304 6.8721 0.0 0
M  V30 37 C 3.3069 0.0000 0.0 0
M  V30 38 C 0.0000 5.7277 0.0 0
M  V30 39 C 20.4242 10.6210 0.0 0
M  V30 40 C 21.7579 9.8510 0.0 0
M  V30 41 C 20.4242 12.1610 0.0 0
M  V30 42 C 23.0916 10.6210 0.0 0
M  V30 43 C 21.7579 12.9310 0.0 0
M  V30 44 C 23.0916 12.1610 0.0 0
M  V30 45 C 24.5563 10.1451 0.0 0
M  V30 46 O 24.5563 12.6369 0.0 0
M  V30 47 C 25.4614 11.3910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 4 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 2 18 19
M  V30 20 2 18 20
M  V30 21 1 18 39
M  V30 22 1 21 40
M  V30 23 1 22 41
M  V30 24 1 23 43
M  V30 25 1 24 47
M  V30 26 1 25 47
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 27 30
M  V30 31 1 28 31
M  V30 32 2 28 32
M  V30 33 1 29 31
M  V30 34 2 29 33
M  V30 35 1 30 34
M  V30 36 2 31 35
M  V30 37 1 32 36
M  V30 38 1 33 37
M  V30 39 2 34 37
M  V30 40 1 35 38
M  V30 41 2 36 38
M  V30 42 1 39 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 1 42 45
M  V30 48 2 43 44
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-[(Triphenylmethyl)thio]propanoic acid
C22H20O2S
27144-18-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.6201 0.0 0
M  V30 2 S 6.1601 4.6201 0.0 0
M  V30 3 C 6.9302 5.9538 0.0 0
M  V30 4 C 8.4702 5.9538 0.0 0
M  V30 5 C 9.2402 7.2876 0.0 0
M  V30 6 O 10.7802 7.2876 0.0 0
M  V30 7 O 8.4702 8.6213 0.0 0
M  V30 8 C 4.6201 3.0801 0.0 0
M  V30 9 C 5.9538 2.3101 0.0 0
M  V30 10 C 3.2864 2.3101 0.0 0
M  V30 11 C 5.9538 0.7700 0.0 0
M  V30 12 C 3.2864 0.7700 0.0 0
M  V30 13 C 4.6201 0.0000 0.0 0
M  V30 14 C 3.0801 4.6201 0.0 0
M  V30 15 C 2.3101 5.9538 0.0 0
M  V30 16 C 2.3101 3.2864 0.0 0
M  V30 17 C 0.7700 5.9538 0.0 0
M  V30 18 C 0.7700 3.2864 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 20 C 4.6201 6.1601 0.0 0
M  V30 21 C 5.9538 6.9302 0.0 0
M  V30 22 C 3.2864 6.9302 0.0 0
M  V30 23 C 5.9538 8.4702 0.0 0
M  V30 24 C 3.2864 8.4702 0.0 0
M  V30 25 C 4.6201 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-...
C35H51N11O9S2
135900-78-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7157 16.0042 0.0 0
M  V30 2 C 9.9457 14.6706 0.0 0 CFG=2
M  V30 3 C 8.4057 14.6706 0.0 0
M  V30 4 N 10.7157 13.3369 0.0 0
M  V30 5 O 7.6357 13.3369 0.0 0
M  V30 6 C 9.9457 12.0031 0.0 0
M  V30 7 C 10.7157 10.6695 0.0 0 CFG=2
M  V30 8 O 8.4057 12.0031 0.0 0
M  V30 9 N 12.2557 10.6695 0.0 0
M  V30 10 C 9.9457 9.3358 0.0 0
M  V30 11 C 13.0257 9.3358 0.0 0
M  V30 12 C 8.4057 9.3358 0.0 0
M  V30 13 C 14.5657 9.3358 0.0 0
M  V30 14 O 12.2557 8.0022 0.0 0
M  V30 15 O 7.6357 8.0022 0.0 0
M  V30 16 O 7.6357 10.6695 0.0 0
M  V30 17 N 15.3357 8.0022 0.0 0
M  V30 18 C 16.8757 8.0022 0.0 0
M  V30 19 C 17.6457 6.6684 0.0 0 CFG=1
M  V30 20 O 17.6457 9.3358 0.0 0
M  V30 21 C 19.1857 6.6684 0.0 0
M  V30 22 N 16.8757 5.3347 0.0 0
M  V30 23 C 19.9557 8.0020 0.0 0
M  V30 24 C 17.6457 4.0011 0.0 0
M  V30 25 C 21.4957 8.0020 0.0 0
M  V30 26 C 16.8757 2.6673 0.0 0
M  V30 27 O 19.1857 4.0011 0.0 0
M  V30 28 C 22.2657 9.3358 0.0 0
M  V30 29 C 17.6457 1.3336 0.0 0
M  V30 30 N 23.8057 9.3358 0.0 0
M  V30 31 S 16.8757 0.0000 0.0 0
M  V30 32 C 24.5758 10.6695 0.0 0
M  V30 33 N 23.8057 12.0031 0.0 0
M  V30 34 N 26.1158 10.6695 0.0 0
M  V30 35 C 5.0737 15.0208 0.0 0
M  V30 36 N 3.5673 15.3409 0.0 0
M  V30 37 O 5.5496 13.5561 0.0 0
M  V30 38 C 2.5369 14.1966 0.0 0 CFG=1
M  V30 39 C 1.0304 14.5167 0.0 0
M  V30 40 C 3.0127 12.7319 0.0 0
M  V30 41 N 0.0000 13.3722 0.0 0
M  V30 42 O 0.5546 15.9813 0.0 0
M  V30 43 S 1.9823 11.5875 0.0 0
M  V30 44 C 12.2557 16.0042 0.0 0
M  V30 45 C 13.1609 17.2501 0.0 0
M  V30 46 C 13.1609 14.7584 0.0 0
M  V30 47 C 14.6255 16.7742 0.0 0
M  V30 48 C 12.8407 18.7565 0.0 0
M  V30 49 N 14.6255 15.2342 0.0 0
M  V30 50 C 15.7700 17.8046 0.0 0
M  V30 51 C 13.9851 19.7869 0.0 0
M  V30 52 C 15.4498 19.3111 0.0 0
M  V30 53 N 7.6357 16.0042 0.0 0
M  V30 54 C 6.1041 16.1652 0.0 0 CFG=2
M  V30 55 C 8.2620 17.4112 0.0 0
M  V30 56 C 5.7840 17.6716 0.0 0
M  V30 57 C 7.1176 18.4416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 44
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 1 3 53
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 35 36
M  V30 37 2 35 37
M  V30 38 1 54 35 CFG=3
M  V30 39 1 36 38
M  V30 40 1 38 39
M  V30 41 1 38 40 CFG=1
M  V30 42 1 39 41
M  V30 43 2 39 42
M  V30 44 1 40 43
M  V30 45 1 44 45
M  V30 46 2 44 46
M  V30 47 1 45 47
M  V30 48 2 45 48
M  V30 49 1 46 49
M  V30 50 1 47 49
M  V30 51 2 47 50
M  V30 52 1 48 51
M  V30 53 1 50 52
M  V30 54 2 51 52
M  V30 55 1 53 54
M  V30 56 1 53 55
M  V30 57 1 54 56
M  V30 58 1 55 57
M  V30 59 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 7 19 38 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 135248-89-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71989-31-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 143824-78-6
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 71989-14-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 29022-11-5
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 1159680-21-3
$DTYPE RXN:RCT(7):CAS_RN
$DATUM 27144-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 135900-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35026067
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 9
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 3849-21-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 14970-87-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-20-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation, solid-supported reaction, peptide synthesizer
used, 30 W used, Fmoc deprotection with piperidine/DMF, attachment to
Rink amide resin in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An optimized safe process from bench to pilot cGMP production of API
eptifibatide using a multigram-scale microwave-assisted solid-phase
peptide synthesizer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Ercole, Annunziata; Pacini, Lorenzo; Sabatino, Giuseppina; Zini,
Matteo; Nuti, Francesca; Ribecai, Arianna; Paio, Alfredo; Rovero, Paolo;
Papini, Anna Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(12), 2754-2771

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
tert-Butoxycarbonyl-D-tryptophan
C16H20N2O4
5241-64-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 4.0011 0.0 0
M  V30 2 C 5.8243 2.6674 0.0 0 CFG=2
M  V30 3 N 7.3643 2.6674 0.0 0
M  V30 4 C 5.0543 1.3336 0.0 0
M  V30 5 C 8.1343 4.0011 0.0 0
M  V30 6 O 5.8243 0.0000 0.0 0
M  V30 7 O 3.5143 1.3336 0.0 0
M  V30 8 O 9.6743 4.0011 0.0 0
M  V30 9 O 7.3643 5.3347 0.0 0
M  V30 10 C 10.4443 5.3347 0.0 0
M  V30 11 C 11.7780 4.5647 0.0 0
M  V30 12 C 11.2143 6.6684 0.0 0
M  V30 13 C 9.1107 6.1047 0.0 0
M  V30 14 C 2.6091 5.2470 0.0 0
M  V30 15 C 3.5143 4.0011 0.0 0
M  V30 16 C 1.1444 4.7711 0.0 0
M  V30 17 C 2.9292 6.7534 0.0 0
M  V30 18 C 2.6091 2.7552 0.0 0
M  V30 19 N 1.1444 3.2311 0.0 0
M  V30 20 C 0.0000 5.8015 0.0 0
M  V30 21 C 1.7849 7.7838 0.0 0
M  V30 22 C 0.3202 7.3080 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Norleucine, (4-nitrophenyl)methyl ester
C13H18N2O4
865650-19-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6698 3.8501 0.0 0 CFG=2
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0035 4.6201 0.0 0
M  V30 7 N 10.6698 2.3101 0.0 0
M  V30 8 C 13.3372 3.8501 0.0 0
M  V30 9 C 14.6708 4.6201 0.0 0
M  V30 10 C 16.0046 3.8501 0.0 0
M  V30 11 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 12 O 0.0000 2.3101 0.0 0
M  V30 13 O 1.3338 0.0000 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6675 3.8501 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-D-tryptophyl-D-norleucine (4-nitrophenyl)met...
C29H36N4O7
865488-27-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.7533 0.0 0
M  V30 2 C 6.1600 7.0869 0.0 0 CFG=1
M  V30 3 C 7.7000 7.0869 0.0 0
M  V30 4 N 5.3900 8.4206 0.0 0
M  V30 5 N 8.4700 8.4206 0.0 0
M  V30 6 O 8.4700 5.7533 0.0 0
M  V30 7 C 3.8500 8.4206 0.0 0
M  V30 8 C 10.0100 8.4206 0.0 0 CFG=2
M  V30 9 O 3.0800 9.7542 0.0 0
M  V30 10 O 3.0800 7.0869 0.0 0
M  V30 11 C 10.7800 9.7542 0.0 0
M  V30 12 C 10.7800 7.0869 0.0 0
M  V30 13 C 1.5400 9.7542 0.0 0
M  V30 14 O 12.3200 9.7542 0.0 0
M  V30 15 O 10.0100 11.0880 0.0 0
M  V30 16 C 12.3200 7.0869 0.0 0
M  V30 17 C 1.5400 8.2142 0.0 0
M  V30 18 C 0.0000 9.7542 0.0 0
M  V30 19 C 1.5400 11.2942 0.0 0
M  V30 20 C 13.0900 11.0880 0.0 0
M  V30 21 C 13.0900 5.7533 0.0 0
M  V30 22 C 14.6300 5.7533 0.0 0
M  V30 23 N 19.2500 11.0880 0.0 0 VAL=5
M  V30 24 O 20.0200 9.7542 0.0 0
M  V30 25 O 20.0200 12.4216 0.0 0
M  V30 26 C 6.1600 4.4195 0.0 0
M  V30 27 C 5.5337 3.0127 0.0 0
M  V30 28 C 7.6915 4.2586 0.0 0
M  V30 29 C 6.6781 1.9823 0.0 0
M  V30 30 C 4.0690 2.5368 0.0 0
M  V30 31 N 8.0117 2.7523 0.0 0
M  V30 32 C 6.3579 0.4759 0.0 0
M  V30 33 C 3.7488 1.0304 0.0 0
M  V30 34 C 4.8932 0.0000 0.0 0
M  V30 35 C 14.6300 11.0880 0.0 0
M  V30 36 C 15.4000 12.4216 0.0 0
M  V30 37 C 15.4000 9.7542 0.0 0
M  V30 38 C 16.9400 12.4216 0.0 0
M  V30 39 C 16.9400 9.7542 0.0 0
M  V30 40 C 17.7100 11.0880 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 16 21
M  V30 22 1 20 35
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 2 23 25
M  V30 26 1 23 40
M  V30 27 1 26 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 2 27 30
M  V30 31 1 28 31
M  V30 32 1 29 31
M  V30 33 2 29 32
M  V30 34 1 30 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5241-64-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865650-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 865488-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37198975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development, synthesis and evaluation of novel fluorescent Endothelin-B
receptor probes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Delahaye, Juliette; Stoelting, Miriam; Geyer, Christiane; Vogl, Thomas;
Eisenblaetter, Michel; Helfen, Anne; Hoeltke, Carsten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 258115568

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
2-Bromo-6-fluorobenzoic acid
C7H4BrFO2
2252-37-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Br 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(2-amino-1-cyclopentyl-1H-benzimidazol-6-yl)-,...
C22H32N4O2
2922001-14-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 3.8409 0.0 0
M  V30 2 C 12.2410 6.4626 0.0 0
M  V30 3 O 13.0110 7.7964 0.0 0
M  V30 4 O 13.0112 5.1290 0.0 0
M  V30 5 C 14.5512 7.7964 0.0 0
M  V30 6 C 14.5512 6.2564 0.0 0
M  V30 7 C 16.0912 7.7964 0.0 0
M  V30 8 C 14.5512 9.3364 0.0 0
M  V30 9 C 3.7712 5.1290 0.0 0
M  V30 10 N 2.7406 3.9846 0.0 0
M  V30 11 C 3.0012 6.4626 0.0 0
M  V30 12 C 5.3112 5.1290 0.0 0
M  V30 13 C 1.3338 4.6109 0.0 0
M  V30 14 N 1.4947 6.1424 0.0 0
M  V30 15 C 3.7712 7.7964 0.0 0
M  V30 16 C 6.0812 6.4626 0.0 0
M  V30 17 C 5.3112 7.7964 0.0 0
M  V30 18 C 3.0607 2.4782 0.0 0
M  V30 19 C 2.0303 1.3338 0.0 0
M  V30 20 C 4.4677 1.8519 0.0 0
M  V30 21 C 2.8003 0.0000 0.0 0
M  V30 22 C 4.3066 0.3203 0.0 0
M  V30 23 C 7.6212 6.4626 0.0 0
M  V30 24 C 8.3912 5.1290 0.0 0
M  V30 25 C 8.3912 7.7964 0.0 0
M  V30 26 C 9.9312 5.1290 0.0 0
M  V30 27 C 9.9312 7.7964 0.0 0
M  V30 28 N 10.7012 6.4626 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 16 23
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[2-[(2-bromo-6-fluorobenzoyl)amino]-1-cyclopen...
C29H34BrFN4O3
2922001-31-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.8409 0.0 0
M  V30 2 C 4.0011 4.6109 0.0 0
M  V30 3 O 4.0011 6.1509 0.0 0
M  V30 4 Br 4.0011 1.5309 0.0 0
M  V30 5 F 1.3336 6.1509 0.0 0
M  V30 6 C 17.5757 6.4626 0.0 0
M  V30 7 O 18.3457 7.7964 0.0 0
M  V30 8 O 18.3457 5.1290 0.0 0
M  V30 9 C 19.8857 7.7964 0.0 0
M  V30 10 C 19.8857 9.3364 0.0 0
M  V30 11 C 21.4257 7.7964 0.0 0
M  V30 12 C 19.8857 6.2564 0.0 0
M  V30 13 C 9.1057 5.1290 0.0 0
M  V30 14 N 8.0753 3.9846 0.0 0
M  V30 15 C 8.3357 6.4626 0.0 0
M  V30 16 C 10.6457 5.1290 0.0 0
M  V30 17 C 6.6684 4.6109 0.0 0
M  V30 18 N 6.8294 6.1424 0.0 0
M  V30 19 C 9.1057 7.7964 0.0 0
M  V30 20 C 11.4157 6.4626 0.0 0
M  V30 21 C 10.6457 7.7964 0.0 0
M  V30 22 C 8.3955 2.4782 0.0 0
M  V30 23 C 7.3651 1.3338 0.0 0
M  V30 24 C 9.8023 1.8519 0.0 0
M  V30 25 C 8.1351 0.0000 0.0 0
M  V30 26 C 9.6413 0.3203 0.0 0
M  V30 27 C 12.9557 6.4626 0.0 0
M  V30 28 C 13.7257 5.1290 0.0 0
M  V30 29 C 13.7257 7.7964 0.0 0
M  V30 30 C 15.2657 5.1290 0.0 0
M  V30 31 C 15.2657 7.7964 0.0 0
M  V30 32 N 16.0357 6.4626 0.0 0
M  V30 33 C 2.6673 3.8409 0.0 0
M  V30 34 C 2.6673 2.3009 0.0 0
M  V30 35 C 1.3336 4.6109 0.0 0
M  V30 36 C 1.3336 1.5309 0.0 0
M  V30 37 C 0.0000 3.8409 0.0 0
M  V30 38 C 0.0000 2.3009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 1 2 33
M  V30 5 1 4 34
M  V30 6 1 5 35
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 32
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 22
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 18
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 20 27
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2252-37-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2922001-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922001-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36146371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process Development for the Synthesis of BI 1702135: A Concise Design
Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Jiang-Ping; Dong, Wei-Tong; Chen, Chengsheng; Sienkiewicz, Alexander;
Beyer, Phouvieng; Wang, Jun; Haddad, Nizar; Lorenz, Jon C.; Reeves,
Jonathan T.; Bunner, Matthew H.; Gonnella, Nina C.; Weinstabl, Harald;
Garavel, Geraldine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(4), 788-797

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL

C22H32N2O7
1863128-21-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 6.6685 0.0 0 CFG=2
M  V30 2 C 7.7002 8.0022 0.0 0
M  V30 3 N 7.7002 5.3348 0.0 0
M  V30 4 C 5.3901 6.6685 0.0 0
M  V30 5 N 9.2402 8.0022 0.0 0
M  V30 6 O 6.9302 9.3360 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 O 4.6201 8.0022 0.0 0
M  V30 9 C 10.0102 9.3360 0.0 0 CFG=1
M  V30 10 O 7.7002 2.6673 0.0 0
M  V30 11 O 5.3901 4.0012 0.0 0
M  V30 12 C 3.0801 8.0022 0.0 0
M  V30 13 C 11.5503 9.3360 0.0 0
M  V30 14 C 9.2402 10.6697 0.0 0 CFG=2
M  V30 15 C 6.9302 1.3337 0.0 0
M  V30 16 O 12.3203 10.6697 0.0 0
M  V30 17 O 12.3203 8.0022 0.0 0
M  V30 18 C 10.0102 12.0033 0.0 0
M  V30 19 O 7.7002 10.6697 0.0 0
M  V30 20 C 5.5965 2.1037 0.0 0
M  V30 21 C 6.1601 0.0000 0.0 0
M  V30 22 C 8.2638 0.5637 0.0 0
M  V30 23 C 13.8603 10.6697 0.0 0
M  V30 24 C 14.6303 12.0033 0.0 0
M  V30 25 C 16.1704 12.0033 0.0 0
M  V30 26 C 2.3101 9.3360 0.0 0
M  V30 27 C 3.0801 10.6697 0.0 0
M  V30 28 C 0.7700 9.3360 0.0 0
M  V30 29 C 2.3101 12.0033 0.0 0
M  V30 30 C 0.0000 10.6697 0.0 0
M  V30 31 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 9 5 CFG=1
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 12 26
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 15 22
M  V30 23 1 16 23
M  V30 24 1 23 24
M  V30 25 2 24 25
M  V30 26 2 26 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 2 28 30
M  V30 30 2 29 31
M  V30 31 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(9-Fluorenylmethoxycarbonyl)-L-glutamic acid γ-tert-butyl ester
C24H27NO6
71989-18-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 O 13.7556 9.8510 0.0 0
M  V30 14 O 12.4219 7.5409 0.0 0
M  V30 15 C 15.0893 9.0810 0.0 0
M  V30 16 C 15.8593 10.4146 0.0 0
M  V30 17 C 16.4229 8.3109 0.0 0
M  V30 18 C 14.3192 7.7473 0.0 0
M  V30 19 C 3.0128 5.0873 0.0 0
M  V30 20 C 4.4196 4.4609 0.0 0
M  V30 21 C 1.9822 3.9428 0.0 0
M  V30 22 C 2.5367 6.5519 0.0 0
M  V30 23 C 4.2587 2.9293 0.0 0
M  V30 24 C 2.7522 2.6091 0.0 0
M  V30 25 C 0.4759 4.2630 0.0 0
M  V30 26 C 1.0304 6.8721 0.0 0
M  V30 27 C 5.2891 1.7849 0.0 0
M  V30 28 C 2.2763 1.1444 0.0 0
M  V30 29 C 0.0000 5.7277 0.0 0
M  V30 30 C 4.8132 0.3202 0.0 0
M  V30 31 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 2 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C41H49N3O10
1863128-23-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 12.3200 0.0 0
M  V30 2 O 7.0869 11.5500 0.0 0
M  V30 3 C 8.4206 12.3200 0.0 0
M  V30 4 N 9.7544 11.5500 0.0 0
M  V30 5 O 8.4206 13.8600 0.0 0
M  V30 6 C 11.0880 12.3200 0.0 0 CFG=1
M  V30 7 C 12.4216 11.5500 0.0 0
M  V30 8 C 11.0880 13.8600 0.0 0
M  V30 9 N 12.4216 10.0100 0.0 0
M  V30 10 O 13.7553 12.3200 0.0 0
M  V30 11 C 12.4216 14.6300 0.0 0
M  V30 12 C 13.7553 9.2400 0.0 0 CFG=1
M  V30 13 C 12.4216 16.1700 0.0 0
M  V30 14 C 13.7553 7.7000 0.0 0
M  V30 15 C 15.0891 10.0100 0.0 0
M  V30 16 O 13.7553 16.9400 0.0 0
M  V30 17 O 11.0880 16.9400 0.0 0
M  V30 18 N 12.4216 6.9300 0.0 0
M  V30 19 O 15.0891 6.9300 0.0 0
M  V30 20 O 16.4227 9.2400 0.0 0
M  V30 21 C 13.7553 18.4800 0.0 0
M  V30 22 C 12.4216 5.3900 0.0 0 CFG=1
M  V30 23 C 17.7564 10.0100 0.0 0
M  V30 24 C 15.2953 18.4800 0.0 0
M  V30 25 C 13.7553 20.0200 0.0 0
M  V30 26 C 12.2153 18.4800 0.0 0
M  V30 27 C 11.0880 4.6200 0.0 0
M  V30 28 C 13.7553 4.6200 0.0 0 CFG=2
M  V30 29 O 11.0880 3.0800 0.0 0
M  V30 30 O 9.7544 5.3900 0.0 0
M  V30 31 C 15.0891 5.3900 0.0 0
M  V30 32 O 13.7553 3.0800 0.0 0
M  V30 33 C 9.7544 2.3100 0.0 0
M  V30 34 C 9.7544 0.7700 0.0 0
M  V30 35 C 8.4206 0.0000 0.0 0
M  V30 36 C 4.4196 11.5500 0.0 0
M  V30 37 C 4.2586 10.0185 0.0 0
M  V30 38 C 3.0127 12.1763 0.0 0
M  V30 39 C 2.7523 9.6983 0.0 0
M  V30 40 C 5.2891 8.8739 0.0 0
M  V30 41 C 1.9823 11.0319 0.0 0
M  V30 42 C 2.5368 13.6410 0.0 0
M  V30 43 C 2.2764 8.2336 0.0 0
M  V30 44 C 4.8131 7.4094 0.0 0
M  V30 45 C 0.4759 11.3521 0.0 0
M  V30 46 C 1.0304 13.9612 0.0 0
M  V30 47 C 3.3068 7.0892 0.0 0
M  V30 48 C 0.0000 12.8168 0.0 0
M  V30 49 C 19.0900 9.2400 0.0 0
M  V30 50 C 19.0900 7.7000 0.0 0
M  V30 51 C 20.4238 10.0100 0.0 0
M  V30 52 C 20.4238 6.9300 0.0 0
M  V30 53 C 21.7574 9.2400 0.0 0
M  V30 54 C 21.7574 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 36
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=1
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 22 18 CFG=1
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 22 28
M  V30 29 1 23 49
M  V30 30 1 27 29
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 1 28 32 CFG=1
M  V30 34 1 29 33
M  V30 35 1 33 34
M  V30 36 2 34 35
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 1 37 39
M  V30 40 2 37 40
M  V30 41 1 38 41
M  V30 42 2 38 42
M  V30 43 1 39 41
M  V30 44 2 39 43
M  V30 45 1 40 44
M  V30 46 2 41 45
M  V30 47 1 42 46
M  V30 48 1 43 47
M  V30 49 2 44 47
M  V30 50 1 45 48
M  V30 51 2 46 48
M  V30 52 2 49 50
M  V30 53 1 49 51
M  V30 54 1 50 52
M  V30 55 2 51 53
M  V30 56 2 52 54
M  V30 57 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 12 22 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1863128-21-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71989-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1863128-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31592256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel macrocyclic peptidomimetics targeting the Polo-box domain of
Polo-like kinase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ryu, SeongShick; Park, Jung-Eun; Ham, Young Jin; Lim, Daniel C.;
Kwiatkowski, Nicholas P.; Kim, Do-Hee; Bhunia, Debabrata; Kim, Nam Doo;
Yaffe, Michael B.; Son, Woolim; Kim, Namkyoung; Choi, Tae-Ik; Swain,
Puspanjali; Kim, Cheol-Hee; Lee, Jin-Young; Gray, Nathanael S.; Lee,
Kyung S.; Sim, Taebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(3), 1915-1932

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Benzocaine
C9H11NO2
94-09-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Chloro-2-cyanophenyl)-5-methoxy-α-(2-methoxyethyl)-2-oxo-1(2H)-pyridinea...
C18H17ClN2O5
1630194-79-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 6.1601 0.0 0
M  V30 2 C 4.0010 7.7002 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 N 6.6685 0.0000 0.0 0
M  V30 5 O 9.3358 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.8501 0.0 0
M  V30 7 C 9.3358 6.1601 0.0 0
M  V30 8 C 10.6697 5.3901 0.0 0
M  V30 9 C 9.3358 7.7002 0.0 0
M  V30 10 C 12.0033 6.1601 0.0 0
M  V30 11 O 8.0022 8.4702 0.0 0
M  V30 12 O 10.6697 8.4702 0.0 0
M  V30 13 O 13.3370 5.3901 0.0 0
M  V30 14 C 14.6707 6.1601 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 8.0022 3.8501 0.0 0
M  V30 20 N 8.0022 5.3901 0.0 0
M  V30 21 C 4.0010 3.0801 0.0 0
M  V30 22 C 4.0010 1.5400 0.0 0
M  V30 23 C 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 0.7700 0.0 0
M  V30 25 C 1.3337 3.0801 0.0 0
M  V30 26 C 1.3337 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 3 3 4
M  V30 4 1 3 22
M  V30 5 2 5 19
M  V30 6 1 6 25
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[[2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxo-1(2H)-pyridinyl]-4-me...
C27H26ClN3O6
1630194-80-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 9.2400 0.0 0
M  V30 2 C 6.6684 10.0100 0.0 0
M  V30 3 C 1.3336 5.3900 0.0 0
M  V30 4 N 1.3336 3.8500 0.0 0
M  V30 5 O 5.3347 3.0800 0.0 0
M  V30 6 Cl 1.3336 11.5500 0.0 0
M  V30 7 C 8.0021 4.6200 0.0 0
M  V30 8 C 9.3358 5.3900 0.0 0
M  V30 9 C 8.0021 3.0800 0.0 0
M  V30 10 N 10.6694 4.6200 0.0 0
M  V30 11 O 9.3358 6.9300 0.0 0
M  V30 12 C 9.3358 2.3100 0.0 0
M  V30 13 O 9.3358 0.7700 0.0 0
M  V30 14 C 10.6694 0.0000 0.0 0
M  V30 15 C 16.0041 7.7000 0.0 0
M  V30 16 O 17.3378 6.9300 0.0 0
M  V30 17 O 16.0041 9.2400 0.0 0
M  V30 18 C 18.6716 7.7000 0.0 0
M  V30 19 C 20.0052 6.9300 0.0 0
M  V30 20 C 4.0011 6.9300 0.0 0
M  V30 21 C 5.3347 7.7000 0.0 0
M  V30 22 C 4.0011 5.3900 0.0 0
M  V30 23 C 6.6684 6.9300 0.0 0
M  V30 24 C 5.3347 4.6200 0.0 0
M  V30 25 N 6.6684 5.3900 0.0 0
M  V30 26 C 2.6674 7.7000 0.0 0
M  V30 27 C 1.3336 6.9300 0.0 0
M  V30 28 C 2.6674 9.2400 0.0 0
M  V30 29 C 0.0000 7.7000 0.0 0
M  V30 30 C 1.3336 10.0100 0.0 0
M  V30 31 C 0.0000 9.2400 0.0 0
M  V30 32 C 12.0031 5.3900 0.0 0
M  V30 33 C 12.0031 6.9300 0.0 0
M  V30 34 C 13.3369 4.6200 0.0 0
M  V30 35 C 13.3369 7.7000 0.0 0
M  V30 36 C 14.6705 5.3900 0.0 0
M  V30 37 C 14.6705 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 3 3 4
M  V30 4 1 3 27
M  V30 5 2 5 24
M  V30 6 1 6 30
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 32
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 37
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 26
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630194-79-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630194-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37692197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 3849-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Preclinical Characterization Program toward Asundexian (BAY
2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment
of Thromboembolic Disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roehrig, Susanne; Ackerstaff, Jens; Jimenez Nunez, Eloisa; Teller,
Henrik; Ellerbrock, Pascal; Meier, Katharina; Heitmeier, Stefan;
Tersteegen, Adrian; Stampfuss, Jan; Lang, Dieter; Schlemmer, Karl-Heinz;
Schaefer, Martina; Gericke, Kersten M.; Kinzel, Tom; Meibom, Daniel;
Schmidt, Martina; Gerdes, Christoph; Follmann, Markus; Hillisch,
Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(17), 12203-12224

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Formamidine acetate
C2H4O2.CH4N2
3473-63-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.8501 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 N 2.6673 4.6201 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 2 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-bromo-5-chloro-3,6-difluorobenzoic acid
C7H3BrClF2NO2
2387928-70-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 F 2.3100 5.3349 0.0 0
M  V30 5 N 2.3100 0.0000 0.0 0
M  V30 6 Cl 5.3900 5.3349 0.0 0
M  V30 7 F 5.3900 0.0000 0.0 0
M  V30 8 Br 6.9300 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-6-chloro-5,8-difluoro-4(3H)-quinazolinone
C8H2BrClF2N2O
2387928-71-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3901 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 F 2.3100 6.6686 0.0 0
M  V30 4 Cl 6.9301 4.0011 0.0 0
M  V30 5 Br 5.3901 6.6686 0.0 0
M  V30 6 C 3.0800 2.6675 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 C 5.3901 4.0011 0.0 0
M  V30 13 N 0.7700 1.3338 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 1 4 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3473-63-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2387928-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387928-71-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40188144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant
GTPase KRASG12C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason G.; Bagal, Sharan K.; Bickerton, Sue; Bodnarchuk, Michael
S.; Boyd, Scott; Breed, Jason; Carbajo, Rodrigo J.; Cassar, Doyle J.;
Chakraborty, Atanu; Cosulich, Sabina; Cumming, Iain; Davies, Michael;
Davies, Nichola L.; Eatherton, Andrew; Evans, Laura; Feron, Lyman;
Fillery, Shaun; Gleave, Emma S.; Goldberg, Frederick W.; Hanson, Lyndsey;
Harlfinger, Stephanie; Howard, Martin; Howells, Rachel; Jackson, Anne;
Kemmitt, Paul; Lamont, Gillian; Lamont, Scott; Lewis, Hilary J.; Liu,
Libin; Niedbala, Michael J.; Phillips, Christopher; Polanski, Radek;
Raubo, Piotr; Robb, Graeme; Robinson, David M.; Ross, Sarah; Sanders,
Matthew G.; Tonge, Michael; Whiteley, Rebecca; Wilkinson, Stephen; Yang,
Junsheng; Zhang, Wenman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(9), 6940-6952

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
(3S)-3-[[(2R)-3-(3-Chloro-4-methoxyphenyl)-1-oxo-2-[(1-oxo-2-propen-1-yl)amin...
C19H25ClN2O5
2097444-45-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 7.6447 0.0 0 CFG=1
M  V30 2 C 5.3900 8.9784 0.0 0
M  V30 3 C 5.3900 6.3111 0.0 0
M  V30 4 N 3.0800 7.6447 0.0 0
M  V30 5 N 4.6200 4.9774 0.0 0
M  V30 6 O 6.9300 6.3111 0.0 0
M  V30 7 C 2.3100 8.9784 0.0 0
M  V30 8 C 5.3900 3.6436 0.0 0 CFG=1
M  V30 9 C 0.7700 8.9784 0.0 0
M  V30 10 O 3.0800 10.3121 0.0 0
M  V30 11 C 4.6200 2.3100 0.0 0
M  V30 12 C 6.9300 3.6436 0.0 0
M  V30 13 C 0.0000 10.3121 0.0 0
M  V30 14 C 5.9536 1.5400 0.0 0
M  V30 15 C 3.2864 3.0800 0.0 0
M  V30 16 C 3.8500 0.9764 0.0 0
M  V30 17 O 7.2874 2.3100 0.0 0
M  V30 18 O 5.9536 0.0000 0.0 0
M  V30 19 Cl 10.0100 11.6458 0.0 0
M  V30 20 O 11.5500 8.9784 0.0 0
M  V30 21 C 12.3200 7.6447 0.0 0
M  V30 22 C 6.9300 8.9784 0.0 0
M  V30 23 C 7.7000 10.3121 0.0 0
M  V30 24 C 7.7000 7.6447 0.0 0
M  V30 25 C 9.2400 10.3121 0.0 0
M  V30 26 C 9.2400 7.6447 0.0 0
M  V30 27 C 10.0100 8.9784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 2 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 19 25
M  V30 20 1 20 21
M  V30 21 1 20 27
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S)-1-[(1R)-2-[(4-Methoxyphenyl)methoxy]-1-methylethyl]-3-buten-1-yl (2S)-2-...
C22H35NO4
2097444-35-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 4.0011 0.0 0 CFG=1
M  V30 2 O 5.9536 5.3347 0.0 0
M  V30 3 C 8.2636 4.0011 0.0 0 CFG=2
M  V30 4 C 5.9536 2.6674 0.0 0
M  V30 5 C 4.4136 5.3347 0.0 0
M  V30 6 C 9.0336 5.3347 0.0 0
M  V30 7 C 9.0336 2.6674 0.0 0
M  V30 8 C 6.7236 1.3336 0.0 0
M  V30 9 C 3.6436 6.6684 0.0 0 CFG=1
M  V30 10 O 3.6436 4.0011 0.0 0
M  V30 11 O 10.5736 5.3347 0.0 0
M  V30 12 C 5.9536 0.0000 0.0 0
M  V30 13 C 2.1036 6.6684 0.0 0
M  V30 14 N 4.4136 8.0021 0.0 0
M  V30 15 C 11.3436 6.6684 0.0 0
M  V30 16 C 1.3336 8.0021 0.0 0
M  V30 17 C 0.0000 7.2321 0.0 0
M  V30 18 C 0.5636 9.3358 0.0 0
M  V30 19 C 2.6673 8.7721 0.0 0
M  V30 20 O 17.5036 6.6684 0.0 0
M  V30 21 C 18.2736 8.0021 0.0 0
M  V30 22 C 12.8836 6.6684 0.0 0
M  V30 23 C 13.6536 8.0021 0.0 0
M  V30 24 C 13.6536 5.3347 0.0 0
M  V30 25 C 15.1936 8.0021 0.0 0
M  V30 26 C 15.1936 5.3347 0.0 0
M  V30 27 C 15.9636 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=3
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 15 22
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 20 21
M  V30 21 1 20 27
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 3 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Chloro-O-methyl-N-(1-oxo-2-propen-1-yl)-D-tyrosyl-(3S)-3-amino-2,2-dimethyl...
C41H58ClN3O8
2097445-21-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 6.1600 5.3347 0.0 0 CFG=1
M  V30 3 C 6.9300 6.6685 0.0 0
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 N 8.4700 6.6685 0.0 0
M  V30 6 O 6.1600 8.0021 0.0 0
M  V30 7 C 6.1600 2.6674 0.0 0
M  V30 8 C 9.2400 8.0021 0.0 0 CFG=1
M  V30 9 C 6.9300 1.3336 0.0 0
M  V30 10 O 4.6200 2.6674 0.0 0
M  V30 11 C 10.7800 8.0021 0.0 0
M  V30 12 C 8.4700 9.3358 0.0 0
M  V30 13 C 6.1600 0.0000 0.0 0
M  V30 14 C 10.7800 9.5421 0.0 0
M  V30 15 C 12.3200 8.0021 0.0 0
M  V30 16 C 10.7800 6.4621 0.0 0
M  V30 17 N 12.1138 10.3121 0.0 0
M  V30 18 O 9.4464 10.3121 0.0 0
M  V30 19 C 12.1138 11.8521 0.0 0 CFG=1
M  V30 20 C 13.4474 12.6221 0.0 0
M  V30 21 C 10.7800 12.6221 0.0 0
M  V30 22 O 14.7811 11.8521 0.0 0
M  V30 23 O 13.4474 14.1621 0.0 0
M  V30 24 C 10.7800 14.1621 0.0 0
M  V30 25 C 16.1147 12.6221 0.0 0 CFG=1
M  V30 26 C 9.4464 13.3921 0.0 0
M  V30 27 C 9.4464 14.9321 0.0 0
M  V30 28 C 12.1138 14.9321 0.0 0
M  V30 29 C 17.4485 11.8521 0.0 0 CFG=2
M  V30 30 C 16.1147 14.1621 0.0 0
M  V30 31 C 18.7821 12.6221 0.0 0
M  V30 32 C 17.4485 10.3121 0.0 0
M  V30 33 C 17.4485 14.9321 0.0 0
M  V30 34 O 20.1158 11.8521 0.0 0
M  V30 35 C 17.4485 16.4721 0.0 0
M  V30 36 C 21.4494 12.6221 0.0 0
M  V30 37 Cl 0.0000 8.0021 0.0 0
M  V30 38 O 1.5400 10.6694 0.0 0
M  V30 39 C 0.0000 10.6694 0.0 0
M  V30 40 O 26.7841 9.5421 0.0 0
M  V30 41 C 28.1179 10.3121 0.0 0
M  V30 42 C 3.8500 6.6685 0.0 0
M  V30 43 C 2.3100 6.6685 0.0 0
M  V30 44 C 4.6200 8.0021 0.0 0
M  V30 45 C 1.5400 8.0021 0.0 0
M  V30 46 C 3.8500 9.3358 0.0 0
M  V30 47 C 2.3100 9.3358 0.0 0
M  V30 48 C 22.7832 11.8521 0.0 0
M  V30 49 C 22.7832 10.3121 0.0 0
M  V30 50 C 24.1169 12.6221 0.0 0
M  V30 51 C 24.1169 9.5421 0.0 0
M  V30 52 C 25.4505 11.8521 0.0 0
M  V30 53 C 25.4505 10.3121 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 42
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 2 9 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 19 21 CFG=1
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 25 30 CFG=1
M  V30 31 1 29 31
M  V30 32 1 29 32 CFG=1
M  V30 33 1 30 33
M  V30 34 1 31 34
M  V30 35 2 33 35
M  V30 36 1 34 36
M  V30 37 1 36 48
M  V30 38 1 37 45
M  V30 39 1 38 39
M  V30 40 1 38 47
M  V30 41 1 40 41
M  V30 42 1 40 53
M  V30 43 2 42 43
M  V30 44 1 42 44
M  V30 45 1 43 45
M  V30 46 2 44 46
M  V30 47 2 45 47
M  V30 48 1 46 47
M  V30 49 2 48 49
M  V30 50 1 48 50
M  V30 51 1 49 51
M  V30 52 2 50 52
M  V30 53 2 51 53
M  V30 54 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 8 19 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2097444-45-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097444-35-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097445-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34504603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1075198-30-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload
for an Antibody-Drug Conjugate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bendelac, Audrey; Benedetti, Francoise; Doublet-Decabras, Valerie;
Lokovi, Rachel; Decalogne, Francois; Bigot, Antony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(8), 2145-2154

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Phenylmethyl (1S,2S,3R,4R)-3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylate
C15H17NO2
2787516-59-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8911 1.5400 0.0 0
M  V30 2 O 6.2250 2.3101 0.0 0
M  V30 3 O 4.8911 0.0000 0.0 0
M  V30 4 C 7.5586 1.5400 0.0 0
M  V30 5 N 3.5458 4.5302 0.0 0
M  V30 6 C 2.1102 2.6398 0.0 0 CFG=2
M  V30 7 C 3.5575 2.3101 0.0 0 CFG=2
M  V30 8 C 1.3639 5.1600 0.0 0
M  V30 9 C 1.0497 1.7256 0.0 0
M  V30 10 C 2.6801 3.2564 0.0 0 CFG=2
M  V30 11 C 1.4328 3.7410 0.0 0 CFG=2
M  V30 12 C 0.3032 2.6425 0.0 0
M  V30 13 C 8.8923 2.3101 0.0 0
M  V30 14 C 8.8923 3.8501 0.0 0
M  V30 15 C 10.2260 1.5400 0.0 0
M  V30 16 C 10.2260 4.6201 0.0 0
M  V30 17 C 11.5598 2.3101 0.0 0
M  V30 18 C 11.5598 3.8501 0.0 0
M  V30 19 H 2.4818 1.1453 0.0 0
M  V30 20 H 0.0000 4.3056 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 10 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 19 CFG=1
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 2 9 12
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 1 11 20 CFG=3
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[[cis-4-(Ethoxycarbonyl)cyclohexyl]oxy]-4-fluoro-2-methoxybenzoic acid
C17H21FO6
2787516-94-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6687 1.5400 0.0 0
M  V30 2 F 4.0012 0.0000 0.0 0
M  V30 3 C 4.0012 6.1601 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 O 2.6675 6.9302 0.0 0
M  V30 6 O 1.3338 4.6201 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 C 12.0035 4.6201 0.0 0
M  V30 9 O 13.3372 3.8501 0.0 0
M  V30 10 O 12.0035 6.1601 0.0 0
M  V30 11 C 14.6708 4.6201 0.0 0
M  V30 12 C 16.0046 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 8.0023 2.3101 0.0 0 CFG=2
M  V30 20 C 9.3360 1.5400 0.0 0
M  V30 21 C 8.0023 3.8501 0.0 0
M  V30 22 C 10.6698 2.3101 0.0 0
M  V30 23 C 9.3360 4.6201 0.0 0
M  V30 24 C 10.6698 3.8501 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 19 1 CFG=3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 16
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 24 8 CFG=3
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-[[5-[[cis-4-(ethoxycarbonyl)cyc...
C32H36FNO7
3083612-83-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6126 9.3415 0.0 0
M  V30 2 C 5.3826 10.6751 0.0 0
M  V30 3 O 4.6126 12.0089 0.0 0
M  V30 4 C 3.0788 6.6753 0.0 0
M  V30 5 O 2.3128 5.3393 0.0 0
M  V30 6 O 4.6188 6.6801 0.0 0
M  V30 7 C 3.0868 4.0080 0.0 0
M  V30 8 O 6.9226 13.3426 0.0 0
M  V30 9 C 7.6926 14.6762 0.0 0
M  V30 10 O 10.0026 8.0078 0.0 0
M  V30 11 F 11.5426 10.6751 0.0 0
M  V30 12 C 16.1626 8.0078 0.0 0
M  V30 13 O 16.9326 6.6742 0.0 0
M  V30 14 O 16.9326 9.3415 0.0 0
M  V30 15 C 18.4726 6.6742 0.0 0
M  V30 16 C 19.2426 5.3404 0.0 0
M  V30 17 C 3.0726 9.3415 0.0 0 CFG=2
M  V30 18 C 2.3046 8.0066 0.0 0 CFG=1
M  V30 19 C 2.3086 10.6694 0.0 0 CFG=1
M  V30 20 C 0.7728 7.9997 0.0 0 CFG=2
M  V30 21 C 1.1314 9.5700 0.0 0
M  V30 22 C 0.7680 10.6676 0.0 0
M  V30 23 C 0.0000 9.3327 0.0 0
M  V30 24 C 6.9226 10.6751 0.0 0
M  V30 25 C 7.6926 12.0089 0.0 0
M  V30 26 C 7.6926 9.3415 0.0 0
M  V30 27 C 9.2326 12.0089 0.0 0
M  V30 28 C 9.2326 9.3415 0.0 0
M  V30 29 C 10.0026 10.6751 0.0 0
M  V30 30 C 2.3208 2.6721 0.0 0
M  V30 31 C 0.7808 2.6673 0.0 0
M  V30 32 C 3.0949 1.3406 0.0 0
M  V30 33 C 0.0149 1.3313 0.0 0
M  V30 34 C 2.3289 0.0046 0.0 0
M  V30 35 C 0.7889 0.0000 0.0 0
M  V30 36 C 11.5426 8.0078 0.0 0 CFG=2
M  V30 37 C 12.3126 6.6742 0.0 0
M  V30 38 C 12.3126 9.3415 0.0 0
M  V30 39 C 13.8526 6.6742 0.0 0
M  V30 40 C 13.8526 9.3415 0.0 0
M  V30 41 C 14.6226 8.0078 0.0 0 CFG=1
M  V30 42 H 3.0789 12.0029 0.0 0
M  V30 43 H 0.0069 6.6636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 30
M  V30 10 1 8 9
M  V30 11 1 8 25
M  V30 12 1 10 28
M  V30 13 1 36 10 CFG=3
M  V30 14 1 11 29
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 41 12 CFG=3
M  V30 18 1 13 15
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21 CFG=1
M  V30 24 1 19 22
M  V30 25 1 19 42
M  V30 26 1 20 21 CFG=1
M  V30 27 1 20 23
M  V30 28 1 20 43
M  V30 29 2 22 23
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 42 1 36 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 17 18 19 20 36 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2787516-59-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787516-94-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3083612-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39864674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Novel Series of Potent and Selective Relaxin Family
Peptide Receptor 1 (RXFP1) Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Fuchigami, Ryuichi; Niwa,
Yasuki; Fujio, Masakazu; Kato, Harutoshi; Bergstroem, Fredrik; Larsson,
Niklas; Persson, Mikael; Villar, Inmaculada C.; Fujita, Takuya; Sugikawa,
Emiko; Althage, Magnus; Yano, Naoko; Yokoyama, Yoshito; Kimura, Junpei;
Lal, Mark; Mochida, Hideki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4442-4462

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
4-(5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)-α-[4-(trifluorometh...
C23H23F3N4O3S
2892557-04-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 5.3901 0.0 0
M  V30 2 C 9.1467 6.9302 0.0 0
M  V30 3 O 10.4804 7.7002 0.0 0
M  V30 4 O 7.8129 7.7002 0.0 0
M  V30 5 O 14.4816 2.3101 0.0 0
M  V30 6 C 15.8152 3.0801 0.0 0
M  V30 7 F 15.8152 4.6201 0.0 0
M  V30 8 F 17.1489 3.8501 0.0 0
M  V30 9 F 17.1489 2.3101 0.0 0
M  V30 10 C 2.4781 3.0801 0.0 0
M  V30 11 C 2.1579 4.5864 0.0 0
M  V30 12 C 3.8119 2.3101 0.0 0
M  V30 13 C 1.1444 2.3101 0.0 0
M  V30 14 C 0.6263 4.7475 0.0 0
M  V30 15 C 3.0631 5.8324 0.0 0
M  V30 16 N 3.8119 0.7700 0.0 0
M  V30 17 S 0.0000 3.3405 0.0 0
M  V30 18 N 1.1444 0.7700 0.0 0
M  V30 19 C 0.0000 6.1543 0.0 0
M  V30 20 C 2.4368 7.2392 0.0 0
M  V30 21 C 2.4781 0.0000 0.0 0
M  V30 22 C 0.9052 7.4002 0.0 0
M  V30 23 N 5.1456 3.0801 0.0 0
M  V30 24 C 6.4792 2.3101 0.0 0
M  V30 25 C 5.1456 4.6201 0.0 0
M  V30 26 C 7.8129 3.0801 0.0 0
M  V30 27 C 6.4792 5.3901 0.0 0
M  V30 28 N 7.8129 4.6201 0.0 0
M  V30 29 C 10.4804 4.6201 0.0 0
M  V30 30 C 10.4804 3.0801 0.0 0
M  V30 31 C 11.8141 5.3901 0.0 0
M  V30 32 C 11.8141 2.3101 0.0 0
M  V30 33 C 13.1477 4.6201 0.0 0
M  V30 34 C 13.1477 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 6
M  V30 7 1 5 34
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 23
M  V30 18 1 13 17
M  V30 19 2 13 18
M  V30 20 1 14 17
M  V30 21 1 14 19
M  V30 22 1 15 20
M  V30 23 2 16 21
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)...
C30H30F3N5O3S
2892557-12-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 8.4702 0.0 0
M  V30 2 C 9.3360 9.2402 0.0 0
M  V30 3 N 10.6697 8.4702 0.0 0
M  V30 4 O 9.3360 10.7802 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 6.6687 1.5400 0.0 0
M  V30 7 F 6.6687 0.0000 0.0 0
M  V30 8 F 5.3348 0.7700 0.0 0
M  V30 9 F 5.3348 2.3101 0.0 0
M  V30 10 O 16.0045 11.5503 0.0 0
M  V30 11 C 17.3383 10.7802 0.0 0
M  V30 12 C 2.6675 13.0903 0.0 0
M  V30 13 C 2.6675 11.5503 0.0 0
M  V30 14 C 3.8119 14.1207 0.0 0
M  V30 15 C 1.3338 13.8603 0.0 0
M  V30 16 N 1.3338 10.7802 0.0 0
M  V30 17 C 3.1856 15.5275 0.0 0
M  V30 18 C 5.3436 13.9598 0.0 0
M  V30 19 S 1.6540 15.3666 0.0 0
M  V30 20 N 0.0000 13.0903 0.0 0
M  V30 21 C 0.0000 11.5503 0.0 0
M  V30 22 C 4.0908 16.7734 0.0 0
M  V30 23 C 6.2487 15.2057 0.0 0
M  V30 24 C 5.6224 16.6125 0.0 0
M  V30 25 N 4.0012 10.7802 0.0 0
M  V30 26 C 5.3348 11.5503 0.0 0
M  V30 27 C 4.0012 9.2402 0.0 0
M  V30 28 C 6.6687 10.7802 0.0 0
M  V30 29 C 5.3348 8.4702 0.0 0
M  V30 30 N 6.6687 9.2402 0.0 0
M  V30 31 C 8.0023 6.9302 0.0 0
M  V30 32 C 9.3360 6.1601 0.0 0
M  V30 33 C 6.6687 6.1601 0.0 0
M  V30 34 C 9.3360 4.6201 0.0 0
M  V30 35 C 6.6687 4.6201 0.0 0
M  V30 36 C 8.0023 3.8501 0.0 0
M  V30 37 C 12.0035 9.2402 0.0 0
M  V30 38 C 13.3372 8.4702 0.0 0
M  V30 39 C 12.0035 10.7802 0.0 0
M  V30 40 C 14.6708 9.2402 0.0 0
M  V30 41 C 13.3372 11.5503 0.0 0
M  V30 42 C 14.6708 10.7802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 1 31
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 37
M  V30 7 1 5 6
M  V30 8 1 5 36
M  V30 9 1 6 7
M  V30 10 1 6 8
M  V30 11 1 6 9
M  V30 12 1 10 11
M  V30 13 1 10 42
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 25
M  V30 19 2 14 17
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 2 15 20
M  V30 23 2 16 21
M  V30 24 1 17 19
M  V30 25 1 17 22
M  V30 26 1 18 23
M  V30 27 1 20 21
M  V30 28 1 22 24
M  V30 29 1 23 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-04-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
9H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(3,4-dimethoxyphenyl)-
C20H16N2O4
859124-22-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 7.4001 0.0 0
M  V30 2 O 1.3337 8.9401 0.0 0
M  V30 3 O 0.0000 6.6301 0.0 0
M  V30 4 O 8.0021 11.2502 0.0 0
M  V30 5 C 6.6684 12.0202 0.0 0
M  V30 6 O 10.6696 9.7101 0.0 0
M  V30 7 C 12.0032 8.9401 0.0 0
M  V30 8 C 5.3348 5.0901 0.0 0
M  V30 9 C 4.0011 4.3201 0.0 0
M  V30 10 C 5.3348 6.6301 0.0 0
M  V30 11 N 6.4792 4.0597 0.0 0
M  V30 12 C 4.3213 2.8138 0.0 0
M  V30 13 C 2.6673 5.0901 0.0 0
M  V30 14 N 4.0011 7.4001 0.0 0
M  V30 15 C 5.8529 2.6527 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 2.6673 6.6301 0.0 0
M  V30 18 C 6.4792 1.2459 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5740 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 6.6684 8.9401 0.0 0
M  V30 23 C 8.0021 6.6301 0.0 0
M  V30 24 C 8.0021 9.7101 0.0 0
M  V30 25 C 9.3359 7.4001 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 6 7
M  V30 7 1 6 26
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 21
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-([1,4′-Bipiperidin]-1′-ylmethyl)benzenamine
C17H27N3
1307702-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 N 6.6685 4.6201 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, N-[4-([1,4′-bipiperidin]-1′-ylmethyl)ph...
C37H41N5O3
3002420-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 7.4001 0.0 0
M  V30 2 N 12.0032 6.6301 0.0 0
M  V30 3 O 10.6696 8.9401 0.0 0
M  V30 4 O 4.0010 11.2502 0.0 0
M  V30 5 C 5.3348 12.0202 0.0 0
M  V30 6 O 1.3337 9.7101 0.0 0
M  V30 7 C 0.0000 8.9401 0.0 0
M  V30 8 C 17.3380 9.7101 0.0 0
M  V30 9 C 6.6684 5.0901 0.0 0
M  V30 10 C 8.0021 4.3201 0.0 0
M  V30 11 C 6.6684 6.6301 0.0 0
M  V30 12 N 5.5239 4.0597 0.0 0
M  V30 13 C 7.6819 2.8138 0.0 0
M  V30 14 C 9.3358 5.0901 0.0 0
M  V30 15 N 8.0021 7.4001 0.0 0
M  V30 16 C 6.1504 2.6527 0.0 0
M  V30 17 C 8.5872 1.5679 0.0 0
M  V30 18 C 9.3358 6.6301 0.0 0
M  V30 19 C 5.5239 1.2459 0.0 0
M  V30 20 C 7.9607 0.1609 0.0 0
M  V30 21 C 6.4291 0.0000 0.0 0
M  V30 22 C 5.3348 7.4001 0.0 0
M  V30 23 C 5.3348 8.9401 0.0 0
M  V30 24 C 4.0010 6.6301 0.0 0
M  V30 25 C 4.0010 9.7101 0.0 0
M  V30 26 C 2.6673 7.4001 0.0 0
M  V30 27 C 2.6673 8.9401 0.0 0
M  V30 28 C 13.3369 7.4001 0.0 0
M  V30 29 C 14.6706 6.6301 0.0 0
M  V30 30 C 13.3369 8.9401 0.0 0
M  V30 31 C 16.0044 7.4001 0.0 0
M  V30 32 C 14.6706 9.7101 0.0 0
M  V30 33 C 16.0044 8.9401 0.0 0
M  V30 34 N 18.6717 8.9401 0.0 0
M  V30 35 C 20.0053 9.7101 0.0 0
M  V30 36 C 18.6717 7.4001 0.0 0
M  V30 37 C 21.3392 8.9401 0.0 0
M  V30 38 C 20.0053 6.6301 0.0 0
M  V30 39 C 21.3392 7.4001 0.0 0
M  V30 40 N 22.6728 6.6301 0.0 0
M  V30 41 C 24.0065 7.4001 0.0 0
M  V30 42 C 22.6728 5.0901 0.0 0
M  V30 43 C 25.3401 6.6301 0.0 0
M  V30 44 C 24.0065 4.3201 0.0 0
M  V30 45 C 25.3401 5.0901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 1 8 33
M  V30 10 1 8 34
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 11 22
M  V30 18 1 12 16
M  V30 19 1 13 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 2 15 18
M  V30 23 2 16 19
M  V30 24 1 17 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 859124-22-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1307702-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3002420-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38589178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the
Treatment of Cystic Echinococcosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu,
Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan,
Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16680-16693

$RFMT $RIREG SCHEME375 STEP1
$RXN



  1  1
$MOL
2-[(2-Amino-4-chlorophenyl)amino]-5-fluorobenzoic acid
C13H10ClFN2O2
2241432-77-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 O 2.3100 6.6685 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 N 6.1600 8.0021 0.0 0
M  V30 7 Cl 10.7800 5.3347 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 2.3100 1.3336 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 9
M  V30 6 1 5 13
M  V30 7 1 6 15
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Chloro-2-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one
C13H8ClFN2O
2241432-78-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.8625 0.0000 0.0 0
M  V30 2 F 0.0000 1.6916 0.0 0
M  V30 3 Cl 11.3136 4.2739 0.0 0
M  V30 4 C 4.0011 4.0016 0.0 0
M  V30 5 C 4.0011 2.4616 0.0 0
M  V30 6 N 5.2051 4.9618 0.0 0
M  V30 7 C 2.6673 4.7716 0.0 0
M  V30 8 C 5.2051 1.5014 0.0 0
M  V30 9 C 2.6673 1.6916 0.0 0
M  V30 10 C 6.7065 4.6191 0.0 0
M  V30 11 C 1.3337 4.0016 0.0 0
M  V30 12 N 6.7065 1.8440 0.0 0
M  V30 13 C 1.3337 2.4616 0.0 0
M  V30 14 C 7.3747 3.2316 0.0 0
M  V30 15 C 7.5740 5.8915 0.0 0
M  V30 16 C 8.9104 3.1165 0.0 0
M  V30 17 C 9.1097 5.7765 0.0 0
M  V30 18 C 9.7779 4.3889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 13
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2241432-77-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241432-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25109422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of
2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine
with clozapine-like mixed activities at muscarinic acetylcholine,
dopamine, and serotonin receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Watanabe, Hitoshi; Ishida, Kyoji; Yamamoto, Masanori; Nakako, Tomokazu;
Horiguchi, Masakuni; Isobe, Yoshiaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 40127911

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
1-Cyclopropyl-1H-imidazole-4-carboxylic acid
C7H8N2O2
1368466-66-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4894 1.5317 0.0 0
M  V30 2 O 6.3283 0.0000 0.0 0
M  V30 3 O 7.8962 2.1580 0.0 0
M  V30 4 N 2.8736 3.2067 0.0 0
M  V30 5 C 3.7789 1.9609 0.0 0
M  V30 6 C 3.7789 4.4528 0.0 0
M  V30 7 C 5.2435 2.4367 0.0 0
M  V30 8 N 5.2435 3.9767 0.0 0
M  V30 9 C 1.3336 3.2067 0.0 0
M  V30 10 C 0.0000 3.9767 0.0 0
M  V30 11 C 0.0000 2.4367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[3-(3-aminophenyl)-4-(4-pyridinyl)-1H-pyrazol...
C23H27N5O2
3055872-81-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 8.3071 0.0 0
M  V30 2 C 12.1457 8.0850 0.0 0
M  V30 3 O 12.9157 9.4186 0.0 0
M  V30 4 O 12.9157 6.7512 0.0 0
M  V30 5 C 14.4557 9.4186 0.0 0
M  V30 6 C 14.4557 10.9586 0.0 0
M  V30 7 C 15.9957 9.4186 0.0 0
M  V30 8 C 14.4557 7.8786 0.0 0
M  V30 9 C 4.6200 5.6398 0.0 0
M  V30 10 C 5.5252 4.3939 0.0 0
M  V30 11 N 5.5252 6.8856 0.0 0
M  V30 12 C 6.9899 4.8698 0.0 0
M  V30 13 N 6.9899 6.4098 0.0 0
M  V30 14 C 3.0800 5.6398 0.0 0
M  V30 15 C 2.3100 6.9734 0.0 0
M  V30 16 C 2.3100 4.3061 0.0 0
M  V30 17 C 0.7700 6.9734 0.0 0
M  V30 18 C 0.7700 4.3061 0.0 0
M  V30 19 C 0.0000 5.6398 0.0 0
M  V30 20 C 5.0494 2.9292 0.0 0
M  V30 21 C 6.0798 1.7849 0.0 0
M  V30 22 C 3.5431 2.6091 0.0 0
M  V30 23 C 5.6039 0.3202 0.0 0
M  V30 24 C 3.0672 1.1444 0.0 0
M  V30 25 N 4.0976 0.0000 0.0 0
M  V30 26 C 8.2358 7.3150 0.0 0 CFG=1
M  V30 27 C 9.7005 6.8391 0.0 0
M  V30 28 C 8.2358 8.8550 0.0 0
M  V30 29 N 10.6057 8.0850 0.0 0
M  V30 30 C 9.7005 9.3309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 29
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 26 13 CFG=1
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[3-[3-[[(1-cyclopropyl-1H-imidazol-4-yl)carbo...
C30H33N7O3
3055872-93-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.1002 8.3071 0.0 0
M  V30 2 C 5.5602 8.3071 0.0 0
M  V30 3 O 4.7902 6.9735 0.0 0
M  V30 4 C 19.2458 8.0849 0.0 0
M  V30 5 O 20.0158 9.4185 0.0 0
M  V30 6 O 20.0158 6.7512 0.0 0
M  V30 7 C 21.5558 9.4185 0.0 0
M  V30 8 C 21.5558 10.9585 0.0 0
M  V30 9 C 23.0958 9.4185 0.0 0
M  V30 10 C 21.5558 7.8785 0.0 0
M  V30 11 C 11.7202 5.6397 0.0 0
M  V30 12 C 12.6254 4.3938 0.0 0
M  V30 13 N 12.6254 6.8857 0.0 0
M  V30 14 C 14.0900 4.8697 0.0 0
M  V30 15 N 14.0900 6.4097 0.0 0
M  V30 16 C 10.1802 5.6397 0.0 0
M  V30 17 C 9.4102 6.9735 0.0 0
M  V30 18 C 9.4102 4.3060 0.0 0
M  V30 19 C 7.8702 6.9735 0.0 0
M  V30 20 C 7.8702 4.3060 0.0 0
M  V30 21 C 7.1002 5.6397 0.0 0
M  V30 22 C 12.1496 2.9292 0.0 0
M  V30 23 C 10.6431 2.6091 0.0 0
M  V30 24 C 13.1800 1.7847 0.0 0
M  V30 25 C 10.1673 1.1444 0.0 0
M  V30 26 C 12.7041 0.3202 0.0 0
M  V30 27 N 11.1977 0.0000 0.0 0
M  V30 28 C 15.3360 7.3149 0.0 0 CFG=1
M  V30 29 C 16.8006 6.8390 0.0 0
M  V30 30 C 15.3360 8.8549 0.0 0
M  V30 31 N 17.7058 8.0849 0.0 0
M  V30 32 C 16.8006 9.3308 0.0 0
M  V30 33 C 4.7902 9.6408 0.0 0
M  V30 34 C 3.2587 9.8017 0.0 0
M  V30 35 N 5.4165 11.0477 0.0 0
M  V30 36 N 2.9385 11.3081 0.0 0
M  V30 37 C 4.2721 12.0781 0.0 0
M  V30 38 C 1.5315 11.9344 0.0 0
M  V30 39 C 0.0000 11.7735 0.0 0
M  V30 40 C 0.6263 13.1803 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 1 2 33
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 31
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 16
M  V30 15 2 12 14
M  V30 16 1 12 22
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 28 15 CFG=1
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1368466-66-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3055872-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055872-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40922535
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of Potent, Efficacious and Selective
Inhibitors Targeting EGFR Exon20 Insertion Mutations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomson, Clare; Barton, Peter; Braybrooke, Erin; Colclough, Nicola; Dong,
Zhiqiang; Evans, Laura; Floch, Nicolas; Guerot, Carine; Hargreaves,
David; Khurana, Puneet; Li, Songlei; Li, Xiuwei; Lister, Andrew; McCoull,
William; McWilliams, Lisa; Orme, Jonathan P.; Packer, Martin J.; Swaih,
Aisha M.; Ward, Richard A.; Winlow, Poppy; Ye, Yang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8988-9027

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
α-(3,4-Difluorophenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-...
C22H22F2N4O2S
2892557-02-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 5.3901 0.0 0
M  V30 2 C 9.1467 6.9302 0.0 0
M  V30 3 O 7.8131 7.7002 0.0 0
M  V30 4 O 10.4804 7.7002 0.0 0
M  V30 5 F 14.4816 5.3901 0.0 0
M  V30 6 F 14.4816 2.3101 0.0 0
M  V30 7 C 2.4782 3.0801 0.0 0
M  V30 8 C 3.8119 2.3101 0.0 0
M  V30 9 C 2.1580 4.5864 0.0 0
M  V30 10 C 1.1444 2.3101 0.0 0
M  V30 11 N 3.8119 0.7700 0.0 0
M  V30 12 C 0.6263 4.7475 0.0 0
M  V30 13 C 3.0631 5.8324 0.0 0
M  V30 14 S 0.0000 3.3405 0.0 0
M  V30 15 N 1.1444 0.7700 0.0 0
M  V30 16 C 2.4782 0.0000 0.0 0
M  V30 17 C 0.0000 6.1543 0.0 0
M  V30 18 C 2.4368 7.2392 0.0 0
M  V30 19 C 0.9052 7.4002 0.0 0
M  V30 20 N 5.1456 3.0801 0.0 0
M  V30 21 C 6.4792 2.3101 0.0 0
M  V30 22 C 5.1456 4.6201 0.0 0
M  V30 23 C 7.8131 3.0801 0.0 0
M  V30 24 C 6.4792 5.3901 0.0 0
M  V30 25 N 7.8131 4.6201 0.0 0
M  V30 26 C 10.4804 4.6201 0.0 0
M  V30 27 C 11.8141 5.3901 0.0 0
M  V30 28 C 10.4804 3.0801 0.0 0
M  V30 29 C 13.1479 4.6201 0.0 0
M  V30 30 C 11.8141 2.3101 0.0 0
M  V30 31 C 13.1479 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 29
M  V30 7 1 6 31
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 20
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 12 14
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 15 16
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3,4-Difluorophenyl)-N-(4-methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothien...
C29H29F2N5O2S
2892557-10-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.1601 0.0 0
M  V30 2 C 9.3360 6.9302 0.0 0
M  V30 3 N 10.6697 6.1601 0.0 0
M  V30 4 O 9.3360 8.4702 0.0 0
M  V30 5 F 5.3348 1.5400 0.0 0
M  V30 6 F 8.0023 0.0000 0.0 0
M  V30 7 O 16.0045 9.2402 0.0 0
M  V30 8 C 17.3383 8.4702 0.0 0
M  V30 9 C 2.6675 10.7802 0.0 0
M  V30 10 C 2.6675 9.2402 0.0 0
M  V30 11 C 3.8119 11.8107 0.0 0
M  V30 12 C 1.3338 11.5503 0.0 0
M  V30 13 N 1.3338 8.4702 0.0 0
M  V30 14 C 3.1856 13.2175 0.0 0
M  V30 15 C 5.3436 11.6497 0.0 0
M  V30 16 S 1.6540 13.0566 0.0 0
M  V30 17 N 0.0000 10.7802 0.0 0
M  V30 18 C 0.0000 9.2402 0.0 0
M  V30 19 C 4.0908 14.4634 0.0 0
M  V30 20 C 6.2487 12.8956 0.0 0
M  V30 21 C 5.6224 14.3024 0.0 0
M  V30 22 N 4.0012 8.4702 0.0 0
M  V30 23 C 5.3348 9.2402 0.0 0
M  V30 24 C 4.0012 6.9302 0.0 0
M  V30 25 C 6.6687 8.4702 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 N 6.6687 6.9302 0.0 0
M  V30 28 C 8.0023 4.6201 0.0 0
M  V30 29 C 6.6687 3.8501 0.0 0
M  V30 30 C 9.3360 3.8501 0.0 0
M  V30 31 C 6.6687 2.3101 0.0 0
M  V30 32 C 9.3360 2.3101 0.0 0
M  V30 33 C 8.0023 1.5400 0.0 0
M  V30 34 C 12.0035 6.9302 0.0 0
M  V30 35 C 12.0035 8.4702 0.0 0
M  V30 36 C 13.3372 6.1601 0.0 0
M  V30 37 C 13.3372 9.2402 0.0 0
M  V30 38 C 14.6708 6.9302 0.0 0
M  V30 39 C 14.6708 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 1 28
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 34
M  V30 7 1 5 31
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 7 39
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 22
M  V30 16 2 11 14
M  V30 17 1 11 15
M  V30 18 1 12 16
M  V30 19 2 12 17
M  V30 20 2 13 18
M  V30 21 1 14 16
M  V30 22 1 14 19
M  V30 23 1 15 20
M  V30 24 1 17 18
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-02-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
α-(3,4-Dichlorophenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-...
C22H22Cl2N4O2S
2892557-03-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 5.3901 0.0 0
M  V30 2 C 9.1467 6.9302 0.0 0
M  V30 3 O 7.8131 7.7002 0.0 0
M  V30 4 O 10.4804 7.7002 0.0 0
M  V30 5 Cl 14.4816 5.3901 0.0 0
M  V30 6 Cl 14.4816 2.3101 0.0 0
M  V30 7 C 2.4782 3.0801 0.0 0
M  V30 8 C 3.8119 2.3101 0.0 0
M  V30 9 C 2.1580 4.5864 0.0 0
M  V30 10 C 1.1444 2.3101 0.0 0
M  V30 11 N 3.8119 0.7700 0.0 0
M  V30 12 C 0.6263 4.7475 0.0 0
M  V30 13 C 3.0631 5.8324 0.0 0
M  V30 14 S 0.0000 3.3405 0.0 0
M  V30 15 N 1.1444 0.7700 0.0 0
M  V30 16 C 2.4782 0.0000 0.0 0
M  V30 17 C 0.0000 6.1543 0.0 0
M  V30 18 C 2.4368 7.2392 0.0 0
M  V30 19 C 0.9052 7.4002 0.0 0
M  V30 20 N 5.1456 3.0801 0.0 0
M  V30 21 C 6.4792 2.3101 0.0 0
M  V30 22 C 5.1456 4.6201 0.0 0
M  V30 23 C 7.8131 3.0801 0.0 0
M  V30 24 C 6.4792 5.3901 0.0 0
M  V30 25 N 7.8131 4.6201 0.0 0
M  V30 26 C 10.4804 4.6201 0.0 0
M  V30 27 C 11.8141 5.3901 0.0 0
M  V30 28 C 10.4804 3.0801 0.0 0
M  V30 29 C 13.1479 4.6201 0.0 0
M  V30 30 C 11.8141 2.3101 0.0 0
M  V30 31 C 13.1479 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 29
M  V30 7 1 6 31
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 20
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 12 14
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 15 16
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3,4-Dichlorophenyl)-N-(4-methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzothien...
C29H29Cl2N5O2S
2892557-11-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.1601 0.0 0
M  V30 2 C 9.3360 6.9302 0.0 0
M  V30 3 N 10.6697 6.1601 0.0 0
M  V30 4 O 9.3360 8.4702 0.0 0
M  V30 5 Cl 5.3348 1.5400 0.0 0
M  V30 6 Cl 8.0023 0.0000 0.0 0
M  V30 7 O 16.0045 9.2402 0.0 0
M  V30 8 C 17.3383 8.4702 0.0 0
M  V30 9 C 2.6675 10.7802 0.0 0
M  V30 10 C 2.6675 9.2402 0.0 0
M  V30 11 C 3.8119 11.8107 0.0 0
M  V30 12 C 1.3338 11.5503 0.0 0
M  V30 13 N 1.3338 8.4702 0.0 0
M  V30 14 C 3.1856 13.2175 0.0 0
M  V30 15 C 5.3436 11.6497 0.0 0
M  V30 16 S 1.6540 13.0566 0.0 0
M  V30 17 N 0.0000 10.7802 0.0 0
M  V30 18 C 0.0000 9.2402 0.0 0
M  V30 19 C 4.0908 14.4634 0.0 0
M  V30 20 C 6.2487 12.8956 0.0 0
M  V30 21 C 5.6224 14.3024 0.0 0
M  V30 22 N 4.0012 8.4702 0.0 0
M  V30 23 C 5.3348 9.2402 0.0 0
M  V30 24 C 4.0012 6.9302 0.0 0
M  V30 25 C 6.6687 8.4702 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 N 6.6687 6.9302 0.0 0
M  V30 28 C 8.0023 4.6201 0.0 0
M  V30 29 C 6.6687 3.8501 0.0 0
M  V30 30 C 9.3360 3.8501 0.0 0
M  V30 31 C 6.6687 2.3101 0.0 0
M  V30 32 C 9.3360 2.3101 0.0 0
M  V30 33 C 8.0023 1.5400 0.0 0
M  V30 34 C 12.0035 6.9302 0.0 0
M  V30 35 C 12.0035 8.4702 0.0 0
M  V30 36 C 13.3372 6.1601 0.0 0
M  V30 37 C 13.3372 9.2402 0.0 0
M  V30 38 C 14.6708 6.9302 0.0 0
M  V30 39 C 14.6708 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 1 28
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 34
M  V30 7 1 5 31
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 7 39
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 22
M  V30 16 2 11 14
M  V30 17 1 11 15
M  V30 18 1 12 16
M  V30 19 2 12 17
M  V30 20 2 13 18
M  V30 21 1 14 16
M  V30 22 1 14 19
M  V30 23 1 15 20
M  V30 24 1 17 18
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-03-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Cyclopropanamine, 1-(2-pyrimidinyl)-, hydrochloride (1:2)
C7H9N3.2ClH
1159734-42-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.8875 1.5400 0.0 0
M  V30 2 C 4.6201 3.0566 0.0 0
M  V30 3 C 6.0671 3.5833 0.0 0
M  V30 4 C 4.8875 4.5733 0.0 0
M  V30 5 C 3.0801 3.0566 0.0 0
M  V30 6 N 2.3101 1.7230 0.0 0
M  V30 7 N 2.3101 4.3903 0.0 0
M  V30 8 C 0.7700 1.7230 0.0 0
M  V30 9 C 0.7700 4.3903 0.0 0
M  V30 10 C 0.0000 3.0566 0.0 0
M  V30 11 Cl 3.0336 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-Fluoro-2-(4-fluorophenyl)-3-[(methylamino)carbonyl]-5-benzofuranyl]-4-me...
C24H17F2NO4
1217340-23-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1802 2.5368 0.0 0
M  V30 2 N 10.3248 1.5063 0.0 0
M  V30 3 O 7.7157 2.0608 0.0 0
M  V30 4 C 10.0046 0.0000 0.0 0
M  V30 5 F 6.1600 3.8538 0.0 0
M  V30 6 C 4.6200 9.1886 0.0 0
M  V30 7 C 1.5400 3.8538 0.0 0
M  V30 8 O 0.0000 3.8538 0.0 0
M  V30 9 O 2.3100 2.5202 0.0 0
M  V30 10 F 16.2421 1.5894 0.0 0
M  V30 11 C 8.4700 5.1875 0.0 0
M  V30 12 C 9.5004 4.0431 0.0 0
M  V30 13 C 9.2400 6.5213 0.0 0
M  V30 14 C 6.9300 5.1875 0.0 0
M  V30 15 C 10.9074 4.6694 0.0 0
M  V30 16 O 10.7464 6.2011 0.0 0
M  V30 17 C 8.4700 7.8549 0.0 0
M  V30 18 C 6.1600 6.5213 0.0 0
M  V30 19 C 6.9300 7.8549 0.0 0
M  V30 20 C 12.2410 3.8994 0.0 0
M  V30 21 C 13.5746 4.6694 0.0 0
M  V30 22 C 12.2410 2.3594 0.0 0
M  V30 23 C 14.9084 3.8994 0.0 0
M  V30 24 C 13.5746 1.5894 0.0 0
M  V30 25 C 14.9084 2.3594 0.0 0
M  V30 26 C 4.6200 6.5213 0.0 0
M  V30 27 C 3.8500 5.1875 0.0 0
M  V30 28 C 3.8500 7.8549 0.0 0
M  V30 29 C 2.3100 5.1875 0.0 0
M  V30 30 C 2.3100 7.8549 0.0 0
M  V30 31 C 1.5400 6.5213 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 28
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 29
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 18 26
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-2-(4-fluorophenyl)-N-methyl-5-[2-methyl-5-[[[1-(2-pyrimidinyl)cyclop...
C31H24F2N4O3
1217338-97-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1114 5.3347 0.0 0
M  V30 2 C 6.6514 5.3347 0.0 0
M  V30 3 O 7.4214 6.6684 0.0 0
M  V30 4 C 9.7314 0.0000 0.0 0
M  V30 5 F 11.2714 5.3347 0.0 0
M  V30 6 C 14.2917 6.6517 0.0 0
M  V30 7 N 15.4360 7.6823 0.0 0
M  V30 8 O 12.8270 7.1277 0.0 0
M  V30 9 C 15.1159 9.1886 0.0 0
M  V30 10 F 21.3533 7.5991 0.0 0
M  V30 11 C 4.3413 6.6684 0.0 0
M  V30 12 C 5.5211 7.6583 0.0 0
M  V30 13 C 4.0739 8.1849 0.0 0
M  V30 14 C 2.8943 6.1417 0.0 0
M  V30 15 N 1.7145 7.1316 0.0 0
M  V30 16 N 2.6268 4.6251 0.0 0
M  V30 17 C 0.2673 6.6048 0.0 0
M  V30 18 C 1.1796 4.0984 0.0 0
M  V30 19 C 0.0000 5.0882 0.0 0
M  V30 20 C 7.4214 4.0011 0.0 0
M  V30 21 C 8.9614 4.0011 0.0 0
M  V30 22 C 6.6514 2.6673 0.0 0
M  V30 23 C 9.7314 2.6673 0.0 0
M  V30 24 C 7.4214 1.3336 0.0 0
M  V30 25 C 8.9614 1.3336 0.0 0
M  V30 26 C 11.2714 2.6673 0.0 0
M  V30 27 C 12.0414 4.0011 0.0 0
M  V30 28 C 12.0414 1.3336 0.0 0
M  V30 29 C 13.5814 4.0011 0.0 0
M  V30 30 C 13.5814 1.3336 0.0 0
M  V30 31 C 14.6118 5.1454 0.0 0
M  V30 32 C 14.3514 2.6673 0.0 0
M  V30 33 C 16.0186 4.5191 0.0 0
M  V30 34 O 15.8577 2.9874 0.0 0
M  V30 35 C 17.3524 5.2891 0.0 0
M  V30 36 C 18.6861 4.5191 0.0 0
M  V30 37 C 17.3524 6.8291 0.0 0
M  V30 38 C 20.0197 5.2891 0.0 0
M  V30 39 C 18.6861 7.5991 0.0 0
M  V30 40 C 20.0197 6.8291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 25
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 31
M  V30 10 1 7 9
M  V30 11 1 10 40
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 23 26
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1159734-42-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1217340-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217338-97-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22513060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of
HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized
Benzofuran through a Telescoped Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Daniel; Krishnananthan, Subramaniam; Meanwell, Nicholas A.;
Mathur, Arvind; Li, Jianqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2020), 24(6), 1157-1163

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
α-(3-Chloro-4-fluorophenyl)-4-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimid...
C22H22ClFN4O2S
2892557-05-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1467 5.3901 0.0 0
M  V30 2 C 9.1467 6.9302 0.0 0
M  V30 3 O 7.8131 7.7002 0.0 0
M  V30 4 O 10.4804 7.7002 0.0 0
M  V30 5 Cl 14.4816 5.3901 0.0 0
M  V30 6 F 14.4816 2.3101 0.0 0
M  V30 7 C 2.4782 3.0801 0.0 0
M  V30 8 C 3.8119 2.3101 0.0 0
M  V30 9 C 2.1580 4.5864 0.0 0
M  V30 10 C 1.1444 2.3101 0.0 0
M  V30 11 N 3.8119 0.7700 0.0 0
M  V30 12 C 0.6263 4.7475 0.0 0
M  V30 13 C 3.0631 5.8324 0.0 0
M  V30 14 S 0.0000 3.3405 0.0 0
M  V30 15 N 1.1444 0.7700 0.0 0
M  V30 16 C 2.4782 0.0000 0.0 0
M  V30 17 C 0.0000 6.1543 0.0 0
M  V30 18 C 2.4368 7.2392 0.0 0
M  V30 19 C 0.9052 7.4002 0.0 0
M  V30 20 N 5.1456 3.0801 0.0 0
M  V30 21 C 6.4792 2.3101 0.0 0
M  V30 22 C 5.1456 4.6201 0.0 0
M  V30 23 C 7.8131 3.0801 0.0 0
M  V30 24 C 6.4792 5.3901 0.0 0
M  V30 25 N 7.8131 4.6201 0.0 0
M  V30 26 C 10.4804 4.6201 0.0 0
M  V30 27 C 11.8141 5.3901 0.0 0
M  V30 28 C 10.4804 3.0801 0.0 0
M  V30 29 C 13.1479 4.6201 0.0 0
M  V30 30 C 11.8141 2.3101 0.0 0
M  V30 31 C 13.1479 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 5 29
M  V30 7 1 6 31
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 20
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 12 14
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 15 16
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3-Chloro-4-fluorophenyl)-N-(4-methoxyphenyl)-4-(5,6,7,8-tetrahydro[1]benzo...
C29H29ClFN5O2S
2892557-13-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.1601 0.0 0
M  V30 2 C 9.3360 6.9302 0.0 0
M  V30 3 N 10.6697 6.1601 0.0 0
M  V30 4 O 9.3360 8.4702 0.0 0
M  V30 5 Cl 5.3348 1.5400 0.0 0
M  V30 6 F 8.0023 0.0000 0.0 0
M  V30 7 O 16.0045 9.2402 0.0 0
M  V30 8 C 17.3383 8.4702 0.0 0
M  V30 9 C 2.6675 10.7802 0.0 0
M  V30 10 C 2.6675 9.2402 0.0 0
M  V30 11 C 3.8119 11.8107 0.0 0
M  V30 12 C 1.3338 11.5503 0.0 0
M  V30 13 N 1.3338 8.4702 0.0 0
M  V30 14 C 3.1856 13.2175 0.0 0
M  V30 15 C 5.3436 11.6497 0.0 0
M  V30 16 S 1.6540 13.0566 0.0 0
M  V30 17 N 0.0000 10.7802 0.0 0
M  V30 18 C 0.0000 9.2402 0.0 0
M  V30 19 C 4.0908 14.4634 0.0 0
M  V30 20 C 6.2487 12.8956 0.0 0
M  V30 21 C 5.6224 14.3024 0.0 0
M  V30 22 N 4.0012 8.4702 0.0 0
M  V30 23 C 5.3348 9.2402 0.0 0
M  V30 24 C 4.0012 6.9302 0.0 0
M  V30 25 C 6.6687 8.4702 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 N 6.6687 6.9302 0.0 0
M  V30 28 C 8.0023 4.6201 0.0 0
M  V30 29 C 6.6687 3.8501 0.0 0
M  V30 30 C 9.3360 3.8501 0.0 0
M  V30 31 C 6.6687 2.3101 0.0 0
M  V30 32 C 9.3360 2.3101 0.0 0
M  V30 33 C 8.0023 1.5400 0.0 0
M  V30 34 C 12.0035 6.9302 0.0 0
M  V30 35 C 12.0035 8.4702 0.0 0
M  V30 36 C 13.3372 6.1601 0.0 0
M  V30 37 C 13.3372 9.2402 0.0 0
M  V30 38 C 14.6708 6.9302 0.0 0
M  V30 39 C 14.6708 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 1 28
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 34
M  V30 7 1 5 31
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 7 39
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 22
M  V30 16 2 11 14
M  V30 17 1 11 15
M  V30 18 1 12 16
M  V30 19 2 12 17
M  V30 20 2 13 18
M  V30 21 1 14 16
M  V30 22 1 14 19
M  V30 23 1 15 20
M  V30 24 1 17 18
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2892557-05-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892557-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35297624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification, in-vitro anti-plasmodial assessment and docking studies
of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular
hybrids as potential antimalarial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Kavita; Raza, Kausar Md; Legac, Jenny; Rahman, Abdur; Manzoor,
Shoaib; Bhattacharjee, Souvik; Rosenthal, Philip J.; Hoda, Nasimul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115055

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
5-(2,4-Difluorophenoxy)-1-(2-methylpropyl)-1H-indazole-6-carboxylic acid
C18H16F2N2O3
765914-40-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.9869 5.3304 0.0 0
M  V30 2 C 13.0173 6.4749 0.0 0
M  V30 3 C 12.5414 7.9395 0.0 0
M  V30 4 C 14.5238 6.1546 0.0 0
M  V30 5 C 8.0023 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 7 O 9.3360 0.0000 0.0 0
M  V30 8 O 5.3348 2.3101 0.0 0
M  V30 9 F 2.6675 0.7700 0.0 0
M  V30 10 F 0.0000 5.3901 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 8.0023 5.3901 0.0 0
M  V30 13 N 10.4804 5.6505 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 6.6687 4.6201 0.0 0
M  V30 16 C 8.3225 6.8964 0.0 0
M  V30 17 N 9.8541 7.0575 0.0 0
M  V30 18 C 8.0023 2.3101 0.0 0
M  V30 19 C 6.6687 3.0801 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 2.6675 2.3101 0.0 0
M  V30 22 C 4.0012 4.6201 0.0 0
M  V30 23 C 1.3338 3.0801 0.0 0
M  V30 24 C 2.6675 5.3901 0.0 0
M  V30 25 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 8 19
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C6H15N3O.2C4H4O4
3033928-61-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 5.7473 0.0 0 CFG=2
M  V30 2 C 4.0011 6.5173 0.0 0
M  V30 3 C 1.3336 6.5173 0.0 0
M  V30 4 N 2.6674 4.2073 0.0 0
M  V30 5 C 5.3347 5.7473 0.0 0
M  V30 6 N 0.0000 5.7473 0.0 0
M  V30 7 O 1.3336 8.0573 0.0 0
M  V30 8 N 6.6685 6.5173 0.0 0
M  V30 9 C 6.6685 8.0573 0.0 0
M  V30 10 C 8.0021 5.7473 0.0 0
M  V30 11 C 3.2311 0.0000 0.0 0
M  V30 12 C 4.7711 0.0000 0.0 0
M  V30 13 C 2.4610 1.3337 0.0 0
M  V30 14 C 5.5411 1.3337 0.0 0
M  V30 15 O 3.2311 2.6673 0.0 0
M  V30 16 O 0.9210 1.3337 0.0 0
M  V30 17 O 7.0811 1.3337 0.0 0
M  V30 18 O 4.7711 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 11 12
M  V30 11 1 11 13
M  V30 12 1 12 14
M  V30 13 1 13 15
M  V30 14 2 13 16
M  V30 15 1 14 17
M  V30 16 2 14 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-1-(Aminocarbonyl)-3-(dimethylamino)propyl]-5-(2,4-difluorophenoxy)-1-...
C24H29F2N5O3
765914-60-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.6100 10.4106 0.0 0
M  V30 2 C 14.1163 10.7307 0.0 0
M  V30 3 C 14.5923 12.1953 0.0 0
M  V30 4 C 15.1468 9.5862 0.0 0
M  V30 5 C 6.6685 9.2400 0.0 0
M  V30 6 N 6.6685 10.7800 0.0 0
M  V30 7 O 5.3347 8.4700 0.0 0
M  V30 8 C 5.3347 11.5500 0.0 0 CFG=2
M  V30 9 C 4.0011 10.7800 0.0 0
M  V30 10 C 5.3347 13.0900 0.0 0
M  V30 11 C 2.6674 11.5500 0.0 0
M  V30 12 N 4.0011 13.8600 0.0 0
M  V30 13 O 6.6684 13.8600 0.0 0
M  V30 14 N 1.3336 10.7800 0.0 0
M  V30 15 C 0.0000 11.5500 0.0 0
M  V30 16 C 1.3336 9.2400 0.0 0
M  V30 17 O 6.6684 6.1600 0.0 0
M  V30 18 F 4.0011 4.6200 0.0 0
M  V30 19 F 6.6684 0.0000 0.0 0
M  V30 20 C 10.6694 8.4700 0.0 0
M  V30 21 C 10.6694 6.9300 0.0 0
M  V30 22 N 12.1341 8.9459 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 9.3358 6.1600 0.0 0
M  V30 25 C 12.1341 6.4541 0.0 0
M  V30 26 N 13.0393 7.7000 0.0 0
M  V30 27 C 8.0021 8.4700 0.0 0
M  V30 28 C 8.0021 6.9300 0.0 0
M  V30 29 C 6.6684 4.6200 0.0 0
M  V30 30 C 5.3347 3.8500 0.0 0
M  V30 31 C 8.0021 3.8500 0.0 0
M  V30 32 C 5.3347 2.3100 0.0 0
M  V30 33 C 8.0021 2.3100 0.0 0
M  V30 34 C 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 27
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 17 28
M  V30 18 1 17 29
M  V30 19 1 18 30
M  V30 20 1 19 34
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 765914-40-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033928-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 765914-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39824402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation
for the Multikilogram Synthesis of Emprumapimod
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brearley, Christopher; Bright, Robert David; Clarke, James; Critcher,
Douglas J.; Torres, Susana; Edwards, Ingrid; Fenton, Harriet; Huang,
Shanjun; Johnson, Rebecca Amy; Jones, Ricky A.; Mathew, Suju P.; Norster,
Rhys; Starbuck, Kathryn Alice; Taylor-Young, Amelia; Waddington, William;
Walton, Robert; Wang, Jimmy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(4), 1253-1259

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Cyclopropanecarboxamide, 1-amino-2-ethenyl-N-[(1-methylcyclopropyl)sulfonyl]-...
C10H16N2O3S.ClH
853269-58-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8302 3.8995 0.0 0
M  V30 2 N 3.3135 3.6321 0.0 0
M  V30 3 O 5.3569 5.3467 0.0 0
M  V30 4 S 2.3236 4.8118 0.0 0 VAL=6
M  V30 5 O 3.5033 5.8017 0.0 0
M  V30 6 O 1.1439 3.8219 0.0 0
M  V30 7 N 4.8302 1.5400 0.0 0
M  V30 8 C 7.9238 4.8235 0.0 0
M  V30 9 C 9.4638 4.8235 0.0 0
M  V30 10 C 2.3236 7.1713 0.0 0
M  V30 11 C 5.8201 2.7198 0.0 0 CFG=1
M  V30 12 C 7.1538 3.4898 0.0 0 CFG=2
M  V30 13 C 7.1538 1.9498 0.0 0
M  V30 14 C 1.3337 5.9915 0.0 0
M  V30 15 C 0.0000 5.2215 0.0 0
M  V30 16 C 0.0000 6.7615 0.0 0
M  V30 17 Cl 4.7319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 11 7 CFG=1
M  V30 9 2 8 9
M  V30 10 1 12 8 CFG=3
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Proline, (3R,5R)-5-(3-buten-1-yl)-N-[(1,1-dimethylethoxy)carbonyl]-3-ethyl-...
C22H38N2O6
1606150-64-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.5253 0.0 0
M  V30 2 C 6.1600 5.8591 0.0 0 CFG=1
M  V30 3 O 3.8500 4.5253 0.0 0
M  V30 4 C 7.7000 5.8591 0.0 0 CFG=2
M  V30 5 N 5.3900 7.1927 0.0 0
M  V30 6 C 8.4700 4.5253 0.0 0
M  V30 7 C 8.4700 7.1927 0.0 0
M  V30 8 C 3.8500 7.1927 0.0 0
M  V30 9 C 10.0100 4.5253 0.0 0 CFG=2
M  V30 10 C 7.7000 8.5264 0.0 0
M  V30 11 O 3.0800 8.5264 0.0 0
M  V30 12 O 3.0800 5.8591 0.0 0
M  V30 13 C 10.7800 5.8591 0.0 0
M  V30 14 C 10.7800 3.1917 0.0 0
M  V30 15 C 1.5400 8.5264 0.0 0
M  V30 16 C 12.3200 5.8591 0.0 0
M  V30 17 C 1.5400 10.0664 0.0 0
M  V30 18 C 0.0000 8.5264 0.0 0
M  V30 19 C 1.5400 6.9864 0.0 0
M  V30 20 C 13.0900 7.1927 0.0 0
M  V30 21 C 14.6300 7.1927 0.0 0
M  V30 22 C 4.0273 1.4645 0.0 0
M  V30 23 O 2.9968 2.6091 0.0 0
M  V30 24 O 3.5514 0.0000 0.0 0
M  V30 25 O 9.4186 0.8980 0.0 0
M  V30 26 N 6.1600 3.1917 0.0 0
M  V30 27 C 5.5337 1.7849 0.0 0 CFG=2
M  V30 28 C 7.6915 3.0307 0.0 0
M  V30 29 C 6.6781 0.7543 0.0 0
M  V30 30 C 8.0117 1.5243 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=1
M  V30 15 1 11 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 20 21
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 1 27 22 CFG=1
M  V30 25 1 30 25 CFG=3
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 4 9 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C32H52N4O8S
3037829-13-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.7686 7.3389 0.0 0
M  V30 2 C 10.2623 7.0187 0.0 0
M  V30 3 O 9.7863 5.5541 0.0 0
M  V30 4 C 14.1052 7.0105 0.0 0
M  V30 5 N 15.4649 6.2875 0.0 0
M  V30 6 O 14.0514 8.5497 0.0 0
M  V30 7 S 16.7710 7.1036 0.0 0 VAL=6
M  V30 8 O 17.5870 5.7976 0.0 0
M  V30 9 O 15.9549 8.4097 0.0 0
M  V30 10 C 14.5897 3.8184 0.0 0
M  V30 11 C 14.3753 2.2934 0.0 0
M  V30 12 C 6.9302 6.6685 0.0 0
M  V30 13 C 5.3901 6.6685 0.0 0 CFG=1
M  V30 14 O 7.7002 5.3348 0.0 0
M  V30 15 C 4.6201 8.0022 0.0 0 CFG=2
M  V30 16 N 4.6201 5.3348 0.0 0
M  V30 17 C 5.3901 9.3360 0.0 0
M  V30 18 C 3.0801 8.0022 0.0 0
M  V30 19 C 5.3901 4.0010 0.0 0
M  V30 20 C 4.6201 10.6697 0.0 0 CFG=2
M  V30 21 C 2.3101 6.6685 0.0 0
M  V30 22 O 4.6201 2.6673 0.0 0
M  V30 23 O 6.9302 4.0010 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 5.3901 12.0033 0.0 0
M  V30 26 C 5.3901 1.3337 0.0 0
M  V30 27 C 2.3101 12.0033 0.0 0
M  V30 28 C 6.7238 2.1037 0.0 0
M  V30 29 C 6.1601 0.0000 0.0 0
M  V30 30 C 4.0564 0.5637 0.0 0
M  V30 31 C 0.7700 12.0033 0.0 0
M  V30 32 C 0.0000 13.3370 0.0 0
M  V30 33 C 17.5000 9.3475 0.0 0
M  V30 34 O 8.0573 11.9711 0.0 0
M  V30 35 C 12.7991 6.1945 0.0 0 CFG=2
M  V30 36 C 13.3761 4.7666 0.0 0 CFG=2
M  V30 37 C 11.8510 4.9809 0.0 0
M  V30 38 C 9.2317 8.1633 0.0 0 CFG=2
M  V30 39 N 7.7002 8.0022 0.0 0
M  V30 40 C 9.5519 9.6696 0.0 0
M  V30 41 C 7.0738 9.4091 0.0 0
M  V30 42 C 8.2182 10.4396 0.0 0 CFG=1
M  V30 43 C 18.0769 7.9198 0.0 0
M  V30 44 C 19.1075 6.7752 0.0 0
M  V30 45 C 19.5834 8.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 35 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 38 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 35 4 CFG=3
M  V30 8 1 5 7
M  V30 9 2 7 8
M  V30 10 2 7 9
M  V30 11 1 7 43
M  V30 12 2 10 11
M  V30 13 1 36 10 CFG=3
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 39
M  V30 17 1 13 15
M  V30 18 1 13 16 CFG=1
M  V30 19 1 15 17
M  V30 20 1 15 18 CFG=3
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 20 25 CFG=1
M  V30 28 1 22 26
M  V30 29 1 24 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 1 27 31
M  V30 34 2 31 32
M  V30 35 1 33 43
M  V30 36 1 42 34 CFG=3
M  V30 37 1 35 36
M  V30 38 1 35 37
M  V30 39 1 36 37
M  V30 40 1 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 41 42
M  V30 45 1 43 44
M  V30 46 1 43 45
M  V30 47 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 13 15 20 35 36 38 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 853269-58-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1606150-64-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037829-13-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40675401
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease
Inhibitor for the Treatment of Hepatitis C Virus Infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Li-Qiang; Mull, Eric; D'Andrea, Stanley; Zheng, Barbara; Hiebert,
Sheldon; Gillis, Eric; Bowsher, Michael; Kandhasamy, Sarkunam; Baratam,
Venkata Rao; Puttaswamy, Sunitha; Pulicharla, Nagalakshmi;
Vishwakrishnan, Sureshbabu; Reddy, Subba; Trivedi, Ravi; Sinha,
Sarmistha; Sivaprasad, Sankar; Rao, Abhijith; Desai, Salil; Ghosh,
Kaushik; Anumula, Rushith; Kumar, Amit; Rajamani, Ramkumar; Wang,
Ying-Kai; Fang, Hua; Mathur, Arvind; Rampulla, Richard; Zvyaga, Tatyana
A.; Mosure, Kathy; Jenkins, Susan; Falk, Paul; Tagore, Debarati M.; Chen,
Chaoqun; Rendunchintala, Kishore; Loy, James; Meanwell, Nicholas A.;
McPhee, Fiona; Scola, Paul M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(23), 14740-14760

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
(2S)-1-(2-Aminoacetyl)-4,4-difluoro-2-pyrrolidinecarbonitrile
C7H9F2N3O
1448440-39-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4415 4.1751 0.0 0
M  V30 2 C 6.2115 5.5088 0.0 0
M  V30 3 O 6.2115 2.8415 0.0 0
M  V30 4 N 7.7515 5.5088 0.0 0
M  V30 5 C 3.4721 1.4645 0.0 0
M  V30 6 N 3.9480 0.0000 0.0 0
M  V30 7 F 1.2114 6.4514 0.0 0
M  V30 8 F 0.0000 4.7842 0.0 0
M  V30 9 N 3.9015 4.1751 0.0 0
M  V30 10 C 2.9962 2.9292 0.0 0 CFG=2
M  V30 11 C 2.9962 5.4210 0.0 0
M  V30 12 C 1.5315 3.4051 0.0 0
M  V30 13 C 1.5315 4.9451 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 10 5 CFG=3
M  V30 7 1 7 13
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Quinolinecarboxylic acid, 6-[3-fluoro-2-[(tetrahydro-2H-pyran-2-yl)oxy]prop...
C18H20FNO5
3056228-30-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3203 5.3348 0.0 0
M  V30 2 O 13.8603 5.3348 0.0 0
M  V30 3 O 11.5503 4.0012 0.0 0
M  V30 4 O 6.9302 4.0012 0.0 0
M  V30 5 C 5.3901 4.0012 0.0 0
M  V30 6 C 4.6201 2.6675 0.0 0
M  V30 7 O 3.0801 2.6675 0.0 0
M  V30 8 C 5.3901 1.3337 0.0 0
M  V30 9 F 4.6201 0.0000 0.0 0
M  V30 10 C 10.0102 6.6685 0.0 0
M  V30 11 C 9.2402 8.0023 0.0 0
M  V30 12 C 11.5503 6.6685 0.0 0
M  V30 13 C 9.2402 5.3348 0.0 0
M  V30 14 C 7.7002 8.0023 0.0 0
M  V30 15 N 10.0102 9.3360 0.0 0
M  V30 16 C 12.3203 8.0023 0.0 0
M  V30 17 C 7.7002 5.3348 0.0 0
M  V30 18 C 6.9302 6.6685 0.0 0
M  V30 19 C 11.5503 9.3360 0.0 0
M  V30 20 C 2.3101 4.0012 0.0 0
M  V30 21 C 0.7700 4.0012 0.0 0
M  V30 22 O 3.0801 5.3348 0.0 0
M  V30 23 C 0.0000 5.3348 0.0 0
M  V30 24 C 2.3101 6.6685 0.0 0
M  V30 25 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 20
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxo...
C20H19F3N4O4
3056228-32-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2127 6.3506 0.0 0
M  V30 2 N 6.6727 6.3506 0.0 0
M  V30 3 O 8.9827 5.0170 0.0 0
M  V30 4 C 5.9026 5.0170 0.0 0
M  V30 5 C 4.3626 5.0170 0.0 0
M  V30 6 O 3.5926 6.3506 0.0 0
M  V30 7 O 13.6028 5.0170 0.0 0
M  V30 8 C 15.1428 5.0170 0.0 0
M  V30 9 C 15.9129 3.6833 0.0 0 CFG=3
M  V30 10 C 17.4529 3.6833 0.0 0
M  V30 11 O 15.1428 2.3496 0.0 0
M  V30 12 F 18.2229 2.3496 0.0 0
M  V30 13 C 1.0304 4.6668 0.0 0
M  V30 14 N 0.0000 5.8112 0.0 0
M  V30 15 F 4.2189 0.2155 0.0 0
M  V30 16 F 2.1693 0.0000 0.0 0
M  V30 17 C 10.5227 7.6845 0.0 0
M  V30 18 C 8.9827 7.6845 0.0 0
M  V30 19 C 11.2928 9.0181 0.0 0
M  V30 20 C 11.2928 6.3506 0.0 0
M  V30 21 C 8.2127 9.0181 0.0 0
M  V30 22 C 12.8328 9.0181 0.0 0
M  V30 23 N 10.5227 10.3518 0.0 0
M  V30 24 C 12.8328 6.3506 0.0 0
M  V30 25 C 8.9827 10.3518 0.0 0
M  V30 26 C 13.6028 7.6845 0.0 0
M  V30 27 N 3.5926 3.6833 0.0 0
M  V30 28 C 2.0610 3.5224 0.0 0 CFG=2
M  V30 29 C 4.2189 2.2763 0.0 0
M  V30 30 C 1.7409 2.0159 0.0 0
M  V30 31 C 3.0745 1.2459 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 5 27
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 3 13 14
M  V30 15 1 28 13 CFG=1
M  V30 16 1 15 31
M  V30 17 1 16 31
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1448440-39-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3056228-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056228-32-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40388161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 24057-28-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanc, Muhammet; Filippi, Nicolo; Van Rymenant, Yentl; Grintsevich,
Sergei; Pintelon, Isabel; Verschuuren, Marlies; De Loose, Joni; Verhulst,
Emile; Moon, Euy Sung; Cianni, Lorenzo; Stroobants, Sigrid; Augustyns,
Koen; Roesch, Frank; De Meester, Ingrid; Elvas, Filipe; Van der Veken,
Pieter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(9), 7068-7087

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Neopentylamine
C5H13N
5813-64-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 C 0.5637 2.6673 0.0 0
M  V30 4 C 0.0000 0.5637 0.0 0
M  V30 5 C 2.1037 0.0000 0.0 0
M  V30 6 N 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S,3R,4S)-3-[[5-[[cis-4-(Ethoxycarbonyl)cyclohexyl]oxy]-4-fluoro-2-methox...
C25H32FNO7
2787516-91-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.6187 5.3348 0.0 0
M  V30 2 C 6.3887 4.0012 0.0 0
M  V30 3 O 5.6187 2.6675 0.0 0
M  V30 4 C 2.9584 7.2517 0.0 0
M  V30 5 O 4.3451 7.9219 0.0 0
M  V30 6 O 1.6848 8.1172 0.0 0
M  V30 7 O 7.9287 1.3337 0.0 0
M  V30 8 C 8.6987 0.0000 0.0 0
M  V30 9 O 11.0088 6.6685 0.0 0
M  V30 10 F 12.5488 4.0012 0.0 0
M  V30 11 C 17.1689 6.6685 0.0 0
M  V30 12 O 17.9389 8.0023 0.0 0
M  V30 13 O 17.9389 5.3348 0.0 0
M  V30 14 C 19.4790 8.0023 0.0 0
M  V30 15 C 20.2490 9.3360 0.0 0
M  V30 16 C 4.0786 5.3348 0.0 0 CFG=1
M  V30 17 C 2.6604 4.8967 0.0 0 CFG=1
M  V30 18 C 2.8457 5.7157 0.0 0 CFG=1
M  V30 19 C 0.7540 6.7061 0.0 0
M  V30 20 C 2.1990 3.5747 0.0 0
M  V30 21 C 1.5231 5.5118 0.0 0 CFG=2
M  V30 22 C 1.0942 3.9956 0.0 0
M  V30 23 C 7.9287 4.0012 0.0 0
M  V30 24 C 8.6987 2.6675 0.0 0
M  V30 25 C 8.6987 5.3348 0.0 0
M  V30 26 C 10.2388 2.6675 0.0 0
M  V30 27 C 10.2388 5.3348 0.0 0
M  V30 28 C 11.0088 4.0012 0.0 0
M  V30 29 C 12.5488 6.6685 0.0 0 CFG=2
M  V30 30 C 13.3188 8.0023 0.0 0
M  V30 31 C 13.3188 5.3348 0.0 0
M  V30 32 C 14.8589 8.0023 0.0 0
M  V30 33 C 14.8589 5.3348 0.0 0
M  V30 34 C 15.6289 6.6685 0.0 0 CFG=1
M  V30 35 H 3.7295 3.7883 0.0 0
M  V30 36 H 0.0000 5.2843 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 9 27
M  V30 11 1 29 9 CFG=1
M  V30 12 1 10 28
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 34 11 CFG=1
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 35 CFG=3
M  V30 23 1 18 21
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 1 21 36 CFG=1
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 16 17 18 21 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl cis-4-[5-[[[(1S,2R,3S,4R)-3-[[(2,2-dimethylpropyl)amino]carbonyl]bicycl...
C30H43FN2O6
2787520-22-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7084 7.2516 0.0 0
M  V30 2 N 2.4348 8.1172 0.0 0
M  V30 3 O 5.0950 7.9218 0.0 0
M  V30 4 C 2.5475 9.6531 0.0 0
M  V30 5 C 1.2738 10.5187 0.0 0
M  V30 6 C 2.1394 11.7923 0.0 0
M  V30 7 C 0.0000 11.3842 0.0 0
M  V30 8 C 0.4081 9.2450 0.0 0
M  V30 9 N 6.3687 5.3348 0.0 0
M  V30 10 C 7.1387 4.0010 0.0 0
M  V30 11 O 6.3687 2.6673 0.0 0
M  V30 12 O 8.6787 1.3337 0.0 0
M  V30 13 C 9.4487 0.0000 0.0 0
M  V30 14 O 11.7588 6.6685 0.0 0
M  V30 15 F 13.2988 4.0010 0.0 0
M  V30 16 C 17.9189 6.6685 0.0 0
M  V30 17 O 18.6889 8.0022 0.0 0
M  V30 18 O 18.6889 5.3348 0.0 0
M  V30 19 C 20.2290 8.0022 0.0 0
M  V30 20 C 20.9990 9.3358 0.0 0
M  V30 21 C 3.5957 5.7157 0.0 0 CFG=1
M  V30 22 C 4.8286 5.3348 0.0 0 CFG=2
M  V30 23 C 2.2731 5.5116 0.0 0 CFG=2
M  V30 24 C 3.4103 4.8965 0.0 0 CFG=1
M  V30 25 C 1.5040 6.7061 0.0 0
M  V30 26 C 1.8442 3.9955 0.0 0
M  V30 27 C 2.9490 3.5746 0.0 0
M  V30 28 C 8.6787 4.0010 0.0 0
M  V30 29 C 9.4487 2.6673 0.0 0
M  V30 30 C 9.4487 5.3348 0.0 0
M  V30 31 C 10.9888 2.6673 0.0 0
M  V30 32 C 10.9888 5.3348 0.0 0
M  V30 33 C 11.7588 4.0010 0.0 0
M  V30 34 C 13.2988 6.6685 0.0 0 CFG=2
M  V30 35 C 14.0688 5.3348 0.0 0
M  V30 36 C 14.0688 8.0022 0.0 0
M  V30 37 C 15.6089 5.3348 0.0 0
M  V30 38 C 15.6089 8.0022 0.0 0
M  V30 39 C 16.3789 6.6685 0.0 0 CFG=1
M  V30 40 H 0.7500 5.2843 0.0 0
M  V30 41 H 4.4795 3.7882 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 22 9 CFG=3
M  V30 11 2 10 11
M  V30 12 1 10 28
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 14 32
M  V30 16 1 34 14 CFG=3
M  V30 17 1 15 33
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 39 16 CFG=3
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 40 CFG=1
M  V30 29 1 24 25
M  V30 30 1 24 27
M  V30 31 1 24 41 CFG=3
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 21 22 23 24 34 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5813-64-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787516-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787520-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40331900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric
RXFP1 Agonist for Treatment of Heart Failure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Larsson, Niklas; Bergstroem,
Fredrik; Fuchigami, Ryuichi; Niwa, Yasuki; Ryberg, Erik; Backmark, Anna;
Kato, Harutoshi; Miyazaki, Shiki; Iguchi, Kaori; Sakamoto, Toshiaki;
Persson, Mikael; Idei, Akiko; Prieto Garcia, Luna; Villar, Inmaculada C.;
Graden, Henrik; Bergonzini, Giulia; Arvidsson, Torbjoern; Fujita, Takuya;
Althage, Magnus; Ulander, Johan; Kimura, Junpei; Yoneda, Hikaru;
Fjellstroem, Ola; Mochida, Hideki; Lal, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4419-4441

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Indole-2-carboxylic acid
C9H7NO2
1477-50-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 N 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C31H27N3O5
2892485-59-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6201 0.0 0
M  V30 2 O 8.0022 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8049 2.7300 0.0 0
M  V30 9 O 18.1784 1.3230 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 N 6.6685 3.8501 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 9.3358 3.8501 0.0 0
M  V30 21 O 10.7428 4.4764 0.0 0
M  V30 22 C 9.4969 2.3185 0.0 0
M  V30 23 C 11.7732 3.3320 0.0 0
M  V30 24 C 11.0032 1.9983 0.0 0
M  V30 25 C 13.3048 3.4930 0.0 0
M  V30 26 C 13.9313 4.8999 0.0 0
M  V30 27 C 14.2100 2.2471 0.0 0
M  V30 28 C 15.4629 5.0609 0.0 0
M  V30 29 C 15.7416 2.4080 0.0 0
M  V30 30 C 16.3681 3.8150 0.0 0
M  V30 31 C 20.3365 2.8910 0.0 0
M  V30 32 C 21.3669 1.7466 0.0 0
M  V30 33 N 21.1065 4.2246 0.0 0
M  V30 34 C 22.7739 2.3729 0.0 0
M  V30 35 C 22.6129 3.9044 0.0 0
M  V30 36 C 24.1807 1.7466 0.0 0
M  V30 37 C 23.8588 4.8097 0.0 0
M  V30 38 C 25.4266 2.6518 0.0 0
M  V30 39 C 25.2656 4.1833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 2 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1477-50-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-59-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
N2-Acetyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysine
C13H24N2O5
23500-04-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.8501 0.0 0 CFG=1
M  V30 2 C 4.0010 4.6201 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 N 9.3358 4.6201 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 O 12.0033 4.6201 0.0 0
M  V30 16 O 10.6697 2.3101 0.0 0
M  V30 17 C 13.3370 3.8501 0.0 0
M  V30 18 C 14.1070 5.1838 0.0 0
M  V30 19 C 14.6707 3.0801 0.0 0
M  V30 20 C 12.5670 2.5164 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H30N4O6.2C2HF3O2
2973279-11-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 12.1137 0.0 0
M  V30 2 C 9.3358 12.8837 0.0 0
M  V30 3 C 5.3347 13.6537 0.0 0
M  V30 4 O 4.0011 14.4237 0.0 0
M  V30 5 O 6.6685 14.4237 0.0 0
M  V30 6 N 8.0021 9.0337 0.0 0
M  V30 7 C 8.0021 7.4937 0.0 0
M  V30 8 C 9.3358 6.7237 0.0 0 CFG=1
M  V30 9 O 6.6685 6.7237 0.0 0
M  V30 10 C 10.6694 7.4937 0.0 0
M  V30 11 N 9.3358 5.1837 0.0 0
M  V30 12 C 12.0032 11.3437 0.0 0
M  V30 13 O 13.3369 10.5737 0.0 0
M  V30 14 O 10.6694 10.5737 0.0 0
M  V30 15 N 9.3358 15.9637 0.0 0
M  V30 16 C 9.3358 17.5037 0.0 0
M  V30 17 C 8.0021 18.2737 0.0 0 CFG=1
M  V30 18 O 10.6694 18.2737 0.0 0
M  V30 19 C 8.0021 19.8137 0.0 0
M  V30 20 N 6.6685 17.5037 0.0 0
M  V30 21 C 6.6685 11.3437 0.0 0
M  V30 22 C 5.3347 12.1137 0.0 0
M  V30 23 C 6.6685 9.8037 0.0 0
M  V30 24 C 4.0011 11.3437 0.0 0
M  V30 25 C 5.3347 9.0337 0.0 0
M  V30 26 C 4.0011 9.8037 0.0 0
M  V30 27 C 10.6694 13.6537 0.0 0
M  V30 28 C 12.0032 12.8837 0.0 0
M  V30 29 C 10.6694 15.1937 0.0 0
M  V30 30 C 13.3369 13.6537 0.0 0
M  V30 31 C 12.0032 15.9637 0.0 0
M  V30 32 C 13.3369 15.1937 0.0 0
M  V30 33 C 2.6674 13.6537 0.0 0
M  V30 34 C 1.3338 14.4237 0.0 0
M  V30 35 C 2.6674 12.1137 0.0 0
M  V30 36 C 0.0000 13.6537 0.0 0
M  V30 37 C 1.3338 11.3437 0.0 0
M  V30 38 C 0.0000 12.1137 0.0 0
M  V30 39 C 14.6705 11.3437 0.0 0
M  V30 40 C 16.0041 10.5737 0.0 0
M  V30 41 C 14.6705 12.8837 0.0 0
M  V30 42 C 17.3379 11.3437 0.0 0
M  V30 43 C 16.0041 13.6537 0.0 0
M  V30 44 C 17.3379 12.8837 0.0 0
M  V30 45 C 8.0021 2.3101 0.0 0
M  V30 46 C 9.3358 1.5400 0.0 0
M  V30 47 F 8.7722 3.6437 0.0 0
M  V30 48 F 6.6685 3.0801 0.0 0
M  V30 49 F 7.2321 0.9764 0.0 0
M  V30 50 O 10.6695 2.3101 0.0 0
M  V30 51 O 9.3358 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 21
M  V30 3 1 2 27
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 33
M  V30 8 1 6 7
M  V30 9 1 6 23
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 8 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 28
M  V30 17 1 13 39
M  V30 18 1 15 16
M  V30 19 1 15 29
M  V30 20 1 16 17
M  V30 21 2 16 18
M  V30 22 1 17 19
M  V30 23 1 17 20 CFG=1
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 48 1 45 46
M  V30 49 1 45 47
M  V30 50 1 45 48
M  V30 51 1 45 49
M  V30 52 1 46 50
M  V30 53 2 46 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C60H74N8O14
2973279-12-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  82 85 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 21.3393 8.4702 0.0 0
M  V30 2 C 21.3393 6.9302 0.0 0
M  V30 3 C 24.0068 10.0102 0.0 0
M  V30 4 O 25.3405 10.7802 0.0 0
M  V30 5 O 24.0068 8.4702 0.0 0
M  V30 6 N 18.6718 10.0102 0.0 0
M  V30 7 C 17.3382 10.7802 0.0 0
M  V30 8 C 16.0045 10.0102 0.0 0 CFG=2
M  V30 9 O 17.3382 12.3203 0.0 0
M  V30 10 N 14.6708 10.7802 0.0 0
M  V30 11 C 16.0045 8.4702 0.0 0
M  V30 12 C 13.3370 10.0102 0.0 0
M  V30 13 C 12.0033 10.7802 0.0 0 CFG=1
M  V30 14 O 13.3370 8.4702 0.0 0
M  V30 15 C 10.6697 10.0102 0.0 0
M  V30 16 N 12.0033 12.3203 0.0 0
M  V30 17 C 9.3360 10.7802 0.0 0
M  V30 18 C 10.6697 13.0903 0.0 0
M  V30 19 C 8.0022 10.0102 0.0 0
M  V30 20 C 10.6697 14.6303 0.0 0
M  V30 21 O 9.3360 12.3203 0.0 0
M  V30 22 C 6.6685 10.7802 0.0 0
M  V30 23 N 5.3348 10.0102 0.0 0
M  V30 24 C 4.0012 10.7802 0.0 0
M  V30 25 O 2.6673 10.0102 0.0 0
M  V30 26 O 4.0012 12.3203 0.0 0
M  V30 27 C 1.3337 10.7802 0.0 0
M  V30 28 C 0.5637 9.4466 0.0 0
M  V30 29 C 0.0000 11.5503 0.0 0
M  V30 30 C 2.1037 12.1139 0.0 0
M  V30 31 C 18.6718 5.3901 0.0 0
M  V30 32 O 17.3382 4.6201 0.0 0
M  V30 33 O 18.6718 6.9302 0.0 0
M  V30 34 N 24.0068 5.3901 0.0 0
M  V30 35 C 25.3405 4.6201 0.0 0
M  V30 36 C 26.6742 5.3901 0.0 0 CFG=2
M  V30 37 O 25.3405 3.0801 0.0 0
M  V30 38 N 28.0078 4.6201 0.0 0
M  V30 39 C 26.6742 6.9302 0.0 0
M  V30 40 C 29.3416 5.3901 0.0 0
M  V30 41 C 30.6753 4.6201 0.0 0 CFG=1
M  V30 42 O 29.3416 6.9302 0.0 0
M  V30 43 C 32.0090 5.3901 0.0 0
M  V30 44 N 30.6753 3.0801 0.0 0
M  V30 45 C 33.3427 4.6201 0.0 0
M  V30 46 C 32.0090 2.3101 0.0 0
M  V30 47 C 34.6765 5.3901 0.0 0
M  V30 48 C 33.3427 3.0801 0.0 0
M  V30 49 O 32.0090 0.7700 0.0 0
M  V30 50 C 36.0101 4.6201 0.0 0
M  V30 51 N 37.3438 5.3901 0.0 0
M  V30 52 C 38.6775 4.6201 0.0 0
M  V30 53 O 40.0113 5.3901 0.0 0
M  V30 54 O 38.6775 3.0801 0.0 0
M  V30 55 C 41.3450 4.6201 0.0 0
M  V30 56 C 42.1150 5.9538 0.0 0
M  V30 57 C 42.6786 3.8501 0.0 0
M  V30 58 C 40.5750 3.2864 0.0 0
M  V30 59 C 21.3393 10.0102 0.0 0
M  V30 60 C 22.6730 10.7802 0.0 0
M  V30 61 C 20.0057 10.7802 0.0 0
M  V30 62 C 22.6730 12.3203 0.0 0
M  V30 63 C 20.0057 12.3203 0.0 0
M  V30 64 C 21.3393 13.0903 0.0 0
M  V30 65 C 21.3393 5.3901 0.0 0
M  V30 66 C 20.0057 4.6201 0.0 0
M  V30 67 C 22.6730 4.6201 0.0 0
M  V30 68 C 20.0057 3.0801 0.0 0
M  V30 69 C 22.6730 3.0801 0.0 0
M  V30 70 C 21.3393 2.3101 0.0 0
M  V30 71 C 25.3405 12.3203 0.0 0
M  V30 72 C 26.6742 13.0903 0.0 0
M  V30 73 C 24.0068 13.0903 0.0 0
M  V30 74 C 26.6742 14.6303 0.0 0
M  V30 75 C 24.0068 14.6303 0.0 0
M  V30 76 C 25.3405 15.4003 0.0 0
M  V30 77 C 17.3382 3.0801 0.0 0
M  V30 78 C 18.6718 2.3101 0.0 0
M  V30 79 C 16.0045 2.3101 0.0 0
M  V30 80 C 18.6718 0.7700 0.0 0
M  V30 81 C 16.0045 0.7700 0.0 0
M  V30 82 C 17.3382 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 59
M  V30 3 1 2 65
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 60
M  V30 7 1 4 71
M  V30 8 1 6 7
M  V30 9 1 6 61
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 8 11 CFG=3
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 13 16 CFG=3
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 31 32
M  V30 34 2 31 33
M  V30 35 1 31 66
M  V30 36 1 32 77
M  V30 37 1 34 35
M  V30 38 1 34 67
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 41 1 36 38
M  V30 42 1 36 39 CFG=3
M  V30 43 1 38 40
M  V30 44 1 40 41
M  V30 45 2 40 42
M  V30 46 1 41 43
M  V30 47 1 41 44 CFG=3
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 46 49
M  V30 53 1 47 50
M  V30 54 1 50 51
M  V30 55 1 51 52
M  V30 56 1 52 53
M  V30 57 2 52 54
M  V30 58 1 53 55
M  V30 59 1 55 56
M  V30 60 1 55 57
M  V30 61 1 55 58
M  V30 62 2 59 60
M  V30 63 1 59 61
M  V30 64 1 60 62
M  V30 65 2 61 63
M  V30 66 2 62 64
M  V30 67 1 63 64
M  V30 68 2 65 66
M  V30 69 1 65 67
M  V30 70 1 66 68
M  V30 71 2 67 69
M  V30 72 2 68 70
M  V30 73 1 69 70
M  V30 74 2 71 72
M  V30 75 1 71 73
M  V30 76 1 72 74
M  V30 77 2 73 75
M  V30 78 2 74 76
M  V30 79 1 75 76
M  V30 80 2 77 78
M  V30 81 1 77 79
M  V30 82 1 78 80
M  V30 83 2 79 81
M  V30 84 2 80 82
M  V30 85 1 81 82
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 13 36 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 23500-04-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2973279-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2973279-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37777542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold:
Synthesis, Conformational Analysis, and Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peacock, Hayden; Henriques, Sonia Troeira; Benfield, Aurelie H.; Elliott,
Alysha G.; Luo, Jinghui; Luccarelli, James; Nagano, Masanobu; Craik,
David J.; Hamilton, Andrew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(20), 1932-1939

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
2-(1,1-Dimethylethyl) 5,7-dichloro-3,4-dihydro-2,6(1H)-isoquinolinedicarboxylate
C15H17Cl2NO4
851784-82-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0010 0.0000 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 O 10.6697 3.8501 0.0 0
M  V30 7 O 9.3360 6.1601 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 C 12.7733 3.2864 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 11.2333 5.9538 0.0 0
M  V30 12 Cl 1.3337 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0010 1.5400 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 4.0010 4.6201 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 20 C 8.0022 2.3101 0.0 0
M  V30 21 N 8.0022 3.8501 0.0 0
M  V30 22 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 22
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 19 22
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, 3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1)
C17H19NO4S.ClH
1194550-59-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0800 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0 CFG=2
M  V30 3 C 9.3360 3.0800 0.0 0
M  V30 4 N 8.0023 5.3901 0.0 0
M  V30 5 O 10.6698 3.8501 0.0 0
M  V30 6 O 9.3360 1.5400 0.0 0
M  V30 7 C 12.0035 3.0800 0.0 0
M  V30 8 S 1.3338 3.0800 0.0 0 VAL=6
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 O 0.5638 4.4137 0.0 0
M  V30 11 O 2.1038 1.7464 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 4.0012 3.0800 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 2.6675 3.8501 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 2.6675 5.3901 0.0 0
M  V30 18 C 13.3372 3.8501 0.0 0
M  V30 19 C 14.6708 3.0800 0.0 0
M  V30 20 C 13.3372 5.3901 0.0 0
M  V30 21 C 16.0046 3.8501 0.0 0
M  V30 22 C 14.6708 6.1601 0.0 0
M  V30 23 C 16.0046 5.3901 0.0 0
M  V30 24 Cl 8.0023 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 8 15
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,7-dichloro-3,4-dihydro-6-[[[(1S)-1-[[3-(methylsulfonyl)ph...
C32H34Cl2N2O7S
1194550-61-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 10.5736 12.0031 0.0 0
M  V30 2 C 17.5036 10.6694 0.0 0
M  V30 3 O 18.2736 12.0031 0.0 0
M  V30 4 O 18.2736 9.3358 0.0 0
M  V30 5 C 19.8136 12.0031 0.0 0
M  V30 6 C 19.8136 10.4631 0.0 0
M  V30 7 C 21.3536 12.0031 0.0 0
M  V30 8 C 19.8136 13.5431 0.0 0
M  V30 9 Cl 10.5736 6.6684 0.0 0
M  V30 10 C 9.0336 9.3358 0.0 0
M  V30 11 N 8.2636 8.0020 0.0 0
M  V30 12 O 8.2636 10.6694 0.0 0
M  V30 13 C 6.7236 8.0020 0.0 0 CFG=2
M  V30 14 C 5.9536 9.3358 0.0 0
M  V30 15 C 5.9536 6.6684 0.0 0
M  V30 16 O 6.7236 5.3347 0.0 0
M  V30 17 O 4.4136 6.6684 0.0 0
M  V30 18 C 5.9536 4.0011 0.0 0
M  V30 19 S 1.3336 12.0031 0.0 0 VAL=6
M  V30 20 C 0.5636 13.3367 0.0 0
M  V30 21 O 2.6673 12.7731 0.0 0
M  V30 22 O 0.0000 11.2331 0.0 0
M  V30 23 C 13.6536 9.3358 0.0 0
M  V30 24 C 12.8836 10.6694 0.0 0
M  V30 25 C 15.1936 9.3358 0.0 0
M  V30 26 C 12.8836 8.0020 0.0 0
M  V30 27 C 11.3436 10.6694 0.0 0
M  V30 28 C 13.6536 12.0031 0.0 0
M  V30 29 N 15.9636 10.6694 0.0 0
M  V30 30 C 11.3436 8.0020 0.0 0
M  V30 31 C 10.5736 9.3358 0.0 0
M  V30 32 C 15.1936 12.0031 0.0 0
M  V30 33 C 4.4136 9.3358 0.0 0
M  V30 34 C 3.6436 10.6694 0.0 0
M  V30 35 C 3.6436 8.0020 0.0 0
M  V30 36 C 2.1036 10.6694 0.0 0
M  V30 37 C 2.1036 8.0020 0.0 0
M  V30 38 C 1.3336 9.3358 0.0 0
M  V30 39 C 6.7236 2.6673 0.0 0
M  V30 40 C 8.2636 2.6673 0.0 0
M  V30 41 C 5.9536 1.3336 0.0 0
M  V30 42 C 9.0336 1.3336 0.0 0
M  V30 43 C 6.7236 0.0000 0.0 0
M  V30 44 C 8.2636 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 29
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 30
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 31
M  V30 13 1 11 13
M  V30 14 1 13 14 CFG=3
M  V30 15 1 13 15
M  V30 16 1 14 33
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 39
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 19 22
M  V30 24 1 19 36
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 2 24 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 1 27 31
M  V30 33 1 28 32
M  V30 34 1 29 32
M  V30 35 2 30 31
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 851784-82-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1194550-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1194550-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43022053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved commercial process for the preparation of Lifitegrast
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Girkar, Arvind; Noronha, Dujon; Patil, Prashant B.; Mandewale, Mustapha;
Sawant, Sudhir; Chandavarkar, Mohan Anand; More, Kishor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(12), 4374-4379

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-amino-, methyl ester, hydrochlo...
C9H13NO2.ClH
2445749-73-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3276 3.0820 0.0 0
M  V30 2 O 6.6612 3.8520 0.0 0
M  V30 3 O 5.3276 1.5420 0.0 0
M  V30 4 C 7.9949 3.0820 0.0 0
M  V30 5 N 2.6662 1.5400 0.0 0
M  V30 6 C 3.9939 3.8520 0.0 0 CFG=2
M  V30 7 C 3.9962 5.3839 0.0 0 CFG=2
M  V30 8 C 2.6614 3.0800 0.0 0 CFG=2
M  V30 9 C 2.4270 5.0205 0.0 0
M  V30 10 C 2.6609 6.1527 0.0 0
M  V30 11 C 1.3313 3.8400 0.0 0 CFG=1
M  V30 12 C 1.3285 5.3807 0.0 0
M  V30 13 H 5.3300 6.1538 0.0 0
M  V30 14 H 0.0000 3.0657 0.0 0
M  V30 15 Cl 3.9975 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 8 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9 CFG=3
M  V30 9 1 7 10
M  V30 10 1 7 13
M  V30 11 1 8 11
M  V30 12 1 11 9 CFG=3
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 11 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Fluoro-2-methoxy-5-[[cis-4-methyl-4-[(1-naphthalenylmethoxy)carbonyl]cycloh...
C27H27FO6
2787515-84-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5397 4.4950 0.0 0
M  V30 2 O 7.0563 4.7623 0.0 0
M  V30 3 C 8.0462 3.5827 0.0 0
M  V30 4 O 7.5195 2.1355 0.0 0
M  V30 5 C 9.0361 5.2971 0.0 0
M  V30 6 O 13.5639 1.5400 0.0 0
M  V30 7 F 16.2311 0.0000 0.0 0
M  V30 8 C 16.2311 6.1600 0.0 0
M  V30 9 O 14.8975 6.9300 0.0 0
M  V30 10 O 17.5649 6.9300 0.0 0
M  V30 11 O 18.8986 4.6200 0.0 0
M  V30 12 C 20.2322 3.8500 0.0 0
M  V30 13 C 3.0332 5.4072 0.0 0
M  V30 14 C 4.5498 5.6746 0.0 0
M  V30 15 C 2.0433 6.5869 0.0 0
M  V30 16 C 2.5065 3.9601 0.0 0
M  V30 17 C 5.0765 7.1217 0.0 0
M  V30 18 C 2.5700 8.0340 0.0 0
M  V30 19 C 0.5267 6.3195 0.0 0
M  V30 20 C 0.9899 3.6926 0.0 0
M  V30 21 C 4.0865 8.3015 0.0 0
M  V30 22 C 0.0000 4.8724 0.0 0
M  V30 23 C 9.5628 3.8500 0.0 0 CFG=2
M  V30 24 C 9.5628 2.3100 0.0 0
M  V30 25 C 10.8964 4.6200 0.0 0
M  V30 26 C 10.8964 1.5400 0.0 0
M  V30 27 C 12.2302 3.8500 0.0 0
M  V30 28 C 12.2302 2.3100 0.0 0 CFG=1
M  V30 29 C 14.8975 2.3100 0.0 0
M  V30 30 C 14.8975 3.8500 0.0 0
M  V30 31 C 16.2311 1.5400 0.0 0
M  V30 32 C 16.2311 4.6200 0.0 0
M  V30 33 C 17.5649 2.3100 0.0 0
M  V30 34 C 17.5649 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 23 3 CFG=3
M  V30 6 1 23 5 CFG=1
M  V30 7 1 28 6 CFG=3
M  V30 8 1 6 29
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 32
M  V30 13 1 11 12
M  V30 14 1 11 34
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 21
M  V30 24 2 19 22
M  V30 25 1 20 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (1S,2S,3R,4R)-3-[[4-fluoro-2-methoxy-5-[[cis-4-methyl-4-[(1-naphthalen...
C36H38FNO7
2787515-86-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.6186 5.3348 0.0 0
M  V30 2 C 6.3886 4.0011 0.0 0
M  V30 3 O 5.6186 2.6673 0.0 0
M  V30 4 C 2.9584 7.2515 0.0 0
M  V30 5 O 1.6846 8.1171 0.0 0
M  V30 6 O 4.3449 7.9219 0.0 0
M  V30 7 C 1.7975 9.6530 0.0 0
M  V30 8 O 7.9286 1.3337 0.0 0
M  V30 9 C 8.6986 0.0000 0.0 0
M  V30 10 O 11.0087 6.6684 0.0 0
M  V30 11 F 12.5487 4.0011 0.0 0
M  V30 12 C 16.8084 7.6584 0.0 0
M  V30 13 O 18.2556 7.1317 0.0 0
M  V30 14 O 16.5410 9.1750 0.0 0
M  V30 15 C 19.4352 8.1216 0.0 0
M  V30 16 C 16.8084 5.6785 0.0 0
M  V30 17 C 4.0786 5.3348 0.0 0 CFG=2
M  V30 18 C 2.8456 5.7156 0.0 0 CFG=1
M  V30 19 C 2.6602 4.8966 0.0 0 CFG=1
M  V30 20 C 1.5231 5.5116 0.0 0 CFG=2
M  V30 21 C 0.7540 6.7060 0.0 0
M  V30 22 C 2.1990 3.5747 0.0 0
M  V30 23 C 1.0940 3.9956 0.0 0
M  V30 24 C 7.9286 4.0011 0.0 0
M  V30 25 C 8.6986 2.6673 0.0 0
M  V30 26 C 8.6986 5.3348 0.0 0
M  V30 27 C 10.2387 2.6673 0.0 0
M  V30 28 C 10.2387 5.3348 0.0 0
M  V30 29 C 11.0087 4.0011 0.0 0
M  V30 30 C 12.5487 6.6684 0.0 0 CFG=1
M  V30 31 C 13.3187 5.3348 0.0 0
M  V30 32 C 13.3187 8.0021 0.0 0
M  V30 33 C 14.8587 5.3348 0.0 0
M  V30 34 C 14.8587 8.0021 0.0 0
M  V30 35 C 15.6287 6.6684 0.0 0 CFG=2
M  V30 36 C 20.8824 7.5948 0.0 0
M  V30 37 C 22.0622 8.5847 0.0 0
M  V30 38 C 21.1499 6.0782 0.0 0
M  V30 39 C 23.5093 8.0580 0.0 0
M  V30 40 C 21.7947 10.1013 0.0 0
M  V30 41 C 22.5970 5.5515 0.0 0
M  V30 42 C 23.7767 6.5414 0.0 0
M  V30 43 C 24.6890 9.0479 0.0 0
M  V30 44 C 22.9745 11.0912 0.0 0
M  V30 45 C 24.4216 10.5645 0.0 0
M  V30 46 H 3.7295 3.7881 0.0 0
M  V30 47 H 0.0000 5.2843 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 28
M  V30 12 1 30 10 CFG=1
M  V30 13 1 11 29
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 35 12 CFG=1
M  V30 17 1 13 15
M  V30 18 1 15 36
M  V30 19 1 35 16 CFG=3
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 19 46 CFG=3
M  V30 26 1 20 21
M  V30 27 1 20 23
M  V30 28 1 20 47 CFG=1
M  V30 29 2 22 23
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 1 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 35
M  V30 42 1 36 37
M  V30 43 2 36 38
M  V30 44 2 37 39
M  V30 45 1 37 40
M  V30 46 1 38 41
M  V30 47 1 39 42
M  V30 48 1 39 43
M  V30 49 2 40 44
M  V30 50 2 41 42
M  V30 51 2 43 45
M  V30 52 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 17 18 19 20 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2445749-73-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787515-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787515-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40332116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric
RXFP1 Agonist for Treatment of Heart Failure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Larsson, Niklas; Bergstroem,
Fredrik; Fuchigami, Ryuichi; Niwa, Yasuki; Ryberg, Erik; Backmark, Anna;
Kato, Harutoshi; Miyazaki, Shiki; Iguchi, Kaori; Sakamoto, Toshiaki;
Persson, Mikael; Idei, Akiko; Prieto Garcia, Luna; Villar, Inmaculada C.;
Graden, Henrik; Bergonzini, Giulia; Arvidsson, Torbjoern; Fujita, Takuya;
Althage, Magnus; Ulander, Johan; Kimura, Junpei; Yoneda, Hikaru;
Fjellstroem, Ola; Mochida, Hideki; Lal, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4419-4441

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
4-Methyl-1H-indole-2-carboxylic acid
C10H9NO2
18474-57-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.4944 0.0 0
M  V30 2 C 6.0811 1.5400 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 O 7.4149 2.3100 0.0 0
M  V30 5 C 3.0801 4.1618 0.0 0
M  V30 6 C 2.3100 2.8281 0.0 0
M  V30 7 N 4.5865 3.8416 0.0 0
M  V30 8 C 2.3100 5.4954 0.0 0
M  V30 9 C 3.3406 1.6836 0.0 0
M  V30 10 C 0.7700 2.8281 0.0 0
M  V30 11 C 4.7474 2.3100 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 13 C 0.0000 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-furanyl]p...
C32H29N3O5
2892485-77-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 4.6201 0.0 0
M  V30 2 O 8.0022 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8997 3.9759 0.0 0
M  V30 8 C 18.8049 2.7300 0.0 0
M  V30 9 O 18.1784 1.3230 0.0 0
M  V30 10 C 24.3418 0.2150 0.0 0
M  V30 11 C 4.0010 3.8501 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 N 6.6685 3.8501 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 9.3358 3.8501 0.0 0
M  V30 22 O 10.7428 4.4764 0.0 0
M  V30 23 C 9.4969 2.3185 0.0 0
M  V30 24 C 11.7732 3.3320 0.0 0
M  V30 25 C 11.0032 1.9983 0.0 0
M  V30 26 C 13.3048 3.4930 0.0 0
M  V30 27 C 13.9313 4.8999 0.0 0
M  V30 28 C 14.2100 2.2471 0.0 0
M  V30 29 C 15.4629 5.0609 0.0 0
M  V30 30 C 15.7416 2.4080 0.0 0
M  V30 31 C 16.3681 3.8150 0.0 0
M  V30 32 C 20.3365 2.8910 0.0 0
M  V30 33 N 21.1065 4.2246 0.0 0
M  V30 34 C 21.3669 1.7466 0.0 0
M  V30 35 C 22.6129 3.9044 0.0 0
M  V30 36 C 22.7739 2.3729 0.0 0
M  V30 37 C 23.8588 4.8097 0.0 0
M  V30 38 C 24.1807 1.7466 0.0 0
M  V30 39 C 25.2656 4.1833 0.0 0
M  V30 40 C 25.4266 2.6518 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 2 8 9
M  V30 11 1 8 32
M  V30 12 1 10 38
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 2 18 19
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18474-57-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
2-Fluoro-3-methoxybenzoic acid
C8H7FO3
137654-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 O 1.3337 4.6201 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 F 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[3-(3-aminophenyl)-4-(4-pyridinyl)-1H-pyrazol...
C23H27N5O2
3055872-81-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 8.3071 0.0 0
M  V30 2 C 12.1457 8.0850 0.0 0
M  V30 3 O 12.9157 9.4186 0.0 0
M  V30 4 O 12.9157 6.7512 0.0 0
M  V30 5 C 14.4557 9.4186 0.0 0
M  V30 6 C 14.4557 10.9586 0.0 0
M  V30 7 C 15.9957 9.4186 0.0 0
M  V30 8 C 14.4557 7.8786 0.0 0
M  V30 9 C 4.6200 5.6398 0.0 0
M  V30 10 C 5.5252 4.3939 0.0 0
M  V30 11 N 5.5252 6.8856 0.0 0
M  V30 12 C 6.9899 4.8698 0.0 0
M  V30 13 N 6.9899 6.4098 0.0 0
M  V30 14 C 3.0800 5.6398 0.0 0
M  V30 15 C 2.3100 6.9734 0.0 0
M  V30 16 C 2.3100 4.3061 0.0 0
M  V30 17 C 0.7700 6.9734 0.0 0
M  V30 18 C 0.7700 4.3061 0.0 0
M  V30 19 C 0.0000 5.6398 0.0 0
M  V30 20 C 5.0494 2.9292 0.0 0
M  V30 21 C 6.0798 1.7849 0.0 0
M  V30 22 C 3.5431 2.6091 0.0 0
M  V30 23 C 5.6039 0.3202 0.0 0
M  V30 24 C 3.0672 1.1444 0.0 0
M  V30 25 N 4.0976 0.0000 0.0 0
M  V30 26 C 8.2358 7.3150 0.0 0 CFG=1
M  V30 27 C 9.7005 6.8391 0.0 0
M  V30 28 C 8.2358 8.8550 0.0 0
M  V30 29 N 10.6057 8.0850 0.0 0
M  V30 30 C 9.7005 9.3309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 29
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 26 13 CFG=1
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[3-[3-[(2-fluoro-3-methoxybenzoyl)amino]pheny...
C31H32FN5O4
3055872-90-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 8.3072 0.0 0
M  V30 2 C 5.3902 8.3072 0.0 0
M  V30 3 O 4.6202 6.9736 0.0 0
M  V30 4 C 19.0757 8.0850 0.0 0
M  V30 5 O 19.8457 9.4186 0.0 0
M  V30 6 O 19.8455 6.7514 0.0 0
M  V30 7 C 21.3857 9.4186 0.0 0
M  V30 8 C 21.3857 7.8786 0.0 0
M  V30 9 C 22.9257 9.4186 0.0 0
M  V30 10 C 21.3857 10.9586 0.0 0
M  V30 11 F 2.3102 8.3072 0.0 0
M  V30 12 O 0.7700 10.9745 0.0 0
M  V30 13 C 0.0000 12.3083 0.0 0
M  V30 14 C 11.5500 5.6398 0.0 0
M  V30 15 C 12.4552 4.3939 0.0 0
M  V30 16 N 12.4552 6.8856 0.0 0
M  V30 17 C 13.9199 4.8698 0.0 0
M  V30 18 N 13.9199 6.4098 0.0 0
M  V30 19 C 10.0100 5.6398 0.0 0
M  V30 20 C 9.2402 6.9736 0.0 0
M  V30 21 C 9.2400 4.3061 0.0 0
M  V30 22 C 7.7000 6.9736 0.0 0
M  V30 23 C 7.7000 4.3061 0.0 0
M  V30 24 C 6.9300 5.6398 0.0 0
M  V30 25 C 11.9794 2.9294 0.0 0
M  V30 26 C 13.0098 1.7849 0.0 0
M  V30 27 C 10.4731 2.6091 0.0 0
M  V30 28 C 12.5339 0.3203 0.0 0
M  V30 29 C 9.9972 1.1445 0.0 0
M  V30 30 N 11.0276 0.0000 0.0 0
M  V30 31 C 15.1658 7.3150 0.0 0 CFG=1
M  V30 32 C 16.6305 6.8391 0.0 0
M  V30 33 C 15.1658 8.8550 0.0 0
M  V30 34 N 17.5357 8.0850 0.0 0
M  V30 35 C 16.6305 9.3309 0.0 0
M  V30 36 C 4.6202 9.6409 0.0 0
M  V30 37 C 3.0800 9.6409 0.0 0
M  V30 38 C 5.3902 10.9745 0.0 0
M  V30 39 C 2.3102 10.9745 0.0 0
M  V30 40 C 4.6202 12.3083 0.0 0
M  V30 41 C 3.0802 12.3083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 2 2 3
M  V30 4 1 2 36
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 34
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 37
M  V30 13 1 12 13
M  V30 14 1 12 39
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 1 15 25
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 31 18 CFG=1
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 137654-20-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3055872-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055872-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40922525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of Potent, Efficacious and Selective
Inhibitors Targeting EGFR Exon20 Insertion Mutations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomson, Clare; Barton, Peter; Braybrooke, Erin; Colclough, Nicola; Dong,
Zhiqiang; Evans, Laura; Floch, Nicolas; Guerot, Carine; Hargreaves,
David; Khurana, Puneet; Li, Songlei; Li, Xiuwei; Lister, Andrew; McCoull,
William; McWilliams, Lisa; Orme, Jonathan P.; Packer, Martin J.; Swaih,
Aisha M.; Ward, Richard A.; Winlow, Poppy; Ye, Yang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 8988-9027

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
4-([1,4′-Bipiperidin]-1′-ylmethyl)benzenamine
C17H27N3
1307702-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 N 6.6685 4.6201 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(2,4-dimethoxyphenyl)-
C20H16N2O4
3002420-87-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 7.4001 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 O 1.3337 8.9401 0.0 0
M  V30 4 O 5.3348 9.7101 0.0 0
M  V30 5 C 5.3348 11.2502 0.0 0
M  V30 6 O 10.6696 9.7101 0.0 0
M  V30 7 C 12.0032 8.9401 0.0 0
M  V30 8 C 5.3348 5.0901 0.0 0
M  V30 9 C 4.0011 4.3201 0.0 0
M  V30 10 C 5.3348 6.6301 0.0 0
M  V30 11 N 6.4792 4.0597 0.0 0
M  V30 12 C 4.3213 2.8138 0.0 0
M  V30 13 C 2.6673 5.0901 0.0 0
M  V30 14 N 4.0011 7.4001 0.0 0
M  V30 15 C 5.8529 2.6527 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 2.6673 6.6301 0.0 0
M  V30 18 C 6.4792 1.2459 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5740 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 6.6684 8.9401 0.0 0
M  V30 23 C 8.0021 6.6301 0.0 0
M  V30 24 C 8.0021 9.7101 0.0 0
M  V30 25 C 9.3359 7.4001 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 6 7
M  V30 7 1 6 26
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 21
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, N-[4-([1,4′-bipiperidin]-1′-ylmethyl)ph...
C37H41N5O3
3002420-83-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 7.4001 0.0 0
M  V30 2 N 12.0033 6.6301 0.0 0
M  V30 3 O 10.6696 8.9401 0.0 0
M  V30 4 O 6.6685 9.7102 0.0 0
M  V30 5 C 6.6685 11.2502 0.0 0
M  V30 6 O 1.3337 9.7102 0.0 0
M  V30 7 C 0.0000 8.9401 0.0 0
M  V30 8 C 17.3381 9.7102 0.0 0
M  V30 9 C 6.6685 5.0901 0.0 0
M  V30 10 C 8.0021 4.3201 0.0 0
M  V30 11 C 6.6685 6.6301 0.0 0
M  V30 12 N 5.5239 4.0597 0.0 0
M  V30 13 C 7.6819 2.8138 0.0 0
M  V30 14 C 9.3358 5.0901 0.0 0
M  V30 15 N 8.0021 7.4001 0.0 0
M  V30 16 C 6.1504 2.6527 0.0 0
M  V30 17 C 8.5872 1.5679 0.0 0
M  V30 18 C 9.3358 6.6301 0.0 0
M  V30 19 C 5.5239 1.2459 0.0 0
M  V30 20 C 7.9607 0.1609 0.0 0
M  V30 21 C 6.4291 0.0000 0.0 0
M  V30 22 C 5.3348 7.4001 0.0 0
M  V30 23 C 5.3348 8.9401 0.0 0
M  V30 24 C 4.0010 6.6301 0.0 0
M  V30 25 C 4.0010 9.7102 0.0 0
M  V30 26 C 2.6673 7.4001 0.0 0
M  V30 27 C 2.6673 8.9401 0.0 0
M  V30 28 C 13.3369 7.4001 0.0 0
M  V30 29 C 14.6706 6.6301 0.0 0
M  V30 30 C 13.3369 8.9401 0.0 0
M  V30 31 C 16.0044 7.4001 0.0 0
M  V30 32 C 14.6706 9.7102 0.0 0
M  V30 33 C 16.0044 8.9401 0.0 0
M  V30 34 N 18.6717 8.9401 0.0 0
M  V30 35 C 20.0054 9.7102 0.0 0
M  V30 36 C 18.6717 7.4001 0.0 0
M  V30 37 C 21.3392 8.9401 0.0 0
M  V30 38 C 20.0054 6.6301 0.0 0
M  V30 39 C 21.3392 7.4001 0.0 0
M  V30 40 N 22.6729 6.6301 0.0 0
M  V30 41 C 22.6729 5.0901 0.0 0
M  V30 42 C 24.0065 7.4001 0.0 0
M  V30 43 C 24.0065 4.3201 0.0 0
M  V30 44 C 25.3402 6.6301 0.0 0
M  V30 45 C 25.3402 5.0901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 1 8 33
M  V30 10 1 8 34
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 11 22
M  V30 18 1 12 16
M  V30 19 1 13 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 2 15 18
M  V30 23 2 16 19
M  V30 24 1 17 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1307702-36-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3002420-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3002420-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38589179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the
Treatment of Cystic Echinococcosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu,
Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan,
Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16680-16693

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
(S)-tert-Butyl 3-aminopiperidine-1-carboxylate
C10H20N2O2
625471-18-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 N 9.3360 3.0801 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0 CFG=1
M  V30 13 C 6.6685 0.0000 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 12 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(1R,2S)-1-(4-Methylphenyl)-2-[(2,2,2-trifluoroacetyl)amino]propoxy]-2-pyri...
C18H17F3N2O4
2089131-21-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0 CFG=2
M  V30 2 O 6.9300 8.0021 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 4 N 7.7000 4.0011 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3336 0.0 0
M  V30 8 O 5.3900 2.6674 0.0 0
M  V30 9 F 8.4700 0.0000 0.0 0
M  V30 10 F 6.3664 0.5636 0.0 0
M  V30 11 F 9.0336 2.1036 0.0 0
M  V30 12 C 13.8600 6.6684 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 O 0.0000 9.3358 0.0 0
M  V30 15 O 0.0000 6.6684 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 11.5500 5.3347 0.0 0
M  V30 21 C 12.3200 6.6684 0.0 0
M  V30 22 C 5.3900 8.0021 0.0 0
M  V30 23 C 4.6200 6.6684 0.0 0
M  V30 24 C 4.6200 9.3358 0.0 0
M  V30 25 C 3.0800 6.6684 0.0 0
M  V30 26 N 3.0800 9.3358 0.0 0
M  V30 27 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 1 3 5 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 12 21
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[[5-[(1R,2S)-1-(4-methylphenyl)-2-[(2,2,2-trifluoro...
C28H35F3N4O5
2089131-40-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0 CFG=2
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 4.6201 0.0 0 CFG=2
M  V30 4 N 4.0012 5.3901 0.0 0
M  V30 5 C 6.6685 5.3901 0.0 0
M  V30 6 C 4.0012 6.9302 0.0 0
M  V30 7 C 2.6673 7.7002 0.0 0
M  V30 8 O 5.3348 7.7002 0.0 0
M  V30 9 F 1.3337 8.4702 0.0 0
M  V30 10 F 3.4374 9.0338 0.0 0
M  V30 11 F 1.8973 6.3665 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 C 12.0033 5.3901 0.0 0
M  V30 14 N 13.3370 4.6201 0.0 0
M  V30 15 O 12.0033 6.9302 0.0 0
M  V30 16 C 18.6718 4.6201 0.0 0
M  V30 17 O 20.0057 5.3901 0.0 0
M  V30 18 O 18.6718 3.0801 0.0 0
M  V30 19 C 21.3393 4.6201 0.0 0
M  V30 20 C 22.1093 5.9538 0.0 0
M  V30 21 C 22.6730 3.8501 0.0 0
M  V30 22 C 20.5693 3.2864 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 24 C 4.0012 0.7700 0.0 0
M  V30 25 C 2.6673 3.0801 0.0 0
M  V30 26 C 2.6673 0.0000 0.0 0
M  V30 27 C 1.3337 2.3101 0.0 0
M  V30 28 C 1.3337 0.7700 0.0 0
M  V30 29 C 8.0022 3.0801 0.0 0
M  V30 30 C 8.0022 4.6201 0.0 0
M  V30 31 C 9.3360 2.3101 0.0 0
M  V30 32 C 9.3360 5.3901 0.0 0
M  V30 33 N 10.6697 3.0801 0.0 0
M  V30 34 C 10.6697 4.6201 0.0 0
M  V30 35 C 14.6708 5.3901 0.0 0 CFG=1
M  V30 36 C 16.0045 4.6201 0.0 0
M  V30 37 C 14.6708 6.9302 0.0 0
M  V30 38 N 17.3382 5.3901 0.0 0
M  V30 39 C 16.0045 7.7002 0.0 0
M  V30 40 C 17.3382 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 23
M  V30 4 1 2 29
M  V30 5 1 3 4
M  V30 6 1 3 5 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 34
M  V30 17 1 35 14 CFG=1
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 16 38
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 37 1 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 3 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 625471-18-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2089131-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2089131-40-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41293635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Topical 'dual-soft' glucocorticoid receptor agonist for dermatology
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dack, Kevin N.; Johnson, Patrick S.; Henriksson, Krister; Eirefelt,
Stefan; Carnerup, Martin A.; Stahlhut, Martin; Ollerstam, Anna K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Isobutylamine
C4H11N
78-81-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S,3R,4S)-3-[[5-[[cis-4-[(1,1-Dimethylethoxy)carbonyl]-4-methylcyclohexyl...
C28H38FNO7
2787516-58-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.6186 5.3348 0.0 0
M  V30 2 C 6.3887 4.0012 0.0 0
M  V30 3 O 5.6186 2.6675 0.0 0
M  V30 4 C 2.9584 7.2517 0.0 0
M  V30 5 O 4.3449 7.9219 0.0 0
M  V30 6 O 1.6846 8.1173 0.0 0
M  V30 7 O 7.9287 1.3338 0.0 0
M  V30 8 C 8.6987 0.0000 0.0 0
M  V30 9 O 11.0088 6.6686 0.0 0
M  V30 10 F 12.5488 4.0012 0.0 0
M  V30 11 C 16.8085 7.6586 0.0 0
M  V30 12 O 18.2557 7.1317 0.0 0
M  V30 13 O 16.5412 9.1752 0.0 0
M  V30 14 C 19.4355 8.1217 0.0 0
M  V30 15 C 20.4254 6.9420 0.0 0
M  V30 16 C 20.6152 9.1116 0.0 0
M  V30 17 C 18.4456 9.3015 0.0 0
M  V30 18 C 16.8085 5.6787 0.0 0
M  V30 19 C 4.0786 5.3348 0.0 0 CFG=1
M  V30 20 C 2.6602 4.8967 0.0 0 CFG=1
M  V30 21 C 2.8457 5.7158 0.0 0 CFG=1
M  V30 22 C 0.7540 6.7062 0.0 0
M  V30 23 C 2.1990 3.5747 0.0 0
M  V30 24 C 1.5231 5.5118 0.0 0 CFG=2
M  V30 25 C 1.0942 3.9956 0.0 0
M  V30 26 C 7.9287 4.0012 0.0 0
M  V30 27 C 8.6987 2.6675 0.0 0
M  V30 28 C 8.6987 5.3348 0.0 0
M  V30 29 C 10.2387 2.6675 0.0 0
M  V30 30 C 10.2387 5.3348 0.0 0
M  V30 31 C 11.0088 4.0012 0.0 0
M  V30 32 C 12.5488 6.6686 0.0 0 CFG=2
M  V30 33 C 13.3188 5.3348 0.0 0
M  V30 34 C 13.3188 8.0023 0.0 0
M  V30 35 C 14.8588 5.3348 0.0 0
M  V30 36 C 14.8588 8.0023 0.0 0
M  V30 37 C 15.6288 6.6686 0.0 0 CFG=1
M  V30 38 H 3.7295 3.7883 0.0 0
M  V30 39 H 0.0000 5.2843 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 27
M  V30 10 1 9 30
M  V30 11 1 32 9 CFG=3
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 37 11 CFG=3
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 37 18 CFG=1
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 20 38 CFG=3
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 1 24 39 CFG=1
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 19 20 21 24 32 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl cis-4-[2-fluoro-4-methoxy-5-[[[(1S,2R,3S,4R)-3-[[(2-methylp...
C32H47FN2O6
2787520-00-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8211 7.2517 0.0 0
M  V30 2 N 2.5475 8.1174 0.0 0
M  V30 3 O 5.2078 7.9219 0.0 0
M  V30 4 C 2.6603 9.6532 0.0 0
M  V30 5 C 1.3865 10.5187 0.0 0
M  V30 6 C 1.4992 12.0548 0.0 0
M  V30 7 C 0.0000 9.8485 0.0 0
M  V30 8 N 6.4814 5.3348 0.0 0
M  V30 9 C 7.2514 4.0012 0.0 0
M  V30 10 O 6.4814 2.6675 0.0 0
M  V30 11 O 8.7914 1.3338 0.0 0
M  V30 12 C 9.5615 0.0000 0.0 0
M  V30 13 O 11.8715 6.6687 0.0 0
M  V30 14 F 13.4115 4.0012 0.0 0
M  V30 15 C 17.6713 7.6586 0.0 0
M  V30 16 O 19.1184 7.1317 0.0 0
M  V30 17 O 17.4039 9.1752 0.0 0
M  V30 18 C 20.2983 8.1217 0.0 0
M  V30 19 C 21.2882 6.9420 0.0 0
M  V30 20 C 21.4779 9.1116 0.0 0
M  V30 21 C 19.3083 9.3015 0.0 0
M  V30 22 C 17.6713 5.6787 0.0 0
M  V30 23 C 3.7084 5.7158 0.0 0 CFG=1
M  V30 24 C 4.9414 5.3348 0.0 0 CFG=2
M  V30 25 C 2.3858 5.5118 0.0 0 CFG=2
M  V30 26 C 3.5231 4.8967 0.0 0 CFG=1
M  V30 27 C 1.6167 6.7062 0.0 0
M  V30 28 C 1.9569 3.9956 0.0 0
M  V30 29 C 3.0617 3.5747 0.0 0
M  V30 30 C 8.7914 4.0012 0.0 0
M  V30 31 C 9.5615 2.6675 0.0 0
M  V30 32 C 9.5615 5.3348 0.0 0
M  V30 33 C 11.1015 2.6675 0.0 0
M  V30 34 C 11.1015 5.3348 0.0 0
M  V30 35 C 11.8715 4.0012 0.0 0
M  V30 36 C 13.4115 6.6687 0.0 0 CFG=2
M  V30 37 C 14.1816 5.3348 0.0 0
M  V30 38 C 14.1816 8.0023 0.0 0
M  V30 39 C 15.7216 5.3348 0.0 0
M  V30 40 C 15.7216 8.0023 0.0 0
M  V30 41 C 16.4916 6.6687 0.0 0 CFG=1
M  V30 42 H 0.8627 5.2843 0.0 0
M  V30 43 H 4.5922 3.7883 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 24 8 CFG=3
M  V30 10 2 9 10
M  V30 11 1 9 30
M  V30 12 1 11 12
M  V30 13 1 11 31
M  V30 14 1 13 34
M  V30 15 1 36 13 CFG=3
M  V30 16 1 14 35
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 41 15 CFG=3
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 1 41 22 CFG=1
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 25 42 CFG=1
M  V30 31 1 26 27
M  V30 32 1 26 29
M  V30 33 1 26 43 CFG=3
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 23 24 25 26 36 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-81-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787516-58-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787520-00-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40331891
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric
RXFP1 Agonist for Treatment of Heart Failure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Larsson, Niklas; Bergstroem,
Fredrik; Fuchigami, Ryuichi; Niwa, Yasuki; Ryberg, Erik; Backmark, Anna;
Kato, Harutoshi; Miyazaki, Shiki; Iguchi, Kaori; Sakamoto, Toshiaki;
Persson, Mikael; Idei, Akiko; Prieto Garcia, Luna; Villar, Inmaculada C.;
Graden, Henrik; Bergonzini, Giulia; Arvidsson, Torbjoern; Fujita, Takuya;
Althage, Magnus; Ulander, Johan; Kimura, Junpei; Yoneda, Hikaru;
Fjellstroem, Ola; Mochida, Hideki; Lal, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4419-4441

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
L-Proline, 1-[5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoyl]-2-methyl-5-oxo-
C16H16N4O5
3055189-26-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7383 5.1047 0.0 0
M  V30 2 O 3.9683 3.7711 0.0 0
M  V30 3 C 0.9052 6.4384 0.0 0
M  V30 4 O 0.0000 7.6844 0.0 0
M  V30 5 O 0.2787 5.0316 0.0 0
M  V30 6 C 2.4368 5.0594 0.0 0
M  V30 7 O 6.1011 8.1655 0.0 0
M  V30 8 O 9.3584 7.7722 0.0 0
M  V30 9 C 10.8984 7.7722 0.0 0
M  V30 10 N 3.9683 6.4384 0.0 0
M  V30 11 C 2.4368 6.5995 0.0 0 CFG=2
M  V30 12 C 4.5948 7.8453 0.0 0
M  V30 13 C 2.1166 8.1058 0.0 0
M  V30 14 C 3.4503 8.8758 0.0 0
M  V30 15 C 6.2784 5.1047 0.0 0
M  V30 16 C 7.0484 3.7711 0.0 0
M  V30 17 C 7.0484 6.4384 0.0 0
M  V30 18 C 8.5884 3.7711 0.0 0
M  V30 19 C 8.5884 6.4384 0.0 0
M  V30 20 C 9.3584 5.1047 0.0 0
M  V30 21 N 6.2784 2.4374 0.0 0
M  V30 22 N 4.7468 2.2763 0.0 0
M  V30 23 N 6.9048 1.0304 0.0 0
M  V30 24 C 4.4266 0.7700 0.0 0
M  V30 25 C 5.7603 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 11 3 CFG=3
M  V30 7 1 11 6 CFG=1
M  V30 8 2 7 12
M  V30 9 1 8 9
M  V30 10 1 8 19
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, 2,3-diamino-6-chloro-
C7H9ClN2O
3055189-27-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 N 2.6675 0.0000 0.0 0
M  V30 4 Cl 5.3348 4.6201 0.0 0
M  V30 5 N 0.0000 1.5400 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 1.5400 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3338 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyrrolidinecarboxamide, N-[2-amino-4-chloro-3-(hydroxymethyl)phenyl]-1-[5-m...
C23H23ClN6O5
3055189-25-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4050 5.1835 0.0 0
M  V30 2 O 7.3103 3.9376 0.0 0
M  V30 3 C 10.0778 6.9106 0.0 0
M  V30 4 N 10.8478 8.2443 0.0 0
M  V30 5 O 10.8478 5.5768 0.0 0
M  V30 6 C 8.6987 5.3789 0.0 0
M  V30 7 O 4.7298 8.0850 0.0 0
M  V30 8 O 1.5315 7.3534 0.0 0
M  V30 9 C 0.0000 7.1923 0.0 0
M  V30 10 N 12.3878 10.9116 0.0 0
M  V30 11 C 15.4678 10.9116 0.0 0
M  V30 12 O 17.0078 10.9116 0.0 0
M  V30 13 Cl 17.0078 8.2443 0.0 0
M  V30 14 N 7.0315 6.5903 0.0 0
M  V30 15 C 8.5378 6.9106 0.0 0 CFG=2
M  V30 16 C 6.2615 7.9241 0.0 0
M  V30 17 C 8.6987 8.4422 0.0 0
M  V30 18 C 7.2919 9.0685 0.0 0
M  V30 19 C 4.8735 5.0226 0.0 0
M  V30 20 C 4.2472 3.6156 0.0 0
M  V30 21 C 3.9683 6.2684 0.0 0
M  V30 22 C 2.7155 3.4547 0.0 0
M  V30 23 C 2.4368 6.1075 0.0 0
M  V30 24 C 1.8104 4.7006 0.0 0
M  V30 25 C 12.3878 8.2443 0.0 0
M  V30 26 C 13.1578 9.5779 0.0 0
M  V30 27 C 13.1578 6.9106 0.0 0
M  V30 28 C 14.6978 9.5779 0.0 0
M  V30 29 C 14.6978 6.9106 0.0 0
M  V30 30 C 15.4678 8.2443 0.0 0
M  V30 31 N 5.1524 2.3698 0.0 0
M  V30 32 N 6.6924 2.3698 0.0 0
M  V30 33 N 4.6764 0.9052 0.0 0
M  V30 34 C 7.1683 0.9052 0.0 0
M  V30 35 C 5.9224 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 15 3 CFG=1
M  V30 7 1 4 25
M  V30 8 1 15 6 CFG=3
M  V30 9 2 7 16
M  V30 10 1 8 9
M  V30 11 1 8 23
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 1 11 28
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 31
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3055189-26-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3055189-27-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055189-25-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36589101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist
Daridorexant to 4-Hydroxypiperidinol Metabolites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Treiber, Alexander; Aissaoui, Hamed; Delahaye, Stephane; Glutz, Sven;
Grimont, Julien; Mueller, Claus; Seeland, Swen; Siefken, Valerie; Boss,
Christoph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2023), 18(10), e202300030

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Boc-ciprofloxacin
C22H26FN3O5
93594-48-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 6.8749 0.0 0
M  V30 2 C 0.7700 4.2074 0.0 0
M  V30 3 O 0.0000 5.5411 0.0 0
M  V30 4 O 0.0000 2.8738 0.0 0
M  V30 5 F 7.7000 8.2085 0.0 0
M  V30 6 C 13.8600 5.5411 0.0 0
M  V30 7 O 14.6300 6.8749 0.0 0
M  V30 8 O 14.6300 4.2074 0.0 0
M  V30 9 C 16.1700 6.8749 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 17.7100 6.8749 0.0 0
M  V30 12 C 16.1700 8.4149 0.0 0
M  V30 13 C 5.3900 4.2074 0.0 0
M  V30 14 N 4.6200 2.8738 0.0 0
M  V30 15 C 4.6200 5.5411 0.0 0
M  V30 16 C 6.9300 4.2074 0.0 0
M  V30 17 C 3.0800 2.8738 0.0 0
M  V30 18 C 3.0800 5.5411 0.0 0
M  V30 19 C 5.3900 6.8749 0.0 0
M  V30 20 C 7.7000 5.5411 0.0 0
M  V30 21 C 2.3100 4.2074 0.0 0
M  V30 22 C 6.9300 6.8749 0.0 0
M  V30 23 C 5.3900 1.5400 0.0 0
M  V30 24 C 5.3900 0.0000 0.0 0
M  V30 25 C 6.7236 0.7700 0.0 0
M  V30 26 N 9.2400 5.5411 0.0 0
M  V30 27 C 10.0100 6.8749 0.0 0
M  V30 28 C 10.0100 4.2074 0.0 0
M  V30 29 C 11.5500 6.8749 0.0 0
M  V30 30 C 11.5500 4.2074 0.0 0
M  V30 31 N 12.3200 5.5411 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 5 22
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 31
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 14 23
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 25 1 20 26
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, α-methyl-4-nitro-, hydrochloride (1:1), (αS)-
C8H10N2O2.ClH
132873-57-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 3.0800 0.0 0 CFG=1
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 N 6.6686 1.5400 0.0 0
M  V30 4 N 1.3337 6.1601 0.0 0 VAL=5
M  V30 5 O 0.0000 5.3900 0.0 0
M  V30 6 O 1.3337 7.7001 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 5.3348 5.3900 0.0 0
M  V30 10 C 2.6675 3.8500 0.0 0
M  V30 11 C 4.0011 6.1601 0.0 0
M  V30 12 C 2.6675 5.3900 0.0 0
M  V30 13 Cl 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[1-cyclopropyl-6-fluoro-1,4-dihydro-3-[[[(1S)-...
C30H34FN5O6
3050771-83-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.3370 8.4702 0.0 0
M  V30 2 C 16.0045 6.9302 0.0 0
M  V30 3 N 17.3382 6.1601 0.0 0
M  V30 4 O 16.0045 8.4702 0.0 0
M  V30 5 C 18.6718 6.9302 0.0 0 CFG=2
M  V30 6 C 18.6718 8.4702 0.0 0
M  V30 7 F 8.0022 6.9302 0.0 0
M  V30 8 C 4.0010 1.5400 0.0 0
M  V30 9 O 2.6673 2.3101 0.0 0
M  V30 10 O 4.0010 0.0000 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 2.1037 0.2064 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 0.5637 2.8737 0.0 0
M  V30 15 N 24.0067 3.8501 0.0 0 VAL=5
M  V30 16 O 25.3403 4.6201 0.0 0
M  V30 17 O 24.0067 2.3101 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 N 13.3370 3.8501 0.0 0
M  V30 20 C 12.0033 6.1601 0.0 0
M  V30 21 C 10.6697 3.8501 0.0 0
M  V30 22 C 14.6707 4.6201 0.0 0
M  V30 23 C 13.3370 6.9302 0.0 0
M  V30 24 C 10.6697 6.9302 0.0 0
M  V30 25 C 9.3358 4.6201 0.0 0
M  V30 26 C 14.6707 6.1601 0.0 0
M  V30 27 C 9.3358 6.1601 0.0 0
M  V30 28 C 13.3370 2.3101 0.0 0
M  V30 29 C 12.5670 0.9764 0.0 0
M  V30 30 C 14.1070 0.9764 0.0 0
M  V30 31 N 8.0022 3.8501 0.0 0
M  V30 32 C 6.6685 4.6201 0.0 0
M  V30 33 C 8.0022 2.3101 0.0 0
M  V30 34 C 5.3348 3.8501 0.0 0
M  V30 35 C 6.6685 1.5400 0.0 0
M  V30 36 N 5.3348 2.3101 0.0 0
M  V30 37 C 20.0055 6.1601 0.0 0
M  V30 38 C 20.0055 4.6201 0.0 0
M  V30 39 C 21.3393 6.9302 0.0 0
M  V30 40 C 21.3393 3.8501 0.0 0
M  V30 41 C 22.6730 6.1601 0.0 0
M  V30 42 C 22.6730 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 26
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 37
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 36
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 42
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 28
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 2 25 27
M  V30 31 1 25 31
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93594-48-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132873-57-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3050771-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40881641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin
Prodrug
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ross, Catherine L.; Lawer, Aggie; Sircombe, Kathleen J.; Pletzer, Daniel;
Gamble, Allan B.; Hook, Sarah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 9599-9612

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
2,6-Diethylaniline
C10H15N
579-66-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-Chloro-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4...
C17H22ClN5O3Si
2820453-44-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2067 1.5192 0.0 0
M  V30 2 Cl 8.0223 0.0000 0.0 0
M  V30 3 C 10.9716 5.2890 0.0 0
M  V30 4 O 11.7416 6.6226 0.0 0
M  V30 5 C 13.2816 6.6226 0.0 0
M  V30 6 C 14.0516 7.9563 0.0 0
M  V30 7 Si 15.5916 7.9563 0.0 0
M  V30 8 C 17.1316 7.9563 0.0 0
M  V30 9 C 15.5916 6.4163 0.0 0
M  V30 10 C 15.5916 9.4963 0.0 0
M  V30 11 C 1.5315 6.6750 0.0 0
M  V30 12 O 0.0000 6.5139 0.0 0
M  V30 13 O 2.1580 8.0818 0.0 0
M  V30 14 C 5.9173 3.4886 0.0 0
M  V30 15 C 7.0617 4.5190 0.0 0
M  V30 16 N 6.2375 1.9821 0.0 0
M  V30 17 C 8.5264 4.0431 0.0 0
M  V30 18 C 7.0617 6.0590 0.0 0
M  V30 19 C 7.7022 1.5063 0.0 0
M  V30 20 N 9.4316 5.2890 0.0 0
M  V30 21 N 8.8465 2.5367 0.0 0
M  V30 22 C 8.5264 6.5348 0.0 0
M  V30 23 C 4.4526 3.9644 0.0 0
M  V30 24 C 3.9767 5.4290 0.0 0
M  V30 25 N 3.2067 3.0592 0.0 0
M  V30 26 C 2.4367 5.4290 0.0 0
M  V30 27 N 1.9609 3.9644 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 26
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-Chloro-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4...
C27H35ClN6O2Si
2820453-45-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2873 2.0142 0.0 0
M  V30 2 Cl 11.9177 0.0000 0.0 0
M  V30 3 C 15.4037 4.9518 0.0 0
M  V30 4 O 16.3089 6.1977 0.0 0
M  V30 5 C 17.8405 6.0368 0.0 0
M  V30 6 C 18.7457 7.2826 0.0 0
M  V30 7 Si 20.2773 7.1217 0.0 0
M  V30 8 C 21.8090 6.9606 0.0 0
M  V30 9 C 20.1163 5.5902 0.0 0
M  V30 10 C 20.4383 8.6533 0.0 0
M  V30 11 C 6.1601 7.3170 0.0 0
M  V30 12 N 4.6201 7.3170 0.0 0
M  V30 13 O 6.9301 8.6507 0.0 0
M  V30 14 C 1.5400 7.3170 0.0 0
M  V30 15 C 0.0000 7.3170 0.0 0
M  V30 16 C 6.1601 9.9843 0.0 0
M  V30 17 C 6.9301 11.3180 0.0 0
M  V30 18 C 10.1888 3.6894 0.0 0
M  V30 19 C 11.4347 4.5947 0.0 0
M  V30 20 N 10.3498 2.1579 0.0 0
M  V30 21 C 12.8417 3.9683 0.0 0
M  V30 22 C 11.5958 6.1262 0.0 0
M  V30 23 C 11.7567 1.5316 0.0 0
M  V30 24 N 13.8721 5.1127 0.0 0
M  V30 25 N 13.0026 2.4368 0.0 0
M  V30 26 C 13.1021 6.4466 0.0 0
M  V30 27 C 8.7820 4.3159 0.0 0
M  V30 28 C 8.4618 5.8222 0.0 0
M  V30 29 N 7.4482 3.5459 0.0 0
M  V30 30 C 6.9301 5.9832 0.0 0
M  V30 31 N 6.3038 4.5763 0.0 0
M  V30 32 C 3.8501 8.6507 0.0 0
M  V30 33 C 2.3100 8.6507 0.0 0
M  V30 34 C 4.6201 9.9843 0.0 0
M  V30 35 C 1.5400 9.9843 0.0 0
M  V30 36 C 3.8501 11.3180 0.0 0
M  V30 37 C 2.3100 11.3180 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 24
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 30
M  V30 14 1 12 32
M  V30 15 1 14 15
M  V30 16 1 14 33
M  V30 17 1 16 17
M  V30 18 1 16 34
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 27
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 579-66-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2820453-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2820453-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34106977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors
with Potent Antitumor Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elsner, Jan; Cashion, Dan; Robinson, Dale; Bahmanyar, Sogole; Tehrani,
Lida; Fultz, Kimberly E.; Narla, Rama Krishna; Peng, Xiaohui; Tran, Tam;
Apuy, Julius; LeBrun, Laurie; Leftheris, Katerina; Boylan, John F.; Zhu,
Dan; Riggs, Jennifer R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(17), 12670-12679

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
6-Methoxy-1H-indole-2-carboxylic acid
C10H9NO3
16732-73-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.5400 0.0 0
M  V30 2 O 0.0000 0.2064 0.0 0
M  V30 3 O 0.0000 2.8737 0.0 0
M  V30 4 O 8.6809 3.0800 0.0 0
M  V30 5 C 10.0147 2.3100 0.0 0
M  V30 6 C 4.6799 2.3100 0.0 0
M  V30 7 C 4.6799 0.7700 0.0 0
M  V30 8 N 3.2152 2.7859 0.0 0
M  V30 9 C 6.0136 3.0800 0.0 0
M  V30 10 C 3.2152 0.2941 0.0 0
M  V30 11 C 6.0136 0.0000 0.0 0
M  V30 12 C 2.3100 1.5400 0.0 0
M  V30 13 C 7.3472 2.3100 0.0 0
M  V30 14 C 7.3472 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxamide, N-[4-[5-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinoli...
C32H29N3O6
2892485-70-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6201 0.0 0
M  V30 2 O 8.0021 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8996 3.9759 0.0 0
M  V30 8 C 18.8048 2.7300 0.0 0
M  V30 9 O 18.1785 1.3230 0.0 0
M  V30 10 O 26.8335 2.0253 0.0 0
M  V30 11 C 28.0793 2.9305 0.0 0
M  V30 12 C 4.0011 3.8501 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 N 6.6685 3.8501 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 2.3100 0.0 0
M  V30 21 C 6.6685 2.3100 0.0 0
M  V30 22 C 9.3360 3.8501 0.0 0
M  V30 23 O 10.7428 4.4764 0.0 0
M  V30 24 C 9.4969 2.3185 0.0 0
M  V30 25 C 11.7732 3.3320 0.0 0
M  V30 26 C 11.0032 1.9983 0.0 0
M  V30 27 C 13.3049 3.4929 0.0 0
M  V30 28 C 13.9313 4.8999 0.0 0
M  V30 29 C 14.2100 2.2471 0.0 0
M  V30 30 C 15.4628 5.0608 0.0 0
M  V30 31 C 15.7417 2.4080 0.0 0
M  V30 32 C 16.3680 3.8150 0.0 0
M  V30 33 C 20.3364 2.8909 0.0 0
M  V30 34 N 21.3670 1.7465 0.0 0
M  V30 35 C 21.1064 4.2246 0.0 0
M  V30 36 C 22.7738 2.3729 0.0 0
M  V30 37 C 22.6129 3.9044 0.0 0
M  V30 38 C 24.1806 1.7465 0.0 0
M  V30 39 C 23.8587 4.8097 0.0 0
M  V30 40 C 25.4267 2.6518 0.0 0
M  V30 41 C 25.2656 4.1833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 1 7 32
M  V30 10 2 8 9
M  V30 11 1 8 33
M  V30 12 1 10 11
M  V30 13 1 10 40
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 2 19 20
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 2 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 16732-73-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
6-Trifluoromethyl-2-pyridinecarboxylic acid
C7H4F3NO2
131747-42-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 N 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-amino-6-(phenylmethoxy)-2H-indazole-2-acetate
C18H19N3O3
1799835-87-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6675 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 13.0111 5.2892 0.0 0
M  V30 4 C 14.3447 4.5192 0.0 0
M  V30 5 O 15.6785 5.2892 0.0 0
M  V30 6 O 14.3447 2.9792 0.0 0
M  V30 7 C 17.0122 4.5192 0.0 0
M  V30 8 C 18.3458 5.2892 0.0 0
M  V30 9 N 6.9300 0.0000 0.0 0
M  V30 10 C 9.2401 4.0011 0.0 0
M  V30 11 C 10.0101 2.6675 0.0 0
M  V30 12 C 7.7001 4.0011 0.0 0
M  V30 13 N 10.2705 5.1456 0.0 0
M  V30 14 C 11.5164 2.9876 0.0 0
M  V30 15 C 9.2401 1.3338 0.0 0
M  V30 16 C 6.9300 2.6675 0.0 0
M  V30 17 N 11.6774 4.5192 0.0 0
M  V30 18 C 7.7001 1.3338 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 2.3100 2.6675 0.0 0
M  V30 21 C 2.3100 5.3349 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 0.7700 5.3349 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(phenylmethoxy)-5-[[[6-(trifluoromethyl)-2-pyridinyl]carbonyl]amino]-...
C25H21F3N4O4
1799835-95-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.7238 8.0022 0.0 0
M  V30 2 C 5.9538 9.3360 0.0 0
M  V30 3 O 6.7238 10.6697 0.0 0
M  V30 4 C 14.3450 10.6241 0.0 0
M  V30 5 C 15.6786 9.8541 0.0 0
M  V30 6 O 17.0124 10.6241 0.0 0
M  V30 7 O 15.6786 8.3140 0.0 0
M  V30 8 C 18.3461 9.8541 0.0 0
M  V30 9 C 19.6798 10.6241 0.0 0
M  V30 10 O 8.2638 5.3348 0.0 0
M  V30 11 C 9.0338 4.0010 0.0 0
M  V30 12 C 1.3337 12.0033 0.0 0
M  V30 13 F 0.0000 11.2333 0.0 0
M  V30 14 F 0.5637 13.3370 0.0 0
M  V30 15 F 2.6673 12.7733 0.0 0
M  V30 16 C 10.5739 9.3360 0.0 0
M  V30 17 C 11.3439 8.0022 0.0 0
M  V30 18 C 9.0338 9.3360 0.0 0
M  V30 19 C 11.6043 10.4804 0.0 0
M  V30 20 C 10.5739 6.6685 0.0 0
M  V30 21 N 12.8503 8.3223 0.0 0
M  V30 22 C 8.2638 8.0022 0.0 0
M  V30 23 N 13.0113 9.8541 0.0 0
M  V30 24 C 9.0338 6.6685 0.0 0
M  V30 25 C 4.4137 9.3360 0.0 0
M  V30 26 N 3.6437 10.6697 0.0 0
M  V30 27 C 3.6437 8.0022 0.0 0
M  V30 28 C 2.1037 10.6697 0.0 0
M  V30 29 C 2.1037 8.0022 0.0 0
M  V30 30 C 1.3337 9.3360 0.0 0
M  V30 31 C 8.2638 2.6673 0.0 0
M  V30 32 C 6.7238 2.6673 0.0 0
M  V30 33 C 9.0338 1.3337 0.0 0
M  V30 34 C 5.9538 1.3337 0.0 0
M  V30 35 C 8.2638 0.0000 0.0 0
M  V30 36 C 6.7238 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 2 2 3
M  V30 4 1 2 25
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 28
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 131747-42-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1799835-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799835-95-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bothe, Ulrich; Guenther, Judith; Nubbemeyer, Reinhard; Siebeneicher,
Holger; Ring, Sven; Boemer, Ulf; Peters, Michaele; Rausch, Alexandra;
Denner, Karsten; Himmel, Herbert; Sutter, Andreas; Terebesi, Ildiko;
Lange, Martin; Wengner, Antje M.; Guimond, Nicolas; Thaler, Tobias;
Platzek, Johannes; Eberspaecher, Uwe; Schaefer, Martina; Steuber, Holger;
Zollner, Thomas M.; Steinmeyer, Andreas; Schmidt, Nicole
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1225-1242

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
(S)-6-Oxopiperidine-2-carboxylic acid
C6H9NO3
34622-39-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 4.6201 0.0 0
M  V30 4 O 6.6686 3.0800 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0 CFG=2
M  V30 6 N 4.0011 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=1
M  V30 4 2 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[[2-amino-4-(3,5-dimethyl-4-isoxazolyl)phenyl]...
C24H28N4O3
3032646-77-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7103 2.4873 0.0 0
M  V30 2 C 3.4209 7.1821 0.0 0
M  V30 3 N 5.1047 0.0000 0.0 0
M  V30 4 N 7.7722 1.5400 0.0 0
M  V30 5 C 13.1071 4.6201 0.0 0
M  V30 6 O 14.4407 3.8501 0.0 0
M  V30 7 O 13.1071 6.1601 0.0 0
M  V30 8 C 15.7744 4.6201 0.0 0
M  V30 9 C 2.4374 4.6201 0.0 0
M  V30 10 C 1.0304 3.9936 0.0 0
M  V30 11 C 2.2763 6.1517 0.0 0
M  V30 12 N 0.0000 5.1382 0.0 0
M  V30 13 O 0.7700 6.4718 0.0 0
M  V30 14 C 3.7711 3.8501 0.0 0
M  V30 15 C 3.7711 2.3101 0.0 0
M  V30 16 C 5.1047 4.6201 0.0 0
M  V30 17 C 5.1047 1.5400 0.0 0
M  V30 18 C 6.4384 3.8501 0.0 0
M  V30 19 C 6.4384 2.3101 0.0 0
M  V30 20 C 9.1059 2.3101 0.0 0
M  V30 21 C 10.4396 1.5400 0.0 0
M  V30 22 C 9.1059 3.8501 0.0 0
M  V30 23 C 11.7734 2.3101 0.0 0
M  V30 24 C 10.4396 4.6201 0.0 0
M  V30 25 N 11.7734 3.8501 0.0 0
M  V30 26 C 17.1082 3.8501 0.0 0
M  V30 27 C 18.4419 4.6201 0.0 0
M  V30 28 C 17.1082 2.3101 0.0 0
M  V30 29 C 19.7756 3.8501 0.0 0
M  V30 30 C 18.4419 1.5400 0.0 0
M  V30 31 C 19.7756 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 1 3 17
M  V30 4 1 4 19
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 25
M  V30 9 1 6 8
M  V30 10 1 8 26
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 14
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[[4-(3,5-dimethyl-4-isoxazolyl)-2-[[[(2S)-6-ox...
C30H35N5O5
3032646-78-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.5980 3.4209 0.0 0
M  V30 2 C 8.2929 0.7103 0.0 0
M  V30 3 N 6.1601 7.7721 0.0 0
M  V30 4 C 4.6201 7.7721 0.0 0
M  V30 5 O 3.8501 6.4384 0.0 0
M  V30 6 N 9.2402 7.7721 0.0 0
M  V30 7 O 0.0000 10.4396 0.0 0
M  V30 8 C 15.4003 7.7721 0.0 0
M  V30 9 O 16.1704 9.1059 0.0 0
M  V30 10 O 16.1704 6.4384 0.0 0
M  V30 11 C 17.7104 9.1059 0.0 0
M  V30 12 C 6.1601 2.4373 0.0 0
M  V30 13 C 4.6286 2.2763 0.0 0
M  V30 14 C 6.7865 1.0304 0.0 0
M  V30 15 N 4.3084 0.7700 0.0 0
M  V30 16 O 5.6421 0.0000 0.0 0
M  V30 17 C 6.9302 3.7711 0.0 0
M  V30 18 C 6.1601 5.1048 0.0 0
M  V30 19 C 8.4702 3.7711 0.0 0
M  V30 20 C 6.9302 6.4384 0.0 0
M  V30 21 C 9.2402 5.1048 0.0 0
M  V30 22 C 8.4702 6.4384 0.0 0
M  V30 23 C 10.7802 7.7721 0.0 0
M  V30 24 C 11.5503 9.1059 0.0 0
M  V30 25 C 11.5503 6.4384 0.0 0
M  V30 26 C 13.0903 9.1059 0.0 0
M  V30 27 C 13.0903 6.4384 0.0 0
M  V30 28 N 13.8603 7.7721 0.0 0
M  V30 29 C 3.8501 9.1059 0.0 0 CFG=2
M  V30 30 N 2.3101 9.1059 0.0 0
M  V30 31 C 4.6201 10.4396 0.0 0
M  V30 32 C 1.5400 10.4396 0.0 0
M  V30 33 C 3.8501 11.7733 0.0 0
M  V30 34 C 2.3101 11.7733 0.0 0
M  V30 35 C 18.4804 10.4396 0.0 0
M  V30 36 C 20.0204 10.4396 0.0 0
M  V30 37 C 17.7104 11.7733 0.0 0
M  V30 38 C 20.7905 11.7733 0.0 0
M  V30 39 C 18.4804 13.1069 0.0 0
M  V30 40 C 20.0204 13.1069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 2 4 5
M  V30 6 1 29 4 CFG=1
M  V30 7 1 6 22
M  V30 8 1 6 23
M  V30 9 2 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 28
M  V30 13 1 9 11
M  V30 14 1 11 35
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 17
M  V30 18 2 13 15
M  V30 19 1 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 34622-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3032646-77-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032646-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39325781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics
for Hepatocellular Carcinoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chang, Qi; Li, Jiayi; Deng, Yue; Zhou, Ruilin; Wang, Bingwei; Wang,
Yujie; Zhang, Mingming; Huang, Xun; Li, Yingxia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(4), 2466-2486

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
2-[(6S,Z)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[...
C19H17ClN4O2S
202592-23-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3988 8.6280 0.0 0
M  V30 2 C 0.4292 8.4909 0.0 0
M  V30 3 C 5.1944 11.1511 0.0 0
M  V30 4 C 3.2311 2.5489 0.0 0
M  V30 5 C 4.3600 1.5015 0.0 0
M  V30 6 O 5.8315 1.9553 0.0 0
M  V30 7 O 4.0172 0.0000 0.0 0
M  V30 8 Cl 11.9033 5.7805 0.0 0
M  V30 9 C 3.5737 7.5106 0.0 0
M  V30 10 C 5.0752 7.1679 0.0 0
M  V30 11 N 2.3698 6.5505 0.0 0
M  V30 12 S 3.4357 9.0444 0.0 0
M  V30 13 C 5.7433 5.7805 0.0 0
M  V30 14 C 5.8651 8.4900 0.0 0
M  V30 15 C 2.3698 5.0105 0.0 0
M  V30 16 C 0.9051 7.0264 0.0 0
M  V30 17 C 4.8518 9.6496 0.0 0
M  V30 18 N 5.0752 4.3930 0.0 0
M  V30 19 C 3.5737 4.0504 0.0 0 CFG=2
M  V30 20 N 0.9051 4.5345 0.0 0
M  V30 21 N 0.0000 5.7805 0.0 0
M  V30 22 C 7.2833 5.7805 0.0 0
M  V30 23 C 8.0533 4.4468 0.0 0
M  V30 24 C 8.0533 7.1142 0.0 0
M  V30 25 C 9.5933 4.4468 0.0 0
M  V30 26 C 9.5933 7.1142 0.0 0
M  V30 27 C 10.3633 5.7805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 16
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 2 13 18
M  V30 18 1 13 22
M  V30 19 2 14 17
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 2 16 21
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[(6-amino-2,4-hexadiyn-1-yl)oxy]acetate
C12H17NO3
2417371-67-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 O 2.6675 3.8501 0.0 0
M  V30 5 O 4.0012 1.5400 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 C 1.3338 3.0801 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 0.5638 4.4137 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 2.1038 1.7464 0.0 0
M  V30 12 C 10.6698 2.3101 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 C 13.3372 0.7700 0.0 0
M  V30 15 C 14.6708 0.0000 0.0 0
M  V30 16 N 16.0046 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 3 8 12
M  V30 12 1 12 13
M  V30 13 3 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[6-[[2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thien...
C31H32ClN5O4S
2417371-68-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.9694 6.7644 0.0 0
M  V30 2 C 0.0000 4.0539 0.0 0
M  V30 3 C 3.6538 0.0000 0.0 0
M  V30 4 C 8.8234 4.0539 0.0 0
M  V30 5 C 9.5934 5.3875 0.0 0
M  V30 6 N 11.1334 5.3875 0.0 0
M  V30 7 O 8.8234 6.7213 0.0 0
M  V30 8 C 11.9034 6.7213 0.0 0
M  V30 9 C 13.4434 6.7213 0.0 0
M  V30 10 C 14.9834 6.7213 0.0 0
M  V30 11 C 16.5234 6.7213 0.0 0
M  V30 12 C 18.0634 6.7213 0.0 0
M  V30 13 C 19.6034 6.7213 0.0 0
M  V30 14 O 20.3734 8.0550 0.0 0
M  V30 15 C 21.9134 8.0550 0.0 0
M  V30 16 C 22.6834 9.3886 0.0 0
M  V30 17 O 24.2234 9.3886 0.0 0
M  V30 18 O 21.9134 10.7222 0.0 0
M  V30 19 C 24.9934 10.7222 0.0 0
M  V30 20 C 26.3272 9.9522 0.0 0
M  V30 21 C 25.7634 12.0560 0.0 0
M  V30 22 C 23.6598 11.4922 0.0 0
M  V30 23 Cl 3.7431 11.7896 0.0 0
M  V30 24 C 3.9099 4.8239 0.0 0
M  V30 25 C 3.9099 3.2839 0.0 0
M  V30 26 C 5.1139 5.7841 0.0 0
M  V30 27 C 2.4452 5.2998 0.0 0
M  V30 28 N 5.1139 2.3237 0.0 0
M  V30 29 S 2.4452 2.8080 0.0 0
M  V30 30 N 6.6152 5.4414 0.0 0
M  V30 31 C 1.5400 4.0539 0.0 0
M  V30 32 C 6.6152 2.6664 0.0 0
M  V30 33 C 4.9759 0.7899 0.0 0
M  V30 34 C 7.2834 4.0539 0.0 0 CFG=1
M  V30 35 N 7.4051 1.3444 0.0 0
M  V30 36 N 6.3919 0.1846 0.0 0
M  V30 37 C 4.7712 7.2854 0.0 0
M  V30 38 C 5.9002 8.3329 0.0 0
M  V30 39 C 3.2996 7.7394 0.0 0
M  V30 40 C 5.5574 9.8343 0.0 0
M  V30 41 C 2.9570 9.2408 0.0 0
M  V30 42 C 4.0859 10.2883 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 2 31
M  V30 3 1 3 33
M  V30 4 1 4 5
M  V30 5 1 34 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 3 9 10
M  V30 11 1 10 11
M  V30 12 3 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 23 42
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 29 2 26 30
M  V30 30 1 26 37
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 28 33
M  V30 34 1 29 31
M  V30 35 1 30 34
M  V30 36 1 32 34
M  V30 37 2 32 35
M  V30 38 2 33 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 202592-23-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2417371-67-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417371-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40132270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1:
Exploration of Antibody Linker, Payload Loading, and Payload Molecular
Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dragovich, Peter S.; Pillow, Thomas H.; Blake, Robert A.; Sadowsky, Jack
D.; Adaligil, Emel; Adhikari, Pragya; Bhakta, Sunil; Blaquiere, Nicole;
Chen, Jinhua; dela Cruz-Chuh, Josefa; Gascoigne, Karen E.; Hartman,
Steven J.; He, Mingtao; Kaufman, Susan; Kleinheinz, Tracy; Kozak,
Katherine R.; Liu, Liang; Liu, Liling; Liu, Qi; Lu, Ying; Meng, Fanwei;
Mulvihill, Melinda M.; O'Donohue, Aimee; Rowntree, Rebecca K.; Staben,
Leanna R.; Staben, Steven T.; Wai, John; Wang, Jian; Wei, BinQing;
Wilson, Catherine; Xin, Jianfeng; Xu, Zijin; Yao, Hui; Zhang, Donglu;
Zhang, Hongyan; Zhou, Hao; Zhu, Xiaoyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(5), 2534-2575

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-(2-aminoethoxy)ethyl]carbamate
C9H20N2O3
127828-22-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5637 2.8737 0.0 0
M  V30 11 O 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 14 N 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indazole-3-carboxylic acid, 5-[[4-(4-formyl-3-methyl-1H-pyrazol-1-yl)-2-py...
C20H19N7O4
3050715-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.7960 1.0304 0.0 0
M  V30 2 O 11.3313 0.5546 0.0 0
M  V30 3 O 13.9404 0.0000 0.0 0
M  V30 4 C 15.5064 5.7253 0.0 0
M  V30 5 C 16.9711 5.2492 0.0 0
M  V30 6 O 18.1155 6.2798 0.0 0
M  V30 7 C 19.5802 5.8040 0.0 0
M  V30 8 N 8.2358 5.0149 0.0 0
M  V30 9 C 0.0000 9.3575 0.0 0
M  V30 10 O 0.1609 10.8890 0.0 0
M  V30 11 C 0.0000 6.0071 0.0 0
M  V30 12 C 12.0858 3.6812 0.0 0
M  V30 13 C 12.8558 5.0149 0.0 0
M  V30 14 C 13.1162 2.5368 0.0 0
M  V30 15 C 10.5458 3.6812 0.0 0
M  V30 16 N 14.3620 4.6947 0.0 0
M  V30 17 C 12.0858 6.3487 0.0 0
M  V30 18 N 14.5230 3.1632 0.0 0
M  V30 19 C 9.7758 5.0149 0.0 0
M  V30 20 C 10.5458 6.3487 0.0 0
M  V30 21 C 7.4658 6.3487 0.0 0
M  V30 22 N 5.9258 6.3487 0.0 0
M  V30 23 N 8.2358 7.6823 0.0 0
M  V30 24 C 5.1558 7.6823 0.0 0
M  V30 25 C 7.4658 9.0159 0.0 0
M  V30 26 C 5.9258 9.0159 0.0 0
M  V30 27 N 3.6158 7.6823 0.0 0
M  V30 28 C 2.7106 8.9282 0.0 0
M  V30 29 N 2.7106 6.4364 0.0 0
M  V30 30 C 1.2459 8.4523 0.0 0
M  V30 31 C 1.2459 6.9123 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 19
M  V30 9 1 8 21
M  V30 10 2 9 10
M  V30 11 1 9 30
M  V30 12 1 11 31
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 2 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[2-[2-[[[5-[[4-(4-formyl-3-methyl-1H-pyrazol-1-yl)-2-pyrimid...
C29H37N9O6
3050715-37-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.8593 2.7843 0.0 0
M  V30 2 C 16.2661 2.1580 0.0 0
M  V30 3 O 16.4270 0.6265 0.0 0
M  V30 4 C 17.8340 0.0000 0.0 0
M  V30 5 C 15.9864 8.0868 0.0 0
M  V30 6 N 17.5264 8.0868 0.0 0
M  V30 7 O 15.2164 9.4206 0.0 0
M  V30 8 C 18.2964 9.4206 0.0 0
M  V30 9 C 19.8364 9.4206 0.0 0
M  V30 10 O 20.6064 10.7543 0.0 0
M  V30 11 C 22.1463 10.7543 0.0 0
M  V30 12 C 22.9163 12.0879 0.0 0
M  V30 13 N 24.4563 12.0879 0.0 0
M  V30 14 C 25.2264 13.4216 0.0 0
M  V30 15 O 26.7664 13.4216 0.0 0
M  V30 16 O 24.4564 14.7554 0.0 0
M  V30 17 C 27.5363 14.7554 0.0 0
M  V30 18 C 28.8701 13.9854 0.0 0
M  V30 19 C 28.3064 16.0890 0.0 0
M  V30 20 C 26.2026 15.5254 0.0 0
M  V30 21 N 9.9313 8.1772 0.0 0
M  V30 22 C 0.9052 10.4609 0.0 0
M  V30 23 O 0.0000 9.2151 0.0 0
M  V30 24 C 3.1471 12.9508 0.0 0
M  V30 25 C 13.3646 5.0859 0.0 0
M  V30 26 C 13.6847 6.5923 0.0 0
M  V30 27 N 14.6982 4.3159 0.0 0
M  V30 28 C 11.9000 4.6100 0.0 0
M  V30 29 C 15.2164 6.7532 0.0 0
M  V30 30 C 12.5404 7.6227 0.0 0
M  V30 31 N 15.8427 5.3464 0.0 0
M  V30 32 C 10.7555 5.6404 0.0 0
M  V30 33 C 11.0757 7.1468 0.0 0
M  V30 34 C 8.4666 7.7014 0.0 0
M  V30 35 N 7.3222 8.7318 0.0 0
M  V30 36 N 8.1464 6.1951 0.0 0
M  V30 37 C 5.8575 8.2559 0.0 0
M  V30 38 C 6.6819 5.7191 0.0 0
M  V30 39 C 5.5374 6.7497 0.0 0
M  V30 40 N 4.7132 9.2864 0.0 0
M  V30 41 C 3.2067 8.9662 0.0 0
M  V30 42 N 4.8741 10.8180 0.0 0
M  V30 43 C 2.4367 10.3000 0.0 0
M  V30 44 C 3.4673 11.4444 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 29
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 33
M  V30 22 1 21 34
M  V30 23 2 22 23
M  V30 24 1 22 43
M  V30 25 1 24 44
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 2 25 28
M  V30 29 1 26 29
M  V30 30 2 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 2 29 31
M  V30 34 1 30 33
M  V30 35 2 32 33
M  V30 36 1 34 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 37 40
M  V30 42 2 38 39
M  V30 43 1 40 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 127828-22-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3050715-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3050715-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37041496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of a series of novel, potent and selective Macrocyclic SYK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grimster, Neil P.; Gingipalli, Lakshmaiah; Balazs, Amber; Barlaam,
Bernard; Boiko, Scott; Boyd, Scott; Dry, Hannah; Goldberg, Frederick W.;
Ikeda, Tim; Johnson, Tony; Kawatkar, Sameer; Kemmitt, Paul; Lamont,
Scott; Lorthioir, Olivier; Mfuh, Adelphe; Patel, Joe; Pike, Andy; Read,
Jon; Romero, Romulo; Sarkar, Ujjal; Sha, Li; Simpson, Iain; Song, Kun;
Su, Qibin; Wang, Haixia; Watson, David; Wu, Allan; Zehnder, Troy E.;
Zheng, XiaoLan; Li, Shaolu; Dong, Zhiqiang; Yang, Dejian; Song, Yanwei;
Wang, Peng; Liu, Xuemei; Dowling, James E.; Edmondson, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2023), 91129352

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
4-([1,4′-Bipiperidin]-1′-ylmethyl)benzenamine
C17H27N3
1307702-36-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 N 6.6685 4.6201 0.0 0
M  V30 9 N 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(2,3-dimethoxyphenyl)-
C20H16N2O4
3002420-86-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9149 0.7700 0.0 0
M  V30 2 O 3.5811 0.0000 0.0 0
M  V30 3 O 6.2486 0.0000 0.0 0
M  V30 4 O 8.9159 3.0800 0.0 0
M  V30 5 C 10.2497 2.3100 0.0 0
M  V30 6 O 11.5833 4.6200 0.0 0
M  V30 7 C 12.9170 5.3900 0.0 0
M  V30 8 C 4.9149 5.3900 0.0 0
M  V30 9 C 3.5811 4.6200 0.0 0
M  V30 10 C 6.2486 4.6200 0.0 0
M  V30 11 N 4.5948 6.8963 0.0 0
M  V30 12 C 2.4368 5.6504 0.0 0
M  V30 13 C 3.5811 3.0800 0.0 0
M  V30 14 N 6.2486 3.0800 0.0 0
M  V30 15 C 3.0631 7.0572 0.0 0
M  V30 16 C 0.9052 5.4895 0.0 0
M  V30 17 C 4.9149 2.3100 0.0 0
M  V30 18 C 2.1579 8.3031 0.0 0
M  V30 19 C 0.0000 6.7354 0.0 0
M  V30 20 C 0.6263 8.1422 0.0 0
M  V30 21 C 7.5822 5.3900 0.0 0
M  V30 22 C 8.9159 4.6200 0.0 0
M  V30 23 C 7.5822 6.9300 0.0 0
M  V30 24 C 10.2497 5.3900 0.0 0
M  V30 25 C 8.9159 7.7000 0.0 0
M  V30 26 C 10.2497 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 21
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, N-[4-([1,4′-bipiperidin]-1′-ylmethyl)ph...
C37H41N5O3
3002420-82-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 8.5288 0.0 0
M  V30 2 N 10.7800 8.5288 0.0 0
M  V30 3 O 8.4700 9.8626 0.0 0
M  V30 4 O 4.6200 8.5288 0.0 0
M  V30 5 C 3.8500 9.8626 0.0 0
M  V30 6 O 1.5400 8.5288 0.0 0
M  V30 7 C 0.0000 8.5288 0.0 0
M  V30 8 C 13.8600 13.8635 0.0 0
M  V30 9 C 6.9300 4.5278 0.0 0
M  V30 10 C 8.4700 4.5278 0.0 0
M  V30 11 C 6.1600 5.8615 0.0 0
M  V30 12 N 6.4541 3.0632 0.0 0
M  V30 13 C 8.9459 3.0632 0.0 0
M  V30 14 C 9.2400 5.8615 0.0 0
M  V30 15 N 6.9300 7.1952 0.0 0
M  V30 16 C 7.7000 2.1580 0.0 0
M  V30 17 C 10.3528 2.4369 0.0 0
M  V30 18 C 8.4700 7.1952 0.0 0
M  V30 19 C 7.8609 0.6265 0.0 0
M  V30 20 C 10.5137 0.9052 0.0 0
M  V30 21 C 9.2679 0.0000 0.0 0
M  V30 22 C 4.6200 5.8615 0.0 0
M  V30 23 C 3.8500 7.1952 0.0 0
M  V30 24 C 3.8500 4.5278 0.0 0
M  V30 25 C 2.3100 7.1952 0.0 0
M  V30 26 C 2.3100 4.5278 0.0 0
M  V30 27 C 1.5400 5.8615 0.0 0
M  V30 28 C 11.5500 9.8626 0.0 0
M  V30 29 C 13.0900 9.8626 0.0 0
M  V30 30 C 10.7800 11.1963 0.0 0
M  V30 31 C 13.8600 11.1963 0.0 0
M  V30 32 C 11.5500 12.5299 0.0 0
M  V30 33 C 13.0900 12.5299 0.0 0
M  V30 34 N 15.4000 13.8635 0.0 0
M  V30 35 C 16.1700 12.5299 0.0 0
M  V30 36 C 16.1700 15.1973 0.0 0
M  V30 37 C 17.7100 12.5299 0.0 0
M  V30 38 C 17.7100 15.1973 0.0 0
M  V30 39 C 18.4800 13.8635 0.0 0
M  V30 40 N 20.0200 13.8635 0.0 0
M  V30 41 C 20.7900 12.5299 0.0 0
M  V30 42 C 20.7900 15.1973 0.0 0
M  V30 43 C 22.3300 12.5299 0.0 0
M  V30 44 C 22.3300 15.1973 0.0 0
M  V30 45 C 23.1000 13.8635 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 6 7
M  V30 8 1 6 25
M  V30 9 1 8 33
M  V30 10 1 8 34
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 11 22
M  V30 18 1 12 16
M  V30 19 1 13 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 2 15 18
M  V30 23 2 16 19
M  V30 24 1 17 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1307702-36-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3002420-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3002420-82-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38589176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the
Treatment of Cystic Echinococcosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bei; Wu, Jianbing; Yan, Zhengsheng; Wu, Hongmei; Gao, Huijing; Liu,
Yun; Zhao, Jun; Wang, Jianhua; Yang, Jianhua; Zhang, Yihua; Pan,
Jingxuan; Ling, Yong; Wen, Hao; Huang, Zhangjian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16680-16693

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
5-Chloro-2-pyrazinecarboxylic acid
C5H3ClN2O2
36070-80-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 N 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,5S,6S)-5-(5-Amino-2,3-difluorophenyl)-1-(methoxymethyl)-5-methyl-2-thia-4...
C14H17F2N3OS
1874240-21-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.8974 6.1903 0.0 0
M  V30 2 O 10.2310 5.4203 0.0 0
M  V30 3 C 11.5648 6.1903 0.0 0
M  V30 4 C 5.5211 2.5701 0.0 0
M  V30 5 N 4.4837 8.0878 0.0 0
M  V30 6 F 4.7189 1.0535 0.0 0
M  V30 7 F 1.8246 0.0000 0.0 0
M  V30 8 N 0.0000 5.0130 0.0 0
M  V30 9 C 6.7937 4.0867 0.0 0 CFG=1
M  V30 10 C 7.5637 5.4203 0.0 0 CFG=2
M  V30 11 C 5.2537 4.0867 0.0 0 CFG=2
M  V30 12 C 8.3337 4.0867 0.0 0
M  V30 13 S 6.7937 6.7540 0.0 0
M  V30 14 N 4.4837 5.4203 0.0 0
M  V30 15 C 5.2537 6.7540 0.0 0
M  V30 16 C 3.8066 3.5600 0.0 0
M  V30 17 C 3.5392 2.0434 0.0 0
M  V30 18 C 2.6269 4.5499 0.0 0
M  V30 19 C 2.0921 1.5166 0.0 0
M  V30 20 C 1.1798 4.0231 0.0 0
M  V30 21 C 0.9123 2.5065 0.0 0
M  V30 22 H 6.7937 2.5467 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 11 4 CFG=3
M  V30 5 1 5 15
M  V30 6 1 6 17
M  V30 7 1 7 19
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 22 CFG=3
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 11 16 CFG=1
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[3-[(1S,5S,6S)-3-Amino-1-(methoxymethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0...
C19H18ClF2N5O2S
1874238-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6268 7.3244 0.0 0
M  V30 2 O 1.1796 6.7977 0.0 0
M  V30 3 C 0.0000 7.7876 0.0 0
M  V30 4 C 5.3232 3.1729 0.0 0
M  V30 5 N 7.3028 8.4266 0.0 0
M  V30 6 F 5.8498 1.5400 0.0 0
M  V30 7 N 11.1846 4.6200 0.0 0
M  V30 8 C 12.5182 3.8500 0.0 0
M  V30 9 O 12.5182 2.3100 0.0 0
M  V30 10 F 8.5171 0.0000 0.0 0
M  V30 11 Cl 17.8529 6.9300 0.0 0
M  V30 12 C 4.3333 4.8875 0.0 0 CFG=1
M  V30 13 C 3.8066 6.3346 0.0 0 CFG=2
M  V30 14 C 5.8498 4.6200 0.0 0 CFG=2
M  V30 15 C 2.8167 5.1548 0.0 0
M  V30 16 S 4.7965 7.5143 0.0 0
M  V30 17 N 6.8398 5.7998 0.0 0
M  V30 18 C 6.3131 7.2468 0.0 0
M  V30 19 C 7.1835 3.8500 0.0 0
M  V30 20 C 8.5171 4.6200 0.0 0
M  V30 21 C 7.1835 2.3100 0.0 0
M  V30 22 C 9.8509 3.8500 0.0 0
M  V30 23 C 8.5171 1.5400 0.0 0
M  V30 24 C 9.8509 2.3100 0.0 0
M  V30 25 C 13.8518 4.6200 0.0 0
M  V30 26 C 15.1856 3.8500 0.0 0
M  V30 27 N 13.8518 6.1600 0.0 0
M  V30 28 N 16.5193 4.6200 0.0 0
M  V30 29 C 15.1856 6.9300 0.0 0
M  V30 30 C 16.5193 6.1600 0.0 0
M  V30 31 H 4.0658 3.3708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 14 4 CFG=1
M  V30 5 1 5 18
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 2 8 9
M  V30 10 1 8 25
M  V30 11 1 10 23
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 31 CFG=1
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 14 19 CFG=3
M  V30 21 1 16 18
M  V30 22 2 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36070-80-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1874240-21-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1874238-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23899050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid
Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo
Selectivity over BACE2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pettus, Liping H.; Bourbeau, Matthew P.; Bradley, Jodi; Bartberger,
Michael D.; Chen, Kui; Hickman, Dean; Johnson, Michael; Liu, Qingyian;
Manning, James R.; Nanez, Adrian; Siegmund, Aaron C.; Wen, Paul H.;
Whittington, Douglas A.; Allen, Jennifer R.; Wood, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(5), 2263-2281

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrol...
C16H13FN2O3
356068-93-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 1.9694 0.0 0
M  V30 2 O 6.0810 5.3013 0.0 0
M  V30 3 F 0.0000 0.0122 0.0 0
M  V30 4 C 8.4414 0.0000 0.0 0
M  V30 5 C 11.1518 1.9694 0.0 0
M  V30 6 O 12.2963 2.9998 0.0 0
M  V30 7 O 11.4721 0.4629 0.0 0
M  V30 8 C 10.1166 5.1556 0.0 0
M  V30 9 C 3.0800 2.6796 0.0 0
M  V30 10 C 4.5865 2.9998 0.0 0
M  V30 11 C 2.3100 4.0133 0.0 0
M  V30 12 C 2.3100 1.3460 0.0 0
M  V30 13 C 4.7474 4.5313 0.0 0
M  V30 14 N 3.3404 5.1576 0.0 0
M  V30 15 C 0.7700 4.0133 0.0 0
M  V30 16 C 0.7700 1.3460 0.0 0
M  V30 17 C 0.0000 2.6796 0.0 0
M  V30 18 C 7.1955 2.4452 0.0 0
M  V30 19 C 8.4414 1.5400 0.0 0
M  V30 20 N 7.6714 3.9098 0.0 0
M  V30 21 C 9.6873 2.4452 0.0 0
M  V30 22 C 9.2114 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 1 18
M  V30 3 2 2 13
M  V30 4 1 3 16
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-tert-Butyl 3-aminopyrrolidine-1-carboxylate
C9H18N2O2
147081-44-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 0.5637 1.2881 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 2.1037 3.9554 0.0 0
M  V30 8 N 9.3037 1.4946 0.0 0
M  V30 9 N 5.3348 1.8517 0.0 0
M  V30 10 C 5.4958 0.3202 0.0 0
M  V30 11 C 6.7417 2.4782 0.0 0
M  V30 12 C 7.0021 0.0000 0.0 0
M  V30 13 C 7.7721 1.3337 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 13 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[[[5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indo...
C25H29FN4O4
3023042-26-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0551 5.5977 0.0 0
M  V30 2 O 7.4179 8.6585 0.0 0
M  V30 3 F 0.0000 5.5073 0.0 0
M  V30 4 C 8.0245 2.8872 0.0 0
M  V30 5 C 11.2109 3.9225 0.0 0
M  V30 6 N 12.6177 4.5489 0.0 0
M  V30 7 O 11.0498 2.3910 0.0 0
M  V30 8 C 11.2109 7.2730 0.0 0
M  V30 9 C 17.7734 2.8736 0.0 0
M  V30 10 O 18.5434 1.5400 0.0 0
M  V30 11 O 18.5434 4.2074 0.0 0
M  V30 12 C 20.0834 1.5400 0.0 0
M  V30 13 C 20.0834 3.0800 0.0 0
M  V30 14 C 21.6234 1.5400 0.0 0
M  V30 15 C 20.0834 0.0000 0.0 0
M  V30 16 C 3.7536 7.0923 0.0 0
M  V30 17 C 5.2851 6.9314 0.0 0
M  V30 18 C 3.4334 8.5987 0.0 0
M  V30 19 C 2.6091 6.0619 0.0 0
M  V30 20 C 5.9114 8.3382 0.0 0
M  V30 21 N 4.7671 9.3687 0.0 0
M  V30 22 C 1.9687 9.0746 0.0 0
M  V30 23 C 1.1445 6.5378 0.0 0
M  V30 24 C 0.8244 8.0442 0.0 0
M  V30 25 C 7.5951 5.5977 0.0 0
M  V30 26 C 8.5003 4.3519 0.0 0
M  V30 27 N 8.5003 6.8436 0.0 0
M  V30 28 C 9.9649 4.8277 0.0 0
M  V30 29 C 9.9649 6.3677 0.0 0
M  V30 30 C 13.8635 3.6436 0.0 0 CFG=1
M  V30 31 C 15.3282 4.1197 0.0 0
M  V30 32 C 13.8635 2.1036 0.0 0
M  V30 33 N 16.2334 2.8736 0.0 0
M  V30 34 C 15.3282 1.6278 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 1 25
M  V30 3 2 2 20
M  V30 4 1 3 23
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 30 6 CFG=3
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 33
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 356068-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147081-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3023042-26-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39026996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on reagent, optimized on solvent, optimized
on stoichiometry of reactants, optimized on temperature, optimized on
time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Economical and Practical Process Development for a Novel Multitarget
Tyrosine Kinase Inhibitor Vorolanib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiu, Xiaomeng; Jia, Hongwei; Liu, Yaoyang; Zhao, Xueqi; Liu, Yang; Yang,
Huali; Cheng, Maosheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(2), 492-499

$RFMT $RIREG SCHEME405 STEP1
$RXN



  3  1
$MOL
Ethanesulfonyl chloride
C2H5ClO2S
594-44-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 Cl 0.0000 0.5637 0.0 0
M  V30 4 O 2.1037 0.0000 0.0 0
M  V30 5 O 0.5637 2.6673 0.0 0
M  V30 6 C 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Proline, 4-(4-chloro-2-fluorophenyl)-3-(3-chlorophenyl)-5-(2,2-dimethylprop...
C40H41Cl2FN2O4
3035578-69-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1039 5.3891 0.0 0
M  V30 2 N 9.4375 6.1591 0.0 0
M  V30 3 C 10.7713 5.3891 0.0 0
M  V30 4 O 12.1050 6.1591 0.0 0
M  V30 5 O 10.7713 3.8491 0.0 0
M  V30 6 C 13.4386 5.3891 0.0 0
M  V30 7 C 9.2154 7.4050 0.0 0
M  V30 8 C 9.9855 8.7387 0.0 0
M  V30 9 C 10.7555 7.4050 0.0 0
M  V30 10 C 11.5255 8.7387 0.0 0
M  V30 11 C 9.2154 10.0723 0.0 0
M  V30 12 C 4.0596 9.0802 0.0 0
M  V30 13 O 4.2206 10.6118 0.0 0
M  V30 14 O 2.6528 8.4538 0.0 0
M  V30 15 C 7.2461 10.1156 0.0 0
M  V30 16 C 6.2157 11.2600 0.0 0
M  V30 17 F 9.4640 4.6659 0.0 0
M  V30 18 Cl 0.0000 6.0774 0.0 0
M  V30 19 Cl 6.8777 0.0000 0.0 0
M  V30 20 C 6.7702 6.1591 0.0 0 CFG=2
M  V30 21 C 5.3055 6.6350 0.0 0 CFG=1
M  V30 22 C 7.6754 7.4050 0.0 0 CFG=2
M  V30 23 C 5.3055 8.1750 0.0 0 CFG=2
M  V30 24 N 6.7702 8.6509 0.0 0
M  V30 25 C 6.7970 4.6193 0.0 0
M  V30 26 C 8.1441 3.8727 0.0 0
M  V30 27 C 5.4771 3.8262 0.0 0
M  V30 28 C 8.1709 2.3330 0.0 0
M  V30 29 C 5.5039 2.2863 0.0 0
M  V30 30 C 6.8509 1.5397 0.0 0
M  V30 31 C 4.0596 5.7298 0.0 0
M  V30 32 C 2.6528 6.3561 0.0 0
M  V30 33 C 4.2206 4.1982 0.0 0
M  V30 34 C 1.4070 5.4510 0.0 0
M  V30 35 C 2.9747 3.2930 0.0 0
M  V30 36 C 1.5679 3.9193 0.0 0
M  V30 37 C 14.7723 6.1591 0.0 0
M  V30 38 C 16.1792 5.5327 0.0 0
M  V30 39 C 14.9334 7.6907 0.0 0
M  V30 40 C 17.2097 6.6772 0.0 0
M  V30 41 C 16.6551 4.0681 0.0 0
M  V30 42 C 16.4397 8.0109 0.0 0
M  V30 43 C 13.9028 8.8351 0.0 0
M  V30 44 C 18.7161 6.3570 0.0 0
M  V30 45 C 18.1616 3.7479 0.0 0
M  V30 46 C 16.9155 9.4756 0.0 0
M  V30 47 C 14.3788 10.2998 0.0 0
M  V30 48 C 19.1920 4.8923 0.0 0
M  V30 49 C 15.8851 10.6199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 20 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 37
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 23 12 CFG=3
M  V30 16 1 15 16
M  V30 17 1 15 24
M  V30 18 1 17 26
M  V30 19 1 18 34
M  V30 20 1 19 30
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=3
M  V30 24 1 21 23
M  V30 25 1 21 31 CFG=1
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 1 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 38 41
M  V30 44 1 39 42
M  V30 45 2 39 43
M  V30 46 1 40 42
M  V30 47 2 40 44
M  V30 48 1 41 45
M  V30 49 2 42 46
M  V30 50 1 43 47
M  V30 51 1 44 48
M  V30 52 2 45 48
M  V30 53 1 46 49
M  V30 54 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-amino-3-methoxy-, methyl ester
C9H11NO3
41608-64-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 5.3349 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 O 1.5400 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 N 0.0000 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[[[(2R,3R,4S,5S)-4-(aminomethyl)-4-(4-chloro-2-fluorophenyl)-...
C34H40Cl2FN3O4
3035578-70-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8061 4.1877 0.0 0
M  V30 2 N 6.9506 3.1573 0.0 0
M  V30 3 C 4.8804 8.1392 0.0 0
M  V30 4 C 5.0413 9.6709 0.0 0
M  V30 5 C 3.5098 9.8318 0.0 0
M  V30 6 C 5.2024 11.2024 0.0 0
M  V30 7 C 6.5730 9.5098 0.0 0
M  V30 8 C 10.0362 6.4642 0.0 0
M  V30 9 N 10.8062 7.7978 0.0 0
M  V30 10 O 10.8062 5.1304 0.0 0
M  V30 11 C 8.0668 9.1745 0.0 0
M  V30 12 C 9.5731 9.4947 0.0 0
M  V30 13 F 4.3160 3.2023 0.0 0
M  V30 14 Cl 6.4819 0.0000 0.0 0
M  V30 15 Cl 0.0000 6.3380 0.0 0
M  V30 16 O 12.3462 10.4651 0.0 0
M  V30 17 C 13.1162 11.7989 0.0 0
M  V30 18 C 16.9662 7.7978 0.0 0
M  V30 19 O 17.7362 9.1314 0.0 0
M  V30 20 O 17.7362 6.4642 0.0 0
M  V30 21 C 19.2762 9.1314 0.0 0
M  V30 22 C 6.1263 5.6942 0.0 0 CFG=2
M  V30 23 C 7.5910 5.2181 0.0 0 CFG=1
M  V30 24 C 6.1263 7.2342 0.0 0 CFG=2
M  V30 25 C 8.4962 6.4642 0.0 0 CFG=2
M  V30 26 N 7.5910 7.7100 0.0 0
M  V30 27 C 4.5947 5.8551 0.0 0
M  V30 28 C 3.6895 4.6092 0.0 0
M  V30 29 C 3.9684 7.2619 0.0 0
M  V30 30 C 2.1580 4.7702 0.0 0
M  V30 31 C 2.4367 7.4230 0.0 0
M  V30 32 C 1.5317 6.1769 0.0 0
M  V30 33 C 8.0668 3.7536 0.0 0
M  V30 34 C 7.0364 2.6091 0.0 0
M  V30 35 C 9.5731 3.4334 0.0 0
M  V30 36 C 7.5123 1.1445 0.0 0
M  V30 37 C 10.0491 1.9687 0.0 0
M  V30 38 C 9.0185 0.8244 0.0 0
M  V30 39 C 12.3462 7.7978 0.0 0
M  V30 40 C 13.1162 9.1314 0.0 0
M  V30 41 C 13.1162 6.4642 0.0 0
M  V30 42 C 14.6562 9.1314 0.0 0
M  V30 43 C 14.6562 6.4642 0.0 0
M  V30 44 C 15.4262 7.7978 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 24 3 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 25 8 CFG=1
M  V30 11 1 9 39
M  V30 12 1 11 12
M  V30 13 1 11 26
M  V30 14 1 13 28
M  V30 15 1 14 36
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 40
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 44
M  V30 22 1 19 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 27 CFG=1
M  V30 26 1 23 25
M  V30 27 1 23 33 CFG=3
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 22 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 594-44-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035578-69-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 41608-64-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035578-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38701167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 616-47-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits
MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor
Efficacy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Jing; Yan, Ziqin; Jiang, Kailong; Liu, Chen; Xu, Dehua; Lyu,
Xilin; Hu, Xiaobei; Zhang, Shiyan; Zhou, Yubo; Li, Jia; Zhao, Yujun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(24), 16991-17025

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Glycine
C2H5NO2
56-40-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-8-methoxy-2H-3,1-benzoxazine-2,4(1H)-dione
C9H6BrNO4
2139973-67-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3336 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 O 3.8500 8.0021 0.0 0
M  V30 4 O 8.4700 5.3347 0.0 0
M  V30 5 Br 0.0000 4.0011 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 N 6.1600 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 4.6200 6.6685 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 15 O 6.1600 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 11
M  V30 4 2 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,4-Benzodiazepine-2,5-dione, 7-bromo-3,4-dihydro-9-methoxy-
C10H9BrN2O3
3055274-64-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0853 1.3336 0.0 0
M  V30 2 C 4.8553 0.0000 0.0 0
M  V30 3 O 5.3401 7.8971 0.0 0
M  V30 4 O 0.0000 4.2564 0.0 0
M  V30 5 Br 8.7053 4.0011 0.0 0
M  V30 6 C 4.0853 4.0011 0.0 0
M  V30 7 C 4.8553 5.3347 0.0 0
M  V30 8 C 4.8553 2.6673 0.0 0
M  V30 9 N 2.5624 3.7715 0.0 0
M  V30 10 C 6.3953 5.3347 0.0 0
M  V30 11 C 4.2926 6.7683 0.0 0
M  V30 12 C 6.3953 2.6673 0.0 0
M  V30 13 C 1.4336 4.8190 0.0 0
M  V30 14 C 7.1653 4.0011 0.0 0
M  V30 15 N 2.8211 7.2221 0.0 0
M  V30 16 C 1.5486 6.3547 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 11
M  V30 4 2 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-40-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2139973-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055274-64-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38824564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 87-69-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Corminboeuf, Olivier; Diethelm, Stefan; Zumbrunn, Cornelia; Lyothier,
Isabelle; Niggli, Nadja; Gnerre, Carmela; Jeay, Sebastien; Lehembre,
Francois; Boss, Christoph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2024), 19(2), e202300606

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
L-Norleucine, methyl ester, hydrochloride (1:1)
C7H15NO2.ClH
3844-54-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0 CFG=1
M  V30 2 C 2.6675 3.0800 0.0 0
M  V30 3 C 5.3348 3.0800 0.0 0
M  V30 4 N 4.0012 5.3901 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 2.6675 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 8.0023 3.0800 0.0 0
M  V30 10 C 9.3360 3.8501 0.0 0
M  V30 11 Cl 4.6680 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
8-[(2,6-Difluorophenyl)methoxy]-2-methylimidazo[1,2-a]pyridine-3-carboxylic acid
C16H12F2N2O3
1415501-19-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 3.0800 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 11.9866 3.0204 0.0 0
M  V30 4 O 13.0170 4.1648 0.0 0
M  V30 5 O 12.4625 1.5557 0.0 0
M  V30 6 C 10.6238 6.0812 0.0 0
M  V30 7 F 4.0011 5.3900 0.0 0
M  V30 8 F 1.3336 0.7700 0.0 0
M  V30 9 C 8.0021 3.0800 0.0 0
M  V30 10 N 9.3358 2.3100 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 N 8.3223 4.5864 0.0 0
M  V30 13 C 10.4802 3.3406 0.0 0
M  V30 14 C 9.3358 0.7700 0.0 0
M  V30 15 C 6.6684 0.7700 0.0 0
M  V30 16 C 9.8538 4.7474 0.0 0
M  V30 17 C 8.0021 0.0000 0.0 0
M  V30 18 C 2.6673 3.0800 0.0 0
M  V30 19 C 2.6674 4.6200 0.0 0
M  V30 20 C 1.3336 2.3100 0.0 0
M  V30 21 C 1.3336 5.3900 0.0 0
M  V30 22 C 0.0000 3.0800 0.0 0
M  V30 23 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 6 16
M  V30 8 1 7 19
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[8-[(2,6-Difluorophenyl)methoxy]-2-methylimidazo[1,2-a]pyridin-3-yl]carbon...
C23H25F2N3O4
1609081-95-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.5182 0.0 0
M  V30 2 C 4.0010 5.2882 0.0 0
M  V30 3 C 11.9867 4.5779 0.0 0
M  V30 4 N 13.0173 3.4334 0.0 0
M  V30 5 O 12.4626 6.0425 0.0 0
M  V30 6 C 14.5236 3.7535 0.0 0
M  V30 7 C 14.9995 5.2183 0.0 0
M  V30 8 C 15.5540 2.6091 0.0 0
M  V30 9 C 16.5059 5.5384 0.0 0
M  V30 10 O 15.0782 1.1444 0.0 0
M  V30 11 O 17.0605 2.9293 0.0 0
M  V30 12 C 16.9818 7.0031 0.0 0
M  V30 13 C 16.1088 0.0000 0.0 0
M  V30 14 C 18.4881 7.3233 0.0 0
M  V30 15 C 10.6239 1.5171 0.0 0
M  V30 16 F 1.3337 6.8282 0.0 0
M  V30 17 F 4.0010 2.2081 0.0 0
M  V30 18 C 8.0022 4.5182 0.0 0
M  V30 19 N 9.3358 5.2882 0.0 0
M  V30 20 C 6.6685 5.2882 0.0 0
M  V30 21 N 8.3223 3.0118 0.0 0
M  V30 22 C 10.4804 4.2577 0.0 0
M  V30 23 C 9.3358 6.8282 0.0 0
M  V30 24 C 6.6685 6.8282 0.0 0
M  V30 25 C 9.8539 2.8508 0.0 0
M  V30 26 C 8.0022 7.5982 0.0 0
M  V30 27 C 2.6673 4.5182 0.0 0
M  V30 28 C 1.3337 5.2882 0.0 0
M  V30 29 C 2.6673 2.9781 0.0 0
M  V30 30 C 0.0000 4.5182 0.0 0
M  V30 31 C 1.3337 2.2081 0.0 0
M  V30 32 C 0.0000 2.9781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 27
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 1 15 25
M  V30 17 1 16 28
M  V30 18 1 17 29
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 2 23 26
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3844-54-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1415501-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1609081-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40577093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine
Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate
Cyclase Stimulator for the Treatment of Resistant Hypertension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vakalopoulos, Alexandros; Wunder, Frank; Hartung, Ingo V.; Redlich,
Gorden; Jautelat, Rolf; Buchgraber, Philipp; Hassfeld, Jorma; Gromov,
Alexey V.; Lindner, Niels; Bierer, Donald; Gries, Joerg; Kroh, Walter;
Paulsen, Holger; Mittendorf, Joachim; Lang, Dieter; Becker-Pelster, Eva;
Brockschnieder, Damian; Geiss, Volker; Li, Volkhart; Straub, Alexander;
Knorr, Andreas; Mondritzki, Thomas; Truebel, Hubert; Raschke, Marian;
Schaefer, Martina; Thomas, Dirk; Sandner, Peter; Stasch, Johannes-Peter;
Follmann, Markus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7280-7303

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Pyrimido[4,5-e]indolizine-7-carboxylic acid, 5,6-dihydro-2-[[4-(4-methyl-1-pi...
C22H23N7O4.ClH
2645399-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 10.2524 0.0 0
M  V30 2 O 0.0000 9.7765 0.0 0
M  V30 3 O 1.7849 11.7588 0.0 0
M  V30 4 N 9.5055 5.5411 0.0 0
M  V30 5 N 11.0455 2.8738 0.0 0 VAL=5
M  V30 6 O 9.5055 2.8738 0.0 0
M  V30 7 O 11.8155 1.5400 0.0 0
M  V30 8 C 20.2855 5.5411 0.0 0
M  V30 9 N 4.8855 8.2085 0.0 0
M  V30 10 C 6.4255 8.2085 0.0 0
M  V30 11 C 4.1155 9.5421 0.0 0
M  V30 12 C 3.8549 7.0640 0.0 0
M  V30 13 C 7.1955 9.5421 0.0 0
M  V30 14 N 7.1955 6.8747 0.0 0
M  V30 15 C 2.6091 9.2220 0.0 0
M  V30 16 C 4.8855 10.8758 0.0 0
M  V30 17 C 2.4481 7.6905 0.0 0
M  V30 18 C 6.4255 10.8758 0.0 0
M  V30 19 C 8.7355 9.5421 0.0 0
M  V30 20 C 8.7355 6.8747 0.0 0
M  V30 21 N 9.5055 8.2085 0.0 0
M  V30 22 C 11.0455 5.5411 0.0 0
M  V30 23 C 11.8155 4.2074 0.0 0
M  V30 24 C 11.8155 6.8747 0.0 0
M  V30 25 C 13.3555 4.2074 0.0 0
M  V30 26 C 13.3555 6.8747 0.0 0
M  V30 27 C 14.1255 5.5411 0.0 0
M  V30 28 N 15.6655 5.5411 0.0 0
M  V30 29 C 16.4355 4.2074 0.0 0
M  V30 30 C 16.4355 6.8747 0.0 0
M  V30 31 C 17.9755 4.2074 0.0 0
M  V30 32 C 17.9755 6.8747 0.0 0
M  V30 33 N 18.7455 5.5411 0.0 0
M  V30 34 Cl 10.1427 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 20
M  V30 5 1 4 22
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 8 33
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 2 13 19
M  V30 20 1 14 20
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diethylaniline
C10H15N
579-66-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,6-Diethylphenyl)-5,6-dihydro-2-[[4-(4-methyl-1-piperazinyl)-2-nitropheny...
C32H36N8O3
2645399-50-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8587 8.7125 0.0 0
M  V30 2 N 4.3940 8.2366 0.0 0
M  V30 3 O 6.1789 10.2188 0.0 0
M  V30 4 N 13.8996 4.0011 0.0 0
M  V30 5 N 15.4396 1.3337 0.0 0 VAL=5
M  V30 6 O 13.8996 1.3337 0.0 0
M  V30 7 O 16.2096 0.0000 0.0 0
M  V30 8 C 1.4647 7.2847 0.0 0
M  V30 9 C 0.0000 6.8089 0.0 0
M  V30 10 C 5.0343 11.2494 0.0 0
M  V30 11 C 5.3545 12.7557 0.0 0
M  V30 12 C 24.6797 4.0011 0.0 0
M  V30 13 N 9.2795 6.6684 0.0 0
M  V30 14 C 10.8195 6.6684 0.0 0
M  V30 15 C 8.5095 8.0022 0.0 0
M  V30 16 C 8.2489 5.5240 0.0 0
M  V30 17 C 11.5896 8.0022 0.0 0
M  V30 18 N 11.5896 5.3348 0.0 0
M  V30 19 C 7.0031 7.6819 0.0 0
M  V30 20 C 9.2795 9.3359 0.0 0
M  V30 21 C 6.8421 6.1504 0.0 0
M  V30 22 C 10.8195 9.3359 0.0 0
M  V30 23 C 13.1296 8.0022 0.0 0
M  V30 24 C 13.1296 5.3348 0.0 0
M  V30 25 N 13.8996 6.6684 0.0 0
M  V30 26 C 15.4396 4.0011 0.0 0
M  V30 27 C 16.2096 2.6675 0.0 0
M  V30 28 C 16.2096 5.3348 0.0 0
M  V30 29 C 17.7496 2.6675 0.0 0
M  V30 30 C 17.7496 5.3348 0.0 0
M  V30 31 C 18.5196 4.0011 0.0 0
M  V30 32 C 3.2496 9.2671 0.0 0
M  V30 33 C 1.7849 8.7912 0.0 0
M  V30 34 C 3.5698 10.7733 0.0 0
M  V30 35 C 0.6405 9.8216 0.0 0
M  V30 36 C 2.4252 11.8039 0.0 0
M  V30 37 C 0.9607 11.3279 0.0 0
M  V30 38 N 20.0596 4.0011 0.0 0
M  V30 39 C 20.8297 2.6675 0.0 0
M  V30 40 C 20.8297 5.3348 0.0 0
M  V30 41 C 22.3697 2.6675 0.0 0
M  V30 42 C 22.3697 5.3348 0.0 0
M  V30 43 N 23.1397 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 32
M  V30 5 1 4 24
M  V30 6 1 4 26
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 27
M  V30 10 1 8 9
M  V30 11 1 8 33
M  V30 12 1 10 11
M  V30 13 1 10 34
M  V30 14 1 12 43
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 1 15 20
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 2 17 23
M  V30 25 1 18 24
M  V30 26 1 19 21
M  V30 27 1 20 22
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 31 38
M  V30 37 2 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2645399-49-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 579-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2645399-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40642152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK)
Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM M. Serafim, Ricardo A.; da Silva Santiago, Andre; Schwalm, Martin P.; Hu,
Zexi; dos Reis, Caio V.; Takarada, Jessica E.; Mezzomo, Priscila;
Massirer, Katlin B.; Kudolo, Mark; Gerstenecker, Stefan; Chaikuad,
Apirat; Zender, Lars; Knapp, Stefan; Laufer, Stefan; Counago, Rafael M.;
Gehringer, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 3173-3192

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
5-(Difluoromethoxy)picolinic acid
C7H5F2NO3
1174323-34-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 F 8.0023 2.3101 0.0 0
M  V30 4 F 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 N 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4aR,6S,8aR)-8a-(4-Amino-2-thiazolyl)-4,4a,5,6,8,8a-hexahydro-6-methylpyra...
C18H20N4O2S2
1818341-12-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.4702 6.6363 0.0 0
M  V30 2 C 9.2402 7.9700 0.0 0
M  V30 3 O 8.4702 9.3037 0.0 0
M  V30 4 C 0.0000 5.3026 0.0 0
M  V30 5 N 5.7473 0.0000 0.0 0
M  V30 6 C 4.6201 5.3026 0.0 0 CFG=2
M  V30 7 C 3.8501 6.6363 0.0 0 CFG=1
M  V30 8 N 6.1601 5.3026 0.0 0
M  V30 9 C 3.8501 3.9688 0.0 0
M  V30 10 C 4.6201 7.9700 0.0 0
M  V30 11 C 2.3101 6.6363 0.0 0
M  V30 12 C 6.9302 6.6363 0.0 0
M  V30 13 O 2.3101 3.9688 0.0 0
M  V30 14 S 6.1601 7.9700 0.0 0
M  V30 15 C 1.5400 5.3026 0.0 0 CFG=2
M  V30 16 C 5.3901 3.9688 0.0 0
M  V30 17 S 6.9217 3.8079 0.0 0
M  V30 18 N 4.7638 2.5620 0.0 0
M  V30 19 C 7.2419 2.3016 0.0 0
M  V30 20 C 5.9082 1.5316 0.0 0
M  V30 21 C 10.7802 7.9700 0.0 0
M  V30 22 C 11.5503 9.3037 0.0 0
M  V30 23 C 11.5503 6.6363 0.0 0
M  V30 24 C 13.0903 9.3037 0.0 0
M  V30 25 C 13.0903 6.6363 0.0 0
M  V30 26 C 13.8603 7.9700 0.0 0
M  V30 27 H 3.0801 7.9700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 21
M  V30 5 1 15 4 CFG=1
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 16 CFG=3
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 27 CFG=3
M  V30 14 2 8 12
M  V30 15 1 9 13
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 1 16 17
M  V30 21 2 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 7 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[2-[(4aR,6S,8aR)-2-(Benzoylamino)-4,4a,5,6-tetrahydro-6-methylpyrano[3,4-d]...
C25H23F2N5O4S2
1818341-22-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 6.6685 0.0 0
M  V30 2 C 3.0800 6.6685 0.0 0
M  V30 3 O 2.3100 5.3348 0.0 0
M  V30 4 N 11.7288 7.6285 0.0 0
M  V30 5 C 11.8898 9.1601 0.0 0
M  V30 6 O 10.6439 10.0653 0.0 0
M  V30 7 C 10.0102 0.0000 0.0 0
M  V30 8 O 17.5173 11.6655 0.0 0
M  V30 9 C 17.6782 13.1972 0.0 0
M  V30 10 F 16.4324 14.1023 0.0 0
M  V30 11 F 19.0852 13.8236 0.0 0
M  V30 12 C 7.7001 4.0010 0.0 0 CFG=2
M  V30 13 C 6.9301 2.6673 0.0 0 CFG=1
M  V30 14 N 6.9301 5.3348 0.0 0
M  V30 15 C 9.2401 4.0010 0.0 0
M  V30 16 C 5.3901 2.6673 0.0 0
M  V30 17 C 7.7001 1.3337 0.0 0
M  V30 18 C 5.3901 5.3348 0.0 0
M  V30 19 O 10.0102 2.6673 0.0 0
M  V30 20 S 4.6201 4.0010 0.0 0
M  V30 21 C 9.2401 1.3337 0.0 0 CFG=2
M  V30 22 C 8.4701 5.3348 0.0 0
M  V30 23 N 10.0017 5.4957 0.0 0
M  V30 24 S 7.8438 6.7416 0.0 0
M  V30 25 C 10.3220 7.0020 0.0 0
M  V30 26 C 8.9882 7.7720 0.0 0
M  V30 27 C 2.3100 8.0021 0.0 0
M  V30 28 C 3.0800 9.3358 0.0 0
M  V30 29 C 0.7700 8.0021 0.0 0
M  V30 30 C 2.3100 10.6696 0.0 0
M  V30 31 C 0.0000 9.3358 0.0 0
M  V30 32 C 0.7700 10.6696 0.0 0
M  V30 33 C 13.2967 9.7864 0.0 0
M  V30 34 C 14.5426 8.8812 0.0 0
M  V30 35 N 13.4577 11.3179 0.0 0
M  V30 36 C 15.9494 9.5076 0.0 0
M  V30 37 C 14.8645 11.9444 0.0 0
M  V30 38 C 16.1105 11.0392 0.0 0
M  V30 39 H 6.1601 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 1 2 27
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 2 5 6
M  V30 8 1 5 33
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 8 38
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 22 CFG=3
M  V30 18 1 13 16
M  V30 19 1 13 17
M  V30 20 1 13 39 CFG=3
M  V30 21 2 14 18
M  V30 22 1 15 19
M  V30 23 1 16 20
M  V30 24 1 17 21
M  V30 25 1 18 20
M  V30 26 1 19 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1174323-34-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1818341-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1818341-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23620855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process Development of a Second Generation β-Amyloid-Cleaving Enzyme
Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using
Continuous Stirred-Tank Reactors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Bryan; Barnhart, Richard W.; Dion, Amelie; Guinness, Steven; Happe,
Alan; Hayward, Cheryl M.; Kohrt, Jeffrey; Makowski, Teresa; Maloney,
Mark; Nelson, Jade D.; Nematalla, Asaad; McWilliams, J. Christopher;
Peng, Zhihui; Raggon, Jeffrey; Sagal, John; Weisenburger, Gerald A.; Bao,
Denghui; Gonzalez, Miguel; Lu, Jiangping; McLaws, Mark D.; Tao, Jian; Wu,
Baolin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(6), 1440-1453

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
5-Chloro-1H-indole-2-carboxylic acid
C9H6ClNO2
10517-21-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(4-Aminophenyl)-2-furanyl](3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)m...
C22H22N2O4
2632874-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0
M  V30 2 O 8.0021 6.1600 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 C 0.0000 6.1600 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8994 3.9758 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 5.3347 1.5400 0.0 0
M  V30 14 N 6.6685 3.8500 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6685 2.3100 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0
M  V30 19 O 10.7427 4.4763 0.0 0
M  V30 20 C 9.4967 2.3185 0.0 0
M  V30 21 C 11.7731 3.3319 0.0 0
M  V30 22 C 11.0031 1.9983 0.0 0
M  V30 23 C 13.3047 3.4929 0.0 0
M  V30 24 C 13.9310 4.8998 0.0 0
M  V30 25 C 14.2099 2.2470 0.0 0
M  V30 26 C 15.4627 5.0607 0.0 0
M  V30 27 C 15.7414 2.4079 0.0 0
M  V30 28 C 16.3677 3.8149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-[4-[5-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-2-...
C31H26ClN3O5
2892485-72-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6201 0.0 0
M  V30 2 O 8.0021 6.1601 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 C 0.0000 6.1601 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 N 17.8996 3.9759 0.0 0
M  V30 8 C 18.8048 2.7300 0.0 0
M  V30 9 O 18.1784 1.3230 0.0 0
M  V30 10 Cl 26.8334 2.0253 0.0 0
M  V30 11 C 4.0011 3.8501 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 N 6.6685 3.8501 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 2.3100 0.0 0
M  V30 20 C 6.6685 2.3100 0.0 0
M  V30 21 C 9.3359 3.8501 0.0 0
M  V30 22 O 10.7427 4.4764 0.0 0
M  V30 23 C 9.4969 2.3185 0.0 0
M  V30 24 C 11.7732 3.3320 0.0 0
M  V30 25 C 11.0032 1.9983 0.0 0
M  V30 26 C 13.3049 3.4929 0.0 0
M  V30 27 C 13.9312 4.8999 0.0 0
M  V30 28 C 14.2100 2.2470 0.0 0
M  V30 29 C 15.4628 5.0608 0.0 0
M  V30 30 C 15.7417 2.4080 0.0 0
M  V30 31 C 16.3680 3.8149 0.0 0
M  V30 32 C 20.3363 2.8909 0.0 0
M  V30 33 N 21.1063 4.2246 0.0 0
M  V30 34 C 21.3669 1.7465 0.0 0
M  V30 35 C 22.6128 3.9044 0.0 0
M  V30 36 C 22.7737 2.3729 0.0 0
M  V30 37 C 23.8587 4.8097 0.0 0
M  V30 38 C 24.1807 1.7465 0.0 0
M  V30 39 C 25.2655 4.1833 0.0 0
M  V30 40 C 25.4266 2.6518 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 2 8 9
M  V30 11 1 8 32
M  V30 12 1 10 40
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 2 18 19
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10517-21-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2632874-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892485-72-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35443514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel phenylfuran-bisamide
derivatives as P-glycoprotein inhibitors against multidrug resistance in
MCF-7/ADR cell
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhikun; Yang, Xue; Li, Yasheng; Cai, Yue; Yu, Yanlei; Zhuang,
Wenya; Sun, Xuanrong; Li, Qingyong; Bao, Xiaoze; Ye, Xinyi; Tian,
Jinmiao; Wei, Bin; Chen, Jianwei; Wu, Qihao; Zhang, Huawei; Mou,
Xiaozhou; Wang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 248115092

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Cyclopropanamine, 1-(2-pyrimidinyl)-, hydrochloride (1:1)
C7H9N3.ClH
1215107-61-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.8875 1.5400 0.0 0
M  V30 2 C 4.6201 3.0566 0.0 0
M  V30 3 C 6.0671 3.5833 0.0 0
M  V30 4 C 4.8875 4.5733 0.0 0
M  V30 5 C 3.0801 3.0566 0.0 0
M  V30 6 N 2.3101 1.7230 0.0 0
M  V30 7 N 2.3101 4.3903 0.0 0
M  V30 8 C 0.7700 1.7230 0.0 0
M  V30 9 C 0.7700 4.3903 0.0 0
M  V30 10 C 0.0000 3.0566 0.0 0
M  V30 11 Cl 3.0336 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (3S,4S)-4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]carbon...
C21H23F2N3O6
2178053-39-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.1699 4.8519 0.0 0
M  V30 2 C 8.8935 5.3347 0.0 0
M  V30 3 N 9.6635 4.0011 0.0 0
M  V30 4 O 9.6635 6.6684 0.0 0
M  V30 5 F 0.0000 9.7254 0.0 0
M  V30 6 C 11.2035 1.3336 0.0 0
M  V30 7 O 9.6635 1.3336 0.0 0
M  V30 8 O 11.9735 0.0000 0.0 0
M  V30 9 C 15.8235 4.0011 0.0 0
M  V30 10 O 16.5935 5.3347 0.0 0
M  V30 11 O 16.5935 2.6673 0.0 0
M  V30 12 C 18.1335 5.3347 0.0 0
M  V30 13 C 18.1335 3.7947 0.0 0
M  V30 14 C 19.6735 5.3347 0.0 0
M  V30 15 C 18.1335 6.8747 0.0 0
M  V30 16 C 3.7377 7.0099 0.0 0
M  V30 17 C 2.3309 6.3835 0.0 0
M  V30 18 C 3.8987 8.5415 0.0 0
M  V30 19 C 1.0849 7.2887 0.0 0
M  V30 20 C 2.6528 9.4467 0.0 0
M  V30 21 C 1.2460 8.8202 0.0 0
M  V30 22 C 4.9836 6.1047 0.0 0
M  V30 23 C 6.4483 6.5806 0.0 0
M  V30 24 O 4.9836 4.5647 0.0 0
M  V30 25 C 7.3535 5.3347 0.0 0
M  V30 26 N 6.4483 4.0889 0.0 0
M  V30 27 C 11.2035 4.0011 0.0 0 CFG=1
M  V30 28 C 11.9735 2.6673 0.0 0 CFG=1
M  V30 29 C 11.9735 5.3347 0.0 0
M  V30 30 C 13.5135 2.6673 0.0 0
M  V30 31 C 13.5135 5.3347 0.0 0
M  V30 32 N 14.2835 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 27 3 CFG=1
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 28 6 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 32
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 22
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S,4S)-4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]carbonyl]a...
C28H30F2N6O5
2178053-40-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.5500 9.0337 0.0 0
M  V30 2 C 5.8836 8.2637 0.0 0
M  V30 3 O 7.2172 9.0337 0.0 0
M  V30 4 N 8.5509 6.7237 0.0 0
M  V30 5 C 9.8847 5.9537 0.0 0
M  V30 6 O 9.8847 4.4137 0.0 0
M  V30 7 C 3.2162 3.6437 0.0 0
M  V30 8 O 3.2162 2.1037 0.0 0
M  V30 9 O 1.8825 4.4137 0.0 0
M  V30 10 C 1.8825 1.3336 0.0 0
M  V30 11 C 1.1125 2.6673 0.0 0
M  V30 12 C 0.5489 0.5636 0.0 0
M  V30 13 C 2.6525 0.0000 0.0 0
M  V30 14 F 15.4660 9.7336 0.0 0
M  V30 15 F 19.7820 6.5979 0.0 0
M  V30 16 C 4.5500 10.5737 0.0 0
M  V30 17 C 6.0666 10.8412 0.0 0
M  V30 18 C 5.0766 12.0208 0.0 0
M  V30 19 C 3.0334 10.8412 0.0 0
M  V30 20 N 2.0434 9.6614 0.0 0
M  V30 21 N 2.5065 12.2883 0.0 0
M  V30 22 C 0.5268 9.9289 0.0 0
M  V30 23 C 0.9899 12.5557 0.0 0
M  V30 24 C 0.0000 11.3760 0.0 0
M  V30 25 C 5.8836 6.7237 0.0 0 CFG=1
M  V30 26 C 7.2172 5.9537 0.0 0 CFG=1
M  V30 27 C 4.5500 5.9537 0.0 0
M  V30 28 C 7.2172 4.4137 0.0 0
M  V30 29 N 4.5500 4.4137 0.0 0
M  V30 30 C 5.8836 3.6437 0.0 0
M  V30 31 C 11.2183 6.7237 0.0 0
M  V30 32 C 12.6251 6.0974 0.0 0
M  V30 33 N 11.3793 8.2552 0.0 0
M  V30 34 C 13.6557 7.2417 0.0 0
M  V30 35 O 12.8857 8.5755 0.0 0
M  V30 36 C 15.1873 7.0808 0.0 0
M  V30 37 C 16.0925 8.3267 0.0 0
M  V30 38 C 15.8136 5.6740 0.0 0
M  V30 39 C 17.6240 8.1657 0.0 0
M  V30 40 C 17.3451 5.5129 0.0 0
M  V30 41 C 18.2503 6.7588 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 25 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 26 4 CFG=1
M  V30 7 2 5 6
M  V30 8 1 5 31
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 29
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 37
M  V30 17 1 15 41
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1215107-61-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2178053-39-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178053-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38927970
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 616-47-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-35-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Scalable, Stereoselective second Generation Route for
CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel
Telescoped Sequence of Transesterification, cis-to-trans-Epimerization
and Saponification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schafer, Gabriel; Fleischer, Tony; Merot, Aurelien; Erhardt, Michael;
Mathys, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(6), 2103-2116

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Cyclopropanamine, 1-(2-pyrimidinyl)-, hydrochloride (1:1)
C7H9N3.ClH
1215107-61-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.8875 1.5400 0.0 0
M  V30 2 C 4.6201 3.0566 0.0 0
M  V30 3 C 6.0671 3.5833 0.0 0
M  V30 4 C 4.8875 4.5733 0.0 0
M  V30 5 C 3.0801 3.0566 0.0 0
M  V30 6 N 2.3101 1.7230 0.0 0
M  V30 7 N 2.3101 4.3903 0.0 0
M  V30 8 C 0.7700 1.7230 0.0 0
M  V30 9 C 0.7700 4.3903 0.0 0
M  V30 10 C 0.0000 3.0566 0.0 0
M  V30 11 Cl 3.0336 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (3S,4S)-4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]carbon...
C21H23F2N3O6
2178053-39-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.1699 4.8519 0.0 0
M  V30 2 C 8.8935 5.3347 0.0 0
M  V30 3 N 9.6635 4.0011 0.0 0
M  V30 4 O 9.6635 6.6684 0.0 0
M  V30 5 F 0.0000 9.7254 0.0 0
M  V30 6 C 11.2035 1.3336 0.0 0
M  V30 7 O 9.6635 1.3336 0.0 0
M  V30 8 O 11.9735 0.0000 0.0 0
M  V30 9 C 15.8235 4.0011 0.0 0
M  V30 10 O 16.5935 5.3347 0.0 0
M  V30 11 O 16.5935 2.6673 0.0 0
M  V30 12 C 18.1335 5.3347 0.0 0
M  V30 13 C 18.1335 3.7947 0.0 0
M  V30 14 C 19.6735 5.3347 0.0 0
M  V30 15 C 18.1335 6.8747 0.0 0
M  V30 16 C 3.7377 7.0099 0.0 0
M  V30 17 C 2.3309 6.3835 0.0 0
M  V30 18 C 3.8987 8.5415 0.0 0
M  V30 19 C 1.0849 7.2887 0.0 0
M  V30 20 C 2.6528 9.4467 0.0 0
M  V30 21 C 1.2460 8.8202 0.0 0
M  V30 22 C 4.9836 6.1047 0.0 0
M  V30 23 C 6.4483 6.5806 0.0 0
M  V30 24 O 4.9836 4.5647 0.0 0
M  V30 25 C 7.3535 5.3347 0.0 0
M  V30 26 N 6.4483 4.0889 0.0 0
M  V30 27 C 11.2035 4.0011 0.0 0 CFG=1
M  V30 28 C 11.9735 2.6673 0.0 0 CFG=1
M  V30 29 C 11.9735 5.3347 0.0 0
M  V30 30 C 13.5135 2.6673 0.0 0
M  V30 31 C 13.5135 5.3347 0.0 0
M  V30 32 N 14.2835 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 27 3 CFG=1
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 28 6 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 32
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 22
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S,4S)-4-[[[5-(2,4-difluorophenyl)-3-isoxazolyl]carbonyl]a...
C28H30F2N6O5
2178053-40-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.5500 9.0337 0.0 0
M  V30 2 C 5.8836 8.2637 0.0 0
M  V30 3 O 7.2172 9.0337 0.0 0
M  V30 4 N 8.5509 6.7237 0.0 0
M  V30 5 C 9.8847 5.9537 0.0 0
M  V30 6 O 9.8847 4.4137 0.0 0
M  V30 7 C 3.2162 3.6437 0.0 0
M  V30 8 O 3.2162 2.1037 0.0 0
M  V30 9 O 1.8825 4.4137 0.0 0
M  V30 10 C 1.8825 1.3336 0.0 0
M  V30 11 C 1.1125 2.6673 0.0 0
M  V30 12 C 0.5489 0.5636 0.0 0
M  V30 13 C 2.6525 0.0000 0.0 0
M  V30 14 F 15.4660 9.7336 0.0 0
M  V30 15 F 19.7820 6.5979 0.0 0
M  V30 16 C 4.5500 10.5737 0.0 0
M  V30 17 C 6.0666 10.8412 0.0 0
M  V30 18 C 5.0766 12.0208 0.0 0
M  V30 19 C 3.0334 10.8412 0.0 0
M  V30 20 N 2.0434 9.6614 0.0 0
M  V30 21 N 2.5065 12.2883 0.0 0
M  V30 22 C 0.5268 9.9289 0.0 0
M  V30 23 C 0.9899 12.5557 0.0 0
M  V30 24 C 0.0000 11.3760 0.0 0
M  V30 25 C 5.8836 6.7237 0.0 0 CFG=1
M  V30 26 C 7.2172 5.9537 0.0 0 CFG=1
M  V30 27 C 4.5500 5.9537 0.0 0
M  V30 28 C 7.2172 4.4137 0.0 0
M  V30 29 N 4.5500 4.4137 0.0 0
M  V30 30 C 5.8836 3.6437 0.0 0
M  V30 31 C 11.2183 6.7237 0.0 0
M  V30 32 C 12.6251 6.0974 0.0 0
M  V30 33 N 11.3793 8.2552 0.0 0
M  V30 34 C 13.6557 7.2417 0.0 0
M  V30 35 O 12.8857 8.5755 0.0 0
M  V30 36 C 15.1873 7.0808 0.0 0
M  V30 37 C 16.0925 8.3267 0.0 0
M  V30 38 C 15.8136 5.6740 0.0 0
M  V30 39 C 17.6240 8.1657 0.0 0
M  V30 40 C 17.3451 5.5129 0.0 0
M  V30 41 C 18.2503 6.7588 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 25 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 26 4 CFG=1
M  V30 7 2 5 6
M  V30 8 1 5 31
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 29
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 37
M  V30 17 1 15 41
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1215107-61-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2178053-39-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2178053-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24100916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist
ACT-1004-1239
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richard-Bildstein, Sylvia; Aissaoui, Hamed; Pothier, Julien; Schafer,
Gabriel; Gnerre, Carmela; Lindenberg, Eleanor; Lehembre, Francois;
Pouzol, Laetitia; Guerry, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(24), 15864-15882

$RFMT $RIREG SCHEME412 STEP1
$RXN



  3  1
$MOL
4-Methoxybenzenebutanoic acid
C11H14O3
4521-28-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 O 10.6697 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(7-methoxy-6-nitro-4-quinazolinyl)oxy]benzenamine
C15H11FN4O4
2761180-24-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 F 9.2400 0.0000 0.0 0
M  V30 8 N 13.8600 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 6.6685 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 10.0100 1.3338 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 1.3338 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 20
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanoyl chloride
C4H7ClO
141-75-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenebutanamide, N-[3-fluoro-4-[[7-methoxy-6-[(1-oxobutyl)amino]-4-quinazol...
C30H31FN4O5
3020728-48-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 8.4700 0.0 0
M  V30 2 N 4.0009 4.6200 0.0 0
M  V30 3 C 5.3347 3.8500 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 O 6.6684 4.6200 0.0 0
M  V30 6 C 4.0009 1.5400 0.0 0
M  V30 7 C 4.0009 0.0000 0.0 0
M  V30 8 O 1.3336 6.1600 0.0 0
M  V30 9 C 0.0000 6.9300 0.0 0
M  V30 10 F 10.6694 6.9300 0.0 0
M  V30 11 N 13.3367 11.5500 0.0 0
M  V30 12 C 14.6703 10.7800 0.0 0
M  V30 13 C 16.0041 11.5500 0.0 0
M  V30 14 O 14.6703 9.2400 0.0 0
M  V30 15 C 17.3378 10.7800 0.0 0
M  V30 16 C 18.6714 11.5500 0.0 0
M  V30 17 O 24.0061 8.4700 0.0 0
M  V30 18 C 25.3398 9.2400 0.0 0
M  V30 19 C 5.3347 8.4700 0.0 0
M  V30 20 C 4.0009 9.2400 0.0 0
M  V30 21 C 6.6684 9.2400 0.0 0
M  V30 22 C 5.3347 6.9300 0.0 0
M  V30 23 C 2.6673 8.4700 0.0 0
M  V30 24 N 4.0009 10.7800 0.0 0
M  V30 25 N 6.6684 10.7800 0.0 0
M  V30 26 C 4.0009 6.1600 0.0 0
M  V30 27 C 2.6673 6.9300 0.0 0
M  V30 28 C 5.3347 11.5500 0.0 0
M  V30 29 C 9.3356 9.2400 0.0 0
M  V30 30 C 10.6694 8.4700 0.0 0
M  V30 31 C 9.3356 10.7800 0.0 0
M  V30 32 C 12.0031 9.2400 0.0 0
M  V30 33 C 10.6694 11.5500 0.0 0
M  V30 34 C 12.0031 10.7800 0.0 0
M  V30 35 C 20.0051 10.7800 0.0 0
M  V30 36 C 21.3389 11.5500 0.0 0
M  V30 37 C 20.0051 9.2400 0.0 0
M  V30 38 C 22.6725 10.7800 0.0 0
M  V30 39 C 21.3389 8.4700 0.0 0
M  V30 40 C 22.6725 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 1 2 26
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 10 30
M  V30 12 1 11 12
M  V30 13 1 11 34
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 35
M  V30 19 1 17 18
M  V30 20 1 17 40
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 2 23 27
M  V30 29 2 24 28
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4521-28-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761180-24-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 141-75-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020728-48-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38556002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solution from stage 1 and 2 prepared separately and added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met
inhibitors for the treatment of NSCLC
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Sheng; Sun, Chuanchuan; He, Xintao; Gan, Wenhui; Wang, Linxiao;
Qiao, Dan; Guan, Xinyu; Xu, Shan; Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 263115939

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-5,5-Difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-1H-cyclopropa...
C10H7F5N2O2
1620056-83-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4237 5.4355 0.0 0
M  V30 2 C 7.7573 4.6655 0.0 0
M  V30 3 O 7.7573 3.1255 0.0 0
M  V30 4 O 9.0910 5.4355 0.0 0
M  V30 5 F 2.4373 8.0901 0.0 0
M  V30 6 F 4.3201 7.2519 0.0 0
M  V30 7 C 2.7964 1.4069 0.0 0
M  V30 8 F 4.2032 0.7805 0.0 0
M  V30 9 F 2.1700 0.0000 0.0 0
M  V30 10 F 1.3895 2.0332 0.0 0
M  V30 11 C 3.6831 5.2918 0.0 0
M  V30 12 C 2.6527 4.1473 0.0 0
M  V30 13 N 5.0901 4.6655 0.0 0
M  V30 14 C 2.9132 6.6254 0.0 0
M  V30 15 C 1.2460 4.7737 0.0 0 CFG=1
M  V30 16 C 3.4227 2.8137 0.0 0
M  V30 17 N 4.9291 3.1338 0.0 0
M  V30 18 C 1.4069 6.3052 0.0 0 CFG=2
M  V30 19 C 0.0000 5.6789 0.0 0
M  V30 20 H 0.4760 3.4401 0.0 0
M  V30 21 H 0.9311 7.7699 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 14
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 20 CFG=3
M  V30 21 2 16 17
M  V30 22 1 18 19
M  V30 23 1 18 21 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-3-Bromo-α-[(3,5-difluorophenyl)methyl]-6-[3-methyl-3-(methylsulfonyl)-1-...
C19H19BrF2N2O2S
2375019-85-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.1060 3.8501 0.0 0 CFG=1
M  V30 2 C 11.4398 4.6201 0.0 0
M  V30 3 N 10.1060 2.3101 0.0 0
M  V30 4 Br 10.1060 6.9302 0.0 0
M  V30 5 C 4.7712 3.8501 0.0 0
M  V30 6 C 3.4375 3.0801 0.0 0
M  V30 7 C 2.1038 2.3101 0.0 0
M  V30 8 S 1.3338 3.6437 0.0 0 VAL=6
M  V30 9 C 2.8739 0.9764 0.0 0
M  V30 10 C 0.7700 1.5400 0.0 0
M  V30 11 C 0.5638 4.9774 0.0 0
M  V30 12 O 0.0000 2.8737 0.0 0
M  V30 13 O 2.6675 4.4137 0.0 0
M  V30 14 F 16.7747 4.6201 0.0 0
M  V30 15 F 14.1072 0.0000 0.0 0
M  V30 16 C 8.7723 4.6201 0.0 0
M  V30 17 N 7.4387 3.8501 0.0 0
M  V30 18 C 8.7723 6.1601 0.0 0
M  V30 19 C 6.1048 4.6201 0.0 0
M  V30 20 C 7.4387 6.9302 0.0 0
M  V30 21 C 6.1048 6.1601 0.0 0
M  V30 22 C 12.7735 3.8501 0.0 0
M  V30 23 C 14.1072 4.6201 0.0 0
M  V30 24 C 12.7735 2.3101 0.0 0
M  V30 25 C 15.4408 3.8501 0.0 0
M  V30 26 C 14.1072 1.5400 0.0 0
M  V30 27 C 15.4408 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 4 18
M  V30 6 3 5 6
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 2 8 13
M  V30 15 1 14 25
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H24BrF7N4O3S
2375020-19-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4697 4.7970 0.0 0
M  V30 2 F 3.6306 6.3287 0.0 0
M  V30 3 F 1.9381 4.9581 0.0 0
M  V30 4 F 3.3086 3.2655 0.0 0
M  V30 5 C 8.7723 5.9242 0.0 0
M  V30 6 C 8.7723 7.4642 0.0 0
M  V30 7 N 10.1059 8.2342 0.0 0
M  V30 8 O 7.4386 8.2342 0.0 0
M  V30 9 C 10.1059 9.7742 0.0 0 CFG=2
M  V30 10 C 11.4397 10.5442 0.0 0
M  V30 11 F 9.2936 3.1942 0.0 0
M  V30 12 F 9.0781 1.1444 0.0 0
M  V30 13 Br 10.1059 12.8543 0.0 0
M  V30 14 C 4.7711 9.7742 0.0 0
M  V30 15 C 3.4375 9.0042 0.0 0
M  V30 16 C 2.1038 8.2342 0.0 0
M  V30 17 S 1.3338 9.5679 0.0 0 VAL=6
M  V30 18 C 0.7700 7.4642 0.0 0
M  V30 19 C 2.8738 6.9005 0.0 0
M  V30 20 C 0.5638 10.9017 0.0 0
M  V30 21 O 0.0000 8.7978 0.0 0
M  V30 22 O 2.6675 10.3379 0.0 0
M  V30 23 F 16.7745 10.5442 0.0 0
M  V30 24 F 14.1071 5.9242 0.0 0
M  V30 25 C 5.7712 3.3024 0.0 0
M  V30 26 C 5.6103 1.7709 0.0 0 CFG=1
M  V30 27 C 7.2775 3.6226 0.0 0
M  V30 28 C 5.0012 4.6361 0.0 0
M  V30 29 C 7.0171 1.1444 0.0 0 CFG=2
M  V30 30 C 5.7712 0.2392 0.0 0
M  V30 31 N 7.4386 5.1541 0.0 0
M  V30 32 C 8.0475 2.2889 0.0 0
M  V30 33 N 6.0317 5.7806 0.0 0
M  V30 34 C 8.7723 10.5442 0.0 0
M  V30 35 N 7.4386 9.7742 0.0 0
M  V30 36 C 8.7723 12.0842 0.0 0
M  V30 37 C 6.1048 10.5442 0.0 0
M  V30 38 C 7.4386 12.8543 0.0 0
M  V30 39 C 6.1048 12.0842 0.0 0
M  V30 40 C 12.7734 9.7742 0.0 0
M  V30 41 C 14.1071 10.5442 0.0 0
M  V30 42 C 12.7734 8.2342 0.0 0
M  V30 43 C 15.4407 9.7742 0.0 0
M  V30 44 C 14.1071 7.4642 0.0 0
M  V30 45 C 15.4407 8.2342 0.0 0
M  V30 46 H 4.0703 1.7709 0.0 0
M  V30 47 H 8.0475 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 28
M  V30 5 1 5 6
M  V30 6 1 5 31
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10 CFG=3
M  V30 11 1 9 34
M  V30 12 1 10 40
M  V30 13 1 11 32
M  V30 14 1 12 32
M  V30 15 1 13 36
M  V30 16 3 14 15
M  V30 17 1 14 37
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 17 21
M  V30 24 2 17 22
M  V30 25 1 23 43
M  V30 26 1 24 44
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 26 30
M  V30 32 1 26 46 CFG=1
M  V30 33 1 27 31
M  V30 34 1 27 32
M  V30 35 2 28 33
M  V30 36 1 29 30
M  V30 37 1 29 32
M  V30 38 1 29 47 CFG=1
M  V30 39 1 31 33
M  V30 40 1 34 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1620056-83-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2375019-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2375020-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41433749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process
Development and Scale-up
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wagner, Anna M.; Bonderoff, Sara A.; Chang, Stanley; Deignan, Jeffrey;
Esanu, Michelle M.; Van Huynh, Huy; Niu, Tianmin; Ngo, Vinh; OKeefe, B.
Michael; Phoenix, Jenny; Rainey, Trevor J.; Roberts, Benjamin J.; Shen,
Jinyu; Stewart, Craig; Vandehey, Amanda L.; Wolckenhauer, Scott A.; Wong,
Chloe Y.; Yarmuch, Brian H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(8), 3382-3395

$RFMT $RIREG SCHEME414 STEP1
$RXN



  3  1
$MOL
4-Methoxybenzenebutanoic acid
C11H14O3
4521-28-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 O 10.6697 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(7-methoxy-6-nitro-4-quinazolinyl)oxy]benzenamine
C15H11FN4O4
2761180-24-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 F 9.2400 0.0000 0.0 0
M  V30 8 N 13.8600 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 6.6685 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 10.0100 1.3338 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 1.3338 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 20
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentanoyl chloride
C5H9ClO
638-29-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenebutanamide, N-[3-fluoro-4-[[7-methoxy-6-[(1-oxopentyl)amino]-4-quinazo...
C31H33FN4O5
3020728-49-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 6.1601 0.0 0
M  V30 2 N 2.6673 4.6201 0.0 0
M  V30 3 C 2.6673 6.1601 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 O 4.0010 6.9302 0.0 0
M  V30 6 C 1.3337 8.4702 0.0 0
M  V30 7 C 0.0000 9.2402 0.0 0
M  V30 8 C 0.0000 10.7802 0.0 0
M  V30 9 O 2.6673 1.5400 0.0 0
M  V30 10 C 2.6673 0.0000 0.0 0
M  V30 11 F 8.0022 9.2402 0.0 0
M  V30 12 N 13.3370 9.2402 0.0 0
M  V30 13 C 14.6707 8.4702 0.0 0
M  V30 14 C 16.0045 9.2402 0.0 0
M  V30 15 O 14.6707 6.9302 0.0 0
M  V30 16 C 17.3382 8.4702 0.0 0
M  V30 17 C 18.6718 9.2402 0.0 0
M  V30 18 O 24.0067 6.1601 0.0 0
M  V30 19 C 25.3403 6.9302 0.0 0
M  V30 20 C 6.6685 3.8501 0.0 0
M  V30 21 C 6.6685 2.3101 0.0 0
M  V30 22 C 8.0022 4.6201 0.0 0
M  V30 23 C 5.3348 4.6201 0.0 0
M  V30 24 C 5.3348 1.5400 0.0 0
M  V30 25 N 8.0022 1.5400 0.0 0
M  V30 26 N 9.3358 3.8501 0.0 0
M  V30 27 C 4.0010 3.8501 0.0 0
M  V30 28 C 4.0010 2.3101 0.0 0
M  V30 29 C 9.3358 2.3101 0.0 0
M  V30 30 C 9.3358 6.9302 0.0 0
M  V30 31 C 9.3358 8.4702 0.0 0
M  V30 32 C 10.6697 6.1601 0.0 0
M  V30 33 C 10.6697 9.2402 0.0 0
M  V30 34 C 12.0033 6.9302 0.0 0
M  V30 35 C 12.0033 8.4702 0.0 0
M  V30 36 C 20.0055 8.4702 0.0 0
M  V30 37 C 20.0055 6.9302 0.0 0
M  V30 38 C 21.3393 9.2402 0.0 0
M  V30 39 C 21.3393 6.1601 0.0 0
M  V30 40 C 22.6730 8.4702 0.0 0
M  V30 41 C 22.6730 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 2 27
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 28
M  V30 12 1 11 31
M  V30 13 1 12 13
M  V30 14 1 12 35
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 36
M  V30 20 1 18 19
M  V30 21 1 18 41
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 2 23 27
M  V30 29 2 24 28
M  V30 30 2 25 29
M  V30 31 1 26 29
M  V30 32 1 27 28
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4521-28-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761180-24-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 638-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020728-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38556005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solution from stage 1 and 2 prepared separately and added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met
inhibitors for the treatment of NSCLC
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Sheng; Sun, Chuanchuan; He, Xintao; Gan, Wenhui; Wang, Linxiao;
Qiao, Dan; Guan, Xinyu; Xu, Shan; Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 263115939

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
2-(Trifluoromethyl)-5-pyrimidinecarboxylic acid
C6H3F3N2O2
306960-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 N 4.6200 0.2064 0.0 0
M  V30 10 N 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H15F2N7O2.C7H8O3S
3063593-11-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 11.2885 0.0 0
M  V30 2 C 5.3901 11.2885 0.0 0
M  V30 3 O 4.6201 9.9548 0.0 0
M  V30 4 O 4.6201 12.6222 0.0 0
M  V30 5 C 3.0801 9.9548 0.0 0 CFG=1
M  V30 6 C 2.3101 11.2885 0.0 0
M  V30 7 C 5.5674 14.3493 0.0 0
M  V30 8 N 13.3536 8.2054 0.0 0
M  V30 9 F 0.0000 9.9548 0.0 0
M  V30 10 F 3.0801 4.6200 0.0 0
M  V30 11 C 9.2317 12.7833 0.0 0
M  V30 12 C 7.7002 12.6222 0.0 0
M  V30 13 N 9.5519 14.2896 0.0 0
M  V30 14 N 7.0737 14.0291 0.0 0
M  V30 15 N 8.2182 15.0596 0.0 0
M  V30 16 C 10.2622 11.6387 0.0 0
M  V30 17 C 11.7686 11.9589 0.0 0
M  V30 18 N 9.7863 10.1741 0.0 0
M  V30 19 C 12.7991 10.8145 0.0 0
M  V30 20 C 10.8167 9.0296 0.0 0
M  V30 21 C 12.3232 9.3498 0.0 0
M  V30 22 C 2.3101 8.6212 0.0 0
M  V30 23 C 0.7700 8.6212 0.0 0
M  V30 24 C 3.0801 7.2873 0.0 0
M  V30 25 N 0.0000 7.2873 0.0 0
M  V30 26 C 2.3101 5.9537 0.0 0
M  V30 27 C 0.7700 5.9537 0.0 0
M  V30 28 S 4.3668 1.5400 0.0 0 VAL=6
M  V30 29 O 4.3668 3.0800 0.0 0
M  V30 30 O 4.3668 0.0000 0.0 0
M  V30 31 O 2.8268 1.5400 0.0 0
M  V30 32 C 10.5268 1.5400 0.0 0
M  V30 33 C 5.9068 1.5400 0.0 0
M  V30 34 C 6.6768 0.2064 0.0 0
M  V30 35 C 6.6768 2.8736 0.0 0
M  V30 36 C 8.2168 0.2064 0.0 0
M  V30 37 C 8.2168 2.8736 0.0 0
M  V30 38 C 8.9868 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 22
M  V30 8 1 7 14
M  V30 9 1 8 21
M  V30 10 1 9 23
M  V30 11 1 10 26
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 2 28 30
M  V30 32 1 28 31
M  V30 33 1 28 33
M  V30 34 1 32 38
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R)-1-(2,5-Difluoro-3-pyridinyl)ethyl N-[1-methyl-4-[5-[[[2-(trifluoromethyl...
C22H16F5N9O3
2750508-72-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.1788 7.5318 0.0 0
M  V30 2 C 4.7142 7.0560 0.0 0
M  V30 3 O 4.3939 5.5495 0.0 0
M  V30 4 O 3.5696 8.0864 0.0 0
M  V30 5 C 2.9293 5.0736 0.0 0 CFG=1
M  V30 6 C 1.7847 6.1042 0.0 0
M  V30 7 C 3.9369 10.0218 0.0 0
M  V30 8 N 13.2407 6.5846 0.0 0
M  V30 9 C 14.5744 7.3546 0.0 0
M  V30 10 O 14.5744 8.8946 0.0 0
M  V30 11 F 0.0000 4.1219 0.0 0
M  V30 12 F 4.5779 0.0000 0.0 0
M  V30 13 C 19.9092 4.2745 0.0 0
M  V30 14 F 19.1392 2.9408 0.0 0
M  V30 15 F 21.2429 3.5045 0.0 0
M  V30 16 F 20.6793 5.6082 0.0 0
M  V30 17 C 7.9059 9.6646 0.0 0
M  V30 18 C 6.4989 9.0383 0.0 0
M  V30 19 N 7.7448 11.1962 0.0 0
M  V30 20 N 5.4685 10.1827 0.0 0
M  V30 21 N 6.2385 11.5164 0.0 0
M  V30 22 C 9.2396 8.8946 0.0 0
M  V30 23 C 9.2396 7.3546 0.0 0
M  V30 24 N 10.5733 9.6646 0.0 0
M  V30 25 C 10.5733 6.5846 0.0 0
M  V30 26 C 11.9069 8.8946 0.0 0
M  V30 27 C 11.9069 7.3546 0.0 0
M  V30 28 C 2.6091 3.5673 0.0 0
M  V30 29 C 1.1444 3.0915 0.0 0
M  V30 30 C 3.7535 2.5369 0.0 0
M  V30 31 N 0.8242 1.5850 0.0 0
M  V30 32 C 3.4334 1.0304 0.0 0
M  V30 33 C 1.9688 0.5546 0.0 0
M  V30 34 C 15.9081 6.5846 0.0 0
M  V30 35 C 17.2418 7.3546 0.0 0
M  V30 36 C 15.9081 5.0445 0.0 0
M  V30 37 N 18.5756 6.5846 0.0 0
M  V30 38 N 17.2418 4.2745 0.0 0
M  V30 39 C 18.5756 5.0445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=1
M  V30 7 1 5 28
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 2 9 10
M  V30 12 1 9 34
M  V30 13 1 11 29
M  V30 14 1 12 32
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 39
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 17 22
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 306960-77-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3063593-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2750508-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43877333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 616-47-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-35-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Early Process Development of an LPAR1 Antagonist, GS-2278
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kadunce, Nathaniel; Wagner, Anna M.; Cottell, Jeromy; Dao, Kathy; Dixon,
Darryl D.; Hodur, Blanka M.; Holte, Dane; Ischay, Michael A.; Kang,
Jihun; Kim, Seongtaek; Kim, Young Ho; Koo, Seung Moh; Lew, Willard; Man,
Lucas; Methuku, Kashi Reddy; Morrison, Henry; Parker, Patrick D.; Siler,
David A.; Wong, Chloe Y.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(11), 4099-4113

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Anemoside A3
C41H66O12
129724-84-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5317 7.9142 0.0 0
M  V30 2 O 0.0000 7.7533 0.0 0
M  V30 3 O 2.1580 9.3210 0.0 0
M  V30 4 C 2.4965 2.6839 0.0 0
M  V30 5 C 1.3521 1.6533 0.0 0
M  V30 6 C 3.9612 2.2079 0.0 0
M  V30 7 C 5.6510 8.2025 0.0 0
M  V30 8 C 6.6582 8.1558 0.0 0
M  V30 9 C 9.2326 3.8006 0.0 0
M  V30 10 C 13.1239 7.1950 0.0 0
M  V30 11 O 13.3914 8.7116 0.0 0
M  V30 12 C 11.4094 8.1849 0.0 0
M  V30 13 O 13.9869 5.3347 0.0 0
M  V30 14 O 17.0669 5.3347 0.0 0
M  V30 15 O 18.6069 2.6673 0.0 0
M  V30 16 O 17.0669 0.0000 0.0 0
M  V30 17 O 18.6069 8.0020 0.0 0
M  V30 18 O 21.6869 8.0020 0.0 0
M  V30 19 C 21.6869 2.6673 0.0 0
M  V30 20 O 23.2269 5.3347 0.0 0
M  V30 21 C 2.4369 6.6684 0.0 0 CFG=1
M  V30 22 C 3.2069 5.3347 0.0 0 CFG=2
M  V30 23 C 3.2069 8.0020 0.0 0
M  V30 24 C 0.9305 6.3482 0.0 0
M  V30 25 C 4.7469 5.3347 0.0 0 CFG=1
M  V30 26 C 2.1763 4.1902 0.0 0 CFG=2
M  V30 27 C 4.7469 8.0020 0.0 0
M  V30 28 C 0.7695 4.8167 0.0 0
M  V30 29 C 5.5169 6.6684 0.0 0 CFG=1
M  V30 30 C 5.5169 4.0009 0.0 0
M  V30 31 C 7.0569 6.6684 0.0 0 CFG=1
M  V30 32 C 7.0569 4.0009 0.0 0
M  V30 33 C 7.8269 5.3347 0.0 0 CFG=1
M  V30 34 C 7.8269 8.0020 0.0 0
M  V30 35 C 9.3669 5.3347 0.0 0 CFG=2
M  V30 36 C 9.3669 8.0020 0.0 0
M  V30 37 C 10.1369 6.6684 0.0 0 CFG=2
M  V30 38 C 10.1369 4.0009 0.0 0
M  V30 39 C 11.6769 6.6684 0.0 0 CFG=2
M  V30 40 C 11.6769 4.0009 0.0 0
M  V30 41 C 12.4469 5.3347 0.0 0 CFG=1
M  V30 42 C 14.7569 4.0009 0.0 0 CFG=2
M  V30 43 C 16.2969 4.0009 0.0 0 CFG=2
M  V30 44 O 13.9869 2.6673 0.0 0
M  V30 45 C 17.0669 2.6673 0.0 0 CFG=1
M  V30 46 C 14.7569 1.3336 0.0 0
M  V30 47 C 16.2969 1.3336 0.0 0 CFG=1
M  V30 48 C 18.6069 5.3347 0.0 0 CFG=2
M  V30 49 C 19.3769 6.6684 0.0 0 CFG=2
M  V30 50 O 19.3769 4.0009 0.0 0
M  V30 51 C 20.9169 6.6684 0.0 0 CFG=2
M  V30 52 C 20.9169 4.0009 0.0 0 CFG=1
M  V30 53 C 21.6869 5.3347 0.0 0 CFG=1
M  V30 54 H 3.4478 3.8137 0.0 0
M  V30 55 H 4.3482 3.8471 0.0 0
M  V30 56 H 7.9610 3.8006 0.0 0
M  V30 57 H 10.9069 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 26 4 CFG=3
M  V30 7 1 29 7 CFG=3
M  V30 8 1 31 8 CFG=1
M  V30 9 1 35 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 39 10 CFG=3
M  V30 12 1 39 12 CFG=1
M  V30 13 1 41 13 CFG=1
M  V30 14 1 42 13 CFG=1
M  V30 15 1 43 14 CFG=3
M  V30 16 1 48 14 CFG=1
M  V30 17 1 45 15 CFG=1
M  V30 18 1 47 16 CFG=1
M  V30 19 1 49 17 CFG=3
M  V30 20 1 51 18 CFG=3
M  V30 21 1 52 19 CFG=3
M  V30 22 1 53 20 CFG=1
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 1 22 26
M  V30 28 1 22 54 CFG=3
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 1 25 29
M  V30 32 1 25 30
M  V30 33 1 25 55 CFG=1
M  V30 34 1 26 28
M  V30 35 1 27 29
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 31 34
M  V30 40 1 32 33
M  V30 41 1 33 35
M  V30 42 1 33 56 CFG=3
M  V30 43 1 34 36
M  V30 44 1 35 37
M  V30 45 1 35 38
M  V30 46 1 36 37
M  V30 47 1 37 39
M  V30 48 1 37 57 CFG=3
M  V30 49 1 38 40
M  V30 50 1 39 41
M  V30 51 1 40 41
M  V30 52 1 42 43
M  V30 53 1 42 44
M  V30 54 1 43 45
M  V30 55 1 44 46
M  V30 56 1 45 47
M  V30 57 1 46 47
M  V30 58 1 48 49
M  V30 59 1 48 50
M  V30 60 1 49 51
M  V30 61 1 50 52
M  V30 62 1 51 53
M  V30 63 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(20 21 22 25 26 29 31 33 35 37 39 41 42 43 45 47 48 49 51 52 53)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 6-aminohexanoate hydrochloride
C7H15NO2.ClH
1926-80-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0800 0.0 0
M  V30 2 C 4.0012 3.8501 0.0 0
M  V30 3 O 1.3337 3.8501 0.0 0
M  V30 4 O 2.6673 1.5400 0.0 0
M  V30 5 C 5.3348 3.0800 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 8.0023 3.0800 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 N 10.6697 3.0800 0.0 0
M  V30 11 Cl 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hexanoic acid, 6-[[(3β,4α)-3-[[2-O-(6-deoxy-α-L-mannopyranosyl)-α-L-arabinopy...
C48H79NO13
2919975-48-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  66 72 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 21.6952 4.3397 0.0 0
M  V30 2 N 23.2267 4.5007 0.0 0
M  V30 3 O 21.0689 2.9329 0.0 0
M  V30 4 C 24.1320 3.2548 0.0 0
M  V30 5 C 25.6635 3.4157 0.0 0
M  V30 6 C 26.5687 2.1699 0.0 0
M  V30 7 C 28.1004 2.3309 0.0 0
M  V30 8 C 29.0054 1.0849 0.0 0
M  V30 9 C 30.5371 1.2460 0.0 0
M  V30 10 O 31.4422 0.0000 0.0 0
M  V30 11 O 31.1634 2.6528 0.0 0
M  V30 12 C 32.9739 0.1611 0.0 0
M  V30 13 C 20.7304 9.5700 0.0 0
M  V30 14 C 21.8748 10.6006 0.0 0
M  V30 15 C 19.2657 10.0460 0.0 0
M  V30 16 C 17.5759 4.0514 0.0 0
M  V30 17 C 16.5687 4.0981 0.0 0
M  V30 18 C 13.9943 8.4534 0.0 0
M  V30 19 C 10.1029 5.0589 0.0 0
M  V30 20 O 9.8355 3.5423 0.0 0
M  V30 21 C 11.8175 4.0690 0.0 0
M  V30 22 O 9.2400 6.9194 0.0 0
M  V30 23 O 6.1600 6.9194 0.0 0
M  V30 24 O 4.6200 9.5867 0.0 0
M  V30 25 O 6.1600 12.2541 0.0 0
M  V30 26 O 4.6200 4.2519 0.0 0
M  V30 27 O 1.5400 4.2519 0.0 0
M  V30 28 C 1.5400 9.5867 0.0 0
M  V30 29 O 0.0000 6.9194 0.0 0
M  V30 30 C 20.7900 5.5856 0.0 0 CFG=1
M  V30 31 C 20.0200 6.9192 0.0 0 CFG=2
M  V30 32 C 20.0200 4.2519 0.0 0
M  V30 33 C 22.2964 5.9057 0.0 0
M  V30 34 C 18.4800 6.9192 0.0 0 CFG=1
M  V30 35 C 21.0506 8.0637 0.0 0 CFG=2
M  V30 36 C 18.4800 4.2519 0.0 0
M  V30 37 C 22.4574 7.4374 0.0 0
M  V30 38 C 17.7100 5.5856 0.0 0 CFG=1
M  V30 39 C 17.7100 8.2530 0.0 0
M  V30 40 C 16.1700 5.5856 0.0 0 CFG=1
M  V30 41 C 16.1700 8.2530 0.0 0
M  V30 42 C 15.4000 6.9192 0.0 0 CFG=1
M  V30 43 C 15.4000 4.2519 0.0 0
M  V30 44 C 13.8600 6.9192 0.0 0 CFG=2
M  V30 45 C 13.8600 4.2519 0.0 0
M  V30 46 C 13.0900 5.5856 0.0 0 CFG=2
M  V30 47 C 13.0900 8.2530 0.0 0
M  V30 48 C 11.5500 5.5856 0.0 0 CFG=2
M  V30 49 C 11.5500 8.2530 0.0 0
M  V30 50 C 10.7800 6.9194 0.0 0 CFG=1
M  V30 51 C 8.4700 8.2530 0.0 0 CFG=2
M  V30 52 C 6.9300 8.2530 0.0 0 CFG=2
M  V30 53 O 9.2400 9.5867 0.0 0
M  V30 54 C 6.1600 9.5867 0.0 0 CFG=1
M  V30 55 C 8.4700 10.9203 0.0 0
M  V30 56 C 6.9300 10.9203 0.0 0 CFG=1
M  V30 57 C 4.6200 6.9194 0.0 0 CFG=2
M  V30 58 C 3.8500 5.5856 0.0 0 CFG=2
M  V30 59 O 3.8500 8.2530 0.0 0
M  V30 60 C 2.3100 5.5856 0.0 0 CFG=2
M  V30 61 C 2.3100 8.2530 0.0 0 CFG=1
M  V30 62 C 1.5400 6.9194 0.0 0 CFG=1
M  V30 63 H 19.7791 8.4403 0.0 0
M  V30 64 H 18.8787 8.4069 0.0 0
M  V30 65 H 15.2659 8.4534 0.0 0
M  V30 66 H 12.3200 4.2519 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 30 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 35 13 CFG=3
M  V30 16 1 38 16 CFG=3
M  V30 17 1 40 17 CFG=1
M  V30 18 1 44 18 CFG=1
M  V30 19 1 19 20
M  V30 20 1 48 19 CFG=3
M  V30 21 1 48 21 CFG=1
M  V30 22 1 50 22 CFG=1
M  V30 23 1 51 22 CFG=1
M  V30 24 1 52 23 CFG=3
M  V30 25 1 57 23 CFG=1
M  V30 26 1 54 24 CFG=1
M  V30 27 1 56 25 CFG=1
M  V30 28 1 58 26 CFG=3
M  V30 29 1 60 27 CFG=3
M  V30 30 1 61 28 CFG=3
M  V30 31 1 62 29 CFG=1
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 1 31 34
M  V30 36 1 31 35
M  V30 37 1 31 63 CFG=3
M  V30 38 1 32 36
M  V30 39 1 33 37
M  V30 40 1 34 38
M  V30 41 1 34 39
M  V30 42 1 34 64 CFG=1
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 40 43
M  V30 49 1 41 42
M  V30 50 1 42 44
M  V30 51 1 42 65 CFG=3
M  V30 52 1 43 45
M  V30 53 1 44 46
M  V30 54 1 44 47
M  V30 55 1 45 46
M  V30 56 1 46 48
M  V30 57 1 46 66 CFG=3
M  V30 58 1 47 49
M  V30 59 1 48 50
M  V30 60 1 49 50
M  V30 61 1 51 52
M  V30 62 1 51 53
M  V30 63 1 52 54
M  V30 64 1 53 55
M  V30 65 1 54 56
M  V30 66 1 55 56
M  V30 67 1 57 58
M  V30 68 1 57 59
M  V30 69 1 58 60
M  V30 70 1 59 61
M  V30 71 1 60 62
M  V30 72 1 61 62
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(20 30 31 34 35 38 40 42 44 46 48 50 51 52 54 56 57 58 60 61 62)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 129724-84-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1926-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919975-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40470986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives
and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lv, Lijuan; Li, Qiurong; Wang, Kexin; Zhao, Jianping; Deng, Kejun; Zhang,
Ran; Chen, Zhong; Khan, Ikhlas A.; Gui, Chunshan; Feng, Suxiang; Yang,
Shilin; Liu, Yanli; Xu, Qiongming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(9), 7385-7405

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
9H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(4-bromobenzoyl)-6-(2-propyn-1-yl...
C22H13BrN2O4
3034176-23-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6685 0.0 0
M  V30 2 O 6.9300 8.0022 0.0 0
M  V30 3 C 6.1600 1.3336 0.0 0
M  V30 4 O 4.6200 1.3336 0.0 0
M  V30 5 O 6.9300 0.0000 0.0 0
M  V30 6 O 14.6451 3.1373 0.0 0
M  V30 7 C 16.0519 3.7636 0.0 0
M  V30 8 C 17.2978 2.8584 0.0 0
M  V30 9 C 18.5438 1.9532 0.0 0
M  V30 10 Br 0.0000 6.6685 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 9.5006 6.4793 0.0 0
M  V30 15 C 10.7465 4.3213 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 N 6.1600 4.0011 0.0 0
M  V30 18 C 10.9074 5.8528 0.0 0
M  V30 19 C 11.9923 3.4160 0.0 0
M  V30 20 C 6.9300 2.6674 0.0 0
M  V30 21 C 12.3143 6.4793 0.0 0
M  V30 22 C 13.3993 4.0425 0.0 0
M  V30 23 C 13.5602 5.5740 0.0 0
M  V30 24 C 4.6200 6.6685 0.0 0
M  V30 25 C 3.8500 5.3347 0.0 0
M  V30 26 C 3.8500 8.0022 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 2.3100 8.0022 0.0 0
M  V30 29 C 1.5400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 20
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 3 8 9
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tryptamine
C10H12N2
61-54-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 C 7.1955 2.7126 0.0 0
M  V30 3 N 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Pyrido[3,4-b]indole-3-carboxamide, 1-(4-bromobenzoyl)-N-[2-(1H-indol-3-yl)...
C32H23BrN4O3
3034176-24-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 15.0892 0.0 0
M  V30 2 O 6.9301 16.4228 0.0 0
M  V30 3 C 6.1601 9.7544 0.0 0
M  V30 4 N 6.9301 8.4207 0.0 0
M  V30 5 O 4.6201 9.7544 0.0 0
M  V30 6 C 6.1601 7.0870 0.0 0
M  V30 7 C 6.9301 5.7532 0.0 0
M  V30 8 O 14.6453 11.5579 0.0 0
M  V30 9 C 16.0521 12.1844 0.0 0
M  V30 10 C 17.2980 11.2791 0.0 0
M  V30 11 C 18.5440 10.3739 0.0 0
M  V30 12 Br 0.0000 15.0892 0.0 0
M  V30 13 C 9.2401 12.4218 0.0 0
M  V30 14 C 8.4701 13.7555 0.0 0
M  V30 15 C 10.7466 12.7420 0.0 0
M  V30 16 C 8.4701 11.0880 0.0 0
M  V30 17 C 6.9301 13.7555 0.0 0
M  V30 18 N 9.5007 14.8999 0.0 0
M  V30 19 C 10.9075 14.2736 0.0 0
M  V30 20 C 11.9925 11.8368 0.0 0
M  V30 21 C 6.9301 11.0880 0.0 0
M  V30 22 N 6.1601 12.4218 0.0 0
M  V30 23 C 12.3145 14.8999 0.0 0
M  V30 24 C 13.3994 12.4631 0.0 0
M  V30 25 C 13.5604 13.9947 0.0 0
M  V30 26 C 4.6201 15.0892 0.0 0
M  V30 27 C 3.8501 13.7555 0.0 0
M  V30 28 C 3.8501 16.4228 0.0 0
M  V30 29 C 2.3100 13.7555 0.0 0
M  V30 30 C 2.3100 16.4228 0.0 0
M  V30 31 C 1.5400 15.0892 0.0 0
M  V30 32 C 6.1601 4.4196 0.0 0
M  V30 33 C 6.7866 3.0127 0.0 0
M  V30 34 C 4.6285 4.2586 0.0 0
M  V30 35 C 5.6420 1.9822 0.0 0
M  V30 36 C 8.2511 2.5367 0.0 0
M  V30 37 N 4.3084 2.7522 0.0 0
M  V30 38 C 5.9624 0.4759 0.0 0
M  V30 39 C 8.5715 1.0304 0.0 0
M  V30 40 C 7.4269 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 1 8 24
M  V30 12 1 9 10
M  V30 13 3 10 11
M  V30 14 1 12 31
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 18 19
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 2 21 22
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 37
M  V30 41 1 35 37
M  V30 42 2 35 38
M  V30 43 1 36 39
M  V30 44 1 38 40
M  V30 45 2 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3034176-23-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3034176-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40478987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Activity of Marinacarboline Analogues
as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative
Breast Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Byun, Woong Sub; Lim, Hyewon; Hong, Junhwa; Bae, Eun Seo; Lee, Seok Beom;
Kim, Younggwan; Lee, Jeeyeon; Lee, Sang Kook; Hong, Suckchang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(4), 3106-3133

$RFMT $RIREG SCHEME418 STEP1
$RXN



  3  1
$MOL
2-Thiophenebutanoic acid
C8H10O2S
4653-11-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 C 7.7722 1.8517 0.0 0
M  V30 5 O 9.1059 2.6218 0.0 0
M  V30 6 O 7.7722 0.3117 0.0 0
M  V30 7 C 2.4374 1.8517 0.0 0
M  V30 8 C 2.2763 0.3202 0.0 0
M  V30 9 S 1.0304 2.4782 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(7-methoxy-6-nitro-4-quinazolinyl)oxy]benzenamine
C15H11FN4O4
2761180-24-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 F 9.2400 0.0000 0.0 0
M  V30 8 N 13.8600 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 6.6685 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 10.0100 1.3338 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 1.3338 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 20
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acryloyl chloride
C3H3ClO
814-68-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenebutanamide, N-[3-fluoro-4-[[7-methoxy-6-[(1-oxo-2-propen-1-yl)amin...
C26H23FN4O4S
3020728-51-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 6.9302 0.0 0
M  V30 2 N 4.0010 3.0801 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 6.6685 3.0801 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 F 10.6697 5.3901 0.0 0
M  V30 10 N 13.3370 10.0102 0.0 0
M  V30 11 C 14.6708 9.2402 0.0 0
M  V30 12 C 16.0045 10.0102 0.0 0
M  V30 13 O 14.6708 7.7002 0.0 0
M  V30 14 C 17.3382 9.2402 0.0 0
M  V30 15 C 18.6718 10.0102 0.0 0
M  V30 16 C 5.3348 6.9302 0.0 0
M  V30 17 C 4.0010 7.7002 0.0 0
M  V30 18 C 6.6685 7.7002 0.0 0
M  V30 19 C 5.3348 5.3901 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 N 4.0010 9.2402 0.0 0
M  V30 22 N 6.6685 9.2402 0.0 0
M  V30 23 C 4.0010 4.6201 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 5.3348 10.0102 0.0 0
M  V30 26 C 9.3358 7.7002 0.0 0
M  V30 27 C 10.6697 6.9302 0.0 0
M  V30 28 C 9.3358 9.2402 0.0 0
M  V30 29 C 12.0033 7.7002 0.0 0
M  V30 30 C 10.6697 10.0102 0.0 0
M  V30 31 C 12.0033 9.2402 0.0 0
M  V30 32 C 20.0057 9.2402 0.0 0
M  V30 33 C 21.4125 9.8665 0.0 0
M  V30 34 S 20.1666 7.7086 0.0 0
M  V30 35 C 22.4429 8.7221 0.0 0
M  V30 36 C 21.6729 7.3885 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 2 23
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 15 32
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 25
M  V30 28 1 23 24
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4653-11-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761180-24-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 814-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020728-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38556004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solution from stage 1 and 2 prepared separately and added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met
inhibitors for the treatment of NSCLC
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Sheng; Sun, Chuanchuan; He, Xintao; Gan, Wenhui; Wang, Linxiao;
Qiao, Dan; Guan, Xinyu; Xu, Shan; Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 263115939

$RFMT $RIREG SCHEME419 STEP1
$RXN



  3  1
$MOL
2-Thiophenebutanoic acid
C8H10O2S
4653-11-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 C 7.7722 1.8517 0.0 0
M  V30 5 O 9.1059 2.6218 0.0 0
M  V30 6 O 7.7722 0.3117 0.0 0
M  V30 7 C 2.4374 1.8517 0.0 0
M  V30 8 C 2.2763 0.3202 0.0 0
M  V30 9 S 1.0304 2.4782 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(7-methoxy-6-nitro-4-quinazolinyl)oxy]benzenamine
C15H11FN4O4
2761180-24-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 F 9.2400 0.0000 0.0 0
M  V30 8 N 13.8600 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 6.6685 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 10.0100 1.3338 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 1.3338 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 20
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanoyl chloride
C4H7ClO
141-75-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenebutanamide, N-[3-fluoro-4-[[7-methoxy-6-[(1-oxobutyl)amino]-4-quin...
C27H27FN4O4S
3020728-54-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 8.4702 0.0 0
M  V30 2 N 4.0010 4.6201 0.0 0
M  V30 3 C 5.3348 3.8501 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 C 0.0000 6.9302 0.0 0
M  V30 10 F 10.6697 6.9302 0.0 0
M  V30 11 N 13.3370 11.5503 0.0 0
M  V30 12 C 14.6708 10.7802 0.0 0
M  V30 13 C 16.0045 11.5503 0.0 0
M  V30 14 O 14.6708 9.2402 0.0 0
M  V30 15 C 17.3382 10.7802 0.0 0
M  V30 16 C 18.6718 11.5503 0.0 0
M  V30 17 C 5.3348 8.4702 0.0 0
M  V30 18 C 6.6685 9.2402 0.0 0
M  V30 19 C 4.0010 9.2402 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 N 6.6685 10.7802 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 N 4.0010 10.7802 0.0 0
M  V30 24 C 4.0010 6.1601 0.0 0
M  V30 25 C 5.3348 11.5503 0.0 0
M  V30 26 C 2.6673 6.9302 0.0 0
M  V30 27 C 9.3358 9.2402 0.0 0
M  V30 28 C 10.6697 8.4702 0.0 0
M  V30 29 C 9.3358 10.7802 0.0 0
M  V30 30 C 12.0033 9.2402 0.0 0
M  V30 31 C 10.6697 11.5503 0.0 0
M  V30 32 C 12.0033 10.7802 0.0 0
M  V30 33 C 20.0057 10.7802 0.0 0
M  V30 34 C 20.1666 9.2487 0.0 0
M  V30 35 S 21.4125 11.4066 0.0 0
M  V30 36 C 21.6729 8.9285 0.0 0
M  V30 37 C 22.4429 10.2622 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 26
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 32
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 33
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 2 23 25
M  V30 29 1 24 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4653-11-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761180-24-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 141-75-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020728-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38556015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solution from stage 1 and 2 prepared separately and added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met
inhibitors for the treatment of NSCLC
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Sheng; Sun, Chuanchuan; He, Xintao; Gan, Wenhui; Wang, Linxiao;
Qiao, Dan; Guan, Xinyu; Xu, Shan; Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 263115939

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
1-[(3,4-Difluorophenyl)methyl]-1,2-dihydro-2-oxo-1,8-naphthyridine-3-carboxyl...
C16H10F2N2O3
2302023-74-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 5.3900 1.3336 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 O 6.9300 1.3336 0.0 0
M  V30 6 F 10.0100 9.3358 0.0 0
M  V30 7 F 11.5500 6.6684 0.0 0
M  V30 8 N 4.6200 5.3347 0.0 0
M  V30 9 C 3.0800 5.3347 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 N 2.3100 6.6684 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6684 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 18 C 6.9300 6.6684 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 2 2 10
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 6 21
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-(2,3-dihydro-2-oxo-1H-indol-5-yl)acetamide
C10H11N3O2
938353-92-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.5400 0.0 0
M  V30 2 N 7.9109 3.0800 0.0 0
M  V30 3 C 9.2445 2.3100 0.0 0
M  V30 4 C 10.5783 3.0800 0.0 0
M  V30 5 O 9.2445 0.7700 0.0 0
M  V30 6 N 11.9120 2.3100 0.0 0
M  V30 7 C 3.9098 0.7700 0.0 0
M  V30 8 C 3.9098 2.3100 0.0 0
M  V30 9 N 2.4452 0.2941 0.0 0
M  V30 10 C 5.2436 0.0000 0.0 0
M  V30 11 C 5.2436 3.0800 0.0 0
M  V30 12 C 2.4452 2.7859 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 C 6.5772 0.7700 0.0 0
M  V30 15 C 6.5772 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3,4-Difluorophenyl)methyl]-N-[2-[(2,3-dihydro-2-oxo-1H-indol-5-yl)amino]-...
C26H19F2N5O4
2169270-96-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 6.1600 6.6684 0.0 0
M  V30 3 C 9.2400 6.6684 0.0 0
M  V30 4 N 10.7800 6.6684 0.0 0
M  V30 5 O 8.4700 8.0020 0.0 0
M  V30 6 C 11.5500 8.0020 0.0 0
M  V30 7 C 13.0900 8.0020 0.0 0
M  V30 8 N 13.8600 9.3358 0.0 0
M  V30 9 O 13.8600 6.6684 0.0 0
M  V30 10 F 0.0000 6.6684 0.0 0
M  V30 11 F 1.5400 9.3358 0.0 0
M  V30 12 O 21.4812 11.9575 0.0 0
M  V30 13 N 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6673 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 8.4700 2.6673 0.0 0
M  V30 17 N 6.1600 1.3336 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 1.3336 0.0 0
M  V30 21 C 6.9300 0.0000 0.0 0
M  V30 22 C 8.4700 0.0000 0.0 0
M  V30 23 C 3.8500 5.3347 0.0 0
M  V30 24 C 2.3100 5.3347 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 1.5400 6.6684 0.0 0
M  V30 27 C 3.8500 8.0020 0.0 0
M  V30 28 C 2.3100 8.0020 0.0 0
M  V30 29 C 15.4000 9.3358 0.0 0
M  V30 30 C 16.1700 10.6694 0.0 0
M  V30 31 C 16.1700 8.0020 0.0 0
M  V30 32 C 17.7100 10.6694 0.0 0
M  V30 33 C 17.7102 8.0020 0.0 0
M  V30 34 C 18.4800 9.3358 0.0 0
M  V30 35 C 18.7406 11.8138 0.0 0
M  V30 36 N 19.9864 9.6560 0.0 0
M  V30 37 C 20.1474 11.1875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 23
M  V30 3 2 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 29
M  V30 12 1 10 26
M  V30 13 1 11 28
M  V30 14 2 12 37
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 19
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 32 35
M  V30 38 2 33 34
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2302023-74-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 938353-92-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2169270-96-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32438839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of potent dual PDK1/AurA kinase inhibitors for cancer
therapy: Lead-optimization, structural insights, and ADME-Tox profile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sestito, Simona; Bacci, Andrea; Chiarugi, Sara; Runfola, Massimiliano;
Gado, Francesca; Margheritis, Eleonora; Gul, Sheraz; Riveiro, Maria E.;
Vazquez, Ramiro; Huguet, Samuel; Manera, Clementina; Rezai, Keyvan;
Garau, Gianpiero; Rapposelli, Simona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 226113895

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
3-(Aminomethyl)-4,6-dimethyl-2(1H)-pyridinone
C8H12N2O
771579-27-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 N 0.0000 4.0011 0.0 0
M  V30 3 C 2.3100 5.3349 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-3-carboxylic acid, 5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4...
C45H48N2O6
3033571-02-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 58 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 6.9302 0.0 0
M  V30 2 C 1.3337 7.7002 0.0 0
M  V30 3 C 0.0000 6.9302 0.0 0
M  V30 4 C 2.6673 10.0102 0.0 0
M  V30 5 C 5.3348 11.5503 0.0 0
M  V30 6 O 4.0010 12.3203 0.0 0
M  V30 7 O 6.6685 12.3203 0.0 0
M  V30 8 N 12.0033 7.7002 0.0 0
M  V30 9 C 13.3370 6.9302 0.0 0
M  V30 10 O 13.3370 5.3901 0.0 0
M  V30 11 O 16.0045 5.3901 0.0 0
M  V30 12 C 17.3382 4.6201 0.0 0
M  V30 13 C 16.0045 11.5503 0.0 0
M  V30 14 C 17.3382 12.3203 0.0 0
M  V30 15 C 14.6708 12.3203 0.0 0
M  V30 16 O 18.6718 10.0102 0.0 0
M  V30 17 C 20.0057 9.2402 0.0 0
M  V30 18 C 4.0010 7.7002 0.0 0
M  V30 19 C 5.3348 6.9302 0.0 0
M  V30 20 C 4.0010 9.2402 0.0 0
M  V30 21 C 6.6685 7.7002 0.0 0
M  V30 22 C 5.3348 10.0102 0.0 0
M  V30 23 C 6.6685 9.2402 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 1.3337 4.6201 0.0 0
M  V30 26 C 4.0010 4.6201 0.0 0
M  V30 27 C 1.3337 3.0801 0.0 0
M  V30 28 C 4.0010 3.0801 0.0 0
M  V30 29 O 2.6673 2.3101 0.0 0
M  V30 30 C 8.0022 6.9302 0.0 0
M  V30 31 C 9.3358 7.7002 0.0 0
M  V30 32 C 8.0022 5.3901 0.0 0
M  V30 33 C 10.6697 6.9302 0.0 0
M  V30 34 C 9.3358 4.6201 0.0 0
M  V30 35 C 10.6697 5.3901 0.0 0
M  V30 36 C 14.6708 7.7002 0.0 0
M  V30 37 C 16.0045 6.9302 0.0 0
M  V30 38 C 14.6708 9.2402 0.0 0
M  V30 39 C 17.3382 7.7002 0.0 0
M  V30 40 C 16.0045 10.0102 0.0 0
M  V30 41 C 17.3382 9.2402 0.0 0
M  V30 42 C 17.3382 3.0801 0.0 0
M  V30 43 C 16.0045 2.3101 0.0 0
M  V30 44 C 18.6718 2.3101 0.0 0
M  V30 45 C 16.0045 0.7700 0.0 0
M  V30 46 C 18.6718 0.7700 0.0 0
M  V30 47 C 17.3382 0.0000 0.0 0
M  V30 48 C 21.3393 10.0102 0.0 0
M  V30 49 C 21.3393 11.5503 0.0 0
M  V30 50 C 22.6730 9.2402 0.0 0
M  V30 51 C 22.6730 12.3203 0.0 0
M  V30 52 C 24.0067 10.0102 0.0 0
M  V30 53 C 24.0067 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 2 3
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 8 9
M  V30 10 1 8 33
M  V30 11 2 9 10
M  V30 12 1 9 36
M  V30 13 1 11 12
M  V30 14 1 11 37
M  V30 15 1 12 42
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 40
M  V30 19 1 16 17
M  V30 20 1 16 41
M  V30 21 1 17 48
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 21 30
M  V30 28 1 22 23
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C53H58N4O6
3033571-04-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  63 69 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0100 4.0011 0.0 0
M  V30 2 C 11.5500 4.0011 0.0 0
M  V30 3 C 12.3200 2.6674 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 5.3900 6.6684 0.0 0
M  V30 6 N 4.6200 8.0021 0.0 0
M  V30 7 O 4.6200 5.3347 0.0 0
M  V30 8 C 3.0800 8.0021 0.0 0
M  V30 9 N 13.8600 10.6694 0.0 0
M  V30 10 C 14.6300 12.0031 0.0 0
M  V30 11 O 13.8600 13.3369 0.0 0
M  V30 12 C 4.6200 10.6694 0.0 0
M  V30 13 O 0.0000 8.0021 0.0 0
M  V30 14 O 16.1700 14.6705 0.0 0
M  V30 15 C 16.9400 16.0041 0.0 0
M  V30 16 C 0.0000 13.3369 0.0 0
M  V30 17 C 19.2500 9.3358 0.0 0
M  V30 18 C 20.7900 9.3358 0.0 0
M  V30 19 C 18.4800 8.0021 0.0 0
M  V30 20 O 20.7900 12.0031 0.0 0
M  V30 21 C 21.5600 13.3369 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 10.0100 6.6684 0.0 0
M  V30 24 C 7.7000 5.3347 0.0 0
M  V30 25 C 9.2400 8.0021 0.0 0
M  V30 26 C 6.9300 6.6684 0.0 0
M  V30 27 C 7.7000 8.0021 0.0 0
M  V30 28 C 9.2400 2.6674 0.0 0
M  V30 29 C 10.0100 1.3336 0.0 0
M  V30 30 C 7.7000 2.6674 0.0 0
M  V30 31 C 9.2400 0.0000 0.0 0
M  V30 32 C 6.9300 1.3336 0.0 0
M  V30 33 O 7.7000 0.0000 0.0 0
M  V30 34 C 10.0100 9.3358 0.0 0
M  V30 35 C 11.5500 9.3358 0.0 0
M  V30 36 C 9.2400 10.6694 0.0 0
M  V30 37 C 12.3200 10.6694 0.0 0
M  V30 38 C 10.0100 12.0031 0.0 0
M  V30 39 C 11.5500 12.0031 0.0 0
M  V30 40 C 2.3100 9.3358 0.0 0
M  V30 41 C 3.0800 10.6694 0.0 0
M  V30 42 C 0.7700 9.3358 0.0 0
M  V30 43 C 2.3100 12.0031 0.0 0
M  V30 44 N 0.0000 10.6694 0.0 0
M  V30 45 C 0.7700 12.0031 0.0 0
M  V30 46 C 16.1700 12.0031 0.0 0
M  V30 47 C 16.9400 13.3369 0.0 0
M  V30 48 C 16.9400 10.6694 0.0 0
M  V30 49 C 18.4800 13.3369 0.0 0
M  V30 50 C 18.4800 10.6694 0.0 0
M  V30 51 C 19.2500 12.0031 0.0 0
M  V30 52 C 16.1700 17.3378 0.0 0
M  V30 53 C 14.6300 17.3378 0.0 0
M  V30 54 C 16.9400 18.6716 0.0 0
M  V30 55 C 13.8600 18.6716 0.0 0
M  V30 56 C 16.1700 20.0052 0.0 0
M  V30 57 C 14.6300 20.0052 0.0 0
M  V30 58 C 23.1000 13.3369 0.0 0
M  V30 59 C 23.8700 12.0031 0.0 0
M  V30 60 C 23.8700 14.6705 0.0 0
M  V30 61 C 25.4100 12.0031 0.0 0
M  V30 62 C 25.4100 14.6705 0.0 0
M  V30 63 C 26.1800 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 1 28
M  V30 4 1 2 3
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 40
M  V30 11 1 9 10
M  V30 12 1 9 37
M  V30 13 2 10 11
M  V30 14 1 10 46
M  V30 15 1 12 41
M  V30 16 2 13 42
M  V30 17 1 14 15
M  V30 18 1 14 47
M  V30 19 1 15 52
M  V30 20 1 16 45
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 17 50
M  V30 24 1 20 21
M  V30 25 1 20 51
M  V30 26 1 21 58
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 25 34
M  V30 33 1 26 27
M  V30 34 1 28 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 33
M  V30 40 2 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 2 36 38
M  V30 44 2 37 39
M  V30 45 1 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 52 2 46 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 2 48 50
M  V30 56 2 49 51
M  V30 57 1 50 51
M  V30 58 2 52 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 2 54 56
M  V30 62 2 55 57
M  V30 63 1 56 57
M  V30 64 2 58 59
M  V30 65 1 58 60
M  V30 66 1 59 61
M  V30 67 2 60 62
M  V30 68 2 61 63
M  V30 69 1 62 63
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 771579-27-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033571-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033571-04-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39174684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking
Antiglioblastoma Activity In Vitro and In Vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Sachin; Wang, Shao-An; Yang, Wen-Bin; Lin, Hong-Yi; Lai,
Mei-Jung; Chen, Hsien-Chung; Kao, Tzu-Yuan; Hsu, Feng-Lin; Nepali, Kunal;
Hsu, Tsung-I.; Liou, Jing-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(4), 2963-2985

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 3-[[[2-[[1,4-dioxo-4-(phenylmethoxy)butyl]methylamino]ethyl](1-...
C27H36N2O5.ClH
2227446-38-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.8747 0.0 0
M  V30 2 N 6.9300 5.5409 0.0 0
M  V30 3 C 6.1600 4.2073 0.0 0
M  V30 4 C 8.4700 5.5409 0.0 0
M  V30 5 C 4.6200 4.2073 0.0 0
M  V30 6 C 6.9300 2.8736 0.0 0
M  V30 7 C 9.2400 6.8747 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 6.1600 1.5400 0.0 0
M  V30 10 N 10.7800 6.8747 0.0 0
M  V30 11 C 11.5500 8.2084 0.0 0
M  V30 12 C 11.5500 5.5409 0.0 0
M  V30 13 C 13.0900 8.2084 0.0 0
M  V30 14 O 10.7800 9.5420 0.0 0
M  V30 15 C 13.8600 9.5420 0.0 0
M  V30 16 C 15.4000 9.5420 0.0 0
M  V30 17 O 16.1700 10.8758 0.0 0
M  V30 18 O 16.1700 8.2084 0.0 0
M  V30 19 C 17.7100 10.8758 0.0 0
M  V30 20 C 1.5400 9.5420 0.0 0
M  V30 21 O 0.0000 9.5420 0.0 0
M  V30 22 O 2.3100 10.8758 0.0 0
M  V30 23 C 4.6200 6.8747 0.0 0
M  V30 24 C 3.8500 8.2084 0.0 0
M  V30 25 C 3.8500 5.5409 0.0 0
M  V30 26 C 2.3100 8.2084 0.0 0
M  V30 27 C 2.3100 5.5409 0.0 0
M  V30 28 C 1.5400 6.8747 0.0 0
M  V30 29 C 18.4800 12.2094 0.0 0
M  V30 30 C 17.7100 13.5431 0.0 0
M  V30 31 C 20.0200 12.2094 0.0 0
M  V30 32 C 18.4800 14.8767 0.0 0
M  V30 33 C 20.7900 13.5431 0.0 0
M  V30 34 C 20.0200 14.8767 0.0 0
M  V30 35 Cl 10.3950 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 29
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 26
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)[1-(4-chlorophenyl)-1H-pyrazol-...
C18H16ClN3OS
2227447-99-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6698 2.1258 0.0 0
M  V30 2 O 5.8308 0.5943 0.0 0
M  V30 3 N 4.9733 5.4030 0.0 0
M  V30 4 Cl 15.4457 3.8010 0.0 0
M  V30 5 C 2.9292 1.9821 0.0 0
M  V30 6 C 4.2630 2.7521 0.0 0
M  V30 7 C 1.7849 3.0127 0.0 0
M  V30 8 C 2.6091 0.4759 0.0 0
M  V30 9 C 3.9429 4.2586 0.0 0
M  V30 10 S 2.4112 4.4195 0.0 0
M  V30 11 C 0.3202 2.5367 0.0 0
M  V30 12 C 1.1445 0.0000 0.0 0
M  V30 13 C 0.0000 1.0304 0.0 0
M  V30 14 C 6.9157 3.0310 0.0 0
M  V30 15 C 8.3804 2.5552 0.0 0
M  V30 16 C 6.9157 4.5711 0.0 0
M  V30 17 N 9.2856 3.8010 0.0 0
M  V30 18 N 8.3804 5.0469 0.0 0
M  V30 19 C 10.8256 3.8010 0.0 0
M  V30 20 C 11.5956 2.4674 0.0 0
M  V30 21 C 11.5956 5.1347 0.0 0
M  V30 22 C 13.1357 2.4674 0.0 0
M  V30 23 C 13.1357 5.1347 0.0 0
M  V30 24 C 13.9057 3.8010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 14
M  V30 4 1 3 9
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[[2-[[[3-[[[3-[[1-(4-chlorophenyl)-1H-pyrazol-4-yl]carbonyl]-4...
C45H50ClN5O5S
2227446-61-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 62 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6119 8.3522 0.0 0
M  V30 2 O 10.0878 6.8877 0.0 0
M  V30 3 N 12.9440 8.0020 0.0 0
M  V30 4 C 14.4840 8.0020 0.0 0
M  V30 5 O 15.2540 9.3358 0.0 0
M  V30 6 C 19.1041 5.3347 0.0 0
M  V30 7 N 19.8741 4.0009 0.0 0
M  V30 8 C 19.1041 2.6673 0.0 0
M  V30 9 C 21.4141 4.0009 0.0 0
M  V30 10 C 17.5641 2.6673 0.0 0
M  V30 11 C 19.8741 1.3336 0.0 0
M  V30 12 C 22.1841 5.3347 0.0 0
M  V30 13 C 16.7941 1.3336 0.0 0
M  V30 14 C 19.1041 0.0000 0.0 0
M  V30 15 N 23.7241 5.3347 0.0 0
M  V30 16 C 24.4941 6.6684 0.0 0
M  V30 17 C 24.4941 4.0009 0.0 0
M  V30 18 C 26.0341 6.6684 0.0 0
M  V30 19 O 23.7241 8.0020 0.0 0
M  V30 20 C 26.8041 8.0020 0.0 0
M  V30 21 C 28.3441 8.0020 0.0 0
M  V30 22 O 29.1141 9.3358 0.0 0
M  V30 23 O 29.1141 6.6684 0.0 0
M  V30 24 C 30.6541 9.3357 0.0 0
M  V30 25 Cl 0.0000 5.9065 0.0 0
M  V30 26 C 10.6425 9.4967 0.0 0
M  V30 27 C 10.3222 11.0030 0.0 0
M  V30 28 C 12.1740 9.3358 0.0 0
M  V30 29 C 11.6560 11.7730 0.0 0
M  V30 30 C 8.9885 11.7730 0.0 0
M  V30 31 S 12.8004 10.7426 0.0 0
M  V30 32 C 11.6560 13.3130 0.0 0
M  V30 33 C 8.9885 13.3130 0.0 0
M  V30 34 C 10.3222 14.0830 0.0 0
M  V30 35 C 8.1057 8.6724 0.0 0
M  V30 36 C 6.9611 7.6420 0.0 0
M  V30 37 C 7.4792 10.0793 0.0 0
M  V30 38 N 5.6275 8.4120 0.0 0
M  V30 39 N 5.9476 9.9184 0.0 0
M  V30 40 C 15.2540 6.6684 0.0 0
M  V30 41 C 16.7941 6.6684 0.0 0
M  V30 42 C 14.4840 5.3347 0.0 0
M  V30 43 C 17.5641 5.3347 0.0 0
M  V30 44 C 15.2540 4.0009 0.0 0
M  V30 45 C 16.7941 4.0009 0.0 0
M  V30 46 C 4.2207 7.7856 0.0 0
M  V30 47 C 2.9747 8.6909 0.0 0
M  V30 48 C 4.0596 6.2541 0.0 0
M  V30 49 C 1.5679 8.0644 0.0 0
M  V30 50 C 2.6528 5.6276 0.0 0
M  V30 51 C 1.4069 6.5329 0.0 0
M  V30 52 C 31.4241 10.6695 0.0 0
M  V30 53 C 30.6541 12.0031 0.0 0
M  V30 54 C 32.9641 10.6695 0.0 0
M  V30 55 C 31.4241 13.3367 0.0 0
M  V30 56 C 33.7341 12.0031 0.0 0
M  V30 57 C 32.9641 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 26
M  V30 3 1 1 35
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 2 4 5
M  V30 7 1 4 40
M  V30 8 1 6 7
M  V30 9 1 6 43
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 1 8 11
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 52
M  V30 28 1 25 51
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 29 31
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 1 38 46
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 51 2 46 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 2 48 50
M  V30 55 2 49 51
M  V30 56 1 50 51
M  V30 57 2 52 53
M  V30 58 1 52 54
M  V30 59 1 53 55
M  V30 60 2 54 56
M  V30 61 2 55 57
M  V30 62 1 56 57
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2227446-38-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227447-99-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227446-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31375482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as
gut-selective NaPi2b inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ushiki, Yasunobu; Kawabe, Kenichi; Yamamoto-Okada, Kumiko; Uneuchi,
Fumito; Asanuma, Yuta; Yamaguchi, Chitose; Ohta, Hiroshi; Shibata,
Tsuyoshi; Abe, Tomohiro; Okumura-Kitajima, Lisa; Kosai, Yuki; Endo,
Mayumi; Otake, Katsumasa; Munetomo, Eiji; Takahashi, Teisuke; Kakinuma,
Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 59128572

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
3,3,3-Trifluoro-2,2-dimethyl-1-propanamine
C5H10F3N
1211517-48-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.3337 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 C 3.4374 2.6673 0.0 0
M  V30 4 C 1.8973 0.0000 0.0 0
M  V30 5 C 4.0012 0.5637 0.0 0
M  V30 6 F 0.5637 0.7700 0.0 0
M  V30 7 F 0.0000 2.8737 0.0 0
M  V30 8 F 2.1037 3.4374 0.0 0
M  V30 9 N 4.9774 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S,3R,4S)-3-[[5-[[cis-4-[(1,1-Dimethylethoxy)carbonyl]-4-methylcyclohexyl...
C28H38FNO7
2787516-58-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.6186 5.3348 0.0 0
M  V30 2 C 6.3887 4.0012 0.0 0
M  V30 3 O 5.6186 2.6675 0.0 0
M  V30 4 C 2.9584 7.2517 0.0 0
M  V30 5 O 4.3449 7.9219 0.0 0
M  V30 6 O 1.6846 8.1173 0.0 0
M  V30 7 O 7.9287 1.3338 0.0 0
M  V30 8 C 8.6987 0.0000 0.0 0
M  V30 9 O 11.0088 6.6686 0.0 0
M  V30 10 F 12.5488 4.0012 0.0 0
M  V30 11 C 16.8085 7.6586 0.0 0
M  V30 12 O 18.2557 7.1317 0.0 0
M  V30 13 O 16.5412 9.1752 0.0 0
M  V30 14 C 19.4355 8.1217 0.0 0
M  V30 15 C 20.4254 6.9420 0.0 0
M  V30 16 C 20.6152 9.1116 0.0 0
M  V30 17 C 18.4456 9.3015 0.0 0
M  V30 18 C 16.8085 5.6787 0.0 0
M  V30 19 C 4.0786 5.3348 0.0 0 CFG=1
M  V30 20 C 2.6602 4.8967 0.0 0 CFG=1
M  V30 21 C 2.8457 5.7158 0.0 0 CFG=1
M  V30 22 C 0.7540 6.7062 0.0 0
M  V30 23 C 2.1990 3.5747 0.0 0
M  V30 24 C 1.5231 5.5118 0.0 0 CFG=2
M  V30 25 C 1.0942 3.9956 0.0 0
M  V30 26 C 7.9287 4.0012 0.0 0
M  V30 27 C 8.6987 2.6675 0.0 0
M  V30 28 C 8.6987 5.3348 0.0 0
M  V30 29 C 10.2387 2.6675 0.0 0
M  V30 30 C 10.2387 5.3348 0.0 0
M  V30 31 C 11.0088 4.0012 0.0 0
M  V30 32 C 12.5488 6.6686 0.0 0 CFG=2
M  V30 33 C 13.3188 5.3348 0.0 0
M  V30 34 C 13.3188 8.0023 0.0 0
M  V30 35 C 14.8588 5.3348 0.0 0
M  V30 36 C 14.8588 8.0023 0.0 0
M  V30 37 C 15.6288 6.6686 0.0 0 CFG=1
M  V30 38 H 3.7295 3.7883 0.0 0
M  V30 39 H 0.0000 5.2843 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 27
M  V30 10 1 9 30
M  V30 11 1 32 9 CFG=3
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 37 11 CFG=3
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 37 18 CFG=1
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 20 38 CFG=3
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 1 24 39 CFG=1
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 19 20 21 24 32 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl cis-4-[2-fluoro-4-methoxy-5-[[[(1S,2R,3S,4R)-3-[[(3,3,3-tri...
C33H46F4N2O6
2787520-04-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0788 6.1052 0.0 0
M  V30 2 N 2.3128 4.7692 0.0 0
M  V30 3 O 4.6188 6.1099 0.0 0
M  V30 4 C 3.0868 3.4379 0.0 0
M  V30 5 C 2.3208 2.1019 0.0 0
M  V30 6 C 3.6569 1.3359 0.0 0
M  V30 7 C 1.5549 0.7658 0.0 0
M  V30 8 C 0.9848 2.8678 0.0 0
M  V30 9 F 4.4227 2.6719 0.0 0
M  V30 10 F 4.9928 0.5700 0.0 0
M  V30 11 F 2.8909 0.0000 0.0 0
M  V30 12 N 4.6126 8.7714 0.0 0
M  V30 13 C 5.3826 10.1052 0.0 0
M  V30 14 O 4.6126 11.4388 0.0 0
M  V30 15 O 6.9226 12.7725 0.0 0
M  V30 16 C 7.6926 14.1061 0.0 0
M  V30 17 O 10.0026 7.4377 0.0 0
M  V30 18 F 11.5426 10.1052 0.0 0
M  V30 19 C 15.8024 6.4478 0.0 0
M  V30 20 O 17.2495 6.9745 0.0 0
M  V30 21 O 15.5349 4.9312 0.0 0
M  V30 22 C 18.4292 5.9847 0.0 0
M  V30 23 C 17.4393 4.8050 0.0 0
M  V30 24 C 19.6088 4.9948 0.0 0
M  V30 25 C 19.4191 7.1644 0.0 0
M  V30 26 C 15.8024 8.4277 0.0 0
M  V30 27 C 2.3046 7.4367 0.0 0 CFG=1
M  V30 28 C 3.0726 8.7714 0.0 0 CFG=2
M  V30 29 C 0.7728 7.4296 0.0 0 CFG=2
M  V30 30 C 2.3086 10.0993 0.0 0 CFG=1
M  V30 31 C 1.1314 8.9999 0.0 0
M  V30 32 C 0.0000 8.7626 0.0 0
M  V30 33 C 0.7678 10.0975 0.0 0
M  V30 34 C 6.9226 10.1052 0.0 0
M  V30 35 C 7.6926 11.4388 0.0 0
M  V30 36 C 7.6926 8.7714 0.0 0
M  V30 37 C 9.2326 11.4388 0.0 0
M  V30 38 C 9.2326 8.7714 0.0 0
M  V30 39 C 10.0026 10.1052 0.0 0
M  V30 40 C 11.5426 7.4377 0.0 0 CFG=2
M  V30 41 C 12.3126 8.7714 0.0 0
M  V30 42 C 12.3126 6.1041 0.0 0
M  V30 43 C 13.8526 8.7714 0.0 0
M  V30 44 C 13.8526 6.1041 0.0 0
M  V30 45 C 14.6226 7.4377 0.0 0 CFG=1
M  V30 46 H 0.0069 6.0935 0.0 0
M  V30 47 H 3.0789 11.4330 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 27 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 12 13
M  V30 13 1 28 12 CFG=1
M  V30 14 2 13 14
M  V30 15 1 13 34
M  V30 16 1 15 16
M  V30 17 1 15 35
M  V30 18 1 17 38
M  V30 19 1 40 17 CFG=1
M  V30 20 1 18 39
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 45 19 CFG=1
M  V30 24 1 20 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 45 26 CFG=3
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31 CFG=1
M  V30 33 1 29 32
M  V30 34 1 29 46
M  V30 35 1 30 31 CFG=1
M  V30 36 1 30 33
M  V30 37 1 30 47
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 27 28 29 30 40 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1211517-48-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787516-58-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787520-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40331892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric
RXFP1 Agonist for Treatment of Heart Failure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Larsson, Niklas; Bergstroem,
Fredrik; Fuchigami, Ryuichi; Niwa, Yasuki; Ryberg, Erik; Backmark, Anna;
Kato, Harutoshi; Miyazaki, Shiki; Iguchi, Kaori; Sakamoto, Toshiaki;
Persson, Mikael; Idei, Akiko; Prieto Garcia, Luna; Villar, Inmaculada C.;
Graden, Henrik; Bergonzini, Giulia; Arvidsson, Torbjoern; Fujita, Takuya;
Althage, Magnus; Ulander, Johan; Kimura, Junpei; Yoneda, Hikaru;
Fjellstroem, Ola; Mochida, Hideki; Lal, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4419-4441

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
3,6,11-Trioxa-9-azatridecanoic acid, 12,12-dimethyl-10-oxo-, compd. with N-cy...
C12H23N.C11H21NO6
560088-79-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 6.1600 0.0 0
M  V30 2 C 4.0012 6.9301 0.0 0
M  V30 3 C 1.3338 6.9301 0.0 0
M  V30 4 N 5.3348 6.1600 0.0 0
M  V30 5 O 4.0012 8.4701 0.0 0
M  V30 6 C 2.1038 8.2637 0.0 0
M  V30 7 C 0.0000 7.7001 0.0 0
M  V30 8 C 0.5638 5.5964 0.0 0
M  V30 9 C 6.6687 6.9301 0.0 0
M  V30 10 C 8.0023 6.1600 0.0 0
M  V30 11 O 9.3360 6.9301 0.0 0
M  V30 12 C 10.6697 6.1600 0.0 0
M  V30 13 C 12.0035 6.9301 0.0 0
M  V30 14 O 13.3372 6.1600 0.0 0
M  V30 15 C 14.6708 6.9301 0.0 0
M  V30 16 C 16.0045 6.1600 0.0 0
M  V30 17 O 16.0045 4.6200 0.0 0
M  V30 18 O 17.3383 6.9301 0.0 0
M  V30 19 N 8.6692 3.0800 0.0 0
M  V30 20 C 7.3355 2.3100 0.0 0
M  V30 21 C 6.0017 3.0800 0.0 0
M  V30 22 C 7.3355 0.7700 0.0 0
M  V30 23 C 4.6681 2.3100 0.0 0
M  V30 24 C 6.0017 0.0000 0.0 0
M  V30 25 C 4.6681 0.7700 0.0 0
M  V30 26 C 10.0028 2.3100 0.0 0
M  V30 27 C 11.3366 3.0800 0.0 0
M  V30 28 C 10.0028 0.7700 0.0 0
M  V30 29 C 12.6702 2.3100 0.0 0
M  V30 30 C 11.3366 0.0000 0.0 0
M  V30 31 C 12.6702 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 19 20
M  V30 19 1 19 26
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[[5-(4-Aminophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluoro...
C23H20F2N4O3S
2230957-10-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.4886 3.7710 0.0 0
M  V30 2 O 8.7186 5.1048 0.0 0
M  V30 3 F 11.0286 6.4384 0.0 0
M  V30 4 F 11.0286 1.1037 0.0 0
M  V30 5 N 14.1086 6.4384 0.0 0
M  V30 6 S 15.6486 6.4384 0.0 0 VAL=6
M  V30 7 C 17.1886 6.4384 0.0 0
M  V30 8 O 15.6486 7.9784 0.0 0
M  V30 9 O 15.6486 4.8984 0.0 0
M  V30 10 C 17.9586 7.7721 0.0 0
M  V30 11 C 19.4986 7.7721 0.0 0
M  V30 12 N 0.0000 6.9528 0.0 0
M  V30 13 C 7.1869 2.2764 0.0 0
M  V30 14 C 8.7186 2.4374 0.0 0
M  V30 15 C 6.8667 0.7700 0.0 0
M  V30 16 C 6.0425 3.3068 0.0 0
M  V30 17 C 9.3449 1.0306 0.0 0
M  V30 18 N 8.2003 0.0000 0.0 0
M  V30 19 N 5.4022 0.2941 0.0 0
M  V30 20 C 4.5778 2.8310 0.0 0
M  V30 21 C 4.2576 1.3246 0.0 0
M  V30 22 C 11.0286 3.7710 0.0 0
M  V30 23 C 11.7986 5.1048 0.0 0
M  V30 24 C 11.7986 2.4374 0.0 0
M  V30 25 C 13.3386 5.1048 0.0 0
M  V30 26 C 13.3386 2.4374 0.0 0
M  V30 27 C 14.1086 3.7710 0.0 0
M  V30 28 C 3.4334 3.8614 0.0 0
M  V30 29 C 1.9687 3.3855 0.0 0
M  V30 30 C 3.7536 5.3678 0.0 0
M  V30 31 C 0.8244 4.4159 0.0 0
M  V30 32 C 2.6091 6.3982 0.0 0
M  V30 33 C 1.1445 5.9224 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 22
M  V30 4 1 3 23
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 5 25
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 10 11
M  V30 13 1 12 33
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 20 28
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[2-[2-[[4-[3-[2,6-difluoro-3-[(propylsulfonyl)amino]be...
C34H39F2N5O8S
2260975-50-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9596 5.9949 0.0 0
M  V30 2 O 9.9900 4.8505 0.0 0
M  V30 3 F 8.0079 3.0656 0.0 0
M  V30 4 F 6.8987 8.2838 0.0 0
M  V30 5 N 4.9951 2.4252 0.0 0
M  V30 6 S 3.4886 2.1051 0.0 0 VAL=6
M  V30 7 C 1.9823 1.7849 0.0 0
M  V30 8 O 3.1685 3.6114 0.0 0
M  V30 9 O 3.8090 0.5986 0.0 0
M  V30 10 C 1.5065 0.3202 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 N 18.9024 4.8554 0.0 0
M  V30 13 C 20.2362 5.6254 0.0 0
M  V30 14 C 21.5699 4.8554 0.0 0
M  V30 15 O 20.2362 7.1655 0.0 0
M  V30 16 O 22.9035 5.6254 0.0 0
M  V30 17 C 24.2372 4.8554 0.0 0
M  V30 18 C 25.5710 5.6254 0.0 0
M  V30 19 O 26.9047 4.8554 0.0 0
M  V30 20 C 28.2384 5.6254 0.0 0
M  V30 21 C 29.5720 4.8554 0.0 0
M  V30 22 N 30.9059 5.6254 0.0 0
M  V30 23 C 32.2395 4.8554 0.0 0
M  V30 24 O 33.5732 5.6254 0.0 0
M  V30 25 O 32.2395 3.3154 0.0 0
M  V30 26 C 34.9069 4.8554 0.0 0
M  V30 27 C 35.6769 6.1891 0.0 0
M  V30 28 C 36.2407 4.0854 0.0 0
M  V30 29 C 34.1370 3.5217 0.0 0
M  V30 30 C 10.9002 7.9355 0.0 0
M  V30 31 C 9.4355 7.4596 0.0 0
M  V30 32 C 10.9002 9.4755 0.0 0
M  V30 33 C 12.2339 7.1655 0.0 0
M  V30 34 C 8.5302 8.7055 0.0 0
M  V30 35 N 9.4355 9.9514 0.0 0
M  V30 36 N 12.2339 10.2455 0.0 0
M  V30 37 C 13.5675 7.9355 0.0 0
M  V30 38 C 13.5675 9.4755 0.0 0
M  V30 39 C 7.4533 5.6747 0.0 0
M  V30 40 C 6.9774 4.2101 0.0 0
M  V30 41 C 6.4227 6.8193 0.0 0
M  V30 42 C 5.4710 3.8898 0.0 0
M  V30 43 C 4.9164 6.4989 0.0 0
M  V30 44 C 4.4405 5.0344 0.0 0
M  V30 45 C 14.9014 7.1655 0.0 0
M  V30 46 C 14.9014 5.6254 0.0 0
M  V30 47 C 16.2350 7.9355 0.0 0
M  V30 48 C 16.2350 4.8554 0.0 0
M  V30 49 C 17.5687 7.1655 0.0 0
M  V30 50 C 17.5687 5.6254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 31
M  V30 3 1 1 39
M  V30 4 1 3 40
M  V30 5 1 4 41
M  V30 6 1 5 6
M  V30 7 1 5 42
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 50
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 26 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 34 2 31 34
M  V30 35 1 32 35
M  V30 36 2 32 36
M  V30 37 1 33 37
M  V30 38 1 34 35
M  V30 39 1 36 38
M  V30 40 2 37 38
M  V30 41 1 37 45
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 48 2 45 46
M  V30 49 1 45 47
M  V30 50 1 46 48
M  V30 51 2 47 49
M  V30 52 2 48 50
M  V30 53 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 560088-79-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2230957-10-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2260975-50-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36813239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in
cancer cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barresi, Elisabetta; Baldanzi, Caterina; Roncetti, Marta; Roggia,
Michele; Baglini, Emma; Lepori, Irene; Vitiello, Marianna; Salerno,
Silvia; Tedeschi, Lorena; Da Settimo, Federico; Cosconati, Sandro;
Poliseno, Laura; Taliani, Sabrina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 256115446

$RFMT $RIREG SCHEME425 STEP1
$RXN



  3  1
$MOL
2-Thiophenebutanoic acid
C8H10O2S
4653-11-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 C 7.7722 1.8517 0.0 0
M  V30 5 O 9.1059 2.6218 0.0 0
M  V30 6 O 7.7722 0.3117 0.0 0
M  V30 7 C 2.4374 1.8517 0.0 0
M  V30 8 C 2.2763 0.3202 0.0 0
M  V30 9 S 1.0304 2.4782 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(7-methoxy-6-nitro-4-quinazolinyl)oxy]benzenamine
C15H11FN4O4
2761180-24-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 F 9.2400 0.0000 0.0 0
M  V30 8 N 13.8600 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 6.6685 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 10.0100 1.3338 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 1.3338 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 20
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-Crotonyl chloride
C4H5ClO
625-35-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 1.3338 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenebutanamide, N-[3-fluoro-4-[[7-methoxy-6-[[(2E)-1-oxo-2-buten-1-yl]...
C27H25FN4O4S
3020728-52-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 8.4702 0.0 0
M  V30 2 N 4.0010 4.6201 0.0 0
M  V30 3 C 5.3348 3.8501 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 C 0.0000 6.9302 0.0 0
M  V30 10 F 10.6697 6.9302 0.0 0
M  V30 11 N 13.3370 11.5503 0.0 0
M  V30 12 C 14.6708 10.7802 0.0 0
M  V30 13 C 16.0045 11.5503 0.0 0
M  V30 14 O 14.6708 9.2402 0.0 0
M  V30 15 C 17.3382 10.7802 0.0 0
M  V30 16 C 18.6718 11.5503 0.0 0
M  V30 17 C 5.3348 8.4702 0.0 0
M  V30 18 C 6.6685 9.2402 0.0 0
M  V30 19 C 4.0010 9.2402 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 N 6.6685 10.7802 0.0 0
M  V30 22 C 2.6673 8.4702 0.0 0
M  V30 23 N 4.0010 10.7802 0.0 0
M  V30 24 C 4.0010 6.1601 0.0 0
M  V30 25 C 5.3348 11.5503 0.0 0
M  V30 26 C 2.6673 6.9302 0.0 0
M  V30 27 C 9.3358 9.2402 0.0 0
M  V30 28 C 10.6697 8.4702 0.0 0
M  V30 29 C 9.3358 10.7802 0.0 0
M  V30 30 C 12.0033 9.2402 0.0 0
M  V30 31 C 10.6697 11.5503 0.0 0
M  V30 32 C 12.0033 10.7802 0.0 0
M  V30 33 C 20.0057 10.7802 0.0 0
M  V30 34 C 20.1666 9.2487 0.0 0
M  V30 35 S 21.4125 11.4066 0.0 0
M  V30 36 C 21.6729 8.9285 0.0 0
M  V30 37 C 22.4429 10.2622 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 26
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 32
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 33
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 2 23 25
M  V30 29 1 24 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4653-11-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761180-24-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 625-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020728-52-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38556008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solution from stage 1 and 2 prepared separately and added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met
inhibitors for the treatment of NSCLC
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Sheng; Sun, Chuanchuan; He, Xintao; Gan, Wenhui; Wang, Linxiao;
Qiao, Dan; Guan, Xinyu; Xu, Shan; Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 263115939

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
5-(Difluoromethyl)-2-pyrazinecarboxylic acid
C6H4F2N2O2
1174321-06-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 F 8.0022 2.3100 0.0 0
M  V30 3 F 6.6686 0.0000 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 N 5.3348 3.8500 0.0 0
M  V30 10 N 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4aS,5R,7aS)-7a-(5-Amino-2-fluorophenyl)-4a,5,7,7a-tetrahydro-5-methyl-4H-fur...
C13H16FN3OS
1388651-24-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 3.9688 6.4219 0.0 0
M  V30 2 C 0.0000 3.6990 0.0 0
M  V30 3 N 6.2997 0.0000 0.0 0
M  V30 4 N 9.3035 3.3418 0.0 0
M  V30 5 C 3.9688 3.3418 0.0 0 CFG=1
M  V30 6 C 2.5620 2.7155 0.0 0 CFG=2
M  V30 7 C 3.8078 4.8735 0.0 0
M  V30 8 N 5.2148 2.4368 0.0 0
M  V30 9 C 1.5315 3.8600 0.0 0 CFG=1
M  V30 10 C 2.4010 1.1840 0.0 0
M  V30 11 O 2.3016 5.1937 0.0 0
M  V30 12 C 5.0537 0.9051 0.0 0
M  V30 13 S 3.6469 0.2787 0.0 0
M  V30 14 C 5.3026 4.1118 0.0 0
M  V30 15 C 5.3026 5.6519 0.0 0
M  V30 16 C 6.6362 3.3418 0.0 0
M  V30 17 C 6.6362 6.4219 0.0 0
M  V30 18 C 7.9699 4.1118 0.0 0
M  V30 19 C 7.9699 5.6519 0.0 0
M  V30 20 H 1.0973 2.2396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 9 2 CFG=1
M  V30 3 1 3 12
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 20 CFG=1
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 1 9 11
M  V30 15 1 10 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 6 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[3-[(4aS,5R,7aS)-2-Amino-5,7-dihydro-5-methyl-4H-furo[3,4-d][1,3]thiazin-7a...
C19H18F3N5O2S
1388651-30-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 3.9690 6.9302 0.0 0
M  V30 2 C 0.0000 4.2072 0.0 0
M  V30 3 N 6.2998 0.5081 0.0 0
M  V30 4 N 9.3038 3.8501 0.0 0
M  V30 5 C 10.6375 4.6201 0.0 0
M  V30 6 O 10.6375 6.1601 0.0 0
M  V30 7 C 15.9723 1.5400 0.0 0
M  V30 8 F 17.3060 2.3101 0.0 0
M  V30 9 F 15.9723 0.0000 0.0 0
M  V30 10 C 3.9690 3.8501 0.0 0 CFG=1
M  V30 11 C 2.5620 3.2238 0.0 0 CFG=2
M  V30 12 C 3.8079 5.3816 0.0 0
M  V30 13 N 5.2149 2.9449 0.0 0
M  V30 14 C 1.5316 4.3682 0.0 0 CFG=1
M  V30 15 C 2.4011 1.6920 0.0 0
M  V30 16 O 2.3016 5.7018 0.0 0
M  V30 17 C 5.0539 1.4133 0.0 0
M  V30 18 S 3.6470 0.7870 0.0 0
M  V30 19 C 5.3026 4.6201 0.0 0
M  V30 20 C 6.6363 3.8501 0.0 0
M  V30 21 C 5.3026 6.1601 0.0 0
M  V30 22 C 7.9700 4.6201 0.0 0
M  V30 23 C 6.6363 6.9302 0.0 0
M  V30 24 C 7.9700 6.1601 0.0 0
M  V30 25 C 11.9711 3.8501 0.0 0
M  V30 26 C 13.3048 4.6201 0.0 0
M  V30 27 N 11.9711 2.3101 0.0 0
M  V30 28 N 14.6386 3.8501 0.0 0
M  V30 29 C 13.3048 1.5400 0.0 0
M  V30 30 C 14.6386 2.3101 0.0 0
M  V30 31 H 1.0974 2.7477 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 14 2 CFG=1
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 2 5 6
M  V30 7 1 5 25
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 30
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 19 CFG=1
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 31 CFG=1
M  V30 18 1 12 16
M  V30 19 2 13 17
M  V30 20 1 14 16
M  V30 21 1 15 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1174321-06-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1388651-24-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1388651-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31495546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 80-73-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition
Following Process Risk Mitigation Strategy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Dae-Shik; Yoshizawa, Kazuhiro; Mitasev, Branko; Schnaderbeck,
Matthew; Zhang, Huiming; Omori, Masayuki; Kayano, Akio; Nagai, Mitsuo;
Wakasugi, Kazunori; Watanabe, Yuzo; Benayoud, Farid; Suzuki, Yuichi;
Motoki, Takafumi; Kaneko, Toshihiko; Takaishi, Mamoru; Ishida, Tasuku;
Takeda, Kunitoshi; Kita, Yoichi; Yamamoto, Noboru; Khan, Afzal;
Dimopoulos, Paschalis; Farthing, Christopher N.; Hall, Adrian; Chanda,
Arani; Lu, Lily; Bracke, Markus; Fang, Francis G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(3), 804-816

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
2-Aminopyridine
C5H6N2
504-29-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Ethyl 4-(4-carboxyphenyl)-2-[(2S)-1-[(1,1-dimethylethoxy)carbonyl]-2-pyrrol...
C22H27N3O6
2557169-11-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.5738 3.7535 0.0 0
M  V30 2 O 7.5434 2.6091 0.0 0
M  V30 3 O 10.0803 3.4333 0.0 0
M  V30 4 C 8.0193 1.1444 0.0 0
M  V30 5 C 6.9889 0.0000 0.0 0
M  V30 6 C 15.1632 6.4640 0.0 0
M  V30 7 O 15.9332 5.1304 0.0 0
M  V30 8 O 15.9332 7.7977 0.0 0
M  V30 9 C 3.4468 6.1987 0.0 0
M  V30 10 O 1.9406 5.8785 0.0 0
M  V30 11 O 4.4774 5.0543 0.0 0
M  V30 12 C 1.4647 4.4140 0.0 0
M  V30 13 C 0.0000 4.8898 0.0 0
M  V30 14 C 0.9888 2.9493 0.0 0
M  V30 15 C 2.9292 3.9380 0.0 0
M  V30 16 C 9.0032 6.4640 0.0 0
M  V30 17 C 8.0980 5.2182 0.0 0
M  V30 18 N 8.0980 7.7099 0.0 0
M  V30 19 N 6.6333 5.6940 0.0 0
M  V30 20 C 6.6333 7.2340 0.0 0
M  V30 21 C 10.5432 6.4640 0.0 0
M  V30 22 C 11.3132 5.1304 0.0 0
M  V30 23 C 11.3132 7.7977 0.0 0
M  V30 24 C 12.8532 5.1304 0.0 0
M  V30 25 C 12.8532 7.7977 0.0 0
M  V30 26 C 13.6232 6.4640 0.0 0
M  V30 27 C 5.3874 8.1392 0.0 0 CFG=2
M  V30 28 N 3.9229 7.6634 0.0 0
M  V30 29 C 5.3874 9.6793 0.0 0
M  V30 30 C 3.0176 8.9093 0.0 0
M  V30 31 C 3.9229 10.1551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 28
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 27 20 CFG=1
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(2S)-1-[(1,1-dimethylethoxy)carbonyl]-2-pyrrolidinyl]-4-[4-[(2-pyrid...
C27H31N5O5
2557169-12-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.5738 3.7535 0.0 0
M  V30 2 O 7.5434 2.6091 0.0 0
M  V30 3 O 10.0802 3.4333 0.0 0
M  V30 4 C 8.0193 1.1444 0.0 0
M  V30 5 C 6.9888 0.0000 0.0 0
M  V30 6 C 15.1632 6.4640 0.0 0
M  V30 7 N 15.9332 7.7977 0.0 0
M  V30 8 O 15.9332 5.1304 0.0 0
M  V30 9 C 3.4468 6.1987 0.0 0
M  V30 10 O 1.9406 5.8785 0.0 0
M  V30 11 O 4.4774 5.0543 0.0 0
M  V30 12 C 1.4647 4.4140 0.0 0
M  V30 13 C 0.0000 4.8898 0.0 0
M  V30 14 C 0.9888 2.9493 0.0 0
M  V30 15 C 2.9292 3.9379 0.0 0
M  V30 16 C 9.0032 6.4640 0.0 0
M  V30 17 C 8.0980 5.2181 0.0 0
M  V30 18 N 8.0980 7.7099 0.0 0
M  V30 19 N 6.6333 5.6940 0.0 0
M  V30 20 C 6.6333 7.2340 0.0 0
M  V30 21 C 10.5432 6.4640 0.0 0
M  V30 22 C 11.3132 5.1304 0.0 0
M  V30 23 C 11.3132 7.7977 0.0 0
M  V30 24 C 12.8532 5.1304 0.0 0
M  V30 25 C 12.8532 7.7977 0.0 0
M  V30 26 C 13.6232 6.4640 0.0 0
M  V30 27 C 5.3874 8.1392 0.0 0 CFG=2
M  V30 28 N 3.9229 7.6634 0.0 0
M  V30 29 C 5.3874 9.6792 0.0 0
M  V30 30 C 3.0176 8.9092 0.0 0
M  V30 31 C 3.9229 10.1551 0.0 0
M  V30 32 C 17.4732 7.7977 0.0 0
M  V30 33 C 18.2432 6.4640 0.0 0
M  V30 34 N 18.2432 9.1315 0.0 0
M  V30 35 C 19.7832 6.4640 0.0 0
M  V30 36 C 19.7832 9.1315 0.0 0
M  V30 37 C 20.5532 7.7977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 7 32
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 28
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 27 20 CFG=1
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 504-29-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2557169-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2557169-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31542523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly
Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Chunhua; Li, Qingyun; Zhao, Minghao; Fan, Goujie; Zhao, Jie; Zhang,
Dandan; Yang, Shouning; Zhang, Shuting; Gao, Dingding; Mao, Longfei; Zhu,
Liang; Li, Wei; Xu, Guiqing; Jiang, Yuqin; Ding, Qingjie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(21), 16242-16270

$RFMT $RIREG SCHEME428 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 3-[[[2-[[1,4-dioxo-4-(phenylmethoxy)butyl]methylamino]ethyl](1-...
C27H36N2O5.ClH
2227446-38-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.8747 0.0 0
M  V30 2 N 6.9300 5.5409 0.0 0
M  V30 3 C 6.1600 4.2073 0.0 0
M  V30 4 C 8.4700 5.5409 0.0 0
M  V30 5 C 4.6200 4.2073 0.0 0
M  V30 6 C 6.9300 2.8736 0.0 0
M  V30 7 C 9.2400 6.8747 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 6.1600 1.5400 0.0 0
M  V30 10 N 10.7800 6.8747 0.0 0
M  V30 11 C 11.5500 8.2084 0.0 0
M  V30 12 C 11.5500 5.5409 0.0 0
M  V30 13 C 13.0900 8.2084 0.0 0
M  V30 14 O 10.7800 9.5420 0.0 0
M  V30 15 C 13.8600 9.5420 0.0 0
M  V30 16 C 15.4000 9.5420 0.0 0
M  V30 17 O 16.1700 10.8758 0.0 0
M  V30 18 O 16.1700 8.2084 0.0 0
M  V30 19 C 17.7100 10.8758 0.0 0
M  V30 20 C 1.5400 9.5420 0.0 0
M  V30 21 O 0.0000 9.5420 0.0 0
M  V30 22 O 2.3100 10.8758 0.0 0
M  V30 23 C 4.6200 6.8747 0.0 0
M  V30 24 C 3.8500 8.2084 0.0 0
M  V30 25 C 3.8500 5.5409 0.0 0
M  V30 26 C 2.3100 8.2084 0.0 0
M  V30 27 C 2.3100 5.5409 0.0 0
M  V30 28 C 1.5400 6.8747 0.0 0
M  V30 29 C 18.4800 12.2094 0.0 0
M  V30 30 C 17.7100 13.5431 0.0 0
M  V30 31 C 20.0200 12.2094 0.0 0
M  V30 32 C 18.4800 14.8767 0.0 0
M  V30 33 C 20.7900 13.5431 0.0 0
M  V30 34 C 20.0200 14.8767 0.0 0
M  V30 35 Cl 10.3950 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 29
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 26
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-Amino-3-[[1-(4-chlorophenyl)-1H-pyrazol-4-yl]carbonyl]-4,7-dihydrothieno...
C19H17ClN4O2S
2227448-07-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0409 3.3320 0.0 0
M  V30 2 O 7.7208 4.8385 0.0 0
M  V30 3 N 8.3912 0.0000 0.0 0
M  V30 4 C 0.7700 2.6217 0.0 0
M  V30 5 C 0.0000 3.9554 0.0 0
M  V30 6 O 0.0000 1.2881 0.0 0
M  V30 7 Cl 17.8560 4.7598 0.0 0
M  V30 8 C 5.3901 2.6217 0.0 0
M  V30 9 C 6.8964 2.3016 0.0 0
M  V30 10 C 4.6201 1.2881 0.0 0
M  V30 11 C 4.6201 3.9554 0.0 0
M  V30 12 C 7.0575 0.7700 0.0 0
M  V30 13 S 5.6505 0.1437 0.0 0
M  V30 14 C 3.0801 1.2881 0.0 0
M  V30 15 C 3.0801 3.9554 0.0 0
M  V30 16 N 2.3100 2.6217 0.0 0
M  V30 17 C 9.5055 2.8561 0.0 0
M  V30 18 C 10.7516 3.7614 0.0 0
M  V30 19 C 9.9815 1.3916 0.0 0
M  V30 20 N 11.9974 2.8561 0.0 0
M  V30 21 N 11.5216 1.3916 0.0 0
M  V30 22 C 13.4620 3.3320 0.0 0
M  V30 23 C 13.7822 4.8385 0.0 0
M  V30 24 C 14.6065 2.3016 0.0 0
M  V30 25 C 15.2469 5.3143 0.0 0
M  V30 26 C 16.0711 2.7774 0.0 0
M  V30 27 C 16.3913 4.2839 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 17
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[[2-[[[3-[[[6-acetyl-3-[[1-(4-chlorophenyl)-1H-pyrazol-4-yl]ca...
C46H51ClN6O6S
2227446-68-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 65 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6120 8.0408 0.0 0
M  V30 2 O 10.0878 9.5054 0.0 0
M  V30 3 N 12.9441 8.3910 0.0 0
M  V30 4 C 14.4841 8.3910 0.0 0
M  V30 5 O 15.2541 7.0572 0.0 0
M  V30 6 C 10.3222 0.7700 0.0 0
M  V30 7 C 11.6560 0.0000 0.0 0
M  V30 8 O 8.9886 0.0000 0.0 0
M  V30 9 C 19.1041 11.0583 0.0 0
M  V30 10 N 19.8741 12.3921 0.0 0
M  V30 11 C 19.1041 13.7258 0.0 0
M  V30 12 C 21.4141 12.3921 0.0 0
M  V30 13 C 17.5641 13.7258 0.0 0
M  V30 14 C 19.8741 15.0594 0.0 0
M  V30 15 C 22.1841 11.0583 0.0 0
M  V30 16 C 16.7941 15.0594 0.0 0
M  V30 17 C 19.1041 16.3931 0.0 0
M  V30 18 N 23.7241 11.0583 0.0 0
M  V30 19 C 24.4941 9.7247 0.0 0
M  V30 20 C 24.4941 12.3921 0.0 0
M  V30 21 C 26.0341 9.7247 0.0 0
M  V30 22 O 23.7241 8.3910 0.0 0
M  V30 23 C 26.8041 8.3910 0.0 0
M  V30 24 C 28.3442 8.3910 0.0 0
M  V30 25 O 29.1142 7.0572 0.0 0
M  V30 26 O 29.1142 9.7247 0.0 0
M  V30 27 C 30.6542 7.0572 0.0 0
M  V30 28 Cl 0.0000 10.4865 0.0 0
M  V30 29 C 10.6425 6.8963 0.0 0
M  V30 30 C 10.3222 5.3900 0.0 0
M  V30 31 C 12.1741 7.0572 0.0 0
M  V30 32 C 11.6560 4.6200 0.0 0
M  V30 33 C 8.9886 4.6200 0.0 0
M  V30 34 S 12.8004 5.6504 0.0 0
M  V30 35 C 11.6560 3.0800 0.0 0
M  V30 36 C 8.9886 3.0800 0.0 0
M  V30 37 N 10.3222 2.3100 0.0 0
M  V30 38 C 8.1057 7.7207 0.0 0
M  V30 39 C 6.9611 8.7511 0.0 0
M  V30 40 C 7.4792 6.3137 0.0 0
M  V30 41 N 5.6275 7.9811 0.0 0
M  V30 42 N 5.9477 6.4747 0.0 0
M  V30 43 C 15.2541 9.7247 0.0 0
M  V30 44 C 16.7941 9.7247 0.0 0
M  V30 45 C 14.4841 11.0583 0.0 0
M  V30 46 C 17.5641 11.0583 0.0 0
M  V30 47 C 15.2541 12.3921 0.0 0
M  V30 48 C 16.7941 12.3921 0.0 0
M  V30 49 C 4.2207 8.6074 0.0 0
M  V30 50 C 4.0596 10.1389 0.0 0
M  V30 51 C 2.9747 7.7022 0.0 0
M  V30 52 C 2.6528 10.7654 0.0 0
M  V30 53 C 1.5679 8.3287 0.0 0
M  V30 54 C 1.4070 9.8602 0.0 0
M  V30 55 C 31.4242 5.7236 0.0 0
M  V30 56 C 30.6542 4.3899 0.0 0
M  V30 57 C 32.9642 5.7236 0.0 0
M  V30 58 C 31.4242 3.0563 0.0 0
M  V30 59 C 33.7342 4.3899 0.0 0
M  V30 60 C 32.9642 3.0563 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 29
M  V30 3 1 1 38
M  V30 4 1 3 4
M  V30 5 1 3 31
M  V30 6 2 4 5
M  V30 7 1 4 43
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 6 37
M  V30 11 1 9 10
M  V30 12 1 9 46
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 27 55
M  V30 31 1 28 54
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 30 33
M  V30 36 1 31 34
M  V30 37 1 32 34
M  V30 38 1 32 35
M  V30 39 1 33 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 1 41 49
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 54 2 49 50
M  V30 55 1 49 51
M  V30 56 1 50 52
M  V30 57 2 51 53
M  V30 58 2 52 54
M  V30 59 1 53 54
M  V30 60 2 55 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 2 57 59
M  V30 64 2 58 60
M  V30 65 1 59 60
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2227446-38-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227448-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227446-68-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31375486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as
gut-selective NaPi2b inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ushiki, Yasunobu; Kawabe, Kenichi; Yamamoto-Okada, Kumiko; Uneuchi,
Fumito; Asanuma, Yuta; Yamaguchi, Chitose; Ohta, Hiroshi; Shibata,
Tsuyoshi; Abe, Tomohiro; Okumura-Kitajima, Lisa; Kosai, Yuki; Endo,
Mayumi; Otake, Katsumasa; Munetomo, Eiji; Takahashi, Teisuke; Kakinuma,
Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 59128572

$RFMT $RIREG SCHEME429 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 3-[[[2-[[1,4-dioxo-4-(phenylmethoxy)butyl]methylamino]ethyl](1-...
C27H36N2O5.ClH
2227446-38-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.8747 0.0 0
M  V30 2 N 6.9300 5.5409 0.0 0
M  V30 3 C 6.1600 4.2073 0.0 0
M  V30 4 C 8.4700 5.5409 0.0 0
M  V30 5 C 4.6200 4.2073 0.0 0
M  V30 6 C 6.9300 2.8736 0.0 0
M  V30 7 C 9.2400 6.8747 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 6.1600 1.5400 0.0 0
M  V30 10 N 10.7800 6.8747 0.0 0
M  V30 11 C 11.5500 8.2084 0.0 0
M  V30 12 C 11.5500 5.5409 0.0 0
M  V30 13 C 13.0900 8.2084 0.0 0
M  V30 14 O 10.7800 9.5420 0.0 0
M  V30 15 C 13.8600 9.5420 0.0 0
M  V30 16 C 15.4000 9.5420 0.0 0
M  V30 17 O 16.1700 10.8758 0.0 0
M  V30 18 O 16.1700 8.2084 0.0 0
M  V30 19 C 17.7100 10.8758 0.0 0
M  V30 20 C 1.5400 9.5420 0.0 0
M  V30 21 O 0.0000 9.5420 0.0 0
M  V30 22 O 2.3100 10.8758 0.0 0
M  V30 23 C 4.6200 6.8747 0.0 0
M  V30 24 C 3.8500 8.2084 0.0 0
M  V30 25 C 3.8500 5.5409 0.0 0
M  V30 26 C 2.3100 8.2084 0.0 0
M  V30 27 C 2.3100 5.5409 0.0 0
M  V30 28 C 1.5400 6.8747 0.0 0
M  V30 29 C 18.4800 12.2094 0.0 0
M  V30 30 C 17.7100 13.5431 0.0 0
M  V30 31 C 20.0200 12.2094 0.0 0
M  V30 32 C 18.4800 14.8767 0.0 0
M  V30 33 C 20.7900 13.5431 0.0 0
M  V30 34 C 20.0200 14.8767 0.0 0
M  V30 35 Cl 10.3950 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 29
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 26
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Amino-6-cyclopropyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-3-yl)[1-(4-chlo...
C20H19ClN4OS
2227447-97-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6045 3.3320 0.0 0
M  V30 2 O 8.2843 4.8384 0.0 0
M  V30 3 N 8.9547 0.0000 0.0 0
M  V30 4 Cl 18.4194 4.7597 0.0 0
M  V30 5 C 5.9537 2.6217 0.0 0
M  V30 6 C 7.4601 2.3015 0.0 0
M  V30 7 C 5.1837 1.2881 0.0 0
M  V30 8 C 5.1837 3.9555 0.0 0
M  V30 9 C 7.6210 0.7700 0.0 0
M  V30 10 C 3.6437 1.2881 0.0 0
M  V30 11 S 6.2141 0.1437 0.0 0
M  V30 12 C 3.6437 3.9555 0.0 0
M  V30 13 N 2.8737 2.6217 0.0 0
M  V30 14 C 10.0692 2.8561 0.0 0
M  V30 15 C 11.3151 3.7613 0.0 0
M  V30 16 C 10.5450 1.3916 0.0 0
M  V30 17 N 12.5609 2.8561 0.0 0
M  V30 18 N 12.0851 1.3916 0.0 0
M  V30 19 C 1.3336 2.6217 0.0 0
M  V30 20 C 0.0000 1.8517 0.0 0
M  V30 21 C 0.0000 3.3917 0.0 0
M  V30 22 C 14.0255 3.3320 0.0 0
M  V30 23 C 15.1700 2.3015 0.0 0
M  V30 24 C 14.3458 4.8384 0.0 0
M  V30 25 C 16.6345 2.7774 0.0 0
M  V30 26 C 15.8103 5.3143 0.0 0
M  V30 27 C 16.9549 4.2838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 14
M  V30 4 1 3 9
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 1 12 13
M  V30 16 1 13 19
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 17 22
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[[2-[[[3-[[[3-[[1-(4-chlorophenyl)-1H-pyrazol-4-yl]carbonyl]-6...
C47H53ClN6O5S
2227446-58-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 66 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6120 8.6045 0.0 0
M  V30 2 O 10.0879 10.0691 0.0 0
M  V30 3 N 12.9441 8.9547 0.0 0
M  V30 4 C 14.4841 8.9547 0.0 0
M  V30 5 O 15.2542 7.6211 0.0 0
M  V30 6 C 19.1042 11.6220 0.0 0
M  V30 7 N 19.8742 12.9558 0.0 0
M  V30 8 C 19.1042 14.2895 0.0 0
M  V30 9 C 21.4142 12.9558 0.0 0
M  V30 10 C 17.5642 14.2895 0.0 0
M  V30 11 C 19.8742 15.6231 0.0 0
M  V30 12 C 22.1842 11.6220 0.0 0
M  V30 13 C 16.7942 15.6231 0.0 0
M  V30 14 C 19.1042 16.9568 0.0 0
M  V30 15 N 23.7242 11.6220 0.0 0
M  V30 16 C 24.4942 10.2884 0.0 0
M  V30 17 C 24.4942 12.9558 0.0 0
M  V30 18 C 26.0343 10.2884 0.0 0
M  V30 19 O 23.7242 8.9547 0.0 0
M  V30 20 C 26.8043 8.9547 0.0 0
M  V30 21 C 28.3443 8.9547 0.0 0
M  V30 22 O 29.1143 7.6211 0.0 0
M  V30 23 O 29.1143 10.2884 0.0 0
M  V30 24 C 30.6543 7.6211 0.0 0
M  V30 25 Cl 0.0000 11.0502 0.0 0
M  V30 26 C 10.6426 7.4600 0.0 0
M  V30 27 C 10.3223 5.9537 0.0 0
M  V30 28 C 12.1741 7.6211 0.0 0
M  V30 29 C 11.6561 5.1837 0.0 0
M  V30 30 C 8.9886 5.1837 0.0 0
M  V30 31 S 12.8004 6.2141 0.0 0
M  V30 32 C 11.6561 3.6437 0.0 0
M  V30 33 C 8.9886 3.6437 0.0 0
M  V30 34 N 10.3223 2.8737 0.0 0
M  V30 35 C 8.1057 8.2844 0.0 0
M  V30 36 C 6.9612 9.3148 0.0 0
M  V30 37 C 7.4792 6.8774 0.0 0
M  V30 38 N 5.6275 8.5448 0.0 0
M  V30 39 N 5.9477 7.0383 0.0 0
M  V30 40 C 15.2542 10.2884 0.0 0
M  V30 41 C 16.7942 10.2884 0.0 0
M  V30 42 C 14.4841 11.6220 0.0 0
M  V30 43 C 17.5642 11.6220 0.0 0
M  V30 44 C 15.2542 12.9558 0.0 0
M  V30 45 C 16.7942 12.9558 0.0 0
M  V30 46 C 10.3223 1.3337 0.0 0
M  V30 47 C 9.5522 0.0000 0.0 0
M  V30 48 C 11.0923 0.0000 0.0 0
M  V30 49 C 4.2207 9.1711 0.0 0
M  V30 50 C 2.9747 8.2659 0.0 0
M  V30 51 C 4.0596 10.7028 0.0 0
M  V30 52 C 1.5679 8.8924 0.0 0
M  V30 53 C 2.6528 11.3291 0.0 0
M  V30 54 C 1.4070 10.4239 0.0 0
M  V30 55 C 31.4243 6.2873 0.0 0
M  V30 56 C 30.6543 4.9536 0.0 0
M  V30 57 C 32.9643 6.2873 0.0 0
M  V30 58 C 31.4243 3.6200 0.0 0
M  V30 59 C 33.7343 4.9536 0.0 0
M  V30 60 C 32.9643 3.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 26
M  V30 3 1 1 35
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 2 4 5
M  V30 7 1 4 40
M  V30 8 1 6 7
M  V30 9 1 6 43
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 1 8 11
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 18 20
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 55
M  V30 28 1 25 54
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 29 31
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 1 34 46
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 1 38 49
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 52 1 46 47
M  V30 53 1 46 48
M  V30 54 1 47 48
M  V30 55 2 49 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 2 51 53
M  V30 59 2 52 54
M  V30 60 1 53 54
M  V30 61 2 55 56
M  V30 62 1 55 57
M  V30 63 1 56 58
M  V30 64 2 57 59
M  V30 65 2 58 60
M  V30 66 1 59 60
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2227446-38-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227447-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227446-58-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31375495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as
gut-selective NaPi2b inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ushiki, Yasunobu; Kawabe, Kenichi; Yamamoto-Okada, Kumiko; Uneuchi,
Fumito; Asanuma, Yuta; Yamaguchi, Chitose; Ohta, Hiroshi; Shibata,
Tsuyoshi; Abe, Tomohiro; Okumura-Kitajima, Lisa; Kosai, Yuki; Endo,
Mayumi; Otake, Katsumasa; Munetomo, Eiji; Takahashi, Teisuke; Kakinuma,
Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 59128572

$RFMT $RIREG SCHEME430 STEP1
$RXN



  2  1
$MOL
3-(4-Fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-5-pyrimidin...
C14H13FN2O4
1437323-26-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3336 0.0 0
M  V30 2 O 4.6200 6.6685 0.0 0
M  V30 3 C 1.5400 1.3336 0.0 0
M  V30 4 O 0.0000 1.3336 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 C 1.5400 6.6685 0.0 0
M  V30 7 C 2.3100 8.0021 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 F 10.7800 4.0011 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 N 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 16 C 6.1600 4.0011 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 8.4700 2.6674 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 14
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propanol, 2-[[4-(4-amino-2-fluorophenoxy)-1H-pyrazolo[3,4-b]pyridin-3-yl]am...
C15H16FN5O2.ClH
3034305-43-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.1600 0.0 0
M  V30 2 N 8.6090 5.7906 0.0 0
M  V30 3 C 10.1154 6.1107 0.0 0 CFG=2
M  V30 4 C 10.5912 7.5753 0.0 0
M  V30 5 C 11.1458 4.9662 0.0 0
M  V30 6 O 12.0977 7.8956 0.0 0
M  V30 7 F 5.3347 9.2400 0.0 0
M  V30 8 N 0.0000 9.2400 0.0 0
M  V30 9 C 6.6685 3.8500 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 8.1331 4.3259 0.0 0
M  V30 12 C 6.6685 2.3100 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 N 9.0383 3.0800 0.0 0
M  V30 15 N 8.1331 1.8341 0.0 0
M  V30 16 N 5.3347 1.5400 0.0 0
M  V30 17 C 4.0011 2.3100 0.0 0
M  V30 18 C 4.0011 6.9300 0.0 0
M  V30 19 C 4.0011 8.4700 0.0 0
M  V30 20 C 2.6674 6.1600 0.0 0
M  V30 21 C 2.6674 9.2400 0.0 0
M  V30 22 C 1.3338 6.9300 0.0 0
M  V30 23 C 1.3338 8.4700 0.0 0
M  V30 24 Cl 6.0488 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 3 4
M  V30 6 1 3 5 CFG=1
M  V30 7 1 4 6
M  V30 8 1 7 19
M  V30 9 1 8 23
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[3-Fluoro-4-[[3-[[(1R)-2-hydroxy-1-methylethyl]amino]-1H-pyrazolo[3,4-b]pyr...
C29H27F2N7O5
2412356-57-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.1457 6.7247 0.0 0
M  V30 2 N 3.1885 4.0739 0.0 0
M  V30 3 C 2.7126 2.6091 0.0 0 CFG=2
M  V30 4 C 3.7431 1.4647 0.0 0
M  V30 5 C 1.2063 2.2890 0.0 0
M  V30 6 O 3.2672 0.0000 0.0 0
M  V30 7 F 7.8131 5.1847 0.0 0
M  V30 8 N 10.4805 9.8048 0.0 0
M  V30 9 C 11.8142 9.0348 0.0 0
M  V30 10 O 11.8142 7.4947 0.0 0
M  V30 11 O 14.4816 7.4947 0.0 0
M  V30 12 C 14.4816 13.6549 0.0 0
M  V30 13 C 13.1479 14.4249 0.0 0
M  V30 14 C 15.8154 14.4249 0.0 0
M  V30 15 O 17.1490 12.1148 0.0 0
M  V30 16 F 21.1502 6.7247 0.0 0
M  V30 17 C 2.4782 6.7247 0.0 0
M  V30 18 C 3.8119 7.4947 0.0 0
M  V30 19 C 2.1580 5.2183 0.0 0
M  V30 20 C 1.1446 7.4947 0.0 0
M  V30 21 C 3.8119 9.0348 0.0 0
M  V30 22 N 0.6265 5.0573 0.0 0
M  V30 23 N 0.0000 6.4641 0.0 0
M  V30 24 N 1.1446 9.0348 0.0 0
M  V30 25 C 2.4782 9.8048 0.0 0
M  V30 26 C 6.4794 7.4947 0.0 0
M  V30 27 C 7.8131 6.7247 0.0 0
M  V30 28 C 6.4794 9.0348 0.0 0
M  V30 29 C 9.1467 7.4947 0.0 0
M  V30 30 C 7.8131 9.8048 0.0 0
M  V30 31 C 9.1467 9.0348 0.0 0
M  V30 32 C 13.1479 9.8048 0.0 0
M  V30 33 C 14.4816 9.0348 0.0 0
M  V30 34 C 13.1479 11.3448 0.0 0
M  V30 35 N 15.8154 9.8048 0.0 0
M  V30 36 N 14.4816 12.1148 0.0 0
M  V30 37 C 15.8154 11.3448 0.0 0
M  V30 38 C 17.1490 9.0348 0.0 0
M  V30 39 C 18.4827 9.8048 0.0 0
M  V30 40 C 17.1490 7.4947 0.0 0
M  V30 41 C 19.8164 9.0348 0.0 0
M  V30 42 C 18.4827 6.7247 0.0 0
M  V30 43 C 19.8164 7.4947 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 3 5 CFG=1
M  V30 7 1 4 6
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 2 9 10
M  V30 12 1 9 32
M  V30 13 2 11 33
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 36
M  V30 17 2 15 37
M  V30 18 1 16 43
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1437323-26-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3034305-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412356-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39945521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 13161-30-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor
Oncology Candidate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Critcher, Douglas J.; Ashcroft, Christopher Paul; Pettman, Alan J.;
Badland, Matthew; Szpera, Robert; Waddington, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(7), 2646-2658

$RFMT $RIREG SCHEME431 STEP1
$RXN



  2  1
$MOL
5-[[cis-4-[(1,1-Dimethylethoxy)carbonyl]-4-methylcyclohexyl]oxy]-4-fluoro-2-m...
C20H27FO6
2787516-56-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 F 4.0011 0.0000 0.0 0
M  V30 3 C 4.0011 6.1600 0.0 0
M  V30 4 O 5.3347 6.9300 0.0 0
M  V30 5 O 2.6673 6.9300 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 12.1860 3.5827 0.0 0
M  V30 9 O 13.1759 4.7623 0.0 0
M  V30 10 O 12.7127 2.1355 0.0 0
M  V30 11 C 14.6925 4.4948 0.0 0
M  V30 12 C 14.4252 2.9782 0.0 0
M  V30 13 C 16.2091 4.2275 0.0 0
M  V30 14 C 14.9599 6.0115 0.0 0
M  V30 15 C 11.1961 5.2971 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 18 C 4.0011 1.5400 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 2.6673 2.3100 0.0 0
M  V30 21 C 2.6673 3.8500 0.0 0
M  V30 22 C 8.0020 2.3100 0.0 0 CFG=2
M  V30 23 C 8.0020 3.8500 0.0 0
M  V30 24 C 9.3358 1.5400 0.0 0
M  V30 25 C 9.3358 4.6200 0.0 0
M  V30 26 C 10.6694 2.3100 0.0 0
M  V30 27 C 10.6694 3.8500 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 22 1 CFG=1
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 19
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 27 8 CFG=1
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 27 15 CFG=3
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Sulfur, [5-[[[(1R,2S,3R,4S)-3-aminobicyclo[2.2.1]hept-2-yl]carbonyl]amino]-2-...
C14H16F6N2OS.ClH
2787518-02-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 5.1600 0.0 0
M  V30 2 N 6.6687 4.3900 0.0 0
M  V30 3 O 8.0023 6.7000 0.0 0
M  V30 4 N 9.3477 2.1699 0.0 0
M  V30 5 S 1.3338 4.3900 0.0 0 VAL=6
M  V30 6 F 0.0000 3.6200 0.0 0
M  V30 7 F 2.6675 3.6200 0.0 0
M  V30 8 F 0.0000 5.1600 0.0 0
M  V30 9 F 1.3338 2.8500 0.0 0
M  V30 10 F 1.3338 5.9300 0.0 0
M  V30 11 F 1.3338 7.4701 0.0 0
M  V30 12 C 10.7833 4.0603 0.0 0 CFG=2
M  V30 13 C 9.3360 4.3900 0.0 0 CFG=2
M  V30 14 C 11.5296 1.5400 0.0 0
M  V30 15 C 11.8438 4.9744 0.0 0
M  V30 16 C 10.2134 3.4436 0.0 0 CFG=2
M  V30 17 C 11.4606 2.9590 0.0 0 CFG=2
M  V30 18 C 12.5902 4.0575 0.0 0
M  V30 19 C 5.3348 5.1600 0.0 0
M  V30 20 C 4.0012 4.3900 0.0 0
M  V30 21 C 5.3348 6.7000 0.0 0
M  V30 22 C 2.6675 5.1600 0.0 0
M  V30 23 C 4.0012 7.4701 0.0 0
M  V30 24 C 2.6675 6.7000 0.0 0
M  V30 25 H 10.4117 5.5547 0.0 0
M  V30 26 H 12.8935 2.3944 0.0 0
M  V30 27 Cl 6.4467 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 19
M  V30 5 1 16 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 5 22
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 25 CFG=1
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 17 26 CFG=3
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H41F7N2O6S
3083612-99-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.9823 10.7689 0.0 0
M  V30 2 C 9.3159 11.5389 0.0 0
M  V30 3 O 9.3159 13.0789 0.0 0
M  V30 4 C 5.3207 9.2269 0.0 0
M  V30 5 N 3.9894 8.4528 0.0 0
M  V30 6 O 6.6568 8.4609 0.0 0
M  V30 7 O 11.9834 13.0789 0.0 0
M  V30 8 C 13.3170 13.8489 0.0 0
M  V30 9 O 11.9834 6.9189 0.0 0
M  V30 10 S 1.3361 3.8247 0.0 0 VAL=6
M  V30 11 F 0.0046 3.0507 0.0 0
M  V30 12 F 2.6721 3.0587 0.0 0
M  V30 13 F 0.0000 4.5907 0.0 0
M  V30 14 F 1.3407 2.2847 0.0 0
M  V30 15 F 1.3313 5.3647 0.0 0
M  V30 16 F 14.6506 8.4589 0.0 0
M  V30 17 F 4.0080 2.2929 0.0 0
M  V30 18 C 16.5111 3.1618 0.0 0
M  V30 19 O 18.0277 2.8943 0.0 0
M  V30 20 O 15.5212 1.9820 0.0 0
M  V30 21 C 18.5544 1.4471 0.0 0
M  V30 22 C 20.0015 1.9738 0.0 0
M  V30 23 C 19.0811 0.0000 0.0 0
M  V30 24 C 17.1072 0.9205 0.0 0
M  V30 25 C 17.5009 4.8763 0.0 0
M  V30 26 C 6.6486 11.5389 0.0 0 CFG=2
M  V30 27 C 5.3161 10.7668 0.0 0 CFG=1
M  V30 28 C 6.6510 13.0707 0.0 0 CFG=1
M  V30 29 C 3.9858 11.5267 0.0 0 CFG=2
M  V30 30 C 5.0817 12.7073 0.0 0
M  V30 31 C 5.3156 13.8395 0.0 0
M  V30 32 C 3.9831 13.0675 0.0 0
M  V30 33 C 10.6496 10.7689 0.0 0
M  V30 34 C 11.9834 11.5389 0.0 0
M  V30 35 C 10.6496 9.2289 0.0 0
M  V30 36 C 13.3170 10.7689 0.0 0
M  V30 37 C 11.9834 8.4589 0.0 0
M  V30 38 C 13.3170 9.2289 0.0 0
M  V30 39 C 3.9940 6.9128 0.0 0
M  V30 40 C 2.6627 6.1387 0.0 0
M  V30 41 C 5.3301 6.1469 0.0 0
M  V30 42 C 2.6674 4.5987 0.0 0
M  V30 43 C 5.3347 4.6069 0.0 0
M  V30 44 C 4.0034 3.8328 0.0 0
M  V30 45 C 13.3170 6.1489 0.0 0 CFG=2
M  V30 46 C 14.6506 6.9189 0.0 0
M  V30 47 C 13.3170 4.6089 0.0 0
M  V30 48 C 15.9843 6.1489 0.0 0
M  V30 49 C 14.6506 3.8389 0.0 0
M  V30 50 C 15.9843 4.6089 0.0 0 CFG=1
M  V30 51 H 7.9847 13.8406 0.0 0
M  V30 52 H 2.6547 10.7526 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 26 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 33
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 27 4 CFG=1
M  V30 8 1 5 39
M  V30 9 1 7 8
M  V30 10 1 7 34
M  V30 11 1 9 37
M  V30 12 1 45 9 CFG=1
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 10 14
M  V30 17 1 10 15
M  V30 18 1 10 42
M  V30 19 1 16 38
M  V30 20 1 17 44
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 50 18 CFG=1
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 1 50 25 CFG=3
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30 CFG=1
M  V30 33 1 28 31
M  V30 34 1 28 51
M  V30 35 1 29 30 CFG=1
M  V30 36 1 29 32
M  V30 37 1 29 52
M  V30 38 1 31 32
M  V30 39 2 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 35 37
M  V30 43 2 36 38
M  V30 44 1 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 1 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 26 27 28 29 45 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2787516-56-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787518-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3083612-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39864712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Novel Series of Potent and Selective Relaxin Family
Peptide Receptor 1 (RXFP1) Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Fuchigami, Ryuichi; Niwa,
Yasuki; Fujio, Masakazu; Kato, Harutoshi; Bergstroem, Fredrik; Larsson,
Niklas; Persson, Mikael; Villar, Inmaculada C.; Fujita, Takuya; Sugikawa,
Emiko; Althage, Magnus; Yano, Naoko; Yokoyama, Yoshito; Kimura, Junpei;
Lal, Mark; Mochida, Hideki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4442-4462

$RFMT $RIREG SCHEME432 STEP1
$RXN



  2  1
$MOL
5-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-2-carboxylic acid
C17H11BrO5
1353747-19-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3358 2.3101 0.0 0
M  V30 3 O 6.6685 5.3901 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 Br 14.6707 5.3901 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 O 2.6673 3.0801 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 12.0033 5.3901 0.0 0
M  V30 22 C 13.3370 3.0801 0.0 0
M  V30 23 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 18
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tryptophan, methyl ester, hydrochloride (1:1)
C12H14N2O2.ClH
7524-52-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 4.1618 0.0 0
M  V30 2 C 7.0869 3.3918 0.0 0 CFG=2
M  V30 3 C 8.4206 4.1618 0.0 0
M  V30 4 N 7.0869 1.8518 0.0 0
M  V30 5 O 9.7544 3.3918 0.0 0
M  V30 6 O 8.4206 5.7018 0.0 0
M  V30 7 C 11.0880 4.1618 0.0 0
M  V30 8 C 3.0127 4.0182 0.0 0
M  V30 9 C 4.4196 3.3918 0.0 0
M  V30 10 C 1.9823 2.8738 0.0 0
M  V30 11 C 2.5368 5.4829 0.0 0
M  V30 12 C 4.2586 1.8602 0.0 0
M  V30 13 N 2.7523 1.5400 0.0 0
M  V30 14 C 0.4759 3.1940 0.0 0
M  V30 15 C 1.0304 5.8030 0.0 0
M  V30 16 C 0.0000 4.6585 0.0 0
M  V30 17 Cl 5.5440 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[[5-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-2-yl]carbonyl]-L-tryptop...
C29H23BrN2O6
2454588-23-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.0643 5.3347 0.0 0
M  V30 2 C 16.6043 5.3347 0.0 0
M  V30 3 O 12.7543 4.0011 0.0 0
M  V30 4 C 8.1343 6.6684 0.0 0
M  V30 5 N 7.3643 8.0020 0.0 0
M  V30 6 O 7.3643 5.3347 0.0 0
M  V30 7 C 5.8243 8.0020 0.0 0 CFG=2
M  V30 8 C 5.0543 6.6684 0.0 0
M  V30 9 C 5.0543 9.3358 0.0 0
M  V30 10 O 5.8243 10.6695 0.0 0
M  V30 11 O 3.5143 9.3358 0.0 0
M  V30 12 C 5.0543 12.0031 0.0 0
M  V30 13 Br 19.6843 0.0000 0.0 0
M  V30 14 C 12.7543 6.6684 0.0 0
M  V30 15 C 11.9843 8.0020 0.0 0
M  V30 16 C 14.2943 6.6684 0.0 0
M  V30 17 C 11.9843 5.3347 0.0 0
M  V30 18 O 10.4443 8.0020 0.0 0
M  V30 19 C 12.7543 9.3358 0.0 0
M  V30 20 C 15.0643 8.0020 0.0 0
M  V30 21 C 10.4443 5.3347 0.0 0
M  V30 22 C 9.6743 6.6684 0.0 0
M  V30 23 C 14.2943 9.3358 0.0 0
M  V30 24 C 17.3743 4.0011 0.0 0
M  V30 25 C 16.6043 2.6673 0.0 0
M  V30 26 C 18.9143 4.0011 0.0 0
M  V30 27 C 17.3743 1.3336 0.0 0
M  V30 28 C 19.6843 2.6673 0.0 0
M  V30 29 C 18.9143 1.3336 0.0 0
M  V30 30 C 3.5143 6.6684 0.0 0
M  V30 31 C 2.6091 5.4225 0.0 0
M  V30 32 C 2.6091 7.9142 0.0 0
M  V30 33 C 1.1445 5.8984 0.0 0
M  V30 34 C 2.9292 3.9161 0.0 0
M  V30 35 N 1.1445 7.4384 0.0 0
M  V30 36 C 0.0000 4.8680 0.0 0
M  V30 37 C 1.7849 2.8857 0.0 0
M  V30 38 C 0.3202 3.3615 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 24
M  V30 4 2 3 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 30
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 2 21 22
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 2 31 34
M  V30 37 1 32 35
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1353747-19-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7524-52-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454588-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22401842
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromones bearing amino acid residues: Easily accessible and potent
inhibitors of the breast cancer resistance protein ABCG2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roussel, Emile; Moreno, Alexis; Altounian, Nicolas; Philouze, Christian;
Peres, Basile; Thomas, Aline; Renaudet, Olivier; Falson, Pierre;
Boumendjel, Ahcene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 202112503

$RFMT $RIREG SCHEME433 STEP1
$RXN



  2  1
$MOL
5-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-2-carboxylic acid
C17H11BrO5
1353747-19-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3358 2.3101 0.0 0
M  V30 3 O 6.6685 5.3901 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 Br 14.6707 5.3901 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 O 2.6673 3.0801 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 12.0033 5.3901 0.0 0
M  V30 22 C 13.3370 3.0801 0.0 0
M  V30 23 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 18
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Tryptophan, methyl ester, hydrochloride (1:1)
C12H14N2O2.ClH
14907-27-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 4.1618 0.0 0
M  V30 2 C 7.0869 3.3918 0.0 0 CFG=1
M  V30 3 C 8.4206 4.1618 0.0 0
M  V30 4 N 7.0869 1.8518 0.0 0
M  V30 5 O 9.7544 3.3918 0.0 0
M  V30 6 O 8.4206 5.7018 0.0 0
M  V30 7 C 11.0880 4.1618 0.0 0
M  V30 8 C 3.0127 4.0182 0.0 0
M  V30 9 C 4.4196 3.3918 0.0 0
M  V30 10 C 1.9823 2.8738 0.0 0
M  V30 11 C 2.5368 5.4829 0.0 0
M  V30 12 C 4.2586 1.8602 0.0 0
M  V30 13 N 2.7523 1.5400 0.0 0
M  V30 14 C 0.4759 3.1940 0.0 0
M  V30 15 C 1.0304 5.8030 0.0 0
M  V30 16 C 0.0000 4.6585 0.0 0
M  V30 17 Cl 5.5440 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[[5-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-2-yl]carbonyl]-D-tryptop...
C29H23BrN2O6
2454588-24-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.0643 5.3347 0.0 0
M  V30 2 C 16.6043 5.3347 0.0 0
M  V30 3 O 12.7543 4.0011 0.0 0
M  V30 4 C 8.1343 6.6684 0.0 0
M  V30 5 N 7.3643 8.0020 0.0 0
M  V30 6 O 7.3643 5.3347 0.0 0
M  V30 7 C 5.8243 8.0020 0.0 0 CFG=1
M  V30 8 C 5.0543 6.6684 0.0 0
M  V30 9 C 5.0543 9.3358 0.0 0
M  V30 10 O 5.8243 10.6695 0.0 0
M  V30 11 O 3.5143 9.3358 0.0 0
M  V30 12 C 5.0543 12.0031 0.0 0
M  V30 13 Br 19.6843 0.0000 0.0 0
M  V30 14 C 12.7543 6.6684 0.0 0
M  V30 15 C 11.9843 8.0020 0.0 0
M  V30 16 C 14.2943 6.6684 0.0 0
M  V30 17 C 11.9843 5.3347 0.0 0
M  V30 18 O 10.4443 8.0020 0.0 0
M  V30 19 C 12.7543 9.3358 0.0 0
M  V30 20 C 15.0643 8.0020 0.0 0
M  V30 21 C 10.4443 5.3347 0.0 0
M  V30 22 C 9.6743 6.6684 0.0 0
M  V30 23 C 14.2943 9.3358 0.0 0
M  V30 24 C 17.3743 4.0011 0.0 0
M  V30 25 C 16.6043 2.6673 0.0 0
M  V30 26 C 18.9143 4.0011 0.0 0
M  V30 27 C 17.3743 1.3336 0.0 0
M  V30 28 C 19.6843 2.6673 0.0 0
M  V30 29 C 18.9143 1.3336 0.0 0
M  V30 30 C 3.5143 6.6684 0.0 0
M  V30 31 C 2.6091 5.4225 0.0 0
M  V30 32 C 2.6091 7.9142 0.0 0
M  V30 33 C 1.1445 5.8984 0.0 0
M  V30 34 C 2.9292 3.9161 0.0 0
M  V30 35 N 1.1445 7.4384 0.0 0
M  V30 36 C 0.0000 4.8680 0.0 0
M  V30 37 C 1.7849 2.8857 0.0 0
M  V30 38 C 0.3202 3.3615 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 24
M  V30 4 2 3 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 8 30
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 2 21 22
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 2 31 34
M  V30 37 1 32 35
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1353747-19-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14907-27-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454588-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22401843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromones bearing amino acid residues: Easily accessible and potent
inhibitors of the breast cancer resistance protein ABCG2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roussel, Emile; Moreno, Alexis; Altounian, Nicolas; Philouze, Christian;
Peres, Basile; Thomas, Aline; Renaudet, Olivier; Falson, Pierre;
Boumendjel, Ahcene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 202112503

$RFMT $RIREG SCHEME434 STEP1
$RXN



  7  1
$MOL
Fmoc-Gly-OH
C17H15NO4
29022-11-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 O 13.7554 5.2310 0.0 0
M  V30 9 O 12.4218 2.9209 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(9-Fluorenylmethoxycarbonyl)-L-glutamic acid γ-tert-butyl ester
C24H27NO6
71989-18-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 O 13.7556 9.8510 0.0 0
M  V30 14 O 12.4219 7.5409 0.0 0
M  V30 15 C 15.0893 9.0810 0.0 0
M  V30 16 C 15.8593 10.4146 0.0 0
M  V30 17 C 16.4229 8.3109 0.0 0
M  V30 18 C 14.3192 7.7473 0.0 0
M  V30 19 C 3.0128 5.0873 0.0 0
M  V30 20 C 4.4196 4.4609 0.0 0
M  V30 21 C 1.9822 3.9428 0.0 0
M  V30 22 C 2.5367 6.5519 0.0 0
M  V30 23 C 4.2587 2.9293 0.0 0
M  V30 24 C 2.7522 2.6091 0.0 0
M  V30 25 C 0.4759 4.2630 0.0 0
M  V30 26 C 1.0304 6.8721 0.0 0
M  V30 27 C 5.2891 1.7849 0.0 0
M  V30 28 C 2.2763 1.1444 0.0 0
M  V30 29 C 0.0000 5.7277 0.0 0
M  V30 30 C 4.8132 0.3202 0.0 0
M  V30 31 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 2 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-leucine
C21H23NO4
35661-60-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4219 4.4608 0.0 0
M  V30 9 C 12.4219 7.5409 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 13.7555 5.2309 0.0 0
M  V30 12 C 13.7555 6.7709 0.0 0
M  V30 13 C 12.4219 9.0809 0.0 0
M  V30 14 C 4.4196 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0128 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 1.9823 3.9428 0.0 0
M  V30 20 C 2.5369 6.5519 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2630 0.0 0
M  V30 24 C 1.0304 6.8721 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-L-Tyr(tBu)-OH
C28H29NO5
71989-38-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1164 0.0 0
M  V30 3 C 7.3643 5.1164 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1164 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 O 11.9843 7.7838 0.0 0
M  V30 10 O 9.6743 9.1175 0.0 0
M  V30 11 O 16.6044 5.1164 0.0 0
M  V30 12 C 17.3744 3.7827 0.0 0
M  V30 13 C 18.7080 4.5527 0.0 0
M  V30 14 C 18.1444 2.4491 0.0 0
M  V30 15 C 16.0407 3.0127 0.0 0
M  V30 16 C 3.5143 3.7827 0.0 0
M  V30 17 C 2.6091 5.0286 0.0 0
M  V30 18 C 2.6091 2.5369 0.0 0
M  V30 19 C 1.1444 4.5527 0.0 0
M  V30 20 C 2.9292 6.5350 0.0 0
M  V30 21 C 1.1444 3.0127 0.0 0
M  V30 22 C 2.9292 1.0304 0.0 0
M  V30 23 C 0.0000 5.5831 0.0 0
M  V30 24 C 1.7849 7.5654 0.0 0
M  V30 25 C 0.0000 1.9823 0.0 0
M  V30 26 C 1.7849 0.0000 0.0 0
M  V30 27 C 0.3202 7.0896 0.0 0
M  V30 28 C 0.3202 0.4759 0.0 0
M  V30 29 C 11.9843 5.1164 0.0 0
M  V30 30 C 12.7543 6.4500 0.0 0
M  V30 31 C 12.7543 3.7827 0.0 0
M  V30 32 C 14.2944 6.4500 0.0 0
M  V30 33 C 14.2944 3.7827 0.0 0
M  V30 34 C 15.0644 5.1164 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 29
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 34
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 2 24 27
M  V30 30 1 25 28
M  V30 31 2 26 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(9-Fluorenylmethoxycarbonyl)-O-tert-butylserine
C22H25NO5
71989-33-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2084 5.3900 0.0 0
M  V30 2 O 6.8748 6.1600 0.0 0
M  V30 3 C 5.5411 5.3900 0.0 0
M  V30 4 N 4.2075 6.1600 0.0 0
M  V30 5 O 5.5411 3.8500 0.0 0
M  V30 6 C 2.8737 5.3900 0.0 0 CFG=2
M  V30 7 C 2.8737 3.8500 0.0 0
M  V30 8 C 1.5400 6.1600 0.0 0
M  V30 9 O 1.5400 3.0800 0.0 0
M  V30 10 O 0.2064 5.3900 0.0 0
M  V30 11 O 1.5400 7.7001 0.0 0
M  V30 12 C 1.5400 1.5400 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 3.0800 1.5400 0.0 0
M  V30 16 C 9.5422 6.1600 0.0 0
M  V30 17 C 9.7032 7.6916 0.0 0
M  V30 18 C 10.9490 5.5336 0.0 0
M  V30 19 C 11.2094 8.0118 0.0 0
M  V30 20 C 8.6727 8.8360 0.0 0
M  V30 21 C 11.9794 6.6781 0.0 0
M  V30 22 C 11.4249 4.0690 0.0 0
M  V30 23 C 11.6853 9.4765 0.0 0
M  V30 24 C 9.1486 10.3007 0.0 0
M  V30 25 C 13.4859 6.3579 0.0 0
M  V30 26 C 12.9313 3.7489 0.0 0
M  V30 27 C 10.6549 10.6208 0.0 0
M  V30 28 C 13.9618 4.8932 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
FMOC-L-valine
C20H21NO4
68858-20-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2308 0.0 0
M  V30 2 O 7.0870 4.4608 0.0 0
M  V30 3 C 8.4207 5.2308 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2308 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4218 4.4608 0.0 0
M  V30 9 C 9.7544 7.5409 0.0 0
M  V30 10 C 12.4218 7.5409 0.0 0
M  V30 11 O 13.7555 5.2308 0.0 0
M  V30 12 O 12.4218 2.9208 0.0 0
M  V30 13 C 4.4196 4.4608 0.0 0
M  V30 14 C 4.2586 2.9293 0.0 0
M  V30 15 C 3.0127 5.0873 0.0 0
M  V30 16 C 2.7523 2.6091 0.0 0
M  V30 17 C 5.2891 1.7849 0.0 0
M  V30 18 C 1.9823 3.9428 0.0 0
M  V30 19 C 2.5369 6.5519 0.0 0
M  V30 20 C 2.2763 1.1444 0.0 0
M  V30 21 C 4.8132 0.3202 0.0 0
M  V30 22 C 0.4759 4.2629 0.0 0
M  V30 23 C 1.0304 6.8720 0.0 0
M  V30 24 C 3.3069 0.0000 0.0 0
M  V30 25 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-L-Asp(OtBu)-OH
C23H25NO6
71989-14-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 C 11.9843 5.1163 0.0 0
M  V30 10 O 11.9843 7.7838 0.0 0
M  V30 11 O 9.6743 9.1174 0.0 0
M  V30 12 O 12.7543 3.7827 0.0 0
M  V30 13 O 12.7543 6.4500 0.0 0
M  V30 14 C 14.2943 3.7827 0.0 0
M  V30 15 C 14.2943 5.3227 0.0 0
M  V30 16 C 15.8343 3.7827 0.0 0
M  V30 17 C 14.2943 2.2427 0.0 0
M  V30 18 C 3.5143 3.7827 0.0 0
M  V30 19 C 2.6091 5.0286 0.0 0
M  V30 20 C 2.6091 2.5368 0.0 0
M  V30 21 C 1.1445 4.5527 0.0 0
M  V30 22 C 2.9292 6.5350 0.0 0
M  V30 23 C 1.1445 3.0127 0.0 0
M  V30 24 C 2.9292 1.0304 0.0 0
M  V30 25 C 0.0000 5.5831 0.0 0
M  V30 26 C 1.7849 7.5654 0.0 0
M  V30 27 C 0.0000 1.9823 0.0 0
M  V30 28 C 1.7849 0.0000 0.0 0
M  V30 29 C 0.3202 7.0895 0.0 0
M  V30 30 C 0.3202 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-α-aspartyl-L-valyl-O-(1,1-dimethylethy...
C72H106N8O18
1787252-17-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  98 101 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 31.5707 14.6708 0.0 0
M  V30 2 O 30.0307 14.6708 0.0 0
M  V30 3 C 29.2606 16.0045 0.0 0
M  V30 4 N 27.7206 16.0045 0.0 0
M  V30 5 O 30.0307 17.3382 0.0 0
M  V30 6 C 26.9506 17.3382 0.0 0 CFG=1
M  V30 7 C 25.4106 17.3382 0.0 0
M  V30 8 C 27.7206 18.6718 0.0 0
M  V30 9 N 24.6405 16.0045 0.0 0
M  V30 10 O 24.6405 18.6718 0.0 0
M  V30 11 C 26.9506 20.0057 0.0 0
M  V30 12 C 23.1005 16.0045 0.0 0 CFG=1
M  V30 13 O 27.7206 21.3393 0.0 0
M  V30 14 O 25.4106 20.0057 0.0 0
M  V30 15 C 22.3305 14.6708 0.0 0
M  V30 16 C 22.3305 17.3382 0.0 0
M  V30 17 C 26.9506 22.6730 0.0 0
M  V30 18 N 20.7905 14.6708 0.0 0
M  V30 19 O 23.1005 13.3370 0.0 0
M  V30 20 C 23.1005 18.6718 0.0 0
M  V30 21 C 20.7905 17.3382 0.0 0
M  V30 22 C 25.6169 21.9030 0.0 0
M  V30 23 C 26.1806 24.0067 0.0 0
M  V30 24 C 28.2843 23.4430 0.0 0
M  V30 25 C 20.0204 13.3370 0.0 0 CFG=1
M  V30 26 C 18.4804 13.3370 0.0 0
M  V30 27 C 20.7905 12.0033 0.0 0
M  V30 28 N 17.7104 12.0033 0.0 0
M  V30 29 O 17.7104 14.6708 0.0 0
M  V30 30 O 20.0204 10.6697 0.0 0
M  V30 31 C 16.1704 12.0033 0.0 0 CFG=1
M  V30 32 C 20.7905 9.3358 0.0 0
M  V30 33 C 15.4003 10.6697 0.0 0
M  V30 34 C 15.4003 13.3370 0.0 0
M  V30 35 C 22.1241 10.1059 0.0 0
M  V30 36 C 21.5605 8.0022 0.0 0
M  V30 37 C 19.4568 8.5658 0.0 0
M  V30 38 N 13.8603 10.6697 0.0 0
M  V30 39 O 16.1704 9.3358 0.0 0
M  V30 40 O 16.1704 14.6708 0.0 0
M  V30 41 C 13.0903 9.3358 0.0 0 CFG=2
M  V30 42 C 15.4003 16.0045 0.0 0
M  V30 43 C 13.8603 8.0022 0.0 0
M  V30 44 C 11.5503 9.3358 0.0 0
M  V30 45 C 14.0667 15.2345 0.0 0
M  V30 46 C 14.6303 17.3382 0.0 0
M  V30 47 C 16.7340 16.7745 0.0 0
M  V30 48 N 10.7802 10.6697 0.0 0
M  V30 49 O 10.7802 8.0022 0.0 0
M  V30 50 C 9.2402 10.6697 0.0 0 CFG=1
M  V30 51 C 8.4702 12.0033 0.0 0
M  V30 52 C 8.4702 9.3358 0.0 0
M  V30 53 N 6.9302 12.0033 0.0 0
M  V30 54 O 9.2402 13.3370 0.0 0
M  V30 55 C 6.9302 9.3358 0.0 0
M  V30 56 C 6.1601 13.3370 0.0 0 CFG=2
M  V30 57 C 6.1601 10.6697 0.0 0
M  V30 58 C 6.1601 8.0022 0.0 0
M  V30 59 C 6.9302 14.6708 0.0 0
M  V30 60 C 4.6201 13.3370 0.0 0
M  V30 61 C 6.1601 16.0045 0.0 0
M  V30 62 N 3.8501 12.0033 0.0 0
M  V30 63 O 3.8501 14.6708 0.0 0
M  V30 64 C 6.9302 17.3382 0.0 0
M  V30 65 C 2.3101 12.0033 0.0 0
M  V30 66 O 6.1601 18.6718 0.0 0
M  V30 67 O 8.4702 17.3382 0.0 0
M  V30 68 C 1.5400 10.6697 0.0 0
M  V30 69 C 6.9302 20.0057 0.0 0
M  V30 70 O 2.3101 9.3358 0.0 0
M  V30 71 O 0.0000 10.6697 0.0 0
M  V30 72 C 5.5965 20.7757 0.0 0
M  V30 73 C 7.7002 21.3393 0.0 0
M  V30 74 C 8.2638 19.2356 0.0 0
M  V30 75 O 10.7802 2.6673 0.0 0
M  V30 76 C 11.5503 1.3337 0.0 0
M  V30 77 C 10.2166 0.5637 0.0 0
M  V30 78 C 12.3203 0.0000 0.0 0
M  V30 79 C 12.8839 2.1037 0.0 0
M  V30 80 C 32.3407 13.3370 0.0 0
M  V30 81 C 31.7142 11.9302 0.0 0
M  V30 82 C 33.8723 13.1761 0.0 0
M  V30 83 C 32.8588 10.8996 0.0 0
M  V30 84 C 30.2496 11.4543 0.0 0
M  V30 85 C 34.1924 11.6696 0.0 0
M  V30 86 C 35.0167 14.2065 0.0 0
M  V30 87 C 32.5386 9.3933 0.0 0
M  V30 88 C 29.9295 9.9478 0.0 0
M  V30 89 C 35.6572 11.1937 0.0 0
M  V30 90 C 36.4814 13.7306 0.0 0
M  V30 91 C 31.0739 8.9174 0.0 0
M  V30 92 C 36.8016 12.2243 0.0 0
M  V30 93 C 13.0903 6.6685 0.0 0
M  V30 94 C 13.8603 5.3348 0.0 0
M  V30 95 C 11.5503 6.6685 0.0 0
M  V30 96 C 13.0903 4.0010 0.0 0
M  V30 97 C 10.7802 5.3348 0.0 0
M  V30 98 C 11.5503 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 80
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16 CFG=3
M  V30 17 1 13 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 17 22
M  V30 23 1 17 23
M  V30 24 1 17 24
M  V30 25 1 18 25
M  V30 26 1 25 26
M  V30 27 1 25 27 CFG=1
M  V30 28 1 26 28
M  V30 29 2 26 29
M  V30 30 1 27 30
M  V30 31 1 28 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 31 34 CFG=3
M  V30 35 1 32 35
M  V30 36 1 32 36
M  V30 37 1 32 37
M  V30 38 1 33 38
M  V30 39 2 33 39
M  V30 40 1 34 40
M  V30 41 1 38 41
M  V30 42 1 40 42
M  V30 43 1 41 43 CFG=1
M  V30 44 1 41 44
M  V30 45 1 42 45
M  V30 46 1 42 46
M  V30 47 1 42 47
M  V30 48 1 43 93
M  V30 49 1 44 48
M  V30 50 2 44 49
M  V30 51 1 48 50
M  V30 52 1 50 51
M  V30 53 1 50 52 CFG=1
M  V30 54 1 51 53
M  V30 55 2 51 54
M  V30 56 1 52 55
M  V30 57 1 53 56
M  V30 58 1 55 57
M  V30 59 1 55 58
M  V30 60 1 56 59 CFG=3
M  V30 61 1 56 60
M  V30 62 1 59 61
M  V30 63 1 60 62
M  V30 64 2 60 63
M  V30 65 1 61 64
M  V30 66 1 62 65
M  V30 67 1 64 66
M  V30 68 2 64 67
M  V30 69 1 65 68
M  V30 70 1 66 69
M  V30 71 1 68 70
M  V30 72 2 68 71
M  V30 73 1 69 72
M  V30 74 1 69 73
M  V30 75 1 69 74
M  V30 76 1 75 76
M  V30 77 1 75 98
M  V30 78 1 76 77
M  V30 79 1 76 78
M  V30 80 1 76 79
M  V30 81 1 80 81
M  V30 82 1 80 82
M  V30 83 1 81 83
M  V30 84 2 81 84
M  V30 85 1 82 85
M  V30 86 2 82 86
M  V30 87 1 83 85
M  V30 88 2 83 87
M  V30 89 1 84 88
M  V30 90 2 85 89
M  V30 91 1 86 90
M  V30 92 1 87 91
M  V30 93 2 88 91
M  V30 94 1 89 92
M  V30 95 2 90 92
M  V30 96 2 93 94
M  V30 97 1 93 95
M  V30 98 1 94 96
M  V30 99 2 95 97
M  V30 100 2 96 98
M  V30 101 1 97 98
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 6 12 25 31 41 50 56)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 29022-11-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71989-18-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 35661-60-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 71989-38-3
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 71989-33-8
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 68858-20-8
$DTYPE RXN:RCT(7):CAS_RN
$DATUM 71989-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1787252-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24126939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 16
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 3849-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, Fmoc chemistry used, MBH-Br resin use (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II) lysinate and pseudoproline assistance in the convergent
synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guryanov, Ivan; Orlandin, Andrea; De Paola, Ivan; Viola, Angelo; Biondi,
Barbara; Badocco, Denis; Formaggio, Fernando; Ricci, Antonio; Cabri,
Walter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(7), 1598-1611

$RFMT $RIREG SCHEME435 STEP1
$RXN



  2  1
$MOL
3-[[5-(1-Azetidinylcarbonyl)-2-pyrazinyl]oxy]-5-(1-methylethoxy)benzoic acid
C18H19N3O5
919784-65-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 6.9302 0.0 0
M  V30 2 C 1.3337 6.9302 0.0 0
M  V30 3 O 0.0000 6.1601 0.0 0
M  V30 4 O 1.3337 8.4702 0.0 0
M  V30 5 O 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 O 12.0033 2.3101 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 4.0012 3.8501 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 8.0023 6.1601 0.0 0
M  V30 18 C 8.0023 4.6201 0.0 0
M  V30 19 N 9.3360 6.9302 0.0 0
M  V30 20 N 9.3360 3.8501 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 N 13.3372 4.6201 0.0 0
M  V30 24 C 13.7357 6.1076 0.0 0
M  V30 25 C 14.8247 4.2215 0.0 0
M  V30 26 C 15.2232 5.7091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 22
M  V30 12 1 9 23
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[(3-amino-1H-pyrazol-1-yl)methyl]phosphonate
C8H16N3O3P
1001419-61-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1558 5.3347 0.0 0
M  V30 2 P 5.9258 4.0009 0.0 0 VAL=5
M  V30 3 O 6.6958 2.6673 0.0 0
M  V30 4 O 7.2594 4.7709 0.0 0
M  V30 5 O 4.5921 3.2309 0.0 0
M  V30 6 C 5.9258 1.3336 0.0 0
M  V30 7 C 8.5931 4.0009 0.0 0
M  V30 8 C 6.6958 0.0000 0.0 0
M  V30 9 C 9.9269 4.7709 0.0 0
M  V30 10 N 0.0000 7.0098 0.0 0
M  V30 11 N 3.6158 5.3347 0.0 0
M  V30 12 N 2.7106 6.5806 0.0 0
M  V30 13 C 2.7106 4.0887 0.0 0
M  V30 14 C 1.2459 6.1047 0.0 0
M  V30 15 C 1.2459 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 10 14
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[[3-[[3-[[5-(1-azetidinylcarbonyl)-2-pyrazinyl]oxy]-5-(1-methyletho...
C26H33N6O7P
1001419-18-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4176 8.0021 0.0 0
M  V30 2 C 13.0376 5.3347 0.0 0
M  V30 3 N 13.8076 6.6685 0.0 0
M  V30 4 O 13.8076 4.0011 0.0 0
M  V30 5 O 8.4176 2.6674 0.0 0
M  V30 6 C 9.1876 1.3338 0.0 0
M  V30 7 C 10.7276 1.3338 0.0 0
M  V30 8 C 8.4176 0.0000 0.0 0
M  V30 9 C 2.2576 8.0021 0.0 0
M  V30 10 O 1.4876 6.6685 0.0 0
M  V30 11 C 18.9633 8.3437 0.0 0
M  V30 12 P 20.3702 7.7172 0.0 0 VAL=5
M  V30 13 O 21.7770 7.0909 0.0 0
M  V30 14 O 20.9965 9.1242 0.0 0
M  V30 15 O 19.7437 6.3105 0.0 0
M  V30 16 C 21.9379 5.5594 0.0 0
M  V30 17 C 22.5280 9.2851 0.0 0
M  V30 18 C 23.3449 4.9329 0.0 0
M  V30 19 C 23.1544 10.6919 0.0 0
M  V30 20 C 9.1876 6.6685 0.0 0
M  V30 21 C 10.7276 6.6685 0.0 0
M  V30 22 C 8.4176 5.3347 0.0 0
M  V30 23 C 11.4976 5.3347 0.0 0
M  V30 24 C 9.1876 4.0011 0.0 0
M  V30 25 C 10.7276 4.0011 0.0 0
M  V30 26 C 6.8776 8.0021 0.0 0
M  V30 27 C 6.1076 6.6685 0.0 0
M  V30 28 N 6.1076 9.3358 0.0 0
M  V30 29 N 4.5676 6.6685 0.0 0
M  V30 30 C 4.5676 9.3358 0.0 0
M  V30 31 C 3.7976 8.0021 0.0 0
M  V30 32 C 15.3476 6.6685 0.0 0
M  V30 33 N 16.2527 7.9144 0.0 0
M  V30 34 C 16.2527 5.4226 0.0 0
M  V30 35 N 17.7174 7.4385 0.0 0
M  V30 36 C 17.7174 5.8985 0.0 0
M  V30 37 N 1.4876 9.3358 0.0 0
M  V30 38 C 1.8862 10.8233 0.0 0
M  V30 39 C 0.0000 9.7343 0.0 0
M  V30 40 C 0.3986 11.2220 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 23
M  V30 6 1 3 32
M  V30 7 1 5 6
M  V30 8 1 5 24
M  V30 9 1 6 7
M  V30 10 1 6 8
M  V30 11 2 9 10
M  V30 12 1 9 31
M  V30 13 1 9 37
M  V30 14 1 11 12
M  V30 15 1 11 35
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 2 12 15
M  V30 19 1 13 16
M  V30 20 1 14 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 1 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 919784-65-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1001419-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001419-18-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40832861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl
((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate
(BMS-820132)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shi, Yan; Wang, Ying; Meng, Wei; Brigance, Robert P.; Ryono, Denis E.;
Bolton, Scott; Zhang, Hao; Chen, Sean; Smirk, Rebecca; Tao, Shiwei; Tino,
Joseph A.; Williams, Kristin N.; Sulsky, Richard; Nielsen, Laura;
Ellsworth, Bruce; Wong, Michael K. Y.; Sun, Jung-Hui; Leith, Leslie W.;
Sun, Dawn; Wu, Dauh-Rurng; Gupta, Anuradha; Rampulla, Richard; Mathur,
Arvind; Chen, Bang-Chi; Wang, Aiying; Fuentes-Catanio, Helen G.;
Kunselman, Lori; Cap, Michael; Zalaznick, Jacob; Ma, Xiaohui; Liu, Heng;
Taylor, Joseph R.; Zebo, Rachel; Jones, Beverly; Kalinowski, Stephen;
Swartz, Joann; Staal, Ada; O'Malley, Kevin; Kopcho, Lisa; Muckelbauer,
Jodi K.; Krystek, Stanley R. Jr.; Spronk, Steven A.; Marcinkeviciene,
Jovita; Everlof, Gerry; Chen, Xue-Qing; Xu, Carrie; Li, Yi-Xin; Langish,
Robert A.; Yang, Yanou; Wang, Qi; Behnia, Kamelia; Fura, Aberra;
Janovitz, Evan B.; Pannacciulli, Nicola; Griffen, Steven; Zinker, Bradley
A.; Krupinski, John; Kirby, Mark; Whaley, Jean; Zahler, Robert; Barrish,
Joel C.; Robl, Jeffrey A.; Cheng, Peter T. W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(5), 4291-4317

$RFMT $RIREG SCHEME436 STEP1
$RXN



  2  1
$MOL
2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
C9H7F6NO
722-92-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.0467 3.0800 0.0 0
M  V30 2 C 2.0467 1.5400 0.0 0
M  V30 3 C 1.3957 4.4757 0.0 0
M  V30 4 O 0.5590 2.6814 0.0 0
M  V30 5 F 0.5067 1.5400 0.0 0
M  V30 6 F 2.0467 0.0000 0.0 0
M  V30 7 F 3.5867 1.5400 0.0 0
M  V30 8 F 2.7916 5.1265 0.0 0
M  V30 9 F 0.7449 5.8714 0.0 0
M  V30 10 F 0.0000 3.8249 0.0 0
M  V30 11 N 8.2067 3.0800 0.0 0
M  V30 12 C 3.5867 3.0800 0.0 0
M  V30 13 C 4.3567 4.4136 0.0 0
M  V30 14 C 4.3567 1.7464 0.0 0
M  V30 15 C 5.8967 4.4136 0.0 0
M  V30 16 C 5.8967 1.7464 0.0 0
M  V30 17 C 6.6667 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 3 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(9H-Fluoren-9-ylmethyl) 5-[[(1-cyanocyclopropyl)methyl]sulfonyl]-1,3-dihydr...
C29H24N2O6S
2101238-41-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 5.1887 0.0 0
M  V30 2 O 6.7708 5.1887 0.0 0
M  V30 3 C 7.5408 3.8551 0.0 0
M  V30 4 O 6.7708 2.5213 0.0 0
M  V30 5 C 9.5101 1.1445 0.0 0
M  V30 6 O 10.5405 0.0000 0.0 0
M  V30 7 O 8.0038 0.8244 0.0 0
M  V30 8 S 15.4517 5.3951 0.0 0 VAL=6
M  V30 9 C 16.7854 6.1651 0.0 0
M  V30 10 O 14.6817 6.7287 0.0 0
M  V30 11 O 16.2217 4.0613 0.0 0
M  V30 12 C 19.1089 6.5747 0.0 0
M  V30 13 N 20.0988 7.7545 0.0 0
M  V30 14 C 4.4608 6.5224 0.0 0
M  V30 15 C 2.9292 6.6833 0.0 0
M  V30 16 C 5.0872 7.9293 0.0 0
M  V30 17 C 2.6091 8.1897 0.0 0
M  V30 18 C 1.7849 5.6529 0.0 0
M  V30 19 C 3.9427 8.9597 0.0 0
M  V30 20 C 6.5518 8.4052 0.0 0
M  V30 21 C 1.1445 8.6656 0.0 0
M  V30 22 C 0.3202 6.1287 0.0 0
M  V30 23 C 4.2629 10.4660 0.0 0
M  V30 24 C 6.8719 9.9114 0.0 0
M  V30 25 C 0.0000 7.6352 0.0 0
M  V30 26 C 5.7276 10.9420 0.0 0
M  V30 27 N 9.0808 3.8551 0.0 0
M  V30 28 C 9.9860 2.6091 0.0 0
M  V30 29 C 9.9860 5.1009 0.0 0
M  V30 30 C 11.4507 3.0851 0.0 0
M  V30 31 C 11.4507 4.6251 0.0 0
M  V30 32 C 12.7843 2.3151 0.0 0
M  V30 33 C 12.7843 5.3951 0.0 0
M  V30 34 C 14.1180 3.0851 0.0 0
M  V30 35 C 14.1180 4.6251 0.0 0
M  V30 36 C 18.1190 5.3951 0.0 0
M  V30 37 C 17.5923 3.9479 0.0 0
M  V30 38 C 19.1089 4.2153 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 27
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 8 35
M  V30 13 1 9 36
M  V30 14 3 12 13
M  V30 15 1 12 36
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 19
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 2 24 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl 5-[[(1-cyanocyclopropyl)methyl]sulfonyl]-1,3-dihydro-1-...
C38H29F6N3O6S
2101238-42-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.6238 12.3242 0.0 0
M  V30 2 S 15.1175 12.0041 0.0 0 VAL=6
M  V30 3 O 14.7972 13.5104 0.0 0
M  V30 4 O 15.4377 10.4976 0.0 0
M  V30 5 C 18.6247 13.5746 0.0 0
M  V30 6 N 20.1498 13.3602 0.0 0
M  V30 7 C 7.8578 11.1871 0.0 0
M  V30 8 N 7.8578 12.7271 0.0 0
M  V30 9 O 6.5241 10.4171 0.0 0
M  V30 10 C 8.2081 7.8551 0.0 0
M  V30 11 O 8.5283 6.3487 0.0 0
M  V30 12 O 6.7434 8.3310 0.0 0
M  V30 13 C 7.3837 5.3183 0.0 0
M  V30 14 C 2.5230 15.8071 0.0 0
M  V30 15 C 3.2930 17.1408 0.0 0
M  V30 16 C 1.2616 14.9238 0.0 0
M  V30 17 O 1.4341 16.8961 0.0 0
M  V30 18 F 1.9594 17.9108 0.0 0
M  V30 19 F 4.0630 18.4746 0.0 0
M  V30 20 F 4.6268 16.3708 0.0 0
M  V30 21 F 0.3782 16.1854 0.0 0
M  V30 22 F 0.0000 14.0406 0.0 0
M  V30 23 F 2.1449 13.6624 0.0 0
M  V30 24 C 17.0997 13.7890 0.0 0
M  V30 25 C 15.7400 14.5118 0.0 0
M  V30 26 C 17.0459 15.3279 0.0 0
M  V30 27 C 13.6111 11.6839 0.0 0
M  V30 28 C 13.1352 10.2192 0.0 0
M  V30 29 C 12.5807 12.8283 0.0 0
M  V30 30 C 11.6288 9.8990 0.0 0
M  V30 31 C 11.0742 12.5081 0.0 0
M  V30 32 C 10.5984 11.0434 0.0 0
M  V30 33 C 10.8588 8.5654 0.0 0
M  V30 34 C 9.1916 10.4171 0.0 0
M  V30 35 N 9.3525 8.8856 0.0 0
M  V30 36 C 6.5241 13.4971 0.0 0
M  V30 37 C 5.1905 12.7271 0.0 0
M  V30 38 C 6.5241 15.0371 0.0 0
M  V30 39 C 3.8568 13.4971 0.0 0
M  V30 40 C 5.1905 15.8071 0.0 0
M  V30 41 C 3.8568 15.0371 0.0 0
M  V30 42 C 7.7039 3.8118 0.0 0
M  V30 43 C 6.6735 2.6675 0.0 0
M  V30 44 C 9.1109 3.1855 0.0 0
M  V30 45 C 7.4435 1.3338 0.0 0
M  V30 46 C 5.1335 2.6675 0.0 0
M  V30 47 C 8.9499 1.6540 0.0 0
M  V30 48 C 10.5177 3.8118 0.0 0
M  V30 49 C 6.6735 0.0000 0.0 0
M  V30 50 C 4.3635 1.3338 0.0 0
M  V30 51 C 10.1958 0.7488 0.0 0
M  V30 52 C 11.7635 2.9066 0.0 0
M  V30 53 C 5.1335 0.0000 0.0 0
M  V30 54 C 11.6026 1.3751 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 27
M  V30 6 3 5 6
M  V30 7 1 5 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 34
M  V30 11 1 8 36
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 10 35
M  V30 15 1 11 13
M  V30 16 1 13 42
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 14 41
M  V30 21 1 15 18
M  V30 22 1 15 19
M  V30 23 1 15 20
M  V30 24 1 16 21
M  V30 25 1 16 22
M  V30 26 1 16 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 2 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 46 1 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 2 43 46
M  V30 50 1 44 47
M  V30 51 2 44 48
M  V30 52 1 45 47
M  V30 53 2 45 49
M  V30 54 1 46 50
M  V30 55 2 47 51
M  V30 56 1 48 52
M  V30 57 1 49 53
M  V30 58 2 50 53
M  V30 59 1 51 54
M  V30 60 2 52 54
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 722-92-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101238-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101238-42-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31159925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of
Retinoic Acid Receptor-Related Orphan Receptor C2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Narjes, Frank; Llinas, Antonio; von Berg, Stefan; Jirholt, Johan; Lever,
Sarah; Pehrson, Rikard; Collins, Mia; Malmberg, Anna; Svanberg, Petter;
Xue, Yafeng; Olsson, Roine I.; Malmberg, Jesper; Hughes, Glyn; Hossain,
Nafizal; Grindebacke, Hanna; Leffler, Agnes; Krutroek, Nina; Baeck,
Elisabeth; Ramnegaard, Marie; Lepistoe, Matti; Thunberg, Linda; Aagaard,
Anna; McPheat, Jane; Hansson, Eva L.; Chen, Rongfeng; Xiong, Yao;
Hansson, Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(18), 13807-13829

$RFMT $RIREG SCHEME437 STEP1
$RXN



  2  1
$MOL
4-Ethyl-2-pyridinamine
C7H10N2
33252-32-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 N 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (2S)-2-[4-(4-carboxyphenyl)-5-(ethoxycarbonyl)-1H-imida...
C23H29N3O6
2557171-64-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0809 7.9700 0.0 0
M  V30 2 O 5.6739 8.5965 0.0 0
M  V30 3 O 8.3268 8.8752 0.0 0
M  V30 4 C 5.5130 10.1280 0.0 0
M  V30 5 C 4.1062 10.7544 0.0 0
M  V30 6 C 14.2031 8.1740 0.0 0
M  V30 7 O 15.4490 7.2688 0.0 0
M  V30 8 O 14.3640 9.7056 0.0 0
M  V30 9 C 3.6437 4.0010 0.0 0
M  V30 10 O 2.1037 4.0010 0.0 0
M  V30 11 O 4.4137 5.3348 0.0 0
M  V30 12 C 1.3337 5.3348 0.0 0
M  V30 13 C 2.6673 6.1048 0.0 0
M  V30 14 C 0.5637 6.6685 0.0 0
M  V30 15 C 0.0000 4.5648 0.0 0
M  V30 16 C 8.5755 5.6684 0.0 0
M  V30 17 C 7.2419 6.4384 0.0 0
M  V30 18 N 8.2554 4.1621 0.0 0
M  V30 19 N 6.0975 5.4080 0.0 0
M  V30 20 C 6.7238 4.0010 0.0 0
M  V30 21 C 9.9825 6.2949 0.0 0
M  V30 22 C 11.2284 5.3897 0.0 0
M  V30 23 C 10.1434 7.8265 0.0 0
M  V30 24 C 12.6352 6.0160 0.0 0
M  V30 25 C 11.5503 8.4528 0.0 0
M  V30 26 C 12.7963 7.5476 0.0 0
M  V30 27 C 5.9538 2.6673 0.0 0 CFG=2
M  V30 28 N 4.4137 2.6673 0.0 0
M  V30 29 C 6.7238 1.3337 0.0 0
M  V30 30 C 3.6437 1.3337 0.0 0
M  V30 31 C 5.9538 0.0000 0.0 0
M  V30 32 C 4.4137 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 28
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 27 20 CFG=3
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[5-(ethoxycarbonyl)-4-[4-[[(4-ethyl-2-pyridinyl)amin...
C30H37N5O5
2557173-60-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6859 8.2050 0.0 0
M  V30 2 O 5.2214 8.6809 0.0 0
M  V30 3 O 7.8305 9.2354 0.0 0
M  V30 4 C 4.9012 10.1873 0.0 0
M  V30 5 C 3.4365 10.6632 0.0 0
M  V30 6 C 13.7478 9.1523 0.0 0
M  V30 7 N 15.0815 8.3823 0.0 0
M  V30 8 O 13.7478 10.6923 0.0 0
M  V30 9 C 3.6826 3.8985 0.0 0
M  V30 10 O 2.1511 3.7376 0.0 0
M  V30 11 O 4.3089 5.3055 0.0 0
M  V30 12 C 1.2459 4.9835 0.0 0
M  V30 13 C 0.0000 4.0782 0.0 0
M  V30 14 C 0.3406 6.2293 0.0 0
M  V30 15 C 2.4917 5.8887 0.0 0
M  V30 16 C 20.4162 8.3823 0.0 0
M  V30 17 C 21.7498 9.1523 0.0 0
M  V30 18 C 8.4131 6.0723 0.0 0
M  V30 19 C 7.0061 6.6987 0.0 0
M  V30 20 N 8.2521 4.5407 0.0 0
M  V30 21 N 5.9757 5.5542 0.0 0
M  V30 22 C 6.7457 4.2205 0.0 0
M  V30 23 C 9.7467 6.8423 0.0 0
M  V30 24 C 9.7467 8.3823 0.0 0
M  V30 25 C 11.0804 6.0723 0.0 0
M  V30 26 C 11.0804 9.1523 0.0 0
M  V30 27 C 12.4142 6.8423 0.0 0
M  V30 28 C 12.4142 8.3823 0.0 0
M  V30 29 C 6.1194 2.8137 0.0 0 CFG=2
M  V30 30 N 4.5878 2.6527 0.0 0
M  V30 31 C 7.0246 1.5677 0.0 0
M  V30 32 C 3.9614 1.2459 0.0 0
M  V30 33 C 6.3981 0.1609 0.0 0
M  V30 34 C 4.8666 0.0000 0.0 0
M  V30 35 C 16.4151 9.1523 0.0 0
M  V30 36 C 17.7489 8.3823 0.0 0
M  V30 37 N 16.4151 10.6923 0.0 0
M  V30 38 C 19.0825 9.1523 0.0 0
M  V30 39 C 17.7489 11.4623 0.0 0
M  V30 40 C 19.0825 10.6923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 28
M  V30 9 1 7 35
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 30
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 38
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 29 22 CFG=3
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 33252-32-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2557171-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2557173-60-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31542534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly
Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Chunhua; Li, Qingyun; Zhao, Minghao; Fan, Goujie; Zhao, Jie; Zhang,
Dandan; Yang, Shouning; Zhang, Shuting; Gao, Dingding; Mao, Longfei; Zhu,
Liang; Li, Wei; Xu, Guiqing; Jiang, Yuqin; Ding, Qingjie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(21), 16242-16270

$RFMT $RIREG SCHEME438 STEP1
$RXN



  2  1
$MOL
5-Bromopicolinic acid
C6H4BrNO2
30766-11-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[(2R,5R)-5-(3-aminophenyl)-5,6-dihydro-2,5-dimethyl-2...
C18H24F3N3O3
1262859-49-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.1914 4.3670 0.0 0
M  V30 2 C 8.9614 5.7006 0.0 0
M  V30 3 O 10.5014 5.7006 0.0 0
M  V30 4 O 8.1914 7.0343 0.0 0
M  V30 5 C 11.2714 7.0343 0.0 0
M  V30 6 C 9.9378 7.8043 0.0 0
M  V30 7 C 12.0414 8.3681 0.0 0
M  V30 8 C 12.6052 6.2643 0.0 0
M  V30 9 C 5.6141 1.5166 0.0 0
M  V30 10 F 7.1307 1.2492 0.0 0
M  V30 11 F 5.3466 0.0000 0.0 0
M  V30 12 F 4.0975 1.7841 0.0 0
M  V30 13 C 7.3286 2.5065 0.0 0
M  V30 14 C 4.6089 7.2172 0.0 0
M  V30 15 N 0.9123 9.7873 0.0 0
M  V30 16 C 6.6514 4.3670 0.0 0
M  V30 17 C 5.8814 3.0333 0.0 0 CFG=2
M  V30 18 N 5.8814 5.7006 0.0 0
M  V30 19 O 4.3414 3.0333 0.0 0
M  V30 20 C 4.3414 5.7006 0.0 0 CFG=1
M  V30 21 C 3.5714 4.3670 0.0 0
M  V30 22 C 2.8943 6.2273 0.0 0
M  V30 23 C 2.6269 7.7439 0.0 0
M  V30 24 C 1.7146 5.2374 0.0 0
M  V30 25 C 1.1798 8.2707 0.0 0
M  V30 26 C 0.2675 5.7642 0.0 0
M  V30 27 C 0.0000 7.2808 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 17 9 CFG=3
M  V30 13 1 17 13 CFG=1
M  V30 14 1 20 14 CFG=3
M  V30 15 1 15 25
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 22 1 20 22 CFG=1
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[(2R,5R)-5-[3-[[(5-bromo-2-pyridinyl)carbonyl]amino]p...
C24H26BrF3N4O4
1262859-50-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2357 7.7094 0.0 0
M  V30 2 N 3.8066 4.6761 0.0 0
M  V30 3 C 4.9862 3.6863 0.0 0
M  V30 4 O 4.7189 2.1696 0.0 0
M  V30 5 O 6.4333 4.2130 0.0 0
M  V30 6 C 5.8985 1.1798 0.0 0
M  V30 7 C 6.8884 2.3594 0.0 0
M  V30 8 C 7.0783 0.1899 0.0 0
M  V30 9 C 4.9086 0.0000 0.0 0
M  V30 10 N 10.4086 10.9034 0.0 0
M  V30 11 C 11.1786 12.2371 0.0 0
M  V30 12 O 10.4086 13.5708 0.0 0
M  V30 13 C 1.4471 7.7094 0.0 0
M  V30 14 F 1.9738 9.1565 0.0 0
M  V30 15 F 0.0000 8.2361 0.0 0
M  V30 16 F 0.9205 6.2623 0.0 0
M  V30 17 C 2.1243 5.8489 0.0 0
M  V30 18 Br 17.3386 12.2371 0.0 0
M  V30 19 C 5.7886 8.2361 0.0 0 CFG=1
M  V30 20 N 5.5211 6.7195 0.0 0
M  V30 21 C 4.6088 9.2260 0.0 0
M  V30 22 C 4.0739 6.1928 0.0 0
M  V30 23 O 3.1616 8.6992 0.0 0
M  V30 24 C 2.8943 7.1826 0.0 0 CFG=2
M  V30 25 C 6.5586 9.5697 0.0 0
M  V30 26 C 8.0986 9.5697 0.0 0
M  V30 27 C 5.7886 10.9034 0.0 0
M  V30 28 C 8.8686 10.9034 0.0 0
M  V30 29 C 6.5586 12.2371 0.0 0
M  V30 30 C 8.0986 12.2371 0.0 0
M  V30 31 C 12.7186 12.2371 0.0 0
M  V30 32 C 13.4886 10.9034 0.0 0
M  V30 33 N 13.4886 13.5708 0.0 0
M  V30 34 C 15.0286 10.9034 0.0 0
M  V30 35 C 15.0286 13.5708 0.0 0
M  V30 36 C 15.7986 12.2371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 28
M  V30 12 2 11 12
M  V30 13 1 11 31
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 24 13 CFG=3
M  V30 18 1 24 17 CFG=1
M  V30 19 1 18 36
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 25 CFG=1
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 30766-11-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262859-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262859-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23513655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1)
Inhibitor NB-360
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rueeger, Heinrich; Lueoend, Rainer; Machauer, Rainer; Veenstra, Siem J.;
Holzer, Philipp; Hurth, Konstanze; Voegtle, Markus; Frederiksen, Mathias;
Rondeau, Jean-Michel; Tintelnot-Blomley, Marina; Jacobson, Laura H.;
Staufenbiel, Matthias; Laue, Grit; Neumann, Ulf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(8), 4677-4696

$RFMT $RIREG SCHEME439 STEP1
$RXN



  2  1
$MOL
21H,23H-Porphine-7-propanoic acid, 3-carboxy-5-(carboxymethyl)-18-ethyl-13-[1...
C40H50N4O7
128146-81-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9000 7.0877 0.0 0
M  V30 2 C 2.4756 5.6073 0.0 0
M  V30 3 O 3.5453 4.4995 0.0 0
M  V30 4 O 0.9813 5.2347 0.0 0
M  V30 5 C 5.4223 3.9554 0.0 0
M  V30 6 C 6.2610 2.6638 0.0 0
M  V30 7 C 5.5618 1.2916 0.0 0
M  V30 8 O 6.4007 0.0000 0.0 0
M  V30 9 O 4.0240 1.2111 0.0 0
M  V30 10 C 8.4231 3.8328 0.0 0
M  V30 11 C 1.3337 8.8230 0.0 0
M  V30 12 O 0.0000 9.5930 0.0 0
M  V30 13 O 1.3337 7.2830 0.0 0
M  V30 14 C 1.6839 12.1552 0.0 0
M  V30 15 C 13.0630 7.5902 0.0 0
M  V30 16 C 13.4132 10.9224 0.0 0 CFG=3
M  V30 17 O 14.7469 10.1524 0.0 0
M  V30 18 C 13.4132 12.4624 0.0 0
M  V30 19 C 16.0806 10.9224 0.0 0
M  V30 20 C 17.4142 10.1524 0.0 0
M  V30 21 C 18.7481 10.9224 0.0 0
M  V30 22 C 20.0817 10.1524 0.0 0
M  V30 23 C 21.4154 10.9224 0.0 0
M  V30 24 C 22.7491 10.1524 0.0 0
M  V30 25 C 6.3237 15.9124 0.0 0
M  V30 26 C 7.0937 17.2462 0.0 0
M  V30 27 C 9.6559 15.5622 0.0 0
M  V30 28 C 5.8013 6.8339 0.0 0
M  V30 29 C 4.3943 7.4602 0.0 0
M  V30 30 C 6.1215 5.3276 0.0 0 CFG=1
M  V30 31 N 7.1350 7.6039 0.0 0
M  V30 32 C 4.0742 8.9667 0.0 0
M  V30 33 C 7.6530 5.1667 0.0 0 CFG=2
M  V30 34 C 8.2794 6.5735 0.0 0
M  V30 35 C 2.6673 9.5930 0.0 0
M  V30 36 N 5.1046 10.1111 0.0 0
M  V30 37 C 9.7858 6.8937 0.0 0
M  V30 38 C 2.8283 11.1246 0.0 0
M  V30 39 C 4.3346 11.4448 0.0 0
M  V30 40 C 10.4122 8.3005 0.0 0
M  V30 41 C 4.9609 12.8517 0.0 0
M  V30 42 N 9.6422 9.6343 0.0 0
M  V30 43 C 11.9185 8.6206 0.0 0
M  V30 44 C 6.4674 13.1719 0.0 0
M  V30 45 C 10.6727 10.7787 0.0 0
M  V30 46 C 12.0794 10.1524 0.0 0
M  V30 47 C 7.0937 14.5787 0.0 0
M  V30 48 N 7.6119 12.1415 0.0 0
M  V30 49 C 10.3526 12.2852 0.0 0
M  V30 50 C 8.6254 14.4178 0.0 0
M  V30 51 C 8.9456 12.9115 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 30 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 33 10 CFG=1
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 35
M  V30 14 1 14 38
M  V30 15 1 15 43
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 46
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 25 26
M  V30 26 1 25 47
M  V30 27 1 27 50
M  V30 28 2 28 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 30 33
M  V30 33 2 31 34
M  V30 34 2 32 35
M  V30 35 1 32 36
M  V30 36 1 33 34
M  V30 37 1 34 37
M  V30 38 1 35 38
M  V30 39 1 36 39
M  V30 40 2 37 40
M  V30 41 2 38 39
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 40 43
M  V30 45 2 41 44
M  V30 46 1 42 45
M  V30 47 2 43 46
M  V30 48 1 44 47
M  V30 49 1 44 48
M  V30 50 1 45 46
M  V30 51 2 45 49
M  V30 52 2 47 50
M  V30 53 2 48 51
M  V30 54 1 49 51
M  V30 55 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 30 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Aspartic acid, 1,4-bis(1,1-dimethylethyl) ester, hydrochloride (1:1)
C12H23NO4.ClH
1791-13-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0800 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 3 C 8.0022 3.8501 0.0 0
M  V30 4 C 4.0012 3.0800 0.0 0
M  V30 5 N 5.3348 5.3901 0.0 0
M  V30 6 O 9.3360 3.0800 0.0 0
M  V30 7 O 8.0022 5.3901 0.0 0
M  V30 8 O 2.6673 3.8501 0.0 0
M  V30 9 O 4.0012 1.5400 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 1.3337 3.0800 0.0 0
M  V30 12 C 11.4397 2.5164 0.0 0
M  V30 13 C 12.0033 4.6201 0.0 0
M  V30 14 C 9.8996 5.1837 0.0 0
M  V30 15 C 0.5637 4.4137 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 2.1037 1.7464 0.0 0
M  V30 18 Cl 6.0017 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,4-Bis(1,1-dimethylethyl) N-[2-[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-18-ethy...
C52H71N5O10
2222800-20-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 71 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 6.5870 0.0 0
M  V30 2 C 6.6684 7.3570 0.0 0
M  V30 3 N 5.3347 6.5870 0.0 0
M  V30 4 O 6.6684 8.8970 0.0 0
M  V30 5 C 4.0011 7.3570 0.0 0 CFG=2
M  V30 6 C 4.0011 8.8970 0.0 0
M  V30 7 C 2.6674 6.5870 0.0 0
M  V30 8 C 2.6674 9.6670 0.0 0
M  V30 9 O 2.6674 5.0470 0.0 0
M  V30 10 O 1.3336 7.3570 0.0 0
M  V30 11 O 2.6674 11.2070 0.0 0
M  V30 12 O 1.3336 8.8970 0.0 0
M  V30 13 C 1.3336 4.2770 0.0 0
M  V30 14 C 1.3336 11.9770 0.0 0
M  V30 15 C 0.5636 5.6107 0.0 0
M  V30 16 C 0.0000 3.5070 0.0 0
M  V30 17 C 2.1036 2.9432 0.0 0
M  V30 18 C 2.1036 13.3107 0.0 0
M  V30 19 C 0.0000 12.7470 0.0 0
M  V30 20 C 0.5636 10.6432 0.0 0
M  V30 21 C 9.5112 4.0112 0.0 0
M  V30 22 C 9.7521 2.4902 0.0 0
M  V30 23 C 8.5553 1.5211 0.0 0
M  V30 24 O 7.1176 2.0730 0.0 0
M  V30 25 O 8.7962 0.0000 0.0 0
M  V30 26 C 6.4275 9.8411 0.0 0
M  V30 27 O 5.5663 8.5644 0.0 0
M  V30 28 O 5.7524 11.2252 0.0 0
M  V30 29 C 12.7474 3.1442 0.0 0
M  V30 30 C 7.3932 12.4179 0.0 0
M  V30 31 C 17.9179 6.1294 0.0 0
M  V30 32 C 12.5636 15.4031 0.0 0
M  V30 33 C 13.5328 16.6000 0.0 0
M  V30 34 C 18.7851 9.3655 0.0 0 CFG=3
M  V30 35 O 19.9818 8.3964 0.0 0
M  V30 36 C 19.0259 10.8866 0.0 0
M  V30 37 C 21.4196 8.9483 0.0 0
M  V30 38 C 22.6163 7.9790 0.0 0
M  V30 39 C 24.0540 8.5310 0.0 0
M  V30 40 C 25.2509 7.5619 0.0 0
M  V30 41 C 26.6885 8.1136 0.0 0
M  V30 42 C 27.8854 7.1445 0.0 0
M  V30 43 C 15.7998 14.5359 0.0 0
M  V30 44 C 9.3358 7.3570 0.0 0
M  V30 45 C 10.6274 6.5182 0.0 0
M  V30 46 C 9.2552 8.8949 0.0 0
M  V30 47 C 10.7079 4.9805 0.0 0 CFG=1
M  V30 48 N 12.0651 7.0701 0.0 0
M  V30 49 C 7.9638 9.7336 0.0 0
M  V30 50 N 10.4520 9.8640 0.0 0
M  V30 51 C 12.1956 4.5818 0.0 0 CFG=2
M  V30 52 C 13.0343 5.8734 0.0 0
M  V30 53 C 8.3624 11.2212 0.0 0
M  V30 54 C 9.9002 11.3018 0.0 0
M  V30 55 C 14.5723 5.9539 0.0 0
M  V30 56 C 10.7389 12.5934 0.0 0
M  V30 57 C 15.4109 7.2455 0.0 0
M  V30 58 C 12.2769 12.6739 0.0 0
M  V30 59 N 14.8590 8.6831 0.0 0
M  V30 60 C 16.9488 7.3261 0.0 0
M  V30 61 C 13.1156 13.9653 0.0 0
M  V30 62 N 13.2460 11.4772 0.0 0
M  V30 63 C 16.0559 9.6523 0.0 0
M  V30 64 C 17.3473 8.8136 0.0 0
M  V30 65 C 14.6031 13.5668 0.0 0
M  V30 66 C 14.6836 12.0291 0.0 0
M  V30 67 C 15.9752 11.1903 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 44
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 21 22
M  V30 22 1 47 21 CFG=3
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 1 26 27
M  V30 27 2 26 28
M  V30 28 1 26 49
M  V30 29 1 51 29 CFG=1
M  V30 30 1 30 53
M  V30 31 1 31 60
M  V30 32 1 32 33
M  V30 33 1 32 61
M  V30 34 1 34 35
M  V30 35 1 34 36
M  V30 36 1 34 64
M  V30 37 1 35 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 1 43 65
M  V30 44 2 44 45
M  V30 45 1 44 46
M  V30 46 1 45 47
M  V30 47 1 45 48
M  V30 48 2 46 49
M  V30 49 1 46 50
M  V30 50 1 47 51
M  V30 51 2 48 52
M  V30 52 1 49 53
M  V30 53 1 50 54
M  V30 54 1 51 52
M  V30 55 1 52 55
M  V30 56 2 53 54
M  V30 57 1 54 56
M  V30 58 2 55 57
M  V30 59 2 56 58
M  V30 60 1 57 59
M  V30 61 1 57 60
M  V30 62 1 58 61
M  V30 63 1 58 62
M  V30 64 1 59 63
M  V30 65 2 60 64
M  V30 66 2 61 65
M  V30 67 2 62 66
M  V30 68 1 63 64
M  V30 69 2 63 67
M  V30 70 1 65 66
M  V30 71 1 66 67
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 47 51)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 128146-81-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1791-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222800-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22782720
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin
e6-based 152- or 131-amino acid derivatives as potent photosensitizers
for photodynamic therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xing-Jie; Han, Gui-Yan; Guo, Chang-Yong; Ma, Zhi-Qiang; Lin,
Mei-Yu; Wang, Yuan; Miao, Zhen-Yuan; Zhang, Wan-Nian; Sheng, Chun-Quan;
Yao, Jian-Zhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 207112715

$RFMT $RIREG SCHEME440 STEP1
$RXN



  2  1
$MOL
4-Aminotetrahydropyran
C5H11NO
38041-19-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 O 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-4-[5-Fluoro-2-(1H-indol-4-yl)-4-pyrimidinyl]-3-methyl-3-morpholinecarbox...
C18H17FN4O3
2415441-73-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1941 1.1798 0.0 0
M  V30 2 O 2.2042 0.0000 0.0 0
M  V30 3 O 4.7107 0.9123 0.0 0
M  V30 4 C 4.2016 2.4926 0.0 0
M  V30 5 F 2.6674 7.2469 0.0 0
M  V30 6 N 2.6674 4.1669 0.0 0
M  V30 7 C 2.6674 2.6269 0.0 0 CFG=2
M  V30 8 C 1.3338 4.9369 0.0 0
M  V30 9 C 1.3338 1.8569 0.0 0
M  V30 10 C 0.0000 4.1669 0.0 0
M  V30 11 O 0.0000 2.6269 0.0 0
M  V30 12 C 4.0011 4.9369 0.0 0
M  V30 13 N 5.3347 4.1669 0.0 0
M  V30 14 C 4.0011 6.4769 0.0 0
M  V30 15 C 6.6685 4.9369 0.0 0
M  V30 16 C 5.3347 7.2469 0.0 0
M  V30 17 N 6.6685 6.4769 0.0 0
M  V30 18 C 8.0021 4.1669 0.0 0
M  V30 19 C 9.3358 4.9369 0.0 0
M  V30 20 C 8.0021 2.6269 0.0 0
M  V30 21 C 10.6694 4.1669 0.0 0
M  V30 22 C 9.6560 6.4432 0.0 0
M  V30 23 C 9.3358 1.8569 0.0 0
M  V30 24 N 11.8140 5.1973 0.0 0
M  V30 25 C 10.6694 2.6269 0.0 0
M  V30 26 C 11.1875 6.6041 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 7 4 CFG=1
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Morpholinecarboxamide, 4-[5-fluoro-2-(1H-indol-4-yl)-4-pyrimidinyl]-3-methy...
C23H26FN5O3
3054124-45-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6946 4.2597 0.0 0
M  V30 2 N 10.2112 3.9923 0.0 0
M  V30 3 O 8.1678 5.7068 0.0 0
M  V30 4 C 7.0539 4.4757 0.0 0
M  V30 5 F 3.7036 0.7700 0.0 0
M  V30 6 N 6.3710 2.3100 0.0 0
M  V30 7 C 7.7047 3.0800 0.0 0 CFG=2
M  V30 8 C 6.3710 0.7700 0.0 0
M  V30 9 C 9.0383 2.3100 0.0 0
M  V30 10 C 7.7047 0.0000 0.0 0
M  V30 11 O 9.0383 0.7700 0.0 0
M  V30 12 C 5.0372 3.0800 0.0 0
M  V30 13 N 5.0372 4.6200 0.0 0
M  V30 14 C 3.7036 2.3100 0.0 0
M  V30 15 C 3.7036 5.3901 0.0 0
M  V30 16 C 2.3699 3.0800 0.0 0
M  V30 17 N 2.3699 4.6200 0.0 0
M  V30 18 C 3.7036 6.9301 0.0 0
M  V30 19 C 2.3699 7.7001 0.0 0
M  V30 20 C 5.0372 7.7001 0.0 0
M  V30 21 C 2.3699 9.2401 0.0 0
M  V30 22 C 0.9052 7.2242 0.0 0
M  V30 23 C 5.0372 9.2401 0.0 0
M  V30 24 C 3.7036 10.0101 0.0 0
M  V30 25 N 0.9052 9.7160 0.0 0
M  V30 26 C 0.0000 8.4701 0.0 0
M  V30 27 C 11.2011 5.1720 0.0 0
M  V30 28 C 10.6743 6.6191 0.0 0
M  V30 29 C 12.7178 4.9046 0.0 0
M  V30 30 C 11.6642 7.7989 0.0 0
M  V30 31 C 13.7077 6.0843 0.0 0
M  V30 32 O 13.1808 7.5314 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 27
M  V30 5 1 7 4 CFG=1
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 2 21 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 1 23 24
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 38041-19-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415441-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3054124-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38259246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of mTOR Inhibitors Using Property-Based Drug Design and
Free-Wilson Analysis for Improved In Vivo Efficacy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murphy, Sean T.; Atienza, Joy; Brown, Jason W.; Cheruvallath, Zacharia
S.; Cukierski, Matthew J.; Fabrey, Robyn; Keung, Walter; Kwok, Lily;
OConnell, Shawn; Tang, Mingnam; Vanderpool, Darin L.; Vincent, Patrick
W.; Zhang, Lilly; Marx, Matthew A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550

$RFMT $RIREG SCHEME441 STEP1
$RXN



  2  1
$MOL
tert-Butyl [2-[2-(2-aminoethoxy)ethoxy]ethyl]carbamate
C11H24N2O4
153086-78-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3338 1.5400 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 C 2.1038 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5638 2.8737 0.0 0
M  V30 11 O 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 O 13.3372 2.3101 0.0 0
M  V30 15 C 14.6708 1.5400 0.0 0
M  V30 16 C 16.0045 2.3101 0.0 0
M  V30 17 N 17.3383 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,4S)-6-(4-Chlorophenyl)-8-methoxy-α,1-dimethyl-4H-[1,2,4]triazolo[4,3-a][1...
C21H19ClN4O3
2865130-01-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.0474 7.0508 0.0 0
M  V30 2 C 0.0000 8.1797 0.0 0
M  V30 3 C 6.2750 11.2924 0.0 0
M  V30 4 C 9.9820 6.9113 0.0 0 CFG=1
M  V30 5 C 11.1861 5.9511 0.0 0
M  V30 6 C 10.2116 8.4341 0.0 0
M  V30 7 O 10.9565 4.4283 0.0 0
M  V30 8 O 12.6196 6.5137 0.0 0
M  V30 9 Cl 2.8852 0.0000 0.0 0
M  V30 10 C 5.0978 6.6073 0.0 0
M  V30 11 C 5.5516 8.0788 0.0 0
M  V30 12 C 5.9653 5.3348 0.0 0
M  V30 13 C 3.5963 6.2645 0.0 0
M  V30 14 N 6.9852 8.6415 0.0 0
M  V30 15 C 4.5041 9.2078 0.0 0
M  V30 16 N 7.5010 5.2197 0.0 0
M  V30 17 C 2.5489 7.3935 0.0 0
M  V30 18 C 8.3189 7.8715 0.0 0
M  V30 19 C 7.3054 10.1478 0.0 0
M  V30 20 C 3.0027 8.8651 0.0 0
M  V30 21 C 8.5485 6.3487 0.0 0 CFG=1
M  V30 22 N 9.4634 8.9019 0.0 0
M  V30 23 N 8.8370 10.3089 0.0 0
M  V30 24 C 5.1953 4.0011 0.0 0
M  V30 25 C 5.9653 2.6675 0.0 0
M  V30 26 C 3.6552 4.0011 0.0 0
M  V30 27 C 5.1953 1.3338 0.0 0
M  V30 28 C 2.8852 2.6675 0.0 0
M  V30 29 C 3.6552 1.3338 0.0 0
M  V30 30 H 9.4160 5.0762 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 21
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 9 29
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 12 24
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 2 18 22
M  V30 25 2 19 23
M  V30 26 1 21 30 CFG=1
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (13R)-13-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,...
C32H41ClN6O6
2757046-11-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.2042 6.6982 0.0 0
M  V30 2 C 0.0000 7.6584 0.0 0
M  V30 3 C 5.7411 11.6716 0.0 0
M  V30 4 C 10.0598 7.8919 0.0 0 CFG=1
M  V30 5 C 11.3935 7.1219 0.0 0
M  V30 6 C 10.0598 9.4319 0.0 0
M  V30 7 N 12.7271 7.8919 0.0 0
M  V30 8 O 11.3935 5.5819 0.0 0
M  V30 9 C 14.0610 7.1219 0.0 0
M  V30 10 C 15.3946 7.8919 0.0 0
M  V30 11 O 16.7283 7.1219 0.0 0
M  V30 12 C 18.0620 7.8919 0.0 0
M  V30 13 C 19.3958 7.1219 0.0 0
M  V30 14 O 20.7295 7.8919 0.0 0
M  V30 15 C 22.0631 7.1219 0.0 0
M  V30 16 C 23.3968 7.8919 0.0 0
M  V30 17 N 24.7306 7.1219 0.0 0
M  V30 18 C 26.0643 7.8919 0.0 0
M  V30 19 O 27.3980 7.1219 0.0 0
M  V30 20 O 26.0643 9.4319 0.0 0
M  V30 21 C 28.7316 7.8919 0.0 0
M  V30 22 C 27.9616 9.2256 0.0 0
M  V30 23 C 30.0655 8.6619 0.0 0
M  V30 24 C 29.5017 6.5582 0.0 0
M  V30 25 Cl 4.0723 0.0000 0.0 0
M  V30 26 C 5.2754 6.8633 0.0 0
M  V30 27 C 5.5049 8.3861 0.0 0
M  V30 28 C 6.3228 5.7343 0.0 0
M  V30 29 C 3.8418 6.3007 0.0 0
M  V30 30 N 6.8385 9.1561 0.0 0
M  V30 31 C 4.3009 9.3463 0.0 0
M  V30 32 N 7.8585 5.8495 0.0 0
M  V30 33 C 2.6376 7.2608 0.0 0
M  V30 34 C 8.2721 8.5935 0.0 0
M  V30 35 C 6.9306 10.6934 0.0 0
M  V30 36 C 2.8672 8.7837 0.0 0
M  V30 37 C 8.7261 7.1219 0.0 0 CFG=1
M  V30 38 N 9.2502 9.7831 0.0 0
M  V30 39 N 8.4212 11.0809 0.0 0
M  V30 40 C 5.7602 4.3009 0.0 0
M  V30 41 C 4.2374 4.0712 0.0 0
M  V30 42 C 6.7204 3.0967 0.0 0
M  V30 43 C 3.6747 2.6378 0.0 0
M  V30 44 C 6.1577 1.6632 0.0 0
M  V30 45 C 4.6349 1.4336 0.0 0
M  V30 46 H 9.7735 5.9930 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 33
M  V30 3 1 3 35
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 37
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 25 45
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 2 27 31
M  V30 31 2 28 32
M  V30 32 1 28 40
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 1 30 35
M  V30 36 1 31 36
M  V30 37 1 32 37
M  V30 38 2 33 36
M  V30 39 1 34 37
M  V30 40 2 34 38
M  V30 41 2 35 39
M  V30 42 1 37 46 CFG=1
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 153086-78-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2865130-01-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757046-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34870693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Guided Design of a "Bump-and-Hole" Bromodomain-Based
Degradation Tag
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nowak, Radoslaw P.; Xiong, Yuan; Kirmani, Nadia; Kalabathula, Joann;
Donovan, Katherine A.; Eleuteri, Nicholas A.; Yuan, J. Christine;
Fischer, Eric S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 11637-11650

$RFMT $RIREG SCHEME442 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 3-[[[2-[[1,4-dioxo-4-(phenylmethoxy)butyl]methylamino]ethyl](1-...
C27H36N2O5.ClH
2227446-38-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.8747 0.0 0
M  V30 2 N 6.9300 5.5409 0.0 0
M  V30 3 C 6.1600 4.2073 0.0 0
M  V30 4 C 8.4700 5.5409 0.0 0
M  V30 5 C 4.6200 4.2073 0.0 0
M  V30 6 C 6.9300 2.8736 0.0 0
M  V30 7 C 9.2400 6.8747 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 6.1600 1.5400 0.0 0
M  V30 10 N 10.7800 6.8747 0.0 0
M  V30 11 C 11.5500 8.2084 0.0 0
M  V30 12 C 11.5500 5.5409 0.0 0
M  V30 13 C 13.0900 8.2084 0.0 0
M  V30 14 O 10.7800 9.5420 0.0 0
M  V30 15 C 13.8600 9.5420 0.0 0
M  V30 16 C 15.4000 9.5420 0.0 0
M  V30 17 O 16.1700 10.8758 0.0 0
M  V30 18 O 16.1700 8.2084 0.0 0
M  V30 19 C 17.7100 10.8758 0.0 0
M  V30 20 C 1.5400 9.5420 0.0 0
M  V30 21 O 0.0000 9.5420 0.0 0
M  V30 22 O 2.3100 10.8758 0.0 0
M  V30 23 C 4.6200 6.8747 0.0 0
M  V30 24 C 3.8500 8.2084 0.0 0
M  V30 25 C 3.8500 5.5409 0.0 0
M  V30 26 C 2.3100 8.2084 0.0 0
M  V30 27 C 2.3100 5.5409 0.0 0
M  V30 28 C 1.5400 6.8747 0.0 0
M  V30 29 C 18.4800 12.2094 0.0 0
M  V30 30 C 17.7100 13.5431 0.0 0
M  V30 31 C 20.0200 12.2094 0.0 0
M  V30 32 C 18.4800 14.8767 0.0 0
M  V30 33 C 20.7900 13.5431 0.0 0
M  V30 34 C 20.0200 14.8767 0.0 0
M  V30 35 Cl 10.3950 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 29
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 26
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-Amino-4,5,6,7-tetrahydro-6-(methylsulfonyl)thieno[2,3-c]pyridin-3-yl][1-(4...
C18H17ClN4O3S2
2227448-03-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8108 3.3319 0.0 0
M  V30 2 O 8.4906 4.8384 0.0 0
M  V30 3 N 9.1610 0.0000 0.0 0
M  V30 4 S 1.5400 2.6217 0.0 0 VAL=6
M  V30 5 C 0.0000 2.6217 0.0 0
M  V30 6 O 1.5400 1.0817 0.0 0
M  V30 7 O 1.5400 4.1617 0.0 0
M  V30 8 Cl 18.6257 4.7597 0.0 0
M  V30 9 C 6.1600 2.6217 0.0 0
M  V30 10 C 7.6663 2.3015 0.0 0
M  V30 11 C 5.3900 1.2881 0.0 0
M  V30 12 C 5.3900 3.9553 0.0 0
M  V30 13 C 7.8274 0.7700 0.0 0
M  V30 14 S 6.4204 0.1437 0.0 0
M  V30 15 C 3.8500 1.2881 0.0 0
M  V30 16 C 3.8500 3.9553 0.0 0
M  V30 17 N 3.0800 2.6217 0.0 0
M  V30 18 C 10.2753 2.8561 0.0 0
M  V30 19 C 11.5214 3.7613 0.0 0
M  V30 20 C 10.7514 1.3915 0.0 0
M  V30 21 N 12.7672 2.8561 0.0 0
M  V30 22 N 12.2914 1.3915 0.0 0
M  V30 23 C 14.2318 3.3319 0.0 0
M  V30 24 C 15.3763 2.3015 0.0 0
M  V30 25 C 14.5519 4.8384 0.0 0
M  V30 26 C 16.8408 2.7774 0.0 0
M  V30 27 C 16.0166 5.3142 0.0 0
M  V30 28 C 17.1610 4.2838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 18
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 17
M  V30 9 1 8 28
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[[2-[[[3-[[[3-[[1-(4-chlorophenyl)-1H-pyrazol-4-yl]carbonyl]-4...
C45H51ClN6O7S2
2227446-66-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 66 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6119 8.8108 0.0 0
M  V30 2 O 10.0878 10.2753 0.0 0
M  V30 3 N 12.9440 9.1610 0.0 0
M  V30 4 C 14.4840 9.1610 0.0 0
M  V30 5 O 15.2540 7.8272 0.0 0
M  V30 6 S 10.3222 1.5400 0.0 0 VAL=6
M  V30 7 C 10.3222 0.0000 0.0 0
M  V30 8 O 11.8622 1.5400 0.0 0
M  V30 9 O 8.7822 1.5400 0.0 0
M  V30 10 C 19.1040 11.8283 0.0 0
M  V30 11 N 19.8740 13.1621 0.0 0
M  V30 12 C 19.1040 14.4957 0.0 0
M  V30 13 C 21.4140 13.1621 0.0 0
M  V30 14 C 17.5640 14.4957 0.0 0
M  V30 15 C 19.8740 15.8294 0.0 0
M  V30 16 C 22.1840 11.8283 0.0 0
M  V30 17 C 16.7940 15.8294 0.0 0
M  V30 18 C 19.1040 17.1630 0.0 0
M  V30 19 N 23.7240 11.8283 0.0 0
M  V30 20 C 24.4940 10.4946 0.0 0
M  V30 21 C 24.4940 13.1621 0.0 0
M  V30 22 C 26.0340 10.4946 0.0 0
M  V30 23 O 23.7240 9.1610 0.0 0
M  V30 24 C 26.8040 9.1610 0.0 0
M  V30 25 C 28.3440 9.1610 0.0 0
M  V30 26 O 29.1140 7.8272 0.0 0
M  V30 27 O 29.1140 10.4946 0.0 0
M  V30 28 C 30.6540 7.8272 0.0 0
M  V30 29 Cl 0.0000 11.2565 0.0 0
M  V30 30 C 10.6425 7.6663 0.0 0
M  V30 31 C 10.3222 6.1600 0.0 0
M  V30 32 C 12.1740 7.8272 0.0 0
M  V30 33 C 11.6560 5.3900 0.0 0
M  V30 34 C 8.9885 5.3900 0.0 0
M  V30 35 S 12.8003 6.4204 0.0 0
M  V30 36 C 11.6560 3.8500 0.0 0
M  V30 37 C 8.9885 3.8500 0.0 0
M  V30 38 N 10.3222 3.0800 0.0 0
M  V30 39 C 8.1056 8.4906 0.0 0
M  V30 40 C 6.9611 9.5211 0.0 0
M  V30 41 C 7.4792 7.0837 0.0 0
M  V30 42 N 5.6275 8.7511 0.0 0
M  V30 43 N 5.9476 7.2446 0.0 0
M  V30 44 C 15.2540 10.4946 0.0 0
M  V30 45 C 16.7940 10.4946 0.0 0
M  V30 46 C 14.4840 11.8283 0.0 0
M  V30 47 C 17.5640 11.8283 0.0 0
M  V30 48 C 15.2540 13.1621 0.0 0
M  V30 49 C 16.7940 13.1621 0.0 0
M  V30 50 C 4.2207 9.3774 0.0 0
M  V30 51 C 4.0596 10.9089 0.0 0
M  V30 52 C 2.9747 8.4722 0.0 0
M  V30 53 C 2.6528 11.5354 0.0 0
M  V30 54 C 1.5679 9.0986 0.0 0
M  V30 55 C 1.4069 10.6302 0.0 0
M  V30 56 C 31.4240 6.4936 0.0 0
M  V30 57 C 32.9640 6.4936 0.0 0
M  V30 58 C 30.6540 5.1599 0.0 0
M  V30 59 C 33.7340 5.1599 0.0 0
M  V30 60 C 31.4240 3.8263 0.0 0
M  V30 61 C 32.9640 3.8263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 30
M  V30 3 1 1 39
M  V30 4 1 3 4
M  V30 5 1 3 32
M  V30 6 2 4 5
M  V30 7 1 4 44
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 6 9
M  V30 11 1 6 38
M  V30 12 1 10 11
M  V30 13 1 10 47
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 20 23
M  V30 26 1 22 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 28 56
M  V30 32 1 29 55
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 31 34
M  V30 37 1 32 35
M  V30 38 1 33 35
M  V30 39 1 33 36
M  V30 40 1 34 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 48 1 42 50
M  V30 49 2 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 2 46 48
M  V30 53 2 47 49
M  V30 54 1 48 49
M  V30 55 2 50 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 2 52 54
M  V30 59 2 53 55
M  V30 60 1 54 55
M  V30 61 2 56 57
M  V30 62 1 56 58
M  V30 63 1 57 59
M  V30 64 2 58 60
M  V30 65 2 59 61
M  V30 66 1 60 61
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2227446-38-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227448-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227446-66-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31375489
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM inverse addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel
1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as
gut-selective NaPi2b inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ushiki, Yasunobu; Kawabe, Kenichi; Yamamoto-Okada, Kumiko; Uneuchi,
Fumito; Asanuma, Yuta; Yamaguchi, Chitose; Ohta, Hiroshi; Shibata,
Tsuyoshi; Abe, Tomohiro; Okumura-Kitajima, Lisa; Kosai, Yuki; Endo,
Mayumi; Otake, Katsumasa; Munetomo, Eiji; Takahashi, Teisuke; Kakinuma,
Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 59128572

$RFMT $RIREG SCHEME443 STEP1
$RXN



  2  1
$MOL
Benzeneethanol, β-amino-3-fluoro-5-methoxy-, hydrochloride (1:1), (βS)-
C9H12FNO2.ClH
2095692-22-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.1601 0.0 0 CFG=2
M  V30 2 C 8.0023 5.3901 0.0 0
M  V30 3 N 6.6685 7.7001 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 O 1.3337 6.1601 0.0 0
M  V30 6 C 0.0000 5.3901 0.0 0
M  V30 7 F 4.0012 1.5400 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 4.0012 6.1601 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 4.0012 3.0800 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 Cl 4.6680 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-6-[5-Chloro-2-[(2-methoxy-4-pyridinyl)amino]-4-pyrimidinyl]-1,3-dihydro-...
C21H18ClN5O4
2095725-95-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.7282 6.6519 0.0 0
M  V30 2 C 2.6674 5.2891 0.0 0 CFG=2
M  V30 3 C 1.3338 4.5191 0.0 0
M  V30 4 C 2.6674 6.8291 0.0 0
M  V30 5 O 1.3336 2.9791 0.0 0
M  V30 6 O 0.0000 5.2891 0.0 0
M  V30 7 Cl 10.2884 0.0000 0.0 0
M  V30 8 N 13.3684 5.3347 0.0 0
M  V30 9 O 17.9884 8.0021 0.0 0
M  V30 10 C 19.5284 8.0021 0.0 0
M  V30 11 C 6.4384 4.0011 0.0 0
M  V30 12 C 5.6684 2.6674 0.0 0
M  V30 13 C 7.9784 4.0011 0.0 0
M  V30 14 C 5.4079 5.1454 0.0 0
M  V30 15 C 4.1620 2.9876 0.0 0
M  V30 16 C 6.4384 1.3336 0.0 0
M  V30 17 C 8.7484 2.6674 0.0 0
M  V30 18 N 4.0011 4.5191 0.0 0
M  V30 19 C 7.9784 1.3336 0.0 0
M  V30 20 C 10.2884 2.6674 0.0 0
M  V30 21 N 11.0584 4.0011 0.0 0
M  V30 22 C 11.0584 1.3336 0.0 0
M  V30 23 C 12.5984 4.0011 0.0 0
M  V30 24 C 12.5984 1.3336 0.0 0
M  V30 25 N 13.3684 2.6674 0.0 0
M  V30 26 C 14.9084 5.3347 0.0 0
M  V30 27 C 15.6784 6.6685 0.0 0
M  V30 28 C 15.6784 4.0011 0.0 0
M  V30 29 C 17.2184 6.6685 0.0 0
M  V30 30 C 17.2184 4.0011 0.0 0
M  V30 31 N 17.9884 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 22
M  V30 8 1 8 23
M  V30 9 1 8 26
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 1 17 20
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-6-[5-Chloro-2-[(2-methoxy-4-pyridinyl)amino]-4-pyrimidinyl]-N-[(1S)-1-(3...
C30H28ClFN6O5
2095720-08-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.2096 8.0454 0.0 0
M  V30 2 C 9.2402 5.3350 0.0 0 CFG=2
M  V30 3 C 8.4702 4.0012 0.0 0
M  V30 4 C 8.4702 6.6687 0.0 0
M  V30 5 N 6.9302 4.0012 0.0 0
M  V30 6 O 9.2402 2.6675 0.0 0
M  V30 7 C 6.1601 2.6675 0.0 0 CFG=1
M  V30 8 C 6.9302 1.3338 0.0 0
M  V30 9 O 6.1601 0.0000 0.0 0
M  V30 10 Cl 15.8175 9.1851 0.0 0
M  V30 11 N 21.1524 6.1050 0.0 0
M  V30 12 O 26.4872 6.1050 0.0 0
M  V30 13 C 27.8210 6.8750 0.0 0
M  V30 14 O 1.5400 0.0000 0.0 0
M  V30 15 C 0.0000 0.0000 0.0 0
M  V30 16 F 1.5400 5.3348 0.0 0
M  V30 17 C 13.1502 6.1050 0.0 0
M  V30 18 C 13.1502 4.5650 0.0 0
M  V30 19 C 14.4839 6.8750 0.0 0
M  V30 20 C 11.6855 6.5809 0.0 0
M  V30 21 C 11.6855 4.0889 0.0 0
M  V30 22 C 14.4839 3.7950 0.0 0
M  V30 23 C 15.8175 6.1050 0.0 0
M  V30 24 N 10.7802 5.3350 0.0 0
M  V30 25 C 15.8175 4.5650 0.0 0
M  V30 26 C 17.1514 6.8750 0.0 0
M  V30 27 N 18.4850 6.1050 0.0 0
M  V30 28 C 17.1514 8.4151 0.0 0
M  V30 29 C 19.8187 6.8750 0.0 0
M  V30 30 C 18.4850 9.1851 0.0 0
M  V30 31 N 19.8187 8.4151 0.0 0
M  V30 32 C 22.4862 6.8750 0.0 0
M  V30 33 C 23.8199 6.1050 0.0 0
M  V30 34 C 22.4862 8.4151 0.0 0
M  V30 35 C 25.1535 6.8750 0.0 0
M  V30 36 C 23.8199 9.1851 0.0 0
M  V30 37 N 25.1535 8.4151 0.0 0
M  V30 38 C 4.6201 2.6675 0.0 0
M  V30 39 C 3.8501 1.3338 0.0 0
M  V30 40 C 3.8501 4.0012 0.0 0
M  V30 41 C 2.3101 1.3338 0.0 0
M  V30 42 C 2.3101 4.0012 0.0 0
M  V30 43 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 24
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8 CFG=3
M  V30 9 1 7 38
M  V30 10 1 8 9
M  V30 11 1 10 28
M  V30 12 1 11 29
M  V30 13 1 11 32
M  V30 14 1 12 13
M  V30 15 1 12 35
M  V30 16 1 14 15
M  V30 17 1 14 41
M  V30 18 1 16 42
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 2 23 25
M  V30 29 1 23 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2095692-22-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095725-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095720-08-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31186582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of ASTX029, A Clinical Candidate Which Modulates the
Phosphorylation and Catalytic Activity of ERK1/2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heightman, Tom D.; Berdini, Valerio; Bevan, Luke; Buck, Ildiko M.; Carr,
Maria G.; Courtin, Aurelie; Coyle, Joseph E.; Day, James E. H.; East,
Charlotte; Fazal, Lynsey; Griffiths-Jones, Charlotte M.; Howard, Steven;
Kucia-Tran, Justyna; Martins, Vanessa; Muench, Sandra; Munck, Joanne M.;
Norton, David; O'Reilly, Marc; Palmer, Nicholas; Pathuri, Puja; Peakman,
Torren M.; Reader, Michael; Rees, David C.; Rich, Sharna J.; Shah,
Alpesh; Wallis, Nicola G.; Walton, Hugh; Wilsher, Nicola E.; Woolford,
Alison J.-A.; Cooke, Michael; Cousin, David; Onions, Stuart; Shannon,
Jonathan; Watts, John; Murray, Christopher W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 12286-12303

$RFMT $RIREG SCHEME444 STEP1
$RXN



  2  1
$MOL
5-[[cis-4-[(1,1-Dimethylethoxy)carbonyl]-4-methylcyclohexyl]oxy]-4-fluoro-2-m...
C20H27FO6
2787516-56-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 F 4.0011 0.0000 0.0 0
M  V30 3 C 4.0011 6.1600 0.0 0
M  V30 4 O 5.3347 6.9300 0.0 0
M  V30 5 O 2.6673 6.9300 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 12.1860 3.5827 0.0 0
M  V30 9 O 13.1759 4.7623 0.0 0
M  V30 10 O 12.7127 2.1355 0.0 0
M  V30 11 C 14.6925 4.4948 0.0 0
M  V30 12 C 14.4252 2.9782 0.0 0
M  V30 13 C 16.2091 4.2275 0.0 0
M  V30 14 C 14.9599 6.0115 0.0 0
M  V30 15 C 11.1961 5.2971 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 18 C 4.0011 1.5400 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 2.6673 2.3100 0.0 0
M  V30 21 C 2.6673 3.8500 0.0 0
M  V30 22 C 8.0020 2.3100 0.0 0 CFG=2
M  V30 23 C 8.0020 3.8500 0.0 0
M  V30 24 C 9.3358 1.5400 0.0 0
M  V30 25 C 9.3358 4.6200 0.0 0
M  V30 26 C 10.6694 2.3100 0.0 0
M  V30 27 C 10.6694 3.8500 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 22 1 CFG=1
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 19
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 27 8 CFG=1
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 27 15 CFG=3
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2S,3R,4S)-3-Amino-N-[3-[(trifluoromethyl)sulfonyl]phenyl]bicyclo[2.2.1]he...
C15H17F3N2O3S
2787517-22-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8911 2.3101 0.0 0
M  V30 2 N 6.2248 3.0801 0.0 0
M  V30 3 O 4.8911 0.7700 0.0 0
M  V30 4 N 3.5458 5.3002 0.0 0
M  V30 5 S 11.5596 3.0801 0.0 0 VAL=6
M  V30 6 C 12.8935 3.8501 0.0 0
M  V30 7 O 12.3297 1.7464 0.0 0
M  V30 8 O 10.7896 4.4139 0.0 0
M  V30 9 F 14.2271 3.0801 0.0 0
M  V30 10 F 14.2271 4.6201 0.0 0
M  V30 11 F 12.8935 5.3901 0.0 0
M  V30 12 C 2.1102 3.4098 0.0 0 CFG=2
M  V30 13 C 3.5575 3.0801 0.0 0 CFG=2
M  V30 14 C 1.3639 5.9301 0.0 0
M  V30 15 C 1.0497 2.4956 0.0 0
M  V30 16 C 2.6801 4.0264 0.0 0 CFG=2
M  V30 17 C 1.4328 4.5111 0.0 0 CFG=2
M  V30 18 C 0.3032 3.4126 0.0 0
M  V30 19 C 7.5586 2.3101 0.0 0
M  V30 20 C 8.8923 3.0801 0.0 0
M  V30 21 C 7.5586 0.7700 0.0 0
M  V30 22 C 10.2260 2.3101 0.0 0
M  V30 23 C 8.8923 0.0000 0.0 0
M  V30 24 C 10.2260 0.7700 0.0 0
M  V30 25 H 2.4818 1.9153 0.0 0
M  V30 26 H 0.0000 5.0756 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 19
M  V30 5 1 16 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 5 22
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 25 CFG=1
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 17 26 CFG=3
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl cis-4-[2-fluoro-4-methoxy-5-[[[(1S,2R,3S,4R)-3-[[[3-[(trifl...
C35H42F4N2O8S
2787520-36-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.3135 10.7689 0.0 0
M  V30 2 C 10.6473 11.5389 0.0 0
M  V30 3 O 10.6473 13.0789 0.0 0
M  V30 4 C 6.6520 9.2269 0.0 0
M  V30 5 N 5.3207 8.4528 0.0 0
M  V30 6 O 7.9880 8.4609 0.0 0
M  V30 7 O 13.3145 13.0789 0.0 0
M  V30 8 C 14.6482 13.8489 0.0 0
M  V30 9 O 13.3145 6.9189 0.0 0
M  V30 10 S 2.6673 3.8247 0.0 0 VAL=6
M  V30 11 C 1.3359 3.0507 0.0 0
M  V30 12 O 1.8933 5.1561 0.0 0
M  V30 13 O 3.4413 2.4934 0.0 0
M  V30 14 F 1.3406 1.5107 0.0 0
M  V30 15 F 0.0046 2.2767 0.0 0
M  V30 16 F 0.0000 3.8167 0.0 0
M  V30 17 F 15.9820 8.4589 0.0 0
M  V30 18 C 17.8423 3.1618 0.0 0
M  V30 19 O 19.3589 2.8943 0.0 0
M  V30 20 O 16.8524 1.9820 0.0 0
M  V30 21 C 19.8856 1.4471 0.0 0
M  V30 22 C 18.4384 0.9205 0.0 0
M  V30 23 C 20.4124 0.0000 0.0 0
M  V30 24 C 21.3327 1.9740 0.0 0
M  V30 25 C 18.8322 4.8763 0.0 0
M  V30 26 C 7.9798 11.5389 0.0 0 CFG=2
M  V30 27 C 6.6473 10.7669 0.0 0 CFG=1
M  V30 28 C 7.9821 13.0709 0.0 0 CFG=1
M  V30 29 C 5.3172 11.5267 0.0 0 CFG=2
M  V30 30 C 6.4130 12.7073 0.0 0
M  V30 31 C 6.6469 13.8395 0.0 0
M  V30 32 C 5.3144 13.0675 0.0 0
M  V30 33 C 11.9809 10.7689 0.0 0
M  V30 34 C 13.3145 11.5389 0.0 0
M  V30 35 C 11.9809 9.2289 0.0 0
M  V30 36 C 14.6482 10.7689 0.0 0
M  V30 37 C 13.3145 8.4589 0.0 0
M  V30 38 C 14.6482 9.2289 0.0 0
M  V30 39 C 5.3253 6.9128 0.0 0
M  V30 40 C 3.9940 6.1387 0.0 0
M  V30 41 C 6.6613 6.1469 0.0 0
M  V30 42 C 3.9986 4.5987 0.0 0
M  V30 43 C 6.6660 4.6069 0.0 0
M  V30 44 C 5.3347 3.8329 0.0 0
M  V30 45 C 14.6482 6.1489 0.0 0 CFG=2
M  V30 46 C 15.9820 6.9189 0.0 0
M  V30 47 C 14.6482 4.6089 0.0 0
M  V30 48 C 17.3156 6.1489 0.0 0
M  V30 49 C 15.9820 3.8389 0.0 0
M  V30 50 C 17.3156 4.6089 0.0 0 CFG=1
M  V30 51 H 9.3159 13.8406 0.0 0
M  V30 52 H 3.9860 10.7526 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 26 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 33
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 27 4 CFG=1
M  V30 8 1 5 39
M  V30 9 1 7 8
M  V30 10 1 7 34
M  V30 11 1 9 37
M  V30 12 1 45 9 CFG=1
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 2 10 13
M  V30 16 1 10 42
M  V30 17 1 11 14
M  V30 18 1 11 15
M  V30 19 1 11 16
M  V30 20 1 17 38
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 50 18 CFG=1
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 1 50 25 CFG=3
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30 CFG=1
M  V30 33 1 28 31
M  V30 34 1 28 51
M  V30 35 1 29 30 CFG=1
M  V30 36 1 29 32
M  V30 37 1 29 52
M  V30 38 1 31 32
M  V30 39 2 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 35 37
M  V30 43 2 36 38
M  V30 44 1 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 1 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 26 27 28 29 45 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2787516-56-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787517-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787520-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39864678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Novel Series of Potent and Selective Relaxin Family
Peptide Receptor 1 (RXFP1) Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Sakamaki, Shigeki; Fuchigami, Ryuichi; Niwa,
Yasuki; Fujio, Masakazu; Kato, Harutoshi; Bergstroem, Fredrik; Larsson,
Niklas; Persson, Mikael; Villar, Inmaculada C.; Fujita, Takuya; Sugikawa,
Emiko; Althage, Magnus; Yano, Naoko; Yokoyama, Yoshito; Kimura, Junpei;
Lal, Mark; Mochida, Hideki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(6), 4442-4462

$RFMT $RIREG SCHEME445 STEP1
$RXN



  2  1
$MOL
(4S)-3,4-Dihydro-2,2-dimethyl-2H-1-benzopyran-4-amine
C11H15NO
235423-04-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.0000 0.0 0
M  V30 2 C 5.8616 5.2970 0.0 0
M  V30 3 C 6.8515 3.5825 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 7 C 1.3338 1.5400 0.0 0
M  V30 8 O 4.0011 4.6201 0.0 0
M  V30 9 C 1.3338 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=3
M  V30 2 1 2 12
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-1-Benzopyran-6-carboxylic acid, 4-[(2E)-2-[[(1,1-dimethylethoxy)carbonyl]i...
C23H31N3O6
2853450-31-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.3357 5.7070 0.0 0
M  V30 2 C 10.6695 4.9370 0.0 0
M  V30 3 O 12.0032 5.7070 0.0 0
M  V30 4 O 10.6695 3.3970 0.0 0
M  V30 5 C 13.3369 4.9370 0.0 0
M  V30 6 C 14.1069 6.2706 0.0 0
M  V30 7 C 14.6705 4.1670 0.0 0
M  V30 8 C 12.5668 3.6032 0.0 0
M  V30 9 O 4.0010 5.7070 0.0 0
M  V30 10 C 1.3337 7.2470 0.0 0
M  V30 11 O 0.0000 8.0170 0.0 0
M  V30 12 O 1.3337 5.7070 0.0 0
M  V30 13 C 7.6584 1.4472 0.0 0
M  V30 14 C 7.1317 0.0000 0.0 0
M  V30 15 C 5.6785 1.4472 0.0 0
M  V30 16 C 4.1619 1.7147 0.0 0
M  V30 17 C 6.6684 7.2470 0.0 0 CFG=2
M  V30 18 C 5.3348 8.0170 0.0 0
M  V30 19 C 8.0021 8.0170 0.0 0
M  V30 20 C 5.3348 9.5570 0.0 0
M  V30 21 C 4.0010 7.2470 0.0 0
M  V30 22 C 8.0021 9.5570 0.0 0
M  V30 23 C 4.0010 10.3270 0.0 0
M  V30 24 O 6.6684 10.3270 0.0 0
M  V30 25 C 2.6673 8.0170 0.0 0
M  V30 26 C 2.6673 9.5570 0.0 0
M  V30 27 N 6.6684 5.7070 0.0 0
M  V30 28 C 8.0021 4.9370 0.0 0
M  V30 29 C 5.3348 4.9370 0.0 0
M  V30 30 N 8.0021 3.3970 0.0 0
M  V30 31 C 5.3348 3.3970 0.0 0
M  V30 32 C 6.6684 2.6270 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 29
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 25
M  V30 13 1 13 14
M  V30 14 1 13 32
M  V30 15 1 15 16
M  V30 16 1 15 32
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 27 CFG=1
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 24
M  V30 27 1 23 26
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[1-[(4R)-6-[[[(4S)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-...
C34H44N4O6
2853450-40-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 14.6300 8.1851 0.0 0
M  V30 2 C 16.1700 8.1851 0.0 0
M  V30 3 O 16.9400 9.5187 0.0 0
M  V30 4 O 16.9400 6.8513 0.0 0
M  V30 5 C 18.4800 9.5187 0.0 0
M  V30 6 C 18.4800 7.9787 0.0 0
M  V30 7 C 20.0200 9.5187 0.0 0
M  V30 8 C 18.4800 11.0587 0.0 0
M  V30 9 O 10.0100 5.5177 0.0 0
M  V30 10 C 15.3071 3.6573 0.0 0
M  V30 11 C 15.5745 2.1408 0.0 0
M  V30 12 C 13.5927 2.6674 0.0 0
M  V30 13 C 12.1455 2.1408 0.0 0
M  V30 14 C 6.9300 5.5177 0.0 0
M  V30 15 N 5.3900 5.5177 0.0 0
M  V30 16 O 7.7000 4.1840 0.0 0
M  V30 17 C 4.3527 0.0000 0.0 0
M  V30 18 C 6.0671 0.9899 0.0 0
M  V30 19 N 12.3200 6.8513 0.0 0
M  V30 20 C 13.8600 6.8513 0.0 0
M  V30 21 C 11.5500 5.5177 0.0 0
M  V30 22 N 14.6300 5.5177 0.0 0
M  V30 23 C 12.3200 4.1840 0.0 0
M  V30 24 C 13.8600 4.1840 0.0 0
M  V30 25 C 11.5500 8.1851 0.0 0 CFG=2
M  V30 26 C 10.0100 8.1851 0.0 0
M  V30 27 C 12.3200 9.5187 0.0 0
M  V30 28 C 9.2400 9.5187 0.0 0
M  V30 29 C 9.2400 6.8513 0.0 0
M  V30 30 C 11.5500 10.8524 0.0 0
M  V30 31 C 7.7000 9.5187 0.0 0
M  V30 32 O 10.0100 10.8524 0.0 0
M  V30 33 C 7.7000 6.8513 0.0 0
M  V30 34 C 6.9300 8.1851 0.0 0
M  V30 35 C 4.6200 4.1840 0.0 0 CFG=1
M  V30 36 C 3.0800 4.1840 0.0 0
M  V30 37 C 5.3900 2.8504 0.0 0
M  V30 38 C 2.3100 2.8504 0.0 0
M  V30 39 C 2.3100 5.5177 0.0 0
M  V30 40 C 4.6200 1.5166 0.0 0
M  V30 41 O 3.0800 1.5166 0.0 0
M  V30 42 C 0.7700 2.8504 0.0 0
M  V30 43 C 0.7700 5.5177 0.0 0
M  V30 44 C 0.0000 4.1840 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 21
M  V30 10 1 10 11
M  V30 11 1 10 24
M  V30 12 1 12 13
M  V30 13 1 12 24
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 33
M  V30 17 1 35 15 CFG=1
M  V30 18 1 17 40
M  V30 19 1 18 40
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 25 19 CFG=1
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 28 31
M  V30 33 1 28 32
M  V30 34 1 29 33
M  V30 35 1 30 32
M  V30 36 1 31 34
M  V30 37 2 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 36 39
M  V30 42 1 37 40
M  V30 43 1 38 41
M  V30 44 2 38 42
M  V30 45 1 39 43
M  V30 46 1 40 41
M  V30 47 1 42 44
M  V30 48 2 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 25 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 235423-04-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2853450-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2853450-40-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34588150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the
Treatment of Malaria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Lera Ruiz, Manuel; Favuzza, Paola; Guo, Zhuyan; Zhao, Lianyun; Hu,
Bin; Lei, Zhiyu; Zhan, Dongmei; Murgolo, Nicholas; Boyce, Christopher W.;
Vavrek, Marissa; Thompson, Jennifer; Ngo, Anna; Jarman, Kate E.; Robbins,
Johnathan; Boddey, Justin; Sleebs, Brad E.; Lowes, Kym N.; Cowman, Alan
F.; Olsen, David B.; McCauley, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754

$RFMT $RIREG SCHEME446 STEP1
$RXN



  2  1
$MOL
2-[(6S,Z)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[...
C19H17ClN4O2S
202592-23-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3988 8.6280 0.0 0
M  V30 2 C 0.4292 8.4909 0.0 0
M  V30 3 C 5.1944 11.1511 0.0 0
M  V30 4 C 3.2311 2.5489 0.0 0
M  V30 5 C 4.3600 1.5015 0.0 0
M  V30 6 O 5.8315 1.9553 0.0 0
M  V30 7 O 4.0172 0.0000 0.0 0
M  V30 8 Cl 11.9033 5.7805 0.0 0
M  V30 9 C 3.5737 7.5106 0.0 0
M  V30 10 C 5.0752 7.1679 0.0 0
M  V30 11 N 2.3698 6.5505 0.0 0
M  V30 12 S 3.4357 9.0444 0.0 0
M  V30 13 C 5.7433 5.7805 0.0 0
M  V30 14 C 5.8651 8.4900 0.0 0
M  V30 15 C 2.3698 5.0105 0.0 0
M  V30 16 C 0.9051 7.0264 0.0 0
M  V30 17 C 4.8518 9.6496 0.0 0
M  V30 18 N 5.0752 4.3930 0.0 0
M  V30 19 C 3.5737 4.0504 0.0 0 CFG=2
M  V30 20 N 0.9051 4.5345 0.0 0
M  V30 21 N 0.0000 5.7805 0.0 0
M  V30 22 C 7.2833 5.7805 0.0 0
M  V30 23 C 8.0533 4.4468 0.0 0
M  V30 24 C 8.0533 7.1142 0.0 0
M  V30 25 C 9.5933 4.4468 0.0 0
M  V30 26 C 9.5933 7.1142 0.0 0
M  V30 27 C 10.3633 5.7805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 16
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 2 13 18
M  V30 18 1 13 22
M  V30 19 2 14 17
M  V30 20 1 15 19
M  V30 21 2 15 20
M  V30 22 2 16 21
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Isoxazoleacetic acid, 3-[(5-aminopentyl)oxy]-α-(1-methylethyl)-, methyl est...
C14H24N2O4.ClH
3055533-17-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 2 C 2.6673 4.6200 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 O 1.3337 3.8500 0.0 0
M  V30 5 O 2.6673 6.1601 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 C 0.0000 4.6200 0.0 0
M  V30 9 O 9.3037 4.9770 0.0 0
M  V30 10 C 10.2090 6.2231 0.0 0
M  V30 11 C 11.7405 6.0620 0.0 0
M  V30 12 C 12.6457 7.3078 0.0 0
M  V30 13 C 14.1773 7.1469 0.0 0
M  V30 14 C 15.0825 8.3928 0.0 0
M  V30 15 N 16.6141 8.2319 0.0 0
M  V30 16 C 5.3348 4.6200 0.0 0
M  V30 17 C 6.7416 3.9936 0.0 0
M  V30 18 O 5.4957 6.1516 0.0 0
M  V30 19 C 7.7722 5.1381 0.0 0
M  V30 20 N 7.0022 6.4718 0.0 0
M  V30 21 Cl 8.3070 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Isoxazoleacetic acid, 3-[[5-[[2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H...
C32H37ClN6O5S
3055533-18-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0608 3.4651 0.0 0
M  V30 2 C 1.1373 10.1655 0.0 0
M  V30 3 C 0.0000 4.8278 0.0 0
M  V30 4 C 7.6414 9.2395 0.0 0
M  V30 5 C 8.9751 8.4695 0.0 0
M  V30 6 N 10.3088 9.2395 0.0 0
M  V30 7 O 8.9751 6.9295 0.0 0
M  V30 8 C 11.6424 8.4695 0.0 0
M  V30 9 C 12.9762 9.2395 0.0 0
M  V30 10 C 14.3099 8.4695 0.0 0
M  V30 11 C 15.6436 9.2395 0.0 0
M  V30 12 C 16.9774 8.4695 0.0 0
M  V30 13 O 18.3110 9.2395 0.0 0
M  V30 14 Cl 7.1095 0.0000 0.0 0
M  V30 15 C 23.6136 8.1124 0.0 0 CFG=3
M  V30 16 C 24.2400 9.5193 0.0 0
M  V30 17 C 24.5189 6.8665 0.0 0
M  V30 18 C 25.7717 9.6803 0.0 0
M  V30 19 C 23.3349 10.7652 0.0 0
M  V30 20 O 26.0504 7.0276 0.0 0
M  V30 21 O 23.8924 5.4597 0.0 0
M  V30 22 C 3.0010 7.4496 0.0 0
M  V30 23 C 3.7711 6.1159 0.0 0
M  V30 24 N 3.5636 8.8832 0.0 0
M  V30 25 S 1.4946 7.1294 0.0 0
M  V30 26 C 5.2938 5.8863 0.0 0
M  V30 27 C 2.7406 4.9714 0.0 0
M  V30 28 C 5.0353 9.3370 0.0 0
M  V30 29 C 2.6772 10.1424 0.0 0
M  V30 30 C 1.3337 5.5978 0.0 0
M  V30 31 N 6.4228 6.9338 0.0 0
M  V30 32 C 6.3076 8.4695 0.0 0 CFG=2
M  V30 33 N 5.0584 10.8769 0.0 0
M  V30 34 N 3.6009 11.3746 0.0 0
M  V30 35 C 5.7478 4.4148 0.0 0
M  V30 36 C 4.7003 3.2858 0.0 0
M  V30 37 C 7.2492 4.0721 0.0 0
M  V30 38 C 5.1543 1.8141 0.0 0
M  V30 39 C 7.7032 2.6005 0.0 0
M  V30 40 C 6.6557 1.4715 0.0 0
M  V30 41 C 19.6447 8.4695 0.0 0
M  V30 42 C 21.0515 9.0960 0.0 0
M  V30 43 N 19.8056 6.9380 0.0 0
M  V30 44 C 22.0821 7.9515 0.0 0
M  V30 45 O 21.3121 6.6178 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 2 29
M  V30 3 1 3 30
M  V30 4 1 4 5
M  V30 5 1 32 4 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 41
M  V30 15 1 14 40
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 44
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 24 29
M  V30 30 1 25 30
M  V30 31 2 26 31
M  V30 32 1 26 35
M  V30 33 2 27 30
M  V30 34 1 28 32
M  V30 35 2 28 33
M  V30 36 2 29 34
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 1 41 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 202592-23-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3055533-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055533-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36342043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic Potency and Property Assessment of VHL Ligands and
Implications on PROTAC Design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krieger, Johannes; Sorrell, Fiona J.; Wegener, Ansgar A.; Leuthner,
Birgitta; Machrouhi-Porcher, Fouzia; Hecht, Martin; Leibrock, Eva M.;
Mueller, Juliane E.; Eisert, Jonathan; Hartung, Ingo V.; Schlesiger,
Sarah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2023), 18(8), e202200615

$RFMT $RIREG SCHEME447 STEP1
$RXN



  2  1
$MOL
5-Cyanopicolinic acid
C7H4N2O2
53234-55-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 N 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(6R)-6-(5-amino-2-fluorophenyl)-3-cyano-5,6-dihydro-6-me...
C19H21FN6O2
1383742-80-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5212 6.6004 0.0 0
M  V30 2 F 4.7189 8.1170 0.0 0
M  V30 3 N 9.1037 3.7501 0.0 0
M  V30 4 C 9.8737 5.0838 0.0 0
M  V30 5 O 11.4137 5.0838 0.0 0
M  V30 6 O 9.1037 6.4175 0.0 0
M  V30 7 C 12.1837 6.4175 0.0 0
M  V30 8 C 13.5175 5.6475 0.0 0
M  V30 9 C 12.9537 7.7511 0.0 0
M  V30 10 C 10.8501 7.1875 0.0 0
M  V30 11 N 0.0000 4.1574 0.0 0
M  V30 12 C 3.3133 0.4759 0.0 0
M  V30 13 N 1.8486 0.0000 0.0 0
M  V30 14 C 5.2537 5.0838 0.0 0 CFG=2
M  V30 15 C 4.4837 3.7501 0.0 0
M  V30 16 N 6.7937 5.0838 0.0 0
M  V30 17 N 5.2537 2.4164 0.0 0
M  V30 18 C 7.5637 3.7501 0.0 0
M  V30 19 C 6.7937 2.4164 0.0 0
M  V30 20 C 4.7779 0.9519 0.0 0
M  V30 21 N 7.2696 0.9519 0.0 0
M  V30 22 C 6.0237 0.0467 0.0 0
M  V30 23 C 3.8066 5.6105 0.0 0
M  V30 24 C 3.5392 7.1271 0.0 0
M  V30 25 C 2.6269 4.6206 0.0 0
M  V30 26 C 2.0921 7.6538 0.0 0
M  V30 27 C 1.1798 5.1473 0.0 0
M  V30 28 C 0.9123 6.6639 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 2 24
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 27
M  V30 12 3 12 13
M  V30 13 1 12 20
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 23 CFG=1
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(6R)-3-cyano-6-[5-[[(5-cyano-2-pyridinyl)carbonyl]amino]...
C26H23FN8O3
1383742-91-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 3.1123 4.6761 0.0 0
M  V30 2 C 4.2921 3.6863 0.0 0
M  V30 3 O 4.0246 2.1697 0.0 0
M  V30 4 O 5.7393 4.2130 0.0 0
M  V30 5 C 5.2044 1.1798 0.0 0
M  V30 6 C 6.1942 2.3594 0.0 0
M  V30 7 C 6.3841 0.1899 0.0 0
M  V30 8 C 4.2145 0.0000 0.0 0
M  V30 9 C 0.8935 10.9472 0.0 0
M  V30 10 N 0.6791 12.4723 0.0 0
M  V30 11 C 6.5415 7.7094 0.0 0
M  V30 12 F 3.5543 10.9034 0.0 0
M  V30 13 N 9.7143 10.9034 0.0 0
M  V30 14 C 10.4843 12.2371 0.0 0
M  V30 15 O 9.7143 13.5708 0.0 0
M  V30 16 C 16.6443 12.2371 0.0 0
M  V30 17 N 18.1843 12.2371 0.0 0
M  V30 18 C 2.2000 7.1826 0.0 0
M  V30 19 N 2.4675 8.6992 0.0 0
M  V30 20 C 3.3798 6.1928 0.0 0
M  V30 21 N 0.6751 6.9683 0.0 0
M  V30 22 C 3.9147 9.2260 0.0 0
M  V30 23 C 1.1077 9.4222 0.0 0
M  V30 24 N 4.8270 6.7195 0.0 0
M  V30 25 C 0.0000 8.3525 0.0 0
M  V30 26 C 5.0943 8.2361 0.0 0 CFG=2
M  V30 27 C 5.8643 9.5697 0.0 0
M  V30 28 C 7.4043 9.5697 0.0 0
M  V30 29 C 5.0943 10.9034 0.0 0
M  V30 30 C 8.1743 10.9034 0.0 0
M  V30 31 C 5.8643 12.2371 0.0 0
M  V30 32 C 7.4043 12.2371 0.0 0
M  V30 33 C 12.0243 12.2371 0.0 0
M  V30 34 C 12.7943 10.9034 0.0 0
M  V30 35 N 12.7943 13.5708 0.0 0
M  V30 36 C 14.3343 10.9034 0.0 0
M  V30 37 C 14.3343 13.5708 0.0 0
M  V30 38 C 15.1043 12.2371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 3 9 10
M  V30 10 1 9 23
M  V30 11 1 26 11 CFG=3
M  V30 12 1 12 29
M  V30 13 1 13 14
M  V30 14 1 13 30
M  V30 15 2 14 15
M  V30 16 1 14 33
M  V30 17 3 16 17
M  V30 18 1 16 38
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27 CFG=1
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53234-55-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383742-80-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1383742-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31769035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3945-69-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor
Elicits Sustained Reduction of Amyloid β In Vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peschiulli, Aldo; Oehlrich, Daniel; Van Gool, Michiel; Austin, Nigel; Van
Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Tresadern,
Gary; Rombouts, Frederik J. R.; Macdonald, Gregor J.; Moechars, Diederik;
Trabanco, Andres A.; Gijsen, Harrie J. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(1), 76-83

$RFMT $RIREG SCHEME448 STEP1
$RXN



  2  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-alanyl-L-alanine
C11H20N2O5
27317-69-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 O 2.6673 1.5400 0.0 0
M  V30 7 O 4.0010 3.8501 0.0 0
M  V30 8 N 9.3360 2.3101 0.0 0
M  V30 9 O 8.0022 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0 CFG=1
M  V30 12 C 2.1037 3.6437 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 0.5637 0.9764 0.0 0
M  V30 15 C 12.0033 2.3101 0.0 0
M  V30 16 C 10.6697 0.0000 0.0 0
M  V30 17 O 13.3370 1.5400 0.0 0
M  V30 18 O 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16 CFG=3
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(11β,16α)-16,17-[[(R)-[4-[(3-Aminophenyl)methyl]phenyl]methylene]bis(oxy)]-11...
C35H39NO6
2166375-82-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.2479 2.6183 0.0 0
M  V30 2 C 10.2375 1.4561 0.0 0
M  V30 3 O 12.7596 2.3245 0.0 0
M  V30 4 O 10.7389 0.0000 0.0 0
M  V30 5 C 10.1453 2.5084 0.0 0
M  V30 6 O 6.1600 1.0869 0.0 0
M  V30 7 C 4.7543 2.2201 0.0 0
M  V30 8 C 19.3100 3.9486 0.0 0
M  V30 9 O 0.0000 3.7542 0.0 0
M  V30 10 N 24.1837 6.1184 0.0 0
M  V30 11 C 10.7465 4.0744 0.0 0 CFG=1
M  V30 12 C 9.2400 3.7542 0.0 0 CFG=2
M  V30 13 C 10.9074 5.6061 0.0 0 CFG=2
M  V30 14 O 12.1533 3.4481 0.0 0
M  V30 15 C 8.4700 5.0880 0.0 0 CFG=2
M  V30 16 C 8.4700 2.4206 0.0 0
M  V30 17 C 9.5006 6.2324 0.0 0
M  V30 18 O 12.4138 5.9263 0.0 0
M  V30 19 C 13.1838 4.5925 0.0 0 CFG=2
M  V30 20 C 6.9300 5.0880 0.0 0 CFG=2
M  V30 21 C 6.9300 2.4206 0.0 0 CFG=2
M  V30 22 C 6.1600 3.7542 0.0 0 CFG=1
M  V30 23 C 6.1600 6.4217 0.0 0
M  V30 24 C 4.6200 3.7542 0.0 0 CFG=2
M  V30 25 C 4.6200 6.4217 0.0 0
M  V30 26 C 3.8500 5.0880 0.0 0
M  V30 27 C 3.8500 2.4206 0.0 0
M  V30 28 C 2.3100 5.0880 0.0 0
M  V30 29 C 2.3100 2.4206 0.0 0
M  V30 30 C 1.5400 3.7542 0.0 0
M  V30 31 C 14.7154 4.4315 0.0 0
M  V30 32 C 15.3417 3.0247 0.0 0
M  V30 33 C 15.6206 5.6774 0.0 0
M  V30 34 C 16.8732 2.8636 0.0 0
M  V30 35 C 17.1521 5.5165 0.0 0
M  V30 36 C 17.7785 4.1097 0.0 0
M  V30 37 C 20.2152 5.1944 0.0 0
M  V30 38 C 21.7469 5.0335 0.0 0
M  V30 39 C 19.5889 6.6014 0.0 0
M  V30 40 C 22.6520 6.2794 0.0 0
M  V30 41 C 20.4941 7.8473 0.0 0
M  V30 42 C 22.0256 7.6863 0.0 0
M  V30 43 H 11.0683 7.1376 0.0 0
M  V30 44 H 8.4970 6.6277 0.0 0
M  V30 45 H 7.3287 6.5755 0.0 0
M  V30 46 H 6.0259 2.2201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 12 5 CFG=3
M  V30 6 1 21 6 CFG=3
M  V30 7 1 24 7 CFG=3
M  V30 8 1 8 36
M  V30 9 1 8 37
M  V30 10 2 9 30
M  V30 11 1 10 40
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 43 CFG=3
M  V30 20 1 14 19
M  V30 21 1 15 17
M  V30 22 1 15 20
M  V30 23 1 15 44 CFG=1
M  V30 24 1 16 21
M  V30 25 1 18 19
M  V30 26 1 19 31 CFG=1
M  V30 27 1 20 22
M  V30 28 1 20 23
M  V30 29 1 20 45 CFG=3
M  V30 30 1 21 22
M  V30 31 1 22 24
M  V30 32 1 22 46 CFG=1
M  V30 33 1 23 25
M  V30 34 1 24 26
M  V30 35 1 24 27
M  V30 36 1 25 26
M  V30 37 2 26 28
M  V30 38 2 27 29
M  V30 39 1 28 30
M  V30 40 1 29 30
M  V30 41 2 31 32
M  V30 42 1 31 33
M  V30 43 1 32 34
M  V30 44 2 33 35
M  V30 45 2 34 36
M  V30 46 1 35 36
M  V30 47 2 37 38
M  V30 48 1 37 39
M  V30 49 1 38 40
M  V30 50 2 39 41
M  V30 51 2 40 42
M  V30 52 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 11 12 13 15 19 20 21 22 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C46H57N3O10
2345733-79-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  63 69 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.8135 6.1703 0.0 0
M  V30 2 C 8.4178 6.8211 0.0 0
M  V30 3 O 11.0749 7.0536 0.0 0
M  V30 4 O 8.2835 8.3552 0.0 0
M  V30 5 C 8.7615 5.8222 0.0 0
M  V30 6 O 4.5426 5.4999 0.0 0
M  V30 7 C 3.7193 3.8929 0.0 0
M  V30 8 C 17.7198 8.2342 0.0 0
M  V30 9 O 0.0000 0.5576 0.0 0
M  V30 10 N 23.0546 8.2342 0.0 0
M  V30 11 C 24.3883 7.4642 0.0 0
M  V30 12 C 25.7221 8.2342 0.0 0 CFG=2
M  V30 13 O 24.3883 5.9242 0.0 0
M  V30 14 N 27.0557 7.4642 0.0 0
M  V30 15 C 25.7221 9.7742 0.0 0
M  V30 16 C 28.3894 8.2342 0.0 0
M  V30 17 C 29.7231 7.4642 0.0 0 CFG=2
M  V30 18 O 28.3894 9.7742 0.0 0
M  V30 19 N 31.0569 8.2342 0.0 0
M  V30 20 C 29.7231 5.9242 0.0 0
M  V30 21 C 32.3905 7.4642 0.0 0
M  V30 22 O 33.7242 8.2342 0.0 0
M  V30 23 O 32.3905 5.9242 0.0 0
M  V30 24 C 35.0580 7.4642 0.0 0
M  V30 25 C 34.2880 6.1305 0.0 0
M  V30 26 C 36.3917 6.6942 0.0 0
M  V30 27 C 35.8279 8.7978 0.0 0
M  V30 28 C 9.9476 4.6361 0.0 0 CFG=1
M  V30 29 C 8.4413 4.3159 0.0 0 CFG=2
M  V30 30 C 10.7176 3.3024 0.0 0 CFG=2
M  V30 31 O 10.9782 5.7806 0.0 0
M  V30 32 C 8.2804 2.7844 0.0 0 CFG=2
M  V30 33 C 7.1954 5.2211 0.0 0
M  V30 34 C 9.6872 2.1579 0.0 0
M  V30 35 O 12.2241 3.6226 0.0 0
M  V30 36 C 12.3850 5.1541 0.0 0 CFG=2
M  V30 37 C 6.8734 2.1579 0.0 0 CFG=2
M  V30 38 C 5.7885 4.5947 0.0 0 CFG=2
M  V30 39 C 5.6276 3.0631 0.0 0 CFG=1
M  V30 40 C 6.7125 0.6263 0.0 0
M  V30 41 C 4.2207 2.4368 0.0 0 CFG=2
M  V30 42 C 5.3055 0.0000 0.0 0
M  V30 43 C 4.0597 0.9052 0.0 0
M  V30 44 C 2.9747 3.3420 0.0 0
M  V30 45 C 2.6528 0.2787 0.0 0
M  V30 46 C 1.5679 2.7155 0.0 0
M  V30 47 C 1.4070 1.1840 0.0 0
M  V30 48 C 13.7187 5.9242 0.0 0
M  V30 49 C 15.0525 5.1541 0.0 0
M  V30 50 C 13.7187 7.4642 0.0 0
M  V30 51 C 16.3862 5.9242 0.0 0
M  V30 52 C 15.0525 8.2342 0.0 0
M  V30 53 C 16.3862 7.4642 0.0 0
M  V30 54 C 19.0535 7.4642 0.0 0
M  V30 55 C 20.3873 8.2342 0.0 0
M  V30 56 C 19.0535 5.9242 0.0 0
M  V30 57 C 21.7209 7.4642 0.0 0
M  V30 58 C 20.3873 5.1541 0.0 0
M  V30 59 C 21.7209 5.9242 0.0 0
M  V30 60 H 11.4876 1.9688 0.0 0
M  V30 61 H 8.9312 1.3886 0.0 0
M  V30 62 H 7.8426 0.9611 0.0 0
M  V30 63 H 4.8809 4.4100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 28 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 29 5 CFG=1
M  V30 6 1 38 6 CFG=1
M  V30 7 1 41 7 CFG=1
M  V30 8 1 8 53
M  V30 9 1 8 54
M  V30 10 2 9 47
M  V30 11 1 10 11
M  V30 12 1 10 57
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15 CFG=3
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20 CFG=1
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 29 32
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 1 30 35
M  V30 36 1 30 60 CFG=1
M  V30 37 1 31 36
M  V30 38 1 32 34
M  V30 39 1 32 37
M  V30 40 1 32 61 CFG=3
M  V30 41 1 33 38
M  V30 42 1 35 36
M  V30 43 1 36 48 CFG=3
M  V30 44 1 37 39
M  V30 45 1 37 40
M  V30 46 1 37 62 CFG=1
M  V30 47 1 38 39
M  V30 48 1 39 41
M  V30 49 1 39 63 CFG=3
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 1 41 44
M  V30 53 1 42 43
M  V30 54 2 43 45
M  V30 55 2 44 46
M  V30 56 1 45 47
M  V30 57 1 46 47
M  V30 58 2 48 49
M  V30 59 1 48 50
M  V30 60 1 49 51
M  V30 61 2 50 52
M  V30 62 2 51 53
M  V30 63 1 52 53
M  V30 64 2 54 55
M  V30 65 1 54 56
M  V30 66 1 55 57
M  V30 67 2 56 58
M  V30 68 2 57 59
M  V30 69 1 58 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 12 17 28 29 30 32 36 37 38 39 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27317-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2166375-82-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2345733-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37217821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-48-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug
Conjugate for Subcutaneous Dosing
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hobson, Adrian D.; Xu, Jianwen; Marvin, Christopher C.; McPherson,
Michael J.; Hollmann, Markus; Gattner, Michael; Dzeyk, Kristina; Fettis,
Margaret M.; Bischoff, Agnieszka K.; Wang, Lu; Fitzgibbons, Julia;
Salomon, Paulin; Hernandez, Axel Jr.; Jia, Ying; Sarvaiya, Hetal; Goess,
Christian A.; Mathieu, Suzanne L.; Santora, Ling C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(13), 9161-9173

$RFMT $RIREG SCHEME449 STEP1
$RXN



  2  1
$MOL
1H-Indol-7-amine, 3-[5-fluoro-2-[[2-fluoro-3-(methylsulfonyl)phenyl]amino]-4-...
C19H15F2N5O2S
2241040-29-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.6496 7.5409 0.0 0
M  V30 2 N 0.0000 0.8242 0.0 0
M  V30 3 N 8.9844 4.4609 0.0 0
M  V30 4 F 11.6519 2.9208 0.0 0
M  V30 5 S 14.3192 4.4609 0.0 0 VAL=6
M  V30 6 C 15.6529 3.6908 0.0 0
M  V30 7 O 13.5492 3.1272 0.0 0
M  V30 8 O 15.0893 5.7945 0.0 0
M  V30 9 C 3.6496 4.4609 0.0 0
M  V30 10 C 3.4886 2.9293 0.0 0
M  V30 11 C 2.2428 5.0873 0.0 0
M  V30 12 C 1.9822 2.6091 0.0 0
M  V30 13 C 4.5191 1.7849 0.0 0
M  V30 14 N 1.2122 3.9428 0.0 0
M  V30 15 C 1.5063 1.1444 0.0 0
M  V30 16 C 4.0432 0.3202 0.0 0
M  V30 17 C 2.5367 0.0000 0.0 0
M  V30 18 C 4.9832 5.2309 0.0 0
M  V30 19 N 6.3171 4.4609 0.0 0
M  V30 20 C 4.9832 6.7709 0.0 0
M  V30 21 C 7.6507 5.2309 0.0 0
M  V30 22 C 6.3171 7.5409 0.0 0
M  V30 23 N 7.6507 6.7709 0.0 0
M  V30 24 C 10.3181 5.2309 0.0 0
M  V30 25 C 11.6519 4.4609 0.0 0
M  V30 26 C 10.3181 6.7709 0.0 0
M  V30 27 C 12.9856 5.2309 0.0 0
M  V30 28 C 11.6519 7.5409 0.0 0
M  V30 29 C 12.9856 6.7709 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 3 24
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 5 27
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 18
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazineacetic acid, α-(methoxymethyl)-4-methyl-, hydrochloride (1:2), (αR)-
C9H18N2O3.2ClH
2408851-66-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0 CFG=1
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 5.3348 2.3100 0.0 0
M  V30 4 O 8.0023 3.8501 0.0 0
M  V30 5 O 4.0012 1.5400 0.0 0
M  V30 6 O 6.6685 1.5400 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 C 0.0000 6.9301 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 4.0012 6.1601 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 2.6675 6.9301 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 N 1.3337 6.1601 0.0 0
M  V30 15 Cl 4.6680 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-N-[3-[5-Fluoro-2-[[2-fluoro-3-(methylsulfonyl)phenyl]amino]-4-pyrimidiny...
C28H31F2N7O4S
2241039-81-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 15.5527 3.9920 0.0 0
M  V30 2 C 16.6972 5.0225 0.0 0
M  V30 3 C 18.1618 4.5466 0.0 0 CFG=2
M  V30 4 O 16.3770 6.5288 0.0 0
M  V30 5 C 18.4821 3.0402 0.0 0
M  V30 6 O 19.9467 2.5643 0.0 0
M  V30 7 C 20.2668 1.0580 0.0 0
M  V30 8 F 9.0338 0.0000 0.0 0
M  V30 9 N 5.9537 5.3348 0.0 0
M  V30 10 F 4.4137 8.0023 0.0 0
M  V30 11 S 1.3337 8.0023 0.0 0 VAL=6
M  V30 12 C 0.5636 9.3359 0.0 0
M  V30 13 O 2.6673 8.7723 0.0 0
M  V30 14 O 0.0000 7.2322 0.0 0
M  V30 15 C 22.7396 8.6685 0.0 0
M  V30 16 C 11.4790 3.9133 0.0 0
M  V30 17 C 10.5738 2.6675 0.0 0
M  V30 18 C 12.9436 3.4375 0.0 0
M  V30 19 C 11.1588 5.4196 0.0 0
M  V30 20 C 11.4790 1.4214 0.0 0
M  V30 21 C 14.0881 4.4679 0.0 0
M  V30 22 N 12.9436 1.8975 0.0 0
M  V30 23 C 12.3032 6.4502 0.0 0
M  V30 24 C 13.7679 5.9742 0.0 0
M  V30 25 C 9.0338 2.6675 0.0 0
M  V30 26 N 8.2638 4.0011 0.0 0
M  V30 27 C 8.2638 1.3337 0.0 0
M  V30 28 C 6.7237 4.0011 0.0 0
M  V30 29 C 6.7237 1.3337 0.0 0
M  V30 30 N 5.9537 2.6675 0.0 0
M  V30 31 C 4.4137 5.3348 0.0 0
M  V30 32 C 3.6437 6.6684 0.0 0
M  V30 33 C 3.6437 4.0011 0.0 0
M  V30 34 C 2.1037 6.6684 0.0 0
M  V30 35 C 2.1037 4.0011 0.0 0
M  V30 36 C 1.3337 5.3348 0.0 0
M  V30 37 N 19.3063 5.5770 0.0 0
M  V30 38 C 18.9861 7.0835 0.0 0
M  V30 39 C 20.7709 5.1012 0.0 0
M  V30 40 C 20.1305 8.1139 0.0 0
M  V30 41 C 21.9154 6.1316 0.0 0
M  V30 42 N 21.5952 7.6380 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 3 37
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 27
M  V30 10 1 9 28
M  V30 11 1 9 31
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 11 14
M  V30 16 1 11 34
M  V30 17 1 15 42
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 17 25
M  V30 23 2 18 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2241040-29-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2408851-66-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241039-81-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36772493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical and Scalable Method for Manufacturing AZD4604, A Potent and
Selective JAK1 Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pithani, Subhash; Aurell, Carl-Johan; Lindhagen, Marika; Nunn, Michael;
Berggren, Kristina; Emtenaes, Hans
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(7), 1317-1329

$RFMT $RIREG SCHEME450 STEP1
$RXN



  2  1
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 7-[4-(3-carboxy-1-oxopropyl)-1-piperazinyl]-1-cyc...
C28H28FN3O6
3035080-41-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 8.4702 0.0 0
M  V30 2 C 6.6685 6.9302 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 O 6.6685 8.4702 0.0 0
M  V30 5 C 4.0010 6.9302 0.0 0
M  V30 6 F 14.6708 6.9302 0.0 0
M  V30 7 C 18.6718 1.5400 0.0 0
M  V30 8 C 20.0057 2.3101 0.0 0
M  V30 9 O 18.6718 0.0000 0.0 0
M  V30 10 C 21.3393 1.5400 0.0 0
M  V30 11 C 22.6730 2.3101 0.0 0
M  V30 12 O 24.0067 1.5400 0.0 0
M  V30 13 O 22.6730 3.8501 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 N 9.3358 3.8501 0.0 0
M  V30 16 C 10.6697 6.1601 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 C 12.0033 6.9302 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 8.0022 6.1601 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 9.3358 2.3101 0.0 0
M  V30 25 C 8.5658 0.9764 0.0 0
M  V30 26 C 10.1059 0.9764 0.0 0
M  V30 27 N 14.6708 3.8501 0.0 0
M  V30 28 C 16.0045 4.6201 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 17.3382 3.8501 0.0 0
M  V30 31 C 16.0045 1.5400 0.0 0
M  V30 32 N 17.3382 2.3101 0.0 0
M  V30 33 C 2.6673 6.1601 0.0 0
M  V30 34 C 1.3337 6.9302 0.0 0
M  V30 35 C 2.6673 4.6201 0.0 0
M  V30 36 C 0.0000 6.1601 0.0 0
M  V30 37 C 1.3337 3.8501 0.0 0
M  V30 38 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 5 33
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 32
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 1 21 27
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[1,4-dioxo-4-[(phenylmethyl)am...
C35H35FN4O5
3035080-64-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 0.0000 0.0 0
M  V30 2 C 6.6684 1.5400 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 6.6684 0.0000 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 14.6707 1.5400 0.0 0
M  V30 7 C 18.6718 6.9301 0.0 0
M  V30 8 C 20.0054 6.1601 0.0 0
M  V30 9 O 18.6718 8.4701 0.0 0
M  V30 10 C 21.3391 6.9301 0.0 0
M  V30 11 C 22.6729 6.1601 0.0 0
M  V30 12 N 24.0066 6.9301 0.0 0
M  V30 13 O 22.6729 4.6201 0.0 0
M  V30 14 C 25.3402 6.1601 0.0 0
M  V30 15 C 10.6695 3.8500 0.0 0
M  V30 16 N 9.3359 4.6201 0.0 0
M  V30 17 C 10.6695 2.3100 0.0 0
M  V30 18 C 12.0032 4.6201 0.0 0
M  V30 19 C 8.0022 3.8500 0.0 0
M  V30 20 C 9.3359 1.5400 0.0 0
M  V30 21 C 12.0032 1.5400 0.0 0
M  V30 22 C 13.3370 3.8500 0.0 0
M  V30 23 C 8.0022 2.3100 0.0 0
M  V30 24 C 13.3370 2.3100 0.0 0
M  V30 25 C 9.3359 6.1601 0.0 0
M  V30 26 C 10.1059 7.4937 0.0 0
M  V30 27 C 8.5659 7.4937 0.0 0
M  V30 28 N 14.6707 4.6201 0.0 0
M  V30 29 C 16.0043 3.8500 0.0 0
M  V30 30 C 14.6707 6.1601 0.0 0
M  V30 31 C 17.3381 4.6201 0.0 0
M  V30 32 C 16.0043 6.9301 0.0 0
M  V30 33 N 17.3381 6.1601 0.0 0
M  V30 34 C 2.6675 2.3100 0.0 0
M  V30 35 C 2.6675 3.8500 0.0 0
M  V30 36 C 1.3337 1.5400 0.0 0
M  V30 37 C 1.3337 4.6201 0.0 0
M  V30 38 C 0.0000 2.3100 0.0 0
M  V30 39 C 0.0000 3.8500 0.0 0
M  V30 40 C 26.6739 6.9301 0.0 0
M  V30 41 C 28.0077 6.1601 0.0 0
M  V30 42 C 26.6739 8.4701 0.0 0
M  V30 43 C 29.3413 6.9301 0.0 0
M  V30 44 C 28.0077 9.2401 0.0 0
M  V30 45 C 29.3413 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 23
M  V30 5 1 3 5
M  V30 6 1 5 34
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 33
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 40
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 16 25
M  V30 22 1 17 20
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 2 19 23
M  V30 26 1 20 23
M  V30 27 1 21 24
M  V30 28 2 22 24
M  V30 29 1 22 28
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035080-41-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035080-64-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35625659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 57951-36-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin
Conjugates as Dual Antibacterial and Antibiofilm Agents against
Pseudomonas aeruginosa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yuan-Yuan; Zhang, Xiao-Yi; Zhong, Xiao-Lin; Huang, Yong-Jun; Lin,
Jing; Chen, Wei-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 2169-2193

$RFMT $RIREG SCHEME451 STEP1
$RXN



  2  1
$MOL
(4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,...
C13H14N2O6
1246616-73-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 6.6684 6.1600 0.0 0
M  V30 3 O 9.3358 4.6200 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 O 9.3358 0.0000 0.0 0
M  V30 6 O 10.6694 2.3100 0.0 0
M  V30 7 C 1.3336 6.1600 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 N 5.3347 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 N 2.6673 3.8500 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0 CFG=2
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0 CFG=2
M  V30 19 O 1.3336 1.5400 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 0.0000 2.3100 0.0 0
M  V30 22 H 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 11
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 18 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 1 16 22 CFG=1
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,4-Difluorobenzylamine
C7H7F2N
72235-52-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 F 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dolutegravir sodium
C20H19F2N3O5.Na
1051375-19-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3338 6.9301 0.0 0
M  V30 2 O 2.6675 9.2402 0.0 0
M  V30 3 O 5.3348 10.7802 0.0 0
M  V30 4 C 8.0023 9.2402 0.0 0
M  V30 5 N 9.3360 8.4702 0.0 0
M  V30 6 O 8.0023 10.7802 0.0 0
M  V30 7 C 10.6698 9.2402 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 F 13.3372 10.7802 0.0 0
M  V30 10 F 16.0046 6.1601 0.0 0
M  V30 11 C 4.0012 6.9301 0.0 0
M  V30 12 N 5.3348 6.1601 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 4.0012 8.4702 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 6.6687 6.9301 0.0 0
M  V30 17 N 2.6675 4.6201 0.0 0
M  V30 18 C 5.3348 9.2402 0.0 0
M  V30 19 C 4.0012 3.8501 0.0 0 CFG=2
M  V30 20 C 6.6687 8.4702 0.0 0
M  V30 21 C 1.3338 3.8501 0.0 0 CFG=2
M  V30 22 O 4.0012 2.3100 0.0 0
M  V30 23 C 1.3338 2.3100 0.0 0
M  V30 24 C 2.6675 1.5400 0.0 0
M  V30 25 C 12.0035 8.4702 0.0 0
M  V30 26 C 13.3372 9.2402 0.0 0
M  V30 27 C 12.0035 6.9301 0.0 0
M  V30 28 C 14.6708 8.4702 0.0 0
M  V30 29 C 13.3372 6.1601 0.0 0
M  V30 30 C 14.6708 6.9301 0.0 0
M  V30 31 H 5.3348 3.0800 0.0 0
M  V30 32 Na 8.0023 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 7 25
M  V30 9 1 21 8 CFG=1
M  V30 10 1 9 26
M  V30 11 1 10 30
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 19
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 1 19 22
M  V30 25 1 19 31 CFG=1
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1246616-73-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72235-52-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1051375-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-24091261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus
Integrase Inhibitor Dolutegravir Sodium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dietz, Jule-Philipp; Lucas, Tobias; Gross, Jonathan; Seitel, Sebastian;
Brauer, Jan; Ferenc, Dorota; Gupton, B. Frank; Opatz, Till
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(8), 1898-1910

$RFMT $RIREG SCHEME452 STEP1
$RXN



  2  1
$MOL
1,4-Benzenediamine, 2,5-difluoro-N1-[trans-3-(1-methyl-1H-pyrazol-3-yl)cyclob...
C20H19F2N7
3054862-82-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3348 0.0 0
M  V30 2 F 6.1601 2.6675 0.0 0
M  V30 3 F 0.0000 2.6675 0.0 0
M  V30 4 N 1.5400 0.0000 0.0 0
M  V30 5 C 13.4936 3.6597 0.0 0
M  V30 6 C 3.8500 6.6686 0.0 0
M  V30 7 C 4.6200 8.0022 0.0 0
M  V30 8 N 2.3100 6.6686 0.0 0
M  V30 9 N 3.8500 9.3359 0.0 0
M  V30 10 C 6.1263 8.3224 0.0 0
M  V30 11 C 1.5400 8.0022 0.0 0
M  V30 12 N 4.8805 10.4804 0.0 0
M  V30 13 C 2.3100 9.3359 0.0 0
M  V30 14 C 6.2873 9.8539 0.0 0
M  V30 15 C 6.1601 5.3348 0.0 0 CFG=2
M  V30 16 C 7.2490 6.4237 0.0 0
M  V30 17 C 7.2490 4.2458 0.0 0
M  V30 18 C 8.3379 5.3348 0.0 0 CFG=2
M  V30 19 C 3.8500 4.0011 0.0 0
M  V30 20 C 4.6200 2.6675 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 3.8500 1.3338 0.0 0
M  V30 23 C 1.5400 2.6675 0.0 0
M  V30 24 C 2.3100 1.3338 0.0 0
M  V30 25 C 9.8780 5.3348 0.0 0
M  V30 26 C 10.7832 6.5808 0.0 0
M  V30 27 N 10.7832 4.0889 0.0 0
M  V30 28 C 12.2477 6.1048 0.0 0
M  V30 29 N 12.2477 4.5648 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 15 1 CFG=1
M  V30 3 1 1 19
M  V30 4 1 2 20
M  V30 5 1 3 23
M  V30 6 1 4 24
M  V30 7 1 5 29
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 13
M  V30 17 2 12 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 18 25 CFG=3
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Pyridazinecarboxylic acid, 2-(5-fluoro-2-pyridinyl)-2,3-dihydro-3-oxo-
C10H6FN3O3
3054862-83-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 1.5400 1.3338 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 F 10.7800 4.0011 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 N 3.8500 5.3349 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 5.3349 0.0 0
M  V30 14 N 6.9300 2.6674 0.0 0
M  V30 15 C 8.4700 5.3349 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyridazinecarboxamide, N-[2,5-difluoro-4-[[trans-3-(1-methyl-1H-pyrazol-3-y...
C30H23F3N10O2
3054862-74-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1457 8.8736 0.0 0
M  V30 2 F 7.8130 7.3335 0.0 0
M  V30 3 F 7.8130 13.4936 0.0 0
M  V30 4 N 10.4804 11.9536 0.0 0
M  V30 5 C 11.8141 11.1836 0.0 0
M  V30 6 O 11.8141 9.6436 0.0 0
M  V30 7 C 3.4704 0.0000 0.0 0
M  V30 8 O 14.4814 9.6436 0.0 0
M  V30 9 F 21.1499 8.8736 0.0 0
M  V30 10 C 3.8118 9.6436 0.0 0
M  V30 11 C 2.4782 8.8736 0.0 0
M  V30 12 N 3.8118 11.1836 0.0 0
M  V30 13 N 1.1445 9.6436 0.0 0
M  V30 14 C 2.1580 7.3673 0.0 0
M  V30 15 C 2.4782 11.9536 0.0 0
M  V30 16 N 0.0000 8.6131 0.0 0
M  V30 17 C 1.1445 11.1836 0.0 0
M  V30 18 C 0.6265 7.2063 0.0 0
M  V30 19 C 5.1457 7.3335 0.0 0 CFG=2
M  V30 20 C 6.2346 6.2446 0.0 0
M  V30 21 C 4.0567 6.2446 0.0 0
M  V30 22 C 5.1457 5.1557 0.0 0 CFG=2
M  V30 23 C 6.4793 9.6436 0.0 0
M  V30 24 C 7.8130 8.8736 0.0 0
M  V30 25 C 6.4793 11.1836 0.0 0
M  V30 26 C 9.1466 9.6436 0.0 0
M  V30 27 C 7.8130 11.9536 0.0 0
M  V30 28 C 9.1466 11.1836 0.0 0
M  V30 29 C 5.1457 3.6156 0.0 0
M  V30 30 C 6.3915 2.7104 0.0 0
M  V30 31 N 3.8996 2.7104 0.0 0
M  V30 32 C 5.9157 1.2459 0.0 0
M  V30 33 N 4.3756 1.2459 0.0 0
M  V30 34 C 13.1477 11.9536 0.0 0
M  V30 35 C 14.4814 11.1836 0.0 0
M  V30 36 C 13.1477 13.4936 0.0 0
M  V30 37 N 15.8152 11.9536 0.0 0
M  V30 38 C 14.4814 14.2636 0.0 0
M  V30 39 N 15.8152 13.4936 0.0 0
M  V30 40 C 17.1488 11.1836 0.0 0
M  V30 41 C 18.4825 11.9536 0.0 0
M  V30 42 N 17.1488 9.6436 0.0 0
M  V30 43 C 19.8161 11.1836 0.0 0
M  V30 44 C 18.4825 8.8736 0.0 0
M  V30 45 C 19.8161 9.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 19 1 CFG=1
M  V30 3 1 1 23
M  V30 4 1 2 24
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 1 4 28
M  V30 8 2 5 6
M  V30 9 1 5 34
M  V30 10 1 7 33
M  V30 11 2 8 35
M  V30 12 1 9 45
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 13 17
M  V30 20 1 14 18
M  V30 21 2 15 17
M  V30 22 2 16 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 1 22 29 CFG=3
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 37 40
M  V30 45 2 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3054862-82-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3054862-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3054862-74-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41901045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active
MET Inhibitors with Intracranial Efficacy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bumpers, Quinn A.; Pipal, Robert W.; Benz-Weeden, Anna M.; Brewster,
James T. II; Cook, Adam; Crooks, Amy L.; Cruz, Cole; Dwulet, Natalie C.;
Gaudino, John J.; Golec, Daniel; Harrison, Jacqueline A.; Hartley, Dylan
P.; Hassanien, Sherif H.; Hicken, Erik J.; Kahn, Dean; Laird, Ellen R.;
Lemieux, Christine; Lewandowski, Nicholas; McCown, Joseph; McDonald,
Matthew G.; McNulty, Oren; Mou, Tung-Chung; Nguyen, Phong; Oko, Lauren;
Opie, Lisa Pieti; Otten, Jennifer; Peck, Spencer C.; Polites, Viktor C.;
Randall, Samuel D.; Rosen, Rachel Z.; Savechenkov, Pavel; Simpson, Helen;
Singh, Anurag; Sparks, Drew; Wickersham, Kyle; Wollenberg, Lance; Wong,
Christina E.; Wong, Jim; Wu, Wen-I.; Elsayed, Mohamed S. A.; Hinklin,
Ronald J.; Tang, Tony P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(16), 14466-14477

$RFMT $RIREG SCHEME453 STEP1
$RXN



  2  1
$MOL
5-Bromopicolinic acid
C6H4BrNO2
30766-11-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[(2R,5R)-5-(5-amino-2-fluorophenyl)-5,6-dihydro-2,5-d...
C18H23F4N3O3
2641064-91-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5212 7.2171 0.0 0
M  V30 2 F 4.7189 8.7336 0.0 0
M  V30 3 N 9.1037 4.3668 0.0 0
M  V30 4 C 9.8737 5.7005 0.0 0
M  V30 5 O 11.4137 5.7005 0.0 0
M  V30 6 O 9.1037 7.0343 0.0 0
M  V30 7 C 12.1837 7.0343 0.0 0
M  V30 8 C 10.8501 7.8043 0.0 0
M  V30 9 C 12.9537 8.3679 0.0 0
M  V30 10 C 13.5175 6.2643 0.0 0
M  V30 11 N 0.0000 4.7742 0.0 0
M  V30 12 C 6.5264 1.5166 0.0 0
M  V30 13 F 8.0430 1.2491 0.0 0
M  V30 14 F 6.2589 0.0000 0.0 0
M  V30 15 F 5.0098 1.7839 0.0 0
M  V30 16 C 8.2408 2.5065 0.0 0
M  V30 17 C 5.2537 5.7005 0.0 0 CFG=1
M  V30 18 N 6.7937 5.7005 0.0 0
M  V30 19 C 4.4837 4.3668 0.0 0
M  V30 20 C 7.5637 4.3668 0.0 0
M  V30 21 O 5.2537 3.0332 0.0 0
M  V30 22 C 6.7937 3.0332 0.0 0 CFG=2
M  V30 23 C 3.8066 6.2271 0.0 0
M  V30 24 C 3.5392 7.7439 0.0 0
M  V30 25 C 2.6269 5.2374 0.0 0
M  V30 26 C 2.0921 8.2706 0.0 0
M  V30 27 C 1.1798 5.7641 0.0 0
M  V30 28 C 0.9123 7.2807 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 1 2 24
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 27
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 22 12 CFG=3
M  V30 16 1 22 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23 CFG=1
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[(2R,5R)-5-[5-[[(5-bromo-2-pyridinyl)carbonyl]amino]-...
C24H25BrF4N4O4
2641064-93-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7094 7.2358 0.0 0
M  V30 2 F 8.2360 8.8687 0.0 0
M  V30 3 N 4.6761 3.8066 0.0 0
M  V30 4 C 3.6862 4.9863 0.0 0
M  V30 5 O 2.1696 4.7189 0.0 0
M  V30 6 O 4.2129 6.4335 0.0 0
M  V30 7 C 1.1797 5.8986 0.0 0
M  V30 8 C 0.0000 4.9087 0.0 0
M  V30 9 C 0.1897 7.0784 0.0 0
M  V30 10 C 2.3593 6.8885 0.0 0
M  V30 11 N 13.5708 5.7886 0.0 0
M  V30 12 C 14.9045 6.5587 0.0 0
M  V30 13 O 14.9045 8.0987 0.0 0
M  V30 14 C 7.7094 1.4472 0.0 0
M  V30 15 F 6.2622 0.9205 0.0 0
M  V30 16 F 8.2360 0.0000 0.0 0
M  V30 17 F 9.1565 1.9738 0.0 0
M  V30 18 C 5.8490 2.1243 0.0 0
M  V30 19 Br 20.2393 3.4786 0.0 0
M  V30 20 C 8.2360 5.7886 0.0 0 CFG=1
M  V30 21 N 6.7194 5.5211 0.0 0
M  V30 22 C 9.2260 4.6088 0.0 0
M  V30 23 C 6.1927 4.0740 0.0 0
M  V30 24 O 8.6993 3.1617 0.0 0
M  V30 25 C 7.1827 2.8943 0.0 0 CFG=2
M  V30 26 C 9.5697 6.5587 0.0 0
M  V30 27 C 10.9035 5.7886 0.0 0
M  V30 28 C 9.5697 8.0987 0.0 0
M  V30 29 C 12.2372 6.5587 0.0 0
M  V30 30 C 10.9035 8.8687 0.0 0
M  V30 31 C 12.2372 8.0987 0.0 0
M  V30 32 C 16.2383 5.7886 0.0 0
M  V30 33 C 17.5720 6.5587 0.0 0
M  V30 34 N 16.2383 4.2486 0.0 0
M  V30 35 C 18.9056 5.7886 0.0 0
M  V30 36 C 17.5720 3.4786 0.0 0
M  V30 37 C 18.9056 4.2486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=1
M  V30 2 1 2 28
M  V30 3 1 3 4
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 2 12 13
M  V30 14 1 12 32
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 25 14 CFG=1
M  V30 19 1 25 18 CFG=3
M  V30 20 1 19 37
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 26 CFG=3
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 20 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 30766-11-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2641064-91-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2641064-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23514679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1)
Inhibitor NB-360
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rueeger, Heinrich; Lueoend, Rainer; Machauer, Rainer; Veenstra, Siem J.;
Holzer, Philipp; Hurth, Konstanze; Voegtle, Markus; Frederiksen, Mathias;
Rondeau, Jean-Michel; Tintelnot-Blomley, Marina; Jacobson, Laura H.;
Staufenbiel, Matthias; Laue, Grit; Neumann, Ulf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(8), 4677-4696

$RFMT $RIREG SCHEME454 STEP1
$RXN



  2  1
$MOL
8-[(2,6-Difluorophenyl)methoxy]-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxyl...
C17H14F2N2O3
1609082-37-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0
M  V30 3 C 11.9866 4.5604 0.0 0
M  V30 4 O 13.0170 5.7048 0.0 0
M  V30 5 O 12.4625 3.0957 0.0 0
M  V30 6 C 10.6238 7.6212 0.0 0
M  V30 7 C 8.0021 0.0000 0.0 0
M  V30 8 F 4.0011 6.9300 0.0 0
M  V30 9 F 1.3336 2.3100 0.0 0
M  V30 10 C 8.0021 4.6200 0.0 0
M  V30 11 N 9.3358 3.8500 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 N 8.3223 6.1264 0.0 0
M  V30 14 C 10.4802 4.8806 0.0 0
M  V30 15 C 9.3358 2.3100 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 9.8538 6.2874 0.0 0
M  V30 18 C 8.0021 1.5400 0.0 0
M  V30 19 C 2.6673 4.6200 0.0 0
M  V30 20 C 2.6674 6.1600 0.0 0
M  V30 21 C 1.3336 3.8500 0.0 0
M  V30 22 C 1.3336 6.9300 0.0 0
M  V30 23 C 0.0000 4.6200 0.0 0
M  V30 24 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-(aminomethyl)-1-methylpropyl]carbamate
C13H20N2O2
1609346-13-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.3101 0.0 0 CFG=2
M  V30 2 N 3.6437 3.0801 0.0 0
M  V30 3 C 1.5400 3.6437 0.0 0
M  V30 4 C 0.9764 1.5400 0.0 0
M  V30 5 C 3.0801 0.9764 0.0 0
M  V30 6 C 4.9775 2.3101 0.0 0
M  V30 7 C 0.0000 3.6437 0.0 0
M  V30 8 N 0.9764 0.0000 0.0 0
M  V30 9 O 6.3112 3.0801 0.0 0
M  V30 10 O 4.9775 0.7700 0.0 0
M  V30 11 C 7.6449 2.3101 0.0 0
M  V30 12 C 8.9786 3.0801 0.0 0
M  V30 13 C 8.9786 4.6201 0.0 0
M  V30 14 C 10.3124 2.3101 0.0 0
M  V30 15 C 10.3124 5.3901 0.0 0
M  V30 16 C 11.6460 3.0801 0.0 0
M  V30 17 C 11.6460 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4 CFG=3
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-[[[[8-[(2,6-difluorophenyl)methoxy]-2,6-dimethylimidaz...
C30H32F2N4O4
1609346-15-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5383 3.9646 0.0 0
M  V30 2 C 4.3939 2.9340 0.0 0
M  V30 3 C 12.0573 5.2891 0.0 0
M  V30 4 N 12.8273 6.6228 0.0 0
M  V30 5 O 12.8273 3.9553 0.0 0
M  V30 6 C 14.3673 6.6228 0.0 0
M  V30 7 C 15.1373 7.9564 0.0 0 CFG=2
M  V30 8 N 16.4709 7.1864 0.0 0
M  V30 9 C 15.9073 9.2901 0.0 0
M  V30 10 C 13.8036 8.7264 0.0 0
M  V30 11 C 17.8046 7.9564 0.0 0
M  V30 12 C 15.1373 10.6238 0.0 0
M  V30 13 O 19.1383 7.1864 0.0 0
M  V30 14 O 17.8046 9.4964 0.0 0
M  V30 15 C 20.4720 7.9564 0.0 0
M  V30 16 C 10.0879 7.9995 0.0 0
M  V30 17 C 9.1080 0.0000 0.0 0
M  V30 18 F 3.7536 5.9467 0.0 0
M  V30 19 F 2.1050 0.8732 0.0 0
M  V30 20 C 8.1474 4.5191 0.0 0
M  V30 21 N 9.6121 4.0433 0.0 0
M  V30 22 C 7.0030 3.4886 0.0 0
M  V30 23 N 8.1474 6.0591 0.0 0
M  V30 24 C 10.5173 5.2891 0.0 0
M  V30 25 C 9.9322 2.5368 0.0 0
M  V30 26 C 7.3232 1.9823 0.0 0
M  V30 27 C 9.6121 6.5350 0.0 0
M  V30 28 C 8.7879 1.5064 0.0 0
M  V30 29 C 2.9292 3.4099 0.0 0
M  V30 30 C 2.6091 4.9163 0.0 0
M  V30 31 C 1.7849 2.3795 0.0 0
M  V30 32 C 1.1445 5.3922 0.0 0
M  V30 33 C 0.3202 2.8553 0.0 0
M  V30 34 C 0.0000 4.3617 0.0 0
M  V30 35 C 21.8056 7.1864 0.0 0
M  V30 36 C 21.8056 5.6464 0.0 0
M  V30 37 C 23.1393 7.9564 0.0 0
M  V30 38 C 23.1393 4.8764 0.0 0
M  V30 39 C 24.4731 7.1864 0.0 0
M  V30 40 C 24.4731 5.6464 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 29
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 24
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8 CFG=1
M  V30 10 1 7 9 CFG=3
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 13 15
M  V30 17 1 15 35
M  V30 18 1 16 27
M  V30 19 1 17 28
M  V30 20 1 18 30
M  V30 21 1 19 31
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 27
M  V30 30 2 25 28
M  V30 31 1 26 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1609082-37-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1609346-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1609346-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40577125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine
Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate
Cyclase Stimulator for the Treatment of Resistant Hypertension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vakalopoulos, Alexandros; Wunder, Frank; Hartung, Ingo V.; Redlich,
Gorden; Jautelat, Rolf; Buchgraber, Philipp; Hassfeld, Jorma; Gromov,
Alexey V.; Lindner, Niels; Bierer, Donald; Gries, Joerg; Kroh, Walter;
Paulsen, Holger; Mittendorf, Joachim; Lang, Dieter; Becker-Pelster, Eva;
Brockschnieder, Damian; Geiss, Volker; Li, Volkhart; Straub, Alexander;
Knorr, Andreas; Mondritzki, Thomas; Truebel, Hubert; Raschke, Marian;
Schaefer, Martina; Thomas, Dirk; Sandner, Peter; Stasch, Johannes-Peter;
Follmann, Markus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7280-7303

$RFMT $RIREG SCHEME455 STEP1
$RXN



  2  1
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N6-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lys...
C57H68N2O8SSi
2844372-19-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  69 74 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.0892 4.0012 0.0 0
M  V30 2 S 16.4229 4.7712 0.0 0
M  V30 3 C 16.4229 6.3112 0.0 0
M  V30 4 C 17.7566 7.0812 0.0 0
M  V30 5 C 17.7566 8.6213 0.0 0
M  V30 6 C 19.0904 9.3913 0.0 0
M  V30 7 C 19.0904 10.9313 0.0 0 CFG=2
M  V30 8 O 17.7566 11.7013 0.0 0
M  V30 9 C 20.4241 11.7013 0.0 0
M  V30 10 C 17.7566 13.2414 0.0 0
M  V30 11 C 21.7577 10.9313 0.0 0
M  V30 12 C 16.4229 14.0114 0.0 0 CFG=2
M  V30 13 O 19.0904 14.0114 0.0 0
M  V30 14 O 23.0914 11.7013 0.0 0
M  V30 15 O 21.7577 9.3913 0.0 0
M  V30 16 N 16.4229 15.5514 0.0 0
M  V30 17 C 15.0892 13.2414 0.0 0
M  V30 18 C 24.4252 10.9313 0.0 0
M  V30 19 C 17.7566 16.3214 0.0 0
M  V30 20 C 13.7556 14.0114 0.0 0
M  V30 21 C 25.7589 11.7013 0.0 0
M  V30 22 O 17.7566 17.8615 0.0 0
M  V30 23 O 19.0904 15.5514 0.0 0
M  V30 24 C 12.4218 13.2414 0.0 0
M  V30 25 Si 27.0926 10.9313 0.0 0
M  V30 26 C 19.0904 18.6315 0.0 0
M  V30 27 C 11.0881 14.0114 0.0 0
M  V30 28 C 28.4262 10.1613 0.0 0
M  V30 29 C 26.3226 9.5976 0.0 0
M  V30 30 C 27.8626 12.2651 0.0 0
M  V30 31 C 19.8604 17.2978 0.0 0
M  V30 32 C 20.4241 19.4015 0.0 0
M  V30 33 C 18.3204 19.9653 0.0 0
M  V30 34 N 9.7544 13.2414 0.0 0
M  V30 35 C 8.4208 14.0114 0.0 0
M  V30 36 O 7.0869 13.2414 0.0 0
M  V30 37 O 8.4208 15.5514 0.0 0
M  V30 38 C 5.7533 14.0114 0.0 0
M  V30 39 C 14.3192 5.3350 0.0 0
M  V30 40 C 12.7792 5.3350 0.0 0
M  V30 41 C 15.0892 6.6687 0.0 0
M  V30 42 C 12.0092 6.6687 0.0 0
M  V30 43 C 14.3192 8.0023 0.0 0
M  V30 44 C 12.7792 8.0023 0.0 0
M  V30 45 C 13.7556 3.2311 0.0 0
M  V30 46 C 13.7556 1.6911 0.0 0
M  V30 47 C 12.4218 4.0012 0.0 0
M  V30 48 C 12.4218 0.9211 0.0 0
M  V30 49 C 11.0881 3.2311 0.0 0
M  V30 50 C 11.0881 1.6911 0.0 0
M  V30 51 C 15.8593 2.6675 0.0 0
M  V30 52 C 17.3993 2.6675 0.0 0
M  V30 53 C 15.0892 1.3338 0.0 0
M  V30 54 C 18.1693 1.3338 0.0 0
M  V30 55 C 15.8593 0.0000 0.0 0
M  V30 56 C 17.3993 0.0000 0.0 0
M  V30 57 C 4.4196 13.2414 0.0 0
M  V30 58 C 4.2587 11.7098 0.0 0
M  V30 59 C 3.0126 13.8678 0.0 0
M  V30 60 C 2.7522 11.3896 0.0 0
M  V30 61 C 5.2891 10.5654 0.0 0
M  V30 62 C 1.9822 12.7233 0.0 0
M  V30 63 C 2.5367 15.3324 0.0 0
M  V30 64 C 2.2763 9.9249 0.0 0
M  V30 65 C 4.8132 9.1007 0.0 0
M  V30 66 C 0.4759 13.0435 0.0 0
M  V30 67 C 1.0304 15.6526 0.0 0
M  V30 68 C 3.3068 8.7805 0.0 0
M  V30 69 C 0.0000 14.5082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 39
M  V30 3 1 1 45
M  V30 4 1 1 51
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 7 9 CFG=1
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 2 11 15
M  V30 18 1 12 16 CFG=3
M  V30 19 1 12 17
M  V30 20 1 14 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 1 25 29
M  V30 32 1 25 30
M  V30 33 1 26 31
M  V30 34 1 26 32
M  V30 35 1 26 33
M  V30 36 1 27 34
M  V30 37 1 34 35
M  V30 38 1 35 36
M  V30 39 2 35 37
M  V30 40 1 36 38
M  V30 41 1 38 57
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 48 2 45 46
M  V30 49 1 45 47
M  V30 50 1 46 48
M  V30 51 2 47 49
M  V30 52 2 48 50
M  V30 53 1 49 50
M  V30 54 2 51 52
M  V30 55 1 51 53
M  V30 56 1 52 54
M  V30 57 2 53 55
M  V30 58 2 54 56
M  V30 59 1 55 56
M  V30 60 1 57 58
M  V30 61 1 57 59
M  V30 62 1 58 60
M  V30 63 2 58 61
M  V30 64 1 59 62
M  V30 65 2 59 63
M  V30 66 1 60 62
M  V30 67 2 60 64
M  V30 68 1 61 65
M  V30 69 2 62 66
M  V30 70 1 63 67
M  V30 71 1 64 68
M  V30 72 2 65 68
M  V30 73 1 66 69
M  V30 74 2 67 69
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 2-[[[2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-thiaz...
C14H19N3O5S
1370372-48-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.8286 0.0 0
M  V30 2 N 4.0010 4.0586 0.0 0
M  V30 3 O 5.3348 6.3687 0.0 0
M  V30 4 C 2.6673 4.8286 0.0 0
M  V30 5 C 1.3337 4.0586 0.0 0
M  V30 6 C 2.6673 6.3687 0.0 0
M  V30 7 O 0.0000 4.8286 0.0 0
M  V30 8 O 1.3337 2.5186 0.0 0
M  V30 9 C 4.0010 7.1387 0.0 0
M  V30 10 C 10.6375 3.7015 0.0 0
M  V30 11 N 11.5427 2.4556 0.0 0
M  V30 12 C 13.0743 2.6165 0.0 0
M  V30 13 O 13.9795 1.3706 0.0 0
M  V30 14 O 13.7006 4.0235 0.0 0
M  V30 15 C 15.5111 1.5316 0.0 0
M  V30 16 C 15.3501 3.0633 0.0 0
M  V30 17 C 17.0426 1.6927 0.0 0
M  V30 18 C 15.6720 0.0000 0.0 0
M  V30 19 C 6.6685 4.0586 0.0 0
M  V30 20 N 8.0753 4.6849 0.0 0
M  V30 21 C 6.8294 2.5270 0.0 0
M  V30 22 C 9.1059 3.5405 0.0 0
M  V30 23 S 8.3359 2.2069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(2Z)-2-[[[2-[[[(1,1-Dimethylethoxy)carbonyl]amino]methyl]-4-thiazolyl]car...
C66H77N5O10S2Si
2844372-20-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  84 90 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 15.1513 0.0 0
M  V30 2 S 6.1601 15.1513 0.0 0
M  V30 3 C 6.9301 16.4851 0.0 0
M  V30 4 C 8.4702 16.4851 0.0 0
M  V30 5 C 9.2402 17.8188 0.0 0
M  V30 6 C 10.7802 17.8188 0.0 0
M  V30 7 C 11.5502 19.1524 0.0 0 CFG=2
M  V30 8 O 13.0902 19.1524 0.0 0
M  V30 9 C 10.7802 20.4861 0.0 0
M  V30 10 C 13.8603 17.8188 0.0 0
M  V30 11 C 11.5502 21.8199 0.0 0
M  V30 12 C 15.4003 17.8188 0.0 0 CFG=2
M  V30 13 O 13.0902 16.4851 0.0 0
M  V30 14 O 10.7802 23.1536 0.0 0
M  V30 15 O 13.0902 21.8199 0.0 0
M  V30 16 N 16.1703 16.4851 0.0 0
M  V30 17 C 16.1703 19.1524 0.0 0
M  V30 18 C 11.5502 24.4872 0.0 0
M  V30 19 C 15.4003 15.1513 0.0 0
M  V30 20 C 17.7103 19.1524 0.0 0
M  V30 21 C 10.7802 25.8209 0.0 0
M  V30 22 C 16.1703 13.8176 0.0 0
M  V30 23 O 13.8603 15.1513 0.0 0
M  V30 24 C 18.4803 20.4861 0.0 0
M  V30 25 Si 11.5502 27.1547 0.0 0
M  V30 26 N 15.4003 12.4839 0.0 0
M  V30 27 C 17.7103 13.8176 0.0 0
M  V30 28 C 20.0204 20.4861 0.0 0
M  V30 29 C 12.3202 28.4884 0.0 0
M  V30 30 C 10.2166 27.9247 0.0 0
M  V30 31 C 12.8839 26.3847 0.0 0
M  V30 32 C 16.1703 11.1503 0.0 0
M  V30 33 C 18.4803 12.4839 0.0 0
M  V30 34 N 20.7904 19.1524 0.0 0
M  V30 35 O 17.7103 11.1503 0.0 0
M  V30 36 C 22.3304 19.1524 0.0 0
M  V30 37 O 23.1004 20.4861 0.0 0
M  V30 38 O 23.1004 17.8188 0.0 0
M  V30 39 C 24.6405 20.4861 0.0 0
M  V30 40 C 15.0432 5.8475 0.0 0
M  V30 41 N 16.4500 5.2212 0.0 0
M  V30 42 C 16.6111 3.6896 0.0 0
M  V30 43 O 18.0179 3.0631 0.0 0
M  V30 44 O 15.3652 2.7844 0.0 0
M  V30 45 C 18.1788 1.5316 0.0 0
M  V30 46 C 19.7105 1.6926 0.0 0
M  V30 47 C 18.3399 0.0000 0.0 0
M  V30 48 C 16.6473 1.3706 0.0 0
M  V30 49 C 4.6201 13.6112 0.0 0
M  V30 50 C 5.9538 12.8412 0.0 0
M  V30 51 C 3.2864 12.8412 0.0 0
M  V30 52 C 5.9538 11.3012 0.0 0
M  V30 53 C 3.2864 11.3012 0.0 0
M  V30 54 C 4.6201 10.5312 0.0 0
M  V30 55 C 3.0801 15.1513 0.0 0
M  V30 56 C 2.3100 13.8176 0.0 0
M  V30 57 C 2.3100 16.4851 0.0 0
M  V30 58 C 0.7700 13.8176 0.0 0
M  V30 59 C 0.7700 16.4851 0.0 0
M  V30 60 C 0.0000 15.1513 0.0 0
M  V30 61 C 4.6201 16.6913 0.0 0
M  V30 62 C 3.2864 17.4613 0.0 0
M  V30 63 C 5.9538 17.4613 0.0 0
M  V30 64 C 3.2864 19.0013 0.0 0
M  V30 65 C 5.9538 19.0013 0.0 0
M  V30 66 C 4.6201 19.7714 0.0 0
M  V30 67 C 15.4003 9.8165 0.0 0
M  V30 68 N 16.0266 8.4096 0.0 0
M  V30 69 C 13.8687 9.6555 0.0 0
M  V30 70 C 14.8822 7.3792 0.0 0
M  V30 71 S 13.5484 8.1492 0.0 0
M  V30 72 C 25.4105 21.8199 0.0 0
M  V30 73 C 26.9420 21.9808 0.0 0
M  V30 74 C 24.7840 23.2267 0.0 0
M  V30 75 C 27.2622 23.4871 0.0 0
M  V30 76 C 28.0864 20.9504 0.0 0
M  V30 77 C 25.9285 24.2571 0.0 0
M  V30 78 C 23.3194 23.7026 0.0 0
M  V30 79 C 28.7269 23.9632 0.0 0
M  V30 80 C 29.5512 21.4263 0.0 0
M  V30 81 C 25.6084 25.7636 0.0 0
M  V30 82 C 22.9993 25.2090 0.0 0
M  V30 83 C 29.8713 22.9326 0.0 0
M  V30 84 C 24.1437 26.2395 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 49
M  V30 3 1 1 55
M  V30 4 1 1 61
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 2 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 7 9 CFG=3
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 2 11 15
M  V30 18 1 12 16
M  V30 19 1 12 17 CFG=3
M  V30 20 1 14 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 2 22 27
M  V30 30 1 24 28
M  V30 31 1 25 29
M  V30 32 1 25 30
M  V30 33 1 25 31
M  V30 34 1 26 32
M  V30 35 1 27 33
M  V30 36 1 28 34
M  V30 37 2 32 35
M  V30 38 1 32 67
M  V30 39 1 34 36
M  V30 40 1 36 37
M  V30 41 2 36 38
M  V30 42 1 37 39
M  V30 43 1 39 72
M  V30 44 1 40 41
M  V30 45 1 40 70
M  V30 46 1 41 42
M  V30 47 1 42 43
M  V30 48 2 42 44
M  V30 49 1 43 45
M  V30 50 1 45 46
M  V30 51 1 45 47
M  V30 52 1 45 48
M  V30 53 2 49 50
M  V30 54 1 49 51
M  V30 55 1 50 52
M  V30 56 2 51 53
M  V30 57 2 52 54
M  V30 58 1 53 54
M  V30 59 2 55 56
M  V30 60 1 55 57
M  V30 61 1 56 58
M  V30 62 2 57 59
M  V30 63 2 58 60
M  V30 64 1 59 60
M  V30 65 2 61 62
M  V30 66 1 61 63
M  V30 67 1 62 64
M  V30 68 2 63 65
M  V30 69 2 64 66
M  V30 70 1 65 66
M  V30 71 1 67 68
M  V30 72 2 67 69
M  V30 73 2 68 70
M  V30 74 1 69 71
M  V30 75 1 70 71
M  V30 76 1 72 73
M  V30 77 1 72 74
M  V30 78 1 73 75
M  V30 79 2 73 76
M  V30 80 1 74 77
M  V30 81 2 74 78
M  V30 82 1 75 77
M  V30 83 2 75 79
M  V30 84 1 76 80
M  V30 85 2 77 81
M  V30 86 1 78 82
M  V30 87 1 79 83
M  V30 88 2 80 83
M  V30 89 1 81 84
M  V30 90 2 82 84
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2844372-19-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1370372-48-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2844372-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34709092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC)
Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in
Triple-Negative Breast Cancer (TNBC)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Kuojun; Liu, Zhiyi; Yao, Yiwu; Qiu, Yatao; Li, Feng; Chen, Dong;
Hamilton, Dale J.; Li, Zheng; Jiang, Sheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(7), 4020-4033

$RFMT $RIREG SCHEME456 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[(2R,5R)-5-(5-amino-2-fluorophenyl)-5,6-dihydro-2,5-dimet...
C18H23F4N3O3
1262859-70-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5212 7.2171 0.0 0
M  V30 2 F 4.7189 8.7336 0.0 0
M  V30 3 N 9.1037 4.3668 0.0 0
M  V30 4 C 9.8737 5.7005 0.0 0
M  V30 5 O 11.4137 5.7005 0.0 0
M  V30 6 O 9.1037 7.0343 0.0 0
M  V30 7 C 12.1837 7.0343 0.0 0
M  V30 8 C 10.8501 7.8043 0.0 0
M  V30 9 C 12.9537 8.3679 0.0 0
M  V30 10 C 13.5175 6.2643 0.0 0
M  V30 11 N 0.0000 4.7742 0.0 0
M  V30 12 C 6.5264 1.5166 0.0 0
M  V30 13 F 8.0430 1.2491 0.0 0
M  V30 14 F 6.2589 0.0000 0.0 0
M  V30 15 F 5.0098 1.7839 0.0 0
M  V30 16 C 8.2408 2.5065 0.0 0
M  V30 17 C 5.2537 5.7005 0.0 0 CFG=1
M  V30 18 N 6.7937 5.7005 0.0 0
M  V30 19 C 4.4837 4.3668 0.0 0
M  V30 20 C 7.5637 4.3668 0.0 0
M  V30 21 O 5.2537 3.0332 0.0 0
M  V30 22 C 6.7937 3.0332 0.0 0 CFG=2
M  V30 23 C 3.8066 6.2271 0.0 0
M  V30 24 C 3.5392 7.7439 0.0 0
M  V30 25 C 2.6269 5.2374 0.0 0
M  V30 26 C 2.0921 8.2706 0.0 0
M  V30 27 C 1.1798 5.7641 0.0 0
M  V30 28 C 0.9123 7.2807 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 1 2 24
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 27
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 22 12 CFG=3
M  V30 16 1 22 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23 CFG=1
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Cyano-3-methylpicolinic acid
C8H6N2O2
1262860-49-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 N 8.4702 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 N 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2R,5R)-5-[5-[[(5-cyano-3-methyl-2-pyridinyl)carbonyl]am...
C26H27F4N5O4
1262859-72-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7094 7.2357 0.0 0
M  V30 2 F 8.2361 8.8686 0.0 0
M  V30 3 N 4.6762 3.8066 0.0 0
M  V30 4 C 3.6863 4.9862 0.0 0
M  V30 5 O 2.1697 4.7189 0.0 0
M  V30 6 O 4.2130 6.4334 0.0 0
M  V30 7 C 1.1798 5.8985 0.0 0
M  V30 8 C 0.0000 4.9086 0.0 0
M  V30 9 C 0.1899 7.0783 0.0 0
M  V30 10 C 2.3594 6.8884 0.0 0
M  V30 11 N 13.5708 5.7886 0.0 0
M  V30 12 C 14.9044 6.5586 0.0 0
M  V30 13 O 14.9044 8.0986 0.0 0
M  V30 14 C 7.7094 1.4471 0.0 0
M  V30 15 F 9.1565 1.9738 0.0 0
M  V30 16 F 8.2361 0.0000 0.0 0
M  V30 17 F 6.2623 0.9205 0.0 0
M  V30 18 C 5.8489 2.1243 0.0 0
M  V30 19 C 17.5719 8.0986 0.0 0
M  V30 20 C 20.2391 3.4786 0.0 0
M  V30 21 N 21.5729 2.7086 0.0 0
M  V30 22 C 8.2361 5.7886 0.0 0 CFG=1
M  V30 23 N 6.7195 5.5211 0.0 0
M  V30 24 C 9.2260 4.6088 0.0 0
M  V30 25 C 6.1928 4.0739 0.0 0
M  V30 26 O 8.6993 3.1616 0.0 0
M  V30 27 C 7.1827 2.8943 0.0 0 CFG=2
M  V30 28 C 9.5697 6.5586 0.0 0
M  V30 29 C 10.9035 5.7886 0.0 0
M  V30 30 C 9.5697 8.0986 0.0 0
M  V30 31 C 12.2371 6.5586 0.0 0
M  V30 32 C 10.9035 8.8686 0.0 0
M  V30 33 C 12.2371 8.0986 0.0 0
M  V30 34 C 16.2382 5.7886 0.0 0
M  V30 35 C 17.5719 6.5586 0.0 0
M  V30 36 N 16.2382 4.2486 0.0 0
M  V30 37 C 18.9055 5.7886 0.0 0
M  V30 38 C 17.5719 3.4786 0.0 0
M  V30 39 C 18.9055 4.2486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 22 1 CFG=1
M  V30 2 1 2 30
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 31
M  V30 13 2 12 13
M  V30 14 1 12 34
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 27 14 CFG=1
M  V30 19 1 27 18 CFG=3
M  V30 20 1 19 35
M  V30 21 3 20 21
M  V30 22 1 20 39
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 28 CFG=3
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1262859-70-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262860-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262859-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23517437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1)
Inhibitor NB-360
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rueeger, Heinrich; Lueoend, Rainer; Machauer, Rainer; Veenstra, Siem J.;
Holzer, Philipp; Hurth, Konstanze; Voegtle, Markus; Frederiksen, Mathias;
Rondeau, Jean-Michel; Tintelnot-Blomley, Marina; Jacobson, Laura H.;
Staufenbiel, Matthias; Laue, Grit; Neumann, Ulf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(8), 4677-4696

$RFMT $RIREG SCHEME457 STEP1
$RXN



  3  1
$MOL
4-Methyl-2-phenyl-5-thiazolecarboxylic acid
C11H9NO2S
33763-20-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4068 1.5315 0.0 0
M  V30 2 O 0.0000 2.1578 0.0 0
M  V30 3 O 1.5679 0.0000 0.0 0
M  V30 4 C 1.4068 4.8818 0.0 0
M  V30 5 C 5.0226 3.2067 0.0 0
M  V30 6 S 4.1173 1.9607 0.0 0
M  V30 7 N 4.1173 4.4526 0.0 0
M  V30 8 C 2.6528 2.4367 0.0 0
M  V30 9 C 2.6528 3.9767 0.0 0
M  V30 10 C 6.5626 3.2067 0.0 0
M  V30 11 C 7.3326 4.5404 0.0 0
M  V30 12 C 7.3326 1.8729 0.0 0
M  V30 13 C 8.8726 4.5404 0.0 0
M  V30 14 C 8.8726 1.8729 0.0 0
M  V30 15 C 9.6426 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(7-methoxy-6-nitro-4-quinazolinyl)oxy]benzenamine
C15H11FN4O4
2761180-24-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 F 9.2400 0.0000 0.0 0
M  V30 8 N 13.8600 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 6.6685 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 10.0100 1.3338 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 1.3338 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 24 C 12.3200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 20
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-Crotonyl chloride
C4H5ClO
625-35-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 1.3338 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Thiazolecarboxamide, N-[3-fluoro-4-[[7-methoxy-6-[[(2E)-1-oxo-2-buten-1-yl]...
C30H24FN5O4S
3020728-65-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 6.1601 0.0 0
M  V30 2 N 4.0011 4.6201 0.0 0
M  V30 3 C 4.0011 6.1601 0.0 0
M  V30 4 C 2.6675 6.9301 0.0 0
M  V30 5 O 5.3348 6.9301 0.0 0
M  V30 6 C 1.3338 6.1601 0.0 0
M  V30 7 C 0.0000 6.9301 0.0 0
M  V30 8 O 4.0011 1.5400 0.0 0
M  V30 9 C 4.0011 0.0000 0.0 0
M  V30 10 F 9.3359 9.2401 0.0 0
M  V30 11 N 14.6707 9.2401 0.0 0
M  V30 12 C 14.6707 10.7802 0.0 0
M  V30 13 O 13.3371 11.5502 0.0 0
M  V30 14 C 15.0209 14.1122 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 8.0023 2.3100 0.0 0
M  V30 17 C 9.3359 4.6201 0.0 0
M  V30 18 C 6.6686 4.6201 0.0 0
M  V30 19 C 6.6686 1.5400 0.0 0
M  V30 20 N 9.3359 1.5400 0.0 0
M  V30 21 N 10.6696 3.8501 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 23 C 5.3348 2.3100 0.0 0
M  V30 24 C 10.6696 2.3100 0.0 0
M  V30 25 C 10.6696 6.9301 0.0 0
M  V30 26 C 10.6696 8.4701 0.0 0
M  V30 27 C 12.0034 6.1601 0.0 0
M  V30 28 C 12.0034 9.2401 0.0 0
M  V30 29 C 13.3371 6.9301 0.0 0
M  V30 30 C 13.3371 8.4701 0.0 0
M  V30 31 C 16.0044 11.5502 0.0 0
M  V30 32 S 17.4114 10.9237 0.0 0
M  V30 33 C 16.1655 13.0817 0.0 0
M  V30 34 C 18.4418 12.0682 0.0 0
M  V30 35 N 17.6718 13.4019 0.0 0
M  V30 36 C 19.9733 11.9073 0.0 0
M  V30 37 C 20.5998 10.5003 0.0 0
M  V30 38 C 20.8786 13.1532 0.0 0
M  V30 39 C 22.1314 10.3394 0.0 0
M  V30 40 C 22.4101 12.9921 0.0 0
M  V30 41 C 23.0366 11.5853 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 23
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 30
M  V30 14 2 12 13
M  V30 15 1 12 31
M  V30 16 1 14 33
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 1 21 24
M  V30 27 1 22 23
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 33763-20-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761180-24-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 625-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020728-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38556017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solution from stage 1 and 2 prepared separately and added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met
inhibitors for the treatment of NSCLC
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Sheng; Sun, Chuanchuan; He, Xintao; Gan, Wenhui; Wang, Linxiao;
Qiao, Dan; Guan, Xinyu; Xu, Shan; Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 263115939

$RFMT $RIREG SCHEME458 STEP1
$RXN



  2  1
$MOL
Bicyclo[2.2.2]octane-1-carboxylic acid, 4-[1-butyl-3-[(2,4-dimethoxyphenyl)me...
C27H34N4O6
3032112-39-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.0123 11.6002 0.0 0
M  V30 2 O 17.0123 13.1402 0.0 0
M  V30 3 O 18.3460 10.8302 0.0 0
M  V30 4 C 6.9301 9.3359 0.0 0
M  V30 5 O 10.0101 4.0010 0.0 0
M  V30 6 O 5.3901 6.6684 0.0 0
M  V30 7 C 6.9301 4.0010 0.0 0
M  V30 8 C 7.7001 2.6673 0.0 0
M  V30 9 C 6.9301 1.3337 0.0 0
M  V30 10 C 7.7001 0.0000 0.0 0
M  V30 11 O 5.3901 12.0032 0.0 0
M  V30 12 C 4.6201 13.3369 0.0 0
M  V30 13 O 0.7700 9.3359 0.0 0
M  V30 14 C 0.0000 10.6696 0.0 0
M  V30 15 C 13.0112 9.2902 0.0 0
M  V30 16 C 13.0107 10.8311 0.0 0
M  V30 17 C 14.3455 8.5192 0.0 0
M  V30 18 C 14.1382 9.2888 0.0 0
M  V30 19 C 14.3444 11.6011 0.0 0
M  V30 20 C 15.6791 9.2893 0.0 0
M  V30 21 C 15.1162 9.8535 0.0 0
M  V30 22 C 15.6785 10.8302 0.0 0
M  V30 23 C 11.6775 8.5202 0.0 0
M  V30 24 N 10.2706 9.1467 0.0 0
M  V30 25 N 11.5164 6.9886 0.0 0
M  V30 26 C 9.2401 8.0021 0.0 0
M  V30 27 C 10.0101 6.6684 0.0 0
M  V30 28 N 7.7001 8.0021 0.0 0
M  V30 29 C 9.2401 5.3348 0.0 0
M  V30 30 C 6.9301 6.6684 0.0 0
M  V30 31 N 7.7001 5.3348 0.0 0
M  V30 32 C 5.3901 9.3359 0.0 0
M  V30 33 C 4.6201 10.6696 0.0 0
M  V30 34 C 4.6201 8.0021 0.0 0
M  V30 35 C 3.0800 10.6696 0.0 0
M  V30 36 C 3.0800 8.0021 0.0 0
M  V30 37 C 2.3100 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 4 28
M  V30 5 1 4 32
M  V30 6 2 5 29
M  V30 7 2 6 30
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 33
M  V30 14 1 13 14
M  V30 15 1 13 37
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 23
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Azidopropan-1-amine
C3H8N4
88192-19-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 N 2.6675 1.5400 0.0 0
M  V30 4 C 6.6687 0.7700 0.0 0
M  V30 5 N 1.3337 0.7700 0.0 0 CHG=1 VAL=4
M  V30 6 N 8.0023 1.5400 0.0 0
M  V30 7 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.2]octane-1-carboxamide, N-(3-azidopropyl)-4-[1-butyl-3-[(2,4-dime...
C30H40N8O5
2972951-72-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.0124 11.6003 0.0 0
M  V30 2 N 18.3461 10.8303 0.0 0
M  V30 3 O 17.0124 13.1403 0.0 0
M  V30 4 C 19.6799 11.6003 0.0 0
M  V30 5 C 21.0136 10.8303 0.0 0
M  V30 6 C 22.3473 11.6003 0.0 0
M  V30 7 N 23.6809 10.8303 0.0 0
M  V30 8 N 25.0148 11.6003 0.0 0 CHG=1 VAL=4
M  V30 9 N 26.3484 12.3703 0.0 0 CHG=-1
M  V30 10 C 6.9302 9.3360 0.0 0
M  V30 11 O 10.0102 4.0010 0.0 0
M  V30 12 O 5.3901 6.6685 0.0 0
M  V30 13 C 6.9302 4.0010 0.0 0
M  V30 14 C 7.7002 2.6673 0.0 0
M  V30 15 C 6.9302 1.3337 0.0 0
M  V30 16 C 7.7002 0.0000 0.0 0
M  V30 17 O 5.3901 12.0033 0.0 0
M  V30 18 C 4.6201 13.3370 0.0 0
M  V30 19 O 0.7700 9.3360 0.0 0
M  V30 20 C 0.0000 10.6697 0.0 0
M  V30 21 C 13.0113 9.2903 0.0 0
M  V30 22 C 13.0108 10.8312 0.0 0
M  V30 23 C 14.3456 8.5193 0.0 0
M  V30 24 C 14.1383 9.2889 0.0 0
M  V30 25 C 14.3445 11.6012 0.0 0
M  V30 26 C 15.6792 9.2893 0.0 0
M  V30 27 C 15.1165 9.8536 0.0 0
M  V30 28 C 15.6788 10.8303 0.0 0
M  V30 29 C 11.6776 8.5202 0.0 0
M  V30 30 N 10.2708 9.1467 0.0 0
M  V30 31 N 11.5167 6.9887 0.0 0
M  V30 32 C 9.2402 8.0022 0.0 0
M  V30 33 C 10.0102 6.6685 0.0 0
M  V30 34 N 7.7002 8.0022 0.0 0
M  V30 35 C 9.2402 5.3348 0.0 0
M  V30 36 C 6.9302 6.6685 0.0 0
M  V30 37 N 7.7002 5.3348 0.0 0
M  V30 38 C 5.3901 9.3360 0.0 0
M  V30 39 C 4.6201 10.6697 0.0 0
M  V30 40 C 4.6201 8.0022 0.0 0
M  V30 41 C 3.0801 10.6697 0.0 0
M  V30 42 C 3.0801 8.0022 0.0 0
M  V30 43 C 2.3100 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 28
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 2 8 9
M  V30 10 1 10 34
M  V30 11 1 10 38
M  V30 12 2 11 35
M  V30 13 2 12 36
M  V30 14 1 13 14
M  V30 15 1 13 37
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 39
M  V30 20 1 19 20
M  V30 21 1 19 43
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 21 29
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032112-39-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88192-19-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2972951-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40275713
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Covalent, Clickable Probes for Adenosine A1 and A3
Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trinh, Phuc N. H.; Chong, Daniel J. W.; Leach, Katie; Hill, Stephen J.;
Tyndall, Joel D. A.; May, Lauren T.; Vernall, Andrea J.; Gregory, Karen
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(12), 8161-8178

$RFMT $RIREG SCHEME459 STEP1
$RXN



  2  1
$MOL

C30H31N3O6
3061506-83-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 6.6685 0.0 0
M  V30 2 O 6.7709 6.6685 0.0 0
M  V30 3 C 7.5409 5.3348 0.0 0
M  V30 4 N 9.0809 5.3348 0.0 0
M  V30 5 O 6.7709 4.0011 0.0 0
M  V30 6 C 9.8509 4.0011 0.0 0 CFG=1
M  V30 7 C 11.3910 4.0011 0.0 0
M  V30 8 C 9.0809 2.6675 0.0 0
M  V30 9 N 12.1610 2.6675 0.0 0
M  V30 10 O 12.1610 5.3348 0.0 0
M  V30 11 C 13.7010 2.6675 0.0 0 CFG=1
M  V30 12 C 14.4710 4.0011 0.0 0
M  V30 13 C 14.4710 1.3337 0.0 0
M  V30 14 C 16.0111 4.0011 0.0 0
M  V30 15 N 16.0111 1.3337 0.0 0
M  V30 16 O 13.7010 0.0000 0.0 0
M  V30 17 C 16.7811 5.3348 0.0 0
M  V30 18 O 18.3211 5.3348 0.0 0
M  V30 19 O 16.0111 6.6685 0.0 0
M  V30 20 C 19.0911 6.6685 0.0 0
M  V30 21 C 4.4608 8.0023 0.0 0
M  V30 22 C 5.0873 9.4091 0.0 0
M  V30 23 C 2.9293 8.1632 0.0 0
M  V30 24 C 3.9428 10.4395 0.0 0
M  V30 25 C 6.5519 9.8850 0.0 0
M  V30 26 C 2.6091 9.6695 0.0 0
M  V30 27 C 1.7849 7.1328 0.0 0
M  V30 28 C 4.2630 11.9460 0.0 0
M  V30 29 C 6.8721 11.3914 0.0 0
M  V30 30 C 1.1444 10.1454 0.0 0
M  V30 31 C 0.3202 7.6087 0.0 0
M  V30 32 C 5.7277 12.4219 0.0 0
M  V30 33 C 0.0000 9.1150 0.0 0
M  V30 34 C 20.6312 6.6685 0.0 0
M  V30 35 C 21.4012 8.0023 0.0 0
M  V30 36 C 21.4012 5.3348 0.0 0
M  V30 37 C 22.9412 8.0023 0.0 0
M  V30 38 C 22.9412 5.3348 0.0 0
M  V30 39 C 23.7112 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 34
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 2 23 27
M  V30 28 1 24 26
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 2 26 30
M  V30 32 1 27 31
M  V30 33 1 28 32
M  V30 34 2 29 32
M  V30 35 1 30 33
M  V30 36 2 31 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C20H26N4O8
3061506-85-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 2.6674 0.0 0 CFG=2
M  V30 3 C 6.9300 1.3336 0.0 0
M  V30 4 C 9.2400 2.6674 0.0 0
M  V30 5 O 5.3900 1.3336 0.0 0
M  V30 6 O 7.7000 0.0000 0.0 0
M  V30 7 N 10.0100 4.0011 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 C 12.3200 5.3347 0.0 0
M  V30 10 O 12.3200 2.6674 0.0 0
M  V30 11 O 11.5500 6.6684 0.0 0
M  V30 12 C 12.3200 8.0021 0.0 0
M  V30 13 C 13.8600 8.0021 0.0 0
M  V30 14 N 14.6300 9.3358 0.0 0
M  V30 15 N 16.1700 9.3358 0.0 0 CHG=1 VAL=4
M  V30 16 N 17.7100 9.3358 0.0 0 CHG=-1
M  V30 17 C 7.7000 5.3347 0.0 0 CFG=2
M  V30 18 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 19 C 9.2400 5.3347 0.0 0 CFG=1
M  V30 20 C 7.7000 8.0021 0.0 0 CFG=1
M  V30 21 O 5.3900 6.6684 0.0 0
M  V30 22 C 10.0100 6.6684 0.0 0 CFG=2
M  V30 23 O 9.2400 8.0021 0.0 0
M  V30 24 C 6.9300 9.3358 0.0 0
M  V30 25 C 4.6200 8.0021 0.0 0 CFG=3
M  V30 26 O 5.3900 9.3358 0.0 0
M  V30 27 C 3.0800 8.0021 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 0.7700 6.6684 0.0 0
M  V30 31 C 0.7700 9.3358 0.0 0
M  V30 32 C 0.0000 8.0021 0.0 0
M  V30 33 H 6.1600 5.3347 0.0 0
M  V30 34 H 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 19 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 22 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 2 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 33 CFG=1
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 34 CFG=3
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 17 18 19 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C35H45N7O11
3061506-84-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 12.0033 0.0 0
M  V30 2 C 9.2402 12.0033 0.0 0 CFG=2
M  V30 3 C 10.0102 13.3372 0.0 0
M  V30 4 C 10.0102 10.6697 0.0 0
M  V30 5 N 11.5503 13.3372 0.0 0
M  V30 6 O 9.2402 14.6708 0.0 0
M  V30 7 C 12.3203 14.6708 0.0 0 CFG=1
M  V30 8 C 13.8603 14.6708 0.0 0
M  V30 9 C 11.5503 16.0045 0.0 0
M  V30 10 N 14.6303 16.0045 0.0 0
M  V30 11 O 14.6303 13.3372 0.0 0
M  V30 12 C 16.1704 16.0045 0.0 0 CFG=1
M  V30 13 C 16.9404 14.6708 0.0 0
M  V30 14 C 16.9404 17.3383 0.0 0
M  V30 15 C 18.4804 14.6708 0.0 0
M  V30 16 N 16.1704 18.6720 0.0 0
M  V30 17 O 18.4804 17.3383 0.0 0
M  V30 18 C 19.2504 13.3372 0.0 0
M  V30 19 O 20.7905 13.3372 0.0 0
M  V30 20 O 18.4804 12.0035 0.0 0
M  V30 21 C 21.5605 12.0035 0.0 0
M  V30 22 N 9.2402 9.3360 0.0 0
M  V30 23 C 10.0102 8.0023 0.0 0
M  V30 24 C 11.5503 8.0023 0.0 0
M  V30 25 O 9.2402 6.6685 0.0 0
M  V30 26 O 7.7002 6.6685 0.0 0
M  V30 27 C 6.9302 5.3348 0.0 0
M  V30 28 C 7.7002 4.0012 0.0 0
M  V30 29 N 6.9302 2.6675 0.0 0
M  V30 30 N 7.7002 1.3337 0.0 0 CHG=1 VAL=4
M  V30 31 N 8.4702 0.0000 0.0 0 CHG=-1
M  V30 32 C 6.9302 10.6697 0.0 0 CFG=2
M  V30 33 C 5.3901 10.6697 0.0 0 CFG=2
M  V30 34 C 7.7002 9.3360 0.0 0 CFG=1
M  V30 35 C 4.6201 9.3360 0.0 0 CFG=1
M  V30 36 O 4.6201 12.0033 0.0 0
M  V30 37 C 6.9302 8.0023 0.0 0 CFG=2
M  V30 38 O 5.3901 8.0023 0.0 0
M  V30 39 C 3.0801 9.3360 0.0 0
M  V30 40 C 3.0801 12.0033 0.0 0 CFG=3
M  V30 41 O 2.3101 10.6697 0.0 0
M  V30 42 C 2.3101 13.3372 0.0 0
M  V30 43 C 3.0801 14.6708 0.0 0
M  V30 44 C 0.7700 13.3372 0.0 0
M  V30 45 C 2.3101 16.0045 0.0 0
M  V30 46 C 0.0000 14.6708 0.0 0
M  V30 47 C 0.7700 16.0045 0.0 0
M  V30 48 C 23.1005 12.0035 0.0 0
M  V30 49 C 23.8705 10.6697 0.0 0
M  V30 50 C 23.8705 13.3372 0.0 0
M  V30 51 C 25.4106 10.6697 0.0 0
M  V30 52 C 25.4106 13.3372 0.0 0
M  V30 53 C 26.1806 12.0035 0.0 0
M  V30 54 H 6.1601 12.0033 0.0 0
M  V30 55 H 3.8501 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 32 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 21 48
M  V30 23 1 22 23
M  V30 24 1 34 22 CFG=1
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 26 27
M  V30 28 1 37 26 CFG=3
M  V30 29 1 27 28
M  V30 30 1 28 29
M  V30 31 2 29 30
M  V30 32 2 30 31
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 1 33 36
M  V30 37 1 33 54 CFG=3
M  V30 38 1 34 37
M  V30 39 1 35 38
M  V30 40 1 35 39
M  V30 41 1 35 55 CFG=1
M  V30 42 1 36 40
M  V30 43 1 37 38
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 2 7 12 32 33 34 35 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3061506-83-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3061506-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061506-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42356617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synergistic immune augmentation enabled by covalently conjugating TLR4
and NOD2 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Dong; Gao, Runing; Lei, Yujuan; Liu, Jianing; Zhou, Chengkai; Wen,
Yu; Zhou, Shihao; Guo, Jun; Li, Tiehai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 278116792

$RFMT $RIREG SCHEME460 STEP1
$RXN



  2  1
$MOL
4-[[[(2R)-2-(1,2-Dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-[[(1,1-dimethylethyl...
C30H40N2O7Si
1989656-07-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 5.3348 0.0 0 CFG=1
M  V30 2 C 6.9302 6.6685 0.0 0
M  V30 3 O 6.9302 4.0012 0.0 0
M  V30 4 N 8.4702 6.6685 0.0 0
M  V30 5 Si 6.1601 2.6673 0.0 0
M  V30 6 C 9.2402 5.3348 0.0 0
M  V30 7 C 9.2402 8.0022 0.0 0
M  V30 8 C 5.3901 1.3337 0.0 0
M  V30 9 C 4.8265 3.4374 0.0 0
M  V30 10 C 7.4938 1.8973 0.0 0
M  V30 11 O 8.4702 9.3360 0.0 0
M  V30 12 O 10.7802 8.0022 0.0 0
M  V30 13 C 4.0564 2.1037 0.0 0
M  V30 14 C 4.6201 0.0000 0.0 0
M  V30 15 C 6.7238 0.5637 0.0 0
M  V30 16 C 9.2402 10.6697 0.0 0
M  V30 17 C 10.5739 9.8996 0.0 0
M  V30 18 C 10.0102 12.0033 0.0 0
M  V30 19 C 7.9065 11.4397 0.0 0
M  V30 20 O 0.0000 5.3348 0.0 0
M  V30 21 O 1.5400 10.6697 0.0 0
M  V30 22 C 15.4003 5.3348 0.0 0
M  V30 23 O 16.1704 4.0012 0.0 0
M  V30 24 O 16.1704 6.6685 0.0 0
M  V30 25 C 4.6201 5.3348 0.0 0
M  V30 26 C 3.8501 6.6685 0.0 0
M  V30 27 C 3.8501 4.0012 0.0 0
M  V30 28 C 2.3101 6.6685 0.0 0
M  V30 29 C 4.6201 8.0022 0.0 0
M  V30 30 C 2.3101 4.0012 0.0 0
M  V30 31 C 1.5400 5.3348 0.0 0
M  V30 32 N 1.5400 8.0022 0.0 0
M  V30 33 C 3.8501 9.3360 0.0 0
M  V30 34 C 2.3101 9.3360 0.0 0
M  V30 35 C 10.7802 5.3348 0.0 0
M  V30 36 C 11.5503 4.0012 0.0 0
M  V30 37 C 11.5503 6.6685 0.0 0
M  V30 38 C 13.0903 4.0012 0.0 0
M  V30 39 C 13.0903 6.6685 0.0 0
M  V30 40 C 13.8603 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 6 35
M  V30 12 1 7 11
M  V30 13 2 7 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 11 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 31
M  V30 22 2 21 34
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 22 40
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 2 27 30
M  V30 31 2 28 31
M  V30 32 1 28 32
M  V30 33 2 29 33
M  V30 34 1 30 31
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 3-(3-aminopropoxy)-α-hydroxy-α-phenyl-, (3R)-1-methyl-3-p...
C23H30N2O4.2ClH
3052116-26-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.1600 0.0 0 CFG=2
M  V30 2 C 5.3900 6.1600 0.0 0
M  V30 3 O 6.9300 7.7000 0.0 0
M  V30 4 O 4.6200 7.4938 0.0 0
M  V30 5 O 4.6200 4.8264 0.0 0
M  V30 6 O 11.5500 8.8274 0.0 0
M  V30 7 C 13.0900 8.8274 0.0 0
M  V30 8 C 13.8600 10.1611 0.0 0
M  V30 9 C 15.4000 10.1611 0.0 0
M  V30 10 N 16.1700 11.4949 0.0 0
M  V30 11 C 0.0000 10.1611 0.0 0
M  V30 12 C 8.4700 6.1600 0.0 0
M  V30 13 C 9.2400 7.4938 0.0 0
M  V30 14 C 9.2400 4.8264 0.0 0
M  V30 15 C 10.7800 7.4938 0.0 0
M  V30 16 C 10.7800 4.8264 0.0 0
M  V30 17 C 11.5500 6.1600 0.0 0
M  V30 18 C 6.9300 4.6200 0.0 0
M  V30 19 C 8.2636 3.8500 0.0 0
M  V30 20 C 5.5964 3.8500 0.0 0
M  V30 21 C 8.2636 2.3100 0.0 0
M  V30 22 C 5.5964 2.3100 0.0 0
M  V30 23 C 6.9300 1.5400 0.0 0
M  V30 24 C 3.0800 7.4938 0.0 0 CFG=2
M  V30 25 C 2.3100 8.8274 0.0 0
M  V30 26 C 2.3100 6.1600 0.0 0
M  V30 27 N 0.7700 8.8274 0.0 0
M  V30 28 C 0.7700 6.1600 0.0 0
M  V30 29 C 0.0000 7.4938 0.0 0
M  V30 30 Cl 8.0850 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12 CFG=1
M  V30 4 1 1 18 CFG=3
M  V30 5 1 2 4
M  V30 6 2 2 5
M  V30 7 1 24 4 CFG=3
M  V30 8 1 6 7
M  V30 9 1 6 15
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 11 27
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 3-[3-[[4-[[[(2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinoli...
C53H68N4O10Si
3052116-61-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  68 73 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 6.6685 0.0 0 CFG=1
M  V30 2 C 6.9302 5.3348 0.0 0
M  V30 3 O 6.9302 8.0022 0.0 0
M  V30 4 N 8.4702 5.3348 0.0 0
M  V30 5 Si 6.1601 9.3360 0.0 0
M  V30 6 C 9.2402 6.6685 0.0 0
M  V30 7 C 9.2402 4.0010 0.0 0
M  V30 8 C 5.3901 10.6697 0.0 0
M  V30 9 C 7.4938 10.1060 0.0 0
M  V30 10 C 4.8265 8.5660 0.0 0
M  V30 11 O 8.4702 2.6673 0.0 0
M  V30 12 O 10.7802 4.0010 0.0 0
M  V30 13 C 4.0564 9.8996 0.0 0
M  V30 14 C 4.6201 12.0033 0.0 0
M  V30 15 C 6.7238 11.4397 0.0 0
M  V30 16 C 9.2402 1.3337 0.0 0
M  V30 17 C 10.5739 2.1037 0.0 0
M  V30 18 C 10.0102 0.0000 0.0 0
M  V30 19 C 7.9065 0.5637 0.0 0
M  V30 20 O 0.0000 6.6685 0.0 0
M  V30 21 O 1.5400 1.3337 0.0 0
M  V30 22 C 15.4003 6.6685 0.0 0
M  V30 23 N 16.1704 8.0022 0.0 0
M  V30 24 O 16.1704 5.3348 0.0 0
M  V30 25 C 17.7104 8.0022 0.0 0
M  V30 26 C 18.4804 9.3360 0.0 0
M  V30 27 C 20.0204 9.3360 0.0 0
M  V30 28 O 20.7905 10.6697 0.0 0
M  V30 29 C 25.4106 13.3370 0.0 0 CFG=2
M  V30 30 C 26.7444 12.5670 0.0 0
M  V30 31 O 26.1806 14.6708 0.0 0
M  V30 32 O 28.0780 13.3370 0.0 0
M  V30 33 O 26.7444 11.0269 0.0 0
M  V30 34 C 33.4129 13.3370 0.0 0
M  V30 35 C 4.6201 6.6685 0.0 0
M  V30 36 C 3.8501 5.3348 0.0 0
M  V30 37 C 3.8501 8.0022 0.0 0
M  V30 38 C 2.3101 5.3348 0.0 0
M  V30 39 C 4.6201 4.0010 0.0 0
M  V30 40 C 2.3101 8.0022 0.0 0
M  V30 41 C 1.5400 6.6685 0.0 0
M  V30 42 N 1.5400 4.0010 0.0 0
M  V30 43 C 3.8501 2.6673 0.0 0
M  V30 44 C 2.3101 2.6673 0.0 0
M  V30 45 C 10.7802 6.6685 0.0 0
M  V30 46 C 11.5503 5.3348 0.0 0
M  V30 47 C 11.5503 8.0022 0.0 0
M  V30 48 C 13.0903 5.3348 0.0 0
M  V30 49 C 13.0903 8.0022 0.0 0
M  V30 50 C 13.8603 6.6685 0.0 0
M  V30 51 C 22.3305 10.6697 0.0 0
M  V30 52 C 23.1005 12.0033 0.0 0
M  V30 53 C 23.1005 9.3360 0.0 0
M  V30 54 C 24.6405 12.0033 0.0 0
M  V30 55 C 24.6405 9.3360 0.0 0
M  V30 56 C 25.4106 10.6697 0.0 0
M  V30 57 C 24.0769 14.1070 0.0 0
M  V30 58 C 24.0769 15.6471 0.0 0
M  V30 59 C 22.7432 13.3370 0.0 0
M  V30 60 C 22.7432 16.4171 0.0 0
M  V30 61 C 21.4094 14.1070 0.0 0
M  V30 62 C 21.4094 15.6471 0.0 0
M  V30 63 C 29.4117 12.5670 0.0 0 CFG=2
M  V30 64 C 30.7454 13.3370 0.0 0
M  V30 65 C 29.4117 11.0269 0.0 0
M  V30 66 N 32.0792 12.5670 0.0 0
M  V30 67 C 30.7454 10.2569 0.0 0
M  V30 68 C 32.0792 11.0269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 35
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 6 45
M  V30 12 1 7 11
M  V30 13 2 7 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 11 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 41
M  V30 22 2 21 44
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 22 50
M  V30 26 1 23 25
M  V30 27 1 25 26
M  V30 28 1 26 27
M  V30 29 1 27 28
M  V30 30 1 28 51
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 29 54 CFG=3
M  V30 34 1 29 57 CFG=1
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 63 32 CFG=1
M  V30 38 1 34 66
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 36 39
M  V30 43 2 37 40
M  V30 44 2 38 41
M  V30 45 1 38 42
M  V30 46 2 39 43
M  V30 47 1 40 41
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 50 2 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 49
M  V30 54 2 48 50
M  V30 55 1 49 50
M  V30 56 2 51 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 2 53 55
M  V30 60 2 54 56
M  V30 61 1 55 56
M  V30 62 2 57 58
M  V30 63 1 57 59
M  V30 64 1 58 60
M  V30 65 2 59 61
M  V30 66 2 60 62
M  V30 67 1 61 62
M  V30 68 1 63 64
M  V30 69 1 63 65
M  V30 70 1 64 66
M  V30 71 1 65 67
M  V30 72 1 66 68
M  V30 73 1 67 68
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 29 63)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1989656-07-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052116-26-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052116-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41010411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Multiparametric Optimization, and Solid-State Driven
Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic
Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory
Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carzaniga, Laura; Linney, Ian D.; Rizzi, Andrea; Schmidt, Wolfgang;
Knight, Christopher K.; Mileo, Valentina; Amadei, Francesco; Pastore,
Fiorella; Miglietta, Daniela; Cesari, Nicola; Riccardi, Benedetta;
Mazzucato, Roberta; Ghidini, Eleonora; Blackaby, Wesley P.; Patacchini,
Riccardo; Battipaglia, Loredana; Villetti, Gino; Puccini, Paola;
Catinella, Silvia; Civelli, Maurizio; Rancati, Fabio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(12), 9816-9841

$RFMT $RIREG SCHEME461 STEP1
$RXN



  2  1
$MOL

C28H43N5O9S2
3034871-49-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3744 12.0032 0.0 0
M  V30 2 C 6.1444 10.6694 0.0 0
M  V30 3 C 7.6844 10.6694 0.0 0
M  V30 4 C 8.4544 9.3358 0.0 0
M  V30 5 C 9.9944 9.3358 0.0 0
M  V30 6 O 10.7644 8.0022 0.0 0
M  V30 7 O 10.7644 10.6694 0.0 0
M  V30 8 C 12.3044 8.0022 0.0 0
M  V30 9 C 13.0744 6.6685 0.0 0
M  V30 10 N 14.6144 6.6685 0.0 0
M  V30 11 C 15.3844 5.3347 0.0 0
M  V30 12 C 15.3844 8.0022 0.0 0
M  V30 13 C 14.6144 4.0011 0.0 0
M  V30 14 O 16.9245 5.3347 0.0 0
M  V30 15 C 16.9245 8.0022 0.0 0
M  V30 16 C 15.3844 2.6674 0.0 0
M  V30 17 O 17.6945 9.3358 0.0 0
M  V30 18 C 14.6144 1.3338 0.0 0
M  V30 19 C 19.2345 9.3358 0.0 0
M  V30 20 O 15.3844 0.0000 0.0 0
M  V30 21 O 13.0744 1.3338 0.0 0
M  V30 22 C 20.0045 10.6694 0.0 0
M  V30 23 O 20.0045 8.0022 0.0 0
M  V30 24 C 21.5445 10.6694 0.0 0
M  V30 25 C 22.3145 12.0032 0.0 0
M  V30 26 C 23.8545 12.0032 0.0 0
M  V30 27 O 0.9888 16.7296 0.0 0
M  V30 28 O 30.1406 13.4380 0.0 0
M  V30 29 C 2.9292 13.2491 0.0 0 CFG=2
M  V30 30 C 1.4647 12.7732 0.0 0 CFG=1
M  V30 31 C 3.8344 12.0032 0.0 0 CFG=2
M  V30 32 N 2.9292 14.7891 0.0 0
M  V30 33 C 1.4647 11.2332 0.0 0
M  V30 34 N 0.5595 14.0191 0.0 0
M  V30 35 S 2.9292 10.7574 0.0 0
M  V30 36 C 1.4647 15.2649 0.0 0
M  V30 37 C 24.6245 13.3369 0.0 0 CFG=2
M  V30 38 C 26.1561 13.4978 0.0 0 CFG=1
M  V30 39 S 23.9981 14.7437 0.0 0
M  V30 40 C 26.4763 15.0042 0.0 0 CFG=1
M  V30 41 N 27.4898 12.7278 0.0 0
M  V30 42 C 25.1425 15.7742 0.0 0
M  V30 43 N 28.0078 15.1652 0.0 0
M  V30 44 C 28.6342 13.7582 0.0 0
M  V30 45 H 4.3939 13.7249 0.0 0
M  V30 46 H 0.0000 12.2974 0.0 0
M  V30 47 H 25.8358 11.9915 0.0 0
M  V30 48 H 26.7965 16.5105 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 31 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 22 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 37 26 CFG=3
M  V30 28 2 27 36
M  V30 29 2 28 44
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 29 45 CFG=1
M  V30 34 1 30 33
M  V30 35 1 30 34
M  V30 36 1 30 46 CFG=1
M  V30 37 1 31 35
M  V30 38 1 32 36
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 38 41
M  V30 45 1 38 47 CFG=1
M  V30 46 1 39 42
M  V30 47 1 40 42
M  V30 48 1 40 43
M  V30 49 1 40 48 CFG=1
M  V30 50 1 41 44
M  V30 51 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 29 30 31 37 38 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-, 2-[2-[2-[(3α)-cholest-5-en-3-yl...
C44H78N2O7
2920717-27-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 30.0245 5.2458 0.0 0
M  V30 2 C 34.8374 7.6917 0.0 0
M  V30 3 C 37.4747 7.4060 0.0 0 CFG=2
M  V30 4 C 37.4747 8.9461 0.0 0
M  V30 5 C 38.8085 6.6360 0.0 0
M  V30 6 C 38.8085 9.7161 0.0 0
M  V30 7 C 38.8085 11.2561 0.0 0
M  V30 8 C 40.1422 12.0261 0.0 0
M  V30 9 C 41.4759 11.2561 0.0 0
M  V30 10 C 40.1422 13.5662 0.0 0
M  V30 11 O 26.6742 1.5400 0.0 0
M  V30 12 C 25.3405 2.3101 0.0 0
M  V30 13 C 24.0067 1.5400 0.0 0
M  V30 14 O 22.6730 2.3101 0.0 0
M  V30 15 C 21.3393 1.5400 0.0 0
M  V30 16 C 20.0057 2.3101 0.0 0
M  V30 17 O 18.6718 1.5400 0.0 0
M  V30 18 C 17.3382 2.3101 0.0 0
M  V30 19 C 16.0045 1.5400 0.0 0
M  V30 20 O 14.6708 2.3101 0.0 0
M  V30 21 C 13.3370 1.5400 0.0 0
M  V30 22 C 12.0033 2.3101 0.0 0 CFG=1
M  V30 23 O 13.3370 0.0000 0.0 0
M  V30 24 C 10.6697 1.5400 0.0 0
M  V30 25 N 12.0033 3.8501 0.0 0
M  V30 26 C 9.3360 2.3101 0.0 0
M  V30 27 C 8.0022 1.5400 0.0 0
M  V30 28 C 6.6685 2.3101 0.0 0
M  V30 29 N 5.3348 1.5400 0.0 0
M  V30 30 C 4.0012 2.3101 0.0 0
M  V30 31 O 2.6673 1.5400 0.0 0
M  V30 32 O 4.0012 3.8501 0.0 0
M  V30 33 C 1.3337 2.3101 0.0 0
M  V30 34 C 0.5637 0.9764 0.0 0
M  V30 35 C 0.0000 3.0801 0.0 0
M  V30 36 C 2.1037 3.6437 0.0 0
M  V30 37 C 33.3427 3.8501 0.0 0 CFG=1
M  V30 38 C 32.0090 4.6201 0.0 0 CFG=2
M  V30 39 C 34.6763 4.6201 0.0 0 CFG=2
M  V30 40 C 33.3427 2.3101 0.0 0
M  V30 41 C 30.6753 3.8501 0.0 0 CFG=2
M  V30 42 C 32.0090 6.1601 0.0 0
M  V30 43 C 34.6763 6.1601 0.0 0 CFG=2
M  V30 44 C 36.1410 4.1442 0.0 0
M  V30 45 C 32.0090 1.5400 0.0 0
M  V30 46 C 30.6753 2.3101 0.0 0
M  V30 47 C 29.3415 4.6201 0.0 0
M  V30 48 C 33.3427 6.9302 0.0 0
M  V30 49 C 36.1410 6.6360 0.0 0 CFG=1
M  V30 50 C 37.0463 5.3901 0.0 0
M  V30 51 C 29.3415 1.5400 0.0 0
M  V30 52 C 28.0078 3.8501 0.0 0
M  V30 53 C 28.0078 2.3101 0.0 0 CFG=2
M  V30 54 H 34.2260 2.5885 0.0 0
M  V30 55 H 31.1256 5.8815 0.0 0
M  V30 56 H 35.4696 3.3000 0.0 0
M  V30 57 H 35.5147 8.0430 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 41 1 CFG=1
M  V30 2 1 43 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=1
M  V30 5 1 3 49
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 53 11 CFG=3
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 22 25 CFG=3
M  V30 26 1 24 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 2 30 32
M  V30 33 1 31 33
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 33 36
M  V30 37 1 37 38
M  V30 38 1 37 39
M  V30 39 1 37 40
M  V30 40 1 37 54 CFG=1
M  V30 41 1 38 41
M  V30 42 1 38 42
M  V30 43 1 38 55 CFG=3
M  V30 44 1 39 43
M  V30 45 1 39 44
M  V30 46 1 39 56 CFG=3
M  V30 47 1 40 45
M  V30 48 1 41 46
M  V30 49 1 41 47
M  V30 50 1 42 48
M  V30 51 1 43 48
M  V30 52 1 43 49
M  V30 53 1 44 50
M  V30 54 2 45 46
M  V30 55 1 46 51
M  V30 56 1 47 52
M  V30 57 1 49 50
M  V30 58 1 49 57 CFG=3
M  V30 59 1 51 53
M  V30 60 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 3 22 37 38 39 41 43 49 53)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Lysine, N2-[4-[bis[2-[[5-[(3aR,4S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imid...
C72H119N7O15S2
3034871-50-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  104 111 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 40.5926 21.0936 0.0 0
M  V30 2 C 44.9116 18.3211 0.0 0
M  V30 3 C 45.9828 15.8942 0.0 0 CFG=2
M  V30 4 C 47.3165 16.6642 0.0 0
M  V30 5 C 45.9828 14.3542 0.0 0
M  V30 6 C 48.6503 15.8942 0.0 0
M  V30 7 C 49.9840 16.6642 0.0 0
M  V30 8 C 51.3176 15.8942 0.0 0
M  V30 9 C 51.3176 14.3542 0.0 0
M  V30 10 C 52.6513 16.6642 0.0 0
M  V30 11 O 35.5026 22.3147 0.0 0
M  V30 12 C 34.1689 21.5447 0.0 0
M  V30 13 C 32.8351 22.3147 0.0 0
M  V30 14 O 31.5015 21.5447 0.0 0
M  V30 15 C 30.1678 22.3147 0.0 0
M  V30 16 C 28.8342 21.5447 0.0 0
M  V30 17 O 27.5004 22.3147 0.0 0
M  V30 18 C 26.1667 21.5447 0.0 0
M  V30 19 C 24.8330 22.3147 0.0 0
M  V30 20 O 23.4994 21.5447 0.0 0
M  V30 21 C 22.1656 22.3147 0.0 0
M  V30 22 C 20.8319 21.5447 0.0 0 CFG=2
M  V30 23 O 22.1656 23.8547 0.0 0
M  V30 24 N 20.8319 20.0046 0.0 0
M  V30 25 C 19.4983 22.3147 0.0 0
M  V30 26 C 19.4983 19.2346 0.0 0
M  V30 27 C 19.4983 23.8547 0.0 0
M  V30 28 C 19.4983 17.6946 0.0 0
M  V30 29 O 18.1646 20.0048 0.0 0
M  V30 30 C 18.1646 24.6247 0.0 0
M  V30 31 C 18.1646 16.9248 0.0 0
M  V30 32 C 18.1646 26.1647 0.0 0
M  V30 33 C 18.1646 15.3847 0.0 0
M  V30 34 N 16.8308 26.9347 0.0 0
M  V30 35 N 16.8308 14.6147 0.0 0
M  V30 36 O 19.4983 14.6147 0.0 0
M  V30 37 C 16.8308 28.4747 0.0 0
M  V30 38 C 15.4972 15.3847 0.0 0
M  V30 39 C 16.8308 13.0747 0.0 0
M  V30 40 O 15.4972 29.2447 0.0 0
M  V30 41 O 18.1646 29.2447 0.0 0
M  V30 42 C 14.1635 14.6147 0.0 0
M  V30 43 C 18.1646 12.3047 0.0 0
M  V30 44 C 15.4972 30.7847 0.0 0
M  V30 45 O 12.8299 15.3847 0.0 0
M  V30 46 O 18.1646 10.7647 0.0 0
M  V30 47 C 13.9572 30.7847 0.0 0
M  V30 48 C 15.4972 32.3249 0.0 0
M  V30 49 C 17.0372 30.7847 0.0 0
M  V30 50 C 11.4961 14.6147 0.0 0
M  V30 51 C 19.4983 9.9947 0.0 0
M  V30 52 C 10.1624 15.3847 0.0 0
M  V30 53 O 11.4961 13.0747 0.0 0
M  V30 54 C 19.4983 8.4547 0.0 0
M  V30 55 O 20.8319 10.7646 0.0 0
M  V30 56 C 8.8288 14.6147 0.0 0
M  V30 57 C 20.8319 7.6847 0.0 0
M  V30 58 C 7.4951 15.3847 0.0 0
M  V30 59 C 20.8319 6.1447 0.0 0
M  V30 60 C 6.1613 14.6147 0.0 0
M  V30 61 C 22.1656 5.3745 0.0 0
M  V30 62 O 0.0000 12.7144 0.0 0
M  V30 63 O 26.8920 0.9888 0.0 0
M  V30 64 C 40.8373 17.6946 0.0 0 CFG=1
M  V30 65 C 40.8373 19.2346 0.0 0 CFG=2
M  V30 66 C 42.1710 16.9246 0.0 0 CFG=2
M  V30 67 C 39.5037 16.9246 0.0 0
M  V30 68 C 39.5037 20.0046 0.0 0 CFG=2
M  V30 69 C 42.1710 20.0046 0.0 0
M  V30 70 C 43.5047 17.6946 0.0 0 CFG=2
M  V30 71 C 42.4912 15.4183 0.0 0
M  V30 72 C 38.1699 17.6946 0.0 0
M  V30 73 C 38.1699 19.2346 0.0 0
M  V30 74 C 39.5037 21.5447 0.0 0
M  V30 75 C 43.5047 19.2346 0.0 0
M  V30 76 C 44.6492 16.6642 0.0 0 CFG=1
M  V30 77 C 44.0227 15.2572 0.0 0
M  V30 78 C 36.8362 20.0046 0.0 0
M  V30 79 C 38.1699 22.3147 0.0 0
M  V30 80 C 36.8362 21.5447 0.0 0 CFG=2
M  V30 81 C 4.8276 15.3847 0.0 0 CFG=2
M  V30 82 C 3.4208 14.7583 0.0 0 CFG=1
M  V30 83 S 4.6667 16.9163 0.0 0
M  V30 84 C 2.3903 15.9028 0.0 0 CFG=1
M  V30 85 N 2.6508 13.4246 0.0 0
M  V30 86 C 3.1603 17.2365 0.0 0
M  V30 87 N 0.9835 15.2763 0.0 0
M  V30 88 C 1.1444 13.7448 0.0 0
M  V30 89 C 22.1656 3.8345 0.0 0 CFG=2
M  V30 90 C 23.4115 2.9294 0.0 0 CFG=1
M  V30 91 S 20.9197 2.9294 0.0 0
M  V30 92 C 22.9356 1.4647 0.0 0 CFG=1
M  V30 93 N 24.9515 2.9294 0.0 0
M  V30 94 C 21.3956 1.4647 0.0 0
M  V30 95 N 24.1815 0.5595 0.0 0
M  V30 96 C 25.4275 1.4647 0.0 0
M  V30 97 H 40.8373 16.1546 0.0 0
M  V30 98 H 41.4882 20.6303 0.0 0
M  V30 99 H 41.4244 15.5777 0.0 0
M  V30 100 H 45.5544 17.9101 0.0 0
M  V30 101 H 4.4513 13.6139 0.0 0
M  V30 102 H 1.3598 17.0472 0.0 0
M  V30 103 H 23.8875 4.3940 0.0 0
M  V30 104 H 22.4597 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 68 1 CFG=1
M  V30 2 1 70 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=1
M  V30 5 1 3 76
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 80 11 CFG=3
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 22 25 CFG=1
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 26 29
M  V30 30 1 27 30
M  V30 31 1 28 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 33 36
M  V30 37 1 34 37
M  V30 38 1 35 38
M  V30 39 1 35 39
M  V30 40 1 37 40
M  V30 41 2 37 41
M  V30 42 1 38 42
M  V30 43 1 39 43
M  V30 44 1 40 44
M  V30 45 1 42 45
M  V30 46 1 43 46
M  V30 47 1 44 47
M  V30 48 1 44 48
M  V30 49 1 44 49
M  V30 50 1 45 50
M  V30 51 1 46 51
M  V30 52 1 50 52
M  V30 53 2 50 53
M  V30 54 1 51 54
M  V30 55 2 51 55
M  V30 56 1 52 56
M  V30 57 1 54 57
M  V30 58 1 56 58
M  V30 59 1 57 59
M  V30 60 1 58 60
M  V30 61 1 59 61
M  V30 62 1 81 60 CFG=1
M  V30 63 1 89 61 CFG=1
M  V30 64 2 62 88
M  V30 65 2 63 96
M  V30 66 1 64 65
M  V30 67 1 64 66
M  V30 68 1 64 67
M  V30 69 1 64 97 CFG=1
M  V30 70 1 65 68
M  V30 71 1 65 69
M  V30 72 1 65 98 CFG=3
M  V30 73 1 66 70
M  V30 74 1 66 71
M  V30 75 1 66 99 CFG=3
M  V30 76 1 67 72
M  V30 77 1 68 73
M  V30 78 1 68 74
M  V30 79 1 69 75
M  V30 80 1 70 75
M  V30 81 1 70 76
M  V30 82 1 71 77
M  V30 83 2 72 73
M  V30 84 1 73 78
M  V30 85 1 74 79
M  V30 86 1 76 77
M  V30 87 1 76 100 CFG=3
M  V30 88 1 78 80
M  V30 89 1 79 80
M  V30 90 1 81 82
M  V30 91 1 81 83
M  V30 92 1 82 84
M  V30 93 1 82 85
M  V30 94 1 82 101 CFG=3
M  V30 95 1 83 86
M  V30 96 1 84 86
M  V30 97 1 84 87
M  V30 98 1 84 102 CFG=3
M  V30 99 1 85 88
M  V30 100 1 87 88
M  V30 101 1 89 90
M  V30 102 1 89 91
M  V30 103 1 90 92
M  V30 104 1 90 93
M  V30 105 1 90 103 CFG=3
M  V30 106 1 91 94
M  V30 107 1 92 94
M  V30 108 1 92 95
M  V30 109 1 92 104 CFG=3
M  V30 110 1 93 96
M  V30 111 1 95 96
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(15 3 22 64 65 66 68 70 76 80 81 82 84 89 90 92)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3034871-49-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2920717-27-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3034871-50-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40278904
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, preparation and evaluation of different branched biotin modified
liposomes for targeting breast cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Baolan; Peng, Yao; Yue, Qiming; Pu, Yanchi; Li, Ru; Zhao, Yi; Hai,
Li; Guo, Li; Wu, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 193112204

$RFMT $RIREG SCHEME462 STEP1
$RXN



  2  1
$MOL

C44H74N4O14
3032117-82-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  62 64 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 9.3356 0.0 0 CFG=1
M  V30 2 C 8.4700 9.3356 0.0 0 CFG=2
M  V30 3 O 6.1600 10.6694 0.0 0
M  V30 4 C 6.1600 8.0020 0.0 0 CFG=1
M  V30 5 C 9.2400 8.0020 0.0 0 CFG=2
M  V30 6 C 9.2400 10.6694 0.0 0
M  V30 7 C 4.6200 8.0020 0.0 0
M  V30 8 C 6.9300 6.6684 0.0 0
M  V30 9 O 8.4700 6.6684 0.0 0
M  V30 10 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 11 O 3.8500 6.6684 0.0 0
M  V30 12 O 3.8500 9.3356 0.0 0
M  V30 13 C 10.7800 9.5420 0.0 0
M  V30 14 C 12.3200 8.0020 0.0 0
M  V30 15 O 10.7800 6.4620 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0 CFG=3
M  V30 17 C 12.1136 10.3120 0.0 0 CFG=1
M  V30 18 C 1.5400 5.3347 0.0 0
M  V30 19 C 1.5400 8.0020 0.0 0
M  V30 20 C 13.4473 9.5420 0.0 0
M  V30 21 C 12.1136 11.8520 0.0 0
M  V30 22 C 2.3100 4.0009 0.0 0
M  V30 23 O 0.0000 5.3347 0.0 0
M  V30 24 C 0.0000 8.0020 0.0 0
M  V30 25 N 14.7809 10.3120 0.0 0
M  V30 26 C 16.1147 9.5420 0.0 0
M  V30 27 C 14.7809 11.8520 0.0 0
M  V30 28 C 16.1147 8.0020 0.0 0 CFG=1
M  V30 29 O 17.4484 10.3120 0.0 0
M  V30 30 C 17.4484 7.2320 0.0 0
M  V30 31 N 14.7811 7.2320 0.0 0
M  V30 32 O 5.1225 16.1871 0.0 0
M  V30 33 C 6.3023 17.1769 0.0 0
M  V30 34 C 6.8371 15.1972 0.0 0
M  V30 35 C 1.5400 13.3367 0.0 0
M  V30 36 O 6.9300 4.0009 0.0 0
M  V30 37 O 3.0800 16.0041 0.0 0
M  V30 38 N 8.4700 1.3336 0.0 0
M  V30 39 C 9.2400 0.0000 0.0 0
M  V30 40 C 6.9300 1.3336 0.0 0
M  V30 41 C 13.0900 4.0009 0.0 0
M  V30 42 N 22.7831 10.3120 0.0 0 VAL=5
M  V30 43 O 24.1167 9.5420 0.0 0
M  V30 44 O 22.7831 11.8520 0.0 0
M  V30 45 C 5.3900 12.0031 0.0 0 CFG=2
M  V30 46 C 6.1600 13.3367 0.0 0
M  V30 47 O 3.8500 12.0031 0.0 0
M  V30 48 C 5.3900 14.6703 0.0 0 CFG=1
M  V30 49 C 3.0800 13.3367 0.0 0 CFG=1
M  V30 50 C 3.8500 14.6703 0.0 0 CFG=1
M  V30 51 C 9.2400 5.3347 0.0 0 CFG=2
M  V30 52 C 8.4700 4.0009 0.0 0 CFG=2
M  V30 53 O 10.7800 5.3347 0.0 0
M  V30 54 C 9.2400 2.6673 0.0 0 CFG=1
M  V30 55 C 11.5500 4.0009 0.0 0 CFG=2
M  V30 56 C 10.7800 2.6673 0.0 0
M  V30 57 C 18.7820 8.0020 0.0 0
M  V30 58 C 18.7820 9.5420 0.0 0
M  V30 59 C 20.1158 7.2320 0.0 0
M  V30 60 C 20.1156 10.3120 0.0 0
M  V30 61 C 21.4494 8.0020 0.0 0
M  V30 62 C 21.4494 9.5420 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 45 3 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8 CFG=1
M  V30 9 1 5 9 CFG=3
M  V30 10 1 5 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 51 9 CFG=3
M  V30 14 1 10 13 CFG=1
M  V30 15 1 10 14 CFG=3
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21 CFG=1
M  V30 23 1 18 22
M  V30 24 2 18 23
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 26 29
M  V30 31 1 28 30
M  V30 32 1 28 31 CFG=3
M  V30 33 1 30 57
M  V30 34 1 32 33
M  V30 35 1 48 32 CFG=3
M  V30 36 1 48 34 CFG=1
M  V30 37 1 49 35 CFG=1
M  V30 38 1 52 36 CFG=1
M  V30 39 1 50 37 CFG=3
M  V30 40 1 38 39
M  V30 41 1 38 40
M  V30 42 1 54 38 CFG=3
M  V30 43 1 55 41 CFG=3
M  V30 44 2 42 43
M  V30 45 2 42 44
M  V30 46 1 42 62
M  V30 47 1 45 46
M  V30 48 1 45 47
M  V30 49 1 46 48
M  V30 50 1 47 49
M  V30 51 1 48 50
M  V30 52 1 49 50
M  V30 53 1 51 52
M  V30 54 1 51 53
M  V30 55 1 52 54
M  V30 56 1 53 55
M  V30 57 1 54 56
M  V30 58 1 55 56
M  V30 59 2 57 58
M  V30 60 1 57 59
M  V30 61 1 58 60
M  V30 62 2 59 61
M  V30 63 2 60 62
M  V30 64 1 61 62
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(15 1 2 4 5 10 17 28 45 48 49 50 51 52 54 55)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
FMOC-L-valine
C20H21NO4
68858-20-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2308 0.0 0
M  V30 2 O 7.0870 4.4608 0.0 0
M  V30 3 C 8.4207 5.2308 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2308 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4218 4.4608 0.0 0
M  V30 9 C 9.7544 7.5409 0.0 0
M  V30 10 C 12.4218 7.5409 0.0 0
M  V30 11 O 13.7555 5.2308 0.0 0
M  V30 12 O 12.4218 2.9208 0.0 0
M  V30 13 C 4.4196 4.4608 0.0 0
M  V30 14 C 4.2586 2.9293 0.0 0
M  V30 15 C 3.0127 5.0873 0.0 0
M  V30 16 C 2.7523 2.6091 0.0 0
M  V30 17 C 5.2891 1.7849 0.0 0
M  V30 18 C 1.9823 3.9428 0.0 0
M  V30 19 C 2.5369 6.5519 0.0 0
M  V30 20 C 2.2763 1.1444 0.0 0
M  V30 21 C 4.8132 0.3202 0.0 0
M  V30 22 C 0.4759 4.2629 0.0 0
M  V30 23 C 1.0304 6.8720 0.0 0
M  V30 24 C 3.3069 0.0000 0.0 0
M  V30 25 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C44H75N5O14
3037120-74-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  63 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 10.5089 0.0 0 CFG=2
M  V30 2 C 7.7002 9.1751 0.0 0 CFG=1
M  V30 3 O 5.3901 10.5089 0.0 0
M  V30 4 C 7.7002 11.8426 0.0 0 CFG=1
M  V30 5 C 6.9302 7.8414 0.0 0 CFG=1
M  V30 6 C 9.2402 9.1751 0.0 0
M  V30 7 C 9.0338 11.0725 0.0 0
M  V30 8 C 6.3663 12.6126 0.0 0
M  V30 9 O 8.4702 13.1762 0.0 0
M  V30 10 O 7.7002 6.5077 0.0 0
M  V30 11 C 5.3901 7.8414 0.0 0 CFG=1
M  V30 12 C 10.3675 11.8426 0.0 0 CFG=1
M  V30 13 C 4.6201 6.5077 0.0 0
M  V30 14 C 4.6201 9.1751 0.0 0
M  V30 15 C 11.7012 11.0725 0.0 0
M  V30 16 C 10.3675 13.3826 0.0 0
M  V30 17 O 3.0801 6.5077 0.0 0
M  V30 18 O 5.3901 5.1741 0.0 0
M  V30 19 N 13.0350 11.8426 0.0 0
M  V30 20 C 14.3687 11.0725 0.0 0
M  V30 21 C 13.0350 13.3826 0.0 0
M  V30 22 C 15.7023 11.8426 0.0 0 CFG=1
M  V30 23 O 14.3687 9.5325 0.0 0
M  V30 24 C 15.7023 13.3826 0.0 0
M  V30 25 N 17.0360 11.0725 0.0 0
M  V30 26 C 17.0360 9.5325 0.0 0
M  V30 27 C 18.3698 8.7625 0.0 0 CFG=1
M  V30 28 O 15.7023 8.7625 0.0 0
M  V30 29 C 18.3698 7.2224 0.0 0
M  V30 30 N 19.7035 9.5325 0.0 0
M  V30 31 C 19.7035 6.4524 0.0 0
M  V30 32 C 17.0360 6.4524 0.0 0
M  V30 33 O 2.3101 10.5089 0.0 0
M  V30 34 N 0.7700 13.1762 0.0 0
M  V30 35 C 0.0000 14.5099 0.0 0
M  V30 36 C 0.0000 11.8426 0.0 0
M  V30 37 C 5.3901 15.8437 0.0 0
M  V30 38 O 8.7375 0.9899 0.0 0
M  V30 39 C 7.5579 0.0000 0.0 0
M  V30 40 C 7.0230 1.9799 0.0 0
M  V30 41 C 12.3203 3.8402 0.0 0
M  V30 42 O 10.7802 1.1729 0.0 0
M  V30 43 N 21.0372 16.4627 0.0 0 VAL=5
M  V30 44 O 21.0372 18.0027 0.0 0
M  V30 45 O 22.3708 15.6926 0.0 0
M  V30 46 C 4.6201 11.8426 0.0 0 CFG=2
M  V30 47 C 3.0801 11.8426 0.0 0 CFG=2
M  V30 48 O 5.3901 13.1762 0.0 0
M  V30 49 C 2.3101 13.1762 0.0 0 CFG=1
M  V30 50 C 4.6201 14.5099 0.0 0 CFG=2
M  V30 51 C 3.0801 14.5099 0.0 0
M  V30 52 C 8.4702 5.1741 0.0 0 CFG=2
M  V30 53 C 7.7002 3.8402 0.0 0
M  V30 54 O 10.0102 5.1741 0.0 0
M  V30 55 C 8.4702 2.5066 0.0 0 CFG=1
M  V30 56 C 10.7802 3.8402 0.0 0 CFG=1
M  V30 57 C 10.0102 2.5066 0.0 0 CFG=1
M  V30 58 C 17.0360 14.1526 0.0 0
M  V30 59 C 18.3698 13.3826 0.0 0
M  V30 60 C 17.0360 15.6926 0.0 0
M  V30 61 C 19.7035 14.1526 0.0 0
M  V30 62 C 18.3698 16.4627 0.0 0
M  V30 63 C 19.7035 15.6926 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 46 3 CFG=1
M  V30 7 1 4 7
M  V30 8 1 4 8 CFG=1
M  V30 9 1 4 9 CFG=3
M  V30 10 1 5 10 CFG=3
M  V30 11 1 5 11
M  V30 12 1 7 12
M  V30 13 1 52 10 CFG=3
M  V30 14 1 11 13
M  V30 15 1 11 14 CFG=3
M  V30 16 1 12 15
M  V30 17 1 12 16 CFG=1
M  V30 18 1 13 17
M  V30 19 2 13 18
M  V30 20 1 15 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 22 24
M  V30 26 1 22 25 CFG=3
M  V30 27 1 24 58
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 27 30 CFG=1
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 47 33 CFG=3
M  V30 36 1 34 35
M  V30 37 1 34 36
M  V30 38 1 49 34 CFG=1
M  V30 39 1 50 37 CFG=1
M  V30 40 1 38 39
M  V30 41 1 55 38 CFG=3
M  V30 42 1 55 40 CFG=1
M  V30 43 1 56 41 CFG=1
M  V30 44 1 57 42 CFG=3
M  V30 45 2 43 44
M  V30 46 2 43 45
M  V30 47 1 43 63
M  V30 48 1 46 47
M  V30 49 1 46 48
M  V30 50 1 47 49
M  V30 51 1 48 50
M  V30 52 1 49 51
M  V30 53 1 50 51
M  V30 54 1 52 53
M  V30 55 1 52 54
M  V30 56 1 53 55
M  V30 57 1 54 56
M  V30 58 1 55 57
M  V30 59 1 56 57
M  V30 60 2 58 59
M  V30 61 1 58 60
M  V30 62 1 59 61
M  V30 63 2 60 62
M  V30 64 2 61 63
M  V30 65 1 62 63
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(16 1 2 4 5 11 12 22 27 46 47 49 50 52 55 56 57)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032117-82-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68858-20-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037120-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40189380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-99-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA
Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kostrun, Sanja; Fajdetic, Andrea; Pesic, Dijana; Brajsa, Karmen; Bencetic
Mihaljevic, Vlatka; Jelic, Dubravko; Petrinic Grba, Adriana; Elenkov,
Ivaylo; Rupcic, Renata; Kapic, Samra; Ozimec Landek, Ivana; Butkovic,
Kristina; Grgicevic, Ana; Ziher, Dinko; Cikos, Ana; Padovan, Jasna;
Saxty, Gordon; Dack, Kevin; Bladh, Haakan; Skak-Nielsen, Tine; Feldbaek
Nielsen, Simon; Lambert, Maja; Stahlhut, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(12), 8354-8383

$RFMT $RIREG SCHEME463 STEP1
$RXN



  2  1
$MOL
Bicyclo[2.2.2]octane-1-carboxylic acid, 4-[1-butyl-3-[(2,4-dimethoxyphenyl)me...
C27H34N4O6
3032112-39-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.0123 11.6002 0.0 0
M  V30 2 O 17.0123 13.1402 0.0 0
M  V30 3 O 18.3460 10.8302 0.0 0
M  V30 4 C 6.9301 9.3359 0.0 0
M  V30 5 O 10.0101 4.0010 0.0 0
M  V30 6 O 5.3901 6.6684 0.0 0
M  V30 7 C 6.9301 4.0010 0.0 0
M  V30 8 C 7.7001 2.6673 0.0 0
M  V30 9 C 6.9301 1.3337 0.0 0
M  V30 10 C 7.7001 0.0000 0.0 0
M  V30 11 O 5.3901 12.0032 0.0 0
M  V30 12 C 4.6201 13.3369 0.0 0
M  V30 13 O 0.7700 9.3359 0.0 0
M  V30 14 C 0.0000 10.6696 0.0 0
M  V30 15 C 13.0112 9.2902 0.0 0
M  V30 16 C 13.0107 10.8311 0.0 0
M  V30 17 C 14.3455 8.5192 0.0 0
M  V30 18 C 14.1382 9.2888 0.0 0
M  V30 19 C 14.3444 11.6011 0.0 0
M  V30 20 C 15.6791 9.2893 0.0 0
M  V30 21 C 15.1162 9.8535 0.0 0
M  V30 22 C 15.6785 10.8302 0.0 0
M  V30 23 C 11.6775 8.5202 0.0 0
M  V30 24 N 10.2706 9.1467 0.0 0
M  V30 25 N 11.5164 6.9886 0.0 0
M  V30 26 C 9.2401 8.0021 0.0 0
M  V30 27 C 10.0101 6.6684 0.0 0
M  V30 28 N 7.7001 8.0021 0.0 0
M  V30 29 C 9.2401 5.3348 0.0 0
M  V30 30 C 6.9301 6.6684 0.0 0
M  V30 31 N 7.7001 5.3348 0.0 0
M  V30 32 C 5.3901 9.3359 0.0 0
M  V30 33 C 4.6201 10.6696 0.0 0
M  V30 34 C 4.6201 8.0021 0.0 0
M  V30 35 C 3.0800 10.6696 0.0 0
M  V30 36 C 3.0800 8.0021 0.0 0
M  V30 37 C 2.3100 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 4 28
M  V30 5 1 4 32
M  V30 6 2 5 29
M  V30 7 2 6 30
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 33
M  V30 14 1 13 14
M  V30 15 1 13 37
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 23
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Azido-1-butanamine
C4H10N4
88192-20-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 8.0023 0.7700 0.0 0 CHG=1 VAL=4
M  V30 7 N 0.0000 0.7700 0.0 0
M  V30 8 N 9.3360 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.2]octane-1-carboxamide, N-(4-azidobutyl)-4-[1-butyl-3-[(2,4-dimet...
C31H42N8O5
2938292-10-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.0124 11.6003 0.0 0
M  V30 2 N 18.3461 10.8303 0.0 0
M  V30 3 O 17.0124 13.1403 0.0 0
M  V30 4 C 19.6798 11.6003 0.0 0
M  V30 5 C 21.0136 10.8303 0.0 0
M  V30 6 C 22.3473 11.6003 0.0 0
M  V30 7 C 23.6809 10.8303 0.0 0
M  V30 8 N 25.0146 11.6003 0.0 0
M  V30 9 N 26.3484 10.8303 0.0 0 CHG=1 VAL=4
M  V30 10 N 27.6821 10.0603 0.0 0 CHG=-1
M  V30 11 C 6.9302 9.3360 0.0 0
M  V30 12 O 10.0102 4.0010 0.0 0
M  V30 13 O 5.3901 6.6685 0.0 0
M  V30 14 C 6.9302 4.0010 0.0 0
M  V30 15 C 7.7002 2.6673 0.0 0
M  V30 16 C 6.9302 1.3337 0.0 0
M  V30 17 C 7.7002 0.0000 0.0 0
M  V30 18 O 5.3901 12.0033 0.0 0
M  V30 19 C 4.6201 13.3370 0.0 0
M  V30 20 O 0.7700 9.3360 0.0 0
M  V30 21 C 0.0000 10.6697 0.0 0
M  V30 22 C 13.0113 9.2903 0.0 0
M  V30 23 C 13.0108 10.8312 0.0 0
M  V30 24 C 14.3456 8.5193 0.0 0
M  V30 25 C 14.1383 9.2889 0.0 0
M  V30 26 C 14.3445 11.6012 0.0 0
M  V30 27 C 15.6792 9.2893 0.0 0
M  V30 28 C 15.1165 9.8536 0.0 0
M  V30 29 C 15.6788 10.8303 0.0 0
M  V30 30 C 11.6776 8.5202 0.0 0
M  V30 31 N 10.2706 9.1467 0.0 0
M  V30 32 N 11.5167 6.9887 0.0 0
M  V30 33 C 9.2402 8.0022 0.0 0
M  V30 34 C 10.0102 6.6685 0.0 0
M  V30 35 N 7.7002 8.0022 0.0 0
M  V30 36 C 9.2402 5.3348 0.0 0
M  V30 37 C 6.9302 6.6685 0.0 0
M  V30 38 N 7.7002 5.3348 0.0 0
M  V30 39 C 5.3901 9.3360 0.0 0
M  V30 40 C 4.6201 10.6697 0.0 0
M  V30 41 C 4.6201 8.0022 0.0 0
M  V30 42 C 3.0801 10.6697 0.0 0
M  V30 43 C 3.0801 8.0022 0.0 0
M  V30 44 C 2.3101 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 2 9 10
M  V30 11 1 11 35
M  V30 12 1 11 39
M  V30 13 2 12 36
M  V30 14 2 13 37
M  V30 15 1 14 15
M  V30 16 1 14 38
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 40
M  V30 21 1 20 21
M  V30 22 1 20 44
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 22 30
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3032112-39-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88192-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2938292-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40275716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Covalent, Clickable Probes for Adenosine A1 and A3
Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trinh, Phuc N. H.; Chong, Daniel J. W.; Leach, Katie; Hill, Stephen J.;
Tyndall, Joel D. A.; May, Lauren T.; Vernall, Andrea J.; Gregory, Karen
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(12), 8161-8178

$RFMT $RIREG SCHEME464 STEP1
$RXN



  2  1
$MOL
2-Furancarboxylic acid, compd. with 3-[5-[(1R,2S)-2-amino-1-(2,3-dihydro-1,4-...
C29H30N4O5.C5H4O3
3028971-78-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 19.0446 8.9688 0.0 0
M  V30 2 N 20.1889 9.9993 0.0 0
M  V30 3 O 19.3647 7.4624 0.0 0
M  V30 4 O 7.7000 8.1797 0.0 0
M  V30 5 C 6.9300 9.5135 0.0 0 CFG=2
M  V30 6 C 7.7000 10.8472 0.0 0 CFG=1
M  V30 7 C 9.2400 10.8472 0.0 0
M  V30 8 N 6.9300 12.1808 0.0 0
M  V30 9 N 13.8264 7.8596 0.0 0
M  V30 10 C 12.3200 8.1797 0.0 0
M  V30 11 N 13.9874 6.3280 0.0 0
M  V30 12 C 11.5500 6.8461 0.0 0
M  V30 13 C 11.5500 9.5135 0.0 0
M  V30 14 C 12.5804 5.7017 0.0 0
M  V30 15 C 10.0100 6.8461 0.0 0
M  V30 16 C 10.0100 9.5135 0.0 0
M  V30 17 C 9.2400 8.1797 0.0 0
M  V30 18 C 14.9708 8.8901 0.0 0
M  V30 19 C 16.4355 8.4141 0.0 0
M  V30 20 C 14.6506 10.3964 0.0 0
M  V30 21 C 17.5799 9.4447 0.0 0
M  V30 22 C 15.7950 11.4268 0.0 0
M  V30 23 C 17.2597 10.9510 0.0 0
M  V30 24 C 21.6536 9.5234 0.0 0 CFG=1
M  V30 25 C 22.8995 10.4286 0.0 0
M  V30 26 C 22.1295 8.0587 0.0 0
M  V30 27 C 24.1454 9.5234 0.0 0
M  V30 28 O 23.6695 8.0587 0.0 0
M  V30 29 C 5.3900 9.5135 0.0 0
M  V30 30 C 4.6200 8.1797 0.0 0
M  V30 31 C 4.6200 10.8472 0.0 0
M  V30 32 C 3.0800 8.1797 0.0 0
M  V30 33 C 3.0800 10.8472 0.0 0
M  V30 34 C 2.3100 9.5135 0.0 0
M  V30 35 O 2.3100 6.8461 0.0 0
M  V30 36 O 0.7700 9.5135 0.0 0
M  V30 37 C 0.7700 6.8461 0.0 0
M  V30 38 C 0.0000 8.1799 0.0 0
M  V30 39 C 13.2913 1.5400 0.0 0
M  V30 40 O 14.6251 2.3100 0.0 0
M  V30 41 O 13.2913 0.0000 0.0 0
M  V30 42 C 11.9576 2.3100 0.0 0
M  V30 43 C 10.5508 1.6835 0.0 0
M  V30 44 O 11.7967 3.8416 0.0 0
M  V30 45 C 9.5203 2.8281 0.0 0
M  V30 46 C 10.2903 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 24 2 CFG=3
M  V30 5 1 5 4 CFG=3
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 1 5 29
M  V30 9 1 6 7
M  V30 10 1 6 8 CFG=1
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 18
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 14
M  V30 18 2 12 15
M  V30 19 1 13 16
M  V30 20 1 15 17
M  V30 21 2 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 32 35
M  V30 39 2 33 34
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 44 1 39 40
M  V30 45 2 39 41
M  V30 46 1 39 42
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 6 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,2-Difluoropropanoic acid
C3H4F2O2
373-96-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 2.8737 2.3100 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 F 0.7700 2.8737 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 O 4.2073 1.5400 0.0 0
M  V30 7 O 2.8737 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[5-[(1R,2S)-2-[(2,2-Difluoro-1-oxopropyl)amino]-1-(2,3-dihydro-1,4-benzodio...
C32H32F2N4O6
1196509-60-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 8.0021 0.0 0
M  V30 2 C 6.9300 6.6685 0.0 0 CFG=2
M  V30 3 C 7.7000 5.3347 0.0 0 CFG=2
M  V30 4 N 6.9300 4.0011 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 C 7.7000 2.6674 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 O 9.2400 2.6674 0.0 0
M  V30 9 C 6.1600 0.0000 0.0 0
M  V30 10 F 5.5964 2.1038 0.0 0
M  V30 11 F 8.2636 0.5638 0.0 0
M  V30 12 C 19.0446 7.2132 0.0 0
M  V30 13 N 20.1889 6.1826 0.0 0
M  V30 14 O 19.3647 8.7195 0.0 0
M  V30 15 C 12.3200 8.0021 0.0 0
M  V30 16 N 13.8264 8.3223 0.0 0
M  V30 17 C 11.5500 9.3358 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 N 13.9874 9.8538 0.0 0
M  V30 20 C 10.0100 9.3358 0.0 0
M  V30 21 C 12.5804 10.4803 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 24 C 14.9708 7.2919 0.0 0
M  V30 25 C 16.4355 7.7678 0.0 0
M  V30 26 C 14.6506 5.7855 0.0 0
M  V30 27 C 17.5799 6.7373 0.0 0
M  V30 28 C 15.7950 4.7551 0.0 0
M  V30 29 C 17.2597 5.2309 0.0 0
M  V30 30 C 5.3900 6.6685 0.0 0
M  V30 31 C 4.6200 8.0021 0.0 0
M  V30 32 C 4.6200 5.3347 0.0 0
M  V30 33 C 3.0800 8.0021 0.0 0
M  V30 34 C 3.0800 5.3347 0.0 0
M  V30 35 C 2.3100 6.6685 0.0 0
M  V30 36 O 2.3100 9.3358 0.0 0
M  V30 37 O 0.7700 6.6685 0.0 0
M  V30 38 C 0.7700 9.3358 0.0 0
M  V30 39 C 0.0000 8.0021 0.0 0
M  V30 40 C 21.6536 6.6587 0.0 0 CFG=1
M  V30 41 C 22.8995 5.7534 0.0 0
M  V30 42 C 22.1295 8.1232 0.0 0
M  V30 43 C 24.1454 6.6587 0.0 0
M  V30 44 O 23.6695 8.1232 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 30
M  V30 5 1 3 4
M  V30 6 1 3 5 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 27
M  V30 16 1 40 13 CFG=1
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 16 24
M  V30 22 2 17 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 2 19 21
M  V30 26 1 20 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 33 36
M  V30 40 2 34 35
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 3 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3028971-78-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 373-96-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1196509-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39283200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 3282-30-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, intermediate from stage 2 added to stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal catalyzed C-N bond forming reaction selection and process
development for the manufacture of AZD7594
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aydin, Gulsevim; Ball, Matthew; Bishop, Thomas George; Burns, Matthew;
Campbell, Andrew D.; Cox, Robert J.; Dai, Kuangchu; Dave, David; Fisk,
Heidi; Hamilton, Laura; Heffernan, Claire; Henry, Jean-Marc; Holman,
Stephen W.; Jones, Martin F.; Noonan, Gary; Patel, Bharti; Streather,
David; Tomasi, Simone
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2024), 28(2), 559-576

$RFMT $RIREG SCHEME465 STEP1
$RXN



  2  1
$MOL
Acetonitrile, 2-amino-, hydrochloride (1:1)
C2H4N2.ClH
6011-14-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3100 0.0 0
M  V30 3 N 4.0010 2.3100 0.0 0
M  V30 4 N 0.0000 3.0800 0.0 0
M  V30 5 Cl 2.0005 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C52H71N7O15
3078809-46-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  74 77 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.8391 8.6445 0.0 0
M  V30 2 C 15.3266 8.2460 0.0 0
M  V30 3 C 15.7252 6.7585 0.0 0
M  V30 4 N 17.2127 6.3598 0.0 0
M  V30 5 C 17.6112 4.8723 0.0 0
M  V30 6 O 19.0989 4.4737 0.0 0
M  V30 7 O 16.5223 3.7833 0.0 0
M  V30 8 C 19.4974 2.9862 0.0 0
M  V30 9 C 20.9849 3.3848 0.0 0
M  V30 10 C 19.8960 1.4986 0.0 0
M  V30 11 C 18.0099 2.5875 0.0 0
M  V30 12 O 8.2638 5.3347 0.0 0
M  V30 13 C 6.7238 5.3347 0.0 0
M  V30 14 C 5.9538 4.0011 0.0 0
M  V30 15 N 4.4138 4.0011 0.0 0
M  V30 16 C 3.6438 2.6674 0.0 0
M  V30 17 O 2.1038 2.6674 0.0 0
M  V30 18 O 4.4138 1.3336 0.0 0
M  V30 19 C 1.3338 1.3336 0.0 0
M  V30 20 C 2.6674 0.5636 0.0 0
M  V30 21 C 0.5638 0.0000 0.0 0
M  V30 22 C 0.0000 2.1036 0.0 0
M  V30 23 N 14.5748 16.2659 0.0 0
M  V30 24 C 14.5748 17.8059 0.0 0
M  V30 25 C 15.9086 15.4959 0.0 0
M  V30 26 C 15.9086 18.5759 0.0 0 CFG=2
M  V30 27 O 13.2411 18.5759 0.0 0
M  V30 28 N 15.9086 20.1159 0.0 0
M  V30 29 C 17.2422 17.8059 0.0 0
M  V30 30 C 14.5748 20.8859 0.0 0
M  V30 31 C 18.5759 18.5759 0.0 0
M  V30 32 O 14.5748 22.4259 0.0 0
M  V30 33 O 13.2411 20.1159 0.0 0
M  V30 34 N 19.9095 17.8059 0.0 0
M  V30 35 C 13.2411 23.1959 0.0 0
M  V30 36 C 21.2433 18.5759 0.0 0
M  V30 37 O 22.5770 17.8059 0.0 0
M  V30 38 O 21.2433 20.1159 0.0 0
M  V30 39 C 23.9106 18.5759 0.0 0
M  V30 40 C 23.1406 19.9095 0.0 0
M  V30 41 C 25.2444 19.3459 0.0 0
M  V30 42 C 24.6806 17.2422 0.0 0
M  V30 43 O 11.9075 17.8059 0.0 0
M  V30 44 C 5.2391 13.9559 0.0 0
M  V30 45 O 3.9053 13.1858 0.0 0
M  V30 46 O 5.2391 15.4959 0.0 0
M  V30 47 C 11.4570 12.6943 0.0 0
M  V30 48 O 9.8910 11.7901 0.0 0
M  V30 49 C 11.9075 11.6458 0.0 0
M  V30 50 C 10.5738 10.8758 0.0 0
M  V30 51 C 13.2411 10.8758 0.0 0
M  V30 52 C 11.9075 13.1858 0.0 0
M  V30 53 C 10.5738 9.3358 0.0 0
M  V30 54 C 9.2400 11.6458 0.0 0
M  V30 55 C 14.5748 11.6458 0.0 0
M  V30 56 C 13.2411 13.9559 0.0 0
M  V30 57 C 9.2400 8.5658 0.0 0
M  V30 58 C 7.9064 10.8758 0.0 0
M  V30 59 C 14.5748 13.1858 0.0 0
M  V30 60 C 13.2411 15.4959 0.0 0 CFG=2
M  V30 61 C 7.9064 9.3358 0.0 0
M  V30 62 C 6.5728 11.6458 0.0 0
M  V30 63 C 11.9075 16.2659 0.0 0
M  V30 64 C 6.5728 13.1858 0.0 0 CFG=1
M  V30 65 N 10.5738 15.4959 0.0 0
M  V30 66 N 7.9064 13.9559 0.0 0
M  V30 67 C 10.5738 13.9559 0.0 0 CFG=1
M  V30 68 C 9.2400 13.1858 0.0 0
M  V30 69 C 13.2411 24.7359 0.0 0
M  V30 70 C 11.9075 25.5059 0.0 0
M  V30 71 C 14.5748 25.5059 0.0 0
M  V30 72 C 11.9075 27.0459 0.0 0
M  V30 73 C 14.5748 27.0459 0.0 0
M  V30 74 C 13.2411 27.8159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 51
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 53
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 60 23 CFG=1
M  V30 26 1 24 26
M  V30 27 2 24 27
M  V30 28 1 26 28
M  V30 29 1 26 29 CFG=1
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 34 1 31 34
M  V30 35 1 32 35
M  V30 36 1 34 36
M  V30 37 1 35 69
M  V30 38 1 36 37
M  V30 39 2 36 38
M  V30 40 1 37 39
M  V30 41 1 39 40
M  V30 42 1 39 41
M  V30 43 1 39 42
M  V30 44 2 43 63
M  V30 45 1 44 45
M  V30 46 2 44 46
M  V30 47 1 64 44 CFG=1
M  V30 48 1 67 47 CFG=1
M  V30 49 2 48 68
M  V30 50 1 49 50
M  V30 51 2 49 51
M  V30 52 1 49 52
M  V30 53 2 50 53
M  V30 54 1 50 54
M  V30 55 1 51 55
M  V30 56 2 52 56
M  V30 57 1 53 57
M  V30 58 2 54 58
M  V30 59 2 55 59
M  V30 60 1 56 59
M  V30 61 1 56 60
M  V30 62 2 57 61
M  V30 63 1 58 61
M  V30 64 1 58 62
M  V30 65 1 60 63
M  V30 66 1 62 64
M  V30 67 1 63 65
M  V30 68 1 64 66
M  V30 69 1 65 67
M  V30 70 1 66 68
M  V30 71 1 67 68
M  V30 72 2 69 70
M  V30 73 1 69 71
M  V30 74 1 70 72
M  V30 75 2 71 73
M  V30 76 2 72 74
M  V30 77 1 73 74
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 26 60 64 67)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C54H73N9O14
3078809-47-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  77 80 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 20.4297 14.9641 0.0 0
M  V30 2 C 20.5638 16.4983 0.0 0
M  V30 3 C 21.9596 17.1491 0.0 0
M  V30 4 N 22.0939 18.6833 0.0 0
M  V30 5 C 23.4896 19.3341 0.0 0
M  V30 6 O 23.6237 20.8683 0.0 0
M  V30 7 O 24.7510 18.4508 0.0 0
M  V30 8 C 25.0195 21.5191 0.0 0
M  V30 9 C 25.6704 20.1234 0.0 0
M  V30 10 C 26.4152 22.1699 0.0 0
M  V30 11 C 24.3686 22.9148 0.0 0
M  V30 12 O 21.1477 9.1296 0.0 0
M  V30 13 C 22.4815 9.8996 0.0 0
M  V30 14 C 23.8151 9.1296 0.0 0
M  V30 15 N 25.1488 9.8996 0.0 0
M  V30 16 C 26.4825 9.1296 0.0 0
M  V30 17 O 27.8163 9.8996 0.0 0
M  V30 18 O 26.4825 7.5896 0.0 0
M  V30 19 C 29.1500 9.1296 0.0 0
M  V30 20 C 29.9200 10.4633 0.0 0
M  V30 21 C 30.4836 8.3596 0.0 0
M  V30 22 C 28.3799 7.7958 0.0 0
M  V30 23 N 11.5502 14.6706 0.0 0
M  V30 24 C 10.0102 14.6706 0.0 0
M  V30 25 C 12.3202 16.0044 0.0 0
M  V30 26 C 9.2402 16.0044 0.0 0 CFG=2
M  V30 27 O 9.2402 13.3370 0.0 0
M  V30 28 N 7.7001 16.0044 0.0 0
M  V30 29 C 10.0102 17.3381 0.0 0
M  V30 30 C 6.9301 14.6706 0.0 0
M  V30 31 C 9.2402 18.6718 0.0 0
M  V30 32 O 5.3901 14.6706 0.0 0
M  V30 33 O 7.7001 13.3370 0.0 0
M  V30 34 N 10.0102 20.0054 0.0 0
M  V30 35 C 4.6201 13.3370 0.0 0
M  V30 36 C 9.2402 21.3392 0.0 0
M  V30 37 O 10.0102 22.6729 0.0 0
M  V30 38 O 7.7001 21.3392 0.0 0
M  V30 39 C 9.2402 24.0066 0.0 0
M  V30 40 C 7.9065 23.2366 0.0 0
M  V30 41 C 8.4702 25.3402 0.0 0
M  V30 42 C 10.5738 24.7766 0.0 0
M  V30 43 O 10.0102 12.0033 0.0 0
M  V30 44 C 13.8603 5.3348 0.0 0
M  V30 45 N 14.6303 4.0010 0.0 0
M  V30 46 O 12.3202 5.3348 0.0 0
M  V30 47 C 13.8603 2.6673 0.0 0
M  V30 48 C 14.6303 1.3337 0.0 0
M  V30 49 N 15.4003 0.0000 0.0 0
M  V30 50 C 15.1217 11.5528 0.0 0
M  V30 51 O 16.0260 9.9868 0.0 0
M  V30 52 C 16.1703 12.0033 0.0 0
M  V30 53 C 16.9403 10.6696 0.0 0
M  V30 54 C 16.9403 13.3370 0.0 0
M  V30 55 C 14.6303 12.0033 0.0 0
M  V30 56 C 18.4803 10.6696 0.0 0
M  V30 57 C 16.1703 9.3358 0.0 0
M  V30 58 C 16.1703 14.6706 0.0 0
M  V30 59 C 13.8603 13.3370 0.0 0
M  V30 60 C 19.2504 9.3358 0.0 0
M  V30 61 C 16.9403 8.0021 0.0 0
M  V30 62 C 14.6303 14.6706 0.0 0
M  V30 63 C 12.3202 13.3370 0.0 0 CFG=2
M  V30 64 C 18.4803 8.0021 0.0 0
M  V30 65 C 16.1703 6.6685 0.0 0
M  V30 66 C 11.5502 12.0033 0.0 0
M  V30 67 C 14.6303 6.6685 0.0 0 CFG=1
M  V30 68 N 12.3202 10.6696 0.0 0
M  V30 69 N 13.8603 8.0021 0.0 0
M  V30 70 C 13.8603 10.6696 0.0 0 CFG=1
M  V30 71 C 14.6303 9.3358 0.0 0
M  V30 72 C 3.0801 13.3370 0.0 0
M  V30 73 C 2.3100 14.6706 0.0 0
M  V30 74 C 2.3100 12.0033 0.0 0
M  V30 75 C 0.7700 14.6706 0.0 0
M  V30 76 C 0.7700 12.0033 0.0 0
M  V30 77 C 0.0000 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 54
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 56
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 63 23 CFG=1
M  V30 26 1 24 26
M  V30 27 2 24 27
M  V30 28 1 26 28
M  V30 29 1 26 29 CFG=1
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 34 1 31 34
M  V30 35 1 32 35
M  V30 36 1 34 36
M  V30 37 1 35 72
M  V30 38 1 36 37
M  V30 39 2 36 38
M  V30 40 1 37 39
M  V30 41 1 39 40
M  V30 42 1 39 41
M  V30 43 1 39 42
M  V30 44 2 43 66
M  V30 45 1 44 45
M  V30 46 2 44 46
M  V30 47 1 67 44 CFG=1
M  V30 48 1 45 47
M  V30 49 1 47 48
M  V30 50 3 48 49
M  V30 51 1 70 50 CFG=1
M  V30 52 2 51 71
M  V30 53 1 52 53
M  V30 54 2 52 54
M  V30 55 1 52 55
M  V30 56 2 53 56
M  V30 57 1 53 57
M  V30 58 1 54 58
M  V30 59 2 55 59
M  V30 60 1 56 60
M  V30 61 2 57 61
M  V30 62 2 58 62
M  V30 63 1 59 62
M  V30 64 1 59 63
M  V30 65 2 60 64
M  V30 66 1 61 64
M  V30 67 1 61 65
M  V30 68 1 63 66
M  V30 69 1 65 67
M  V30 70 1 66 68
M  V30 71 1 67 69
M  V30 72 1 68 70
M  V30 73 1 69 71
M  V30 74 1 70 71
M  V30 75 2 72 73
M  V30 76 1 72 74
M  V30 77 1 73 75
M  V30 78 2 74 76
M  V30 79 2 75 77
M  V30 80 1 76 77
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 26 63 67 70)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6011-14-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3078809-46-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3078809-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-44938560
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Novel Arylomycins against
Multidrug-Resistant Gram-Negative Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yinyong; Zhang, Dan; Zhao, Wenhao; Li, Hongyuan; Lu, Zhengyu; Guo,
Bin; Meng, Xin; Zhou, Xianli; Yang, Yushe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(8), 6585-6609

$RFMT $RIREG SCHEME466 STEP1
$RXN



  2  1
$MOL
N-Acetyl-1-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-α-muramic acid
C25H29NO8
73089-68-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 2.6674 0.0 0 CFG=2
M  V30 3 C 6.9300 1.3336 0.0 0
M  V30 4 C 9.2400 2.6674 0.0 0
M  V30 5 O 7.7000 0.0000 0.0 0
M  V30 6 O 5.3900 1.3336 0.0 0
M  V30 7 N 10.0100 4.0011 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 C 12.3200 2.6674 0.0 0
M  V30 10 O 12.3200 5.3347 0.0 0
M  V30 11 O 11.5500 6.6684 0.0 0
M  V30 12 C 12.3200 8.0021 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 14 C 7.7000 5.3347 0.0 0 CFG=2
M  V30 15 C 7.7000 8.0021 0.0 0 CFG=1
M  V30 16 O 5.3900 6.6684 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0 CFG=1
M  V30 18 O 9.2400 8.0021 0.0 0
M  V30 19 C 6.9300 9.3358 0.0 0
M  V30 20 C 4.6200 8.0021 0.0 0 CFG=2
M  V30 21 C 10.0100 6.6684 0.0 0 CFG=1
M  V30 22 O 5.3900 9.3358 0.0 0
M  V30 23 C 3.0800 8.0021 0.0 0
M  V30 24 C 2.3100 9.3358 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 C 0.7700 9.3358 0.0 0
M  V30 27 C 0.7700 6.6684 0.0 0
M  V30 28 C 0.0000 8.0021 0.0 0
M  V30 29 C 13.8600 8.0021 0.0 0
M  V30 30 C 14.6300 9.3358 0.0 0
M  V30 31 C 14.6300 6.6684 0.0 0
M  V30 32 C 16.1700 9.3358 0.0 0
M  V30 33 C 16.1700 6.6684 0.0 0
M  V30 34 C 16.9400 8.0021 0.0 0
M  V30 35 H 6.1600 5.3347 0.0 0
M  V30 36 H 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 17 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 21 11 CFG=3
M  V30 13 1 12 29
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 35 CFG=1
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 15 36 CFG=3
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 20 23 CFG=3
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 2 13 14 15 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Alanyl-D-α-glutamine phenylmethyl ester
C15H21N3O4
62853-36-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7801 5.3348 0.0 0
M  V30 2 O 9.2401 5.3348 0.0 0
M  V30 3 C 8.4701 4.0011 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 O 9.2401 2.6675 0.0 0
M  V30 6 C 6.1601 2.6675 0.0 0
M  V30 7 C 4.6201 2.6675 0.0 0 CFG=2
M  V30 8 N 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3337 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 N 2.3100 1.3337 0.0 0
M  V30 12 O 4.6201 0.0000 0.0 0
M  V30 13 C 1.5400 5.3348 0.0 0 CFG=1
M  V30 14 O 1.5400 2.6675 0.0 0
M  V30 15 C 2.3100 6.6684 0.0 0
M  V30 16 N 0.0000 5.3348 0.0 0
M  V30 17 C 11.5501 6.6684 0.0 0
M  V30 18 C 10.7801 8.0022 0.0 0
M  V30 19 C 13.0901 6.6684 0.0 0
M  V30 20 C 11.5501 9.3359 0.0 0
M  V30 21 C 13.8602 8.0022 0.0 0
M  V30 22 C 13.0901 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 13 15
M  V30 16 1 13 16 CFG=1
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[N-Acetyl-1-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-α-muramoyl]-L-alan...
C40H48N4O11
170210-30-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 61 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 10.6694 0.0 0
M  V30 2 C 9.2400 10.6694 0.0 0 CFG=2
M  V30 3 C 10.0100 12.0032 0.0 0
M  V30 4 C 10.0100 9.3358 0.0 0
M  V30 5 N 11.5500 12.0032 0.0 0
M  V30 6 O 9.2400 13.3369 0.0 0
M  V30 7 C 12.3200 13.3369 0.0 0 CFG=1
M  V30 8 C 13.8600 13.3369 0.0 0
M  V30 9 C 11.5500 14.6705 0.0 0
M  V30 10 N 14.6300 14.6705 0.0 0
M  V30 11 O 14.6300 12.0032 0.0 0
M  V30 12 C 16.1700 14.6705 0.0 0 CFG=1
M  V30 13 C 16.9400 13.3369 0.0 0
M  V30 14 C 16.9400 16.0041 0.0 0
M  V30 15 C 18.4800 13.3369 0.0 0
M  V30 16 N 16.1700 17.3379 0.0 0
M  V30 17 O 18.4800 16.0041 0.0 0
M  V30 18 C 19.2500 12.0032 0.0 0
M  V30 19 O 20.7900 12.0032 0.0 0
M  V30 20 O 18.4800 10.6694 0.0 0
M  V30 21 C 21.5600 10.6694 0.0 0
M  V30 22 N 9.2400 8.0021 0.0 0
M  V30 23 C 10.0100 6.6685 0.0 0
M  V30 24 C 11.5500 6.6685 0.0 0
M  V30 25 O 9.2400 5.3347 0.0 0
M  V30 26 O 7.7000 5.3347 0.0 0
M  V30 27 C 6.9300 4.0011 0.0 0
M  V30 28 C 5.3900 9.3358 0.0 0 CFG=2
M  V30 29 C 6.9300 9.3358 0.0 0 CFG=2
M  V30 30 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 31 O 4.6200 10.6694 0.0 0
M  V30 32 C 7.7000 8.0021 0.0 0 CFG=1
M  V30 33 O 5.3900 6.6685 0.0 0
M  V30 34 C 3.0800 8.0021 0.0 0
M  V30 35 C 3.0800 10.6694 0.0 0 CFG=2
M  V30 36 C 6.9300 6.6685 0.0 0 CFG=1
M  V30 37 O 2.3100 9.3358 0.0 0
M  V30 38 C 2.3100 12.0032 0.0 0
M  V30 39 C 3.0800 13.3369 0.0 0
M  V30 40 C 0.7700 12.0032 0.0 0
M  V30 41 C 2.3100 14.6705 0.0 0
M  V30 42 C 0.0000 13.3369 0.0 0
M  V30 43 C 0.7700 14.6705 0.0 0
M  V30 44 C 7.7000 2.6674 0.0 0
M  V30 45 C 6.9300 1.3338 0.0 0
M  V30 46 C 9.2400 2.6674 0.0 0
M  V30 47 C 7.7000 0.0000 0.0 0
M  V30 48 C 10.0100 1.3338 0.0 0
M  V30 49 C 9.2400 0.0000 0.0 0
M  V30 50 C 23.1000 10.6694 0.0 0
M  V30 51 C 23.8700 9.3358 0.0 0
M  V30 52 C 23.8700 12.0032 0.0 0
M  V30 53 C 25.4100 9.3358 0.0 0
M  V30 54 C 25.4100 12.0032 0.0 0
M  V30 55 C 26.1800 10.6694 0.0 0
M  V30 56 H 6.1600 10.6694 0.0 0
M  V30 57 H 3.8500 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 29 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 13 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 21 50
M  V30 23 1 22 23
M  V30 24 1 32 22 CFG=1
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 26 27
M  V30 28 1 36 26 CFG=1
M  V30 29 1 27 44
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 28 31
M  V30 33 1 28 56 CFG=3
M  V30 34 1 29 32
M  V30 35 1 30 33
M  V30 36 1 30 34
M  V30 37 1 30 57 CFG=1
M  V30 38 1 31 35
M  V30 39 1 32 36
M  V30 40 1 33 36
M  V30 41 1 34 37
M  V30 42 1 35 37
M  V30 43 1 35 38 CFG=1
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 50 2 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 56 2 50 51
M  V30 57 1 50 52
M  V30 58 1 51 53
M  V30 59 2 52 54
M  V30 60 2 53 55
M  V30 61 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 7 12 28 29 30 32 35 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 73089-68-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62853-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 170210-30-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-44479951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of novel lipophilic 2,
5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mhamane, Tukaram B.; Sambyal, Shainy; Vemireddy, Sravanthi; Paturu, Rama
Subba Reddy; Katragadda, Suresh Babu; Syed, Shafi; Khan, Arif; Halmuthur
M., Sampath Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 88-89117296

$RFMT $RIREG SCHEME467 STEP1
$RXN



  2  1
$MOL
1-Propanesulfonic acid, 3-(4-aminophenoxy)-, sodium salt (1:1)
C9H13NO4S.Na
58480-39-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 5.7473 0.0 0
M  V30 2 C 5.3900 4.4136 0.0 0
M  V30 3 C 3.8500 4.4136 0.0 0
M  V30 4 C 3.0800 3.0800 0.0 0
M  V30 5 S 1.5400 3.0800 0.0 0 VAL=6
M  V30 6 O 1.5400 4.6200 0.0 0
M  V30 7 O 1.5400 1.5400 0.0 0
M  V30 8 O 0.0000 3.0800 0.0 0
M  V30 9 N 12.3200 5.7473 0.0 0
M  V30 10 C 7.7000 5.7473 0.0 0
M  V30 11 C 8.4700 4.4136 0.0 0
M  V30 12 C 8.4700 7.0809 0.0 0
M  V30 13 C 10.0100 4.4136 0.0 0
M  V30 14 C 10.0100 7.0809 0.0 0
M  V30 15 C 10.7800 5.7473 0.0 0
M  V30 16 Na 6.1600 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C89H97N3O21
3036050-18-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  113 123 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 7.7000 0.0 0
M  V30 2 C 8.0021 6.9300 0.0 0 CFG=1
M  V30 3 C 9.3358 7.7000 0.0 0
M  V30 4 C 8.0021 5.3900 0.0 0
M  V30 5 O 6.6684 4.6200 0.0 0
M  V30 6 O 9.3358 4.6200 0.0 0
M  V30 7 C 6.6684 3.0800 0.0 0
M  V30 8 O 9.3358 9.2400 0.0 0
M  V30 9 C 10.6694 10.0100 0.0 0
M  V30 10 O 10.6694 11.5500 0.0 0
M  V30 11 O 4.0011 9.2400 0.0 0
M  V30 12 C 2.6674 8.4700 0.0 0
M  V30 13 O 1.3336 9.2400 0.0 0
M  V30 14 O 9.3358 12.3200 0.0 0
M  V30 15 C 9.3358 13.8600 0.0 0 CFG=1
M  V30 16 C 10.6694 14.6300 0.0 0 CFG=2
M  V30 17 C 8.0021 14.6300 0.0 0
M  V30 18 O 10.6694 16.1700 0.0 0
M  V30 19 C 12.0031 13.8600 0.0 0
M  V30 20 O 8.0021 16.1700 0.0 0
M  V30 21 O 6.6684 13.8600 0.0 0
M  V30 22 O 13.3369 14.6300 0.0 0
M  V30 23 O 12.0031 12.3200 0.0 0
M  V30 24 C 6.6684 16.9400 0.0 0
M  V30 25 C 14.6705 13.8600 0.0 0 CFG=1
M  V30 26 C 6.6684 18.4800 0.0 0
M  V30 27 C 5.3347 16.1700 0.0 0
M  V30 28 C 16.0041 14.6300 0.0 0
M  V30 29 C 14.6705 12.3200 0.0 0
M  V30 30 C 17.3378 13.8600 0.0 0
M  V30 31 C 18.6716 14.6300 0.0 0
M  V30 32 C 4.0011 12.3200 0.0 0
M  V30 33 O 2.6674 11.5500 0.0 0
M  V30 34 C 1.3336 12.3200 0.0 0
M  V30 35 O 10.6694 19.2500 0.0 0
M  V30 36 C 10.6694 20.7900 0.0 0
M  V30 37 O 13.3369 20.7900 0.0 0
M  V30 38 C 14.6705 21.5600 0.0 0
M  V30 39 C 16.0041 16.1700 0.0 0
M  V30 40 O 16.0041 19.2500 0.0 0
M  V30 41 C 17.3378 18.4800 0.0 0
M  V30 42 C 23.9741 13.5029 0.0 0
M  V30 43 C 24.8793 12.2570 0.0 0
M  V30 44 C 26.4108 12.4179 0.0 0
M  V30 45 C 27.3161 11.1721 0.0 0
M  V30 46 C 28.8476 11.3332 0.0 0
M  V30 47 O 29.4739 12.7400 0.0 0
M  V30 48 O 29.7528 10.0872 0.0 0
M  V30 49 C 6.6684 9.2400 0.0 0 CFG=1
M  V30 50 C 8.0021 10.0100 0.0 0 CFG=1
M  V30 51 C 5.3347 10.0100 0.0 0 CFG=1
M  V30 52 C 8.0021 11.5500 0.0 0 CFG=2
M  V30 53 C 5.3347 11.5500 0.0 0 CFG=1
M  V30 54 O 6.6684 12.3200 0.0 0
M  V30 55 C 12.2036 9.8757 0.0 0
M  V30 56 C 13.0869 11.1373 0.0 0
M  V30 57 C 12.8544 8.4800 0.0 0
M  V30 58 C 14.6211 11.0030 0.0 0
M  V30 59 C 14.3885 8.3459 0.0 0
M  V30 60 C 15.2719 9.6073 0.0 0
M  V30 61 C 2.6674 6.9300 0.0 0
M  V30 62 C 4.0011 6.1600 0.0 0
M  V30 63 C 1.3336 6.1600 0.0 0
M  V30 64 C 4.0011 4.6200 0.0 0
M  V30 65 C 1.3336 4.6200 0.0 0
M  V30 66 C 2.6674 3.8500 0.0 0
M  V30 67 C 10.6694 6.9300 0.0 0
M  V30 68 C 12.0031 7.7000 0.0 0
M  V30 69 C 10.6694 5.3900 0.0 0
M  V30 70 C 13.3369 6.9300 0.0 0
M  V30 71 C 12.0031 4.6200 0.0 0
M  V30 72 C 13.3369 5.3900 0.0 0
M  V30 73 C 1.3336 13.8600 0.0 0
M  V30 74 C 2.6674 14.6300 0.0 0
M  V30 75 C 0.0000 14.6300 0.0 0
M  V30 76 C 2.6674 16.1700 0.0 0
M  V30 77 C 0.0000 16.1700 0.0 0
M  V30 78 C 1.3336 16.9400 0.0 0
M  V30 79 C 8.0021 2.3100 0.0 0
M  V30 80 C 8.0021 0.7700 0.0 0
M  V30 81 C 9.3358 3.0800 0.0 0
M  V30 82 C 9.3358 0.0000 0.0 0
M  V30 83 C 10.6694 2.3100 0.0 0
M  V30 84 C 10.6694 0.7700 0.0 0
M  V30 85 C 12.0031 16.9400 0.0 0 CFG=2
M  V30 86 C 12.0031 18.4800 0.0 0 CFG=1
M  V30 87 O 13.3369 16.1700 0.0 0
M  V30 88 C 13.3369 19.2500 0.0 0 CFG=2
M  V30 89 C 14.6705 16.9400 0.0 0 CFG=1
M  V30 90 C 14.6705 18.4800 0.0 0 CFG=2
M  V30 91 C 9.3358 21.5600 0.0 0
M  V30 92 C 8.0021 20.7900 0.0 0
M  V30 93 C 9.3358 23.1000 0.0 0
M  V30 94 C 6.6684 21.5600 0.0 0
M  V30 95 C 8.0021 23.8700 0.0 0
M  V30 96 C 6.6684 23.1000 0.0 0
M  V30 97 C 14.6705 23.1000 0.0 0
M  V30 98 C 16.0041 23.8700 0.0 0
M  V30 99 C 13.3369 23.8700 0.0 0
M  V30 100 C 16.0041 25.4100 0.0 0
M  V30 101 C 13.3369 25.4100 0.0 0
M  V30 102 C 14.6705 26.1800 0.0 0
M  V30 103 N 20.0052 13.8600 0.0 0
M  V30 104 C 21.4120 14.4863 0.0 0
M  V30 105 N 20.1661 12.3285 0.0 0
M  V30 106 C 22.4426 13.3419 0.0 0
M  V30 107 N 21.6726 12.0083 0.0 0
M  V30 108 C 18.6716 19.2500 0.0 0
M  V30 109 C 20.0052 18.4800 0.0 0
M  V30 110 C 18.6716 20.7900 0.0 0
M  V30 111 C 21.3389 19.2500 0.0 0
M  V30 112 C 20.0052 21.5600 0.0 0
M  V30 113 C 21.3389 20.7900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 49 1 CFG=1
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 67
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 79
M  V30 10 1 8 9
M  V30 11 1 50 8 CFG=3
M  V30 12 2 9 10
M  V30 13 1 9 55
M  V30 14 1 11 12
M  V30 15 1 51 11 CFG=1
M  V30 16 2 12 13
M  V30 17 1 12 61
M  V30 18 1 15 14 CFG=1
M  V30 19 1 52 14 CFG=1
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18 CFG=1
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 85 18 CFG=1
M  V30 27 1 19 22
M  V30 28 2 19 23
M  V30 29 1 20 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 25 28
M  V30 34 1 25 29 CFG=3
M  V30 35 1 28 30
M  V30 36 1 30 31
M  V30 37 1 31 103
M  V30 38 1 32 33
M  V30 39 1 53 32 CFG=1
M  V30 40 1 33 34
M  V30 41 1 34 73
M  V30 42 1 35 36
M  V30 43 1 86 35 CFG=1
M  V30 44 1 36 91
M  V30 45 1 37 38
M  V30 46 1 88 37 CFG=3
M  V30 47 1 38 97
M  V30 48 1 89 39 CFG=3
M  V30 49 1 40 41
M  V30 50 1 90 40 CFG=3
M  V30 51 1 41 108
M  V30 52 1 42 43
M  V30 53 1 42 106
M  V30 54 1 43 44
M  V30 55 1 44 45
M  V30 56 1 45 46
M  V30 57 1 46 47
M  V30 58 2 46 48
M  V30 59 1 49 50
M  V30 60 1 49 51
M  V30 61 1 50 52
M  V30 62 1 51 53
M  V30 63 1 52 54
M  V30 64 1 53 54
M  V30 65 2 55 56
M  V30 66 1 55 57
M  V30 67 1 56 58
M  V30 68 2 57 59
M  V30 69 2 58 60
M  V30 70 1 59 60
M  V30 71 2 61 62
M  V30 72 1 61 63
M  V30 73 1 62 64
M  V30 74 2 63 65
M  V30 75 2 64 66
M  V30 76 1 65 66
M  V30 77 2 67 68
M  V30 78 1 67 69
M  V30 79 1 68 70
M  V30 80 2 69 71
M  V30 81 2 70 72
M  V30 82 1 71 72
M  V30 83 2 73 74
M  V30 84 1 73 75
M  V30 85 1 74 76
M  V30 86 2 75 77
M  V30 87 2 76 78
M  V30 88 1 77 78
M  V30 89 2 79 80
M  V30 90 1 79 81
M  V30 91 1 80 82
M  V30 92 2 81 83
M  V30 93 2 82 84
M  V30 94 1 83 84
M  V30 95 1 85 86
M  V30 96 1 85 87
M  V30 97 1 86 88
M  V30 98 1 87 89
M  V30 99 1 88 90
M  V30 100 1 89 90
M  V30 101 2 91 92
M  V30 102 1 91 93
M  V30 103 1 92 94
M  V30 104 2 93 95
M  V30 105 2 94 96
M  V30 106 1 95 96
M  V30 107 2 97 98
M  V30 108 1 97 99
M  V30 109 1 98 100
M  V30 110 2 99 101
M  V30 111 2 100 102
M  V30 112 1 101 102
M  V30 113 1 103 104
M  V30 114 1 103 105
M  V30 115 2 104 106
M  V30 116 2 105 107
M  V30 117 1 106 107
M  V30 118 2 108 109
M  V30 119 1 108 110
M  V30 120 1 109 111
M  V30 121 2 110 112
M  V30 122 2 111 113
M  V30 123 1 112 113
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 2 15 16 25 49 50 51 52 53 85 86 88 89 90)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C98H108N4O24S.Na
3036050-26-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  128 138 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 20.7902 0.0 0
M  V30 2 C 10.6696 21.5603 0.0 0 CFG=1
M  V30 3 C 10.6696 23.1003 0.0 0
M  V30 4 C 12.0032 20.7902 0.0 0
M  V30 5 O 12.0032 19.2502 0.0 0
M  V30 6 O 13.3369 21.5603 0.0 0
M  V30 7 C 13.3369 18.4802 0.0 0
M  V30 8 O 11.7585 18.7992 0.0 0
M  V30 9 C 11.3600 20.2868 0.0 0
M  V30 10 O 9.8723 20.6854 0.0 0
M  V30 11 O 6.6684 18.4802 0.0 0
M  V30 12 C 6.6684 20.0202 0.0 0
M  V30 13 O 8.0021 20.7902 0.0 0
M  V30 14 O 12.0032 15.4002 0.0 0
M  V30 15 C 12.0032 13.8602 0.0 0 CFG=1
M  V30 16 C 13.3369 13.0901 0.0 0 CFG=2
M  V30 17 C 10.6696 13.0901 0.0 0
M  V30 18 O 13.3369 11.5501 0.0 0
M  V30 19 C 14.6707 13.8602 0.0 0
M  V30 20 O 10.6696 11.5501 0.0 0
M  V30 21 O 9.3359 13.8602 0.0 0
M  V30 22 O 16.0043 13.0901 0.0 0
M  V30 23 O 14.6707 15.4002 0.0 0
M  V30 24 C 9.3359 10.7801 0.0 0
M  V30 25 C 17.3380 13.8602 0.0 0 CFG=2
M  V30 26 C 8.0021 11.5501 0.0 0
M  V30 27 C 9.3359 9.2401 0.0 0
M  V30 28 C 17.3380 15.4002 0.0 0
M  V30 29 C 18.6717 13.0901 0.0 0
M  V30 30 C 18.6717 16.1702 0.0 0
M  V30 31 C 20.0055 15.4002 0.0 0
M  V30 32 C 6.6684 15.4002 0.0 0
M  V30 33 O 5.3348 16.1702 0.0 0
M  V30 34 C 4.0011 15.4002 0.0 0
M  V30 35 O 13.3369 8.4701 0.0 0
M  V30 36 C 12.0032 7.7001 0.0 0
M  V30 37 O 16.0043 6.9301 0.0 0
M  V30 38 C 17.3380 6.1601 0.0 0
M  V30 39 C 18.6717 11.5501 0.0 0
M  V30 40 O 18.6717 8.4701 0.0 0
M  V30 41 C 20.0055 9.2401 0.0 0
M  V30 42 C 25.3081 16.5273 0.0 0
M  V30 43 C 26.2133 17.7732 0.0 0
M  V30 44 C 27.7448 17.6123 0.0 0
M  V30 45 C 28.6501 18.8581 0.0 0
M  V30 46 C 30.1816 18.6972 0.0 0
M  V30 47 N 31.0868 19.9431 0.0 0
M  V30 48 O 30.8079 17.2902 0.0 0
M  V30 49 O 28.5812 25.5706 0.0 0
M  V30 50 C 27.0497 25.7316 0.0 0
M  V30 51 C 26.4233 27.1385 0.0 0
M  V30 52 C 24.8916 27.2994 0.0 0
M  V30 53 S 24.2653 28.7063 0.0 0 VAL=6
M  V30 54 O 22.8585 28.0799 0.0 0
M  V30 55 O 25.6723 29.3327 0.0 0
M  V30 56 O 23.6390 30.1132 0.0 0
M  V30 57 C 9.3359 18.4802 0.0 0 CFG=1
M  V30 58 C 10.6696 17.7102 0.0 0 CFG=1
M  V30 59 C 8.0021 17.7102 0.0 0 CFG=1
M  V30 60 C 10.6696 16.1702 0.0 0 CFG=2
M  V30 61 C 8.0021 16.1702 0.0 0 CFG=1
M  V30 62 O 9.3359 15.4002 0.0 0
M  V30 63 C 12.4133 23.1810 0.0 0
M  V30 64 C 13.9299 23.4485 0.0 0
M  V30 65 C 11.4234 24.3608 0.0 0
M  V30 66 C 14.4566 24.8956 0.0 0
M  V30 67 C 11.9501 25.8079 0.0 0
M  V30 68 C 13.4667 26.0753 0.0 0
M  V30 69 C 5.3348 20.7902 0.0 0
M  V30 70 C 5.3348 22.3303 0.0 0
M  V30 71 C 4.0011 20.0202 0.0 0
M  V30 72 C 4.0011 23.1003 0.0 0
M  V30 73 C 2.6673 20.7902 0.0 0
M  V30 74 C 2.6673 22.3303 0.0 0
M  V30 75 C 9.3359 23.8703 0.0 0
M  V30 76 C 8.0021 23.1003 0.0 0
M  V30 77 C 9.3359 25.4103 0.0 0
M  V30 78 C 6.6684 23.8703 0.0 0
M  V30 79 C 8.0021 26.1803 0.0 0
M  V30 80 C 6.6684 25.4103 0.0 0
M  V30 81 C 2.6673 16.1702 0.0 0
M  V30 82 C 2.6673 17.7102 0.0 0
M  V30 83 C 1.3337 15.4002 0.0 0
M  V30 84 C 1.3337 18.4802 0.0 0
M  V30 85 C 0.0000 16.1702 0.0 0
M  V30 86 C 0.0000 17.7102 0.0 0
M  V30 87 C 14.6707 19.2502 0.0 0
M  V30 88 C 14.6707 20.7902 0.0 0
M  V30 89 C 16.0043 18.4802 0.0 0
M  V30 90 C 16.0043 21.5603 0.0 0
M  V30 91 C 17.3380 19.2502 0.0 0
M  V30 92 C 17.3380 20.7902 0.0 0
M  V30 93 C 14.6707 10.7801 0.0 0 CFG=2
M  V30 94 C 14.6707 9.2401 0.0 0 CFG=1
M  V30 95 O 16.0043 11.5501 0.0 0
M  V30 96 C 16.0043 8.4701 0.0 0 CFG=2
M  V30 97 C 17.3380 10.7801 0.0 0 CFG=1
M  V30 98 C 17.3380 9.2401 0.0 0 CFG=2
M  V30 99 C 12.0032 6.1601 0.0 0
M  V30 100 C 10.6696 5.3900 0.0 0
M  V30 101 C 13.3369 5.3900 0.0 0
M  V30 102 C 10.6696 3.8500 0.0 0
M  V30 103 C 13.3369 3.8500 0.0 0
M  V30 104 C 12.0032 3.0800 0.0 0
M  V30 105 C 17.3380 4.6200 0.0 0
M  V30 106 C 16.0043 3.8500 0.0 0
M  V30 107 C 18.6717 3.8500 0.0 0
M  V30 108 C 16.0043 2.3100 0.0 0
M  V30 109 C 18.6717 2.3100 0.0 0
M  V30 110 C 17.3380 1.5400 0.0 0
M  V30 111 N 21.3391 16.1702 0.0 0
M  V30 112 C 22.7459 15.5439 0.0 0
M  V30 113 N 21.5001 17.7019 0.0 0
M  V30 114 C 23.7765 16.6882 0.0 0
M  V30 115 N 23.0065 18.0221 0.0 0
M  V30 116 C 21.3391 8.4701 0.0 0
M  V30 117 C 22.6728 9.2401 0.0 0
M  V30 118 C 21.3391 6.9301 0.0 0
M  V30 119 C 24.0064 8.4701 0.0 0
M  V30 120 C 22.6728 6.1601 0.0 0
M  V30 121 C 24.0064 6.9301 0.0 0
M  V30 122 C 30.4604 21.3500 0.0 0
M  V30 123 C 28.9288 21.5110 0.0 0
M  V30 124 C 31.3656 22.5959 0.0 0
M  V30 125 C 28.3025 22.9178 0.0 0
M  V30 126 C 30.7393 24.0027 0.0 0
M  V30 127 C 29.2077 24.1637 0.0 0
M  V30 128 Na 15.6828 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 57 1 CFG=3
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 75
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 87
M  V30 10 1 8 9
M  V30 11 1 58 8 CFG=1
M  V30 12 2 9 10
M  V30 13 1 9 63
M  V30 14 1 11 12
M  V30 15 1 59 11 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 69
M  V30 18 1 15 14 CFG=3
M  V30 19 1 60 14 CFG=3
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18 CFG=3
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 93 18 CFG=3
M  V30 27 1 19 22
M  V30 28 2 19 23
M  V30 29 1 20 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 25 28
M  V30 34 1 25 29 CFG=1
M  V30 35 1 28 30
M  V30 36 1 30 31
M  V30 37 1 31 111
M  V30 38 1 32 33
M  V30 39 1 61 32 CFG=3
M  V30 40 1 33 34
M  V30 41 1 34 81
M  V30 42 1 35 36
M  V30 43 1 94 35 CFG=3
M  V30 44 1 36 99
M  V30 45 1 37 38
M  V30 46 1 96 37 CFG=1
M  V30 47 1 38 105
M  V30 48 1 97 39 CFG=1
M  V30 49 1 40 41
M  V30 50 1 98 40 CFG=1
M  V30 51 1 41 116
M  V30 52 1 42 43
M  V30 53 1 42 114
M  V30 54 1 43 44
M  V30 55 1 44 45
M  V30 56 1 45 46
M  V30 57 1 46 47
M  V30 58 2 46 48
M  V30 59 1 47 122
M  V30 60 1 49 50
M  V30 61 1 49 127
M  V30 62 1 50 51
M  V30 63 1 51 52
M  V30 64 1 52 53
M  V30 65 2 53 54
M  V30 66 2 53 55
M  V30 67 1 53 56
M  V30 68 1 57 58
M  V30 69 1 57 59
M  V30 70 1 58 60
M  V30 71 1 59 61
M  V30 72 1 60 62
M  V30 73 1 61 62
M  V30 74 2 63 64
M  V30 75 1 63 65
M  V30 76 1 64 66
M  V30 77 2 65 67
M  V30 78 2 66 68
M  V30 79 1 67 68
M  V30 80 2 69 70
M  V30 81 1 69 71
M  V30 82 1 70 72
M  V30 83 2 71 73
M  V30 84 2 72 74
M  V30 85 1 73 74
M  V30 86 2 75 76
M  V30 87 1 75 77
M  V30 88 1 76 78
M  V30 89 2 77 79
M  V30 90 2 78 80
M  V30 91 1 79 80
M  V30 92 2 81 82
M  V30 93 1 81 83
M  V30 94 1 82 84
M  V30 95 2 83 85
M  V30 96 2 84 86
M  V30 97 1 85 86
M  V30 98 2 87 88
M  V30 99 1 87 89
M  V30 100 1 88 90
M  V30 101 2 89 91
M  V30 102 2 90 92
M  V30 103 1 91 92
M  V30 104 1 93 94
M  V30 105 1 93 95
M  V30 106 1 94 96
M  V30 107 1 95 97
M  V30 108 1 96 98
M  V30 109 1 97 98
M  V30 110 2 99 100
M  V30 111 1 99 101
M  V30 112 1 100 102
M  V30 113 2 101 103
M  V30 114 2 102 104
M  V30 115 1 103 104
M  V30 116 2 105 106
M  V30 117 1 105 107
M  V30 118 1 106 108
M  V30 119 2 107 109
M  V30 120 2 108 110
M  V30 121 1 109 110
M  V30 122 1 111 112
M  V30 123 1 111 113
M  V30 124 2 112 114
M  V30 125 2 113 115
M  V30 126 1 114 115
M  V30 127 2 116 117
M  V30 128 1 116 118
M  V30 129 1 117 119
M  V30 130 2 118 120
M  V30 131 2 119 121
M  V30 132 1 120 121
M  V30 133 2 122 123
M  V30 134 1 122 124
M  V30 135 1 123 125
M  V30 136 2 124 126
M  V30 137 2 125 127
M  V30 138 1 126 127
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 2 15 16 25 57 58 59 60 61 93 94 96 97 98)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 58480-39-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036050-18-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036050-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39877263
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sialyl LewisX glycomimetics bearing an extended anionic chain targeting
E- and P- selectin binding sites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Belouin, Audrey; Simard, Ryan D.; Joyal, Mathieu; Maharsy, Wael; Lau,
Alice; Prevost, Michel; Nemer, Mona; Guindon, Yvan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2024), 98117553

$RFMT $RIREG SCHEME468 STEP1
$RXN



  2  1
$MOL
1-Propanesulfonic acid, 3-(4-aminophenoxy)-, sodium salt (1:1)
C9H13NO4S.Na
58480-39-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 5.7473 0.0 0
M  V30 2 C 5.3900 4.4136 0.0 0
M  V30 3 C 3.8500 4.4136 0.0 0
M  V30 4 C 3.0800 3.0800 0.0 0
M  V30 5 S 1.5400 3.0800 0.0 0 VAL=6
M  V30 6 O 1.5400 4.6200 0.0 0
M  V30 7 O 1.5400 1.5400 0.0 0
M  V30 8 O 0.0000 3.0800 0.0 0
M  V30 9 N 12.3200 5.7473 0.0 0
M  V30 10 C 7.7000 5.7473 0.0 0
M  V30 11 C 8.4700 4.4136 0.0 0
M  V30 12 C 8.4700 7.0809 0.0 0
M  V30 13 C 10.0100 4.4136 0.0 0
M  V30 14 C 10.0100 7.0809 0.0 0
M  V30 15 C 10.7800 5.7473 0.0 0
M  V30 16 Na 6.1600 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C89H97N3O21
3036050-17-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  113 123 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 18.4804 0.0 0
M  V30 2 C 10.6697 19.2504 0.0 0 CFG=1
M  V30 3 C 12.0033 18.4804 0.0 0
M  V30 4 C 10.6697 20.7905 0.0 0
M  V30 5 O 12.0033 21.5605 0.0 0
M  V30 6 O 9.3360 21.5605 0.0 0
M  V30 7 C 12.0033 23.1005 0.0 0
M  V30 8 O 12.0033 16.9404 0.0 0
M  V30 9 C 13.3370 16.1704 0.0 0
M  V30 10 O 13.3370 14.6303 0.0 0
M  V30 11 O 6.6685 16.9404 0.0 0
M  V30 12 C 6.6685 18.4804 0.0 0
M  V30 13 O 8.0022 19.2504 0.0 0
M  V30 14 O 12.0033 13.8603 0.0 0
M  V30 15 C 12.0033 12.3203 0.0 0 CFG=1
M  V30 16 C 13.3370 11.5503 0.0 0 CFG=2
M  V30 17 C 10.6697 11.5503 0.0 0
M  V30 18 O 13.3370 10.0102 0.0 0
M  V30 19 C 14.6708 12.3203 0.0 0
M  V30 20 O 9.3360 12.3203 0.0 0
M  V30 21 O 10.6697 10.0102 0.0 0
M  V30 22 O 16.0045 11.5503 0.0 0
M  V30 23 O 14.6708 13.8603 0.0 0
M  V30 24 C 8.0022 11.5503 0.0 0
M  V30 25 C 17.3382 12.3203 0.0 0 CFG=2
M  V30 26 C 6.6685 12.3203 0.0 0
M  V30 27 C 8.0022 10.0102 0.0 0
M  V30 28 C 18.6718 11.5503 0.0 0
M  V30 29 C 17.3382 13.8603 0.0 0
M  V30 30 C 20.0057 12.3203 0.0 0
M  V30 31 C 21.3393 11.5503 0.0 0
M  V30 32 C 6.6685 13.8603 0.0 0
M  V30 33 O 5.3348 14.6303 0.0 0
M  V30 34 C 4.0012 13.8603 0.0 0
M  V30 35 O 13.3370 6.9302 0.0 0
M  V30 36 C 12.0033 7.7002 0.0 0
M  V30 37 O 16.0045 5.3901 0.0 0
M  V30 38 C 14.6708 4.6201 0.0 0
M  V30 39 C 18.6718 10.0102 0.0 0
M  V30 40 O 18.6718 6.9302 0.0 0
M  V30 41 C 20.0057 7.7002 0.0 0
M  V30 42 C 26.6420 12.6774 0.0 0
M  V30 43 C 27.5472 13.9233 0.0 0
M  V30 44 C 29.0788 13.7624 0.0 0
M  V30 45 C 29.9840 15.0082 0.0 0
M  V30 46 C 31.5156 14.8473 0.0 0
M  V30 47 O 32.1420 13.4403 0.0 0
M  V30 48 O 32.4208 16.0932 0.0 0
M  V30 49 C 9.3360 16.9404 0.0 0 CFG=1
M  V30 50 C 10.6697 16.1704 0.0 0 CFG=1
M  V30 51 C 8.0022 16.1704 0.0 0 CFG=1
M  V30 52 C 10.6697 14.6303 0.0 0 CFG=2
M  V30 53 C 8.0022 14.6303 0.0 0 CFG=1
M  V30 54 O 9.3360 13.8603 0.0 0
M  V30 55 C 14.8712 16.3046 0.0 0
M  V30 56 C 15.7545 15.0430 0.0 0
M  V30 57 C 15.5222 17.7004 0.0 0
M  V30 58 C 17.2887 15.1773 0.0 0
M  V30 59 C 17.0562 17.8345 0.0 0
M  V30 60 C 17.9395 16.5731 0.0 0
M  V30 61 C 5.3348 19.2504 0.0 0
M  V30 62 C 4.0012 18.4804 0.0 0
M  V30 63 C 5.3348 20.7905 0.0 0
M  V30 64 C 2.6673 19.2504 0.0 0
M  V30 65 C 4.0012 21.5605 0.0 0
M  V30 66 C 2.6673 20.7905 0.0 0
M  V30 67 C 13.3370 19.2504 0.0 0
M  V30 68 C 14.6708 18.4804 0.0 0
M  V30 69 C 13.3370 20.7905 0.0 0
M  V30 70 C 16.0045 19.2504 0.0 0
M  V30 71 C 14.6708 21.5605 0.0 0
M  V30 72 C 16.0045 20.7905 0.0 0
M  V30 73 C 2.6673 14.6303 0.0 0
M  V30 74 C 1.3337 13.8603 0.0 0
M  V30 75 C 2.6673 16.1704 0.0 0
M  V30 76 C 0.0000 14.6303 0.0 0
M  V30 77 C 1.3337 16.9404 0.0 0
M  V30 78 C 0.0000 16.1704 0.0 0
M  V30 79 C 10.6697 23.8705 0.0 0
M  V30 80 C 10.6697 25.4106 0.0 0
M  V30 81 C 9.3360 23.1005 0.0 0
M  V30 82 C 9.3360 26.1806 0.0 0
M  V30 83 C 8.0022 23.8705 0.0 0
M  V30 84 C 8.0022 25.4106 0.0 0
M  V30 85 C 14.6708 9.2402 0.0 0 CFG=2
M  V30 86 C 14.6708 7.7002 0.0 0 CFG=1
M  V30 87 O 16.0045 10.0102 0.0 0
M  V30 88 C 16.0045 6.9302 0.0 0 CFG=2
M  V30 89 C 17.3382 9.2402 0.0 0 CFG=1
M  V30 90 C 17.3382 7.7002 0.0 0 CFG=2
M  V30 91 C 10.6697 6.9302 0.0 0
M  V30 92 C 9.3360 7.7002 0.0 0
M  V30 93 C 10.6697 5.3901 0.0 0
M  V30 94 C 8.0022 6.9302 0.0 0
M  V30 95 C 9.3360 4.6201 0.0 0
M  V30 96 C 8.0022 5.3901 0.0 0
M  V30 97 C 14.6708 3.0801 0.0 0
M  V30 98 C 13.3370 2.3101 0.0 0
M  V30 99 C 16.0045 2.3101 0.0 0
M  V30 100 C 13.3370 0.7700 0.0 0
M  V30 101 C 16.0045 0.7700 0.0 0
M  V30 102 C 14.6708 0.0000 0.0 0
M  V30 103 N 22.6730 12.3203 0.0 0
M  V30 104 C 24.0800 11.6939 0.0 0
M  V30 105 N 22.8339 13.8518 0.0 0
M  V30 106 C 25.1104 12.8383 0.0 0
M  V30 107 N 24.3404 14.1720 0.0 0
M  V30 108 C 21.3393 6.9302 0.0 0
M  V30 109 C 21.3393 5.3901 0.0 0
M  V30 110 C 22.6730 7.7002 0.0 0
M  V30 111 C 22.6730 4.6201 0.0 0
M  V30 112 C 24.0067 6.9302 0.0 0
M  V30 113 C 24.0067 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 49 1 CFG=3
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 67
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 79
M  V30 10 1 8 9
M  V30 11 1 50 8 CFG=1
M  V30 12 2 9 10
M  V30 13 1 9 55
M  V30 14 1 11 12
M  V30 15 1 51 11 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 61
M  V30 18 1 15 14 CFG=3
M  V30 19 1 52 14 CFG=3
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18 CFG=3
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 85 18 CFG=3
M  V30 27 1 19 22
M  V30 28 2 19 23
M  V30 29 1 20 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 25 28
M  V30 34 1 25 29 CFG=3
M  V30 35 1 28 30
M  V30 36 1 30 31
M  V30 37 1 31 103
M  V30 38 1 32 33
M  V30 39 1 53 32 CFG=3
M  V30 40 1 33 34
M  V30 41 1 34 73
M  V30 42 1 35 36
M  V30 43 1 86 35 CFG=3
M  V30 44 1 36 91
M  V30 45 1 37 38
M  V30 46 1 88 37 CFG=1
M  V30 47 1 38 97
M  V30 48 1 89 39 CFG=1
M  V30 49 1 40 41
M  V30 50 1 90 40 CFG=1
M  V30 51 1 41 108
M  V30 52 1 42 43
M  V30 53 1 42 106
M  V30 54 1 43 44
M  V30 55 1 44 45
M  V30 56 1 45 46
M  V30 57 1 46 47
M  V30 58 2 46 48
M  V30 59 1 49 50
M  V30 60 1 49 51
M  V30 61 1 50 52
M  V30 62 1 51 53
M  V30 63 1 52 54
M  V30 64 1 53 54
M  V30 65 2 55 56
M  V30 66 1 55 57
M  V30 67 1 56 58
M  V30 68 2 57 59
M  V30 69 2 58 60
M  V30 70 1 59 60
M  V30 71 2 61 62
M  V30 72 1 61 63
M  V30 73 1 62 64
M  V30 74 2 63 65
M  V30 75 2 64 66
M  V30 76 1 65 66
M  V30 77 2 67 68
M  V30 78 1 67 69
M  V30 79 1 68 70
M  V30 80 2 69 71
M  V30 81 2 70 72
M  V30 82 1 71 72
M  V30 83 2 73 74
M  V30 84 1 73 75
M  V30 85 1 74 76
M  V30 86 2 75 77
M  V30 87 2 76 78
M  V30 88 1 77 78
M  V30 89 2 79 80
M  V30 90 1 79 81
M  V30 91 1 80 82
M  V30 92 2 81 83
M  V30 93 2 82 84
M  V30 94 1 83 84
M  V30 95 1 85 86
M  V30 96 1 85 87
M  V30 97 1 86 88
M  V30 98 1 87 89
M  V30 99 1 88 90
M  V30 100 1 89 90
M  V30 101 2 91 92
M  V30 102 1 91 93
M  V30 103 1 92 94
M  V30 104 2 93 95
M  V30 105 2 94 96
M  V30 106 1 95 96
M  V30 107 2 97 98
M  V30 108 1 97 99
M  V30 109 1 98 100
M  V30 110 2 99 101
M  V30 111 2 100 102
M  V30 112 1 101 102
M  V30 113 1 103 104
M  V30 114 1 103 105
M  V30 115 2 104 106
M  V30 116 2 105 107
M  V30 117 1 106 107
M  V30 118 2 108 109
M  V30 119 1 108 110
M  V30 120 1 109 111
M  V30 121 2 110 112
M  V30 122 2 111 113
M  V30 123 1 112 113
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 2 15 16 25 49 50 51 52 53 85 86 88 89 90)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C98H108N4O24S.Na
3036050-24-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  128 138 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0101 21.5453 0.0 0
M  V30 2 C 9.2400 22.8790 0.0 0 CFG=1
M  V30 3 C 7.7000 22.8790 0.0 0
M  V30 4 C 10.0101 24.2128 0.0 0
M  V30 5 O 9.2400 25.5464 0.0 0
M  V30 6 O 11.5501 24.2128 0.0 0
M  V30 7 C 10.0101 26.8801 0.0 0
M  V30 8 O 11.5501 18.8780 0.0 0
M  V30 9 C 13.0901 18.8780 0.0 0
M  V30 10 O 13.8601 17.5442 0.0 0
M  V30 11 O 6.9300 21.5453 0.0 0
M  V30 12 C 5.3900 21.5453 0.0 0
M  V30 13 O 4.6200 20.2117 0.0 0
M  V30 14 O 10.0101 16.2106 0.0 0
M  V30 15 C 9.2400 14.8769 0.0 0 CFG=1
M  V30 16 C 10.0101 13.5431 0.0 0 CFG=2
M  V30 17 C 7.7000 14.8769 0.0 0
M  V30 18 O 9.2400 12.2095 0.0 0
M  V30 19 C 11.5501 13.5433 0.0 0
M  V30 20 O 6.9300 13.5431 0.0 0
M  V30 21 O 6.9300 16.2106 0.0 0
M  V30 22 O 12.3201 12.2095 0.0 0
M  V30 23 O 12.3201 14.8769 0.0 0
M  V30 24 C 5.3900 13.5431 0.0 0
M  V30 25 C 13.8601 12.2095 0.0 0 CFG=1
M  V30 26 C 4.6200 14.8769 0.0 0
M  V30 27 C 4.6200 12.2095 0.0 0
M  V30 28 C 14.6301 13.5433 0.0 0
M  V30 29 C 14.6301 10.8758 0.0 0
M  V30 30 C 13.8601 14.8769 0.0 0
M  V30 31 C 14.6301 16.2106 0.0 0
M  V30 32 C 5.3900 18.8780 0.0 0
M  V30 33 O 4.6200 17.5442 0.0 0
M  V30 34 C 3.0800 17.5442 0.0 0
M  V30 35 O 7.7000 9.5422 0.0 0
M  V30 36 C 6.9300 8.2084 0.0 0
M  V30 37 O 9.2400 6.8747 0.0 0
M  V30 38 C 10.0101 5.5411 0.0 0
M  V30 39 C 13.8601 9.5422 0.0 0
M  V30 40 O 12.3201 6.8747 0.0 0
M  V30 41 C 13.0901 5.5411 0.0 0
M  V30 42 C 19.7859 17.8858 0.0 0
M  V30 43 C 21.1927 17.2595 0.0 0
M  V30 44 C 22.4387 18.1645 0.0 0
M  V30 45 C 23.8455 17.5382 0.0 0
M  V30 46 C 25.0913 18.4434 0.0 0
M  V30 47 N 26.4983 17.8171 0.0 0
M  V30 48 O 24.9304 19.9750 0.0 0
M  V30 49 O 31.4818 21.4378 0.0 0
M  V30 50 C 32.8887 20.8115 0.0 0
M  V30 51 C 34.1346 21.7166 0.0 0
M  V30 52 C 35.5414 21.0902 0.0 0
M  V30 53 S 36.7874 21.9955 0.0 0 VAL=6
M  V30 54 O 37.6925 20.7496 0.0 0
M  V30 55 O 35.8822 23.2413 0.0 0
M  V30 56 O 38.0333 22.9007 0.0 0
M  V30 57 C 9.2400 20.2117 0.0 0 CFG=1
M  V30 58 C 10.0101 18.8780 0.0 0 CFG=1
M  V30 59 C 7.7000 20.2117 0.0 0 CFG=1
M  V30 60 C 9.2400 17.5442 0.0 0 CFG=2
M  V30 61 C 6.9300 18.8780 0.0 0 CFG=1
M  V30 62 O 7.7000 17.5442 0.0 0
M  V30 63 C 13.8601 20.2117 0.0 0
M  V30 64 C 13.0901 21.5453 0.0 0
M  V30 65 C 15.4001 20.2117 0.0 0
M  V30 66 C 13.8601 22.8790 0.0 0
M  V30 67 C 16.1701 21.5453 0.0 0
M  V30 68 C 15.4001 22.8790 0.0 0
M  V30 69 C 4.1286 22.4287 0.0 0
M  V30 70 C 2.7329 21.7779 0.0 0
M  V30 71 C 4.2627 23.9628 0.0 0
M  V30 72 C 1.4713 22.6611 0.0 0
M  V30 73 C 3.0013 24.8460 0.0 0
M  V30 74 C 1.6056 24.1952 0.0 0
M  V30 75 C 6.9300 24.2128 0.0 0
M  V30 76 C 7.7000 25.5464 0.0 0
M  V30 77 C 5.3900 24.2128 0.0 0
M  V30 78 C 6.9300 26.8801 0.0 0
M  V30 79 C 4.6200 25.5464 0.0 0
M  V30 80 C 5.3900 26.8801 0.0 0
M  V30 81 C 2.3100 16.2106 0.0 0
M  V30 82 C 0.7700 16.2106 0.0 0
M  V30 83 C 3.0800 14.8769 0.0 0
M  V30 84 C 0.0000 14.8769 0.0 0
M  V30 85 C 2.3100 13.5431 0.0 0
M  V30 86 C 0.7700 13.5431 0.0 0
M  V30 87 C 9.2400 28.2137 0.0 0
M  V30 88 C 10.0101 29.5475 0.0 0
M  V30 89 C 7.7000 28.2137 0.0 0
M  V30 90 C 9.2400 30.8812 0.0 0
M  V30 91 C 6.9300 29.5475 0.0 0
M  V30 92 C 7.7000 30.8812 0.0 0
M  V30 93 C 10.0101 10.8758 0.0 0 CFG=2
M  V30 94 C 9.2400 9.5422 0.0 0 CFG=1
M  V30 95 O 11.5501 10.8758 0.0 0
M  V30 96 C 10.0101 8.2084 0.0 0 CFG=2
M  V30 97 C 12.3201 9.5422 0.0 0 CFG=1
M  V30 98 C 11.5501 8.2084 0.0 0 CFG=2
M  V30 99 C 5.3900 8.2084 0.0 0
M  V30 100 C 4.6200 6.8747 0.0 0
M  V30 101 C 4.6200 9.5422 0.0 0
M  V30 102 C 3.0800 6.8747 0.0 0
M  V30 103 C 3.0800 9.5422 0.0 0
M  V30 104 C 2.3100 8.2084 0.0 0
M  V30 105 C 9.2400 4.2074 0.0 0
M  V30 106 C 7.7000 4.2074 0.0 0
M  V30 107 C 10.0101 2.8736 0.0 0
M  V30 108 C 6.9300 2.8736 0.0 0
M  V30 109 C 9.2400 1.5400 0.0 0
M  V30 110 C 7.7000 1.5400 0.0 0
M  V30 111 N 16.1701 16.2106 0.0 0
M  V30 112 C 17.0753 17.4564 0.0 0
M  V30 113 N 17.0753 14.9647 0.0 0
M  V30 114 C 18.5400 16.9806 0.0 0
M  V30 115 N 18.5400 15.4406 0.0 0
M  V30 116 C 14.6301 5.5411 0.0 0
M  V30 117 C 15.4001 4.2074 0.0 0
M  V30 118 C 15.4001 6.8747 0.0 0
M  V30 119 C 16.9401 4.2074 0.0 0
M  V30 120 C 16.9401 6.8747 0.0 0
M  V30 121 C 17.7101 5.5411 0.0 0
M  V30 122 C 27.7442 18.7222 0.0 0
M  V30 123 C 29.1510 18.0959 0.0 0
M  V30 124 C 27.5831 20.2539 0.0 0
M  V30 125 C 30.3968 19.0011 0.0 0
M  V30 126 C 28.8291 21.1589 0.0 0
M  V30 127 C 30.2359 20.5326 0.0 0
M  V30 128 Na 19.0166 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 57 1 CFG=3
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 75
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 87
M  V30 10 1 8 9
M  V30 11 1 58 8 CFG=1
M  V30 12 2 9 10
M  V30 13 1 9 63
M  V30 14 1 11 12
M  V30 15 1 59 11 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 69
M  V30 18 1 15 14 CFG=3
M  V30 19 1 60 14 CFG=3
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18 CFG=3
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 93 18 CFG=3
M  V30 27 1 19 22
M  V30 28 2 19 23
M  V30 29 1 20 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 25 28
M  V30 34 1 25 29 CFG=3
M  V30 35 1 28 30
M  V30 36 1 30 31
M  V30 37 1 31 111
M  V30 38 1 32 33
M  V30 39 1 61 32 CFG=3
M  V30 40 1 33 34
M  V30 41 1 34 81
M  V30 42 1 35 36
M  V30 43 1 94 35 CFG=3
M  V30 44 1 36 99
M  V30 45 1 37 38
M  V30 46 1 96 37 CFG=1
M  V30 47 1 38 105
M  V30 48 1 97 39 CFG=1
M  V30 49 1 40 41
M  V30 50 1 98 40 CFG=1
M  V30 51 1 41 116
M  V30 52 1 42 43
M  V30 53 1 42 114
M  V30 54 1 43 44
M  V30 55 1 44 45
M  V30 56 1 45 46
M  V30 57 1 46 47
M  V30 58 2 46 48
M  V30 59 1 47 122
M  V30 60 1 49 50
M  V30 61 1 49 127
M  V30 62 1 50 51
M  V30 63 1 51 52
M  V30 64 1 52 53
M  V30 65 2 53 54
M  V30 66 2 53 55
M  V30 67 1 53 56
M  V30 68 1 57 58
M  V30 69 1 57 59
M  V30 70 1 58 60
M  V30 71 1 59 61
M  V30 72 1 60 62
M  V30 73 1 61 62
M  V30 74 2 63 64
M  V30 75 1 63 65
M  V30 76 1 64 66
M  V30 77 2 65 67
M  V30 78 2 66 68
M  V30 79 1 67 68
M  V30 80 2 69 70
M  V30 81 1 69 71
M  V30 82 1 70 72
M  V30 83 2 71 73
M  V30 84 2 72 74
M  V30 85 1 73 74
M  V30 86 2 75 76
M  V30 87 1 75 77
M  V30 88 1 76 78
M  V30 89 2 77 79
M  V30 90 2 78 80
M  V30 91 1 79 80
M  V30 92 2 81 82
M  V30 93 1 81 83
M  V30 94 1 82 84
M  V30 95 2 83 85
M  V30 96 2 84 86
M  V30 97 1 85 86
M  V30 98 2 87 88
M  V30 99 1 87 89
M  V30 100 1 88 90
M  V30 101 2 89 91
M  V30 102 2 90 92
M  V30 103 1 91 92
M  V30 104 1 93 94
M  V30 105 1 93 95
M  V30 106 1 94 96
M  V30 107 1 95 97
M  V30 108 1 96 98
M  V30 109 1 97 98
M  V30 110 2 99 100
M  V30 111 1 99 101
M  V30 112 1 100 102
M  V30 113 2 101 103
M  V30 114 2 102 104
M  V30 115 1 103 104
M  V30 116 2 105 106
M  V30 117 1 105 107
M  V30 118 1 106 108
M  V30 119 2 107 109
M  V30 120 2 108 110
M  V30 121 1 109 110
M  V30 122 1 111 112
M  V30 123 1 111 113
M  V30 124 2 112 114
M  V30 125 2 113 115
M  V30 126 1 114 115
M  V30 127 2 116 117
M  V30 128 1 116 118
M  V30 129 1 117 119
M  V30 130 2 118 120
M  V30 131 2 119 121
M  V30 132 1 120 121
M  V30 133 2 122 123
M  V30 134 1 122 124
M  V30 135 1 123 125
M  V30 136 2 124 126
M  V30 137 2 125 127
M  V30 138 1 126 127
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 2 15 16 25 57 58 59 60 61 93 94 96 97 98)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 58480-39-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036050-17-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036050-24-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39877281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sialyl LewisX glycomimetics bearing an extended anionic chain targeting
E- and P- selectin binding sites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Belouin, Audrey; Simard, Ryan D.; Joyal, Mathieu; Maharsy, Wael; Lau,
Alice; Prevost, Michel; Nemer, Mona; Guindon, Yvan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2024), 98117553

$RFMT $RIREG SCHEME469 STEP1
$RXN



  2  1
$MOL
6-Maleimidocaproic acid
C10H13NO4
55750-53-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.3322 0.0 0
M  V30 2 C 5.1048 2.5622 0.0 0
M  V30 3 C 6.4384 3.3322 0.0 0
M  V30 4 C 7.7722 2.5622 0.0 0
M  V30 5 C 9.1059 3.3322 0.0 0
M  V30 6 C 10.4396 2.5622 0.0 0
M  V30 7 O 11.7733 3.3322 0.0 0
M  V30 8 O 10.4396 1.0221 0.0 0
M  V30 9 O 0.7103 4.6949 0.0 0
M  V30 10 O 3.4209 0.0000 0.0 0
M  V30 11 N 2.4373 2.5622 0.0 0
M  V30 12 C 1.0304 3.1885 0.0 0
M  V30 13 C 2.2763 1.0306 0.0 0
M  V30 14 C 0.0000 2.0441 0.0 0
M  V30 15 C 0.7700 0.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 12
M  V30 10 2 10 13
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C54H61N9O8
2467802-98-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  73 81 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.7563 4.1352 0.0 0
M  V30 2 O 13.6525 0.7700 0.0 0
M  V30 3 C 12.3187 0.0000 0.0 0
M  V30 4 O 16.3198 2.3100 0.0 0
M  V30 5 C 17.6534 3.0800 0.0 0
M  V30 6 C 18.9872 2.3100 0.0 0
M  V30 7 C 20.3209 3.0800 0.0 0
M  V30 8 O 21.6545 2.3100 0.0 0
M  V30 9 C 0.0000 14.6982 0.0 0
M  V30 10 O 24.3220 0.7700 0.0 0
M  V30 11 C 25.6556 0.0000 0.0 0
M  V30 12 O 28.2180 4.1352 0.0 0
M  V30 13 N 34.1571 12.0955 0.0 0
M  V30 14 C 35.5445 11.4273 0.0 0
M  V30 15 C 36.8170 12.2948 0.0 0 CFG=1
M  V30 16 O 35.6597 9.8916 0.0 0
M  V30 17 N 38.2044 11.6268 0.0 0
M  V30 18 C 36.7018 13.8305 0.0 0
M  V30 19 C 39.4769 12.4942 0.0 0
M  V30 20 C 40.8643 11.8260 0.0 0 CFG=1
M  V30 21 O 39.3619 14.0299 0.0 0
M  V30 22 C 42.1368 12.6935 0.0 0
M  V30 23 N 40.9795 10.2903 0.0 0
M  V30 24 C 42.0218 14.2292 0.0 0
M  V30 25 C 43.5244 12.0253 0.0 0
M  V30 26 N 10.4313 6.6542 0.0 0
M  V30 27 C 11.2987 7.9267 0.0 0 CFG=2
M  V30 28 C 10.8852 5.1827 0.0 0
M  V30 29 C 8.9530 7.0862 0.0 0
M  V30 30 C 10.3567 9.1450 0.0 0
M  V30 31 C 12.8344 8.0418 0.0 0
M  V30 32 C 12.3187 4.6200 0.0 0
M  V30 33 C 8.9070 8.6254 0.0 0
M  V30 34 N 13.8819 6.9129 0.0 0
M  V30 35 C 13.6525 5.3900 0.0 0
M  V30 36 C 12.3187 3.0800 0.0 0
M  V30 37 C 14.9861 4.6200 0.0 0
M  V30 38 C 13.6525 2.3100 0.0 0
M  V30 39 C 14.9861 3.0800 0.0 0
M  V30 40 C 7.6346 9.4929 0.0 0
M  V30 41 C 7.7496 11.0288 0.0 0
M  V30 42 C 6.2470 8.8249 0.0 0
M  V30 43 C 6.4773 11.8963 0.0 0
M  V30 44 C 4.9747 9.6924 0.0 0
M  V30 45 C 5.0897 11.2281 0.0 0
M  V30 46 N 3.8174 12.0955 0.0 0
M  V30 47 C 2.4298 11.4273 0.0 0
M  V30 48 C 3.9324 13.6312 0.0 0
M  V30 49 C 1.1575 12.2948 0.0 0
M  V30 50 C 2.6601 14.4987 0.0 0
M  V30 51 N 1.2725 13.8307 0.0 0
M  V30 52 C 22.9882 3.0800 0.0 0
M  V30 53 C 24.3220 2.3100 0.0 0
M  V30 54 C 22.9882 4.6200 0.0 0
M  V30 55 C 25.6556 3.0800 0.0 0
M  V30 56 C 24.3220 5.3900 0.0 0
M  V30 57 C 25.6556 4.6200 0.0 0
M  V30 58 N 24.0924 6.9129 0.0 0
M  V30 59 C 27.0892 5.1827 0.0 0
M  V30 60 C 25.1399 8.0418 0.0 0
M  V30 61 N 27.5431 6.6542 0.0 0
M  V30 62 C 26.6756 7.9267 0.0 0 CFG=2
M  V30 63 C 29.0213 7.0862 0.0 0
M  V30 64 C 27.6176 9.1450 0.0 0
M  V30 65 C 29.0674 8.6254 0.0 0
M  V30 66 C 30.3397 9.4929 0.0 0
M  V30 67 C 31.7273 8.8249 0.0 0
M  V30 68 C 30.2247 11.0286 0.0 0
M  V30 69 C 32.9998 9.6924 0.0 0
M  V30 70 C 31.4972 11.8963 0.0 0
M  V30 71 C 32.8846 11.2281 0.0 0
M  V30 72 H 11.9252 9.3335 0.0 0
M  V30 73 H 26.0493 9.3335 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 28
M  V30 2 1 2 3
M  V30 3 1 2 38
M  V30 4 1 4 5
M  V30 5 1 4 39
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 52
M  V30 10 1 9 51
M  V30 11 1 10 11
M  V30 12 1 10 53
M  V30 13 2 12 59
M  V30 14 1 13 14
M  V30 15 1 13 71
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 15 18 CFG=1
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23 CFG=3
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 27 72 CFG=3
M  V30 33 1 28 32
M  V30 34 2 29 33
M  V30 35 1 30 33
M  V30 36 2 31 34
M  V30 37 1 32 35
M  V30 38 2 32 36
M  V30 39 1 33 40
M  V30 40 1 34 35
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 51 1 45 46
M  V30 52 1 46 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 1 50 51
M  V30 58 2 52 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 2 54 56
M  V30 62 2 55 57
M  V30 63 1 56 57
M  V30 64 1 56 58
M  V30 65 1 57 59
M  V30 66 2 58 60
M  V30 67 1 59 61
M  V30 68 1 60 62
M  V30 69 1 61 62
M  V30 70 1 61 63
M  V30 71 1 62 64
M  V30 72 1 62 73 CFG=1
M  V30 73 2 63 65
M  V30 74 1 64 65
M  V30 75 1 65 66
M  V30 76 2 66 67
M  V30 77 1 66 68
M  V30 78 1 67 69
M  V30 79 2 68 70
M  V30 80 2 69 71
M  V30 81 1 70 71
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 20 27 62)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C64H72N10O11
2467803-01-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  87 96 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.9396 5.3118 0.0 0
M  V30 2 O 12.5734 1.6649 0.0 0
M  V30 3 C 11.1859 0.9967 0.0 0
M  V30 4 O 15.3483 3.0012 0.0 0
M  V30 5 C 16.7359 3.6694 0.0 0
M  V30 6 C 18.0083 2.8019 0.0 0
M  V30 7 C 19.3958 3.4701 0.0 0
M  V30 8 O 20.6682 2.6026 0.0 0
M  V30 9 C 0.0000 16.5742 0.0 0
M  V30 10 O 23.2130 0.8675 0.0 0
M  V30 11 C 24.4854 0.0000 0.0 0
M  V30 12 O 27.3498 3.9321 0.0 0
M  V30 13 N 33.8670 11.4264 0.0 0
M  V30 14 C 35.2006 10.6564 0.0 0
M  V30 15 C 36.5344 11.4264 0.0 0 CFG=1
M  V30 16 O 35.2006 9.1164 0.0 0
M  V30 17 N 37.8681 10.6564 0.0 0
M  V30 18 C 36.5344 12.9664 0.0 0
M  V30 19 C 39.2017 11.4264 0.0 0
M  V30 20 C 40.5354 10.6564 0.0 0 CFG=2
M  V30 21 O 39.2017 12.9664 0.0 0
M  V30 22 N 41.8692 11.4264 0.0 0
M  V30 23 C 40.5354 9.1164 0.0 0
M  V30 24 C 43.2028 10.6564 0.0 0
M  V30 25 C 41.8692 8.3464 0.0 0
M  V30 26 C 39.2017 8.3464 0.0 0
M  V30 27 C 44.5365 11.4264 0.0 0
M  V30 28 O 43.2028 9.1164 0.0 0
M  V30 29 C 45.8701 10.6564 0.0 0
M  V30 30 C 47.2039 11.4264 0.0 0
M  V30 31 C 48.5375 10.6564 0.0 0
M  V30 32 C 49.8712 11.4264 0.0 0
M  V30 33 O 52.9320 12.7890 0.0 0
M  V30 34 O 50.2214 8.0943 0.0 0
M  V30 35 N 9.8009 7.7734 0.0 0
M  V30 36 C 10.7611 8.9773 0.0 0 CFG=2
M  V30 37 C 8.3590 8.3145 0.0 0
M  V30 38 C 10.1436 6.2720 0.0 0
M  V30 39 C 9.9127 10.2626 0.0 0
M  V30 40 C 12.3011 8.9773 0.0 0
M  V30 41 C 8.4282 9.8530 0.0 0
M  V30 42 C 11.5311 5.6038 0.0 0
M  V30 43 N 13.2613 7.7734 0.0 0
M  V30 44 C 12.9185 6.2720 0.0 0
M  V30 45 C 11.4159 4.0681 0.0 0
M  V30 46 C 14.1910 5.4045 0.0 0
M  V30 47 C 12.6884 3.2006 0.0 0
M  V30 48 C 14.0760 3.8688 0.0 0
M  V30 49 C 7.2242 10.8132 0.0 0
M  V30 50 C 5.7906 10.2505 0.0 0
M  V30 51 C 7.4536 12.3359 0.0 0
M  V30 52 C 4.5866 11.2107 0.0 0
M  V30 53 C 6.2497 13.2961 0.0 0
M  V30 54 C 4.8161 12.7334 0.0 0
M  V30 55 N 3.6121 13.6936 0.0 0
M  V30 56 C 2.1785 13.1310 0.0 0
M  V30 57 C 3.8416 15.2165 0.0 0
M  V30 58 C 0.9745 14.0912 0.0 0
M  V30 59 C 2.6376 16.1767 0.0 0
M  V30 60 N 1.2040 15.6140 0.0 0
M  V30 61 C 22.0557 3.2707 0.0 0
M  V30 62 C 23.3281 2.4032 0.0 0
M  V30 63 C 22.1707 4.8064 0.0 0
M  V30 64 C 24.7156 3.0714 0.0 0
M  V30 65 C 23.5583 5.4746 0.0 0
M  V30 66 C 24.8306 4.6071 0.0 0
M  V30 67 N 23.4431 7.0103 0.0 0
M  V30 68 C 26.3023 5.0611 0.0 0
M  V30 69 C 24.5721 8.0578 0.0 0
M  V30 70 N 26.8648 6.4945 0.0 0
M  V30 71 C 26.0948 7.8283 0.0 0 CFG=2
M  V30 72 C 28.3713 6.8148 0.0 0
M  V30 73 C 27.1254 8.9727 0.0 0
M  V30 74 C 28.5322 8.3464 0.0 0
M  V30 75 C 29.8659 9.1164 0.0 0
M  V30 76 C 31.1997 8.3464 0.0 0
M  V30 77 C 29.8659 10.6564 0.0 0
M  V30 78 C 32.5333 9.1164 0.0 0
M  V30 79 C 31.1997 11.4264 0.0 0
M  V30 80 C 32.5333 10.6564 0.0 0
M  V30 81 N 51.2048 10.6564 0.0 0
M  V30 82 C 52.6118 11.2827 0.0 0
M  V30 83 C 51.3659 9.1247 0.0 0
M  V30 84 C 53.6422 10.1382 0.0 0
M  V30 85 C 52.8722 8.8045 0.0 0
M  V30 86 H 11.4908 10.3335 0.0 0
M  V30 87 H 25.5754 9.2781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 38
M  V30 2 1 2 3
M  V30 3 1 2 47
M  V30 4 1 4 5
M  V30 5 1 4 48
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 61
M  V30 10 1 9 60
M  V30 11 1 10 11
M  V30 12 1 10 62
M  V30 13 2 12 68
M  V30 14 1 13 14
M  V30 15 1 13 80
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 15 18 CFG=1
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23 CFG=1
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 2 24 28
M  V30 30 1 27 29
M  V30 31 1 29 30
M  V30 32 1 30 31
M  V30 33 1 31 32
M  V30 34 1 32 81
M  V30 35 2 33 82
M  V30 36 2 34 83
M  V30 37 1 35 36
M  V30 38 1 35 37
M  V30 39 1 35 38
M  V30 40 1 36 39
M  V30 41 1 36 40
M  V30 42 1 36 86 CFG=3
M  V30 43 2 37 41
M  V30 44 1 38 42
M  V30 45 1 39 41
M  V30 46 2 40 43
M  V30 47 1 41 49
M  V30 48 1 42 44
M  V30 49 2 42 45
M  V30 50 1 43 44
M  V30 51 2 44 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 48
M  V30 55 2 49 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 2 51 53
M  V30 59 2 52 54
M  V30 60 1 53 54
M  V30 61 1 54 55
M  V30 62 1 55 56
M  V30 63 1 55 57
M  V30 64 1 56 58
M  V30 65 1 57 59
M  V30 66 1 58 60
M  V30 67 1 59 60
M  V30 68 2 61 62
M  V30 69 1 61 63
M  V30 70 1 62 64
M  V30 71 2 63 65
M  V30 72 2 64 66
M  V30 73 1 65 66
M  V30 74 1 65 67
M  V30 75 1 66 68
M  V30 76 2 67 69
M  V30 77 1 68 70
M  V30 78 1 69 71
M  V30 79 1 70 71
M  V30 80 1 70 72
M  V30 81 1 71 73
M  V30 82 1 71 87 CFG=1
M  V30 83 2 72 74
M  V30 84 1 73 74
M  V30 85 1 74 75
M  V30 86 2 75 76
M  V30 87 1 75 77
M  V30 88 1 76 78
M  V30 89 2 77 79
M  V30 90 2 78 80
M  V30 91 1 79 80
M  V30 92 1 81 82
M  V30 93 1 81 83
M  V30 94 1 82 84
M  V30 95 1 83 85
M  V30 96 2 84 85
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 20 36 71)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55750-53-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2467802-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2467803-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23439616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Early Development, Scale-Up, and Reverse-Phase Purification of a Highly
Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug
Conjugates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Holte, Dane; Rao, Meera; Huters, Alexander; Simanis, Justin; Califano,
Jean-Christophe; Kempema, Aaron; Levy, Jean-Noel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(4), 799-809

$RFMT $RIREG SCHEME470 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-amino-2-(3,4-difluorophenyl)ethyl]carbamate
C13H18F2N2O2
1270494-14-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 5.3348 0.0000 0.0 0
M  V30 4 N 8.0022 1.5400 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 11.2333 3.6437 0.0 0
M  V30 10 C 13.3370 3.0801 0.0 0
M  V30 11 C 12.7733 0.9764 0.0 0
M  V30 12 F 0.0000 1.5400 0.0 0
M  V30 13 F 0.0000 4.6201 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 17
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[(2,6-Difluorophenyl)methoxy]-2-methylimidazo[1,2-a]pyridine-3-carboxylic acid
C16H12F2N2O3
1415501-19-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 3.0800 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 11.9866 3.0204 0.0 0
M  V30 4 O 13.0170 4.1648 0.0 0
M  V30 5 O 12.4625 1.5557 0.0 0
M  V30 6 C 10.6238 6.0812 0.0 0
M  V30 7 F 4.0011 5.3900 0.0 0
M  V30 8 F 1.3336 0.7700 0.0 0
M  V30 9 C 8.0021 3.0800 0.0 0
M  V30 10 N 9.3358 2.3100 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 N 8.3223 4.5864 0.0 0
M  V30 13 C 10.4802 3.3406 0.0 0
M  V30 14 C 9.3358 0.7700 0.0 0
M  V30 15 C 6.6684 0.7700 0.0 0
M  V30 16 C 9.8538 4.7474 0.0 0
M  V30 17 C 8.0021 0.0000 0.0 0
M  V30 18 C 2.6673 3.0800 0.0 0
M  V30 19 C 2.6674 4.6200 0.0 0
M  V30 20 C 1.3336 2.3100 0.0 0
M  V30 21 C 1.3336 5.3900 0.0 0
M  V30 22 C 0.0000 3.0800 0.0 0
M  V30 23 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 6 16
M  V30 8 1 7 19
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-(3,4-difluorophenyl)-2-[[[8-[(2,6-difluorophenyl)metho...
C29H28F4N4O4
1609344-74-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0336 6.6684 0.0 0
M  V30 2 N 8.2636 5.3347 0.0 0
M  V30 3 O 8.2636 8.0020 0.0 0
M  V30 4 C 6.7236 5.3347 0.0 0
M  V30 5 C 5.9536 6.6684 0.0 0
M  V30 6 N 4.4136 6.6684 0.0 0
M  V30 7 C 3.6436 8.0020 0.0 0
M  V30 8 O 2.1036 8.0020 0.0 0
M  V30 9 O 4.4136 9.3358 0.0 0
M  V30 10 C 1.3336 9.3358 0.0 0
M  V30 11 C 0.0000 8.5658 0.0 0
M  V30 12 C 0.5636 10.6694 0.0 0
M  V30 13 C 2.6674 10.1058 0.0 0
M  V30 14 O 15.5526 7.9929 0.0 0
M  V30 15 C 16.6970 9.0235 0.0 0
M  V30 16 C 11.0030 3.9578 0.0 0
M  V30 17 F 18.9859 11.0843 0.0 0
M  V30 18 F 17.3373 6.0108 0.0 0
M  V30 19 F 6.7236 0.0000 0.0 0
M  V30 20 F 3.6436 0.0000 0.0 0
M  V30 21 N 11.4789 7.9142 0.0 0
M  V30 22 C 12.9435 7.4384 0.0 0
M  V30 23 C 10.5736 6.6684 0.0 0
M  V30 24 C 11.1587 9.4206 0.0 0
M  V30 25 C 14.0879 8.4688 0.0 0
M  V30 26 N 12.9435 5.8984 0.0 0
M  V30 27 C 11.4789 5.4225 0.0 0
M  V30 28 C 12.3032 10.4511 0.0 0
M  V30 29 C 13.7678 9.9752 0.0 0
M  V30 30 C 18.1617 8.5475 0.0 0
M  V30 31 C 19.3061 9.5780 0.0 0
M  V30 32 C 18.4818 7.0412 0.0 0
M  V30 33 C 20.7708 9.1022 0.0 0
M  V30 34 C 19.9464 6.5653 0.0 0
M  V30 35 C 21.0909 7.5957 0.0 0
M  V30 36 C 5.9536 4.0011 0.0 0
M  V30 37 C 6.7236 2.6673 0.0 0
M  V30 38 C 4.4136 4.0011 0.0 0
M  V30 39 C 5.9536 1.3336 0.0 0
M  V30 40 C 3.6436 2.6673 0.0 0
M  V30 41 C 4.4136 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 36
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 1 14 25
M  V30 17 1 15 30
M  V30 18 1 16 27
M  V30 19 1 17 31
M  V30 20 1 18 32
M  V30 21 1 19 39
M  V30 22 1 20 41
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 2 23 27
M  V30 29 2 24 28
M  V30 30 2 25 29
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1270494-14-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1415501-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1609344-74-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40577123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 81
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine
Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate
Cyclase Stimulator for the Treatment of Resistant Hypertension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vakalopoulos, Alexandros; Wunder, Frank; Hartung, Ingo V.; Redlich,
Gorden; Jautelat, Rolf; Buchgraber, Philipp; Hassfeld, Jorma; Gromov,
Alexey V.; Lindner, Niels; Bierer, Donald; Gries, Joerg; Kroh, Walter;
Paulsen, Holger; Mittendorf, Joachim; Lang, Dieter; Becker-Pelster, Eva;
Brockschnieder, Damian; Geiss, Volker; Li, Volkhart; Straub, Alexander;
Knorr, Andreas; Mondritzki, Thomas; Truebel, Hubert; Raschke, Marian;
Schaefer, Martina; Thomas, Dirk; Sandner, Peter; Stasch, Johannes-Peter;
Follmann, Markus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(11), 7280-7303

$RFMT $RIREG SCHEME471 STEP1
$RXN



  2  1
$MOL
5′-S-(2-Aminoethyl)-2′,3′-O-(1-methylethylidene)-5′-thioadenosine
C15H22N6O3S
67381-04-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.7467 5.4548 0.0 0
M  V30 2 S 10.0669 6.9611 0.0 0
M  V30 3 C 11.5316 7.4369 0.0 0
M  V30 4 C 11.8518 8.9433 0.0 0
M  V30 5 N 13.3163 9.4192 0.0 0
M  V30 6 C 8.0668 0.0000 0.0 0
M  V30 7 C 6.0058 0.0000 0.0 0
M  V30 8 N 0.0000 8.2531 0.0 0
M  V30 9 C 5.7904 4.9789 0.0 0 CFG=2
M  V30 10 C 6.2662 3.5143 0.0 0 CFG=2
M  V30 11 O 7.0362 5.8840 0.0 0
M  V30 12 C 7.8062 3.5143 0.0 0 CFG=2
M  V30 13 O 5.7904 2.0496 0.0 0
M  V30 14 C 8.2822 4.9789 0.0 0 CFG=2
M  V30 15 O 8.2822 2.0496 0.0 0
M  V30 16 C 7.0362 1.1445 0.0 0
M  V30 17 N 4.3258 5.4548 0.0 0
M  V30 18 C 3.8500 6.9193 0.0 0
M  V30 19 C 3.0800 4.5496 0.0 0
M  V30 20 C 2.3098 6.9193 0.0 0
M  V30 21 N 4.6198 8.2531 0.0 0
M  V30 22 N 1.8340 5.4548 0.0 0
M  V30 23 C 1.5400 8.2531 0.0 0
M  V30 24 C 3.8500 9.5867 0.0 0
M  V30 25 N 2.3098 9.5867 0.0 0
M  V30 26 H 4.7262 3.5143 0.0 0
M  V30 27 H 9.3462 3.5143 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 16
M  V30 7 1 7 16
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 17 CFG=3
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 26 CFG=3
M  V30 15 1 11 14
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 12 27 CFG=3
M  V30 19 1 13 16
M  V30 20 1 15 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 2 19 22
M  V30 26 1 20 22
M  V30 27 2 20 23
M  V30 28 1 21 24
M  V30 29 1 23 25
M  V30 30 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
C15H19NO4
151838-62-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 7.7000 5.3349 0.0 0
M  V30 3 O 7.7000 2.6674 0.0 0
M  V30 4 C 9.2400 5.3349 0.0 0
M  V30 5 C 9.2400 3.7949 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 C 9.2400 6.8749 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 O 6.9300 1.3338 0.0 0
M  V30 10 O 4.6200 0.0000 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 12
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C30H39N7O6S
2736457-96-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4050 10.6694 0.0 0
M  V30 2 S 9.1750 9.3358 0.0 0
M  V30 3 C 10.7150 9.3358 0.0 0
M  V30 4 C 11.4850 8.0021 0.0 0
M  V30 5 N 13.0250 8.0021 0.0 0
M  V30 6 C 13.7950 6.6684 0.0 0
M  V30 7 O 13.0250 5.3347 0.0 0
M  V30 8 C 5.1216 15.3381 0.0 0
M  V30 9 C 3.1616 14.7011 0.0 0
M  V30 10 N 0.0000 4.9961 0.0 0
M  V30 11 C 15.3350 4.0011 0.0 0
M  V30 12 O 16.1050 2.6674 0.0 0
M  V30 13 O 13.7950 4.0011 0.0 0
M  V30 14 C 15.3350 1.3336 0.0 0
M  V30 15 C 16.6688 0.5636 0.0 0
M  V30 16 C 14.5650 0.0000 0.0 0
M  V30 17 C 14.0014 2.1036 0.0 0
M  V30 18 C 4.4953 9.8994 0.0 0 CFG=2
M  V30 19 C 4.4953 11.4394 0.0 0 CFG=2
M  V30 20 O 5.9600 9.4236 0.0 0
M  V30 21 C 5.9600 11.9153 0.0 0 CFG=2
M  V30 22 O 3.5900 12.6853 0.0 0
M  V30 23 C 6.8650 10.6694 0.0 0 CFG=2
M  V30 24 O 5.9600 13.4553 0.0 0
M  V30 25 C 4.4953 13.9311 0.0 0
M  V30 26 N 3.2494 8.9942 0.0 0
M  V30 27 C 3.2494 7.4542 0.0 0
M  V30 28 C 1.7847 9.4701 0.0 0
M  V30 29 C 1.7847 6.9784 0.0 0
M  V30 30 N 4.3938 6.4238 0.0 0
M  V30 31 N 0.8795 8.2242 0.0 0
M  V30 32 C 1.4645 5.4721 0.0 0
M  V30 33 C 4.0736 4.9174 0.0 0
M  V30 34 N 2.6091 4.4415 0.0 0
M  V30 35 C 15.3350 6.6684 0.0 0 CFG=3
M  V30 36 N 16.1050 5.3347 0.0 0
M  V30 37 C 16.1050 8.0021 0.0 0
M  V30 38 C 17.6450 5.3347 0.0 0
M  V30 39 C 17.6450 8.0021 0.0 0
M  V30 40 C 18.4150 6.6684 0.0 0
M  V30 41 C 18.4150 9.3358 0.0 0
M  V30 42 C 19.9550 6.6684 0.0 0
M  V30 43 C 19.9550 9.3358 0.0 0
M  V30 44 C 20.7250 8.0021 0.0 0
M  V30 45 H 3.0306 10.9636 0.0 0
M  V30 46 H 7.4245 12.3911 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 6 35
M  V30 9 1 8 25
M  V30 10 1 9 25
M  V30 11 1 10 32
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 36
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 26 CFG=1
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 45 CFG=1
M  V30 25 1 20 23
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 1 21 46 CFG=1
M  V30 29 1 22 25
M  V30 30 1 24 25
M  V30 31 1 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 27 30
M  V30 35 2 28 31
M  V30 36 1 29 31
M  V30 37 2 29 32
M  V30 38 1 30 33
M  V30 39 1 32 34
M  V30 40 2 33 34
M  V30 41 1 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 1 39 40
M  V30 47 2 39 41
M  V30 48 2 40 42
M  V30 49 1 41 43
M  V30 50 1 42 44
M  V30 51 2 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 67381-04-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 151838-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2736457-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24840905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Drug Design of Bisubstrate Inhibitors of
Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity
at Both Substrate Binding Domains1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Jian; Bart, Aaron G.; Wu, Qian; Criscione, Kevin R.; McLeish, Michael
J.; Scott, Emily E.; Grunewald, Gary L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(22), 13878-13898

$RFMT $RIREG SCHEME472 STEP1
$RXN



  2  1
$MOL
3-Chloro-5-(trifluoromethyl)picolinic acid
C7H3ClF3NO2
80194-68-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6673 0.0 0
M  V30 2 F 6.9300 4.2073 0.0 0
M  V30 3 F 8.4700 2.6673 0.0 0
M  V30 4 F 6.9300 1.1273 0.0 0
M  V30 5 Cl 2.3100 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 O 0.0000 1.3336 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 N 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2R,5R)-5-(6-amino-3-fluoro-2-pyridinyl)-5,6-dihydro-2,5...
C17H22F4N4O3
1387561-59-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5212 7.2171 0.0 0
M  V30 2 F 4.7189 8.7336 0.0 0
M  V30 3 N 9.1037 4.3668 0.0 0
M  V30 4 C 9.8737 5.7005 0.0 0
M  V30 5 O 11.4137 5.7005 0.0 0
M  V30 6 O 9.1037 7.0343 0.0 0
M  V30 7 C 12.1837 7.0343 0.0 0
M  V30 8 C 10.8501 7.8043 0.0 0
M  V30 9 C 12.9537 8.3679 0.0 0
M  V30 10 C 13.5175 6.2643 0.0 0
M  V30 11 N 0.0000 4.7742 0.0 0
M  V30 12 C 6.5264 1.5166 0.0 0
M  V30 13 F 8.0430 1.2491 0.0 0
M  V30 14 F 6.2589 0.0000 0.0 0
M  V30 15 F 5.0098 1.7839 0.0 0
M  V30 16 C 8.2408 2.5065 0.0 0
M  V30 17 C 5.2537 5.7005 0.0 0 CFG=1
M  V30 18 N 6.7937 5.7005 0.0 0
M  V30 19 C 4.4837 4.3668 0.0 0
M  V30 20 C 7.5637 4.3668 0.0 0
M  V30 21 O 5.2537 3.0332 0.0 0
M  V30 22 C 6.7937 3.0332 0.0 0 CFG=2
M  V30 23 C 3.8066 6.2271 0.0 0
M  V30 24 C 3.5392 7.7439 0.0 0
M  V30 25 N 2.6269 5.2374 0.0 0
M  V30 26 C 2.0921 8.2706 0.0 0
M  V30 27 C 1.1798 5.7641 0.0 0
M  V30 28 C 0.9123 7.2807 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 1 2 24
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 27
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 22 12 CFG=3
M  V30 16 1 22 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23 CFG=1
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2R,5R)-5-[6-[[[3-chloro-5-(trifluoromethyl)-2-pyridinyl...
C24H23ClF7N5O4
2173393-97-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7094 7.2357 0.0 0
M  V30 2 F 8.2361 8.8686 0.0 0
M  V30 3 N 4.6762 3.8066 0.0 0
M  V30 4 C 3.6863 4.9862 0.0 0
M  V30 5 O 2.1697 4.7189 0.0 0
M  V30 6 O 4.2130 6.4334 0.0 0
M  V30 7 C 1.1798 5.8985 0.0 0
M  V30 8 C 0.0000 4.9086 0.0 0
M  V30 9 C 0.1899 7.0783 0.0 0
M  V30 10 C 2.3594 6.8884 0.0 0
M  V30 11 N 13.5708 5.7886 0.0 0
M  V30 12 C 14.9044 6.5586 0.0 0
M  V30 13 O 14.9044 8.0986 0.0 0
M  V30 14 C 7.7094 1.4471 0.0 0
M  V30 15 F 9.1565 1.9738 0.0 0
M  V30 16 F 8.2361 0.0000 0.0 0
M  V30 17 F 6.2623 0.9205 0.0 0
M  V30 18 C 5.8489 2.1243 0.0 0
M  V30 19 Cl 17.5719 8.0986 0.0 0
M  V30 20 C 20.2391 3.4786 0.0 0
M  V30 21 F 19.4691 2.1449 0.0 0
M  V30 22 F 21.5729 2.7086 0.0 0
M  V30 23 F 21.0091 4.8122 0.0 0
M  V30 24 C 8.2361 5.7886 0.0 0 CFG=1
M  V30 25 N 6.7195 5.5211 0.0 0
M  V30 26 C 9.2260 4.6088 0.0 0
M  V30 27 C 6.1928 4.0739 0.0 0
M  V30 28 O 8.6993 3.1616 0.0 0
M  V30 29 C 7.1827 2.8943 0.0 0 CFG=2
M  V30 30 C 9.5697 6.5586 0.0 0
M  V30 31 N 10.9035 5.7886 0.0 0
M  V30 32 C 9.5697 8.0986 0.0 0
M  V30 33 C 12.2371 6.5586 0.0 0
M  V30 34 C 10.9035 8.8686 0.0 0
M  V30 35 C 12.2371 8.0986 0.0 0
M  V30 36 C 16.2382 5.7886 0.0 0
M  V30 37 C 17.5719 6.5586 0.0 0
M  V30 38 N 16.2382 4.2486 0.0 0
M  V30 39 C 18.9055 5.7886 0.0 0
M  V30 40 C 17.5719 3.4786 0.0 0
M  V30 41 C 18.9055 4.2486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=1
M  V30 2 1 2 32
M  V30 3 1 3 4
M  V30 4 1 3 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 33
M  V30 13 2 12 13
M  V30 14 1 12 36
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 29 14 CFG=1
M  V30 19 1 29 18 CFG=3
M  V30 20 1 19 37
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 41
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 24 30 CFG=3
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80194-68-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1387561-59-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173393-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34708798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious
β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Machauer, Rainer; Lueoend, Rainer; Hurth, Konstanze; Veenstra, Siem J.;
Rueeger, Heinrich; Voegtle, Markus; Tintelnot-Blomley, Marina; Rondeau,
Jean-Michel; Jacobson, Laura H.; Laue, Grit; Beltz, Karen; Neumann, Ulf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(20), 15262-15279

$RFMT $RIREG SCHEME473 STEP1
$RXN



  2  1
$MOL

C68H92N8O13SSi2
2757278-40-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  92 97 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 20.5841 5.7534 0.0 0
M  V30 2 O 21.3541 7.0871 0.0 0
M  V30 3 C 20.5841 8.4207 0.0 0
M  V30 4 N 21.3541 9.7544 0.0 0
M  V30 5 O 19.0441 8.4207 0.0 0
M  V30 6 C 20.5841 11.0882 0.0 0
M  V30 7 C 21.3541 12.4219 0.0 0 CFG=2
M  V30 8 C 20.5841 13.7556 0.0 0
M  V30 9 N 22.8941 12.4219 0.0 0
M  V30 10 N 19.0441 13.7556 0.0 0
M  V30 11 O 21.3541 15.0892 0.0 0
M  V30 12 C 23.6642 13.7556 0.0 0
M  V30 13 C 18.2740 15.0892 0.0 0 CFG=1
M  V30 14 C 25.2042 13.7556 0.0 0 CFG=2
M  V30 15 O 22.8941 15.0892 0.0 0
M  V30 16 C 16.7340 15.0892 0.0 0
M  V30 17 C 19.0441 16.4231 0.0 0
M  V30 18 N 25.9742 15.0892 0.0 0
M  V30 19 C 25.9742 12.4219 0.0 0
M  V30 20 N 15.9640 16.4231 0.0 0
M  V30 21 O 15.9640 13.7556 0.0 0
M  V30 22 C 18.2740 17.7567 0.0 0
M  V30 23 C 27.5142 15.0892 0.0 0
M  V30 24 C 14.4240 16.4231 0.0 0 CFG=1
M  V30 25 C 19.0441 19.0904 0.0 0
M  V30 26 C 28.2843 16.4231 0.0 0
M  V30 27 O 28.2843 13.7556 0.0 0
M  V30 28 C 13.6539 17.7567 0.0 0 CFG=3
M  V30 29 C 13.6539 15.0892 0.0 0 CFG=1
M  V30 30 N 29.8243 16.4231 0.0 0
M  V30 31 C 12.1139 17.7567 0.0 0
M  V30 32 O 14.4240 19.0904 0.0 0
M  V30 33 C 14.4240 13.7556 0.0 0
M  V30 34 C 12.1139 15.0892 0.0 0
M  V30 35 C 30.5943 17.7567 0.0 0
M  V30 36 N 11.3439 16.4231 0.0 0
M  V30 37 O 11.3439 19.0904 0.0 0
M  V30 38 Si 13.6539 20.4241 0.0 0
M  V30 39 C 13.6539 12.4219 0.0 0
M  V30 40 O 29.8243 19.0904 0.0 0
M  V30 41 C 9.8039 16.4231 0.0 0 CFG=2
M  V30 42 C 12.8839 21.7579 0.0 0
M  V30 43 C 12.3203 19.6541 0.0 0
M  V30 44 C 14.9876 21.1941 0.0 0
M  V30 45 C 9.0338 17.7567 0.0 0
M  V30 46 C 11.5503 20.9879 0.0 0
M  V30 47 C 12.1139 23.0916 0.0 0
M  V30 48 C 14.2176 22.5279 0.0 0
M  V30 49 O 36.7544 17.7567 0.0 0
M  V30 50 C 8.6767 11.1204 0.0 0
M  V30 51 C 7.4308 10.2152 0.0 0
M  V30 52 C 7.5917 8.6835 0.0 0
M  V30 53 O 8.9987 8.0571 0.0 0
M  V30 54 O 6.3459 7.7784 0.0 0
M  V30 55 O 2.8737 17.7567 0.0 0
M  V30 56 Si 2.1037 19.0904 0.0 0
M  V30 57 C 1.3337 20.4242 0.0 0
M  V30 58 C 0.7700 18.3204 0.0 0
M  V30 59 C 3.4374 19.8604 0.0 0
M  V30 60 C 0.0000 19.6542 0.0 0
M  V30 61 C 0.5637 21.7579 0.0 0
M  V30 62 C 2.6673 21.1943 0.0 0
M  V30 63 C 21.3541 4.4196 0.0 0
M  V30 64 C 22.8857 4.2587 0.0 0
M  V30 65 C 20.7278 3.0128 0.0 0
M  V30 66 C 23.2058 2.7523 0.0 0
M  V30 67 C 24.0302 5.2891 0.0 0
M  V30 68 C 21.8722 1.9823 0.0 0
M  V30 69 C 19.2630 2.5369 0.0 0
M  V30 70 C 24.6706 2.2763 0.0 0
M  V30 71 C 25.4948 4.8132 0.0 0
M  V30 72 C 21.5520 0.4759 0.0 0
M  V30 73 C 18.9429 1.0304 0.0 0
M  V30 74 C 25.8150 3.3069 0.0 0
M  V30 75 C 20.0873 0.0000 0.0 0
M  V30 76 C 32.1343 17.7567 0.0 0
M  V30 77 C 32.9044 19.0904 0.0 0
M  V30 78 C 32.9044 16.4231 0.0 0
M  V30 79 C 34.4444 19.0904 0.0 0
M  V30 80 C 34.4444 16.4231 0.0 0
M  V30 81 C 35.2144 17.7567 0.0 0
M  V30 82 C 9.0338 15.0894 0.0 0
M  V30 83 N 9.6602 13.6824 0.0 0
M  V30 84 S 7.5023 14.9283 0.0 0
M  V30 85 C 8.5158 12.6520 0.0 0
M  V30 86 C 7.1821 13.4220 0.0 0
M  V30 87 C 7.4938 17.7567 0.0 0
M  V30 88 C 6.7238 16.4231 0.0 0
M  V30 89 C 6.7238 19.0904 0.0 0
M  V30 90 C 5.1838 16.4231 0.0 0
M  V30 91 C 5.1838 19.0904 0.0 0
M  V30 92 C 4.4137 17.7567 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 63
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17 CFG=3
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=1
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 2 23 27
M  V30 28 1 24 28 CFG=1
M  V30 29 1 24 29
M  V30 30 1 26 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 1 29 34 CFG=3
M  V30 35 1 30 35
M  V30 36 1 31 36
M  V30 37 2 31 37
M  V30 38 1 32 38
M  V30 39 1 33 39
M  V30 40 2 35 40
M  V30 41 1 35 76
M  V30 42 1 36 41
M  V30 43 1 38 42
M  V30 44 1 38 43
M  V30 45 1 38 44
M  V30 46 1 41 45 CFG=3
M  V30 47 1 41 82
M  V30 48 1 42 46
M  V30 49 1 42 47
M  V30 50 1 42 48
M  V30 51 1 45 87
M  V30 52 1 49 81
M  V30 53 2 50 51
M  V30 54 1 50 85
M  V30 55 1 51 52
M  V30 56 1 52 53
M  V30 57 2 52 54
M  V30 58 1 55 56
M  V30 59 1 55 92
M  V30 60 1 56 57
M  V30 61 1 56 58
M  V30 62 1 56 59
M  V30 63 1 57 60
M  V30 64 1 57 61
M  V30 65 1 57 62
M  V30 66 1 63 64
M  V30 67 1 63 65
M  V30 68 1 64 66
M  V30 69 2 64 67
M  V30 70 1 65 68
M  V30 71 2 65 69
M  V30 72 1 66 68
M  V30 73 2 66 70
M  V30 74 1 67 71
M  V30 75 2 68 72
M  V30 76 1 69 73
M  V30 77 1 70 74
M  V30 78 2 71 74
M  V30 79 1 72 75
M  V30 80 2 73 75
M  V30 81 2 76 77
M  V30 82 1 76 78
M  V30 83 1 77 79
M  V30 84 2 78 80
M  V30 85 2 79 81
M  V30 86 1 80 81
M  V30 87 2 82 83
M  V30 88 1 82 84
M  V30 89 1 83 85
M  V30 90 1 84 86
M  V30 91 2 85 86
M  V30 92 2 87 88
M  V30 93 1 87 89
M  V30 94 1 88 90
M  V30 95 2 89 91
M  V30 96 2 90 92
M  V30 97 1 91 92
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 7 13 14 24 29 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-(Triphenylmethyl)-L-cysteine 2-propen-1-yl ester
C25H25NO2S
1026823-61-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.0012 0.0 0
M  V30 2 S 5.3348 3.2311 0.0 0
M  V30 3 C 6.6685 4.0012 0.0 0
M  V30 4 C 8.0022 3.2311 0.0 0 CFG=2
M  V30 5 C 9.3358 4.0012 0.0 0
M  V30 6 N 8.0022 1.6911 0.0 0
M  V30 7 O 10.6697 3.2311 0.0 0
M  V30 8 O 9.3358 5.5412 0.0 0
M  V30 9 C 12.0033 4.0012 0.0 0
M  V30 10 C 13.3370 3.2311 0.0 0
M  V30 11 C 14.6707 4.0012 0.0 0
M  V30 12 C 3.2310 2.6675 0.0 0
M  V30 13 C 4.0010 1.3337 0.0 0
M  V30 14 C 1.6910 2.6675 0.0 0
M  V30 15 C 3.2310 0.0000 0.0 0
M  V30 16 C 0.9209 1.3337 0.0 0
M  V30 17 C 1.6910 0.0000 0.0 0
M  V30 18 C 2.6673 4.7712 0.0 0
M  V30 19 C 1.3337 4.0012 0.0 0
M  V30 20 C 2.6673 6.3112 0.0 0
M  V30 21 C 0.0000 4.7712 0.0 0
M  V30 22 C 1.3337 7.0812 0.0 0
M  V30 23 C 0.0000 6.3112 0.0 0
M  V30 24 C 4.7710 5.3348 0.0 0
M  V30 25 C 4.0010 6.6687 0.0 0
M  V30 26 C 6.3111 5.3348 0.0 0
M  V30 27 C 4.7710 8.0023 0.0 0
M  V30 28 C 7.0811 6.6687 0.0 0
M  V30 29 C 6.3111 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 1 24
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 4 6 CFG=1
M  V30 9 1 5 7
M  V30 10 2 5 8
M  V30 11 1 7 9
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C93H115N9O14S2Si2
2757278-25-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  120 128 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4755 10.7613 0.0 0
M  V30 2 S 7.6366 12.2929 0.0 0
M  V30 3 C 6.3907 13.1981 0.0 0
M  V30 4 C 6.5516 14.7297 0.0 0 CFG=1
M  V30 5 N 7.9584 15.3560 0.0 0
M  V30 6 C 5.3057 15.6349 0.0 0
M  V30 7 C 8.1195 16.8877 0.0 0
M  V30 8 O 3.8987 15.0086 0.0 0
M  V30 9 O 5.4667 17.1664 0.0 0
M  V30 10 C 9.5263 17.5140 0.0 0
M  V30 11 O 6.8735 17.7929 0.0 0
M  V30 12 C 2.6529 15.9136 0.0 0
M  V30 13 C 9.6873 19.0456 0.0 0
M  V30 14 C 1.2460 15.2873 0.0 0
M  V30 15 C 0.0000 16.1925 0.0 0
M  V30 16 C 13.7160 22.6731 0.0 0 CFG=1
M  V30 17 C 12.9460 24.0068 0.0 0
M  V30 18 N 15.2560 22.6731 0.0 0
M  V30 19 C 16.0261 21.3393 0.0 0
M  V30 20 C 17.5661 21.3393 0.0 0 CFG=3
M  V30 21 O 15.2560 20.0057 0.0 0
M  V30 22 C 18.3361 20.0057 0.0 0 CFG=2
M  V30 23 O 18.3361 22.6731 0.0 0
M  V30 24 N 19.8761 20.0057 0.0 0
M  V30 25 C 17.5661 18.6720 0.0 0 CFG=1
M  V30 26 Si 17.5661 24.0068 0.0 0
M  V30 27 C 20.6462 18.6720 0.0 0
M  V30 28 C 18.3361 17.3383 0.0 0
M  V30 29 C 16.0261 18.6720 0.0 0
M  V30 30 C 16.7961 25.3405 0.0 0
M  V30 31 C 18.8998 24.7768 0.0 0
M  V30 32 C 16.2324 23.2368 0.0 0
M  V30 33 C 22.1862 18.6720 0.0 0 CFG=2
M  V30 34 O 19.8761 17.3383 0.0 0
M  V30 35 C 17.5661 16.0045 0.0 0
M  V30 36 C 15.4624 24.5705 0.0 0
M  V30 37 C 16.0261 26.6742 0.0 0
M  V30 38 C 18.1297 26.1105 0.0 0
M  V30 39 N 22.9562 17.3383 0.0 0
M  V30 40 C 22.9562 20.0057 0.0 0
M  V30 41 C 24.4962 17.3383 0.0 0
M  V30 42 C 22.1862 21.3393 0.0 0
M  V30 43 C 25.2663 16.0045 0.0 0 CFG=2
M  V30 44 O 25.2663 18.6720 0.0 0
M  V30 45 C 22.9562 22.6731 0.0 0
M  V30 46 N 24.4962 14.6708 0.0 0
M  V30 47 C 26.8063 16.0045 0.0 0
M  V30 48 C 25.2663 13.3372 0.0 0
M  V30 49 N 27.5763 17.3383 0.0 0
M  V30 50 C 24.4962 12.0035 0.0 0 CFG=2
M  V30 51 O 26.8063 13.3372 0.0 0
M  V30 52 C 29.1163 17.3383 0.0 0
M  V30 53 N 25.2663 10.6697 0.0 0
M  V30 54 C 22.9562 12.0035 0.0 0
M  V30 55 O 29.8864 18.6720 0.0 0
M  V30 56 O 29.8864 16.0045 0.0 0
M  V30 57 C 24.4962 9.3360 0.0 0
M  V30 58 C 31.4264 18.6720 0.0 0
M  V30 59 C 25.2663 8.0023 0.0 0
M  V30 60 O 22.9562 9.3360 0.0 0
M  V30 61 N 24.4962 6.6687 0.0 0
M  V30 62 C 25.2663 5.3348 0.0 0
M  V30 63 O 26.8063 5.3348 0.0 0
M  V30 64 O 6.7858 24.0068 0.0 0
M  V30 65 Si 6.0158 25.3405 0.0 0
M  V30 66 C 5.2458 26.6742 0.0 0
M  V30 67 C 4.6822 24.5705 0.0 0
M  V30 68 C 7.3495 26.1105 0.0 0
M  V30 69 C 3.9121 25.9041 0.0 0
M  V30 70 C 4.4758 28.0080 0.0 0
M  V30 71 C 6.5795 27.4442 0.0 0
M  V30 72 O 22.1862 0.0000 0.0 0
M  V30 73 C 5.9439 10.9222 0.0 0
M  V30 74 C 5.0387 9.6763 0.0 0
M  V30 75 C 5.3176 12.3292 0.0 0
M  V30 76 C 3.5071 9.8373 0.0 0
M  V30 77 C 3.7860 12.4901 0.0 0
M  V30 78 C 2.8808 11.2442 0.0 0
M  V30 79 C 7.3145 9.2297 0.0 0
M  V30 80 C 5.9077 8.6032 0.0 0
M  V30 81 C 8.5604 8.3245 0.0 0
M  V30 82 C 5.7466 7.0717 0.0 0
M  V30 83 C 8.3995 6.7929 0.0 0
M  V30 84 C 6.9927 6.1664 0.0 0
M  V30 85 C 9.0072 10.6004 0.0 0
M  V30 86 C 9.9124 11.8462 0.0 0
M  V30 87 C 9.6335 9.1934 0.0 0
M  V30 88 C 11.4440 11.6852 0.0 0
M  V30 89 C 11.1651 9.0325 0.0 0
M  V30 90 C 12.0703 10.2783 0.0 0
M  V30 91 C 11.0942 19.6721 0.0 0
M  V30 92 N 11.4144 21.1784 0.0 0
M  V30 93 C 12.4279 18.9021 0.0 0
M  V30 94 C 12.9460 21.3393 0.0 0
M  V30 95 S 13.5725 19.9325 0.0 0
M  V30 96 C 11.4060 24.0068 0.0 0
M  V30 97 C 10.6359 25.3405 0.0 0
M  V30 98 C 10.6359 22.6731 0.0 0
M  V30 99 C 9.0959 25.3405 0.0 0
M  V30 100 C 9.0959 22.6731 0.0 0
M  V30 101 C 8.3259 24.0068 0.0 0
M  V30 102 C 32.1964 20.0057 0.0 0
M  V30 103 C 33.7280 20.1666 0.0 0
M  V30 104 C 31.5701 21.4126 0.0 0
M  V30 105 C 34.0481 21.6730 0.0 0
M  V30 106 C 34.8725 19.1361 0.0 0
M  V30 107 C 32.7145 22.4431 0.0 0
M  V30 108 C 30.1053 21.8885 0.0 0
M  V30 109 C 35.5129 22.1489 0.0 0
M  V30 110 C 36.3371 19.6120 0.0 0
M  V30 111 C 32.3943 23.9494 0.0 0
M  V30 112 C 29.7852 23.3948 0.0 0
M  V30 113 C 36.6574 21.1185 0.0 0
M  V30 114 C 30.9297 24.4254 0.0 0
M  V30 115 C 24.4962 4.0012 0.0 0
M  V30 116 C 25.2663 2.6675 0.0 0
M  V30 117 C 22.9562 4.0012 0.0 0
M  V30 118 C 24.4962 1.3338 0.0 0
M  V30 119 C 22.1862 2.6675 0.0 0
M  V30 120 C 22.9562 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 73
M  V30 3 1 1 79
M  V30 4 1 1 85
M  V30 5 1 2 3
M  V30 6 1 4 3 CFG=1
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 2 6 9
M  V30 12 1 7 10
M  V30 13 2 7 11
M  V30 14 1 8 12
M  V30 15 2 10 13
M  V30 16 1 12 14
M  V30 17 1 13 91
M  V30 18 2 14 15
M  V30 19 1 16 17 CFG=3
M  V30 20 1 16 18
M  V30 21 1 16 94
M  V30 22 1 17 96
M  V30 23 1 18 19
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 1 20 22
M  V30 27 1 20 23
M  V30 28 1 22 24 CFG=1
M  V30 29 1 22 25
M  V30 30 1 23 26
M  V30 31 1 24 27
M  V30 32 1 25 28
M  V30 33 1 25 29 CFG=3
M  V30 34 1 26 30
M  V30 35 1 26 31
M  V30 36 1 26 32
M  V30 37 1 27 33
M  V30 38 2 27 34
M  V30 39 1 28 35
M  V30 40 1 30 36
M  V30 41 1 30 37
M  V30 42 1 30 38
M  V30 43 1 33 39
M  V30 44 1 33 40 CFG=3
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 41 44
M  V30 49 1 42 45
M  V30 50 1 43 46 CFG=3
M  V30 51 1 43 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 2 48 51
M  V30 56 1 49 52
M  V30 57 1 50 53
M  V30 58 1 50 54 CFG=1
M  V30 59 1 52 55
M  V30 60 2 52 56
M  V30 61 1 53 57
M  V30 62 1 55 58
M  V30 63 1 57 59
M  V30 64 2 57 60
M  V30 65 1 58 102
M  V30 66 1 59 61
M  V30 67 1 61 62
M  V30 68 2 62 63
M  V30 69 1 62 115
M  V30 70 1 64 65
M  V30 71 1 64 101
M  V30 72 1 65 66
M  V30 73 1 65 67
M  V30 74 1 65 68
M  V30 75 1 66 69
M  V30 76 1 66 70
M  V30 77 1 66 71
M  V30 78 1 72 120
M  V30 79 2 73 74
M  V30 80 1 73 75
M  V30 81 1 74 76
M  V30 82 2 75 77
M  V30 83 2 76 78
M  V30 84 1 77 78
M  V30 85 2 79 80
M  V30 86 1 79 81
M  V30 87 1 80 82
M  V30 88 2 81 83
M  V30 89 2 82 84
M  V30 90 1 83 84
M  V30 91 2 85 86
M  V30 92 1 85 87
M  V30 93 1 86 88
M  V30 94 2 87 89
M  V30 95 2 88 90
M  V30 96 1 89 90
M  V30 97 1 91 92
M  V30 98 2 91 93
M  V30 99 2 92 94
M  V30 100 1 93 95
M  V30 101 1 94 95
M  V30 102 2 96 97
M  V30 103 1 96 98
M  V30 104 1 97 99
M  V30 105 2 98 100
M  V30 106 2 99 101
M  V30 107 1 100 101
M  V30 108 1 102 103
M  V30 109 1 102 104
M  V30 110 1 103 105
M  V30 111 2 103 106
M  V30 112 1 104 107
M  V30 113 2 104 108
M  V30 114 1 105 107
M  V30 115 2 105 109
M  V30 116 1 106 110
M  V30 117 2 107 111
M  V30 118 1 108 112
M  V30 119 1 109 113
M  V30 120 2 110 113
M  V30 121 1 111 114
M  V30 122 2 112 114
M  V30 123 2 115 116
M  V30 124 1 115 117
M  V30 125 1 116 118
M  V30 126 2 117 119
M  V30 127 2 118 120
M  V30 128 1 119 120
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 4 16 22 25 33 43 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2757278-40-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1026823-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757278-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35054346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 80
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo
biological evaluation for acute lung injury
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Yingjun; Zhang, Mengyi; Xu, Honglei; Zhang, Tingrong; Zhang,
Songming; Zhao, Xiuhe; Jiang, Peng; Li, Jing; Ye, Baijun; Sun, Yuanjun;
Wang, Mukuo; Deng, Yangping; Meng, Qing; Liu, Yang; Fu, Qiang; Lin,
Jianping; Wang, Liang; Chen, Yue
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(4), 2971-2987

$RFMT $RIREG SCHEME474 STEP1
$RXN



  2  1
$MOL
3-Quinolinecarboxylic acid, 7-[4-(3-carboxy-1-oxopropyl)-1-piperazinyl]-1-cyc...
C28H28FN3O6
3035080-41-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 8.4702 0.0 0
M  V30 2 C 6.6685 6.9302 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 O 6.6685 8.4702 0.0 0
M  V30 5 C 4.0010 6.9302 0.0 0
M  V30 6 F 14.6708 6.9302 0.0 0
M  V30 7 C 18.6718 1.5400 0.0 0
M  V30 8 C 20.0057 2.3101 0.0 0
M  V30 9 O 18.6718 0.0000 0.0 0
M  V30 10 C 21.3393 1.5400 0.0 0
M  V30 11 C 22.6730 2.3101 0.0 0
M  V30 12 O 24.0067 1.5400 0.0 0
M  V30 13 O 22.6730 3.8501 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 N 9.3358 3.8501 0.0 0
M  V30 16 C 10.6697 6.1601 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 C 12.0033 6.9302 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 8.0022 6.1601 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 9.3358 2.3101 0.0 0
M  V30 25 C 8.5658 0.9764 0.0 0
M  V30 26 C 10.1059 0.9764 0.0 0
M  V30 27 N 14.6708 3.8501 0.0 0
M  V30 28 C 16.0045 4.6201 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 17.3382 3.8501 0.0 0
M  V30 31 C 16.0045 1.5400 0.0 0
M  V30 32 N 17.3382 2.3101 0.0 0
M  V30 33 C 2.6673 6.1601 0.0 0
M  V30 34 C 1.3337 6.9302 0.0 0
M  V30 35 C 2.6673 4.6201 0.0 0
M  V30 36 C 0.0000 6.1601 0.0 0
M  V30 37 C 1.3337 3.8501 0.0 0
M  V30 38 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 5 33
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 32
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 1 21 27
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(1H)-Pyridinone, 1-(3-aminopropyl)-2-methyl-5-(phenylmethoxy)-
C16H20N2O2
3035080-68-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 6.6685 0.0 0
M  V30 2 C 6.9302 5.3348 0.0 0
M  V30 3 O 4.6201 9.3360 0.0 0
M  V30 4 C 1.5400 4.0012 0.0 0
M  V30 5 C 2.3101 2.6675 0.0 0
M  V30 6 C 1.5400 1.3337 0.0 0
M  V30 7 N 2.3101 0.0000 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 4.6201 6.6685 0.0 0
M  V30 10 C 3.8501 5.3348 0.0 0
M  V30 11 C 3.8501 8.0023 0.0 0
M  V30 12 N 2.3101 5.3348 0.0 0
M  V30 13 C 2.3101 8.0023 0.0 0
M  V30 14 C 1.5400 6.6685 0.0 0
M  V30 15 C 8.4702 5.3348 0.0 0
M  V30 16 C 9.2402 6.6685 0.0 0
M  V30 17 C 9.2402 4.0012 0.0 0
M  V30 18 C 10.7802 6.6685 0.0 0
M  V30 19 C 10.7802 4.0012 0.0 0
M  V30 20 C 11.5503 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-[[3-[2...
C44H46FN5O7
3035080-69-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 C 6.6687 1.5400 0.0 0
M  V30 3 O 5.3348 2.3101 0.0 0
M  V30 4 O 6.6687 0.0000 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 F 14.6708 1.5400 0.0 0
M  V30 7 C 18.6720 6.9302 0.0 0
M  V30 8 C 20.0057 6.1601 0.0 0
M  V30 9 O 18.6720 8.4702 0.0 0
M  V30 10 C 21.3395 6.9302 0.0 0
M  V30 11 C 22.6731 6.1601 0.0 0
M  V30 12 N 24.0068 6.9302 0.0 0
M  V30 13 O 22.6731 4.6201 0.0 0
M  V30 14 C 25.3405 6.1601 0.0 0
M  V30 15 C 26.6743 6.9302 0.0 0
M  V30 16 C 28.0080 6.1601 0.0 0
M  V30 17 C 28.0080 9.2402 0.0 0
M  V30 18 O 33.3428 6.1601 0.0 0
M  V30 19 C 33.3428 4.6201 0.0 0
M  V30 20 O 33.3428 9.2402 0.0 0
M  V30 21 C 10.6697 3.8501 0.0 0
M  V30 22 N 9.3360 4.6201 0.0 0
M  V30 23 C 10.6697 2.3101 0.0 0
M  V30 24 C 12.0035 4.6201 0.0 0
M  V30 25 C 8.0023 3.8501 0.0 0
M  V30 26 C 9.3360 1.5400 0.0 0
M  V30 27 C 12.0035 1.5400 0.0 0
M  V30 28 C 13.3372 3.8501 0.0 0
M  V30 29 C 8.0023 2.3101 0.0 0
M  V30 30 C 13.3372 2.3101 0.0 0
M  V30 31 C 9.3360 6.1601 0.0 0
M  V30 32 C 10.1060 7.4938 0.0 0
M  V30 33 C 8.5660 7.4938 0.0 0
M  V30 34 N 14.6708 4.6201 0.0 0
M  V30 35 C 14.6708 6.1601 0.0 0
M  V30 36 C 16.0045 3.8501 0.0 0
M  V30 37 C 16.0045 6.9302 0.0 0
M  V30 38 C 17.3383 4.6201 0.0 0
M  V30 39 N 17.3383 6.1601 0.0 0
M  V30 40 C 2.6675 2.3101 0.0 0
M  V30 41 C 1.3338 1.5400 0.0 0
M  V30 42 C 2.6675 3.8501 0.0 0
M  V30 43 C 0.0000 2.3101 0.0 0
M  V30 44 C 1.3338 4.6201 0.0 0
M  V30 45 C 0.0000 3.8501 0.0 0
M  V30 46 N 29.3416 6.9302 0.0 0
M  V30 47 C 30.6753 6.1601 0.0 0
M  V30 48 C 29.3416 8.4702 0.0 0
M  V30 49 C 32.0091 6.9302 0.0 0
M  V30 50 C 30.6753 9.2402 0.0 0
M  V30 51 C 32.0091 8.4702 0.0 0
M  V30 52 C 34.6765 3.8501 0.0 0
M  V30 53 C 34.6765 2.3101 0.0 0
M  V30 54 C 36.0101 4.6201 0.0 0
M  V30 55 C 36.0101 1.5400 0.0 0
M  V30 56 C 37.3440 3.8501 0.0 0
M  V30 57 C 37.3440 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 26
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 29
M  V30 5 1 3 5
M  V30 6 1 5 40
M  V30 7 1 6 30
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 39
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 46
M  V30 19 1 17 48
M  V30 20 1 18 19
M  V30 21 1 18 49
M  V30 22 1 19 52
M  V30 23 2 20 51
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 22 31
M  V30 29 1 23 26
M  V30 30 2 23 27
M  V30 31 1 24 28
M  V30 32 2 25 29
M  V30 33 1 26 29
M  V30 34 1 27 30
M  V30 35 2 28 30
M  V30 36 1 28 34
M  V30 37 1 31 32
M  V30 38 1 31 33
M  V30 39 1 32 33
M  V30 40 1 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 1 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 52 1 46 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 2 48 50
M  V30 56 1 49 51
M  V30 57 1 50 51
M  V30 58 2 52 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 2 54 56
M  V30 62 2 55 57
M  V30 63 1 56 57
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3035080-41-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035080-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035080-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35625672
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 86
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 57951-36-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin
Conjugates as Dual Antibacterial and Antibiofilm Agents against
Pseudomonas aeruginosa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yuan-Yuan; Zhang, Xiao-Yi; Zhong, Xiao-Lin; Huang, Yong-Jun; Lin,
Jing; Chen, Wei-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 2169-2193

$RFMT $RIREG SCHEME475 STEP1
$RXN



  2  1
$MOL
2-(Aminomethyl)-1-methyl-5-(phenylmethoxy)-4(1H)-pyridinone
C14H16N2O2
812653-97-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 C 11.5500 2.6674 0.0 0
M  V30 6 N 12.3200 1.3338 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3338 0.0 0
M  V30 11 N 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 7-[4-(4-carboxy-1-oxobutyl)-1-piperazinyl]-1-cycl...
C29H30FN3O6
3035080-42-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 5.3348 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 F 14.6707 1.5400 0.0 0
M  V30 7 C 18.6718 6.9302 0.0 0
M  V30 8 C 20.0055 6.1601 0.0 0
M  V30 9 O 18.6718 8.4702 0.0 0
M  V30 10 C 21.3393 6.9302 0.0 0
M  V30 11 C 22.6730 6.1601 0.0 0
M  V30 12 C 24.0067 6.9302 0.0 0
M  V30 13 O 24.0067 8.4702 0.0 0
M  V30 14 O 25.3403 6.1601 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 N 9.3358 4.6201 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 8.0022 3.8501 0.0 0
M  V30 20 C 9.3358 1.5400 0.0 0
M  V30 21 C 12.0033 1.5400 0.0 0
M  V30 22 C 13.3370 3.8501 0.0 0
M  V30 23 C 8.0022 2.3101 0.0 0
M  V30 24 C 13.3370 2.3101 0.0 0
M  V30 25 C 9.3358 6.1601 0.0 0
M  V30 26 C 10.1059 7.4938 0.0 0
M  V30 27 C 8.5658 7.4938 0.0 0
M  V30 28 N 14.6707 4.6201 0.0 0
M  V30 29 C 16.0045 3.8501 0.0 0
M  V30 30 C 14.6707 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 C 16.0045 6.9302 0.0 0
M  V30 33 N 17.3382 6.1601 0.0 0
M  V30 34 C 2.6673 2.3101 0.0 0
M  V30 35 C 1.3337 1.5400 0.0 0
M  V30 36 C 2.6673 3.8501 0.0 0
M  V30 37 C 0.0000 2.3101 0.0 0
M  V30 38 C 1.3337 4.6201 0.0 0
M  V30 39 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 23
M  V30 5 1 3 5
M  V30 6 1 5 34
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 33
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 16 25
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 1 22 28
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[5-[[[1,4-dihydro-1-methyl-4-o...
C43H44FN5O7
3035080-49-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 62 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 6.6686 0.0000 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 14.6707 1.5400 0.0 0
M  V30 7 C 18.6718 6.9301 0.0 0
M  V30 8 C 20.0054 6.1601 0.0 0
M  V30 9 O 18.6718 8.4701 0.0 0
M  V30 10 C 21.3392 6.9301 0.0 0
M  V30 11 C 22.6729 6.1601 0.0 0
M  V30 12 C 24.0066 6.9301 0.0 0
M  V30 13 N 25.3402 6.1601 0.0 0
M  V30 14 O 24.0066 8.4701 0.0 0
M  V30 15 C 26.6740 6.9301 0.0 0
M  V30 16 C 29.3413 8.4701 0.0 0
M  V30 17 O 29.3413 2.3100 0.0 0
M  V30 18 O 32.0088 3.8500 0.0 0
M  V30 19 C 33.3424 4.6201 0.0 0
M  V30 20 C 10.6695 3.8500 0.0 0
M  V30 21 N 9.3359 4.6201 0.0 0
M  V30 22 C 10.6695 2.3100 0.0 0
M  V30 23 C 12.0034 4.6201 0.0 0
M  V30 24 C 8.0022 3.8500 0.0 0
M  V30 25 C 9.3359 1.5400 0.0 0
M  V30 26 C 12.0034 1.5400 0.0 0
M  V30 27 C 13.3370 3.8500 0.0 0
M  V30 28 C 8.0022 2.3100 0.0 0
M  V30 29 C 13.3370 2.3100 0.0 0
M  V30 30 C 9.3359 6.1601 0.0 0
M  V30 31 C 10.1059 7.4937 0.0 0
M  V30 32 C 8.5659 7.4937 0.0 0
M  V30 33 N 14.6707 4.6201 0.0 0
M  V30 34 C 16.0043 3.8500 0.0 0
M  V30 35 C 14.6707 6.1601 0.0 0
M  V30 36 C 17.3381 4.6201 0.0 0
M  V30 37 C 16.0043 6.9301 0.0 0
M  V30 38 N 17.3381 6.1601 0.0 0
M  V30 39 C 2.6675 2.3100 0.0 0
M  V30 40 C 2.6675 3.8500 0.0 0
M  V30 41 C 1.3338 1.5400 0.0 0
M  V30 42 C 1.3338 4.6201 0.0 0
M  V30 43 C 0.0000 2.3100 0.0 0
M  V30 44 C 0.0000 3.8500 0.0 0
M  V30 45 C 28.0077 6.1601 0.0 0
M  V30 46 N 29.3413 6.9301 0.0 0
M  V30 47 C 28.0077 4.6201 0.0 0
M  V30 48 C 30.6750 6.1601 0.0 0
M  V30 49 C 29.3413 3.8500 0.0 0
M  V30 50 C 30.6750 4.6201 0.0 0
M  V30 51 C 34.6761 3.8500 0.0 0
M  V30 52 C 36.0098 4.6201 0.0 0
M  V30 53 C 34.6761 2.3100 0.0 0
M  V30 54 C 37.3436 3.8500 0.0 0
M  V30 55 C 36.0098 1.5400 0.0 0
M  V30 56 C 37.3436 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 28
M  V30 5 1 3 5
M  V30 6 1 5 39
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 38
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 45
M  V30 18 1 16 46
M  V30 19 2 17 49
M  V30 20 1 18 19
M  V30 21 1 18 50
M  V30 22 1 19 51
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 1 21 30
M  V30 28 1 22 25
M  V30 29 2 22 26
M  V30 30 1 23 27
M  V30 31 2 24 28
M  V30 32 1 25 28
M  V30 33 1 26 29
M  V30 34 2 27 29
M  V30 35 1 27 33
M  V30 36 1 30 31
M  V30 37 1 30 32
M  V30 38 1 31 32
M  V30 39 1 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 1 45 46
M  V30 52 2 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 2 48 50
M  V30 56 1 49 50
M  V30 57 2 51 52
M  V30 58 1 51 53
M  V30 59 1 52 54
M  V30 60 2 53 55
M  V30 61 2 54 56
M  V30 62 1 55 56
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 812653-97-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035080-42-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035080-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35625641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 57951-36-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin
Conjugates as Dual Antibacterial and Antibiofilm Agents against
Pseudomonas aeruginosa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yuan-Yuan; Zhang, Xiao-Yi; Zhong, Xiao-Lin; Huang, Yong-Jun; Lin,
Jing; Chen, Wei-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 2169-2193

$RFMT $RIREG SCHEME476 STEP1
$RXN



  2  1
$MOL
2-[[6-[[2-[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]tri...
C27H24ClN5O4S
2417371-30-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.9692 6.7645 0.0 0
M  V30 2 C 0.0000 4.0539 0.0 0
M  V30 3 C 3.6536 0.0000 0.0 0
M  V30 4 C 8.8233 4.0539 0.0 0
M  V30 5 C 9.5933 5.3875 0.0 0
M  V30 6 N 11.1333 5.3875 0.0 0
M  V30 7 O 8.8233 6.7212 0.0 0
M  V30 8 C 11.9033 6.7212 0.0 0
M  V30 9 C 13.4433 6.7212 0.0 0
M  V30 10 C 14.9833 6.7212 0.0 0
M  V30 11 C 16.5233 6.7212 0.0 0
M  V30 12 C 18.0633 6.7212 0.0 0
M  V30 13 C 19.6033 6.7212 0.0 0
M  V30 14 O 20.3733 8.0550 0.0 0
M  V30 15 C 21.9133 8.0550 0.0 0
M  V30 16 C 22.6833 9.3886 0.0 0
M  V30 17 O 24.2233 9.3886 0.0 0
M  V30 18 O 21.9133 10.7223 0.0 0
M  V30 19 Cl 3.7430 11.7896 0.0 0
M  V30 20 C 3.9098 4.8239 0.0 0
M  V30 21 C 3.9098 3.2839 0.0 0
M  V30 22 C 5.1137 5.7841 0.0 0
M  V30 23 C 2.4451 5.2998 0.0 0
M  V30 24 N 5.1137 2.3237 0.0 0
M  V30 25 S 2.4451 2.8080 0.0 0
M  V30 26 N 6.6152 5.4414 0.0 0
M  V30 27 C 1.5400 4.0539 0.0 0
M  V30 28 C 6.6152 2.6664 0.0 0
M  V30 29 C 4.9757 0.7899 0.0 0
M  V30 30 C 7.2833 4.0539 0.0 0 CFG=1
M  V30 31 N 7.4051 1.3444 0.0 0
M  V30 32 N 6.3918 0.1846 0.0 0
M  V30 33 C 4.7711 7.2854 0.0 0
M  V30 34 C 3.2994 7.7394 0.0 0
M  V30 35 C 5.9000 8.3329 0.0 0
M  V30 36 C 2.9568 9.2408 0.0 0
M  V30 37 C 5.5572 9.8343 0.0 0
M  V30 38 C 4.0858 10.2883 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 2 27
M  V30 3 1 3 29
M  V30 4 1 4 5
M  V30 5 1 30 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 3 9 10
M  V30 11 1 10 11
M  V30 12 3 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 19 38
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 22 33
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 24 29
M  V30 30 1 25 27
M  V30 31 1 26 30
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 2 29 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, 3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]...
C22H30N4O3S
1448297-52-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0133 5.3027 0.0 0
M  V30 2 N 8.5533 5.3027 0.0 0
M  V30 3 O 6.2433 6.6363 0.0 0
M  V30 4 C 9.3233 6.6363 0.0 0
M  V30 5 C 3.6814 4.9525 0.0 0
M  V30 6 C 2.1749 4.6322 0.0 0 CFG=1
M  V30 7 O 4.1572 6.4170 0.0 0
M  V30 8 C 1.1445 5.7767 0.0 0
M  V30 9 N 1.6991 3.1676 0.0 0
M  V30 10 C 0.0000 4.7463 0.0 0
M  V30 11 C 0.1141 6.9211 0.0 0
M  V30 12 C 2.2889 6.8071 0.0 0
M  V30 13 O 5.8862 0.0000 0.0 0
M  V30 14 C 15.9127 9.3469 0.0 0
M  V30 15 C 6.2433 3.9689 0.0 0 CFG=2
M  V30 16 N 4.7118 3.8080 0.0 0
M  V30 17 C 6.8698 2.5621 0.0 0
M  V30 18 C 4.3916 2.3017 0.0 0
M  V30 19 C 5.7253 1.5317 0.0 0 CFG=1
M  V30 20 C 10.8633 6.6363 0.0 0
M  V30 21 C 11.6333 7.9700 0.0 0
M  V30 22 C 11.6333 5.3027 0.0 0
M  V30 23 C 13.1733 7.9700 0.0 0
M  V30 24 C 13.1733 5.3027 0.0 0
M  V30 25 C 13.9434 6.6363 0.0 0
M  V30 26 C 15.4834 6.6363 0.0 0
M  V30 27 S 16.3886 5.3905 0.0 0
M  V30 28 C 16.3886 7.8822 0.0 0
M  V30 29 C 17.8533 5.8663 0.0 0
M  V30 30 N 17.8533 7.4063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 6 9 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 19 13 CFG=1
M  V30 15 1 14 28
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C49H52ClN9O6S2
2417371-31-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 73 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.9694 6.7646 0.0 0
M  V30 2 C 0.0000 4.0540 0.0 0
M  V30 3 C 3.6539 0.0000 0.0 0
M  V30 4 C 8.8236 4.0540 0.0 0
M  V30 5 C 9.5936 5.3876 0.0 0
M  V30 6 N 11.1336 5.3876 0.0 0
M  V30 7 O 8.8236 6.7213 0.0 0
M  V30 8 C 11.9036 6.7213 0.0 0
M  V30 9 C 13.4436 6.7213 0.0 0
M  V30 10 C 14.9837 6.7213 0.0 0
M  V30 11 C 16.5237 6.7213 0.0 0
M  V30 12 C 18.0637 6.7213 0.0 0
M  V30 13 C 19.6037 6.7213 0.0 0
M  V30 14 O 20.3738 8.0551 0.0 0
M  V30 15 C 21.9138 8.0551 0.0 0
M  V30 16 C 22.6838 9.3888 0.0 0
M  V30 17 N 24.2238 9.3888 0.0 0
M  V30 18 O 21.9138 10.7224 0.0 0
M  V30 19 C 24.9938 10.7224 0.0 0 CFG=1
M  V30 20 C 26.5338 10.7224 0.0 0
M  V30 21 C 24.2238 12.0561 0.0 0
M  V30 22 O 27.3039 12.0561 0.0 0
M  V30 23 C 22.8901 11.2861 0.0 0
M  V30 24 C 23.4538 13.3899 0.0 0
M  V30 25 C 25.5575 12.8261 0.0 0
M  V30 26 Cl 3.7432 11.7898 0.0 0
M  V30 27 C 29.8658 10.3722 0.0 0
M  V30 28 N 31.3723 10.0520 0.0 0
M  V30 29 O 29.3900 11.8369 0.0 0
M  V30 30 C 32.4027 11.1964 0.0 0
M  V30 31 O 27.6610 5.4198 0.0 0
M  V30 32 C 39.4117 12.4779 0.0 0
M  V30 33 C 3.9100 4.8240 0.0 0
M  V30 34 C 3.9100 3.2839 0.0 0
M  V30 35 C 5.1140 5.7842 0.0 0
M  V30 36 C 2.4453 5.2998 0.0 0
M  V30 37 N 5.1140 2.3237 0.0 0
M  V30 38 S 2.4453 2.8081 0.0 0
M  V30 39 N 6.6153 5.4415 0.0 0
M  V30 40 C 1.5400 4.0540 0.0 0
M  V30 41 C 6.6153 2.6664 0.0 0
M  V30 42 C 4.9758 0.7899 0.0 0
M  V30 43 C 7.2835 4.0540 0.0 0 CFG=1
M  V30 44 N 7.4052 1.3444 0.0 0
M  V30 45 N 6.3920 0.1846 0.0 0
M  V30 46 C 4.7713 7.2855 0.0 0
M  V30 47 C 5.9001 8.3331 0.0 0
M  V30 48 C 3.2997 7.7395 0.0 0
M  V30 49 C 5.5575 9.8344 0.0 0
M  V30 50 C 2.9570 9.2409 0.0 0
M  V30 51 C 4.0858 10.2884 0.0 0
M  V30 52 N 27.3039 9.3888 0.0 0
M  V30 53 C 28.8354 9.2278 0.0 0 CFG=2
M  V30 54 C 26.6775 7.9819 0.0 0
M  V30 55 C 29.1556 7.7214 0.0 0
M  V30 56 C 27.8219 6.9514 0.0 0 CFG=2
M  V30 57 C 33.9092 10.8763 0.0 0
M  V30 58 C 34.9396 12.0208 0.0 0
M  V30 59 C 34.3850 9.4117 0.0 0
M  V30 60 C 36.4459 11.7006 0.0 0
M  V30 61 C 35.8913 9.0915 0.0 0
M  V30 62 C 36.9219 10.2359 0.0 0
M  V30 63 C 38.4282 9.9158 0.0 0
M  V30 64 S 39.0547 8.5089 0.0 0
M  V30 65 C 39.5728 10.9462 0.0 0
M  V30 66 C 40.5863 8.6699 0.0 0
M  V30 67 N 40.9064 10.1762 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 36
M  V30 2 1 2 40
M  V30 3 1 3 42
M  V30 4 1 4 5
M  V30 5 1 43 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 3 9 10
M  V30 11 1 10 11
M  V30 12 3 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 19 21 CFG=1
M  V30 22 2 20 22
M  V30 23 1 20 52
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 26 51
M  V30 28 1 27 28
M  V30 29 2 27 29
M  V30 30 1 53 27 CFG=3
M  V30 31 1 28 30
M  V30 32 1 30 57
M  V30 33 1 56 31 CFG=1
M  V30 34 1 32 65
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 33 36
M  V30 38 1 34 37
M  V30 39 1 34 38
M  V30 40 2 35 39
M  V30 41 1 35 46
M  V30 42 2 36 40
M  V30 43 1 37 41
M  V30 44 1 37 42
M  V30 45 1 38 40
M  V30 46 1 39 43
M  V30 47 1 41 43
M  V30 48 2 41 44
M  V30 49 2 42 45
M  V30 50 1 44 45
M  V30 51 2 46 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 2 48 50
M  V30 55 2 49 51
M  V30 56 1 50 51
M  V30 57 1 52 53
M  V30 58 1 52 54
M  V30 59 1 53 55
M  V30 60 1 54 56
M  V30 61 1 55 56
M  V30 62 2 57 58
M  V30 63 1 57 59
M  V30 64 1 58 60
M  V30 65 2 59 61
M  V30 66 2 60 62
M  V30 67 1 61 62
M  V30 68 1 62 63
M  V30 69 1 63 64
M  V30 70 2 63 65
M  V30 71 1 64 66
M  V30 72 1 65 67
M  V30 73 2 66 67
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 43 53 56)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2417371-30-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448297-52-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417371-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40132273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1:
Exploration of Antibody Linker, Payload Loading, and Payload Molecular
Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dragovich, Peter S.; Pillow, Thomas H.; Blake, Robert A.; Sadowsky, Jack
D.; Adaligil, Emel; Adhikari, Pragya; Bhakta, Sunil; Blaquiere, Nicole;
Chen, Jinhua; dela Cruz-Chuh, Josefa; Gascoigne, Karen E.; Hartman,
Steven J.; He, Mingtao; Kaufman, Susan; Kleinheinz, Tracy; Kozak,
Katherine R.; Liu, Liang; Liu, Liling; Liu, Qi; Lu, Ying; Meng, Fanwei;
Mulvihill, Melinda M.; O'Donohue, Aimee; Rowntree, Rebecca K.; Staben,
Leanna R.; Staben, Steven T.; Wai, John; Wang, Jian; Wei, BinQing;
Wilson, Catherine; Xin, Jianfeng; Xu, Zijin; Yao, Hui; Zhang, Donglu;
Zhang, Hongyan; Zhou, Hao; Zhu, Xiaoyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(5), 2534-2575

$RFMT $RIREG SCHEME477 STEP1
$RXN



  1  1
$MOL
1-(1,1-Dimethylethyl) 4-(3-amino-7-bromo-6-chloro-4-quinolinyl)-1,3-piperazin...
C19H22BrClN4O4
2349395-32-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 8.4701 0.0 0
M  V30 2 C 3.8730 9.8647 0.0 0
M  V30 3 O 4.8629 11.0444 0.0 0
M  V30 4 O 2.3564 10.1321 0.0 0
M  V30 5 Cl 5.3348 1.5400 0.0 0
M  V30 6 Br 2.6673 0.0000 0.0 0
M  V30 7 C 8.4636 8.1257 0.0 0
M  V30 8 O 9.5527 7.0368 0.0 0
M  V30 9 O 8.8623 9.6134 0.0 0
M  V30 10 C 11.0402 7.4353 0.0 0
M  V30 11 C 10.6417 8.9230 0.0 0
M  V30 12 C 12.5277 7.8341 0.0 0
M  V30 13 C 11.4388 5.9478 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 1.3337 6.9301 0.0 0
M  V30 17 C 1.3337 3.8500 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 0.0000 6.1601 0.0 0
M  V30 20 N 0.0000 4.6200 0.0 0
M  V30 21 C 1.3337 2.3100 0.0 0
M  V30 22 C 4.0011 2.3100 0.0 0
M  V30 23 C 2.6673 1.5400 0.0 0
M  V30 24 N 4.0011 6.9301 0.0 0
M  V30 25 C 4.3997 8.4176 0.0 0
M  V30 26 C 5.0901 5.8411 0.0 0
M  V30 27 C 5.8872 8.8161 0.0 0
M  V30 28 C 6.5776 6.2397 0.0 0
M  V30 29 N 6.9761 7.7272 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 5 22
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 29
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 24
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 20
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-Pyrazino[1′,2′:4,5]pyrazino[2,3-c]quinoline-3-carboxylic acid, 10-bromo-11...
C19H20BrClN4O3
2349395-37-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 9.0338 0.0 0
M  V30 2 Cl 10.6697 2.1037 0.0 0
M  V30 3 C 2.6673 3.6437 0.0 0
M  V30 4 O 2.6673 2.1037 0.0 0
M  V30 5 O 1.3337 4.4137 0.0 0
M  V30 6 C 1.3337 1.3337 0.0 0
M  V30 7 C 2.1037 0.0000 0.0 0
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 C 0.5637 2.6673 0.0 0
M  V30 10 Br 13.3370 3.6437 0.0 0
M  V30 11 C 8.0022 6.7238 0.0 0
M  V30 12 N 6.6685 5.9538 0.0 0
M  V30 13 C 9.3358 5.9538 0.0 0
M  V30 14 C 8.0022 8.2638 0.0 0
M  V30 15 C 5.3348 6.7238 0.0 0
M  V30 16 C 6.6685 4.4137 0.0 0
M  V30 17 C 10.6697 6.7238 0.0 0
M  V30 18 C 9.3360 4.4137 0.0 0
M  V30 19 N 6.6685 9.0338 0.0 0
M  V30 20 C 9.3360 9.0338 0.0 0
M  V30 21 C 4.0010 5.9538 0.0 0
M  V30 22 C 5.3348 8.2638 0.0 0
M  V30 23 C 5.3348 3.6437 0.0 0
M  V30 24 N 10.6697 8.2638 0.0 0
M  V30 25 C 12.0033 5.9538 0.0 0
M  V30 26 C 10.6697 3.6437 0.0 0
M  V30 27 N 4.0010 4.4137 0.0 0
M  V30 28 C 12.0033 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 26
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 27
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 28
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 16 23
M  V30 23 1 17 24
M  V30 24 2 17 25
M  V30 25 1 18 26
M  V30 26 1 19 22
M  V30 27 2 20 24
M  V30 28 1 21 27
M  V30 29 1 23 27
M  V30 30 1 25 28
M  V30 31 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2349395-32-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2349395-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24891371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design and Pharmacokinetic Optimization of Covalent
Allosteric Inhibitors of the Mutant GTPase KRASG12C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason G.; Bagal, Sharan K.; Bickerton, Sue; Bodnarchuk, Michael
S.; Breed, Jason; Carbajo, Rodrigo J.; Cassar, Doyle J.; Chakraborty,
Atanu; Cosulich, Sabina; Cumming, Iain; Davies, Michael; Eatherton,
Andrew; Evans, Laura; Feron, Lyman; Fillery, Shaun; Gleave, Emma S.;
Goldberg, Frederick W.; Harlfinger, Stephanie; Hanson, Lyndsey; Howard,
Martin; Howells, Rachel; Jackson, Anne; Kemmitt, Paul; Kingston, Jennifer
K.; Lamont, Scott; Lewis, Hilary J.; Li, Songlei; Liu, Libin; Ogg, Derek;
Phillips, Christopher; Polanski, Radek; Robb, Graeme; Robinson, David;
Ross, Sarah; Smith, James M.; Tonge, Michael; Whiteley, Rebecca; Yang,
Junsheng; Zhang, Longfei; Zhao, Xiliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(9), 4468-4483

$RFMT $RIREG SCHEME478 STEP1
$RXN



  2  1
$MOL
1,3,6-Naphthalenetrisulfonic acid, 8-amino-, sodium salt (1:3)
C10H9NO9S3.3Na
901-79-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 3.0800 0.0 0 VAL=6
M  V30 2 O 2.4611 3.0800 0.0 0
M  V30 3 O 5.5411 3.0800 0.0 0
M  V30 4 O 4.0011 1.5400 0.0 0
M  V30 5 N 6.6684 3.0800 0.0 0
M  V30 6 S 1.3337 7.7001 0.0 0 VAL=6
M  V30 7 O 0.5636 6.3664 0.0 0
M  V30 8 O 2.1037 9.0337 0.0 0
M  V30 9 O 0.0000 8.4701 0.0 0
M  V30 10 S 9.3359 7.7001 0.0 0 VAL=6
M  V30 11 O 8.5659 9.0337 0.0 0
M  V30 12 O 10.1059 6.3664 0.0 0
M  V30 13 O 10.6695 8.4701 0.0 0
M  V30 14 C 5.3348 5.3900 0.0 0
M  V30 15 C 5.3348 6.9301 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 6.6684 4.6200 0.0 0
M  V30 18 C 4.0011 7.7001 0.0 0
M  V30 19 C 6.6684 7.7001 0.0 0
M  V30 20 C 2.6673 5.3900 0.0 0
M  V30 21 C 8.0022 5.3900 0.0 0
M  V30 22 C 2.6673 6.9301 0.0 0
M  V30 23 C 8.0022 6.9301 0.0 0
M  V30 24 Na 5.3348 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 16
M  V30 5 1 5 17
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 6 22
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 10 23
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C89H97N3O21
3036050-17-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  113 123 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 18.4804 0.0 0
M  V30 2 C 10.6697 19.2504 0.0 0 CFG=1
M  V30 3 C 12.0033 18.4804 0.0 0
M  V30 4 C 10.6697 20.7905 0.0 0
M  V30 5 O 12.0033 21.5605 0.0 0
M  V30 6 O 9.3360 21.5605 0.0 0
M  V30 7 C 12.0033 23.1005 0.0 0
M  V30 8 O 12.0033 16.9404 0.0 0
M  V30 9 C 13.3370 16.1704 0.0 0
M  V30 10 O 13.3370 14.6303 0.0 0
M  V30 11 O 6.6685 16.9404 0.0 0
M  V30 12 C 6.6685 18.4804 0.0 0
M  V30 13 O 8.0022 19.2504 0.0 0
M  V30 14 O 12.0033 13.8603 0.0 0
M  V30 15 C 12.0033 12.3203 0.0 0 CFG=1
M  V30 16 C 13.3370 11.5503 0.0 0 CFG=2
M  V30 17 C 10.6697 11.5503 0.0 0
M  V30 18 O 13.3370 10.0102 0.0 0
M  V30 19 C 14.6708 12.3203 0.0 0
M  V30 20 O 9.3360 12.3203 0.0 0
M  V30 21 O 10.6697 10.0102 0.0 0
M  V30 22 O 16.0045 11.5503 0.0 0
M  V30 23 O 14.6708 13.8603 0.0 0
M  V30 24 C 8.0022 11.5503 0.0 0
M  V30 25 C 17.3382 12.3203 0.0 0 CFG=2
M  V30 26 C 6.6685 12.3203 0.0 0
M  V30 27 C 8.0022 10.0102 0.0 0
M  V30 28 C 18.6718 11.5503 0.0 0
M  V30 29 C 17.3382 13.8603 0.0 0
M  V30 30 C 20.0057 12.3203 0.0 0
M  V30 31 C 21.3393 11.5503 0.0 0
M  V30 32 C 6.6685 13.8603 0.0 0
M  V30 33 O 5.3348 14.6303 0.0 0
M  V30 34 C 4.0012 13.8603 0.0 0
M  V30 35 O 13.3370 6.9302 0.0 0
M  V30 36 C 12.0033 7.7002 0.0 0
M  V30 37 O 16.0045 5.3901 0.0 0
M  V30 38 C 14.6708 4.6201 0.0 0
M  V30 39 C 18.6718 10.0102 0.0 0
M  V30 40 O 18.6718 6.9302 0.0 0
M  V30 41 C 20.0057 7.7002 0.0 0
M  V30 42 C 26.6420 12.6774 0.0 0
M  V30 43 C 27.5472 13.9233 0.0 0
M  V30 44 C 29.0788 13.7624 0.0 0
M  V30 45 C 29.9840 15.0082 0.0 0
M  V30 46 C 31.5156 14.8473 0.0 0
M  V30 47 O 32.1420 13.4403 0.0 0
M  V30 48 O 32.4208 16.0932 0.0 0
M  V30 49 C 9.3360 16.9404 0.0 0 CFG=1
M  V30 50 C 10.6697 16.1704 0.0 0 CFG=1
M  V30 51 C 8.0022 16.1704 0.0 0 CFG=1
M  V30 52 C 10.6697 14.6303 0.0 0 CFG=2
M  V30 53 C 8.0022 14.6303 0.0 0 CFG=1
M  V30 54 O 9.3360 13.8603 0.0 0
M  V30 55 C 14.8712 16.3046 0.0 0
M  V30 56 C 15.7545 15.0430 0.0 0
M  V30 57 C 15.5222 17.7004 0.0 0
M  V30 58 C 17.2887 15.1773 0.0 0
M  V30 59 C 17.0562 17.8345 0.0 0
M  V30 60 C 17.9395 16.5731 0.0 0
M  V30 61 C 5.3348 19.2504 0.0 0
M  V30 62 C 4.0012 18.4804 0.0 0
M  V30 63 C 5.3348 20.7905 0.0 0
M  V30 64 C 2.6673 19.2504 0.0 0
M  V30 65 C 4.0012 21.5605 0.0 0
M  V30 66 C 2.6673 20.7905 0.0 0
M  V30 67 C 13.3370 19.2504 0.0 0
M  V30 68 C 14.6708 18.4804 0.0 0
M  V30 69 C 13.3370 20.7905 0.0 0
M  V30 70 C 16.0045 19.2504 0.0 0
M  V30 71 C 14.6708 21.5605 0.0 0
M  V30 72 C 16.0045 20.7905 0.0 0
M  V30 73 C 2.6673 14.6303 0.0 0
M  V30 74 C 1.3337 13.8603 0.0 0
M  V30 75 C 2.6673 16.1704 0.0 0
M  V30 76 C 0.0000 14.6303 0.0 0
M  V30 77 C 1.3337 16.9404 0.0 0
M  V30 78 C 0.0000 16.1704 0.0 0
M  V30 79 C 10.6697 23.8705 0.0 0
M  V30 80 C 10.6697 25.4106 0.0 0
M  V30 81 C 9.3360 23.1005 0.0 0
M  V30 82 C 9.3360 26.1806 0.0 0
M  V30 83 C 8.0022 23.8705 0.0 0
M  V30 84 C 8.0022 25.4106 0.0 0
M  V30 85 C 14.6708 9.2402 0.0 0 CFG=2
M  V30 86 C 14.6708 7.7002 0.0 0 CFG=1
M  V30 87 O 16.0045 10.0102 0.0 0
M  V30 88 C 16.0045 6.9302 0.0 0 CFG=2
M  V30 89 C 17.3382 9.2402 0.0 0 CFG=1
M  V30 90 C 17.3382 7.7002 0.0 0 CFG=2
M  V30 91 C 10.6697 6.9302 0.0 0
M  V30 92 C 9.3360 7.7002 0.0 0
M  V30 93 C 10.6697 5.3901 0.0 0
M  V30 94 C 8.0022 6.9302 0.0 0
M  V30 95 C 9.3360 4.6201 0.0 0
M  V30 96 C 8.0022 5.3901 0.0 0
M  V30 97 C 14.6708 3.0801 0.0 0
M  V30 98 C 13.3370 2.3101 0.0 0
M  V30 99 C 16.0045 2.3101 0.0 0
M  V30 100 C 13.3370 0.7700 0.0 0
M  V30 101 C 16.0045 0.7700 0.0 0
M  V30 102 C 14.6708 0.0000 0.0 0
M  V30 103 N 22.6730 12.3203 0.0 0
M  V30 104 C 24.0800 11.6939 0.0 0
M  V30 105 N 22.8339 13.8518 0.0 0
M  V30 106 C 25.1104 12.8383 0.0 0
M  V30 107 N 24.3404 14.1720 0.0 0
M  V30 108 C 21.3393 6.9302 0.0 0
M  V30 109 C 21.3393 5.3901 0.0 0
M  V30 110 C 22.6730 7.7002 0.0 0
M  V30 111 C 22.6730 4.6201 0.0 0
M  V30 112 C 24.0067 6.9302 0.0 0
M  V30 113 C 24.0067 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 49 1 CFG=3
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 67
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 79
M  V30 10 1 8 9
M  V30 11 1 50 8 CFG=1
M  V30 12 2 9 10
M  V30 13 1 9 55
M  V30 14 1 11 12
M  V30 15 1 51 11 CFG=3
M  V30 16 2 12 13
M  V30 17 1 12 61
M  V30 18 1 15 14 CFG=3
M  V30 19 1 52 14 CFG=3
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18 CFG=3
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 85 18 CFG=3
M  V30 27 1 19 22
M  V30 28 2 19 23
M  V30 29 1 20 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 25 28
M  V30 34 1 25 29 CFG=3
M  V30 35 1 28 30
M  V30 36 1 30 31
M  V30 37 1 31 103
M  V30 38 1 32 33
M  V30 39 1 53 32 CFG=3
M  V30 40 1 33 34
M  V30 41 1 34 73
M  V30 42 1 35 36
M  V30 43 1 86 35 CFG=3
M  V30 44 1 36 91
M  V30 45 1 37 38
M  V30 46 1 88 37 CFG=1
M  V30 47 1 38 97
M  V30 48 1 89 39 CFG=1
M  V30 49 1 40 41
M  V30 50 1 90 40 CFG=1
M  V30 51 1 41 108
M  V30 52 1 42 43
M  V30 53 1 42 106
M  V30 54 1 43 44
M  V30 55 1 44 45
M  V30 56 1 45 46
M  V30 57 1 46 47
M  V30 58 2 46 48
M  V30 59 1 49 50
M  V30 60 1 49 51
M  V30 61 1 50 52
M  V30 62 1 51 53
M  V30 63 1 52 54
M  V30 64 1 53 54
M  V30 65 2 55 56
M  V30 66 1 55 57
M  V30 67 1 56 58
M  V30 68 2 57 59
M  V30 69 2 58 60
M  V30 70 1 59 60
M  V30 71 2 61 62
M  V30 72 1 61 63
M  V30 73 1 62 64
M  V30 74 2 63 65
M  V30 75 2 64 66
M  V30 76 1 65 66
M  V30 77 2 67 68
M  V30 78 1 67 69
M  V30 79 1 68 70
M  V30 80 2 69 71
M  V30 81 2 70 72
M  V30 82 1 71 72
M  V30 83 2 73 74
M  V30 84 1 73 75
M  V30 85 1 74 76
M  V30 86 2 75 77
M  V30 87 2 76 78
M  V30 88 1 77 78
M  V30 89 2 79 80
M  V30 90 1 79 81
M  V30 91 1 80 82
M  V30 92 2 81 83
M  V30 93 2 82 84
M  V30 94 1 83 84
M  V30 95 1 85 86
M  V30 96 1 85 87
M  V30 97 1 86 88
M  V30 98 1 87 89
M  V30 99 1 88 90
M  V30 100 1 89 90
M  V30 101 2 91 92
M  V30 102 1 91 93
M  V30 103 1 92 94
M  V30 104 2 93 95
M  V30 105 2 94 96
M  V30 106 1 95 96
M  V30 107 2 97 98
M  V30 108 1 97 99
M  V30 109 1 98 100
M  V30 110 2 99 101
M  V30 111 2 100 102
M  V30 112 1 101 102
M  V30 113 1 103 104
M  V30 114 1 103 105
M  V30 115 2 104 106
M  V30 116 2 105 107
M  V30 117 1 106 107
M  V30 118 2 108 109
M  V30 119 1 108 110
M  V30 120 1 109 111
M  V30 121 2 110 112
M  V30 122 2 111 113
M  V30 123 1 112 113
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 2 15 16 25 49 50 51 52 53 85 86 88 89 90)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C99H104N4O29S3.3Na
3036050-20-8 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  136 147 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0101 8.2085 0.0 0
M  V30 2 C 9.2400 6.8749 0.0 0 CFG=1
M  V30 3 C 7.7000 6.8749 0.0 0
M  V30 4 C 10.0101 5.5411 0.0 0
M  V30 5 O 9.2400 4.2074 0.0 0
M  V30 6 O 11.5501 5.5411 0.0 0
M  V30 7 C 10.0101 2.8738 0.0 0
M  V30 8 O 11.5501 10.8758 0.0 0
M  V30 9 C 12.3201 9.5422 0.0 0
M  V30 10 O 11.5501 8.2085 0.0 0
M  V30 11 O 6.9300 8.2085 0.0 0
M  V30 12 C 5.3900 8.2085 0.0 0
M  V30 13 O 4.6200 9.5422 0.0 0
M  V30 14 O 10.0101 13.5433 0.0 0
M  V30 15 C 9.2400 14.8769 0.0 0 CFG=1
M  V30 16 C 10.0101 16.2106 0.0 0 CFG=2
M  V30 17 C 7.7000 14.8769 0.0 0
M  V30 18 O 9.2400 17.5444 0.0 0
M  V30 19 C 11.5501 16.2106 0.0 0
M  V30 20 O 6.9300 16.2106 0.0 0
M  V30 21 O 6.9300 13.5433 0.0 0
M  V30 22 O 12.3201 14.8769 0.0 0
M  V30 23 O 12.3201 17.5444 0.0 0
M  V30 24 C 5.3900 16.2106 0.0 0
M  V30 25 C 13.8601 14.8769 0.0 0 CFG=1
M  V30 26 C 4.6200 14.8769 0.0 0
M  V30 27 C 4.6200 17.5444 0.0 0
M  V30 28 C 14.6301 16.2106 0.0 0
M  V30 29 C 14.6301 13.5433 0.0 0
M  V30 30 C 13.8601 17.5444 0.0 0
M  V30 31 C 14.6301 18.8780 0.0 0
M  V30 32 C 5.3900 10.8758 0.0 0
M  V30 33 O 4.6200 12.2096 0.0 0
M  V30 34 C 3.0800 12.2096 0.0 0
M  V30 35 O 7.7000 20.2117 0.0 0
M  V30 36 C 6.9300 21.5453 0.0 0
M  V30 37 O 9.2400 22.8791 0.0 0
M  V30 38 C 10.0101 24.2128 0.0 0
M  V30 39 C 13.8601 20.2117 0.0 0
M  V30 40 O 12.3201 22.8791 0.0 0
M  V30 41 C 13.8601 22.8791 0.0 0
M  V30 42 C 19.7859 20.5532 0.0 0
M  V30 43 C 21.1927 19.9268 0.0 0
M  V30 44 C 22.4385 20.8320 0.0 0
M  V30 45 C 23.8455 20.2057 0.0 0
M  V30 46 C 25.0913 21.1109 0.0 0
M  V30 47 N 26.4981 20.4844 0.0 0
M  V30 48 O 24.9304 22.6424 0.0 0
M  V30 49 S 29.1510 20.7633 0.0 0 VAL=6
M  V30 50 O 30.6825 20.9242 0.0 0
M  V30 51 O 27.6194 20.6024 0.0 0
M  V30 52 O 28.9900 22.2948 0.0 0
M  V30 53 S 24.3284 15.6109 0.0 0 VAL=6
M  V30 54 O 25.2336 14.3650 0.0 0
M  V30 55 O 23.4232 16.8568 0.0 0
M  V30 56 O 23.0826 14.7057 0.0 0
M  V30 57 S 32.2867 16.4474 0.0 0 VAL=6
M  V30 58 O 31.6603 15.0405 0.0 0
M  V30 59 O 32.9131 17.8542 0.0 0
M  V30 60 O 33.6935 15.8211 0.0 0
M  V30 61 C 9.2400 9.5422 0.0 0 CFG=1
M  V30 62 C 10.0101 10.8758 0.0 0 CFG=1
M  V30 63 C 7.7000 9.5422 0.0 0 CFG=1
M  V30 64 C 9.2400 12.2096 0.0 0 CFG=2
M  V30 65 C 6.9300 10.8758 0.0 0 CFG=1
M  V30 66 O 7.7000 12.2096 0.0 0
M  V30 67 C 13.8601 9.5422 0.0 0
M  V30 68 C 14.6301 10.8758 0.0 0
M  V30 69 C 14.6301 8.2085 0.0 0
M  V30 70 C 16.1701 10.8758 0.0 0
M  V30 71 C 16.1701 8.2085 0.0 0
M  V30 72 C 16.9401 9.5422 0.0 0
M  V30 73 C 4.1286 7.3252 0.0 0
M  V30 74 C 4.2627 5.7910 0.0 0
M  V30 75 C 2.7327 7.9760 0.0 0
M  V30 76 C 3.0013 4.9077 0.0 0
M  V30 77 C 1.4713 7.0927 0.0 0
M  V30 78 C 1.6056 5.5587 0.0 0
M  V30 79 C 6.9300 5.5411 0.0 0
M  V30 80 C 7.7000 4.2074 0.0 0
M  V30 81 C 5.3900 5.5411 0.0 0
M  V30 82 C 6.9300 2.8738 0.0 0
M  V30 83 C 4.6200 4.2074 0.0 0
M  V30 84 C 5.3900 2.8738 0.0 0
M  V30 85 C 2.3100 13.5433 0.0 0
M  V30 86 C 3.0800 14.8769 0.0 0
M  V30 87 C 0.7700 13.5433 0.0 0
M  V30 88 C 2.3100 16.2106 0.0 0
M  V30 89 C 0.0000 14.8769 0.0 0
M  V30 90 C 0.7700 16.2106 0.0 0
M  V30 91 C 11.5501 2.8738 0.0 0
M  V30 92 C 12.3201 4.2074 0.0 0
M  V30 93 C 12.3201 1.5400 0.0 0
M  V30 94 C 13.8601 4.2074 0.0 0
M  V30 95 C 13.8601 1.5400 0.0 0
M  V30 96 C 14.6301 2.8738 0.0 0
M  V30 97 C 10.0101 18.8780 0.0 0 CFG=2
M  V30 98 C 9.2400 20.2117 0.0 0 CFG=1
M  V30 99 O 11.5501 18.8780 0.0 0
M  V30 100 C 10.0101 21.5453 0.0 0 CFG=2
M  V30 101 C 12.3201 20.2117 0.0 0 CFG=1
M  V30 102 C 11.5501 21.5453 0.0 0 CFG=2
M  V30 103 C 5.3900 21.5453 0.0 0
M  V30 104 C 4.6200 22.8791 0.0 0
M  V30 105 C 4.6200 20.2117 0.0 0
M  V30 106 C 3.0800 22.8791 0.0 0
M  V30 107 C 3.0800 20.2117 0.0 0
M  V30 108 C 2.3100 21.5453 0.0 0
M  V30 109 C 9.2400 25.5464 0.0 0
M  V30 110 C 10.0101 26.8801 0.0 0
M  V30 111 C 7.7000 25.5464 0.0 0
M  V30 112 C 9.2400 28.2139 0.0 0
M  V30 113 C 6.9300 26.8801 0.0 0
M  V30 114 C 7.7000 28.2139 0.0 0
M  V30 115 N 16.1701 18.8780 0.0 0
M  V30 116 C 17.0753 20.1239 0.0 0
M  V30 117 N 17.0753 17.6322 0.0 0
M  V30 118 C 18.5398 19.6480 0.0 0
M  V30 119 N 18.5398 18.1080 0.0 0
M  V30 120 C 14.6301 24.2128 0.0 0
M  V30 121 C 13.8601 25.5464 0.0 0
M  V30 122 C 16.1701 24.2128 0.0 0
M  V30 123 C 14.6301 26.8801 0.0 0
M  V30 124 C 16.9401 25.5464 0.0 0
M  V30 125 C 16.1701 26.8801 0.0 0
M  V30 126 C 26.6592 18.9529 0.0 0
M  V30 127 C 28.0660 18.3265 0.0 0
M  V30 128 C 25.4134 18.0477 0.0 0
M  V30 129 C 28.2270 16.7950 0.0 0
M  V30 130 C 29.3119 19.2318 0.0 0
M  V30 131 C 25.5743 16.5161 0.0 0
M  V30 132 C 26.9811 15.8898 0.0 0
M  V30 133 C 29.6339 16.1685 0.0 0
M  V30 134 C 30.7188 18.6053 0.0 0
M  V30 135 C 30.8798 17.0738 0.0 0
M  V30 136 Na 16.8468 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 61 1 CFG=1
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 79
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 91
M  V30 10 1 8 9
M  V30 11 1 62 8 CFG=3
M  V30 12 2 9 10
M  V30 13 1 9 67
M  V30 14 1 11 12
M  V30 15 1 63 11 CFG=1
M  V30 16 2 12 13
M  V30 17 1 12 73
M  V30 18 1 15 14 CFG=1
M  V30 19 1 64 14 CFG=1
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18 CFG=1
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 97 18 CFG=1
M  V30 27 1 19 22
M  V30 28 2 19 23
M  V30 29 1 20 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 25 28
M  V30 34 1 25 29 CFG=3
M  V30 35 1 28 30
M  V30 36 1 30 31
M  V30 37 1 31 115
M  V30 38 1 32 33
M  V30 39 1 65 32 CFG=1
M  V30 40 1 33 34
M  V30 41 1 34 85
M  V30 42 1 35 36
M  V30 43 1 98 35 CFG=1
M  V30 44 1 36 103
M  V30 45 1 37 38
M  V30 46 1 100 37 CFG=3
M  V30 47 1 38 109
M  V30 48 1 101 39 CFG=3
M  V30 49 1 40 41
M  V30 50 1 102 40 CFG=3
M  V30 51 1 41 120
M  V30 52 1 42 43
M  V30 53 1 42 118
M  V30 54 1 43 44
M  V30 55 1 44 45
M  V30 56 1 45 46
M  V30 57 1 46 47
M  V30 58 2 46 48
M  V30 59 1 47 126
M  V30 60 2 49 50
M  V30 61 2 49 51
M  V30 62 1 49 52
M  V30 63 1 49 130
M  V30 64 2 53 54
M  V30 65 2 53 55
M  V30 66 1 53 56
M  V30 67 1 53 131
M  V30 68 2 57 58
M  V30 69 2 57 59
M  V30 70 1 57 60
M  V30 71 1 57 135
M  V30 72 1 61 62
M  V30 73 1 61 63
M  V30 74 1 62 64
M  V30 75 1 63 65
M  V30 76 1 64 66
M  V30 77 1 65 66
M  V30 78 2 67 68
M  V30 79 1 67 69
M  V30 80 1 68 70
M  V30 81 2 69 71
M  V30 82 2 70 72
M  V30 83 1 71 72
M  V30 84 2 73 74
M  V30 85 1 73 75
M  V30 86 1 74 76
M  V30 87 2 75 77
M  V30 88 2 76 78
M  V30 89 1 77 78
M  V30 90 2 79 80
M  V30 91 1 79 81
M  V30 92 1 80 82
M  V30 93 2 81 83
M  V30 94 2 82 84
M  V30 95 1 83 84
M  V30 96 2 85 86
M  V30 97 1 85 87
M  V30 98 1 86 88
M  V30 99 2 87 89
M  V30 100 2 88 90
M  V30 101 1 89 90
M  V30 102 2 91 92
M  V30 103 1 91 93
M  V30 104 1 92 94
M  V30 105 2 93 95
M  V30 106 2 94 96
M  V30 107 1 95 96
M  V30 108 1 97 98
M  V30 109 1 97 99
M  V30 110 1 98 100
M  V30 111 1 99 101
M  V30 112 1 100 102
M  V30 113 1 101 102
M  V30 114 2 103 104
M  V30 115 1 103 105
M  V30 116 1 104 106
M  V30 117 2 105 107
M  V30 118 2 106 108
M  V30 119 1 107 108
M  V30 120 2 109 110
M  V30 121 1 109 111
M  V30 122 1 110 112
M  V30 123 2 111 113
M  V30 124 2 112 114
M  V30 125 1 113 114
M  V30 126 1 115 116
M  V30 127 1 115 117
M  V30 128 2 116 118
M  V30 129 2 117 119
M  V30 130 1 118 119
M  V30 131 2 120 121
M  V30 132 1 120 122
M  V30 133 1 121 123
M  V30 134 2 122 124
M  V30 135 2 123 125
M  V30 136 1 124 125
M  V30 137 1 126 127
M  V30 138 2 126 128
M  V30 139 2 127 129
M  V30 140 1 127 130
M  V30 141 1 128 131
M  V30 142 1 129 132
M  V30 143 1 129 133
M  V30 144 2 130 134
M  V30 145 2 131 132
M  V30 146 2 133 135
M  V30 147 1 134 135
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 2 15 16 25 61 62 63 64 65 97 98 100 101 102)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 901-79-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036050-17-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036050-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39877262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sialyl LewisX glycomimetics bearing an extended anionic chain targeting
E- and P- selectin binding sites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Belouin, Audrey; Simard, Ryan D.; Joyal, Mathieu; Maharsy, Wael; Lau,
Alice; Prevost, Michel; Nemer, Mona; Guindon, Yvan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2024), 98117553

$RFMT $RIREG SCHEME479 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[(5S)-5-amino-6-[(4-methyl-2-oxo-2H-1-benzopyran-7-yl)amino]...
C31H31N3O5.C2HF3O2
1857308-63-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 10.4148 0.0 0
M  V30 2 O 7.0871 9.6447 0.0 0
M  V30 3 C 8.4207 10.4148 0.0 0
M  V30 4 N 9.7544 9.6447 0.0 0
M  V30 5 O 8.4207 11.9548 0.0 0
M  V30 6 C 11.0881 10.4148 0.0 0
M  V30 7 C 12.4219 9.6447 0.0 0
M  V30 8 C 13.7556 10.4148 0.0 0
M  V30 9 C 15.0892 9.6447 0.0 0
M  V30 10 C 16.4229 10.4148 0.0 0 CFG=2
M  V30 11 C 17.7567 9.6447 0.0 0
M  V30 12 N 16.4229 11.9548 0.0 0
M  V30 13 N 19.0904 10.4148 0.0 0
M  V30 14 O 17.7567 8.1047 0.0 0
M  V30 15 C 24.4252 5.7947 0.0 0
M  V30 16 O 27.0926 10.4148 0.0 0
M  V30 17 C 4.4196 9.6447 0.0 0
M  V30 18 C 3.0128 10.2711 0.0 0
M  V30 19 C 4.2587 8.1130 0.0 0
M  V30 20 C 1.9822 9.1267 0.0 0
M  V30 21 C 2.5367 11.7358 0.0 0
M  V30 22 C 2.7522 7.7928 0.0 0
M  V30 23 C 5.2891 6.9686 0.0 0
M  V30 24 C 0.4759 9.4468 0.0 0
M  V30 25 C 1.0304 12.0560 0.0 0
M  V30 26 C 2.2763 6.3283 0.0 0
M  V30 27 C 4.8132 5.5039 0.0 0
M  V30 28 C 0.0000 10.9114 0.0 0
M  V30 29 C 3.3068 5.1837 0.0 0
M  V30 30 C 20.4241 9.6447 0.0 0
M  V30 31 C 21.7577 10.4148 0.0 0
M  V30 32 C 20.4241 8.1047 0.0 0
M  V30 33 C 23.0916 9.6447 0.0 0
M  V30 34 C 21.7577 7.3347 0.0 0
M  V30 35 C 23.0916 8.1047 0.0 0
M  V30 36 O 24.4252 10.4148 0.0 0
M  V30 37 C 24.4252 7.3347 0.0 0
M  V30 38 C 25.7589 9.6447 0.0 0
M  V30 39 C 25.7589 8.1047 0.0 0
M  V30 40 C 12.8795 2.3101 0.0 0
M  V30 41 C 14.2131 1.5400 0.0 0
M  V30 42 F 13.6495 3.6437 0.0 0
M  V30 43 F 11.5458 3.0801 0.0 0
M  V30 44 F 12.1094 0.9764 0.0 0
M  V30 45 O 15.5468 2.3101 0.0 0
M  V30 46 O 14.2131 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 30
M  V30 16 1 15 37
M  V30 17 2 16 38
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 22
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 33 36
M  V30 39 2 34 35
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 40 43
M  V30 47 1 40 44
M  V30 48 1 41 45
M  V30 49 2 41 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C42H53N5O8
2407529-05-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 N 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9538 0.0 0
M  V30 4 C 8.4700 5.9538 0.0 0
M  V30 5 O 6.1600 7.2874 0.0 0
M  V30 6 C 9.2400 7.2874 0.0 0
M  V30 7 C 10.7800 7.2874 0.0 0 CFG=2
M  V30 8 C 11.5500 8.6211 0.0 0
M  V30 9 N 11.5500 5.9538 0.0 0
M  V30 10 O 13.0900 8.6211 0.0 0
M  V30 11 C 13.0900 5.9538 0.0 0
M  V30 12 C 13.8600 7.2874 0.0 0
M  V30 13 O 13.8600 4.6200 0.0 0
M  V30 14 C 12.9127 11.6818 0.0 0
M  V30 15 N 13.3886 13.1465 0.0 0
M  V30 16 O 13.9433 10.5373 0.0 0
M  V30 17 C 14.8950 13.4667 0.0 0 CFG=2
M  V30 18 C 15.9254 12.3222 0.0 0
M  V30 19 C 15.3709 14.9312 0.0 0
M  V30 20 C 17.4319 12.6423 0.0 0
M  V30 21 O 14.3405 16.0758 0.0 0
M  V30 22 O 16.8773 15.2514 0.0 0
M  V30 23 C 18.4623 11.4979 0.0 0
M  V30 24 C 19.9686 11.8181 0.0 0
M  V30 25 N 20.9991 10.6737 0.0 0
M  V30 26 C 22.5054 10.9939 0.0 0
M  V30 27 O 23.5360 9.8494 0.0 0
M  V30 28 O 22.9813 12.4584 0.0 0
M  V30 29 C 25.0422 10.1695 0.0 0
M  V30 30 C 24.7221 11.6760 0.0 0
M  V30 31 C 26.5487 10.4897 0.0 0
M  V30 32 C 25.3624 8.6633 0.0 0
M  V30 33 C 4.6200 3.0800 0.0 0
M  V30 34 C 3.2864 2.3100 0.0 0
M  V30 35 C 5.9538 2.3100 0.0 0
M  V30 36 C 3.2864 0.7700 0.0 0
M  V30 37 C 5.9538 0.7700 0.0 0
M  V30 38 C 4.6200 0.0000 0.0 0
M  V30 39 C 3.0800 4.6200 0.0 0
M  V30 40 C 2.3100 5.9538 0.0 0
M  V30 41 C 2.3100 3.2864 0.0 0
M  V30 42 C 0.7700 5.9538 0.0 0
M  V30 43 C 0.7700 3.2864 0.0 0
M  V30 44 C 0.0000 4.6200 0.0 0
M  V30 45 C 4.2214 6.1076 0.0 0
M  V30 46 C 5.3104 7.1966 0.0 0
M  V30 47 C 2.7340 6.5062 0.0 0
M  V30 48 C 4.9118 8.6841 0.0 0
M  V30 49 C 2.3354 7.9937 0.0 0
M  V30 50 C 3.4243 9.0826 0.0 0
M  V30 51 N 10.7800 9.9547 0.0 0
M  V30 52 C 11.4065 11.3617 0.0 0 CFG=2
M  V30 53 C 9.2485 10.1158 0.0 0
M  V30 54 C 10.2619 12.3921 0.0 0
M  V30 55 C 8.9283 11.6221 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 33
M  V30 3 1 1 39
M  V30 4 1 1 45
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 7 9 CFG=1
M  V30 12 2 8 10
M  V30 13 1 8 51
M  V30 14 1 9 11
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 52 14 CFG=1
M  V30 20 1 15 17
M  V30 21 1 17 18 CFG=3
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 23 24
M  V30 28 1 24 25
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 29 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 48 2 45 46
M  V30 49 1 45 47
M  V30 50 1 46 48
M  V30 51 2 47 49
M  V30 52 2 48 50
M  V30 53 1 49 50
M  V30 54 1 51 52
M  V30 55 1 51 53
M  V30 56 1 52 54
M  V30 57 1 53 55
M  V30 58 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 17 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C73H82N8O12.C2HF3O2
2448494-11-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  100 107 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7535 17.9760 0.0 0
M  V30 2 N 4.7840 16.8315 0.0 0
M  V30 3 C 6.2904 17.1516 0.0 0
M  V30 4 C 7.3209 16.0072 0.0 0
M  V30 5 O 6.7663 18.6164 0.0 0
M  V30 6 C 8.8273 16.3274 0.0 0
M  V30 7 C 9.8578 15.1830 0.0 0 CFG=2
M  V30 8 C 11.3641 15.5032 0.0 0
M  V30 9 N 9.3819 13.7183 0.0 0
M  V30 10 O 11.8401 16.9677 0.0 0
M  V30 11 C 7.8754 13.3981 0.0 0
M  V30 12 C 6.8450 14.5425 0.0 0
M  V30 13 O 7.3996 11.9334 0.0 0
M  V30 14 C 14.6962 15.8534 0.0 0
M  V30 15 N 16.2363 15.8534 0.0 0
M  V30 16 O 13.9262 17.1871 0.0 0
M  V30 17 C 17.0063 17.1871 0.0 0 CFG=1
M  V30 18 C 18.5463 17.1871 0.0 0
M  V30 19 C 16.2363 18.5207 0.0 0
M  V30 20 N 19.3163 15.8534 0.0 0
M  V30 21 O 19.3163 18.5207 0.0 0
M  V30 22 C 17.0063 19.8545 0.0 0
M  V30 23 C 20.8564 15.8534 0.0 0 CFG=1
M  V30 24 C 16.2363 21.1882 0.0 0
M  V30 25 C 21.6264 14.5196 0.0 0
M  V30 26 C 21.6264 17.1871 0.0 0
M  V30 27 C 17.0063 22.5219 0.0 0
M  V30 28 N 20.8564 13.1859 0.0 0
M  V30 29 O 23.1664 14.5196 0.0 0
M  V30 30 C 23.1664 17.1871 0.0 0
M  V30 31 N 16.2363 23.8555 0.0 0
M  V30 32 C 23.9364 18.5207 0.0 0
M  V30 33 C 17.0063 25.1894 0.0 0
M  V30 34 C 25.4765 18.5207 0.0 0
M  V30 35 O 16.2363 26.5230 0.0 0
M  V30 36 O 18.5463 25.1894 0.0 0
M  V30 37 N 26.2465 17.1871 0.0 0
M  V30 38 C 17.0063 27.8567 0.0 0
M  V30 39 C 27.7865 17.1871 0.0 0
M  V30 40 C 15.6726 28.6267 0.0 0
M  V30 41 C 17.7763 29.1904 0.0 0
M  V30 42 C 18.3400 27.0867 0.0 0
M  V30 43 O 28.5565 18.5207 0.0 0
M  V30 44 O 28.5565 15.8534 0.0 0
M  V30 45 C 30.0966 18.5207 0.0 0
M  V30 46 C 25.4765 7.8511 0.0 0
M  V30 47 O 20.8564 5.1837 0.0 0
M  V30 48 C 4.5922 19.2675 0.0 0
M  V30 49 C 3.8932 20.6397 0.0 0
M  V30 50 C 6.1303 19.1869 0.0 0
M  V30 51 C 4.7319 21.9313 0.0 0
M  V30 52 C 6.9690 20.4786 0.0 0
M  V30 53 C 6.2698 21.8507 0.0 0
M  V30 54 C 2.7231 19.1204 0.0 0
M  V30 55 C 1.2166 18.8002 0.0 0
M  V30 56 C 3.1990 20.5851 0.0 0
M  V30 57 C 0.1862 19.9446 0.0 0
M  V30 58 C 2.1685 21.7295 0.0 0
M  V30 59 C 0.6621 21.4094 0.0 0
M  V30 60 C 2.6091 16.9454 0.0 0
M  V30 61 C 1.1444 17.4213 0.0 0
M  V30 62 C 2.9293 15.4391 0.0 0
M  V30 63 C 0.0000 16.3909 0.0 0
M  V30 64 C 1.7847 14.4087 0.0 0
M  V30 65 C 0.3202 14.8845 0.0 0
M  V30 66 N 12.3947 14.3586 0.0 0
M  V30 67 C 13.9262 14.5196 0.0 0 CFG=2
M  V30 68 C 12.0745 12.8523 0.0 0
M  V30 69 C 14.5525 13.1127 0.0 0
M  V30 70 C 13.4081 12.0823 0.0 0
M  V30 71 C 21.6264 11.8522 0.0 0
M  V30 72 C 20.8564 10.5186 0.0 0
M  V30 73 C 23.1664 11.8522 0.0 0
M  V30 74 C 21.6264 9.1847 0.0 0
M  V30 75 C 23.9364 10.5186 0.0 0
M  V30 76 C 23.1664 9.1847 0.0 0
M  V30 77 O 20.8564 7.8511 0.0 0
M  V30 78 C 23.9364 7.8511 0.0 0
M  V30 79 C 21.6264 6.5174 0.0 0
M  V30 80 C 23.1664 6.5174 0.0 0
M  V30 81 C 30.8666 19.8544 0.0 0
M  V30 82 C 30.2403 21.2614 0.0 0
M  V30 83 C 32.3982 20.0155 0.0 0
M  V30 84 C 31.3847 22.2918 0.0 0
M  V30 85 C 28.7755 21.7372 0.0 0
M  V30 86 C 32.7183 21.5218 0.0 0
M  V30 87 C 33.5427 18.9849 0.0 0
M  V30 88 C 31.0645 23.7983 0.0 0
M  V30 89 C 28.4554 23.2437 0.0 0
M  V30 90 C 34.1830 21.9977 0.0 0
M  V30 91 C 35.0073 19.4608 0.0 0
M  V30 92 C 29.5999 24.2741 0.0 0
M  V30 93 C 35.3274 20.9672 0.0 0
M  V30 94 C 16.9969 2.3101 0.0 0
M  V30 95 C 18.3306 1.5400 0.0 0
M  V30 96 F 17.7669 3.6437 0.0 0
M  V30 97 F 15.6632 3.0801 0.0 0
M  V30 98 F 16.2269 0.9764 0.0 0
M  V30 99 O 19.6642 2.3101 0.0 0
M  V30 100 O 18.3306 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 48
M  V30 3 1 1 54
M  V30 4 1 1 60
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 7 9 CFG=1
M  V30 12 2 8 10
M  V30 13 1 8 66
M  V30 14 1 9 11
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 67 14 CFG=3
M  V30 20 1 15 17
M  V30 21 1 17 18
M  V30 22 1 17 19 CFG=1
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 1 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 23 26 CFG=1
M  V30 30 1 24 27
M  V30 31 1 25 28
M  V30 32 2 25 29
M  V30 33 1 26 30
M  V30 34 1 27 31
M  V30 35 1 28 71
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 33 36
M  V30 41 1 34 37
M  V30 42 1 35 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 38 41
M  V30 46 1 38 42
M  V30 47 1 39 43
M  V30 48 2 39 44
M  V30 49 1 43 45
M  V30 50 1 45 81
M  V30 51 1 46 78
M  V30 52 2 47 79
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 59 2 54 55
M  V30 60 1 54 56
M  V30 61 1 55 57
M  V30 62 2 56 58
M  V30 63 2 57 59
M  V30 64 1 58 59
M  V30 65 2 60 61
M  V30 66 1 60 62
M  V30 67 1 61 63
M  V30 68 2 62 64
M  V30 69 2 63 65
M  V30 70 1 64 65
M  V30 71 1 66 67
M  V30 72 1 66 68
M  V30 73 1 67 69
M  V30 74 1 68 70
M  V30 75 1 69 70
M  V30 76 1 71 72
M  V30 77 2 71 73
M  V30 78 2 72 74
M  V30 79 1 73 75
M  V30 80 1 74 76
M  V30 81 1 74 77
M  V30 82 2 75 76
M  V30 83 1 76 78
M  V30 84 1 77 79
M  V30 85 2 78 80
M  V30 86 1 79 80
M  V30 87 1 81 82
M  V30 88 1 81 83
M  V30 89 1 82 84
M  V30 90 2 82 85
M  V30 91 1 83 86
M  V30 92 2 83 87
M  V30 93 1 84 86
M  V30 94 2 84 88
M  V30 95 1 85 89
M  V30 96 2 86 90
M  V30 97 1 87 91
M  V30 98 1 88 92
M  V30 99 2 89 92
M  V30 100 1 90 93
M  V30 101 2 91 93
M  V30 102 1 94 95
M  V30 103 1 94 96
M  V30 104 1 94 97
M  V30 105 1 94 98
M  V30 106 1 95 99
M  V30 107 2 95 100
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 17 23 67)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1857308-63-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2407529-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2448494-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22721830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using
Mechanism-Based Sirtuin Inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajabi, Nima; Nielsen, Alexander L.; Olsen, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892

$RFMT $RIREG SCHEME480 STEP1
$RXN



  2  1
$MOL
2-(Aminomethyl)-1-methyl-5-(phenylmethoxy)-4(1H)-pyridinone
C14H16N2O2
812653-97-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 C 11.5500 2.6674 0.0 0
M  V30 6 N 12.3200 1.3338 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3338 0.0 0
M  V30 11 N 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 7-[4-(3-carboxy-1-oxopropyl)-1-piperazinyl]-1-cyc...
C28H28FN3O6
3035080-41-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 8.4702 0.0 0
M  V30 2 C 6.6685 6.9302 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 O 6.6685 8.4702 0.0 0
M  V30 5 C 4.0010 6.9302 0.0 0
M  V30 6 F 14.6708 6.9302 0.0 0
M  V30 7 C 18.6718 1.5400 0.0 0
M  V30 8 C 20.0057 2.3101 0.0 0
M  V30 9 O 18.6718 0.0000 0.0 0
M  V30 10 C 21.3393 1.5400 0.0 0
M  V30 11 C 22.6730 2.3101 0.0 0
M  V30 12 O 24.0067 1.5400 0.0 0
M  V30 13 O 22.6730 3.8501 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 N 9.3358 3.8501 0.0 0
M  V30 16 C 10.6697 6.1601 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 C 12.0033 6.9302 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 8.0022 6.1601 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 9.3358 2.3101 0.0 0
M  V30 25 C 8.5658 0.9764 0.0 0
M  V30 26 C 10.1059 0.9764 0.0 0
M  V30 27 N 14.6708 3.8501 0.0 0
M  V30 28 C 16.0045 4.6201 0.0 0
M  V30 29 C 14.6708 2.3101 0.0 0
M  V30 30 C 17.3382 3.8501 0.0 0
M  V30 31 C 16.0045 1.5400 0.0 0
M  V30 32 N 17.3382 2.3101 0.0 0
M  V30 33 C 2.6673 6.1601 0.0 0
M  V30 34 C 1.3337 6.9302 0.0 0
M  V30 35 C 2.6673 4.6201 0.0 0
M  V30 36 C 0.0000 6.1601 0.0 0
M  V30 37 C 1.3337 3.8501 0.0 0
M  V30 38 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 5 33
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 32
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 24
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 1 21 27
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[4-[[[1,4-dihydro-1-methyl-4-o...
C42H42FN5O7
3035080-47-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 11.5503 0.0 0
M  V30 2 C 6.6685 10.0102 0.0 0
M  V30 3 O 5.3348 9.2402 0.0 0
M  V30 4 O 6.6685 11.5503 0.0 0
M  V30 5 C 4.0010 10.0102 0.0 0
M  V30 6 F 14.6707 10.0102 0.0 0
M  V30 7 C 18.6718 4.6201 0.0 0
M  V30 8 C 20.0055 5.3901 0.0 0
M  V30 9 O 18.6718 3.0801 0.0 0
M  V30 10 C 21.3393 4.6201 0.0 0
M  V30 11 C 22.6730 5.3901 0.0 0
M  V30 12 N 24.0067 4.6201 0.0 0
M  V30 13 O 22.6730 6.9302 0.0 0
M  V30 14 C 25.3403 5.3901 0.0 0
M  V30 15 C 28.0078 6.9302 0.0 0
M  V30 16 O 28.0078 0.7700 0.0 0
M  V30 17 O 30.6752 2.3101 0.0 0
M  V30 18 C 32.0090 3.0801 0.0 0
M  V30 19 C 10.6697 7.7002 0.0 0
M  V30 20 N 9.3358 6.9302 0.0 0
M  V30 21 C 10.6697 9.2402 0.0 0
M  V30 22 C 12.0033 6.9302 0.0 0
M  V30 23 C 8.0022 7.7002 0.0 0
M  V30 24 C 9.3358 10.0102 0.0 0
M  V30 25 C 12.0033 10.0102 0.0 0
M  V30 26 C 13.3370 7.7002 0.0 0
M  V30 27 C 8.0022 9.2402 0.0 0
M  V30 28 C 13.3370 9.2402 0.0 0
M  V30 29 C 9.3358 5.3901 0.0 0
M  V30 30 C 8.5658 4.0564 0.0 0
M  V30 31 C 10.1059 4.0564 0.0 0
M  V30 32 N 14.6707 6.9302 0.0 0
M  V30 33 C 14.6707 5.3901 0.0 0
M  V30 34 C 16.0045 7.7002 0.0 0
M  V30 35 C 16.0045 4.6201 0.0 0
M  V30 36 C 17.3382 6.9302 0.0 0
M  V30 37 N 17.3382 5.3901 0.0 0
M  V30 38 C 2.6673 9.2402 0.0 0
M  V30 39 C 1.3337 10.0102 0.0 0
M  V30 40 C 2.6673 7.7002 0.0 0
M  V30 41 C 0.0000 9.2402 0.0 0
M  V30 42 C 1.3337 6.9302 0.0 0
M  V30 43 C 0.0000 7.7002 0.0 0
M  V30 44 C 26.6742 4.6201 0.0 0
M  V30 45 N 28.0078 5.3901 0.0 0
M  V30 46 C 26.6742 3.0801 0.0 0
M  V30 47 C 29.3415 4.6201 0.0 0
M  V30 48 C 28.0078 2.3101 0.0 0
M  V30 49 C 29.3415 3.0801 0.0 0
M  V30 50 C 33.3427 2.3101 0.0 0
M  V30 51 C 33.3427 0.7700 0.0 0
M  V30 52 C 34.6763 3.0801 0.0 0
M  V30 53 C 34.6763 0.0000 0.0 0
M  V30 54 C 36.0100 2.3101 0.0 0
M  V30 55 C 36.0100 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 1 5 38
M  V30 7 1 6 28
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 37
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 44
M  V30 17 1 15 45
M  V30 18 2 16 48
M  V30 19 1 17 18
M  V30 20 1 17 49
M  V30 21 1 18 50
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 20 29
M  V30 27 1 21 24
M  V30 28 2 21 25
M  V30 29 1 22 26
M  V30 30 2 23 27
M  V30 31 1 24 27
M  V30 32 1 25 28
M  V30 33 2 26 28
M  V30 34 1 26 32
M  V30 35 1 29 30
M  V30 36 1 29 31
M  V30 37 1 30 31
M  V30 38 1 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 36 37
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 50 1 44 45
M  V30 51 2 44 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 56 2 50 51
M  V30 57 1 50 52
M  V30 58 1 51 53
M  V30 59 2 52 54
M  V30 60 2 53 55
M  V30 61 1 54 55
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 812653-97-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035080-41-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035080-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35625660
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 57951-36-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin
Conjugates as Dual Antibacterial and Antibiofilm Agents against
Pseudomonas aeruginosa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yuan-Yuan; Zhang, Xiao-Yi; Zhong, Xiao-Lin; Huang, Yong-Jun; Lin,
Jing; Chen, Wei-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 2169-2193

$RFMT $RIREG SCHEME481 STEP1
$RXN



  2  1
$MOL
o-Phenylenediamine
C6H8N2
95-54-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indolo[2′,3′:3,4]pyrido[2,1-b]quinazoline-13(5H)-carboxylic acid, 10-(3-carbo...
C28H30FN3O6
3037149-89-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1803 4.0432 0.0 0
M  V30 2 O 10.3249 3.0127 0.0 0
M  V30 3 O 7.7158 3.5673 0.0 0
M  V30 4 C 10.0047 1.5063 0.0 0
M  V30 5 C 11.5110 1.1861 0.0 0
M  V30 6 C 9.6844 0.0000 0.0 0
M  V30 7 C 8.4983 1.8265 0.0 0
M  V30 8 C 6.9301 4.0265 0.0 0
M  V30 9 O 3.8500 9.3613 0.0 0
M  V30 10 O 14.6451 8.8914 0.0 0
M  V30 11 C 16.0520 8.2651 0.0 0
M  V30 12 C 17.2979 9.1703 0.0 0
M  V30 13 C 18.7047 8.5438 0.0 0
M  V30 14 C 19.9507 9.4491 0.0 0
M  V30 15 O 19.7897 10.9806 0.0 0
M  V30 16 O 21.3575 8.8227 0.0 0
M  V30 17 F 0.0000 5.3602 0.0 0
M  V30 18 C 8.4701 6.6940 0.0 0
M  V30 19 C 9.2401 8.0276 0.0 0
M  V30 20 C 6.9301 6.6940 0.0 0
M  V30 21 N 9.5005 5.5494 0.0 0
M  V30 22 C 10.7464 7.7075 0.0 0
M  V30 23 C 8.4701 9.3613 0.0 0
M  V30 24 N 6.1601 8.0276 0.0 0
M  V30 25 N 6.1601 5.3603 0.0 0
M  V30 26 C 10.9075 6.1759 0.0 0
M  V30 27 C 11.9924 8.6127 0.0 0
M  V30 28 C 6.9301 9.3613 0.0 0
M  V30 29 C 4.6200 8.0276 0.0 0
M  V30 30 C 4.6200 5.3602 0.0 0
M  V30 31 C 12.3143 5.5494 0.0 0
M  V30 32 C 13.3992 7.9862 0.0 0
M  V30 33 C 3.8500 6.6940 0.0 0
M  V30 34 C 3.8500 4.0265 0.0 0
M  V30 35 C 13.5601 6.4547 0.0 0
M  V30 36 C 2.3100 6.6940 0.0 0
M  V30 37 C 2.3100 4.0265 0.0 0
M  V30 38 C 1.5400 5.3602 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 25
M  V30 9 2 9 29
M  V30 10 1 10 11
M  V30 11 1 10 32
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 17 38
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 22 26
M  V30 27 2 22 27
M  V30 28 1 23 28
M  V30 29 1 24 28
M  V30 30 1 24 29
M  V30 31 1 25 30
M  V30 32 2 26 31
M  V30 33 1 27 32
M  V30 34 1 29 33
M  V30 35 1 30 33
M  V30 36 2 30 34
M  V30 37 1 31 35
M  V30 38 2 32 35
M  V30 39 2 33 36
M  V30 40 1 34 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indolo[2′,3′:3,4]pyrido[2,1-b]quinazoline-13(5H)-carboxylic acid, 10-[4-[(2-a...
C34H36FN5O5
3037149-90-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9924 4.0738 0.0 0
M  V30 2 O 10.0228 2.9292 0.0 0
M  V30 3 O 7.4861 3.7536 0.0 0
M  V30 4 C 9.5470 1.4647 0.0 0
M  V30 5 C 8.0824 1.9406 0.0 0
M  V30 6 C 9.0711 0.0000 0.0 0
M  V30 7 C 11.0117 0.9888 0.0 0
M  V30 8 C 6.7528 4.2925 0.0 0
M  V30 9 O 4.2472 9.9200 0.0 0
M  V30 10 O 14.9341 8.3244 0.0 0
M  V30 11 C 16.2677 7.5544 0.0 0
M  V30 12 C 17.6014 8.3244 0.0 0
M  V30 13 C 18.9350 7.5544 0.0 0
M  V30 14 C 20.2688 8.3244 0.0 0
M  V30 15 N 21.6025 7.5544 0.0 0
M  V30 16 O 20.2688 9.8644 0.0 0
M  V30 17 F 0.0000 6.3433 0.0 0
M  V30 18 N 24.2698 6.0143 0.0 0
M  V30 19 C 8.5631 6.7844 0.0 0
M  V30 20 C 9.4683 8.0302 0.0 0
M  V30 21 C 7.0315 6.9453 0.0 0
M  V30 22 N 9.4683 5.5383 0.0 0
M  V30 23 C 10.9330 7.5544 0.0 0
M  V30 24 C 8.8420 9.4370 0.0 0
M  V30 25 N 6.4052 8.3521 0.0 0
M  V30 26 N 6.1263 5.6994 0.0 0
M  V30 27 C 10.9330 6.0143 0.0 0
M  V30 28 C 12.2666 8.3244 0.0 0
M  V30 29 C 7.3104 9.5981 0.0 0
M  V30 30 C 4.8737 8.5132 0.0 0
M  V30 31 C 4.5948 5.8603 0.0 0
M  V30 32 C 12.2666 5.2443 0.0 0
M  V30 33 C 13.6003 7.5544 0.0 0
M  V30 34 C 3.9684 7.2673 0.0 0
M  V30 35 C 3.6896 4.6145 0.0 0
M  V30 36 C 13.6003 6.0143 0.0 0
M  V30 37 C 2.4368 7.4282 0.0 0
M  V30 38 C 2.1580 4.7754 0.0 0
M  V30 39 C 1.5317 6.1824 0.0 0
M  V30 40 C 22.9361 8.3244 0.0 0
M  V30 41 C 24.2698 7.5544 0.0 0
M  V30 42 C 22.9361 9.8644 0.0 0
M  V30 43 C 25.6036 8.3244 0.0 0
M  V30 44 C 24.2698 10.6344 0.0 0
M  V30 45 C 25.6036 9.8644 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 26
M  V30 9 2 9 30
M  V30 10 1 10 11
M  V30 11 1 10 33
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 40
M  V30 18 1 17 39
M  V30 19 1 18 41
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 23 27
M  V30 29 2 23 28
M  V30 30 1 24 29
M  V30 31 1 25 29
M  V30 32 1 25 30
M  V30 33 1 26 31
M  V30 34 2 27 32
M  V30 35 1 28 33
M  V30 36 1 30 34
M  V30 37 1 31 34
M  V30 38 2 31 35
M  V30 39 1 32 36
M  V30 40 2 33 36
M  V30 41 2 34 37
M  V30 42 1 35 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 95-54-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3037149-89-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037149-90-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40804341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors:
Novel Orally Active Antitumor Agents for Leukemia Therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Shanchao; Huang, Yahui; Wang, Ting; Li, Keliang; Lu, Junjie; Huang,
Min; Dong, Guoqiang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(6), 4818-4831

$RFMT $RIREG SCHEME482 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[7-[2-[(1S)-1-Amino-2-(3,5-difluorophenyl)ethyl]-7-bromo-4-oxo-3(4H)-quinaz...
C25H20BrClF2N6O3S
2417093-05-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6399 5.3513 0.0 0
M  V30 2 C 10.9702 8.0021 0.0 0 CFG=1
M  V30 3 C 12.5102 8.0021 0.0 0
M  V30 4 N 10.2002 9.3359 0.0 0
M  V30 5 O 6.3501 5.3348 0.0 0
M  V30 6 N 2.9293 10.0462 0.0 0
M  V30 7 S 1.4647 9.5703 0.0 0 VAL=6
M  V30 8 C 0.0000 9.0943 0.0 0
M  V30 9 O 1.9406 8.1056 0.0 0
M  V30 10 O 0.9887 11.0349 0.0 0
M  V30 11 Cl 5.5801 12.0032 0.0 0
M  V30 12 Br 10.9702 0.0000 0.0 0
M  V30 13 F 12.5102 13.3369 0.0 0
M  V30 14 F 17.1303 10.6696 0.0 0
M  V30 15 C 7.8901 8.0021 0.0 0
M  V30 16 C 6.3501 8.0021 0.0 0
M  V30 17 C 8.6602 9.3359 0.0 0
M  V30 18 C 5.5801 9.3359 0.0 0
M  V30 19 N 5.3197 6.8577 0.0 0
M  V30 20 C 7.8901 10.6696 0.0 0
M  V30 21 C 4.0738 9.0156 0.0 0
M  V30 22 C 6.3501 10.6696 0.0 0
M  V30 23 N 3.9127 7.4840 0.0 0
M  V30 24 N 8.6602 6.6684 0.0 0
M  V30 25 C 10.2002 6.6684 0.0 0
M  V30 26 C 7.8901 5.3348 0.0 0
M  V30 27 N 10.9702 5.3348 0.0 0
M  V30 28 C 8.6602 4.0010 0.0 0
M  V30 29 C 10.2002 4.0010 0.0 0
M  V30 30 C 7.8901 2.6673 0.0 0
M  V30 31 C 10.9702 2.6673 0.0 0
M  V30 32 C 8.6602 1.3337 0.0 0
M  V30 33 C 10.2002 1.3337 0.0 0
M  V30 34 C 13.2802 9.3359 0.0 0
M  V30 35 C 12.5102 10.6696 0.0 0
M  V30 36 C 14.8202 9.3359 0.0 0
M  V30 37 C 13.2802 12.0032 0.0 0
M  V30 38 C 15.5903 10.6696 0.0 0
M  V30 39 C 14.8202 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 25
M  V30 5 1 3 34
M  V30 6 2 5 26
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 22
M  V30 13 1 12 33
M  V30 14 1 13 37
M  V30 15 1 14 38
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 24
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3bS,4aR)-N-[(1S)-1-[(3S)-7-Bromo-3-[4-chloro-1-methyl-3-[(methylsulfonyl)ami...
C35H26BrClF6N8O4S
2250415-70-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5579 13.3047 0.0 0
M  V30 2 F 3.3118 14.2100 0.0 0
M  V30 3 F 5.9647 13.9312 0.0 0
M  V30 4 C 5.6848 8.0021 0.0 0
M  V30 5 C 7.2249 8.0021 0.0 0
M  V30 6 N 7.9949 6.6685 0.0 0
M  V30 7 O 7.9949 9.3358 0.0 0
M  V30 8 C 9.5349 6.6685 0.0 0
M  V30 9 C 10.3049 5.3348 0.0 0
M  V30 10 F 2.9548 7.4808 0.0 0
M  V30 11 F 0.9051 7.6963 0.0 0
M  V30 12 O 14.1550 9.3358 0.0 0
M  V30 13 F 5.6848 2.6673 0.0 0
M  V30 14 F 10.3049 0.0000 0.0 0
M  V30 15 C 14.8654 9.3193 0.0 0
M  V30 16 Br 9.5349 14.6706 0.0 0
M  V30 17 N 17.5758 4.6244 0.0 0
M  V30 18 S 19.0406 5.1004 0.0 0 VAL=6
M  V30 19 C 20.5051 5.5763 0.0 0
M  V30 20 O 18.5647 6.5650 0.0 0
M  V30 21 O 19.5164 3.6357 0.0 0
M  V30 22 Cl 14.9250 2.6673 0.0 0
M  V30 23 C 3.0631 11.0032 0.0 0
M  V30 24 C 1.5316 11.1641 0.0 0
M  V30 25 C 3.3833 9.4969 0.0 0
M  V30 26 C 4.3968 11.7732 0.0 0
M  V30 27 C 0.9051 9.7573 0.0 0
M  V30 28 C 0.0000 11.0032 0.0 0
M  V30 29 N 4.9148 9.3358 0.0 0
M  V30 30 C 2.0496 8.7269 0.0 0
M  V30 31 N 5.5413 10.7427 0.0 0
M  V30 32 C 10.3049 8.0021 0.0 0
M  V30 33 N 11.8449 8.0021 0.0 0
M  V30 34 N 9.5349 9.3358 0.0 0
M  V30 35 C 12.6150 9.3358 0.0 0
M  V30 36 C 10.3049 10.6696 0.0 0
M  V30 37 C 11.8449 10.6696 0.0 0
M  V30 38 C 9.5349 12.0033 0.0 0
M  V30 39 C 12.6150 12.0033 0.0 0
M  V30 40 C 10.3049 13.3369 0.0 0
M  V30 41 C 11.8449 13.3369 0.0 0
M  V30 42 C 9.5349 4.0010 0.0 0
M  V30 43 C 7.9949 4.0010 0.0 0
M  V30 44 C 10.3049 2.6673 0.0 0
M  V30 45 C 7.2249 2.6673 0.0 0
M  V30 46 C 9.5349 1.3337 0.0 0
M  V30 47 C 7.9949 1.3337 0.0 0
M  V30 48 C 12.6150 6.6685 0.0 0
M  V30 49 C 14.1550 6.6685 0.0 0
M  V30 50 C 11.8449 5.3348 0.0 0
M  V30 51 C 14.9250 5.3348 0.0 0
M  V30 52 N 15.1856 7.8129 0.0 0
M  V30 53 C 12.6150 4.0010 0.0 0
M  V30 54 C 16.4314 5.6550 0.0 0
M  V30 55 C 14.1550 4.0010 0.0 0
M  V30 56 N 16.5924 7.1865 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 26
M  V30 4 1 4 5
M  V30 5 1 4 29
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 32
M  V30 11 1 9 42
M  V30 12 1 10 30
M  V30 13 1 11 30
M  V30 14 2 12 35
M  V30 15 1 13 45
M  V30 16 1 14 46
M  V30 17 1 15 52
M  V30 18 1 16 40
M  V30 19 1 17 18
M  V30 20 1 17 54
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 18 21
M  V30 24 1 22 55
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 2 26 31
M  V30 33 1 27 28
M  V30 34 1 27 30
M  V30 35 1 29 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 33 48
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 43 2 36 38
M  V30 44 2 37 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 54 2 48 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 1 49 52
M  V30 58 2 50 53
M  V30 59 1 51 54
M  V30 60 2 51 55
M  V30 61 1 52 56
M  V30 62 1 53 55
M  V30 63 2 54 56
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2417093-05-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2250415-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431795
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME483 STEP1
$RXN



  2  1
$MOL

C28H41N5O14
3058079-02-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8525 8.4155 0.0 0
M  V30 2 O 11.8425 9.5951 0.0 0
M  V30 3 O 9.3359 8.6828 0.0 0
M  V30 4 C 11.3158 11.0423 0.0 0
M  V30 5 C 5.3348 7.5637 0.0 0 CFG=2
M  V30 6 C 5.3348 9.1037 0.0 0 CFG=2
M  V30 7 O 4.0011 6.7937 0.0 0
M  V30 8 C 4.0011 9.8737 0.0 0
M  V30 9 O 6.6684 9.8737 0.0 0
M  V30 10 C 4.0011 5.2536 0.0 0
M  V30 11 O 2.6675 9.1037 0.0 0
M  V30 12 C 6.6684 11.4137 0.0 0
M  V30 13 C 2.6675 4.4836 0.0 0
M  V30 14 O 5.3348 4.4836 0.0 0
M  V30 15 C 1.3337 9.8737 0.0 0
M  V30 16 C 8.0023 12.1837 0.0 0
M  V30 17 O 5.3348 12.1837 0.0 0
M  V30 18 C 1.3337 11.4137 0.0 0
M  V30 19 O 0.0000 9.1037 0.0 0
M  V30 20 O 12.8324 3.1617 0.0 0
M  V30 21 C 14.3490 3.4290 0.0 0
M  V30 22 C 15.3389 2.2494 0.0 0
M  V30 23 O 14.8757 4.8762 0.0 0
M  V30 24 C 16.6818 8.0954 0.0 0
M  V30 25 N 17.5871 9.3413 0.0 0
M  V30 26 C 19.1188 9.1802 0.0 0
M  V30 27 O 20.0238 10.4263 0.0 0
M  V30 28 O 19.7451 7.7734 0.0 0
M  V30 29 C 21.5555 10.2652 0.0 0
M  V30 30 C 21.3944 8.7336 0.0 0
M  V30 31 C 23.0871 10.1042 0.0 0
M  V30 32 C 21.7165 11.7969 0.0 0
M  V30 33 N 9.7992 2.6268 0.0 0
M  V30 34 C 10.7891 1.4472 0.0 0
M  V30 35 C 10.2622 0.0000 0.0 0
M  V30 36 O 12.3057 1.7145 0.0 0
M  V30 37 C 11.3792 6.9683 0.0 0 CFG=1
M  V30 38 O 9.8626 6.7008 0.0 0
M  V30 39 C 12.3691 5.7885 0.0 0
M  V30 40 C 9.3359 5.2536 0.0 0 CFG=1
M  V30 41 C 11.8425 4.3413 0.0 0 CFG=2
M  V30 42 C 10.3258 4.0740 0.0 0 CFG=2
M  V30 43 N 12.7129 7.7383 0.0 0
M  V30 44 C 14.1198 7.1118 0.0 0
M  V30 45 N 12.8740 9.2699 0.0 0
M  V30 46 C 15.1503 8.2564 0.0 0
M  V30 47 N 14.3803 9.5900 0.0 0
M  V30 48 H 8.3460 4.0740 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 37 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 40
M  V30 8 1 6 8
M  V30 9 1 6 9 CFG=1
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 20 21
M  V30 21 1 41 20 CFG=3
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 24 25
M  V30 25 1 24 46
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 33 34
M  V30 34 1 42 33 CFG=1
M  V30 35 1 34 35
M  V30 36 2 34 36
M  V30 37 1 37 38
M  V30 38 1 37 39
M  V30 39 1 37 43 CFG=3
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 1 40 42
M  V30 43 1 40 48 CFG=1
M  V30 44 1 41 42
M  V30 45 1 43 44
M  V30 46 1 43 45
M  V30 47 2 44 46
M  V30 48 2 45 47
M  V30 49 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 5 6 37 40 41 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Azidohexanoic acid
C6H11N3O2
79598-53-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 N 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 10.6697 2.3101 0.0 0 CHG=1 VAL=4
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 N 12.0033 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C29H42N8O13
3058079-04-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8525 8.4154 0.0 0
M  V30 2 O 11.8424 9.5951 0.0 0
M  V30 3 O 9.3359 8.6828 0.0 0
M  V30 4 C 11.3156 11.0422 0.0 0
M  V30 5 C 5.3348 7.5636 0.0 0 CFG=2
M  V30 6 C 5.3348 9.1036 0.0 0 CFG=2
M  V30 7 O 4.0011 6.7936 0.0 0
M  V30 8 C 4.0011 9.8737 0.0 0
M  V30 9 O 6.6684 9.8737 0.0 0
M  V30 10 C 4.0011 5.2536 0.0 0
M  V30 11 O 2.6673 9.1036 0.0 0
M  V30 12 C 6.6684 11.4137 0.0 0
M  V30 13 C 2.6673 4.4836 0.0 0
M  V30 14 O 5.3348 4.4836 0.0 0
M  V30 15 C 1.3337 9.8737 0.0 0
M  V30 16 C 8.0021 12.1837 0.0 0
M  V30 17 O 5.3348 12.1837 0.0 0
M  V30 18 C 1.3337 11.4137 0.0 0
M  V30 19 O 0.0000 9.1036 0.0 0
M  V30 20 O 12.8322 3.1617 0.0 0
M  V30 21 C 14.3489 3.4290 0.0 0
M  V30 22 C 15.3387 2.2493 0.0 0
M  V30 23 O 14.8756 4.8761 0.0 0
M  V30 24 C 16.6817 8.0954 0.0 0
M  V30 25 N 17.5870 9.3413 0.0 0
M  V30 26 C 19.1185 9.1802 0.0 0
M  V30 27 C 20.0237 10.4262 0.0 0
M  V30 28 O 19.7450 7.7734 0.0 0
M  V30 29 C 21.5553 10.2651 0.0 0
M  V30 30 C 22.4605 11.5110 0.0 0
M  V30 31 C 23.9920 11.3501 0.0 0
M  V30 32 C 24.8973 12.5959 0.0 0
M  V30 33 N 26.4288 12.4350 0.0 0
M  V30 34 N 27.3340 13.6809 0.0 0 CHG=1 VAL=4
M  V30 35 N 28.2393 14.9267 0.0 0 CHG=-1
M  V30 36 N 9.7990 2.6268 0.0 0
M  V30 37 C 10.7889 1.4472 0.0 0
M  V30 38 C 10.2622 0.0000 0.0 0
M  V30 39 O 12.3055 1.7145 0.0 0
M  V30 40 C 11.3792 6.9683 0.0 0 CFG=1
M  V30 41 O 9.8626 6.7008 0.0 0
M  V30 42 C 12.3691 5.7885 0.0 0
M  V30 43 C 9.3359 5.2536 0.0 0 CFG=1
M  V30 44 C 11.8424 4.3413 0.0 0 CFG=2
M  V30 45 C 10.3258 4.0740 0.0 0 CFG=2
M  V30 46 N 12.7128 7.7383 0.0 0
M  V30 47 C 14.1198 7.1118 0.0 0
M  V30 48 N 12.8738 9.2698 0.0 0
M  V30 49 C 15.1502 8.2563 0.0 0
M  V30 50 N 14.3802 9.5900 0.0 0
M  V30 51 H 8.3460 4.0740 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 40 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 43
M  V30 8 1 6 8
M  V30 9 1 6 9 CFG=1
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 20 21
M  V30 21 1 44 20 CFG=3
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 24 25
M  V30 25 1 24 49
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 2 33 34
M  V30 35 2 34 35
M  V30 36 1 36 37
M  V30 37 1 45 36 CFG=1
M  V30 38 1 37 38
M  V30 39 2 37 39
M  V30 40 1 40 41
M  V30 41 1 40 42
M  V30 42 1 40 46 CFG=3
M  V30 43 1 41 43
M  V30 44 1 42 44
M  V30 45 1 43 45
M  V30 46 1 43 51 CFG=1
M  V30 47 1 44 45
M  V30 48 1 46 47
M  V30 49 1 46 48
M  V30 50 2 47 49
M  V30 51 2 48 50
M  V30 52 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 5 6 40 43 44 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3058079-02-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79598-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3058079-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37832985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 85
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus
hemagglutinin/neuraminidase and aggregates virion particles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lao, Zhiqi; Li, Yang; Mi, Xue; Tang, Qi; Li, Jie; Chen, Yue; Yang, Yang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115578

$RFMT $RIREG SCHEME484 STEP1
$RXN



  2  1
$MOL
Cyclopropanecarboxamide, 1-amino-2-ethenyl-N-[(1-methylcyclopropyl)sulfonyl]-...
C10H16N2O3S.ClH
853269-58-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8302 3.8995 0.0 0
M  V30 2 N 3.3135 3.6321 0.0 0
M  V30 3 O 5.3569 5.3467 0.0 0
M  V30 4 S 2.3236 4.8118 0.0 0 VAL=6
M  V30 5 O 3.5033 5.8017 0.0 0
M  V30 6 O 1.1439 3.8219 0.0 0
M  V30 7 N 4.8302 1.5400 0.0 0
M  V30 8 C 7.9238 4.8235 0.0 0
M  V30 9 C 9.4638 4.8235 0.0 0
M  V30 10 C 2.3236 7.1713 0.0 0
M  V30 11 C 5.8201 2.7198 0.0 0 CFG=1
M  V30 12 C 7.1538 3.4898 0.0 0 CFG=2
M  V30 13 C 7.1538 1.9498 0.0 0
M  V30 14 C 1.3337 5.9915 0.0 0
M  V30 15 C 0.0000 5.2215 0.0 0
M  V30 16 C 0.0000 6.7615 0.0 0
M  V30 17 Cl 4.7319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 11 7 CFG=1
M  V30 9 2 8 9
M  V30 10 1 12 8 CFG=3
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H40N4O7
2109744-60-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.3315 6.6685 0.0 0
M  V30 2 C 11.8715 6.6685 0.0 0 CFG=2
M  V30 3 O 9.5615 5.3348 0.0 0
M  V30 4 N 12.6415 5.3348 0.0 0
M  V30 5 C 12.6415 8.0022 0.0 0
M  V30 6 C 11.8715 4.0010 0.0 0
M  V30 7 C 14.1816 8.0022 0.0 0
M  V30 8 O 12.6415 2.6673 0.0 0
M  V30 9 O 10.3315 4.0010 0.0 0
M  V30 10 C 14.9516 9.3358 0.0 0
M  V30 11 C 11.8715 1.3337 0.0 0
M  V30 12 C 16.4916 9.3358 0.0 0
M  V30 13 C 10.5378 2.1037 0.0 0
M  V30 14 C 11.1015 0.0000 0.0 0
M  V30 15 C 13.2052 0.5637 0.0 0
M  V30 16 C 17.2616 10.6697 0.0 0
M  V30 17 C 18.8017 10.6697 0.0 0
M  V30 18 C 19.5717 12.0033 0.0 0
M  V30 19 C 6.9993 7.0187 0.0 0
M  V30 20 O 7.4753 5.5540 0.0 0
M  V30 21 O 5.4930 7.3389 0.0 0
M  V30 22 O 9.2043 11.9711 0.0 0
M  V30 23 C 9.5263 15.0343 0.0 0
M  V30 24 O 1.2459 12.8077 0.0 0
M  V30 25 C 0.0000 13.7128 0.0 0
M  V30 26 N 9.5615 8.0022 0.0 0
M  V30 27 C 8.0299 8.1631 0.0 0 CFG=2
M  V30 28 C 10.1878 9.4091 0.0 0
M  V30 29 C 7.7097 9.6696 0.0 0
M  V30 30 C 9.0434 10.4396 0.0 0 CFG=2
M  V30 31 C 7.9584 12.8764 0.0 0
M  V30 32 N 6.5515 12.2500 0.0 0
M  V30 33 C 8.1194 14.4079 0.0 0
M  V30 34 C 5.3056 13.1551 0.0 0
M  V30 35 N 6.8735 15.3132 0.0 0
M  V30 36 C 5.4667 14.6868 0.0 0
M  V30 37 C 3.8987 12.5288 0.0 0
M  V30 38 C 4.2206 15.5919 0.0 0
M  V30 39 C 2.6529 13.4340 0.0 0
M  V30 40 C 2.8138 14.9656 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 27 19 CFG=3
M  V30 22 1 30 22 CFG=1
M  V30 23 1 22 31
M  V30 24 1 23 33
M  V30 25 1 24 25
M  V30 26 1 24 39
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 34 37
M  V30 38 1 35 36
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C39H54N6O9S
2109744-22-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.8146 12.8477 0.0 0
M  V30 2 C 9.3209 13.1678 0.0 0
M  V30 3 O 9.7968 14.6324 0.0 0
M  V30 4 C 5.4781 13.1760 0.0 0
M  V30 5 N 4.1184 13.8990 0.0 0
M  V30 6 O 5.5319 11.6369 0.0 0
M  V30 7 S 2.8124 13.0830 0.0 0 VAL=6
M  V30 8 O 3.6284 11.7769 0.0 0
M  V30 9 O 1.9963 14.3889 0.0 0
M  V30 10 C 4.9936 16.3681 0.0 0
M  V30 11 C 5.2080 17.8930 0.0 0
M  V30 12 C 12.6530 13.5180 0.0 0
M  V30 13 C 14.1930 13.5180 0.0 0 CFG=2
M  V30 14 O 11.8830 14.8517 0.0 0
M  V30 15 N 14.9630 14.8517 0.0 0
M  V30 16 C 14.9630 12.1844 0.0 0
M  V30 17 C 16.5030 14.8517 0.0 0
M  V30 18 C 16.5030 12.1844 0.0 0
M  V30 19 O 17.2730 16.1855 0.0 0
M  V30 20 O 17.2730 13.5180 0.0 0
M  V30 21 C 17.2730 10.8506 0.0 0
M  V30 22 C 18.8130 16.1855 0.0 0
M  V30 23 C 18.8130 10.8506 0.0 0
M  V30 24 C 18.8130 17.7253 0.0 0
M  V30 25 C 20.3531 16.1855 0.0 0
M  V30 26 C 18.8130 14.6455 0.0 0
M  V30 27 C 19.5830 9.5169 0.0 0
M  V30 28 C 21.1231 9.5169 0.0 0
M  V30 29 C 21.8931 8.1833 0.0 0
M  V30 30 C 2.0833 10.8389 0.0 0
M  V30 31 O 11.5259 8.2155 0.0 0
M  V30 32 C 8.7121 9.4681 0.0 0
M  V30 33 O 8.2711 0.9052 0.0 0
M  V30 34 C 7.0252 0.0000 0.0 0
M  V30 35 C 6.7842 13.9921 0.0 0 CFG=2
M  V30 36 C 6.2072 15.4199 0.0 0 CFG=2
M  V30 37 C 7.7322 15.2056 0.0 0
M  V30 38 C 10.3515 12.0233 0.0 0 CFG=2
M  V30 39 N 11.8830 12.1844 0.0 0
M  V30 40 C 10.0313 10.5170 0.0 0
M  V30 41 C 12.5093 10.7774 0.0 0
M  V30 42 C 11.3650 9.7470 0.0 0 CFG=1
M  V30 43 C 1.5064 12.2668 0.0 0
M  V30 44 C 0.4759 13.4113 0.0 0
M  V30 45 C 0.0000 11.9466 0.0 0
M  V30 46 C 10.2800 7.3103 0.0 0
M  V30 47 N 10.4409 5.7787 0.0 0
M  V30 48 C 8.8731 7.9366 0.0 0
M  V30 49 C 9.1951 4.8735 0.0 0
M  V30 50 N 7.6272 7.0314 0.0 0
M  V30 51 C 7.7883 5.4998 0.0 0
M  V30 52 C 9.3560 3.3420 0.0 0
M  V30 53 C 6.5423 4.5946 0.0 0
M  V30 54 C 8.1101 2.4368 0.0 0
M  V30 55 C 6.7033 3.0631 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 35 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 38 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 35 4 CFG=3
M  V30 8 1 5 7
M  V30 9 2 7 8
M  V30 10 2 7 9
M  V30 11 1 7 43
M  V30 12 2 10 11
M  V30 13 1 36 10 CFG=3
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 39
M  V30 17 1 13 15
M  V30 18 1 13 16 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 27 28
M  V30 31 2 28 29
M  V30 32 1 30 43
M  V30 33 1 42 31 CFG=3
M  V30 34 1 31 46
M  V30 35 1 32 48
M  V30 36 1 33 34
M  V30 37 1 33 54
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 41 42
M  V30 46 1 43 44
M  V30 47 1 43 45
M  V30 48 1 44 45
M  V30 49 2 46 47
M  V30 50 1 46 48
M  V30 51 1 47 49
M  V30 52 2 48 50
M  V30 53 2 49 51
M  V30 54 1 49 52
M  V30 55 1 50 51
M  V30 56 1 51 53
M  V30 57 2 52 54
M  V30 58 2 53 55
M  V30 59 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 13 35 36 38 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 853269-58-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2109744-60-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2109744-22-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34107357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease
Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus
Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nageswara Rao, Desaboini; Zephyr, Jacqueto; Henes, Mina; Chan, Elise T.;
Matthew, Ashley N.; Hedger, Adam K.; Conway, Hasahn L.; Saeed, Mohsan;
Newton, Alicia; Petropoulos, Christos J.; Huang, Wei; Kurt Yilmaz, Nese;
Schiffer, Celia A.; Ali, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(16), 11972-11989

$RFMT $RIREG SCHEME485 STEP1
$RXN



  2  1
$MOL
L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-L-alanyl-3-methyl-L-...
C26H39F2N5O5
2227366-26-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2489 3.8500 0.0 0
M  V30 2 C 9.5825 3.0800 0.0 0 CFG=2
M  V30 3 O 6.9152 3.0800 0.0 0
M  V30 4 N 10.9161 3.8500 0.0 0
M  V30 5 C 9.5825 1.5400 0.0 0
M  V30 6 C 12.2499 3.0800 0.0 0
M  V30 7 C 11.1225 1.5400 0.0 0
M  V30 8 C 9.5825 0.0000 0.0 0
M  V30 9 C 8.0425 1.5400 0.0 0
M  V30 10 C 13.5836 3.8500 0.0 0 CFG=2
M  V30 11 O 12.2499 1.5400 0.0 0
M  V30 12 N 14.9172 3.0800 0.0 0
M  V30 13 C 13.5836 5.3900 0.0 0
M  V30 14 C 16.2509 3.8500 0.0 0
M  V30 15 C 14.9172 1.5400 0.0 0
M  V30 16 O 17.5846 3.0800 0.0 0
M  V30 17 O 16.2509 5.3900 0.0 0
M  V30 18 C 18.9183 3.8500 0.0 0
M  V30 19 C 18.1483 5.1836 0.0 0
M  V30 20 C 20.2519 4.6200 0.0 0
M  V30 21 C 19.6883 2.5162 0.0 0
M  V30 22 C 5.5383 5.8192 0.0 0
M  V30 23 N 4.3939 6.8498 0.0 0
M  V30 24 O 5.2181 4.3129 0.0 0
M  V30 25 N 9.9241 9.0056 0.0 0
M  V30 26 F 2.1050 8.9106 0.0 0
M  V30 27 F 3.7534 3.8371 0.0 0
M  V30 28 N 8.2489 5.3900 0.0 0
M  V30 29 C 7.0030 6.2952 0.0 0 CFG=2
M  V30 30 C 9.4947 6.2952 0.0 0
M  V30 31 C 7.4789 7.7598 0.0 0
M  V30 32 C 9.0189 7.7598 0.0 0 CFG=1
M  V30 33 C 2.9292 6.3739 0.0 0
M  V30 34 C 1.7849 7.4043 0.0 0
M  V30 35 C 2.6091 4.8675 0.0 0
M  V30 36 C 0.3202 6.9285 0.0 0
M  V30 37 C 1.1444 4.3916 0.0 0
M  V30 38 C 0.0000 5.4220 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 28
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=3
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 1 29 22 CFG=3
M  V30 25 1 23 33
M  V30 26 1 32 25 CFG=3
M  V30 27 1 26 34
M  V30 28 1 27 35
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 32
M  V30 34 2 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 2 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 10 29 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
15-[4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyri...
C35H48N8O8
2450305-24-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3338 3.9098 0.0 0
M  V30 2 C 4.0012 8.5299 0.0 0
M  V30 3 N 9.3360 3.9098 0.0 0
M  V30 4 C 1.3338 6.9899 0.0 0
M  V30 5 C 1.3338 8.5299 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 18.6720 9.3000 0.0 0
M  V30 8 C 20.0057 8.5299 0.0 0
M  V30 9 N 21.3393 9.3000 0.0 0
M  V30 10 O 20.0057 6.9899 0.0 0
M  V30 11 C 22.6731 8.5299 0.0 0
M  V30 12 C 24.0068 9.3000 0.0 0
M  V30 13 O 25.3405 8.5299 0.0 0
M  V30 14 C 26.6742 9.3000 0.0 0
M  V30 15 C 28.0080 8.5299 0.0 0
M  V30 16 O 29.3416 9.3000 0.0 0
M  V30 17 C 30.6753 8.5299 0.0 0
M  V30 18 C 32.0090 9.3000 0.0 0
M  V30 19 O 33.3428 8.5299 0.0 0
M  V30 20 C 34.6765 9.3000 0.0 0
M  V30 21 C 36.0101 8.5299 0.0 0
M  V30 22 C 37.3438 9.3000 0.0 0
M  V30 23 O 37.3438 10.8400 0.0 0
M  V30 24 O 38.6776 8.5299 0.0 0
M  V30 25 C 5.3348 4.6799 0.0 0
M  V30 26 N 4.0012 3.9098 0.0 0
M  V30 27 C 5.3348 6.2199 0.0 0
M  V30 28 N 6.6687 3.9098 0.0 0
M  V30 29 C 2.6675 4.6799 0.0 0
M  V30 30 C 4.0012 6.9899 0.0 0
M  V30 31 C 6.6687 6.9899 0.0 0
M  V30 32 C 8.0023 4.6799 0.0 0
M  V30 33 C 2.6675 6.2199 0.0 0
M  V30 34 N 8.0023 6.2199 0.0 0
M  V30 35 C 4.0012 2.3698 0.0 0
M  V30 36 C 5.2470 1.4646 0.0 0
M  V30 37 C 2.7553 1.4646 0.0 0
M  V30 38 C 4.7712 0.0000 0.0 0
M  V30 39 C 3.2311 0.0000 0.0 0
M  V30 40 C 10.6697 4.6799 0.0 0
M  V30 41 C 12.0035 3.9098 0.0 0
M  V30 42 N 10.6697 6.2199 0.0 0
M  V30 43 C 13.3372 4.6799 0.0 0
M  V30 44 C 12.0035 6.9899 0.0 0
M  V30 45 C 13.3372 6.2199 0.0 0
M  V30 46 N 14.6708 6.9899 0.0 0
M  V30 47 C 16.0045 6.2199 0.0 0
M  V30 48 C 14.6708 8.5299 0.0 0
M  V30 49 C 17.3383 6.9899 0.0 0
M  V30 50 C 16.0045 9.3000 0.0 0
M  V30 51 N 17.3383 8.5299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 29
M  V30 2 1 2 30
M  V30 3 1 3 32
M  V30 4 1 3 40
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 33
M  V30 8 1 7 8
M  V30 9 1 7 51
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 2 25 28
M  V30 29 1 26 29
M  V30 30 1 26 35
M  V30 31 1 27 30
M  V30 32 2 27 31
M  V30 33 1 28 32
M  V30 34 1 29 33
M  V30 35 2 30 33
M  V30 36 1 31 34
M  V30 37 2 32 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 49 1 45 46
M  V30 50 1 46 47
M  V30 51 1 46 48
M  V30 52 1 47 49
M  V30 53 1 48 50
M  V30 54 1 49 51
M  V30 55 1 50 51
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C61H85F2N13O12
2450305-26-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  88 94 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 46.3353 14.1151 0.0 0
M  V30 2 C 43.6680 9.4951 0.0 0
M  V30 3 N 38.3333 14.1151 0.0 0
M  V30 4 C 46.3353 11.0351 0.0 0
M  V30 5 C 47.6691 11.8051 0.0 0
M  V30 6 O 46.3353 9.4951 0.0 0
M  V30 7 C 28.9974 8.7251 0.0 0
M  V30 8 C 27.6638 9.4951 0.0 0
M  V30 9 N 26.3301 8.7251 0.0 0
M  V30 10 O 27.6638 11.0351 0.0 0
M  V30 11 C 24.9963 9.4951 0.0 0
M  V30 12 C 23.6627 8.7251 0.0 0
M  V30 13 O 22.3290 9.4951 0.0 0
M  V30 14 C 20.9954 8.7251 0.0 0
M  V30 15 C 19.6616 9.4951 0.0 0
M  V30 16 O 18.3279 8.7251 0.0 0
M  V30 17 C 16.9943 9.4951 0.0 0
M  V30 18 C 15.6606 8.7251 0.0 0
M  V30 19 O 14.3268 9.4951 0.0 0
M  V30 20 C 12.9932 8.7251 0.0 0
M  V30 21 C 11.6596 9.4951 0.0 0
M  V30 22 C 10.3259 8.7251 0.0 0
M  V30 23 N 8.9921 9.4951 0.0 0
M  V30 24 O 10.3259 7.1851 0.0 0
M  V30 25 C 3.6896 8.3679 0.0 0
M  V30 26 C 3.0632 9.7749 0.0 0 CFG=2
M  V30 27 O 2.7843 7.1221 0.0 0
M  V30 28 N 3.9684 11.0208 0.0 0
M  V30 29 C 1.5317 9.9358 0.0 0
M  V30 30 C 3.3420 12.4277 0.0 0
M  V30 31 C 1.3706 8.4043 0.0 0
M  V30 32 C 0.0000 10.0968 0.0 0
M  V30 33 C 1.6926 11.4674 0.0 0
M  V30 34 C 4.2472 13.6736 0.0 0 CFG=2
M  V30 35 O 1.8104 12.5886 0.0 0
M  V30 36 N 3.6209 15.0804 0.0 0
M  V30 37 C 5.7787 13.5125 0.0 0
M  V30 38 C 4.5261 16.3262 0.0 0
M  V30 39 C 2.0892 15.2413 0.0 0
M  V30 40 O 3.8996 17.7332 0.0 0
M  V30 41 O 6.0576 16.1653 0.0 0
M  V30 42 C 4.8048 18.9791 0.0 0
M  V30 43 C 3.5590 19.8843 0.0 0
M  V30 44 C 5.7100 20.2249 0.0 0
M  V30 45 C 6.0507 18.0738 0.0 0
M  V30 46 C 5.3648 5.4664 0.0 0
M  V30 47 N 6.2700 4.2205 0.0 0
M  V30 48 O 3.8332 5.3055 0.0 0
M  V30 49 F 3.2068 3.8987 0.0 0
M  V30 50 F 8.0803 1.7288 0.0 0
M  V30 51 C 42.3344 13.3451 0.0 0
M  V30 52 N 43.6680 14.1151 0.0 0
M  V30 53 C 42.3344 11.8051 0.0 0
M  V30 54 N 41.0006 14.1151 0.0 0
M  V30 55 C 45.0016 13.3451 0.0 0
M  V30 56 C 43.6680 11.0351 0.0 0
M  V30 57 C 41.0006 11.0351 0.0 0
M  V30 58 C 39.6669 13.3451 0.0 0
M  V30 59 C 45.0016 11.8051 0.0 0
M  V30 60 N 39.6669 11.8051 0.0 0
M  V30 61 C 43.6680 15.6551 0.0 0
M  V30 62 C 42.4221 16.5603 0.0 0
M  V30 63 C 44.9139 16.5603 0.0 0
M  V30 64 C 42.8980 18.0250 0.0 0
M  V30 65 C 44.4380 18.0250 0.0 0
M  V30 66 C 36.9996 13.3451 0.0 0
M  V30 67 C 36.9996 11.8051 0.0 0
M  V30 68 N 35.6658 14.1151 0.0 0
M  V30 69 C 35.6658 11.0351 0.0 0
M  V30 70 C 34.3322 13.3451 0.0 0
M  V30 71 C 34.3322 11.8051 0.0 0
M  V30 72 N 32.9985 11.0351 0.0 0
M  V30 73 C 32.9985 9.4951 0.0 0
M  V30 74 C 31.6649 11.8051 0.0 0
M  V30 75 C 31.6649 8.7251 0.0 0
M  V30 76 C 30.3311 11.0351 0.0 0
M  V30 77 N 30.3311 9.4951 0.0 0
M  V30 78 C 7.6585 8.7251 0.0 0 CFG=1
M  V30 79 C 6.2517 9.3515 0.0 0
M  V30 80 C 7.4975 7.1935 0.0 0
M  V30 81 N 5.2211 8.2070 0.0 0
M  V30 82 C 5.9911 6.8734 0.0 0 CFG=1
M  V30 83 C 5.6435 2.8137 0.0 0
M  V30 84 C 4.1120 2.6528 0.0 0
M  V30 85 C 6.5487 1.5679 0.0 0
M  V30 86 C 3.4857 1.2459 0.0 0
M  V30 87 C 5.9224 0.1609 0.0 0
M  V30 88 C 4.3909 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 55
M  V30 2 1 2 56
M  V30 3 1 3 58
M  V30 4 1 3 66
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 59
M  V30 8 1 7 8
M  V30 9 1 7 77
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 78 23 CFG=1
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 25 81
M  V30 30 1 26 28
M  V30 31 1 26 29 CFG=3
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 33
M  V30 36 1 30 34
M  V30 37 2 30 35
M  V30 38 1 34 36
M  V30 39 1 34 37 CFG=1
M  V30 40 1 36 38
M  V30 41 1 36 39
M  V30 42 1 38 40
M  V30 43 2 38 41
M  V30 44 1 40 42
M  V30 45 1 42 43
M  V30 46 1 42 44
M  V30 47 1 42 45
M  V30 48 1 46 47
M  V30 49 2 46 48
M  V30 50 1 82 46 CFG=1
M  V30 51 1 47 83
M  V30 52 1 49 84
M  V30 53 1 50 85
M  V30 54 1 51 52
M  V30 55 1 51 53
M  V30 56 2 51 54
M  V30 57 1 52 55
M  V30 58 1 52 61
M  V30 59 1 53 56
M  V30 60 2 53 57
M  V30 61 1 54 58
M  V30 62 1 55 59
M  V30 63 2 56 59
M  V30 64 1 57 60
M  V30 65 2 58 60
M  V30 66 1 61 62
M  V30 67 1 61 63
M  V30 68 1 62 64
M  V30 69 1 63 65
M  V30 70 1 64 65
M  V30 71 2 66 67
M  V30 72 1 66 68
M  V30 73 1 67 69
M  V30 74 2 68 70
M  V30 75 2 69 71
M  V30 76 1 70 71
M  V30 77 1 71 72
M  V30 78 1 72 73
M  V30 79 1 72 74
M  V30 80 1 73 75
M  V30 81 1 74 76
M  V30 82 1 75 77
M  V30 83 1 76 77
M  V30 84 1 78 79
M  V30 85 1 78 80
M  V30 86 1 79 81
M  V30 87 1 80 82
M  V30 88 1 81 82
M  V30 89 2 83 84
M  V30 90 1 83 85
M  V30 91 1 84 86
M  V30 92 2 85 87
M  V30 93 2 86 88
M  V30 94 1 87 88
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 26 34 78 82)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2227366-26-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2450305-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2450305-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22470947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective CDK6 degradation mediated by cereblon, VHL, and novel
IAP-recruiting PROTACs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anderson, Niall A.; Cryan, Jenni; Ahmed, Adil; Dai, Han; McGonagle, Grant
A.; Rozier, Christine; Benowitz, Andrew B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106

$RFMT $RIREG SCHEME486 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[(1S)-1-[3-[4-chloro-3-[[(4-methoxyphenyl)methyl](methylsulf...
C38H37ClF2N6O6S
2249975-11-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3900 0.0 0 CFG=1
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 N 5.3347 4.6200 0.0 0
M  V30 4 C 4.0011 5.3900 0.0 0
M  V30 5 O 2.6674 4.6200 0.0 0
M  V30 6 O 4.0011 6.9300 0.0 0
M  V30 7 C 1.3338 5.3900 0.0 0
M  V30 8 C 2.1038 6.7236 0.0 0
M  V30 9 C 0.0000 6.1600 0.0 0
M  V30 10 C 0.5638 4.0564 0.0 0
M  V30 11 O 9.3358 10.0100 0.0 0
M  V30 12 C 9.9592 10.3508 0.0 0
M  V30 13 N 14.6539 7.6402 0.0 0
M  V30 14 C 15.1299 6.1757 0.0 0
M  V30 15 S 15.6844 8.7848 0.0 0 VAL=6
M  V30 16 C 16.7149 9.9291 0.0 0
M  V30 17 O 16.8288 7.7542 0.0 0
M  V30 18 O 14.5399 9.8152 0.0 0
M  V30 19 Cl 13.3369 4.6200 0.0 0
M  V30 20 F 10.6694 0.0000 0.0 0
M  V30 21 F 5.3347 0.0000 0.0 0
M  V30 22 O 21.1553 4.8949 0.0 0
M  V30 23 C 21.6311 3.4303 0.0 0
M  V30 24 N 8.0021 7.7000 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 8.0021 9.2400 0.0 0
M  V30 27 N 5.3347 7.7000 0.0 0
M  V30 28 C 6.6685 10.0100 0.0 0
M  V30 29 C 5.3347 9.2400 0.0 0
M  V30 30 C 6.6685 11.5500 0.0 0
M  V30 31 C 4.0011 10.0100 0.0 0
M  V30 32 C 5.3347 12.3200 0.0 0
M  V30 33 C 4.0011 11.5500 0.0 0
M  V30 34 C 9.3358 6.9300 0.0 0
M  V30 35 C 10.6694 7.7000 0.0 0
M  V30 36 C 9.3358 5.3900 0.0 0
M  V30 37 C 12.0032 6.9300 0.0 0
M  V30 38 N 10.9896 9.2063 0.0 0
M  V30 39 C 10.6694 4.6200 0.0 0
M  V30 40 C 13.1476 7.9604 0.0 0
M  V30 41 C 12.0032 5.3900 0.0 0
M  V30 42 N 12.5213 9.3674 0.0 0
M  V30 43 C 8.0021 3.0800 0.0 0
M  V30 44 C 9.3358 2.3100 0.0 0
M  V30 45 C 6.6685 2.3100 0.0 0
M  V30 46 C 9.3358 0.7700 0.0 0
M  V30 47 C 6.6685 0.7700 0.0 0
M  V30 48 C 8.0021 0.0000 0.0 0
M  V30 49 C 16.6362 5.8554 0.0 0
M  V30 50 C 17.1120 4.3908 0.0 0
M  V30 51 C 17.6666 6.9999 0.0 0
M  V30 52 C 18.6184 4.0707 0.0 0
M  V30 53 C 19.1730 6.6798 0.0 0
M  V30 54 C 19.6489 5.2151 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 25
M  V30 4 1 2 43
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 26
M  V30 13 1 12 38
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 40
M  V30 17 1 14 49
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 15 18
M  V30 21 1 19 41
M  V30 22 1 20 46
M  V30 23 1 21 47
M  V30 24 1 22 23
M  V30 25 1 22 54
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 34
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 35 38
M  V30 42 2 36 39
M  V30 43 1 37 40
M  V30 44 2 37 41
M  V30 45 1 38 42
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 54 2 49 50
M  V30 55 1 49 51
M  V30 56 1 50 52
M  V30 57 2 51 53
M  V30 58 2 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C43H35ClF6N8O5S
2896197-72-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  66 74 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 3.6714 0.0 0
M  V30 2 F 3.7016 2.4255 0.0 0
M  V30 3 F 1.2648 3.5104 0.0 0
M  V30 4 C 6.4238 7.7000 0.0 0
M  V30 5 C 7.7575 6.9300 0.0 0
M  V30 6 N 9.0911 7.7000 0.0 0
M  V30 7 O 7.7575 5.3900 0.0 0
M  V30 8 C 10.4249 6.9300 0.0 0 CFG=2
M  V30 9 C 11.7585 7.7000 0.0 0
M  V30 10 F 4.3202 9.5165 0.0 0
M  V30 11 F 2.4374 10.3547 0.0 0
M  V30 12 O 13.0922 2.3100 0.0 0
M  V30 13 F 14.4258 12.3200 0.0 0
M  V30 14 F 9.0911 12.3200 0.0 0
M  V30 15 C 13.7156 1.9692 0.0 0
M  V30 16 N 18.4104 4.6798 0.0 0
M  V30 17 C 18.8863 6.1443 0.0 0
M  V30 18 S 19.4409 3.5352 0.0 0 VAL=6
M  V30 19 C 20.4713 2.3909 0.0 0
M  V30 20 O 18.2963 2.5048 0.0 0
M  V30 21 O 20.5852 4.5658 0.0 0
M  V30 22 Cl 17.0933 7.7000 0.0 0
M  V30 23 O 24.9117 7.4251 0.0 0
M  V30 24 C 25.3876 8.8897 0.0 0
M  V30 25 C 2.6528 6.4120 0.0 0
M  V30 26 C 1.2459 7.0383 0.0 0 CFG=1
M  V30 27 C 3.6832 7.5563 0.0 0
M  V30 28 C 3.4228 5.0783 0.0 0
M  V30 29 C 1.4069 8.5698 0.0 0 CFG=2
M  V30 30 C 0.0000 7.9435 0.0 0
M  V30 31 N 5.0902 6.9300 0.0 0
M  V30 32 C 2.9132 8.8901 0.0 0
M  V30 33 N 4.9291 5.3985 0.0 0
M  V30 34 C 10.4249 5.3900 0.0 0
M  V30 35 N 11.7585 4.6200 0.0 0
M  V30 36 N 9.0911 4.6200 0.0 0
M  V30 37 C 11.7585 3.0800 0.0 0
M  V30 38 C 9.0911 3.0800 0.0 0
M  V30 39 C 10.4249 2.3100 0.0 0
M  V30 40 C 7.7575 2.3100 0.0 0
M  V30 41 C 10.4249 0.7700 0.0 0
M  V30 42 C 7.7575 0.7700 0.0 0
M  V30 43 C 9.0911 0.0000 0.0 0
M  V30 44 C 11.7585 9.2400 0.0 0
M  V30 45 C 13.0922 10.0100 0.0 0
M  V30 46 C 10.4249 10.0100 0.0 0
M  V30 47 C 13.0922 11.5500 0.0 0
M  V30 48 C 10.4249 11.5500 0.0 0
M  V30 49 C 11.7585 12.3200 0.0 0
M  V30 50 C 13.0922 5.3900 0.0 0
M  V30 51 C 14.4258 4.6200 0.0 0
M  V30 52 C 13.0922 6.9300 0.0 0
M  V30 53 C 15.7596 5.3900 0.0 0
M  V30 54 N 14.7460 3.1137 0.0 0
M  V30 55 C 14.4258 7.7000 0.0 0
M  V30 56 C 16.9040 4.3596 0.0 0
M  V30 57 C 15.7596 6.9300 0.0 0
M  V30 58 N 16.2777 2.9526 0.0 0
M  V30 59 C 20.3926 6.4645 0.0 0
M  V30 60 C 20.8684 7.9292 0.0 0
M  V30 61 C 21.4231 5.3201 0.0 0
M  V30 62 C 22.3749 8.2493 0.0 0
M  V30 63 C 22.9294 5.6403 0.0 0
M  V30 64 C 23.4053 7.1050 0.0 0
M  V30 65 H 0.4759 5.7046 0.0 0
M  V30 66 H 0.9309 10.0345 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 28
M  V30 4 1 4 5
M  V30 5 1 4 31
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 34
M  V30 11 1 9 44
M  V30 12 1 10 32
M  V30 13 1 11 32
M  V30 14 2 12 37
M  V30 15 1 13 47
M  V30 16 1 14 48
M  V30 17 1 15 54
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 56
M  V30 21 1 17 59
M  V30 22 1 18 19
M  V30 23 2 18 20
M  V30 24 2 18 21
M  V30 25 1 22 57
M  V30 26 1 23 24
M  V30 27 1 23 64
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 1 26 65 CFG=3
M  V30 34 1 27 31
M  V30 35 1 27 32
M  V30 36 2 28 33
M  V30 37 1 29 30
M  V30 38 1 29 32
M  V30 39 1 29 66 CFG=3
M  V30 40 1 31 33
M  V30 41 1 34 35
M  V30 42 2 34 36
M  V30 43 1 35 37
M  V30 44 1 35 50
M  V30 45 1 36 38
M  V30 46 1 37 39
M  V30 47 1 38 39
M  V30 48 2 38 40
M  V30 49 2 39 41
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 2 42 43
M  V30 53 2 44 45
M  V30 54 1 44 46
M  V30 55 1 45 47
M  V30 56 2 46 48
M  V30 57 2 47 49
M  V30 58 1 48 49
M  V30 59 2 50 51
M  V30 60 1 50 52
M  V30 61 1 51 53
M  V30 62 1 51 54
M  V30 63 2 52 55
M  V30 64 1 53 56
M  V30 65 2 53 57
M  V30 66 1 54 58
M  V30 67 1 55 57
M  V30 68 2 56 58
M  V30 69 2 59 60
M  V30 70 1 59 61
M  V30 71 1 60 62
M  V30 72 2 61 63
M  V30 73 2 62 64
M  V30 74 1 63 64
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2249975-11-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896197-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME487 STEP1
$RXN



  2  1
$MOL
2-[[Bis(phenylmethoxy)phosphinyl]oxy]acetic acid
C16H17O6P
1207741-89-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 6.9301 4.6201 0.0 0 VAL=5
M  V30 2 O 5.3901 4.6201 0.0 0
M  V30 3 O 8.4701 4.6201 0.0 0
M  V30 4 O 6.9301 3.0800 0.0 0
M  V30 5 O 6.9301 6.1601 0.0 0
M  V30 6 C 4.6201 5.9537 0.0 0
M  V30 7 C 9.2401 5.9537 0.0 0
M  V30 8 C 5.5964 2.3100 0.0 0
M  V30 9 C 5.5964 0.7700 0.0 0
M  V30 10 O 4.2626 0.0000 0.0 0
M  V30 11 O 6.9301 0.0000 0.0 0
M  V30 12 C 3.0800 5.9537 0.0 0
M  V30 13 C 2.3100 4.6201 0.0 0
M  V30 14 C 2.3100 7.2874 0.0 0
M  V30 15 C 0.7700 4.6201 0.0 0
M  V30 16 C 0.7700 7.2874 0.0 0
M  V30 17 C 0.0000 5.9537 0.0 0
M  V30 18 C 10.7801 5.9537 0.0 0
M  V30 19 C 11.5501 4.6201 0.0 0
M  V30 20 C 11.5501 7.2874 0.0 0
M  V30 21 C 13.0901 4.6201 0.0 0
M  V30 22 C 13.0901 7.2874 0.0 0
M  V30 23 C 13.8602 5.9537 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 12
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Valine, [5-[(2R,5R)-1-[3,5-difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phe...
C63H76F5N11O10
2227023-22-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  89 98 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 17.1200 10.5684 0.0 0
M  V30 2 F 14.9622 17.6729 0.0 0
M  V30 3 F 11.9202 10.6694 0.0 0
M  V30 4 F 16.5402 8.0020 0.0 0
M  V30 5 C 22.4092 7.6192 0.0 0
M  V30 6 O 23.7428 6.8492 0.0 0
M  V30 7 C 23.7428 5.3092 0.0 0
M  V30 8 C 25.0764 4.5392 0.0 0 CFG=1
M  V30 9 O 22.4092 4.5392 0.0 0
M  V30 10 C 25.0764 2.9992 0.0 0
M  V30 11 N 26.4101 5.3092 0.0 0
M  V30 12 C 23.7428 2.2292 0.0 0
M  V30 13 C 26.4101 2.2292 0.0 0
M  V30 14 C 26.3654 12.0337 0.0 0
M  V30 15 C 27.6992 12.8037 0.0 0 CFG=2
M  V30 16 O 25.0318 12.8037 0.0 0
M  V30 17 N 29.0329 12.0337 0.0 0
M  V30 18 C 27.6992 14.3437 0.0 0 CFG=1
M  V30 19 C 30.3665 12.8037 0.0 0
M  V30 20 O 29.0329 15.1137 0.0 0
M  V30 21 C 26.3654 15.1137 0.0 0
M  V30 22 O 31.7001 12.0337 0.0 0
M  V30 23 O 30.3665 14.3437 0.0 0
M  V30 24 C 29.0329 16.6537 0.0 0
M  V30 25 C 33.0339 12.8037 0.0 0
M  V30 26 C 6.6685 16.2088 0.0 0
M  V30 27 C 5.3347 16.9788 0.0 0 CFG=2
M  V30 28 O 8.0021 16.9788 0.0 0
M  V30 29 N 4.0011 16.2088 0.0 0
M  V30 30 C 5.3347 18.5188 0.0 0 CFG=1
M  V30 31 C 2.6674 16.9788 0.0 0
M  V30 32 O 6.6685 19.2888 0.0 0
M  V30 33 C 4.0011 19.2888 0.0 0
M  V30 34 O 1.3338 16.2088 0.0 0
M  V30 35 O 2.6674 18.5188 0.0 0
M  V30 36 C 6.6685 20.8288 0.0 0
M  V30 37 C 0.0000 16.9788 0.0 0
M  V30 38 F 8.8402 0.0000 0.0 0
M  V30 39 N 16.5402 13.3367 0.0 0
M  V30 40 C 18.0718 13.4978 0.0 0 CFG=1
M  V30 41 C 15.9139 14.7437 0.0 0 CFG=1
M  V30 42 C 18.3921 15.0041 0.0 0
M  V30 43 C 17.0583 15.7741 0.0 0
M  V30 44 C 15.7702 12.0031 0.0 0
M  V30 45 C 14.2302 12.0031 0.0 0
M  V30 46 C 16.5402 10.6694 0.0 0
M  V30 47 C 13.4602 10.6694 0.0 0
M  V30 48 C 15.7702 9.3358 0.0 0
M  V30 49 C 14.2302 9.3358 0.0 0
M  V30 50 C 19.1023 12.3533 0.0 0
M  V30 51 C 20.6086 12.6734 0.0 0
M  V30 52 C 18.6265 10.8887 0.0 0
M  V30 53 C 21.6392 11.5291 0.0 0
M  V30 54 C 19.6569 9.7442 0.0 0
M  V30 55 C 21.1631 10.0644 0.0 0
M  V30 56 N 23.1792 11.5291 0.0 0
M  V30 57 N 22.4092 9.1592 0.0 0
M  V30 58 C 23.6550 10.0644 0.0 0
M  V30 59 C 14.4075 15.0638 0.0 0
M  V30 60 C 13.3771 13.9193 0.0 0
M  V30 61 C 13.9316 16.5284 0.0 0
M  V30 62 C 11.8708 14.2396 0.0 0
M  V30 63 C 12.4253 16.8487 0.0 0
M  V30 64 C 11.3948 15.7042 0.0 0
M  V30 65 N 10.6248 13.3344 0.0 0
M  V30 66 N 9.8548 15.7042 0.0 0
M  V30 67 C 9.3789 14.2396 0.0 0
M  V30 68 N 13.4602 8.0020 0.0 0
M  V30 69 C 14.2302 6.6684 0.0 0
M  V30 70 C 11.9202 8.0020 0.0 0
M  V30 71 C 13.4602 5.3347 0.0 0
M  V30 72 C 11.1502 6.6684 0.0 0
M  V30 73 C 11.9202 5.3347 0.0 0
M  V30 74 C 25.1196 9.5885 0.0 0 CFG=2
M  V30 75 N 26.3654 10.4937 0.0 0
M  V30 76 C 25.5954 8.1238 0.0 0
M  V30 77 C 27.6114 9.5885 0.0 0
M  V30 78 C 27.1354 8.1238 0.0 0
M  V30 79 C 7.9144 13.7636 0.0 0 CFG=2
M  V30 80 N 6.6685 14.6688 0.0 0
M  V30 81 C 7.4385 12.2991 0.0 0
M  V30 82 C 5.4225 13.7636 0.0 0
M  V30 83 C 5.8985 12.2991 0.0 0
M  V30 84 C 11.1502 4.0011 0.0 0
M  V30 85 C 9.6102 4.0011 0.0 0
M  V30 86 C 11.9202 2.6673 0.0 0
M  V30 87 C 8.8402 2.6673 0.0 0
M  V30 88 C 11.1502 1.3336 0.0 0
M  V30 89 C 9.6102 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 52
M  V30 2 1 2 61
M  V30 3 1 3 47
M  V30 4 1 4 48
M  V30 5 1 5 6
M  V30 6 1 5 57
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 75
M  V30 17 1 15 17 CFG=3
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21 CFG=1
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 26 27
M  V30 27 2 26 28
M  V30 28 1 26 80
M  V30 29 1 27 29 CFG=1
M  V30 30 1 27 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 30 33 CFG=1
M  V30 34 1 31 34
M  V30 35 2 31 35
M  V30 36 1 32 36
M  V30 37 1 34 37
M  V30 38 1 38 89
M  V30 39 1 39 40
M  V30 40 1 39 41
M  V30 41 1 39 44
M  V30 42 1 40 42
M  V30 43 1 40 50 CFG=3
M  V30 44 1 41 43
M  V30 45 1 41 59 CFG=1
M  V30 46 1 42 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 2 46 48
M  V30 51 2 47 49
M  V30 52 1 48 49
M  V30 53 1 49 68
M  V30 54 1 50 51
M  V30 55 2 50 52
M  V30 56 2 51 53
M  V30 57 1 52 54
M  V30 58 1 53 55
M  V30 59 1 53 56
M  V30 60 2 54 55
M  V30 61 1 55 57
M  V30 62 2 56 58
M  V30 63 1 57 58
M  V30 64 1 74 58 CFG=1
M  V30 65 1 59 60
M  V30 66 2 59 61
M  V30 67 2 60 62
M  V30 68 1 61 63
M  V30 69 1 62 64
M  V30 70 1 62 65
M  V30 71 2 63 64
M  V30 72 1 64 66
M  V30 73 1 65 67
M  V30 74 2 66 67
M  V30 75 1 79 67 CFG=3
M  V30 76 1 68 69
M  V30 77 1 68 70
M  V30 78 1 69 71
M  V30 79 1 70 72
M  V30 80 1 71 73
M  V30 81 1 72 73
M  V30 82 1 73 84
M  V30 83 1 74 75
M  V30 84 1 74 76
M  V30 85 1 75 77
M  V30 86 1 76 78
M  V30 87 1 77 78
M  V30 88 1 79 80
M  V30 89 1 79 81
M  V30 90 1 80 82
M  V30 91 1 81 83
M  V30 92 1 82 83
M  V30 93 2 84 85
M  V30 94 1 84 86
M  V30 95 1 85 87
M  V30 96 2 86 88
M  V30 97 2 87 89
M  V30 98 1 88 89
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 8 15 18 27 30 40 41 74 79)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6,8-Dioxa-3-aza-7-phosphanonanoic acid, 2-(1-methylethyl)-4-oxo-9-phenyl-7-(p...
C79H91F5N11O15P
3036194-95-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  111 122 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 19.8592 15.3406 0.0 0
M  V30 2 F 13.4008 18.2160 0.0 0
M  V30 3 F 15.9811 8.7631 0.0 0
M  V30 4 F 11.1076 10.9330 0.0 0
M  V30 5 C 22.8084 10.0515 0.0 0
M  V30 6 O 23.5784 11.3851 0.0 0
M  V30 7 C 25.1185 11.3851 0.0 0
M  V30 8 C 25.8885 12.7189 0.0 0 CFG=2
M  V30 9 O 25.8885 10.0515 0.0 0
M  V30 10 N 27.4285 12.7189 0.0 0
M  V30 11 C 25.1185 14.0526 0.0 0
M  V30 12 C 28.1985 14.0526 0.0 0
M  V30 13 C 25.8885 15.3862 0.0 0
M  V30 14 C 23.5784 14.0526 0.0 0
M  V30 15 C 29.7385 14.0526 0.0 0
M  V30 16 O 27.4285 15.3862 0.0 0
M  V30 17 O 30.5085 15.3862 0.0 0
M  V30 18 P 32.0485 15.3862 0.0 0 VAL=5
M  V30 19 O 33.5885 15.3862 0.0 0
M  V30 20 O 32.0485 13.8462 0.0 0
M  V30 21 O 32.0485 16.9262 0.0 0
M  V30 22 C 34.3585 16.7199 0.0 0
M  V30 23 C 33.3821 13.0762 0.0 0
M  V30 24 C 18.3939 6.0950 0.0 0
M  V30 25 C 17.6238 4.7614 0.0 0 CFG=2
M  V30 26 O 17.6238 7.4287 0.0 0
M  V30 27 N 16.0838 4.7614 0.0 0
M  V30 28 C 18.3939 3.4277 0.0 0 CFG=1
M  V30 29 C 15.3138 3.4277 0.0 0
M  V30 30 O 19.9339 3.4277 0.0 0
M  V30 31 C 17.6238 2.0939 0.0 0
M  V30 32 O 16.0838 2.0939 0.0 0
M  V30 33 O 13.7738 3.4277 0.0 0
M  V30 34 C 20.7039 2.0939 0.0 0
M  V30 35 C 15.3138 0.7603 0.0 0
M  V30 36 C 5.3055 15.8930 0.0 0
M  V30 37 C 3.8987 16.5195 0.0 0 CFG=2
M  V30 38 O 6.5513 16.7983 0.0 0
M  V30 39 N 3.7378 18.0510 0.0 0
M  V30 40 C 2.6528 15.6143 0.0 0 CFG=1
M  V30 41 C 4.9836 18.9563 0.0 0
M  V30 42 O 1.2459 16.2406 0.0 0
M  V30 43 C 2.8137 14.0828 0.0 0
M  V30 44 O 4.8225 20.4878 0.0 0
M  V30 45 O 6.3904 18.3298 0.0 0
M  V30 46 C 0.0000 15.3354 0.0 0
M  V30 47 C 3.4157 21.1141 0.0 0
M  V30 48 F 9.1598 0.0000 0.0 0
M  V30 49 N 15.4235 14.0686 0.0 0
M  V30 50 C 16.9299 14.3888 0.0 0 CFG=2
M  V30 51 C 14.6535 15.4022 0.0 0 CFG=1
M  V30 52 C 17.0909 15.9203 0.0 0
M  V30 53 C 15.6841 16.5468 0.0 0
M  V30 54 C 14.7972 12.6618 0.0 0
M  V30 55 C 15.7024 11.4158 0.0 0
M  V30 56 C 13.2656 12.5007 0.0 0
M  V30 57 C 15.0759 10.0090 0.0 0
M  V30 58 C 12.6392 11.0939 0.0 0
M  V30 59 C 13.5444 9.8480 0.0 0
M  V30 60 C 18.0743 13.3583 0.0 0
M  V30 61 C 17.7541 11.8519 0.0 0
M  V30 62 C 19.5390 13.8342 0.0 0
M  V30 63 C 18.8987 10.8215 0.0 0
M  V30 64 C 20.6834 12.8038 0.0 0
M  V30 65 C 20.3632 11.2973 0.0 0
M  V30 66 N 18.8987 9.2815 0.0 0
M  V30 67 N 21.2684 10.0515 0.0 0
M  V30 68 C 20.3632 8.8056 0.0 0
M  V30 69 C 13.1219 15.5633 0.0 0
M  V30 70 C 12.2167 14.3173 0.0 0
M  V30 71 C 12.4956 16.9701 0.0 0
M  V30 72 C 10.6852 14.4784 0.0 0
M  V30 73 C 10.9639 17.1310 0.0 0
M  V30 74 C 10.0589 15.8852 0.0 0
M  V30 75 N 9.5408 13.4478 0.0 0
M  V30 76 N 8.5272 15.7242 0.0 0
M  V30 77 C 8.2070 14.2178 0.0 0
M  V30 78 N 12.9180 8.4411 0.0 0
M  V30 79 C 11.3865 8.2802 0.0 0
M  V30 80 C 13.8233 7.1952 0.0 0
M  V30 81 C 10.7600 6.8734 0.0 0
M  V30 82 C 13.1968 5.7884 0.0 0
M  V30 83 C 11.6653 5.6273 0.0 0
M  V30 84 C 20.8391 7.3409 0.0 0 CFG=2
M  V30 85 N 19.9339 6.0950 0.0 0
M  V30 86 C 22.3038 6.8650 0.0 0
M  V30 87 C 20.8391 4.8492 0.0 0
M  V30 88 C 22.3038 5.3250 0.0 0
M  V30 89 C 6.8002 13.5915 0.0 0 CFG=2
M  V30 90 N 5.4666 14.3615 0.0 0
M  V30 91 C 6.4800 12.0852 0.0 0
M  V30 92 C 4.3220 13.3311 0.0 0
M  V30 93 C 4.9485 11.9241 0.0 0
M  V30 94 C 11.0389 4.2205 0.0 0
M  V30 95 C 11.9441 2.9747 0.0 0
M  V30 96 C 9.5072 4.0596 0.0 0
M  V30 97 C 11.3177 1.5677 0.0 0
M  V30 98 C 8.8809 2.6527 0.0 0
M  V30 99 C 9.7861 1.4068 0.0 0
M  V30 100 C 35.8985 16.7199 0.0 0
M  V30 101 C 36.6685 18.0537 0.0 0
M  V30 102 C 36.6685 15.3862 0.0 0
M  V30 103 C 38.2085 18.0537 0.0 0
M  V30 104 C 38.2085 15.3862 0.0 0
M  V30 105 C 38.9785 16.7199 0.0 0
M  V30 106 C 33.3821 11.5362 0.0 0
M  V30 107 C 34.7158 10.7662 0.0 0
M  V30 108 C 32.0485 10.7662 0.0 0
M  V30 109 C 34.7158 9.2262 0.0 0
M  V30 110 C 32.0485 9.2262 0.0 0
M  V30 111 C 33.3821 8.4562 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 62
M  V30 2 1 2 71
M  V30 3 1 3 57
M  V30 4 1 4 58
M  V30 5 1 5 6
M  V30 6 1 5 67
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 22 100
M  V30 25 1 23 106
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 1 24 85
M  V30 29 1 25 27 CFG=3
M  V30 30 1 25 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31 CFG=3
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 1 30 34
M  V30 37 1 32 35
M  V30 38 1 36 37
M  V30 39 2 36 38
M  V30 40 1 36 90
M  V30 41 1 37 39 CFG=3
M  V30 42 1 37 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 40 43 CFG=1
M  V30 46 1 41 44
M  V30 47 2 41 45
M  V30 48 1 42 46
M  V30 49 1 44 47
M  V30 50 1 48 99
M  V30 51 1 49 50
M  V30 52 1 49 51
M  V30 53 1 49 54
M  V30 54 1 50 52
M  V30 55 1 50 60 CFG=1
M  V30 56 1 51 53
M  V30 57 1 51 69 CFG=1
M  V30 58 1 52 53
M  V30 59 2 54 55
M  V30 60 1 54 56
M  V30 61 1 55 57
M  V30 62 2 56 58
M  V30 63 2 57 59
M  V30 64 1 58 59
M  V30 65 1 59 78
M  V30 66 1 60 61
M  V30 67 2 60 62
M  V30 68 2 61 63
M  V30 69 1 62 64
M  V30 70 1 63 65
M  V30 71 1 63 66
M  V30 72 2 64 65
M  V30 73 1 65 67
M  V30 74 2 66 68
M  V30 75 1 67 68
M  V30 76 1 84 68 CFG=3
M  V30 77 1 69 70
M  V30 78 2 69 71
M  V30 79 2 70 72
M  V30 80 1 71 73
M  V30 81 1 72 74
M  V30 82 1 72 75
M  V30 83 2 73 74
M  V30 84 1 74 76
M  V30 85 1 75 77
M  V30 86 2 76 77
M  V30 87 1 89 77 CFG=3
M  V30 88 1 78 79
M  V30 89 1 78 80
M  V30 90 1 79 81
M  V30 91 1 80 82
M  V30 92 1 81 83
M  V30 93 1 82 83
M  V30 94 1 83 94
M  V30 95 1 84 85
M  V30 96 1 84 86
M  V30 97 1 85 87
M  V30 98 1 86 88
M  V30 99 1 87 88
M  V30 100 1 89 90
M  V30 101 1 89 91
M  V30 102 1 90 92
M  V30 103 1 91 93
M  V30 104 1 92 93
M  V30 105 2 94 95
M  V30 106 1 94 96
M  V30 107 1 95 97
M  V30 108 2 96 98
M  V30 109 2 97 99
M  V30 110 1 98 99
M  V30 111 2 100 101
M  V30 112 1 100 102
M  V30 113 1 101 103
M  V30 114 2 102 104
M  V30 115 2 103 105
M  V30 116 1 104 105
M  V30 117 2 106 107
M  V30 118 1 106 108
M  V30 119 1 107 109
M  V30 120 2 108 110
M  V30 121 2 109 111
M  V30 122 1 110 111
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 8 25 28 37 40 50 51 84 89)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1207741-89-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227023-22-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036194-95-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40724397
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor
Pibrentasvir (ABT-530)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Randolph, John T.; Voight, Eric A.; Greszler, Stephen N.; Uno, Brice E.;
Newton, James N.; Gleason, Kenneth M.; Stolarik, DeAnne; Van Handel,
Cecilia; Bow, Daniel A. J.; DeGoey, David A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(19), 11034-11044

$RFMT $RIREG SCHEME488 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanesulfonamide, N-[7-[2-[(1S)-1-amino-2-(3,5-difluorophenyl)ethyl]-6-fluo...
C33H28ClF3N6O4S.ClH
2896197-79-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7594 14.1500 0.0 0
M  V30 2 N 11.1806 14.1500 0.0 0
M  V30 3 C 12.3249 13.1196 0.0 0
M  V30 4 S 11.5007 15.6563 0.0 0 VAL=6
M  V30 5 C 11.8209 17.1627 0.0 0
M  V30 6 O 9.9943 15.9766 0.0 0
M  V30 7 O 13.0070 15.3361 0.0 0
M  V30 8 Cl 11.5500 10.8758 0.0 0
M  V30 9 C 5.3900 8.2084 0.0 0 CFG=1
M  V30 10 C 4.6200 6.8747 0.0 0
M  V30 11 N 6.9300 8.2084 0.0 0
M  V30 12 O 5.3900 13.5431 0.0 0
M  V30 13 F 0.0000 14.8769 0.0 0
M  V30 14 F 9.2400 4.2074 0.0 0
M  V30 15 F 4.6200 1.5400 0.0 0
M  V30 16 O 18.1836 15.0230 0.0 0
M  V30 17 C 19.3279 13.9926 0.0 0
M  V30 18 C 7.7000 12.2094 0.0 0
M  V30 19 C 6.9300 10.8758 0.0 0
M  V30 20 C 9.2400 12.2094 0.0 0
M  V30 21 N 7.2241 13.6741 0.0 0
M  V30 22 C 7.7000 9.5421 0.0 0
M  V30 23 C 9.7159 13.6741 0.0 0
M  V30 24 C 10.0100 10.8758 0.0 0
M  V30 25 N 8.4700 14.5793 0.0 0
M  V30 26 C 9.2400 9.5421 0.0 0
M  V30 27 N 5.3900 10.8758 0.0 0
M  V30 28 C 4.6200 9.5421 0.0 0
M  V30 29 C 4.6200 12.2094 0.0 0
M  V30 30 N 3.0800 9.5421 0.0 0
M  V30 31 C 3.0800 12.2094 0.0 0
M  V30 32 C 2.3100 10.8758 0.0 0
M  V30 33 C 2.3100 13.5431 0.0 0
M  V30 34 C 0.7700 10.8758 0.0 0
M  V30 35 C 0.7700 13.5431 0.0 0
M  V30 36 C 0.0000 12.2094 0.0 0
M  V30 37 C 13.7896 13.5954 0.0 0
M  V30 38 C 14.1098 15.1017 0.0 0
M  V30 39 C 14.9340 12.5649 0.0 0
M  V30 40 C 15.5743 15.5776 0.0 0
M  V30 41 C 16.3987 13.0409 0.0 0
M  V30 42 C 16.7189 14.5471 0.0 0
M  V30 43 C 5.3900 5.5411 0.0 0
M  V30 44 C 6.9300 5.5411 0.0 0
M  V30 45 C 4.6200 4.2074 0.0 0
M  V30 46 C 7.7000 4.2074 0.0 0
M  V30 47 C 5.3900 2.8736 0.0 0
M  V30 48 C 6.9300 2.8736 0.0 0
M  V30 49 Cl 9.6640 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 23
M  V30 5 1 3 37
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 28
M  V30 13 1 10 43
M  V30 14 2 12 29
M  V30 15 1 13 35
M  V30 16 1 14 46
M  V30 17 1 15 47
M  V30 18 1 16 17
M  V30 19 1 16 42
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 19 27
M  V30 25 1 20 23
M  V30 26 2 20 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C43H34ClF7N8O5S
2896197-80-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 5.2114 0.0 0
M  V30 2 F 3.7015 3.9655 0.0 0
M  V30 3 F 1.2648 5.0504 0.0 0
M  V30 4 C 6.4238 9.2400 0.0 0
M  V30 5 C 7.7574 8.4700 0.0 0
M  V30 6 N 9.0911 9.2400 0.0 0
M  V30 7 O 7.7574 6.9300 0.0 0
M  V30 8 C 10.4249 8.4700 0.0 0 CFG=2
M  V30 9 C 11.7585 9.2400 0.0 0
M  V30 10 F 4.3202 11.0564 0.0 0
M  V30 11 F 2.4374 11.8947 0.0 0
M  V30 12 O 13.0922 3.8500 0.0 0
M  V30 13 F 9.0911 13.8600 0.0 0
M  V30 14 F 14.4258 13.8600 0.0 0
M  V30 15 C 13.7155 3.5092 0.0 0
M  V30 16 N 18.4104 6.2198 0.0 0
M  V30 17 C 18.8863 7.6843 0.0 0
M  V30 18 S 19.4408 5.0752 0.0 0 VAL=6
M  V30 19 C 20.4712 3.9309 0.0 0
M  V30 20 O 20.5852 6.1058 0.0 0
M  V30 21 O 18.2963 4.0448 0.0 0
M  V30 22 Cl 17.0932 9.2400 0.0 0
M  V30 23 F 9.0911 0.0000 0.0 0
M  V30 24 O 24.9117 8.9651 0.0 0
M  V30 25 C 25.3875 10.4297 0.0 0
M  V30 26 C 2.6528 7.9519 0.0 0
M  V30 27 C 1.2459 8.5783 0.0 0 CFG=1
M  V30 28 C 3.6832 9.0963 0.0 0
M  V30 29 C 3.4228 6.6183 0.0 0
M  V30 30 C 1.4069 10.1099 0.0 0 CFG=2
M  V30 31 C 0.0000 9.4835 0.0 0
M  V30 32 N 5.0902 8.4700 0.0 0
M  V30 33 C 2.9132 10.4301 0.0 0
M  V30 34 N 4.9291 6.9385 0.0 0
M  V30 35 C 10.4249 6.9300 0.0 0
M  V30 36 N 11.7585 6.1600 0.0 0
M  V30 37 N 9.0911 6.1600 0.0 0
M  V30 38 C 11.7585 4.6200 0.0 0
M  V30 39 C 9.0911 4.6200 0.0 0
M  V30 40 C 10.4249 3.8500 0.0 0
M  V30 41 C 7.7574 3.8500 0.0 0
M  V30 42 C 10.4249 2.3100 0.0 0
M  V30 43 C 7.7574 2.3100 0.0 0
M  V30 44 C 9.0911 1.5400 0.0 0
M  V30 45 C 11.7585 10.7800 0.0 0
M  V30 46 C 10.4249 11.5500 0.0 0
M  V30 47 C 13.0922 11.5500 0.0 0
M  V30 48 C 10.4249 13.0900 0.0 0
M  V30 49 C 13.0922 13.0900 0.0 0
M  V30 50 C 11.7585 13.8600 0.0 0
M  V30 51 C 13.0922 6.9300 0.0 0
M  V30 52 C 14.4258 6.1600 0.0 0
M  V30 53 C 13.0922 8.4700 0.0 0
M  V30 54 C 15.7596 6.9300 0.0 0
M  V30 55 N 14.7460 4.6537 0.0 0
M  V30 56 C 14.4258 9.2400 0.0 0
M  V30 57 C 16.9040 5.8996 0.0 0
M  V30 58 C 15.7596 8.4700 0.0 0
M  V30 59 N 16.2776 4.4926 0.0 0
M  V30 60 C 20.3925 8.0045 0.0 0
M  V30 61 C 20.8684 9.4692 0.0 0
M  V30 62 C 21.4231 6.8601 0.0 0
M  V30 63 C 22.3748 9.7893 0.0 0
M  V30 64 C 22.9294 7.1802 0.0 0
M  V30 65 C 23.4052 8.6449 0.0 0
M  V30 66 H 0.4759 7.2446 0.0 0
M  V30 67 H 0.9309 11.5745 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 29
M  V30 4 1 4 5
M  V30 5 1 4 32
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 35
M  V30 11 1 9 45
M  V30 12 1 10 33
M  V30 13 1 11 33
M  V30 14 2 12 38
M  V30 15 1 13 48
M  V30 16 1 14 49
M  V30 17 1 15 55
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 57
M  V30 21 1 17 60
M  V30 22 1 18 19
M  V30 23 2 18 20
M  V30 24 2 18 21
M  V30 25 1 22 58
M  V30 26 1 23 44
M  V30 27 1 24 25
M  V30 28 1 24 65
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 66 CFG=3
M  V30 35 1 28 32
M  V30 36 1 28 33
M  V30 37 2 29 34
M  V30 38 1 30 31
M  V30 39 1 30 33
M  V30 40 1 30 67 CFG=3
M  V30 41 1 32 34
M  V30 42 1 35 36
M  V30 43 2 35 37
M  V30 44 1 36 38
M  V30 45 1 36 51
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 40
M  V30 49 2 39 41
M  V30 50 2 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 43 44
M  V30 54 2 45 46
M  V30 55 1 45 47
M  V30 56 1 46 48
M  V30 57 2 47 49
M  V30 58 2 48 50
M  V30 59 1 49 50
M  V30 60 2 51 52
M  V30 61 1 51 53
M  V30 62 1 52 54
M  V30 63 1 52 55
M  V30 64 2 53 56
M  V30 65 1 54 57
M  V30 66 2 54 58
M  V30 67 1 55 59
M  V30 68 1 56 58
M  V30 69 2 57 59
M  V30 70 2 60 61
M  V30 71 1 60 62
M  V30 72 1 61 63
M  V30 73 2 62 64
M  V30 74 2 63 65
M  V30 75 1 64 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2896197-79-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896197-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME489 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanesulfonamide, N-[7-[2-[(1S)-1-amino-2-(3,5-difluorophenyl)ethyl]-7-fluo...
C33H28ClF3N6O4S.ClH
2249975-17-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2994 14.1500 0.0 0
M  V30 2 N 12.7206 14.1500 0.0 0
M  V30 3 C 13.8649 13.1196 0.0 0
M  V30 4 S 13.0407 15.6563 0.0 0 VAL=6
M  V30 5 C 13.3609 17.1627 0.0 0
M  V30 6 O 11.5343 15.9764 0.0 0
M  V30 7 O 14.5470 15.3361 0.0 0
M  V30 8 Cl 13.0900 10.8758 0.0 0
M  V30 9 C 6.9300 8.2084 0.0 0 CFG=1
M  V30 10 C 6.1600 6.8747 0.0 0
M  V30 11 N 8.4700 8.2084 0.0 0
M  V30 12 O 6.9300 13.5431 0.0 0
M  V30 13 F 0.0000 12.2094 0.0 0
M  V30 14 F 10.7800 4.2074 0.0 0
M  V30 15 F 6.1600 1.5400 0.0 0
M  V30 16 O 19.7235 15.0230 0.0 0
M  V30 17 C 20.8679 13.9926 0.0 0
M  V30 18 C 9.2400 12.2094 0.0 0
M  V30 19 C 8.4700 10.8758 0.0 0
M  V30 20 C 10.7800 12.2094 0.0 0
M  V30 21 N 8.7641 13.6741 0.0 0
M  V30 22 C 9.2400 9.5421 0.0 0
M  V30 23 C 11.2559 13.6741 0.0 0
M  V30 24 C 11.5500 10.8758 0.0 0
M  V30 25 N 10.0100 14.5793 0.0 0
M  V30 26 C 10.7800 9.5421 0.0 0
M  V30 27 N 6.9300 10.8758 0.0 0
M  V30 28 C 6.1600 9.5421 0.0 0
M  V30 29 C 6.1600 12.2094 0.0 0
M  V30 30 N 4.6200 9.5421 0.0 0
M  V30 31 C 4.6200 12.2094 0.0 0
M  V30 32 C 3.8500 10.8758 0.0 0
M  V30 33 C 3.8500 13.5431 0.0 0
M  V30 34 C 2.3100 10.8758 0.0 0
M  V30 35 C 2.3100 13.5431 0.0 0
M  V30 36 C 1.5400 12.2094 0.0 0
M  V30 37 C 15.3296 13.5954 0.0 0
M  V30 38 C 15.6498 15.1017 0.0 0
M  V30 39 C 16.4740 12.5649 0.0 0
M  V30 40 C 17.1143 15.5776 0.0 0
M  V30 41 C 17.9387 13.0409 0.0 0
M  V30 42 C 18.2589 14.5471 0.0 0
M  V30 43 C 6.9300 5.5411 0.0 0
M  V30 44 C 8.4700 5.5411 0.0 0
M  V30 45 C 6.1600 4.2074 0.0 0
M  V30 46 C 9.2400 4.2074 0.0 0
M  V30 47 C 6.9300 2.8736 0.0 0
M  V30 48 C 8.4700 2.8736 0.0 0
M  V30 49 Cl 10.4340 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 23
M  V30 5 1 3 37
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 28
M  V30 13 1 10 43
M  V30 14 2 12 29
M  V30 15 1 13 36
M  V30 16 1 14 46
M  V30 17 1 15 47
M  V30 18 1 16 17
M  V30 19 1 16 42
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 19 27
M  V30 25 1 20 23
M  V30 26 2 20 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C43H34ClF7N8O5S
2249975-18-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 8.6487 0.0 0
M  V30 2 F 1.2648 8.8096 0.0 0
M  V30 3 F 3.7016 9.8946 0.0 0
M  V30 4 C 6.4238 4.6200 0.0 0
M  V30 5 C 7.7575 5.3900 0.0 0
M  V30 6 N 9.0911 4.6200 0.0 0
M  V30 7 O 7.7575 6.9300 0.0 0
M  V30 8 C 10.4249 5.3900 0.0 0 CFG=2
M  V30 9 C 11.7586 4.6200 0.0 0
M  V30 10 F 4.3202 2.8036 0.0 0
M  V30 11 F 2.4374 1.9654 0.0 0
M  V30 12 O 13.0922 10.0101 0.0 0
M  V30 13 F 14.4259 0.0000 0.0 0
M  V30 14 F 9.0911 0.0000 0.0 0
M  V30 15 C 13.7156 10.3509 0.0 0
M  V30 16 F 6.4238 12.3201 0.0 0
M  V30 17 N 18.4105 7.6403 0.0 0
M  V30 18 C 18.8863 6.1757 0.0 0
M  V30 19 S 19.4409 8.7848 0.0 0 VAL=6
M  V30 20 C 20.4713 9.9292 0.0 0
M  V30 21 O 18.2964 9.8152 0.0 0
M  V30 22 O 20.5853 7.7542 0.0 0
M  V30 23 Cl 17.0933 4.6200 0.0 0
M  V30 24 O 24.9118 4.8949 0.0 0
M  V30 25 C 25.3876 3.4304 0.0 0
M  V30 26 C 2.6528 5.9081 0.0 0
M  V30 27 C 1.2459 5.2818 0.0 0 CFG=1
M  V30 28 C 3.6832 4.7637 0.0 0
M  V30 29 C 3.4228 7.2417 0.0 0
M  V30 30 C 1.4070 3.7501 0.0 0 CFG=2
M  V30 31 C 0.0000 4.3765 0.0 0
M  V30 32 N 5.0902 5.3900 0.0 0
M  V30 33 C 2.9132 3.4299 0.0 0
M  V30 34 N 4.9291 6.9216 0.0 0
M  V30 35 C 10.4249 6.9300 0.0 0
M  V30 36 N 11.7586 7.7000 0.0 0
M  V30 37 N 9.0911 7.7000 0.0 0
M  V30 38 C 11.7586 9.2400 0.0 0
M  V30 39 C 9.0911 9.2400 0.0 0
M  V30 40 C 10.4249 10.0101 0.0 0
M  V30 41 C 7.7575 10.0101 0.0 0
M  V30 42 C 10.4249 11.5501 0.0 0
M  V30 43 C 7.7575 11.5501 0.0 0
M  V30 44 C 9.0911 12.3201 0.0 0
M  V30 45 C 11.7586 3.0800 0.0 0
M  V30 46 C 13.0922 2.3100 0.0 0
M  V30 47 C 10.4249 2.3100 0.0 0
M  V30 48 C 13.0922 0.7700 0.0 0
M  V30 49 C 10.4249 0.7700 0.0 0
M  V30 50 C 11.7586 0.0000 0.0 0
M  V30 51 C 13.0922 6.9300 0.0 0
M  V30 52 C 14.4259 7.7000 0.0 0
M  V30 53 C 13.0922 5.3900 0.0 0
M  V30 54 C 15.7597 6.9300 0.0 0
M  V30 55 N 14.7460 9.2063 0.0 0
M  V30 56 C 14.4259 4.6200 0.0 0
M  V30 57 C 16.9041 7.9605 0.0 0
M  V30 58 C 15.7597 5.3900 0.0 0
M  V30 59 N 16.2777 9.3674 0.0 0
M  V30 60 C 20.3926 5.8556 0.0 0
M  V30 61 C 21.4232 7.0000 0.0 0
M  V30 62 C 20.8685 4.3909 0.0 0
M  V30 63 C 22.9295 6.6798 0.0 0
M  V30 64 C 22.3749 4.0707 0.0 0
M  V30 65 C 23.4053 5.2151 0.0 0
M  V30 66 H 0.4759 6.6154 0.0 0
M  V30 67 H 0.9309 2.2855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 29
M  V30 4 1 4 5
M  V30 5 1 4 32
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 35
M  V30 11 1 9 45
M  V30 12 1 10 33
M  V30 13 1 11 33
M  V30 14 2 12 38
M  V30 15 1 13 48
M  V30 16 1 14 49
M  V30 17 1 15 55
M  V30 18 1 16 43
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 57
M  V30 22 1 18 60
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 19 22
M  V30 26 1 23 58
M  V30 27 1 24 25
M  V30 28 1 24 65
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 66 CFG=1
M  V30 35 1 28 32
M  V30 36 1 28 33
M  V30 37 2 29 34
M  V30 38 1 30 31
M  V30 39 1 30 33
M  V30 40 1 30 67 CFG=1
M  V30 41 1 32 34
M  V30 42 1 35 36
M  V30 43 2 35 37
M  V30 44 1 36 38
M  V30 45 1 36 51
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 40
M  V30 49 2 39 41
M  V30 50 2 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 43 44
M  V30 54 2 45 46
M  V30 55 1 45 47
M  V30 56 1 46 48
M  V30 57 2 47 49
M  V30 58 2 48 50
M  V30 59 1 49 50
M  V30 60 2 51 52
M  V30 61 1 51 53
M  V30 62 1 52 54
M  V30 63 1 52 55
M  V30 64 2 53 56
M  V30 65 1 54 57
M  V30 66 2 54 58
M  V30 67 1 55 59
M  V30 68 1 56 58
M  V30 69 2 57 59
M  V30 70 2 60 61
M  V30 71 1 60 62
M  V30 72 1 61 63
M  V30 73 2 62 64
M  V30 74 2 63 65
M  V30 75 1 64 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2249975-17-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2249975-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME490 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanesulfonamide, N-[7-[2-[(1S)-1-amino-2-(3,5-difluorophenyl)ethyl]-7-chlo...
C33H28Cl2F2N6O4S
2896197-85-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2994 12.6100 0.0 0
M  V30 2 N 12.7206 12.6100 0.0 0
M  V30 3 C 13.8649 11.5796 0.0 0
M  V30 4 S 13.0407 14.1163 0.0 0 VAL=6
M  V30 5 C 13.3609 15.6227 0.0 0
M  V30 6 O 11.5343 14.4364 0.0 0
M  V30 7 O 14.5470 13.7961 0.0 0
M  V30 8 Cl 13.0900 9.3358 0.0 0
M  V30 9 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 10 C 6.1600 5.3347 0.0 0
M  V30 11 N 8.4700 6.6684 0.0 0
M  V30 12 O 6.9300 12.0031 0.0 0
M  V30 13 Cl 0.0000 10.6694 0.0 0
M  V30 14 F 10.7800 2.6674 0.0 0
M  V30 15 F 6.1600 0.0000 0.0 0
M  V30 16 O 19.7235 13.4830 0.0 0
M  V30 17 C 20.8679 12.4526 0.0 0
M  V30 18 C 9.2400 10.6694 0.0 0
M  V30 19 C 8.4700 9.3358 0.0 0
M  V30 20 C 10.7800 10.6694 0.0 0
M  V30 21 N 8.7641 12.1341 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 11.2559 12.1341 0.0 0
M  V30 24 C 11.5500 9.3358 0.0 0
M  V30 25 N 10.0100 13.0393 0.0 0
M  V30 26 C 10.7800 8.0021 0.0 0
M  V30 27 N 6.9300 9.3358 0.0 0
M  V30 28 C 6.1600 8.0021 0.0 0
M  V30 29 C 6.1600 10.6694 0.0 0
M  V30 30 N 4.6200 8.0021 0.0 0
M  V30 31 C 4.6200 10.6694 0.0 0
M  V30 32 C 3.8500 9.3358 0.0 0
M  V30 33 C 3.8500 12.0031 0.0 0
M  V30 34 C 2.3100 9.3358 0.0 0
M  V30 35 C 2.3100 12.0031 0.0 0
M  V30 36 C 1.5400 10.6694 0.0 0
M  V30 37 C 15.3296 12.0554 0.0 0
M  V30 38 C 15.6498 13.5617 0.0 0
M  V30 39 C 16.4740 11.0249 0.0 0
M  V30 40 C 17.1143 14.0376 0.0 0
M  V30 41 C 17.9387 11.5009 0.0 0
M  V30 42 C 18.2589 13.0071 0.0 0
M  V30 43 C 6.9300 4.0011 0.0 0
M  V30 44 C 8.4700 4.0011 0.0 0
M  V30 45 C 6.1600 2.6674 0.0 0
M  V30 46 C 9.2400 2.6674 0.0 0
M  V30 47 C 6.9300 1.3336 0.0 0
M  V30 48 C 8.4700 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 23
M  V30 5 1 3 37
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 28
M  V30 13 1 10 43
M  V30 14 2 12 29
M  V30 15 1 13 36
M  V30 16 1 14 46
M  V30 17 1 15 47
M  V30 18 1 16 17
M  V30 19 1 16 42
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 19 27
M  V30 25 1 20 23
M  V30 26 2 20 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C43H34Cl2F6N8O5S
2896197-86-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 8.6487 0.0 0
M  V30 2 F 3.7016 9.8946 0.0 0
M  V30 3 F 1.2648 8.8096 0.0 0
M  V30 4 C 6.4238 4.6200 0.0 0
M  V30 5 C 7.7575 5.3900 0.0 0
M  V30 6 N 9.0911 4.6200 0.0 0
M  V30 7 O 7.7575 6.9300 0.0 0
M  V30 8 C 10.4249 5.3900 0.0 0 CFG=2
M  V30 9 C 11.7586 4.6200 0.0 0
M  V30 10 F 4.3202 2.8036 0.0 0
M  V30 11 F 2.4374 1.9654 0.0 0
M  V30 12 O 13.0922 10.0101 0.0 0
M  V30 13 F 9.0911 0.0000 0.0 0
M  V30 14 F 14.4259 0.0000 0.0 0
M  V30 15 C 13.7156 10.3509 0.0 0
M  V30 16 Cl 6.4238 12.3201 0.0 0
M  V30 17 N 18.4105 7.6403 0.0 0
M  V30 18 C 18.8863 6.1757 0.0 0
M  V30 19 S 19.4409 8.7848 0.0 0 VAL=6
M  V30 20 C 20.4713 9.9292 0.0 0
M  V30 21 O 20.5853 7.7542 0.0 0
M  V30 22 O 18.2964 9.8152 0.0 0
M  V30 23 Cl 17.0933 4.6200 0.0 0
M  V30 24 O 24.9118 4.8949 0.0 0
M  V30 25 C 25.3876 3.4304 0.0 0
M  V30 26 C 2.6528 5.9081 0.0 0
M  V30 27 C 1.2459 5.2818 0.0 0 CFG=1
M  V30 28 C 3.6832 4.7637 0.0 0
M  V30 29 C 3.4228 7.2417 0.0 0
M  V30 30 C 1.4070 3.7501 0.0 0 CFG=2
M  V30 31 C 0.0000 4.3765 0.0 0
M  V30 32 N 5.0902 5.3900 0.0 0
M  V30 33 C 2.9132 3.4299 0.0 0
M  V30 34 N 4.9291 6.9216 0.0 0
M  V30 35 C 10.4249 6.9300 0.0 0
M  V30 36 N 11.7586 7.7000 0.0 0
M  V30 37 N 9.0911 7.7000 0.0 0
M  V30 38 C 11.7586 9.2400 0.0 0
M  V30 39 C 9.0911 9.2400 0.0 0
M  V30 40 C 10.4249 10.0101 0.0 0
M  V30 41 C 7.7575 10.0101 0.0 0
M  V30 42 C 10.4249 11.5501 0.0 0
M  V30 43 C 7.7575 11.5501 0.0 0
M  V30 44 C 9.0911 12.3201 0.0 0
M  V30 45 C 11.7586 3.0800 0.0 0
M  V30 46 C 10.4249 2.3100 0.0 0
M  V30 47 C 13.0922 2.3100 0.0 0
M  V30 48 C 10.4249 0.7700 0.0 0
M  V30 49 C 13.0922 0.7700 0.0 0
M  V30 50 C 11.7586 0.0000 0.0 0
M  V30 51 C 13.0922 6.9300 0.0 0
M  V30 52 C 14.4259 7.7000 0.0 0
M  V30 53 C 13.0922 5.3900 0.0 0
M  V30 54 C 15.7597 6.9300 0.0 0
M  V30 55 N 14.7460 9.2063 0.0 0
M  V30 56 C 14.4259 4.6200 0.0 0
M  V30 57 C 16.9041 7.9605 0.0 0
M  V30 58 C 15.7597 5.3900 0.0 0
M  V30 59 N 16.2777 9.3674 0.0 0
M  V30 60 C 20.3926 5.8556 0.0 0
M  V30 61 C 20.8685 4.3909 0.0 0
M  V30 62 C 21.4232 7.0000 0.0 0
M  V30 63 C 22.3749 4.0707 0.0 0
M  V30 64 C 22.9295 6.6798 0.0 0
M  V30 65 C 23.4053 5.2151 0.0 0
M  V30 66 H 0.4759 6.6154 0.0 0
M  V30 67 H 0.9309 2.2855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 29
M  V30 4 1 4 5
M  V30 5 1 4 32
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 35
M  V30 11 1 9 45
M  V30 12 1 10 33
M  V30 13 1 11 33
M  V30 14 2 12 38
M  V30 15 1 13 48
M  V30 16 1 14 49
M  V30 17 1 15 55
M  V30 18 1 16 43
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 57
M  V30 22 1 18 60
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 19 22
M  V30 26 1 23 58
M  V30 27 1 24 25
M  V30 28 1 24 65
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 66 CFG=1
M  V30 35 1 28 32
M  V30 36 1 28 33
M  V30 37 2 29 34
M  V30 38 1 30 31
M  V30 39 1 30 33
M  V30 40 1 30 67 CFG=1
M  V30 41 1 32 34
M  V30 42 1 35 36
M  V30 43 2 35 37
M  V30 44 1 36 38
M  V30 45 1 36 51
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 40
M  V30 49 2 39 41
M  V30 50 2 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 43 44
M  V30 54 2 45 46
M  V30 55 1 45 47
M  V30 56 1 46 48
M  V30 57 2 47 49
M  V30 58 2 48 50
M  V30 59 1 49 50
M  V30 60 2 51 52
M  V30 61 1 51 53
M  V30 62 1 52 54
M  V30 63 1 52 55
M  V30 64 2 53 56
M  V30 65 1 54 57
M  V30 66 2 54 58
M  V30 67 1 55 59
M  V30 68 1 56 58
M  V30 69 2 57 59
M  V30 70 2 60 61
M  V30 71 1 60 62
M  V30 72 1 61 63
M  V30 73 2 62 64
M  V30 74 2 63 65
M  V30 75 1 64 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2896197-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896197-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 89
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME491 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanesulfonamide, N-[7-[2-[(1S)-1-amino-2-(3,5-difluorophenyl)ethyl]-5-fluo...
C33H28ClF3N6O4S.ClH
2896197-82-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7594 14.1500 0.0 0
M  V30 2 N 11.1806 14.1500 0.0 0
M  V30 3 C 12.3249 13.1196 0.0 0
M  V30 4 S 11.5007 15.6563 0.0 0 VAL=6
M  V30 5 C 11.8209 17.1627 0.0 0
M  V30 6 O 9.9943 15.9766 0.0 0
M  V30 7 O 13.0070 15.3361 0.0 0
M  V30 8 Cl 11.5500 10.8758 0.0 0
M  V30 9 C 5.3900 8.2084 0.0 0 CFG=1
M  V30 10 C 4.6200 6.8747 0.0 0
M  V30 11 N 6.9300 8.2084 0.0 0
M  V30 12 O 5.3900 13.5431 0.0 0
M  V30 13 F 3.0800 14.8769 0.0 0
M  V30 14 F 4.6200 1.5400 0.0 0
M  V30 15 F 9.2400 4.2074 0.0 0
M  V30 16 O 18.1836 15.0230 0.0 0
M  V30 17 C 19.3279 13.9926 0.0 0
M  V30 18 C 7.7000 12.2094 0.0 0
M  V30 19 C 6.9300 10.8758 0.0 0
M  V30 20 C 9.2400 12.2094 0.0 0
M  V30 21 N 7.2241 13.6741 0.0 0
M  V30 22 C 7.7000 9.5421 0.0 0
M  V30 23 C 9.7159 13.6741 0.0 0
M  V30 24 C 10.0100 10.8758 0.0 0
M  V30 25 N 8.4700 14.5793 0.0 0
M  V30 26 C 9.2400 9.5421 0.0 0
M  V30 27 N 5.3900 10.8758 0.0 0
M  V30 28 C 4.6200 9.5421 0.0 0
M  V30 29 C 4.6200 12.2094 0.0 0
M  V30 30 N 3.0800 9.5421 0.0 0
M  V30 31 C 3.0800 12.2094 0.0 0
M  V30 32 C 2.3100 10.8758 0.0 0
M  V30 33 C 2.3100 13.5431 0.0 0
M  V30 34 C 0.7700 10.8758 0.0 0
M  V30 35 C 0.7700 13.5431 0.0 0
M  V30 36 C 0.0000 12.2094 0.0 0
M  V30 37 C 13.7896 13.5954 0.0 0
M  V30 38 C 14.9340 12.5649 0.0 0
M  V30 39 C 14.1098 15.1017 0.0 0
M  V30 40 C 16.3987 13.0409 0.0 0
M  V30 41 C 15.5743 15.5776 0.0 0
M  V30 42 C 16.7189 14.5471 0.0 0
M  V30 43 C 5.3900 5.5411 0.0 0
M  V30 44 C 4.6200 4.2074 0.0 0
M  V30 45 C 6.9300 5.5411 0.0 0
M  V30 46 C 5.3900 2.8736 0.0 0
M  V30 47 C 7.7000 4.2074 0.0 0
M  V30 48 C 6.9300 2.8736 0.0 0
M  V30 49 Cl 9.6640 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 23
M  V30 5 1 3 37
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 28
M  V30 13 1 10 43
M  V30 14 2 12 29
M  V30 15 1 13 33
M  V30 16 1 14 46
M  V30 17 1 15 47
M  V30 18 1 16 17
M  V30 19 1 16 42
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 19 27
M  V30 25 1 20 23
M  V30 26 2 20 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C43H34ClF7N8O5S
2896197-83-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 8.6487 0.0 0
M  V30 2 F 3.7016 9.8946 0.0 0
M  V30 3 F 1.2648 8.8096 0.0 0
M  V30 4 F 4.3202 2.8036 0.0 0
M  V30 5 F 2.4374 1.9654 0.0 0
M  V30 6 C 6.4238 4.6200 0.0 0
M  V30 7 C 7.7575 5.3900 0.0 0
M  V30 8 N 9.0911 4.6200 0.0 0
M  V30 9 O 7.7575 6.9300 0.0 0
M  V30 10 C 10.4249 5.3900 0.0 0 CFG=2
M  V30 11 C 11.7586 4.6200 0.0 0
M  V30 12 O 13.0922 10.0101 0.0 0
M  V30 13 F 9.0911 0.0000 0.0 0
M  V30 14 F 14.4259 0.0000 0.0 0
M  V30 15 C 13.7156 10.3509 0.0 0
M  V30 16 F 11.7586 12.3201 0.0 0
M  V30 17 N 18.4105 7.6403 0.0 0
M  V30 18 C 18.8863 6.1757 0.0 0
M  V30 19 S 19.4409 8.7848 0.0 0 VAL=6
M  V30 20 C 20.4713 9.9292 0.0 0
M  V30 21 O 18.2964 9.8152 0.0 0
M  V30 22 O 20.5853 7.7542 0.0 0
M  V30 23 Cl 17.0933 4.6200 0.0 0
M  V30 24 O 24.9118 4.8949 0.0 0
M  V30 25 C 25.3876 3.4304 0.0 0
M  V30 26 C 1.2459 5.2818 0.0 0 CFG=1
M  V30 27 C 2.6528 5.9081 0.0 0
M  V30 28 C 1.4070 3.7501 0.0 0 CFG=2
M  V30 29 C 0.0000 4.3765 0.0 0
M  V30 30 C 3.6832 4.7637 0.0 0
M  V30 31 C 3.4228 7.2417 0.0 0
M  V30 32 C 2.9132 3.4299 0.0 0
M  V30 33 N 5.0902 5.3900 0.0 0
M  V30 34 N 4.9291 6.9216 0.0 0
M  V30 35 C 10.4249 6.9300 0.0 0
M  V30 36 N 11.7586 7.7000 0.0 0
M  V30 37 N 9.0911 7.7000 0.0 0
M  V30 38 C 11.7586 9.2400 0.0 0
M  V30 39 C 9.0911 9.2400 0.0 0
M  V30 40 C 10.4249 10.0101 0.0 0
M  V30 41 C 7.7575 10.0101 0.0 0
M  V30 42 C 10.4249 11.5501 0.0 0
M  V30 43 C 7.7575 11.5501 0.0 0
M  V30 44 C 9.0911 12.3201 0.0 0
M  V30 45 C 11.7586 3.0800 0.0 0
M  V30 46 C 10.4249 2.3100 0.0 0
M  V30 47 C 13.0922 2.3100 0.0 0
M  V30 48 C 10.4249 0.7700 0.0 0
M  V30 49 C 13.0922 0.7700 0.0 0
M  V30 50 C 11.7586 0.0000 0.0 0
M  V30 51 C 13.0922 6.9300 0.0 0
M  V30 52 C 14.4259 7.7000 0.0 0
M  V30 53 C 13.0922 5.3900 0.0 0
M  V30 54 C 15.7597 6.9300 0.0 0
M  V30 55 N 14.7460 9.2063 0.0 0
M  V30 56 C 14.4259 4.6200 0.0 0
M  V30 57 C 16.9041 7.9605 0.0 0
M  V30 58 C 15.7597 5.3900 0.0 0
M  V30 59 N 16.2777 9.3674 0.0 0
M  V30 60 C 20.3926 5.8556 0.0 0
M  V30 61 C 21.4232 7.0000 0.0 0
M  V30 62 C 20.8685 4.3909 0.0 0
M  V30 63 C 22.9295 6.6798 0.0 0
M  V30 64 C 22.3749 4.0707 0.0 0
M  V30 65 C 23.4053 5.2151 0.0 0
M  V30 66 H 0.4759 6.6154 0.0 0
M  V30 67 H 0.9309 2.2855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 31
M  V30 4 1 4 32
M  V30 5 1 5 32
M  V30 6 1 6 7
M  V30 7 1 6 33
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 35
M  V30 13 1 11 45
M  V30 14 2 12 38
M  V30 15 1 13 48
M  V30 16 1 14 49
M  V30 17 1 15 55
M  V30 18 1 16 42
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 57
M  V30 22 1 18 60
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 19 22
M  V30 26 1 23 58
M  V30 27 1 24 25
M  V30 28 1 24 65
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 26 66 CFG=1
M  V30 33 2 27 30
M  V30 34 1 27 31
M  V30 35 1 28 29
M  V30 36 1 28 32
M  V30 37 1 28 67 CFG=1
M  V30 38 1 30 32
M  V30 39 1 30 33
M  V30 40 2 31 34
M  V30 41 1 33 34
M  V30 42 1 35 36
M  V30 43 2 35 37
M  V30 44 1 36 38
M  V30 45 1 36 51
M  V30 46 1 37 39
M  V30 47 1 38 40
M  V30 48 1 39 40
M  V30 49 2 39 41
M  V30 50 2 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 43 44
M  V30 54 2 45 46
M  V30 55 1 45 47
M  V30 56 1 46 48
M  V30 57 2 47 49
M  V30 58 2 48 50
M  V30 59 1 49 50
M  V30 60 2 51 52
M  V30 61 1 51 53
M  V30 62 1 52 54
M  V30 63 1 52 55
M  V30 64 2 53 56
M  V30 65 1 54 57
M  V30 66 2 54 58
M  V30 67 1 55 59
M  V30 68 1 56 58
M  V30 69 2 57 59
M  V30 70 2 60 61
M  V30 71 1 60 62
M  V30 72 1 61 63
M  V30 73 2 62 64
M  V30 74 2 63 65
M  V30 75 1 64 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2896197-82-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896197-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431776
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME492 STEP1
$RXN



  2  1
$MOL
(3bS,4aR)-3-(Difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[...
C10H8F4N2O2
1626337-85-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4238 5.2745 0.0 0
M  V30 2 C 7.7575 4.5045 0.0 0
M  V30 3 O 9.0913 5.2745 0.0 0
M  V30 4 O 7.7575 2.9645 0.0 0
M  V30 5 F 2.4374 7.9292 0.0 0
M  V30 6 F 4.3202 7.0909 0.0 0
M  V30 7 C 2.7965 1.2459 0.0 0
M  V30 8 F 1.2648 1.0849 0.0 0
M  V30 9 F 3.7017 0.0000 0.0 0
M  V30 10 C 3.6832 5.1308 0.0 0
M  V30 11 C 2.6528 3.9865 0.0 0
M  V30 12 N 5.0902 4.5045 0.0 0
M  V30 13 C 2.9132 6.4646 0.0 0
M  V30 14 C 1.2460 4.6128 0.0 0 CFG=1
M  V30 15 C 3.4228 2.6528 0.0 0
M  V30 16 N 4.9292 2.9730 0.0 0
M  V30 17 C 1.4069 6.1443 0.0 0 CFG=2
M  V30 18 C 0.0000 5.5180 0.0 0
M  V30 19 H 0.4760 3.2791 0.0 0
M  V30 20 H 0.9311 7.6090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19 CFG=3
M  V30 20 2 15 16
M  V30 21 1 17 18
M  V30 22 1 17 20 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanesulfonamide, N-[7-[2-[(1S)-1-amino-2-(3,5-difluorophenyl)ethyl]-7-meth...
C34H31ClF2N6O5S.ClH
2896197-74-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0695 14.1500 0.0 0
M  V30 2 N 13.4906 14.1500 0.0 0
M  V30 3 C 14.6350 13.1196 0.0 0
M  V30 4 S 13.8108 15.6563 0.0 0 VAL=6
M  V30 5 C 14.1309 17.1627 0.0 0
M  V30 6 O 12.3043 15.9766 0.0 0
M  V30 7 O 15.3170 15.3361 0.0 0
M  V30 8 Cl 13.8600 10.8758 0.0 0
M  V30 9 C 7.7000 8.2084 0.0 0 CFG=1
M  V30 10 C 6.9300 6.8747 0.0 0
M  V30 11 N 9.2400 8.2084 0.0 0
M  V30 12 O 7.7000 13.5431 0.0 0
M  V30 13 O 0.7700 12.2095 0.0 0
M  V30 14 C 0.0000 13.5431 0.0 0
M  V30 15 F 6.9300 1.5400 0.0 0
M  V30 16 F 11.5500 4.2074 0.0 0
M  V30 17 O 20.4934 15.0230 0.0 0
M  V30 18 C 21.6380 13.9926 0.0 0
M  V30 19 C 10.0100 12.2095 0.0 0
M  V30 20 C 9.2400 10.8758 0.0 0
M  V30 21 C 11.5500 12.2095 0.0 0
M  V30 22 N 9.5342 13.6742 0.0 0
M  V30 23 C 10.0100 9.5422 0.0 0
M  V30 24 C 12.0259 13.6742 0.0 0
M  V30 25 C 12.3200 10.8758 0.0 0
M  V30 26 N 10.7800 14.5794 0.0 0
M  V30 27 C 11.5500 9.5422 0.0 0
M  V30 28 N 7.7000 10.8758 0.0 0
M  V30 29 C 6.9300 9.5422 0.0 0
M  V30 30 C 6.9300 12.2095 0.0 0
M  V30 31 N 5.3900 9.5422 0.0 0
M  V30 32 C 5.3900 12.2095 0.0 0
M  V30 33 C 4.6200 10.8758 0.0 0
M  V30 34 C 4.6200 13.5431 0.0 0
M  V30 35 C 3.0800 10.8758 0.0 0
M  V30 36 C 3.0800 13.5431 0.0 0
M  V30 37 C 2.3100 12.2095 0.0 0
M  V30 38 C 16.0997 13.5955 0.0 0
M  V30 39 C 17.2440 12.5649 0.0 0
M  V30 40 C 16.4198 15.1017 0.0 0
M  V30 41 C 18.7087 13.0409 0.0 0
M  V30 42 C 17.8844 15.5776 0.0 0
M  V30 43 C 19.0289 14.5472 0.0 0
M  V30 44 C 7.7000 5.5411 0.0 0
M  V30 45 C 6.9300 4.2074 0.0 0
M  V30 46 C 9.2400 5.5411 0.0 0
M  V30 47 C 7.7000 2.8736 0.0 0
M  V30 48 C 10.0100 4.2074 0.0 0
M  V30 49 C 9.2400 2.8736 0.0 0
M  V30 50 Cl 10.8190 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 24
M  V30 5 1 3 38
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 29
M  V30 13 1 10 44
M  V30 14 2 12 30
M  V30 15 1 13 14
M  V30 16 1 13 37
M  V30 17 1 15 47
M  V30 18 1 16 48
M  V30 19 1 17 18
M  V30 20 1 17 43
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 20 28
M  V30 26 1 21 24
M  V30 27 2 21 25
M  V30 28 1 22 26
M  V30 29 2 23 27
M  V30 30 2 24 26
M  V30 31 1 25 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 37
M  V30 43 2 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 49 2 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 2 46 48
M  V30 53 2 47 49
M  V30 54 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C44H37ClF6N8O6S
2896197-75-2 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  68 76 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.7963 5.2114 0.0 0
M  V30 2 F 1.2648 5.0504 0.0 0
M  V30 3 F 3.7016 3.9655 0.0 0
M  V30 4 C 6.4238 9.2400 0.0 0
M  V30 5 C 7.7575 8.4700 0.0 0
M  V30 6 N 9.0911 9.2400 0.0 0
M  V30 7 O 7.7575 6.9300 0.0 0
M  V30 8 C 10.4249 8.4700 0.0 0 CFG=2
M  V30 9 C 11.7585 9.2400 0.0 0
M  V30 10 F 4.3202 11.0565 0.0 0
M  V30 11 F 2.4374 11.8947 0.0 0
M  V30 12 O 13.0922 3.8500 0.0 0
M  V30 13 F 9.0911 13.8600 0.0 0
M  V30 14 F 14.4258 13.8600 0.0 0
M  V30 15 C 13.7156 3.5092 0.0 0
M  V30 16 O 6.4238 1.5400 0.0 0
M  V30 17 C 6.4238 0.0000 0.0 0
M  V30 18 N 18.4104 6.2198 0.0 0
M  V30 19 C 18.8863 7.6843 0.0 0
M  V30 20 S 19.4409 5.0752 0.0 0 VAL=6
M  V30 21 C 20.4713 3.9309 0.0 0
M  V30 22 O 18.2963 4.0448 0.0 0
M  V30 23 O 20.5852 6.1058 0.0 0
M  V30 24 Cl 17.0933 9.2400 0.0 0
M  V30 25 O 24.9117 8.9651 0.0 0
M  V30 26 C 25.3876 10.4297 0.0 0
M  V30 27 C 2.6528 7.9520 0.0 0
M  V30 28 C 1.2459 8.5783 0.0 0 CFG=1
M  V30 29 C 3.6832 9.0963 0.0 0
M  V30 30 C 3.4228 6.6183 0.0 0
M  V30 31 C 1.4069 10.1100 0.0 0 CFG=2
M  V30 32 C 0.0000 9.4835 0.0 0
M  V30 33 N 5.0902 8.4700 0.0 0
M  V30 34 C 2.9132 10.4301 0.0 0
M  V30 35 N 4.9291 6.9385 0.0 0
M  V30 36 C 10.4249 6.9300 0.0 0
M  V30 37 N 11.7585 6.1600 0.0 0
M  V30 38 N 9.0911 6.1600 0.0 0
M  V30 39 C 11.7585 4.6200 0.0 0
M  V30 40 C 9.0911 4.6200 0.0 0
M  V30 41 C 10.4249 3.8500 0.0 0
M  V30 42 C 7.7575 3.8500 0.0 0
M  V30 43 C 10.4249 2.3100 0.0 0
M  V30 44 C 7.7575 2.3100 0.0 0
M  V30 45 C 9.0911 1.5400 0.0 0
M  V30 46 C 11.7585 10.7800 0.0 0
M  V30 47 C 10.4249 11.5500 0.0 0
M  V30 48 C 13.0922 11.5500 0.0 0
M  V30 49 C 10.4249 13.0900 0.0 0
M  V30 50 C 13.0922 13.0900 0.0 0
M  V30 51 C 11.7585 13.8600 0.0 0
M  V30 52 C 13.0922 6.9300 0.0 0
M  V30 53 C 14.4258 6.1600 0.0 0
M  V30 54 C 13.0922 8.4700 0.0 0
M  V30 55 C 15.7596 6.9300 0.0 0
M  V30 56 N 14.7460 4.6537 0.0 0
M  V30 57 C 14.4258 9.2400 0.0 0
M  V30 58 C 16.9040 5.8996 0.0 0
M  V30 59 C 15.7596 8.4700 0.0 0
M  V30 60 N 16.2777 4.4927 0.0 0
M  V30 61 C 20.3926 8.0045 0.0 0
M  V30 62 C 21.4231 6.8601 0.0 0
M  V30 63 C 20.8684 9.4692 0.0 0
M  V30 64 C 22.9294 7.1803 0.0 0
M  V30 65 C 22.3749 9.7893 0.0 0
M  V30 66 C 23.4053 8.6450 0.0 0
M  V30 67 H 0.4759 7.2446 0.0 0
M  V30 68 H 0.9309 11.5745 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 30
M  V30 4 1 4 5
M  V30 5 1 4 33
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 36
M  V30 11 1 9 46
M  V30 12 1 10 34
M  V30 13 1 11 34
M  V30 14 2 12 39
M  V30 15 1 13 49
M  V30 16 1 14 50
M  V30 17 1 15 56
M  V30 18 1 16 17
M  V30 19 1 16 44
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 58
M  V30 23 1 19 61
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 20 23
M  V30 27 1 24 59
M  V30 28 1 25 26
M  V30 29 1 25 66
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 35 1 28 67 CFG=3
M  V30 36 1 29 33
M  V30 37 1 29 34
M  V30 38 2 30 35
M  V30 39 1 31 32
M  V30 40 1 31 34
M  V30 41 1 31 68 CFG=3
M  V30 42 1 33 35
M  V30 43 1 36 37
M  V30 44 2 36 38
M  V30 45 1 37 39
M  V30 46 1 37 52
M  V30 47 1 38 40
M  V30 48 1 39 41
M  V30 49 1 40 41
M  V30 50 2 40 42
M  V30 51 2 41 43
M  V30 52 1 42 44
M  V30 53 1 43 45
M  V30 54 2 44 45
M  V30 55 2 46 47
M  V30 56 1 46 48
M  V30 57 1 47 49
M  V30 58 2 48 50
M  V30 59 2 49 51
M  V30 60 1 50 51
M  V30 61 2 52 53
M  V30 62 1 52 54
M  V30 63 1 53 55
M  V30 64 1 53 56
M  V30 65 2 54 57
M  V30 66 1 55 58
M  V30 67 2 55 59
M  V30 68 1 56 60
M  V30 69 1 57 59
M  V30 70 2 58 60
M  V30 71 2 61 62
M  V30 72 1 61 63
M  V30 73 1 62 64
M  V30 74 2 63 65
M  V30 75 2 64 66
M  V30 76 1 65 66
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1626337-85-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2896197-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896197-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35431768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of diastereomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a
Versatile Quinazolin-4-one Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillis, Eric P.; Parcella, Kyle; Bowsher, Michael; Cook, James H.;
Iwuagwu, Christiana; Naidu, B. Narasimhulu; Patel, Manoj; Peese, Kevin;
Huang, Haichang; Valera, Lourdes; Wang, Chunfu; Kieltyka, Kasia; Parker,
Dawn D.; Simmermacher, Jean; Arnoult, Eric; Nolte, Robert T.; Wang,
Liping; Bender, John A.; Frennesson, David B.; Saulnier, Mark; Wang, Alan
Xiangdong; Meanwell, Nicholas A.; Belema, Makonen; Hanumegowda, Umesh;
Jenkins, Susan; Krystal, Mark; Kadow, John F.; Cockett, Mark; Fridell,
Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(3), 1941-1954

$RFMT $RIREG SCHEME493 STEP1
$RXN



  2  1
$MOL
Cyclopropanecarboxamide, 1-amino-2-ethenyl-N-[(1-methylcyclopropyl)sulfonyl]-...
C10H16N2O3S.ClH
853269-58-6 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8302 3.8995 0.0 0
M  V30 2 N 3.3135 3.6321 0.0 0
M  V30 3 O 5.3569 5.3467 0.0 0
M  V30 4 S 2.3236 4.8118 0.0 0 VAL=6
M  V30 5 O 3.5033 5.8017 0.0 0
M  V30 6 O 1.1439 3.8219 0.0 0
M  V30 7 N 4.8302 1.5400 0.0 0
M  V30 8 C 7.9238 4.8235 0.0 0
M  V30 9 C 9.4638 4.8235 0.0 0
M  V30 10 C 2.3236 7.1713 0.0 0
M  V30 11 C 5.8201 2.7198 0.0 0 CFG=1
M  V30 12 C 7.1538 3.4898 0.0 0 CFG=2
M  V30 13 C 7.1538 1.9498 0.0 0
M  V30 14 C 1.3337 5.9915 0.0 0
M  V30 15 C 0.0000 5.2215 0.0 0
M  V30 16 C 0.0000 6.7615 0.0 0
M  V30 17 Cl 4.7319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 11 7 CFG=1
M  V30 9 2 8 9
M  V30 10 1 12 8 CFG=3
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (2S,4R)-4-[[2-[4-(1-methylethoxy)phenyl]benzofuro[3,2-d...
C29H31N3O7
1315326-78-3 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.2401 5.8615 0.0 0
M  V30 2 C 13.2687 9.4888 0.0 0
M  V30 3 O 14.5147 8.5836 0.0 0
M  V30 4 O 13.4298 11.0204 0.0 0
M  V30 5 C 15.9215 9.2101 0.0 0
M  V30 6 C 15.2952 10.6169 0.0 0
M  V30 7 C 17.3283 9.8364 0.0 0
M  V30 8 C 16.5478 7.8031 0.0 0
M  V30 9 C 10.3671 11.1641 0.0 0
M  V30 10 O 8.9603 11.7904 0.0 0
M  V30 11 O 11.6132 12.0693 0.0 0
M  V30 12 O 2.3100 12.5299 0.0 0
M  V30 13 C 0.7700 12.5299 0.0 0
M  V30 14 C 0.0000 13.8636 0.0 0
M  V30 15 C 0.0000 11.1963 0.0 0
M  V30 16 C 6.9301 4.5278 0.0 0
M  V30 17 C 5.3901 4.5278 0.0 0
M  V30 18 C 7.7001 5.8615 0.0 0
M  V30 19 O 7.4060 3.0631 0.0 0
M  V30 20 C 4.9141 3.0631 0.0 0
M  V30 21 N 4.6201 5.8615 0.0 0
M  V30 22 N 6.9301 7.1951 0.0 0
M  V30 23 C 6.1601 2.1579 0.0 0
M  V30 24 C 3.5072 2.4368 0.0 0
M  V30 25 C 5.3901 7.1951 0.0 0
M  V30 26 C 5.9990 0.6263 0.0 0
M  V30 27 C 3.3463 0.9051 0.0 0
M  V30 28 C 4.5922 0.0000 0.0 0
M  V30 29 C 10.0101 7.1951 0.0 0 CFG=2
M  V30 30 C 11.5417 7.3561 0.0 0
M  V30 31 C 9.3837 8.6021 0.0 0
M  V30 32 N 11.8619 8.8625 0.0 0
M  V30 33 C 10.5282 9.6325 0.0 0 CFG=1
M  V30 34 C 4.6201 8.5288 0.0 0
M  V30 35 C 3.0800 8.5288 0.0 0
M  V30 36 C 5.3901 9.8626 0.0 0
M  V30 37 C 2.3100 9.8626 0.0 0
M  V30 38 C 4.6201 11.1963 0.0 0
M  V30 39 C 3.0800 11.1963 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 29 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 32
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 33 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 39
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 1 25 34
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Pyrrolidinecarboxamide, N-[(1R,2S)-2-ethenyl-1-[[[(1-methylcyclopropyl)sulf...
C34H37N5O7S.ClH
2763632-49-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.8659 13.9349 0.0 0
M  V30 2 C 9.3974 14.0958 0.0 0
M  V30 3 O 10.0239 15.5026 0.0 0
M  V30 4 C 5.5765 14.5056 0.0 0
M  V30 5 N 4.2999 15.3668 0.0 0
M  V30 6 O 5.4692 12.9693 0.0 0
M  V30 7 S 2.9157 14.6917 0.0 0 VAL=6
M  V30 8 O 2.2406 16.0758 0.0 0
M  V30 9 O 3.5908 13.3075 0.0 0
M  V30 10 C 5.4284 17.7309 0.0 0
M  V30 11 C 5.8011 19.2251 0.0 0
M  V30 12 C 1.9560 12.5363 0.0 0
M  V30 13 O 11.0727 8.9400 0.0 0
M  V30 14 O 20.4085 11.2501 0.0 0
M  V30 15 C 21.7421 10.4801 0.0 0
M  V30 16 C 21.7421 8.9400 0.0 0
M  V30 17 C 23.0758 11.2501 0.0 0
M  V30 18 C 6.9607 15.1808 0.0 0 CFG=2
M  V30 19 C 6.5363 16.6610 0.0 0 CFG=2
M  V30 20 C 8.0305 16.2885 0.0 0
M  V30 21 C 10.3026 12.8500 0.0 0 CFG=1
M  V30 22 C 9.8268 11.3853 0.0 0
M  V30 23 N 11.8427 12.8500 0.0 0
M  V30 24 C 11.0727 10.4801 0.0 0 CFG=1
M  V30 25 C 12.3185 11.3853 0.0 0
M  V30 26 C 1.5315 14.0167 0.0 0
M  V30 27 C 0.6263 15.2625 0.0 0
M  V30 28 C 0.0000 13.8556 0.0 0
M  V30 29 C 12.4063 8.1700 0.0 0
M  V30 30 C 12.4063 6.6300 0.0 0
M  V30 31 N 13.7401 8.9400 0.0 0
M  V30 32 C 13.7401 5.8600 0.0 0
M  V30 33 O 11.2619 5.5996 0.0 0
M  V30 34 C 15.0737 8.1700 0.0 0
M  V30 35 C 13.4198 4.3537 0.0 0
M  V30 36 N 15.0737 6.6300 0.0 0
M  V30 37 C 11.8882 4.1928 0.0 0
M  V30 38 C 14.3250 3.1079 0.0 0
M  V30 39 C 11.2619 2.7859 0.0 0
M  V30 40 C 13.6987 1.7009 0.0 0
M  V30 41 C 12.1671 1.5400 0.0 0
M  V30 42 C 16.4074 8.9400 0.0 0
M  V30 43 C 16.4074 10.4801 0.0 0
M  V30 44 C 17.7410 8.1700 0.0 0
M  V30 45 C 17.7410 11.2501 0.0 0
M  V30 46 C 19.0748 8.9400 0.0 0
M  V30 47 C 19.0748 10.4801 0.0 0
M  V30 48 Cl 11.5379 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 21 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 5 7
M  V30 9 2 7 8
M  V30 10 2 7 9
M  V30 11 1 7 26
M  V30 12 2 10 11
M  V30 13 1 19 10 CFG=3
M  V30 14 1 12 26
M  V30 15 1 24 13 CFG=3
M  V30 16 1 13 29
M  V30 17 1 14 15
M  V30 18 1 14 47
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 2 31 34
M  V30 37 1 32 35
M  V30 38 2 32 36
M  V30 39 1 33 37
M  V30 40 1 34 36
M  V30 41 1 34 42
M  V30 42 1 35 37
M  V30 43 2 35 38
M  V30 44 2 37 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 21 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 853269-58-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315326-78-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2763632-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31814271
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 87
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study (stage 1), optimized on base (stage 1), optimized on
reagent (stage 1), optimized on solvent (stage 1), optimized on
temperature (stage 1), optimized on time (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor,
Furaprevir
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Weihong; Li, Shixi; Liu, Haiwang; Zhang, Yingjun; Xie, Hongpeng;
Peng, Dahua; Peng, Hongtao; Ou, Zijian; Peng, Zhihong; Dong, Wanrong; An,
Delie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(4), 1078-1093

$RFMT $RIREG SCHEME494 STEP1
$RXN



  2  1
$MOL

C28H32N4O8
2493230-04-7 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.3271 8.0884 0.0 0
M  V30 2 C 8.6608 7.3183 0.0 0
M  V30 3 C 9.9944 8.0884 0.0 0 CFG=1
M  V30 4 N 11.3281 7.3183 0.0 0
M  V30 5 C 9.9944 9.6284 0.0 0
M  V30 6 C 12.6619 8.0884 0.0 0
M  V30 7 O 8.6608 10.3984 0.0 0
M  V30 8 O 11.3281 10.3984 0.0 0
M  V30 9 O 13.9956 7.3183 0.0 0
M  V30 10 O 12.6619 9.6284 0.0 0
M  V30 11 C 15.3292 8.0884 0.0 0
M  V30 12 C 3.6996 4.0597 0.0 0
M  V30 13 N 4.6048 2.8138 0.0 0
M  V30 14 N 3.9785 1.4068 0.0 0 CHG=1 VAL=4
M  V30 15 N 3.3520 0.0000 0.0 0 CHG=-1
M  V30 16 C 2.1491 10.4899 0.0 0
M  V30 17 C 0.7423 11.1162 0.0 0
M  V30 18 C 0.7700 8.9582 0.0 0
M  V30 19 C 0.0000 7.6245 0.0 0
M  V30 20 C 4.5865 7.9447 0.0 0 CFG=1
M  V30 21 C 3.5559 6.8003 0.0 0 CFG=2
M  V30 22 C 5.9933 7.3183 0.0 0 CFG=2
M  V30 23 O 3.8165 9.2785 0.0 0
M  V30 24 C 4.3259 5.4666 0.0 0 CFG=1
M  V30 25 O 2.1491 7.4266 0.0 0
M  V30 26 O 5.8324 5.7868 0.0 0
M  V30 27 C 2.3100 8.9582 0.0 0
M  V30 28 C 16.6629 7.3183 0.0 0
M  V30 29 C 18.0699 7.9447 0.0 0
M  V30 30 C 16.8240 5.7868 0.0 0
M  V30 31 C 19.1003 6.8003 0.0 0
M  V30 32 C 18.5457 9.4094 0.0 0
M  V30 33 C 18.3303 5.4666 0.0 0
M  V30 34 C 15.7934 4.6422 0.0 0
M  V30 35 C 20.6067 7.1205 0.0 0
M  V30 36 C 20.0520 9.7296 0.0 0
M  V30 37 C 18.8061 4.0019 0.0 0
M  V30 38 C 16.2693 3.1777 0.0 0
M  V30 39 C 21.0826 8.5850 0.0 0
M  V30 40 C 17.7757 2.8575 0.0 0
M  V30 41 H 5.6169 9.0892 0.0 0
M  V30 42 H 2.5255 5.6557 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 24 12 CFG=3
M  V30 15 2 13 14
M  V30 16 2 14 15
M  V30 17 1 16 17
M  V30 18 1 16 27
M  V30 19 1 18 19
M  V30 20 1 18 27
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 41 CFG=3
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 21 42 CFG=3
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 33
M  V30 37 2 30 34
M  V30 38 1 31 33
M  V30 39 2 31 35
M  V30 40 1 32 36
M  V30 41 2 33 37
M  V30 42 1 34 38
M  V30 43 1 35 39
M  V30 44 2 36 39
M  V30 45 1 37 40
M  V30 46 2 38 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 3 20 21 22 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5′-Amino-5′-deoxy-2′,3′-O-(1-methylethylidene)uridine
C12H17N3O5
68691-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9295 1.2459 0.0 0
M  V30 2 N 3.8348 0.0000 0.0 0
M  V30 3 C 0.0000 6.1445 0.0 0
M  V30 4 C 1.3791 7.6760 0.0 0
M  V30 5 O 7.8905 2.9645 0.0 0
M  V30 6 O 10.5580 7.5845 0.0 0
M  V30 7 C 3.8163 5.1308 0.0 0 CFG=2
M  V30 8 C 5.2232 4.5045 0.0 0 CFG=2
M  V30 9 C 2.7859 3.9865 0.0 0 CFG=2
M  V30 10 O 3.0463 6.4646 0.0 0
M  V30 11 O 5.0623 2.9730 0.0 0
M  V30 12 C 3.5559 2.6528 0.0 0 CFG=1
M  V30 13 O 1.3791 4.6128 0.0 0
M  V30 14 C 1.5400 6.1445 0.0 0
M  V30 15 N 6.5569 5.2745 0.0 0
M  V30 16 C 7.8905 4.5045 0.0 0
M  V30 17 C 6.5569 6.8145 0.0 0
M  V30 18 N 9.2243 5.2745 0.0 0
M  V30 19 C 7.8905 7.5845 0.0 0
M  V30 20 C 9.2243 6.8145 0.0 0
M  V30 21 H 4.8469 6.2754 0.0 0
M  V30 22 H 1.7555 2.8421 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 3 14
M  V30 4 1 4 14
M  V30 5 2 5 16
M  V30 6 2 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 21 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 15 CFG=3
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 22 CFG=3
M  V30 16 1 10 14
M  V30 17 1 11 12
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 8 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C40H47N7O12
2493230-08-1 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  63 70 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4864 12.4217 0.0 0
M  V30 2 C 8.2564 11.0881 0.0 0
M  V30 3 C 9.7965 11.0881 0.0 0 CFG=2
M  V30 4 C 10.5665 12.4217 0.0 0
M  V30 5 N 10.5665 9.7543 0.0 0
M  V30 6 N 12.1065 12.4217 0.0 0
M  V30 7 O 9.7965 13.7553 0.0 0
M  V30 8 C 9.7965 8.4206 0.0 0
M  V30 9 C 12.8765 13.7553 0.0 0
M  V30 10 O 10.5665 7.0870 0.0 0
M  V30 11 O 8.2564 8.4206 0.0 0
M  V30 12 C 9.7965 5.7533 0.0 0
M  V30 13 C 2.3308 10.7465 0.0 0
M  V30 14 N 2.4917 9.2149 0.0 0
M  V30 15 N 1.2459 8.3097 0.0 0 CHG=1 VAL=4
M  V30 16 N 0.0000 7.4045 0.0 0 CHG=-1
M  V30 17 C 4.2030 17.0904 0.0 0
M  V30 18 C 3.2978 18.3363 0.0 0
M  V30 19 C 2.2430 16.4534 0.0 0
M  V30 20 C 0.9092 15.6834 0.0 0
M  V30 21 C 16.1599 18.4240 0.0 0
M  V30 22 C 18.1200 17.7872 0.0 0
M  V30 23 O 16.4644 9.9223 0.0 0
M  V30 24 O 21.7699 9.3646 0.0 0
M  V30 25 C 5.0412 13.6676 0.0 0 CFG=1
M  V30 26 C 3.5767 13.1917 0.0 0 CFG=2
M  V30 27 C 5.9464 12.4217 0.0 0 CFG=2
M  V30 28 O 5.0412 15.2076 0.0 0
M  V30 29 C 3.5767 11.6517 0.0 0 CFG=1
M  V30 30 O 2.6715 14.4376 0.0 0
M  V30 31 O 5.0412 11.1758 0.0 0
M  V30 32 C 3.5767 15.6834 0.0 0
M  V30 33 C 14.4165 13.7553 0.0 0 CFG=1
M  V30 34 C 15.3217 15.0012 0.0 0 CFG=1
M  V30 35 O 15.3217 12.5095 0.0 0
M  V30 36 C 16.7864 14.5254 0.0 0 CFG=1
M  V30 37 O 15.3217 16.5412 0.0 0
M  V30 38 C 16.7864 12.9853 0.0 0 CFG=1
M  V30 39 O 17.6916 15.7712 0.0 0
M  V30 40 C 16.7864 17.0172 0.0 0
M  V30 41 C 10.5665 4.4195 0.0 0
M  V30 42 C 9.9401 3.0127 0.0 0
M  V30 43 C 12.0981 4.2586 0.0 0
M  V30 44 C 11.0845 1.9823 0.0 0
M  V30 45 C 8.4754 2.5369 0.0 0
M  V30 46 C 12.4183 2.7523 0.0 0
M  V30 47 C 13.2425 5.2890 0.0 0
M  V30 48 C 10.7643 0.4759 0.0 0
M  V30 49 C 8.1553 1.0304 0.0 0
M  V30 50 C 13.8829 2.2763 0.0 0
M  V30 51 C 14.7072 4.8131 0.0 0
M  V30 52 C 9.2998 0.0000 0.0 0
M  V30 53 C 15.0274 3.3069 0.0 0
M  V30 54 N 18.0323 12.0801 0.0 0
M  V30 55 C 17.8713 10.5486 0.0 0
M  V30 56 C 19.4391 12.7066 0.0 0
M  V30 57 N 19.1172 9.6434 0.0 0
M  V30 58 C 20.6851 11.8014 0.0 0
M  V30 59 C 20.5240 10.2699 0.0 0
M  V30 60 H 6.5059 14.1434 0.0 0
M  V30 61 H 2.1120 12.7158 0.0 0
M  V30 62 H 13.8571 15.4772 0.0 0
M  V30 63 H 18.2509 14.0495 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 27 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 33 9 CFG=3
M  V30 13 1 10 12
M  V30 14 1 12 41
M  V30 15 1 13 14
M  V30 16 1 29 13 CFG=3
M  V30 17 2 14 15
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 32
M  V30 21 1 19 20
M  V30 22 1 19 32
M  V30 23 1 21 40
M  V30 24 1 22 40
M  V30 25 2 23 55
M  V30 26 2 24 59
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 25 60 CFG=3
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 1 26 61 CFG=3
M  V30 34 1 27 31
M  V30 35 1 28 32
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 34 37
M  V30 42 1 34 62 CFG=3
M  V30 43 1 35 38
M  V30 44 1 36 38
M  V30 45 1 36 39
M  V30 46 1 36 63 CFG=3
M  V30 47 1 37 40
M  V30 48 1 38 54 CFG=3
M  V30 49 1 39 40
M  V30 50 1 41 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 42 45
M  V30 54 1 43 46
M  V30 55 2 43 47
M  V30 56 1 44 46
M  V30 57 2 44 48
M  V30 58 1 45 49
M  V30 59 2 46 50
M  V30 60 1 47 51
M  V30 61 1 48 52
M  V30 62 2 49 52
M  V30 63 1 50 53
M  V30 64 2 51 53
M  V30 65 1 54 55
M  V30 66 1 54 56
M  V30 67 1 55 57
M  V30 68 2 56 58
M  V30 69 1 57 59
M  V30 70 1 58 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 3 25 26 27 29 33 34 36 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2493230-04-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68691-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2493230-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22862660
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 84
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Novel Muraymycin Analogues; using a Serine Template Strategy
for Linking Key Pharmacophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Bhautikkumar; Kerr, Rachel V.; Malde, Alpeshkumar K.; Zunk,
Matthew; Bugg, Timothy D. H.; Grant, Gary; Rudrawar, Santosh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(15), 1429-1438

$RFMT $RIREG SCHEME495 STEP1
$RXN



  2  1
$MOL

C28H32N4O8
2493230-06-9 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.3271 8.0884 0.0 0
M  V30 2 C 8.6608 7.3183 0.0 0
M  V30 3 C 9.9944 8.0884 0.0 0 CFG=2
M  V30 4 N 11.3281 7.3183 0.0 0
M  V30 5 C 9.9944 9.6284 0.0 0
M  V30 6 C 12.6619 8.0884 0.0 0
M  V30 7 O 8.6608 10.3984 0.0 0
M  V30 8 O 11.3281 10.3984 0.0 0
M  V30 9 O 13.9956 7.3183 0.0 0
M  V30 10 O 12.6619 9.6284 0.0 0
M  V30 11 C 15.3292 8.0884 0.0 0
M  V30 12 C 3.6996 4.0597 0.0 0
M  V30 13 N 4.6048 2.8138 0.0 0
M  V30 14 N 3.9785 1.4068 0.0 0 CHG=1 VAL=4
M  V30 15 N 3.3520 0.0000 0.0 0 CHG=-1
M  V30 16 C 2.1491 10.4899 0.0 0
M  V30 17 C 0.7423 11.1162 0.0 0
M  V30 18 C 0.7700 8.9582 0.0 0
M  V30 19 C 0.0000 7.6245 0.0 0
M  V30 20 C 4.5865 7.9447 0.0 0 CFG=1
M  V30 21 C 3.5559 6.8003 0.0 0 CFG=2
M  V30 22 C 5.9933 7.3183 0.0 0 CFG=2
M  V30 23 O 3.8165 9.2785 0.0 0
M  V30 24 C 4.3259 5.4666 0.0 0 CFG=1
M  V30 25 O 2.1491 7.4266 0.0 0
M  V30 26 O 5.8324 5.7868 0.0 0
M  V30 27 C 2.3100 8.9582 0.0 0
M  V30 28 C 16.6629 7.3183 0.0 0
M  V30 29 C 18.0699 7.9447 0.0 0
M  V30 30 C 16.8240 5.7868 0.0 0
M  V30 31 C 19.1003 6.8003 0.0 0
M  V30 32 C 18.5457 9.4094 0.0 0
M  V30 33 C 18.3303 5.4666 0.0 0
M  V30 34 C 15.7934 4.6422 0.0 0
M  V30 35 C 20.6067 7.1205 0.0 0
M  V30 36 C 20.0520 9.7296 0.0 0
M  V30 37 C 18.8061 4.0019 0.0 0
M  V30 38 C 16.2693 3.1777 0.0 0
M  V30 39 C 21.0826 8.5850 0.0 0
M  V30 40 C 17.7757 2.8575 0.0 0
M  V30 41 H 5.6169 9.0892 0.0 0
M  V30 42 H 2.5255 5.6557 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 24 12 CFG=3
M  V30 15 2 13 14
M  V30 16 2 14 15
M  V30 17 1 16 17
M  V30 18 1 16 27
M  V30 19 1 18 19
M  V30 20 1 18 27
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 41 CFG=3
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 21 42 CFG=3
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 33
M  V30 37 2 30 34
M  V30 38 1 31 33
M  V30 39 2 31 35
M  V30 40 1 32 36
M  V30 41 2 33 37
M  V30 42 1 34 38
M  V30 43 1 35 39
M  V30 44 2 36 39
M  V30 45 1 37 40
M  V30 46 2 38 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 3 20 21 22 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5′-Amino-5′-deoxy-2′,3′-O-(1-methylethylidene)uridine
C12H17N3O5
68691-77-0 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.9295 1.2459 0.0 0
M  V30 2 N 3.8348 0.0000 0.0 0
M  V30 3 C 0.0000 6.1445 0.0 0
M  V30 4 C 1.3791 7.6760 0.0 0
M  V30 5 O 7.8905 2.9645 0.0 0
M  V30 6 O 10.5580 7.5845 0.0 0
M  V30 7 C 3.8163 5.1308 0.0 0 CFG=2
M  V30 8 C 5.2232 4.5045 0.0 0 CFG=2
M  V30 9 C 2.7859 3.9865 0.0 0 CFG=2
M  V30 10 O 3.0463 6.4646 0.0 0
M  V30 11 O 5.0623 2.9730 0.0 0
M  V30 12 C 3.5559 2.6528 0.0 0 CFG=1
M  V30 13 O 1.3791 4.6128 0.0 0
M  V30 14 C 1.5400 6.1445 0.0 0
M  V30 15 N 6.5569 5.2745 0.0 0
M  V30 16 C 7.8905 4.5045 0.0 0
M  V30 17 C 6.5569 6.8145 0.0 0
M  V30 18 N 9.2243 5.2745 0.0 0
M  V30 19 C 7.8905 7.5845 0.0 0
M  V30 20 C 9.2243 6.8145 0.0 0
M  V30 21 H 4.8469 6.2754 0.0 0
M  V30 22 H 1.7555 2.8421 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 3 14
M  V30 4 1 4 14
M  V30 5 2 5 16
M  V30 6 2 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 21 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 15 CFG=3
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 22 CFG=3
M  V30 16 1 10 14
M  V30 17 1 11 12
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 8 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C40H47N7O12
2493230-10-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  63 70 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4864 12.4217 0.0 0
M  V30 2 C 8.2564 11.0881 0.0 0
M  V30 3 C 9.7965 11.0881 0.0 0 CFG=1
M  V30 4 C 10.5665 12.4217 0.0 0
M  V30 5 N 10.5665 9.7543 0.0 0
M  V30 6 N 12.1065 12.4217 0.0 0
M  V30 7 O 9.7965 13.7553 0.0 0
M  V30 8 C 9.7965 8.4206 0.0 0
M  V30 9 C 12.8765 13.7553 0.0 0
M  V30 10 O 10.5665 7.0870 0.0 0
M  V30 11 O 8.2564 8.4206 0.0 0
M  V30 12 C 9.7965 5.7533 0.0 0
M  V30 13 C 2.3308 10.7465 0.0 0
M  V30 14 N 2.4917 9.2149 0.0 0
M  V30 15 N 1.2459 8.3097 0.0 0 CHG=1 VAL=4
M  V30 16 N 0.0000 7.4045 0.0 0 CHG=-1
M  V30 17 C 4.2030 17.0904 0.0 0
M  V30 18 C 3.2978 18.3363 0.0 0
M  V30 19 C 2.2430 16.4534 0.0 0
M  V30 20 C 0.9092 15.6834 0.0 0
M  V30 21 C 16.1599 18.4240 0.0 0
M  V30 22 C 18.1200 17.7872 0.0 0
M  V30 23 O 16.4644 9.9223 0.0 0
M  V30 24 O 21.7699 9.3646 0.0 0
M  V30 25 C 5.0412 13.6676 0.0 0 CFG=1
M  V30 26 C 3.5767 13.1917 0.0 0 CFG=2
M  V30 27 C 5.9464 12.4217 0.0 0 CFG=2
M  V30 28 O 5.0412 15.2076 0.0 0
M  V30 29 C 3.5767 11.6517 0.0 0 CFG=1
M  V30 30 O 2.6715 14.4376 0.0 0
M  V30 31 O 5.0412 11.1758 0.0 0
M  V30 32 C 3.5767 15.6834 0.0 0
M  V30 33 C 14.4165 13.7553 0.0 0 CFG=1
M  V30 34 C 15.3217 15.0012 0.0 0 CFG=1
M  V30 35 O 15.3217 12.5095 0.0 0
M  V30 36 C 16.7864 14.5254 0.0 0 CFG=1
M  V30 37 O 15.3217 16.5412 0.0 0
M  V30 38 C 16.7864 12.9853 0.0 0 CFG=1
M  V30 39 O 17.6916 15.7712 0.0 0
M  V30 40 C 16.7864 17.0172 0.0 0
M  V30 41 C 10.5665 4.4195 0.0 0
M  V30 42 C 12.0980 4.2586 0.0 0
M  V30 43 C 9.9401 3.0127 0.0 0
M  V30 44 C 12.4183 2.7523 0.0 0
M  V30 45 C 13.2425 5.2890 0.0 0
M  V30 46 C 11.0845 1.9823 0.0 0
M  V30 47 C 8.4754 2.5369 0.0 0
M  V30 48 C 13.8829 2.2763 0.0 0
M  V30 49 C 14.7072 4.8131 0.0 0
M  V30 50 C 10.7643 0.4759 0.0 0
M  V30 51 C 8.1553 1.0304 0.0 0
M  V30 52 C 15.0274 3.3069 0.0 0
M  V30 53 C 9.2998 0.0000 0.0 0
M  V30 54 N 18.0323 12.0801 0.0 0
M  V30 55 C 17.8713 10.5486 0.0 0
M  V30 56 C 19.4391 12.7066 0.0 0
M  V30 57 N 19.1172 9.6434 0.0 0
M  V30 58 C 20.6851 11.8014 0.0 0
M  V30 59 C 20.5240 10.2699 0.0 0
M  V30 60 H 6.5059 14.1434 0.0 0
M  V30 61 H 2.1120 12.7158 0.0 0
M  V30 62 H 13.8571 15.4772 0.0 0
M  V30 63 H 18.2509 14.0495 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 27 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 33 9 CFG=3
M  V30 13 1 10 12
M  V30 14 1 12 41
M  V30 15 1 13 14
M  V30 16 1 29 13 CFG=3
M  V30 17 2 14 15
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 32
M  V30 21 1 19 20
M  V30 22 1 19 32
M  V30 23 1 21 40
M  V30 24 1 22 40
M  V30 25 2 23 55
M  V30 26 2 24 59
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 25 60 CFG=3
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 1 26 61 CFG=3
M  V30 34 1 27 31
M  V30 35 1 28 32
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 34 37
M  V30 42 1 34 62 CFG=3
M  V30 43 1 35 38
M  V30 44 1 36 38
M  V30 45 1 36 39
M  V30 46 1 36 63 CFG=3
M  V30 47 1 37 40
M  V30 48 1 38 54 CFG=3
M  V30 49 1 39 40
M  V30 50 1 41 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 42 45
M  V30 54 1 43 46
M  V30 55 2 43 47
M  V30 56 1 44 46
M  V30 57 2 44 48
M  V30 58 1 45 49
M  V30 59 2 46 50
M  V30 60 1 47 51
M  V30 61 1 48 52
M  V30 62 2 49 52
M  V30 63 1 50 53
M  V30 64 2 51 53
M  V30 65 1 54 55
M  V30 66 1 54 56
M  V30 67 1 55 57
M  V30 68 2 56 58
M  V30 69 1 57 59
M  V30 70 1 58 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 3 25 26 27 29 33 34 36 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2493230-06-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68691-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2493230-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22861646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 82
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Novel Muraymycin Analogues; using a Serine Template Strategy
for Linking Key Pharmacophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Bhautikkumar; Kerr, Rachel V.; Malde, Alpeshkumar K.; Zunk,
Matthew; Bugg, Timothy D. H.; Grant, Gary; Rudrawar, Santosh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(15), 1429-1438

$RFMT $RIREG SCHEME496 STEP1
$RXN



  1  1
$MOL

C44H51IN4O8.ClH
3076055-82-5 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 20.7905 13.5435 0.0 0
M  V30 2 C 21.5605 14.8772 0.0 0
M  V30 3 C 20.7905 16.2108 0.0 0
M  V30 4 O 21.5605 17.5445 0.0 0
M  V30 5 O 19.2504 16.2108 0.0 0
M  V30 6 C 19.2504 10.8760 0.0 0
M  V30 7 O 18.4804 9.5423 0.0 0
M  V30 8 O 23.8705 13.5435 0.0 0
M  V30 9 C 25.4106 13.5435 0.0 0
M  V30 10 C 26.1806 14.8772 0.0 0
M  V30 11 I 23.8705 8.2087 0.0 0
M  V30 12 C 12.3203 9.5423 0.0 0
M  V30 13 C 11.5503 8.2087 0.0 0
M  V30 14 N 10.0102 8.2087 0.0 0
M  V30 15 C 9.2402 6.8748 0.0 0
M  V30 16 C 7.7002 6.8748 0.0 0 CFG=2
M  V30 17 O 10.0102 5.5412 0.0 0
M  V30 18 C 6.9302 5.5412 0.0 0
M  V30 19 N 6.9302 8.2087 0.0 0
M  V30 20 C 5.3901 8.2087 0.0 0
M  V30 21 C 4.6201 9.5423 0.0 0 CFG=2
M  V30 22 O 4.6201 6.8748 0.0 0
M  V30 23 N 5.3901 10.8760 0.0 0
M  V30 24 C 4.6201 12.2097 0.0 0
M  V30 25 C 5.3901 13.5435 0.0 0
M  V30 26 O 3.0801 12.2097 0.0 0
M  V30 27 N 2.3101 18.8783 0.0 0
M  V30 28 C 21.5605 12.2097 0.0 0
M  V30 29 C 20.7905 10.8760 0.0 0
M  V30 30 C 23.1005 12.2097 0.0 0
M  V30 31 C 21.5605 9.5423 0.0 0
M  V30 32 C 23.8705 10.8760 0.0 0
M  V30 33 C 23.1005 9.5423 0.0 0
M  V30 34 C 16.9404 9.5423 0.0 0
M  V30 35 C 16.1704 10.8760 0.0 0
M  V30 36 C 16.1704 8.2087 0.0 0
M  V30 37 C 14.6303 10.8760 0.0 0
M  V30 38 C 14.6303 8.2087 0.0 0
M  V30 39 C 13.8603 9.5423 0.0 0
M  V30 40 C 7.7002 4.2075 0.0 0
M  V30 41 C 9.2402 4.2075 0.0 0
M  V30 42 C 6.9302 2.8738 0.0 0
M  V30 43 C 10.0102 2.8738 0.0 0
M  V30 44 C 7.7002 1.5400 0.0 0
M  V30 45 C 9.2402 1.5400 0.0 0
M  V30 46 C 3.0801 9.5423 0.0 0
M  V30 47 C 2.3101 10.8760 0.0 0
M  V30 48 C 2.3101 8.2087 0.0 0
M  V30 49 C 0.7700 10.8760 0.0 0
M  V30 50 C 0.7700 8.2087 0.0 0
M  V30 51 C 0.0000 9.5423 0.0 0
M  V30 52 C 4.6201 14.8772 0.0 0 CFG=2
M  V30 53 C 5.3901 16.2108 0.0 0
M  V30 54 C 3.0801 14.8772 0.0 0
M  V30 55 C 4.6201 17.5445 0.0 0
M  V30 56 C 2.3101 16.2108 0.0 0
M  V30 57 C 3.0801 17.5445 0.0 0 CFG=1
M  V30 58 Cl 13.0903 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 29
M  V30 8 1 7 34
M  V30 9 1 8 9
M  V30 10 1 8 30
M  V30 11 1 9 10
M  V30 12 1 11 33
M  V30 13 1 12 13
M  V30 14 1 12 39
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18 CFG=1
M  V30 20 1 16 19
M  V30 21 1 18 40
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23 CFG=3
M  V30 26 1 21 46
M  V30 27 1 23 24
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 1 52 25 CFG=3
M  V30 31 1 57 27 CFG=3
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 50 2 46 47
M  V30 51 1 46 48
M  V30 52 1 47 49
M  V30 53 2 48 50
M  V30 54 2 49 51
M  V30 55 1 50 51
M  V30 56 1 52 53
M  V30 57 1 52 54
M  V30 58 1 53 55
M  V30 59 1 54 56
M  V30 60 1 55 57
M  V30 61 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 21 52 57)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C44H49IN4O7
3076781-10-4 Copyright (C) 2025 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 19.1397 10.2208 0.0 0
M  V30 2 C 20.6797 10.2208 0.0 0
M  V30 3 C 21.4497 8.8872 0.0 0
M  V30 4 I 19.1397 15.5555 0.0 0
M  V30 5 O 14.0137 8.0631 0.0 0
M  V30 6 O 8.6362 1.3184 0.0 0
M  V30 7 O 3.6111 9.1725 0.0 0
M  V30 8 C 4.1246 6.7480 0.0 0
M  V30 9 O 5.0832 4.7269 0.0 0
M  V30 10 C 16.8297 11.5546 0.0 0
M  V30 11 C 16.0597 12.8883 0.0 0
M  V30 12 C 18.3697 11.5546 0.0 0
M  V30 13 O 16.0588 10.2502 0.0 0
M  V30 14 C 14.5176 12.9241 0.0 0
M  V30 15 C 16.8297 14.2219 0.0 0
M  V30 16 C 19.1397 12.8883 0.0 0
M  V30 17 C 16.5692 8.8063 0.0 0
M  V30 18 O 13.5169 14.0815 0.0 0
M  V30 19 C 18.3697 14.2219 0.0 0
M  V30 20 C 15.5016 7.6660 0.0 0
M  V30 21 C 11.9878 13.6897 0.0 0
M  V30 22 N 15.8541 6.1654 0.0 0
M  V30 23 C 11.6339 12.1654 0.0 0
M  V30 24 C 10.8732 14.7481 0.0 0
M  V30 25 C 14.6651 5.1384 0.0 0
M  V30 26 C 10.1468 11.7208 0.0 0
M  V30 27 C 9.3704 14.3031 0.0 0
M  V30 28 C 13.2043 5.6864 0.0 0
M  V30 29 C 14.9275 3.6161 0.0 0
M  V30 30 C 9.0112 12.7889 0.0 0
M  V30 31 C 12.0069 4.6941 0.0 0
M  V30 32 C 13.7306 2.6182 0.0 0
M  V30 33 C 7.5271 12.3283 0.0 0
M  V30 34 C 12.2624 3.1595 0.0 0
M  V30 35 C 7.1958 10.7934 0.0 0
M  V30 36 C 11.0846 2.1629 0.0 0
M  V30 37 N 5.7316 10.3332 0.0 0
M  V30 38 C 9.6212 2.5022 0.0 0
M  V30 39 C 5.1413 8.9988 0.0 0
M  V30 40 N 8.9999 3.9296 0.0 0
M  V30 41 C 5.4128 7.5917 0.0 0
M  V30 42 C 7.4750 4.0813 0.0 0
M  V30 43 N 6.6828 6.7198 0.0 0
M  V30 44 C 6.5524 5.1889 0.0 0
M  V30 45 C 6.7534 2.7209 0.0 0
M  V30 46 C 5.2143 2.6656 0.0 0
M  V30 47 C 7.5706 1.4157 0.0 0
M  V30 48 C 4.4926 1.3051 0.0 0
M  V30 49 C 6.8490 0.0553 0.0 0
M  V30 50 C 5.3099 0.0000 0.0 0
M  V30 51 C 2.7497 7.4417 0.0 0
M  V30 52 C 1.4615 6.5980 0.0 0
M  V30 53 C 2.6631 8.9793 0.0 0
M  V30 54 C 0.0865 7.2917 0.0 0
M  V30 55 C 1.2882 9.6730 0.0 0
M  V30 56 C 0.0000 8.8293 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 19
M  V30 5 2 5 20
M  V30 6 2 6 38
M  V30 7 2 7 39
M  V30 8 1 8 41
M  V30 9 1 8 51
M  V30 10 2 9 44
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 1 30 33
M  V30 36 1 31 34
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 42 45
M  V30 49 1 43 44
M  V30 50 2 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 49
M  V30 54 2 48 50
M  V30 55 1 49 50
M  V30 56 2 51 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 2 53 55
M  V30 60 2 54 56
M  V30 61 1 55 56
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3076055-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3076781-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-44725294
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Potent Mcl-1 Inhibitors: Structural Investigations on
Macrocycles Originating from a DNA-Encoded Chemical Library Screen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hekking, Koen F. W.; Maroto, Sergio; van Kekem, Kees; Haasjes, Frank S.;
Slootweg, Jack C.; Oude Alink, Patrick G. B.; Dirks, Ron; Sardana,
Malvika; Bolster, Marjon G.; Kuijpers, Brian; Smith, Dennis; Doodeman,
Robin; Scheepstra, Marcel; Zech, Birgit; Mulvihill, Mark; Renzetti, Louis
M.; Babiss, Lee; Centrella, Paolo A.; Clark, Matthew A.; Cuozzo, John W.;
Guie, Marie-Aude; Sigel, Eric; Habeshian, Sevan; Hupp, Christopher D.;
Liu, Julie; Thomson, Heather A.; Zhang, Ying; Keefe, Anthony D.; Mueller,
Gerhard; Gremmen, Stijn
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(4), 3039-3065

